PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cuzon, G; Bonnin, RA; Nordmann, P				Cuzon, Gaelle; Bonnin, Remy A.; Nordmann, Patrice			First Identification of Novel NDM Carbapenemase, NDM-7, in Escherichia coli in France	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ENVIRONMENT	Background: The NDM-1 carbapenemase has been identified in 2008 in Enterobacteriaceae. Since then, several reports have emphasized its rapid dissemination throughout the world. The spread of NDM carbapenemases involve several bla(NDM) gene variants associated with various plasmids among several Gram negative species. Methodology: A multidrug-resistant E. coli isolate recovered from urine of a patient who had travelled to Burma has been characterized genetically and biochemically. Principal Findings: E. coli COU was resistant to all antibiotics tested except amikacin, tigecycline, fosfomycin, and chloramphenicol. Analysis of the antibiotic resistance traits identified a metallo-beta-lactamase, a novel NDM variant, NDM-7. It differs from NDM-4 by a single amino acid substitution sharing an identical extended spectrum profile towards carbapenems. The bla(NDM-7) gene was located on an untypeable conjugative plasmid and associated with a close genetic background similar to those described among the bla(NDM-1) genes. The isolate also harbours bla(CTXM-15) and bla(OXA-1) genes and belonged to ST167. Significance: This study highlights that spread of NDM producers correspond to spread of multiple blaNDM genes and clones and therefore will be difficult to control.	[Cuzon, Gaelle; Bonnin, Remy A.; Nordmann, Patrice] Hop Bicetre, AP HP, INSERM, U914,Fae Med Paris Sud,Serv Bacteriol Virol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Nordmann, P (corresponding author), Hop Bicetre, AP HP, INSERM, U914,Fae Med Paris Sud,Serv Bacteriol Virol, Paris, France.	nordmann.patrice@bct.aphp.fr		Bonnin, Remy A./0000-0002-2307-3232	European Community [241742]	European Community(European Commission)	This work was funded by the European Community (7th Framework program FP7/2007-2013 under grant agreement no. 241742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernabeu S, 2012, DIAGN MICR INFEC DIS, V74, P88, DOI 10.1016/j.diagmicrobio.2012.05.021; Bonnin RA, 2013, ANTIMICROB AGENTS CH, V57, P674, DOI 10.1128/AAC.01086-12; Bonnin RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034752; Borgia S, 2012, CLIN INFECT DIS, V55, pE109, DOI 10.1093/cid/cis737; Carattoli A, 2012, ANTIMICROB AGENTS CH, V56, P783, DOI 10.1128/AAC.05116-11; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Dortet L, 2012, EMERG INFECT DIS, V18, P1540, DOI 10.3201/eid1809.120011; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Hornsey M, 2011, ANTIMICROB AGENTS CH, V55, P5952, DOI 10.1128/AAC.05108-11; Isozumi R, 2012, EMERG INFECT DIS, V18, P1383, DOI 10.3201/eid1808.111816; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Kaase M, 2011, J ANTIMICROB CHEMOTH, V66, P1260, DOI 10.1093/jac/dkr135; Livermore DM, 2011, LANCET INFECT DIS, V11, P164, DOI 10.1016/S1473-3099(11)70048-2; Nordmann P, 2012, ANTIMICROB AGENTS CH, V56, P2184, DOI 10.1128/AAC.05961-11; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P1821, DOI 10.1128/AAC.01761-10; Rimrang B, 2012, J ANTIMICROB CHEMOTH, V67, P2626, DOI 10.1093/jac/dks267; Tran HH, 2012, J CLIN MICROBIOL, DOI [10.1128/JCM.02322-12, DOI 10.1128/JCM.02322-12]; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	26	72	76	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61322	10.1371/journal.pone.0061322	http://dx.doi.org/10.1371/journal.pone.0061322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593461	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300070
J	He, SM; Ivanova, N; Kirton, E; Allgaier, M; Bergin, C; Scheffrahn, RH; Kyrpides, NC; Warnecke, F; Tringe, SG; Hugenholtz, P				He, Shaomei; Ivanova, Natalia; Kirton, Edward; Allgaier, Martin; Bergin, Claudia; Scheffrahn, Rudolf H.; Kyrpides, Nikos C.; Warnecke, Falk; Tringe, Susannah G.; Hugenholtz, Philip			Comparative Metagenomic and Metatranscriptomic Analysis of Hindgut Paunch Microbiota in Wood- and Dung-Feeding Higher Termites	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; PHYLOGENETIC DIVERSITY; FORMATE DEHYDROGENASE; GENE DIVERSITY; CATTLE DUNG; GUT; SEQUENCE; PROFILES; ISOPTERA; NITROGEN	Termites effectively feed on many types of lignocellulose assisted by their gut microbial symbionts. To better understand the microbial decomposition of biomass with varied chemical profiles, it is important to determine whether termites harbor different microbial symbionts with specialized functionalities geared toward different feeding regimens. In this study, we compared the microbiota in the hindgut paunch of Amitermes wheeleri collected from cow dung and Nasutitermes corniger feeding on sound wood by 16S rRNA pyrotag, comparative metagenomic and metatranscriptomic analyses. We found that Firmicutes and Spirochaetes were the most abundant phyla in A. wheeleri, in contrast to N. corniger where Spirochaetes and Fibrobacteres dominated. Despite this community divergence, a convergence was observed for functions essential to termite biology including hydrolytic enzymes, homoacetogenesis and cell motility and chemotaxis. Overrepresented functions in A. wheeleri relative to N. corniger microbiota included hemicellulose breakdown and fixed-nitrogen utilization. By contrast, glycoside hydrolases attacking celluloses and nitrogen fixation genes were overrepresented in N. corniger microbiota. These observations are consistent with dietary differences in carbohydrate composition and nutrient contents, but may also reflect the phylogenetic difference between the hosts.	[He, Shaomei; Ivanova, Natalia; Kyrpides, Nikos C.; Warnecke, Falk; Hugenholtz, Philip] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [He, Shaomei; Ivanova, Natalia; Kirton, Edward; Allgaier, Martin; Kyrpides, Nikos C.; Warnecke, Falk; Tringe, Susannah G.; Hugenholtz, Philip] US Dept Energy DOE Joint Genome Inst, Walnut Creek, CA USA; [Allgaier, Martin] Berlin Ctr Genom Biodivers Res, Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Bergin, Claudia] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Scheffrahn, Rudolf H.] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of California System; University of California Berkeley; United States Department of Energy (DOE); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Uppsala University; State University System of Florida; University of Florida; University of Queensland; University of Queensland	Hugenholtz, P (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	p.hugenholtz@uq.edu.au	Kyrpides, Nikos C./A-6305-2014; Hugenholtz, Philip/AAD-9138-2019; Tringe, Susannah Green/T-9431-2019	Kyrpides, Nikos C./0000-0002-6131-0462; Hugenholtz, Philip/0000-0001-5386-7925; Tringe, Susannah Green/0000-0001-6479-8427; Ivanova, Natalia/0000-0002-5802-9485	Energy Biosciences Institute; U.S. Department of Energy Joint Genome Institute [DE-AC02-05CH11231]	Energy Biosciences Institute; U.S. Department of Energy Joint Genome Institute(United States Department of Energy (DOE))	Sample collection, DNA extraction and data analysis were funded by the Energy Biosciences Institute and sequencing and sequence data processing were funded by the U.S. Department of Energy Joint Genome Institute under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Antikainen R, 2004, J CLEAN PROD, V12, P919, DOI 10.1016/j.jclepro.2004.02.027; Ballor NR, 2012, MICROB ECOL, V63, P586, DOI 10.1007/s00248-011-9941-5; Ballor NR, 2012, APPL ENV MICROBIOLOG; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; BRAUMAN A, 1992, SCIENCE, V257, P1384, DOI 10.1126/science.257.5075.1384; Brauman A, 2001, FEMS MICROBIOL ECOL, V35, P27, DOI 10.1111/j.1574-6941.2001.tb00785.x; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Brune A, 1996, J INSECT PHYSIOL, V42, P1121, DOI 10.1016/S0022-1910(96)00036-4; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Brune A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P439, DOI 10.1007/0-387-30741-9_17; Brune A, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P439, DOI 10.1007/978-90-481-3977-4_16; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; CHARON NW, 1992, RES MICROBIOL, V143, P597, DOI 10.1016/0923-2508(92)90117-7; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Constantino R, 2002, J APPL ENTOMOL, V126, P355, DOI 10.1046/j.1439-0418.2002.00670.x; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; ETTERSHANK G, 1980, ENVIRON ENTOMOL, V9, P645, DOI 10.1093/ee/9.5.645; FERRAR P, 1970, Journal of the Australian Entomological Society, V9, P100; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Freymann BP, 2008, EUR J ENTOMOL, V105, P165, DOI 10.14411/eje.2008.025; GREENHAM PM, 1972, J ANIM ECOL, V41, P153, DOI 10.2307/3510; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hoekstra NJ, 2002, AGR ECOSYST ENVIRON, V93, P189, DOI 10.1016/S0167-8809(01)00348-6; Hongoh Y, 2003, FEMS MICROBIOL ECOL, V44, P231, DOI 10.1016/S0168-6496(03)00026-6; Hongoh Y, 2006, APPL ENVIRON MICROB, V72, P6780, DOI 10.1128/AEM.00891-06; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P1327, DOI 10.1111/j.1462-2920.2009.01949.x; Ji R, 2001, BIOL FERT SOILS, V33, P166, DOI 10.1007/s003740000310; Ji R, 2006, BIOGEOCHEMISTRY, V78, P267, DOI 10.1007/s10533-005-4279-z; Kohler T, 2008, ENVIRON MICROBIOL, V10, P1260, DOI 10.1111/j.1462-2920.2007.01540.x; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, LBNL4516EPOSTERP; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Matson EG, 2010, ENVIRON MICROBIOL, V12, P2245, DOI 10.1111/j.1462-2920.2010.02188.x; Mavromatis K, 2009, STAND GENOMIC SCI, V1, DOI [10.4056/sigs.4632, DOI 10.4056/SIGS.4632]; McDowell RW, 2005, J ENVIRON QUAL, V34, P598, DOI 10.2134/jeq2005.0598; Nene YL, 2006, UTILIZING TRADITIONA, P32; Nimchua T, 2012, J MICROBIOL BIOTECHN, V22, P462, DOI 10.4014/jmb.1108.08037; Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15; Ottesen EA, 2011, APPL ENVIRON MICROB, V77, P3461, DOI 10.1128/AEM.02657-10; Pester M, 2007, ISME J, V1, P551, DOI 10.1038/ismej.2007.62; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Russell JB, 2002, J MOL MICROB BIOTECH, V4, P347; Salmassi TM, 2003, MICROBIOL-SGM, V149, P2529, DOI 10.1099/mic.0.26351-0; SAXENA KK, 1989, BIOL WASTE, V28, P73, DOI 10.1016/0269-7483(89)90051-7; Scheffrahn RH, 2005, ANN ENTOMOL SOC AM, V98, P273, DOI 10.1603/0013-8746(2005)098[0273:SONATN]2.0.CO;2; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schmitt-Wagner D, 2003, APPL ENVIRON MICROB, V69, P6007, DOI 10.1128/AEM.69.10.6007-6017.2003; Schmitt-Wagner D, 1999, APPL ENVIRON MICROB, V65, P4490; Schmitt-Wagner D, 2003, APPL ENVIRON MICROB, V69, P6018, DOI 10.1128/AEM.69.10.6018-6024.2003; SCURFIELD G, 1970, J EXP BOT, V21, P857, DOI 10.1093/jxb/21.4.857; Shinzato N, 2007, BIOSCI BIOTECH BIOCH, V71, P906, DOI 10.1271/bbb.60540; Silberbach M, 2005, J BIOTECHNOL, V119, P357, DOI 10.1016/j.jbiotec.2005.04.007; SLAYTOR M, 1994, COMP BIOCHEM PHYS B, V107, P1, DOI 10.1016/0305-0491(94)90218-6; SUBRAHMANYAM PVR, 1960, J WATER POLLUT CON F, V32, P344; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WOOD T. G., 1978, PRODUCTION ECOLOGY A, P55; Yang H, 2005, ENVIRON MICROBIOL, V7, P916, DOI 10.1111/j.1462-2920.2005.00760.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang XN, 2011, ENVIRON MICROBIOL, V13, P307, DOI 10.1111/j.1462-2920.2010.02330.x; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	72	109	113	2	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61126	10.1371/journal.pone.0061126	http://dx.doi.org/10.1371/journal.pone.0061126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593407	Green Submitted, Green Published, gold			2022-12-27	WOS:000317385300051
J	Nishino, R; Sakaue, T; Nakanishi, H				Nishino, Ryota; Sakaue, Takahiro; Nakanishi, Hiizu			Transcription Fluctuation Effects on Biochemical Oscillations	PLOS ONE			English	Article							DROSOPHILA CIRCADIAN CLOCK; STOCHASTIC GENE-EXPRESSION; COUPLED CHEMICAL-REACTIONS; MOLECULAR NOISE; RHYTHMS; FEEDBACK; CELLS; MODEL; CONSEQUENCES; ROBUSTNESS	Some biochemical systems show oscillation. They often consist of feedback loops with repressive transcription regulation. Such biochemical systems have distinctive characteristics in comparison with ordinary chemical systems: i) numbers of molecules involved are small, ii) there are typically only a couple of genes in a cell with a finite regulation time. Due to the fluctuations caused by these features, the system behavior can be quite different from the one by deterministic rate equations, because the rate equations ignore molecular fluctuations and thus are exact only in the infinite molecular number limit. The molecular fluctuations on a free-running circadian system have been studied by Gonze et al. (2002) by introducing a scale parameter Omega for the system size. They consider, however, only the first effect, assuming that the gene process is fast enough for the second effect to be ignored, but this has not been examined systematically yet. Here we study fluctuation effects due to the finite gene regulation time by introducing a new scale parameter tau, which we take as the unbinding time of a nuclear protein from the gene. We focus on the case where the fluctuations due to small molecular numbers are negligible. In simulations on the same system studied by Gonze et al., we find the system is unexpectedly sensitive to the fluctuation in the transcription regulation; the period of oscillation fluctuates about 30 min even when the regulation time scale tau is around 30 s, that is even smaller than 1/1000 of its circadian period. We also demonstrate that the distribution width for the oscillation period and amplitude scales with root tau, and the correlation time scales with 1/tau in the small tau regime. The relative fluctuations for the period are about half of that for the amplitude, namely, the periodicity is more stable than the amplitude.	[Nishino, Ryota; Sakaue, Takahiro; Nakanishi, Hiizu] Kyushu Univ, Dept Phys, Fukuoka 812, Japan	Kyushu University	Nakanishi, H (corresponding author), Kyushu Univ, Dept Phys, Fukuoka 812, Japan.	nakanisi@phys.kyushu-u.ac.jp	Sakaue, Takahiro/J-4387-2018	Sakaue, Takahiro/0000-0002-0863-6682	Kyushu University	Kyushu University	The funding was provided by Kyushu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdaoud M, 2007, P NATL ACAD SCI USA, V104, P7051, DOI 10.1073/pnas.0609315104; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Blau J, 2001, SEMIN CELL DEV BIOL, V12, P287, DOI 10.1006/scdb.2001.0256; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; GOLDBETER A, 1995, P ROY SOC B-BIOL SCI, V261, P319, DOI 10.1098/rspb.1995.0153; Goldbeter A, 1996, BIOCH OSCILL CELLULA; Gonze D, 2002, J CHEM PHYS, V116, P10997, DOI 10.1063/1.1475765; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kusakina J, 2012, TRENDS PLAN IN PRESS; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nicolis G, 1972, J STAT PHYS, V6, P195, DOI [10.1007/BF01023688, DOI 10.1007/BF01023688]; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	35	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60938	10.1371/journal.pone.0060938	http://dx.doi.org/10.1371/journal.pone.0060938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593354	gold, Green Submitted, Green Published			2022-12-27	WOS:000317385300037
J	Sitek, EJ; Narozanska, E; Peplonska, B; Filipek, S; Barczak, A; Styczynska, M; Mlynarczyk, K; Brockhuis, B; Portelius, E; Religa, D; Barcikowska, M; Slawek, J; Zekanowski, C				Sitek, Emilia J.; Narozanska, Ewa; Peplonska, Beata; Filipek, Slawomir; Barczak, Anna; Styczynska, Maria; Mlynarczyk, Krzysztof; Brockhuis, Bogna; Portelius, Erik; Religa, Dorota; Barcikowska, Maria; Slawek, Jaroslaw; Zekanowski, Cezary			A Patient with Posterior Cortical Atrophy Possesses a Novel Mutation in the Presenilin 1 Gene	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; GAMMA-SECRETASE COMPLEX; TRANSMEMBRANE DOMAIN-4; CEREBROSPINAL-FLUID; FORCE-FIELD; PROTEIN; CSF; BIOMARKERS; DIAGNOSIS; DEMENTIA	Posterior cortical atrophy is a dementia syndrome with symptoms of cortical visual dysfunction, associated with amyloid plaques and neurofibrillary tangles predominantly affecting visual association cortex. Most patients diagnosed with posterior cortical atrophy will finally develop a typical Alzheimer's disease. However, there are a variety of neuropathological processes, which could lead towards a clinical presentation of posterior cortical atrophy. Mutations in the presenilin 1 gene, affecting the function of gamma-secretase, are the most common genetic cause of familial, early-onset Alzheimer's disease. Here we present a patient with a clinical diagnosis of posterior cortical atrophy who harbors a novel Presenilin 1 mutation (I211M). In silico analysis predicts that the mutation could influence the interaction between presenilin 1 and presenilin1 enhancer-2 protein, a protein partner within the gamma-secretase complex. These findings along with published literature support the inclusion of posterior cortical atrophy on the Alzheimer's disease spectrum.	[Sitek, Emilia J.; Narozanska, Ewa; Slawek, Jaroslaw] Med Univ Gdansk, Dept Neurol & Psychiat Nursing, Gdansk, Poland; [Sitek, Emilia J.; Narozanska, Ewa; Slawek, Jaroslaw] St Adalbert Hosp, Dept Neurol, Gdansk, Poland; [Peplonska, Beata; Styczynska, Maria; Barcikowska, Maria; Zekanowski, Cezary] Polish Acad Sci, Dept Neurodegenerat Disorders, Mossakowski Med Res Ctr, Warsaw, Poland; [Filipek, Slawomir; Mlynarczyk, Krzysztof] Univ Warsaw, Fac Chem, Warsaw, Poland; [Barczak, Anna] MSWiA Hosp, Neurol Clin, Dept Neurodegenerat Dis, Warsaw, Poland; [Brockhuis, Bogna] Med Univ, Dept Nucl Med, Gdansk, Poland; [Portelius, Erik] Univ Gothenburg, Sahlgrenska Acad, Clin Neurochem Lab, Inst Neurosci & Physiol,Dept Psychiat & Neurochem, Gothenburg, Sweden; [Religa, Dorota] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden	Fahrenheit Universities; Medical University Gdansk; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; University of Warsaw; Fahrenheit Universities; Medical University Gdansk; University of Gothenburg; Karolinska Institutet	Zekanowski, C (corresponding author), Polish Acad Sci, Dept Neurodegenerat Disorders, Mossakowski Med Res Ctr, Warsaw, Poland.	c.zekanowski@imdik.pan.pl	Sitek, Emilia/AAJ-2666-2021; Sitek, Emilia/I-6913-2013; Pepłońska, Beata/X-8321-2018; Filipek, Slawomir/A-2985-2008	Sitek, Emilia/0000-0003-4141-072X; Sitek, Emilia/0000-0003-4141-072X; Pepłońska, Beata/0000-0002-6987-1993; Religa, Dorota/0000-0003-4583-4570; Narozanska, Ewa/0000-0003-2916-1433; Brockhuis, Bogna/0000-0002-9035-6160; Filipek, Slawomir/0000-0003-3147-3858; Barcikowska, Maria/0000-0001-5657-9670; Mlynarczyk, Krzysztof/0000-0001-9032-0574; Slawek, Jaroslaw/0000-0001-6816-0877; Zekanowski, Cezary/0000-0001-7332-8494	Ministry of Science and Higher Education (Poland) [N N401557840]; START Scholarship from the Foundation for Polish Science; Ministry of Science and Higher Education (Poland); Foundation Stiftelsen Gamla Tjanarinnor; Swedish Brain Fund; Alzheimer Foundation, Sweden; Dementia Association, Sweden; Stiftelsen for alderssjukdomar vid Karolinska Institutet	Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland); START Scholarship from the Foundation for Polish Science; Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland); Foundation Stiftelsen Gamla Tjanarinnor; Swedish Brain Fund; Alzheimer Foundation, Sweden; Dementia Association, Sweden; Stiftelsen for alderssjukdomar vid Karolinska Institutet	This work was partially supported by grant no N N401557840 from the Ministry of Science and Higher Education (Poland). EJS was supported by START Scholarship from the Foundation for Polish Science and a scholarship from the Ministry of Science and Higher Education (Poland). EP was supported by Foundation Stiftelsen Gamla Tjanarinnor, the Swedish Brain Fund, the Alzheimer Foundation, Sweden, and the Dementia Association, Sweden. DR was supported by Stiftelsen for alderssjukdomar vid Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alladi S, 2007, BRAIN, V130, P2636, DOI 10.1093/brain/awm213; Bammens L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216978; Baumann TP, 2010, DEMENT GERIATR COGN, V29, P530, DOI 10.1159/000314679; Beaufils E, 2013, J ALZHEIMERS DIS, V33, P775, DOI 10.3233/JAD-2012-121267; Coen K, 2010, BIOCHEM SOC T, V38, P1474, DOI 10.1042/BST0381474; Crutch SJ, 2012, LANCET NEUROL, V11, P170, DOI 10.1016/S1474-4422(11)70289-7; de Souza LC, 2011, J NEUROL NEUROSUR PS, V82, P240, DOI 10.1136/jnnp.2010.207183; Depaz R, 2012, ALZ DIS ASSOC DIS, V26, P289, DOI 10.1097/WAD.0b013e318231e449; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fassler M, 2010, TRAFFIC, V11, P250, DOI 10.1111/j.1600-0854.2009.01014.x; Gacia M, 2006, J NEURAL TRANSM, V113, P1747, DOI 10.1007/s00702-006-0540-4; Goldstein MA, 2011, COMPR PSYCHIAT, V52, P326, DOI 10.1016/j.comppsych.2010.06.013; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hof PR, 1997, VISION RES, V37, P3609, DOI 10.1016/S0042-6989(96)00240-4; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Koedam ELGE, 2010, J ALZHEIMERS DIS, V19, P1401, DOI 10.3233/JAD-2010-1337; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Licht Eliot A, 2007, Am J Alzheimers Dis Other Demen, V22, P218, DOI 10.1177/1533317506299156; Mattsson N, 2011, NEUROLOGY, V76, P366, DOI 10.1212/WNL.0b013e318208f4ab; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McMonagle P, 2006, NEUROLOGY, V66, P331, DOI 10.1212/01.wnl.0000196477.78548.db; Mendez MF, 2002, DEMENT GERIATR COGN, V14, P33, DOI 10.1159/000058331; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Rabinovici GD, 2010, BRAIN, V133, P512, DOI 10.1093/brain/awp326; Raciti L, 2011, NEUROL SCI, V32, P533, DOI 10.1007/s10072-011-0497-4; Renner JA, 2004, NEUROLOGY, V63, P1175, DOI 10.1212/01.WNL.0000140290.80962.BF; Saint-Aubert L, 2012, ALZHEIMER DIS ASS DI; Seguin J, 2011, NEUROLOGY, V76, P1782, DOI 10.1212/WNL.0b013e31821ccc98; Snowden JS, 2007, CORTEX, V43, P835, DOI 10.1016/S0010-9452(08)70683-X; Stevens JC, 2011, MAMM GENOME, V22, P139, DOI 10.1007/s00335-011-9319-5; Swerdlow RH, 2010, NEUROLOGY, V74, P790, DOI 10.1212/WNL.0b013e3181d3e429; Takeo K, 2012, J BIOL CHEM, V287, P25834, DOI 10.1074/jbc.M111.336347; Tang-Wai D, 2006, NEUROLOGY, V66, P300, DOI 10.1212/01.wnl.0000202093.81603.d8; Tang-Wai DF, 2004, NEUROLOGY, V63, P1168, DOI 10.1212/01.WNL.0000140289.18472.15; Uttner I, 2010, EUR J NEUROL, V17, P631, DOI 10.1111/j.1468-1331.2009.02810.x; VICTOROFF J, 1994, ARCH NEUROL-CHICAGO, V51, P269, DOI 10.1001/archneur.1994.00540150063018; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zekanowski C, 2006, EXP NEUROL, V200, P82, DOI 10.1016/j.expneurol.2006.01.022	41	23	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61074	10.1371/journal.pone.0061074	http://dx.doi.org/10.1371/journal.pone.0061074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593396	Green Submitted, Green Published, gold			2022-12-27	WOS:000317385300047
J	Cassese, A; Raciti, GA; Fiory, F; Nigro, C; Ulianich, L; Castano, I; D'Esposito, V; Terracciano, D; Pastore, L; Formisano, P; Beguinot, F; Miele, C				Cassese, Angela; Raciti, Gregory A.; Fiory, Francesca; Nigro, Cecilia; Ulianich, Luca; Castano, Ilenia; D'Esposito, Vittoria; Terracciano, Daniela; Pastore, Lucio; Formisano, Pietro; Beguinot, Francesco; Miele, Claudia			Adenoviral Gene Transfer of PLD1-D4 Enhances Insulin Sensitivity in Mice by Disrupting Phospholipase D1 Interaction with PED/PEA-15 (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							PROTEIN-KINASE-C; ADP-RIBOSYLATION FACTOR; GLUCOSE-TRANSPORT; ACTIVATION; EXPRESSION; RAT; INVOLVEMENT; SECRETION; ISOFORMS; BETA	Over-expression of phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes (PED/PEA-15) causes insulin resistance by interacting with the D4 domain of phospholipase D1 (PLD1). Indeed, the disruption of this association restores insulin sensitivity in cultured cells over-expressing PED/PEA-15. Whether the displacement of PLD1 from PED/PEA-15 improves insulin sensitivity in vivo has not been explored yet. In this work we show that treatment with a recombinant adenoviral vector containing the human D4 cDNA (Ad-D4) restores normal glucose homeostasis in transgenic mice overexpressing PED/PEA-15 (Tg (ped/pea-15)) by improving both insulin sensitivity and secretion. In skeletal muscle of these mice, D4 over-expression inhibited PED/PEA-15-PLD1 interaction, decreased Protein Kinase C alpha activation and restored insulin induced Protein Kinase C zeta activation, leading to amelioration of insulin-dependent glucose uptake. Interestingly, Ad-D4 administration improved insulin sensitivity also in high-fat diet treated obese C57Bl/6 mice. We conclude that PED/PEA-15-PLD1 interaction may represent a novel target for interventions aiming at improving glucose tolerance.	[Cassese, Angela; Raciti, Gregory A.; Fiory, Francesca; Nigro, Cecilia; Ulianich, Luca; D'Esposito, Vittoria; Terracciano, Daniela; Formisano, Pietro; Beguinot, Francesco; Miele, Claudia] Univ Naples Federico II, Dipartimento Sci Med & Traslazionali, Naples, Italy; [Cassese, Angela; Raciti, Gregory A.; Fiory, Francesca; Nigro, Cecilia; Ulianich, Luca; D'Esposito, Vittoria; Terracciano, Daniela; Beguinot, Francesco; Miele, Claudia] CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, Naples, Italy; [Castano, Ilenia; Pastore, Lucio] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy; [Castano, Ilenia; Pastore, Lucio] CEINGE Biotecnol Avanzate, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate	Beguinot, F (corresponding author), Univ Naples Federico II, Dipartimento Sci Med & Traslazionali, Naples, Italy.	beguino@unina.it; c.miele@ieos.cnr.it	D'Esposito, Vittoria/K-7633-2016; Pastore, Lucio/F-4668-2010; NIGRO, Cecilia/AAB-9189-2019; Ulianich, Luca/ABD-2530-2020; Terracciano, Daniela/AAB-9521-2022; Nigro, Cecilia/K-7338-2016; Formisano, Pietro/J-4237-2018; Pastore, Lucio/AAF-3487-2019	D'Esposito, Vittoria/0000-0002-3675-8062; NIGRO, Cecilia/0000-0001-8924-9731; Terracciano, Daniela/0000-0003-4296-429X; Pastore, Lucio/0000-0001-6894-9317; RACITI, GREGORYALEXANDER/0000-0003-2742-5634; Formisano, Pietro/0000-0001-7020-6870	European Community's FP6 PREPOBEDIA [201681]; European Foundation for the Study of Diabetes (EFSD); Associazione Italiana per la Ricerca sul Cancro (AIRC); Ministero dell'Universitae della Ricerca Scientifica	European Community's FP6 PREPOBEDIA; European Foundation for the Study of Diabetes (EFSD); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universitae della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR))	This study was supported in part by the European Community's FP6 PREPOBEDIA (201681), the European Foundation for the Study of Diabetes (EFSD), the Associazione Italiana per la Ricerca sul Cancro (AIRC) and by the Ministero dell'Universitae della Ricerca Scientifica (grants PRIN and FIRB-MERIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay G, 1999, BIOCHEM J, V337, P461, DOI 10.1042/0264-6021:3370461; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Cerreto M, 2012, CURR GENE THER, V12, P48, DOI 10.2174/156652312799789280; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DeFronzo RA, 2010, AM J MED, V123, pS38, DOI 10.1016/j.amjmed.2009.12.008; Doti N, 2010, MOL BIOSYST, V6, P2039, DOI 10.1039/c005272h; Gan D, 2006, DIABETES ATLAS 2006; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; KURIBARA H, 1995, J BIOL CHEM, V270, P25667, DOI 10.1074/jbc.270.43.25667; Leitges M, 2002, MOL ENDOCRINOL, V16, P1203; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; Malecki MT, 2005, PHARMACOL REP, V57, P20; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; Pastore L, 2004, GENE, V327, P153, DOI 10.1016/j.gene.2003.11.024; Raciti GA, 2011, DIABETOLOGIA, V54, P2911, DOI 10.1007/s00125-011-2263-9; Raciti GA, 2010, DIABETOLOGIA, V53, P955, DOI 10.1007/s00125-010-1676-1; Singer WD, 1996, J BIOL CHEM, V271, P4504; Ungaro P, 2012, J BIOL CHEM, V287, P42951, DOI 10.1074/jbc.M112.406637; Valentino R, 2006, DIABETOLOGIA, V49, P3058, DOI 10.1007/s00125-006-0455-5; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; Viparelli F, 2008, J BIOL CHEM, V283, P21769, DOI 10.1074/jbc.M803771200; Zhang Y, 2000, J BIOL CHEM, V275, P35224, DOI 10.1074/jbc.M003329200; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	29	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60555	10.1371/journal.pone.0060555	http://dx.doi.org/10.1371/journal.pone.0060555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585839	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600027
J	Hedlund, L; Brembeck, P; Olausson, H				Hedlund, Linnea; Brembeck, Petra; Olausson, Hanna			Determinants of Vitamin D Status in Fair-Skinned Women of Childbearing Age at Northern Latitudes	PLOS ONE			English	Article							PLASMA 25-HYDROXYVITAMIN D; D DEFICIENCY; D INSUFFICIENCY; POPULATION; ASSOCIATION; PREVALENCE; INCREASES; PREGNANCY; EXPOSURE; SWEDEN	Background and Objective: Poor vitamin D status during pregnancy has been associated with unfavorable outcomes for mother and child. Thus, adequate vitamin D status in women of childbearing age may be important. The aim of this study is to investigate the determinants of 25-hydroxyvitamin D (25(OH)D) serum concentrations in women of childbearing age living in Sweden, at latitude 57-58 degrees north. Method: Eighty four non-pregnant, non-lactating, healthy, fair-skinned women aged between 25-40 years were included. All subjects provided blood samples, four day food records and answered questionnaires about sun exposure and lifestyle. Total serum 25(OH) D was analyzed using Roche Cobas (R) electrochemoluminiescent immunoassay. Results: Mean 25(OH) D was 65.8+/-19.9 nmol/l and 23% of the subjects had concentrations <50 nmol/l. Only 1% had concentrations <25 nmol/l. Determinants of 25(OH)D concentrations were recent sunbed use, recent travel to southern latitude, season, estrogen contraceptive use and use of supplementary vitamin D (R-2 = 0.27). Conclusion: Every fifth woman had 25(OH)D concentrations <50 nmol/l. About 30% of the variation in vitamin D status was explained by sun exposure, use of vitamin D supplements and use of estrogen contraceptives. Cutaneous vitamin D synthesis seems to be a major contributor to vitamin D status, even at northern latitudes. Thus, recommendations on safe UV-B exposure could be beneficial for vitamin D status.	[Hedlund, Linnea; Brembeck, Petra; Olausson, Hanna] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden	University of Gothenburg	Olausson, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden.	hanna.olausson@gu.se			Graduate School Environment and Health; Martina and Wilhelm Lundgrens Foundation; Hvitfeldtska Foundation; Magnus Bergvall Foundation; Fredrik and Ingrid Thuring Foundation; Swedish Research Council Formas [216-2009-1504, 222-2007-398]	Graduate School Environment and Health; Martina and Wilhelm Lundgrens Foundation; Hvitfeldtska Foundation; Magnus Bergvall Foundation; Fredrik and Ingrid Thuring Foundation; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Graduate School Environment and Health, Martina and Wilhelm Lundgrens Foundation (http://www.wmlundgren.se/), Hvitfeldtska Foundation, Magnus Bergvall Foundation (http://www.magnbergvallsstiftelse.nu/) Fredrik and Ingrid Thuring Foundation (http://www.thuringsstiftelse.com/) and The Swedish Research Council Formas (http://www.formas.se/Grant number 216-2009-1504, and 222-2007-398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2005, EUR J CLIN NUTR, V59, P533, DOI 10.1038/sj.ejcn.1602108; Astner S, 2004, J INVESTIGATIVE DERM, V122; Berry D, 2011, CURR OPIN NEPHROL HY, V20, P331, DOI 10.1097/MNH.0b013e328346d6ba; Bexelius C, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1298; Binkley N, 2009, J CLIN DENSITOM, V12, P417, DOI 10.1016/j.jocd.2009.06.001; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bogh MKB, 2012, BRIT J DERMATOL, V167, P625, DOI 10.1111/j.1365-2133.2012.11069.x; Brembeck P, 2013, BRIT J NUTR, V110, P856, DOI 10.1017/S0007114512005855; Brustad M, 2004, PUBLIC HEALTH NUTR, V7, P327, DOI 10.1079/PHN2003536; Burgaz A, 2007, AM J CLIN NUTR, V86, P1399, DOI 10.1093/ajcn/86.5.1399; Burris HH, 2012, ANN EPIDEMIOL, V22, P581, DOI 10.1016/j.annepidem.2012.04.015; Cashman KD, 2008, AM J CLIN NUTR, V88, P1535, DOI 10.3945/ajcn.2008.26594; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Duplessis CA, 2005, AVIAT SPACE ENVIR MD, V76, P569; Food and Agriculture Organization World Health Organization United Nations University, 2001, REP JOINT FAO WHO UN; Gagnon C, 2010, EUR J ENDOCRINOL, V163, P819, DOI 10.1530/EJE-10-0441; Glass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006477; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Harris SS, 1998, J AM COLL NUTR, V17, P282, DOI 10.1080/07315724.1998.10718760; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Jaaskelainen T, 2012, EUR J NUTR, P1; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; LANDINWILHELMSEN K, 1995, EUR J CLIN NUTR, V49, P400; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Littorin B, 2006, DIABETOLOGIA, V49, P2847, DOI 10.1007/s00125-006-0426-x; Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217; Moan J, 2012, PUBLIC HEALTH NUTR, V15, P711, DOI 10.1017/S1368980011002801; Mughal M Zulf, 2011, Curr Osteoporos Rep, V9, P291, DOI 10.1007/s11914-011-0081-0; National Food Administration, 1997, MATM; Ojah RCI, 2012, NUTRIENTS, V4, P399, DOI 10.3390/nu4050399; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Roth HJ, 2008, ANN CLIN BIOCHEM, V45, P153, DOI 10.1258/acb.2007.007091; Rucker D, 2002, CAN MED ASSOC J, V166, P1517; Salzer J, 2012, NEUROLOGY, V79, P2140, DOI 10.1212/WNL.0b013e3182752ea8; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; SOWERS MR, 1986, AM J CLIN NUTR, V43, P621, DOI 10.1093/ajcn/43.4.621; Statistics Sweden, 2010, WOM MEN SWED 2010 OR; Thieden E, 2008, PHOTOCHEM PHOTOBIOL, V84, P1487, DOI 10.1111/j.1751-1097.2008.00372.x; Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; Vieth R, 2001, EUR J CLIN NUTR, V55, P1091, DOI 10.1038/sj.ejcn.1601275; Zhang CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003753	43	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60864	10.1371/journal.pone.0060864	http://dx.doi.org/10.1371/journal.pone.0060864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593333	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600063
J	Lin, Q; Wang, FF; Yang, R; Zheng, XM; Gao, HB; Zhang, P				Lin, Qiang; Wang, Feifei; Yang, Rong; Zheng, Xinmin; Gao, Huibao; Zhang, Ping			Effect of Chronic Restraint Stress on Human Colorectal Carcinoma Growth in Mice	PLOS ONE			English	Article							BETA-ADRENERGIC-RECEPTOR; TOBACCO-SPECIFIC CARCINOGEN; PANCREATIC-CANCER CELL; PROMOTES TUMOR-GROWTH; ONCOGENIC K-RAS; SIGNALING PATHWAYS; OVARIAN-CARCINOMA; ACETYLCHOLINE-RECEPTOR; IMMUNE-RESPONSE; DNA-SYNTHESIS	Stress alters immunological and neuroendocrinological functions. An increasing number of studies indicate that chronic stress can accelerate tumor growth, but its role in colorectal carcinoma (CRC) progression is not well understood. The aim of this study is to investigate the effects of chronic restraint stress (CRS) on CRC cell growth in nude mice and the possible underlying mechanisms. In this study, we showed that CRS increased the levels of plasma catecholamines including epinephrine (E) and norepinephrine (NE), and stimulated the growth of CRC cell-derived tumors in vivo. Treatment with the adrenoceptor (AR) antagonists phentolamine (PHE, alpha-AR antagonist) and propranolol (PRO, beta-AR antagonist) significantly inhibited the CRS-enhanced CRC cell growth in nude mice. In addition, the stress hormones E and NE remarkably enhanced CRC cell proliferation and viability in culture, as well as tumor growth in vivo. These effects were antagonized by the AR antagonists PHE and PRO, indicating that the stress hormone-induced CRC cell proliferation is AR dependent. We also observed that the beta-AR antagonists atenolol (ATE, beta 1- AR antagonist) and ICI 118,551 (ICI, beta 2- AR antagonist) inhibited tumor cell proliferation and decreased the stress hormone-induced phosphorylation of extracellular signal-regulated kinases-1/2 (ERK1/2) in vitro and in vivo. The ERK1/2 inhibitor U0126 also blocked the function of the stress hormone, suggesting the involvement of ERK1/2 in the tumor-promoting effect of CRS. We conclude that CRS promotes CRC xenograft tumor growth in nude mice by stimulating CRC cell proliferation through the AR signaling-dependent activation of ERK1/2.	[Lin, Qiang; Wang, Feifei; Yang, Rong; Zheng, Xinmin; Gao, Huibao; Zhang, Ping] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China; [Zheng, Xinmin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Shanghai Jiao Tong University; Cornell University	Gao, HB (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China.	hbaogao@126.com; zpsjtu@163.com			National Natural Science Foundation of China [30870930]; Institutes of Medical Sciences, Shanghai Jiaotong University School of Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institutes of Medical Sciences, Shanghai Jiaotong University School of Medicine	This study was supported in part by the grant 30870930 from National Natural Science Foundation of China, the Elevation Project for Young Teachers from Institutes of Medical Sciences, Shanghai Jiaotong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRASS CK, 1985, J IMMUNOL, V135, P1338; Al-Wadei HA, 2009, ANTI-CANCER DRUG, V20, P477, DOI 10.1097/CAD.0b013e32832bd1e3; Allison PJ, 2003, J CLIN ONCOL, V21, P543, DOI 10.1200/JCO.2003.10.092; Andersen BL, 2004, J CLIN ONCOL, V22, P3570, DOI 10.1200/JCO.2004.06.030; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Armaiz-Pena GN, 2008, BRAIN BEHAV IMMUN, V22, P8; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Ben-Eliyahu S, 1999, INT J CANCER, V80, P880; Calcagno SR, 2008, INT J CANCER, V122, P2462, DOI 10.1002/ijc.23383; Courtney JG, 1996, EPIDEMIOLOGY, V7, P175, DOI 10.1097/00001648-199603000-00012; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Glaser R, 2001, J GERONTOL A-BIOL, V56, pM477, DOI 10.1093/gerona/56.8.M477; Guo JS, 2005, LIFE SCI, V77, P220, DOI 10.1016/j.lfs.2004.12.027; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hasegawa H, 2002, JPN J CANCER RES, V93, P729, DOI 10.1111/j.1349-7006.2002.tb01313.x; Kim MO, 2008, J CELL BIOCHEM, V104, P1407, DOI 10.1002/jcb.21716; Kojima M, 2005, PSYCHOSOM MED, V67, P72, DOI 10.1097/01.psy.0000151742.43774.6d; Laconi E, 2000, CANCER LETT, V161, P215, DOI 10.1016/S0304-3835(00)00621-2; Lang K, 2004, INT J CANCER, V112, P231, DOI 10.1002/ijc.20410; Lara HE, 2002, MICROSC RES TECHNIQ, V59, P495, DOI 10.1002/jemt.10229; Lara HE, 2001, ENDOCRINE, V15, P187, DOI 10.1385/ENDO:15:2:187; Lee JW, 2009, CLIN CANCER RES, V15, P2695, DOI 10.1158/1078-0432.CCR-08-2966; LESHAN L, 1959, J NATL CANCER I, V22, P1; Liu H, 2005, WORLD J GASTROENTERO, V11, P5902, DOI 10.3748/wjg.v11.i37.5902; Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015; MARCHETTI B, 1991, J STEROID BIOCHEM, V38, P307, DOI 10.1016/0960-0760(91)90102-B; Masur K, 2001, CANCER RES, V61, P2866; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Mikami M, 2008, EUR J PHARMACOL, V589, P14, DOI 10.1016/j.ejphar.2008.04.045; Moreno-Smith M, 2011, CLIN CANCER RES, V17, P3649, DOI 10.1158/1078-0432.CCR-10-2441; Mravec B, 2008, ANN NY ACAD SCI, V1148, P196, DOI 10.1196/annals.1410.010; Page GG, 1999, DEV COMP IMMUNOL, V23, P87, DOI 10.1016/S0145-305X(98)00040-8; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; RADOJCIC T, 1991, J NEUROSCI RES, V30, P328, DOI 10.1002/jnr.490300208; Re G, 1996, PHARMACOL RES, V33, P255, DOI 10.1006/phrs.1996.0036; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; REYNOLDS P, 1990, BEHAV MED, V16, P101, DOI 10.1080/08964289.1990.9934597; Rivera CA, 2011, J DENT RES, V90, P799, DOI 10.1177/0022034511399911; Frick LR, 2009, BIOL PSYCHIAT, V65, P935, DOI 10.1016/j.biopsych.2008.12.013; RUPP H, 1994, J CARDIOVASC PHARM, V24, pS16, DOI 10.1097/00005344-199424001-00004; Ruscica M, 2007, ADV EXP MED BIOL, V604, P96, DOI 10.1007/978-0-387-69116-9_7; Schmidt C, 1996, Eur J Med Res, V1, P528; Schuller HM, 1999, CANCER RES, V59, P4510; Schuller HM, 2000, J CANCER RES CLIN, V126, P624, DOI 10.1007/PL00008474; Schuller HM, 2002, NAT REV CANCER, V2, P455, DOI 10.1038/nrc824; Seya Y, 2006, EUR J PHARMACOL, V553, P54, DOI 10.1016/j.ejphar.2006.09.048; Shahzad MMK, 2010, J BIOL CHEM, V285, P35462, DOI 10.1074/jbc.M110.109579; Sheridan JF, 1998, ANN NY ACAD SCI, V840, P803, DOI 10.1111/j.1749-6632.1998.tb09618.x; Shin VY, 2007, TOXICOL SCI, V96, P21, DOI 10.1093/toxsci/kfl118; Shin VY, 2008, TOXICOL APPL PHARM, V233, P254, DOI 10.1016/j.taap.2008.08.012; Slotkin TA, 2000, BREAST CANCER RES TR, V60, P153, DOI 10.1023/A:1006338232150; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Souza RF, 2004, AM J PHYSIOL-GASTR L, V287, pG743, DOI 10.1152/ajpgi.00144.2004; STEPLEWSKI Z, 1985, CANCER RES, V45, P5128; Tanaka Takuji, 2009, J Carcinog, V8, P5; Teunis MAT, 2002, FASEB J, V16, P1465, DOI 10.1096/fj.02-0145fje; Thaker PH, 2007, CELL CYCLE, V6, P430, DOI 10.4161/cc.6.4.3829; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tominaga K, 2004, ALIMENT PHARM THER, V20, P143, DOI 10.1111/j.1365-2036.2004.01986.x; Tsuchiya Y, 2003, SURGERY, V133, P547, DOI 10.1067/msy.2003.141; VANDEWALLE B, 1990, J CANCER RES CLIN, V116, P303, DOI 10.1007/BF01612908; Weddle DL, 2001, CARCINOGENESIS, V22, P473, DOI 10.1093/carcin/22.3.473; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Wong HPS, 2009, DIGESTION, V80, P209, DOI 10.1159/000231898; Wong HPS, 2007, TOXICOL APPL PHARM, V221, P261, DOI 10.1016/j.taap.2007.04.002; Wu WKK, 2005, CANCER RES, V65, P5272, DOI 10.1158/0008-5472.CAN-05-0205; Yin DL, 2006, J NEUROIMMUNOL, V177, P11, DOI 10.1016/j.jneuroim.2006.05.004; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; Zhang D, 2010, CANCER BIOL THER, V10, P19, DOI 10.4161/cbt.10.1.11944; Zhang D, 2009, PANCREAS, V38, P94, DOI 10.1097/MPA.0b013e318184f50c; Zschauer AOA, 1997, J APPL PHYSIOL, V82, P1918, DOI 10.1152/jappl.1997.82.6.1918	75	43	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61435	10.1371/journal.pone.0061435	http://dx.doi.org/10.1371/journal.pone.0061435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585898	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600113
J	Pouw, ME; Peelen, LM; Lingsma, HF; Pieter, D; Steyerberg, E; Kalkman, CJ; Moons, KGM				Pouw, Maurice E.; Peelen, Linda M.; Lingsma, Hester F.; Pieter, Daniel; Steyerberg, Ewout; Kalkman, Cor J.; Moons, Karel G. M.			Hospital Standardized Mortality Ratio: Consequences of Adjusting Hospital Mortality with Indirect Standardization	PLOS ONE			English	Article							DUTCH HOSPITALS; QUALITY	Background: The hospital standardized mortality ratio (HSMR) is developed to evaluate and improve hospital quality. Different methods can be used to standardize the hospital mortality ratio. Our aim was to assess the validity and applicability of directly and indirectly standardized hospital mortality ratios. Methods: Retrospective scenario analysis using routinely collected hospital data to compare deaths predicted by the indirectly standardized case-mix adjustment method with observed deaths. Discharges from Dutch hospitals in the period 2003-2009 were used to estimate the underlying prediction models. We analysed variation in indirectly standardized hospital mortality ratios (HSMRs) when changing the case-mix distributions using different scenarios. Sixty-one Dutch hospitals were included in our scenario analysis. Results: A numerical example showed that when interaction between hospital and case-mix is present and case-mix differs between hospitals, indirectly standardized HSMRs vary between hospitals providing the same quality of care. In empirical data analysis, the differences between directly and indirectly standardized HSMRs for individual hospitals were limited. Conclusion: Direct standardization is not affected by the presence of interaction between hospital and case-mix and is therefore theoretically preferable over indirect standardization. Since direct standardization is practically impossible when multiple predictors are included in the case-mix adjustment model, indirect standardization is the only available method to compute the HSMR. Before interpreting such indirectly standardized HSMRs the case-mix distributions of individual hospitals and the presence of interactions between hospital and case-mix should be assessed.	[Pouw, Maurice E.; Kalkman, Cor J.] Univ Med Ctr Utrecht, Dept Anesthesiol, Utrecht, Netherlands; [Peelen, Linda M.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Lingsma, Hester F.; Steyerberg, Ewout] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Pieter, Daniel] Tilburg Univ, Dept Social & Behav Sci, NL-5000 LE Tilburg, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Tilburg University	Pouw, ME (corresponding author), Univ Med Ctr Utrecht, Dept Anesthesiol, Utrecht, Netherlands.	m.pouw@umcutrecht.nl	Kalkman, Cor/O-3215-2019; Steyerberg, Ewout W/C-1509-2018	Kalkman, Cor/0000-0002-8372-6960; Steyerberg, Ewout W/0000-0002-7787-0122				Brien Susan E, 2008, Healthc Pap, V8, P57; Brown C, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-81; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Figler Shauna, 2008, Healthc Pap, V8, P54; Heijink R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-73; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jarman B, 2010, QUAL SAF HEALTH CARE, V19, P9, DOI 10.1136/qshc.2009.032953; Julious SA, 2001, J PUBLIC HEALTH MED, V23, P40, DOI 10.1093/pubmed/23.1.40; Steven A, 2007, PUBLIC HEALTH, V121, P902, DOI 10.1016/j.puhe.2006.06.021; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; McKinley John, 2008, Healthc Pap, V8, P43; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; Rixom A, 2002, BMJ-BRIT MED J, V325, P177, DOI 10.1136/bmj.325.7357.177; Rothman K, 1986, MODERN EPIDEMIOLOGY; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Wen Eugene, 2008, Healthc Pap, V8, P26; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Zahn Catherine, 2008, Healthc Pap, V8, P50	18	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e59160	10.1371/journal.pone.0059160	http://dx.doi.org/10.1371/journal.pone.0059160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593133	Green Published, gold			2022-12-27	WOS:000317909600005
J	Shi, H; Liu, Z; Li, A; Yin, J; Chong, AGL; Tan, KSW; Zhang, Y; Lim, CT				Shi, Hui; Liu, Zhuo; Li, Ang; Yin, Jing; Chong, Alvin G. L.; Tan, Kevin S. W.; Zhang, Yong; Lim, Chwee Teck			Life Cycle-Dependent Cytoskeletal Modifications in Plasmodium falciparum Infected Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; SPECTRIN; PARASITE; PROTEIN; SKELETON	Plasmodium falciparum infection of human erythrocytes is known to result in the modification of the host cell cytoskeleton by parasite-coded proteins. However, such modifications and corresponding implications in malaria pathogenesis have not been fully explored. Here, we probed the gradual modification of infected erythrocyte cytoskeleton with advancing stages of infection using atomic force microscopy (AFM). We reported a novel strategy to derive accurate and quantitative information on the knob structures and their connections with the spectrin network by performing AFM-based imaging analysis of the cytoplasmic surface of infected erythrocytes. Significant changes on the red cell cytoskeleton were observed from the expansion of spectrin network mesh size, extension of spectrin tetramers and the decrease of spectrin abundance with advancing stages of infection. The spectrin network appeared to aggregate around knobs but also appeared sparser at non-knob areas as the parasite matured. This dramatic modification of the erythrocyte skeleton during the advancing stage of malaria infection could contribute to the loss of deformability of the infected erythrocyte.	[Shi, Hui; Zhang, Yong; Lim, Chwee Teck] Natl Univ Singapore, Dept Bioengn, Nano Biomech Lab, Singapore 117548, Singapore; [Liu, Zhuo] Natl Univ Singapore, Dept Civil Engn, Infrastruct Syst Lab, Singapore 117548, Singapore; [Li, Ang; Lim, Chwee Teck] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore; [Yin, Jing; Chong, Alvin G. L.; Tan, Kevin S. W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Lab Mol & Cellular Parasitol, Singapore 117595, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore; National University of Singapore	Lim, CT (corresponding author), Natl Univ Singapore, Dept Bioengn, Nano Biomech Lab, Singapore 117548, Singapore.	ctlim@nus.edu.sg	Zhang, Yong/F-2803-2010; Lim, chwee Teck/B-3307-2011; Tan, Kevin/C-9653-2014	Zhang, Yong/0000-0002-1303-0458; Lim, chwee Teck/0000-0003-4019-9782; 				An XL, 2002, J BIOL CHEM, V277, P31796, DOI 10.1074/jbc.M204567200; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; COPPEL RL, 1992, MOL BIOCHEM PARASIT, V50, P335, DOI 10.1016/0166-6851(92)90231-8; CRANSTON HA, 1984, SCIENCE, V223, P400, DOI 10.1126/science.6362007; Dhermy D, 2007, CURR OPIN HEMATOL, V14, P198, DOI 10.1097/MOH.0b013e3280d21afd; Discher DE, 2001, CELL MOL BIOL LETT, V6, P593; FOGEL BJ, 1966, AM J TROP MED HYG, V15, P269, DOI 10.4269/ajtmh.1966.15.269; Garcia CRS, 1997, J STRUCT BIOL, V119, P92, DOI 10.1006/jsbi.1997.3886; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; Hanspal M, 2002, BLOOD, V100, P1048, DOI 10.1182/blood-2002-01-0101; JANSE CJ, 1987, EXP PARASITOL, V64, P88, DOI 10.1016/0014-4894(87)90012-9; Le Bonniec S, 1999, J BIOL CHEM, V274, P14218, DOI 10.1074/jbc.274.20.14218; Li A, 2006, J MICROBIOL METH, V66, P434, DOI 10.1016/j.mimet.2006.01.009; Liu F, 2003, CELL BIOCHEM BIOPHYS, V38, P251, DOI 10.1385/CBB:38:3:251; MCGOUGH AM, 1990, P NATL ACAD SCI USA, V87, P5208, DOI 10.1073/pnas.87.13.5208; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Millholland MG, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010678-1, 10.1074/mcp.M111.010678]; Mills JP, 2007, P NATL ACAD SCI USA, V104, P9213, DOI 10.1073/pnas.0703433104; Murakoshi M, 2009, PFLUG ARCH EUR J PHY, V457, P885, DOI 10.1007/s00424-008-0560-z; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Oh S S, 1997, Curr Opin Hematol, V4, P148; PAULITSCHKE M, 1993, J LAB CLIN MED, V122, P581; Pei XH, 2005, J BIOL CHEM, V280, P31166, DOI 10.1074/jbc.M505298200; Puthia MK, 2005, PARASITOL RES, V95, P176, DOI 10.1007/s00436-004-1266-6; Raphael P, 2000, MOL BIOCHEM PARASIT, V110, P259, DOI 10.1016/S0166-6851(00)00283-8; Rosenthal PJ, 2002, CURR OPIN HEMATOL, V9, P140, DOI 10.1097/00062752-200203000-00010; Shi H, 2009, IFMBE PROC, V23, P1965; Swihart AH, 2001, J MICROSC-OXFORD, V204, P212, DOI 10.1046/j.1365-2818.2001.00960.x; Takeuchi M, 1998, BIOPHYS J, V74, P2171, DOI 10.1016/S0006-3495(98)77926-3; TAYLOR DW, 1987, EXP PARASITOL, V64, P178, DOI 10.1016/0014-4894(87)90141-X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; WAUGH RE, 1988, J CLIN INVEST, V81, P133, DOI 10.1172/JCI113284	37	37	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61170	10.1371/journal.pone.0061170	http://dx.doi.org/10.1371/journal.pone.0061170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585879	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600092
J	Cao, H; Li, LP; Zhang, MZ; Li, HN				Cao, He; Li, Liping; Zhang, Mingzhi; Li, Hongni			Epidemiology of Pediatric Ocular Trauma in the Chaoshan Region, China, 2001-2010	PLOS ONE			English	Article							OPEN GLOBE INJURIES; EYE INJURIES; UNITED-STATES; EMERGENCY-DEPARTMENT; CHILDREN	Background: Ocular trauma is the leading cause of monocular visual disability and noncongenital unilateral blindness in children. This study describes the epidemiology and medical care associated with nonfatal pediatric (<= 17 years of age) eye injury-related hospitalization in the largest industrial base for plastic toy production in China. Methods: A population-based retrospective study of patients hospitalized for ocular and orbital trauma in the ophthalmology departments of 3 major tertiary hospitals from 1st January 2001 to 31st December 2010 was performed. Results: The study included 1035 injured eyes from 1018 patients over a 10-year period: 560 (54.1%) eyes exhibited open globe injuries, 402 (38.8%) eyes suffered closed globe injuries, 10 (1.0%) eyes suffered chemical injuries and 8 (0.8%) eyes exhibited thermal injuries, representing an average annual hospitalization rate of 0.37 per 10,000 (95% confidence interval [CI], 0.36-0.38) due to pediatric eye injury in the Chaoshan region. The mean patient age was 9.2 +/- 4.4 years with a male-to-female ratio of 3.3:1 (P = 0.007). Children aged 6 to 11 years accounted for the highest percentage (40.8%, 416/1018) of hospitalization, 56.7% (236/416) of whom were hospitalized for open globe wounds. Injury occurred most frequently at home (73.1%). Open globe wounds cost the single most expensive financial burden (60.8%) of total charges with $998 +/- 702 mean charges per hospitalization. Conclusions: Open globe wounds occurred at home are earmarked for the priorities to prevention strategies. Higher public awareness of protecting primary schoolchildren from home-related eye injuries should be strengthened urgently by legislation or regulation since the traditional industrial mode seems to remain the pattern for the foreseeable future. Further research that provide detailed information on the specific inciting agents of pediatric eye injuries are recommended for facilitating the development and targeting of appropriate injury prevention initiatives.	[Cao, He; Li, Liping] Shantou Univ, Coll Med, Injury Prevent Res Ctr, Shantou, Guangdong, Peoples R China; [Zhang, Mingzhi] Joint Shantou Int Eye Ctr, Shantou, Guangdong, Peoples R China; [Li, Hongni] Shantou Cent Hosp, Dept Ophthalmol, Shantou, Guangdong, Peoples R China	Shantou University	Li, LP (corresponding author), Shantou Univ, Coll Med, Injury Prevent Res Ctr, Shantou, Guangdong, Peoples R China.	lpli@stu.edu.cn; zmz@jsiec.org						Acar U, 2011, EYE, V25, P370, DOI 10.1038/eye.2010.211; Al-Mahdi HS, 2011, INT EMERG NURS, V19, P186, DOI 10.1016/j.ienj.2011.06.008; Armstrong GW, 2012, GRAEFES ARCH CLIN EX, V14; Augsberger J, 2008, GEN OPHTHALMOLOGY; Bogdanici Camelia, 2002, Rev Med Chir Soc Med Nat Iasi, V106, P762; Bouhaimed M, 2009, GRAEF ARCH CLIN EXP, V247, P463, DOI 10.1007/s00417-008-0956-7; Bron AM, 2010, CLIN OPHTHALMOL, V4, P1361, DOI 10.2147/OPTH.S15359; Brophy M, 2006, PEDIATRICS, V117, pE1263, DOI 10.1542/peds.2005-1950; Burgueno Montanes C, 1998, An Esp Pediatr, V48, P625; Cao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048377; Cariello Angelino Julio, 2007, Arq. Bras. Oftalmol., V70, P271, DOI 10.1590/S0004-27492007000200015; Cillino S, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-6; Coody D, 1997, J Pediatr Health Care, V11, P182, DOI 10.1016/S0891-5245(97)90125-5; Cross JM, 2008, J AAPOS, V12, P626, DOI 10.1016/j.jaapos.2008.07.005; Dulal S, 2012, NEPAL J OPHTHALMOL, V4, P134, DOI 10.3126/nepjoph.v4i1.5865; El-Sebaity DM, 2011, CLIN OPHTHALMOL, V5, P1417, DOI 10.2147/OPTH.S24679; Garcia TA, 2005, J PEDIAT OPHTH STRAB, V42, P349; Jandeck C, 2000, GRAEF ARCH CLIN EXP, V238, P420, DOI 10.1007/s004170050373; Karaman K, 2009, OPHTHALMIC RES, V42, P199, DOI 10.1159/000232403; KLOPFER J, 1992, ARCH OPHTHALMOL-CHIC, V110, P838, DOI 10.1001/archopht.1992.01080180110037; Knyazer B, 2008, CLIN EXP OPHTHALMOL, V36, P836, DOI 10.1111/j.1442-9071.2009.01922.x; Kuhn F, 2004, J FR OPHTALMOL, V27, P206, DOI 10.1016/S0181-5512(04)96122-0; Kuhn F, 1996, OPHTHALMOLOGY, V103, P240; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P163, DOI 10.1016/S0896-1549(02)00007-X; Lee Ching-Hsing, 2008, Chang Gung Med J, V31, P59; Li F, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-121; Liu ML, 2010, J PEDIAT OPHTH STRAB, V47, P88, DOI 10.3928/01913913-20100308-06; MacEwen CJ, 1999, BRIT J OPHTHALMOL, V83, P933, DOI 10.1136/bjo.83.8.933; May DR, 2000, GRAEF ARCH CLIN EXP, V238, P153, DOI 10.1007/PL00007884; McGwin G, 2006, INVEST OPHTH VIS SCI, V47, P521, DOI 10.1167/iovs.05-0909; McGwin G, 2005, ARCH OPHTHALMOL-CHIC, V123, P662, DOI 10.1001/archopht.123.5.662; Meier P, 2010, GRAEF ARCH CLIN EXP, V248, P1207, DOI 10.1007/s00417-010-1414-x; Motley WW, 2003, J AAPOS, V7, P380, DOI 10.1016/S1091-8531(03)00217-9; Onakpoya OH, 2009, CLINICS, V64, P947, DOI 10.1590/S1807-59322009001000003; Podbielski DW, 2009, CAN J OPHTHALMOL, V44, P519, DOI 10.3129/i09-093; Pollard KA, 2012, CLIN PEDIATR, V51, P374, DOI 10.1177/0009922811427583; Poon A. S. Y., 1998, Hong Kong Medical Journal, V4, P371; Prevent Blindness America, SCOP EYE INJ PROBL; Salvin JH, 2007, CURR OPIN OPHTHALMOL, V18, P366, DOI 10.1097/ICU.0b013e3282ba54ac; Saxena Rohit, 2002, Indian Journal of Pediatrics, V69, P863, DOI 10.1007/BF02723708; Scribano PV, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.4.e5; Seidman CJ, 2011, AM J OPHTHALMOL, V151, P1041, DOI 10.1016/j.ajo.2011.01.001; Serrano JC, 2003, ARCH OPHTHALMOL-CHIC, V121, P1439, DOI 10.1001/archopht.121.10.1439; Soylu Merih, 2010, International Ophthalmology, V30, P143, DOI 10.1007/s10792-009-9300-4; STRAHLMAN E, 1990, ARCH OPHTHALMOL-CHIC, V108, P603, DOI 10.1001/archopht.1990.01070060151066; Uysal Y, 2008, J TRAUMA, V65, P1284, DOI 10.1097/TA.0b013e31817de3cc; Washington RL, 2004, PEDIATRICS, V113, P619; Wei LA, 2011, J AAPOS, V15, P173, DOI 10.1016/j.jaapos.2011.02.005; Witsaman RJ, 2006, PEDIATRICS, V118, P296, DOI 10.1542/peds.2006-0790; Yen KL, 2000, PEDIATR EMERG CARE, V16, P215, DOI 10.1097/00006565-200006000-00021	50	50	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60844	10.1371/journal.pone.0060844	http://dx.doi.org/10.1371/journal.pone.0060844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593323	Green Published, gold			2022-12-27	WOS:000317898000076
J	Kantele, A; Pakkanen, SH; Karttunen, R; Kantele, JM				Kantele, Anu; Pakkanen, Sari H.; Karttunen, Riitta; Kantele, Jussi M.			Head-to-Head Comparison of Humoral Immune Responses to Vi Capsular Polysaccharide and Salmonella Typhi Ty21a Typhoid Vaccines-A Randomized Trial	PLOS ONE			English	Article							ANTIBODY-SECRETING CELLS; ENTERIC-COATED CAPSULES; HOMING RECEPTORS; FEVER VACCINES; EFFICACY; IMMUNOGENICITY; ANTIGEN; IMMUNIZATION; VACCINATION; POTENTIALS	Background: The two typhoid vaccines, the parenteral Vi capsular polysaccharide and the oral live whole-cell Salmonella Typhi Ty21a vaccine, provide similar levels of protection in field trials. Sharing no antigens, they are thought to confer protection by different mechanisms. This is the first head-to-head study to compare the humoral immune responses to these two vaccines. Methods: 50 age-and gender-matched volunteers were immunized, 25 with the Vi and 25 with the Ty21a vaccine. Circulating plasmablasts reactive with whole-cell Salmonella Typhi or one of the typhoidal antigenic structures, Vi, O-9,12, and H-d antigens, were identified as antibody-secreting cells (ASC) with ELISPOT. Homing receptor (HR) expressions were determined. These results were compared with ASC in four patients with typhoid fever. Antibodies to S. Typhi lipopolysaccharides were assessed in cultures of ALS (antibodies in lymphocyte supernatants) and in serum with ELISA. Results: In 49 out of 50 vaccinees, no typhoid-specific plasmablasts were seen before vaccination. On day 7, response to Vi antigen was mounted in 24/25 volunteers in the Vi, and none in the Ty21a group; response to S. Typhi and O-9,12 was mounted in 49/50 vaccinees; and to H-d in 3/50. The numbers of typhoid-specific plasmablasts (total of ASC to Vi, O-9,12 and H-d antigens) proved equal in the vaccination groups. The HR expressions indicated a mainly systemic homing in the Vi and intestinal in the Ty21a group, the latter resembling that in natural infection. Plasmablasts proved more sensitive than serum and ALS in assessing the immune response. Conclusions: The typhoid-specific humoral responses to Vi and Ty21a vaccines are similar in magnitude, but differ in expected localization and antigen-specificity. The unforeseen O antigen-specific response in the Vi group is probably due to lipopolysaccharide contaminating the vaccine preparation. Only the response to Ty21a vaccine was found to imitate that in natural infection.	[Kantele, Anu; Pakkanen, Sari H.] Univ Helsinki, Cent Hosp, Div Infect Dis, Dept Med, Helsinki, Finland; [Kantele, Anu; Pakkanen, Sari H.] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Kantele, Anu] Univ Helsinki, Inst Clin Med, Dept Med, Helsinki, Finland; [Karttunen, Riitta] Helsinki Univ Hosp, Dept Virol & Immunol, Div Clin Microbiol, Helsinki, Finland; [Kantele, Jussi M.] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku	Kantele, A (corresponding author), Univ Helsinki, Cent Hosp, Div Infect Dis, Dept Med, Helsinki, Finland.	anu.kantele@hus.fi	Kantele, Anu/AAS-4131-2021	Kantele, Anu/0000-0002-0004-1000; Pakkanen, Sari/0000-0003-4522-5337	Crucell Switzerland AG; Finnish Governmental Subsidy for Health Science Research; Finnish Concordia Fund	Crucell Switzerland AG; Finnish Governmental Subsidy for Health Science Research; Finnish Concordia Fund	This work was supported by Crucell Switzerland AG, Finnish Governmental Subsidy for Health Science Research and Finnish Concordia Fund (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; CAMERINI D, 1989, NATURE, V342, P78, DOI 10.1038/342078a0; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Engels EA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001261, DOI 10.1002/14651858.CD001261]; FERRECCIO C, 1989, J INFECT DIS, V159, P766, DOI 10.1093/infdis/159.4.766; Fraser A, 2007, VACCINE, V25, P7848, DOI 10.1016/j.vaccine.2007.08.027; Guzman CA, 2006, VACCINE, V24, P3804, DOI 10.1016/j.vaccine.2005.07.111; Hornick R B, 1967, Trans Am Clin Climatol Assoc, V78, P70; KANTELE A, 1991, VACCINE, V9, P423, DOI 10.1016/0264-410X(91)90129-T; Kantele A, 2005, J INFECT DIS, V191, P312, DOI 10.1086/426943; Kantele A, 1997, J IMMUNOL, V158, P574; KANTELE A, 1986, J INFECT DIS, V153, P1126, DOI 10.1093/infdis/153.6.1126; KANTELE A, 1991, MICROB PATHOGENESIS, V10, P117, DOI 10.1016/0882-4010(91)90072-I; Kantele A, 1999, VACCINE, V17, P229, DOI 10.1016/S0264-410X(98)00193-5; KANTELE A, 1990, VACCINE, V8, P321, DOI 10.1016/0264-410X(90)90088-4; Kantele A, 2012, VACCINE, V30, P7238, DOI 10.1016/j.vaccine.2012.10.002; Kantele A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/279206; Kantele JM, 1996, GASTROENTEROLOGY, V110, P1061, DOI 10.1053/gast.1996.v110.pm8612994; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; LEVINE MM, 1990, LANCET, V336, P891; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Lundgren A, 2009, VACCINE, V27, P4529, DOI 10.1016/j.vaccine.2009.05.005; Pakkanen SH, 2012, VACCINE, V30, P6047, DOI 10.1016/j.vaccine.2012.07.051; Pakkanen SH, 2010, CLIN VACCINE IMMUNOL, V17, P393, DOI 10.1128/CVI.00475-09; ROBBINS JD, 1984, J INFECT DIS, V150, P436, DOI 10.1093/infdis/150.3.436; Salerno-Goncalves R, 2010, CLIN VACCINE IMMUNOL, V17, P1305, DOI 10.1128/CVI.00234-10; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sundstrom P, 2008, EUR J IMMUNOL, V38, P3327, DOI 10.1002/eji.200838506; TACKET CO, 1986, J INFECT DIS, V154, P342, DOI 10.1093/infdis/154.2.342; TAGLIABUE A, 1986, J IMMUNOL, V137, P1504; Viret JF, 1999, INFECT IMMUN, V67, P3680, DOI 10.1128/IAI.67.7.3680-3685.1999; Whitaker JA, 2009, J TRAVEL MED, V16, P46, DOI 10.1111/j.1708-8305.2008.00273.x; WONG KH, 1974, INFECT IMMUN, V9, P348, DOI 10.1128/IAI.9.2.348-353.1974; Yang HH, 2001, B WORLD HEALTH ORGAN, V79, P625	35	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60583	10.1371/journal.pone.0060583	http://dx.doi.org/10.1371/journal.pone.0060583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593253	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000040
J	Wang, TZ; Zhang, JL; Tian, QY; Zhao, MG; Zhang, WH				Wang, Tian-Zuo; Zhang, Jin-Li; Tian, Qiu-Ying; Zhao, Min-Gui; Zhang, Wen-Hao			A Medicago truncatula EF-Hand Family Gene, MtCaMP1, Is Involved in Drought and Salt Stress Tolerance	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PROTEIN-KINASES; ABIOTIC STRESS; SIGNAL-TRANSDUCTION; CALCIUM; PROLINE; EXPRESSION; CALMODULIN; INDUCTION; RADIATION	Background: Calcium-binding proteins that contain EF-hand motifs have been reported to play important roles in transduction of signals associated with biotic and abiotic stresses. To functionally characterize gens of EF-hand family in response to abiotic stress, an MtCaMP1 gene belonging to EF-hand family from legume model plant Medicago truncatula was isolated and its function in response to drought and salt stress was investigated by expressing MtCaMP1 in Arabidopsis. Methodology/Principal Findings: Transgenic Arabidopsis seedlings expressing MtCaMP1 exhibited higher survival rate than wild-type seedlings under drought and salt stress, suggesting that expression of MtCaMP1 confers tolerance of Arabidopsis to drought and salt stress. The transgenic plants accumulated greater amounts of Pro due to up-regulation of P5CS1 and down-regulation of ProDH than wild-type plants under drought stress. There was a less accumulation of Na+ in the transgenic plants than in WT plants due to reduced up-regulation of AtHKT1 and enhanced regulation of AtNHX1 in the transgenic plants compared to WT plants under salt stress. There was a reduced accumulation of H2O2 and malondialdehyde in the transgenic plants than in WT plants under both drought and salt stress. Conclusions/Significance: The expression of MtCaMP1 in Arabidopsis enhanced tolerance of the transgenic plants to drought and salt stress by effective osmo-regulation due to greater accumulation of Pro and by minimizing toxic Na+ accumulation, respectively. The enhanced accumulation of Pro and reduced accumulation of Na+ under drought and salt stress would protect plants from water default and Na+ toxicity, and alleviate the associated oxidative stress. These findings demonstrate that MtCaMP1 encodes a stress-responsive EF-hand protein that plays a regulatory role in response of plants to drought and salt stress.	[Wang, Tian-Zuo; Zhang, Jin-Li; Tian, Qiu-Ying; Zhao, Min-Gui; Zhang, Wen-Hao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhang, Wen-Hao] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Global Change Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences	Zhang, WH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	whzhang@ibcas.ac.cn	Wang, Tianzuo/C-7291-2013; Zhang, Wen-Hao/B-5805-2009	Wang, Tianzuo/0000-0001-9374-6167; Zhang, Wen-Hao/0000-0003-2708-2221	State Key Lab of Vegetation and Environmental Change	State Key Lab of Vegetation and Environmental Change	The work was supported by the State Key Lab of Vegetation and Environmental Change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Cook DR, 1999, CURR OPIN PLANT BIOL, V2, P301, DOI 10.1016/S1369-5266(99)80053-3; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; Dhanda SS, 1998, EUPHYTICA, V104, P39, DOI 10.1023/A:1018644113378; Franz S, 2011, MOL PLANT, V4, P83, DOI 10.1093/mp/ssq064; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Knight H, 2000, INT REV CYTOL, V195, P269; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; KRAMER GF, 1991, PHYTOCHEMISTRY, V30, P2101, DOI 10.1016/0031-9422(91)83595-C; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Kudla J, 1999, P NATL ACAD SCI USA, V96, P4718, DOI 10.1073/pnas.96.8.4718; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Li CJ, 2006, FUNCT PLANT BIOL, V33, P381, DOI 10.1071/FP06026; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; POOVAIAH BW, 1993, CRIT REV PLANT SCI, V12, P185, DOI 10.1080/713608046; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Rus A, 2001, P NATL ACAD SCI USA, V98, P14150, DOI 10.1073/pnas.241501798; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Takano M, 1997, PLANT CELL PHYSIOL, V38, P385, DOI 10.1093/oxfordjournals.pcp.a029180; Takezawa D, 2000, PLANT MOL BIOL, V42, P807, DOI 10.1023/A:1006431724090; Talke IN, 2003, TRENDS PLANT SCI, V8, P286, DOI 10.1016/S1360-1385(03)00099-2; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Wang MY, 2007, PLANT MOL BIOL, V65, P733, DOI 10.1007/s11103-007-9238-8; Wang TianZuo, 2012, Acta Prataculturae Sinica, V21, P175; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoo JH, 2005, J BIOL CHEM, V280, P3697, DOI 10.1074/jbc.M408237200; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	46	47	50	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e58952	10.1371/journal.pone.0058952	http://dx.doi.org/10.1371/journal.pone.0058952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593126	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000006
J	Chen, XL; Chen, XZ; Yang, C; Liao, YB; Li, H; Wang, L; Yang, K; Li, K; Hu, JK; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG				Chen, Xiao-Long; Chen, Xin-Zu; Yang, Chen; Liao, Yan-Biao; Li, He; Wang, Li; Yang, Kun; Li, Ka; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang			Docetaxel, Cisplatin and Fluorouracil (DCF) Regimen Compared with Non-Taxane-Containing Palliative Chemotherapy for Gastric Carcinoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA; S-1 COMBINATION THERAPY; QUALITY-OF-LIFE; PHASE-III TRIAL; PLUS FLUOROURACIL; 1ST-LINE THERAPY; G-CSF; CANCER; EPIRUBICIN; LEUCOVORIN	Background: Gastric carcinoma (GC) is one of the highest cancer-mortality diseases with a high incidence rate in Asia. For surgically unfit but medically fit patients, palliative chemotherapy is the main treatment. The chemotherapy regimen of docetaxel, cisplatin and 5-fluorouracil (DCF) has been used to treat the advanced stage or metastatic GC. It is necessary to compare effectiveness and toxicities of DCF regimen with non-taxane-containing palliative chemotherapy for GC. Methods: PubMed, EmBase, Cochrane Central Register of Controlled Trials and China National Knowledge Infrastructure databases were searched to select relative randomized controlled trials (RCTs) comparing DCF to non-taxane-containing chemotherapy for patients with palliatively resected, unresectable, recurrent or metastatic GC. Primary outcome measures were 1-year and 2-year overall survival (OS) rates. Secondary outcome measures were median survival time (MST), median time to progression (TTP), response rate and toxicities. Results: Twelve RCTs were eligible and 1089 patients were analyzed totally (549 in DCF and 540 in control). DCF regimen increased partial response rate (38.8% vs 27.9%, p = 0.0003) and reduced progressive disease rate (18.9% vs 33.3%, p = 0.0005) compared to control regimen. Significant improvement of 2-year OS rate was found in DCF regimen (RR = 2.03, p = 0.006), but not of 1-year OS rate (RR = 1.22, p = 0.08). MST was significantly prolonged by DCF regimen (p = 0.039), but not median TTP (p = 0.054). Both 1-year OS rate and median TTP had a trend of prolongation by DCF regimen. Chemotherapy-related mortality was comparable (RR = 1.23, p = 0.49) in both regimens. In grade I-IV toxicities, DCF regimen showed a major raise of febrile neutropenia (RR = 2.33, p<0.0001) and minor raises of leucopenia (RR = 1.25, p<0.00001), neutropenia (RR = 1.19, p<0.00001), and diarrhea (RR = 1.59, p<0.00001), while in other toxicities there were no significant differences. Conclusion: DCF regimen has better response than non-taxane containing regimen and could potentially improve the survival outcomes. The chemotherapy-related toxicity of DCF regimen is acceptable to some extent.	[Chen, Xiao-Long; Chen, Xin-Zu; Yang, Kun; Li, Ka; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan, Peoples R China; [Chen, Xiao-Long; Yang, Chen; Liao, Yan-Biao; Li, He] Sichuan Univ, West China Sch Med, Fac Med, Chengdu 610064, Sichuan, Peoples R China; [Wang, Li] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan, Peoples R China.	hujkwch@126.com	Yang, Kun/A-4293-2010; Chen, Xin-Zu/C-2515-2009; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019	Chen, Xin-Zu/0000-0002-7619-6244; , Zongguang/0000-0002-7616-1199	National Natural Science Foundation of China [81071777]; Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China [2011SCU04B19]; New Century Excellent Talents in University support program, Ministry of Education of China [2012SCU-NCET-11-0343]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China; New Century Excellent Talents in University support program, Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This research was funded by these sources: 1) National Natural Science Foundation of China (No. 81071777); 2) Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China (No.2011SCU04B19); 3) New Century Excellent Talents in University support program, Ministry of Education of China (2012SCU-NCET-11-0343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2002, ONCOLOGY-NY, V16, P89; Ajani JA, 2007, J CLIN ONCOL, V25, P3210, DOI 10.1200/JCO.2006.08.3956; Ajani JA, 2007, J CLIN ONCOL, V25, P3205, DOI 10.1200/JCO.2006.10.4968; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Bang YJ, 2002, JPN J CLIN ONCOL, V32, P248, DOI 10.1093/jjco/hyf057; Bittoni A, 2010, EUR REV MED PHARMACO, V14, P309; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; Chen XZ, 2008, WORLD J GASTROENTERO, V14, P2715, DOI 10.3748/wjg.14.2715; Chen XZ, 2011, WORLD J GASTROENTERO, V17, P4542, DOI 10.3748/wjg.v17.i40.4542; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chu JH, 2006, CHIN J CLIN ONCOL, V11, P541; CORTES JE, 1995, J CLIN ONCOL, V13, P2643, DOI 10.1200/JCO.1995.13.10.2643; Das P, 2005, EXPERT OPIN PHARMACO, V6, P2805, DOI 10.1517/14656566.6.16.2805; Gao H, 2010, CHIN J CLIN ONCOL, V15, P529; Giuliani F, 2003, ANTICANCER RES, V23, P4219; Haller DG, 2002, ANTI-CANCER DRUG, V13, P451, DOI 10.1097/00001813-200206000-00003; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hou AnJi, 2009, Tumor, V29, P160; Hu JK, 2007, J CHEMOTHERAPY, V19, P359, DOI 10.1179/joc.2007.19.4.359; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Hu JK, 2002, WORLD J GASTROENTERO, V8, P1023, DOI 10.3748/wjg.v8.i6.1023; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kakeji Y, 2009, ONCOLOGY-BASEL, V77, P49, DOI 10.1159/000226111; Li CP, 2010, BRIT J CANCER, V103, P1343, DOI 10.1038/sj.bjc.6605928; Li XQ, 2007, MODERN ONCOL, V15, P659; Liang B, 2010, CHIN J CLIN ONCOL RE, V17, P59; Lorenzen S, 2007, ANN ONCOL, V18, P1673, DOI 10.1093/annonc/mdm269; Makatsoris T, 2007, MED ONCOL, V24, P301, DOI 10.1007/s12032-007-0004-1; Mavroudis D, 2000, AM J CLIN ONCOL-CANC, V23, P341, DOI 10.1097/00000421-200008000-00005; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Oh DY, 2005, JPN J CLIN ONCOL, V35, P380, DOI 10.1093/jjco/hyi107; Oh SC, 2005, BRIT J CANCER, V92, P827, DOI 10.1038/sj.bjc.6602446; Ohtsu Atsushi, 2005, Gastric Cancer, V8, P95, DOI 10.1007/s10120-005-0324-9; Park SR, 2005, AM J CLIN ONCOL-CANC, V28, P433, DOI 10.1097/01.coc.0000162424.69631.79; Rino Y, 2006, ANTICANCER RES, V26, P1455; Roth AD, 2003, ANN ONCOL, V14, P41, DOI 10.1093/annonc/mdg728; Roth AD, 2000, ANN ONCOL, V11, P301, DOI 10.1023/A:1008342013224; Roth AD, 2007, J CLIN ONCOL, V25, P3217, DOI 10.1200/JCO.2006.08.0135; Sadighi S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-274; Sato Y, 2010, CANCER CHEMOTH PHARM, V66, P721, DOI 10.1007/s00280-009-1215-2; Shah MA, 2011, J CLIN ONCOL, V29, P868, DOI 10.1200/JCO.2010.32.0770; Shen YC, 2009, J BASIC CLIN ONCOL, V22, P318; Sun WJ, 2010, J CLIN ONCOL, V28, P2947, DOI 10.1200/JCO.2009.27.7988; Takayama T, 2007, BRIT J CANCER, V97, P851, DOI 10.1038/sj.bjc.6603957; Tsai James Y, 2003, Curr Oncol Rep, V5, P210, DOI 10.1007/s11912-003-0112-9; Van Cutsem E, 2004, EJC SUPPL, V2, P52, DOI 10.1016/j.ejcsup.2004.04.016; Van Cutsem E, 2004, ONCOLOGIST, V9, P9, DOI 10.1634/theoncologist.9-suppl_2-9; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Wagner AD, 2009, DRUG AGING, V26, P627, DOI 10.2165/11315740-000000000-00000; Wu GC, 2008, J SHANDONG MED, V48, P73; Yamaguchi K, 2006, BRIT J CANCER, V94, P1803, DOI 10.1038/sj.bjc.6603196; Yamamoto K, 2009, ANTICANCER RES, V29, P4211; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yoshida K, 2004, ANTICANCER RES, V24, P1843; Yoshida K, 2006, CLIN CANCER RES, V12, P3402, DOI 10.1158/1078-0432.CCR-05-2425; Zhang FL, 2008, CHIN J CLIN ONCOL, V35, p[1397, 1406]; 赵帆, 2009, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V29, P237	61	34	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60320	10.1371/journal.pone.0060320	http://dx.doi.org/10.1371/journal.pone.0060320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593191	Green Submitted, gold, Green Published			2022-12-27	WOS:000319108100031
J	Daniels, R; Chang, HH; Sene, PD; Park, DC; Neafsey, DE; Schaffner, SF; Hamilton, EJ; Lukens, AK; Van Tyne, D; Mboup, S; Sabeti, PC; Ndiaye, D; Wirth, DF; Hartl, DL; Volkman, SK				Daniels, Rachel; Chang, Hsiao-Han; Sene, Papa Diogoye; Park, Danny C.; Neafsey, Daniel E.; Schaffner, Stephen F.; Hamilton, Elizabeth J.; Lukens, Amanda K.; Van Tyne, Daria; Mboup, Souleymane; Sabeti, Pardis C.; Ndiaye, Daouda; Wirth, Dyann F.; Hartl, Daniel L.; Volkman, Sarah K.			Genetic Surveillance Detects Both Clonal and Epidemic Transmission of Malaria following Enhanced Intervention in Senegal	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM	Using parasite genotyping tools, we screened patients with mild uncomplicated malaria seeking treatment at a clinic in Thie's, Senegal, from 2006 to 2011. We identified a growing frequency of infections caused by genetically identical parasite strains, coincident with increased deployment of malaria control interventions and decreased malaria deaths. Parasite genotypes in some cases persisted clonally across dry seasons. The increase in frequency of genetically identical parasite strains corresponded with decrease in the probability of multiple infections. Further, these observations support evidence of both clonal and epidemic population structures. These data provide the first evidence of a temporal correlation between the appearance of identical parasite types and increased malaria control efforts in Africa, which here included distribution of insecticide treated nets (ITNs), use of rapid diagnostic tests (RDTs) for malaria detection, and deployment of artemisinin combination therapy (ACT). Our results imply that genetic surveillance can be used to evaluate the effectiveness of disease control strategies and assist a rational global malaria eradication campaign.	[Daniels, Rachel; Lukens, Amanda K.; Van Tyne, Daria; Wirth, Dyann F.; Volkman, Sarah K.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Daniels, Rachel; Park, Danny C.; Neafsey, Daniel E.; Schaffner, Stephen F.; Lukens, Amanda K.; Sabeti, Pardis C.; Wirth, Dyann F.; Volkman, Sarah K.] Broad Inst, Cambridge, MA USA; [Chang, Hsiao-Han; Park, Danny C.; Sabeti, Pardis C.; Hartl, Daniel L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Sene, Papa Diogoye; Mboup, Souleymane; Ndiaye, Daouda] Cheikh Anta Diop Univ, Fac Med & Pharm, Dakar, Senegal; [Hamilton, Elizabeth J.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Sabeti, Pardis C.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Volkman, Sarah K.] Simmons Coll, Sch Nursing & Hlth Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University Cheikh Anta Diop Dakar; Harvard University; Harvard University; Simmons University	Volkman, SK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	svolkman@hsph.harvard.edu	Sabeti, Pardis/GQH-8610-2022; Schaffner, Stephen F/D-1189-2011; Van Tyne, Daria/K-1251-2019; Daniels, Rachel/H-9467-2013	Van Tyne, Daria/0000-0001-7284-0103; Schaffner, Stephen/0000-0001-6699-3568; Daniels, Rachel/0000-0002-9712-4581	Bill and Melinda Gates Foundation; National Institutes of Health [1R01AI075080-01A1, 1R56AI082589, 5R01GM061351, D43TW001503]; ExxonMobile Foundation; T32 training grant [AI007535]; FOGARTY INTERNATIONAL CENTER [D43TW001503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099105, R01AI075080, R56AI082589, T32AI007638, T32AI007535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061351] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ExxonMobile Foundation(Exxon Mobil Corporation); T32 training grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by the Bill and Melinda Gates Foundation, National Institutes of Health (grants 1R01AI075080-01A1, 1R56AI082589, and 5R01GM061351), ExxonMobile Foundation, and National Institutes of Health Fogarty (grant D43TW001503). RFD is supported by T32 training grant (AI007535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2005, GENETICS, V170, P955, DOI 10.1534/genetics.104.038349; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Branch OH, 2011, MOL BIOL EVOL, V28, P1973, DOI 10.1093/molbev/msq311; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Echeverry DF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-2; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; MALARIA RB, 2010, FOCUS SENEGAL PROGR; Mobegi VA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-223; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Mzilahowa T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000613; Ndiath MO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-270; Ndiaye D, 2010, AM J TROP MED HYG, V82, P228, DOI 10.4269/ajtmh.2010.09-0470; Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171; Nkhoma SC, 2013, MOL ECOL, V22, P273, DOI 10.1111/mec.12099; Roper C, 1996, AM J TROP MED HYG, V54, P325, DOI 10.4269/ajtmh.1996.54.325; SMITH JM, 1993, CLONAL ARE BACTERIA; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; WAPLES RS, 1989, GENETICS, V121, P379; *WORLD HLTH ORG, 2011, WORLD MAL REP 2011, P246	22	73	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60780	10.1371/journal.pone.0060780	http://dx.doi.org/10.1371/journal.pone.0060780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593309	Green Submitted, gold, Green Published			2022-12-27	WOS:000319108100064
J	Kerdivel, G; Le Guevel, R; Habauzit, D; Brion, F; Ait-Aissa, S; Pakdel, F				Kerdivel, Gwenneg; Le Guevel, Remy; Habauzit, Denis; Brion, Francois; Ait-Aissa, Selim; Pakdel, Farzad			Estrogenic Potency of Benzophenone UV Filters in Breast Cancer Cells: Proliferative and Transcriptional Activity Substantiated by Docking Analysis	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; BODY TOPICAL APPLICATION; RECEPTOR-ALPHA; GENE-EXPRESSION; IN-VITRO; ER-ALPHA; SURFACE WATERS; SEWAGE-SLUDGE; WASTE-WATER; SWISS LAKES	The results from recent studies show that some benzophenones (BPs) and their hydroxylated metabolites can function as weak estrogens (E2) in the environment. However, little is known about the structure-activity relationship of these molecules. We have examined the effects of exposure to ten different BPs on the proliferation of estrogen receptor (ER)positive breast cancer cells and on the transcriptional activity of E2-target genes. We analyzed two genes that are tightly linked with estrogen-mediated proliferation, the CXCL12 and amphiregulin genes and two classical estrogen-responsive genes, the pS2 and progesterone receptor. Significant differences in the BPs efficiency to induce cell proliferation and endogenous E2-target gene expressions were observed. Using ERE-, Sp1-, AP1- and C3-reporter genes that contain different ER-binding sites in their promoter, we also showed significant differences in the BPs efficiency in activation of the ER transactivation. Together, our analyzes showed that the most active molecule is 4-hydroxy-BP. Docking analysis of the interaction of BPs in the ligand-binding pocket of ER alpha suggests that the minimum structural requirement for the estrogenic activity of BPs is a hydroxyl (OH) group in the phenyl A-ring that allows interaction with Glu-353, Arg-394 or Phe-404, which enhances the stability between BPs and ER alpha. Our modeling also indicates a loss of interaction between the OH groups of the phenyl B-ring and His-524. In addition, the presence of some OH groups in the phenyl B-ring can create repulsion forces, which may constrain helix 12 in an unfavorable position, explaining the differential estrogenic effects of BPs. These results, together with our analysis of BPs for their potency in activation of cell proliferation and ER-mediated transcription, report an improved understanding of the mechanism and structure-activity relationship of BPs.	[Kerdivel, Gwenneg; Habauzit, Denis; Pakdel, Farzad] Univ Rennes 1, Transcript Environm & Canc Grp, IRSET, INSERM U1085, Rennes, France; [Le Guevel, Remy] Univ Rennes 1, SFR Biosit, ImPACcell, Rennes, France; [Brion, Francois; Ait-Aissa, Selim] Inst Natl Environm Ind & Risques INERIS, In Vitro & In Vitro Ecotoxicol Grp, Verneuil En Halatte, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes; Institut National de l'Environnement Industriel et des Risques (INERIS)	Pakdel, F (corresponding author), Univ Rennes 1, Transcript Environm & Canc Grp, IRSET, INSERM U1085, Rennes, France.	farzad.pakdel@univ-rennes1.fr	Pakdel, Farzad/K-1700-2015; AIT-AISSA, Selim/Q-8702-2018; BRION, Francois/Q-8713-2018; Habauzit, Denis/K-1779-2015; Kerdivel, Gwenneg/AAN-9195-2020	Pakdel, Farzad/0000-0002-3067-3156; AIT-AISSA, Selim/0000-0001-7817-1932; BRION, Francois/0000-0003-2341-4196; Habauzit, Denis/0000-0001-8101-3839; 	Brittany Region; French Ministry of Ecology, Energy and Sustainable Development (PNRPE); Post-Grenelle grant NEMO; INSERM; French League against Cancer (La Ligue Contre le Cancer) [IFR140 Biosit]; University of Rennes 1; European University of Brittany	Brittany Region(Region Bretagne); French Ministry of Ecology, Energy and Sustainable Development (PNRPE); Post-Grenelle grant NEMO; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French League against Cancer (La Ligue Contre le Cancer); University of Rennes 1; European University of Brittany	This work was supported by fellowships from the Brittany Region (to GK) and funds from the French Ministry of Ecology, Energy and Sustainable Development (PNRPE) and the Post-Grenelle grant NEMO (to FB, SAA and FP), the INSERM, the French League against Cancer (La Ligue Contre le Cancer, to FP), IFR140 Biosit, the University of Rennes 1, and the European University of Brittany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Balaguer P, 1999, SCI TOTAL ENVIRON, V233, P47, DOI 10.1016/S0048-9697(99)00178-3; Balmer ME, 2005, ENVIRON SCI TECHNOL, V39, P953, DOI 10.1021/es040055r; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P893, DOI 10.1289/ehp.11269; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Cosnefroy A, 2012, TOXICOL SCI, V125, P439, DOI 10.1093/toxsci/kfr297; D'Ursi P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S10; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Fent K, 2010, ENVIRON POLLUT, V158, P1817, DOI 10.1016/j.envpol.2009.11.005; Fenton SE, 2006, ENDOCRINOLOGY, V147, pS18, DOI 10.1210/en.2005-1131; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; FLOURIOT G, 1995, J MOL ENDOCRINOL, V15, P143, DOI 10.1677/jme.0.0150143; Gago-Ferrero P, 2011, CHEMOSPHERE, V84, P1158, DOI 10.1016/j.chemosphere.2011.04.003; Habauzit D, 2010, ENVIRON TOXICOL, V25, P495, DOI 10.1002/tox.20594; Habauzit D, 2008, ANAL BIOANAL CHEM, V390, P873, DOI 10.1007/s00216-007-1725-x; HAGEDORNLEWEKE U, 1995, PHARMACEUT RES, V12, P1354, DOI 10.1023/A:1016286026462; Hayashi T, 2006, TOXICOL LETT, V167, P1, DOI 10.1016/j.toxlet.2006.08.001; Janjua NR, 2008, J EUR ACAD DERMATOL, V22, P456, DOI 10.1111/j.1468-3083.2007.02492.x; Janjua NR, 2004, J INVEST DERMATOL, V123, P57, DOI 10.1111/j.0022-202X.2004.22725.x; Jeon HK, 2008, TOXICOLOGY, V248, P89, DOI 10.1016/j.tox.2008.02.009; Jeon HK, 2006, J CHROMATOGR A, V1131, P192, DOI 10.1016/j.chroma.2006.07.036; Jiang R, 1999, BRIT J CLIN PHARMACO, V48, P635; Kawaguchi M, 2008, J CHROMATOGR A, V1200, P260, DOI 10.1016/j.chroma.2008.05.084; Kawamura A, 2005, CHIRALITY, V17, P332, DOI 10.1002/chir.20169; Kerdivel G, 2013, BIOCHEM BIOPH RES CO, V431, P729, DOI 10.1016/j.bbrc.2013.01.050; Kunisue T, 2012, ENVIRON SCI TECHNOL, V46, P4624, DOI 10.1021/es204415a; Kunz PY, 2006, TOXICOL APPL PHARM, V217, P86, DOI 10.1016/j.taap.2006.07.014; Kunz PY, 2006, TOXICOL SCI, V90, P349, DOI 10.1093/toxsci/kfj082; Meng X, 2010, ANAL BIOANAL CHEM, V396, P625, DOI 10.1007/s00216-009-3112-2; Merot Y, 2004, J BIOL CHEM, V279, P26184, DOI 10.1074/jbc.M402148200; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Molina-Molina JM, 2008, TOXICOL APPL PHARM, V232, P384, DOI 10.1016/j.taap.2008.07.017; Nakagawa Y, 2002, CHEM-BIOL INTERACT, V139, P115, DOI 10.1016/S0009-2797(01)00293-9; Negreira N, 2009, ANAL CHIM ACTA, V654, P162, DOI 10.1016/j.aca.2009.09.033; Nohynek GJ, 2001, REGUL TOXICOL PHARM, V33, P285, DOI 10.1006/rtph.2001.1476; Philippat C, 2012, ENVIRON HEALTH PERSP, V120, P464, DOI 10.1289/ehp.1103634; Poiger T, 2004, CHEMOSPHERE, V55, P951, DOI 10.1016/j.chemosphere.2004.01.012; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Schlumpf M, 2008, INT J ANDROL, V31, P144, DOI 10.1111/j.1365-2605.2007.00856.x; Schlumpf M, 2010, CHEMOSPHERE, V81, P1171, DOI 10.1016/j.chemosphere.2010.09.079; Schmutzler C, 2007, ENDOCRINOLOGY, V148, P2835, DOI 10.1210/en.2006-1280; Schultz JR, 2005, J BIOL CHEM, V280, P347, DOI 10.1074/jbc.M407879200; Seidlova-Wuttke D, 2005, TOXICOLOGY, V213, P13, DOI 10.1016/j.tox.2005.05.001; Sheng S, 2008, MOL CELL ENDOCRINOL, V296, P1, DOI 10.1016/j.mce.2008.09.022; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Suzuki T, 2005, TOXICOL APPL PHARM, V203, P9, DOI 10.1016/j.taap.2004.07.005; Tarazona I, 2010, J CHROMATOGR A, V1217, P4771, DOI 10.1016/j.chroma.2010.05.047; Vajdos FF, 2007, PROTEIN SCI, V16, P897, DOI 10.1110/ps.062729207; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007; Yi P, 2002, MOL ENDOCRINOL, V16, P674, DOI 10.1210/me.16.4.674; Zhang ZF, 2011, ENVIRON SCI TECHNOL, V45, P3909, DOI 10.1021/es2004057; Zucchi S, 2011, TOXICOL APPL PHARM, V250, P137, DOI 10.1016/j.taap.2010.10.001	54	48	50	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60567	10.1371/journal.pone.0060567	http://dx.doi.org/10.1371/journal.pone.0060567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593250	Green Published, gold			2022-12-27	WOS:000319108100055
J	Moy, ML; Teylan, M; Weston, NA; Gagnon, DR; Garshick, E				Moy, Marilyn L.; Teylan, Merilee; Weston, Nicole A.; Gagnon, David R.; Garshick, Eric			Daily Step Count Predicts Acute Exacerbations in a US Cohort with COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; 6-MINUTE WALK DISTANCE; MINIMAL IMPORTANT DIFFERENCE; PHYSICAL-ACTIVITY; FUNCTIONAL STATUS; HEALTH-STATUS; RISK-FACTORS; HOSPITALIZATION; PREVENTION; MORTALITY	Background: COPD is characterized by variability in exercise capacity and physical activity (PA), and acute exacerbations (AEs). Little is known about the relationship between daily step count, a direct measure of PA, and the risk of AEs, including hospitalizations. Methods: In an observational cohort study of 169 persons with COPD, we directly assessed PA with the StepWatch Activity Monitor, an ankle-worn accelerometer that measures daily step count. We also assessed exercise capacity with the 6-minute walk test (6MWT) and patient-reported PA with the St. George's Respiratory Questionnaire Activity Score (SGRQ-AS). AEs and COPD-related hospitalizations were assessed and validated prospectively over a median of 16 months. Results: Mean daily step count was 5804 +/- 3141 steps. Over 209 person-years of observation, there were 263 AEs (incidence rate 1.3 +/- 1.6 per person-year) and 116 COPD-related hospitalizations (incidence rate 0.56 +/- 1.09 per person-year). Adjusting for FEV1 % predicted and prednisone use for AE in previous year, for each 1000 fewer steps per day walked at baseline, there was an increased rate of AEs (rate ratio 1.07; 95%CI = 1.003-1.15) and COPD-related hospitalizations (rate ratio 1.24; 95%CI = 1.08-1.42). There was a significant linear trend of decreasing daily step count by quartiles and increasing rate ratios for AEs (P = 0.008) and COPD-related hospitalizations (P = 0.003). Each 30-meter decrease in 6MWT distance was associated with an increased rate ratio of 1.07 (95%CI = 1.01-1.14) for AEs and 1.18 (95%CI = 1.07-1.30) for COPD-related hospitalizations. Worsening of SGRQ-AS by 4 points was associated with an increased rate ratio of 1.05 (95%CI = 1.01-1.09) for AEs and 1.10 (95%CI = 1.02-1.17) for COPD-related hospitalizations. Conclusions: Lower daily step count, lower 6MWT distance, and worse SGRQ-AS predict future AEs and COPD-related hospitalizations, independent of pulmonary function and previous AE history. These results support the importance of assessing PA in patients with COPD, and provide the rationale to promote PA as part of exacerbation-prevention strategies.	[Moy, Marilyn L.; Garshick, Eric] Vet Hlth Adm, Rehabil Res & Dev Serv, Dept Veteran Affairs, Washington, DC USA; [Moy, Marilyn L.; Teylan, Merilee; Weston, Nicole A.; Garshick, Eric] VA Boston Healthcare Syst, Pulm & Crit Care Med Sect, Boston, MA USA; [Moy, Marilyn L.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Garshick, Eric] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Moy, Marilyn L.; Garshick, Eric] Harvard Univ, Sch Med, Boston, MA USA; [Gagnon, David R.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Gagnon, David R.] VA Cooperat Studies, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University	Moy, ML (corresponding author), Vet Hlth Adm, Rehabil Res & Dev Serv, Dept Veteran Affairs, Washington, DC USA.	marilyn.moy@va.gov	Garshick, Eric/Y-6509-2019	Gagnon, David/0000-0002-6367-3179	Department of Veteran Affairs, Veterans Health Administration, Rehabilitation Research; Development Service through a VA Career Development Award; CIMIT: Center for Integration of Medicine and Innovative Technology; VA Rehabilitation Research and Development Merit Review [B6618R]	Department of Veteran Affairs, Veterans Health Administration, Rehabilitation Research(US Department of Veterans Affairs); Development Service through a VA Career Development Award; CIMIT: Center for Integration of Medicine and Innovative Technology; VA Rehabilitation Research and Development Merit Review	The research reported here was supported by the Department of Veteran Affairs, Veterans Health Administration, Rehabilitation Research and Development Service through a VA Career Development Award to Dr. Moy. Supported in part by CIMIT: Center for Integration of Medicine and Innovative Technology (Dr. Moy). Supported in part by VA Rehabilitation Research and Development Merit Review Grant B6618R (Dr. Garshick). This study was initiated by the investigators. The results of the present study do not constitute endorsement of the StepWatch Activity Monitor by the authors. Orthocare Innovations had no involvement in the study design, the collection, analysis, and interpretation of data, in the writing of the manuscript, or in the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2008, THORAX, V63, P122, DOI 10.1136/thx.2007.082636; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benzo RP, 2010, RESPIRATION, V80, P10, DOI 10.1159/000296504; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Depew ZS, 2012, RESPIROLOGY, V17, P1026, DOI 10.1111/j.1440-1843.2012.02207.x; Faganello MM, 2010, AM J MED SCI, V339, P10, DOI 10.1097/MAJ.0b013e3181bb8111; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Garcia-Aymerich J, 2003, THORAX, V58, P100, DOI 10.1136/thorax.58.2.100; Garcia-Aymerich J, 2001, AM J RESP CRIT CARE, V164, P1002, DOI 10.1164/ajrccm.164.6.2006012; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jenkins CR, 2012, EUR RESPIR J, V39, P38, DOI 10.1183/09031936.00194610; Jones Paul W, 2005, COPD, V2, P75; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kessler R, 1999, AM J RESP CRIT CARE, V159, P158, DOI 10.1164/ajrccm.159.1.9803117; Kocks JWH, 2011, PRIM CARE RESP J, V20, P269, DOI 10.4104/pcrj.2011.00031; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Mannino David M, 2007, Proc Am Thorac Soc, V4, P502, DOI 10.1513/pats.200701-001FM; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moy ML, 2012, RESP MED, V106, P1342, DOI 10.1016/j.rmed.2012.06.013; Moy ML, 2012, RESP MED, V106, P962, DOI 10.1016/j.rmed.2012.03.016; Moy ML, 2009, J REHABIL RES DEV, V46, P277, DOI 10.1682/JRRD.2008.07.0083; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Niewoehner DE, 2007, CHEST, V131, P20, DOI 10.1378/chest.06-1316; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Polkey MI, 2013, AM J RESP CRIT CARE, V187, P382, DOI 10.1164/rccm.201209-1596OC; Puhan MA, 2008, EUR RESPIR J, V32, P637, DOI 10.1183/09031936.00140507; Puhan MA, 2011, EUR RESPIR J, V37, P784, DOI 10.1183/09031936.00063810; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seidel D, 2012, INT J TUBERC LUNG D, V16, P1015, DOI 10.5588/ijtld.12.0050; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; van Gestel AJR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048081; Walker PP, 2008, THORAX, V63, P683, DOI 10.1136/thx.2007.087130; Waschki B, 2012, RESP MED, V106, P522, DOI 10.1016/j.rmed.2011.10.022; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830	51	90	91	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60400	10.1371/journal.pone.0060400	http://dx.doi.org/10.1371/journal.pone.0060400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593211	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100038
J	Sagar, A; Klemm, C; Hartjes, L; Mauerer, S; van Zandbergen, G; Spellerberg, B				Sagar, Anubha; Klemm, Carolin; Hartjes, Lara; Mauerer, Stefanie; van Zandbergen, Ger; Spellerberg, Barbara			The beta-Hemolysin and Intracellular Survival of Streptococcus agalactiae in Human Macrophages	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; NECROSIS-FACTOR-ALPHA; GRAM-POSITIVE BACTERIA; LUNG EPITHELIAL-CELLS; CAPSULAR POLYSACCHARIDE; STAPHYLOCOCCUS-AUREUS; TROJAN HORSES; INVASION; HEMOLYSIN/CYTOLYSIN; EXPRESSION	S. agalactiae (group B streptococci, GBS) is a major microbial pathogen in human neonates and causes invasive infections in pregnant women and immunocompromised individuals. The S. agalactiae beta-hemolysin is regarded as an important virulence factor for the development of invasive disease. To examine the role of b-hemolysin in the interaction with professional phagocytes, the THP-1 monocytic cell line and human granulocytes were infected with a serotype Ia S. agalactiae wild type strain and its isogenic nonhemolytic mutant. We could show that the nonhemolytic mutants were able to survive in significantly higher numbers than the hemolytic wild type strain, in THP-1 macrophage-like cells and in assays with human granulocytes. Intracellular bacterial multiplication, however, could not be observed. The hemolytic wild type strain stimulated a significantly higher release of Tumor Necrosis Factor-a than the nonhemolytic mutant in THP-1 cells, while similar levels of the chemokine Interleukin-8 were induced. In order to investigate bacterial mediators of IL-8 release in this setting, purified cell wall preparations from both strains were tested and found to exert a potent proinflammatory stimulus on THP-1 cells. In conclusion, our results indicate that the b-hemolysin has a strong influence on the intracellular survival of S. agalactiae and that a tightly controlled regulation of b-hemolysin expression is required for the successful establishment of S. agalactiae in different host niches.	[Sagar, Anubha; Klemm, Carolin; Hartjes, Lara; Mauerer, Stefanie; Spellerberg, Barbara] Univ Ulm, Inst Med Microbiol & Hosp Hyg, D-89069 Ulm, Germany; [van Zandbergen, Ger] Paul Ehrlich Inst, Fed Inst Vaccines & Biomed Drug, Langen, Germany	Ulm University; Paul Ehrlich Institute	Spellerberg, B (corresponding author), Univ Ulm, Inst Med Microbiol & Hosp Hyg, D-89069 Ulm, Germany.	barbara.spellerberg@uniklinik-ulm.de	van Zandbergen, Ger/M-1571-2013; Spellerberg, Barbara/D-3443-2011	Spellerberg, Barbara/0000-0001-7552-8764	Deutsche Forschungsgemeinschaft (DFG) [GSC270]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work of AS and BS was supproted by Deutsche Forschungsgemeinschaft (DFG) grant GSC270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aymanns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019822; Cumley NJ, 2012, INFECT IMMUN, V80, P1650, DOI 10.1128/IAI.05443-11; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Fan H, 2007, IMMUNOLOGY, V122, P116, DOI 10.1111/j.1365-2567.2007.02619.x; FARLEY MM, 1995, DRUG AGING, V6, P293, DOI 10.2165/00002512-199506040-00004; Fettucciari K, 2000, J IMMUNOL, V165, P3923, DOI 10.4049/jimmunol.165.7.3923; Fettucciari K, 2011, CELL MICROBIOL, V13, P859, DOI 10.1111/j.1462-5822.2011.01584.x; GIBSON RL, 1993, INFECT IMMUN, V61, P478, DOI 10.1128/IAI.61.2.478-485.1993; GIVNER LB, 1995, PEDIATR RES, V38, P551, DOI 10.1203/00006450-199510000-00013; Gottschalk B, 2006, J BACTERIOL, V188, P5984, DOI 10.1128/JB.00768-05; GRECO R, 1995, RES MICROBIOL, V146, P551, DOI 10.1016/0923-2508(96)80561-4; Harvey RM, 2011, INFECT IMMUN, V79, P4122, DOI 10.1128/IAI.05418-11; Hertzen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035218; HEUMANN D, 1994, INFECT IMMUN, V62, P2715, DOI 10.1128/IAI.62.7.2715-2721.1994; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Kwak DJ, 2000, INFECT IMMUN, V68, P320, DOI 10.1128/IAI.68.1.320-327.2000; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; Lemire P, 2012, MICROBES INFECT, V14, P1064, DOI 10.1016/j.micinf.2012.05.015; Littmann M, 2009, EMBO MOL MED, V1, P211, DOI 10.1002/emmm.200900025; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Luck S, 2003, LANCET, V361, P1953, DOI 10.1016/S0140-6736(03)13553-2; Morinis J, 2011, PAED CHILD HEALT-CAN, V16, pE48, DOI 10.1093/pch/16.6.e48; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; RUBENS CE, 1992, INFECT IMMUN, V60, P5157, DOI 10.1128/IAI.60.12.5157-5163.1992; Schwan WR, 2003, FEMS IMMUNOL MED MIC, V38, P23, DOI 10.1016/S0928-8244(03)00098-1; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Sendi P, 2009, EMERG INFECT DIS, V15, P223, DOI 10.3201/eid1502.080990; Spellerberg B, 1999, J BACTERIOL, V181, P3212, DOI 10.1128/JB.181.10.3212-3219.1999; Teixeira CF, 2001, MICROSC RES TECHNIQ, V54, P254, DOI 10.1002/jemt.1137; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; Ulett GC, 2005, J IMMUNOL, V175, P2555, DOI 10.4049/jimmunol.175.4.2555; ValentinWeigand P, 1996, INFECT IMMUN, V64, P2467, DOI 10.1128/IAI.64.7.2467-2473.1996; Vallejo JG, 1996, INFECT IMMUN, V64, P5042, DOI 10.1128/IAI.64.12.5042-5046.1996; Zangwill Kenneth M., 1992, Morbidity and Mortality Weekly Report, V41, P25	39	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60160	10.1371/journal.pone.0060160	http://dx.doi.org/10.1371/journal.pone.0060160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593170	gold, Green Submitted, Green Published			2022-12-27	WOS:000319108100019
J	Cox, RA; Garcia, MJ				Cox, Robert Ashley; Garcia, Maria Jesus			Adaptation of Mycobacteria to Growth Conditions: A Theoretical Analysis of Changes in Gene Expression Revealed by Microarrays	PLOS ONE			English	Article							OUTER-MEMBRANE; TUBERCULOSIS; PROTEIN; SYSTEMS; MODULATION; SMEGMATIS; SEQUENCE; RATES; PE	Background: Microarray analysis is a powerful technique for investigating changes in gene expression. Currently, results (r-values) are interpreted empirically as either unchanged or up- or down-regulated. We now present a mathematical framework, which relates r-values to the macromolecular properties of population-average cells. The theory is illustrated by the analysis of published data for two species; namely, Mycobacterium bovis BCG Pasteur and Mycobacterium smegmatis mc(2) 155. Each species was grown in a chemostat at two different growth rates. Application of the theory reveals the growth rate dependent changes in the mycobacterial proteomes. Principal Findings: The r-value r((i)) of any ORF (ORF(i)) encoding protein p((i)) was shown to be equal to the ratio of the concentrations of p((i)) and so directly proportional to the ratio of the numbers of copies of p((i)) per population-average cells of the two cultures. The proportionality constant can be obtained from the ratios DNA: RNA: protein. Several subgroups of ORFs were identified because they shared a particular r-value. Histograms of the number of ORFs versus the expression ratio were simulated by combining the particular r-values of several subgroups of ORFs. The largest subgroup was ORF(j) (r((j)) = 1.00 +/- SD) which was estimated to comprise respectively 59% and 49% of ORFs of M. bovis BCG Pasteur and M. smegmatis mc(2) 155. The standard deviations reflect the properties of the cDNA preparations investigated. Significance: The analysis provided a quantitative view of growth rate dependent changes in the proteomes of the mycobacteria studied. The majority of the ORFs were found to be constitutively expressed. In contrast, the protein compositions of the outer permeability barriers and cytoplasmic membranes were found to be dependent on growth rate; thus illustrating the response of bacteria to their environment. The theoretical approach applies to any cultivatable bacterium under a wide range of growth conditions.	[Cox, Robert Ashley] Natl Inst Med Res, Div Mycobacterial Res, London NW7 1AA, England; [Garcia, Maria Jesus] Univ Autonoma Madrid, Fac Med, Dept Med Prevent, E-28049 Madrid, Spain	MRC National Institute for Medical Research; Autonomous University of Madrid	Cox, RA (corresponding author), Natl Inst Med Res, Div Mycobacterial Res, Mill Hill, London NW7 1AA, England.	rcox@nimr.mrc.ac.uk	Garcia, Maria Jesus Garcia/B-7624-2014	Cox, Robert Ashley/0000-0002-4854-4379				Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Beste DJV, 2007, J BACTERIOL, V189, P3969, DOI 10.1128/JB.01787-06; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; BRATBAK G, 1984, APPL ENVIRON MICROB, V48, P755, DOI 10.1128/AEM.48.4.755-757.1984; Bremer H, 1996, ESCHERICHIA COLI SAL; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; BYRNE R, 1964, P NATL ACAD SCI USA, V52, P140, DOI 10.1073/pnas.52.1.140; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Chen TA, 2010, MICROB PATHOGENESIS, V49, P311, DOI 10.1016/j.micpath.2010.07.004; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cook GM, 2009, ADV MICROB PHYSIOL, V55, P81, DOI 10.1016/S0065-2911(09)05502-7; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; Cox RA, 2007, MICROBIOL-SGM, V153, P3337, DOI 10.1099/mic.0.2007/005868-0; Cox RA, 2007, CURR MOL MED, V7, P231, DOI 10.2174/156652407780598584; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Frampton R, 2012, J BIOL CHEM, V287, P5340, DOI 10.1074/jbc.M111.286856; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Goodfellow Michael, 1998, P1; Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Holland I. B., 2003, ABC PROTEINS BACTERI; Garcia MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011575; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Lu P, 2005, NAT BIOTECHNOL, V25, P117; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Mahfoud M, 2006, J BIOL CHEM, V281, P5908, DOI 10.1074/jbc.M511642200; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; RISON SCG, 2005, MYCOBACTERIUM MOL MI, P29; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Senaratne RH, 1998, J BACTERIOL, V180, P3541, DOI 10.1128/JB.180.14.3541-3547.1998; Sidders B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r265; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Southern E M, 2001, Methods Mol Biol, V170, P1; Stadthagen-Gomez G, 2008, FEMS MICROBIOL LETT, V280, P102, DOI 10.1111/j.1574-6968.2007.01050.x; STENT GS, 1964, SCIENCE, V144, P816, DOI 10.1126/science.144.3620.816; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; TERHORST C, 1972, FEBS LETT, V28, P325, DOI 10.1016/0014-5793(72)80742-7; Tyagi JS, 2004, CURR SCI INDIA, V86, P93; ULBRICH B, 1975, EUR J BIOCHEM, V57, P49, DOI 10.1111/j.1432-1033.1975.tb02275.x; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076	56	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e59883	10.1371/journal.pone.0059883	http://dx.doi.org/10.1371/journal.pone.0059883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593152	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300009
J	Savina, M; Condie, SA; Fulton, EA				Savina, Marie; Condie, Scott A.; Fulton, Elizabeth A.			The Role of Pre-Existing Disturbances in the Effect of Marine Reserves on Coastal Ecosystems: A Modelling Approach	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; PROTECTED AREAS; FISH COMMUNITIES; PERFORMANCE; MANAGEMENT; SIZE; SIMULATION; FISHERIES; DYNAMICS; PATTERNS	We have used an end-to-end ecosystem model to explore responses over 30 years to coastal no-take reserves covering up to 6% of the fifty thousand square kilometres of continental shelf and slope off the coast of New South Wales (Australia). The model is based on the Atlantis framework, which includes a deterministic, spatially resolved three-dimensional biophysical model that tracks nutrient flows through key biological groups, as well as extraction by a range of fisheries. The model results support previous empirical studies in finding clear benefits of reserves to top predators such as sharks and rays throughout the region, while also showing how many of their major prey groups (including commercial species) experienced significant declines. It was found that the net impact of marine reserves was dependent on the pre-existing levels of disturbance (i.e. fishing pressure), and to a lesser extent on the size of the marine reserves. The high fishing scenario resulted in a strongly perturbed system, where the introduction of marine reserves had clear and mostly direct effects on biomass and functional biodiversity. However, under the lower fishing pressure scenario, the introduction of marine reserves caused both direct positive effects, mainly on shark groups, and indirect negative effects through trophic cascades. Our study illustrates the need to carefully align the design and implementation of marine reserves with policy and management objectives. Trade-offs may exist not only between fisheries and conservation objectives, but also among conservation objectives.	[Savina, Marie] Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Brisbane, Qld, Australia; [Condie, Scott A.; Fulton, Elizabeth A.] Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Savina, M (corresponding author), Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Brisbane, Qld, Australia.	Marie.Savina-Rolland@csiro.au	Fulton, Beth/A-2871-2008; Fulton, Beth/AAJ-1398-2021; Condie, Scott A/C-2953-2012	Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917; Savina-Rolland, Marie/0000-0001-9762-3295	"Wealth from Oceans" Commonwealth Scientific and Industrial Research Organisation flagship; New South Wales Department of Primary Industries; CSIRO Wealth From Oceans Flagship; NSW Department of Primary Industries	"Wealth from Oceans" Commonwealth Scientific and Industrial Research Organisation flagship; New South Wales Department of Primary Industries; CSIRO Wealth From Oceans Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); NSW Department of Primary Industries	This work was funded by the "Wealth from Oceans" Commonwealth Scientific and Industrial Research Organisation flagship and the New South Wales Department of Primary Industries. The CSIRO Wealth From Oceans Flagship and the NSW Department of Primary Industries co-funded this work. Both bodies contributed to some extent to the study design, but none had any role in the decision to publish or in the preparation of the manuscript.	Ainsworth CH, 2012, MAR POLICY, V36, P1275, DOI 10.1016/j.marpol.2012.03.016; Ainsworth CH, 2006, ECOL INDIC, V6, P623, DOI 10.1016/j.ecolind.2005.08.024; Albouy C, 2010, MAR ECOL PROG SER, V412, P207, DOI 10.3354/meps08679; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Boersma PD, 1999, ECOL ECON, V31, P287, DOI 10.1016/S0921-8009(99)00085-3; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Clemente S, 2010, MAR ECOL PROG SER, V413, P55, DOI 10.3354/meps08700; Colleter M, 2012, ECOL MODEL, V232, P1, DOI 10.1016/j.ecolmodel.2012.01.019; Condie SA, 2006, MAR FRESHWATER RES, V57, P569, DOI 10.1071/MF06009; Fanshawe S, 2003, CONSERV BIOL, V17, P273, DOI 10.1046/j.1523-1739.2003.00432.x; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2004, ECOL MODEL, V173, P371, DOI 10.1016/j.ecolmodel.2003.09.024; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Fulton EA, 2007, ALTERNATIVE MANAGEME; FULTON EA, 2004, R991546 AFMA; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; GARDNER RH, 1982, ECOLOGY, V63, P1771, DOI 10.2307/1940119; Gerber LR, 2003, ECOL APPL, V13, pS47; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Halpern BS, 2003, ECOL APPL, V13, pS117; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; HOCKEY PAR, 1986, OIKOS, V46, P3, DOI 10.2307/3565373; Johnson P, 2011, NAT RESOUR MODEL, V24, P335, DOI 10.1111/j.1939-7445.2011.00094.x; Kaplan DM, 2009, MAR ECOL PROG SER, V377, P213, DOI 10.3354/meps07825; Kaplan IC, 2012, PROG OCEANOGR, V102, P5, DOI 10.1016/j.pocean.2012.03.009; Kemp J, 2012, OCEANOGR MAR BIOL, V50, P287; Lamb RW, 2010, MAR ECOL PROG SER, V408, P169, DOI 10.3354/meps08509; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Libralato S, 2010, BIOL CONSERV, V143, P2182, DOI 10.1016/j.biocon.2010.06.002; Maury O, 2007, PROG OCEANOGR, V74, P479, DOI 10.1016/j.pocean.2007.05.002; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mouillot D, 2008, BIOL CONSERV, V141, P1569, DOI 10.1016/j.biocon.2008.04.002; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; NSW Department of Infrastructure Planning and Natural Resources, 2006, PINEENA DAT; Oguz T, 2008, MAR ECOL PROG SER, V369, P229, DOI 10.3354/meps07540; Oke PR, 2008, OCEAN MODEL, V21, P46, DOI 10.1016/j.ocemod.2007.11.002; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Rose KA, 2010, MAR COAST FISH, V2, P115, DOI 10.1577/C09-059.1; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Salomon Anne K., 2002, Aquatic Ecology, V36, P85, DOI 10.1023/A:1013346622536; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Savina M, ECOLOGICAL EFF UNPUB; Stelzenmuller V, 2009, AQUAT CONSERV, V19, P554, DOI 10.1002/aqc.1003; Tesfaye M, 2003, SOIL BIOL BIOCHEM, V35, P1103, DOI 10.1016/S0038-0717(03)00162-7; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Travers M, 2010, PROG OCEANOGR, V84, P118, DOI 10.1016/j.pocean.2009.09.014; Valls A, 2012, MAR ECOL PROG SER, V456, P201, DOI 10.3354/meps09701; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Waldbusser GG, 2004, LIMNOL OCEANOGR, V49, P1482, DOI 10.4319/lo.2004.49.5.1482; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; White JW, 2011, FRONT ECOL ENVIRON, V9, P390, DOI 10.1890/100138; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	55	13	13	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61207	10.1371/journal.pone.0061207	http://dx.doi.org/10.1371/journal.pone.0061207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593432	Green Published, gold			2022-12-27	WOS:000317385300060
J	Chai, LP; Wang, ZF; Liang, WY; Chen, L; Chen, D; Wang, AX; Zhang, ZQ				Chai, Li-Ping; Wang, Zhang-Feng; Liang, Wei-Ying; Chen, Lei; Chen, Dan; Wang, An-Xun; Zhang, Zhao-Qiang			In Vitro and In Vivo Effect of 5-FC Combined Gene Therapy with TNF-alpha and CD Suicide Gene on Human Laryngeal Carcinoma Cell Line Hep-2	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CYTOSINE DEAMINASE GENE; CANCER; XENOGRAFTS	This study was aimed to investigate the effect of combined cancer gene therapy with exogenous tumor necrosis factor-alpha (TNF-alpha) and cytosine deaminase (CD) suicide gene on laryngeal carcinoma cell line Hep-2 in vitro and in vivo. Transfection of the recombinant eukaryotic vectors of pcDNA3.1 (+) containing TNF-alpha and/or CD into Hep-2 cells resulted in expression of TNF-alpha and/or CD gene in vitro. The significant increase in apoptotic Hep-2 cells and decrease of Hep-2 cell proliferation were observed using 5-FC treatment combined with TNF-a expression by CD/5-FC suicide system. Moreover, bystander effect was also observed in the TNF-alpha and CD gene co-expression group. Laryngeal squamous cell carcinoma (LSCC) mice model was established by using BALB/c mice which different transfected Hep-2 cells with pcDNA3.1 (+) containing TNF-alpha and/or CD were applied subcutaneously. So these mice are divided into four groups, namely, (1)Hep-2/TIC group; (2)Hep-2/CD group; (3)Hep-2/TNF-alpha group; (4)Hep-2/0 group. At day 29 after cell inoculation, volume of grafted tumor had significant difference between each two of them (P<0.05). These results showed that the products of combined CD and TNF-alpha genes inhibited the growth of transplanted LSCC in mice model. So by our observed parameters and many others results, we hypothesized that 5-FC combined gene therapy with TNF-alpha and CD suicide gene should be an effective treatment on Laryngeal carcinoma.	[Chai, Li-Ping; Wang, Zhang-Feng] Sun Yat Sen Univ, Dept Otolaryngol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Chai, Li-Ping; Wang, Zhang-Feng] Sun Yat Sen Univ, Otolaryngol Inst, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Wei-Ying] Univ Hong Kong, Shenzhen Hosp, Dept Otolaryngol, Shenzhen, Guangdong, Peoples R China; [Chen, Lei] Sun Yat Sen Univ, Dept Burns Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Dan; Wang, An-Xun] Sun Yat Sen Univ, Dept Oral & Mallofacial Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Zhao-Qiang] Guangzhou Med Univ, Hosp Stomatol, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Chai, LP (corresponding author), Sun Yat Sen Univ, Dept Otolaryngol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	clp58612@163.com	Chen, Lei/AAF-8797-2020; 兆强, 张/GRJ-1212-2022; Chen, Dan/GRY-2691-2022; Zhang, Zhaoqiang/AAE-3664-2019	Chen, Lei/0000-0001-7146-4636; 兆强, 张/0000-0002-9183-7273; Chen, Dan/0000-0002-1570-9034; Zhang, Zhaoqiang/0000-0002-9183-7273	Science and Technology Project of Guangdong Province [2004B30901007, 2007B031516010]	Science and Technology Project of Guangdong Province	This work was supported by grants from the Science and Technology Project of Guangdong Province, No. 2004B30901007 and No. 2007B031516010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER A, 1987, J IMMUNOL, V138, P963; BALKWILL FR, 1986, CANCER RES, V46, P3990; Cao XT, 2000, CANCER GENE THER, V7, P177, DOI 10.1038/sj.cgt.7700114; FUKUMURA D, 1995, CANCER RES, V55, P4824; Hall EJ, 2003, HEALTH PHYS, V85, P31, DOI 10.1097/00004032-200307000-00008; Hallahan D E, 1995, Cancer J Sci Am, V1, P204; Hanna NN, 1997, CANCER RES, V57, P4205; HAWKINS NV, 1975, LARYNGOSCOPE, V85, P1485, DOI 10.1288/00005537-197509000-00009; JESSE RH, 1975, LARYNGOSCOPE, V85, P1424, DOI 10.1288/00005537-197509000-00002; Liu J, 2002, INT J ONCOL, V21, P661; Nyati MK, 2002, GENE THER, V9, P844, DOI 10.1038/sj.gt.3301706; RENARD N, 1994, INT J CANCER, V57, P656, DOI 10.1002/ijc.2910570508; Rosenberg SA, 1990, HUM GENE THER, V1, P441; Sambrook J, 1999, MOL CLONING LAB MANU, V16-26, P50; SHAH JP, 1974, AM J SURG, V128, P494, DOI 10.1016/0002-9610(74)90262-1; Shang C, 2003, ADV MOL CYTOGENETICS, V26, P360; Situ ZQ, 2007, CELL CULTRURE, P173; Conejeros JMT, 2007, ACTA OTORRINOLAR ESP, V58, P449, DOI 10.1016/S0001-6519(07)74965-8; Topf N, 1998, GENE THER, V5, P507, DOI 10.1038/sj.gt.3300611; Trzcieniecka-Green A, 2007, J PHYSIOL PHARMACOL, V58, P699; Uslu C, 2003, ANN CLIN LAB SCI, V33, P156	21	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61136	10.1371/journal.pone.0061136	http://dx.doi.org/10.1371/journal.pone.0061136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593411	Green Submitted, Green Published, gold			2022-12-27	WOS:000317383200042
J	Tokman, M; Lee, JH; Levine, ZA; Ho, MC; Colvin, ME; Vernier, PT				Tokman, Mayya; Lee, Jane HyoJin; Levine, Zachary A.; Ho, Ming-Chak; Colvin, Michael E.; Vernier, P. Thomas			Electric Field-Driven Water Dipoles: Nanoscale Architecture of Electroporation	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BILAYER-LIPID-MEMBRANES; ELECTROPERMEABILIZATION; ELECTROCHEMOTHERAPY; BREAKDOWN; THERAPY; CELLS; MODEL	Electroporation is the formation of permeabilizing structures in the cell membrane under the influence of an externally imposed electric field. The resulting increased permeability of the membrane enables a wide range of biological applications, including the delivery of normally excluded substances into cells. While electroporation is used extensively in biology, biotechnology, and medicine, its molecular mechanism is not well understood. This lack of knowledge limits the ability to control and fine-tune the process. In this article we propose a novel molecular mechanism for the electroporation of a lipid bilayer based on energetics analysis. Using molecular dynamics simulations we demonstrate that pore formation is driven by the reorganization of the interfacial water molecules. Our energetics analysis and comparisons of simulations with and without the lipid bilayer show that the process of poration is driven by field-induced reorganization of water dipoles at the water-lipid or water-vacuum interfaces into more energetically favorable configurations, with their molecular dipoles oriented in the external field. Although the contributing role of water in electroporation has been noted previously, here we propose that interfacial water molecules are the main players in the process, its initiators and drivers. The role of the lipid layer, to a first-order approximation, is then reduced to a relatively passive barrier. This new view of electroporation simplifies the study of the problem, and opens up new opportunities in both theoretical modeling of the process and experimental research to better control or to use it in new, innovative ways.	[Tokman, Mayya; Lee, Jane HyoJin; Colvin, Michael E.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Levine, Zachary A.; Ho, Ming-Chak] Univ So Calif, Dept Phys & Astron, Los Angeles, CA USA; [Vernier, P. Thomas] Univ So Calif, Ming Hsieh Dept Elect Engn, Los Angeles, CA USA	University of California System; University of California Merced; University of Southern California; University of Southern California	Tokman, M (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	mtokman@ucmerced.edu	Vernier, P. Thomas/D-7926-2016	Vernier, P. Thomas/0000-0003-2335-1500	U.S. Department of Energy, Office of Science, Offices of Advanced Scientific Computing Research, and Biological & Environmental Research through the U.C. Merced Center for Computational Biology [DE-FG02-04ER25625]	U.S. Department of Energy, Office of Science, Offices of Advanced Scientific Computing Research, and Biological & Environmental Research through the U.C. Merced Center for Computational Biology(United States Department of Energy (DOE))	This work was in part supported by a grant from the U.S. Department of Energy, Office of Science, Offices of Advanced Scientific Computing Research, and Biological & Environmental Research through the U.C. Merced Center for Computational Biology #DE-FG02-04ER25625. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDOR IG, 1979, BIOELECTROCH BIOENER, V6, P37; BENZ R, 1979, J MEMBRANE BIOL, V48, P181, DOI 10.1007/BF01872858; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bockmann RA, 2008, BIOPHYS J, V95, P1837, DOI 10.1529/biophysj.108.129437; Bostick D, 2003, BIOPHYS J, V85, P97, DOI 10.1016/S0006-3495(03)74458-0; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FERGUSON DM, 1995, J COMPUT CHEM, V16, P501, DOI 10.1002/jcc.540160413; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; GENCO I, 1993, BIOCHIM BIOPHYS ACTA, V1149, P10, DOI 10.1016/0005-2736(93)90019-V; Goncalves PFB, 2004, PURE APPL CHEM, V76, P231, DOI 10.1351/pac200476010231; Heller R, 1996, CANCER-AM CANCER SOC, V77, P964, DOI 10.1002/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hu Q, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031914; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kalinowski S, 1998, BBA-BIOMEMBRANES, V1369, P204, DOI 10.1016/S0005-2736(97)00222-8; Kotnik T, 2000, IEEE T BIO-MED ENG, V47, P1074, DOI 10.1109/10.855935; Kotulska M, 2010, J MEMBRANE BIOL, V236, P37, DOI 10.1007/s00232-010-9285-y; Levine ZA, 2010, J MEMBRANE BIOL, V236, P27, DOI 10.1007/s00232-010-9277-y; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Melikov KC, 2001, BIOPHYS J, V80, P1829, DOI 10.1016/S0006-3495(01)76153-X; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; ROBELLO M, 1989, BIOCHIM BIOPHYS ACTA, V982, P173, DOI 10.1016/0005-2736(89)90189-2; Rols MP, 2006, BBA-BIOMEMBRANES, V1758, P423, DOI 10.1016/j.bbamem.2006.01.005; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Tarek M, 2005, BIOPHYS J, V88, P4045, DOI 10.1529/biophysj.104.050617; Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006; Tieleman D. Peter, 2004, BMC Biochemistry, V5, P10, DOI 10.1186/1471-2091-5-10; Vanderlinde J., 2004, CLASSICAL ELECTROMAG, P33; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; ZIMMERMANN U, 1982, BIOCHIM BIOPHYS ACTA, V694, P227, DOI 10.1016/0304-4157(82)90007-7	36	58	58	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61111	10.1371/journal.pone.0061111	http://dx.doi.org/10.1371/journal.pone.0061111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593404	Green Submitted, Green Published, gold			2022-12-27	WOS:000317383200041
J	Farias, AR; Garrido, MV; Semin, GR				Farias, Ana Rita; Garrido, Margarida V.; Semin, Gun R.			Converging Modalities Ground Abstract Categories: The Case of Politics	PLOS ONE			English	Article							SPATIAL ORIENTATION; MOTOR SYSTEM; LANGUAGE; REPRESENTATION; COMPREHENSION; PERCEPTION; WORDS; TIME; BIAS	Three studies are reported examining the grounding of abstract concepts across two modalities (visual and auditory) and their symbolic representation. A comparison of the outcomes across these studies reveals that the symbolic representation of political concepts and their visual and auditory modalities is convergent. In other words, the spatial relationships between specific instances of the political categories are highly overlapping across the symbolic, visual and auditory modalities. These findings suggest that abstract categories display redundancy across modal and amodal representations, and are multimodal.	[Farias, Ana Rita; Garrido, Margarida V.] Cis IUL, Inst Univ Lisboa ISCTE IUL, Lisbon, Portugal; [Farias, Ana Rita; Garrido, Margarida V.; Semin, Gun R.] Univ Utrecht, Fac Social & Behav Sci, Utrecht, Netherlands; [Semin, Gun R.] Koc Univ, Coll Social Sci & Humanities, Istanbul, Turkey	Instituto Universitario de Lisboa; Utrecht University; Koc University	Semin, GR (corresponding author), Univ Utrecht, Fac Social & Behav Sci, Utrecht, Netherlands.	G.R.Semin@uu.nl	Farias, Ana Rita/K-1944-2015; Semin, Gun/J-4046-2013; Garrido, Margarida/J-4083-2013	Farias, Ana Rita/0000-0002-7686-4046; Semin, Gun/0000-0002-5304-5566; Garrido, Margarida/0000-0003-3651-9245	Fundacao para a Ciencia e Tecnologia [SFRH/BD/60698/2009, PTDC/PSI/PSO/099346/2008]; Marie Curie Grant (Intra European Fellowships FP7-PEOPLE-2011-IEF Grant) [301410]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Grant (Intra European Fellowships FP7-PEOPLE-2011-IEF Grant)	This research reported here was supported in part by the Fundacao para a Ciencia e Tecnologia (Grant SFRH/BD/60698/2009, awarded to the first author and Grant PTDC/PSI/PSO/099346/2008, awarded to the second author), and a Marie Curie Grant (Intra European Fellowships FP7-PEOPLE-2011-IEF Grant Agreement Number 301410) awarded to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou L., 2008, SYMBOLS EMBODIMENT D, P245, DOI [DOI 10.1093/ACPROF:OSO/9780199217274.003.0013, 10.1093/acprof:oso/9780199217274.003.0013, DOI 10.1093/ACPROF:OSO/9780199217274.003]; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Boroditsky L, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P98; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Crawford LE, 2006, COGNITION EMOTION, V20, P1153, DOI 10.1080/02699930500347794; Dove G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00242; Dove G, 2009, COGNITION, V110, P412, DOI 10.1016/j.cognition.2008.11.016; Estes Z, 2008, PSYCHOL SCI, V19, P93, DOI 10.1111/j.1467-9280.2008.02051.x; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Fodor J. A., 1975, LANGUAGE THOUGHT; Glenberg AM, 2012, CORTEX, V48, P905, DOI 10.1016/j.cortex.2011.04.010; Glenberg AM, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P43; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Kaschak MP, 2005, COGNITION, V94, pB79, DOI 10.1016/j.cognition.2004.06.005; KIMURA D, 1961, CAN J PSYCHOLOGY, V15, P166, DOI 10.1037/h0083219; Kintsch W, 1998, INT J PSYCHOL, V33, P411, DOI 10.1080/002075998400169; Lakens D, 2011, CONSCIOUS COGN, V20, P437, DOI 10.1016/j.concog.2010.09.020; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Louwerse M.M., 2008, SYMBOLS EMBODIMENT D, P309, DOI [DOI 10.1093/ACPROF:OSO/9780199217274.003.0015, 10.1093/acprof:oso/9780199217274.003.0015]; Louwerse M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00105; Louwerse MM, 2008, PSYCHON B REV, V15, P838, DOI 10.3758/PBR.15.4.838; Louwerse MM, 2010, COGNITION, V114, P96, DOI 10.1016/j.cognition.2009.09.002; Maass A, 2003, PSYCHOL SCI, V14, P296, DOI 10.1111/1467-9280.14421; Maass A, 2007, SOC COGNITION, V25, P833, DOI 10.1521/soco.2007.25.6.833; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Meteyard L, 2007, PSYCHOL SCI, V18, P1007, DOI 10.1111/j.1467-9280.2007.02016.x; Oppenheimer DM, 2010, SOC COGNITION, V28, P651, DOI 10.1521/soco.2010.28.5.651; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Richardson DC, 2003, COGNITIVE SCI, V27, P767, DOI 10.1016/S0364-0213(03)00064-8; Richardson DC, 2000, COGNITION, V76, P269, DOI 10.1016/S0010-0277(00)00084-6; Santiago J, 2011, SPATIAL DIMENSIONS S, P39; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Semin GR, 2013, DUAL PROCES IN PRESS; Setic M, 2007, LANG COGNITIVE PROC, V22, P297, DOI 10.1080/01690960600732430; van Elk M, 2010, Q J EXP PSYCHOL, V63, P2202, DOI 10.1080/17470218.2010.495160; Van Peer W, 2009, COGNITIVE POETICS GO, P421; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1; Zwaan RA, 2003, PSYCHON B REV, V10, P954, DOI 10.3758/BF03196557; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 2009, EUR J SOC PSYCHOL, V39, P1142, DOI 10.1002/ejsp.661; Zwaan Rolf A., 2008, SYMBOLS EMBODIMENT D, P165, DOI DOI 10.1093/ACPROF:OSO/9780199217274.003.0009	45	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60971	10.1371/journal.pone.0060971	http://dx.doi.org/10.1371/journal.pone.0060971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123IQ	23593360	Green Published, gold			2022-12-27	WOS:000317382000031
J	Nair, A; Kuwahara, A; Nagase, A; Yamaguchi, H; Yamazaki, T; Hosoya, M; Omura, A; Kiyomoto, K; Yamaguchi, M; Shimoyama, T; Takahashi, S; Nakayama, T				Nair, Arun; Kuwahara, Akika; Nagase, Akihiro; Yamaguchi, Haruhiko; Yamazaki, Tatsuya; Hosoya, Miho; Omura, Ayano; Kiyomoto, Kunio; Yamaguchi, Masa-atsu; Shimoyama, Takefumi; Takahashi, Seiji; Nakayama, Toru			Purification, Gene Cloning, and Biochemical Characterization of a beta-Glucosidase Capable of Hydrolyzing Sesaminol Triglucoside from Paenibacillus sp KB0549	PLOS ONE			English	Article							SESAMOLIN; BACTERIA; LIGNANS; SYSTEM	The triglucoside of sesaminol, i.e., 2,6-O-di(beta-D-glucopyranosyl)-beta-D- glucopyranosylsesaminol (STG), occurs abundantly in sesame seeds and sesame oil cake and serves as an inexpensive source for the industrial production of sesaminol, an antioxidant that displays a number of bioactivities beneficial to human health. However, STG has been shown to be highly resistant to the action of beta-glucosidases, in part due to its branched-chain glycon structure, and these circumstances hampered the efficient utilization of STG. We found that a strain (KB0549) of the genus Paenibacillus produced a novel enzyme capable of efficiently hydrolyzing STG. This enzyme, termed PSTG, was a tetrameric protein consisting of identical subunits with an approximate molecular mass of 80 kDa. The PSTG gene was cloned on the basis of the partial amino acid sequences of the purified enzyme. Sequence comparison showed that the enzyme belonged to the glycoside hydrolase family 3, with significant similarities to the Paenibacillus glucocerebrosidase (63% identity) and to Bgl3B of Thermotoga neapolitana (37% identity). The recombinant enzyme (rPSTG) was highly specific for beta-glucosidic linkage, and k(cat) and k(cat)/K-m values for the rPSTG-catalyzed hydrolysis of p-nitrophenyl-beta-glucopyraniside at 37 degrees C and pH 6.5 were 44 s(-1) and 426 s(-1) mM (-1), respectively. The specificity analyses also revealed that the enzyme acted more efficiently on sophorose than on cellobiose and gentiobiose. Thus, rPSTG is the first example of a beta-glucosidase with higher reactivity for beta-1,2-glucosidic linkage than for beta-1,4- and beta-1,6-glucosidic linkages, as far as could be ascertained. This unique specificity is, at least in part, responsible for the enzyme's ability to efficiently decompose STG.	[Nair, Arun; Omura, Ayano; Kiyomoto, Kunio] Kiyomoto Co Ltd, Nobeoka, Miyazaki, Japan; [Kuwahara, Akika; Nagase, Akihiro; Yamaguchi, Haruhiko; Yamazaki, Tatsuya; Hosoya, Miho; Shimoyama, Takefumi; Takahashi, Seiji; Nakayama, Toru] Tohoku Univ, Lab Appl Life Chem, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Yamaguchi, Masa-atsu] Minami Kyushu Univ, Fac Hlth & Nutr, Dept Food Sci Hlth, Miyakonojo, Miyazaki, Japan	Tohoku University	Nakayama, T (corresponding author), Tohoku Univ, Lab Appl Life Chem, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 980, Japan.	nakayama@seika.che.tohoku.ac.jp		Takahashi, Seiji/0000-0002-2288-4340	JAPAN SCIENCE AND TECHNOLOGY AGENCY	JAPAN SCIENCE AND TECHNOLOGY AGENCY(Japan Science & Technology Agency (JST))	This work was in part supported by a grant "Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP)" from JAPAN SCIENCE AND TECHNOLOGY AGENCY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelsberger H, 2004, MICROBIOL-SGM, V150, P2257, DOI 10.1099/mic.0.27066-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; FUKUDA Y, 1986, J AM OIL CHEM SOC, V63, P1027, DOI 10.1007/BF02673792; FUKUDA Y, 1986, HETEROCYCLES, V24, P923, DOI 10.3987/R-1986-04-0923; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; Huang JN, 2012, EUR J LIPID SCI TECH, V114, P842, DOI 10.1002/ejlt.201100247; Hwang IT, 2003, BIOTECHNIQUES, V35, P1180, DOI 10.2144/03356st03; Kang MH, 1998, LIPIDS, V33, P1031, DOI 10.1007/s11745-998-0302-y; Kang MH, 1999, LIFE SCI, V66, P161, DOI 10.1016/S0024-3205(99)00574-3; KATSUZAKI H, 1993, HETEROCYCLES, V36, P933; KATSUZAKI H, 1994, PHYTOCHEMISTRY, V35, P773, DOI 10.1016/S0031-9422(00)90603-4; Kumazawa S., 2003, Journal of Oleo Science, V52, P303; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEATHERBARROW RJ, 1990, TRENDS BIOCHEM SCI, V15, P455, DOI 10.1016/0968-0004(90)90295-M; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Miyahara Y, 2001, INT J MOL MED, V7, P485; Miyake Y, 2005, J AGR FOOD CHEM, V53, P22, DOI 10.1021/jf048743h; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nguyen TAD, 2010, BIORESOURCE TECHNOL, V101, pS38, DOI 10.1016/j.biortech.2009.03.041; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Paal K, 2004, BIOCHEM J, V378, P141, DOI 10.1042/BJ20031028; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; RAYNAL A, 1987, CURR GENET, V12, P175, DOI 10.1007/BF00436876; Richard JP, 1996, BIOCHEMISTRY-US, V35, P12377, DOI 10.1021/bi961028j; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAWAIHATANAKA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1221, DOI 10.1271/bbb.59.1221; Seidle HF, 2004, PROTEIN J, V23, P11, DOI 10.1023/B:JOPC.0000016254.58189.2a; Suja KP, 2004, J AGR FOOD CHEM, V52, P912, DOI 10.1021/jf0303621; Sumida T, 2002, J BIOCHEM, V132, P237, DOI 10.1093/oxfordjournals.jbchem.a003216; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watanabe K, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-23; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	33	12	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60538	10.1371/journal.pone.0060538	http://dx.doi.org/10.1371/journal.pone.0060538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593237	Green Published, gold, Green Submitted			2022-12-27	WOS:000317382000019
J	Shanechi, MM; Williams, ZM; Wornell, GW; Hu, RC; Powers, M; Brown, EN				Shanechi, Maryam M.; Williams, Ziv M.; Wornell, Gregory W.; Hu, Rollin C.; Powers, Marissa; Brown, Emery N.			A Real-Time Brain-Machine Interface Combining Motor Target and Trajectory Intent Using an Optimal Feedback Control Design	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; GOAL-DIRECTED MOVEMENTS; PREMOTOR CORTEX; CORTICAL-NEURONS; NEURAL PROSTHETICS; COMPUTER INTERFACE; SPIKING ACTIVITY; REACHING TASK; ARM MOVEMENTS; STATE	Real-time brain-machine interfaces (BMI) have focused on either estimating the continuous movement trajectory or target intent. However, natural movement often incorporates both. Additionally, BMIs can be modeled as a feedback control system in which the subject modulates the neural activity to move the prosthetic device towards a desired target while receiving real-time sensory feedback of the state of the movement. We develop a novel real-time BMI using an optimal feedback control design that jointly estimates the movement target and trajectory of monkeys in two stages. First, the target is decoded from neural spiking activity before movement initiation. Second, the trajectory is decoded by combining the decoded target with the peri-movement spiking activity using an optimal feedback control design. This design exploits a recursive Bayesian decoder that uses an optimal feedback control model of the sensorimotor system to take into account the intended target location and the sensory feedback in its trajectory estimation from spiking activity. The real-time BMI processes the spiking activity directly using point process modeling. We implement the BMI in experiments consisting of an instructed-delay center-out task in which monkeys are presented with a target location on the screen during a delay period and then have to move a cursor to it without touching the incorrect targets. We show that the two-stage BMI performs more accurately than either stage alone. Correct target prediction can compensate for inaccurate trajectory estimation and vice versa. The optimal feedback control design also results in trajectories that are smoother and have lower estimation error. The two-stage decoder also performs better than linear regression approaches in offline cross-validation analyses. Our results demonstrate the advantage of a BMI design that jointly estimates the target and trajectory of movement and more closely mimics the sensorimotor control system.	[Shanechi, Maryam M.] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA; [Shanechi, Maryam M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Shanechi, Maryam M.; Wornell, Gregory W.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Shanechi, Maryam M.; Williams, Ziv M.; Hu, Rollin C.; Powers, Marissa] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Shanechi, Maryam M.; Williams, Ziv M.; Hu, Rollin C.; Brown, Emery N.] Harvard Univ, Sch Med, Boston, MA USA; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA	Cornell University; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Shanechi, MM (corresponding author), Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA.	shanechi@cornell.edu			National Institutes of Health (NIH) [DP1-0D003646-01, R01-EB006385]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006385] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) Grant Nos. DP1-0D003646-01 and R01-EB006385. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERSON GA, 1970, IEEE T AUTOMAT CONTR, VAC15, P10, DOI 10.1109/TAC.1970.1099359; Andersen RA, 2004, TRENDS COGN SCI, V8, P486, DOI 10.1016/j.tics.2004.09.009; ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; Averbeck BB, 2005, J NEUROPHYSIOL, V93, P508, DOI 10.1152/jn.00357.2004; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Bertsekas D. P., 2005, DYNAMIC PROGRAMMING; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Boussaoud D, 1999, EXP BRAIN RES, V128, P170, DOI 10.1007/s002210050832; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chase SM, 2009, NEURAL NETWORKS, V22, P1203, DOI 10.1016/j.neunet.2009.05.005; Chen R, 2000, J R STAT SOC B, V62, P493, DOI 10.1111/1467-9868.00246; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Crutcher MD, 2004, EXP BRAIN RES, V158, P278, DOI 10.1007/s00221-004-1895-0; Cunningham JP, 2011, J NEUROPHYSIOL, V105, P1932, DOI 10.1152/jn.00503.2010; DiGiovanna J, 2009, IEEE T BIO-MED ENG, V56, P54, DOI 10.1109/TBME.2008.926699; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Kemere C, 2005, INT CONF ACOUST SPEE, P353; Kemere C, 2008, J NEUROPHYSIOL, V100, P2441, DOI 10.1152/jn.00924.2007; Kim SP, 2006, J NEURAL ENG, V3, P145, DOI 10.1088/1741-2560/3/2/009; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Kulkarni JE, 2008, IEEE SIGNAL PROC MAG, V25, P78, DOI 10.1109/MSP.2008.4408444; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; Li ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008443; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; LOEB GE, 1990, COLD SH Q B, V55, P791; MARQUARDT DW, 1975, AM STAT, V29, P3, DOI 10.2307/2683673; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Mussa-Ivaldi FA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.008.2010; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Pohlmeyer EA, 2003, P IEEE EMBS, P17; Sanchez JC, 2002, NEURAL NETWORKS FOR SIGNAL PROCESSING XII, PROCEEDINGS, P139, DOI 10.1109/NNSP.2002.1030025; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shanechi MM, 2013, IEEE T NEUR SYS REH, V21, P129, DOI 10.1109/TNSRE.2012.2221743; Shanechi MM, 2012, NAT NEUROSCI, V15, P1715, DOI 10.1038/nn.3250; Shanechi MM, 2010, INT CONF ACOUST SPEE, P521, DOI 10.1109/ICASSP.2010.5495644; Shanechi MM, 2011, COMP SYST NEUR COSYN; Shanechi MM, 2011, THESIS MIT; Shanechi MM, 2010, RES ENC DEC NEUR ENS; Shanechi MM, 2010, SOC NEUR SFN M SAN D; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Srinivasan L, 2007, J NEUROPHYSIOL, V98, P2456, DOI 10.1152/jn.01118.2006; Srinivasan L, 2006, NEURAL COMPUT, V18, P2465, DOI 10.1162/neco.2006.18.10.2465; Srinivasan L, 2011, IEEE T BIO-MED ENG, V58, P1555, DOI 10.1109/TBME.2010.2101599; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Todorov E, 2005, NEURAL COMPUT, V17, P1084, DOI 10.1162/0899766053491887; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	73	52	53	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e59049	10.1371/journal.pone.0059049	http://dx.doi.org/10.1371/journal.pone.0059049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593130	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000003
J	Eldor, R; Arbit, E; Corcos, A; Kidron, M				Eldor, Roy; Arbit, Ehud; Corcos, Asher; Kidron, Miriam			Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study	PLOS ONE			English	Article							MIXED MEAL; HOMEOSTASIS; METABOLISM; LIVER	The unpredictable behavior of uncontrolled type 1 diabetes often involves frequent swings in blood glucose levels that impact maintenance of a daily routine. An intensified insulin regimen is often unsuccessful, while other therapeutic options, such as amylin analog injections, use of continuous glucose sensors, and islet or pancreas transplantation are of limited clinical use. In efforts to provide patients with a more compliable treatment method, Oramed Pharmaceuticals tested the capacity of its oral insulin capsule (ORMD-0801, 8 mg insulin) in addressing this resistant clinical state. Eight Type I diabetes patients with uncontrolled diabetes (HbA1c: 7.5-10%) were monitored throughout the 15-day study period by means of a blind continuous glucose monitoring device. Baseline patient blood glucose behavior was monitored and recorded over a five-day pretreatment screening period. During the ensuing ten-day treatment phase, patients were asked to conduct themselves as usual and to self-administer an oral insulin capsule three times daily, just prior to meal intake. CGM data sufficient for pharmacodynamics analyses were obtained from 6 of the 8 subjects. Treatment with ORMD-0801 was associated with a significant 24.4% reduction in the frequencies of glucose readings >200 mg/dL (60.1 +/- 7.9% pretreatment vs. 45.4 +/- 4.9% during ORMD-0801 treatment; p = 0.023) and a significant mean 16.6% decrease in glucose area under the curve (AUC) (66055 +/- 5547 mg/dL/24 hours vs. 55060 +/- 3068 mg/dL/24 hours, p = 0.023), with a greater decrease during the early evening hours. In conclusion, ORMD-0801 oral insulin capsules in conjunction with subcutaneous insulin injections, well tolerated and effectively reduced glycemia throughout the day.	[Eldor, Roy] Hadassah Univ Hosp, Diabet Unit, IL-91120 Jerusalem, Israel; [Arbit, Ehud; Kidron, Miriam] Oramed Pharmaceut, Jerusalem, Israel; [Corcos, Asher] Hebrew Univ Jerusalem, Hadassah Med Sch, Gen Hlth Serv, Diabet & Endocrine Clin, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Eldor, R (corresponding author), Hadassah Univ Hosp, Diabet Unit, IL-91120 Jerusalem, Israel.	eldorroy@yahoo.com	Arbit, Ehud/N-9033-2019; Eldor, Roy/AAD-4397-2022		Oramed Pharmaceuticals, Jerusalem, Israel	Oramed Pharmaceuticals, Jerusalem, Israel	Funding for this work was supplied by Oramed Pharmaceuticals, Jerusalem, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbit Ehud, 2009, J Diabetes Sci Technol, V3, P562; Bischof MG, 2001, DIABETES, V50, P392, DOI 10.2337/diabetes.50.2.392; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; DeVries JH, 2002, DIABETIC MED, V19, P496, DOI 10.1046/j.1464-5491.2002.00727.x; FELIG P, 1971, J CLIN INVEST, V50, P1702, DOI 10.1172/JCI106659; Maheux P, 1997, DIABETOLOGIA, V40, P1300, DOI 10.1007/s001250050824; Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, pE419, DOI 10.1152/ajpendo.00032.2001; Schade D S, 1995, Adv Endocrinol Metab, V6, P289; Sindelar DK, 1996, DIABETES, V45, P1594, DOI 10.2337/diabetes.45.11.1594; Singhal P, 2002, AM J PHYSIOL-ENDOC M, V283, pE275, DOI 10.1152/ajpendo.00424.2001; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379	11	62	67	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e59524	10.1371/journal.pone.0059524	http://dx.doi.org/10.1371/journal.pone.0059524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593142	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600007
J	Hardlei, TF; Obeid, R; Herrmann, W; Nexo, E				Hardlei, Tore Forsingdal; Obeid, Rima; Herrmann, Wolfgang; Nexo, Ebba			Cobalamin Analogues in Humans: A Study on Maternal and Cord Blood	PLOS ONE			English	Article							RADIOISOTOPE DILUTION ASSAYS; TRANSCOBALAMIN-II; HAPTOCORRIN; VITAMIN-B12; DEFICIENCY	Background: Haptocorrin (HC) carries cobalamin analogues (CorA), but whether CorA are produced in the body is unknown. All cobalamins (Cbl) to the foetus are delivered by the Cbl-specific protein transcobalamin (TC), and therefore analysis of cord serum for CorA may help to clarify the origin of CorA. Methods: HC-CorA were quantified in paired samples of cord serum from newborns and serum from mothers (n = 69). Results: The CorA-concentration was higher in cord serum (median = 380, range: 41-780 pmol/L) than in serum from the mothers (median = 160, range: 64-330 pmol/L), (p<0.0001). HPLC-analysis showed CorA-peaks with retention times of 13.5, 14,5 and 16.5 min in samples from both the mother and cord serum. The peak with retention time 16.5 min constituted 24% (mother) and 45% (cord serum) of the total amount CorA, and eluted as does dicyanocobinamide. Conclusion: Our results support that CorA in the human body are derived from Cbl.	[Hardlei, Tore Forsingdal; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Obeid, Rima; Herrmann, Wolfgang] Univ Hosp Saarland, Fac Med, Dept Clin Chem, Homburg, Germany	Aarhus University; Universitatsklinikum des Saarlandes	Hardlei, TF (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	torehard@rm.dk	Obeid, Rima/AAR-9906-2020	Nexo, Ebba/0000-0001-9406-9081	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Danish Medical Research Council and the Lundbeck Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RH, 2008, AM J CLIN NUTR, V87, P1324, DOI 10.1093/ajcn/87.5.1324; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; BEGLEY JA, 1981, J CLIN PATHOL, V34, P630, DOI 10.1136/jcp.34.6.630; FERNANDESCOSTA F, 1979, BRIT J HAEMATOL, V43, P625, DOI 10.1111/j.1365-2141.1979.tb03795.x; FRIEDMAN PA, 1977, J CLIN INVEST, V59, P51, DOI 10.1172/JCI108621; Gimsing P, 1989, Scand J Clin Lab Invest Suppl, V194, P37; Hardlei TF, 2007, CLIN BIOCHEM, V40, P1392, DOI 10.1016/j.clinbiochem.2007.09.008; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; JACOBSEN DW, 1982, ANAL BIOCHEM, V120, P394, DOI 10.1016/0003-2697(82)90363-3; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; Lildballe DL, 2011, CLIN CHEM, V57, P1436, DOI 10.1373/clinchem.2011.165944; Moestrup SK, 2001, ANNU REV NUTR, V21, P407, DOI 10.1146/annurev.nutr.21.1.407; Morkbak AL, 2006, CLIN CHEM, V52, P1104, DOI 10.1373/clinchem.2005.061549; Nexo E, 2002, CLIN CHEM, V48, P561; NEXO E, 1998, VITAMIN B12 B12 PROT, P461, DOI DOI 10.1002/9783527612192.CH30; Obeid R, 2006, CLIN CHEM, V52, P263, DOI 10.1373/clinchem.2005.057810; QUADROS EV, 1994, ARCH BIOCHEM BIOPHYS, V308, P192, DOI 10.1006/abbi.1994.1027; Seetharam Bellur, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006422	18	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61194	10.1371/journal.pone.0061194	http://dx.doi.org/10.1371/journal.pone.0061194			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585880	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600093
J	Holmlund-Suila, E; Koskivirta, P; Metso, T; Andersson, S; Makitie, O; Viljakainen, HT				Holmlund-Suila, Elisa; Koskivirta, Panu; Metso, Tuula; Andersson, Sture; Makitie, Outi; Viljakainen, Heli T.			Vitamin D Deficiency in Children with a Chronic Illness-Seasonal and Age-Related Variations in Serum 25-hydroxy Vitamin D Concentrations	PLOS ONE			English	Article							PERIPUBERTAL FINNISH GIRLS; BONE HEALTH; PEDIATRIC-PATIENTS; D SUPPLEMENTATION; ADOLESCENTS; GROWTH; TRANSPLANTATION; DISEASE; ASSOCIATION; PREVALENCE	Introduction: Children and adolescents with a chronic illness have potential risk factors for vitamin D deficiency. An optimal vitamin D status might have multiple health effects. This study evaluated vitamin D status and its association with age, gender, and season in a large cohort of chronically ill Finnish patients at a tertiary pediatric outpatient clinic. A cross-sectional register-based study was carried out, involving altogether 1351 children (51% boys, age range 0.2-18 years), who visited the outpatient clinic during 2007-2010 and had their vitamin D status (S-25-OHD) determined. A post-doc analysis was conducted to identify predisposing and preventing factors for vitamin D deficiency. Results: Almost half (47%) of the S-25-OHD values were consistent with subnormal vitamin D status (S-25-OHD <50 nmol/L) while only 12% were >80 nmol/L. Age and season were the most important determinants for S-25-OHD concentration. Mean S-25-OHD concentration differed between age groups (Kruskal-Wallis; p<0.001), adolescents being at highest risk for vitamin D insufficiency. Young age and vitamin D supplementation were preventive factors for deficiency, while non-Finnish ethnic background was a predisposing factor. S-25-OHD showed significant seasonal variation in children older than 6 years. In the whole cohort, S-25-OHD was on average 13 nmol/L higher in summer than in winter, and the prevalence of vitamin D deficiency (= S-25-OHD <37.5 nmol/l) varied from 11% in summer to 29% in winter. Conclusions: The finding that almost half of the studied Finnish children with a chronic illness had suboptimal vitamin D status is alarming. Inferior vitamin D status was noted in adolescents compared with younger children, suggesting that imbalance between intake and requirement evolves with age. Although less common during summer, subnormal vitamin D status was still observed in 28% of those evaluated in summer. Clinicians should identify individuals at risk and actively recommend vitamin D supplementation.	[Holmlund-Suila, Elisa; Koskivirta, Panu; Andersson, Sture; Makitie, Outi; Viljakainen, Heli T.] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Holmlund-Suila, Elisa; Koskivirta, Panu; Andersson, Sture; Makitie, Outi; Viljakainen, Heli T.] Univ Helsinki, Helsinki, Finland; [Metso, Tuula] Univ Helsinki, Cent Hosp, Div Allergy, Skin & Allergy Hosp, Helsinki, Finland; [Viljakainen, Heli T.] Univ Bristol, Musculoskeletal Res Unit, Bristol, Avon, England; [Makitie, Outi] Folkhalsan Res Ctr, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Bristol; Folkhalsan Research Center	Viljakainen, HT (corresponding author), Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland.	heli.viljakainen@helsinki.fi		Makitie, Outi/0000-0002-4547-001X	Academy of Finland; Finska Lakaresallskapet	Academy of Finland(Academy of Finland); Finska Lakaresallskapet	The Academy of Finland and Finska Lakaresallskapet have supported the writing of the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas LAG, 2007, J AM ACAD DERMATOL, V57, P588, DOI 10.1016/j.jaad.2007.03.004; Cheng S, 2005, AM J CLIN NUTR, V82, P1115, DOI 10.1093/ajcn/82.5.1115; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; Davies JH, 2011, J PEDIATR ORTHOPED, V31, P798, DOI 10.1097/BPO.0b013e31822f1af1; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Dong YB, 2010, PEDIATRICS, V125, P1104, DOI 10.1542/peds.2009-2055; Hamed EA, 2011, PEDIATR DIABETES, V12, P536, DOI 10.1111/j.1399-5448.2010.00739.x; HENRIKSEN C, 1995, EUR J CLIN NUTR, V49, P211; Hill TR, 2010, OSTEOPOROSIS INT, V21, P695, DOI 10.1007/s00198-009-0959-1; Holick MF, 2012, JPEN-PARENTER ENTER, V36, p9S, DOI 10.1177/0148607111430189; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollams EM, 2012, CURR OPIN ALLERGY CL, V12, P228, DOI 10.1097/ACI.0b013e3283534a32; Hypponen E, 2010, DIABETES OBES METAB, V12, P737, DOI 10.1111/j.1463-1326.2010.01211.x; Institute of Medicine, 2011, FOOD NUTR BOARD DIET; Johnson MD, 2010, J PEDIATR-US, V156, P444, DOI 10.1016/j.jpeds.2009.09.070; Kumar GT, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2975; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Kyttala P, 2010, PUBLIC HEALTH NUTR, V13, P947, DOI 10.1017/S136898001000114X; LAMBERG-ALLARDT C, 1984, ANN NUTR METAB, V28, P144, DOI 10.1159/000176796; Lehtonen-Veromaa M, 2002, EUR J CLIN NUTR, V56, P431, DOI 10.1038/sj.ejcn.1601330; Lehtonen-Veromaa M, 2008, BRIT J NUTR, V100, P418, DOI 10.1017/S0007114508894469; Lehtonen-Veromaa MKM, 2002, AM J CLIN NUTR, V76, P1446, DOI 10.1093/ajcn/76.6.1446; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Molgaard C, 1999, ARCH DIS CHILD, V81, P10, DOI 10.1136/adc.81.1.10; Norman AW, 2008, AM J CLIN NUTR, V88, P1455, DOI 10.3945/ajcn.2008.27049; Official Statistics of Finland, 2012, POP STRUCT ANN REV 2; Okumus O, 2008, INDIAN J PEDIATR, V75, P239, DOI 10.1007/s12098-008-0052-3; Parfitt AM, 2003, CURR OPIN NEPHROL HY, V12, P387, DOI 10.1097/00041552-200307000-00007; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Saron Margareth L. G., 2009, Arq. Gastroenterol., V46, P62, DOI 10.1590/S0004-28032009000100016; Seeherunvong W, 2009, J PEDIATR-US, V154, P906, DOI 10.1016/j.jpeds.2008.12.006; Sinha A, 2011, PEDIATR BLOOD CANCER, V57, P594, DOI 10.1002/pbc.22963; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P490, DOI 10.1111/j.1651-2227.1990.tb11502.x; Taskinen M, 2000, LANCET, V356, P993, DOI 10.1016/S0140-6736(00)02717-3; Taskinen M, 2007, CANCER, V110, P442, DOI 10.1002/cncr.22796; Turpeinen U, 2003, CLIN CHEM, V49, P1521, DOI 10.1373/49.9.1521; Valta H, 2008, AM J TRANSPLANT, V8, P150, DOI 10.1111/j.1600-6143.2007.02015.x; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Viljakainen HT, 2011, OSTEOPOROSIS INT, V22, P883, DOI 10.1007/s00198-010-1499-4; Viljakainen HT, 2011, BONE, V48, P212, DOI 10.1016/j.bone.2010.09.022; Walther F, 2006, J PEDIATR GASTR NUTR, V43, P42, DOI 10.1097/01.mpg.0000228105.91240.80; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Weaver CM, 2007, J BONE MINER RES, V22, pV45, DOI 10.1359/JBMR.07S201	43	17	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60856	10.1371/journal.pone.0060856	http://dx.doi.org/10.1371/journal.pone.0060856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585857	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600062
J	Kaunitz, L; Fracasso, A; Lingnau, A; Melcher, D				Kaunitz, Lisandro; Fracasso, Alessio; Lingnau, Angelika; Melcher, David			Non-Conscious Processing of Motion Coherence Can Boost Conscious Access	PLOS ONE			English	Article							CONTINUOUS FLASH SUPPRESSION; BIOLOGICAL MOTION; PERCEPTION; INTEGRATION; MECHANISMS; DEPENDS; FACE	Research on the scope and limits of non-conscious vision can advance our understanding of the functional and neural underpinnings of visual awareness. Here we investigated whether distributed local features can be bound, outside of awareness, into coherent patterns. We used continuous flash suppression (CFS) to create interocular suppression, and thus lack of awareness, for a moving dot stimulus that varied in terms of coherence with an overall pattern (radial flow). Our results demonstrate that for radial motion, coherence favors the detection of patterns of moving dots even under interocular suppression. Coherence caused dots to break through the masks more often: this indicates that the visual system was able to integrate low-level motion signals into a coherent pattern outside of visual awareness. In contrast, in an experiment using meaningful or scrambled biological motion we did not observe any increase in the sensitivity of detection for meaningful patterns. Overall, our results are in agreement with previous studies on face processing and with the hypothesis that certain features are spatiotemporally bound into coherent patterns even outside of attention or awareness.	[Kaunitz, Lisandro; Fracasso, Alessio; Lingnau, Angelika; Melcher, David] Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Italy; [Kaunitz, Lisandro] Univ Leicester, Ctr Syst Neurosci, Leicester, Leics, England; [Fracasso, Alessio] Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands; [Melcher, David] Univ Trento, Dept Cognit Sci, Trento, Italy	University of Trento; University of Leicester; Utrecht University; University of Trento	Kaunitz, L (corresponding author), Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Italy.	lkaunitz@gmail.com	Fracasso, Alessio/AAC-4830-2022; Lingnau, Angelika/D-2004-2010; Melcher, David/D-1775-2010	Fracasso, Alessio/0000-0002-4542-112X; Melcher, David/0000-0003-0926-585X; Lingnau, Angelika/0000-0001-8620-3009	Provincia Autonoma di Trento; Fondazione Cassa di Risparmio di Trento e Rovereto	Provincia Autonoma di Trento(Autonomous Province of Trento); Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro)	This work has been realized thanks to the support from the Provincia Autonoma di Trento and the Fondazione Cassa di Risparmio di Trento e Rovereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; Burr DC, 2001, CURR BIOL, V11, P798, DOI 10.1016/S0960-9822(01)00183-X; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Gaillard R, 2006, P NATL ACAD SCI USA, V103, P7524, DOI 10.1073/pnas.0600584103; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Kaunitz L, 2011, J VISION, V11, DOI 10.1167/11.13.10; Kawakami O, 2002, HUM BRAIN MAPP, V16, P104, DOI 10.1002/hbm.10033; Koch C, 2003, QUEST CONSCIOUSNESS; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; LEHMKUHLE SW, 1975, VISION RES, V15, P855, DOI 10.1016/0042-6989(75)90266-7; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Lingnau A, 2013, CEREB CORTEX, V23, P1342, DOI 10.1093/cercor/bhs112; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Maruya K, 2008, J VISION, V8, DOI 10.1167/8.11.7; MATHER G, 1992, P ROY SOC B-BIOL SCI, V249, P149, DOI 10.1098/rspb.1992.0097; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; MORRONE MC, 1995, NATURE, V376, P507, DOI 10.1038/376507a0; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; PURCELL DG, 1988, PERCEPT PSYCHOPHYS, V43, P355, DOI 10.3758/BF03208806; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Seth A., 2007, SCHOLARPEDIA, V2, P1328, DOI [10.4249/scholarpedia.1328, DOI 10.4249/SCHOLARPEDIA.1328]; Stein T, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00167; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Stuit SM, 2011, J VISION, V11, DOI 10.1167/11.10.7; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Vaina LM, 2001, BRAIN, V124, P310, DOI 10.1093/brain/124.2.310; VandeWalle GA, 1996, CHILD DEV, V67, P2621, DOI 10.2307/1131743; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; Watson TL, 2004, CURR BIOL, V14, P1670, DOI 10.1016/j.cub.2004.08.064; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990	38	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60787	10.1371/journal.pone.0060787	http://dx.doi.org/10.1371/journal.pone.0060787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593311	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600047
J	Lahrmann, B; Valous, NA; Eisenmann, U; Wentzensen, N; Grabe, N				Lahrmann, Bernd; Valous, Nektarios A.; Eisenmann, Urs; Wentzensen, Nicolas; Grabe, Niels			Semantic Focusing Allows Fully Automated Single-Layer Slide Scanning of Cervical Cytology Slides	PLOS ONE			English	Article							LIQUID-BASED CYTOLOGY; HUMAN-PAPILLOMAVIRUS; CANCER; PERFORMANCE; COLPOSCOPY; SYSTEMS	Liquid-based cytology (LBC) in conjunction with Whole-Slide Imaging (WSI) enables the objective and sensitive and quantitative evaluation of biomarkers in cytology. However, the complex three-dimensional distribution of cells on LBC slides requires manual focusing, long scanning-times, and multi-layer scanning. Here, we present a solution that overcomes these limitations in two steps: first, we make sure that focus points are only set on cells. Secondly, we check the total slide focus quality. From a first analysis we detected that superficial dust can be separated from the cell layer (thin layer of cells on the glass slide) itself. Then we analyzed 2,295 individual focus points from 51 LBC slides stained for p16 and Ki67. Using the number of edges in a focus point image, specific color values and size-inclusion filters, focus points detecting cells could be distinguished from focus points on artifacts (accuracy 98.6%). Sharpness as total focus quality of a virtual LBC slide is computed from 5 sharpness features. We trained a multi-parameter SVM classifier on 1,600 images. On an independent validation set of 3,232 cell images we achieved an accuracy of 94.8% for classifying images as focused. Our results show that single-layer scanning of LBC slides is possible and how it can be achieved. We assembled focus point analysis and sharpness classification into a fully automatic, iterative workflow, free of user intervention, which performs repetitive slide scanning as necessary. On 400 LBC slides we achieved a scanning-time of 13.9 +/- 10.1 min with 29.1 +/- 15.5 focus points. In summary, the integration of semantic focus information into whole-slide imaging allows automatic high-quality imaging of LBC slides and subsequent biomarker analysis.	[Lahrmann, Bernd; Valous, Nektarios A.; Grabe, Niels] Heidelberg Univ, Hamamatsu Tissue Imaging & Anal Ctr TIGA, BIOQUANT, Heidelberg, Germany; [Lahrmann, Bernd; Valous, Nektarios A.; Grabe, Niels] Heidelberg Univ, Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany; [Wentzensen, Nicolas] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Eisenmann, Urs] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Lahrmann, Bernd] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Grabe, N (corresponding author), Heidelberg Univ, Hamamatsu Tissue Imaging & Anal Ctr TIGA, BIOQUANT, Heidelberg, Germany.	niels.grabe@bioquant.uni-heidelberg.de	Grabe, Niels/AAP-6493-2020; Grabe, Niels/I-6214-2016; Wentzensen, Nicolas/AAG-8522-2019; Valous, Nek/J-2032-2015	Valous, Nek/0000-0002-4014-2404; Eisenmann, Urs/0000-0001-8770-3822; Grabe, Niels/0000-0003-1732-3706	German Ministry for Research and Education (BMBF) [0315401B, 0315263]; Intramural Research Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010124] Funding Source: NIH RePORTER	German Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the German Ministry for Research and Education (BMBF) in their MEDSYS and FORSYS funding programs, Grant Numbers 0315401B (MEDSYS), 0315263 (FORSYS). The work was in part supported by the Intramural Research Program of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolick DR, 1998, ACTA CYTOL, V42, P209, DOI 10.1159/000331548; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Denny L, 2012, BEST PRACT RES CL OB, V26, P189, DOI 10.1016/j.bpobgyn.2011.08.001; Dijkstra MG, 2010, J CLIN PATHOL, V63, P972, DOI 10.1136/jcp.2010.078634; Evered A, 2011, CYTOPATHOLOGY, V22, P82, DOI 10.1111/j.1365-2303.2010.00758.x; Rojo MG, 2006, INT J SURG PATHOL, V14, P285, DOI 10.1177/1066896906292274; Grabe N, 2010, CELL ONCOL, V32, P109, DOI 10.3233/CLO-2009-0508; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Karnon J, 2004, HEALTH TECHNOL ASSES, V8, P1; Kenyon S, 2010, CANCER CYTOPATHOL, V118, P244, DOI 10.1002/cncy.20096; Lahrmann B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028048; Lee R, 2011, RUNNING THE WORLDS MARKETS: THE GOVERNANCE OF FINANCIAL INFRASTRUCTURE, P9; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Monsonego J, 2001, BRIT J CANCER, V84, P360, DOI 10.1054/bjoc.2000.1588; Montalto MC, 2011, J PATHOLOGY INFORM, V2, P1; Mori I, 2011, DIAGNOSTIC PATHOLOGY, V6, P24; Mori I, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-S1-S15; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pantanowitz L., 2011, J PATHOL INFORM, V2, P1; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schiffman M, 2007, CANCER CYTOPATHOL, V111, P145, DOI 10.1002/cncr.22751; Schmidt D, 2011, CANCER CYTOPATHOL, V119, P158, DOI 10.1002/cncy.20140; Song L. H., 2000, SMJ Singapore Medical Journal, V41, P575; Wentzensen N, 2009, INT J CANCER, V124, P964, DOI 10.1002/ijc.23969; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Wright PK, 2010, CYTOPATHOLOGY, V21, P374, DOI 10.1111/j.1365-2303.2010.00772.x; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8	32	24	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61441	10.1371/journal.pone.0061441	http://dx.doi.org/10.1371/journal.pone.0061441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585899	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600114
J	Plascak, JJ; Fisher, JL				Plascak, Jesse J.; Fisher, James L.			Area-Based Socioeconomic Position and Adult Glioma: A Hierarchical Analysis of Surveillance Epidemiology and End Results Data	PLOS ONE			English	Article							BRAIN-TUMOR INCIDENCE; INCOME INEQUALITY; LAG TIME; HEALTH; RISK; OCCUPATION; EXPOSURE	Background: Glioma rates vary by demographic factors and geo-political boundaries and this variation suggests higher glioma rates in groups of higher socioeconomic position. The primary goal of this analysis is to investigate the relationship between glioma and county socioeconomic position using U. S. Surveillance Epidemiology and End Results (SEER) data. Methods: Cases were individuals 25+ years diagnosed with glioma between 2000 and 2006 and residing within the SEER-17 catchment area. County-, sex-, race-, age-specific rates were created in order to investigate individual-level associations (population data from U. S. Census 2000). A Bayesian hierarchical Poisson spatial conditionally autoregressive (CAR) model was utilized to simultaneously estimate individual- and county-level associations while controlling for county spatial dependence. Results: Those residing in counties of the second, third, and fourth highest quartiles of socioeconomic position have glioma incidence rates that are 1.10 (95% CI: 1.02,1.19), 1.11 (95% CI: 1.02,1.20), 1.14 (95% CI: 1.05,1.23) times that of the first quartile, respectively. A CAR model properly controlled for error spatial dependence. Investigated lag times suggest year 2000 census data yields superior model fit. Conclusion: Demographically adjusted rates of glioma are elevated in counties of higher socioeconomic position. More well-grounded theory concerning the glioma-socioeconomic position association along with socioeconomic data collected at multiple levels is recommended for future studies investigating this relationship.	[Plascak, Jesse J.; Fisher, James L.] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA; [Plascak, Jesse J.; Fisher, James L.] Solove Res Inst, Columbus, OH USA; [Plascak, Jesse J.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Fisher, JL (corresponding author), Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA.	jay.fisher@osumc.edu	Fisher, James Larry/F-4996-2012; Fisher, James L/N-3935-2019	Fisher, James L/0000-0003-3211-2691				BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P318, DOI 10.1136/jech.54.4.318; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P367, DOI 10.1136/jech.54.5.367; Boyle P, 2008, WORLD CANC REPORT 20; Chakrabarti I, 2005, CANCER-AM CANCER SOC, V104, P2798, DOI 10.1002/cncr.21539; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; Counsell CE, 1996, J NEUROL NEUROSUR PS, V61, P143, DOI 10.1136/jnnp.61.2.143; Davis FG, 1996, NEUROEPIDEMIOLOGY, V15, P103, DOI 10.1159/000109895; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Fisher JL, 2007, NEUROL CLIN, V25, P867, DOI 10.1016/j.ncl.2007.07.002; Gadalla TM, 2008, AM J PUBLIC HEALTH, V98, P2187, DOI 10.2105/AJPH.2008.134940; Gelman A., 2004, BAYESIAN DATA ANAL; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Grayson JK, 1996, AM J EPIDEMIOL, V143, P480, DOI 10.1093/oxfordjournals.aje.a008768; GREENLAND S, 1980, AM J EPIDEMIOL, V112, P564, DOI 10.1093/oxfordjournals.aje.a113025; Guthrie KA, 2001, J ROY STAT SOC A STA, V164, P141, DOI 10.1111/1467-985X.00193; Inskip PD, 2003, INT J EPIDEMIOL, V32, P225, DOI 10.1093/ije/dyg051; Inskip PD, 1995, EPIDEMIOL REV, V17, P382; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kentucky Cancer Registry, 2008, CANC INC MORT KENT 2; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; Krishnan G, 2003, J OCCUP ENVIRON MED, V45, P639, DOI 10.1097/01.jom.0000069245.06498.48; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; National Cancer Institute, 2010, SURV EP END RES; National Cancer Institute, 2009, WHAT YOU NEED KNOW B; Navas-Acien A, 2002, AM J IND MED, V42, P214, DOI 10.1002/ajim.10107; Ohio Cancer Incidence Surveillance System, 2011, CANC INC MORT OH RES; Pamuk E, 1998, SOCIOECONOMIC STATUS; PRESTONMARTIN S, 1993, CANCER CAUSE CONTROL, V4, P529, DOI 10.1007/BF00052428; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Roux AVD, 2004, EPIDEMIOL REV, V26, P104, DOI 10.1093/epirev/mxh006; Sherwood PR, 2004, NEUROLOGY, V62, P1788, DOI 10.1212/01.WNL.0000125195.26224.7C; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; Surawicz T S, 1999, Neuro Oncol, V1, P14, DOI 10.1093/neuonc/1.1.14; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; VELEMA JP, 1987, J NATL CANCER I, V79, P623; WHO, 2000, INT CLASSIFICATION D, V3rd; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Wigertz A, 2010, J EPIDEMIOL COMMUN H, V64, P736, DOI 10.1136/jech.2008.085845; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278	41	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60910	10.1371/journal.pone.0060910	http://dx.doi.org/10.1371/journal.pone.0060910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JB	23585860	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600067
J	Yu, LS; Thakur, S; Leong-Quong, RYY; Suzuki, K; Pang, AD; Bjorge, JD; Riabowol, K; Fujita, DJ				Yu, Lisa; Thakur, Satbir; Leong-Quong, Rebecca Y. Y.; Suzuki, Keiko; Pang, Andy; Bjorge, Jeffrey D.; Riabowol, Karl; Fujita, Donald J.			Src Regulates the Activity of the ING1 Tumor Suppressor	PLOS ONE			English	Article							PP60C-SRC PROTEIN-KINASE; PHOSPHORYLATION SITES; P33(ING1B) INHIBITOR; GENETIC ALTERATIONS; NUCLEAR EXPRESSION; INDUCED APOPTOSIS; GENOMIC STRUCTURE; TYROSINE KINASE; GROWTH PROTEIN; MELANOMA-CELLS	The INhibitor of Growth 1 (ING1) is stoichiometric member of histone deacetylase (HDAC) complexes and functions as an epigenetic regulator and a type II tumor suppressor. It impacts cell growth, aging, apoptosis, and DNA repair, by affecting chromatin conformation and gene expression. Down regulation and mislocalization of ING1 have been reported in diverse tumor types and Ser/Thr phosphorylation has been implicated in both of these processes. Here we demonstrate that both in vitro and in vivo, the tyrosine kinase Src is able to physically associate with, and phosphorylate ING1, which results in a nuclear to cytoplasmic relocalization of ING1 in cells and a decrease of ING1 stability. Functionally, Src antagonizes the ability of ING1 to induce apoptosis, most likely through relocalization of ING1 and down regulation of ING1 levels. These effects were due to both kinase-dependent and kinase-independent properties of Src, and were most apparent at elevated levels of Src expression. These findings suggest that Src may play a major role in regulating ING1 levels during tumorigenesis in those cancers in which high levels of Src expression or activity are present. These data represent the first report of tyrosine kinase-mediated regulation of ING1 levels and suggest that kinase activation can impact chromatin structure through the ING1 epigenetic regulator.	[Yu, Lisa; Thakur, Satbir; Leong-Quong, Rebecca Y. Y.; Suzuki, Keiko; Pang, Andy; Bjorge, Jeffrey D.; Riabowol, Karl; Fujita, Donald J.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Riabowol, Karl] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Yu, Lisa; Thakur, Satbir; Leong-Quong, Rebecca Y. Y.; Suzuki, Keiko; Pang, Andy; Bjorge, Jeffrey D.; Riabowol, Karl; Fujita, Donald J.] Univ Calgary, Southern Alberta Canc Res Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Fujita, DJ (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	dfujita@ucalgary.ca			Canadian Breast Cancer Foundation; Alberta Cancer Foundation; Canadian Institutes of Health Research; Alberta Innovates-Health Solutions; Alberta Cancer Foundation Postdoctoral Fellowship Award; ACF	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Alberta Cancer Foundation Postdoctoral Fellowship Award; ACF(United States Department of Health & Human Services)	This work was supported by grants from the Canadian Breast Cancer Foundation (DJF and KR), the Alberta Cancer Foundation (DJF), the Canadian Institutes of Health Research (KR) and Alberta Innovates-Health Solutions (KR). LY was supported by an Alberta Cancer Foundation Postdoctoral Fellowship Award, ST is a recipient of an ACF Studentship, and KR is a Scientist of the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2011, AGING CELL, V10, P158, DOI 10.1111/j.1474-9726.2010.00651.x; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boland D, 2000, HYBRIDOMA, V19, P161, DOI 10.1089/02724570050031202; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; Chen LS, 2001, CANCER RES, V61, P4345; Cheung KJ, 2002, EXP CELL RES, V279, P291, DOI 10.1006/excr.2002.5610; Chou Mary T-H, 2010, Genes Cancer, V1, P225; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Egan C, 1999, ONCOGENE, V18, P1227, DOI 10.1038/sj.onc.1202233; Feng XL, 2006, MOL CELL BIOL, V26, P9244, DOI 10.1128/MCB.01538-06; Garate M, 2008, EMBO REP, V9, P576, DOI 10.1038/embor.2008.48; Garate M, 2007, FASEB J, V21, P3705, DOI 10.1096/fj.07-8069com; Garkavtsev I, 1997, CYTOGENET CELL GENET, V76, P176, DOI 10.1159/000134539; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1999, NAT GENET, V23, P373, DOI 10.1038/15566; Goh YM, 2010, J BIOL CHEM, V285, P10122, DOI 10.1074/jbc.M109.071381; Gong W, 2006, MOL CELL BIOL, V26, P2947, DOI 10.1128/MCB.26.8.2947-2954.2006; Gong W, 2005, INT J BIOCHEM CELL B, V37, P1054, DOI 10.1016/j.biocel.2004.09.008; Gunduz M, 2000, CANCER RES, V60, P3143; Han XJ, 2008, NAT CELL BIOL, V10, P1333, DOI 10.1038/ncb1792; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Helbing CC, 1997, CANCER RES, V57, P1255; Jager D, 1999, CANCER RES, V59, P6197; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Kichina JV, 2006, ONCOGENE, V25, P857, DOI 10.1038/sj.onc.1209118; KRUEGER JG, 1980, P NATL ACAD SCI-BIOL, V77, P4142, DOI 10.1073/pnas.77.7.4142; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Nouman GS, 2003, J CLIN PATHOL, V56, P507, DOI 10.1136/jcp.56.7.507; Nouman GS, 2002, J CLIN PATHOL, V55, P596, DOI 10.1136/jcp.55.8.596; Nouman GS, 2002, HYBRIDOMA HYBRIDOM, V21, P1, DOI 10.1089/15368590252917584; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Russell MW, 2008, BIOCHEM BIOPH RES CO, V374, P490, DOI 10.1016/j.bbrc.2008.07.076; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Scott M, 2001, J CELL SCI, V114, P3455; Shah S, 2009, BIOCHEM CELL BIOL, V87, P117, DOI 10.1139/O08-107; Shen DH, 2005, CARCINOGENESIS, V26, P855, DOI 10.1093/carcin/bgi011; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Soliman MA, 2008, AGING CELL, V7, P783, DOI 10.1111/j.1474-9726.2008.00427.x; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tamannai M, 2010, ONCOL RES, V18, P469, DOI 10.3727/096504010X12704916124828; Thakur S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043671; Tokunaga E, 2000, CANCER LETT, V152, P15, DOI 10.1016/S0304-3835(99)00434-6; Toyama T, 1999, ONCOGENE, V18, P5187, DOI 10.1038/sj.onc.1202905; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; Vieyra D, 2003, CLIN CANCER RES, V9, P5952; Vieyra D, 2002, CANCER RES, V62, P4445; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Ythier D, 2008, INT J CANCER, V123, P1483, DOI 10.1002/ijc.23790	57	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60943	10.1371/journal.pone.0060943	http://dx.doi.org/10.1371/journal.pone.0060943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585863	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600070
J	Zhang, WR; Davis, CM; Edin, ML; Lee, CR; Zeldin, DC; Alkayed, NJ				Zhang, Wenri; Davis, Catherine M.; Edin, Matthew L.; Lee, Craig R.; Zeldin, Darryl C.; Alkayed, Nabil J.			Role of Endothelial Soluble Epoxide Hydrolase in Cerebrovascular Function and Ischemic Injury	PLOS ONE			English	Article							SEX-DIFFERENCES; EPOXYEICOSATRIENOIC ACIDS; HYPERPOLARIZING FACTOR; EPOXYGENASE; BRAIN; EPOXYEICOSANOIDS; NEUROPROTECTION; VASODILATION; DYSFUNCTION; INHIBITION	Soluble Epoxide Hydrolase (sEH) is a key enzyme in the metabolism and termination of action of epoxyeicosatrienoic acids, derivatives of arachidonic acid, which are protective against ischemic stroke. Mice lacking sEH globally are protected from injury following stroke; however, little is known about the role of endothelial sEH in brain ischemia. We generated transgenic mice with endothelial-specific expression of human sEH (Tie2-hsEH), and assessed the effect of transgenic overexpression of endothelial sEH on endothelium-dependent vascular reactivity and ischemic injury following middle cerebral artery occlusion (MCAO). Compared to wild-type, male Tie2-hsEH mice exhibited impaired vasodilation in response to stimulation with 1 mu M acetylcholine as assessed by laser-Doppler perfusion monitoring in an in-vivo cranial window preparation. No difference in infarct size was observed between wild-type and Tie2-hsEH male mice. In females, however, Tie2-hsEH mice sustained larger infarcts in striatum, but not cortex, compared to wild-type mice. Sex difference in ischemic injury was maintained in the cortex of Tie2-hsEH mice. In the striatum, expression of Tie2-hsEH resulted in a sex difference, with larger infarct in females than males. These findings demonstrate that transgenic expression of sEH in endothelium results in impaired endothelium-dependent vasodilation in the cerebral circulation, and that females are more susceptible to enhanced ischemic damage as a result of increased endothelial sEH than males, especially in end-arteriolar striatal region.	[Zhang, Wenri; Davis, Catherine M.; Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Lee, Craig R.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA	Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill	Alkayed, NJ (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA.	alkayen@ohsu.edu	Edin, Matthew/AAI-1934-2019; Zeldin, Darryl C/Y-7091-2018; Davis, Catherine/R-2215-2018	Zeldin, Darryl C/0000-0002-2087-7307; Davis, Catherine/0000-0001-9654-3509; Edin, Matthew/0000-0002-7042-500X; Lee, Craig/0000-0003-3595-5301	Division of Intramural Research of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences [NIH Z01 ES025034]; AHA; NIH [T32 GM082770-03, R01 NS044313, NS070837]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034, Z01ES025034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082770, R01GM088199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800, R01NS044313, R01NS070837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG043857] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences; AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This manuscript was supported in part by the Division of Intramural Research of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences, NIH Z01 ES025034 to DCZ (http://grants.nih.gov/grants/oer.htm); AHA postdoctoral fellowship to CMD (http://my.americanheart.org/professional/Research/Research_UCM_316889_SubHomePage.jsp); NIH T32 GM082770-03, NIH R01 NS044313 and NS070837 to NJA, and NIH R01 to CRL (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkayed NJ, 1996, AM J PHYSIOL-HEART C, V271, pH1541, DOI 10.1152/ajpheart.1996.271.4.H1541; Alkayed NJ, 2002, STROKE, V33, P1677, DOI 10.1161/01.STR.0000016332.37292.59; Appelros P, 2010, ACTA NEUROL SCAND, V121, P359, DOI 10.1111/j.1600-0404.2009.01258.x; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; Davis CM, 2011, WOMENS HEALTH, V7, P293, DOI [10.2217/whe.11.26, 10.2217/WHE.11.26]; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Gebremedhin D, 1998, J VASC RES, V35, P274, DOI 10.1159/000025594; Gupta NC, 2012, ARTERIOSCL THROM VAS, V32, P1936, DOI 10.1161/ATVBAHA.112.251520; Halcox JPJ, 2001, CIRC RES, V89, P969, DOI 10.1161/hh2301.100980; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Higashimori H, 2010, AM J PHYSIOL-CELL PH, V299, pC1068, DOI 10.1152/ajpcell.00225.2010; Iliff JJ, 2009, AM J PHYSIOL-HEART C, V296, pH1352, DOI 10.1152/ajpheart.00950.2008; Koerner IP, 2007, J NEUROSCI, V27, P4642, DOI 10.1523/JNEUROSCI.0056-07.2007; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Liu M, 2005, J CEREBR BLOOD F MET, V25, P939, DOI 10.1038/sj.jcbfm.9600085; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; Newton DJ, 2001, CLIN SCI, V101, P567, DOI 10.1042/CS20010128; Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Sura P, 2008, J HISTOCHEM CYTOCHEM, V56, P551, DOI 10.1369/jhc.2008.950659; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang LN, 2011, EUR J PHARMACOL, V654, P68, DOI 10.1016/j.ejphar.2010.12.016; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494; Zhang WR, 2009, J CEREBR BLOOD F MET, V29, P1475, DOI 10.1038/jcbfm.2009.65	28	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61244	10.1371/journal.pone.0061244	http://dx.doi.org/10.1371/journal.pone.0061244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585883	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600096
J	Chaimowitz, NS; Falanga, YT; Ryan, JJ; Conrad, DH				Chaimowitz, Natalia S.; Falanga, Yves T.; Ryan, John J.; Conrad, Daniel H.			Fyn Kinase Is Required for Optimal Humoral Responses	PLOS ONE			English	Article							TYROSINE KINASE; T-CELLS; SIGNAL TRANSDUCER; GENETIC-EVIDENCE; CD38 LIGATION; MICE LACKING; SAP; RECEPTOR; DIFFERENTIATION; SRC	The generation of antigen-specific antibodies and the development of immunological memory require collaboration between B and T cells. T cell-secreted IL-4 is important for B cell survival, isotype switch to IgG1 and IgE, affinity maturation, and the development of germinal centers (GC). Fyn, a member of the Src family tyrosine kinase, is widely expressed in many cell types, including lymphocytes. This kinase is known to interact with both the B cell and T cell receptor (BCR and TCR, respectively). While Fyn deletion does not impair the development of immature T cells and B cells, TCR signaling is altered in mature T cells. The current study demonstrates that Fyn deficient (KO) B cells have impaired IL-4 signaling. Fyn KO mice displayed low basal levels of IgG1, IgE and IgG2c, and delayed antigen-specific IgG1 and IgG2b production, with a dramatic decrease in antigen-specific IgG2c following immunization with a T-dependent antigen. Defects in antibody production correlated with significantly reduced numbers of GC B cells, follicular T helper cells (T-FH), and splenic plasma cells (PC). Taken together, our data demonstrate that Fyn kinase is required for optimal humoral responses.	[Chaimowitz, Natalia S.; Conrad, Daniel H.] Virginia Commonwealth Univ, Sch Med, Dept Microbiol & Immunol, Richmond, VA 23284 USA; [Falanga, Yves T.; Ryan, John J.] Virginia Commonwealth Univ, Sch Med, Dept Biol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Conrad, DH (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Microbiol & Immunol, Richmond, VA 23284 USA.	dconrad@vcu.edu			National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101153] Funding Source: NIH RePORTER	National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEBY MW, 1995, J EXP MED, V182, P811, DOI 10.1084/jem.182.3.811; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; BURKHARDT AL, 1992, J VIROL, V66, P5161, DOI 10.1128/JVI.66.8.5161-5167.1992; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Caven TH, 2005, CELL IMMUNOL, V238, P123, DOI 10.1016/j.cellimm.2006.03.001; Chaimowitz NS, 2011, J IMMUNOL, V187, P5114, DOI 10.4049/jimmunol.1102172; CHALUPNY NJ, 1995, EUR J IMMUNOL, V25, P2978, DOI 10.1002/eji.1830251040; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; Damdinsuren B, 2010, IMMUNITY, V32, P355, DOI 10.1016/j.immuni.2010.02.013; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Fukushima A, 2005, GRAEF ARCH CLIN EXP, V243, P1043, DOI 10.1007/s00417-005-1158-1; Fukushima A, 2005, IMMUNOGENETICS, V57, P337, DOI 10.1007/s00251-005-0805-3; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Horikawa K, 1999, INT IMMUNOL, V11, P1441, DOI 10.1093/intimm/11.9.1441; IKIZAWA K, 1994, J ALLERGY CLIN IMMUN, V94, P620, DOI 10.1016/0091-6749(94)90138-4; KIKUCHI Y, 1995, P NATL ACAD SCI USA, V92, P11814, DOI 10.1073/pnas.92.25.11814; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Kudlacz EM, 2001, AM J RESP CELL MOL, V24, P469, DOI 10.1165/ajrcmb.24.4.4266; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lischke A, 1998, J BIOL CHEM, V273, P31222, DOI 10.1074/jbc.273.47.31222; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Ma CS, 2011, ANN NY ACAD SCI, V1217, P32, DOI 10.1111/j.1749-6632.2010.05824.x; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mamchak AA, 2008, J IMMUNOL, V181, P5374, DOI 10.4049/jimmunol.181.8.5374; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nunez-Cruz S, 2008, J IMMUNOL, V181, P2311, DOI 10.4049/jimmunol.181.4.2311; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; Pullen NA, 2012, J BIOL CHEM, V287, P2045, DOI 10.1074/jbc.M111.311142; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Reiter R, 2002, IMMUNOLOGY, V106, P222, DOI 10.1046/j.1365-2567.2002.01405.x; Rodriguez-Alba JC, 2008, BLOOD, V111, P3644, DOI 10.1182/blood-2007-08-107714; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Tamura T, 2001, J IMMUNOL, V167, P1962, DOI 10.4049/jimmunol.167.4.1962; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Vu F, 2008, J IMMUNOL, V180, P2284, DOI 10.4049/jimmunol.180.4.2284; Wang J, 1996, CELL IMMUNOL, V174, P138, DOI 10.1006/cimm.1996.0303; Yasue T, 1997, P NATL ACAD SCI USA, V94, P10307, DOI 10.1073/pnas.94.19.10307; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	51	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60640	10.1371/journal.pone.0060640	http://dx.doi.org/10.1371/journal.pone.0060640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593269	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000045
J	Liu, L; Zhong, R; Wei, S; Xiang, H; Chen, JG; Xie, DS; Yin, JY; Zou, L; Sun, JW; Chen, W; Miao, XP; Nie, SF				Liu, Li; Zhong, Rong; Wei, Sheng; Xiang, Hao; Chen, Jigui; Xie, Duoshuang; Yin, Jieyun; Zou, Li; Sun, Jingwen; Chen, Wei; Miao, Xiaoping; Nie, Shaofa			The Leptin Gene Family and Colorectal Cancer: Interaction with Smoking Behavior and Family History of Cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BREAST-CANCER; METABOLIC FACTORS; PROSTATE-CANCER; NORTHERN SWEDEN; PLASMA LEPTIN; RISK; RECEPTOR; OBESITY; POLYMORPHISMS	Background: Pathologic condition associated with metabolic syndrome traits seems to increase the risk of colorectal cancer. One mechanism underlying this relationship may involve the growth-promoting effects of the circulation hormones associated with obesity and insulin resistance, such as leptin. Methodology/Principal Findings: A two-stage case-control study was used to explore the role of polymorphisms of Leptin (LEP) and Leptin receptor (LEPR), either alone or in combination with environmental factors in colorectal carcinogenesis. In stage 1, 20 single nucleotide polymorphisms (SNPs) that tag common SNPs in these two genes were genotyped among 470 cases and 458 controls. In stage 2, another population with 314 cases and 355 controls were genotyped for the two most promising SNPs from stage 1. LEPR rs12037879 only presented modestly increased colorectal cancer risk, with odds ratios of 1.41 (95% confidence interval [CI] 1.13-1.76) and 1.74 (95% CI 1.08-2.81) for GA and AA genotype when compared with GG genotype in combined population. Smokers carrying LEPR rs12037879 A allele presented 1.67-fold (95% CI 1.39-fold to 2.01-fold) increased colorectal cancer risk when compared with non-smokers carrying GG genotype in combined analysis. Individuals with family history of cancer harboring LEPR rs12037879 A allele showed 1.52-fold (95% CI: 1.24-fold to 1.86-fold) increased colorectal cancer risk, compared with individuals without family history of cancer harboring GG genotype. Multifactor gene-environment interaction analysis revealed significant interactions among LEPR rs12037879, LEPR rs6690625, smoking status and family history of cancer, exhibiting a gradient of increased colorectal cancer risk along with the increasing number of risk factors (P = 9.82610(-10)). Conclusions/Significance: Our research supports that polymorphisms in LEPR may be associated with marginal increase in the risk for colorectal cancer. Moreover, this association could be strengthened by cigarette smoking and family history of cancer.	[Liu, Li; Zhong, Rong; Wei, Sheng; Yin, Jieyun; Zou, Li; Sun, Jingwen; Chen, Wei; Miao, Xiaoping; Nie, Shaofa] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China; [Liu, Li; Zhong, Rong; Wei, Sheng; Yin, Jieyun; Zou, Li; Sun, Jingwen; Chen, Wei; Miao, Xiaoping; Nie, Shaofa] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Xiang, Hao] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430072, Hubei, Peoples R China; [Chen, Jigui] Eighth Hosp Wuhan, Dept Surg, Wuhan, Hubei, Peoples R China; [Xie, Duoshuang] Taihe Hosp, Yunyang Med Coll, Dept Infect Control, Shiyan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China.	miaoxp@mail.hust.edu.cn; sf_nie@mails.tjmu.edu.cn	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722	National Natural Science Foundation of China [NSFC-30972534, 81172752, NSFC-81001275, 81171878, 81222038]; Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China [131038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China	This work was supported by the National Natural Science Foundation of China [NSFC-30972534, 81172752 to S.N., and NSFC-81001275, 81171878, 81222038 to X.M. http://www.nsfc.gov.cn/Portal0/default124.htm] and the Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China [131038 to X. M.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mutairi SS, 2008, ANN NUTR METAB, V52, P329, DOI 10.1159/000151487; Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; Aparicio T, 2005, GUT, V54, P1136, DOI 10.1136/gut.2004.060533; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Furusawa T, 2010, HUM GENET, V127, P287, DOI 10.1007/s00439-009-0768-9; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Han CZ, 2008, BIOL TRACE ELEM RES, V126, P38, DOI 10.1007/s12011-008-8182-z; Hansel NN, 2009, EUR RESPIR J, V34, P103, DOI 10.1183/09031936.00120408; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; He J, 2012, CHINESE CANC REGISTR, V2012, pP56; Helzlsouer KJ, 1998, J NATL CANCER I, V90, P512, DOI 10.1093/jnci/90.7.512; Hirose Y, 2004, CARCINOGENESIS, V25, P821, DOI 10.1093/carcin/bgh059; Hodge AM, 1997, INT J OBESITY, V21, P50, DOI 10.1038/sj.ijo.0800362; Holmes MD, 2004, AM J EPIDEMIOL, V159, P732, DOI 10.1093/aje/kwh112; Hsing AW, 2001, JNCI-J NATL CANCER I, V93, P783, DOI 10.1093/jnci/93.10.783; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Jianjun C, 2005, J HUBEI MED U, V26, P497; Karagiannides I, 2007, CURR OPIN GASTROEN, V23, P661, DOI 10.1097/MOG.0b013e3282c8c8d3; Koda M, 2007, ANN ONCOL, V18, P116, DOI 10.1093/annonc/mdm238; Koebnick C, 2008, DIABETIC MED, V25, P1043, DOI 10.1111/j.1464-5491.2008.02537.x; Li YL, 2012, J CANCER RES CLIN, V138, P311, DOI 10.1007/s00432-011-1098-6; Liu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027301; Liuzzi A, 1999, INT J OBESITY, V23, P1066, DOI 10.1038/sj.ijo.0801036; Lukanova A, 2006, INT J CANCER, V118, P458, DOI 10.1002/ijc.21354; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Marzi C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001213; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Nam SY, 2010, CLIN GASTROENTEROL H, V8, P443, DOI 10.1016/j.cgh.2010.02.001; Nyante SJ, 2011, BREAST CANCER RES TR, V129, P593, DOI 10.1007/s10549-011-1517-z; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Ribeiro R, 2004, PROSTATE, V59, P268, DOI 10.1002/pros.20004; Ribeiro R, 2006, EUR J CANCER, V42, P1188, DOI 10.1016/j.ejca.2006.02.004; Schram K, 2011, ENDOCRINOLOGY, V152, P2037, DOI 10.1210/en.2010-1166; Stattin P, 2003, ONCOL REP, V10, P2015; Stocks T, 2011, CANCER-AM CANCER SOC, V117, P2398, DOI 10.1002/cncr.25772; Tamakoshi K, 2005, ONCOLOGY-BASEL, V68, P454, DOI 10.1159/000086988; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; Uddin S, 2009, CARCINOGENESIS, V30, P1832, DOI 10.1093/carcin/bgp145; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yapijakis C, 2009, J CANCER RES CLIN, V135, P603, DOI 10.1007/s00432-008-0494-z; Yi GQ, 2010, J PUB HLTH PREV MED, V21, P9; Zervoudakis A, 2011, J NATL CANCER I, V103, P826, DOI 10.1093/jnci/djr101; Zhou W, 2011, BRIT J CANCER, V104, P128, DOI 10.1038/sj.bjc.6606013; Zimmet P, 1996, BRIT MED J, V313, P965, DOI 10.1136/bmj.313.7063.965	50	22	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60777	10.1371/journal.pone.0060777	http://dx.doi.org/10.1371/journal.pone.0060777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593308	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000066
J	Coventry, PA; Bower, P; Keyworth, C; Kenning, C; Knopp, J; Garrett, C; Hind, D; Malpass, A; Dickens, C				Coventry, Peter A.; Bower, Peter; Keyworth, Christopher; Kenning, Cassandra; Knopp, Jasmin; Garrett, Charlotte; Hind, Daniel; Malpass, Alice; Dickens, Chris			The Effect of Complex Interventions on Depression and Anxiety in Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; COPD PATIENTS; PRIMARY-CARE; REHABILITATION PROGRAM; HOSPITAL READMISSION; HEALTH OUTCOMES; RISK-FACTORS	Background: Depression and anxiety are very common in people with chronic obstructive pulmonary disease (COPD) and are associated with excess morbidity and mortality. Patients prefer non-drug treatments and clinical guidelines promote non-pharmacological interventions as first line therapy for depression and anxiety in people with long term conditions. However the comparative effectiveness of psychological and lifestyle interventions among COPD patients is not known. We assessed whether complex psychological and/or lifestyle interventions are effective in reducing symptoms of anxiety and depression in patients with COPD. We then determined what types of psychological and lifestyle interventions are most effective. Methods and Findings: Systematic review of randomised controlled trials of psychological and/or lifestyle interventions for adults with COPD that measured symptoms of depression and/or anxiety. CENTRAL, Medline, Embase, PsychINFO, CINAHL, ISI Web of Science and Scopus were searched up to April 2012. Meta-analyses using random effects models were undertaken to estimate the average effect of interventions on depression and anxiety. Thirty independent comparisons from 29 randomised controlled trials (n = 2063) were included in the meta-analysis. Overall, psychological and/or lifestyle interventions were associated with small reductions in symptoms of depression (standardised mean difference -0.28, 95% confidence interval -0.41 to -0.14) and anxiety (standardised mean difference -0.23, 95% confidence interval -0.38 to -0.09). Multi-component exercise training was the only intervention subgroup associated with significant treatment effects for depression (standardised mean difference -0.47, 95% confidence interval -0.66 to -0.28), and for anxiety (standardised mean difference -0.45, 95% confidence interval -0.71 to -0.18). Conclusions: Complex psychological and/or lifestyle interventions that include an exercise component significantly improve symptoms of depression and anxiety in people with COPD. Furthermore, multi-component exercise training effectively reduces symptoms of anxiety and depression in all people with COPD regardless of severity of depression or anxiety, highlighting the importance of promoting physical activity in this population.	[Coventry, Peter A.; Garrett, Charlotte] Univ Manchester, Ctr Primary Care, Collaborat Leadership Appl Hlth Res & Care Greate, Manchester, Lancs, England; [Coventry, Peter A.; Garrett, Charlotte] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Bower, Peter; Knopp, Jasmin] Univ Manchester, Ctr Primary Care, Natl Inst Hlth Res, Sch Primary Care Res, Manchester, Lancs, England; [Bower, Peter; Keyworth, Christopher; Kenning, Cassandra; Knopp, Jasmin] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Keyworth, Christopher] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England; [Kenning, Cassandra] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, Manchester, Lancs, England; [Hind, Daniel] Univ Sheffield, Sch Hlth & Related Res, Clin Trials Res Unit, Sheffield, S Yorkshire, England; [Malpass, Alice] Univ Bristol, Sch Social & Community Based Med, Bristol, Avon, England; [Dickens, Chris] Univ Exeter, Mental Hlth Res Grp, Peninsula Coll Med & Dent, Exeter, Devon, England; [Dickens, Chris] Univ Exeter, Natl Inst Hlth Res, Collaborat Leadership Appl Hlth Res & Care South, Exeter, Devon, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Sheffield; University of Bristol; University of Exeter; University of Plymouth; University of Exeter	Coventry, PA (corresponding author), Univ Manchester, Ctr Primary Care, Collaborat Leadership Appl Hlth Res & Care Greate, Manchester, Lancs, England.	peter.a.coventry@manchester.ac.uk	Coventry, Peter/H-6714-2014; malpass, alice/AAX-8110-2020; Bower, Peter/A-1508-2011; Hind, Daniel/AAE-1769-2020; Coventry, Peter/AAA-9344-2019; Keyworth, Chris/I-9901-2019; Hind, Daniel/A-2180-2010	Coventry, Peter/0000-0003-0625-3829; malpass, alice/0000-0002-6329-4304; Bower, Peter/0000-0001-9558-3349; Hind, Daniel/0000-0002-6409-4793; Coventry, Peter/0000-0003-0625-3829; Keyworth, Chris/0000-0002-7815-6174; Hind, Daniel/0000-0002-6409-4793; Dickens, Chris/0000-0001-6326-7544; Kenning, Cassandra/0000-0001-6041-4051	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for Greater Manchester; Medical Research Council [G106/1242] Funding Source: researchfish; MRC [G106/1242] Funding Source: UKRI	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for Greater Manchester(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded from the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for Greater Manchester. The views expressed in this article are those of the authors and not necessarily those of the NIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, INT J GERIATR PSYCH, V23, P447, DOI 10.1002/gps.1925; Baraniak A, 2011, PATIENT EDUC COUNS, V83, P29, DOI 10.1016/j.pec.2010.04.010; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Blumenthal JA, 2006, J CONSULT CLIN PSYCH, V74, P535, DOI 10.1037/0022-006X.74.3.535; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brenes GA, 2003, PSYCHOSOM MED, V65, P963, DOI 10.1097/01.PSY.0000097339.75789.81; Bucknall CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1060; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Coventry PA, 2008, BRIT J HEALTH PSYCH, V13, P381, DOI 10.1348/135910707X203723; Coventry PA, 2007, J PSYCHOSOM RES, V63, P551, DOI 10.1016/j.jpsychores.2007.08.002; Coventry PA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-49; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Dahlen I, 2002, CHEST, V122, P1633, DOI 10.1378/chest.122.5.1633; de Blok BMJ, 2006, PATIENT EDUC COUNS, V61, P48, DOI 10.1016/j.pec.2005.02.005; de Godoy DV, 2003, ARCH PHYS MED REHAB, V84, P1154, DOI 10.1016/S0003-9993(03)00239-9; Devine EC, 1996, PATIENT EDUC COUNS, V29, P167, DOI 10.1016/0738-3991(96)00862-2; Dickens C, 2013, PSYCHOSOM MED, V75, P211, DOI 10.1097/PSY.0b013e31827ac009; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Donesky-Cuenco D, 2009, J ALTERN COMPLEM MED, V15, P225, DOI 10.1089/acm.2008.0389; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Effing T, 2011, RESP MED, V105, P418, DOI 10.1016/j.rmed.2010.09.017; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eisner MD, 2010, THORAX, V65, P229, DOI 10.1136/thx.2009.126201; Elci A, 2008, RESPIROLOGY, V13, P703, DOI 10.1111/j.1440-1843.2008.01327.x; Emery CF, 1998, HEALTH PSYCHOL, V17, P232, DOI 10.1037/0278-6133.17.3.232; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Fritzsche A, 2011, RESP MED, V105, P1422, DOI 10.1016/j.rmed.2011.05.014; GIFT AG, 1992, NURS RES, V41, P242; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; Gudmundsson G, 2005, EUR RESPIR J, V26, P414, DOI 10.1183/09031936.05.00078504; Guell R, 2006, CHEST, V129, P899, DOI 10.1378/chest.129.4.899; Hanania NA, 2011, AM J RESP CRIT CARE, V183, P604, DOI 10.1164/rccm.201003-0472OC; Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519; Herring MP, 2012, ARCH INTERN MED, V172, P101, DOI 10.1001/archinternmed.2011.696; Herring MP, 2010, ARCH INTERN MED, V170, P321, DOI 10.1001/archinternmed.2009.530; Hewitt C, 2005, BMJ-BRIT MED J, V330, P1057, DOI 10.1136/bmj.38413.576713.AE; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hill K, 2008, EUR RESPIR J, V31, P667, DOI 10.1183/09031936.00125707; Hospes G, 2009, PATIENT EDUC COUNS, V75, P274, DOI 10.1016/j.pec.2008.10.005; Hynninen MJ, 2010, RESP MED, V104, P986, DOI 10.1016/j.rmed.2010.02.020; Jain S, 2012, ANN BEHAV MED, V33, P11; Kapella MC, 2011, INT J CHRONIC OBSTR, V6, P625, DOI 10.2147/COPD.S24858; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kayahan B, 2006, RESP MED, V100, P1050, DOI 10.1016/j.rmed.2005.09.031; Kunik ME, 2008, PSYCHOL MED, V38, P385, DOI 10.1017/S0033291707001687; Kunik ME, 2001, PSYCHOL MED, V31, P717, DOI 10.1017/S0033291701003890; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lamers F, 2010, COPD, V7, P315, DOI 10.3109/15412555.2010.510156; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; Lipsey MW, 2000, PRACTICAL METAANALYS; Livermore N, 2010, EUR RESPIR J, V35, P557, DOI 10.1183/09031936.00060309; Lolak S, 2008, PSYCHOTHER PSYCHOSOM, V77, P119, DOI 10.1159/000112889; Lord VM, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-41; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McGeoch GRB, 2006, RESPIROLOGY, V11, P611, DOI 10.1111/j.1440-1843.2006.00892.x; Mercer SW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5559; Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Mularski RA, 2009, J ALTERN COMPLEM MED, V15, P1083, DOI 10.1089/acm.2009.0037; National Collaborating Centre for Mental Health, 2010, NICE CLIN GUIDELINES; National Institute for Health and Clinical Excellence, 2010, CHRON OBSTR PULM DIS; Ng TP, 2007, ARCH INTERN MED, V167, P60, DOI 10.1001/archinte.167.1.60; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Ozdemir EP, 2010, TURK KLIN TIP BILIM, V30, P880; Pauwels R A, 2001, Respir Care, V46, P798; Pavey TG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6462; Paz-Diaz H, 2007, AM J PHYS MED REHAB, V86, P30, DOI 10.1097/PHM.0b013e31802b8eca; RIES AL, 1995, ANN INTERN MED, V122, P823, DOI 10.7326/0003-4819-122-11-199506010-00003; Rimer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub5; Rose C, 2002, PATIENT EDUC COUNS, V47, P311, DOI 10.1016/S0738-3991(02)00004-6; Rosmalen JGM, 2012, PSYCHOSOM MED, V74, P377, DOI 10.1097/PSY.0b013e3182545d47; ROSSER R, 1983, PSYCHOL MED, V13, P93, DOI 10.1017/S0033291700050108; SASSIDAMBRON DE, 1995, CHEST, V107, P724, DOI 10.1378/chest.107.3.724; Schulz KF, 2002, LANCET, V359, P781, DOI 10.1016/S0140-6736(02)07882-0; Spencer LM, 2010, EUR RESPIR J, V35, P571, DOI 10.1183/09031936.00073609; Spruit MA, 2010, RESP MED, V104, P849, DOI 10.1016/j.rmed.2009.12.007; Stanley MA, 2009, JAMA-J AM MED ASSOC, V301, P1460, DOI 10.1001/jama.2009.458; Taylor SJC, 2009, THORAX, V64, pA95, DOI 10.1136/thx.2009.127134y; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; TOSHIMA MT, 1990, HEALTH PSYCHOL, V9, P237, DOI 10.1037/0278-6133.9.3.237; Trappenburg JCA, 2011, THORAX, V66, P977, DOI 10.1136/thoraxjnl-2011-200071; Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149; van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x; Wempe JB, 2004, PATIENT EDUC COUNS, V52, P237, DOI 10.1016/S0738-3991(03)00097-1; Xu WN, 2008, AM J RESP CRIT CARE, V178, P913, DOI 10.1164/rccm.200804-619OC; Yeh GY, 2010, RESP CARE, V55, P1475; Zhang MWB, 2011, GEN HOSP PSYCHIAT, V33, P217, DOI 10.1016/j.genhosppsych.2011.03.009	91	89	95	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60532	10.1371/journal.pone.0060532	http://dx.doi.org/10.1371/journal.pone.0060532			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RZ	23585837	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000319109800059
J	Chien, MH; Liu, YF; Hsin, CH; Lin, CH; Shih, CH; Yang, SF; Cheng, CW; Lin, CW				Chien, Ming-Hsien; Liu, Yu-Fan; Hsin, Chung-Han; Lin, Chien-Huang; Shih, Chun-Han; Yang, Shun-Fa; Cheng, Chao-Wen; Lin, Chiao-Wen			Impact of VEGF-C Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GROWTH-FACTOR RECEPTOR-3; TUMOR ANGIOGENESIS; FACTOR (VEGF)-C; EXPRESSION; HEAD; PROLIFERATION; PROGRESSION; METASTASIS; MIGRATION	Background: Oral cancer, which is the fourth most common male cancer, is associated with environmental carcinogens in Taiwan. Vascular endothelial growth factor (VEGF)-C, an angiogenic/lymphangiogenic factor with high expression levels in tumor tissues, plays important roles in the development of several malignancies. This study was designed to examine associations of five VEGF-C gene polymorphisms with the susceptibility to and clinicopathological characteristics of oral squamous cell carcinoma. Methodology/Principal Findings: Five single-nucleotide polymorphisms (SNPs) of VEGF-C were analyzed by a real-time polymerase chain reaction (PCR) in 470 male patients with oral cancer and 426 cancer-free controls. In this study, we found that the VEGF-C rs7664413 and rs2046463 polymorphisms were associated with oral-cancer susceptibility but not with any clinicopathological parameters. The GGACA or GACTG haplotype of five VEGF-C SNPs (rs3775194, rs11947611, rs1485766, rs7664413, and rs2046463) combined was also related to the risk of oral cancer. Among 611 male smokers, VEGF-C polymorphism carriers who also chewed betel quid were found to have a 14.5-24.2-fold risk of having oral cancer compared to the VEGF-C wild-type carrier who did not chew betel quid. Among 461 male betel-quid chewers, VEGF-C polymorphism carriers who also smoked had a 2.7-18.1-fold risk of having oral cancer compared to those who carried the wild type but did not smoke. Conclusions: Our results suggest that the two SNPs of VEGF-C (rs7664413 and rs2046463) and either of two haplotypes of five SNPs combined have potential predictive significance in oral carcinogenesis. Gene-environmental interactions among VEGF-C polymorphisms, smoking, and betel-quid chewing might alter one's susceptibility to oral cancer.	[Chien, Ming-Hsien; Cheng, Chao-Wen] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fan Hosp, Taipei, Taiwan; [Liu, Yu-Fan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Shih, Chun-Han] Taipei Med Univ, Wan Fan Hosp, Dept Trauma & Emergency Surg, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Cheng, CW (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	ccheng@tmu.edu.tw; cwlin@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Lin, Chien-Huang/0000-0002-0916-8737	National Science Council, Taiwan [NSC100-2632-B-040-001-MY3]; Taipei Medical University-Wan Fang Hospital [101swf03]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-Wan Fang Hospital	This study was supported by research grant from National Science Council, Taiwan (NSC100-2632-B-040-001-MY3) and a grant from Taipei Medical University-Wan Fang Hospital (grant no. 101swf03 to Dr. Chien and Dr. Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIOLCHINI F, 2005, REV MINERVA STOMATOL, V54, P405; Califano J, 1996, CANCER RES, V56, P2488; Chang KW, 2004, BRIT J CANCER, V91, P1551, DOI 10.1038/sj.bjc.6602186; Chen MK, 2012, HUM GENET, V131, P1861, DOI 10.1007/s00439-012-1211-1; Cheng CY, 2008, ORAL SURG ORAL MED O, V106, P79, DOI 10.1016/j.tripleo.2007.10.009; Chien MH, 2013, EXPERT OPIN THER TAR, V17, P203, DOI 10.1517/14728222.2013.740012; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Dias S, 2002, BLOOD, V99, P2179, DOI 10.1182/blood.V99.6.2179; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Goode EL, 2010, CLIN CANCER RES, V16, P995, DOI 10.1158/1078-0432.CCR-09-2553; He YL, 2004, BBA-REV CANCER, V1654, P3, DOI 10.1016/j.bbcan.2003.07.003; Hong JM, 2010, EXP MOL MED, V42, P376, DOI 10.3858/emm.2010.42.5.039; Huang SF, 2009, ORAL ONCOL, V45, P16, DOI 10.1016/j.oraloncology.2008.03.006; Inamine M, 2012, INT J CLIN ONCOL, V17, P498, DOI 10.1007/s10147-011-0322-3; Jakubowska A, 2008, CANCER LETT, V262, P71, DOI 10.1016/j.canlet.2007.11.029; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jennbacken K, 2005, PROSTATE, V65, P110, DOI 10.1002/pros.20276; KODAMA M, 2011, CLIN CANCER RES, V14, P7205; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Li R, 2004, PROSTATE, V58, P193, DOI 10.1002/pros.10321; Lin MH, 2004, ARCH TOXICOL, V78, P167, DOI 10.1007/s00204-003-0524-1; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Lin SC, 2006, CANCER LETT, V243, P47, DOI 10.1016/j.canlet.2005.11.019; Lurje G, 2008, ANN ONCOL, V19, P1734, DOI 10.1093/annonc/mdn368; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Marchio S, 1999, J BIOL CHEM, V274, P27617, DOI 10.1074/jbc.274.39.27617; Masood R, 2003, INT J CANCER, V104, P603, DOI 10.1002/ijc.10996; Nagaraj NS, 2006, TOXICOL LETT, V165, P182, DOI 10.1016/j.toxlet.2006.03.008; Neuchrist C, 2003, HEAD NECK-J SCI SPEC, V25, P464, DOI 10.1002/hed.10235; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Schultheis AM, 2008, CLIN CANCER RES, V14, P7554, DOI 10.1158/1078-0432.CCR-08-0351; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Srinivas SK, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.040; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; Van Trappen PO, 2003, J PATHOL, V201, P544, DOI 10.1002/path.1467; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Warburton G, 2007, J ORAL MAXIL SURG, V65, P475, DOI 10.1016/j.joms.2005.12.074; Weng CJ, 2011, ANN SURG ONCOL, V18, P805, DOI 10.1245/s10434-010-1432-2; Weng CJ, 2010, ORAL ONCOL, V46, P767, DOI 10.1016/j.oraloncology.2010.07.011; Yokoyama Y, 2003, CLIN CANCER RES, V9, P1361	49	18	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60283	10.1371/journal.pone.0060283	http://dx.doi.org/10.1371/journal.pone.0060283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593187	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100029
J	Martin-Rodriguez, JF; Madrazo-Atutxa, A; Venegas-Moreno, E; Benito-Lopez, P; Galvez, MA; Cano, DA; Tinahones, FJ; Torres-Vela, E; Soto-Moreno, A; Leal-Cerro, A				Francisco Martin-Rodriguez, Juan; Madrazo-Atutxa, Ainara; Venegas-Moreno, Eva; Benito-Lopez, Pedro; Angeles Galvez, Maria; Cano, David A.; Tinahones, Francisco J.; Torres-Vela, Elena; Soto-Moreno, Alfonso; Leal-Cerro, Alfonso			Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naive Acromegaly	PLOS ONE			English	Article							LONG-TERM CURE; ELECTROMAGNETIC TOMOGRAPHY; COGNITIVE PERFORMANCE; COMPLEX FIGURE; GROWTH; MEMORY; IMPAIRMENT; DEFICIENCY; PATTERNS; STROKE	Patients with active untreated acromegaly show mild to moderate neurocognitive disorders that are associated to chronic exposure to growth hormone (GH) and insulin-like growth factor (IGF-I) hypersecretion. However, it is unknown whether these disorders improve after controlling GH/IGF-I hypersecretion. The aim of this study was to compare neurocognitive functions of patients who successfully underwent GH-secreting adenoma transsphenoidal surgery (cured patients) with patients with naive acromegaly. In addition, we wanted to determine the impact of different clinical and biochemical variables on neurocognitive status in patients with active disease and after long-term cure. A battery of six standardized neuropsychological tests assessed attention, memory and executive functioning. In addition, a quantitative electroencephalography with Low-Resolution Electromagnetic Tomography (LORETA) solution was performed to obtain information about the neurophysiological state of the patients. Neurocognitive data was compared to that of a healthy control group. Multiple linear regression analysis was also conducted using clinical and hormonal parameters to obtain a set of independent predictors of neurocognitive state before and after cure. Both groups of patients scored significantly poorer than the healthy controls on memory tests, especially those assessing visual and verbal recall. Patients with cured acromegaly did not obtain better cognitive measures than naive patients. Furthermore memory deficits were associated with decreased beta activity in left medial temporal cortex in both groups of patients. Regression analysis showed longer duration of untreated acromegaly was associated with more severe neurocognitive complications, regardless of the diagnostic group, whereas GH levels at the time of assessment was related to neurocognitive outcome only in naive patients. Longer duration of post-operative biochemical remission of acromegaly was associated with better neurocognitive state. Overall, this data suggests that the effects of chronic exposure to GH/IGF-I hypersecretion could have long-term effects on brain functions.	[Francisco Martin-Rodriguez, Juan; Madrazo-Atutxa, Ainara; Venegas-Moreno, Eva; Cano, David A.; Soto-Moreno, Alfonso; Leal-Cerro, Alfonso] Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain; [Francisco Martin-Rodriguez, Juan; Madrazo-Atutxa, Ainara; Venegas-Moreno, Eva; Cano, David A.; Soto-Moreno, Alfonso; Leal-Cerro, Alfonso] Virgen del Rocio Univ Hosp, Div Endocrinol, Seville, Spain; [Benito-Lopez, Pedro; Angeles Galvez, Maria] Univ Cordoba, Hosp Univ Reina Sofia, Div Endocrinol, Cordoba, Spain; [Tinahones, Francisco J.] Virgen de la Victoria Hosp, Div Endocrinol, Malaga, Spain; [Torres-Vela, Elena] San Cecilio Hosp, Div Endocrinol, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; Universidad de Cordoba	Leal-Cerro, A (corresponding author), Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.	alealcerro@us.es	Cano, David A./B-8013-2015; Tinahones, Francisco José/AAB-2882-2020	Cano, David A./0000-0001-6264-3288; Martin Rodriguez, Juan Francisco/0000-0003-1392-8775; Tinahones, Francisco J/0000-0001-6871-4403	R&D grant from Novartis Oncology; Plan Andaluz de Investigacion [CTS-444]; Spanish Ministry of Science and Innovation [RYC-2006-001071]; Plan Andaluz de Investigacion of the Andalusian Regional Government [CTS-444]	R&D grant from Novartis Oncology; Plan Andaluz de Investigacion; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Andaluz de Investigacion of the Andalusian Regional Government	Funding for this project was provided by an R&D grant from Novartis Oncology and the Plan Andaluz de Investigacion (CTS-444). DAC was supported by the "Ramon y Cajal'' program (RYC-2006-001071) of the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by an R&D grant from Novartis Oncology and the "Plan Andaluz de Investigacion'' (CTS-444) of the Andalusian Regional Government. DAC was supported by the "Ramon y Cajal'' program (RYC-2006-001071) of the Spanish Ministry of Science and Innovation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aberg ND, 2010, GROWTH HORM IGF RES, V20, P264, DOI 10.1016/j.ghir.2009.12.003; Badia Xavier, 2004, Health Qual Life Outcomes, V2, P13, DOI 10.1186/1477-7525-2-13; Ben-Shlomo A, 2011, PITUITARY, V14, P284, DOI 10.1007/s11102-011-0310-7; Biermasz NR, 2004, J CLIN ENDOCR METAB, V89, P5369, DOI 10.1210/jc.2004-0669; Brummelman P, 2012, EUR J CLIN INVEST, V42, P1317, DOI 10.1111/j.1365-2362.2012.02721.x; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Davi MV, 2008, EUR J ENDOCRINOL, V159, P533, DOI 10.1530/EJE-08-0442; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kneebone AC, 2007, J INT NEUROPSYCH SOC, V13, P664, DOI 10.1017/S135617707070828; Kraft A, 2014, CORTEX, V56, P38, DOI 10.1016/j.cortex.2012.10.004; Lange G, 2000, ARCH PHYS MED REHAB, V81, P89, DOI 10.1053/apmr.2000.0810089; Le Greves M, 2002, P NATL ACAD SCI USA, V99, P7119, DOI 10.1073/pnas.092135399; Leon-Carrion J, 2010, J CLIN ENDOCR METAB, V95, P4367, DOI 10.1210/jc.2010-0394; Leon-Carrion J, 2009, CLIN ENDOCRINOL, V70, P192, DOI 10.1111/j.1365-2265.2008.03355.x; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Luzzi S, 2011, NEUROL SCI, V32, P1081, DOI 10.1007/s10072-011-0641-1; McConley R, 2008, EPILEPSY BEHAV, V13, P174, DOI 10.1016/j.yebeh.2008.03.003; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Ransome MI, 2004, EUR J NEUROSCI, V19, P2069, DOI 10.1111/j.0953-816X.2004.03308.x; Sievers C, 2009, PITUITARY, V12, P177, DOI 10.1007/s11102-008-0143-1; Sievers C, 2012, PITUITARY, V15, P350, DOI 10.1007/s11102-011-0326-z; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Szabo K, 2009, STROKE, V40, P2042, DOI 10.1161/STROKEAHA.108.536144; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanriverdi F, 2009, GROWTH HORM IGF RES, V19, P24, DOI 10.1016/j.ghir.2008.05.002; TERZOLO M, 1995, J ENDOCRINOL INVEST, V18, P613, DOI 10.1007/BF03349779; Tiemensma J, 2010, J CLIN ENDOCR METAB, V95, pE392, DOI 10.1210/jc.2010-1253; Wassenaar MJE, 2009, EUR J ENDOCRINOL, V160, P357, DOI 10.1530/EJE-08-0845	37	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60041	10.1371/journal.pone.0060041	http://dx.doi.org/10.1371/journal.pone.0060041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593161	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100015
J	LeBlanc, MA; Fairn, GD; Russo, SB; Czyz, O; Zaremberg, V; Cowart, LA; McMaster, CR				LeBlanc, Marissa A.; Fairn, Gregory D.; Russo, Sarah B.; Czyz, Ola; Zaremberg, Vanina; Cowart, L. Ashley; McMaster, Christopher R.			The Yeast Oxysterol Binding Protein Kes1 Maintains Sphingolipid Levels	PLOS ONE			English	Article							PLASMA-MEMBRANE ATPASE; SACCHAROMYCES-CEREVISIAE; STEROL MOVEMENT; TRAFFICKING; PATHWAYS; CELL; ER; PHOSPHATIDYLINOSITOL; HOMEOSTASIS; METABOLISM	The oxysterol binding protein family are amphitropic proteins that bind oxysterols, sterols, and possibly phosphoinositides, in a conserved binding pocket. The Saccharomyces cerevisiae oxysterol binding protein family member Kes1 (also known as Osh4) also binds phosphoinositides on a distinct surface of the protein from the conserved binding pocket. In this study, we determine that the oxysterol binding protein family member Kes1 is required to maintain the ratio of complex sphingolipids and levels of ceramide, sphingosine-phosphate and sphingosine. This inability to maintain normal sphingolipid homeostasis resulted in misdistribution of Pma1, a protein that requires normal sphingolipid synthesis to occur to partition into membrane rafts at the Golgi for its trafficking to the plasma membrane.	[LeBlanc, Marissa A.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Fairn, Gregory D.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Russo, Sarah B.; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Czyz, Ola; Zaremberg, Vanina] Univ Calgary, Dept Biol, Calgary, AB T2N 1N4, Canada; [Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [McMaster, Christopher R.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada	Dalhousie University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Medical University of South Carolina; University of Calgary; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca		Fairn, Greg/0000-0001-6508-168X; McMaster, Christopher/0000-0003-0822-5776	CIHR; NIH; VA; NSERC	CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by CIHR (http://www.cihr-irsc.gc.ca/e/193.html), NIH (http://www.nih.gov/), VA (http://www.research.va.gov/funding/), and NSERC (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beh CT, 2012, J BIOL CHEM, V287, P11481, DOI 10.1074/jbc.R111.338400; Beh CT, 2001, GENETICS, V157, P1117; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cowart LA, 2006, BIOCHEM J, V393, P733, DOI 10.1042/BJ20050643; De Matteis MA, 2007, BBA-MOL CELL BIOL L, V1771, P761, DOI 10.1016/j.bbalip.2007.04.004; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; LeBlanc MA, 2010, J BIOL CHEM, V285, P33875, DOI 10.1074/jbc.M110.147264; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; Muthusamy BP, 2009, MOL BIOL CELL, V20, P2920, DOI 10.1091/mbc.E08-10-1036; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200	24	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60485	10.1371/journal.pone.0060485	http://dx.doi.org/10.1371/journal.pone.0060485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593226	Green Submitted, gold, Green Published			2022-12-27	WOS:000319108100047
J	Glesby, MJ; Albu, J; Chiu, YL; Ham, K; Engelson, E; He, Q; Muthukrishnan, V; Ginsberg, HN; Donovan, D; Ernst, J; Lesser, M; Kotler, DP				Glesby, Marshall J.; Albu, Jeanine; Chiu, Ya-Lin; Ham, Kirsis; Engelson, Ellen; He, Qing; Muthukrishnan, Varalakshmi; Ginsberg, Henry N.; Donovan, Daniel; Ernst, Jerry; Lesser, Martin; Kotler, Donald P.			Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; BODY-COMPOSITION; MYOCARDIAL-INFARCTION; SAFETY EXTENSION; LIPODYSTROPHY; SENSITIVITY; RISK; PIOGLITAZONE; GLUCOSE; METAANALYSIS	Background: Recombinant human growth hormone (rhGH) reduces visceral adipose tissue (VAT) volume in HIV-infected patients but can worsen glucose homeostasis and lipoatrophy. We aimed to determine if adding rosiglitazone to rhGH would abrogate the adverse effects of rhGH on insulin sensitivity (SI) and subcutaneous adipose tissue (SAT) volume. Methodology/Principal Findings: Randomized, double-blind, placebo-controlled, multicenter trial using a 2x2 factorial design in which HIV-infected subjects with abdominal obesity and insulin resistance were randomized to rhGH 3 mg daily, rosiglitazone 4 mg twice daily, combination rhGH + rosiglitazone, or double placebo (control) for 12 weeks. The primary endpoint was change in SI by frequently sampled intravenous glucose tolerance test from entry to week 12. Body composition was assessed by whole body magnetic resonance imaging (MRI) and dual Xray absorptiometry (DEXA). Seventy-seven subjects were randomized of whom 72 initiated study drugs. Change in SI from entry to week 12 differed across the 4 arms by 1-way ANCOVA (P = 0.02); by pair-wise comparisons, only rhGH (decreasing SI; P = 0.03) differed significantly from control. Changes from entry to week 12 in fasting glucose and glucose area under the curve on 2-hour oral glucose tolerance test differed across arms (1-way ANCOVA P = 0.004), increasing in the rhGH arm relative to control. VAT decreased significantly in the rhGH arms (-17.5% in rhGH/rosiglitazone and -22.7% in rhGH) but not in the rosiglitazone alone (-2.5%) or control arms (-1.9%). SAT did not change significantly in any arm. DEXA results were consistent with the MRI data. There was no significant rhGH x rosiglitazone interaction for any body composition parameter. Conclusions/Significance: The addition of rosiglitazone abrogated the adverse effects of rhGH on insulin sensitivity and glucose tolerance while not significantly modifying the lowering effect of rhGH on VAT.	[Glesby, Marshall J.; Ham, Kirsis] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Glesby, Marshall J.; Chiu, Ya-Lin] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA; [Albu, Jeanine; Engelson, Ellen; He, Qing; Muthukrishnan, Varalakshmi; Kotler, Donald P.] St Lukes Roosevelt Hosp, Dept Med, New York, NY USA; [Ginsberg, Henry N.; Donovan, Daniel] Columbia Univ Coll Physicians & Surg, Dept Med, New York, NY USA; [Ernst, Jerry] AIDS Community Res Initiat Amer, New York, NY USA; [Lesser, Martin] Feinstein Inst Med Res, Manhasset, NY USA; [Lesser, Martin] Hofstra North Shore LIJ Sch Med, Manhasset, NY USA	Cornell University; Cornell University; Mount Sinai St. Luke's; Mount Sinai West; Columbia University; Northwell Health; Hofstra University; Northwell Health	Glesby, MJ (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY USA.	mag2005@med.cornell.edu			National Institutes of Health [R01 DK065515, K24 AI078884, UL1 RR024996, M01 RR 00047, M01 RR 00645-27, UL1 TR000040-07, P30 DK026687]; EMD Serono; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040, UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000047, UL1RR024996, M01RR000645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI078884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK065515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMD Serono; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (R01 DK065515, K24 AI078884, UL1 RR024996, M01 RR 00047, M01 RR 00645-27, UL1 TR000040-07, and P30 DK026687. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. Recombinant human growth hormone and rosiglitazone, with matching placebos, were generously donated by EMD Serono and GlaxoSmithKline, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MG has served as a consultant to EMD Serono on two occasions, most recently in 2007. His institution (Weill Cornell Medical College) received research support from EMD Serono for a clinical trial of recombinant human growth hormone for which he was the local principal investigator from 2004-2005. DPK and EE received research support from EMD Serono to their institution (St. Luke's-Roosevelt Hospital) for a substudy of the present study (not reported herein). EE served as a consultant to Thera Technologies in 2010, which licenses tesamorelin to EMD Serono. For this study, recombinant human growth hormone and rosiglitazone, with matching placebos, were generously donated by EMD Serono and GlaxoSmithKline, respectively. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Attallah Hamdee, 2007, PLoS Clin Trials, V2, pe21, DOI 10.1371/journal.pctr.0020021; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Bourg CA, 2012, ANN PHARMACOTHER, V46, P282, DOI 10.1345/aph.1Q400; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Brown TT, 2012, NAT REV ENDOCRINOL, V8, P11, DOI 10.1038/nrendo.2011.151; Engelson ES, 2002, J ACQ IMMUN DEF SYND, V30, P379, DOI 10.1097/01.QAI.0000020501.93209.1C; Engelson ES, 1999, AM J CLIN NUTR, V69, P1162; Falutz J, 2005, AIDS, V19, P1279, DOI 10.1097/01.aids.0000180099.35146.30; Falutz J, 2007, NEW ENGL J MED, V357, P2359, DOI 10.1056/NEJMoa072375; Falutz J, 2010, J CLIN ENDOCR METAB, V95, P4291, DOI 10.1210/jc.2010-0490; Falutz J, 2010, JAIDS-J ACQ IMM DEF, V53, P311, DOI 10.1097/QAI.0b013e3181cbdaff; Gelato MC, 2002, JAIDS-J ACQ IMM DEF, V31, P163, DOI 10.1097/00126334-200210010-00006; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Grunfeld C, 2007, JAIDS-J ACQ IMM DEF, V45, P286; Iman R, 1982, P ANN SAS US GROUP I, V7, P676; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kawai T, 1999, METABOLISM, V48, P1102, DOI 10.1016/S0026-0495(99)90122-1; Kotler Donald P, 2006, J Acquir Immune Defic Syndr, V43, P378, DOI 10.1097/01.qai.0000243108.26136.66; Kotler DP, 2004, JAIDS-J ACQ IMM DEF, V35, P239, DOI 10.1097/00126334-200403010-00004; Koutkia P, 2005, J CLIN ENDOCR METAB, V90, P32, DOI 10.1210/jc.2004-1342; Lo JC, 2001, J CLIN ENDOCR METAB, V86, P3480, DOI 10.1210/jc.86.8.3480; LUKASKI HC, 1985, AM J CLIN NUTR, V41, P363, DOI 10.1093/ajcn/41.2.363; Macallan DC, 2008, HIV CLIN TRIALS, V9, P254, DOI 10.1310/hct0904-254; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; McComsey GA, 2011, CLIN INFECT DIS, V53, P185, DOI 10.1093/cid/cir324; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Miyazaki Y, 2001, DIABETOLOGIA, V44, P2210, DOI 10.1007/s001250100031; Molarius A, 1998, INT J OBESITY, V22, P719, DOI 10.1038/sj.ijo.0800660; Mori Y, 1999, DIABETES CARE, V22, P908, DOI 10.2337/diacare.22.6.908; Nakamura T, 2001, DIABETES RES CLIN PR, V54, P181, DOI 10.1016/S0168-8227(01)00319-9; Nielsen S, 2001, DIABETES, V50, P2301, DOI 10.2337/diabetes.50.10.2301; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Raboud JM, 2010, HIV CLIN TRIALS, V11, P39, DOI 10.1310/hct1101-39; Rietschel P, 2001, J CLIN ENDOCR METAB, V86, P504, DOI 10.1210/jc.86.2.504; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Segerlantz M, 2001, J CLIN ENDOCR METAB, V86, P5813, DOI 10.1210/jc.86.12.5813; Sheth SH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-183; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Slama L, 2008, ANTIVIR THER, V13, P67; Smith SR, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2004.07.008; STEIL GM, 1994, DIABETES, V43, P1365, DOI 10.2337/diabetes.43.11.1365; Tungsiripat M, 2010, AIDS, V24, P1291, DOI 10.1097/QAD.0b013e328339e274; WONG WW, 1989, AM J CLIN NUTR, V50, P1290, DOI 10.1093/ajcn/50.6.1290	45	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61160	10.1371/journal.pone.0061160	http://dx.doi.org/10.1371/journal.pone.0061160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593417	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300054
J	Tucker, G; Adams, R; Wilson, D				Tucker, Graeme; Adams, Robert; Wilson, David			Observed Agreement Problems between Sub-Scales and Summary Components of the SF-36 Version 2-An Alternative Scoring Method Can Correct the Problem	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; PHYSICAL-ACTIVITY; MENTAL-DISORDERS; SCORES; ALGORITHMS	Purpose: A number of previous studies have shown inconsistencies between sub-scale scores and component summary scores using traditional scoring methods of the SF-36 version 1. This study addresses the issue in Version 2 and asks if the previous problems of disagreement between the eight SF-36 Version 1 sub-scale scores and the Physical and Mental Component Summary persist in version 2. A second study objective is to review the recommended scoring methods for the creation of factor scoring weights and the effect on producing summary scale scores Methods: The 2004 South Australian Health Omnibus Survey dataset was used for the production of coefficients. There were 3,014 observations with full data for the SF-36. Data were analysed in LISREL V8.71. Confirmatory factor analysis models were fit to the data producing diagonally weighted least squares estimates. Scoring coefficients were validated on an independent dataset, the 2008 South Australian Health Omnibus Survey. Results: Problems of agreement were observed with the recommended orthogonal scoring methods which were corrected using confirmatory factor analysis. Conclusions: Confirmatory factor analysis is the preferred method to analyse SF-36 data, allowing for the correlation between physical and mental health.	[Tucker, Graeme] SA Dept Hlth, Adelaide, SA, Australia; [Tucker, Graeme] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Adams, Robert; Wilson, David] Queen Elizabeth Hosp, Woodville, SA 5011, Australia	University of Adelaide	Tucker, G (corresponding author), SA Dept Hlth, Adelaide, SA, Australia.	Graeme.Tucker@health.sa.gov.au	Adams, Robert/Z-3197-2019; Tucker, Graeme R/AAP-4228-2020	Tucker, Graeme/0000-0003-2621-5942				Alonso J, 2007, J CLIN PSYCHIAT, V68, P3; Anagnostopoulos F, 2009, QUAL LIFE RES, V18, P53, DOI 10.1007/s11136-008-9423-5; Chapman Daniel P, 2005, Prev Chronic Dis, V2, pA14; Collingwood J, PSYCH CENTRAL; Farivar SS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-54; Fleishman JA, 2010, QUAL LIFE RES, V19, P231, DOI 10.1007/s11136-009-9582-z; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Forero CG, 2009, STRUCT EQU MODELING, V16, P625, DOI 10.1080/10705510903203573; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; Hann M, 2008, QUAL LIFE RES, V17, P413, DOI 10.1007/s11136-008-9310-0; Hawthorne G, 2007, QUAL LIFE RES, V16, P661, DOI 10.1007/s11136-006-9154-4; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hemingway H, 1997, BMJ-BRIT MED J, V315, P1273, DOI 10.1136/bmj.315.7118.1273; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joreskog KG, 2000, LATENT VARIABLE SCOR; Joreskog KG, 1996, LISREL USERS REF GUI; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Kosinski M, 1999, MED CARE, V37, pMS23, DOI 10.1097/00005650-199905001-00003; MacDonald R. P, 1999, TEST THEORY UNIFIED; Mindrila D, 2010, INT J DIGITAL SOC, V1, P60, DOI [10.20533/ijds.2040.2570.2010.0010, DOI 10.20533/IJDS.2040.2570.2010.0010]; Nye CD, 2011, ORGAN RES METHODS, V14, P548, DOI 10.1177/1094428110368562; RIGDON EE, 1991, J MARKETING RES, V28, P491, DOI 10.2307/3172790; Satorra A., 1988, AM STAT ASS 1988 P B, P308; Simon GE, 1998, MED CARE, V36, P567, DOI 10.1097/00005650-199804000-00012; StataCorp, 2011, STAT STAT SOFTW REL; Strohle A, 2007, PSYCHOL MED, V37, P1657, DOI 10.1017/S003329170700089X; Taft C, 2001, QUAL LIFE RES, V10, P395, DOI 10.1023/A:1012552211996; Tucker G, 2010, QUAL LIFE RES, V19, P1069, DOI 10.1007/s11136-010-9658-9; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Ware JE, 2001, QUAL LIFE RES, V10, P405, DOI 10.1023/A:1012588218728; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Wilson D, 2000, SOZ PRAVENTIV MED, V45, P239, DOI 10.1007/BF01591686; Wilson DH., 1992, HLTH PROMOT J AUST, V2, P47; Wothke J.L, 1999, AMOS 4 0 USERS GUIDE	35	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61191	10.1371/journal.pone.0061191	http://dx.doi.org/10.1371/journal.pone.0061191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123JP	23593428	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300057
J	Kishimoto, Y; Hirono, M; Atarashi, R; Sakaguchi, S; Yoshioka, T; Katamine, S; Kirino, Y				Kishimoto, Yasushi; Hirono, Moritoshi; Atarashi, Ryuichiro; Sakaguchi, Suehiro; Yoshioka, Tohru; Katamine, Shigeru; Kirino, Yutaka			Age-Dependent Impairment of Eyeblink Conditioning in Prion Protein-Deficient Mice	PLOS ONE			English	Article							PRP-LIKE PROTEIN; CEREBELLAR INTERPOSITUS NUCLEUS; PURKINJE-CELL DEGENERATION; GRANULE CELLS; MUTANT MOUSE; SYNAPTIC PLASTICITY; ECTOPIC EXPRESSION; MESSENGER-RNA; UP-REGULATION; DOPPEL	Mice lacking the prion protein (PrPC) gene (Prnp), Ngsk Prnp(0/0) mice, show late-onset cerebellar Purkinje cell (PC) degeneration because of ectopic overexpression of PrPC-like protein (PrPLP/Dpl). Because PrPC is highly expressed in cerebellar neurons (including PCs and granule cells), it may be involved in cerebellar synaptic function and cerebellar cognitive function. However, no studies have been conducted to investigate the possible involvement of PrPC and/or PrPLP/Dpl in cerebellum-dependent discrete motor learning. Therefore, the present cross-sectional study was designed to examine cerebellum-dependent delay eyeblink conditioning in Ngsk Prnp(0/0) mice in adulthood (16, 40, and 60 weeks of age). The aims of the present study were two-fold: (1) to examine the role of PrPC and/or PrPLP/Dpl in cerebellum-dependent motor learning and (2) to confirm the age-related deterioration of eyeblink conditioning in Ngsk Prnp(0/0) mice as an animal model of progressive cerebellar degeneration. Ngsk Prnp(0/0) mice aged 16 weeks exhibited intact acquisition of conditioned eyeblink responses (CRs), although the CR timing was altered. The same result was observed in another line of PrPc-deficient mice, ZrchI Prnp(0/0) mice. However, at 40 weeks of age, CR incidence impairment was observed in Ngsk Prnp(0/0) mice. Furthermore, Ngsk Prnp(0/0) mice aged 60 weeks showed more significantly impaired CR acquisition than Ngsk Prnp(0/0) mice aged 40 weeks, indicating the temporal correlation between cerebellar PC degeneration and motor learning deficits. Our findings indicate the importance of the cerebellar cortex in delay eyeblink conditioning and suggest an important physiological role of prion protein in cerebellar motor learning.	[Kishimoto, Yasushi; Kirino, Yutaka] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neurobiophys, Tokyo, Japan; [Hirono, Moritoshi] RIKEN Brain Sci Inst, Lab Motor Learning Control, Wako, Saitama, Japan; [Atarashi, Ryuichiro; Katamine, Shigeru] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Sakaguchi, Suehiro] Univ Tokushima, Inst Enzyme Res, Div Mol Neurobiol, Tokushima 770, Japan; [Yoshioka, Tohru] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Katamine, Shigeru] Nagasaki Univ, Ctr Int Collaborat Res, Nagasaki 852, Japan	University of Tokyo; RIKEN; Nagasaki University; Tokushima University; Kaohsiung Medical University; Nagasaki University	Kirino, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neurobiophys, Tokyo, Japan.	y-kirino@tokushima.bunri-u.ac.jp	Kishimoto, Yasushi/AAH-4923-2021	Kishimoto, Yasushi/0000-0002-4828-1249; Hirono, Moritoshi/0000-0001-6068-1045	Ministry of Education, Science, Sports and Culture of Japan [13877365, 20790084, 24590133]; Grants-in-Aid for Scientific Research [24590133] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aids (#13877365 to Y. Kirino, and # 20790084 and #24590133 to Y. Kishimoto) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; Bao SW, 1998, BEHAV NEUROSCI, V112, P714; Bao SW, 1998, LEARN MEMORY, V5, P355; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; Bracha V, 2004, PROG BRAIN RES, V143, P331, DOI 10.1016/S0079-6123(03)43032-X; Bracha V, 1997, BRAIN, V120, P1401, DOI 10.1093/brain/120.8.1401; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; BULLOCK D, 1994, NEURAL NETWORKS, V7, P1101, DOI 10.1016/S0893-6080(05)80161-3; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Chen L, 1996, J NEUROSCI, V16, P2829; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; DAUM I, 1989, J NEUROL NEUROSUR PS, V52, P47, DOI 10.1136/jnnp.52.1.47; Dimitrova A, 2008, BRAIN RES, V1198, P73, DOI 10.1016/j.brainres.2008.01.034; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; Gerwig M, 2007, CEREBELLUM, V6, P38, DOI 10.1080/14734220701225904; Gerwig M, 2005, J NEUROSCI, V25, P3919, DOI 10.1523/JNEUROSCI.0266-05.2005; Gruart A, 2008, NEUROBIOL DIS, V30, P439, DOI 10.1016/j.nbd.2008.03.001; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Herms JW, 2000, J NEUROCHEM, V75, P1487, DOI 10.1046/j.1471-4159.2000.0751487.x; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Jimenez-Diaz L, 2004, J NEUROSCI, V24, P9138, DOI 10.1523/JNEUROSCI.2025-04.2004; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kishimoto Y, 1997, NEUROREPORT, V8, P3717, DOI 10.1097/00001756-199712010-00012; Kishimoto Y, 2002, EUR J NEUROSCI, V16, P2416, DOI 10.1046/j.1460-9568.2002.02407.x; Kishimoto Y, 2001, NEUROREPORT, V12, P3349, DOI 10.1097/00001756-200110290-00040; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1221, DOI 10.1046/j.0953-816x.2001.01486.x; Kishimoto Y, 2006, J NEUROSCI, V26, P8829, DOI 10.1523/JNEUROSCI.1236-06.2006; Kishimoto Y, 2013, NEUROSCI LETT, V538, P15, DOI 10.1016/j.neulet.2013.01.025; Kishimoto Y, 2012, NEUROSCI LETT, V506, P155, DOI 10.1016/j.neulet.2011.10.071; Kopacek J, 2000, J VIROL, V74, P411, DOI 10.1128/JVI.74.1.411-417.2000; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Laine J, 2001, EUR J NEUROSCI, V14, P47, DOI 10.1046/j.0953-816x.2001.01621.x; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; Legname G, 2002, P NATL ACAD SCI USA, V99, P16285, DOI 10.1073/pnas.242611999; Li AM, 2000, CELL MOL NEUROBIOL, V20, P553, DOI 10.1023/A:1007059827541; Li AM, 2000, AM J PATHOL, V157, P1447, DOI 10.1016/S0002-9440(10)64782-7; Lopez-Ramos JC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.005; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; MASULLO C, 1994, ANN NY ACAD SCI, V724, P358, DOI 10.1111/j.1749-6632.1994.tb38931.x; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; Mauk MD, 1997, NEURON, V18, P343, DOI 10.1016/S0896-6273(00)81235-0; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Miyata M, 2011, J NEUROSCI, V31, P6067, DOI 10.1523/JNEUROSCI.5651-10.2011; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Nishida N, 1997, CELL MOL NEUROBIOL, V17, P537, DOI 10.1023/A:1026315006619; Nishida N, 1999, LAB INVEST, V79, P689; Nolan BC, 2006, LEARN MEMORY, V13, P359, DOI 10.1101/lm.168506; Peoc'h K, 2002, J BIOL CHEM, V277, P43071, DOI 10.1074/jbc.M206357200; PERRETT SP, 1993, J NEUROSCI, V13, P1708; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Porras-Garcia E, 2010, J NEUROPHYSIOL, V104, P346, DOI 10.1152/jn.00180.2010; Prestori F, 2008, J NEUROSCI, V28, P7091, DOI 10.1523/JNEUROSCI.0409-08.2008; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qiao XX, 1998, J NEUROSCI, V18, P6990; Rangel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007592; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Sakurai-Yamashita Y, 2005, NEUROSCIENCE, V136, P281, DOI 10.1016/j.neuroscience.2005.06.095; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Sanchez-Campusano R, 2007, J NEUROSCI, V27, P6620, DOI 10.1523/JNEUROSCI.0488-07.2007; Sanchez-Campusano R, 2009, J NEUROSCI, V29, P10750, DOI 10.1523/JNEUROSCI.2178-09.2009; SchulzSchaeffer WJ, 1996, CLIN NEUROPATHOL, V15, P353; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Silverman GL, 2000, J BIOL CHEM, V275, P26834; SOLOMON PR, 1983, SCIENCE, V220, P329, DOI 10.1126/science.6836277; Tanji K, 1995, INTERVIROLOGY, V38, P309, DOI 10.1159/000150457; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; TOPKA H, 1993, BRAIN, V116, P961, DOI 10.1093/brain/116.4.961; Tuzi NL, 2002, J GEN VIROL, V83, P705, DOI 10.1099/0022-1317-83-3-705; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; Weissmann C, 1999, SCIENCE, V286, P914, DOI 10.1126/science.286.5441.914; WEISSMANN C, 1994, ANN NY ACAD SCI, V724, P235, DOI 10.1111/j.1749-6632.1994.tb38913.x; WELSH JP, 1989, J NEUROSCI, V9, P299; Westaway D, 2011, TOP CURR CHEM, V305, P225, DOI 10.1007/128_2011_190; Woodruff-Pak D S, 1990, Neuroreport, V1, P165, DOI 10.1097/00001756-199010000-00020; Woodruff-Pak DS, 1998, PSYCHOL AGING, V13, P193, DOI 10.1037/0882-7974.13.2.193; WoodruffPak DS, 1997, BRAIN RES, V747, P207, DOI 10.1016/S0006-8993(96)01191-2; WoodruffPak DS, 1996, NEUROBIOL AGING, V17, P505; WOODRUFFPAK DS, 1990, ANN NY ACAD SCI, V608, P150, DOI 10.1111/j.1749-6632.1990.tb48896.x; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023; Yoshikawa D, 2007, GENE, V386, P139, DOI 10.1016/j.gene.2006.08.028	96	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60627	10.1371/journal.pone.0060627	http://dx.doi.org/10.1371/journal.pone.0060627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593266	gold, Green Published, Green Submitted			2022-12-27	WOS:000317382000022
J	Bae, SM; Kim, HJ; Lee, JB; Choi, JB; Shin, TY; Koo, HN; Choi, JY; Lee, KS; Je, YH; Jin, BR; Yoo, SS; Woo, SD				Bae, Sung Min; Kim, Hee Jung; Lee, Jun Beom; Choi, Jae Bang; Shin, Tae Young; Koo, Hyun Na; Choi, Jae Young; Lee, Kwang Sik; Je, Yeon Ho; Jin, Byung Rae; Yoo, Sung Sik; Woo, Soo Dong			Hyper-Enhanced Production of Foreign Recombinant Protein by Fusion with the Partial Polyhedrin of Nucleopolyhedrovirus	PLOS ONE			English	Article							INSECT CELLS; BACULOVIRAL POLYHEDRIN; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; INCLUSION-BODY; SWINE; GENERATION; TRANSPORT; SEQUENCE; COMPLEX	To enhance the production efficiency of foreign protein in baculovirus expression systems, the effects of polyhedrin fragments were investigated by fusion expressing them with the enhanced green fluorescent protein (EGFP). Recombinant viruses were generated to express EGFP fused with polyhedrin fragments based on the previously reported minimal region for self-assembly and the KRKK nuclear localization signal (NLS). Fusion expressions with polyhedrin amino acids 19 to 110 and 32 to 110 lead to localization of recombinant protein into the nucleus and mediate its assembly. The marked increase of EGFP by these fusion expressions was confirmed through protein and fluorescence intensity analyses. The importance of nuclear localization for enhanced production was shown by the mutation of the NLS within the fused polyhedrin fragment. In addition, when the polyhedrin fragment fused with EGFP was not localized in the nucleus, some fragments increased the production of protein. Among these fragments, some degradation of only the fused polyhedrin was observed in the fusion of amino acids 19 to 85 and 32 to 85. The fusion of amino acids 32 to 85 may be more useful for the enhanced and intact production of recombinant protein. The production of E2 protein, which is a major antigen of classical swine fever virus, was dramatically increased by fusion expression with polyhedrin amino acids 19 to 110, and its preliminary immunogenicity was verified using experimental guinea pigs. This study suggests a new option for higher expression of useful foreign recombinant protein by using the partial polyhedrin in baculovirus.	[Bae, Sung Min; Kim, Hee Jung; Lee, Jun Beom; Choi, Jae Bang; Shin, Tae Young; Koo, Hyun Na; Woo, Soo Dong] Chungbuk Natl Univ, Dept Agr Biol, Coll Agr Life & Environm Sci, Cheongju, South Korea; [Choi, Jae Young; Je, Yeon Ho] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea; [Lee, Kwang Sik; Jin, Byung Rae] Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea; [Je, Yeon Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Yoo, Sung Sik] Choong Ang Vaccine Lab, Taejon, South Korea	Chungbuk National University; Seoul National University (SNU); Dong A University; Seoul National University (SNU)	Woo, SD (corresponding author), Chungbuk Natl Univ, Dept Agr Biol, Coll Agr Life & Environm Sci, Cheongju, South Korea.	sdwoo@cbnu.ac.kr	Choi, Jae Young/G-1731-2010		Next-Generation BioGreen 21 Program [PJ007995]; BioGreen 21 Project, Rural Development Administration, Republic of Korea [20070401034002]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); BioGreen 21 Project, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by grant from the Next-Generation BioGreen 21 Program (number PJ007995), and BioGreen 21 Project (number 20070401034002), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2005, NUCLEIC ACIDS RES, V33, P3751, DOI 10.1093/nar/gki692; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Blanchard P, 2003, VACCINE, V21, P4565, DOI 10.1016/S0264-410X(03)00503-6; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; Cox MM, 2012, VACCINE; Fisk HJ, 1998, PLANT SCI, V133, P177, DOI 10.1016/S0168-9452(98)00033-8; Harper DM, 2009, CURR OPIN OBSTET GYN, V21, P457, DOI 10.1097/GCO.0b013e328332c910; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hendil KB, 2004, CURR PROTEIN PEPT SC, V5, P135, DOI 10.2174/1389203043379747; Hitchman Richard B, 2009, Recent Pat Biotechnol, V3, P46; HULST MM, 1993, J VIROL, V67, P5435, DOI 10.1128/JVI.67.9.5435-5442.1993; Ishiyama S, 2010, BIOTECHNOL LETT, V32, P1637, DOI 10.1007/s10529-010-0340-7; JARVIS DL, 1991, VIROLOGY, V185, P795, DOI 10.1016/0042-6822(91)90551-L; Je YH, 2001, BIOTECHNOL LETT, V23, P575; Ji XY, 2010, EMBO J, V29, P505, DOI 10.1038/emboj.2009.352; KIDD IM, 1993, APPL BIOCHEM BIOTECH, V42, P137, DOI 10.1007/BF02788049; Lamond, 2006, CELL BIOL LAB HDB, P103, DOI [10.1016/b978-012164730-8/50087-3, DOI 10.1016/B978-012164730-8/50087-3]; Li L, 2007, BIOTECHNOL BIOENG, V96, P1183, DOI 10.1002/bit.21193; Liu L, 2008, PROTEIN EXPRES PURIF, V62, P21, DOI 10.1016/j.pep.2008.07.010; Manohar SL, 2010, BIOTECHNOL BIOENG, V107, P909, DOI 10.1002/bit.22896; MARUMOTO Y, 1987, J GEN VIROL, V68, P2599, DOI 10.1099/0022-1317-68-10-2599; Moormann RJM, 2000, VET MICROBIOL, V73, P209, DOI 10.1016/S0378-1135(00)00146-2; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Park JS, 2007, APPL MICROBIOL BIOT, V75, P347, DOI 10.1007/s00253-006-0826-3; PETERS R, 1986, BIOCHIM BIOPHYS ACTA, V864, P305, DOI 10.1016/0304-4157(86)90003-1; Possee RD., 1992, BACULOVIRUS EXPRESSI; Roh JY, 2010, BIOSCI BIOTECH BIOCH, V74, P1522, DOI 10.1271/bbb.100016; Roldao A, 2011, J INVERTEBR PATHOL, V107, pS94, DOI 10.1016/j.jip.2011.05.009; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Sekimoto T, 2012, GENES CELLS, V17, P525, DOI 10.1111/j.1365-2443.2012.01609.x; Seo JH, 2003, BIOTECHNOL BIOENG, V84, P467, DOI 10.1002/bit.10798; SMITH GE, 1985, P NATL ACAD SCI USA, V82, P8404, DOI 10.1073/pnas.82.24.8404; Tiwari P, 2010, MOL BIOTECHNOL, V46, P80, DOI 10.1007/s12033-010-9284-3; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2011, N END RULE PATHWAY R; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wen ZY, 2009, ANTIVIR RES, V84, P215, DOI 10.1016/j.antiviral.2009.09.005	38	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60835	10.1371/journal.pone.0060835	http://dx.doi.org/10.1371/journal.pone.0060835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593321	gold, Green Submitted, Green Published			2022-12-27	WOS:000317909600056
J	Kuo, RC; Zhang, H; Zhuang, YY; Hannick, L; Lin, SJ				Kuo, Rita C.; Zhang, Huan; Zhuang, Yunyun; Hannick, Linda; Lin, Senjie			Transcriptomic Study Reveals Widespread Spliced Leader Trans-Splicing, Short 5 '-UTRs and Potential Complex Carbon Fixation Mechanisms in the Euglenoid Alga Eutreptiella sp.	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE; PARAMYLON SYNTHESIS; C-4 PHOTOSYNTHESIS; SEQUENCE FLANKING; PROTEIN-SYNTHESIS; GENE-EXPRESSION; GENOME ANALYSIS; GRACILIS; DINOFLAGELLATE; RNA	Eutreptiella are an evolutionarily unique and ecologically important genus of microalgae, but they are poorly understood with regard to their genomic make-up and expression profiles. Through the analysis of the full-length cDNAs from a Eutreptiella species, we found a conserved 28-nt spliced leader sequence (Eut-SL, ACACUUUCUGAGUGUCUAUUUUUUUUCG) was trans-spliced to the mRNAs of Eutreptiella sp. Using a primer derived from Eut-SL, we constructed four cDNA libraries under contrasting physiological conditions for 454 pyrosequencing. Clustering analysis of the similar to 1.9x10(6) original reads (average length 382 bp) yielded 36,643 unique transcripts. Although only 28% of the transcripts matched documented genes, this fraction represents a functionally very diverse gene set, suggesting that SL trans-splicing is likely ubiquitous in this alga's transcriptome. The mRNAs of Eutreptiella sp. seemed to have short 5'-untranslated regions, estimated to be 21 nucleotides on average. Among the diverse biochemical pathways represented in the transcriptome we obtained, carbonic anhydrase and genes known to function in the C-4 pathway and heterotrophic carbon fixation were found, posing a question whether Eutreptiella sp. employs multifaceted strategies to acquire and fix carbon efficiently. This first large-scale transcriptomic dataset for a euglenoid uncovers many potential novel genes and overall offers a valuable genetic resource for research on euglenoid algae.	[Kuo, Rita C.; Zhang, Huan; Zhuang, Yunyun; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Hannick, Linda] J Craig Venter Inst, Rockville, MD USA	University of Connecticut; J. Craig Venter Institute	Zhang, H (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	huan.zhang@uconn.edu; senjie.lin@uconn.edu	Guo, chentao/G-7320-2016; Lin, Senjie/A-7466-2011; zhang, yaqun/J-8478-2014	Hannick, Linda/0000-0002-8018-8466	Department of Marine Sciences at UConn; Multidisciplinary Environmental Research Award from the Center of Environmental Science and Engineering at UConn; National Science Foundation [EF-0629624]	Department of Marine Sciences at UConn; Multidisciplinary Environmental Research Award from the Center of Environmental Science and Engineering at UConn; National Science Foundation(National Science Foundation (NSF))	The research was supported by the Predoctoral Awards of the Department of Marine Sciences at UConn (to RCK), Multidisciplinary Environmental Research Award from the Center of Environmental Science and Engineering at UConn (to RCK), and National Science Foundation "Assembling the Tree of Life (AToL)" grant EF-0629624 (to SL and collaborators). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Gongora C, 2006, MAR POLLUT BULL, V52, P48, DOI 10.1016/j.marpolbul.2005.08.006; Anderson D.M, 2000, ESTIMATED ANN EC IMP; BADGER MR, 1994, ANNU REV PLANT PHYS, V45, P369, DOI 10.1146/annurev.pp.45.060194.002101; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bates S., 2006, CANADIAN TECHNICAL R; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BLACK CC, 1973, ANNU REV PLANT PHYS, V24, P253, DOI 10.1146/annurev.pp.24.060173.001345; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; BRIAND J, 1981, PLANTA, V151, P168, DOI 10.1007/BF00387819; CALVAYRAC R, 1981, PLANTA, V153, P6, DOI 10.1007/BF00385311; CASSIN JM, 1978, B TORREY BOT CLUB, V105, P205, DOI 10.2307/2484116; CLARKE AE, 1960, BIOCHIM BIOPHYS ACTA, V44, P161, DOI 10.1016/0006-3002(60)91534-1; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; De Angioletti M, 2004, BRIT J HAEMATOL, V124, P224, DOI 10.1046/j.1365-2141.2003.04754.x; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frantz C, 2000, CURR GENET, V37, P349, DOI 10.1007/s002940000116; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Henriksen P, 2002, J PLANKTON RES, V24, P835, DOI 10.1093/plankt/24.9.835; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Hrda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033746; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; KIVIC PA, 1984, ORIGINS LIFE EVOL B, V13, P269, DOI 10.1007/BF00927177; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kuo RC, 2013, PROTIST, V164, P60, DOI 10.1016/j.protis.2012.08.004; Lapointe M, 2008, PLANT PHYSIOL, V147, P1427, DOI 10.1104/pp.108.117077; LAVALMARTIN D, 1981, PLANTA, V151, P157, DOI 10.1007/BF00387818; Leedale GF, 1967, EUGLENOID FLAGELLATE; Li Y, 2004, MONITORING PHYTOPLAN, P45; Lin S, 2010, P 13 INT C HARMF ALG, P166; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Lindholm T, 1995, GREEN WATER CAUSED E, P181; Lukes J, 2009, P NATL ACAD SCI USA, V106, P9963, DOI 10.1073/pnas.0901004106; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; McManus GB, 2004, LIMNOL OCEANOGR, V49, P308, DOI 10.4319/lo.2004.49.1.0308; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Moreno-Paz M, 2006, ENVIRON MICROBIOL, V8, P1064, DOI 10.1111/j.1462-2920.2006.00998.x; Olli K, 1996, J PLANKTON RES, V18, P1587, DOI 10.1093/plankt/18.9.1587; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; PEAK JG, 1981, BIOCHIM BIOPHYS ACTA, V677, P390, DOI 10.1016/0304-4165(81)90251-8; Raven JA, 2010, PHOTOSYNTH RES, V106, P123, DOI 10.1007/s11120-010-9563-7; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Riebesell U, 2000, NATURE, V407, P959, DOI 10.1038/35039665; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Rodriguez-Grana L, 2008, MAR ECOL PROG SER, V362, P69, DOI 10.3354/meps07401; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Seong KA, 2006, MAR ECOL PROG SER, V322, P85, DOI 10.3354/meps322085; Stonik I. V., 2007, Ocean Science Journal, V42, P81; Stonik V., 2001, RUSS J MAR BIOL, V27, P174; Takeyama H, 1997, BIOTECHNOL BIOENG, V53, P185, DOI 10.1002/(SICI)1097-0290(19970120)53:2<185::AID-BIT8>3.0.CO;2-K; Teilhet M, 1998, GENE, V222, P91, DOI 10.1016/S0378-1119(98)00470-3; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; WALDER JA, 1986, SCIENCE, V233, P569, DOI 10.1126/science.3523758; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Yamane Y, 2001, BIOTECHNOL LETT, V23, P1223, DOI 10.1023/A:1010573218863; YAMAUCHI K, 1991, NUCLEIC ACIDS RES, V19, P2715, DOI 10.1093/nar/19.10.2715; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083	74	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60826	10.1371/journal.pone.0060826	http://dx.doi.org/10.1371/journal.pone.0060826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585853	gold, Green Submitted, Green Published			2022-12-27	WOS:000317909600051
J	Li, XM; Li, ZP; Xue, M; Ou, ZM; Liu, M; Yang, MX; Liu, SH; Yang, SY; Li, XJ				Li, Xiumin; Li, Zhipeng; Xue, Mei; Ou, Zhimin; Liu, Ming; Yang, Mingxing; Liu, Suhuan; Yang, Shuyu; Li, Xuejun			Fructus Xanthii Attenuates Hepatic Steatosis in Rats Fed on High-Fat Diet	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; LIVER-X-RECEPTOR; ELEMENT-BINDING PROTEIN; GLUCOSE-METABOLISM; ACID-METABOLISM; ALPHA; LXR; OBESITY; CHREBP; GENE	Fructus Xanthii (FX) has been widely used as a traditional herbal medicine for rhinitis, headache, cold, etc. Modern pharmacological studies revealed that FX possesses anti-inflammatory, anti-oxidative, and anti-hyperglycemic properties. The present study was designed to investigate the effects of FX on glucose and insulin tolerance, and hepatic lipid metabolism in rats fed on high-fat diet (HFD). Hepatic steatosis was induced by HFD feeding. Aqueous extraction fractions of FX or vehicle were orally administered by gavage for 6 weeks. Body weight and blood glucose were monitored. Glucose and insulin tolerance test were performed. Liver morphology was visualized by hematoxylin and eosin, and oil red O staining. Expression of liver lipogenic and lipolytic genes was measured by real-time PCR. We showed here that FX improved glucose tolerance and insulin sensitivity in HFD rats. FX significantly decreased the expression of lipogenic genes and increased the expression of lipolytic genes, ameliorated lipid accumulation and decreased the total liver triglyceride (TG) content, and thus attenuated HFD-induced hepatic steatosis. In conclusion, FX improves glucose tolerance and insulin sensitivity, decreases lipogenesis and increases lipid oxidation in the liver of HFD rats, implying a potential application in the treatment of non-alcoholic fatty liver disease.	[Li, Xiumin; Li, Zhipeng; Xue, Mei; Ou, Zhimin; Liu, Ming; Yang, Mingxing; Liu, Suhuan; Yang, Shuyu; Li, Xuejun] Xiamen Univ, Affiliated Hosp 1, Xiamen Diabet Inst, Xiamen, Peoples R China; [Yang, Shuyu; Li, Xuejun] Xiamen Univ, Affiliated Hosp 1, Div Endocrinol & Diabet, Xiamen, Peoples R China; [Liu, Suhuan] Xiamen Univ, Affiliated Hosp 1, Cent Lab, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Yang, SY (corresponding author), Xiamen Univ, Affiliated Hosp 1, Xiamen Diabet Inst, Xiamen, Peoples R China.	yang.shuyu@yahoo.com.cn; lixuejun@yahoo.com.cn	li, xiu/GXV-1745-2022		Xiamen Science and Technology Bureau (Xiamen Research Platform for Systems Biology of Metabolic Disease) [3502Z20100001]; National Natural Science Foundation [30973912, 81073113, 81270901]	Xiamen Science and Technology Bureau (Xiamen Research Platform for Systems Biology of Metabolic Disease); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Xiamen Science and Technology Bureau (Xiamen Research Platform for Systems Biology of Metabolic Disease, 3502Z20100001), National Natural Science Foundation to Shuyu Yang (30973912), Xuejun Li (81073113), and Suhuan Liu (81270901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SP, 2004, MOL PHARMACOL, V66, P1440, DOI 10.1124/mol.104.005496; BERGMAN RN, 1985, ENDOCR REV, V6, P45, DOI 10.1210/edrv-6-1-45; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chakravarthy MV, 2009, J LIPID RES, V50, P630, DOI 10.1194/jlr.M800379-JLR200; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Endo M, 2007, EXP BIOL MED, V232, P614; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang MH, 2011, J ETHNOPHARMACOL, V135, P545, DOI 10.1016/j.jep.2011.03.057; Hulsmans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030414; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Jaskiewicz K, 2008, DIGEST DIS SCI, V53, P785, DOI 10.1007/s10620-007-9942-x; Jeong HW, 2011, DIABETES, V60, P496, DOI 10.2337/db09-1145; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Miyata KS, 1996, J BIOL CHEM, V271, P9189, DOI 10.1074/jbc.271.16.9189; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Song MY, 2009, INT J MOL MED, V23, P547, DOI 10.3892/ijmm_00000163; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	29	9	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61499	10.1371/journal.pone.0061499	http://dx.doi.org/10.1371/journal.pone.0061499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585904	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600119
J	Ma, WY; Zhuang, L; Han, B; Tang, B				Ma, Weiyuan; Zhuang, Le; Han, Bo; Tang, Bo			Association between Glutathione S-Transferase T1 Null Genotype and Gastric Cancer Risk: A Meta-Analysis of 48 Studies	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; METABOLIC GENES; STOMACH-CANCER; TOBACCO-SMOKE; DNA-REPAIR; M1 GSTM1; GSTT1; SUSCEPTIBILITY; GSTP1; ALCOHOL	Background: Glutathione S-transferases (GSTs) have proved to be involved in the detoxifying several carcinogens and may play an important role in carcinogenesis of cancer. Previous studies on the association between Glutathione S-transferase T1 (GSTT1) polymorphism and gastric cancer risk reported inconclusive results. To clarify the possible association, we conducted a meta-analysis of eligible studies. Methods: We searched in the Pubmed, Embase, and Wangfang Medicine databases for studies assessing the association between GSTT1 null genotype and gastric cancer risk. The pooled odds ratio (OR) and its 95% confidence interval (95% CI) was calculated to assess the strength of the association. A total of 48 studies with a total of 24,440 individuals were ultimately eligible for meta-analysis. Results: Overall, GSTT1 null genotype was significantly associated with increased risk of gastric cancer (Random-effect OR = 1.23, 95% CI 1.13-1.35, P (OR) <0.001, I-2 = 45.5%). Significant association was also found in Caucasians, East Asians, and Indians (P (Caucasians) = 0.010; P (East Asians) = 0.003; P (Indians) = 0.017). After adjusting for other confounding variables, GSTT1 null genotype was also significantly associated with increased risk of gastric cancer (Random-effect OR = 1.43, 95% CI 1.20-1.71, P OR,0.001, I-2 = 48.1%). Conclusion: The meta-analysis provides strong evidence for the significant association between GSTT1 null genotype and increased risk of gastric cancer.	[Ma, Weiyuan; Zhuang, Le] Shandong Univ, Dept Dermatol, Qilu Hosp, Jinan 250100, Peoples R China; [Han, Bo] Shandong Univ, Inst Pathol, Sch Med, Jinan 250100, Peoples R China; [Tang, Bo] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China	Shandong University; Shandong University; Army Medical University	Han, B (corresponding author), Shandong Univ, Inst Pathol, Sch Med, Jinan 250100, Peoples R China.	doctor19cn@yahoo.cn						Agudo A, 2006, CANCER EPIDEM BIOMAR, V15, P2427, DOI 10.1158/1055-9965.EPI-06-0072; Al-Moundhri MS, 2009, J CLIN GASTROENTEROL, V43, P152, DOI 10.1097/MCG.0b013e31815853fa; Garcia-Gonzalez MA, 2012, MUTAGENESIS, V27, P771, DOI 10.1093/mutage/ges049; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhardwaj R, 2012, TUMOR BIOL, V33, P1021, DOI 10.1007/s13277-012-0335-1; Boccia S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-206; Cai L, 2001, WORLD J GASTROENTERO, V7, P506; Chen B, 2010, DIGEST DIS SCI, V55, P1831, DOI 10.1007/s10620-009-1000-4; Chen J, 2012, MOL BIOL REP, V39, P10383, DOI 10.1007/s11033-012-1917-0; Choi SC, 2003, CANCER LETT, V195, P169, DOI 10.1016/S0304-3835(03)00158-7; Chourasia D, 2011, INDIAN J GASTROENTER, V30, P12, DOI 10.1007/s12664-011-0144-2; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Colombo J, 2004, WORLD J GASTROENTERO, V10, P1240; Deakin M, 1996, CARCINOGENESIS, V17, P881, DOI 10.1093/carcin/17.4.881; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gao CM, 2002, CANCER LETT, V188, P95, DOI 10.1016/S0304-3835(02)00115-5; Gonzalez A, 2004, REV BIOL TROP, V52, P591; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong Su Hyung, 2006, J Prev Med Public Health, V39, P135; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jing C, 2012, ASIAN PAC J CANCER P, V13, P3325, DOI 10.7314/APJCP.2012.13.7.3325; Katoh T, 1996, CARCINOGENESIS, V17, P1855, DOI 10.1093/carcin/17.9.1855; Lan Q, 2001, PHARMACOGENETICS, V11, P655, DOI 10.1097/00008571-200111000-00003; Li P, 2011, J ENV OCCUP MED, V28, P1217; Lourenco GJ, 2011, TUMOR BIOL, V32, P1209, DOI 10.1007/s13277-011-0224-z; Luo YP, 2011, TUMOR BIOL, V32, P215, DOI 10.1007/s13277-010-0115-8; Malik Manzoor A, 2009, J Gastrointest Cancer, V40, P26, DOI 10.1007/s12029-009-9072-0; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martinez C, 2006, PHARMACOGENOMICS, V7, P711, DOI 10.2217/14622416.7.5.711; Masoudi M, 2009, MOL BIOL REP, V36, P781, DOI 10.1007/s11033-008-9245-0; Moy KA, 2009, INT J CANCER, V125, P2652, DOI 10.1002/ijc.24583; Mu LN, 2005, INT J CANCER, V116, P972, DOI 10.1002/ijc.21137; Nan HM, 2005, WORLD J GASTROENTERO, V11, P3175, DOI 10.3748/wjg.v11.i21.3175; Nguyen TV, 2009, ONCOL RES, V18, P349, DOI 10.3727/096504010X12626118080064; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Onul A, 2012, TUMOR BIOL, V33, P739, DOI 10.1007/s13277-011-0271-5; Palli D, 2005, INT J CANCER, V115, P284, DOI 10.1002/ijc.20864; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Parvin S, 2012, MOL BIOL REP, V39, P7327, DOI 10.1007/s11033-012-1564-5; Piao JM, 2009, WORLD J GASTROENTERO, V15, P5716, DOI 10.3748/wjg.15.5716; Qian Y, 2003, CHINESE J PREVENTION, V11, P107; Qiu MZ, 2011, TUMOR BIOL, V32, P489, DOI 10.1007/s13277-010-0142-5; Roth MJ, 2004, CANCER CAUSE CONTROL, V15, P1077, DOI 10.1007/s10552-004-2233-3; Ruzzo A, 2007, CLIN CHEM LAB MED, V45, P822, DOI 10.1515/CCLM.2007.143; Saadat I, 2001, CANCER LETT, V169, P21, DOI 10.1016/S0304-3835(01)00550-X; Setiawan VW, 2000, CANCER EPIDEM BIOMAR, V9, P73; Setiawan VW, 2001, CANCER CAUSE CONTROL, V12, P673, DOI 10.1023/A:1011261602940; Shen J, 2002, ZHONG LIU ZA ZHI, V22; Shen X, 2005, J ENV OCCUP MED, V22, P325; [沈孝兵 Shen Xiaobing], 2004, [环境与健康杂志, Journal of Environment and Health], V21, P210; Soerjomataram I, 2012, LANCET; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tamer L, 2005, CELL BIOCHEM FUNCT, V23, P267, DOI 10.1002/cbf.1148; Torres María M, 2004, Biomed., V24, P153; Tripathi S, 2008, SCAND J GASTROENTERO, V43, P431, DOI 10.1080/00365520701742930; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Wideroff L, 2007, CANCER DETECT PREV, V31, P233, DOI 10.1016/j.cdp.2007.03.004; Wu MS, 2002, INT J COLORECTAL DIS, V17, P338, DOI 10.1007/s00384-001-0383-2; Xie S, 2008, CLIN FOCUS, V23, P1393; Yadav D, 2011, GENE, V487, P166, DOI [10.1016/j.gene.2011.07.010, 10.1016/j.gene.2011.07.017]; Yadav DS, 2010, GENET TEST MOL BIOMA, V14, P715, DOI 10.1089/gtmb.2010.0087; Ye M, 2003, WORLD CHIN J DIGESTO, V11, P1314; Zendehdel K, 2009, CANCER CAUSE CONTROL, V20, P2031, DOI 10.1007/s10552-009-9399-7; Zhang AP, 2011, ASIAN PAC J CANCER P, V12, P3421; Zheng TR, 2002, SHI YONG ZHONG LIU Z, V17, P155	69	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60833	10.1371/journal.pone.0060833	http://dx.doi.org/10.1371/journal.pone.0060833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585855	Green Submitted, gold, Green Published			2022-12-27	WOS:000317909600055
J	Zhang, XM; Herrmann, U; Weyer, SW; Both, M; Muller, UC; Korte, M; Draguhn, A				Zhang, Xiaomin; Herrmann, Ulrike; Weyer, Sascha W.; Both, Martin; Mueller, Ulrike C.; Korte, Martin; Draguhn, Andreas			Hippocampal Network Oscillations in APP/APLP2-Deficient Mice	PLOS ONE			English	Article							AMYLOID-PRECURSOR PROTEIN; WAVE-RIPPLE COMPLEXES; GAMMA-OSCILLATIONS; DEFICIENT MICE; MOUSE HIPPOCAMPUS; SHARP WAVES; APP FAMILY; IN-VITRO; MECHANISMS; TRANSMISSION	The physiological function of amyloid precursor protein (APP) and its two homologues APP-like protein 1 (APLP1) and 2 (APLP2) is largely unknown. Previous work suggests that lack of APP or APLP2 impairs synaptic plasticity and spatial learning. There is, however, almost no data on the role of APP or APLP at the network level which forms a critical interface between cellular functions and behavior. We have therefore investigated memory-related synaptic and network functions in hippocampal slices from three lines of transgenic mice: APPs alpha-KI (mice expressing extracellular fragment of APP, corresponding to the secreted APPs alpha ectodomain), APLP2-KO, and combined APPs alpha-KI/APLP2-KO (APPs alpha-DM for "double mutants"). We analyzed two prominent patterns of network activity, gamma oscillations and sharp-wave ripple complexes (SPW-R). Both patterns were generally preserved in all strains. We find, however, a significantly reduced frequency of gamma oscillations in CA3 of APLP2-KO mice in comparison to APPs alpha-KI and WT mice. Network activity, basic synaptic transmission and short-term plasticity were unaltered in the combined mutants (APPs alpha-DM) which showed, however, reduced long-term potentiation (LTP). Together, our data indicate that APLP2 and the intracellular domain of APP are not essential for coherent activity patterns in the hippocampus, but have subtle effects on synaptic plasticity and fine-tuning of network oscillations.	[Zhang, Xiaomin; Both, Martin; Draguhn, Andreas] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Herrmann, Ulrike; Korte, Martin] TU Braunschweig, Inst Zool, Braunschweig, Germany; [Weyer, Sascha W.; Mueller, Ulrike C.] Heidelberg Univ, Dept Bioinformat & Funct Genom, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Braunschweig University of Technology; Ruprecht Karls University Heidelberg	Draguhn, A (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany.	andreas.draguhn@physiologie.uni-heidelberg.de	Zhang, Xiaomin/GVT-8927-2022	Zhang, Xiaomin/0000-0003-0256-6529	DFG [FG 1332]	DFG(German Research Foundation (DFG))	This work was funded by DFG (FG 1332, projects 1 and 6, U. M., M. K., and A. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Both M, 2008, HIPPOCAMPUS, V18, P899, DOI 10.1002/hipo.20446; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Driver JE, 2007, EUR J NEUROSCI, V26, P1280, DOI 10.1111/j.1460-9568.2007.05705.x; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P65, DOI 10.1113/jphysiol.2004.077388; Fitzjohn SM, 2000, NEUROSCI LETT, V288, P9, DOI 10.1016/S0304-3940(00)01204-0; Hermann D, 2009, NEUROSCIENCE, V162, P1081, DOI 10.1016/j.neuroscience.2009.05.044; Jinde S, 2009, EUR J NEUROSCI, V30, P1036, DOI 10.1111/j.1460-9568.2009.06896.x; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Korte M, 2012, EXP BRAIN RES, V217, P435, DOI 10.1007/s00221-011-2894-6; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Martin SJ, 2007, CELL MOL LIFE SCI, V64, P401, DOI 10.1007/s00018-007-6336-3; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Reichinnek S, 2010, J NEUROSCI, V30, P15441, DOI 10.1523/JNEUROSCI.2535-10.2010; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Senechal Y, 2008, BEHAV BRAIN RES, V186, P126, DOI 10.1016/j.bbr.2007.08.003; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Traub RD, 1998, PROG NEUROBIOL, V55, P563, DOI 10.1016/S0301-0082(98)00020-3; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; YLINEN A, 1995, J NEUROSCI, V15, P30; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	35	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61198	10.1371/journal.pone.0061198	http://dx.doi.org/10.1371/journal.pone.0061198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585881	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600094
J	Bose, A; Huhtaniemi, I; Singh, O; Pal, R				Bose, Anjali; Huhtaniemi, Ilpo; Singh, Om; Pal, Rahul			Synergistic Activation of Innate and Adaptive Immune Mechanisms in the Treatment of Gonadotropin-Sensitive Tumors	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-VACCAE SRL172; ACTIVE SPECIFIC IMMUNOTHERAPY; HUMAN DENDRITIC CELLS; BETA-SUBUNIT; MONOCLONAL-ANTIBODIES; CONTRACEPTIVE VACCINE; COLORECTAL-CANCER; IMPROVED SURVIVAL	Human chorionic gonadotropin (hCG) prolongs the secretion of progesterone from the corpus luteum, providing a critical stimulus for the sustenance of pregnancy. hCG (or individual subunits) is also secreted by a variety of trophoblastic and non-trophoblastic cancers and has been associated with poor prognosis. Early clinical studies have indicated merit in anti-hCG vaccination as potential immunotherapy, but anti-tumor efficacy is believed to be compromised by sub-optimal immunogenecity. In the present study, enhanced tumorigenesis was observed when SP2/O cells were subcutaneously injected in either male or female BALB/c x FVB/J(beta hCG/-) F1 transgenic mice, establishing the growth-promoting effects of the gonadotropin for implanted tumors in vivo. The utility of Mycobacterium indicus pranii (MIP) was evaluated, as an innate antitumor immunomodulator as well as adjuvant in mice. MIP elicited the secretion of the inflammatory cytokines IFN gamma, IL-6, IL-12p40, KC and TNF alpha from murine antigen presenting cells. When MIP was incorporated into an anti-hCG vaccine formulation previously employed in humans (a beta hCG-TT conjugate adsorbed on alum), elevated T cell recall proliferative and cytokine responses to hCG, beta hCG and TT were observed. MIP increased vaccine immunogenicity in mice of diverse genetic background (including in traditionally low-responder murine strains), leading to enhanced titres of bioneutralizing anti-hCG antibodies which exhibited cytotoxicity towards tumor cells. Individual administration of MIP and beta hCG-TT to BALB/c mice subcutaneously implanted with SP2/O cells resulted in anti-tumor effects; significantly, immunization with beta hCG-TT supplemented with MIP invoked synergistic benefits in terms of tumor volume, incidence and survival. The development of novel vaccine formulations stimulating both adaptive and innate anti-tumor immunity to induce collaborative beneficial effects may fill a niche in the adjunct treatment of hCG-sensitive tumors that are resistant to conventional therapy.	[Bose, Anjali; Singh, Om; Pal, Rahul] Natl Inst Immunol, Immunoendocrinol Lab, New Delhi 110067, India; [Huhtaniemi, Ilpo] Univ Turku, Dept Physiol, Turku, Finland; [Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Dept Reprod & Dev Biol, London, England	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Turku; Imperial College London	Singh, O (corresponding author), Natl Inst Immunol, Immunoendocrinol Lab, New Delhi 110067, India.	omsingh@gmail.com; rahul@nii.ac.in			Department of Biotechnology, Government of India [BT/PR/5861/Med/14/705/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by an extra-mural grant from the Department of Biotechnology, Government of India (BT/PR/5861/Med/14/705/2005) to OS and RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025424; Cekan SZ, 1998, J CLIN LAB ANAL, V12, P60, DOI 10.1002/(SICI)1098-2825(1998)12:1<60::AID-JCLA10>3.0.CO;2-M; Chaudhuri D, 2009, CURR PHARM BIOTECHNO, V10, P166, DOI 10.2174/138920109787315114; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Crawford RAF, 1998, J CLIN PATHOL, V51, P685, DOI 10.1136/jcp.51.9.685; de Gruijl TD, 2008, CANCER IMMUNOL IMMUN, V57, P1569, DOI 10.1007/s00262-008-0536-z; Gillott DJ, 1996, BRIT J CANCER, V73, P323, DOI 10.1038/bjc.1996.56; Hanna MG, 2001, VACCINE, V19, P2576, DOI 10.1016/S0264-410X(00)00485-0; Henderson RA, 1997, J IMMUNOL, V159, P635; HERLYN D, 1982, P NATL ACAD SCI-BIOL, V79, P4761, DOI 10.1073/pnas.79.15.4761; Herr HW, 2008, J UROLOGY, V179, P53, DOI 10.1016/j.juro.2007.08.122; Hrouda D, 1998, BRIT J UROL, V82, P568; Hrouda D, 1998, BRIT J UROL, V82, P870; Huhtaniemi I, 2005, MOL CELL ENDOCRINOL, V234, P117, DOI 10.1016/j.mce.2004.10.013; JONES WR, 1988, LANCET, V1, P1295; KIPPS TJ, 1985, J EXP MED, V161, P1, DOI 10.1084/jem.161.1.1; Kuroda H, 1998, INT J CANCER, V76, P571, DOI 10.1002/(SICI)1097-0215(19980518)76:4<571::AID-IJC21>3.3.CO;2-P; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Lund T, 1998, REV REPROD, V3, P71, DOI 10.1530/ror.0.0030071; Lundin M, 2000, ANTICANCER RES, V20, P4949; Mandokhot A, 2000, CLIN EXP IMMUNOL, V122, P101, DOI 10.1046/j.1365-2249.2000.01351.x; Maraveyas A, 1999, ANN ONCOL, V10, P817, DOI 10.1023/A:1008307821189; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Morse MA, 2011, CLIN CANCER RES, V17, P4844, DOI 10.1158/1078-0432.CCR-11-0891; Moulton HM, 2002, CLIN CANCER RES, V8, P2044; PAL R, 1990, AM J REPROD IMMUNOL, V22, P124, DOI 10.1111/j.1600-0897.1990.tb00654.x; Pal R, 2001, FERTIL STERIL, V76, P332, DOI 10.1016/S0015-0282(01)01897-0; Patel PM, 2008, EUR J CANCER, V44, P216, DOI 10.1016/j.ejca.2007.11.003; Rakshit S, 2012, INT J CANCER, V130, P865, DOI 10.1002/ijc.26099; REGELSON W, 1995, CANCER, V76, P1299, DOI 10.1002/1097-0142(19951015)76:8<1299::AID-CNCR2820760802>3.0.CO;2-L; Rulli SB, 2002, ENDOCRINOLOGY, V143, P4084, DOI 10.1210/en.2002-220490; Sachdeva R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051125; Sano K, 1999, AM J RESP CELL MOL, V20, P1260, DOI 10.1165/ajrcmb.20.6.3546; SINGH O, 1989, FERTIL STERIL, V52, P739; Stanford JL, 2008, EUR J CANCER, V44, P224, DOI 10.1016/j.ejca.2007.08.021; Sugino N, 2000, J CLIN ENDOCR METAB, V85, P4379, DOI 10.1210/jc.85.11.4379; Sur Prabir Kumar, 2003, J Indian Med Assoc, V101, P120; Szturmowicz M, 1999, TUMOR BIOL, V20, P99, DOI 10.1159/000030052; TALWAR GP, 1994, P NATL ACAD SCI USA, V91, P8532, DOI 10.1073/pnas.91.18.8532; Thurnher M, 1997, INT J CANCER, V70, P128; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; YAMAMURA Y, 1979, CANCER-AM CANCER SOC, V43, P1314, DOI 10.1002/1097-0142(197904)43:4<1314::AID-CNCR2820430420>3.0.CO;2-6; Zygmunt M, 2002, J CLIN ENDOCR METAB, V87, P5290, DOI 10.1210/jc.2002-020642	45	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61288	10.1371/journal.pone.0061288	http://dx.doi.org/10.1371/journal.pone.0061288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593454	gold, Green Submitted, Green Published			2022-12-27	WOS:000317898000121
J	Garcia, AJ; Rotem-Kohavi, N; Doi, A; Ramirez, JM				Garcia, Alfredo J., III; Rotem-Kohavi, Naama; Doi, Atsushi; Ramirez, Jan-Marino			Post-Hypoxic Recovery of Respiratory Rhythm Generation Is Gender Dependent	PLOS ONE			English	Article							PRE-BOTZINGER COMPLEX; INFANT-DEATH-SYNDROME; VENTILATORY RESPONSE; FREQUENCY DECLINE; HYPOXIC RESPONSE; IN-VITRO; NEURONS; EXPRESSION; NETWORK; NUCLEI	The preBotzinger complex (preBotC) is a critical neuronal network for the generation of breathing. Lesioning the preBotC abolishes respiration, while when isolated in vitro, the preBotC continues to generate respiratory rhythmic activity. Although several factors influence rhythmogenesis from this network, little is known about how gender may affect preBotC function. This study examines the influence of gender on respiratory activity and in vitro rhythmogenesis from the preBotC. Recordings of respiratory activity from neonatal mice (P10-13) show that sustained post-hypoxic depression occurs with greater frequency in males compared to females. Moreover, extracellular population recordings from the preBotC in neonatal brainstem slices (P10-13) reveal that the time to the first inspiratory burst following reoxygenation (TTFB) is significantly delayed in male rhythmogenesis when compared to the female rhythms. Altering activity of ATP sensitive potassium channels (K-ATP) with either the agonist, diazoxide, or the antagonist, tolbutamide, eliminates differences in TTFB. By contrast, glucose supplementation improves post-hypoxic recovery of female but not male rhythmogenesis. We conclude that post-hypoxic recovery of respiration is gender dependent, which is, in part, centrally manifested at the level of the preBotC. Moreover, these findings provide potential insight into the basis of increased male vulnerability in a variety of conditions such as Sudden Infant Death Syndrome (SIDS).	[Garcia, Alfredo J., III; Rotem-Kohavi, Naama; Doi, Atsushi; Ramirez, Jan-Marino] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Doi, Atsushi; Ramirez, Jan-Marino] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Garcia, AJ (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA.	alfredo.garcia@seattlechildrens.org		Ramirez, Jan-Marino/0000-0002-5626-3999	National Institutes of Health (NIH) [P01HL090554, RO1HL107084]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090554, R01HL107084] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants P01HL090554 and RO1HL107084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chervin RD, 2002, PEDIATRICS, V109, P449, DOI 10.1542/peds.109.3.449; Coles SK, 1998, AM J PHYSIOL-REG I, V274, pR1546, DOI 10.1152/ajpregu.1998.274.6.R1546; Coles SK, 1996, J PHYSIOL-LONDON, V497, P79, DOI 10.1113/jphysiol.1996.sp021751; Cummings KJ, 2011, J APPL PHYSIOL, V111, P825, DOI 10.1152/japplphysiol.00336.2011; Dick TE, 2000, RESP PHYSIOL, V121, P87, DOI 10.1016/S0034-5687(00)00121-3; DUNNE MJ, 1988, J MEMBRANE BIOL, V104, P165, DOI 10.1007/BF01870928; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Garcia AJ, 2011, PROG BRAIN RES, V188, P31, DOI 10.1016/B978-0-444-53825-3.00008-5; Garcia AJ, 2010, J APPL PHYSIOL, V109, P804, DOI 10.1152/japplphysiol.91429.2008; Haller M, 2001, J PHYSIOL-LONDON, V537, P69, DOI 10.1111/j.1469-7793.2001.0069k.x; Hill AA, 2011, J NEUROPHYSIOL, V105, P625, DOI 10.1152/jn.00237.2010; Lee H, 2005, EUR J NEUROSCI, V21, P2593, DOI 10.1111/j.1460-9568.2005.04084.x; Li AH, 2008, J PHYSIOL-LONDON, V586, P2321, DOI 10.1113/jphysiol.2008.152231; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Lijowska AS, 1997, J APPL PHYSIOL, V83, P219, DOI 10.1152/jappl.1997.83.1.219; Liu Q, 2012, NEUROSCIENCE, V210, P1, DOI 10.1016/j.neuroscience.2012.03.018; Liu QL, 2006, BRAIN RES, V1098, P129, DOI 10.1016/j.brainres.2006.05.001; Mage DT, 2006, J WOMENS HEALTH, V15, P786, DOI 10.1089/jwh.2006.15.786; Mage DT, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/368270; Mage DT, 2004, ACTA PAEDIATR, V93, P1210, DOI 10.1080/08035250410031305; Paton JFR, 2006, NAT NEUROSCI, V9, P311, DOI 10.1038/nn1650; Pena F, 2002, J NEUROSCI, V22, P11055; Pena F, 2004, NEURON, V43, P105, DOI 10.1016/j.neuron.2004.06.023; Penatti E, 2011, RESP PHYSIOL NEUROBI, V177, P61, DOI 10.1016/j.resp.2011.02.006; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Poets CF, 1999, PEDIATR RES, V45, P350, DOI 10.1203/00006450-199903000-00010; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Ramirez JM, 1998, J PHYSIOL-LONDON, V507, P571, DOI 10.1111/j.1469-7793.1998.571bt.x; Ramirez JM, 1998, J PHYSIOL-LONDON, V507, P895, DOI 10.1111/j.1469-7793.1998.895bs.x; Ramirez JM, 1996, J PHYSIOL-LONDON, V491, P799, DOI 10.1113/jphysiol.1996.sp021258; Richardson HL, 2010, SLEEP, V33, P1055, DOI 10.1093/sleep/33.8.1055; Sanfilippo-Cohn B, 2006, SLEEP, V29, P152, DOI 10.1093/sleep/29.2.152; Schwarzacher SW, 2011, BRAIN, V134, P24, DOI 10.1093/brain/awq327; Sridhar R, 2003, PEDIATR PULM, V36, P113, DOI 10.1002/ppul.10287; St John WA, 2007, RESP PHYSIOL NEUROBI, V155, P97, DOI 10.1016/j.resp.2006.04.018; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Telgkamp P, 1999, J NEUROPHYSIOL, V82, P2163, DOI 10.1152/jn.1999.82.5.2163; Telgkamp P, 2002, J NEUROPHYSIOL, V88, P206, DOI 10.1152/jn.2002.88.1.206; Teppema LJ, 2010, PHYSIOL REV, V90, P675, DOI 10.1152/physrev.00012.2009; Tester DJ, 2011, CIRC-CARDIOVASC GENE, V4, P510, DOI 10.1161/CIRCGENETICS.111.960195; Thach BP, 2009, HEREDITY, V103, P469, DOI 10.1038/hdy.2009.89; Thoby-Brisson M, 2000, J NEUROSCI, V20, P5858, DOI 10.1523/JNEUROSCI.20-15-05858.2000; Trachtenberg FL, 2012, PEDIATRICS, V129, P630, DOI 10.1542/peds.2011-1419; Tryba AK, 2006, J NEUROSCI, V26, P2623, DOI 10.1523/JNEUROSCI.4186-05.2006; Webber MP, 2002, PEDIATR PULM, V34, P105, DOI 10.1002/ppul.10146; Woischneck D, 2009, NEUROL RES, V31, P1019, DOI 10.1179/174313209X385608; Wulbrand H, 2008, SLEEP, V31, P833, DOI 10.1093/sleep/31.6.833; YOUNG T, 1993, SLEEP, V16, pS1, DOI 10.1093/sleep/16.suppl_8.S1	49	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60695	10.1371/journal.pone.0060695	http://dx.doi.org/10.1371/journal.pone.0060695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593283	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000052
J	Lye, SH; Chahil, JK; Bagali, P; Alex, L; Vadivelu, J; Ahmad, WAW; Chan, SP; Thong, MK; Zain, SM; Mohamed, R				Lye, Say-Hean; Chahil, Jagdish Kaur; Bagali, Pramod; Alex, Livy; Vadivelu, Jamunarani; Ahmad, Wan Azman Wan; Chan, Siew-Pheng; Thong, Meow-Keong; Zain, Shamsul Mohd; Mohamed, Rosmawati			Genetic Polymorphisms in LDLR, APOB, PCSK9 and Other Lipid Related Genes Associated with Familial Hypercholesterolemia in Malaysia	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LIPOPROTEIN RECEPTOR GENE; UPSTREAM STIMULATORY FACTOR; HARDY-WEINBERG EQUILIBRIUM; GROWTH-HORMONE; RISK-FACTOR; CHOLESTEROL; POPULATION; MUTATIONS; PREVALENCE	Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by elevations in total cholesterol (TC) and low density lipoprotein cholesterol (LDLc). Development of FH can result in the increase of risk for premature cardiovascular diseases (CVD). FH is primarily caused by genetic variations in Low Density Lipoprotein Receptor (LDLR), Apolipoprotein B (APOB) or Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) genes. Although FH has been extensively studied in the Caucasian population, there are limited reports of FH mutations in the Asian population. We investigated the association of previously reported genetic variants that are involved in lipid regulation in our study cohort. A total of 1536 polymorphisms previously implicated in FH were evaluated in 141 consecutive patients with clinical FH (defined by the Dutch Lipid Clinic Network criteria) and 111 unrelated control subjects without FH using high throughput microarray genotyping platform. Fourteen Single Nucleotide Polymorphisms (SNPs) were found to be significantly associated with FH, eleven with increased FH risk and three with decreased FH risk. Of the eleven SNPs associated with an increased risk of FH, only one SNP was found in the LDLR gene, seven in the APOB gene and three in the PCSK9 gene. SNP rs12720762 in APOB gene is associated with the highest risk of FH (odds ratio 14.78, p<0.001). Amongst the FH cases, 108 out of 141 (76.60%) have had at least one significant risk-associated SNP. Our study adds new information and knowledge on the genetic polymorphisms amongst Asians with FH, which may serve as potential markers in risk prediction and disease management.	[Lye, Say-Hean; Chahil, Jagdish Kaur; Bagali, Pramod; Alex, Livy] INFOVALLEY Grp Co, Mines Resort City, Selangor, Malaysia; [Vadivelu, Jamunarani; Ahmad, Wan Azman Wan; Chan, Siew-Pheng; Thong, Meow-Keong; Mohamed, Rosmawati] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia; [Zain, Shamsul Mohd] Univ Malaya, Fac Med, Dept Pharmacol, Pharmacogenom Lab, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Alex, L (corresponding author), INFOVALLEY Grp Co, Mines Resort City, Selangor, Malaysia.	drlivy@infovalley.net.my	Zain, Shamsul Mohd/U-8718-2019; Chan, Siew Pheng/GPP-7197-2022; Shivraj, A/N-3715-2019; ZAIN, SHAMSUL MOHD/N-6995-2013; VADIVELU, JAMUNARANI S/B-8696-2010; Thong, Meow-Keong/B-9960-2010	Zain, Shamsul Mohd/0000-0002-3441-6659; ZAIN, SHAMSUL MOHD/0000-0002-3441-6659; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Thong, Meow-Keong/0000-0002-7288-7910; Alex, Livy/0000-0002-4937-5116	Ministry of Science, Technology and Innovation (MOSTI), the government of Malaysia [36-02-03-6058]	Ministry of Science, Technology and Innovation (MOSTI), the government of Malaysia	The research reported in this research article has been funded by the Ministry of Science, Technology and Innovation (MOSTI), the government of Malaysia (grant number 36-02-03-6058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Allaf Faisal A, 2010, Int Arch Med, V3, P36, DOI 10.1186/1755-7682-3-36; Al-Khateeb A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-40; Alex L, 2012, J HUM GENET, V57, P358, DOI 10.1038/jhg.2012.34; Alonso R, 2009, CLIN BIOCHEM, V42, P899, DOI 10.1016/j.clinbiochem.2009.01.017; Alonso-Orgaz S, 2006, J PROTEOME RES, V5, P2301, DOI 10.1021/pr060159w; Anderson RGW, 2003, TRENDS CELL BIOL, V13, P534, DOI 10.1016/j.tcb.2003.08.007; Ando H, 2001, ENDOCR J, V48, P113, DOI 10.1507/endocrj.48.113; Austin MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/aje/kwh236; Azian M, 2006, Malays J Pathol, V28, P7; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Betteridge J., 2000, LIPIDS VASCULAR DIS; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cox DG, 2006, HUM HERED, V61, P10, DOI 10.1159/000091787; deKnijff P, 1996, CURR OPIN LIPIDOL, V7, P59, DOI 10.1097/00041433-199604000-00002; Dinu I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043035; Dorsch MF, 2001, BMJ-BRIT MED J, V322, P111, DOI 10.1136/bmj.322.7278.111; Fouchier SW, 2001, HUM GENET, V109, P602, DOI 10.1007/s00439-001-0628-8; Jarvik GP, 2008, J AM COLL CARDIOL, V52, P1554, DOI 10.1016/j.jacc.2008.08.012; Khoo K L, 2000, Med J Malaysia, V55, P249; Khoo K L, 2000, Med J Malaysia, V55, P409; Khoo KL, 2003, ATHEROSCLEROSIS, V169, P1, DOI 10.1016/S0021-9150(03)00009-1; Khoo KL, 2000, CLIN GENET, V58, P98, DOI 10.1034/j.1399-0004.2000.580202.x; Lee JC, 2007, ARTERIOSCL THROM VAS, V27, P2222, DOI 10.1161/ATVBAHA.107.151530; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Li M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-28; LOMBARDI P, 1995, J LIPID RES, V36, P860; Marais A David, 2004, Clin Biochem Rev, V25, P49; Matasconi M, 2005, BBA-MOL CELL BIOL L, V1736, P221, DOI 10.1016/j.bbalip.2005.08.012; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Pastier D, 2002, J BIOL CHEM, V277, P15199, DOI 10.1074/jbc.M200227200; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Rees A, 2008, EUR HEART J, V29, P2583, DOI 10.1093/eurheartj/ehn448; Ribeiro A, 1999, J BIOL CHEM, V274, P1216, DOI 10.1074/jbc.274.3.1216; Rudling M, 1997, J CLIN INVEST, V99, P2239, DOI 10.1172/JCI119398; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Stamler J, 1986, JAMA-J AM MED ASSOC; STEINBERG D, 1990, JAMA-J AM MED ASSOC, V264, P3047, DOI 10.1001/jama.264.23.3047; Trapani L., 2010, CURR GERONTOL GERIAT; van der Vleuten GM, 2007, J LIPID RES, V48, P193, DOI 10.1194/jlr.M600184-JLR200; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; Yuan G, 2006, CAN MED ASSOC J, V174, P1124, DOI 10.1503/cmaj.051313	46	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60729	10.1371/journal.pone.0060729	http://dx.doi.org/10.1371/journal.pone.0060729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593297	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000055
J	Yang, L; Zhou, J; Ma, Q; Wang, C; Chen, KL; Meng, WJ; Yu, YY; Zhou, ZG; Sun, XF				Yang, Lie; Zhou, Jin; Ma, Qin; Wang, Cun; Chen, Keling; Meng, Wenjian; Yu, Yongyang; Zhou, Zongguang; Sun, Xiaofeng			Knockdown of PPAR delta Gene Promotes the Growth of Colon Cancer and Reduces the Sensitivity to Bevacizumab in Nude Mice Model	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; COLORECTAL-CANCER; CELL-PROLIFERATION; RECTAL-CANCER; DIFFERENTIATION; BETA/DELTA; MECHANISMS; INHIBITION; EXPRESSION; PATTERNS	The role of peroxisome proliferator - activated receptor- delta (PPAR delta) gene in colon carcinogenesis remains highly controversial. Here, we established nude mice xenograft model using a human colon cancer cell line KM12C either with PPAR delta silenced or normal. The xenografts in PPAR delta-silenced group grew significantly larger and heavier with less differentiation, promoted cell proliferation, increased expression of vascular endothelial growth factor (VEGF) and similar apoptosis index compared with those of PPAR delta-normal group. After treated with the specific VEGF inhibitor bevacizumab, the capacities of growth and proliferation of xenografts were decreased in both groups while still significantly higher in PPAR delta-silenced group than in PPAR delta-normal group. Administration of PPAR delta agonist significantly decreased VEGF expression in PPAR delta-normal KM12C cells but not in PPAR delta-silenced cells. These findings demonstrate that, knockdown of PPAR delta promotes the growth of colon cancer by inducing less differentiation, accelerating the proliferation and VEGF expression of tumor cells in vivo, and reduces tumor sensitivity to bevacizumab. This study indicates that PPAR delta attenuates colon carcinogenesis.	[Yang, Lie; Zhou, Jin; Ma, Qin; Wang, Cun; Chen, Keling; Meng, Wenjian; Yu, Yongyang; Zhou, Zongguang; Sun, Xiaofeng] Sichuan Univ, Inst Digest Surg, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Yang, Lie; Zhou, Jin; Ma, Qin; Wang, Cun; Chen, Keling; Meng, Wenjian; Yu, Yongyang; Zhou, Zongguang; Sun, Xiaofeng] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Sun, Xiaofeng] Linkoping Univ, Dept Oncol, Dept Clin & Expt Med, Linkoping, Sweden	Sichuan University; Sichuan University; Linkoping University	Yu, YY (corresponding author), Sichuan Univ, Inst Digest Surg, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China.	yuyongyang@hotmail.com; zhou767@163.com	Wang, Cun/C-5600-2015	, Zongguang/0000-0002-7616-1199	Natural Science Foundation of China [30801332]; Ph.D. Programs Foundation of Ministry of Education of China [200806100058]; Swedish Cancer Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Swedish Cancer Foundation	The authors acknowledge grant support from the Natural Science Foundation of China (No. 30801332; http://www.nsfc.gov.cn/), Ph.D. Programs Foundation of Ministry of Education of China (No. 200806100058; http://www.chinapostdoctor.org.cn/), and the Swedish Cancer Foundation (http://www.cancerfonden.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bergsland EK, 2004, AM J HEALTH-SYST PH, V61, pS4, DOI 10.1093/ajhp/61.suppl_5.S4; Burdick AD, 2006, CELL SIGNAL, V18, P9, DOI 10.1016/j.cellsig.2005.07.009; Girroir EE, 2008, BIOCHEM BIOPH RES CO, V371, P456, DOI 10.1016/j.bbrc.2008.04.086; Grimaldi PA, 2010, CURR OPIN LIPIDOL, V21, P186, DOI 10.1097/MOL.0b013e32833884a4; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; Holly EH, 2008, CARCINOGENESIS, V29, P169; Kim DJ, 2006, CELL DEATH DIFFER, V13, P53, DOI 10.1038/sj.cdd.4401713; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lim HJ, 2009, ATHEROSCLEROSIS, V202, P446, DOI 10.1016/j.atherosclerosis.2008.05.023; Lin H, 2008, J CELL PHYSIOL, V214, P434, DOI 10.1002/jcp.21214; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Yang L, 2008, DIS COLON RECTUM, V51, P318, DOI 10.1007/s10350-007-9145-8; Yang L, 2006, EJSO-EUR J SURG ONC, V32, P181, DOI 10.1016/j.ejso.2005.11.005; Yang L, 2010, ONCOGENE, V29, P516, DOI 10.1038/onc.2009.370; Yang L, 2011, CLIN CANCER RES, V17, P3760, DOI 10.1158/1078-0432.CCR-10-2779	26	28	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60715	10.1371/journal.pone.0060715	http://dx.doi.org/10.1371/journal.pone.0060715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593291	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000054
J	Atsawasuwan, P; Lu, XY; Ito, Y; Zhang, YB; Evans, CA; Luan, XH				Atsawasuwan, Phimon; Lu, Xuanyu; Ito, Yoshihiro; Zhang, Youbin; Evans, Carla A.; Luan, Xianghong			Ameloblastin Inhibits Cranial Suture Closure by Modulating Msx2 Expression and Proliferation	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; PROGENITOR CELLS; BONE-FORMATION; GENE; DIFFERENTIATION; GROWTH; MUTATIONS; SKULL; CRANIOSYNOSTOSIS	Deformities of cranial sutures such as craniosynostosis and enlarged parietal foramina greatly impact human development and quality of life. Here we have examined the role of the extracellular matrix protein ameloblastin (Ambn), a recent addition to the family of non-collagenous extracellular bone matrix proteins, in craniofacial bone development and suture formation. Using RT-PCR, western blot and immunohistochemistry, Ambn was localized in mouse calvarial bone and adjacent condensed mesenchyme. Five-fold Ambn overexpression in a K14-driven transgenic mouse model resulted in delayed posterior frontal suture fusion and incomplete suture closure. Moreover, Ambn overexpressor skulls weighed 13.2% less, their interfrontal bones were 35.3% thinner, and the width between frontal bones plus interfrontal suture was 14.3% wider. Ambn overexpressing mice also featured reduced cell proliferation in suture blastemas and in mesenchymal cells from posterior frontal sutures. There was a more than 2-fold reduction of Msx2 in Ambn overexpressing calvariae and suture mesenchymal cells, and this effect was inversely proportionate to the level of Ambn overexpression in different cell lines. The reduction of Msx2 expression as a result of Ambn overexpression was further enhanced in the presence of the MEK/ ERK pathway inhibitor O126. Finally, Ambn overexpression significantly reduced Msx2 down-stream target gene expression levels, including osteogenic transcription factors Runx2 and Osx, the bone matrix proteins Ibsp, Coll, Ocn and Opn, and the cell cycle-related gene CcnD1. Together, these data suggest that Ambn plays a crucial role in the regulation of cranial bone growth and suture closure via Msx 2 suppression and proliferation inhibition.	[Atsawasuwan, Phimon; Lu, Xuanyu; Ito, Yoshihiro; Zhang, Youbin; Luan, Xianghong] Univ Illinois, Coll Dent, Dept Oral Biol, Brodie Lab Craniofacial Genet, Chicago, IL 60607 USA; [Atsawasuwan, Phimon; Evans, Carla A.; Luan, Xianghong] Univ Illinois, Coll Dent, Dept Orthodont, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Luan, XH (corresponding author), Univ Illinois, Coll Dent, Dept Oral Biol, Brodie Lab Craniofacial Genet, Chicago, IL 60607 USA.	luan@uic.edu	Ito, Yoshihiro/T-1095-2019	Ito, Yoshihiro/0000-0002-1154-253X; Atsawasuwan, Phimon/0000-0002-2576-060X; Evans, Carla/0000-0002-0473-383X	National Institute of Dental and Craniofacial Ressearch [DE19155]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019155] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Ressearch; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study has been generously supported by grant DE19155 from the National Institute of Dental and Craniofacial Ressearch (http://www.nidcr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Bruce JA, 1941, AM J ANAT, V68, P41, DOI 10.1002/aja.1000680103; Carinci P, 2000, INT J DEV BIOL, V44, P715; Cohen MM, 2000, CRANIOSYNOSTOSIS DIA, V2nd; Corcoran JP, 1997, DEV DYNAM, V210, P355; Dangaria SJ, 2011, STEM CELLS DEV, V20, P39, DOI 10.1089/scd.2010.0180; Diekwisch T, 2011, EUR J ORAL SCI, V119, P293, DOI 10.1111/j.1600-0722.2011.00931.x; Dodig M, 1999, DEV BIOL, V209, P298, DOI 10.1006/dbio.1999.9258; ElGhouzzi V, 1997, NAT GENET, V15, P42; Fong CD, 1998, EUR J ORAL SCI, V106, P324, DOI 10.1111/j.1600-0722.1998.tb02193.x; Fukumoto S, 2005, CELLS TISSUES ORGANS, V181, P189, DOI 10.1159/000091380; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Hall B.K., 2015, BONES CARTILAGE DEV; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hao JJ, 2005, BONE, V37, P578, DOI 10.1016/j.bone.2005.05.013; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Hukki Jyri, 2008, V12, P79, DOI 10.1159/000115033; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kopher RA, 2003, J BONE MINER RES, V18, P521, DOI 10.1359/jbmr.2003.18.3.521; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Kumar A, 2010, PROTEOMICS, V10, P1730, DOI 10.1002/pmic.200900666; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee SK, 2003, MOL CELLS, V15, P216; Lee SK, 1996, INT J DEV BIOL, V40, P1141; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOVELAND BE, 1992, BIOCHEM INT, V27, P501; Lu XY, 2011, EUR J ORAL SCI, V119, P254, DOI 10.1111/j.1600-0722.2011.00905.x; Luan XH, 2006, DEV DYNAM, V235, P1167, DOI 10.1002/dvdy.20674; Marijanovic I, 2009, COLLEGIUM ANTROPOL, V33, P919; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nunez J, 2010, J PERIODONTAL RES, V45, P809, DOI 10.1111/j.1600-0765.2010.01291.x; Opperman LA, 2005, CELLS TISSUES ORGANS, V181, P127, DOI 10.1159/000091374; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Rice David P., 2008, V12, P91, DOI 10.1159/000115034; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shah SB, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/704061; Shen K, 2009, ORTHOD CRANIOFAC RES, V12, P254, DOI 10.1111/j.1601-6343.2009.01460.x; Sonoda A, 2009, J BIOL CHEM, V284, P27176, DOI 10.1074/jbc.M109.033464; Spahr A, 2002, Clin Oral Investig, V6, P51; Spahr A, 2006, EUR J ORAL SCI, V114, P504, DOI 10.1111/j.1600-0722.2006.00403.x; Tamburstuen MV, 2011, BONE, V48, P406, DOI 10.1016/j.bone.2010.09.007; Tamburstuen MV, 2010, EUR J ORAL SCI, V118, P451, DOI 10.1111/j.1600-0722.2010.00760.x; Vijayaraj P, 2010, EUR J CELL BIOL, V89, P299, DOI 10.1016/j.ejcb.2009.10.016; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Webb PP, 1995, CONNECT TISSUE RES, V32, P71, DOI 10.3109/03008209509013708; WHITAKER LA, 1979, PLAST RECONSTR SURG, V64, P198, DOI 10.1097/00006534-197908000-00011; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Zhang X, 2011, EUR J ORAL SCI, V119, P270, DOI 10.1111/j.1600-0722.2011.00889.x; Zhang YB, 2011, EUR J ORAL SCI, V119, P280, DOI 10.1111/j.1600-0722.2011.00887.x	54	11	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e52800	10.1371/journal.pone.0052800	http://dx.doi.org/10.1371/journal.pone.0052800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593111	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100001
J	Chekaluk, Y; Wu, CL; Rosenberg, J; Riester, M; Dai, QS; Lin, S; Guo, YA; McDougal, WS; Kwiatkowski, DJ				Chekaluk, Yvonne; Wu, Chin-Lee; Rosenberg, Jonathan; Riester, Markus; Dai, Qishan; Lin, Sharron; Guo, Yanan; McDougal, W. Scott; Kwiatkowski, David J.			Identification of Nine Genomic Regions of Amplification in Urothelial Carcinoma, Correlation with Stage, and Potential Prognostic and Therapeutic Value	PLOS ONE			English	Article							COPY NUMBER ALTERATIONS; TRANSITIONAL-CELL CARCINOMA; PAPILLARY BLADDER-CANCER; CHROMOSOMAL-ABERRATIONS; GENETIC ALTERATIONS; HYBRIDIZATION; MUTATIONS; FREQUENT; TUMORS; TARGET	We performed a genome wide analysis of 164 urothelial carcinoma samples and 27 bladder cancer cell lines to identify copy number changes associated with disease characteristics, and examined the association of amplification events with stage and grade of disease. Multiplex inversion probe (MIP) analysis, a recently developed genomic technique, was used to study 80 urothelial carcinomas to identify mutations and copy number changes. Selected amplification events were then analyzed in a validation cohort of 84 bladder cancers by multiplex ligation-dependent probe assay (MLPA). In the MIP analysis, 44 regions of significant copy number change were identified using GISTIC. Nine gene-containing regions of amplification were selected for validation in the second cohort by MLPA. Amplification events at these 9 genomic regions were found to correlate strongly with stage, being seen in only 2 of 23 (9%) Ta grade 1 or 1-2 cancers, in contrast to 31 of 61 (51%) Ta grade 3 and T2 grade 2 cancers, p<0.001. These observations suggest that analysis of genomic amplification of these 9 regions might help distinguish non-invasive from invasive urothelial carcinoma, although further study is required. Both MIP and MLPA methods perform well on formalin-fixed paraffin-embedded DNA, enhancing their potential clinical use. Furthermore several of the amplified genes identified here (ERBB2, MDM2, CCND1) are potential therapeutic targets.	[Chekaluk, Yvonne; Guo, Yanan; Kwiatkowski, David J.] Brigham & Womens Hosp, Div Translat Med, Boston, MA 02115 USA; [Wu, Chin-Lee; Lin, Sharron; Guo, Yanan] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Rosenberg, Jonathan] Mem Sloan Kettering Canc Ctr, Div Genitourinary Oncol, York, NY USA; [Riester, Markus] Harvard Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA USA; [Riester, Markus] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA USA; [McDougal, W. Scott] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	McDougal, WS (corresponding author), Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA.	WMCDOUGAL@PARTNERS.ORG; dk@rics.bwh.harvard.edu		Riester, Markus/0000-0002-4759-8332; Rosenberg, Jonathan/0000-0003-2637-4249	National Institutes of Health (NIH), National Cancer Institute (NCI) [1P01CA120964]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH), National Cancer Institute (NCI) 1P01CA120964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkar AA, 2003, CANCER RES, V63, P8108; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Cheng LA, 2011, HUM PATHOL, V42, P455, DOI 10.1016/j.humpath.2010.07.007; Edge SB, 2010, AJCC CANC STAGING MA; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Fleischmann A, 2011, EUR UROL, V60, P350, DOI 10.1016/j.eururo.2011.05.035; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hasselblatt M, 2013, GENE CHROMOSOME CANC, V52, P185, DOI 10.1002/gcc.22018; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hornigold N, 1999, ONCOGENE, V18, P2657, DOI 10.1038/sj.onc.1202854; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Jahromi MS, 2012, CANCER GENET-NY, V205, P391, DOI 10.1016/j.cancergen.2012.05.012; Johnson CE, 2012, BREAST CANCER RES TR, V133, P889, DOI 10.1007/s10549-011-1835-1; KALLIONIEMI A, 1995, GENE CHROMOSOME CANC, V12, P213, DOI 10.1002/gcc.2870120309; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Knowles MA, 2008, SCAND J UROL NEPHROL, V42, P116, DOI 10.1080/03008880802284605; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Kozlowski P, 2007, HUM GENET, V121, P389, DOI 10.1007/s00439-006-0308-9; Lae M, 2010, ANN ONCOL, V21, P815, DOI 10.1093/annonc/mdp488; Lee HW, 2012, INT J ONCOL, V41, P2013, DOI 10.3892/ijo.2012.1663; Lopez-Beltran A, 2010, VIRCHOWS ARCH, V457, P555, DOI 10.1007/s00428-010-0969-6; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; National Comprehensive Cancer Network I, 2012, NCCN CLIN PRACT GUID; Nord H, 2010, INT J CANCER, V126, P1390, DOI 10.1002/ijc.24954; Obermann EC, 2003, J PATHOL, V199, P50, DOI 10.1002/path.1259; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Prat E, 2010, UROLOGY, V75, P347, DOI 10.1016/j.urology.2009.04.080; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Richter J, 1998, AM J PATHOL, V153, P1615, DOI 10.1016/S0002-9440(10)65750-1; Richter J, 1997, CANCER RES, V57, P2860; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simon R, 1998, J PATHOL, V185, P345; Sjodahl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018583; Thompson PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023543; van Rhijn BSW, 2004, CANCER RES, V64, P1911, DOI 10.1158/0008-5472.CAN-03-2421; Veerakumarasivam A, 2008, CLIN CANCER RES, V14, P2527, DOI 10.1158/1078-0432.CCR-07-4129; VOORTER C, 1995, AM J PATHOL, V146, P1341; Wang Y, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-8; WILLIAMSON MP, 1995, HUM MOL GENET, V4, P1569, DOI 10.1093/hmg/4.9.1569; Yuan Y, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-16	48	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60927	10.1371/journal.pone.0060927	http://dx.doi.org/10.1371/journal.pone.0060927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593348	Green Submitted, Green Published, gold			2022-12-27	WOS:000319108100069
J	Cheng, XW; Zhao, X; Khurana, S; Bruggeman, LA; Kao, HY				Cheng, Xiwen; Zhao, Xuan; Khurana, Simran; Bruggeman, Leslie A.; Kao, Hung-Ying			Microarray Analyses of Glucocorticoid and Vitamin D3 Target Genes in Differentiating Cultured Human Podocytes	PLOS ONE			English	Article							EXPRESSION; NEPHRIN; ALPHA; ILLUMINA; GLOMERULOSCLEROSIS; CHEMOATTRACTANT; BIOINFORMATICS; DEXAMETHASONE; BIOCONDUCTOR; MECHANISM	Glomerular podocytes are highly differentiated epithelial cells that are key components of the kidney filtration units. Podocyte damage or loss is the hallmark of nephritic diseases characterized by severe proteinuria. Recent studies implicate that hormones including glucocorticoids (ligand for glucocorticoid receptor) and vitamin D3 (ligand for vitamin D receptor) protect or promote repair of podocytes from injury. In order to elucidate the mechanisms underlying hormone-mediated podocyte-protecting activity from injury, we carried out microarray gene expression studies to identify the target genes and corresponding pathways in response to these hormones during podocyte differentiation. We used immortalized human cultured podocytes (HPCs) as a model system and carried out in vitro differentiation assays followed by dexamethasone (Dex) or vitamin D3 (VD3) treatment. Upon the induction of differentiation, multiple functional categories including cell cycle, organelle dynamics, mitochondrion, apoptosis and cytoskeleton organization were among the most significantly affected. Interestingly, while Dex and VD3 are capable of protecting podocytes from injury, they only share limited target genes and affected pathways. Compared to VD3 treatment, Dex had a broader and greater impact on gene expression profiles. In-depth analyses of Dex altered genes indicate that Dex crosstalks with a broad spectrum of signaling pathways, of which inflammatory responses, cell migration, angiogenesis, NF-kappa B and TGF beta pathways are predominantly altered. Together, our study provides new information and identifies several new avenues for future investigation of hormone signaling in podocytes.	[Cheng, Xiwen; Zhao, Xuan; Khurana, Simran; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Cheng, Xiwen; Zhao, Xuan; Khurana, Simran; Kao, Hung-Ying] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Educ, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; MetroHealth System	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Cheng, Xiwen/B-8385-2014	Cheng, Xiwen/0000-0001-7398-1522	National Institutes of Health [R01 HL093269, DK078965]; Case Comprehensive Cancer Center Program in Aging and Energy Balance, NCI [P20 CA103767]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Comprehensive Cancer Center Program in Aging and Energy Balance, NCI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the National Institutes of Health R01 HL093269, DK078965 to H.-Y.K. and Case Comprehensive Cancer Center Program in Aging and Energy Balance, NCI P20 CA103767. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benigni A, 2006, J AM SOC NEPHROL, V17, P1624, DOI 10.1681/ASN.2005090983; BRAHLER S, 2012, AM J PHYSL RENAL PHY; Camici Marcello, 2012, Front Biosci (Elite Ed), V4, P1058, DOI 10.2741/E441; Cheng XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-453; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; Floege J, 1997, KIDNEY INT, V51, P230, DOI 10.1038/ki.1997.28; Fujii Y, 2006, KIDNEY INT, V69, P1350, DOI 10.1038/sj.ki.5000317; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kawachi H, 2009, CLIN EXP NEPHROL, V13, P275, DOI 10.1007/s10157-009-0162-x; Khurana S, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-33; Khurana S, 2012, J BIOL CHEM, V287, P12027, DOI 10.1074/jbc.M112.345421; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Kummer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027457; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li YC, 2011, CURR DIABETES REV, V7, P35, DOI 10.2174/157339911794273964; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lorenzen J, 2008, J AM SOC NEPHROL, V19, P884, DOI 10.1681/ASN.2007040486; Merline R, 2009, J PHYSIOL PHARMACOL, V60, P5; Niemir ZI, 1997, KIDNEY INT, V52, P393, DOI 10.1038/ki.1997.346; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Peters I, 2006, J AM SOC NEPHROL, V17, P1644, DOI 10.1681/ASN.2005111209; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Ransom RF, 2005, KIDNEY INT, V67, P1275, DOI 10.1111/j.1523-1755.2005.00205.x; RDC T, 2009, R LANG ENV STAT COMP; Reiser J, 2011, NAT MED, V17, P44, DOI 10.1038/nm0111-44; Ren SY, 2005, BIOCHEM BIOPH RES CO, V338, P1818, DOI 10.1016/j.bbrc.2005.10.158; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Rossing P, 2013, NAT REV ENDOCRINOL, V9, P6, DOI 10.1038/nrendo.2012.227; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang D, 2011, KIDNEY INT, V80, P1159, DOI 10.1038/ki.2011.255; Wang YL, 2012, J AM SOC NEPHROL, V23, P1977, DOI 10.1681/ASN.2012040383; Wasilewska A, 2011, SCAND J UROL NEPHROL, V45, P52, DOI 10.3109/00365599.2010.526140; Welsh-Bacic D, 2011, NEPHROL DIAL TRANSPL, V26, P1211, DOI 10.1093/ndt/gfq560; Westenberg MA, 2010, BIOINFORMATICS, V26, P2922, DOI 10.1093/bioinformatics/btq535; Woltman AM, 2005, AM J TRANSPLANT, V5, P2114, DOI 10.1111/j.1600-6143.2005.00997.x; Wu DT, 2005, J AM SOC NEPHROL, V16, P3211, DOI 10.1681/ASN.2004121055; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655	53	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60213	10.1371/journal.pone.0060213	http://dx.doi.org/10.1371/journal.pone.0060213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593176	Green Submitted, gold, Green Published			2022-12-27	WOS:000319108100022
J	Lin, YL; Lai, ZX				Lin, Yuling; Lai, Zhongxiong			Comparative Analysis Reveals Dynamic Changes in miRNAs and Their Targets and Expression during Somatic Embryogenesis in Longan (Dimocarpus longan Lour.)	PLOS ONE			English	Article							PLANT MICRORNAS; ARABIDOPSIS-THALIANA; CONSERVED MICRORNAS; REGULATORY ROLES; IDENTIFICATION; STRESS; AUXIN; BIOGENESIS; GENES; SIRNA	Somatic embryogenesis (SE), which resembles zygotic embryogenesis, is an essential component of the process of plant cell differentiation and embryo development. Although microRNAs (miRNAs) are important regulators of many plant developmental processes, their roles in SE have not been thoroughly investigated. In this study, we used deep-sequencing, computational, and qPCR methods to identify, profile, and describe conserved and novel miRNAs involved in longan (Dimocarpus longan) SE. A total of 643 conserved and 29 novel miRNAs (including star strands) from more than 169 miRNA families were identified in longan embryogenic tissue using Solexa sequencing. By combining computational and degradome sequencing approaches, we were able to predict 2063 targets of 272 miRNAs and verify 862 targets of 181 miRNAs. Target annotation revealed that the putative targets were involved in a broad variety of biological processes, including plant metabolism, signal transduction, and stimulus response. Analysis of stage-and tissue-specific expressions of 20 conserved and 4 novel miRNAs indicated their possible roles in longan SE. These miRNAs were dlo-miR156 family members and dlo-miR166c* associated with early embryonic culture developmental stages; dlo-miR26, dlo-miR160a, and families dlo-miR159, dlo-miR390, and dlo-miR398b related to heart-shaped and torpedo-shaped embryo formation; dlo-miR4a, dlo-miR24, dlo-miR167a, dlo-miR168a*, dlo-miR397a, dlo-miR398b. 1, dlo-miR398b. 2, dlo-miR808 and dlo-miR5077 involved in cotyledonary embryonic development; and dlo-miR17 and dlo-miR2089*-1 that have regulatory roles during longan SE. In addition, dlo-miR167a, dlo-miR808, and dlo-miR5077 may be required for mature embryo formation. This study is the first reported investigation of longan SE involving large-scale cloning, characterization, and expression profiling of miRNAs and their targets. The reported results contribute to our knowledge of somatic embryo miRNAs and provide insights into miRNA biogenesis and expression in plant somatic embryo development.	[Lin, Yuling; Lai, Zhongxiong] Fujian Agr & Forestry, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University	Lai, ZX (corresponding author), Fujian Agr & Forestry, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China.	laizx01@163.com			National Natural Science Foundation of China [31078717, 31272149, 31201614]; Doctoral Program of Higher Education of the Chinese Ministry of Education [20093515110005, 20123515120008]; Fujian Provincial Natural Science Foundation of China [2012J05042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of the Chinese Ministry of Education; Fujian Provincial Natural Science Foundation of China	This work was funded by the National Natural Science Foundation of China (31078717, 31272149, and 31201614), the Doctoral Program of Higher Education of the Chinese Ministry of Education (20093515110005 and 20123515120008), and Fujian Provincial Natural Science Foundation of China (2012J05042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen ChunLing, 2002, Journal of Fujian Agricultural and Forestry University, V31, P192; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Constabel CP, 2000, PLANT PHYSIOL, V124, P285, DOI 10.1104/pp.124.1.285; Cui KR, 2002, PLANT CELL TISS ORG, V68, P187, DOI 10.1023/A:1013871500575; Dezulian T., 2005, GENOME BIOL, V6, pP13, DOI DOI 10.1186/GB-2005-6-11-P13; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fang ZZ, 2009, CHINESE AGR SCI B, V25, P152; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Lai Z.X., 1998, AGR BIOTECHNOLOGY LA, P369; Lai ZhongXiong, 1997, Journal of Fujian Agricultural University, V26, P271; [赖钟雄 Lai Zhongxiong], 2002, [热带作物学报, Chinese Journal of Tropical Crops], V23, P41; Lai ZX, 2001, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2001.558.18; Lai ZX, 2000, FOR SCI, V67, P415; Lai ZX, 2010, ACTA HORT ISHS, V863; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; [林玉玲 LIN Yuling], 2011, [热带作物学报, Chinese Journal of Tropical Crops], V32, P632; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Liu XD, 2010, PLANT J, V62, P416, DOI 10.1111/j.1365-313X.2010.04164.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Oh TJ, 2008, NEW PHYTOL, V179, P67, DOI 10.1111/j.1469-8137.2008.02448.x; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Pasternak TP, 2002, PLANT PHYSIOL, V129, P1807, DOI 10.1104/pp.000810; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tabata R, 2010, PLANT CELL PHYSIOL, V51, P164, DOI 10.1093/pcp/pcp176; Takahata K, 2008, BIOSCI BIOTECH BIOCH, V72, P900, DOI 10.1271/bbb.70730; Tokuji Y, 2003, J PLANT PHYSIOL, V160, P133, DOI 10.1078/0176-1617-00892; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Wu XM, 2011, PLANTA, V233, P495, DOI 10.1007/s00425-010-1312-9; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang SG, 2010, BIOCHEM BIOPH RES CO, V398, P355, DOI 10.1016/j.bbrc.2010.06.056; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]	62	90	126	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60337	10.1371/journal.pone.0060337	http://dx.doi.org/10.1371/journal.pone.0060337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593197	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200005
J	Liu, JS; Bai, YG; Lamb, EG; Simpson, D; Liu, GF; Wei, YS; Wang, DL; McKenney, DW; Papadopol, P				Liu, Jushan; Bai, Yuguang; Lamb, Eric G.; Simpson, Dale; Liu, Guofang; Wei, Yongsheng; Wang, Deli; McKenney, Daniel W.; Papadopol, Pia			Patterns of Cross-Continental Variation in Tree Seed Mass in the Canadian Boreal Forest	PLOS ONE			English	Article							PRIMARY PRODUCTIVITY NPP; COMPARING GLOBAL-MODELS; PICEA-MARIANA; PINUS-BANKSIANA; SPECIES DISTRIBUTION; CLIMATE-CHANGE; SIZE; POPULATIONS; GROWTH; SPRUCE	Seed mass is an adaptive trait affecting species distribution, population dynamics and community structure. In widely distributed species, variation in seed mass may reflect both genetic adaptation to local environments and adaptive phenotypic plasticity. Acknowledging the difficulty in separating these two aspects, we examined the causal relationships determining seed mass variation to better understand adaptability and/or plasticity of selected tree species to spatial/climatic variation. A total of 504, 481 and 454 seed collections of black spruce (Picea mariana (Mill.) B. S. P.), white spruce (Picea glauca (Moench) Voss) and jack pine (Pinus banksiana Lamb) across the Canadian Boreal Forest, respectively, were selected. Correlation analyses were used to determine how seed mass vary with latitude, longitude, and altitude. Structural Equation Modeling was used to examine how geographic and climatic variables influence seed mass. Climatic factors explained a large portion of the variation in seed mass (34, 14 and 29%, for black spruce, white spruce and jack pine, respectively), indicating species-specific adaptation to long term climate conditions. Higher annual mean temperature and winter precipitation caused greater seed mass in black spruce, but annual precipitation was the controlling factor for white spruce. The combination of factors such as growing season temperature and evapotranspiration, temperature seasonality and annual precipitation together determined seed mass of jack pine. Overall, sites with higher winter temperatures were correlated with larger seeds. Thus, long-term climatic conditions, at least in part, determined spatial variation in seed mass. Black spruce and Jack pine, species with relatively more specific habitat requirements and less plasticity, had more variation in seed mass explained by climate than did the more plastic species white spruce. As traits such as seed mass are related to seedling growth and survival, they potentially influence forest species composition in a changing climate and should be included in future modeling of vegetation shifts.	[Liu, Jushan; Bai, Yuguang; Lamb, Eric G.; Wei, Yongsheng] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Liu, Jushan; Wang, Deli] NE Normal Univ, Inst Grassland Sci, Changchun, Peoples R China; [Liu, Jushan; Wang, Deli] Minist Educ Res, Key Lab Vegetat Ecol, Changchun, Peoples R China; [Simpson, Dale] Nat Resources Canada, Atlantic Forestry Ctr, Fredericton, NB, Canada; [Liu, Guofang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Wei, Yongsheng] NW A&F Univ, Coll Life Sci, Yangling, Peoples R China; [McKenney, Daniel W.; Papadopol, Pia] Nat Resources Canada, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada	University of Saskatchewan; Northeast Normal University - China; Natural Resources Canada; Canadian Forest Service; Chinese Academy of Sciences; Institute of Botany, CAS; Northwest A&F University - China; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Bai, YG (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada.	yuguang.bai@usask.ca	Lamb, Eric G/D-9319-2011	Lamb, Eric G/0000-0001-5201-4541				BAKER HG, 1972, ECOLOGY, V53, P997, DOI 10.2307/1935413; BLACK RA, 1980, ECOL MONOGR, V50, P331, DOI 10.2307/2937255; Bondeau A, 1999, GLOB CHANGE BIOL, V5, P35, DOI 10.1046/j.1365-2486.1999.00005.x; Fleming RA, 2002, CLIMATIC CHANGE, V55, P251, DOI 10.1023/A:1020299422491; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Godbout J, 2005, MOL ECOL, V14, P3497, DOI 10.1111/j.1365-294X.2005.02674.x; Grace J.B., 2006, STRUCT EQ MOD NAT; Greene DF, 1999, CAN J FOREST RES, V29, P824, DOI 10.1139/cjfr-29-6-824; Greene DF, 2005, AM J BOT, V92, P998, DOI 10.3732/ajb.92.6.998; Guo H, 2010, J ECOL, V98, P1232, DOI 10.1111/j.1365-2745.2010.01688.x; Guo QF, 2000, ECOLOGY, V81, P2149, DOI 10.1890/0012-9658(2000)081[2149:COSSOP]2.0.CO;2; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Harel D, 2011, BASIC APPL ECOL, V12, P674, DOI 10.1016/j.baae.2011.09.003; Hewitt N, 1998, OECOLOGIA, V114, P432, DOI 10.1007/s004420050467; HOULE G, 1993, AM J BOT, V80, P1242, DOI 10.2307/2445707; Jaramillo-Correa JP, 2004, MOL ECOL, V13, P2735, DOI 10.1111/j.1365-294X.2004.02258.x; Kelly D, 2000, OIKOS, V90, P477, DOI 10.1034/j.1600-0706.2000.900306.x; Kuster EC, 2011, ECOGRAPHY, V34, P507, DOI 10.1111/j.1600-0587.2010.05892.x; Lamb EG, 2011, CAN J PLANT SCI, V91, P603, DOI [10.4141/CJPS2010-035, 10.4141/cjps2010-035]; Lazaro A, 2008, EVOL ECOL, V23, P1; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; LEISHMAN MR, 1994, FUNCT ECOL, V8, P205, DOI 10.2307/2389903; Leishman MR, 2001, OIKOS, V94, P151, DOI 10.1034/j.1600-0706.2001.10392.x; Luo JX, 2006, FOREST ECOL MANAG, V221, P285, DOI 10.1016/j.foreco.2005.10.004; Malmstrom CM, 2000, GLOBAL CHANGE BIOL, V6, P35, DOI 10.1046/j.1365-2486.2000.06012.x; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; McLeod TK, 1997, J BIOGEOGR, V24, P865, DOI 10.1046/j.1365-2699.1997.00151.x; Messaoud Y, 2007, AM J BOT, V94, P746, DOI 10.3732/ajb.94.5.746; Meunier C, 2007, ECOL MONOGR, V77, P361, DOI 10.1890/06-1543.1; Moles AT, 2007, GLOBAL ECOL BIOGEOGR, V16, P109, DOI 10.1111/j.1466-8238.2006.00259.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Moles AT, 2003, J BIOGEOGR, V30, P105, DOI 10.1046/j.1365-2699.2003.00781.x; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Murray BR, 2004, J BIOGEOGR, V31, P379, DOI 10.1046/j.0305-0270.2003.00993.x; Murray BR, 2003, AUST J BOT, V51, P47, DOI 10.1071/BT02069; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Owens JN, 1998, CAN J FOREST RES, V28, P1146, DOI 10.1139/cjfr-28-8-1146; Pichancourt JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032323; Pringle EG, 2007, PLANT ECOL, V193, P211, DOI 10.1007/s11258-006-9259-4; R TDC, 2011, LANG ENV STAT COMP; Schloss AL, 1999, GLOBAL CHANGE BIOL, V5, P25, DOI 10.1046/j.1365-2486.1999.00004.x; Selas V, 2000, CAN J BOT, V78, P423, DOI 10.1139/cjb-78-4-423; Selas V, 2002, CAN J FOREST RES, V32, P217, DOI 10.1139/X01-192; SILVERTOWN J, 1989, TRENDS ECOL EVOL, V4, P24, DOI 10.1016/0169-5347(89)90013-X; Vaughton G, 1998, J ECOL, V86, P563, DOI 10.1046/j.1365-2745.1998.00279.x; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; WULFF RD, 1986, J ECOL, V74, P87, DOI 10.2307/2260350	50	21	21	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61060	10.1371/journal.pone.0061060	http://dx.doi.org/10.1371/journal.pone.0061060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593392	gold, Green Published			2022-12-27	WOS:000317383200038
J	Keeling, KM; Wang, D; Dai, YY; Murugesan, S; Chenna, B; Clark, J; Belakhov, V; Kandasamy, J; Velu, SE; Baasov, T; Bedwell, DM				Keeling, Kim M.; Wang, Dan; Dai, Yanying; Murugesan, Srinivasan; Chenna, Balachandra; Clark, Jeremy; Belakhov, Valery; Kandasamy, Jeyakumar; Velu, Sadanandan E.; Baasov, Timor; Bedwell, David M.			Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense Suppression	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; EXON JUNCTION COMPLEX; ALPHA-L-IDURONIDASE; PTC124 TREATMENT; ENZYME-KINETICS; NMD FACTORS; MUTATIONS; GENE; PHOSPHORYLATION; TERMINATION	Nonsense suppression therapy is an approach to treat genetic diseases caused by nonsense mutations. This therapeutic strategy pharmacologically suppresses translation termination at Premature Termination Codons (PTCs) in order to restore expression of functional protein. However, the process of Nonsense-Mediated mRNA Decay (NMD), which reduces the abundance of mRNAs containing PTCs, frequently limits this approach. Here, we used a mouse model of the lysosomal storage disease mucopolysaccharidosis I-Hurler (MPS I-H) that carries a PTC in the Idua locus to test whether NMD attenuation can enhance PTC suppression in vivo. Idua encodes alpha-L-iduronidase, an enzyme required for degradation of the glycosaminoglycans (GAGs) heparan sulfate and dermatan sulfate. We found that the NMD attenuator NMDI-1 increased the abundance of the PTC-containing Idua transcript. Furthermore, co-administration of NMDI-1 with the PTC suppression drug gentamicin enhanced alpha-L-iduronidase activity compared to gentamicin alone, leading to a greater reduction of GAG storage in mouse tissues, including the brain. These results demonstrate that NMD attenuation significantly enhances suppression therapy in vivo.	[Keeling, Kim M.; Dai, Yanying; Bedwell, David M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Wang, Dan; Bedwell, David M.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Murugesan, Srinivasan; Chenna, Balachandra; Clark, Jeremy; Velu, Sadanandan E.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Belakhov, Valery; Kandasamy, Jeyakumar; Baasov, Timor] Technion Israel Inst Technol, Edith & Joseph Fischer Enzyme Inhibitors Lab, Schulich Fac Chem, Haifa, Israel	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Technion Israel Institute of Technology	Keeling, KM (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	kkeeling@uab.edu	Kandasamy, Jeyakumar/F-5805-2013; Baasov, Timor/L-5173-2019; Chenna, Bala Chandra/ABE-8348-2021	Baasov, Timor/0000-0002-1427-2619; Chenna, Bala Chandra/0000-0002-2660-5302; Belakhov, Valery/0000-0003-1918-974X; Wang, Dan/0000-0001-9079-2360; Bedwell, David/0000-0002-6605-818X; Kandasamy, Jeyakumar/0000-0003-3285-971X; Murugesan, SRINIVASAN/0000-0002-5880-5421; Velu, Sadanandan/0000-0002-0342-2378	University of Pennsylvania; NIH [5R01NS057412, 1R01GM094792]; US-Israel Binational Science Foundation [2006/301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057412] Funding Source: NIH RePORTER	University of Pennsylvania; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the University of Pennsylvania (KMK, DMB), NIH 5R01NS057412 (DMB), NIH 1R01GM094792 (TB & DMB), and the US-Israel Binational Science Foundation (2006/301 for TB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON LJ, 1992, AM J HUM GENET, V50, P787; Boelz S, 2006, BIOCHEM BIOPH RES CO, V349, P186, DOI 10.1016/j.bbrc.2006.08.017; Brooks DA, 2006, TRENDS MOL MED, V12, P367, DOI 10.1016/j.molmed.2006.06.001; Bunge S, 1998, BBA-MOL BASIS DIS, V1407, P249, DOI 10.1016/S0925-4439(98)00046-5; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Clancy JP, 2006, PED PULMONOL S41; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Frischmeyer-Guerrerio PA, 2011, P NATL ACAD SCI USA, V108, P10638, DOI 10.1073/pnas.1019352108; Garbett Nichola C., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P149, DOI 10.2174/1568011043482070; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang LL, 2011, MOL CELL, V43, P950, DOI 10.1016/j.molcel.2011.06.031; Hwang J, 2011, CURR OPIN GENET DEV, V21, P422, DOI 10.1016/j.gde.2011.03.008; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Keeling KM, 2012, CRIT REV BIOCHEM MOL, V47, P444, DOI 10.3109/10409238.2012.694846; Keeling KM, 2011, WIRES RNA, V2, P837, DOI 10.1002/wrna.95; Keeling KM, 2010, NUCLEIC ACIDS MOL BI, V24, P123, DOI 10.1007/978-0-387-89382-2_6; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Konstan M, 2012, EUR CYST FIBR C 2012; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Linde L, 2008, TRENDS GENET, V24, P552, DOI 10.1016/j.tig.2008.08.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; McIlwain DR, 2010, P NATL ACAD SCI USA, V107, P12186, DOI 10.1073/pnas.1007336107; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; MENON KP, 1994, CELL MOL BIOL, V40, P999; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Nudelman I, 2010, BIOORGAN MED CHEM, V18, P3735, DOI 10.1016/j.bmc.2010.03.060; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; RIVALLE C, 1980, J ORG CHEM, V45, P2176, DOI 10.1021/jo01299a028; RIVALLE C, 1981, TETRAHEDRON, V37, P2097, DOI 10.1016/S0040-4020(01)97964-5; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Seoighe C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011657; Sermet-Gaudelus I, 2008, J CYST FIBROS, V7, pS22; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Usuki F, 2004, ANN NEUROL, V55, P740, DOI 10.1002/ana.20107; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Wang D, 2012, MOL GENET METAB, V105, P116, DOI 10.1016/j.ymgme.2011.10.005; Wang D, 2010, MOL GENET METAB, V99, P62, DOI 10.1016/j.ymgme.2009.08.002; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wilschanski M, 2000, AM J RESP CRIT CARE, V161, P860, DOI 10.1164/ajrccm.161.3.9904116; Wilschanski M, 2011, EUR RESPIR J, V38, P59, DOI 10.1183/09031936.00120910; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Wilschanski M, 2008, J CYSTIC FIBROSIS S2, V7, pS22; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Wraith JE, 2005, EXPERT OPIN PHARMACO, V6, P489, DOI 10.1517/14656566.6.3.489; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yepiskoposyan H, 2011, RNA, V17, P2108, DOI 10.1261/rna.030247.111	56	74	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60478	10.1371/journal.pone.0060478	http://dx.doi.org/10.1371/journal.pone.0060478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593225	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000017
J	Dominguez, EL; Hernandez, SEP; Gomez, GR; Medina, MA				Lopez Dominguez, Eduardo; Pomares Hernandez, Saul E.; Rodriguez Gomez, Gustavo; Auxilio Medina, Maria			An Efficient Two-Tier Causal Protocol for Mobile Distributed Systems	PLOS ONE			English	Article								Causal ordering is a useful tool for mobile distributed systems (MDS) to reduce the non-determinism induced by three main aspects: host mobility, asynchronous execution, and unpredictable communication delays. Several causal protocols for MDS exist. Most of them, in order to reduce the overhead and the computational cost over wireless channels and mobile hosts (MH), ensure causal ordering at and according to the causal view of the Base Stations. Nevertheless, these protocols introduce certain disadvantage, such as unnecessary inhibition at the delivery of messages. In this paper, we present an efficient causal protocol for groupware that satisfies the MDS's constraints, avoiding unnecessary inhibitions and ensuring the causal delivery based on the view of the MHs. One interesting aspect of our protocol is that it dynamically adapts the causal information attached to each message based on the number of messages with immediate dependency relation, and this is not directly proportional to the number of MHs.	[Lopez Dominguez, Eduardo] Lab Nacl Informat Avanzada, Res & Innovat Ctr, Xalapa, Veracruz, Mexico; [Pomares Hernandez, Saul E.; Rodriguez Gomez, Gustavo] Inst Nacl Astrofis Opt & Electr, Dept Comp Sci, Puebla, Mexico; [Pomares Hernandez, Saul E.] CNRS, LAAS, F-31077 Toulouse, France; [Pomares Hernandez, Saul E.] Univ Toulouse, Toulouse, France; [Auxilio Medina, Maria] Univ Politecn Puebla, Dept Comp Sci, Puebla, Mexico	Instituto Nacional de Astrofisica, Optica y Electronica; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Dominguez, EL (corresponding author), Lab Nacl Informat Avanzada, Res & Innovat Ctr, Xalapa, Veracruz, Mexico.	elopez@lania.mx	POMARES HERNANDEZ, SAUL EDUARDO/H-2009-2012; Medina Nieto, Maria Auxilio/AAN-4571-2020; Gomez, Gustavo Rodriguez/N-1315-2019; Rodriguez-Gomez, Gustavo/B-7273-2012	POMARES HERNANDEZ, SAUL EDUARDO/0000-0002-0560-1687; Medina Nieto, Maria Auxilio/0000-0001-6391-4799; Gomez, Gustavo Rodriguez/0000-0002-4925-8892; Rodriguez-Gomez, Gustavo/0000-0002-4925-8892; Lopez Dominguez, Eduardo/0000-0002-6167-6309				Alagar S, 1997, IEEE T COMPUT, V46, P353, DOI 10.1109/12.580430; Benzaid C, 2005, MOBILE COMPUTING COM, V9, P19; Chandra P, 2004, IEEE COMPUTER SOCIETY'S 12TH ANNUAL INTERNATIONAL SYMPOSIUM ON MODELING, ANALYSIS, AND SIMULATION OF COMPUTER AND TELECOMMUNICATIONS SYSTEMS - PROCEEDINGS, P213, DOI 10.1109/MASCOT.2004.1348235; Chao-Ping Li, 1999, Proceedings of the National Science Council, Republic of China, Part A (Physical Science and Engineering), V23, P100; Chi KH, 2000, IEICE T INF SYST, VE83D, P2065; LAMPORT L, 1978, COMMUN ACM, V21, P558, DOI 10.1145/359545.359563; Mattern F., 1988, PARALLEL DISTRIBUTED, P215; Pomares HSE, 2004, ANN REV SCALABLE COM, V6, P61; Pomares HSE, 2009, INT J INTERNET PROTO, V4, P207; Prakash R, 1996, INT CON DISTR COMP S, P744, DOI 10.1109/ICDCS.1996.508027; Prakash R, 1997, WIREL NETW, V3, P349, DOI 10.1023/A:1019134007206; Skawratananond C., 1999, Proceedings of the ISCA 12th International Conference. Parallel and Distributed Systems, P245; Tarkoma S, 2003, CONCURRENT ENGINEERING: ENHANCED INTEROPERABLE SYSTEMS, P105; Yap GE, 2007, IEEE T KNOWL DATA EN, V19, P977, DOI [10.1109/TKDE.2007.1065, 10.1109/TKDE.2007.1065.]; Yen L, 1998, J ACM BALTZER MOBILE, V2, P365	15	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e59904	10.1371/journal.pone.0059904	http://dx.doi.org/10.1371/journal.pone.0059904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585828	Green Published, gold			2022-12-27	WOS:000317909600010
J	Munari, F; Rezaei-Ghaleh, N; Xiang, SQ; Fischle, W; Zweckstetter, M				Munari, Francesca; Rezaei-Ghaleh, Nasrollah; Xiang, Shengqi; Fischle, Wolfgang; Zweckstetter, Markus			Structural Plasticity in Human Heterochromatin Protein 1 beta	PLOS ONE			English	Article							CHEMICAL-SHIFT ANISOTROPY; SCATTERING DATA-ANALYSIS; X-RAY-SCATTERING; HISTONE H3; BIOLOGICAL MACROMOLECULES; SECONDARY STRUCTURE; HP1 SUGGESTS; IN-VITRO; NMR; BINDING	As essential components of the molecular machine assembling heterochromatin in eukaryotes, HP1 (Heterochromatin Protein 1) proteins are key regulators of genome function. While several high-resolution structures of the two globular regions of HP1, chromo and chromoshadow domains, in their free form or in complex with recognition-motif peptides are available, less is known about the conformational behavior of the full-length protein. Here, we used NMR spectroscopy in combination with small angle X-ray scattering and dynamic light scattering to characterize the dynamic and structural properties of full-length human HP1 beta (hHP1 beta) in solution. We show that the hinge region is highly flexible and enables a largely unrestricted spatial search by the two globular domains for their binding partners. In addition, the binding pockets within the chromo and chromoshadow domains experience internal dynamics that can be useful for the versatile recognition of different binding partners. In particular, we provide evidence for the presence of a distinct structural propensity in free hHP1 beta that prepares a binding-competent interface for the formation of the intermolecular beta-sheet with methylated histone H3. The structural plasticity of hHP1 beta supports its ability to bind and connect a wide variety of binding partners in epigenetic processes.	[Munari, Francesca; Rezaei-Ghaleh, Nasrollah; Xiang, Shengqi; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Munari, Francesca; Rezaei-Ghaleh, Nasrollah; Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, Gottingen, Germany; [Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society	Zweckstetter, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany.	markus.zweckstetter@dzne.de	Rezaei-Ghaleh, Nasrollah/B-9443-2008	Rezaei-Ghaleh, Nasrollah/0000-0001-6935-6564; Zweckstetter, Markus/0000-0002-2536-6581; Munari, Francesca/0000-0002-8217-1481	European Union; Deutsche Forschungsgemeinschaft [SFB 860]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the European Union (Marie Curie Reintegration Fellowship and NET Fellowship of the NoE Epigenome to WF) and the Deutsche Forschungsgemeinschaft (SFB 860 to MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hiragami-Hamada K, 2011, MOL CELL BIOL, V31, P1186, DOI 10.1128/MCB.01012-10; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Mendez DL, 2011, CHEMBIOCHEM, V12, P1084, DOI 10.1002/cbic.201000598; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Munari F, 2012, J BIOL CHEM, V287, P33756, DOI 10.1074/jbc.M112.390849; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Ravichandran M, PDB ID 3F2U CRYSTAL; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Ruan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035376; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Singh P B, 2010, Genetika, V46, P1424; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tjandra N, 1996, J AM CHEM SOC, V118, P6986, DOI 10.1021/ja960510m; Walker O, 2004, J MAGN RESON, V168, P336, DOI 10.1016/j.jmr.2004.03.019; Walsh JD, 2010, BIOPHYS J, V99, P2636, DOI 10.1016/j.bpj.2010.08.036; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Yao LS, 2010, J AM CHEM SOC, V132, P4295, DOI 10.1021/ja910186u; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Zeng W, 2010, EPIGENETICS-US, V5, P287, DOI 10.4161/epi.5.4.11683; Zhao T, 2000, J BIOL CHEM, V275, P28332; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200; Zheng G, 2008, J MAGN RESON, V191, P159, DOI 10.1016/j.jmr.2007.12.001; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	59	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60887	10.1371/journal.pone.0060887	http://dx.doi.org/10.1371/journal.pone.0060887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585859	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600066
J	Badano, MN; Camicia, GL; Lombardi, G; Maglioco, A; Cabrera, G; Costa, H; Meiss, RP; Piazzon, I; Nepomnaschy, I				Noel Badano, Maria; Lorena Camicia, Gabriela; Lombardi, Gabriela; Maglioco, Andrea; Cabrera, Gabriel; Costa, Hector; Pablo Meiss, Roberto; Piazzon, Isabel; Nepomnaschy, Irene			B-Cell Lymphopoiesis Is Regulated by Cathepsin L	PLOS ONE			English	Article							GROWTH-FACTOR-I; HAIR FOLLICLE MORPHOGENESIS; FACTOR BINDING-PROTEINS; PRO-B; EXTRACELLULAR-MATRIX; NACKT NKT; SELECTION; DEFICIENT; MOUSE; DIFFERENTIATION	Cathepsin L (CTSL) is a ubiquitously expressed lysosomal cysteine peptidase with diverse and highly specific functions. The involvement of CTSL in thymic CD4+ T-cell positive selection has been well documented. Using CTSLnkt/nkt mice that lack CTSL activity, we have previously demonstrated that the absence of CTSL activity affects the homeostasis of the T-cell pool by decreasing CD4+ cell thymic production and increasing CD8+ thymocyte production. Herein we investigated the influence of CTSL activity on the homeostasis of peripheral B-cell populations and bone marrow (BM) B-cell maturation. B-cell numbers were increased in lymph nodes (LN), spleen and blood from CTSLnkt/nkt mice. Increases in splenic B-cell numbers were restricted to transitional T1 and T2 cells and to the marginal zone (MZ) cell subpopulation. No alterations in the proliferative or apoptosis levels were detected in peripheral B-cell populations from CTSLnkt/nkt mice. In the BM, the percentage and the absolute number of pre-pro-B, pro-B, pre-B, immature and mature B cells were not altered. However, in vitro and in vivo experiments showed that BM B-cell production was markedly increased in CTSLnkt/nkt mice. Besides, BM B-cell emigration to the spleen was increased in CTSLnkt/nkt mice. Colony-forming unit pre-B (CFU pre-B) assays in the presence of BM stromal cells (SC) and reciprocal BM chimeras revealed that both BM B-cell precursors and SC would contribute to sustain the increased B-cell hematopoiesis in CTSLnkt/nkt mice. Overall, our data clearly demonstrate that CTSL negatively regulates BM B-cell production and output therefore influencing the homeostasis of peripheral B cells.	[Noel Badano, Maria; Lorena Camicia, Gabriela; Maglioco, Andrea; Cabrera, Gabriel; Costa, Hector; Piazzon, Isabel; Nepomnaschy, Irene] Acad Nacl Med Buenos Aires, CSIC, Lab Inmunol Expt, Inst Med Expt, Buenos Aires, DF, Argentina; [Lombardi, Gabriela] Univ Buenos Aires, Fac Med, CONICET, Lab Inmunofarmacol Tumoral,Ctr Estudios Farmacol, Buenos Aires, DF, Argentina; [Pablo Meiss, Roberto] Acad Nacl Med Buenos Aires, Ctr Estudios Oncol, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Buenos Aires National Academy of Medicine	Nepomnaschy, I (corresponding author), Acad Nacl Med Buenos Aires, CSIC, Lab Inmunol Expt, Inst Med Expt, Buenos Aires, DF, Argentina.	irenepo@hematologia.anm.edu.ar	Badano, Maria Noel/ABD-3854-2020		CONICET (National Research Council, Argentine); FUNDALEU (Fundacion para Combatir la Leucemia)	CONICET (National Research Council, Argentine); FUNDALEU (Fundacion para Combatir la Leucemia)	This work was supported by grants from CONICET (National Research Council, Argentine) to IN and IP and FUNDALEU (Fundacion para Combatir la Leucemia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOUD SL, 1991, J CLIN INVEST, V88, P470, DOI 10.1172/JCI115327; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Baracho GV, 2011, CURR OPIN IMMUNOL, V23, P178, DOI 10.1016/j.coi.2011.01.001; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; Benavides F, 2001, IMMUNOGENETICS, V53, P233, DOI 10.1007/s002510100320; Benavides F, 1999, IMMUNOGENETICS, V49, P413, DOI 10.1007/s002510050514; Cabrera G, 2008, J VIROL, V82, P7422, DOI 10.1128/JVI.00102-08; Camicia G, 2007, IMMUNOLOGY 2007, P537; Cancro MP, 1998, IMMUNOL RES, V17, P3, DOI 10.1007/BF02786425; Cariappa A, 1999, J IMMUNOL, V162, P4417; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; CHAPMAN HA, 1994, AM J RESP CRIT CARE, V150, pS155, DOI 10.1164/ajrccm/150.6_Pt_2.S155; Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Ellis TM, 2001, INT IMMUNOL, V13, P553, DOI 10.1093/intimm/13.4.553; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Fowlkes JL, 1997, TRENDS ENDOCRIN MET, V8, P299, DOI 10.1016/S1043-2760(97)00112-4; GIBSON LF, 1993, BLOOD, V82, P3005; Hardy RR, 2003, CURR OPIN IMMUNOL, V15, P158, DOI 10.1016/S0952-7915(03)00012-8; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Harima A, 2008, HEMATOLOGY, V13, P236, DOI 10.1179/102453308X348315; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hook V, 2009, ENDOCRINE, V35, P429, DOI 10.1007/s12020-009-9163-5; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; KIRSCHKE H, 1982, BIOCHEM J, V201, P367, DOI 10.1042/bj2010367; Kitagawa J, 2010, J CLIN EXP HEMATOP, V50, P99, DOI 10.3960/jslrt.50.99; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lalanne AI, 2010, J IMMUNOL, V184, P5678, DOI 10.4049/jimmunol.0903854; LANDRETH KS, 1992, BLOOD, V80, P1207; Lankelma JM, 2010, LIFE SCI, V86, P225, DOI 10.1016/j.lfs.2009.11.016; Lombardi G, 2005, J IMMUNOL, V174, P7022, DOI 10.4049/jimmunol.174.11.7022; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Mollen KP, 2008, J LEUKOCYTE BIOL, V83, P80, DOI 10.1189/jlb.0407201; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nepomnaschy I, 2000, SCAND J IMMUNOL, V52, P555, DOI 10.1046/j.1365-3083.2000.00818.x; Osmond DG, 1998, IMMUNOL TODAY, V19, P65, DOI 10.1016/S0167-5699(97)01203-6; Otero DC, 2003, J IMMUNOL, V171, P5921, DOI 10.4049/jimmunol.171.11.5921; Petermann I, 2006, FASEB J, V20, P1266, DOI 10.1096/fj.05-5517fje; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Sater RA, 1998, INT IMMUNOL, V10, P1673, DOI 10.1093/intimm/10.11.1673; Schmid I, 2000, J IMMUNOL METHODS, V235, P121, DOI 10.1016/S0022-1759(99)00225-2; Stypmann J, 2002, P NATL ACAD SCI USA, V99, P6234, DOI 10.1073/pnas.092637699; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Sun M, 2011, CARDIOVASC RES, V89, P374, DOI 10.1093/cvr/cvq328; Taguchi T, 2006, EXP HEMATOL, V34, P508, DOI 10.1016/j.exphem.2006.01.009; Tang QZ, 2009, J MOL MED, V87, P249, DOI 10.1007/s00109-008-0423-2; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Tsuboi I, 2004, EXP BIOL MED, V229, P494, DOI 10.1177/153537020422900607; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Zou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022815; Zwad O, 2002, FEBS LETT, V510, P211, DOI 10.1016/S0014-5793(01)03267-7	61	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61347	10.1371/journal.pone.0061347	http://dx.doi.org/10.1371/journal.pone.0061347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585893	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600107
J	Sana, TR; Gordon, DB; Fischer, SM; Tichy, SE; Kitagawa, N; Lai, C; Gosnell, WL; Chang, SP				Sana, Theodore R.; Gordon, D. Benjamin; Fischer, Steven M.; Tichy, Shane E.; Kitagawa, Norton; Lai, Cindy; Gosnell, William L.; Chang, Sandra P.			Global Mass Spectrometry Based Metabolomics Profiling of Erythrocytes Infected with Plasmodium falciparum	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; HYDROPHILIC METABOLITES; ELEMENTAL COMPOSITIONS; ACID METABOLISM; HOST-CELL; PROTEIN; SEQUENCE; IDENTIFICATION; CHROMATOGRAPHY; HYDROLYSIS	Malaria is a global infectious disease that threatens the lives of millions of people. Transcriptomics, proteomics and functional genomics studies, as well as sequencing of the Plasmodium falciparum and Homo sapiens genomes, have shed new light on this host-parasite relationship. Recent advances in accurate mass measurement mass spectrometry, sophisticated data analysis software, and availability of biological pathway databases, have converged to facilitate our global, untargeted biochemical profiling study of in vitro P. falciparum-infected (IRBC) and uninfected (NRBC) erythrocytes. In order to expand the number of detectable metabolites, several key analytical steps in our workflows were optimized. Untargeted and targeted data mining resulted in detection of over one thousand features or chemical entities. Untargeted features were annotated via matching to the METLIN metabolite database. For targeted data mining, we queried the data using a compound database derived from a metabolic reconstruction of the P. falciparum genome. In total, over one hundred and fifty differential annotated metabolites were observed. To corroborate the representation of known biochemical pathways from our data, an inferential pathway analysis strategy was used to map annotated metabolites onto the BioCyc pathway collection. This hypothesis-generating approach resulted in over-representation of many metabolites onto several IRBC pathways, most prominently glycolysis. In addition, components of the "branched" TCA cycle, partial urea cycle, and nucleotide, amino acid, chorismate, sphingolipid and fatty acid metabolism were found to be altered in IRBCs. Interestingly, we detected and confirmed elevated levels for cyclic ADP ribose and phosphoribosyl AMP in IRBCs, a novel observation. These metabolites may play a role in regulating the release of intracellular Ca2+ during P. falciparum infection. Our results support a strategy of global metabolite profiling by untargeted data acquisition. Untargeted and targeted data mining workflows, when used together to perform pathway-inferred metabolomics, have the benefit of obviating MS/MS confirmation for every detected compound.	[Sana, Theodore R.; Gordon, D. Benjamin; Fischer, Steven M.; Tichy, Shane E.; Kitagawa, Norton; Lai, Cindy] Agilent Technol, Life Sci Grp, Santa Clara, CA USA; [Gosnell, William L.; Chang, Sandra P.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA	Agilent Technologies; University of Hawaii System; University of Hawaii Manoa	Chang, SP (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	sandrac@hawaii.edu	Chang, Sandra/HGB-6020-2022		John A. Burns School of Medicine; Department of Defense (DOD) [W81XWH-07-2-0073]; Research Centers in Minority Institutions Program, National Center for Research Resources (NCRR), National Institutes of Health (NIH) [G12RR003061]; Research Centers in Minority Institutions Translational Research Network, National Center for Research Resources (NCRR), National Institutes of Health (NIH) [U54RR022762]; Research Centers in Minority Institutions Multidisciplinary and Translational Research Infrastructure Expansion, National Center for Research Resources (NCRR), National Institutes of Health (NIH) [U54RR026136]; Centers of Biomedical Research Excellence, National Center for Research Resources (NCRR), National Institutes of Health (NIH) [P20RR018727]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR018727, U54RR022762, U54RR026136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008149] Funding Source: NIH RePORTER	John A. Burns School of Medicine; Department of Defense (DOD)(United States Department of Defense); Research Centers in Minority Institutions Program, National Center for Research Resources (NCRR), National Institutes of Health (NIH); Research Centers in Minority Institutions Translational Research Network, National Center for Research Resources (NCRR), National Institutes of Health (NIH); Research Centers in Minority Institutions Multidisciplinary and Translational Research Infrastructure Expansion, National Center for Research Resources (NCRR), National Institutes of Health (NIH); Centers of Biomedical Research Excellence, National Center for Research Resources (NCRR), National Institutes of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported in part by institutional funds from the John A. Burns School of Medicine and grants from the Department of Defense (DOD)(W81XWH-07-2-0073) and the Research Centers in Minority Institutions Program (G12RR003061), Research Centers in Minority Institutions Translational Research Network (U54RR022762), Research Centers in Minority Institutions Multidisciplinary and Translational Research Infrastructure Expansion (U54RR026136), and Centers of Biomedical Research Excellence (P20RR018727), National Center for Research Resources (NCRR), National Institutes of Health (NIH). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official view of NCRR, NIH or DOD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, DRUG RESISTANCE MALA; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bailey VC, 1997, CHEM BIOL, V4, P51, DOI 10.1016/S1074-5521(97)90236-2; Bowen BP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S6; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Canales J, 2009, FEBS LETT, V583, P1593, DOI 10.1016/j.febslet.2009.04.023; CURRIE KPM, 1992, MOL BIOL CELL, V3, P1415, DOI 10.1091/mbc.3.12.1415; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; ELFORD BC, 1985, MOL BIOCHEM PARASIT, V16, P43, DOI 10.1016/0166-6851(85)90048-9; Fiehn O, 2000, ANAL CHEM, V72, P3573, DOI 10.1021/ac991142i; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Friend SH, 2006, CANCER CELL, V10, P349, DOI 10.1016/j.ccr.2006.10.011; GALIONE A, 1992, TRENDS PHARMACOL SCI, V13, P304, DOI 10.1016/0165-6147(92)90096-O; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S; Gowda DC, 1999, PARASITOL TODAY, V15, P147, DOI 10.1016/S0169-4758(99)01412-X; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Jones ML, 2009, MOL BIOCHEM PARASIT, V168, P55, DOI 10.1016/j.molbiopara.2009.06.007; KANAANI J, 1991, J CELL PHYSIOL, V149, P469, DOI 10.1002/jcp.1041490316; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Lakshmanan V, 2012, J INFECT DIS, V206, P238, DOI 10.1093/infdis/jis339; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; OLSZEWSKI KL, 2010, MOL BIOCH PARASITOL; PALMER KL, 1982, J PARASITOL, V68, P1180, DOI 10.2307/3281124; Pesek JJ, 2008, J CHROMATOGR A, V1204, P48, DOI 10.1016/j.chroma.2008.07.077; Pesek JJ, 2009, J SEP SCI, V32, P2200, DOI 10.1002/jssc.200900270; Phyo AP, 2012, LANCET; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; ROTH E, 1990, BLOOD CELLS, V16, P453; ROTH E, 1990, BLOOD CELLS, V16, P466; Sana T, 2010, LC MS METABOLOMICS D; Sana TR, 2008, J CHROMATOGR B, V871, P314, DOI 10.1016/j.jchromb.2008.04.030; Sana TR, 2010, METABOLOMICS, V6, P451, DOI 10.1007/s11306-010-0218-7; Sana Theodore R, 2008, J Biomol Tech, V19, P258; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Technologies A, 2008, AG FIEHN GC MS MET R; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; van Iersel MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304	56	69	69	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60840	10.1371/journal.pone.0060840	http://dx.doi.org/10.1371/journal.pone.0060840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593322	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600057
J	Shipitsyna, E; Roos, A; Datcu, R; Hallen, A; Fredlund, H; Jensen, JS; Engstrand, L; Unemo, M				Shipitsyna, Elena; Roos, Annika; Datcu, Raluca; Hallen, Anders; Fredlund, Hans; Jensen, Jorgen S.; Engstrand, Lars; Unemo, Magnus			Composition of the Vaginal Microbiota in Women of Reproductive Age - Sensitive and Specific Molecular Diagnosis of Bacterial Vaginosis Is Possible?	PLOS ONE			English	Article							REAL-TIME PCR; GARDNERELLA-VAGINALIS; ATOPOBIUM-VAGINAE; GRAM-STAIN; INDEPENDENT ANALYSIS; L.-GASSERI; ASSOCIATION; MICROFLORA; DIVERSITY; INFECTION	Background and Objective: Bacterial vaginosis (BV) is the most common vaginal disorder, characterized by depletion of the normal lactobacillus-dominant microbiota and overgrowth of commensal anaerobic bacteria. This study aimed to investigate the composition of the vaginal microbiota in women of reproductive age (healthy women and women with BV), with the view of developing molecular criteria for BV diagnosis. Materials and Methods: Vaginal samples from 163 women (79 control, 73 BV and 11 intermediate (Lactobacillary grade II flora) cases) were analyzed using 454 pyrosequencing of the hypervariable regions V3-V4 of the 16S rRNA gene and 16 quantitative bacterial species/genus-specific real-time PCR assays. Sensitivities and specificities of potential BV markers were computed using the Amsel criteria as reference standard for BV. The use of quantitative thresholds for prediction of BV, determined for both relative abundance measured with 454 pyrosequencing and bacterial load measured with qPCR, was evaluated. Results: Relative to the healthy women, the BV patients had in their vaginal microbiota significantly higher prevalence, loads and relative abundances of the majority of BV associated bacteria. However, only Gardnerella vaginalis, Atopobium vaginae, Eggerthella, Prevotella, BVAB2 and Megasphaera type 1 detected at or above optimal thresholds were highly predictable for BV, with the best diagnostic accuracy shown for A. vaginae. The depletion of Lactobacillus species combined with the presence of either G. vaginalis or A. vaginae at diagnostic levels was a highly accurate BV predictor. Conclusions: Quantitative determination of the presence of G. vaginalis, A. vaginae, Eggerthella, Prevotella, BVAB2 and Megasphaera type 1 as well as the depletion of Lactobacillus was highly accurate for BV diagnosis. Measurements of abundance of normal and BV microbiota relative to total bacteria in vaginal fluid may provide more accurate BV diagnosis, and be used for test-of-cure, rather than qualitative detection or absolute counts of BV related microorganisms.	[Shipitsyna, Elena] DO Ott Res Inst Obstet & Gynecol, Microbiol Lab, St Petersburg, Russia; [Roos, Annika; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden; [Datcu, Raluca; Jensen, Jorgen S.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Hallen, Anders] Univ Uppsala Hosp, Dept Dermatol & Venereol, Uppsala, Sweden; [Fredlund, Hans; Unemo, Magnus] Orebro Univ Hosp, World Hlth Org, Collaborating Ctr Gonorrhoea & Other Sexually Tra, Swedish Reference Lab Pathogen Neisseria, Orebro, Sweden	Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology; Karolinska Institutet; Statens Serum Institut; Uppsala University; Uppsala University Hospital; Orebro University; World Health Organization	Unemo, M (corresponding author), Orebro Univ Hosp, World Hlth Org, Collaborating Ctr Gonorrhoea & Other Sexually Tra, Swedish Reference Lab Pathogen Neisseria, Orebro, Sweden.	magnus.unemo@orebroll.se	Jensen, Jørgen Skov/H-5159-2019; Unemo, Magnus/ABD-6653-2021; Shipitsyna, Elena/K-1271-2018	Jensen, Jørgen Skov/0000-0002-7464-7435; Shipitsyna, Elena/0000-0002-2309-3604	Soderberg's Foundation; Orebro County Council Research Committee; Foundation for Medical Research at Orebro University Hospital, Sweden	Soderberg's Foundation; Orebro County Council Research Committee; Foundation for Medical Research at Orebro University Hospital, Sweden	This work was supported by general grants from the Soderberg's Foundation, the Orebro County Council Research Committee and the Foundation for Medical Research at Orebro University Hospital, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.060; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Cartwright CP, 2012, J CLIN MICROBIOL, V50, P2321, DOI 10.1128/JCM.00506-12; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; DONDERS GGG, 1999, INFECT DIS OBSTET GY, V7, P12; Donders GGG, 2007, BEST PRACT RES CL OB, V21, P355, DOI 10.1016/j.bpobgyn.2007.01.002; ESCHENBACH DA, 1993, CLIN INFECT DIS, V16, pS282, DOI 10.1093/clinids/16.Supplement_4.S282; Ferris MJ, 2007, J CLIN MICROBIOL, V45, P1016, DOI 10.1128/JCM.02085-06; Fethers K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030633; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Goffinet F, 2003, EUR J OBSTET GYN R B, V108, P146, DOI 10.1016/S0301-2115(02)00423-2; Haggerty CL, 2004, CLIN INFECT DIS, V39, P990, DOI 10.1086/423963; Hillier SL, 1996, AM J OBSTET GYNECOL, V175, P435, DOI 10.1016/S0002-9378(96)70158-8; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Maidak BL, 2000, NUCLEIC ACIDS RES, V28, P173, DOI 10.1093/nar/28.1.173; Menard JP, 2012, EUR J CLIN MICROBIOL, V31, P513, DOI 10.1007/s10096-011-1341-8; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Morris M, 2001, BRIT J OBSTET GYNAEC, V108, P439; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Obata-Yasuoka M, 2002, OBSTET GYNECOL, V100, P759, DOI 10.1016/S0029-7844(02)02201-9; Pavlova SI, 2002, J APPL MICROBIOL, V92, P451, DOI 10.1046/j.1365-2672.2002.01547.x; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rosenstein IJ, 1996, J MED MICROBIOL, V45, P120, DOI 10.1099/00222615-45-2-120; Schwebke J R, 1995, Infect Dis Obstet Gynecol, V3, P119, DOI 10.1155/S1064744995000445; Schwebke JR, 2002, SEX TRANSM DIS, V29, P59, DOI 10.1097/00007435-200201000-00010; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; Shi Y, 2009, J OBSTET GYNAECOL RE, V35, P525, DOI 10.1111/j.1447-0756.2008.00971.x; SILVER HM, 1989, AM J OBSTET GYNECOL, V161, P808, DOI 10.1016/0002-9378(89)90406-7; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Spiegel CA, 2002, REV MED MICROBIOL, V13, P43; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; SWEET RL, 1995, CLIN INFECT DIS, V20, pS271, DOI 10.1093/clinids/20.Supplement_2.S271; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Vasquez A, 2002, J CLIN MICROBIOL, V40, P2746, DOI 10.1128/JCM.40.8.2746-2749.2002; Verhelst R, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-61; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Verstraelen H, 2004, AM J OBSTET GYNECOL, V191, P1130, DOI 10.1016/j.ajog.2004.04.013; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X; Zariffard MR, 2002, FEMS IMMUNOL MED MIC, V34, P277, DOI 10.1111/j.1574-695X.2002.tb00634.x; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zozaya-Hinchliffe M, 2008, APPL ENVIRON MICROB, V74, P1656, DOI 10.1128/AEM.02127-07; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	61	144	165	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60670	10.1371/journal.pone.0060670	http://dx.doi.org/10.1371/journal.pone.0060670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585843	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600034
J	Satija, A; Agrawal, S; Bowen, L; Khandpur, N; Kinra, S; Prabhakaran, D; Reddy, KS; Smith, GD; Ebrahim, S				Satija, Ambika; Agrawal, Sutapa; Bowen, Liza; Khandpur, Neha; Kinra, Sanjay; Prabhakaran, Dorairaj; Reddy, Kolli Srinath; Smith, George Davey; Ebrahim, Shah			Association between Milk and Milk Product Consumption and Anthropometric Measures in Adult Men and Women in India: A Cross-Sectional Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; BODY-MASS INDEX; DAIRY CONSUMPTION; PHYSICAL-ACTIVITY; WEIGHT MAINTENANCE; DIETARY CALCIUM; MENDELIAN RANDOMIZATION; DEVELOPING-COUNTRIES; WAIST CIRCUMFERENCE; ASIAN INDIANS	Background: The nutritional aetiology of obesity remains unclear, especially with regard to the role of dairy products in developing countries. Objective: To examine whether milk/milk product consumption is associated with obesity and high waist circumference among adult Indians. Methods: Information on plain milk, tea, curd and buttermilk/lassi consumption assessed using a Food Frequency Questionnaire was obtained from the cross-sectional sib-pair designed Indian Migration Study (3698 men and 2659 women), conducted at four factory locations across north, central and south India. The anthropometric measures included were Body Mass Index (BMI) and Waist Circumference (WC). Mixed-effect logistic regression models were conducted to accommodate sib-pair design and adjust for potential confounders. Results: After controlling for potential confounders, the risk of being obese (BMI >= 25 kg/m(2)) was lower among women (OR = 0.57; 95% CI: 0.43-0.76; p <= 0.0001) and men (OR = 0.67; 95% CI: 0.51-0.87; p = 0.005), and the risk of a high WC (men:> 90 cm; women: > 80 cm) was lower among men (OR = 0.71; 95% CI: 0.54-0.93; p = 0.005) and women (OR = 0.79; 95%CI: 0.59-1.05; p > 0.05) who consume >= 1 portions of plain milk daily than those who do not consume any milk. The inverse association between daily plain milk consumption and obesity was also confirmed in sibling-pair analyses. Daily tea consumption of >= 1 portion was associated with obesity (OR = 1.51; 95% CI: 1.00-2.25; p > 0.050) and high WC (OR = 1.65; 95% CI: 1.08-2.51; p > 0.019) among men but not among women but there was no strong evidence of association of curd and buttermilk/lassi consumption with obesity and high waist circumference among both men and women. Conclusions: The independent, inverse association of daily plain milk consumption with the risk of being obese suggests that high plain milk intake may lower the risk of obesity in adult Indians. However, this is an observational finding and uncontrolled confounding cannot be excluded as an explanation for the association. Therefore, confirmatory studies are needed to clarify this relationship.	[Satija, Ambika; Khandpur, Neha; Reddy, Kolli Srinath] Publ Hlth Fdn India, New Delhi, India; [Satija, Ambika; Agrawal, Sutapa; Ebrahim, Shah] Publ Hlth Fdn India, South Asia Network Chron Dis, New Delhi, India; [Bowen, Liza; Kinra, Sanjay; Ebrahim, Shah] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Smith, George Davey] Univ Bristol, Bristol, Avon, England	Public Health Foundation of India; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Agrawal, S (corresponding author), Publ Hlth Fdn India, South Asia Network Chron Dis, New Delhi, India.	sutapa.agrawal@phfi.org	Bowen, Liza/AAA-5502-2019; Prabhakaran, Dorairaj/B-4147-2011; Davey Smith, George/A-7407-2013	Prabhakaran, Dorairaj/0000-0002-3172-834X; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Reddy, K Srinath/0000-0003-3416-3548; Bowen, Liza/0000-0001-8318-8421; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Khandpur, Neha/0000-0002-4766-8361	Wellcome Trust [GR070797MF, Z/041825]; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Wellcome Trust project grant GR070797MF. The funder had no role in study design, data collection, analysis, or interpretation, in writing the report, or in the decision to submit the article for publication. The researchers are all independent from the funding source. SA is supported by a Wellcome Trust Strategic Award Grant No Z/041825.	Abbott RD, 1996, STROKE, V27, P813, DOI 10.1161/01.STR.27.5.813; Alonso A, 2005, AM J CLIN NUTR, V82, P972, DOI 10.1093/ajcn/82.5.972; [Anonymous], 2003, DIET NUTR PREV CHRON; Azadbakht L, 2008, PUBLIC HEALTH NUTR, V11, P528, DOI 10.1017/S1368980007000882; Bansal D., 2010, PUBLIC HEALTH NUTR, P1; Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; Bharathi AV, 2010, PUBLIC HEALTH NUTR, V13, P47, DOI 10.1017/S1368980009005850; Bharathi AV, 2000, INDIAN J MED RES, V111, P95; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; Bowen L, 2012, ASIA PAC J CLIN NUTR, V21, P355; Bowen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014822; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Census, 2011, PRIM CENS ABSTR JAMM; *DEP ENV FOOD RUR, 2007, DESKT STUD DEM DAIR; Dougkas A, 2011, NUTR RES REV, V24, P72, DOI 10.1017/S095442241000034X; Drapeau V, 2004, AM J CLIN NUTR, V80, P29; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Elwood PC, 2005, INT J EPIDEMIOL, V34, P1160, DOI 10.1093/ije/dyi136; Ensminger A., 1986, FOOD HLTH NUTR ENCY; FAO, FAOSTAT FOOD BAL SHE; Harvey-Berino J, 2005, OBES RES, V13, P1720, DOI 10.1038/oby.2005.210; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heaney RP, 2002, J AM COLL NUTR, V21, p152S, DOI 10.1080/07315724.2002.10719213; Hebert JR, 1999, PUBLIC HEALTH NUTR, V2, P39, DOI 10.1017/S1368980099000051; Hebert JR, 1998, PUBLIC HEALTH NUTR, V1, P123, DOI 10.1079/PHN19980019; Hebert JR, 2000, EUR J CLIN NUTR, V54, P479, DOI 10.1038/sj.ejcn.1601042; Hoppe C, 2006, ANNU REV NUTR, V26, P131, DOI 10.1146/annurev.nutr.26.010506.103757; Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Indian Consensus Group, 1996, J NUTR ENV MED, V6, P309, DOI DOI 10.3109/13590849609007257; Kinra S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4974; Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061; Kumar S., 2009, POSITION STATEMENT D; Laaksonen MML, 2009, BRIT J NUTR, V102, P8, DOI 10.1017/S0007114508184677; Lahti-Koski M, 2002, AM J CLIN NUTR, V75, P809, DOI 10.1093/ajcn/75.5.809; Marchioni DML, 2007, CAD SAUDE PUBLICA, V23, P2187, DOI 10.1590/S0102-311X2007000900026; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; Malik VS, 2011, AM J CLIN NUTR, V94, P854, DOI 10.3945/ajcn.110.009621; Ministry of Statistics and Programme Implementation Government of India, 2012, 54166103 NSS NSO MIN; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Misra A, 2009, J Assoc Physicians India, V57, P163; National Sample Survey Organisation, 2007, NUTR INT IND 2004 20; Ness AR, 2001, J EPIDEMIOL COMMUN H, V55, P379, DOI 10.1136/jech.55.6.379; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Olivares S, 2004, EUR J CLIN NUTR, V58, P1278, DOI 10.1038/sj.ejcn.1601962; Pandey D, 2005, NATL MED J INDIA, V18, P230; Parr CL, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-4; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Phillips SM, 2003, INT J OBESITY, V27, P1106, DOI 10.1038/sj.ijo.0802370; PINGALI P, 2004, 17 ANN C IND SOC AGR; Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559; Reddy KS, 2006, B WORLD HEALTH ORGAN, V84, P461, DOI 10.2471/BLT.05.027037; Reddy KS, 1998, CIRCULATION, V97, P596; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Rosell M, 2006, AM J CLIN NUTR, V84, P1481, DOI 10.1093/ajcn/84.6.1481; Satija A, 2012, NATL MED J INDIA, V25, P10; SHAPER AG, 1991, BMJ-BRIT MED J, V302, P786; Shi LL, 2011, J EPIDEMIOL COMMUN H, V65, pA16, DOI 10.1136/jech.2011.142976a.38; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2009, EUR J HUM GENET, V17, P357, DOI 10.1038/ejhg.2008.156; Snijder MB, 2008, OBESITY, V16, P706, DOI 10.1038/oby.2007.93; Snijder MB, 2007, AM J CLIN NUTR, V85, P989, DOI 10.1093/ajcn/85.4.989; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Sudha V, 2006, INT J FOOD SCI NUTR, V57, P481, DOI 10.1080/09637480600969220; Taylor AE, 2011, J OBES, V2011, DOI 10.1155/2011/307542; Timpson NJ, 2010, CANCER EPIDEM BIOMAR, V19, P1341, DOI 10.1158/1055-9965.EPI-09-1019; Tremblay A, 2009, J AM COLL NUTR, V28, p91S, DOI 10.1080/07315724.2009.10719809; Vergnaud AC, 2008, AM J CLIN NUTR, V88, P1248, DOI 10.3945/ajcn.2007.25151; Vernarelli JA, 2012, EUR J NUTR; Wang Y, 2008, FOOD NUTR BULL, V29, P172, DOI 10.1177/156482650802900303; WHO, 2010, WHO GLOB INF DAT SAV; WHO, WHO INF; Wiley AS, 2011, FOOD FOODWAYS, V19, P11, DOI 10.1080/07409710.2011.544159; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67; Zemel MB, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-28	86	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60739	10.1371/journal.pone.0060739	http://dx.doi.org/10.1371/journal.pone.0060739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593300	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000317898000057
J	Wang, J; Yang, YG; Zhou, M; Xu, JY; Zhang, QG; Zhou, RF; Chen, B; Ouyang, J				Wang, Jing; Yang, Yong-Gong; Zhou, Min; Xu, Jing-Yan; Zhang, Qi-Guo; Zhou, Rong-Fu; Chen, Bing; Ouyang, Jian			Meta-Analysis of Randomised Clinical Trials Comparing Idarubicin plus Cytarabine with Daunorubicin plus Cytarabine as the Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukaemia	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; 1ST COMPLETE REMISSION; HIGH-DOSE DAUNORUBICIN; PUBLICATION BIAS; ADULT PATIENTS; THERAPY; MULTICENTER; COMBINATION; RECOMMENDATIONS; FLUDARABINE	Background: To determine whether the use of idarubicin+cytarabine (IA) is more effective than the use of daunorubicin+cytarabine (DA) as induction chemotherapy for patients with newly diagnosed acute myeloid leukaemia. Methods: A computer-based search was performed. Randomised trials comparing IA with DA as induction therapy for newly diagnosed AML were included in this meta-analysis. The primary outcome of interest for our analysis was survival (disease-free survival, event-free survival and overall survival); the secondary endpoint was complete remission. Results: Ten trials with 4,060 patients were eligible for this meta-analysis. Our pooled results suggest that IA is associated with a significant advantage in CR (RR = 1.23; 95% CI = 1.07-1.41, p = 0.004), EFS (HR = 0.64; 95% CI = 0.45-0.91, p = 0.013), and OS (HR = 0.88; 95% CI = 0.81-0.95, p = 0.02) but not in DFS (HR = 0.90; 95% CI = 0.80-1.00, p = 0.06). In the subgroup analysis, age had a significant interaction with OS and CR benefits. Conclusion: Our analysis indicated that IA could improve the duration of overall survival compared to DA as induction therapy for young patients with newly diagnosed AML. Further study is needed to determine whether IA can produce clinical benefits in selected genetic or molecular subgroups of young AML patients.	[Wang, Jing; Yang, Yong-Gong; Zhou, Min; Xu, Jing-Yan; Zhang, Qi-Guo; Zhou, Rong-Fu; Chen, Bing; Ouyang, Jian] Nanjing Univ, Dept Hematol, Affiliated DrumTower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Ouyang, J (corresponding author), Nanjing Univ, Dept Hematol, Affiliated DrumTower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	ouyang211@hotmail.com	zhou, rongfu/L-1743-2016	zhou, rongfu/0000-0002-3217-9194; Yang, Yonggong/0000-0002-6475-2696; Wang, Jing/0000-0001-9981-5530				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BEGG CB, 1988, J ROY STAT SOC A STA, V151, P419, DOI 10.2307/2982993; BERLIN JA, 1989, STAT MED, V8, P141, DOI 10.1002/sim.4780080202; BERMAN E, 1991, BLOOD, V77, P1666; Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Candoni A, 2008, LEUKEMIA RES, V32, P1800, DOI 10.1016/j.leukres.2008.05.011; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Chevallier P, 2010, LEUKEMIA, V24, P1380, DOI 10.1038/leu.2010.111; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Creutzig U, 2001, LEUKEMIA, V15, P348, DOI 10.1038/sj.leu.2402046; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Ferrara F, 2008, CRIT REV ONCOL HEMAT, V66, P181, DOI 10.1016/j.critrevonc.2007.09.008; Gardin C, 2007, BLOOD, V109, P5129, DOI 10.1182/blood-2007-02-069666; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P783, DOI 10.1093/oxfordjournals.aje.a117326; Holowiecki J, 2004, LEUKEMIA, V18, P989, DOI 10.1038/sj.leu.2403336; Holowiecki J, 2012, J CLIN ONCOL, V30, P2441, DOI 10.1200/JCO.2011.37.1286; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lee JH, 2011, BLOOD, V118, P3832, DOI 10.1182/blood-2011-06-361410; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liddle J., 1996, METHOD EVALUATING RE; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; MANDELLI F, 1991, EUR J CANCER, V27, P750, DOI 10.1016/0277-5379(91)90181-C; Mandelli F, 2009, J CLIN ONCOL, V27, P5397, DOI 10.1200/JCO.2008.20.6490; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ohtake S, 2011, BLOOD, V117, P2358, DOI 10.1182/blood-2010-03-273243; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pautas C, 2010, J CLIN ONCOL, V28, P808, DOI 10.1200/JCO.2009.23.2652; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Poole C, 1999, AM J EPIDEMIOL, V150, P469, DOI 10.1093/oxfordjournals.aje.a010035; Reiffers J, 1996, LEUKEMIA, V10, P389; Roboz GJ, 2011, HEMATOL-AM SOC HEMAT, P43, DOI 10.1182/asheducation-2011.1.43; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Rowe JM, 1997, BLOOD, V90, P2121; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; VOGLER WR, 1992, J CLIN ONCOL, V10, P1103, DOI 10.1200/JCO.1992.10.7.1103; Wheatley D, 1998, BRIT J HAEMATOL, V103, P100; WIERNIK PH, 1992, BLOOD, V79, P313	43	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60699	10.1371/journal.pone.0060699	http://dx.doi.org/10.1371/journal.pone.0060699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23593285	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800092
J	Reeske, A; Spallek, J; Bammann, K; Eiben, G; De Henauw, S; Kourides, Y; Nagy, P; Ahrens, W				Reeske, Anna; Spallek, Jacob; Bammann, Karin; Eiben, Gabriele; De Henauw, Stefaan; Kourides, Yiannis; Nagy, Peter; Ahrens, Wolfgang			Migrant Background and Weight Gain in Early Infancy: Results from the German Study Sample of the IDEFICS Study	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; ETHNIC-DIFFERENCES; FEEDING PRACTICES; HEALTH INTERVIEW; BIRTH-WEIGHT; CHILDREN; OBESITY; OVERWEIGHT; CHILDHOOD	Objective: To examine variations in infant weight gain between children of parents with and without migrant background and to investigate how these differences are explained by pre- and perinatal factors. Methods: We used data on birth weight and weight at six months from well-child check-up books that were collected from a population-based German sample of children in the IDEFICS study (n = 1,287). We calculated unadjusted and adjusted means for weight z-scores at birth and six months later. We applied linear regression for change in weight z-score and we calculated odds ratios and 95% confidence intervals (95% CI) for rapid weight gain by logistic regression, adjusted for biological, social and behavioural factors. Results: Weight z-scores for migrants and Germans differed slightly at birth, but were markedly increased for Turkish and Eastern European infants at age six months. Turkish infants showed the highest change in weight z-score during the first 6 months (beta = 0.35; 95% CI 0.14-0.56) and an increased probability of rapid weight gain compared with German infants. Examination of the joint effect of migrant and socioeconomic status (SES) showed the greatest change in weight z-scores in Turkish infants from middle SES families (beta = 0.77; 95% CI 0.40-1.14) and infants of parents from Eastern European countries with high SES (beta = 0.72; 95% CI 0.13-1.32). Conclusions: Our results support the hypothesis that migrant background is an independent risk factor for infant weight gain and suggest that the onset of health inequalities in overweight starts in early infancy.	[Reeske, Anna; Spallek, Jacob; Bammann, Karin; Ahrens, Wolfgang] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Spallek, Jacob] Univ Bielefeld, Sch Publ Hlth, Dept Epidemiol & Int Publ Hlth, D-33615 Bielefeld, Germany; [Bammann, Karin] Univ Bremen, Inst Publ Hlth & Nursing Res, D-28359 Bremen, Germany; [Eiben, Gabriele] Univ Gothenburg, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [De Henauw, Stefaan] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Kourides, Yiannis] Res & Educ Inst Child Hlth, Strovolos, Cyprus; [Nagy, Peter] Univ Pecs, Dept Pediat, Pecs, Hungary; [Ahrens, Wolfgang] Univ Bremen, Inst Stat, D-28359 Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bielefeld; University of Bremen; University of Gothenburg; Ghent University; University of Pecs; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen	Ahrens, W (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	ahrens@bips.uni-bremen.de	Spallek, Jacob/G-6200-2016; Ahrens, Wolfgang/A-2740-2012	Ahrens, Wolfgang/0000-0003-3777-570X; Bammann, Karin/0000-0002-5623-8160	European Community within the Sixth RTD Framework Programme [016181 (FOOD)]	European Community within the Sixth RTD Framework Programme	This work was done as part of the IDEFICS Study (www.idefics.eu). The authors gratefully acknowledge the financial support of the European Community within the Sixth RTD Framework Programme Contract No. 016181 (FOOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; Alikasifoglu M, 2001, J Hum Lact, V17, P220, DOI 10.1177/089033440101700305; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Bammann K, 2013, PEDIATR OBES, V8, P1, DOI 10.1111/j.2047-6310.2012.00075.x; Bammann K, 2006, J PUBLIC HEALTH-HEID, V14, P279, DOI 10.1007/s10389-006-0058-0; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bulk-Bunschoten AMW, 2002, PAEDIATR PERINAT EP, V16, P361, DOI 10.1046/j.1365-3016.2002.00440.x; Bulk-Bunschoten AMW, 2008, J HUM LACT, V24, P42, DOI 10.1177/0890334407311338; de Hoog MLA, 2011, BRIT J NUTR, V106, P1592, DOI 10.1017/S0007114511002327; de Hoog MLA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-611; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Deierlein AL, 2012, PEDIATR OBES, V7, P134, DOI 10.1111/j.2047-6310.2011.00025.x; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Garnett SP, 2001, INT J OBESITY, V25, P1667, DOI 10.1038/sj.ijo.0801821; Gillmann MW, 2005, LIFE COURSE APPROACH, P189; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; HERNGREEN WP, 1994, ANN HUM BIOL, V21, P449, DOI 10.1080/03014469400003472; Hof MHP, 2011, ANN HUM BIOL, V38, P544, DOI 10.3109/03014460.2011.576701; Hunsberger M, 2013, PUBLIC HEALTH NUTR, V16, P219, DOI 10.1017/S1368980012003850; Kelly Y, 2009, J PUBLIC HEALTH-UK, V31, P131, DOI 10.1093/pubmed/fdn057; Kelly YJ, 2006, PEDIATRICS, V118, pE1428, DOI 10.1542/peds.2006-0714; Kumar BN, 2006, INT J OBESITY, V30, P684, DOI 10.1038/sj.ijo.0803051; Lange C, 2007, BUNDESGESUNDHEITSBLA, V50, P624, DOI 10.1007/s00103-007-0223-9; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mesman I, 2009, ARCH DIS CHILD, V94, P587, DOI 10.1136/adc.2008.137737; Nazroo J. Y., 2006, SOCIAL DETERMINANTS, P238; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Pan H., 2011, LMSCHARTMAKER PROVER; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Reeske A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-63; Robert Koch Institute, 2008, KIGGS 2003 2006 CHIL; Robert Koch Institute, 2008, LEB GES KIND JUG DEU, P14; Savitz DA, 2011, ANN EPIDEMIOL, V21, P78, DOI 10.1016/j.annepidem.2010.06.009; Saxena S, 2004, ARCH DIS CHILD, V89, P30; Schenk L, 2007, BUNDESGESUNDHEITSBLA, V50, P590, DOI 10.1007/s00103-007-0220-z; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; SMITH GD, 1992, BRIT MED J, V305, P757, DOI 10.1136/bmj.305.6856.757; Smith GD, 2000, AM J PUBLIC HEALTH, V90, P1694, DOI 10.2105/AJPH.90.11.1694; Spallek J, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-6; Taveras EM, 2010, PEDIATRICS, V125, P686, DOI 10.1542/peds.2009-2100; Troe EJWM, 2007, BJOG-INT J OBSTET GY, V114, P1557, DOI 10.1111/j.1471-0528.2007.01508.x; UNESCO, 2006, INT STAND CLASS ED I; van Rossem L, 2010, J EPIDEMIOL COMMUN H, V64, P1080, DOI 10.1136/jech.2009.095380; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Waters E, 2008, INT J PEDIATR OBES, V3, P196, DOI 10.1080/17477160802141846; Wijlaars LPMM, 2011, INT J OBESITY, V35, P963, DOI 10.1038/ijo.2011.88; Winkler J., 1998, MESSUNG SOZIODEMOGRA, P69	49	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60648	10.1371/journal.pone.0060648	http://dx.doi.org/10.1371/journal.pone.0060648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593270	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100061
J	Yang, RM; Li, L; Wei, XH; Guo, YM; Huang, YH; Lai, LS; Chen, AM; Liu, GS; Xiong, WF; Luo, LP; Jiang, XQ				Yang, Rui-Meng; Li, Long; Wei, Xin-Hua; Guo, Yong-Mei; Huang, Yun-Hai; Lai, Li-Sha; Chen, A-Mei; Liu, Guo-Shun; Xiong, Wei-Feng; Luo, Liang-Ping; Jiang, Xin-Qing			Differentiation of Central Lung Cancer from Atelectasis: Comparison of Diffusion-Weighted MRI with PET/CT	PLOS ONE			English	Article							POSTOBSTRUCTIVE LOBAR COLLAPSE; BRONCHOGENIC-CARCINOMA; TUMOR-DETECTION; NECK LESIONS; BODY; TISSUE; HEAD	Objective: Prospectively assess the performance of diffusion-weighted magnetic resonance imaging (DW-MRI) for differentiation of central lung cancer from atelectasis. Materials and Methods: 38 consecutive lung cancer patients (26 males, 12 females; age range: 28-71 years; mean age: 49 years) who were referred for thoracic MR imaging examinations were enrolled. MR examinations were performed using a 1.5-T clinical scanner and scanning sequences of T1WI, T2WI, and DWI. Cancers and atelectasis were measured by mapping of the apparent diffusion coefficients (ADCs) obtained with a b-value of 500 s/mm(2). Results: PET/CT and DW-MR allowed differentiation of tumor and atelectasis in all 38 cases, but T2WI did not allow differentiation in 9 cases. Comparison of conventional T2WI and DW-MRI indicated a higher contrast noise ratio of the central lung carcinoma than the atelectasis by DW-MRI. ADC maps indicated significantly lower mean ADC in the central lung carcinoma than in the atelectasis (1.83 +/- 0.58 vs. 2.90 +/- 0.26 mm(2)/s, p<0.0001). ADC values of small cell lung carcinoma were significantly greater than those from squamous cell carcinoma and adenocarcinoma (p<0.0001 for both). Conclusions: DW-MR imaging provides valuable information not obtained by conventional MR and may be useful for differentiation of central lung carcinoma from atelectasis. Future developments may allow DW-MR imaging to be used as an alternative to PET-CT in imaging of patients with lung cancer.	[Yang, Rui-Meng; Wei, Xin-Hua; Guo, Yong-Mei; Huang, Yun-Hai; Lai, Li-Sha; Chen, A-Mei; Liu, Guo-Shun; Xiong, Wei-Feng; Jiang, Xin-Qing] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Li, Long] Chinese Peoples Armed Police, Guangdong Prov Corps Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Luo, Liang-Ping] Jinan Univ, Clin Med Coll 1, Dept Radiol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Jinan University	Luo, LP (corresponding author), Jinan Univ, Clin Med Coll 1, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	tluop@jnu.edu.cn; jxqv@qq.com	; yang, karen/A-4677-2019	luo, liangping/0000-0002-7312-5782; yang, karen/0000-0002-6065-6197; LI, Long/0000-0002-1342-860X; Jiang, Xinqing/0000-0003-0773-523X	National Natural Science Foundation of China [81201087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by the National Natural Science Foundation of China (number 81201087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baysal T, 2009, MAGN RESON IMAGING, V27, P1447, DOI 10.1016/j.mri.2009.05.024; BOURGOUIN PM, 1991, J THORAC IMAG, V6, P22, DOI 10.1097/00005382-199104000-00006; Chen W, 2010, MAGN RESON IMAGING, V28, P613, DOI 10.1016/j.mri.2010.02.009; Cho A, 2011, EUR RADIOL, V21, P1077, DOI 10.1007/s00330-010-2006-1; Henzler T, 2010, EUR J RADIOL, V76, P329, DOI 10.1016/j.ejrad.2010.05.005; Herneth AM, 2003, EUR J RADIOL, V45, P208, DOI 10.1016/S0720-048X(02)00310-8; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Koh Dow-Mu, 2007, Magn Reson Med Sci, V6, P211, DOI 10.2463/mrms.6.211; Komori T, 2007, ANN NUCL MED, V21, P209, DOI 10.1007/s12149-007-0010-6; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Maheshwari S, 2002, AM J NEURORADIOL, V23, P847; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; Naganawa S, 2005, J MAGN RESON IMAGING, V21, P836, DOI 10.1002/jmri.20346; Ohno Y, 2008, RADIOLOGY, V248, P643, DOI 10.1148/radiol.2482072039; ONITSUKA H, 1991, J THORAC IMAG, V6, P28, DOI 10.1097/00005382-199104000-00007; Qi LP, 2009, EUR RADIOL, V19, P333, DOI 10.1007/s00330-008-1134-3; Sakamoto J, 2009, EUR J RADIOL, V69, P260, DOI 10.1016/j.ejrad.2007.10.008; SHIOYA S, 1988, RADIOLOGY, V167, P105, DOI 10.1148/radiology.167.1.3347709; TOBLER J, 1987, INVEST RADIOL, V22, P538, DOI 10.1097/00004424-198707000-00002; Unal O, 2011, EUR J RADIOL, V77, P490, DOI 10.1016/j.ejrad.2009.08.025; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Wang JC, 2001, RADIOLOGY, V220, P621, DOI 10.1148/radiol.2202010063	22	31	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60279	10.1371/journal.pone.0060279	http://dx.doi.org/10.1371/journal.pone.0060279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593186	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100028
J	Soberg, K; Jahnsen, T; Rognes, T; Skalhegg, BS; Laerdahl, JK				Soberg, Kristoffer; Jahnsen, Tore; Rognes, Torbjorn; Skalhegg, Bjorn S.; Laerdahl, Jon K.			Evolutionary Paths of the cAMP-Dependent Protein Kinase (PKA) Catalytic Subunits	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RI-ALPHA SUBUNITS; C-GAMMA; SPLICE VARIANTS; CYCLIC-AMP; DIFFERENTIAL EXPRESSION; PHYLOGENETIC TREES; GENOME DUPLICATION; CRYSTAL-STRUCTURE; KAKS-CALCULATOR	3',5'-cyclic adenosine monophosphate (cAMP) dependent protein kinase or protein kinase A (PKA) has served as a prototype for the large family of protein kinases that are crucially important for signal transduction in eukaryotic cells. The PKA catalytic subunits C alpha and C beta, encoded by the two genes PRKACA and PRKACB, respectively, are among the best understood and characterized human kinases. Here we have studied the evolution of this gene family in chordates, arthropods, mollusks and other animals employing probabilistic methods and show that C alpha and C beta arose by duplication of an ancestral PKA catalytic subunit in a common ancestor of vertebrates. The two genes have subsequently been duplicated in teleost fishes. The evolution of the PRKACG retroposon in simians was also investigated. Although the degree of sequence conservation in the PKA C alpha/C beta kinase family is exceptionally high, a small set of signature residues defining C alpha and C beta subfamilies were identified. These conserved residues might be important for functions that are unique to the C alpha or C beta clades. This study also provides a good example of a seemingly simple phylogenetic problem which, due to a very high degree of sequence conservation and corresponding weak phylogenetic signals, combined with problematic nonphylogenetic signals, is nontrivial for state-of-the-art probabilistic phylogenetic methods.	[Soberg, Kristoffer; Skalhegg, Bjorn S.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Soberg, Kristoffer; Jahnsen, Tore] Univ Oslo, Dept Biochem, Inst Basic Med Sci, Oslo 3, Norway; [Rognes, Torbjorn] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Rognes, Torbjorn; Laerdahl, Jon K.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Microbiol,CMBN, N-0027 Oslo, Norway; [Laerdahl, Jon K.] Univ Oslo, Dept Informat, Bioinformat Core Facil, N-0316 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Laerdahl, JK (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Microbiol,CMBN, N-0027 Oslo, Norway.	j.k.lardahl@medisin.uio.no	Rognes, Torbjørn/A-9692-2008; Skålhegg, Bjørn Steen/AAZ-2976-2021	Rognes, Torbjørn/0000-0002-9329-9974; Skålhegg, Bjørn Steen/0000-0002-3481-8084; Laerdahl, Jon Kristen/0000-0002-0826-9464	Research Council of Norway	Research Council of Norway(Research Council of Norway)	The project was funded by the Research Council of Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anand GS, 2010, MOL CELL PROTEOMICS, V9, P2225, DOI 10.1074/mcp.M900388-MCP200; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Badrinarayan P, 2011, J CHEM INF MODEL, V51, P115, DOI 10.1021/ci100340w; BEEBE SJ, 1992, J BIOL CHEM, V267, P25505; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; Breitenlechner C, 2004, BIOCHEMISTRY-US, V43, P7743, DOI 10.1021/bi0362525; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; CORBIN JD, 1975, J BIOL CHEM, V250, P218; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Desseyn JL, 2000, P NATL ACAD SCI USA, V97, P6433, DOI 10.1073/pnas.97.12.6433; DOSKELAND SO, 1981, INT J BIOCHEM, V13, P1, DOI 10.1016/0020-711X(81)90131-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, INFERRING PHYLOGENIE; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Funderud Ane, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-20; Gesellchen F, 2006, BBA-PROTEINS PROTEOM, V1764, P1788, DOI 10.1016/j.bbapap.2006.10.001; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Khavrutskii IV, 2009, BIOCHEMISTRY-US, V48, P11532, DOI 10.1021/bi901475g; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Kvissel AK, 2004, CELL SIGNAL, V16, P577, DOI 10.1016/j.cellsig.2003.08.014; Larsen ACV, 2008, FEBS J, V275, P250, DOI 10.1111/j.1742-4658.2007.06195.x; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Orstavik S, 2001, EUR J BIOCHEM, V268, P5066, DOI 10.1046/j.0014-2956.2001.02429.x; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Reinton N, 2000, BIOL REPROD, V63, P607, DOI 10.1095/biolreprod63.2.607; Reinton N, 1998, GENOMICS, V49, P290, DOI 10.1006/geno.1998.5240; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; San Agustin JT, 1998, J BIOL CHEM, V273, P24874, DOI 10.1074/jbc.273.38.24874; San Agustin JT, 2001, BIOL REPROD, V65, P151, DOI 10.1095/biolreprod65.1.151; Savolainen P, 2005, CYTOGENET GENOME RES, V111, P79, DOI 10.1159/000085674; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Schiebel K, 1997, HUM MOL GENET, V6, P1985, DOI 10.1093/hmg/6.11.1985; Seifert MHJ, 2002, BIOCHEMISTRY-US, V41, P5968, DOI 10.1021/bi025509g; SHOWERS MO, 1988, METHOD ENZYMOL, V159, P311; Sjoberg TJ, 2010, PROTEIN SCI, V19, P1213, DOI 10.1002/pro.400; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tasken K, 1997, ADV SEC MESS PHOSPH, V31, P191; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Thompson EE, 2009, PROTEIN SCI, V18, P2016, DOI 10.1002/pro.209; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; UHLER MD, 1986, J BIOL CHEM, V261, P5360; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang L, 2001, P NATL ACAD SCI USA, V98, P3220, DOI 10.1073/pnas.051633398; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; WIEMANN S, 1991, J BIOL CHEM, V266, P5140; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Zhang WQ, 2004, PROTEIN EXPRES PURIF, V35, P156, DOI 10.1016/j.pep.2004.01.006; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zimmermann B, 1999, J BIOL CHEM, V274, P5370, DOI 10.1074/jbc.274.9.5370	90	34	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60935	10.1371/journal.pone.0060935	http://dx.doi.org/10.1371/journal.pone.0060935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593352	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300036
J	Ribeiro, S; Berge, T; Lundholm, N; Ellegaard, M				Ribeiro, Sofia; Berge, Terje; Lundholm, Nina; Ellegaard, Marianne			Hundred Years of Environmental Change and Phytoplankton Ecophysiological Variability Archived in Coastal Sediments	PLOS ONE			English	Article							DINOFLAGELLATE CYSTS; KOLJO-FJORD; GENETIC DIFFERENTIATION; MARINE-PHYTOPLANKTON; EMILIANIA-HUXLEYI; GROWTH; PH; PATTERNS; DIATOM; CALCIFICATION	Marine protist species have been used for several decades as environmental indicators under the assumption that their ecological requirements have remained more or less stable through time. However, a growing body of evidence suggests that marine protists, including several phytoplankton species, are in fact highly diverse and may quickly respond to changes in the environment. Predicting how future climate will impact phytoplankton populations is important, but this task has been challenged by a lack of time-series of ecophysiological parameters at time-scales relevant for climate studies (i.e. at least decadal). Here, we report on ecophysiological variability in a marine dinoflagellate over a 100-year period of well-documented environmental change, by using the sedimentary archive of living cysts from a Scandinavian fjord (Koljo Fjord, Sweden). During the past century, Koljo Fjord has experienced important changes in salinity linked to the North Atlantic Oscillation (NAO). We revived resting cysts of Pentapharsodinium dalei preserved in the fjord sediments and determined growth rates for 18 strains obtained from 3 sediment core layers at salinity 15 and 30, which represent extreme sea-surface conditions during periods of predominantly negative and positive NAO phases, respectively. Upper pH tolerance limits for growth were also tested. In general, P. dalei grew at a higher rate in salinity 30 than 15 for all layers, but there were significant differences among strains. When accounting for inter-strain variability, cyst age had no effect on growth performance or upper pH tolerance limits for this species, indicating a stable growth response over the 100-year period in spite of environmental fluctuations. Our findings give some support for the use of morphospecies in environmental studies, particularly at decadal to century scales. Furthermore, the high intra-specific variability found down to sediment layers dated as ca. 50 years-old indicates that cyst-beds of P. dalei are repositories of ecophysiological diversity.	[Ribeiro, Sofia; Ellegaard, Marianne] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark; [Berge, Terje] Univ Copenhagen, Marine Biol Sect, Dept Biol, Helsingor, Denmark; [Lundholm, Nina] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Ribeiro, S (corresponding author), Geol Survey Denmark & Greenland, Dept Marine Geol & Glaciol, Copenhagen, Denmark.	sri@geus.dk	Ribeiro, Sofia/AAZ-2782-2021; Lundholm, Nina/A-4856-2013; Lundholm, Nina/AAY-6249-2020; Ellegaard, Marianne/H-6748-2014; Ribeiro, Sofia/G-9213-2018	Ribeiro, Sofia/0000-0003-0672-9161; Lundholm, Nina/0000-0002-2035-1997; Lundholm, Nina/0000-0002-2035-1997; Ellegaard, Marianne/0000-0002-6032-3376; Ribeiro, Sofia/0000-0003-0672-9161	Danish Research Council project [2111-04-0011]; Gotheburg Marine Research Centre in Sweden; Carlsberg Foundation, Denmark [2001_01_0337]	Danish Research Council project; Gotheburg Marine Research Centre in Sweden; Carlsberg Foundation, Denmark(Carlsberg Foundation)	This study was funded by the Danish Research Council project 2111-04-0011. The authors would like to thank Dr. Anna Godhe and Dr. Karolina Harnstrom, Gothenburg University and the Gotheburg Marine Research Centre in Sweden (grant to AG) for organising and sponsoring the fieldwork in Koljo Fjord. The funders had no role in the design of this study, data collection and analysis, decision to publish, or preparation of the manuscript. The first author holds a postdoctoral fellowship from the Carlsberg Foundation, Denmark (2001_01_0337).	Alpermann TJ, 2010, J PHYCOL, V46, P18, DOI 10.1111/j.1529-8817.2009.00767.x; Appleby PG, 2001, TRACKING ENV CHANGE, V1, P117; Bachvaroff TR, 2009, J PHYCOL, V45, P137, DOI 10.1111/j.1529-8817.2008.00629.x; Berge T, 2012, HARMFUL ALGAE, V20, P101, DOI 10.1016/j.hal.2012.08.006; Berge T, 2010, MAR ECOL PROG SER, V416, P79, DOI 10.3354/meps08780; Bjork G, 2000, ESTUARIES, V23, P367, DOI 10.2307/1353329; Bolch CJS, 1997, PHYCOLOGIA, V36, P472, DOI 10.2216/i0031-8884-36-6-472.1; BRAND LE, 1982, LIMNOL OCEANOGR, V27, P236, DOI 10.4319/lo.1982.27.2.0236; DALE B, 1977, BRIT PHYCOL J, V12, P241, DOI 10.1080/00071617700650261; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Filipsson HL, 2004, J FORAMIN RES, V34, P277, DOI 10.2113/34.4.277; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; GOLDMAN JC, 1973, SCIENCE, V182, P306, DOI 10.1126/science.182.4109.306; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hairston NG, 2008, INT REV HYDROBIOL, V93, P578, DOI 10.1002/iroh.200811057; HAIRSTON NG, 1988, NATURE, V336, P239, DOI 10.1038/336239a0; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; Hansen PJ, 2007, MAR ECOL PROG SER, V334, P63, DOI 10.3354/meps334063; Hansen PJ, 2002, AQUAT MICROB ECOL, V28, P279, DOI 10.3354/ame028279; Harland R, 2004, REV PALAEOBOT PALYNO, V128, P119, DOI 10.1016/S0034-6667(03)00116-7; Harland R, 2004, REV PALAEOBOT PALYNO, V128, P107, DOI 10.1016/S0034-6667(03)00115-5; Hinga KR, 2002, MAR ECOL PROG SER, V238, P281, DOI 10.3354/meps238281; Howe JA, 2010, GEOL SOC SPEC PUBL, V344, P61, DOI 10.1144/SP344.6; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kremp A, 2012, ECOL EVOL, V2, P1195, DOI 10.1002/ece3.245; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Larsen NH, 1994, TL MEDIUM SCANDINAVI; Limburg PA, 2002, P ROY SOC B-BIOL SCI, V269, P281, DOI 10.1098/rspb.2001.1868; Loret P, 2002, J PLANKTON RES, V24, P735, DOI 10.1093/plankt/24.7.735; Lundholm N, 2004, MAR ECOL PROG SER, V273, P1, DOI 10.3354/meps273001; Lundholm N, 2011, PHYCOLOGIA, V50, P629, DOI 10.2216/11-16.1; Nordberg K, 2001, J SEA RES, V46, P187, DOI 10.1016/S1385-1101(01)00084-3; R Development Core Team, 2012, R LANG ENV STAT COMP; Ribeiro S, 2012, BOREAS, V41, P68, DOI 10.1111/j.1502-3885.2011.00216.x; Ribeiro S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1314; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; ROCHON A, 1999, AM ASS STRATIGRAPHIC, V35, P152; Roger F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045007; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Shankle AM, 2004, J PHYCOL, V40, P239, DOI 10.1111/j.1529-8817.2004.03021.x; SODERSTROM J, 1971, BOT MAR, V14, P39, DOI 10.1515/botm.1971.14.1.39; Zonneveld K, REV PALAEOB IN PRESS	46	25	25	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61184	10.1371/journal.pone.0061184	http://dx.doi.org/10.1371/journal.pone.0061184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593424	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200045
J	Watanabe, S; Kawamura, M; Odahara, Y; Anai, Y; Ochi, H; Nakagawa, S; Endo, Y; Tsujimoto, H; Nishigaki, K				Watanabe, Shinya; Kawamura, Maki; Odahara, Yuka; Anai, Yukari; Ochi, Haruyo; Nakagawa, So; Endo, Yasuyuki; Tsujimoto, Hajime; Nishigaki, Kazuo			Phylogenetic and Structural Diversity in the Feline Leukemia Virus Env Gene	PLOS ONE			English	Article							LONG TERMINAL REPEAT; MULTIPLE SEQUENCE ALIGNMENT; CELL-SURFACE RECEPTOR; NUCLEOTIDE-SEQUENCES; ENVELOPE GENES; SUBGROUP-C; IMMUNODEFICIENCY DISEASE; MOLECULAR-CLONING; CLUSTAL-W; PROTEIN	Feline leukemia virus ( FeLV) belongs to the genus Gammaretrovirus, and causes a variety of neoplastic and non-neoplastic diseases in cats. Alteration of viral env sequences is thought to be associated with disease specificity, but the way in which genetic diversity of FeLV contributes to the generation of such variants in nature is poorly understood. We isolated FeLV env genes from naturally infected cats in Japan and analyzed the evolutionary dynamics of these genes. Phylogenetic reconstructions separated our FeLV samples into three distinct genetic clusters, termed Genotypes I, II, and III. Genotype I is a major genetic cluster and can be further classified into Clades 1-7 in Japan. Genotypes were correlated with geographical distribution; Genotypes I and II were distributed within Japan, whilst FeLV samples from outside Japan belonged to Genotype III. These results may be due to geographical isolation of FeLVs in Japan. The observed structural diversity of the FeLV env gene appears to be caused primarily by mutation, deletion, insertion and recombination, and these variants may be generated de novo in individual cats. FeLV interference assay revealed that FeLV genotypes did not correlate with known FeLV receptor subgroups. We have identified the genotypes which we consider to be reliable for evaluating phylogenetic relationships of FeLV, which embrace the high structural diversity observed in our sample. Overall, these findings extend our understanding of Gammaretrovirus evolutionary patterns in the field, and may provide a useful basis for assessing the emergence of novel strains and understanding the molecular mechanisms of FeLV transmission in cats.	[Watanabe, Shinya; Kawamura, Maki; Nishigaki, Kazuo] Yamaguchi Univ, United Grad Sch Vet Sci, Lab Mol Immunol & Infect Dis, Yamaguchi, Japan; [Odahara, Yuka; Anai, Yukari; Ochi, Haruyo; Nishigaki, Kazuo] Yamaguchi Univ, Joint Fac Vet Med, Lab Mol Immunol & Infect Dis, Yamaguchi, Japan; [Nakagawa, So] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Endo, Yasuyuki] Kagoshima Univ, Lab Small Anim Internal Med, Joint Fac Vet Med, Kagoshima 890, Japan; [Tsujimoto, Hajime] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Tokyo, Japan	Yamaguchi University; Yamaguchi University; Harvard University; Kagoshima University; University of Tokyo	Nishigaki, K (corresponding author), Yamaguchi Univ, United Grad Sch Vet Sci, Lab Mol Immunol & Infect Dis, Yamaguchi, Japan.	kaz@yamaguchi-u.ac.jp	Nakagawa, So/Q-2712-2015	Nakagawa, So/0000-0003-1760-3839; Tsujimoto, Hajime/0000-0002-3771-6235	Ministry of Education, Culture, Sports, Science and Technology of Japan [22380168]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 22380168 to Kazuo Nishigaki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Anai Y, 2012, J VIROL, V86, P8634, DOI 10.1128/JVI.00280-12; Anderson MM, 2000, SCIENCE, V287, P1828, DOI 10.1126/science.287.5459.1828; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; ATHAS GB, 1995, J VIROL, V69, P3324, DOI 10.1128/JVI.69.6.3324-3332.1995; Bae YM, 1997, J VIROL, V71, P2092, DOI 10.1128/JVI.71.3.2092-2099.1997; Brown MA, 2008, EMERG INFECT DIS, V14, P252, DOI 10.3201/eid1402.070981; Chandhasin C, 2005, J VIROL, V79, P5278, DOI 10.1128/JVI.79.9.5278-5287.2005; Chandhasin C, 2005, J VIROL, V79, P1351, DOI 10.1128/JVI.79.3.1351-1360.2005; Chen H, 1998, J VIROL, V72, P7048, DOI 10.1128/JVI.72.9.7048-7056.1998; Coelho FM, 2008, J GEN VIROL, V89, P2799, DOI 10.1099/vir.0.2008/003855-0; DONAHUE PR, 1991, J VIROL, V65, P4461, DOI 10.1128/JVI.65.8.4461-4469.1991; DONAHUE PR, 1988, J VIROL, V62, P722, DOI 10.1128/JVI.62.3.722-731.1988; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FULTON R, 1990, J VIROL, V64, P1675, DOI 10.1128/JVI.64.4.1675-1682.1990; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hisasue M, 2009, INT J CANCER, V124, P1133, DOI 10.1002/ijc.24050; JARRETT WFH, 1964, NATURE, V202, P567, DOI 10.1038/202567a0; JARRETT WFH, 1964, NATURE, V202, P566, DOI 10.1038/202567a0; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim CH, 1997, GENE, V199, P293, DOI 10.1016/S0378-1119(97)00384-3; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVESQUE KS, 1990, J VIROL, V64, P3455, DOI 10.1128/JVI.64.7.3455-3462.1990; Levy LS, 2008, VET IMMUNOL IMMUNOP, V123, P14, DOI 10.1016/j.vetimm.2008.01.008; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MATSUMOTO Y, 1992, VIROLOGY, V189, P745, DOI 10.1016/0042-6822(92)90598-J; MCDOUGALL AS, 1994, J VIROL, V68, P2151, DOI 10.1128/JVI.68.4.2151-2160.1994; Meli ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004744; Mendoza R, 2006, J VIROL, V80, P3378, DOI 10.1128/JVI.80.7.3378-3385.2006; MIURA T, 1989, VIROLOGY, V169, P458, DOI 10.1016/0042-6822(89)90172-4; Nakamura Y, 2010, J VET MED SCI, V72, P1051, DOI 10.1292/jvms.09-0574; Neil J C, 1991, Curr Top Microbiol Immunol, V171, P67; Nishigaki K, 2002, J VIROL, V76, P1527, DOI 10.1128/JVI.76.3.1527-1532.2002; Nishigaki K, 1997, J VIROL, V71, P9823, DOI 10.1128/JVI.71.12.9823-9827.1997; NUNBERG JH, 1984, J VIROL, V49, P629, DOI 10.1128/JVI.49.2.629-632.1984; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; OVERBAUGH J, 1988, NATURE, V332, P731, DOI 10.1038/332731a0; Overbaugh J, 2001, MICROBIOL MOL BIOL R, V65, P371, DOI 10.1128/MMBR.65.3.371-389.2001; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rasheed S, 1980, FELINE LEUKEMIA VIRU, P393; RIEDEL N, 1986, J VIROL, V60, P242, DOI 10.1128/JVI.60.1.242-250.1986; RIGBY MA, 1992, J GEN VIROL, V73, P2839, DOI 10.1099/0022-1317-73-11-2839; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; ROHN JL, 1994, J VIROL, V68, P2458, DOI 10.1128/JVI.68.4.2458-2467.1994; RoyBurman P, 1995, VIRUS GENES, V11, P147, DOI 10.1007/BF01728655; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Shalev Z, 2009, J VIROL, V83, P6706, DOI 10.1128/JVI.02317-08; SHEETS RL, 1993, J VIROL, V67, P3118, DOI 10.1128/JVI.67.6.3118-3125.1993; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEWART MA, 1986, J VIROL, V58, P825, DOI 10.1128/JVI.58.3.825-834.1986; SWAIN A, 1992, SCIENCE, V255, P841, DOI 10.1126/science.1371365; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSATSANIS C, 1994, J VIROL, V68, P8296, DOI 10.1128/JVI.68.12.8296-8303.1994; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zavorotinskaya T, 2004, J VIROL, V78, P473, DOI 10.1128/JVI.78.1.473-481.2004	68	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61009	10.1371/journal.pone.0061009	http://dx.doi.org/10.1371/journal.pone.0061009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593376	Green Submitted, gold, Green Published			2022-12-27	WOS:000317383200034
J	Branas-Garza, P; Kovarik, J; Neyse, L				Branas-Garza, Pablo; Kovarik, Jaromir; Neyse, Levent			Second-to-Fourth Digit Ratio Has a Non-Monotonic Impact on Altruism	PLOS ONE			English	Article							TESTOSTERONE; 2ND; BEHAVIOR; GAME; SEX; HORMONE; LENGTH	Gene-culture co-evolution emphasizes the joint role of culture and genes for the emergence of altruistic and cooperative behaviors and behavioral genetics provides estimates of their relative importance. However, these approaches cannot assess which biological traits determine altruism or how. We analyze the association between altruism in adults and the exposure to prenatal sex hormones, using the second-to-fourth digit ratio. We find an inverted U-shaped relation for left and right hands, which is very consistent for men and less systematic for women. Subjects with both high and low digit ratios give less than individuals with intermediate digit ratios. We repeat the exercise with the same subjects seven months later and find a similar association, even though subjects' behavior differs the second time they play the game. We then construct proxies of the median digit ratio in the population (using more than 1000 different subjects), show that subjects' altruism decreases with the distance of their ratio to these proxies. These results provide direct evidence that prenatal events contribute to the variation of altruistic behavior and that the exposure to fetal hormones is one of the relevant biological factors. In addition, the findings suggest that there might be an optimal level of exposure to these hormones from social perspective.	[Branas-Garza, Pablo] Middlesex Univ, Sch Business, London N17 8HR, England; [Kovarik, Jaromir] Univ Basque Country, Dpto Fundamentos Anal Econ 1, Bilbao, Spain; [Kovarik, Jaromir] Univ Basque Country, BRiDGE, Bilbao, Spain; [Neyse, Levent] Univ Granada, GLOBE Dept Econ, Granada, Spain	Middlesex University; University of Basque Country; University of Basque Country; University of Granada	Kovarik, J (corresponding author), Univ Basque Country, Dpto Fundamentos Anal Econ 1, Bilbao, Spain.	jaromir.kovarik@ehu.es	Brañas-Garza, Pablo/Q-1532-2018; Branas-Garza, Pablo/AAH-8894-2020; Kovarik, Jaromir/AAE-6921-2021; Kovarik, Jaromir/H-2938-2014	Brañas-Garza, Pablo/0000-0001-8456-6009; Branas-Garza, Pablo/0000-0001-8456-6009; KOVARIK, JAROMIR/0000-0002-0436-929X	Spanish Ministry of Science and Innovation [ECO2010{17049, ECO2009-09120]; Government of Andalusia Project for Excellence in Research [P07.SEJ.02547]; Government of the Basque Country [IT-223-07]; Fundacion Ramon Areces [I+D-2011]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of Andalusia Project for Excellence in Research; Government of the Basque Country; Fundacion Ramon Areces	Financial support from the Spanish Ministry of Science and Innovation (ECO2010{17049; ECO2009-09120), the Government of Andalusia Project for Excellence in Research (P07.SEJ.02547), the Government of the Basque Country (IT-223-07) and Fundacion Ramon Areces (I+D-2011)is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar F, 2009, EXP ECON, V12, P93, DOI 10.1007/s10683-008-9199-z; Alexander RM, 1996, OPTIMA ANIMALS; Andreoni J, 2001, Q J ECON, V116, P293, DOI 10.1162/003355301556419; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bardsley N, 2008, EXP ECON, V11, P122, DOI 10.1007/s10683-007-9172-2; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Boyd R., 1985, CULTURE EVOLUTIONARY; Branas-Garza P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029842; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Buser T, 2012, GAME ECON BEHAV, V76, P457, DOI 10.1016/j.geb.2012.07.006; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Darwin C., 1871, P423; Dawkins R, 1989, SELFISH GENE; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fehr E, 2011, J PUBLIC ECON, V95, P1144, DOI 10.1016/j.jpubeco.2011.05.013; Fehr E, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P215, DOI 10.1016/B978-0-12-374176-9.00015-4; Garbarino E, 2011, J RISK UNCERTAINTY, V42, P1, DOI 10.1007/s11166-010-9109-6; Goy R. W., 1980, SEXUAL DIFFERENTIATI; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Hopp RN, 2012, PERS INDIV DIFFER, V52, P643, DOI 10.1016/j.paid.2011.12.013; Kovarik J, 2012, PHYSICA A, V391, P849, DOI 10.1016/j.physa.2011.08.040; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Long JS, 1997, REGRESSION MODELS CA; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Manning JT, 2013, ANDROLOGY-US, V1, P94, DOI 10.1111/j.2047-2927.2012.00013.x; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; Manning JT., 2002, DIGIT RATIO POINTER; McFadden D, 2002, ARCH SEX BEHAV, V31, P99, DOI 10.1023/A:1014087319682; Millet K, 2006, BIOL PSYCHOL, V71, P111, DOI 10.1016/j.biopsycho.2005.06.001; Millet K, 2009, BRIT J PSYCHOL, V100, P151, DOI 10.1348/000712608X324359; Nye JVC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046319; Richerson PJ, 2010, P NATL ACAD SCI USA, V107, P8985, DOI 10.1073/pnas.0914631107; Ronay R, 2011, J EXP SOC PSYCHOL, V47, P702, DOI 10.1016/j.jesp.2010.11.009; ROTH AE, 1991, AM ECON REV, V81, P1068; Sanchez-Pages S, 2010, PHYSIOL BEHAV, V99, P355, DOI 10.1016/j.physbeh.2009.11.013; Sanders G, 2002, ARCH SEX BEHAV, V31, P145, DOI 10.1023/A:1014095521499; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Stenstrom E, 2011, PERS INDIV IN PRESS; Sutherland WJ, 2005, NATURE, V435, P569, DOI 10.1038/435569a; van Honk J, 2012, NATURE, V485, pE4, DOI 10.1038/nature11136; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	52	46	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60419	10.1371/journal.pone.0060419	http://dx.doi.org/10.1371/journal.pone.0060419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123IQ	23593214	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000317382000016
J	Giedt, RJ; Koch, PD; Weissleder, R				Giedt, Randy J.; Koch, Peter D.; Weissleder, Ralph			Single Cell Analysis of Drug Distribution by Intravital Imaging	PLOS ONE			English	Article							IN-VIVO; SELECTION METHOD; OPEN-LABEL; SEGMENTATION; INHIBITION; MULTICENTER; OLAPARIB; KINASE; CANCER; TUMORS	Recent advances in the field of intravital imaging have for the first time allowed us to conduct pharmacokinetic and pharmacodynamic studies at the single cell level in live animal models. Due to these advances, there is now a critical need for automated analysis of pharmacokinetic data. To address this, we began by surveying common thresholding methods to determine which would be most appropriate for identifying fluorescently labeled drugs in intravital imaging. We then developed a segmentation algorithm that allows semi-automated analysis of pharmacokinetic data at the single cell level. Ultimately, we were able to show that drug concentrations can indeed be extracted from serial intravital imaging in an automated fashion. We believe that the application of this algorithm will be of value to the analysis of intravital microscopy imaging particularly when imaging drug action at the single cell level.	[Giedt, Randy J.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Koch, Peter D.; Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Weissleder, R (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu		/0000-0003-0828-4143	National Institutes of Health [R01 CA164448, P01 CA139980, T32 CA079443]; NATIONAL CANCER INSTITUTE [R01CA164448, T32CA079443, P01CA139980] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants R01 CA164448, P01 CA139980 and T32 CA079443 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGHDADI A, 1995, GRAPH MODEL IM PROC, V57, P197, DOI 10.1006/gmip.1995.1019; Budin G, 2011, ANGEW CHEM INT EDIT, V50, P9378, DOI 10.1002/anie.201103273; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; DOYLE W, 1962, J ACM, V9, P259, DOI 10.1145/321119.321123; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532, DOI 10.1006/cgip.1993.1040; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kapur J.N., 1985, COMPUTER GRAPHICS VI, V11-12, P273; Kaye SB, 2012, J CLIN ONCOL, V30, P372, DOI 10.1200/JCO.2011.36.9215; KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0; LEE H, 1990, IEEE T SYST MAN CYB, V20, P741, DOI 10.1109/21.57290; Lee S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2060; LEVINE MD, 1985, IEEE T PATTERN ANAL, V7, P155, DOI 10.1109/TPAMI.1985.4767640; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Luca AD., 1972, INF CONTROL, V20, P301, DOI [10.1016/S0019-9958(72)90199-4, DOI 10.1016/S0019-9958(72)90199-4]; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Orth JD, 2011, CANCER RES, V71, P4608, DOI 10.1158/0008-5472.CAN-11-0412; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Ray N, 2009, EDGE SENSITIVE VARIA; Reiner T, 2012, NEOPLASIA, V14, P169, DOI 10.1593/neo.12414; Reiner T, 2011, P NATL ACAD SCI USA, V108, P12815, DOI 10.1073/pnas.1109859108; Reiner T, 2010, CHEMBIOCHEM, V11, P2374, DOI 10.1002/cbic.201000477; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Rudin M, 2003, NAT REV DRUG DISCOV, V2, P123, DOI 10.1038/nrd1007; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; SHANBHAG AG, 1994, CVGIP-GRAPH MODEL IM, V56, P414, DOI 10.1006/cgip.1994.1037; Sungon Lee CV, 2012, NATURE COMMUNICATION; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Thurber GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024696; TSAI WH, 1985, COMPUT VISION GRAPH, V29, P377, DOI 10.1016/0734-189X(85)90133-1; WU KN, 1995, IEEE T BIO-MED ENG, V42, P1, DOI 10.1109/10.362924; Yang KS, 2012, ANGEW CHEM INT EDIT, V51, P6598, DOI 10.1002/anie.201200994; YASNOFF WA, 1977, PATTERN RECOGN, V9, P217, DOI 10.1016/0031-3203(77)90006-1; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zhang YJ, 1996, PATTERN RECOGN, V29, P1335, DOI 10.1016/0031-3203(95)00169-7	42	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60988	10.1371/journal.pone.0060988	http://dx.doi.org/10.1371/journal.pone.0060988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593370	gold, Green Published, Green Submitted			2022-12-27	WOS:000317382000035
J	Ji, XT; Qian, NS; Zhang, T; Li, JM; Li, XK; Wang, P; Zhao, DS; Huang, G; Zhang, L; Fei, Z; Jia, D; Niu, L				Ji, Xi-Tuan; Qian, Nian-Song; Zhang, Tao; Li, Jin-Mao; Li, Xin-Kui; Wang, Peng; Zhao, Dong-Sheng; Huang, Gang; Zhang, Lei; Fei, Zhou; Jia, Dong; Niu, Le			Spinal Astrocytic Activation Contributes to Mechanical Allodynia in a Rat Chemotherapy-Induced Neuropathic Pain Model	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE EXPRESSION; INDUCED PERIPHERAL NEUROPATHY; NERVE-INJURY; MICROGLIAL ACTIVATION; GLIAL ACTIVATION; PERSISTENT PAIN; CANCER PAIN; INDUCED HYPERALGESIA; PATHOLOGICAL PAIN; CORD CONTRIBUTES	Chemotherapy-induced neuropathic pain (CNP) is the major dose-limiting factor in cancer chemotherapy. However, the neural mechanisms underlying CNP remain enigmatic. Accumulating evidence implicates the involvement of spinal glia in some neuropathic pain models. In this study, using a vincristine-evoked CNP rat model with obvious mechanical allodynia, we found that spinal astrocyte rather than microglia was dramatically activated. The mechanical allodynia was dose-dependently attenuated by intrathecal administratration of L-alpha-aminoadipate (astrocytic specific inhibitor); whereas minocycline (microglial specific inhibitor) had no such effect, indicating that spinal astrocytic activation contributes to allodynia in CNP rat. Furthermore, oxidative stress mediated the development of spinal astrocytic activation, and activated astrocytes dramatically increased interleukin-1 beta expression which induced N-methyl-D-aspartic acid receptor (NMDAR) phosphorylation in spinal neurons to strengthen pain transmission. Taken together, our findings suggest that spinal activated astrocytes may be a crucial component of the pathophysiology of CNP and "Astrocyte-Cytokine-NMDAR-neuron'' pathway may be one detailed neural mechanisms underlying CNP. Thus, inhibiting spinal astrocytic activation may represent a novel therapeutic strategy for treating CNP.	[Ji, Xi-Tuan; Zhao, Dong-Sheng; Huang, Gang; Zhang, Lei; Fei, Zhou; Niu, Le] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Qian, Nian-Song] Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Zhang, Tao] Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China; [Li, Jin-Mao] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Peoples R China; [Li, Xin-Kui] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Wang, Peng; Jia, Dong] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Niu, Le] Fourth Mil Med Univ, Sch Basic Med Sci, Xian 710032, Peoples R China	Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Southern Theater Command General Hospital; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China.	feizhoufmmu1@163.com; jiadong69@163.com; niulelesci@163.com			National Natural Science Foundation of China [81172095, 81171135, 81200324]; Bureau of Health Medical Scientific Research Foundation of Hainan Province [2012 PT-70]; China Postdoctoral Science Foundation [2012m521875]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Health Medical Scientific Research Foundation of Hainan Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Natural Science Foundation of China (Nos. 81172095, 81171135, 81200324), Bureau of Health Medical Scientific Research Foundation of Hainan Province (Qiongwei 2012 PT-70), and China Postdoctoral Science Foundation funded project (2012m521875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosnjak S, 2002, J CHEMOTHERAPY, V14, P214, DOI 10.1179/joc.2002.14.2.214; Brenner GJ, 2004, EUR J NEUROSCI, V20, P375, DOI 10.1111/j.1460-9568.2004.03506.x; Cata JP, 2006, MINERVA ANESTESIOL, V72, P151; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Christoph T, 2006, NEUROPHARMACOLOGY, V51, P12, DOI 10.1016/j.neuropharm.2006.02.007; Dahl JL, 2002, J PAIN SYMPTOM MANAG, V24, P136, DOI 10.1016/S0885-3924(02)00472-4; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Farquhar-Smith Paul, 2011, Curr Opin Support Palliat Care, V5, P1, DOI 10.1097/SPC.0b013e328342f9cc; Feng QX, 2010, NEUROSCIENCE, V167, P501, DOI 10.1016/j.neuroscience.2010.02.005; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Gradinaru D, 2012, TOXICOL LETT, V213, P316, DOI 10.1016/j.toxlet.2012.07.014; Guasti L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-35; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Hao JX, 1999, ACTA ANAESTH SCAND, V43, P1027, DOI 10.1034/j.1399-6576.1999.431010.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hempenstall Kathleen, 2002, Curr Opin Investig Drugs, V3, P441; HEPPELMANN B, 1994, CELL TISSUE RES, V275, P493, DOI 10.1007/BF00318818; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Kautio AL, 2011, SUPPORT CARE CANCER, V19, P1991, DOI 10.1007/s00520-010-1043-2; Khurgel M, 1996, GLIA, V16, P351, DOI 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2; Kiguchi N, 2008, NEUROSCI LETT, V445, P140, DOI 10.1016/j.neulet.2008.09.009; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Liu J, 2007, NEUROSCI LETT, V412, P268, DOI 10.1016/j.neulet.2006.11.022; Lynch JJ, 2004, PAIN, V110, P56, DOI 10.1016/j.pain.2004.03.010; Mei XP, 2011, NEUROSCI RES, V70, P305, DOI 10.1016/j.neures.2011.03.012; Mei XP, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-50; Meuser T, 2001, PAIN, V93, P247, DOI 10.1016/S0304-3959(01)00324-4; Nadeson R, 2002, BRIT J ANAESTH, V88, P685, DOI 10.1093/bja/88.5.685; Nozaki-Taguchi N, 2001, PAIN, V93, P69, DOI 10.1016/S0304-3959(01)00294-9; Pacharinsak C, 2008, COMPARATIVE MED, V58, P220; Padi SSV, 2008, EUR J PHARMACOL, V601, P79, DOI 10.1016/j.ejphar.2008.10.018; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Sweitzer SM, 2006, NEUROSCI LETT, V400, P258, DOI 10.1016/j.neulet.2006.02.058; Tanner KD, 2003, NEUROSCIENCE, V118, P809, DOI 10.1016/S0306-4522(03)00023-X; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Topp KS, 2000, J COMP NEUROL, V424, P563; Uhm, 1999, Curr Treat Options Neurol, V1, P428, DOI 10.1007/s11940-996-0006-x; Ultenius C, 2006, NEUROSCI LETT, V399, P85, DOI 10.1016/j.neulet.2006.01.018; Virmani A, 2005, ANN NY ACAD SCI, V1053, P183, DOI 10.1196/annals.1344.016; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006973; Watkins LR, 2005, J INTERN MED, V257, P139, DOI 10.1111/j.1365-2796.2004.01443.x; Watkins LR, 2003, ADV EXP MED BIOL, V521, P1; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Weng HR, 2003, PAIN, V103, P131, DOI 10.1016/S0304-3959(02)00445-1; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zanchet EM, 2004, BRAIN RES, V1021, P101, DOI 10.1016/j.brainres.2004.06.041; Zhang HJ, 2012, J PAIN, V13, P293, DOI 10.1016/j.jpain.2011.12.002; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Zheng FY, 2011, NEUROSCIENCE, V176, P447, DOI 10.1016/j.neuroscience.2010.12.052; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	61	85	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60733	10.1371/journal.pone.0060733	http://dx.doi.org/10.1371/journal.pone.0060733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585846	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600043
J	van der Linden, M; Winkel, N; Kuntzel, S; Farkas, A; Perniciaro, SR; Reinert, RR; Imohl, M				van der Linden, Mark; Winkel, Nadine; Kuentzel, Sharon; Farkas, Aron; Perniciaro, Stephanie Russo; Reinert, Ralf Rene; Imoehl, Matthias			Epidemiology of Streptococcus pneumoniae Serogroup 6 Isolates from IPD in Children and Adults in Germany	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; SEROTYPE 6D; SPAIN; IDENTIFICATION; ASSOCIATION; RESISTANCE; TRENDS; LOCUS	This study presents serogroup 6 isolates from invasive pneumococcal disease (IPD) before and after the recommendation for childhood pneumococcal conjugate vaccination in Germany (July 2006). A total of 19,299 (children: 3508, adults: 15,791) isolates were serotyped. Serogroup 6 isolates accounted for 9.5% (children) and 6.7% (adults), respectively. 548 isolates had serotype 6A, 558 had serotype 6B, 285 had serotype 6C, and 4 had serotype 6D. Among children, serotype 6B was most prevalent (7.5% of isolates) before vaccination, followed by 6A and 6C. After the 7-valent pneumococcal conjugate vaccine (PCV7), the prevalence of serotype 6B significantly decreased (p = 0.040), a pattern which continued in the higher-valent PCV period (PCV10, PCV13). Serotype 6A prevalence showed a slight increase directly after the start of PCV7 vaccination, followed by a decrease which continued throughout the PCV10/13 period. Serotype 6C prevalence remained low. Serotype 6D was not found among IPD isolates from children. Among adults, prevalence of both 6A and 6B decreased, with 6B reaching statistical significance (p = 0.045) and 6A showing a small increase in 2011-2012. Serotype 6C prevalence was 1.5% or lower before vaccination, but increased post-vaccination to 3.6% in 2011/12 (p = 0.031). Four serotype 6D isolates were found post-PCV7 childhood vaccination, and two post-PCV10/13. Antibiotic resistance was found mainly in serotype 6B; serotype 6A showed lower resistance rates. Serotype 6C isolates only showed resistance among adults; serotype 6D isolates showed no resistance. Multilocus sequence typing showed that sequence type (ST) 1692 was the most prevalent serotype 6C clone. Thirty-two other STs were found among serotype 6C isolates, of which 12 have not been previously reported. The four serotype 6D isolates had ST 948, ST 2185 and two new STs: 8422 and 8442. Two serogroup 6 isolates could not be assigned to a serotype, but had STs common to serogroup 6.	[van der Linden, Mark; Winkel, Nadine; Kuentzel, Sharon; Farkas, Aron; Perniciaro, Stephanie Russo; Reinert, Ralf Rene; Imoehl, Matthias] Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	van der Linden, M (corresponding author), Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany.	mlinden@ukaachen.de	Imöhl, Matthias/P-5014-2014; Perniciaro, Stephanie R/J-3669-2017; van der Linden, Mark/B-9305-2009	Imöhl, Matthias/0000-0002-8372-0251; Perniciaro, Stephanie R/0000-0002-3146-2182; van der Linden, Mark/0000-0002-6574-4313	Pfizer Pharmaceuticals; Pfizer; GSK; SanofiPasteurMSD; Merck	Pfizer Pharmaceuticals(Pfizer); Pfizer(Pfizer); GSK(GlaxoSmithKline); SanofiPasteurMSD; Merck(Merck & Company)	Parts of this work have been funded by Pfizer Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; ML has received grant support and speakers honoraria from, and has served as an advisory board member for Pfizer, GSK, SanofiPasteurMSD and Merck. RRR is currently an employee of Pfizer Pharmaceuticals. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. NW, SK, AF, SRP and MI have declared that no competing interests exist.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; Bratcher PE, 2011, MICROBIOL-SGM, V157, P189, DOI 10.1099/mic.0.043901-0; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Bratcher PE, 2009, MICROBIOL-SGM, V155, P576, DOI 10.1099/mic.0.024521-0; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Choi EH, 2010, EMERG INFECT DIS, V16, P1751, DOI 10.3201/eid1611.100941; Clinical Laboratory Standards Institute, 2011, M100S21 I CLS; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Cooke B, 2010, J MED MICROBIOL, V59, P1212, DOI 10.1099/jmm.0.022954-0; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Imohl M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-299; Imohl M, 2010, J CLIN MICROBIOL, V48, P1291, DOI 10.1128/JCM.01937-09; Jacobs MR, 2009, J CLIN MICROBIOL, V47, P64, DOI 10.1128/JCM.01524-08; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Kuch A, 2010, VACCINE, V28, P6406, DOI 10.1016/j.vaccine.2010.07.051; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; Nahm MH, 2011, J MED MICROBIOL, V60, P46, DOI 10.1099/jmm.0.023853-0; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Rolo D, 2011, J ANTIMICROB CHEMOTH, V66, P1712, DOI 10.1093/jac/dkr193; Rolo D, 2011, J CLIN MICROBIOL, V49, P2328, DOI 10.1128/JCM.02545-10; Ruckinger S, 2009, PEDIATR INFECT DIS J, V28, P118, DOI 10.1097/INF.0b013e318187e215; Satzke C, 2010, J CLIN MICROBIOL, V48, P4298, DOI 10.1128/JCM.00861-10; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yu XH, 1999, J INFECT DIS, V180, P1569, DOI 10.1086/315096	29	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60848	10.1371/journal.pone.0060848	http://dx.doi.org/10.1371/journal.pone.0060848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593324	Green Published, gold			2022-12-27	WOS:000317909600059
J	Yang, QQ; Yu, FW; Yin, YN; Ma, ZH				Yang, Qianqian; Yu, Fangwei; Yin, Yanni; Ma, Zhonghua			Involvement of Protein Tyrosine Phosphatases BcPtpA and BcPtpB in Regulation of Vegetative Development, Virulence and Multi-Stress Tolerance in Botrytis cinerea	PLOS ONE			English	Article							MAP KINASE; HISTIDINE KINASE; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; MAGNAPORTHE-GRISEA; GENE; YEAST; PATHWAY; CLONING; FUNGUS	Tyrosine phosphorylation and dephosphorylation have emerged as fundamentally important mechanisms of signal transduction and regulation in eukaryotic cells, governing many processes, but little has been known about their functions in filamentous fungi. In this study, we deleted two putative protein tyrosine phosphatase (PTP) genes (BcPTPA and BcPTPB) in Botrytis cinerea, encoding the orthologs of Saccharomyces cerevisiae Ptp2 and Ptp3, respectively. Although BcPtpA and BcPtpB have opposite functions in conidiation, they are essential for sclerotial formation in B. cinerea. BcPTPA and BcPTPB deletion mutants Delta BcPtpA-10 and Delta BcPtpB-4 showed significantly increased sensitivity to osmotic and oxidative stresses, and to cell wall damaging agents. Inoculation tests showed that both mutants exhibited dramatically decreased virulence on tomato leaves, apples and grapes. In S. cerevisiae, it has been shown that Ptp2 and Ptp3 negatively regulate the high-osmolarity glycerol (HOG) pathway and the cell wall integrity (CWI) pathway. Although both BcPtpA and BcPtpB were able to inactive Hog1 and Mpk1 in S. cerevisiae, in contrast to S. cerevisiae, they positively regulate phosphorylation of BcSak1 (the homologue of Hog1) and BcBmp3 (the homologue of Mpk1) in B. cinerea under stress conditions. These results demonstrated that functions of PTPs in B. cinerea are different from those in S. cerevisiae, and BcPtpA and BcPtpB play important roles in regulation of vegetative development, virulence and in adaptation to oxidative, osmotic and cell-wall damage stresses in B. cinerea.	[Yang, Qianqian; Yu, Fangwei; Yin, Yanni; Ma, Zhonghua] Zhejiang Univ, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Ma, ZH (corresponding author), Zhejiang Univ, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	zhma@zju.edu.cn	Ma, Zhonghua/J-6972-2014	Ma, Zhonghua/0000-0002-5426-0997; Yin, Yanni/0000-0002-0798-3420	National Key Basic Research and Development Program [2012CB114004]; National Science Foundation [31171881]; Zhejiang Provincial Natural Science Foundation [Z3110057]; earmarked fund for Modern Agro-industry Technology Research System [CARS-3-1-15]	National Key Basic Research and Development Program(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); earmarked fund for Modern Agro-industry Technology Research System	This research was supported by the National Key Basic Research and Development Program (2012CB114004), National Science Foundation (31171881), Zhejiang Provincial Natural Science Foundation (Z3110057), and the earmarked fund for Modern Agro-industry Technology Research System (CARS-3-1-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbelet D, 2010, MOL PLANT MICROBE IN, V23, P1324, DOI 10.1094/MPMI-02-10-0046; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; BROWNSHIMER S, 1990, P NATL ACAD SCI USA, V87, P5148, DOI 10.1073/pnas.87.13.5148; CHARBONNEAU H, 1989, P NATL ACAD SCI USA, V86, P5252, DOI 10.1073/pnas.86.14.5252; CHERNOFF J, 1990, P NATL ACAD SCI USA, V87, P2735, DOI 10.1073/pnas.87.7.2735; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Elad Y, 2007, BOTRYTIS BIOL PATHOL, P1, DOI DOI 10.1007/978-1-4020-2626-3_1; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Harren K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041761; HENKEL E, 1982, FRESEN Z ANAL CHEM, V311, P451, DOI 10.1007/BF00481817; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Kojima K, 2004, MOL MICROBIOL, V53, P1785, DOI 10.1111/j.1365-2958.2004.04244.x; Kuzniak E, 2005, PLANTA, V222, P192, DOI 10.1007/s00425-005-1514-8; Lew RR, 2007, MICROBIOL-SGM, V153, P1530, DOI 10.1099/mic.0.2006/004085-0; Liu WW, 2008, FUNGAL GENET BIOL, V45, P1062, DOI 10.1016/j.fgb.2008.04.003; Liu WW, 2011, FUNGAL GENET BIOL, V48, P377, DOI 10.1016/j.fgb.2010.12.004; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRobbie EAC, 2002, P NATL ACAD SCI USA, V99, P11963, DOI 10.1073/pnas.172360399; Mattison CP, 1999, MOL CELL BIOL, V19, P7651; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Motoyama T, 2005, CURR GENET, V47, P298, DOI 10.1007/s00294-005-0572-6; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Murakami Y, 2008, MOL CELL BIOL, V28, P2481, DOI 10.1128/MCB.01817-07; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Perpetua NS, 1996, MOL PLANT MICROBE IN, V9, P323, DOI 10.1094/MPMI-9-0323; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rolke Y, 2004, MOL PLANT PATHOL, V5, P17, DOI 10.1111/j.1364-3703.2004.00201.x; Rui O, 2007, MOL PLANT PATHOL, V8, P173, DOI 10.1111/J.1364-3703.2007.00383.X; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schumacher J, 2008, MOL PLANT MICROBE IN, V21, P1443, DOI 10.1094/MPMI-21-11-1443; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Soulie MC, 2006, CELL MICROBIOL, V8, P1310, DOI 10.1111/j.1462-5822.2006.00711.x; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Thompson JE, 2000, J BIOL CHEM, V275, P34867, DOI 10.1074/jbc.M006659200; Thompson JE, 1997, BIOCHEMISTRY-US, V36, P1852, DOI 10.1021/bi962355u; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Viaud M, 2006, MOL PLANT MICROBE IN, V19, P1042, DOI 10.1094/MPMI-19-1042; vonTiedemann A, 1997, PHYSIOL MOL PLANT P, V50, P151; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Wojda I, 2003, MICROBIOL-SGM, V149, P1193, DOI 10.1099/mic.0.26110-0; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yang Q, 2012, APPL MICROBIOL BIOT, V96, P1; Yang QQ, 2013, FUNGAL GENET BIOL, V50, P63, DOI 10.1016/j.fgb.2012.10.003; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690	52	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61307	10.1371/journal.pone.0061307	http://dx.doi.org/10.1371/journal.pone.0061307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585890	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600104
J	Siletz, A; Schnabel, M; Kniazeva, E; Schumacher, AJ; Shin, S; Jeruss, JS; Shea, LD				Siletz, Anaar; Schnabel, Michael; Kniazeva, Ekaterina; Schumacher, Andrew J.; Shin, Seungjin; Jeruss, Jacqueline S.; Shea, Lonnie D.			Dynamic Transcription Factor Networks in Epithelial-Mesenchymal Transition in Breast Cancer Models	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; E-CADHERIN EXPRESSION; SNAIL; CELLS; SLUG; REPRESSION; ALLIANCE; INVASION; BIOLOGY; EMT	The epithelial-mesenchymal transition (EMT) is a complex change in cell differentiation that allows breast carcinoma cells to acquire invasive properties. EMT involves a cascade of regulatory changes that destabilize the epithelial phenotype and allow mesenchymal features to manifest. As transcription factors (TFs) are upstream effectors of the genome-wide expression changes that result in phenotypic change, understanding the sequential changes in TF activity during EMT provides rich information on the mechanism of this process. Because molecular interactions will vary as cells progress from an epithelial to a mesenchymal differentiation program, dynamic networks are needed to capture the changing context of molecular processes. In this study we applied an emerging high-throughput, dynamic TF activity array to define TF activity network changes in three cell-based models of EMT in breast cancer based on HMLE Twist ER and MCF-7 mammary epithelial cells. The TF array distinguished conserved from model-specific TF activity changes in the three models. Time-dependent data was used to identify pairs of TF activities with significant positive or negative correlation, indicative of interdependent TF activity throughout the six-day study period. Dynamic TF activity patterns were clustered into groups of TFs that change along a time course of gene expression changes and acquisition of invasive capacity. Time-dependent TF activity data was combined with prior knowledge of TF interactions to construct dynamic models of TF activity networks as epithelial cells acquire invasive characteristics. These analyses show EMT from a unique and targetable vantage and may ultimately contribute to diagnosis and therapy.	[Siletz, Anaar; Kniazeva, Ekaterina; Shin, Seungjin; Shea, Lonnie D.] Northwestern Univ, McCormick Sch Engn, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Siletz, Anaar] Northwestern Univ, Feinberg Sch Med, Med Scientist Training Program, Chicago, IL 60611 USA; [Schnabel, Michael] Northwestern Univ, Phys Sci Oncol Ctr, Northwestern Inst Complex Syst, Dept Appl Math, Evanston, IL USA; [Schnabel, Michael] Northwestern Univ, Phys Sci Oncol Ctr, Northwestern Inst Complex Syst, Dept Phys, Evanston, IL USA; [Schumacher, Andrew J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Jeruss, Jacqueline S.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Surg, Chicago, IL 60611 USA; [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Shea, Lonnie D.] Northwestern Univ, Inst Bionanotechnol Med IBNAM, Chicago, IL 60611 USA; [Shea, Lonnie D.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University	Shea, LD (corresponding author), Northwestern Univ, McCormick Sch Engn, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	l-shea@northwestern.edu	Shea, Lonnie D/B-7615-2009		National Center for Research Resources (NCRR), National Institutes of Health (NIH) [TL1 RR025740]; National Institute of General Medical Sciences (NIGMS) [R01GM097220]; Robert H. Lurie Comprehensive Cancer Center Malkin Scholars Program; Chicago Biomedical Consortium (CBC); Searle Funds at The Chicago Community Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097220] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Robert H. Lurie Comprehensive Cancer Center Malkin Scholars Program; Chicago Biomedical Consortium (CBC); Searle Funds at The Chicago Community Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the National Center for Research Resources (NCRR), National Institutes of Health (NIH) through Grant Number TL1 RR025740, the National Institute of General Medical Sciences (NIGMS) through Grant Number R01GM097220, the Robert H. Lurie Comprehensive Cancer Center Malkin Scholars Program, and the Chicago Biomedical Consortium (CBC) with support from the Searle Funds at The Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SG, 2011, PROG BIOPHYS MOL BIO, V106, P410, DOI 10.1016/j.pbiomolbio.2011.03.002; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bonavida Benjamin, 2011, Critical Reviews in Oncogenesis, V16, P211; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cheng WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034705; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Dubois-Marshall S, 2011, CLIN EXP METASTAS, V28, P811, DOI 10.1007/s10585-011-9412-x; Dutta B, 2012, BRIT J CANCER, V106, P1107, DOI 10.1038/bjc.2011.584; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fernando RI, 2010, J CLIN INVEST, V120, P533, DOI 10.1172/JCI38379; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jiang JA, 2011, CANCER BIOL THER, V11, P714, DOI 10.4161/cbt.11.8.15274; Jiang X, 2006, ASSAY DRUG DEV TECHN, V4, P293, DOI 10.1089/adt.2006.4.293; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katz E, 2011, ANAL CELL PATHOL, V34, P35, DOI [10.3233/ACP-2011-0003, 10.1155/2011/864847]; Katz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017083; Kim HD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008433; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Laubenbacher R, 2009, BBA-REV CANCER, V1796, P129, DOI 10.1016/j.bbcan.2009.06.001; Li ZH, 2012, ONCOL REP, V27, P1879, DOI 10.3892/or.2012.1728; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Neagu A, 2010, BIOSYSTEMS, V100, P23, DOI 10.1016/j.biosystems.2009.12.004; Neilson Eric G, 2010, Trans Am Clin Climatol Assoc, V121, P240; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; R Development Core Team, 2021, R PROJECT STAT COMPU; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Roselli M, 2012, CLIN CANCER RES, V18, P3868, DOI 10.1158/1078-0432.CCR-11-3211; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Siletz A, 2012, CANC MICROENVIRON; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Tkacik G, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/15/153102; Turner C, 2012, SEMIN CANC BIOL; Veiga DFT, 2010, MOL BIOSYST, V6, P469, DOI 10.1039/b916989j; Venkov C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025354; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weiss MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014026; Xi C, 2012, J BIOL CHEM; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Ye Y, 2008, BIOCHEM J, V416, P179, DOI 10.1042/BJ20080328; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	71	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e57180	10.1371/journal.pone.0057180	http://dx.doi.org/10.1371/journal.pone.0057180			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593114	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000001
J	D'Addio, F; Ueno, T; Clarkson, M; Zhu, BG; Vergani, A; Freeman, GJ; Sayegh, MH; Ansari, MJI; Fiorina, P; Habicht, A				D'Addio, Francesca; Ueno, Takuya; Clarkson, Michael; Zhu, Baogong; Vergani, Andrea; Freeman, Gordon J.; Sayegh, Mohamed H.; Ansari, Mohammed Javeed I.; Fiorina, Paolo; Habicht, Antje			CD160Ig Fusion Protein Targets a Novel Costimulatory Pathway and Prolongs Allograft Survival	PLOS ONE			English	Article							CD8(+) T-CELLS; MHC CLASS-I; HERPESVIRUS ENTRY MEDIATOR; CHRONIC VIRAL-INFECTION; CARDIAC ALLOGRAFTS; CUTTING EDGE; NK CELLS; TRANSPLANTATION TOLERANCE; CD28-DEFICIENT MICE; SUPPRESSOR-CELLS	CD160 is a cell surface molecule expressed by most NK cells and approximately 50% of CD8(+) cytotoxic T lymphocytes. Engagement of CD160 by MHC class-I directly triggers a costimulatory signal to TCR-induced proliferation, cytokine production and cytotoxic effector functions. The role of CD160 in alloimmunity is unknown. Using a newly generated CD160 fusion protein (CD160Ig) we examined the role of the novel costimulatory molecule CD160 in mediating CD4(+) or CD8(+) T cell driven allograft rejection. CD160Ig inhibits alloreactive CD8(+) T cell proliferation and IFN-gamma production in vitro, in particular in the absence of CD28 costimulation. Consequently CD160Ig prolongs fully mismatched cardiac allograft survival in CD4(-/-), C28(-/-) knockout and CTLA4Ig treated WT recipients, but not in WT or CD8(-/-) knockout recipients. The prolonged cardiac allograft survival is associated with reduced alloreactive CD8(+) T cell proliferation, effector/memory responses and alloreactive IFN-gamma production. Thus, CD160 signaling is particularly important in CD28-independent effector/memory CD8(+) alloreactive T cell activation in vivo and therefore may serve as a novel target for prevention of allograft rejection.	[D'Addio, Francesca; Ueno, Takuya; Clarkson, Michael; Vergani, Andrea; Sayegh, Mohamed H.; Ansari, Mohammed Javeed I.; Fiorina, Paolo; Habicht, Antje] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal,Transplantat Res Ctr, Boston, MA 02115 USA; [D'Addio, Francesca; Ueno, Takuya; Clarkson, Michael; Vergani, Andrea; Sayegh, Mohamed H.; Ansari, Mohammed Javeed I.; Fiorina, Paolo; Habicht, Antje] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [D'Addio, Francesca; Fiorina, Paolo] Ist Sci San Raffaele, Transplantat & Internal Med Div, I-20132 Milan, Italy; [Clarkson, Michael] Cork Univ Hosp, Dept Renal Med, Cork, Ireland; [Zhu, Baogong; Freeman, Gordon J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Habicht, Antje] Univ Hosp, Transplant Ctr Munich LMU, Munich, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University College Cork; Harvard University; Dana-Farber Cancer Institute; University of Munich	Habicht, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal,Transplantat Res Ctr, Boston, MA 02115 USA.	antje.habicht@med.uni-muenchen.de	D'Addio, Francesca/F-3417-2017; Freeman, Gordon/AAC-5380-2019; Fiorina, Paolo/B-4532-2019	D'Addio, Francesca/0000-0002-0345-0694; Freeman, Gordon/0000-0002-7210-5616; Sayegh, Mohamed/0000-0002-2847-588X; Fiorina, Paolo/0000-0002-1093-7724	National Kidney Foundation; AST-Wyeth Basic Science Faculty; National Institutes of Health [K08 AI080836-01]; ERA-EDTA; SISQT-Biotest Fellowship; ISSNAF-Fondazione Marche fellowship grant;  [AI56299];  [AI1051559]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI080836, P01AI056299] Funding Source: NIH RePORTER	National Kidney Foundation; AST-Wyeth Basic Science Faculty; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERA-EDTA; SISQT-Biotest Fellowship; ISSNAF-Fondazione Marche fellowship grant; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AH was supported by a National Kidney Foundation fellowship grant, MJA was supported by an AST-Wyeth Basic Science Faculty development grant and a National Institutes of Health grant K08 AI080836-01. MHS and GJF were supported by AI56299 and AI1051559. FD was supported by the ERA-EDTA and the SISQT-Biotest Fellowship, and she is the recipient of ISSNAF-Fondazione Marche fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2002, AM J TRANSPLANT, V2, P12, DOI 10.1034/j.1600-6143.2002.020104.x; Agrawal S, 1999, J IMMUNOL, V162, P1223; Anumanthan A, 1998, J IMMUNOL, V161, P2780; Barakonyi A, 2004, J IMMUNOL, V173, P5349, DOI 10.4049/jimmunol.173.9.5349; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Clarkson MR, 2005, TRANSPLANTATION, V80, P555, DOI 10.1097/01.tp.0000168432.60022.99; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Cortesini R, 2001, IMMUNOL REV, V182, P201, DOI 10.1034/j.1600-065X.2001.1820116.x; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Fons P, 2006, BLOOD, V108, P2608, DOI 10.1182/blood-2005-12-019919; Giustiniani J, 2007, J IMMUNOL, V178, P1293, DOI 10.4049/jimmunol.178.3.1293; Giustiniani J, 2009, J IMMUNOL, V182, P63, DOI 10.4049/jimmunol.182.1.63; Harada H, 2003, J CLIN INVEST, V112, P234, DOI 10.1172/JCI200317008; Kishimoto K, 2002, J CLIN INVEST, V109, P1471, DOI 10.1172/JCI14947; Lakkis FG, 1997, J IMMUNOL, V158, P2443; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Le Bouteiller P, 2002, P NATL ACAD SCI USA, V99, P16963, DOI 10.1073/pnas.012681099; LENSCHOW DJ, 1995, TRANSPLANTATION, V60, P1171, DOI 10.1097/00007890-199511270-00019; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Lin H, 1998, J EXP MED, V188, P199, DOI 10.1084/jem.188.1.199; Maeda M, 2005, J IMMUNOL, V175, P4426, DOI 10.4049/jimmunol.175.7.4426; Maier S, 2001, NAT MED, V7, P557, DOI 10.1038/87880; MAIZA H, 1993, J EXP MED, V178, P1121, DOI 10.1084/jem.178.3.1121; Manavalan JS, 2004, INT IMMUNOL, V16, P1055, DOI 10.1093/intimm/dxh107; Matesic D, 1998, J IMMUNOL, V161, P5236; McNerney ME, 2006, AM J TRANSPLANT, V6, P505, DOI 10.1111/j.1600-6143.2005.01226.x; Najafian N, 2003, J CLIN INVEST, V112, P1037, DOI 10.1172/JCI200317935; Nanji SA, 2006, DIABETES, V55, P27, DOI 10.2337/diabetes.55.01.06.db04-1154; Nanji SA, 2004, AM J TRANSPLANT, V4, P526, DOI 10.1111/j.1600-6143.2004.00384.x; Newell KA, 1999, J IMMUNOL, V163, P2358; Nikolova M, 2002, INT IMMUNOL, V14, P445, DOI 10.1093/intimm/14.5.445; Nikolova MH, 2005, CELL IMMUNOL, V237, P96, DOI 10.1016/j.cellimm.2005.01.012; Okazaki T, 2006, CELL, V124, P459, DOI 10.1016/j.cell.2006.01.022; PEARSON TC, 1994, TRANSPLANTATION, V57, P1701, DOI 10.1097/00007890-199457120-00002; Rabot M, 2007, INT IMMUNOL, V19, P401, DOI 10.1093/intimm/dxm005; Rothstein DM, 2003, IMMUNOL REV, V196, P85, DOI 10.1046/j.1600-065X.2003.00088.x; SAYEGH MH, 1995, J EXP MED, V181, P1869, DOI 10.1084/jem.181.5.1869; Sho M, 2001, TRANSPL P, V33, P3826, DOI 10.1016/S0041-1345(01)02620-3; Smith TRF, 2008, TRENDS IMMUNOL, V29, P337, DOI 10.1016/j.it.2008.04.002; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Szot GL, 2001, AM J TRANSPLANT, V1, P38, DOI 10.1034/j.1600-6143.2001.010108.x; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; Tsujimura K, 2006, IMMUNOL LETT, V106, P48, DOI 10.1016/j.imlet.2006.04.006; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; Valujskikh A, 2002, AM J TRANSPLANT, V2, P501, DOI 10.1034/j.1600-6143.2002.20603.x; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965; Yamada A, 2005, J IMMUNOL, V174, P1357, DOI 10.4049/jimmunol.174.3.1357	51	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60391	10.1371/journal.pone.0060391	http://dx.doi.org/10.1371/journal.pone.0060391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593209	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100037
J	Elman, I; Gurvits, TV; Tschibelu, E; Spring, JD; Lasko, NB; Pitman, RK				Elman, Igor; Gurvits, Tamara V.; Tschibelu, Evelyne; Spring, Justin D.; Lasko, Natasha B.; Pitman, Roger K.			Neurological Soft Signs in Individuals with Pathological Gambling	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; CARDIOVASCULAR COMPLICATIONS; SCHIZOPHRENIC-PATIENTS; AUTONOMIC AROUSAL; COCAINE USE; HEART-RATE; NEUROBIOLOGY; STRESS; ABNORMALITIES; CORTISOL	Increased neurological soft signs (NSSs) have been found in a number of neuropsychiatric syndromes, including chemical addiction. The present study examined NSSs related to perceptual-motor and visuospatial processing in a behavioral addiction viz., pathological gambling (PG). As compared to mentally healthy individuals, pathological gamblers displayed significantly poorer ability to copy two- and three-dimensional figures, to recognize objects against a background noise, and to orient in space on a road-map test. Results indicated that PG is associated with subtle cerebral cortical abnormalities. Further prospective clinical research is needed to address the NSSs' origin and chronology (e. g., predate or follow the development of PG) as well as their response to therapeutic interventions and/or their ability to predict such a response.	[Elman, Igor] Harvard Univ, Sch Med, Providence VA Med Ctr, Cambridge, MA 02138 USA; [Elman, Igor; Tschibelu, Evelyne] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Cambridge, MA 02138 USA; [Gurvits, Tamara V.; Spring, Justin D.; Lasko, Natasha B.; Pitman, Roger K.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA	Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Harvard University; Cambridge Health Alliance; Harvard University; Massachusetts General Hospital	Elman, I (corresponding author), Harvard Univ, Sch Med, Providence VA Med Ctr, Cambridge, MA 02138 USA.	ielman@cha.harvard.edu	Elman, Igor/O-2884-2017	Elman, Igor/0000-0002-1345-2677	National Institute on Drug Abuse [017959]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017959] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant DA #017959 (to IE) from the National Institute on Drug Abuse. This study was also supported with resources and the use of facilities at the Providence VA Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1997, METHODS NEUROPSYCHOL; Aron JL, 2007, ADDICTION, V102, P33, DOI 10.1111/j.1360-0443.2006.01778.x; BENOWITZ NL, 1992, CIBA F SYMP, V166, P125; Bergh C, 1997, PSYCHOL MED, V27, P473, DOI 10.1017/S0033291796003789; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; Brewer JA, 2008, BIOCHEM PHARMACOL, V75, P63, DOI 10.1016/j.bcp.2007.06.043; BUCHANAN RW, 1994, BIOL PSYCHIAT, V36, P198, DOI 10.1016/0006-3223(94)91225-4; Caramelli P, 1996, Sao Paulo Med J, V114, P1255; CARLTON PL, 1987, J CLIN PSYCHIAT, V48, P487; Chan RCK, 2010, SCHIZOPHRENIA BULL, V36, P1089, DOI 10.1093/schbul/sbp011; Chen YLR, 2000, J NERV MENT DIS, V188, P84, DOI 10.1097/00005053-200002000-00004; Cherian A, 1989, Indian J Psychiatry, V31, P224; Conversano C, 2012, HARVARD REV PSYCHIAT, V20, P130, DOI 10.3109/10673229.2012.694318; Critchley MacDonald, 1969, PARIETAL LOBES; Cunningham-Williams RM, 2005, J PSYCHIATR RES, V39, P377, DOI 10.1016/j.jpsychires.2004.09.002; Dannon PN, 2011, BRAIN IMAGING BEHAV, V5, P45, DOI 10.1007/s11682-010-9109-9; Dazzan P, 2004, BRAIN, V127, P143, DOI 10.1093/brain/awh015; Dazzan P, 2008, BRIT J PSYCHIAT, V193, P197, DOI 10.1192/bjp.bp.107.045450; DE GM, 2010, HUM BRAIN MAPP, V31, P1802; DeCaria CM, 1996, J CLIN PSYCHIAT, V57, P80; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Denis C, 2012, DRUG ALCOHOL DEPEN, V122, P22, DOI 10.1016/j.drugalcdep.2011.09.006; Egan MF, 2001, AM J PSYCHIAT, V158, P1827, DOI 10.1176/appi.ajp.158.11.1827; Elman I, 2006, NEUROPSYCHOPHARMACOL, V31, P2091, DOI [10.1038/sj.npp.1301141, 10.1038/sj.npp.1301051]; Elman I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031118; Elman I, 2010, AM J ADDICTION, V19, P332, DOI 10.1111/j.1521-0391.2010.00055.x; Elman I, 2008, J NEUROPSYCH CLIN N, V20, P478, DOI 10.1176/appi.neuropsych.20.4.478; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; First M. B., 2002, USERS GUIDE SCID 1 S; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORBUSH KT, 2005, CNS SPECTRUMS, V13, P306; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Gerstein D., 1999, GAMBLING IMPACT BEHA; Goswami U, 2007, J AFFECT DISORDERS, V103, P99, DOI 10.1016/j.jad.2007.01.009; Goudriaan AE, 2004, NEUROSCI BIOBEHAV R, V28, P123, DOI 10.1016/j.neubiorev.2004.03.001; Grinols EL., 2004, GAMBLING AM COSTS BE; Grisham JR, 2011, PSYCH MED, P1; Gurvits TV, 2006, ARCH GEN PSYCHIAT, V63, P571, DOI 10.1001/archpsyc.63.5.571; Gurvits TV, 2002, PSYCHIAT RES, V112, P263, DOI 10.1016/S0165-1781(02)00234-2; Gurvits TV, 2000, ARCH GEN PSYCHIAT, V57, P181, DOI 10.1001/archpsyc.57.2.181; HEINRICHS DW, 1988, AM J PSYCHIAT, V145, P11; Hollander E, 1991, J Neuropsychiatry Clin Neurosci, V3, P186; Hollander E, 2005, J NEUROPSYCH CLIN N, V17, P472, DOI 10.1176/appi.neuropsych.17.4.472; HOLLANDER E, 1990, ARCH GEN PSYCHIAT, V47, P27; Hollander E, 2007, CNS SPECTRUMS, V12, P5, DOI 10.1017/S1092852900002467; Hsue PY, 2002, CIRCULATION, V105, P1592, DOI 10.1161/01.CIR.0000012524.44897.3A; HUR JW, 2012, CNS SPECTRUMS, P1; Ibrahim GM, 2012, STROKE, V43, P2102, DOI 10.1161/STROKEAHA.112.658153; Inui T, 2000, NEUROSCI LETT, V282, P145, DOI 10.1016/S0304-3940(00)00899-5; Ismail B, 1998, AM J PSYCHIAT, V155, P1695, DOI 10.1176/ajp.155.12.1695; JAAFARI N, 2012, PSYCHOL MED, P1; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; Kalechstein AD, 2007, J NEUROPSYCH CLIN N, V19, P298, DOI 10.1176/appi.neuropsych.19.3.298; Karadag F, 2011, PROG NEURO-PSYCHOPH, V35, P1074, DOI 10.1016/j.pnpbp.2011.03.003; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krebs MO, 2000, SCHIZOPHR RES, V45, P245, DOI 10.1016/S0920-9964(99)00206-6; Krueger THC, 2005, NEUROPSYCHOBIOLOGY, V52, P206, DOI 10.1159/000089004; Lange RA, 2001, NEW ENGL J MED, V345, P351, DOI 10.1056/NEJM200108023450507; Langenbucher J, 2001, PSYCHOL ADDICT BEHAV, V15, P77, DOI 10.1037/0893-164X.15.1.77; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Lobo DSS, 2009, ADDICTION, V104, P1454, DOI 10.1111/j.1360-0443.2009.02671.x; LURIA AR, 1966, HIGH CORTICAL FUNCTI; Marazziti Donatella, 2008, Clin Pract Epidemiol Ment Health, V4, P7, DOI 10.1186/1745-0179-4-7; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Mergl R, 2005, PSYCHOPHARMACOLOGY, V179, P826, DOI 10.1007/s00213-004-2115-0; Mergl R, 2004, PSYCHOPHARMACOLOGY, V171, P179, DOI 10.1007/s00213-003-1568-x; Meyer G, 2000, BIOL PSYCHIAT, V48, P948, DOI 10.1016/S0006-3223(00)00888-X; Meyer G, 2004, PSYCHONEUROENDOCRINO, V29, P1272, DOI 10.1016/j.psyneuen.2004.03.005; MONEY J, 1965, ROAD MAP TEST DIRECT; Moodie C, 2005, ADDICTION, V100, P51, DOI 10.1111/j.1360-0443.2005.00942.x; Nanda A, 2006, ACTA NEUROCHIR SUPPL, V96, P91; Negash A, 2004, J AFFECT DISORDERS, V80, P221, DOI 10.1016/S0165-0327(03)00116-2; Neiman J, 2000, EUR J NEUROL, V7, P595, DOI 10.1046/j.1468-1331.2000.00045.x; Nishida Y, 2001, NEUROREPORT, V12, P2259, DOI 10.1097/00001756-200107200-00043; O'Connor AD, 2005, MED CLIN N AM, V89, P1343, DOI 10.1016/j.mcna.2005.06.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patankar V C, 2012, Indian J Psychiatry, V54, P159, DOI 10.4103/0019-5545.99540; Patrizi R, 2006, J AM COLL CARDIOL, V47, P2120, DOI 10.1016/j.jacc.2005.12.060; Peralta V, 2010, PSYCHOL MED, V22, P1; Potenza MN, 2003, AM J PSYCHIAT, V160, P1990, DOI 10.1176/appi.ajp.160.11.1990; Potenza MN, 2001, JAMA-J AM MED ASSOC, V286, P141, DOI 10.1001/jama.286.2.141; Prasad KM, 2009, SCHIZOPHR RES, V108, P163, DOI 10.1016/j.schres.2008.11.019; RIEDER RO, 1979, ARCH GEN PSYCHIAT, V36, P665; Robledo-Carmona J, 2006, INT J CARDIOL, V112, P130, DOI 10.1016/j.ijcard.2005.09.058; ROY A, 1988, ARCH GEN PSYCHIAT, V45, P369; SEYMOUR GE, 1976, J PSYCHOSOM RES, V20, P469, DOI 10.1016/0022-3999(76)90011-8; Shaffer HJ, 1997, SUBST USE MISUSE, V32, P1573, DOI 10.3109/10826089709055879; SHARPE L, 1995, ADDICTION, V90, P1529, DOI 10.1111/j.1360-0443.1995.tb02815.x; Sharpe L, 2004, J GAMBL STUD, V20, P95, DOI 10.1023/B:JOGS.0000016706.96540.43; Smith RC, 1999, SCHIZOPHRENIA BULL, V25, P813, DOI 10.1093/oxfordjournals.schbul.a033421; STEIN DJ, 1993, J NEUROPSYCH CLIN N, V5, P9; Steinhauer JR, 2001, CARDIOVASC PATHOL, V10, P141, DOI 10.1016/S1054-8807(01)00074-6; Strickland TL, 1998, NEUROPSYCHOL REV, V8, P1, DOI 10.1023/A:1025613322003; STRUB RL, 2000, CONSTRUCTIONAL ABILI; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Thalemann R, 2007, BEHAV NEUROSCI, V121, P614, DOI 10.1037/0735-7044.121.3.614; THIENEMANN M, 1995, J NEUROPSYCH CLIN N, V7, P218; TONKONOGY IM, 1973, INTRO CLIN NEUROPSYC; Topf JL, 2009, J ADDICT MED, V3, P111, DOI 10.1097/ADM.0b013e31819b7bff; Tschuor C, 2008, CRIT CARE, V12, DOI 10.1186/cc6931; TUOR UI, 1990, BRAIN RES, V529, P224, DOI 10.1016/0006-8993(90)90831-U; van Holst RJ, 2010, CURR PSYCHIAT REP, V12, P418, DOI 10.1007/s11920-010-0141-7; van Holst RJ, 2010, NEUROSCI BIOBEHAV R, V34, P87, DOI 10.1016/j.neubiorev.2009.07.007; VIDAL MS, 2012, BMJ CASE REP; Welte JW, 2004, J GAMBL STUD, V20, P405, DOI 10.1007/s10899-004-4582-y; Westover AN, 2007, ARCH GEN PSYCHIAT, V64, P495, DOI 10.1001/archpsyc.64.4.495; Wohl MJA, 2008, J GAMBL STUD, V24, P79, DOI 10.1007/s10899-007-9080-6; WOODS BT, 1985, BIOL PSYCHIAT, V20, P192, DOI 10.1016/0006-3223(85)90081-2	110	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60885	10.1371/journal.pone.0060885	http://dx.doi.org/10.1371/journal.pone.0060885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RK	23593341	Green Submitted, gold, Green Published			2022-12-27	WOS:000319108100067
J	Rattray, I; Smith, E; Gale, R; Matsumoto, K; Bates, GP; Modo, M				Rattray, Ivan; Smith, Edward; Gale, Richard; Matsumoto, Kaoru; Bates, Gillian P.; Modo, Michel			Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/2 Mouse Model of HD	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HUNTINGTONS-DISEASE MUTATION; KNOCK-IN MICE; TRANSGENIC MICE; MUTANT HUNTINGTIN; SEX-DIFFERENCES; BASAL GANGLIA; CAG REPEAT; EXON-1; IRON	Huntington's disease (HD) is caused by the expansion of a CAG repeat in the huntingtin (HTT) gene. The R6/2 mouse model of HD expresses a mutant version of exon 1 HTT and develops motor and cognitive impairments, a widespread huntingtin (HTT) aggregate pathology and brain atrophy. Despite the vast number of studies that have been performed on this model, the association between the molecular and cellular neuropathology with brain atrophy, and with the development of behavioral phenotypes remains poorly understood. In an attempt to link these factors, we have performed longitudinal assessments of behavior (rotarod, open field, passive avoidance) and of regional brain abnormalities determined through magnetic resonance imaging (MRI) (whole brain, striatum, cortex, hippocampus, corpus callosum), as well as an end-stage histological assessment. Detailed correlative analyses of these three measures were then performed. We found a gender-dependent emergence of motor impairments that was associated with an age-related loss of regional brain volumes. MRI measurements further indicated that there was no striatal atrophy, but rather a lack of striatal growth beyond 8 weeks of age. T2 relaxivity further indicated tissue-level changes within brain regions. Despite these dramatic motor and neuroanatomical abnormalities, R6/2 mice did not exhibit neuronal loss in the striatum or motor cortex, although there was a significant increase in neuronal density due to tissue atrophy. The deposition of the mutant HTT (mHTT) protein, the hallmark of HD molecular pathology, was widely distributed throughout the brain. End-stage histopathological assessments were not found to be as robustly correlated with the longitudinal measures of brain atrophy or motor impairments. In conclusion, modeling pre-manifest and early progression of the disease in more slowly progressing animal models will be key to establishing which changes are causally related.	[Rattray, Ivan; Smith, Edward; Matsumoto, Kaoru; Modo, Michel] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Smith, Edward; Gale, Richard; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Modo, Michel] Univ Pittsburgh, Dept Radiol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA	University of London; King's College London; University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Modo, M (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England.	modomm@upmc.edu	; Bates, Gillian/E-1146-2012	Modo, Michel/0000-0003-4436-735X; Bates, Gillian/0000-0002-4041-6305	Medical Research Council [G0800846]; CHDI Foundation; MRC [G0800846] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CHDI Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (G0800846) and CHDI Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2012, NEUROIMAGE, V60, P2086, DOI 10.1016/j.neuroimage.2012.01.141; Aylward EH, 2012, BIOL PSYCHIAT, V71, P822, DOI 10.1016/j.biopsych.2011.07.030; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Bartzokis G, 1999, ARCH NEUROL-CHICAGO, V56, P569, DOI 10.1001/archneur.56.5.569; Bartzokis G, 2007, NEUROCHEM RES, V32, P1655, DOI 10.1007/s11064-007-9352-7; Bode FJ, 2008, HUM MOL GENET, V17, P2595, DOI 10.1093/hmg/ddn159; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cowin RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028409; Delmaire C, 2013, HUM BRAIN MAPP, V34, P2141, DOI 10.1002/hbm.22055; DEXTER DT, 1992, ANN NEUROL, V32, pS94, DOI 10.1002/ana.410320716; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Dumas EM, 2012, NEUROIMAGE, V61, P558, DOI 10.1016/j.neuroimage.2012.03.056; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hickey MA, 2005, NEUROBIOL DIS, V20, P1, DOI 10.1016/j.nbd.2005.01.024; Jurgens CK, 2010, PLOS CURR, P2; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kusakabe M, 2001, J COMP NEUROL, V430, P485, DOI 10.1002/1096-9861(20010219)430:4<485::AID-CNE1045>3.0.CO;2-6; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Ma L, 2003, GLIA, V43, P274, DOI 10.1002/glia.10261; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Meade CA, 2002, J COMP NEUROL, V449, P241, DOI 10.1002/cne.10295; Menalled LB, 2002, J NEUROSCI, V22, P8266; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Mouton PR, 2011, UNBIASED STEREOLOGY; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rosas HD, 2012, ARCH NEUROL-CHICAGO, V69, P887, DOI 10.1001/archneurol.2011.2945; Sadikot AF, 1997, J COMP NEUROL, V389, P193; Samadi P, 2013, GENES BRAIN BEHAV, V12, P108, DOI 10.1111/j.1601-183X.2012.00858.x; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P12, DOI 10.1016/j.nbd.2008.09.017; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Stout JC, 2012, J NEUROL NEUROSUR PS, V83, P687, DOI 10.1136/jnnp-2011-301940; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Vymazal J, 2007, J NEUROL SCI, V263, P20, DOI 10.1016/j.jns.2007.05.018; Welker KM, 2012, SEMIN NEUROL, V32, P15, DOI 10.1055/s-0032-1306382; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wood NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009077; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Zacharoff L, 2012, J CEREBR BLOOD F MET, V32, P502, DOI 10.1038/jcbfm.2011.157; Zarringhalam K, 2012, BEHAV BRAIN RES, V229, P216, DOI 10.1016/j.bbr.2012.01.015; Zhang JY, 2010, NEUROIMAGE, V49, P2340, DOI 10.1016/j.neuroimage.2009.10.027	56	36	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60012	10.1371/journal.pone.0060012	http://dx.doi.org/10.1371/journal.pone.0060012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593159	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000319108100014
J	Jin, X; Pang, Y; Jia, FX; Xiao, GH; Li, Q; Zhu, YX				Jin, Xiang; Pang, Yu; Jia, Fangxing; Xiao, Guanghui; Li, Qin; Zhu, Yuxian			A Potential Role for CHH DNA Methylation in Cotton Fiber Growth Patterns	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; CYTOSINE METHYLATION; CLOCK; DEMETHYLATION; GENES; METHYLTRANSFERASES; MAINTENANCE; EXPRESSION; ETHYLENE; PLANTS	DNA methylation controls many aspects of plant growth and development. Here, we report a novel annual growth potential change that may correlate with changes in levels of the major DNA demethylases and methyltransferases in cotton ovules harvested at different times of the year. The abundances of DNA demethylases, at both the mRNA and protein levels, increased significantly from February to August and decreased during the remainder of the 12-month period, with the opposite pattern observed for DNA methyltransferases. Over the course of one year, substantial changes in methylcytosine content was observed at certain CHH sites (H = A, C, or T) in the promoter regions of the ETHYLENE RESPONSIVE FACTOR 6 (ERF6), SUPPRESSION OF RVS 161 DELTA 4 (SUR4) and 3-KETOACYL-COA SYNTHASE 13 (KCS13), which regulate cotton fiber growth. Three independent techniques were used to confirm the annual fluctuations in DNA methylation. Furthermore, in homozygous RNAi lines specifically targeting REPRESSOR OF SILENCING 1 (ROS1, a conserved DNA demethylase domain), promotion of DNA methylation significantly reduced fiber growth during August.	[Jin, Xiang; Pang, Yu; Jia, Fangxing; Xiao, Guanghui; Li, Qin; Zhu, Yuxian] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Zhu, Yuxian] Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences	Zhu, YX (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	zhuyx2@pku.edu.cn	Li, Qin/AAP-9448-2020	Li, Qin/0000-0002-8948-2717; Zhu, Yuxian/0000-0003-2371-5933	China National Basic Research Program [2010CB126002]; National Natural Science Foundation of China [90717009]; 111 Project; Chinese Ministry of Education	China National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by grants from the China National Basic Research Program (Grant number 2010CB126002), the National Natural Science Foundation of China (Grant number 90717009), and the 111 Project funded by the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Berdasco M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003306; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1732; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dong WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003105; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Han P, 2008, PLANT CELL, V20, P1482, DOI 10.1105/tpc.108.058867; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Henderson IR, 2010, EPIGENETICS-US, V5, P47, DOI 10.4161/epi.5.1.10560; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li HB, 2007, NEW PHYTOL, V175, P462, DOI 10.1111/j.1469-8137.2007.02120.x; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Singh A, 2008, PLANT J, V56, P814, DOI 10.1111/j.1365-313X.2008.03640.x; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yan HH, 2010, PLANT J, V63, P353, DOI 10.1111/j.1365-313X.2010.04246.x; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhu JK, 2008, CELL, V133, P395, DOI 10.1016/j.cell.2008.04.016	38	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60547	10.1371/journal.pone.0060547	http://dx.doi.org/10.1371/journal.pone.0060547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593241	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300019
J	Venuti, S; Copetti, D; Foria, S; Falginella, L; Hoffmann, S; Bellin, D; Cindric, P; Kozma, P; Scalabrin, S; Morgante, M; Testolin, R; Di Gaspero, G				Venuti, Silvia; Copetti, Dario; Foria, Serena; Falginella, Luigi; Hoffmann, Sarolta; Bellin, Diana; Cindric, Petar; Kozma, Pal; Scalabrin, Simone; Morgante, Michele; Testolin, Raffaele; Di Gaspero, Gabriele			Historical Introgression of the Downy Mildew Resistance Gene Rpv12 from the Asian Species Vitis amurensis into Grapevine Varieties	PLOS ONE			English	Article							LOCUS; MAP	The Amur grape (Vitis amurensis Rupr.) thrives naturally in cool climates of Northeast Asia. Resistance against the introduced pathogen Plasmopara viticola is common among wild ecotypes that were propagated from Manchuria into Chinese vineyards or collected by Soviet botanists in Siberia, and used for the introgression of resistance into wine grapes (Vitis vinifera L.). A QTL analysis revealed a dominant gene Rpv12 that explained 79% of the phenotypic variance for downy mildew resistance and was inherited independently of other resistance genes. A Mendelian component of resistance-a hypersensitive response in leaves challenged with P. viticola-was mapped in an interval of 0.2 cM containing an array of coiled-coil NB-LRR genes on chromosome 14. We sequenced 10-kb genic regions in the Rpv12(+) haplotype and identified polymorphisms in 12 varieties of V. vinifera using next-generation sequencing. The combination of two SNPs in single-copy genes flanking the NB-LRR cluster distinguished the resistant haplotype from all others found in 200 accessions of V. vinifera, V. amurensis, and V. amurensis x V. vinifera crosses. The Rpv12(+) haplotype is shared by 15 varieties, the most ancestral of which are the century-old 'Zarja severa' and 'Michurinets'. Before this knowledge, the chromosome segment around Rpv12(+) became introgressed, shortened, and pyramided with another downy mildew resistance gene from North American grapevines (Rpv3) only by phenotypic selection. Rpv12(+) has an additive effect with Rpv3(+) to protect vines against natural infections, and confers foliar resistance to strains that are virulent on Rpv3(+) plants.	[Copetti, Dario; Scalabrin, Simone; Morgante, Michele; Testolin, Raffaele; Di Gaspero, Gabriele] Ist Genom Applicata Parco Sci & Tecnol Luigi Dani, Udine, Italy; [Hoffmann, Sarolta; Kozma, Pal] Univ Pecs, Res Inst Viticulture & Enol, Pecs, Hungary; [Cindric, Petar] Univ Novi Sad, Fac Agr, Novi Sad 21000, Serbia	University of Pecs; University of Novi Sad	Di Gaspero, G (corresponding author), Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy.	gabriele.digaspero@uniud.it	Testolin, Raffaele/J-5306-2019; BELLIN, Diana/AAJ-9376-2021; Di Gaspero, Gabriele/AAF-2982-2020; Bellin, Diana/GZH-1880-2022	BELLIN, Diana/0000-0002-0308-7733; Bellin, Diana/0000-0002-0308-7733; di gaspero, gabriele/0000-0001-5810-2163; Copetti, Dario/0000-0002-2680-2568; MORGANTE, Michele/0000-0003-2591-2156	European Research Council under the European Union's Seventh Framework Programme (FP) [294780]; Regional Government of Friuli Venezia Giulia, Grape Breeding Project	European Research Council under the European Union's Seventh Framework Programme (FP)(European Research Council (ERC)); Regional Government of Friuli Venezia Giulia, Grape Breeding Project	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n.294780 (http://erc.europa.eu) and from the Regional Government of Friuli Venezia Giulia, Grape Breeding Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacilieri R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-25; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Blasi P, 2011, THEOR APPL GENET, V123, P43, DOI 10.1007/s00122-011-1565-0; Cannon SB, 2002, J MOL EVOL, V54, P548, DOI [10.1007/s00239-001-0057-2, 10.1007/s0023901-0057-2]; Casagrande K, 2011, PLANTA, V234, P1097, DOI 10.1007/s00425-011-1461-5; Di Gaspero G, 2007, THEOR APPL GENET, V114, P1249, DOI 10.1007/s00122-007-0516-2; Di Gaspero G, 2012, THEOR APPL GENET, V124, P277, DOI 10.1007/s00122-011-1703-8; Dick MW, 2002, ADVANCES IN DOWNY MILDEW RESEARCH, P1, DOI 10.1007/0-306-47914-1_1; Fangmei L, 1989, P 5 INT S GRAP BREED, P212; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Koleda I., 1975, Vitis, V14, P1; Loskutov I.G., 1999, VAVILOV HIS I HIST W, DOI 10.13140/2.1.2632.0644; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Merdinoglu D, 2003, ACTA HORTIC, P451, DOI 10.17660/ActaHortic.2003.603.57; Moroldo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-66; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Schwander F, 2012, THEOR APPL GENET, V124, P163, DOI 10.1007/s00122-011-1695-4; Wan YZ, 2008, VITIS, V47, P81; Wan YZ, 2008, VITIS, V47, P77; Wan YZ, 2007, VITIS, V46, P132; Wang Jun, 2004, Journal of Northeast Forestry University, V32, P29; Zecca G, 2012, MOL PHYLOGENET EVOL, V62, P736, DOI 10.1016/j.ympev.2011.11.015	22	85	90	0	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61228	10.1371/journal.pone.0061228	http://dx.doi.org/10.1371/journal.pone.0061228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593440	gold, Green Submitted, Green Published			2022-12-27	WOS:000317385300065
J	Ruiz-de la Torre, MC; Maske, H; Ochoa, J; Almeda-Jauregui, CO				Carmen Ruiz-de la Torre, Mary; Maske, Helmut; Ochoa, Jose; Almeda-Jauregui, Cesar O.			Maintenance of Coastal Surface Blooms by Surface Temperature Stratification and Wind Drift	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; DIURNAL VERTICAL MIGRATION; RED-TIDE; DINOFLAGELLATE; OCEAN; PHYTOPLANKTON; SEA; POPULATION; THERMOCLINE; TRANSPORT	Algae blooms are an increasingly recurrent phenomenon of potentially socio-economic impact in coastal waters globally and in the coastal upwelling region off northern Baja California, Mexico. In coastal upwelling areas the diurnal wind pattern is directed towards the coast during the day. We regularly found positive Near Surface Temperature Stratification (NSTS), the resulting density stratification is expected to reduce the frictional coupling of the surface layer from deeper waters and allow for its more efficient wind transport. We propose that the net transport of the top layer of approximately 2.7 kilometers per day towards the coast helps maintain surface blooms of slow growing dinoflagellate such as Lingulodinium polyedrum. We measured: near surface stratification with a free-rising CTD profiler, trajectories of drifter buoys with attached thermographs, wind speed and direction, velocity profiles via an Acoustic Doppler Current Profiler, Chlorophyll and cell concentration from water samples and vertical migration using sediment traps. The ADCP and drifter data agree and show noticeable current shear within the first meters of the surface where temperature stratification and high cell densities of L. polyedrum were found during the day. Drifters with 1m depth drogue moved towards the shore, whereas drifters at 3 and 5 m depth showed trajectories parallel or away from shore. A small part of the surface population migrated down to the sea floor during night thus reducing horizontal dispersion. The persistent transport of the surface bloom population towards shore should help maintain the bloom in favorable environmental conditions with high nutrients, but also increasing the potential socioeconomic impact of the blooms. The coast wise transport is not limited to blooms but includes all dissolved and particulate constituents in surface waters.	[Carmen Ruiz-de la Torre, Mary; Maske, Helmut; Ochoa, Jose; Almeda-Jauregui, Cesar O.] Ctr Invest Cient & Educ Super Ensenada, Biol Oceanog Dept, Ensenada, Baja California, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Ruiz-de la Torre, MC (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Biol Oceanog Dept, Ensenada, Baja California, Mexico.	mcruiz@cicese.edu.mx	de la Torre, Jose Luis Ochoa/AAH-2120-2019	de la Torre, Jose Luis Ochoa/0000-0001-6121-3972; /0000-0002-5566-6294; Maske, Helmut/0000-0002-8047-6484	Nortek USA; Nortek Student Equipment Grant	Nortek USA; Nortek Student Equipment Grant	Nortek USA supported this research with a 7th student grant including an ADCP loan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ruth Gingold (sweepandmore.com) for the critical revision of an earlier version of this manuscript. The ADCP current profiler was on loan from Nortek Student Equipment Grant. We also thank SEMAR, Segunda Region Naval for providing local wind data. The manuscript was very thoroughly and constructively reviewed by an anonymous reviewer.	ALVAREZ L. G., 1988, CIENC MAR, V14, P135, DOI [10.7773/cm.v14i4.609, DOI 10.7773/CM.V14I4.609]; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Bissett W. Paul, 2001, Oceanography, V14, P30; Burkholder JM, 2006, ECOL STU AN, V189, P53, DOI 10.1007/978-3-540-32210-8_5; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Cheriton OM, 2009, MAR ECOL PROG SER, V378, P55, DOI 10.3354/meps07847; Cullen J.J., 1985, Contributions in Marine Science, V27, P135; Cullen J.J., 1998, NAT ASI SER G ECOL S, V41, P559; CULLEN JJ, 1981, MAR BIOL, V62, P81, DOI 10.1007/BF00388169; Dekshenieks MM, 2001, MAR ECOL PROG SER, V223, P61, DOI 10.3354/meps223061; DIETRICH G, 1975, ALLGEMEINE MEERESKUN, P593; Doblin MA, 2006, HARMFUL ALGAE, V5, P665, DOI 10.1016/j.hal.2006.02.002; Donaghay PL, 1997, LIMNOL OCEANOGR, V42, P1283, DOI 10.4319/lo.1997.42.5_part_2.1283; Donlon CJ, 2002, J CLIMATE, V15, P353, DOI 10.1175/1520-0442(2002)015<0353:TIVOSS>2.0.CO;2; DORTCH Q, 1982, MAR ECOL PROG SER, V9, P299, DOI 10.3354/meps009299; ESPINOZA MLA, 1991, ATMOSFERA, V4, P101; Fiedler PC, 2010, LIMNOL OCEANOGR-METH, V8, P313, DOI 10.4319/lom.2010.8.313; Gentemann CL, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004825; Gentemann CL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004540; Gentemann CL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016291; Gentien Patrick, 2005, Oceanography, V18, P172; Gilbert P.M., 2005, OCEANOGRAPHY, V18, P136, DOI DOI 10.5670/0CEA-N0G.2005.49; Glibert PM, 2006, ECOL STU AN, V189, P341, DOI 10.1007/978-3-540-32210-8_26; Haase AT, 2012, ESTUAR COAST SHELF S, V101, P33, DOI 10.1016/j.ecss.2012.02.011; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; HEANEY S I, 1981, Journal of Plankton Research, V3, P331, DOI 10.1093/plankt/3.2.331; Hernandez-Walls R, 1986, THESIS UABC LIEENCIA; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimate1388, 10.1038/NCLIMATE1388]; Hyder P, 2011, CONT SHELF RES, V31, P1576, DOI 10.1016/j.csr.2011.06.001; Ji RB, 2007, MAR ECOL PROG SER, V344, P49, DOI 10.3354/meps06952; Juhl AR, 2002, J PHYCOL, V38, P683, DOI 10.1046/j.1529-8817.2002.00165.x; Kamykowski D, 1997, LIMNOL OCEANOGR, V42, P1189, DOI 10.4319/lo.1997.42.5_part_2.1189; KAMYKOWSKI D, 1977, LIMNOL OCEANOGR, V22, P148, DOI 10.4319/lo.1977.22.1.0148; Kaplan DM, 2003, ESTUAR COAST SHELF S, V57, P385, DOI 10.1016/S0272-7714(02)00363-3; Katano Toshiya, 2011, Plankton & Benthos Research, V6, P92; Kirkpatrick B, 2006, HARMFUL ALGAE, V5, P526, DOI 10.1016/j.hal.2005.09.004; Kudela Raphael, 2005, Oceanography, V18, P184; Lewitus AJ, 2012, HARMFUL ALGAE, V19, P133, DOI 10.1016/j.hal.2012.06.009; Lucas AJ, 2012, DEEP SEA RES 2; MacIntyre JG, 1997, MAR ECOL PROG SER, V148, P201, DOI 10.3354/meps148201; Maske H, 2012, LIMNOL OCEANOGR-METH, V10, P475, DOI 10.4319/lom.2012.10.475; McManus MA, 2012, J EXP BIOL, V215, P1008, DOI 10.1242/jeb.059014; Minnett P, 2003, INT J REMOTE SENS, V24, P5033, DOI 10.1080/0143116031000095880; Minnett PJ, 2011, DEEP-SEA RES PT II, V58, P861, DOI 10.1016/j.dsr2.2010.10.024; Noh Y, 2009, J PHYS OCEANOGR, V39, P1244, DOI 10.1175/2008JPO4032.1; Omand MM, 2011, LIMNOL OCEANOGR, V56, P787, DOI 10.4319/lo.2011.56.3.0787; Pena-Manjarrez JL, 2005, CONT SHELF RES, V25, P1375, DOI 10.1016/j.csr.2005.02.002; Pierce RH, 2011, J PLANKTON RES, V33, P343, DOI 10.1093/plankt/fbq115; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; PRICE JF, 1987, SCIENCE, V238, P1534, DOI 10.1126/science.238.4833.1534; Ruddick KG, 2006, LIMNOL OCEANOGR, V51, P1167, DOI 10.4319/lo.2006.51.2.1167; Shulman I, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007480; Simpson J. E., 1994, SEA BREEZE LOCAL WIN; Sinclair GA, 2008, J PLANKTON RES, V30, P829, DOI 10.1093/plankt/fbn042; Smayda TJ, 2010, PROG OCEANOGR, V85, P71, DOI 10.1016/j.pocean.2010.02.005; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; Tang YQ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012644, 10.1371/journal.pone.0015631]; Tang YZ, 2007, APPL ENVIRON MICROB, V73, P2306, DOI 10.1128/AEM.01741-06; Tapia FJ, 2004, CONT SHELF RES, V24, P1573, DOI 10.1016/j.csr.2004.03.013; Tobin ED, 2011, HARMFUL ALGAE, V10, P619, DOI 10.1016/j.hal.2011.04.014; Townsend DW, 2001, CONT SHELF RES, V21, P347, DOI 10.1016/S0278-4343(00)00093-5; Ward B, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002689; Ward B, 2004, J ATMOS OCEAN TECH, V21, P207, DOI 10.1175/1520-0426(2004)021<0207:SAPIFU>2.0.CO;2; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Yamamoto T, 2000, J PLANKTON RES, V22, P363, DOI 10.1093/plankt/22.2.363	65	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e58958	10.1371/journal.pone.0058958	http://dx.doi.org/10.1371/journal.pone.0058958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593127	gold, Green Published, Green Submitted			2022-12-27	WOS:000317383200001
J	Sheridan, J; Mack, DR; Amre, DK; Israel, DM; Cherkasov, A; Li, HF; Grimard, G; Steiner, TS				Sheridan, Jared; Mack, David R.; Amre, Devendra K.; Israel, David M.; Cherkasov, Artem; Li, Huifang; Grimard, Guy; Steiner, Theodore S.			A Non-Synonymous Coding Variant (L616F) in the TLR5 Gene Is Potentially Associated with Crohn's Disease and Influences Responses to Bacterial Flagellin	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; CANADIAN CHILDREN; DEFICIENT MICE; RECEPTOR; COLITIS; SUSCEPTIBILITY; PROTECTS; TOLL-LIKE-RECEPTOR-5; RADIATION	Background and Objectives: Although numerous studies have implicated TLR5, or its ligands, bacterial flagellins, in the pathogenesis of Crohn's disease (CD), genome-wide association studies (GWAS) have not reported associations with the TLR5 gene. We aimed to examine potential CD-associated TLR5 variants and assess whether they modified inflammatory responses to bacterial flagellins. Methods and Principal Results: A two-stage study was carried out. In stage 1, we genotyped tagging single-nucleotide polymorphisms (tag-SNPs) in the TLR5 gene in a sample of CD cases (<20 years of age, N = 566) and controls (N = 536). Single SNP and haplotype analysis was carried out. In Stage 2, we assessed the functional significance of potential CD-associated variant(s) vis-a-vis effects on the inflammatory response to bacterial flagellin using HEK293T cells. We observed marginal association between a non-synonymous coding SNP rs5744174 (p = 0.05) and CD. Associations between SNP rs851139 that is in high linkage disequilibrium (LD) with SNP rs5744174 were also suggested (p = 0.07). Haplotype analysis revealed that a 3 marker haplotype was significantly associated with CD (p = 0.01). Functional studies showed that the risk allele (616F) (corresponding to the C allele of SNP rs5744174) conferred significantly greater production of CCL20 in response to a range of flagellin doses than the comparator allele (616L). Conclusions: Our findings suggest that a non-synonymous coding variation in the TLR5 gene may confer modest susceptibility for CD.	[Sheridan, Jared; Steiner, Theodore S.] Vancouver Hosp, Div Infect Dis, Vancouver, BC, Canada; [Sheridan, Jared; Steiner, Theodore S.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Mack, David R.] Childrens Hosp Eastern Ontario, Div Gastroenterol, Ottawa, ON K1H 8L1, Canada; [Amre, Devendra K.; Grimard, Guy] CHU Ste Justine, Res Ctr, Montreal, PQ, Canada; [Amre, Devendra K.; Grimard, Guy] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Israel, David M.] British Columbia Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Vancouver, BC, Canada; [Cherkasov, Artem; Li, Huifang] Vancouver Coastal Res Inst, Prostate Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Ottawa; Children's Hospital of Eastern Ontario; Universite de Montreal; Universite de Montreal; BC Childrens Hospital; University of British Columbia; Vancouver Coastal Health Research Institute	Amre, DK (corresponding author), CHU Ste Justine, Res Ctr, Montreal, PQ, Canada.	devendra.amre@umontreal.ca; tsteiner@mail.ubc.ca	Cherkasov, Artem/A-2134-2012; AMRE, DEVENDRA K/D-4988-2015	Steiner, Ted/0000-0002-3136-6668	Canadian Institutes of Health Research (CIHR-IBD NET GRANT, Institute of Infection and Immunity); Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec	Canadian Institutes of Health Research (CIHR-IBD NET GRANT, Institute of Infection and Immunity)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR-IBD NET GRANT, Institute of Infection and Immunity). Dr. Amre was supported by a research salary award from the Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2010, ALIMENT PHARM THER, V31, P1186, DOI 10.1111/j.1365-2036.2010.04294.x; Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Amre DK, 2008, AM J GASTROENTEROL, V103, P615, DOI 10.1111/j.1572-0241.2007.01661.x; Amre DK, 2010, HUM GENET, V128, P131, DOI 10.1007/s00439-010-0835-2; Amre DK, 2009, AM J GASTROENTEROL, V104, P2824, DOI 10.1038/ajg.2009.430; Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2012, INT J RADIAT ONCOL, V83, P228, DOI 10.1016/j.ijrobp.2011.05.055; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carvalho FA, 2012, GUT, V61, P373, DOI 10.1136/gut.2011.240556; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hardenberg G, 2012, INFLAMM BOWEL DIS, V18, P85, DOI 10.1002/ibd.21738; Himmel ME, 2008, IMMUNOLOGY, V125, P145, DOI 10.1111/j.1365-2567.2008.02939.x; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Ivison SM, 2007, BIOCHEM BIOPH RES CO, V352, P936, DOI 10.1016/j.bbrc.2006.11.132; Ivison SM, 2010, INFLAMM BOWEL DIS, V16, P401, DOI 10.1002/ibd.21097; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Shen C, 2008, INFLAMM BOWEL DIS, V14, P1641, DOI 10.1002/ibd.20645; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Zhou KF, 2012, J STRUCT BIOL, V177, P402, DOI 10.1016/j.jsb.2011.12.002	25	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61326	10.1371/journal.pone.0061326	http://dx.doi.org/10.1371/journal.pone.0061326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593463	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200051
J	Zou, DY; Coudron, TA; Liu, CX; Zhang, LS; Wang, MQ; Chen, HY				Zou, Deyu; Coudron, Thomas A.; Liu, Chenxi; Zhang, Lisheng; Wang, Mengqing; Chen, Hongyin			Nutrigenomics in Arma chinensis: Transcriptome Analysis of Arma chinensis Fed on Artificial Diet and Chinese Oak Silk Moth Antheraea pernyi Pupae	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; GENE-EXPRESSION; SPERM COMPETITION; SEMINAL FLUID; COST-ANALYSIS; LIFE-HISTORY; BED BUG; DROSOPHILA; GROWTH; TOR	Background: The insect predator, Arma chinensis, is capable of effectively controlling many pests, such as Colorado potato beetle, cotton bollworm, and mirid bugs. Our previous study demonstrated several life history parameters were diminished for A. chinensis reared on an artificial diet compared to a natural food source like the Chinese oak silk moth pupae. The molecular mechanisms underlying the nutritive impact of the artificial diet on A. chinensis health are unclear. So we utilized transcriptome information to better understand the impact of the artificial diet on A. chinensis at the molecular level. Methodology/Principal Findings: Illumina HiSeq2000 was used to sequence 4.79 and 4.70 Gb of the transcriptome from pupae-fed and artificial diet-fed A. chinensis libraries, respectively, and a de novo transcriptome assembly was performed (Trinity short read assembler). This resulted in 112,029 and 98,724 contigs, clustered into 54,083 and 54,169 unigenes for pupae-fed and diet-fed A. chinensis, respectively. Unigenes from each sample's assembly underwent sequence splicing and redundancy removal to acquire non-redundant unigenes. We obtained 55,189 unigenes of A. chinensis, including 12,046 distinct clusters and 43,143 distinct singletons. Unigene sequences were aligned by BLASTx to nr, Swiss-Prot, KEGG and COG (E-value <10(-5)), and further aligned by BLASTn to nt (E-value <10(-5)), retrieving proteins of highest sequence similarity with the given unigenes along with their protein functional annotations. Totally, 22,964, 7,898, 18,069, 15,416, 8,066 and 5,341 unigenes were annotated in nr, nt, Swiss-Prot, KEGG, COG and GO, respectively. We compared gene expression variations and found thousands of genes were differentially expressed between pupae-fed and diet-fed A. chinensis. Conclusions/Significance: Our study provides abundant genomic data and offers comprehensive sequence information for studying A. chinensis. Additionally, the physiological roles of the differentially expressed genes enable us to predict effects of some dietary ingredients and subsequently propose formulation improvements to artificial diets.	[Zou, Deyu; Liu, Chenxi; Zhang, Lisheng; Wang, Mengqing; Chen, Hongyin] Chinese Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing, Peoples R China; [Zou, Deyu; Liu, Chenxi; Zhang, Lisheng; Wang, Mengqing; Chen, Hongyin] ARS, USDA, Sinoamer Biol Control Lab, Beijing, Peoples R China; [Coudron, Thomas A.] ARS, Biol Control Insects Res Lab, USDA, Columbia, MO USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Chen, HY (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing, Peoples R China.	hongyin@gmail.com	Zou, Deyu/HHN-8097-2022		973 Program [2013CB127602]; Special Fund for Agro-scientific Research in the Public Interest [201103002]; Project of International Cooperation of Agriculture of China [2011-G4]; Sino-America Biocontrol International Cooperation Program [58-4001-4-053]	973 Program(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Project of International Cooperation of Agriculture of China; Sino-America Biocontrol International Cooperation Program	This research was supported by the 973 Program (2013CB127602), Special Fund for Agro-scientific Research in the Public Interest (no. 201103002), Project of International Cooperation of Agriculture of China (no. 2011-G4) and Sino-America Biocontrol International Cooperation Program (no. 58-4001-4-053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TS, 2000, ANN ENTOMOL SOC AM, V93, P529, DOI 10.1603/0013-8746(2000)093[0529:EODAMS]2.0.CO;2; Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Baltzer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006935; Benoit JB, 2009, MED VET ENTOMOL, V23, P418, DOI 10.1111/j.1365-2915.2009.00832.x; Cameron E, 2007, AM NAT, V169, pE158, DOI 10.1086/516718; Chai XiMin, 2000, Journal of Zhejiang Forestry Science and Technology, V20, P1; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Chen Jing, 2007, Natural Enemies of Insects, V29, P149; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coudron TA, 2012, BIOL CONTROL, V61, P141, DOI 10.1016/j.biocontrol.2012.01.011; Coudron TA, 2004, J ECON ENTOMOL, V97, P807, DOI 10.1603/0022-0493(2004)097[0807:LHACAF]2.0.CO;2; Coudron TA, 2002, J ECON ENTOMOL, V95, P1159, DOI 10.1603/0022-0493-95.6.1159; Coudron TA, 2011, ARCH INSECT BIOCHEM, V76, P67, DOI 10.1002/arch.20398; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Ferro David N., 1993, American Entomologist, V39, P38; Fricke C, 2009, J EVOLUTION BIOL, V22, P275, DOI 10.1111/j.1420-9101.2008.01638.x; Gao Z, 2010, STUDIES BIOL CHARACT, P11; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Glenister C. S., 1998, PREDATORY HETEROPTER, P199; GLENISTER CS, 1998, MASS REARED NATURAL, P242; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grafius Edward J., 1995, American Entomologist, V41, P104; Greany PD, 1998, US Patent, Patent No. 5799607; Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Haselton A, 2010, CELL CYCLE, V9, P3063, DOI 10.4161/cc.9.15.12458; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hodgson DJ, 2006, J THEOR BIOL, V243, P230, DOI 10.1016/j.jtbi.2006.06.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang SW, 2005, EMERG INFECT DIS, V11, P533, DOI 10.3201/eid1104.041126; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jaworski DC, 2010, INSECT MOL BIOL, V19, P617, DOI 10.1111/j.1365-2583.2010.01037.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Li L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-7; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liang Zhen-Pu, 2006, Chinese Bulletin of Entomology, V43, P147; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Mockett RJ, 1999, FASEB J, V13, P1733, DOI 10.1096/fasebj.13.13.1733; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Olafson PU, 2010, ARCH INSECT BIOCHEM, V74, P179, DOI 10.1002/arch.20372; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; RUBERSON JR, 1998, PREDATORY HETEROPTER, P225; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Sun JT, 1999, MOL CELL BIOL, V19, P216; Thompson SN, 1999, ANNU REV ENTOMOL, V44, P561, DOI 10.1146/annurev.ento.44.1.561; Tiefenbock SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; WHALON ME, 1993, J ECON ENTOMOL, V86, P226, DOI 10.1093/jee/86.2.226; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Wittmeyer JL, 2001, J ECON ENTOMOL, V94, P1344, DOI 10.1603/0022-0493-94.6.1344; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yan Jia-He, 2006, Chinese Bulletin of Entomology, V43, P245; Yan Jia-He, 2006, Chinese Bulletin of Entomology, V43, P562; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yocum GD, 2006, J INSECT PHYSIOL, V52, P586, DOI 10.1016/j.jinsphys.2006.02.006; Yu E. Y., 1993, JILIN FOR SCI TECHNO, V2, P16; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600; Zou DY, 2012, ZOOTAXA, P41, DOI 10.11646/zootaxa.3382.1.4; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	84	15	31	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60881	10.1371/journal.pone.0060881	http://dx.doi.org/10.1371/journal.pone.0060881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593338	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200023
J	Lazenby, JJ; Griffin, PE; Kyd, J; Whitchurch, CB; Cooley, MA				Lazenby, James J.; Griffin, Phoebe E.; Kyd, Jennelle; Whitchurch, Cynthia B.; Cooley, Margaret A.			A Quadruple Knockout of lasIR and rhlIR of Pseudomonas aeruginosa PAO1 That Retains Wild-Type Twitching Motility Has Equivalent Infectivity and Persistence to PAO1 in a Mouse Model of Lung Infection	PLOS ONE			English	Article							QUORUM-SENSING SYSTEMS; CYSTIC-FIBROSIS; PULMONARY INFECTION; VIRULENCE FACTORS; IDENTIFICATION; SEQUENCES; PNEUMONIA; ELASTASE; MUTANTS; SERUM	It has been widely reported that quorum-sensing incapable strains of Pseudomonas aeruginosa are less virulent than wild type strains. However, quorum sensing mutants of P. aeruginosa have been shown to develop other spontaneous mutations under prolonged culture conditions, and one of the phenotypes of P. aeruginosa that is frequently affected by this phenomenon is type IV pili-dependent motility, referred to as twitching motility. As twitching motility has been reported to be important for adhesion and colonisation, we aimed to generate a quorum-sensing knockout for which the heritage was recorded and the virulence factor production in areas unrelated to quorum sensing was known to be intact. We created a lasIRrhlIR quadruple knockout in PAO1 using a published technique that allows for the deletion of antibiotic resistance cartridges following mutagenesis, to create an unmarked QS knockout of PAO1, thereby avoiding the need for use of antibiotics in culturing, which can have subtle effects on bacterial phenotype. We phenotyped this mutant demonstrating that it produced reduced levels of protease and elastase, barely detectable levels of pyoverdin and undetectable levels of the quorum sensing signal molecules N-3-oxododecanoly-L-homoserine lactone and N-butyryl homoserine lactone, but retained full twitching motility. We then used a mouse model of acute lung infection with P. aeruginosa to demonstrate that the lasIRrhlIR knockout strain showed equal persistence to wild type parental PAO1, induced equal or greater neutrophil infiltration to the lungs, and induced similar levels of expression of inflammatory cytokines in the lungs and similar antibody responses, both in terms of magnitude and isotype. Our results suggest, in contrast to previous reports, that lack of quorum sensing alone does not significantly affect the immunogenicity, infectiveness and persistence of P. aeruginosa in a mouse model of acute lung infection.	[Lazenby, James J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Griffin, Phoebe E.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Kyd, Jennelle; Cooley, Margaret A.] CQUniversity, Rockhampton, Qld, Australia; [Whitchurch, Cynthia B.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia	University of New South Wales Sydney; University of Tasmania; Central Queensland University; University of Technology Sydney	Cooley, MA (corresponding author), CQUniversity, Rockhampton, Qld, Australia.	Margaret.Cooley@utas.edu.au	Whitchurch, Cynthia/A-5954-2008	Whitchurch, Cynthia/0000-0003-2296-3791; Griffin, Phoebe/0000-0001-8208-5818; Kyd, Jennelle/0000-0002-3331-3658	National Health and Medical Research Council, Australia [529309]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council, Australia, Grant No 529309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1996, J BACTERIOL, V178, P3809, DOI 10.1128/jb.178.13.3809-3817.1996; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Beatson SA, 2002, J BACTERIOL, V184, P3598, DOI 10.1128/KB.184.13.3598-3604.2002; Bjarnsholt T, 2007, ANAL BIOANAL CHEM, V387, P409, DOI 10.1007/s00216-006-0774-x; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Brennan S, 2008, PAEDIATR RESPIR REV, V9, P271, DOI 10.1016/j.prrv.2008.05.008; BRETT MM, 1986, ARCH DIS CHILD, V61, P1114, DOI 10.1136/adc.61.11.1114; Bryan R, 1999, J INFECT DIS, V179, P1449, DOI 10.1086/314755; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; Glessner A, 1999, J BACTERIOL, V181, P1623, DOI 10.1128/JB.181.5.1623-1629.1999; Hahn HP, 1997, GENE, V192, P99, DOI 10.1016/S0378-1119(97)00116-9; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; KITA E, 1991, J ANTIMICROB CHEMOTH, V27, P273, DOI 10.1093/jac/27.3.273; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Kondo A, 2006, MICROBIOL IMMUNOL, V50, P395, DOI 10.1111/j.1348-0421.2006.tb03806.x; Lee B, 2011, APMIS, V119, P263, DOI 10.1111/j.1600-0463.2011.02726.x; Lesprit P, 2003, AM J RESP CRIT CARE, V167, P1478, DOI 10.1164/rccm.200207-736BC; Mittal Rahul, 2006, Journal of Microbiology Immunology and Infection, V39, P302; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Pearson JP, 2000, INFECT IMMUN, V68, P4331, DOI 10.1128/IAI.68.7.4331-4334.2000; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rice S. A., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P1629; Rivas-Carrillo JD, 2007, DIABETES, V56, P1259, DOI 10.2337/db06-1679; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Rumbaugh KP, 2000, MICROBES INFECT, V2, P1721, DOI 10.1016/S1286-4579(00)01327-7; RUST L, 1994, METHOD ENZYMOL, V235, P554; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skindersoe ME, 2008, ANTIMICROB AGENTS CH, V52, P3648, DOI 10.1128/AAC.01230-07; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; Swift S, 1997, J BACTERIOL, V179, P5271, DOI 10.1128/jb.179.17.5271-5281.1997; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Whitchurch CB, 2005, MOL MICROBIOL, V55, P1357, DOI 10.1111/j.1365-2958.2005.04479.x; WINNIE GB, 1991, PEDIATR PULM, V10, P92, DOI 10.1002/ppul.1950100210; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Wu H, 2001, MICROBIOL-SGM, V147, P1105, DOI 10.1099/00221287-147-5-1105; Wu H, 2004, MICROBES INFECT, V6, P34, DOI 10.1016/j.micinf.2003.10.006	45	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60973	10.1371/journal.pone.0060973	http://dx.doi.org/10.1371/journal.pone.0060973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593362	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000032
J	Suaya, JA; Eisenberg, DF; Fang, C; Miller, LG				Suaya, Jose A.; Eisenberg, Debra F.; Fang, Christy; Miller, Loren G.			Skin and Soft Tissue Infections and Associated Complications among Commercially Insured Patients Aged 0-64 Years with and without Diabetes in the US	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; RISK; EPIDEMIOLOGY; LIMB; VISITS; COHORT; TRENDS	Introduction: Skin and soft tissue infections (SSTIs) are common infections occurring in ambulatory and inpatient settings. The extent of complications associated with these infections by diabetes status is not well established. Methods: Using a very large repository database, we examined medical and pharmacy claims of individuals aged 0-64 between 2005 and 2010 enrolled in U.S. health plans. Diabetes, SSTIs, and SSTI-associated complications were identified by ICD-9 codes. SSTIs were stratified by clinical category and setting of initial diagnosis. Results: We identified 2,227,401 SSTI episodes, 10% of which occurred in diabetic individuals. Most SSTIs were initially diagnosed in ambulatory settings independent from diabetes status. Abscess/cellulitis was the more common SSTI group in diabetic and non-diabetic individuals (66% and 59%, respectively). There were differences in the frequencies of SSTI categories between diabetic and non-diabetic individuals (p<0.01). Among SSTIs diagnosed in ambulatory settings, the SSTI-associated complication rate was over five times higher in people with diabetes than in people without diabetes (4.9% vs. 0.8%, p<0.01) and SSTI-associated hospitalizations were 4.9% and 1.1% in patients with and without diabetes, respectively. Among SSTIs diagnosed in the inpatient setting, bacteremia/endocarditis/septicemia/sepsis was the most common associated complication occurring in 25% and 16% of SSTIs in patients with and without diabetes, respectively (p<0.01). Conclusions: Among persons with SSTIs, we found SSTI-associated complications were five times higher and SSTI-associated hospitalizations were four times higher, in patients with diabetes compared to those without diabetes. SSTI prevention efforts in individuals with diabetes may have significant impact on morbidity and healthcare resource utilization.	[Suaya, Jose A.] GlaxoSmithKlineVaccines, Philadelphia, PA USA; [Eisenberg, Debra F.; Fang, Christy] HealthCore Inc, Wilmington, DE USA; [Miller, Loren G.] Harbor UCLA Med Ctr, Los Angeles BioMed Res Ctr, Harbor UCLA, Div Infect Dis, Torrance, CA 90509 USA; [Miller, Loren G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	GlaxoSmithKline; HealthCore, Inc; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Suaya, JA (corresponding author), GlaxoSmithKlineVaccines, Philadelphia, PA USA.	Jose.2.Suaya@GSK.com			GlaxoSmithKline (GSK); Pfizer; Cubist; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	GlaxoSmithKline (GSK)(GlaxoSmithKline); Pfizer(Pfizer); Cubist; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This observational study has been sponsored by GlaxoSmithKline (GSK). This original research is a collaboration among researchers from HealthCore, Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and GSK. While J.A.S. is a GSK employee, decisions on study design, data collection and analysis, decision where to publish, and preparation of the manuscript were done solely and collectively by the authors and not by the funder.; This observational study has been sponsored by GlaxoSmithKline. J.A.S. is employed by the GlaxoSmithKline group of companies. At the time of this study, J.A.S. worked at GSK Vaccines. D.E. is an employee of HealthCore, which has received funds for GSK for performing research. C.F. was an employee of HealthCore at the time of this research. L.M. has received consulting fees for this study from GSK. L.M. has also received consulting fees from GSK, Pfizer, and Cubist for other research projects. Decisions on study design, data collection and analysis, decision where to publish, and preparation of the manuscript were done solely and collectively by the authors. Authors adhere to all the PLOS ONE policies on sharing data and materials.	Aragon-Sanchez J, 2009, INT J LOW EXTR WOUND, V8, P141, DOI 10.1177/1534734609344106; Bhavan KP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-158; Bjorndottir S, 2005, CLIN INFECT DIS, V41, P1416, DOI 10.1086/497127; Capitano B, 2003, J AM GERIATR SOC, V51, P10, DOI 10.1034/j.1601-5215.2002.51003.x; Chira S, 2010, EPIDEMIOL INFECT, V138, P313, DOI 10.1017/S0950268809990483; Chong CP, 2008, SOUTH MED J, V101, P1141, DOI 10.1097/SMJ.0b013e318181d5b5; Dang CN, 2003, DIABETIC MED, V20, P159, DOI 10.1046/j.1464-5491.2003.00860.x; Edelsberg J, 2009, EMERG INFECT DIS, V15, P1516, DOI 10.3201/eid1509.081228; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Jackson LA, 2005, CLIN INFECT DIS, V41, P289, DOI 10.1086/431594; Kao Lillian S, 2005, Surg Infect (Larchmt), V6, P427, DOI 10.1089/sur.2005.6.427; Kessler RC, 2010, SLEEP, V33, P1539, DOI 10.1093/sleep/33.11.1539; Kim SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3107; Lee TA, 2010, CURR MED RES OPIN, V26, P2851, DOI 10.1185/03007995.2010.531255; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nather A, 2008, J DIABETES COMPLICAT, V22, P77, DOI 10.1016/j.jdiacomp.2007.04.004; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Rajagopalan S, 2005, CLIN INFECT DIS, V40, P990, DOI 10.1086/427690; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Sreeramoju P, 2011, AM J SURG, V201, P216, DOI 10.1016/j.amjsurg.2009.12.024; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Wilson J, 2011, J HOSP INFECT, V79, P211, DOI 10.1016/j.jhin.2011.05.013; Yood MU, 2010, PHARMACOEPIDEM DR S, V19, P1124, DOI 10.1002/pds.2047	23	66	67	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60057	10.1371/journal.pone.0060057	http://dx.doi.org/10.1371/journal.pone.0060057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593162	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000007
J	Vianna, GMS; Meekan, MG; Meeuwig, JJ; Speed, CW				Vianna, Gabriel M. S.; Meekan, Mark G.; Meeuwig, Jessica J.; Speed, Conrad W.			Environmental Influences on Patterns of Vertical Movement and Site Fidelity of Grey Reef Sharks (Carcharhinus amblyrhynchos) at Aggregation Sites	PLOS ONE			English	Article							MARINE PROTECTED AREAS; DIEL ACTIVITY PATTERNS; SEXUAL SEGREGATION; ACOUSTIC RECEIVERS; HABITAT SELECTION; BEHAVIOR; CONSERVATION; TEMPERATURES; PREFERENCES; PERFORMANCE	We used acoustic telemetry to describe the patterns of vertical movement, site fidelity and residency of grey reef sharks (Carcharhinus amblyrhynchos) on the outer slope of coral reefs in Palau, Micronesia, over a period of two years and nine months. We tagged 39 sharks (mostly adult females) of which 31 were detected regularly throughout the study. Sharks displayed strong inter-annual residency with greater attendance at monitored sites during summer than winter months. More individuals were detected during the day than at night. Mean depths of tagged sharks increased from 35 m in winter to 60 m in spring following an increase in water temperature at 60 m, with maximum mean depths attained when water temperatures at 60 m stabilised around 29 degrees C. Sharks descended to greater depths and used a wider range of depths around the time of the full moon. There were also crepuscular cycles in mean depth, with sharks moving into shallower waters at dawn and dusk each day. We suggest that daily, lunar and seasonal cycles in vertical movement and residency are strategies for optimising both energetic budgets and foraging behaviour. Cyclical patterns of movement in response to environmental variables might affect the susceptibility of reef sharks to fishing, a consideration that should be taken into account in the implementation of conservation strategies.	[Vianna, Gabriel M. S.; Meekan, Mark G.; Speed, Conrad W.] Australian Inst Marine Sci, Perth, WA, Australia; [Vianna, Gabriel M. S.; Meeuwig, Jessica J.] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Vianna, Gabriel M. S.; Meeuwig, Jessica J.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia	Australian Institute of Marine Science; University of Western Australia; University of Western Australia	Vianna, GMS (corresponding author), Australian Inst Marine Sci, Perth, WA, Australia.	g.vianna@aims.gov.au	Speed, Conrad W/F-2913-2015	Speed, Conrad W/0000-0003-3186-8710; Meeuwig, Jessica/0000-0003-1169-8785; Meekan, Mark/0000-0002-3067-9427	Save Our Seas Foundation; Australian Institute of Marine Science; University of Western Australia; Micronesian Shark Foundation; National Oceanographic and Atmospheric Administration's Integrated Ocean Observing System	Save Our Seas Foundation; Australian Institute of Marine Science; University of Western Australia; Micronesian Shark Foundation; National Oceanographic and Atmospheric Administration's Integrated Ocean Observing System	This project was funded by the Save Our Seas Foundation (http://saveourseas.com), Australian Institute of Marine Science (http://www.aims.gov.au), The University of Western Australia (http://www.uwa.edu.au), and the Micronesian Shark Foundation (http://www.msfpalau.org). We would also like to acknowledge the financial support of the National Oceanographic and Atmospheric Administration's Integrated Ocean Observing System (http://oos.soest.hawaii.edu/pacioos/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlstein E, 1998, BERNOULLI, V4, P305, DOI 10.2307/3318719; Castro ALF, 2005, ENVIRON BIOL FISH, V72, P213, DOI 10.1007/s10641-004-1479-7; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Chapman DD, 2007, MAR ECOL PROG SER, V344, P271, DOI 10.3354/meps06941; Chatfield C, 1996, ANAL TIME SERIES; Colin P.L., 2009, MARINE ENV PALAU; Crawshaw Larry I., 1997, Society for Experimental Biology Seminar Series, V61, P351; Dagorn L, 2000, MAR BIOL, V136, P361, DOI 10.1007/s002270050694; deBruyn AMH, 2001, MAR ECOL PROG SER, V214, P307, DOI 10.3354/meps214307; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Howey-Jordan LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056588; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Knip DM, 2012, BIOL CONSERV, V148, P200, DOI 10.1016/j.biocon.2012.01.008; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; MORRISSEY JF, 1993, ENVIRON BIOL FISH, V38, P311, DOI 10.1007/BF00007524; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Nelson D, 1980, NATL GEOGR SOC RES R, V12, P479; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; O'Shea OR, 2010, MAR FRESHWATER RES, V61, P65, DOI 10.1071/MF08301; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Patton A, 2009, ECONOMET REV, V28, P372, DOI 10.1080/07474930802459016; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; Politis D. N., 2004, ECON REV, V23, P53, DOI [DOI 10.1081/ETC-120028836, 10.1081/ETC-120028836]; RASMUSSEN OI, 1994, MAR BIOL, V120, P649, DOI 10.1007/BF00350086; Sepulveda CA, 2004, MAR BIOL, V145, P191, DOI 10.1007/s00227-004-1356-0; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Speed CW, 2012, MAR ECOL PROG SER, V463, P231, DOI 10.3354/meps09864; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Takahashi M, 2003, MAR FRESHWATER RES, V54, P527, DOI 10.1071/MF01245; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Weng KC, 2009, J FISH BIOL, V74, P1434, DOI 10.1111/j.1095-8649.2009.02209.x; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; Whitney NM, 2007, AQUAT LIVING RESOUR, V20, P299, DOI 10.1051/alr:2008006; Zar J. H., 1999, STAT ANAL, V661, P11	54	83	83	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60331	10.1371/journal.pone.0060331	http://dx.doi.org/10.1371/journal.pone.0060331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593193	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000011
J	Bosch, OG; Wagner, M; Jessen, F; Kuhn, KU; Joe, A; Seifritz, E; Maier, W; Biersack, HJ; Quednow, BB				Bosch, Oliver G.; Wagner, Michael; Jessen, Frank; Kuehn, Kai-Uwe; Joe, Alexius; Seifritz, Erich; Maier, Wolfgang; Biersack, Hans-Juergen; Quednow, Boris B.			Verbal Memory Deficits Are Correlated with Prefrontal Hypometabolism in (18)FDG PET of Recreational MDMA Users	PLOS ONE			English	Article							SEROTONIN TRANSPORTER BINDING; POSITRON-EMISSION-TOMOGRAPHY; WORKING-MEMORY; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; ECSTASY USERS; HIPPOCAMPAL DYSFUNCTION; COGNITIVE PERFORMANCE; (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; NEUROPSYCHOLOGICAL EVIDENCE; FORMER USERS	Introduction: 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") is a recreational club drug with supposed neurotoxic effects selectively on the serotonin system. MDMA users consistently exhibit memory dysfunction but there is an ongoing debate if these deficits are induced mainly by alterations in the prefrontal or mediotemporal cortex, especially the hippocampus. Thus, we investigated the relation of verbal memory deficits with alterations of regional cerebral brain glucose metabolism (rMRGlu) in recreational MDMA users. Methods: Brain glucose metabolism in rest was assessed using 2-deoxy-2-(F-18) fluoro-D-glucose positron emission tomography ((18)FDG PET) in 19 male recreational users of MDMA and 19 male drug-naive controls. (18)FDG PET data were correlated with memory performance assessed with a German version of the Rey Auditory Verbal Learning Test. Results: As previously shown, MDMA users showed significant impairment in verbal declarative memory performance. PET scans revealed significantly decreased rMRGlu in the bilateral dorsolateral prefrontal and inferior parietal cortex, bilateral thalamus, right hippocampus, right precuneus, right cerebellum, and pons (at the level of raphe nuclei) of MDMA users. Among MDMA users, learning and recall were positively correlated with rMRGlu predominantly in bilateral frontal and parietal brain regions, while recognition was additionally related to rMRGlu in the right mediotemporal and bihemispheric lateral temporal cortex. Moreover, cumulative lifetime dose of MDMA was negatively correlated with rMRGlu in the left dorsolateral and bilateral orbital and medial PFC, left inferior parietal and right lateral temporal cortex. Conclusions: Verbal learning and recall deficits of recreational MDMA users are correlated with glucose hypometabolism in prefrontal and parietal cortex, while word recognition was additionally correlated with mediotemporal hypometabolism. We conclude that memory deficits of MDMA users arise from combined fronto-parieto-mediotemporal dysfunction.	[Bosch, Oliver G.; Seifritz, Erich; Quednow, Boris B.] Univ Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Wagner, Michael; Jessen, Frank; Kuehn, Kai-Uwe; Maier, Wolfgang; Quednow, Boris B.] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Wagner, Michael; Jessen, Frank; Maier, Wolfgang] German Ctr Neurodegenerat Disorders DZNE, Bonn, Germany; [Kuehn, Kai-Uwe] Univ Saarland, Med Ctr, Dept Psychiat, Homburg, Germany; [Joe, Alexius; Biersack, Hans-Juergen] Univ Bonn, Dept Nucl Med, Bonn, Germany; [Seifritz, Erich; Quednow, Boris B.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Saarland University; University of Bonn; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Quednow, BB (corresponding author), Univ Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland.	quednow@bli.uzh.ch	Wagner, Michael/E-2325-2011; Jessen, Frank/AAK-6170-2020; Quednow, Boris B./A-1666-2008	Wagner, Michael/0000-0003-2589-6440; Quednow, Boris B./0000-0001-7933-2865	German Research Foundation (DFG) [QU 218/1-1]; University of Zurich (Nachwuchsforderungskredit); Swiss National Science Foundation (SNSF) [PP00P1_123516]; Department of Psychiatry, University of Bonn, Germany	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Zurich (Nachwuchsforderungskredit); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Department of Psychiatry, University of Bonn, Germany	Dr. Quednow received personal grants from the German Research Foundation (DFG, grant QU 218/1-1), the University of Zurich (Nachwuchsforderungskredit), and the Swiss National Science Foundation (SNSF, grant PP00P1_123516). The study was funded by the Department of Psychiatry, University of Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; ALI SF, 1993, NEUROTOXICOL TERATOL, V15, P91, DOI 10.1016/0892-0362(93)90067-X; Anneken JH, 2012, NEUROPHARMACOLOGY, V63, P1022, DOI 10.1016/j.neuropharm.2012.07.026; [Anonymous], 2012, WORLD DRUG REP 2012; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bartenstein P, 2002, EUR J NUCL MED MOL I, V29, pBP43; Becker B, 2012, PSYCHOPHARMACOLOGY B; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bhattachary S, 2001, PSYCHOL MED, V31, P647, DOI 10.1017/S0033291701003828; Bolla KI, 1998, NEUROLOGY, V51, P1532, DOI 10.1212/WNL.51.6.1532; Buchert R, 2004, AM J PSYCHIAT, V161, P1181, DOI 10.1176/appi.ajp.161.7.1181; Buchert R, 2003, J NUCL MED, V44, P375; Buchert R, 2001, NUCL MED COMMUN, V22, P889, DOI 10.1097/00006231-200108000-00007; Buchert R, 2007, J PSYCHOPHARMACOL, V21, P628, DOI 10.1177/0269881106071975; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; CAM, 2001, COORD CTR ASS MON NE; Christophersen AS, 2000, TOXICOL LETT, V112, P127, DOI 10.1016/S0378-4274(99)00205-2; Croft RJ, 2001, AM J PSYCHIAT, V158, P1687, DOI 10.1176/appi.ajp.158.10.1687; Curran HV, 2000, NEUROPSYCHOBIOLOGY, V42, P34, DOI 10.1159/000026668; Daumann J, 2005, PSYCHOPHARMACOLOGY, V180, P607, DOI 10.1007/s00213-004-2002-8; Daumann J, 2004, BIOL PSYCHIAT, V56, P349, DOI 10.1016/j.biopsych.2004.06.011; Daumann J, 2003, COGNITIVE BRAIN RES, V16, P479, DOI 10.1016/S0926-6410(03)00075-2; de Win MML, 2008, BRIT J PSYCHIAT, V193, P289, DOI 10.1192/bjp.bp.106.035089; Delis DC., 2000, CALIFORNIA VERBAL LE; Di Iorio CR, 2011, ARCH GEN PSYCHIAT; Dzietko M, 2010, DEV NEUROSCI-BASEL, V32, P197, DOI 10.1159/000313473; Ensslin HK, 1996, J CHROMATOGR B, V683, P189, DOI 10.1016/0378-4347(96)00129-6; Erritzoe D, 2011, ARCH GEN PSYCHIAT, V68, P562, DOI 10.1001/archgenpsychiatry.2011.56; FISCHER C, 1995, J NEUROSCI, V15, P5476; Forrester G., 1991, CLIN NEUROPSYCHOL, V5, P345, DOI [DOI 10.1080/13854049108404102, 10.1080/13854049108404102]; Fox HC, 2001, HUM PSYCHOPHARM CLIN, V16, P613, DOI 10.1002/hup.344; Fox HC, 2002, PSYCHOPHARMACOLOGY, V162, P203, DOI 10.1007/s00213-002-1071-9; Gouzoulis-Mayfrank E, 2003, PROG NEURO-PSYCHOPH, V27, P819, DOI 10.1016/S0278-5846(03)00114-3; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Green DM, 1966, SIGNAL DETECTION THE; Hagino Y, 2011, CURR NEUROPHARMACOL, V9, P91, DOI 10.2174/157015911795017254; Hampel H, 2002, J NEURAL TRANSM, V109, P837, DOI 10.1007/s007020200069; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Helmstaedter C, 2001, VERBALER LERN MERKFA, V1; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; INSEL TR, 1989, J PHARMACOL EXP THER, V249, P713; Jacobsen LK, 2004, PSYCHOPHARMACOLOGY, V173, P383, DOI 10.1007/s00213-003-1679-4; Kalechstein AD, 2007, PSYCHOPHARMACOLOGY, V189, P531, DOI 10.1007/s00213-006-0601-2; KEW JJM, 1994, NEUROLOGY, V44, P1101, DOI 10.1212/WNL.44.6.1101; Kish SJ, 2002, PHARMACOL BIOCHEM BE, V71, P845, DOI 10.1016/S0091-3057(01)00708-0; Kish SJ, 2010, BRAIN, V133, P1779, DOI 10.1093/brain/awq103; Kuypers KPC, 2011, J PSYCHOPHARMACOL, V25, P1053, DOI 10.1177/0269881111405361; Lehrl S., 2005, MANUAL ZUM MWT B MEH; Lyles J, 2003, BRAIN RES REV, V42, P155, DOI 10.1016/S0165-0173(03)00173-5; McCann UD, 2005, NEUROPSYCHOPHARMACOL, V30, P1741, DOI 10.1038/sj.npp.1300736; McCann UD, 1999, PSYCHOPHARMACOLOGY, V143, P417, DOI 10.1007/s002130050967; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; MCCANN UD, 1994, NEUROPSYCHOPHARMACOL, V10, P129, DOI 10.1038/npp.1994.15; Millien I, 2002, J CEREBR BLOOD F MET, V22, P1248, DOI 10.1097/01.WCB.0000037997.34930.67; Moeller FG, 2004, PSYCHOPHARMACOLOGY, V177, P185, DOI 10.1007/s00213-004-1908-5; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039830; Morgan MJ, 1999, PSYCHOPHARMACOLOGY, V141, P30, DOI 10.1007/s002130050803; Newhouse PA, 2011, BIOCHEM PHARMACOL, V82, P943, DOI 10.1016/j.bcp.2011.06.008; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Obrocki J, 2002, TOXICOL LETT, V127, P285, DOI 10.1016/S0378-4274(01)00511-2; Obrocki J, 1999, BRIT J PSYCHIAT, V175, P186, DOI 10.1192/bjp.175.2.186; Parrott AC, 2009, NEUROPSYCHOBIOLOGY, V60, P148, DOI 10.1159/000253551; Quednow BB, 2004, NEUROPSYCHOPHARMACOL, V29, P982, DOI 10.1038/sj.npp.1300396; Quednow BB, 2007, PSYCHOPHARMACOLOGY, V189, P517, DOI 10.1007/s00213-005-0256-4; Quednow BB, 2006, J PSYCHOPHARMACOL, V20, P373, DOI 10.1177/0269881106061200; Quednow BB, 2012, NEUROIMAGE, V59, P3922, DOI 10.1016/j.neuroimage.2011.09.045; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; Reneman L, 2002, NEUROPSYCHOPHARMACOL, V26, P387, DOI 10.1016/S0893-133X(01)00366-9; Rey A, 1964, LEXAMEN CLINIQUE PSY; RICAURTE GA, 1988, JAMA-J AM MED ASSOC, V260, P51, DOI 10.1001/jama.260.1.51; RICAURTE GA, 1992, J PHARMACOL EXP THER, V261, P616; RICAURTE GA, 1990, ANN NY ACAD SCI, V600, P699; Roberts GMP, 2009, BRAIN RES, V1292, P71, DOI 10.1016/j.brainres.2009.07.040; Rodgers J, 2000, PSYCHOPHARMACOLOGY, V151, P19, DOI 10.1007/s002130000467; Rosenberg NL, 1995, NEUROTOXICOLOGY APPR; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Scheffel U, 1998, SYNAPSE, V29, P183, DOI 10.1002/(SICI)1098-2396(199806)29:2<183::AID-SYN9>3.0.CO;2-3; Selvaraj S, 2009, BRIT J PSYCHIAT, V194, P355, DOI 10.1192/bjp.bp.108.050344; Steinkellner T, 2011, BIOL CHEM, V392, P103, DOI 10.1515/BC.2011.016; Stuerenburg HJ, 2002, NEUROENDOCRINOL LETT, V23, P259; Sumnall HR, 2006, J PSYCHOPHARMACOL, V20, P670, DOI 10.1177/0269881106060764; Taffe MA, 2002, NEUROPSYCHOPHARMACOL, V27, P993, DOI 10.1016/S0893-133X(02)00380-9; Tuchtenhagen F, 2000, NEUROPSYCHOPHARMACOL, V22, P608, DOI 10.1016/S0893-133X(99)00140-2; Tulving E, 1999, HIPPOCAMPUS, V9, P71, DOI 10.1002/(SICI)1098-1063(1999)9:1<71::AID-HIPO8>3.0.CO;2-F; Urban NBL, 2012, NEUROPSYCHOPHARMACOL, V37, P1465, DOI 10.1038/npp.2011.332; Valdes IH, 2006, PSYCHIAT RES-NEUROIM, V147, P239, DOI 10.1016/j.pscychresns.2006.01.014; Vul E, 2012, NEUROIMAGE, V62, P945, DOI 10.1016/j.neuroimage.2012.01.027; Wareing M, 2005, HUM PSYCHOPHARM CLIN, V20, P115, DOI 10.1002/hup.670; Wareing M, 2004, HUM PSYCHOPHARM CLIN, V19, P225, DOI 10.1002/hup.586; WILSON MA, 1989, NEUROSCIENCE, V28, P121, DOI 10.1016/0306-4522(89)90237-6; Wylie KP, 2012, NEUROIMAGE, V63, P73, DOI 10.1016/j.neuroimage.2012.06.079	92	23	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61234	10.1371/journal.pone.0061234	http://dx.doi.org/10.1371/journal.pone.0061234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585882	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000317909600095
J	Park, YM; Lee, SH; Lee, HJ; Kang, SG; Min, JA; Chae, JH				Park, Young-Min; Lee, Seung-Hwan; Lee, Heon-Jeong; Kang, Seung-Gul; Min, Jung-Ah; Chae, Jeong-Ho			Association between BDNF Gene Polymorphisms and Serotonergic Activity Using Loudness Dependence of Auditory Evoked Potentials in Healthy Subjects	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; NEUROTROPHIC FACTOR GENE; INTENSITY DEPENDENCE; CLINICAL-RESPONSE; BRAIN; SCHIZOPHRENIA; ANTIDEPRESSANTS; EXPRESSION; PREDICTOR; LDAEP	It has been proposed that the loudness dependence of auditory evoked potentials (LDAEP) would be a reliable indicator of central serotonin system activity in humans. Serotonin levels and turnover are also increased by brain-derived neurotrophic factor (BDNF). The aim of the present study was to determine whether there is an association between genetic polymorphisms of BDNF and the LDAEP in healthy Korean young adults. The cohort comprised 211 mentally and physically healthy subjects, all of whom were nonsmokers (111 males, 100 females; age: 20,32 years). To avoid hormonal effects, the LDAEP was measured during days 2-5 after the beginning of menstruation for female subjects. In addition, BDNF polymorphisms (rs6265, rs2030324, and rs1491850) were genotyped. The strength of the LDAEP differed significantly among the BDNF genotype groups. Furthermore, the distribution of genotypic frequencies differed significantly between subjects with high and low LDAEPs. In particular, subjects with the Val/Met (A/G) genotype for rs6265, the T/T genotype for rs2030324, or the C/C genotype for rs1491850 had a higher LDAEP, indicating lower central serotonergic activity. A low LDAEP was more prevalent than a high LDAEP among those with the C-T haplotype (C genotype for rs2030424 and T genotype for rs1491850). Our results concur with previous findings on BDNF polymorphisms and serotonergic drug responses in psychiatric disorder patients. The present results suggest the possibility that BDNF polymorphisms and LDAEP patterns can predict altered serotonergic activity.	[Park, Young-Min; Lee, Seung-Hwan] Inje Univ, Ilsan Paik Hosp, Dept Psychiat, Goyang, South Korea; [Park, Young-Min; Lee, Seung-Hwan] Clin Emot & Cognit Res Lab, Goyang, South Korea; [Lee, Heon-Jeong] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea; [Kang, Seung-Gul] Gachon Univ, Sch Med, Inchon, South Korea; [Min, Jung-Ah; Chae, Jeong-Ho] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea	Inje University; Korea University; Korea University Medicine (KU Medicine); Gachon University; Catholic University of Korea; Seoul St. Mary's Hospital	Lee, SH (corresponding author), Inje Univ, Ilsan Paik Hosp, Dept Psychiat, Goyang, South Korea.	lshpss@paik.ac.kr	Lee, Heon-Jeong/K-5871-2015	Lee, Heon-Jeong/0000-0002-9560-2383; Kang, Seung-Gul/0000-0003-4933-0433	Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A070001]	Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A070001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAR CA, 1994, EXP NEUROL, V130, P31, DOI 10.1006/exnr.1994.1182; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Beuten J, 2005, AM J MED GENET B, V139B, P73, DOI 10.1002/ajmg.b.30231; Calabrese F, 2007, NEUROPSYCHOPHARMACOL, V32, P2351, DOI 10.1038/sj.npp.1301360; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Chourbaji S, 2004, MOL BRAIN RES, V121, P28, DOI 10.1016/j.molbrainres.2003.11.002; Djalali S, 2005, J NEUROCHEM, V92, P616, DOI 10.1111/j.1471-4159.2004.02911.x; Dmitrzak-Weglarz M, 2008, PHARMACOGENOMICS, V9, P1595, DOI 10.2217/14622416.9.11.1595; First MB., 1997, USERS GUIDE STRUCTUR; Gallinat J, 2000, PSYCHOPHARMACOLOGY, V148, P404, DOI 10.1007/s002130050070; Gudlowski Y, 2009, SCHIZOPHR RES, V109, P141, DOI 10.1016/j.schres.2009.02.008; Hagenmuller F, 2011, HUM PSYCHOPHARM CLIN, V26, P147, DOI 10.1002/hup.1186; HEGERL U, 1993, BIOL PSYCHIAT, V33, P173, DOI 10.1016/0006-3223(93)90137-3; Hegerl U, 2001, J AFFECT DISORDERS, V62, P93, DOI 10.1016/S0165-0327(00)00353-0; Juckel G, 1997, BIOL PSYCHIAT, V41, P1181, DOI 10.1016/S0006-3223(96)00240-5; Juckel G, 2004, PHARMACOPSYCHIATRY, V37, P46; Juckel G, 2003, SCHIZOPHR RES, V64, P115, DOI 10.1016/S0920-9964(03)00016-1; Juckel G, 2007, J CLIN PSYCHIAT, V68, P1206, DOI 10.4088/JCP.v68n0806; Juckel G, 2010, J PSYCHIATR RES, V44, P541, DOI 10.1016/j.jpsychires.2009.11.006; Kocabas NA, 2011, INT CLIN PSYCHOPHARM, V26, P1, DOI 10.1097/YIC.0b013e32833d18f8; Lang UE, 2005, NEUROPSYCHOPHARMACOL, V30, P1148, DOI 10.1038/sj.npp.1300666; Liebl DJ, 1997, J NEUROSCI, V17, P9113; Linka T, 2004, NEUROSCI LETT, V367, P375, DOI 10.1016/j.neulet.2004.06.038; Linka T, 2007, J AFFECT DISORDERS, V103, P139, DOI 10.1016/j.jad.2007.01.018; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Meltzer CC, 2001, BRAIN RES, V895, P9, DOI 10.1016/S0006-8993(00)03211-X; Min JA, 2012, PSYCHIAT RES, V200, P374, DOI 10.1016/j.psychres.2012.06.038; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nibuya M, 1996, J NEUROSCI, V16, P2365; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Oliva JL, 2011, HUM PSYCHOPHARM CLIN, V26, P172, DOI 10.1002/hup.1187; Park YM, 2012, PSYCHIAT INVEST, V9, P80, DOI 10.4306/pi.2012.9.1.80; Park YM, 2011, PSYCHOPHARMACOLOGY, V213, P625, DOI 10.1007/s00213-010-2061-y; Park YM, 2010, PROG NEURO-PSYCHOPH, V34, P313, DOI 10.1016/j.pnpbp.2009.12.004; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Qian L, 2007, BIOCHEM BIOPH RES CO, V353, P738, DOI 10.1016/j.bbrc.2006.12.121; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Real E, 2009, BIOL PSYCHIAT, V66, P674, DOI 10.1016/j.biopsych.2009.05.017; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Strobel A, 2003, AM J MED GENET B, V118B, P41, DOI 10.1002/ajmg.b.10019; Tsai SJ, 2003, AM J MED GENET B, V123B, P19, DOI 10.1002/ajmg.b.20026; Yoshida K, 2007, J PSYCHOPHARMACOL, V21, P650, DOI 10.1177/0269881106072192; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Zou YF, 2010, EUR NEUROPSYCHOPHARM, V20, P535, DOI 10.1016/j.euroneuro.2009.12.005	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60340	10.1371/journal.pone.0060340	http://dx.doi.org/10.1371/journal.pone.0060340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593198	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600019
J	Peng, H; Li, HM; Li, C; Chao, XQ; Zhang, Q; Zhang, YH				Peng, Hao; Li, Hongmei; Li, Chao; Chao, Xiangqin; Zhang, Qiu; Zhang, Yonghong			Association between Vitamin D Insufficiency and Elevated Serum Uric Acid among Middle-Aged and Elderly Chinese Han Women	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CALCIUM SUPPLEMENTATION; POSTMENOPAUSAL WOMEN; HYPERURICEMIA; RISK; HEALTH; GOUT	Background: Association between vitamin D insufficiency and hyperuricemia has not been reported so far. We aimed to study the association of vitamin D insufficiency with elevated serum uric acid among middle-aged and elderly Chinese Han women. Methods: We collected data from participants residing in Jinchang district of Suzhou from January to May, 2010. Serum uric acid, 25-hydroxy vitamin D and other traditional biomarkers including fasting plasma glucose and blood lipids were determined in 1726 women aged above 30 years. Association between vitamin D insufficiency and elevated uric acid was analyzed in premenopausal and postmenopausal women, respectively. Results: Among postmenopausal women, 25-hydroxy vitamin D level of participants with elevated uric acid was lower than that of those with normal uric acid (median [interquartile range]: 35[28-57] vs 40[32-58], mu g/L; P = 0.006). Elevated uric acid was more prevalent in participants with vitamin D insufficiency compared to those without vitamin D insufficiency (16.50% vs 8.08%; P<0.001). Association between vitamin D insufficiency and elevated uric acid was not significant among premenopausal women. However, participants with vitamin D insufficiency were more likely to have elevated uric acid compared with those without vitamin D insufficiency among postmenopausal women (OR, 95% CI: 2.38, 1.47-3.87). Moreover, after excluding individuals with diabetes and/or hypertension, the association of vitamin D insufficiency with elevated uric acid was still significant (OR, 95% CI: 2.48, 1.17-5.44). Conclusions: Vitamin D insufficiency was significantly associated with elevated uric acid among postmenopausal Chinese Han women. This study suggested that a clinical trial should be conducted to confirm the association of vitamin D insufficiency with hyperuricemia.	[Peng, Hao; Li, Hongmei; Zhang, Yonghong] Soochow Univ, Sch Publ Hlth, Coll Med, Dept Epidemiol, Suzhou, Peoples R China; [Li, Chao] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chao, Xiangqin; Zhang, Qiu] Ctr Dis Prevent & Control Jinchang Dist, Suzhou, Peoples R China	Soochow University - China; University of Hong Kong	Zhang, YH (corresponding author), Soochow Univ, Sch Publ Hlth, Coll Med, Dept Epidemiol, Suzhou, Peoples R China.	yhzhang@suda.edu.cn	Peng, Hao/AAB-4759-2022; Peng, Hao/I-1134-2014	Peng, Hao/0000-0001-6277-662X	Youth Found of the National Natural Science Foundation of China [81102189]; Suzhou Science and Technology Project [SS0910]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	Youth Found of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Science and Technology Project; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	The study is supported by Youth Found of the National Natural Science Foundation of China (Grant No. 81102189) and the Suzhou Science and Technology Project (grant NO. SS0910) and partially supported by a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010; Burgaz A, 2011, J HYPERTENS, V29, P636, DOI 10.1097/HJH.0b013e32834320f9; Cheung E, 2011, MATURITAS, V69, P50, DOI 10.1016/j.maturitas.2011.01.010; Dalbeth N, 2009, RHEUMATOLOGY, V48, P195, DOI 10.1093/rheumatology/ken416; Ejaz AA, 2007, CLIN J AM SOC NEPHRO, V2, P16, DOI 10.2215/CJN.00350106; Emilion E, 2011, INT J VITAM NUTR RES, V81, P218, DOI 10.1024/0300-9831/a000073; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Hui JY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3769; Keenan RT, 2009, BULL HOSP JT DIS, V67, P285; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Li YC, 2012, CURR OPIN NEPHROL HY, V21, P72, DOI 10.1097/MNH.0b013e32834de4ee; Liu B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-832; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Miller PD, 2007, OSTEOPOROSIS INT, V18, P59, DOI 10.1007/s00198-006-0189-8; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Park S, 2012, NUTR RES PRACT, V6, P162, DOI 10.4162/nrp.2012.6.2.162; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Strasak A, 2008, CLIN CHEM, V54, P273, DOI 10.1373/clinchem.2007.094425; Sun Q, 2011, AM J CLIN NUTR, V94, P534, DOI 10.3945/ajcn.110.008763; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; ZANCHETTI A, 1993, HYPERTENSION, V22, P392; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zittermann A, 2003, BRIT J NUTR, V89, P552, DOI 10.1079/BJN2003837	28	41	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61159	10.1371/journal.pone.0061159	http://dx.doi.org/10.1371/journal.pone.0061159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585876	gold, Green Submitted, Green Published			2022-12-27	WOS:000317909600087
J	Suter, L; Widmer, A				Suter, Leonie; Widmer, Alex			Environmental Heat and Salt Stress Induce Transgenerational Phenotypic Changes in Arabidopsis thaliana	PLOS ONE			English	Article							PLANTAGO-LANCEOLATA L; EPIGENETIC CONTRIBUTION; EXPRESSION PATTERNS; ADAPTIVE RESPONSES; GENE-EXPRESSION; DNA METHYLATION; TEMPERATURE; ADAPTATION; SEED; ACCLIMATION	Plants that can adapt their phenotype may be more likely to survive changing environmental conditions. Heritable epigenetic variation could provide a way to rapidly adapt to such changes. Here we tested whether environmental stress induces heritable, potentially adaptive phenotypic changes independent of genetic variation over few generations in Arabidopsis thaliana. We grew two accessions (Col-0, Sha-0) of A. thaliana for three generations under salt, heat and control conditions and tested for induced heritable phenotypic changes in the fourth generation (G4) and in reciprocal F1 hybrids generated in generation three. Using these crosses we further tested whether phenotypic changes were maternally or paternally transmitted. In generation five (G5), we assessed whether phenotypic effects persisted over two generations in the absence of stress. We found that exposure to heat stress in previous generations accelerated flowering under G4 control conditions in Sha-0, but heritable effects disappeared in G5 after two generations without stress exposure. Previous exposure to salt stress increased salt tolerance in one of two reciprocal F1 hybrids. Transgenerational effects were maternally and paternally inherited. Lacking genetic variability, maternal and paternal inheritance and reversibility of transgenerational effects together indicate that stress can induce heritable, potentially adaptive phenotypic changes, probably through epigenetic mechanisms. These effects were strongly dependent on plant genotype and may not be a general response to stress in A. thaliana.	[Suter, Leonie; Widmer, Alex] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Widmer, A (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	alex.widmer@env.ethz.ch	Widmer, Alex/B-6841-2009; Suter, Leonie/A-3157-2017	Widmer, Alex/0000-0001-8253-5137; Suter, Leonie/0000-0002-6434-1766	Competence Center Environment and Sustainability (CCES) of the ETH-Domain in the framework of the BioChange project	Competence Center Environment and Sustainability (CCES) of the ETH-Domain in the framework of the BioChange project	This work was partially supported by the Competence Center Environment and Sustainability (CCES) of the ETH-Domain in the framework of the BioChange project. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER HM, 1985, J ECOL, V73, P271, DOI 10.2307/2259783; AMZALLAG GN, 1990, J EXP BOT, V41, P29, DOI 10.1093/jxb/41.1.29; [Anonymous], 2010, R LANG ENV STAT COMP; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Begcy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023776; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; Blodner C, 2007, PLANT CELL ENVIRON, V30, P165, DOI 10.1111/j.1365-3040.2006.01615.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Case AL, 1996, HEREDITY, V76, P287, DOI 10.1038/hdy.1996.42; Crow JF, 2002, EVOLUTION, V56, P1313; Demiral T, 2011, ADV BOT RES, V57, P293, DOI 10.1016/B978-0-12-387692-8.00008-4; DeRose-Wilson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022832; Diggle PK, 1997, INT J PLANT SCI, V158, pS99, DOI 10.1086/297510; Donohue K, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P137; Etterson JR, 2002, AM J BOT, V89, P1899, DOI 10.3732/ajb.89.12.1899; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Galloway LF, 2001, ECOLOGY, V82, P2781, DOI 10.1890/0012-9658(2001)082[2781:PEEOLH]2.0.CO;2; Galloway LF, 2001, AM J BOT, V88, P832, DOI 10.2307/2657035; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Gehring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023687; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Guo M, 2008, PLANT MOL BIOL, V66, P551, DOI 10.1007/s11103-008-9290-z; HIGHKIN HR, 1960, COLD SPRING HARB SYM, V25, P231, DOI 10.1101/SQB.1960.025.01.023; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Jablonka E, 2002, ANN NY ACAD SCI, V981, P82; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johannsen W, 1913, DREIUNDZW VORL EINFL, P401; Kohler C, 2011, BBA-GENE REGUL MECH, V1809, P438, DOI 10.1016/j.bbagrm.2011.04.004; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Lacey EP, 1996, EVOLUTION, V50, P865, DOI 10.1111/j.1558-5646.1996.tb03895.x; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; MIAO SL, 1991, ECOLOGY, V72, P1634, DOI 10.2307/1940963; MIAO SL, 1991, ECOLOGY, V72, P586, DOI 10.2307/2937198; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Rahavi MR, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00091; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Reboud X, 2004, Plant Adaptation: Molecular Genetics and Ecology, P135; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Richards CL, 2010, BIOSCIENCE, V60, P232, DOI 10.1525/bio.2010.60.3.9; Saze H, 2008, SEMIN CELL DEV BIOL, V19, P527, DOI 10.1016/j.semcdb.2008.07.017; Springer NM, 2007, PLANT CELL, V19, P2391, DOI 10.1105/tpc.107.052258; Swanson-Wagner RA, 2009, SCIENCE, V326, P1118, DOI 10.1126/science.1178294; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; Xie YJ, 2011, PLANT J, V66, P280, DOI 10.1111/j.1365-313X.2011.04488.x; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhai JX, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000056; Zhang JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023153; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	64	61	63	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60364	10.1371/journal.pone.0060364	http://dx.doi.org/10.1371/journal.pone.0060364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585834	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600021
J	Wang, LS; Zang, WD; Liu, J; Xie, DL; Ji, WD; Pan, YS; Li, ZQ; Shen, JW; Shi, YY				Wang, Lishan; Zang, Weidong; Liu, Jiang; Xie, Dongli; Ji, Weidong; Pan, Yaosheng; Li, Zhiqiang; Shen, Jiawei; Shi, Yongyong			RETRACTED: Association of CYP2A6*4 with Susceptibility of Lung Cancer: A Meta-Analysis (Retracted article. See vol. 11, e160299, 2016)	PLOS ONE			English	Article; Retracted Publication							GENETIC POLYMORPHISMS; NICOTINE METABOLISM; C-OXIDATION; HUMAN LIVER; SMOKING; DELETION; RISK; IDENTIFICATION	Objectives: To assess the association between the variant of Cytochrome P450 2A6 whole gene deletion (CYP2A6*4) polymorphism and risk of lung cancer. Methods: Two investigators independently searched the PubMed, Elsevier, EMBASE, Web of Science, Wiley Online Library and Chinese National Knowledge Infrastructure (CNKI). Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) for CYP2A6*4 and lung cancer were calculated in a fixed-effects model (the Mantel-Haenszel method) and a random-effects model (the DerSimonian and Laird method) when appropriate. Results: This meta-analysis included seven eligible studies, which included 2524 lung cancer cases and 2258 controls (cancer-free). Overall, CYP2A6*4 was associated with the risk of lung cancer (allele*4 vs. allele non-*4, pooled OR = 0.826, 95% CI = 0.725-0.941, P-value = 0.004). When stratifying for population, significant association was observed in Asian (additive model, pooled OR = 0.794, 95% CI = 0.694-0.909, P-value = 0.001; dominant model, pooled OR = 0.827, 95% CI = 0.709-0.965, P-value = 0.016; recessive model (pooled OR = 0.444, 95% CI = 0.293-0.675, P-value <0.0001). In the overall analysis, a comparably significant decrease in the frequency of *4/*4 genotype was detected between cases and controls in Asian while no *4/*4 genotype was detected in Caucasian in collected data. Conclusion: This meta-analysis suggests that the CYP2A6*4 polymorphism is associated with susceptibility of lung cancer in Asian. The whole gene deletion of CYP2A6 may decrease the risk of lung cancer in Asian samples.	[Wang, Lishan; Ji, Weidong; Pan, Yaosheng; Li, Zhiqiang; Shen, Jiawei; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Shanghai 200030, Peoples R China; [Wang, Lishan; Ji, Weidong; Pan, Yaosheng; Li, Zhiqiang; Shen, Jiawei; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Affiliated Changning Mental Hlth Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Wang, Lishan; Zang, Weidong; Xie, Dongli] FengHe ShangHai Informat Technol Co Ltd, Shanghai, Peoples R China; [Liu, Jiang] E China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Liu, Jiang] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Ji, Weidong; Pan, Yaosheng; Shi, Yongyong] Shanghai Changning Mental Hlth Ctr, Shanghai, Peoples R China; [Ji, Weidong; Pan, Yaosheng; Shi, Yongyong] Shanghai Jiao Tong Univ, Inst Neuropsychiat Sci & Syst Biol Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China Normal University; Hangzhou Normal University; Shanghai Jiao Tong University	Shi, YY (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Shanghai 200030, Peoples R China.	shiyongyongsh@hotmail.com						Ariyoshi N, 2004, PHARMACOGENETICS, V14, P701, DOI 10.1097/00008571-200410000-00008; BOYLE P, 1995, LUNG CANCER, V12, P167, DOI 10.1016/0169-5002(95)00443-5; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fujieda M, 2004, CARCINOGENESIS, V25, P2451, DOI 10.1093/carcin/bgh258; Gambier N, 2005, PHARMACOGENOMICS J, V5, P271, DOI 10.1038/sj.tpj.6500314; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffman SMG, 2001, PHARMACOGENETICS, V11, P687, DOI 10.1097/00008571-200111000-00007; Koskela S, 1999, BIOCHEM PHARMACOL, V57, P1407, DOI 10.1016/S0006-2952(99)00015-5; Light R.J., 1984, SUMMING SCI REV RES; Loriot MA, 2001, PHARMACOGENETICS, V11, P39, DOI 10.1097/00008571-200102000-00005; Miyamoto M, 1999, BIOCHEM BIOPH RES CO, V261, P658, DOI 10.1006/bbrc.1999.1089; Nakada T, 2012, J TOXICOL SCI, V37, P555; Nakajima M, 1996, DRUG METAB DISPOS, V24, P1212; Nakajima M, 2001, CLIN PHARMACOL THER, V69, P72, DOI 10.1067/mcp.2001.112688; Oscarson M, 1999, FEBS LETT, V460, P321, DOI 10.1016/S0014-5793(99)01364-2; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Peamkrasatam S, 2006, DRUG METAB PHARMACOK, V21, P475, DOI 10.2133/dmpk.21.475; Tamaki Y, 2011, DRUG METAB PHARMACOK, V26, P516, DOI 10.2133/dmpk.DMPK-11-RG-046; Tan W, 2001, INT J CANCER, V95, P96, DOI 10.1002/1097-0215(20010320)95:2&lt;96::AID-IJC1017&gt;3.0.CO;2-2; Tyndale RF, 2002, THER DRUG MONIT, V24, P163, DOI 10.1097/00007691-200202000-00026; Vasconcelos GM, 2005, PHARMACOGENOMICS J, V5, P42, DOI 10.1038/sj.tpj.6500290; Wassenaar CA, 2011, J NATL CANCER I, V103, P1342, DOI 10.1093/jnci/djr237; Xu C, 2002, BIOCHEM BIOPH RES CO, V290, P318, DOI 10.1006/bbrc.2001.6209; Yamazaki H, 1999, ARCH TOXICOL, V73, P65, DOI 10.1007/s002040050588; Yoshida R, 2002, BRIT J CLIN PHARMACO, V54, P511, DOI 10.1046/j.1365-2125.2002.01667.x	26	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e59556	10.1371/journal.pone.0059556	http://dx.doi.org/10.1371/journal.pone.0059556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585826	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600008
J	Berezniuk, I; Sironi, JJ; Wardman, J; Pasek, RC; Berbari, NF; Yoder, BK; Fricker, LD				Berezniuk, Iryna; Sironi, Juan J.; Wardman, Jonathan; Pasek, Raymond C.; Berbari, Nicolas F.; Yoder, Bradley K.; Fricker, Lloyd D.			Quantitative Peptidomics of Purkinje Cell Degeneration Mice	PLOS ONE			English	Article							CYSTIC KIDNEY-DISEASE; MOUSE-BRAIN; POSTTRANSLATIONAL MODIFICATIONS; PCD MICE; TUBULIN POLYGLUTAMYLATION; SUBSTRATE-SPECIFICITY; EMBRYONIC-DEVELOPMENT; ABNORMAL-DEVELOPMENT; SPERMATID FLAGELLA; GENE TG737	Cytosolic carboxypeptidase 1 (CCP1) is a metallopeptidase that removes C-terminal and side-chain glutamates from tubulin. The Purkinje cell degeneration (pcd) mouse lacks CCP1 due to a mutation. Previously, elevated levels of peptides derived from cytosolic and mitochondrial proteins were found in adult pcd mouse brain, raising the possibility that CCP1 functions in the degradation of intracellular peptides. To test this hypothesis, we used a quantitative peptidomics technique to compare peptide levels in wild-type and pcd mice, examining adult heart, spleen, and brain, and presymptomatic 3 week-old amygdala and cerebellum. Contrary to adult mouse brain, young pcd brain and adult heart and spleen did not show a large increase in levels of intracellular peptides. Unexpectedly, levels of peptides derived from secretory pathway proteins were altered in adult pcd mouse brain. The pattern of changes for the intracellular and secretory pathway peptides in pcd mice was generally similar to the pattern observed in mice lacking primary cilia. Collectively, these results suggest that intracellular peptide accumulation in adult pcd mouse brain is a secondary effect and is not due to a role of CCP1 in peptide turnover.	[Berezniuk, Iryna; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Sironi, Juan J.; Wardman, Jonathan; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Pasek, Raymond C.; Berbari, Nicolas F.; Yoder, Bradley K.] Univ Alabama Birmingham, Med Sch Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.	lloyd.fricker@einstein.yu.edu		Berbari, Nicolas/0000-0003-2863-1069; Pasek, Raymond/0000-0002-1817-8697	NIH [R01-DA004494, R01-DK75996, P30-DK074038]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075996, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01-DA004494, R01-DK75996 and P30-DK074038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Baltanas FC, 2011, J BIOL CHEM, V286, P28287, DOI 10.1074/jbc.M111.246041; BAURLE J, 1994, ACTA NEUROPATHOL, V88, P237; Berbari NF, 2013, CYTOSKELETON, V70, P24, DOI 10.1002/cm.21088; Berbari NF, 2011, DEV BIOL, V360, P66, DOI 10.1016/j.ydbio.2011.09.001; Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Campbell PK, 2002, GENETICS, V162, P307; Chakrabarti L, 2006, MAMM GENOME, V17, P103, DOI 10.1007/s00335-005-0096-x; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Otazo MRD, 2013, FASEB J, V27, P424, DOI 10.1096/fj.12-209080; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Gelman JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053263; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kyuhou S, 2006, NEUROSCI LETT, V396, P91, DOI 10.1016/j.neulet.2005.11.023; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Lyons PJ, 2011, J BIOL CHEM, V286, P39023, DOI 10.1074/jbc.M111.265819; Lyons PJ, 2010, J BIOL CHEM, V285, P38234, DOI 10.1074/jbc.M110.158626; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Mzhavia N, 2003, J BIOL CHEM, V278, P14704, DOI 10.1074/jbc.M211242200; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; Tanco S, 2010, J BIOL CHEM, V285, P18385, DOI 10.1074/jbc.M109.060350; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Vogel P, 2010, VET PATHOL, V47, P703, DOI 10.1177/0300985810363485; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wardman JH, 2010, J NEUROCHEM, V114, P215, DOI 10.1111/j.1471-4159.2010.06760.x; Wloga D, 2010, EUKARYOT CELL, V9, P184, DOI 10.1128/EC.00176-09; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	62	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60981	10.1371/journal.pone.0060981	http://dx.doi.org/10.1371/journal.pone.0060981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593366	gold, Green Submitted, Green Published			2022-12-27	WOS:000317898000088
J	Brito, LP; Linss, JGB; Lima-Camara, TN; Belinato, TA; Peixoto, AA; Lima, JBP; Valle, D; Martins, AJ				Brito, Luiz Paulo; Linss, Jutta G. B.; Lima-Camara, Tamara N.; Belinato, Thiago A.; Peixoto, Alexandre A.; Lima, Jose Bento P.; Valle, Denise; Martins, Ademir J.			Assessing the Effects of Aedes aegypti kdr Mutations on Pyrethroid Resistance and Its Fitness Cost	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; RIO-DE-JANEIRO; INSECTICIDE RESISTANCE; ANOPHELES-GAMBIAE; CULEX-PIPIENS; LIFE-HISTORY; POPULATIONS; DIPTERA; COMPETITION; PERMETHRIN	Pyrethroids are the most used insecticide class worldwide. They target the voltage gated sodium channel (Na-V), inducing the knockdown effect. In Aedes aegypti, the main dengue vector, the AaNa(V) substitutions Val1016Ile and Phe1534Cys are the most important knockdown resistance (kdr) mutations. We evaluated the fitness cost of these kdr mutations related to distinct aspects of development and reproduction, in the absence of any other major resistance mechanism. To accomplish this, we initially set up 68 crosses with mosquitoes from a natural population. Allele-specific PCR revealed that one couple, the one originating the CIT-32 strain, had both parents homozygous for both kdr mutations. However, this pyrethroid resistant strain also presented high levels of detoxifying enzymes, which synergistically account for resistance, as revealed by biological and biochemical assays. Therefore, we carried out backcrosses between CIT-32 and Rockefeller (an insecticide susceptible strain) for eight generations in order to bring the kdr mutation into a susceptible genetic background. This new strain, named Rock-kdr, was highly resistant to pyrethroid and presented reduced alteration of detoxifying activity. Fitness of the Rock-kdr was then evaluated in comparison with Rockefeller. In this strain, larval development took longer, adults had an increased locomotor activity, fewer females laid eggs, and produced a lower number of eggs. Under an inter-strain competition scenario, the Rock-kdr larvae developed even slower. Moreover, when Rockefeller and Rock-kdr were reared together in population cage experiments during 15 generations in absence of insecticide, the mutant allele decreased in frequency. These results strongly suggest that the Ae. aegypti kdr mutations have a high fitness cost. Therefore, enhanced surveillance for resistance should be priority in localities where the kdr mutation is found before new adaptive alleles can be selected for diminishing the kdr deleterious effects.	[Brito, Luiz Paulo; Linss, Jutta G. B.; Belinato, Thiago A.; Lima, Jose Bento P.; Valle, Denise; Martins, Ademir J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, BR-21045900 Rio De Janeiro, RJ, Brazil; [Lima-Camara, Tamara N.; Peixoto, Alexandre A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, RJ, Brazil; [Belinato, Thiago A.; Peixoto, Alexandre A.; Valle, Denise; Martins, Ademir J.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Martins, AJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, BR-21045900 Rio De Janeiro, RJ, Brazil.	ademirjr@ioc.fiocruz.br	Valle, Denise/F-5069-2013; Martins, Ademir J./B-4117-2009; Camara, Tamara N Lima/G-3476-2016; Martins, Ademir/W-3251-2019	Martins, Ademir/0000-0001-5739-1215	Programa Nacional de Controle da Dengue/Secretaria de Vigilancia em Saude/Ministerio da Saude (PNCD/SVS/MS); Conselho Nacional de Desenvolvimento Cientifico e Tecnoloico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ; Howard Hughes Medical Institute (HHMI); Instituto Nacional de Ciencia e Tecnologia - Entomologia Molecular (INCT-EM)	Programa Nacional de Controle da Dengue/Secretaria de Vigilancia em Saude/Ministerio da Saude (PNCD/SVS/MS); Conselho Nacional de Desenvolvimento Cientifico e Tecnoloico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Instituto Nacional de Ciencia e Tecnologia - Entomologia Molecular (INCT-EM)	This work was supported by the Programa Nacional de Controle da Dengue/Secretaria de Vigilancia em Saude/Ministerio da Saude (PNCD/SVS/MS), Conselho Nacional de Desenvolvimento Cientifico e Tecnoloico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, the Howard Hughes Medical Institute (HHMI) and the Instituto Nacional de Ciencia e Tecnologia - Entomologia Molecular (INCT-EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; [Anonymous], QUANTIFICATION METOD; Barbosa S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001387; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026086; Bedhomme S, 2003, J EVOLUTION BIOL, V16, P721, DOI 10.1046/j.1420-9101.2003.00576.x; Belinato TA, 2012, MEM I OSWALDO CRUZ, V107, P916, DOI 10.1590/S0074-02762012000700013; Belinato TA, 2009, MEM I OSWALDO CRUZ, V104, P43, DOI 10.1590/S0074-02762009000100007; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Catterall WA, 2003, PHARMACOL REV, V55, P573, DOI 10.1124/pr.55.4.5; CEUA, 2008, MAN UT AN FIOCR, P54; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011681; Chevillon C, 1997, GENET RES, V70, P195, DOI 10.1017/S0016672397003029; Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020; Fenton B, 2010, B ENTOMOL RES, V100, P451, DOI 10.1017/S0007485309990447; Filipecki Ana Tereza Pinto, 2011, ILAR J, V52, pE8; Foster SP, 2011, B ENTOMOL RES, V101, P659, DOI 10.1017/S0007485310000623; Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285; Gazave L, 2001, HEREDITY, V87, P441, DOI 10.1046/j.1365-2540.2001.00926.x; Gentile C, 2006, INSECT BIOCHEM MOLEC, V36, P878, DOI 10.1016/j.ibmb.2006.08.008; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Ingles PJ, 1996, INSECT BIOCHEM MOLEC, V26, P319, DOI 10.1016/0965-1748(95)00093-3; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329; Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Luz PM, 2011, MEM I OSWALDO CRUZ, V106, P755, DOI 10.1590/S0074-02762011000600017; Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889; Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x; Martins AJ, 2009, AM J TROP MED HYG, V81, P108, DOI 10.4269/ajtmh.2009.81.108; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001; Okumu FO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-208; Park Y, 1997, INSECT BIOCHEM MOLEC, V27, P9, DOI 10.1016/S0965-1748(96)00077-X; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Rodpradit P, 2005, J AM MOSQUITO CONTR, V21, P71, DOI 10.2987/8756-971X(2005)21[71:CPGMCA]2.0.CO;2; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340; van Uitregt VO, 2012, J ANIM ECOL, V81, P108, DOI 10.1111/j.1365-2656.2011.01880.x; Verhaeghen K, 2010, AM J TROP MED HYG, V82, P566, DOI 10.4269/ajtmh.2010.08-0668; WHO, 2009, WHO TECH REP SER, V958, P1; World Health Organization, 2006, PEST THEIR APPL CONT; Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x	58	133	137	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60878	10.1371/journal.pone.0060878	http://dx.doi.org/10.1371/journal.pone.0060878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593337	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000080
J	Lindskog, C; Ellstrom, P; Olsen, B; Ponten, F; van Riel, D; Munster, VJ; Gonzalez-Acuna, D; Kuiken, T; Jourdain, E				Lindskog, Cecilia; Ellstrom, Patrik; Olsen, Bjorn; Ponten, Fredrik; van Riel, Debby; Munster, Vincent J.; Gonzalez-Acuna, Daniel; Kuiken, Thijs; Jourdain, Elsa			European H16N3 Gull Influenza Virus Attaches to the Human Respiratory Tract and Eye	PLOS ONE			English	Article							A VIRUS; HEMAGGLUTININ SUBTYPE; RECEPTOR-BINDING; MALLARD DUCKS; WILD BIRDS; REPLICATION; PATTERNS; MAMMALS; HOST	We explored the attachment of an H16N3 influenza virus to human, mallard, and gull tissues using virus histochemistry applied to tissue microarrays and employing human and mallard viruses as references. Of the viruses tested, the H16N3 gull virus most readily attached to the human respiratory tract and eye. These results underscore the need to assess the potential for gull influenza viruses to replicate in human tissues and further investigate the role of gulls in influenza virus ecology.	[Lindskog, Cecilia; Ponten, Fredrik] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Ellstrom, Patrik; Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [van Riel, Debby; Kuiken, Thijs] Erasmus MC, Rotterdam, Netherlands; [Munster, Vincent J.] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Gonzalez-Acuna, Daniel] Univ Concepcion, Chillan, Chile; [Jourdain, Elsa] INRA, UR346, F-63122 St Genes Champanelle, France	Uppsala University; Uppsala University; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidad de Concepcion; INRAE	Jourdain, E (corresponding author), INRA, UR346, F-63122 St Genes Champanelle, France.	elsa.jourdain@clermont.inra.fr	Munster, Vincent/I-7607-2018; Lindskog, Cecilia/AAO-2441-2021; Lindskog, Cecilia/AAE-5462-2019	Munster, Vincent/0000-0002-2288-3196; Kuiken, Thijs/0000-0001-5501-9049; van Riel, Debby/0000-0001-9753-3564; Lindskog, Cecilia/0000-0001-5611-1015; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council for Spatial Planning and Agriculture [FORMAS 216-2009-1220]; Swedish Research Council Vetenskapsradet [VR 2010-36963-78952-78]; Knut and Alice Wallenberg Foundation; FONDECYT [1070464]; Division of Intramural Research, the National Institute of Allergy and Infectious Diseases; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001179] Funding Source: NIH RePORTER	Swedish Research Council for Spatial Planning and Agriculture; Swedish Research Council Vetenskapsradet(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Division of Intramural Research, the National Institute of Allergy and Infectious Diseases; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was financially supported by the Swedish Research Council for Spatial Planning and Agriculture (FORMAS 216-2009-1220), the Swedish Research Council Vetenskapsradet (VR 2010-36963-78952-78), the Knut and Alice Wallenberg Foundation, and the FONDECYT project (1070464). VJM is supported by the Division of Intramural Research, the National Institute of Allergy and Infectious Diseases, and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belant JL, 1997, LANDSCAPE URBAN PLAN, V38, P245, DOI 10.1016/S0169-2046(97)00037-6; Costa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-28; Costa TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015987; Daoust PY, 2011, J WILDLIFE DIS, V47, P401, DOI 10.7589/0090-3558-47.2.401; Ellstrom P, 2008, VACCINE, V26, P4414, DOI 10.1016/j.vaccine.2008.06.027; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Jourdain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024155; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lin YP, 2012, P NATL ACAD SCI USA, P12; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ramis AJ, 2012, EMERG INFECT DIS, V18, P817, DOI 10.3201/eid1805.111828; Shelton H, 2011, J VIROL, V85, P1875, DOI 10.1128/JVI.01822-10; SLEMONS RD, 1978, AVIAN DIS, V22, P367, DOI 10.2307/1589291; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; van Riel D, 2012, FUTURE VIROL, V7, P295, DOI 10.2217/fvl.12.11; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; White MR, 2009, ORAL MICROBIOL IMMUN, V24, P18, DOI 10.1111/j.1399-302X.2008.00468.x; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Yamnikova S. S., 2009, Voprosy Virusologii, V54, P10; Yamnikova SS, 2003, AVIAN DIS, V47, P1164, DOI 10.1637/0005-2086-47.s3.1164; Zhu XY, 2013, P NATL ACAD SCI USA, V110, P1458, DOI 10.1073/pnas.1218509110	27	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60757	10.1371/journal.pone.0060757	http://dx.doi.org/10.1371/journal.pone.0060757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593303	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000061
J	Asmussen, MJ; Jacobs, MF; Lee, KGH; Zapallow, CM; Nelson, AJ				Asmussen, Michael J.; Jacobs, Mark F.; Lee, Kevin G. H.; Zapallow, Christopher M.; Nelson, Aimee J.			Short-Latency Afferent Inhibition Modulation during Finger Movement	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; SOMATOSENSORY-EVOKED POTENTIALS; REACTION-TIME-TASK; VOLUNTARY MOVEMENT; CUTANEOMOTOR INTEGRATION; INTRACORTICAL INHIBITION; ELECTRICAL-STIMULATION; CENTRIFUGAL REGULATION; SURROUND INHIBITION	When somatosensory input via electrical stimulation of a peripheral nerve precedes a transcranial magnetic stimulation (TMS) pulse over the primary motor cortex (M1) the corticospinal output is substantially reduced, a phenomenon known as short-latency afferent inhibition (SAI). The present study investigated SAI during rest and during pre-movement, phasic and tonic components of movement. Participants were required to perform an index finger flexion reaction time task in response to an auditory cue. In a series of experiments, SAI was evoked from the mixed, median nerve at the wrist or the cutaneous, digital nerve stimulation of the index finger. To assess the spinal versus cortical origin of movement-related modulation of SAI, F-wave amplitudes were measured during rest and the three movement components. Results indicated that SAI was reduced during all movement components compared to rest, an effect that occurred for both nerves stimulated. Pre-movement SAI reduction was primarily attributed to reduced cortical inhibition, while increased spinal excitability additionally contributed to reduced SAI during tonic and phasic components of movement. SAI was differentially modulated across movement components with mixed but not cutaneous nerve stimulation. These findings reveal that SAI is reduced during movement and this reduction begins as early as the preparation to move. Further, these data suggest that the degree of SAI reduction during movement may be specific to the volume and/or composition of afferent input carried by each nerve.	[Asmussen, Michael J.; Jacobs, Mark F.; Lee, Kevin G. H.; Zapallow, Christopher M.; Nelson, Aimee J.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Nelson, Aimee J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	University of Waterloo; McMaster University	Nelson, AJ (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	nelsonaj@mcmaster.ca			Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the Natural Sciences and Engineering Research Council to AJN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2009, J PHYSIOL-LONDON, V587, P5163, DOI 10.1113/jphysiol.2009.179820; Baumer T, 2007, MOVEMENT DISORD, V22, P81, DOI 10.1002/mds.21219; Beck S, 2008, J NEUROSCI, V28, P10363, DOI 10.1523/JNEUROSCI.3564-08.2008; Classen J, 2000, EXP BRAIN RES, V130, P48, DOI 10.1007/s002210050005; DAY BL, 1991, J PHYSIOL-LONDON, V433, P41, DOI 10.1113/jphysiol.1991.sp018413; Devanne H, 2009, EUR J NEUROSCI, V30, P439, DOI 10.1111/j.1460-9568.2009.06815.x; Di Lazzaro V, 2007, CLIN NEUROPHYSIOL, V118, P2207, DOI 10.1016/j.clinph.2007.07.005; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V569, P315, DOI 10.1113/jphysiol.2005.092155; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V564, P661, DOI 10.1113/jphysiol.2004.061747; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; Di Lazzaro V, 2000, EXP BRAIN RES, V135, P455, DOI 10.1007/s002210000543; Di Lazzaro V, 2012, STROKE, V43, P250, DOI 10.1161/STROKEAHA.111.631085; Fischer M, 2011, BRAIN STIMUL, V4, P202, DOI 10.1016/j.brs.2010.10.005; GHOSH S, 1988, J PHYSIOL-LONDON, V400, P617, DOI 10.1113/jphysiol.1988.sp017139; Hara M, 2010, MUSCLE NERVE, V42, P208, DOI 10.1002/mus.21667; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; JONES EG, 1969, BRAIN, V92, P477, DOI 10.1093/brain/92.3.477; JONES EG, 1969, BRAIN RES, V13, P298, DOI 10.1016/0006-8993(69)90289-3; Kessler KR, 2005, MOVEMENT DISORD, V20, P238, DOI 10.1002/mds.20295; Kida T, 2006, EXP BRAIN RES, V169, P289, DOI 10.1007/s00221-005-0141-8; Kida T, 2004, CLIN NEUROPHYSIOL, V115, P2223, DOI 10.1016/j.clinph.2004.04.017; Kida T, 2006, NEUROIMAGE, V32, P1355, DOI 10.1016/j.neuroimage.2006.05.015; Lin JZ, 2004, MUSCLE NERVE, V30, P289, DOI 10.1002/mus.20110; Mang CS, 2012, NEUROSCI LETT, V529, P80, DOI 10.1016/j.neulet.2012.08.072; Master S, 2009, EXP BRAIN RES, V194, P163, DOI 10.1007/s00221-008-1679-z; Mesrati F, 2004, NEUROPHYSIOL CLIN, V34, P217, DOI 10.1016/j.neucli.2004.09.005; Morita H, 1998, EXP BRAIN RES, V120, P143, DOI 10.1007/s002210050388; Ni Z, 2011, J NEUROPHYSIOL, V105, P749, DOI 10.1152/jn.00640.2010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PADEL Y, 1991, J NEUROPHYSIOL, V66, P2041, DOI 10.1152/jn.1991.66.6.2041; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Richardson SP, 2008, MUSCLE NERVE, V37, P358, DOI 10.1002/mus.20943; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; ROTHWELL JC, 1991, EXP PHYSIOL, V76, P159, DOI 10.1113/expphysiol.1991.sp003485; Sailer A, 2003, BRAIN, V126, P1883, DOI 10.1093/brain/awg183; Seki K, 2012, J NEUROSCI, V32, P890, DOI 10.1523/JNEUROSCI.4958-11.2012; Sinclair C, 2008, EXP BRAIN RES, V186, P385, DOI 10.1007/s00221-007-1241-4; Sinclair C, 2009, EXP BRAIN RES, V194, P103, DOI 10.1007/s00221-008-1684-2; Sohn YH, 2004, EXP BRAIN RES, V158, P397, DOI 10.1007/s00221-004-1909-y; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; SWADLOW HA, 1994, J NEUROPHYSIOL, V71, P437, DOI 10.1152/jn.1994.71.2.437; Tamburin S, 2005, EXP BRAIN RES, V167, P362, DOI 10.1007/s00221-005-0041-y; Tamburin S, 2003, CLIN NEUROPHYSIOL, V114, P643, DOI 10.1016/S1388-2457(03)00002-6; Tamburin S, 2001, EXP BRAIN RES, V141, P232, DOI 10.1007/s002210100859; TAYLOR JL, 1992, J PHYSIOL-LONDON, V453, P575, DOI 10.1113/jphysiol.1992.sp019245; Thickbroom GW, 2011, BRAIN STIMUL, V4, P77, DOI 10.1016/j.brs.2010.04.002; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Tsutsumi R, 2012, J NEUROPHYSIOL, V108, P1130, DOI 10.1152/jn.00300.2012; Udupa K, 2009, EXP BRAIN RES, V199, P177, DOI 10.1007/s00221-009-1997-9; Voller B, 2006, EXP BRAIN RES, V169, P226, DOI 10.1007/s00221-005-0140-9; Voller B, 2005, J NEUROPHYSIOL, V94, P1115, DOI 10.1152/jn.00333.2005; Young-Bernier M, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-17; Zamir O, 2012, CLIN NEUROPHYSIOL, V123, P815, DOI 10.1016/j.clinph.2011.07.051; Ziemann U, 2000, J CLIN NEUROPHYSIOL, V17, P397, DOI 10.1097/00004691-200007000-00005	56	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60496	10.1371/journal.pone.0060496	http://dx.doi.org/10.1371/journal.pone.0060496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593228	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100048
J	Bell, CE; Watson, AJ				Bell, Christine E.; Watson, Andrew J.			p38 MAPK Regulates Cavitation and Tight Junction Function in the Mouse Blastocyst	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CULTURE-MEDIUM OSMOLARITY; PREIMPLANTATION DEVELOPMENT; MESENCHYMAL TRANSITION; MOLECULAR REGULATION; EMBRYO DEVELOPMENT; E-CADHERIN; DIFFERENTIATION; TROPHECTODERM; EXPRESSION	Blastocyst formation is essential for implantation and maintenance of pregnancy and is dependent on the expression and coordinated function of a series of proteins involved in establishing and maintaining the trans-trophectoderm ion gradient that enables blastocyst expansion. These consist of Na/K-ATPase, adherens junctions, tight junctions (TJ) and aquaporins (AQP). While their role in supporting blastocyst formation is established, the intracellular signaling pathways that coordinate their function is unclear. The p38 MAPK pathway plays a role in regulating these proteins in other cell types and is required for embryo development at the 8-16 cell stage, but its role has not been investigated in the blastocyst. Hypothesis: p38 MAPK regulates blastocyst formation by regulating blastocyst formation gene expression and function. Methods: Embryos were cultured from the early blastocyst stage for 12 h or 24 h in the presence of a potent and specific p38 MAPK inhibitor, SB 220025. Blastocyst expansion, hatching, gene family expression and localization, TJ function and apoptosis levels were analyzed. Results: Inhibition of the p38 MAPK pathway reduced blastocyst expansion and hatching, increased tight junction permeability, affected TJP1 localization, reduced Aqp3 expression, and induced a significant increase in apoptosis. Conclusion: The p38 MAPK pathway coordinates the overall events that regulate blastocyst formation.	[Bell, Christine E.; Watson, Andrew J.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Bell, Christine E.; Watson, Andrew J.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Bell, Christine E.; Watson, Andrew J.] Childrens Hlth Res Inst, London, ON, Canada; [Bell, Christine E.; Watson, Andrew J.] Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Bell, CE (corresponding author), Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada.	cejbell@gmail.com	Watson, Andrew J/A-5636-2015	Watson, Andrew J/0000-0002-2344-3061	Canadian Institute for Health Research-Operating Grant [MOP-49-449]	Canadian Institute for Health Research-Operating Grant(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institute for Health Research-Operating Grant MOP-49-449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Baltz JM, 2010, HUM REPROD UPDATE, V16, P166, DOI 10.1093/humupd/dmp045; Barcroft LC, 2004, MECH DEVELOP, V121, P417, DOI 10.1016/j.mod.2004.04.005; Barcroft LC, 2003, DEV BIOL, V256, P342, DOI 10.1016/S0012-1606(02)00127-6; Behr R, 2005, STEM CELLS, V23, P805, DOI 10.1634/stemcells.2004-0234; Bell CE, 2009, PLOS ONE, V4; Bell CE, 2009, HUM REPROD, V24, P1373, DOI 10.1093/humrep/dep010; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Betts DH, 1998, DEV BIOL, V197, P77, DOI 10.1006/dbio.1998.8874; Betts DH, 1997, MOL REPROD DEV, V46, P114, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;114::AID-MRD2&gt;3.0.CO;2-T; Byrne AT, 1999, J REPROD FERTIL, V117, P97, DOI 10.1530/jrf.0.1170097; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Ellish NJ, 1996, HUM REPROD, V11, P406, DOI 10.1093/HUMREP/11.2.406; FLEMING TP, 1989, J CELL BIOL, V108, P1407, DOI 10.1083/jcb.108.4.1407; FLEMING TP, 1993, J CELL SCI, P119; Fong B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-2; Giannatselis H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023704; HARTSOCK A, 2007, BIOCH BIOPHYS ACTA; Houde M, 2001, J BIOL CHEM, V276, P21885, DOI 10.1074/jbc.M100236200; Huerta S, 2007, J SURG RES, V139, P143, DOI 10.1016/j.jss.2006.07.034; Jackson JR, 1998, J PHARMACOL EXP THER, V284, P687; Kidder GM, 2005, SEMIN NEPHROL, V25, P352, DOI 10.1016/j.semnephrol.2005.03.011; Kim J, 2004, MOL CELLS, V17, P248; Lee SH, 2010, INT J NURS STUD, V47, P1159, DOI 10.1016/j.ijnurstu.2010.02.006; MacPhee DJ, 2000, DEV BIOL, V222, P486, DOI 10.1006/dbio.2000.9708; Madan P, 2007, J BIOL CHEM, V282, P12127, DOI 10.1074/jbc.M700696200; MCLAREN A, 1977, NATURE, V267, P351, DOI 10.1038/267351a0; MESROGLI M, 1991, GEBURTSH FRAUENHEILK, V51, P688, DOI 10.1055/s-2007-1023817; Natale DR, 2004, DEV BIOL, V268, P76, DOI 10.1016/j.ydbio.2003.12.011; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Paliga AJM, 2005, BIOL CELL, V97, P629, DOI 10.1042/BC20040146; Rossant J, 1997, COLD SPRING HARB SYM, V62, P127; Rossant J, 2004, SEMIN CELL DEV BIOL, V15, P573, DOI 10.1016/j.semcdb.2004.04.003; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Sebastiani G, 2009, AN PEDIATR, V70, P323, DOI 10.1016/j.anpedi.2009.01.011; Sheth B, 2000, MECH DEVELOP, V97, P93, DOI 10.1016/S0925-4773(00)00416-0; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Violette MI, 2006, DEV BIOL, V289, P406, DOI 10.1016/j.ydbio.2005.11.004; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang YC, 2005, FERTIL STERIL, V83, P1144, DOI 10.1016/j.fertnstert.2004.08.038; WATSON AJ, 1990, DEV GENET, V11, P41, DOI 10.1002/dvg.1020110106; Watson AJ, 2004, ANIM REPROD SCI, V82-3, P583, DOI 10.1016/j.anireprosci.2004.04.004; Xie Y, 2006, MOL HUM REPROD, V12, P217, DOI 10.1093/molehr/gal021; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	47	39	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e59528	10.1371/journal.pone.0059528	http://dx.doi.org/10.1371/journal.pone.0059528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593143	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100007
J	van der Loos, MJHM; Rietveld, CA; Eklund, N; Koellinger, PD; Rivadeneira, F; Abecasis, GR; Ankra-Badu, GA; Baumeister, SE; Benjamin, DJ; Biffar, R; Blankenberg, S; Boomsma, DI; Cesarini, D; Cucca, F; de Geus, EJC; Dedoussis, G; Deloukas, P; Dimitriou, M; Eiriksdottir, G; Eriksson, J; Gieger, C; Gudnason, V; Hohne, B; Holle, R; Hottenga, JJ; Isaacs, A; Jarvelin, MR; Johannesson, M; Kaakinen, M; Kahonen, M; Kanoni, S; Laaksonen, MA; Lahti, J; Launer, LJ; Lehtimaki, T; Loitfelder, M; Magnusson, PKE; Naitza, S; Oostra, BA; Perola, M; Petrovic, K; Quaye, L; Raitakari, O; Ripatti, S; Scheet, P; Schlessinger, D; Schmidt, CO; Schmidt, H; Schmidt, R; Senft, A; Smith, AV; Spector, TD; Surakka, I; Svento, R; Terracciano, A; Tikkanen, E; van Duijn, CM; Viikari, J; Volzke, H; Wichmann, HE; Wild, PS; Willems, SM; Willemsen, G; van Rooij, FJA; Groenen, PJF; Uitterlinden, AG; Hofman, A; Thurik, AR				van der Loos, Matthijs J. H. M.; Rietveld, Cornelius A.; Eklund, Niina; Koellinger, Philipp D.; Rivadeneira, Fernando; Abecasis, Goncalo R.; Ankra-Badu, Georgina A.; Baumeister, Sebastian E.; Benjamin, Daniel J.; Biffar, Reiner; Blankenberg, Stefan; Boomsma, Dorret I.; Cesarini, David; Cucca, Francesco; de Geus, Eco J. C.; Dedoussis, George; Deloukas, Panos; Dimitriou, Maria; Eiriksdottir, Guony; Eriksson, Johan; Gieger, Christian; Gudnason, Vilmundur; Hoehne, Birgit; Holle, Rolf; Hottenga, Jouke-Jan; Isaacs, Aaron; Jarvelin, Marjo-Riitta; Johannesson, Magnus; Kaakinen, Marika; Kahonen, Mika; Kanoni, Stavroula; Laaksonen, Maarit A.; Lahti, Jari; Launer, Lenore J.; Lehtimaki, Terho; Loitfelder, Marisa; Magnusson, Patrik K. E.; Naitza, Silvia; Oostra, Ben A.; Perola, Markus; Petrovic, Katja; Quaye, Lydia; Raitakari, Olli; Ripatti, Samuli; Scheet, Paul; Schlessinger, David; Schmidt, Carsten O.; Schmidt, Helena; Schmidt, Reinhold; Senft, Andrea; Smith, Albert V.; Spector, Timothy D.; Surakka, Ida; Svento, Rauli; Terracciano, Antonio; Tikkanen, Emmi; van Duijn, Cornelia M.; Viikari, Jorma; Voelzke, Henry; Wichmann, H. -Erich; Wild, Philipp S.; Willems, Sara M.; Willemsen, Gonneke; van Rooij, Frank J. A.; Groenen, Patrick J. F.; Uitterlinden, Andre G.; Hofman, Albert; Thurik, A. Roy			The Molecular Genetic Architecture of Self-Employment	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; COMMON SNPS EXPLAIN; SOCIOECONOMIC-STATUS; EDUCATIONAL-ATTAINMENT; MISSING HERITABILITY; LARGE PROPORTION; RISK-FACTORS; ENTREPRENEURSHIP; HEALTH	Economic variables such as income, education, and occupation are known to affect mortality and morbidity, such as cardiovascular disease, and have also been shown to be partly heritable. However, very little is known about which genes influence economic variables, although these genes may have both a direct and an indirect effect on health. We report results from the first large-scale collaboration that studies the molecular genetic architecture of an economic variable-entrepreneurship-that was operationalized using self-employment, a widely-available proxy. Our results suggest that common SNPs when considered jointly explain about half of the narrow-sense heritability of self-employment estimated in twin data (sigma(2)(g)/sigma(2)(P) = 25%, h(2) = 55%). However, a meta-analysis of genome-wide association studies across sixteen studies comprising 50,627 participants did not identify genome-wide significant SNPs. 58 SNPs with p<10(-5) were tested in a replication sample (n = 3,271), but none replicated. Furthermore, a gene-based test shows that none of the genes that were previously suggested in the literature to influence entrepreneurship reveal significant associations. Finally, SNP-based genetic scores that use results from the meta-analysis capture less than 0.2% of the variance in self-employment in an independent sample (p >= 0.039). Our results are consistent with a highly polygenic molecular genetic architecture of self-employment, with many genetic variants of small effect. Although self-employment is a multi-faceted, heavily environmentally influenced, and biologically distal trait, our results are similar to those for other genetically complex and biologically more proximate outcomes, such as height, intelligence, personality, and several diseases.	[van der Loos, Matthijs J. H. M.; Rietveld, Cornelius A.; Koellinger, Philipp D.; Thurik, A. Roy] Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands; [van der Loos, Matthijs J. H. M.; Rietveld, Cornelius A.; Koellinger, Philipp D.; Rivadeneira, Fernando; van Rooij, Frank J. A.; Uitterlinden, Andre G.; Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Eklund, Niina; Perola, Markus; Ripatti, Samuli; Surakka, Ida; Tikkanen, Emmi] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Eklund, Niina; Perola, Markus; Ripatti, Samuli; Surakka, Ida; Tikkanen, Emmi] Natl Inst Hlth & Welf THL, Dept Chron Dis Prevent, Publ Hlth Genom Unit, Helsinki, Finland; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Ankra-Badu, Georgina A.; Quaye, Lydia; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Baumeister, Sebastian E.; Schmidt, Carsten O.; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Benjamin, Daniel J.] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Biffar, Reiner] Ernst Moritz Arndt Univ Greifswald, Ctr Oral Hlth, Dept Prosthet Dent Gerodontol & Biomat, Greifswald, Germany; [Blankenberg, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Boomsma, Dorret I.; de Geus, Eco J. C.; Hottenga, Jouke-Jan; Willemsen, Gonneke] Vrije Univ Amsterdam, Dept Biol Psychol, Netherlands Twin Register, Amsterdam, Netherlands; [Cesarini, David] NYU, Dept Econ, Ctr Expt Social Sci, New York, NY 10003 USA; [Cucca, Francesco; Naitza, Silvia] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Dedoussis, George; Dimitriou, Maria] Harokopio Univ Athens, Dept Nutr & Dietet, Athens, Greece; [Deloukas, Panos; Kanoni, Stavroula; Ripatti, Samuli] Wellcome Trust Sanger Inst, Hinxton, England; [Eiriksdottir, Guony; Gudnason, Vilmundur; Smith, Albert V.] Iceland Heart Assoc, Kopavogur, Iceland; [Eriksson, Johan] Natl Inst Hlth & Welf THL, Dept Chron Dis Prevent, Diabet Prevent Unit, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan] Vaasa Cent Hosp, Vaasa, Finland; [Gieger, Christian; Hoehne, Birgit] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Gudnason, Vilmundur; Smith, Albert V.] Univ Iceland, Dept Med, Reykjavik, Iceland; [Hoehne, Birgit] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Holle, Rolf] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Isaacs, Aaron; van Duijn, Cornelia M.; Willems, Sara M.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Isaacs, Aaron; van Duijn, Cornelia M.] Ctr Med Syst Biol, Leiden, Netherlands; [Jarvelin, Marjo-Riitta; Kaakinen, Marika] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta; Kaakinen, Marika] Univ Oulu, Bioctr, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Life Course & Serv, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat, London, England; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Laaksonen, Maarit A.] Natl Inst Hlth & Welf THL, Dept Hlth Funct Capac & Welf, Populat Hlth Res Unit, Helsinki, Finland; [Lahti, Jari] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Fimlab Labs, FIN-33521 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33101 Tampere, Finland; [Loitfelder, Marisa; Schmidt, Reinhold] Med Univ Graz, Div Neurogeriatr, Dept Neurol, Graz, Austria; [Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Perola, Markus] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Petrovic, Katja] Gen Hosp, Dept Neurol, Div Gen Neurol, Graz, Austria; [Petrovic, Katja] Med Univ Graz, Graz, Austria; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Schlessinger, David; Terracciano, Antonio] NIA, NIH, Baltimore, MD 21224 USA; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Senft, Andrea] Med Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Svento, Rauli] Univ Oulu, Oulu Business Sch, Dept Econ, Oulu, Finland; [Terracciano, Antonio] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; [Viikari, Jorma] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. -Erich] Univ Munich, Klinikum Grosshadern, D-80539 Munich, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, D-55122 Mainz, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Med 2, D-55122 Mainz, Germany; [Groenen, Patrick J. F.] Erasmus Univ, Erasmus Sch Econ, Inst Econometr, Rotterdam, Netherlands; [Thurik, A. Roy] Panteia, Zoetermeer, Netherlands; [Thurik, A. Roy] GSCM Montpellier Business Sch, Montpellier, France	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; University of Helsinki; Finland National Institute for Health & Welfare; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of London; King's College London; Greifswald Medical School; Cornell University; Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf; Vrije Universiteit Amsterdam; New York University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Harokopio University Athens; Wellcome Trust Sanger Institute; Icelandic Heart Association; Finland National Institute for Health & Welfare; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Iceland; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Imperial College London; Stockholm School of Economics; Tampere University; Tampere University Hospital; Tampere University; Finland National Institute for Health & Welfare; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Tampere University; Tampere University Hospital; Tampere University; Medical University of Graz; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; University of Tartu; Medical University of Graz; University of Turku; University of Turku; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Medical University of Graz; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Oulu; State University System of Florida; Florida State University; University of Turku; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Erasmus University Rotterdam	van der Loos, MJHM (corresponding author), Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands.	mvanderloos@ese.eur.nl	Magnusson, Patrik KE/C-4458-2017; Terracciano, Antonio/H-7403-2019; Boomsma, Dorret I/AAX-4470-2020; Naitza, Silvia/D-5620-2017; Lahti, Jari/P-2283-2019; de Geus, Eco J.C./M-9318-2015; Kanoni, Stavroula/AAN-7161-2021; Raitakari, Olli/AAQ-7389-2021; Gudnason, Vilmundur/K-6885-2015; Rivadeneira, Fernando/O-5385-2015; Deloukas, Panos/B-2922-2013; Schmidt, Reinhold/E-1137-2014; Schmidt, Carsten Oliver/AAH-2778-2019; Ripatti, Samuli/H-9446-2014; Smith, Albert Vernon/K-5150-2015; Thurik, Roy/A-9386-2012; Baumeister, Sebastian-Edgar/P-7894-2019; Johannesson, Magnus/E-9680-2011; Wichmann, Heinz Erich/AAA-5695-2022; Lehtimäki, Terho/AAD-1094-2022; Dedoussis, George/AAN-7252-2021; Gudnason, Vilmundur/AAE-7126-2019; Laaksonen, Maarit A/O-3467-2016; Wild, Philipp S./M-2106-2019; NAITZA, SILVIA/AAB-8775-2022; Holle, Rolf/D-9333-2013; Lahti, Jari/P-7987-2018	Magnusson, Patrik KE/0000-0002-7315-7899; Terracciano, Antonio/0000-0001-5799-8885; Lahti, Jari/0000-0002-4310-5297; de Geus, Eco J.C./0000-0001-6022-2666; Kanoni, Stavroula/0000-0002-1691-9615; Gudnason, Vilmundur/0000-0001-5696-0084; Rivadeneira, Fernando/0000-0001-9435-9441; Deloukas, Panos/0000-0001-9251-070X; Schmidt, Carsten Oliver/0000-0001-5266-9396; Ripatti, Samuli/0000-0002-0504-1202; Smith, Albert Vernon/0000-0003-1942-5845; Thurik, Roy/0000-0002-0242-6908; Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Johannesson, Magnus/0000-0001-8759-6393; Lehtimäki, Terho/0000-0002-2555-4427; Dedoussis, George/0000-0002-7798-6221; Gudnason, Vilmundur/0000-0001-5696-0084; Laaksonen, Maarit A/0000-0002-3676-0787; NAITZA, SILVIA/0000-0002-0108-757X; Holle, Rolf/0000-0001-5395-2695; Lahti, Jari/0000-0002-4310-5297; Koellinger, Philipp/0000-0001-7413-0412; Cesarini, David/0000-0002-0043-009X; Surakka, Ida/0000-0002-6669-5541; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Gieger, Christian/0000-0001-6986-9554; Abecasis, Goncalo/0000-0003-1509-1825; Kaakinen, Marika/0000-0002-9228-0462; Van Duijn, Cornelia/0000-0002-2374-9204; Eriksson, Johan/0000-0002-2516-2060; Groenen, Patrick/0000-0001-6683-8971; Kahonen, Mika/0000-0002-4510-7341; CUCCA, Francesco/0000-0002-7414-1995; Willemsen, Gonneke/0000-0003-3755-0236; Wild, Philipp/0000-0003-4413-9752	National Institutes of Health [N01-AG-12100]; NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); Austrian Science Fond (FWF) [P20545-P05, P13180]; EUROSPAN (European Special Populations Research Network); European Commission [018947, LSHG-CT-2006-01947, QLG1-CT-2000-01643]; Netherlands Organization for Scientific Research, Erasmus MC; Centre for Medical Systems Biology (CMSB); Netherlands Brain Foundation (Hersenstichting Nederland); government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation") [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; Philips Medical Systems; Gutenberg Health Study [H2000]; budgetary funds of National Institute for Health and Welfare (THL); Finnish Centre for Pensions (ETK); Social Insurance Institution of Finland (KELA); Local Government Pensions Institution (KEVA); Academy of Finland [120315, 129287, 1129457, 1216965, 120386, 125876, 104781, 129418, 126925, 121584, 124282, 129378, 117787, 41071]; Finnish Diabetes Research Society; Folkhalsan Research Foundation; Novo Nordisk Foundation; Finska Lakaresallskapet; European Science Foundation (EuroSTRESS); Wellcome Trust [89061/Z/09/Z, 089062/Z/09/Z]; Samfundet Folkhalsan; Signe and Ane Gyllenberg foundation; Finnish Academy SALVE program "Pubgensense" [129322]; National Institute on Aging [NIA U01AG009740, NO1-AG-1-2109]; Helmholtz Zentrum Munchen; German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network (NGFN); Munich Center of Health Sciences (MC Health) as part of LMUinnovativ [NFBC1966]; Center of Excellence in Complex Disease Genetics and SALVE; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; NHLBI through the STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; ENGAGE project [HEALTH-F4-2007-201413]; Medical Research Council, UK [G0500539, G0600705]; Netherlands Organization for Scientific Research (NWO) [904-61-090, 985-10-002, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008 Middelgroot-911-09-032, Spinozapremie 56-46414192]; Center for Medical Systems Biology (CSMB, NWO Genomics); NBIC/BioAssist/RK [2008.024]; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL) [184.021.007]; VU University's Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); European Science Foundation (ESF) [EU/QLRT-2001-01254]; European Community; ENGAGE [HEALTH-F4-2007-201413]; European Science Council (ERC) [230374]; Rutgers University Cell and DNA Repository [NIMH U24 MH068457-06]; Avera Institute, Sioux Falls, South Dakota (USA); National Institutes of Health (NIH) [R01D0042157-01A]; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health; NIMH [MH081802]; Grand Opportunity from the NIMH [1RC2MH089951-01, 1RC2 MH089995-01]; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Municipality of Rotterdam; Netherlands Organisation for Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015]; Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) [050-060-810]; Netherlands Scientific Organization [NWO 480-05-003]; Intramural Research Program of the National Institute on Aging, NIH; Federal Ministry of Education and Research [BMBF 01ZZ9603, 01ZZ0103, 03IS2061A, 03ZIK012]; Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Swedish Council for Working Life and Social Research; Jan Wallander and Tom Hedelius Foundation; Ragnar Soderberg Foundation; Ministry for Higher Education; Swedish Research Council [M-2005-1112]; GenomEUtwin [EU/QLRT-2001-01254, QLG2-CT-2002-01254]; NIH [DK U01-066134]; Swedish Foundation for Strategic Research (SSF); Heart and Lung foundation [20070481]; Greek General Secretary of Research and Technology [PENED 2003]; Wellcome Trust Sanger Institute; Wellcome Trust; Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; National Eye Institute via an NIH/CIDR genotyping project; Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds [9M048]; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RC2MH089995, RL1MH083268, U24MH068457, R01MH081802, RC2MH089951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740, N01AG012100] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1064089] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Althingi (the Icelandic Parliament); Austrian Science Fond (FWF)(Austrian Science Fund (FWF)); EUROSPAN (European Special Populations Research Network); European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research, Erasmus MC; Centre for Medical Systems Biology (CMSB); Netherlands Brain Foundation (Hersenstichting Nederland); government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation"); Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); Philips Medical Systems; Gutenberg Health Study; budgetary funds of National Institute for Health and Welfare (THL); Finnish Centre for Pensions (ETK); Social Insurance Institution of Finland (KELA); Local Government Pensions Institution (KEVA); Academy of Finland(Academy of Finland); Finnish Diabetes Research Society; Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Finska Lakaresallskapet; European Science Foundation (EuroSTRESS)(European Science Foundation (ESF)); Wellcome Trust(Wellcome TrustEuropean Commission); Samfundet Folkhalsan; Signe and Ane Gyllenberg foundation; Finnish Academy SALVE program "Pubgensense"; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFN); Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; Center of Excellence in Complex Disease Genetics and SALVE; University Hospital Oulu, Biocenter, University of Oulu, Finland; NHLBI through the STAMPEED program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center for Medical Systems Biology (CSMB, NWO Genomics); NBIC/BioAssist/RK; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); VU University's Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); European Science Foundation (ESF)(European Science Foundation (ESF)); European Community(European Commission); ENGAGE; European Science Council (ERC)(European Research Council (ERC)); Rutgers University Cell and DNA Repository; Avera Institute, Sioux Falls, South Dakota (USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grand Opportunity from the NIMH; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Municipality of Rotterdam; Netherlands Organisation for Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA); Netherlands Scientific Organization; Intramural Research Program of the National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg-West Pomerania; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Jan Wallander and Tom Hedelius Foundation; Ragnar Soderberg Foundation; Ministry for Higher Education; Swedish Research Council(Swedish Research CouncilEuropean Commission); GenomEUtwin; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Heart and Lung foundation(Swedish Heart-Lung Foundation); Greek General Secretary of Research and Technology; Wellcome Trust Sanger Institute(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; National Eye Institute via an NIH/CIDR genotyping project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	AGES: The AGES-Reykjavik Study is funded by National Institutes of Health contract N01-AG-12100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament); ASPS: The research reported in this article was funded by the Austrian Science Fond (FWF) grant number P20545-P05 and P13180. The Medical University of Graz supports the databank of the ASPS; ERF: The genotyping for the ERF study was supported by EUROSPAN (European Special Populations Research Network) and the European Commission FP6 STRP grant (018947; LSHG-CT-2006-01947). The ERF study was further supported by grants from the Netherlands Organization for Scientific Research, Erasmus MC, the Centre for Medical Systems Biology (CMSB) and the Netherlands Brain Foundation (Hersenstichting Nederland); GHS: This work/the Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation'', contract number AZ 961-386261/733), the research programs "Wissen schafft Zukunft'' and "Schwerpunkt Vaskulare Pravention'' of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and Philips Medical Systems including an unrestricted grant for the Gutenberg Health Study; H2000: The study was funded mainly by the budgetary funds of National Institute for Health and Welfare (THL). The Finnish Centre for Pensions (ETK), the Social Insurance Institution of Finland (KELA), the Local Government Pensions Institution (KEVA) and other organisations listed on the website of the survey (http://www.terveys2000.fi) also contributed to funding; HBCS: The Helsinki Birth Cohort Study has been supported by grants from the Academy of Finland (Grant No. 120315 and 129287 to EW, 1129457 and 1216965 to KR, 120386 and 125876 to JGE), the Finnish Diabetes Research Society, Folkhalsan Research Foundation, Novo Nordisk Foundation, Finska Lakaresallskapet, the European Science Foundation (EuroSTRESS), the Wellcome Trust (Grant No. 89061/Z/09/Z and 089062/Z/09/Z), Samfundet Folkhalsan, Finska Lakaresallskapet and the Signe and Ane Gyllenberg foundation. Markus Perola is partly financially supported for this work by the Finnish Academy SALVE program "Pubgensense'' 129322; HRS: The Health and Retirement Study is sponsored by the National Institute on Aging (grant number NIA U01AG009740) and is conducted by the University of Michigan; KORA S4: The KORA Augsburg studies were financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany and supported by grants from the German Federal Ministry of Education and Research (BMBF). Part of this work was financed by the German National Genome Research Network (NGFN).; Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; NFBC1966: Academy of Finland [project grants 104781, 120315, 129418 and Center of Excellence in Complex Disease Genetics and SALVE], University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission [EURO-BLCS, Framework 5 award QLG1-CT-2000-01643], NHLBI [5R01HL087679-02] through the STAMPEED program [1RL1MH083268-01], NIH/NIMH [5R01MH63706:02], ENGAGE project and grant agreement [HEALTH-F4-2007-201413], and the Medical Research Council, UK [G0500539, G0600705, PrevMetSyn/SALVE]; NTR: The Netherlands Twin Register data collection and genotyping has been funded by the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW grants 904-61-090, 985-10-002,904-61-193,480-04-004, 400-05-717, Addiction-31160008 Middelgroot-911-09-032, Spinozapremie 56-46414192), Center for Medical Systems Biology (CSMB, NWO Genomics), NBIC/BioAssist/RK(2008.024), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL, 184.021.007), the VU University's Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA), the European Science Foundation (ESF, EU/QLRT-2001-01254), the European Community's Seventh Framework Program (FP7/2007-2013), ENGAGE (HEALTH-F4-2007-201413); the European Science Council (ERC Advanced, 230374), Rutgers University Cell and DNA Repository (NIMH U24 MH068457-06), the Avera Institute, Sioux Falls, South Dakota (USA) and the National Institutes of Health (NIH, R01D0042157-01A). Part of the genotyping and analyses were funded by the Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health, the (NIMH, MH081802) and by the Grand Opportunity grants 1RC2MH089951-01 and 1RC2 MH089995-01 from the NIMH; RS: The Rotterdam Study is funded by the Erasmus Medical Center and Erasmus University, Rotterdam, the Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The GWAS database of the Rotterdam Study was funded by the Netherlands Organisation for Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), and the Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810. Statistical analyses were partly carried out on the Genetic Cluster Computer (http://www.geneticcluster.org) which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003) along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam; SardiNIA: This research was supported in part by the Intramural Research Program of the National Institute on Aging, NIH, and by the National Institute on Aging contract NO1-AG-1-2109 to the SardiNIA/ProgeNIA team; SHIP: SHIP is part of the Community Medicine Research net (www.community-medicine.de) and the Greifswald Approach to Individualized Medicine (GANI_MED) consortium (www.gani-med.de) of the University Medicine Greifswald, Germany, which are funded by the Federal Ministry of Education and Research (BMBF 01ZZ9603, 01ZZ0103 and 03IS2061A), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania.; Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of the Siemens AG and the Cache Campus program of the InterSystems GmbH; STR: Financial support was received from The Swedish Council for Working Life and Social Research, The Jan Wallander and Tom Hedelius Foundation, the Ragnar Soderberg Foundation, the Ministry for Higher Education, the Swedish Research Council (M-2005-1112), GenomEUtwin (EU/QLRT-2001-01254; QLG2-CT-2002-01254), NIH DK U01-066134, The Swedish Foundation for Strategic Research (SSF), and the Heart and Lung foundation no. 20070481; THISEAS: Recruitment for THISEAS was partially funded by a research grant (PENED 2003) from the Greek General Secretary of Research and Technology. Genotyping was supported by the Wellcome Trust Sanger Institute; TwinsUK: The study was funded by the Wellcome Trust, the European Community's Seventh Framework Programme (FP7/2007-2013), and the ENGAGE project grant agreement (HEALTH-F4-2007-201413). The study also receives support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior Investigator and is holder of an ERC Advanced Principal Investigator award. Genotyping was performed by The Wellcome Trust Sanger Institute, support of the National Eye Institute via an NIH/CIDR genotyping project; YFS: The Young Finns Study has been financially supported by the Academy of Finland: grants 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi), the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds (grant 9M048 for TeLeht), Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation, Tampere Tuberculosis Foundation and Emil Aaltonen Foundation (TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andersson L, 2010, SMALL BUS ECON, V34, P261, DOI 10.1007/s11187-008-9117-y; [Anonymous], 2002, ENTREP THEORY PRACT, DOI DOI 10.1177/104225870202600303; Ansolabehere S, 2008, AM POLIT SCI REV, V102, P215, DOI 10.1017/S0003055408080210; Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Argyle M, 1997, PSYCHOL HEALTH, V12, P769, DOI 10.1080/08870449708406738; Bates T, 2002, J BUS VENTURING, V17, P313, DOI 10.1016/S0883-9026(00)00066-5; Beauchamp JP, 2011, J ECON PERSPECT, V25, P57, DOI 10.1257/jep.25.4.57; BEHRMAN J, 1976, AM ECON REV, V66, P436; Benjamin DJ, 2012, ANNU REV ECON, V4, P627, DOI 10.1146/annurev-economics-080511-110939; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Benz M, 2008, ECONOMICA, V75, P362, DOI 10.1111/j.1468-0335.2007.00594.x; Bjorklund A, 2007, BE J ECON ANAL POLI, V7; Blanchflower DG, 1998, J LABOR ECON, V16, P26, DOI 10.1086/209881; Block J, 2009, KYKLOS, V62, P191, DOI 10.1111/j.1467-6435.2009.00431.x; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Charney E, 2008, PERSPECT POLIT, V6, P299, DOI 10.1017/S1537592708080626; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Colombier N, 2008, SMALL BUS ECON, V30, P423, DOI 10.1007/s11187-007-9059-9; Cooper C. L., 1985, JOB STRESS BLUE COLL; COOPER CL, 1976, J OCCUP PSYCHOL, V49, P11, DOI 10.1111/j.2044-8325.1976.tb00325.x; Dahl MS, 2010, SCAND J PUBLIC HEALT, V38, P857, DOI 10.1177/1403494810375490; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; DEMPSTER ER, 1950, GENETICS, V35, P212; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dowd JB, 2011, INT J EPIDEMIOL, V40, P183, DOI 10.1093/ije/dyq189; Du Rietz A, 2000, SMALL BUS ECON, V14, P1, DOI 10.1023/A:1008106215480; Dunn T, 2000, J LABOR ECON, V18, P282, DOI 10.1086/209959; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Ettner SL, 1996, J HEALTH ECON, V15, P67, DOI 10.1016/0167-6296(95)00032-1; EVANS DS, 1989, AM ECON REV, V79, P519; Falconer D.S., 1960, INTRO QUANTITATIVE G, P1, DOI [10.2307/2985722, DOI 10.2307/2985722]; Georgellis Y, 2005, INT REV APPL ECON, V19, P321, DOI 10.1080/02692170500119854; Goddard ME, 2009, STAT SCI, V24, P517, DOI 10.1214/09-STS306; Hamilton BH, 2000, J POLIT ECON, V108, P604, DOI 10.1086/262131; HAYNES SG, 1980, AM J PUBLIC HEALTH, V70, P133, DOI 10.2105/AJPH.70.2.133; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Koellinger P, 2011, OXFORD B EC IN PRESS; Koellinger PD, 2010, SMALL BUS ECON, V35, P1, DOI 10.1007/s11187-010-9286-3; Lager ACJ, 2012, P NATL ACAD SCI USA, V109, P8461, DOI 10.1073/pnas.1105839109; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; LENTZ BF, 1990, CAN J ECON, V23, P563, DOI 10.2307/135648; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LEWINEPSTEIN N, 1991, WORK OCCUPATION, V18, P291, DOI 10.1177/0730888491018003003; LICHTENSTEIN P, 1992, ACTA SOCIOL, V35, P13, DOI 10.1177/000169939203500102; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; LOOMIS JB, 1989, AM J AGR ECON, V71, P76, DOI 10.2307/1241776; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; MATTHEWS KA, 1989, AM J EPIDEMIOL, V129, P1132, DOI 10.1093/oxfordjournals.aje.a115235; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; Miller P, 2001, ECON EDUC REV, V20, P211, DOI 10.1016/S0272-7757(00)00018-2; Mitchell BD, 2001, AM J MED GENET, V102, P346, DOI 10.1002/ajmg.1483; Neale M. C, 2003, MX STAT MODELING, V6th; Nicolaou N, 2008, MANAGE SCI, V54, P167, DOI 10.1287/mnsc.1070.0761; Nicolaou N, 2011, SMALL BUS ECON, V36, P151, DOI 10.1007/s11187-010-9308-1; Nicolaou N, 2010, J ECON BEHAV ORGAN, V76, P3, DOI 10.1016/j.jebo.2010.02.009; Parker S.C., 2009, EC ENTREPRENEURSHIP, V1st; Paterson AD, 1999, NEUROPSYCHOPHARMACOL, V21, P3, DOI 10.1016/S0893-133X(98)00115-8; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; RIDING AL, 1990, J BUS VENTURING, V5, P327, DOI 10.1016/0883-9026(90)90009-I; Sacerdote B, 2007, Q J ECON, V122, P119, DOI 10.1162/qjec.122.1.119; SCARR S, 1994, BEHAV GENET, V24, P301, DOI 10.1007/BF01067532; SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121; Shane S, 2000, ACAD MANAGE REV, V25, P217, DOI 10.5465/amr.2000.2791611; Shane S., 2010, BORN ENTREPRENEURS B; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; TAUBMAN P, 1976, AM ECON REV, V66, P858; Terracciano A, 2009, AM J MED GENET B, V150B, P1070, DOI 10.1002/ajmg.b.30932; van der Loos MJHM, 2011, SMALL BUS ECON, V37, P269, DOI 10.1007/s11187-011-9339-2; van der Loos MJHM, 2010, EUR J EPIDEMIOL, V25, P1, DOI 10.1007/s10654-009-9418-8; van der Zwan P, 2010, APPL ECON, V42, P2183, DOI 10.1080/00036840701765437; van Kippersluis H, 2011, J HUM RESOUR, V46, P695, DOI 10.1353/jhr.2011.0006; Verheul I, 2001, SMALL BUS ECON, V16, P329, DOI 10.1023/A:1011178629240; Verheul I, 2012, J ECON PSYCHOL, V33, P325, DOI 10.1016/j.joep.2011.02.009; Verweij KJH, 2012, EVOLUTION, V66, P3238, DOI 10.1111/j.1558-5646.2012.01679.x; Verweij KJH, 2010, BIOL PSYCHOL, V85, P306, DOI 10.1016/j.biopsycho.2010.07.018; Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Weertman A, 2003, J PERS DISORD, V17, P562, DOI 10.1521/pedi.17.6.562.25359; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang Z, 2009, ORGAN BEHAV HUM DEC, V110, P93, DOI 10.1016/j.obhdp.2009.07.002; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	105	25	26	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60542	10.1371/journal.pone.0060542	http://dx.doi.org/10.1371/journal.pone.0060542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RK	23593239	Green Published, gold			2022-12-27	WOS:000319108100052
J	Wang, YJ; Sun, MA; Bao, HX; Zhang, Q; Guo, DJ				Wang, Yejun; Sun, Ming'an; Bao, Hongxia; Zhang, Qing; Guo, Dianjing			Effective Identification of Bacterial Type III Secretion Signals Using Joint Element Features	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SALMONELLA-TYPHIMURIUM; PROTEIN-STRUCTURE; MESSENGER-RNA; PREDICTION; SYSTEM; TRANSLOCATION; REPERTOIRE; HOMOLOGY; GENES	Type III secretion system (T3SS) plays important roles in bacteria and host cell interactions by specifically translocating type III effectors into the cytoplasm of the host cells. The N-terminal amino acid sequences of the bacterial type III effectors determine their specific secretion via type III secretion conduits. It is still unclear as to how the N-terminal sequences guide this specificity. In this work, the amino acid composition, secondary structure, and solvent accessibility in the N-termini of type III and non-type III secreted proteins were compared and contrasted. A high-efficacy mathematical model based on these joint features was developed to distinguish the type III proteins from the non-type III ones. The results indicate that secondary structure and solvent accessibility may make important contribution to the specific recognition of type III secretion signals. Analysis also showed that the joint feature of the N-terminal 6 th -10 th amino acids are especially important for guiding specific type III secretion. Furthermore, a genome-wide screening was performed to predict Salmonella type III secreted proteins, and 8 new candidates were experimentally validated. Interestingly, type III secretion signals were also predicted in gram-positive bacteria and yeasts. Experimental validation showed that two candidates from yeast can indeed be secreted through Salmonella type III secretion conduit. This research provides the first line of direct evidence that secondary structure and solvent accessibility contain important features for guiding specific type III secretion. The new software based on these joint features ensures a high accuracy (general cross-validation sensitivity of similar to 96% at a specificity of similar to 98%) in silico identification of new type III secreted proteins, which may facilitate our understanding about the specificity of type III secretion and the evolution of type III secreted proteins.	[Wang, Yejun; Sun, Ming'an; Zhang, Qing; Guo, Dianjing] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Wang, Yejun; Sun, Ming'an; Zhang, Qing; Guo, Dianjing] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Wang, Yejun; Bao, Hongxia] Harbin Med Univ, Genome Res Ctr, Harbin, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Harbin Medical University	Guo, DJ (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	djguo@cuhk.edu.hk	Sun, Mingan/D-7141-2019	Sun, Mingan/0000-0002-4661-3027	Institute of Plant Molecular Biology and Agricultural Biotechnology; Chinese University of Hong Kong	Institute of Plant Molecular Biology and Agricultural Biotechnology; Chinese University of Hong Kong(Chinese University of Hong Kong)	This work is partially supported by a grant from the Institute of Plant Molecular Biology and Agricultural Biotechnology, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arnold R, 2010, MICROBES INFECT, V12, P346, DOI 10.1016/j.micinf.2010.02.003; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Buchko GW, 2010, MOL BIOSYST, V6, P2448, DOI 10.1039/c0mb00097c; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Girard F, 2009, INFECT IMMUN, V77, P1304, DOI 10.1128/IAI.01351-08; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Higashide W, 2006, J BACTERIOL, V188, P2411, DOI 10.1128/JB.188.7.2411-2420.2006; Hong KH, 1998, J BACTERIOL, V180, P1793, DOI 10.1128/JB.180.7.1793-1802.1998; HUANG HC, 1995, MOL PLANT MICROBE IN, V8, P733, DOI 10.1094/MPMI-8-0733; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Karavolos MH, 2005, J BACTERIOL, V187, P1559, DOI 10.1128/JB.187.5.1559-1567.2005; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Lindeberg M, 2009, TRENDS MICROBIOL, V17, P304, DOI 10.1016/j.tim.2009.04.001; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Noel L, 2003, J BACTERIOL, V185, P7092, DOI 10.1128/JB.185.24.7092-7102.2003; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x; Russmann H, 2001, J IMMUNOL, V167, P357, DOI 10.4049/jimmunol.167.1.357; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Scholkopf B., 2002, LEARNING KERNELS; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; WANG Y, 2013, PLOS ONE IN PRESS; Wang YJ, 2008, CANCER LETT, V263, P67, DOI 10.1016/j.canlet.2007.12.022; Wang YJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-66; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; White AP, 1999, VACCINE, V17, P2150, DOI 10.1016/S0264-410X(98)00491-5; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47; Zhang JF, 2010, PROTEINS, V78, P1137, DOI 10.1002/prot.22634	48	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e59754	10.1371/journal.pone.0059754	http://dx.doi.org/10.1371/journal.pone.0059754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593149	Green Submitted, gold, Green Published			2022-12-27	WOS:000319108100010
J	Hawi, Z; Matthews, N; Wagner, J; Wallace, RH; Butler, TJ; Vance, A; Kent, L; Gill, M; Bellgrove, MA				Hawi, Ziarih; Matthews, Natasha; Wagner, Joseph; Wallace, Robyn H.; Butler, Tim J.; Vance, Alasdair; Kent, Lindsey; Gill, Michael; Bellgrove, Mark A.			DNA Variation in the SNAP25 Gene Confers Risk to ADHD and Is Associated with Reduced Expression in Prefrontal Cortex	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; GENOME-WIDE ASSOCIATION; CANDIDATE GENE; SNARE COMPLEX; ATTENTION; SNAP-25; SUSCEPTIBILITY; IDENTIFICATION; POLYMORPHISMS; VARIANTS	Background: The Coloboma mouse carries a similar to 2 cM deletion encompassing the SNAP25 gene and has a hyperactive phenotype similar to that of ADHD. Such mice are 3 fold more active compared to their control littermates. Genetic association studies support a role for allelic variants of the human SNAP25 gene in predisposing to ADHD. Methods/Principal Findings: We performed association analysis across the SNAP25 gene in 1,107 individuals (339 ADHD trios). To assess the functional relevance of the SNAP25-ADHD associated allele, we performed quantitative PCR on postmortem tissue derived from the inferior frontal gyrus of 89 unaffected adults. Significant associations with the A allele of SNP rs362990 (chi(2) = 10, p-corrected = 0.019, OR = 1.5) and three marker haplotypes (rs6108461, rs362990 and rs362998) were observed. Furthermore, a significant additive decrease in the expression of the SNAP25 transcript as a function of the risk allele was also observed. This effect was detected at the haplotype level, where increasing copies of the ADHD-associated haplotype reduced the expression of the transcript. Conclusions: Our data show that DNA variation at SNAP25 confers risk to ADHD and reduces the expression of the transcript in a region of the brain that is critical for the regulation of attention and inhibition.	[Hawi, Ziarih; Matthews, Natasha; Wagner, Joseph; Wallace, Robyn H.; Butler, Tim J.; Bellgrove, Mark A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Vance, Alasdair] Univ Melbourne, Royal Childrens Hosp, Melbourne, Vic 3010, Australia; [Kent, Lindsey] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Gill, Michael] Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland; [Hawi, Ziarih; Bellgrove, Mark A.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia	University of Queensland; Royal Children's Hospital Melbourne; University of Melbourne; University of St Andrews; Trinity College Dublin; Monash University	Hawi, Z (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	z.hawi@uq.edu.au	Bellgrove, Mark/AAB-3114-2019	Kent, Lindsey/0000-0002-5315-3399; Hawi, Ziarih/0000-0002-0814-9112; Wallace, Robyn/0000-0001-6141-3317; Matthews, Natasha/0000-0001-5683-7289; Vance, Alasdair/0000-0002-7471-9769; Gill, Michael/0000-0003-0206-5337; Bellgrove, Mark/0000-0003-0186-8349	Australian National Health and Medical Research council (NHMRC) [APP1002458, 569636]; NHMRC [569631]; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) [R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725, R24AA012725] Funding Source: NIH RePORTER	Australian National Health and Medical Research council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	ZH and MAB were supported by the Australian National Health and Medical Research council (NHMRC) grants APP1002458 and MAB, AV and RHW (569636). MAB is supported by an NHMRC Career Development Award (569631). The funders had no role in study design, data collection, and analysis, decision to publish, or operation of the manuscript.; The authors would like to acknowledge the support of participating families. We would also like to acknowledge the Queensland Brain Bank and the Victorian Brain Bank for providing the non-pathological brain tissue samples. These centers are funded by the Australia's National Health and Medical Research council (NHMRC). Tissues were also obtained from the New South Wales Tissue Resource Centre at the University of Sydney which is supported by the National Health and Medical Research Council of Australia, Schizophrenia Research Institute, National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R24AA012725.	Arnsten AFT, 2011, PHARMACOL BIOCHEM BE, V99, P211, DOI 10.1016/j.pbb.2011.01.020; Barr CL, 2000, MOL PSYCHIATR, V5, P405, DOI 10.1038/sj.mp.4000733; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Brophy K, 2002, MOL PSYCHIATR, V7, P913, DOI 10.1038/sj.mp.4001092; Chan E, 2009, J CHILD PSYCHOL PSYC, V50, P1064, DOI 10.1111/j.1469-7610.2009.02096.x; Choi TK, 2007, MOL PSYCHIATR, V12, P224, DOI 10.1038/sj.mp.4001922; Durston S, 2006, BIOL PSYCHIAT, V60, P1062, DOI 10.1016/j.biopsych.2005.12.020; Elia J, 2009, PSYCHIAT GENET, V19, P134, DOI 10.1097/YPG.0b013e32832a5043; Feng Y, 2005, MOL PSYCHIATR, V10, P998, DOI 10.1038/sj.mp.4001722; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Guan L, 2009, MOL PSYCHIATR, V14, P546, DOI 10.1038/sj.mp.4002139; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; HESS EJ, 1994, GENOMICS, V21, P257, DOI 10.1006/geno.1994.1254; Jones MD, 2003, PHARMACOL BIOCHEM BE, V75, P209, DOI 10.1016/S0091-3057(03)00073-X; Jones MD, 2001, MOL BRAIN RES, V96, P114, DOI 10.1016/S0169-328X(01)00281-9; Kent L, 2002, MOL PSYCHIATR, V7, P908, DOI 10.1038/sj.mp.4001100; Kim JW, 2007, AM J MED GENET B, V144B, P781, DOI 10.1002/ajmg.b.30522; Kirley A, 2004, AM J MED GENET B, V131B, P38, DOI 10.1002/ajmg.b.30072; Kovacs-Nagy R, 2011, ELECTROPHORESIS, V32, P2013, DOI 10.1002/elps.201000536; Kustanovich V, 2003, MOL PSYCHIATR, V8, P309, DOI 10.1038/sj.mp.4001247; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1355, DOI 10.1002/ajmg.b.30869; Maglott DR, 1996, MAMM GENOME, V7, P400, DOI 10.1007/s003359900120; Mick E, 2010, J AM ACAD CHILD PSY, V49, P898, DOI 10.1016/j.jaac.2010.02.014; Mill J, 2004, MOL PSYCHIATR, V9, P801, DOI 10.1038/sj.mp.4001482; Mill J, 2002, AM J MED GENET, V114, P269, DOI 10.1002/ajmg.10253; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Renner TJ, 2008, J NEURAL TRANSM, V115, P317, DOI 10.1007/s00702-007-0840-3; Sarkar K, 2012, NEUROCHEM RES, V37, P349, DOI 10.1007/s11064-011-0618-8; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	36	36	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60274	10.1371/journal.pone.0060274	http://dx.doi.org/10.1371/journal.pone.0060274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593184	gold, Green Published			2022-12-27	WOS:000317385300013
J	Moschioni, M; Lo Sapio, M; Crisafulli, G; Torricelli, G; Guidotti, S; Muzzi, A; Barocchi, MA; Donati, C				Moschioni, Monica; Lo Sapio, Morena; Crisafulli, Giovanni; Torricelli, Giulia; Guidotti, Silvia; Muzzi, Alessandro; Barocchi, Michele A.; Donati, Claudio			Sequence Analysis of 96 Genomic Regions Identifies Distinct Evolutionary Lineages within CC156, the Largest Streptococcus pneumoniae Clonal Complex in the MLST Database	PLOS ONE			English	Article							PILUS; DISEASE; SEROTYPES; EXPANSION; INFERENCE; PREVALENT; CARRIAGE; OUTBREAK; CHILDREN; FINLAND	Multi-Locus Sequence Typing (MLST) of Streptococcus pneumoniae is based on the sequence of seven housekeeping gene fragments. The analysis of MLST allelic profiles by eBURST allows the grouping of genetically related strains into Clonal Complexes (CCs) including those genotypes with a common descent from a predicted ancestor. However, the increasing use of MLST to characterize S. pneumoniae strains has led to the identification of a large number of new Sequence Types (STs) causing the merger of formerly distinct lineages into larger CCs. An example of this is the CC156, displaying a high level of complexity and including strains with allelic profiles differing in all seven of the MLST loci, capsular type and the presence of the Pilus Islet-1 (PI-1). Detailed analysis of the CC156 indicates that the identification of new STs, such as ST4945, induced the merging of formerly distinct clonal complexes. In order to discriminate the strain diversity within CC156, a recently developed typing schema, 96-MLST, was used to analyse 66 strains representative of 41 different STs. Analysis of allelic profiles by hierarchical clustering and a minimum spanning tree identified ten genetically distinct evolutionary lineages. Similar results were obtained by phylogenetic analysis on the concatenated sequences with different methods. The identified lineages are homogenous in capsular type and PI-1 presence. ST4945 strains were unequivocally assigned to one of the lineages. In conclusion, the identification of new STs through an exhaustive analysis of pneumococcal strains from various laboratories has highlighted that potentially unrelated subgroups can be grouped into a single CC by eBURST. The analysis of additional loci, such as those included in the 96-MLST schema, will be necessary to accurately discriminate the clonal evolution of the pneumococcal population.	[Moschioni, Monica; Lo Sapio, Morena; Crisafulli, Giovanni; Torricelli, Giulia; Guidotti, Silvia; Muzzi, Alessandro; Barocchi, Michele A.; Donati, Claudio] Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy	Novartis	Moschioni, M (corresponding author), Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy.	monica.moschioni@novartis.com	Muzzi, Alessandro/J-6200-2012; Donati, Claudio/J-5180-2012; Donati, Claudio/AAF-1246-2020; Crisafulli, Giovanni/AAB-6256-2019	Crisafulli, Giovanni/0000-0002-5511-1555; Donati, Claudio/0000-0001-8688-1651				Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Calix JJ, 2012, J BIOL CHEM, V287, P13996, DOI 10.1074/jbc.M112.346924; Crisafulli G, 2012, INFECT GENET EVOL, pS1567, DOI [10.1016/j.mee-gid.2012.09.008., DOI 10.1016/J.MEE-GID.2012.09.008]; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019668; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Esteva C, 2011, CLIN MICROBIOL INFEC, V17, P1441, DOI 10.1111/j.1469-0691.2011.03526.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gruber WC, 2012, ANN NY ACAD SCI, V1263, P15, DOI 10.1111/j.1749-6632.2012.06673.x; Hanage WP, 2011, PEDIATR INFECT DIS J, V30, P302, DOI 10.1097/INF.0b013e318201a154; KAUFMAN L, 2005, WILEY SERIES PROBABI; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Ma X, 2013, EPIDEMIOL INFECT, V141, P1690, DOI 10.1017/S0950268812002269; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Melchiorre S, 2009, CLIN MICROBIOL INFEC; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Munoz-Almagro C, 2010, CLIN VACCINE IMMUNOL, V17, P1672, DOI 10.1128/CVI.00271-10; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pandya GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015950; Pelton SI, 2009, PEDIATR INFECT DIS J, V28, pS133, DOI 10.1097/INF.0b013e3181b6d81a; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Sadowy E, 2010, ANTIMICROB AGENTS CH, V54, P1720, DOI 10.1128/AAC.01340-09; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Selva L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041587; Siira L, 2009, ANTIMICROB AGENTS CH, V53, P2066, DOI 10.1128/AAC.01464-08; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vainio A, 2009, APMIS, V117, P488, DOI 10.1111/j.1600-0463.2009.02463.x; van Cuyck H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-241; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x	45	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61003	10.1371/journal.pone.0061003	http://dx.doi.org/10.1371/journal.pone.0061003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593373	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300041
J	Zhao, L; Li, WZ; Tian, P				Zhao, Li; Li, Wenzhao; Tian, Pu			Reconciling Mediating and Slaving Roles of Water in Protein Conformational Dynamics	PLOS ONE			English	Article							HYDRATION DYNAMICS; MOLECULAR-DYNAMICS; SOLVENT; DEPENDENCE; VISCOSITY; MOTIONS	Proteins accomplish their physiological functions with remarkably organized dynamic transitions among a hierarchical network of conformational substates. Despite the essential contribution of water molecules in shaping functionally important protein dynamics, their exact role is still controversial. Water molecules were reported either as mediators that facilitate or as masters that slave protein dynamics. Since dynamic behaviour of a given protein is ultimately determined by the underlying energy landscape, we systematically analysed protein self energies and protein-water interaction energies obtained from extensive molecular dynamics simulation trajectories of barstar. We found that protein-water interaction energy plays the dominant role when compared with protein self energy, and these two energy terms on average have negative correlation that increases with increasingly longer time scales ranging from 10 femtoseconds to 100 nanoseconds. Water molecules effectively roughen potential energy surface of proteins in the majority part of observed conformational space and smooth in the remaining part. These findings support a scenario wherein water on average slave protein conformational dynamics but facilitate a fraction of transitions among different conformational substates, and reconcile the controversy on the facilitating and slaving roles of water molecules in protein conformational dynamics.	[Zhao, Li; Li, Wenzhao] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Tian, Pu] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Tian, Pu] Jilin Univ, MOE Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Tian, P (corresponding author), Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China.	tianpu@jlu.edu.cn			Jilin University; National Natural Science Foundation of China [31270758]; National Institutes of Diabetes, Digestive and Kidneys Diseases	Jilin University(Jilin University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Diabetes, Digestive and Kidneys Diseases	This research was partially funded by a start-up fund from Jilin University, by the National Natural Science Foundation of China (Grant#:31270758), and by the Intramural program of the National Institutes of Diabetes, Digestive and Kidneys Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s; ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Barron LD, 1997, NEW CONCEPTS BIOCH L, V36, P0; Borreguero JM, 2011, J PHYS CHEM B, V115, P8925, DOI 10.1021/jp201346x; Chang CW, 2010, J AM CHEM SOC, V132, P12741, DOI 10.1021/ja1050154; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Frauenfelder H, 2006, P NATL ACAD SCI USA, V103, P15469, DOI 10.1073/pnas.0607168103; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frauenfelder H, 2007, IUBMB LIFE, V59, P506, DOI 10.1080/15216540701194113; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; HARTLEY RW, 1988, J MOL BIOL, V202, P913, DOI 10.1016/0022-2836(88)90568-2; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Jha A, 2010, BIOCHEMISTRY-US, P397; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kwon OH, 2010, P NATL ACAD SCI USA, V107, P17101, DOI 10.1073/pnas.1011569107; Mamontov E, 2012, PHYS CHEM CHEM PHYS, V14, P11573, DOI 10.1039/c2cp41443k; Materese CK, 2008, P NATL ACAD SCI USA, V105, P10659, DOI 10.1073/pnas.0801850105; Mattos C, 2002, TRENDS BIOCHEM SCI, V27, P203, DOI 10.1016/S0968-0004(02)02067-4; Miller TF, 2007, P NATL ACAD SCI USA, V104, P14559, DOI 10.1073/pnas.0705830104; Nelson ED, 2008, P NATL ACAD SCI USA, V105, P1489, DOI 10.1073/pnas.0705707105; Oleinikova A, 2005, J PHYS CHEM B, V109, P1988, DOI 10.1021/jp045903j; Paciaroni A, 2003, CHEM PHYS, V292, P397, DOI 10.1016/S0301-0104(03)00102-2; Papoian GA, 2004, P NATL ACAD SCI USA, V101, P3352, DOI 10.1073/pnas.0307851100; Perez J, 1999, BIOPHYS J, V77, P454, DOI 10.1016/S0006-3495(99)76903-1; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; SCHINKEL JE, 1985, BIOCHEMISTRY-US, V24, P352, DOI 10.1021/bi00323a018; Scorciapino MA, 2010, J AM CHEM SOC, V132, P5156, DOI 10.1021/ja909822d; SUNDARALINGAM M, 1989, SCIENCE, V244, P1333, DOI 10.1126/science.2734612; Tarek M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.138101; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Vitkup D, 2000, NATURE STRUCTURAL BI, V7, P1; Wu S, 2008, BIOPHYS J, V95, P5524, DOI 10.1529/biophysj.108.136697; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P18461, DOI 10.1073/pnas.0707647104; Zong CH, 2006, J AM CHEM SOC, V128, P5168, DOI 10.1021/ja058589v	37	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60553	10.1371/journal.pone.0060553	http://dx.doi.org/10.1371/journal.pone.0060553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593243	gold, Green Published, Green Submitted			2022-12-27	WOS:000317383200011
J	Perez-Lozano, ML; Sandoval, P; Rynne-Vidal, A; Aguilera, A; Jimenez-Heffernan, JA; Albar-Vizcaino, P; Majano, PL; Sanchez-Tomero, JA; Selgas, R; Lopez-Cabrera, M				Luisa Perez-Lozano, Maria; Sandoval, Pilar; Rynne-Vidal, Angela; Aguilera, Abelardo; Antonio Jimenez-Heffernan, Jose; Albar-Vizcaino, Patricia; Majano, Pedro L.; Antonio Sanchez-Tomero, Jose; Selgas, Rafael; Lopez-Cabrera, Manuel			Functional Relevance of the Switch of VEGF Receptors/Co-Receptors during Peritoneal Dialysis-Induced Mesothelial to Mesenchymal Transition	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOLUTE TRANSPORT RATE; EX-VIVO; NEUROPILIN-1 OVEREXPRESSION; EXTRACELLULAR-MATRIX; MEMBRANE FAILURE; PROGENITOR CELLS; SEMAPHORIN-III; INDUCED DAMAGE; CANCER-CELLS	Vascular endothelial growth factor (VEGF) is up-regulated during mesothelial to mesenchymal transition (MMT) and has been associated with peritoneal membrane dysfunction in peritoneal dialysis (PD) patients. It has been shown that normal and malignant mesothelial cells (MCs) express VEGF receptors (VEGFRs) and co-receptors and that VEGF is an autocrine growth factor for mesothelioma. Hence, we evaluated the expression patterns and the functional relevance of the VEGF/VEGFRs/co-receptors axis during the mesenchymal conversion of MCs induced by peritoneal dialysis. Omentum-derived MCs treated with TGF-beta 1 plus IL-1 beta (in vitro MMT) and PD effluent-derived MCs with non-epithelioid phenotype (ex vivo MMT) showed down-regulated expression of the two main receptors Flt-1/VEGFR-1 and KDR/VEGFR-2, whereas the coreceptor neuropilin-1 (Nrp-1) was up-regulated. The expression of the Nrp-1 ligand semaphorin-3A (Sema-3A), a functional VEGF competitor, was repressed throughout the MMT process. These expression pattern changes were accompanied by a reduction of the proliferation capacity and by a parallel induction of the invasive capacity of MCs that had undergone an in vitro or ex vivo MMT. Treatment with neutralizing anti-VEGF or anti-Nrp-1 antibodies showed that these molecules played a relevant role in cellular proliferation only in naive omentum-derived MCs. Conversely, treatment with these blocking antibodies, as well as with recombinant Sema-3A, indicated that the switched VEGF/VEGFRs/co-receptors axis drove the enhanced invasion capacity of MCs undergoing MMT. In conclusion, the expression patterns of VEGFRs and co-receptors change in MCs during MMT, which in turn would determine their behaviour in terms of proliferation and invasion in response to VEGF.	[Luisa Perez-Lozano, Maria; Sandoval, Pilar; Rynne-Vidal, Angela; Lopez-Cabrera, Manuel] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Aguilera, Abelardo; Albar-Vizcaino, Patricia; Majano, Pedro L.; Antonio Sanchez-Tomero, Jose] Hosp Univ Princesa, Unidad Biol Mol, Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Aguilera, Abelardo; Albar-Vizcaino, Patricia; Majano, Pedro L.; Antonio Sanchez-Tomero, Jose; Lopez-Cabrera, Manuel] Hosp Univ Princesa, Serv Nefrol, Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Antonio Jimenez-Heffernan, Jose] Hosp Univ Princesa, Serv Anat Patol, Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Selgas, Rafael] Hosp Univ La Paz, Serv Nefrol, Inst Invest Sanitaria la Paz IdiPAZ, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario La Paz	Lopez-Cabrera, M (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	mlcabrera@cbm.uam.es	Lozano, Maria Luisa Pérez/J-9840-2017; SANCHEZ TOMERO, JOSE ANTONIO/Q-9346-2017; Cabrera, Manuel López/AAA-5463-2019; Sandoval, Pilar/GVS-6463-2022	Lozano, Maria Luisa Pérez/0000-0002-6473-3823; Sandoval, Pilar/0000-0002-5893-7037; Lopez Cabrera, Manuel/0000-0002-0976-9719; Majano, Pedro Lorenzo/0000-0002-5495-1413; Rynne-Vidal, Angela/0000-0002-6316-530X	Ministerio de Economia y Competitividad [SAF2010-21249]; Comunidad Autonoma de Madrid [S2010/BMD-2321]; Fondo de Investigaciones Sanitarias [PI 09/0776]; REDinREN, Fondos FEDER, EU [RETICS 06/0016]	Ministerio de Economia y Competitividad(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); REDinREN, Fondos FEDER, EU	This work was supported by grant SAF2010-21249 from the "Ministerio de Economia y Competitividad'' to M.L.C. and by grant S2010/BMD-2321 from "Comunidad Autonoma de Madrid'' to M.L.C. and R.S. This work was also partially supported by grants PI 09/0776 from "Fondo de Investigaciones Sanitarias'' to A.A., and RETICS 06/0016 (REDinREN, Fondos FEDER, EU) to R.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Aroeira LS, 2009, J AM SOC NEPHROL, V20, P582, DOI 10.1681/ASN.2008020211; Bajo MA, 2011, NEPHROL DIAL TRANSPL, V26, P282, DOI 10.1093/ndt/gfq357; Baba T, 2007, GYNECOL ONCOL, V105, P703, DOI 10.1016/j.ygyno.2007.02.005; Bachelder RE, 2002, CANCER RES, V62, P7203; Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Barr MP, 2005, BRIT J CANCER, V92, P328, DOI 10.1038/sj.bjc.6602308; Berge M, 2011, J HEPATOL, V55, P866, DOI 10.1016/j.jhep.2011.01.033; Boulanger E, 2007, KIDNEY INT, V71, P126, DOI 10.1038/sj.ki.5002016; Cai HB, 1999, J NEUROSCI, V19, P6519; Cariboni A, 2011, DEVELOPMENT, V138, P3723, DOI 10.1242/dev.063362; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; Ding HX, 2011, CELL BIOCHEM BIOPHYS, V59, P39, DOI 10.1007/s12013-010-9109-9; Fernandez-Perpen A, 2012, PERITON DIALYSIS INT, V32, P292, DOI 10.3747/pdi.2010.00315; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; Fukasawa M, 2007, CANCER BIOL THER, V6, P1173; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Ha H, 2002, PERITON DIALYSIS INT, V22, P171; Hansel DE, 2004, AM J SURG PATHOL, V28, P347, DOI 10.1097/00000478-200403000-00007; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HodacPannekeet MM, 1997, PERITON DIALYSIS INT, V17, P144; Jubb AM, 2012, J PATHOL, V226, P50, DOI 10.1002/path.2989; Kihm LP, 2011, J AM SOC NEPHROL, V22, P914, DOI 10.1681/ASN.2010070750; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Krediet RT, 2000, PERITON DIALYSIS INT, V20, pS19; Kurschat P, 2006, J BIOL CHEM, V281, P2721, DOI 10.1074/jbc.M507860200; Lai KN, 2000, AM J KIDNEY DIS, V35, P644, DOI 10.1016/S0272-6386(00)70011-4; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; Li M, 2004, CANCER-AM CANCER SOC, V101, P2341, DOI 10.1002/cncr.20634; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Liu WB, 2005, CYTOKINE, V32, P206, DOI 10.1016/j.cyto.2005.09.009; Lopez-Cabrera M, 2006, PERITON DIALYSIS INT, V26, P26; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Loureiro J, 2010, NEPHROL DIAL TRANSPL, V25, P1098, DOI 10.1093/ndt/gfp618; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Medici D, NATURE MED, V16, P1400; Mizutani M, 2010, AM J PHYSIOL-RENAL, V298, pF721, DOI 10.1152/ajprenal.00368.2009; Murga M, 2005, BLOOD, V105, P1992, DOI 10.1182/blood-2004-07-2598; Narazaki M, 2006, BLOOD, V107, P3892, DOI 10.1182/blood-2005-10-4113; Numata M, 2003, PERITON DIALYSIS INT, V23, P116; Pallaoro A, 2011, P NATL ACAD SCI USA, V108, P16559, DOI 10.1073/pnas.1109490108; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1480, DOI 10.1093/ndt/17.8.1480; Rossignol M, 2000, GENOMICS, V70, P211, DOI 10.1006/geno.2000.6381; Sandoval P, 2010, LAB INVEST, V90, P1517, DOI 10.1038/labinvest.2010.111; SELGAS R, 1994, AM J KIDNEY DIS, V23, P64, DOI 10.1016/S0272-6386(12)80814-6; Selgas R, 2000, PERITON DIALYSIS INT, V20, P798; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Yamada Y, 2003, BLOOD, V101, P1801, DOI 10.1182/blood-2002-01-0119; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang WS, 1999, PERITON DIALYSIS INT, V19, P211; Yu MA, 2009, J AM SOC NEPHROL, V20, P567, DOI 10.1681/ASN.2008040424; Zweers MM, 1999, J LAB CLIN MED, V134, P124, DOI 10.1016/S0022-2143(99)90116-6	75	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60776	10.1371/journal.pone.0060776	http://dx.doi.org/10.1371/journal.pone.0060776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585849	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600046
J	Moritoki, M; Kadowaki, T; Niki, T; Nakano, D; Soma, G; Mori, H; Kobara, H; Masaki, T; Kohno, M; Hirashima, M				Moritoki, Masahiro; Kadowaki, Takeshi; Niki, Toshiro; Nakano, Daisuke; Soma, Genichiro; Mori, Hirohito; Kobara, Hideki; Masaki, Tsutomu; Kohno, Masakazu; Hirashima, Mitsuomi			Galectin-9 Ameliorates Clinical Severity of MRL/lpr Lupus-Prone Mice by Inducing Plasma Cell Apoptosis Independently of Tim-3	PLOS ONE			English	Article							REGULATORY T-CELLS; AUTOIMMUNE-DISEASE; B-LYMPHOCYTE; ERYTHEMATOSUS; TH17; EXPRESSION; INFECTION; APRIL; IMMUNOGLOBULIN; POPULATION	Galectin-9 ameliorates various murine autoimmune disease models by regulating T cells and macrophages, although it is not known what role it may have in B cells. The present experiment shows that galectin-9 ameliorates a variety of clinical symptoms, such as proteinuria, arthritis, and hematocrit in MRL/lpr lupus-prone mice. As previously reported, galectin-9 reduces the frequency of Th1, Th17, and activated CD8(+) T cells. Although anti-dsDNA antibody was increased in MRL/lpr lupus-prone mice, galectin-9 suppressed anti-dsDNA antibody production, at least partly, by decreasing the number of plasma cells. Galectin-9 seemed to decrease the number of plasma cells by inducing plasma cell apoptosis, and not by suppressing BAFF production. Although about 20% of CD19(-/low) CD138(+) plasma cells expressed Tim-3 in MRL/lpr lupus-prone mice, Tim-3 may not be directly involved in the galectin-9-induced apoptosis, because anti-Tim-3 blocking antibody did not block galectin-9-induced apoptosis. This is the first report of plasma cell apoptosis being induced by galectin-9. Collectively, it is likely that galectin-9 attenuates the clinical severity of MRL lupus-prone mice by regulating T cell function and inducing plasma cell apoptosis.	[Moritoki, Masahiro; Kohno, Masakazu] Kagawa Univ, Dept Cardiorenal & Cerebrovasc Med, Fac Med, Takamatsu, Kagawa 760, Japan; [Kadowaki, Takeshi; Niki, Toshiro; Hirashima, Mitsuomi] Kagawa Univ, Dept Immunol & Immunopathol, Fac Med, Takamatsu, Kagawa 760, Japan; [Kadowaki, Takeshi; Soma, Genichiro] Kagawa Univ, Dept Holist Immunol, Takamatsu, Kagawa 760, Japan; [Nakano, Daisuke] Kagawa Univ, Dept Pharmacol, Fac Med, Takamatsu, Kagawa 760, Japan; [Mori, Hirohito; Kobara, Hideki; Masaki, Tsutomu; Hirashima, Mitsuomi] Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, Takamatsu, Kagawa 760, Japan	Kagawa University; Kagawa University; Kagawa University; Kagawa University; Kagawa University	Hirashima, M (corresponding author), Kagawa Univ, Dept Immunol & Immunopathol, Fac Med, Takamatsu, Kagawa 760, Japan.	mitsuomi@kms.ac.jp	ma, chunhong/C-6043-2008	ma, chunhong/0000-0002-8121-4718	Japan Society for Promotion of Science [22590360, 23256004]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in part, by Scientific Research (C) 2010 - (22590360) and Scientific Research (A) 2011 - (23256004) from the Japan Society for Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya JM, 2011, CLIN REV ALLERG IMMU, V40, P199, DOI 10.1007/s12016-010-8249-4; Arikawa T, 2010, EUR J IMMUNOL, V40, P548, DOI 10.1002/eji.200939886; Arikawa T, 2009, CLIN IMMUNOL, V133, P382, DOI 10.1016/j.clim.2009.09.004; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Chu VT, 2007, J IMMUNOL, V179, P5947, DOI 10.4049/jimmunol.179.9.5947; Dall'Era M, 2007, ARTHRITIS RHEUM, V56, P4142, DOI 10.1002/art.23047; Davidson A, 2012, CURR RHEUMATOL REP, V14, P295, DOI 10.1007/s11926-012-0258-2; Dillon SR, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2959; Fagiolo E, 2003, AUTOIMMUNITY, V36, P199, DOI 10.1080/0891693031000151238; Fiorina Paolo, 2009, F1000 Biol Rep, V1, P39, DOI 10.3410/B1-39; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hou LF, 2011, ARTHRITIS RHEUM-US, V63, P2445, DOI 10.1002/art.30392; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kadowaki T, 2012, CLIN IMMUNOL, V142, P296, DOI 10.1016/j.clim.2011.11.006; Kanzaki M, 2012, ENDOCRINOLOGY, V153, P612, DOI 10.1210/en.2011-1579; Kleczynska W, 2011, FOLIA HISTOCHEM CYTO, V49, P646, DOI 10.5603/FHC.2011.0088; Koopman W J, 1988, Scand J Rheumatol Suppl, V75, P284; Koyama T, 2005, ANN RHEUM DIS, V64, P1065, DOI 10.1136/ard.2004.022491; Lee J, 2012, INFLAMMATION, V35, P633, DOI 10.1007/s10753-011-9355-z; Liu Z, 2011, TRENDS IMMUNOL, V32, P388, DOI 10.1016/j.it.2011.06.004; Liu Z, 2011, EXP CELL RES, V317, P1270, DOI 10.1016/j.yexcr.2011.02.005; Mackay Fabienne, 2005, V8, P243; Manzi S, 2012, ANN RHEUM DIS; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Mohan AK, 2002, LANCET, V360, P646, DOI 10.1016/S0140-6736(02)09800-8; Nagel A, 2009, J INVEST DERMATOL, V129, P2202, DOI 10.1038/jid.2009.27; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Pan HF, 2010, MOL BIOL REP, V37, P395, DOI 10.1007/s11033-009-9833-7; Reddy PBJ, 2011, J IMMUNOL, V187, P5745, DOI 10.4049/jimmunol.1102105; Sakai K, 2011, EUR J IMMUNOL, V41, P67, DOI 10.1002/eji.200939931; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shah K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2964; Tsuchiyama Y, 2000, KIDNEY INT, V58, P1941, DOI 10.1111/j.1523-1755.2000.00366.x; Wang F, 2007, CELL IMMUNOL, V250, P68, DOI 10.1016/j.cellimm.2008.01.006; Wang F, 2011, CELL IMMUNOL, V269, P22, DOI 10.1016/j.cellimm.2011.03.005; Wang Y, 2008, SCAND J IMMUNOL, V67, P63, DOI 10.1111/j.1365-3083.2007.02038.x; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Wilson LE, 2002, SEMIN ARTHRITIS RHEU, V32, P163, DOI 10.1053/sarh.2002.37277; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1589, DOI 10.1002/art.33488; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499	42	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60807	10.1371/journal.pone.0060807	http://dx.doi.org/10.1371/journal.pone.0060807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585851	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600049
J	Shi, JY; Yao, QZ; Li, XM; Zhou, GT; Fu, SQ				Shi, Jia-Yuan; Yao, Qi-Zhi; Li, Xi-Ming; Zhou, Gen-Tao; Fu, Sheng-Quan			Formation of Asymmetrical Structured Silica Controlled by a Phase Separation Process and Implication for Biosilicification	PLOS ONE			English	Article							AMORPHOUS SILICA; FINE-STRUCTURE; DIATOM; WALL; BIOMINERALIZATION; MORPHOGENESIS; NANOTUBE; PROTEIN; NANOSTRUCTURE; FABRICATION	Biogenetic silica displays intricate patterns assembling from nano- to microsize level and interesting non-spherical structures differentiating in specific directions. Several model systems have been proposed to explain the formation of biosilica nanostructures. Of them, phase separation based on the physicochemical properties of organic amines was considered to be responsible for the pattern formation of biosilica. In this paper, using tetraethyl orthosilicate (TEOS, Si(OCH2CH3)(4)) as silica precursor, phospholipid (PL) and dodecylamine (DA) were introduced to initiate phase separation of organic components and influence silica precipitation. Morphology, structure and composition of the mineralized products were characterized using a range of techniques including field emission scanning electron microscopy (FESEM), transmission electron microscope (TEM), X-ray diffraction (XRD), thermogravimetric and differential thermal analysis (TG-DTA), infrared spectra (IR), and nitrogen physisorption. The results demonstrate that the phase separation process of the organic components leads to the formation of asymmetrically non-spherical silica structures, and the aspect ratios of the asymmetrical structures can be well controlled by varying the concentration of PL and DA. On the basis of the time-dependent experiments, a tentative mechanism is also proposed to illustrate the asymmetrical morphogenesis. Therefore, our results imply that in addition to explaining the hierarchical porous nanopatterning of biosilica, the phase separation process may also be responsible for the growth differentiation of siliceous structures in specific directions. Because organic amine (e. g., long-chair polyamines), phospholipids (e. g., silicalemma) and the phase separation process are associated with the biosilicification of diatoms, our results may provide a new insight into the mechanism of biosilicification.	[Shi, Jia-Yuan; Zhou, Gen-Tao] Chinese Acad Sci, Univ Sci & Technol China, Sch Earth & Space Sci, Key Lab Crust Mantle Mat & Environm, Hefei, Peoples R China; [Yao, Qi-Zhi; Li, Xi-Ming] Univ Sci & Technol China, Sch Chem & Mat, Hefei 230026, Peoples R China; [Fu, Sheng-Quan] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, GT (corresponding author), Chinese Acad Sci, Univ Sci & Technol China, Sch Earth & Space Sci, Key Lab Crust Mantle Mat & Environm, Hefei, Peoples R China.	gtzhou@ustc.edu.cn		Li, Ximing/0000-0003-0764-8451	Chinese Ministry of Science and Technology [2011CB808800]; Natural Science Foundation of China [41172049]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-QN501]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work was financially supported by the Chinese Ministry of Science and Technology (No. 2011CB808800), the Natural Science Foundation of China (No. 41172049) and the Knowledge Innovation Program of the Chinese Academy of Sciences, Grant No. KZCX2-YW-QN501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAL S, 1993, CHEM MATER, V5, P145, DOI 10.1021/cm00026a001; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Bauerlein E, 2004, BIOMINERALIZATION PR; Coradin T, 2003, CHEMBIOCHEM, V4, P251, DOI 10.1002/cbic.200390044; Davis AK, 2005, J PHYCOL, V41, P577, DOI 10.1111/j.1529-8817.2005.00076.x; DAVIS AK, 2007, METAL IONS LIFE SCI, V4, P255; Di Renzo F, 1999, MICROPOR MESOPOR MAT, V28, P437, DOI 10.1016/S1387-1811(98)00315-1; Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328; Dimos K, 2009, MICROPOR MESOPOR MAT, V126, P65, DOI 10.1016/j.micromeso.2009.05.021; DRUM RW, 1964, J ULTRA MOL STRUCT R, V10, P217, DOI 10.1016/S0022-5320(64)80006-X; Ehrlich H, 2010, NAT CHEM, V2, P1084, DOI 10.1038/NCHEM.899; Finkel ZV, 2010, GEOBIOLOGY, V8, P433, DOI 10.1111/j.1472-4669.2010.00250.x; Galarneau A, 2010, J PHYS CHEM B, V114, P2140, DOI 10.1021/jp908828q; GORDON R, 1994, INT REV CYTOL, V150, P243; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Hildebrand M, 2009, J STRUCT BIOL, V166, P316, DOI 10.1016/j.jsb.2009.02.014; HOAGLAND KD, 1993, J PHYCOL, V29, P537, DOI 10.1111/j.0022-3646.1993.00537.x; Hu JK, 2010, MICROPOR MESOPOR MAT, V129, P210, DOI 10.1016/j.micromeso.2009.09.017; Hukkamaki J, 2003, MICROPOR MESOPOR MAT, V65, P189, DOI 10.1016/j.micromeso.2003.08.007; Ji Q, 2004, CHEM MATER, V16, P250, DOI 10.1021/cm034356w; Ji QM, 2007, CHEM MATER, V19, P1329, DOI 10.1021/cm0625124; Ji QM, 2005, J MATER CHEM, V15, P743, DOI 10.1039/b412725k; Jiang S, 2008, LANGMUIR, V24, P2438, DOI 10.1021/la703274a; Kinrade SD, 2002, J CHEM SOC DALTON, P307, DOI 10.1039/b105379p; Konno Y, 2010, J OLEO SCI, V59, P581, DOI 10.5650/jos.59.581; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Lin HY, 2005, J POROUS MAT, V12, P95, DOI 10.1007/s10934-005-6766-y; Liu B, 2009, CHEM COMMUN, P3871, DOI 10.1039/b905981d; Livage J, 2006, REV MINERAL GEOCHEM, V64, P315, DOI 10.2138/rmg.2006.64.10; Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778; MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0; Mann S, 2001, BIOMINERALIZATION PR; Matsukizono H, 2012, ANGEW CHEM INT EDIT, V51, P5862, DOI 10.1002/anie.201108914; Matsunaga S, 2007, CHEMBIOCHEM, V8, P1729, DOI 10.1002/cbic.200700305; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Michaux F, 2008, MICROPOR MESOPOR MAT, V116, P308, DOI 10.1016/j.micromeso.2008.04.018; Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5; NAKAJIMA T, 1970, BIOCHEM BIOPH RES CO, V39, P28, DOI 10.1016/0006-291X(70)90752-7; NAKAJIMA T, 1969, SCIENCE, V164, P1400, DOI 10.1126/science.164.3886.1400; Nassif N, 2011, CHEM SOC REV, V40, P849, DOI 10.1039/c0cs00122h; Noll F, 2002, NANO LETT, V2, P91, DOI 10.1021/nl015581k; OLIVER S, 1995, NATURE, V378, P47, DOI 10.1038/378047a0; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Park BJ, 2010, LANGMUIR, V26, P10406, DOI 10.1021/la101030h; Patwardhan SV, 2011, CHEM COMMUN, V47, P7567, DOI 10.1039/c0cc05648k; Patwardhan SV, 2006, BIOMACROMOLECULES, V7, P491, DOI 10.1021/bm050717k; Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100; Qu XF, 2010, J PHYS CHEM C, V114, P8734, DOI 10.1021/jp912278r; Ramanathan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017707; Round F. E., 1990, DIATOMS BIOL MORPHOL; Sadasivan S, 2005, CHEM MATER, V17, P2765, DOI 10.1021/cm047926g; SCHMID AMM, 1979, PROTOPLASMA, V100, P267, DOI 10.1007/BF01279316; Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h; Shan W, 2005, CHEM COMMUN, P1877, DOI 10.1039/b418006b; Shi JY, 2012, AM MINERAL, V97, P1381, DOI 10.2138/am.2012.4081; Sumper M, 2002, SCIENCE, V295, P2430, DOI 10.1126/science.1070026; Sumper M., 2006, ADV FUNCTIONAL MAT, V16, P217; Sumper M, 2006, CHEMBIOCHEM, V7, P1419, DOI 10.1002/cbic.200600184; Tesson B, 2008, ANAL BIOANAL CHEM, V390, P1889, DOI 10.1007/s00216-008-1908-0; Tesson B, 2009, CHEMBIOCHEM, V10, P2011, DOI 10.1002/cbic.200800811; Venkatathri N, 2008, MICROPOR MESOPOR MAT, V112, P147, DOI 10.1016/j.micromeso.2007.09.025; Wang JG, 2007, J PHYS CHEM C, V111, P16544, DOI 10.1021/jp075667n; Wang JG, 2006, ADV MATER, V18, P3284, DOI 10.1002/adma.200601321; Yan ZJ, 2010, CHEM COMMUN, V46, P8410, DOI 10.1039/c0cc03568h; Zhang HA, 2011, CHEM COMMUN, V47, P7791, DOI 10.1039/c1cc11787d; Zhao YF, 2008, MICROPOR MESOPOR MAT, V111, P300, DOI 10.1016/j.micromeso.2007.08.004; Zurzolo C, 1999, PLANT PHYSIOL, V127, P1339	72	13	14	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61164	10.1371/journal.pone.0061164	http://dx.doi.org/10.1371/journal.pone.0061164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585878	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600090
J	Skrzypiec, AE; Shah, RS; Schiavon, E; Baker, E; Skene, N; Pawlak, R; Mucha, M				Skrzypiec, Anna E.; Shah, Rahul S.; Schiavon, Emanuele; Baker, Eva; Skene, Nathan; Pawlak, Robert; Mucha, Mariusz			Stress-Induced Lipocalin-2 Controls Dendritic Spine Formation and Neuronal Activity in the Amygdala	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; MEMORY FORMATION; COGNITIVE IMPAIRMENT; MOUSE HIPPOCAMPUS; PROTEIN FAMILY; RECEPTOR; EXPRESSION; NEUROPSIN; ANXIETY; IRON	Behavioural adaptation to psychological stress is dependent on neuronal plasticity and dysfunction at this cellular level may underlie the pathogenesis of affective disorders such as depression and post-traumatic stress disorder. Taking advantage of genome-wide microarray assay, we performed detailed studies of stress-affected transcripts in the amygdala - an area which forms part of the innate fear circuit in mammals. Having previously demonstrated the role of lipocalin-2 (Lcn-2) in promoting stress-induced changes in dendritic spine morphology/function and neuronal excitability in the mouse hippocampus, we show here that the Lcn-2 gene is one of the most highly upregulated transcripts detected by microarray analysis in the amygdala after acute restraint-induced psychological stress. This is associated with increased Lcn-2 protein synthesis, which is found on immunohistochemistry to be predominantly localised to neurons. Stress-naive Lcn-2(-/-) mice show a higher spine density in the basolateral amygdala and a 2-fold higher rate of neuronal firing rate compared to wildtype mice. Unlike their wild-type counterparts, Lcn-2(-/-) mice did not show an increase in dendritic spine density in response to stress but did show a distinct pattern of spine morphology. Thus, amygdala-specific neuronal responses to Lcn-2 may represent a mechanism for behavioural adaptation to psychological stress.	[Skrzypiec, Anna E.; Pawlak, Robert] Univ Exeter, Sch Med, Exeter, Devon, England; [Shah, Rahul S.; Schiavon, Emanuele; Baker, Eva; Mucha, Mariusz] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Shah, Rahul S.] Wessex Neurol Ctr, Dept Neurosurg, Southampton, Hants, England; [Mucha, Mariusz] UCL, Wolfson Inst Biomed Res, London, England; [Mucha, Mariusz] UCL, Dept Cell & Dev Biol, London, England; [Skene, Nathan] Wellcome Trust Sanger Inst, Cambridge, England	University of Exeter; University of Leicester; University of London; University College London; University of London; University College London; Wellcome Trust Sanger Institute	Pawlak, R (corresponding author), Univ Exeter, Sch Med, Exeter, Devon, England.	r.pawlak@exeter.ac.uk		Schiavon, Emanuele/0000-0002-4592-6961; Skene, Nathan/0000-0002-6807-3180; Shah, Rahul/0000-0002-8616-8693	European Commission [MEXT-CT-2006-042265]; Medical Research Council [G0500231/73852]; COST Action ECMNet [BM1001]	European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); COST Action ECMNet(European Cooperation in Science and Technology (COST))	This work was supported by a Marie Curie Excellence Grant MEXT-CT-2006-042265 from the European Commission (http://www.cordis.europa.eu/ mariecurie-actions/ext/home.html), Medical Research Council Project Grant G0500231/73852 (http://www.mrc.ac.uk/index.htm) and the COST Action ECMNet, BM1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antharam V, 2012, NEUROIMAGE, V59, P1249, DOI 10.1016/j.neuroimage.2011.08.019; Attwood BK, 2011, NATURE, V473, P372, DOI 10.1038/nature09938; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Brown LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013905; Campanacci V, 2006, FEBS LETT, V580, P4877, DOI 10.1016/j.febslet.2006.07.086; Choi J, 2011, J NEUROL SCI, V305, P28, DOI 10.1016/j.jns.2011.03.023; Chudzinski-Tavassi AM, 2010, FEBS LETT, V584, P2896, DOI 10.1016/j.febslet.2010.05.008; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; Cui H, 2008, NEUROSCIENCE, V152, P703, DOI 10.1016/j.neuroscience.2007.12.028; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Ferland CL, 2011, NEUROSCIENCE, V174, P104, DOI 10.1016/j.neuroscience.2010.10.077; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Guilloux JP, 2012, MOL PSYCHIAT; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Harada A, 2008, NEUROSCI LETT, V436, P273, DOI 10.1016/j.neulet.2008.03.042; Hirase H, 2005, TRENDS NEUROSCI, V28, P217, DOI 10.1016/j.tins.2005.03.002; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; Kim BG, 2007, J NEUROSCI METH, V162, P237, DOI 10.1016/j.jneumeth.2007.01.016; Lee CT, 2007, J NEUROCHEM, V100, P1531, DOI 10.1111/j.1471-4159.2006.04284.x; Lee EHY, 2003, EUR J NEUROSCI, V18, P2842, DOI 10.1111/j.1460-9568.2003.03032.x; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; LeVine SM, 1997, BRAIN RES, V760, P298, DOI 10.1016/S0006-8993(97)00470-8; Liu ZM, 2011, J BIOL CHEM, V286, P20606, DOI 10.1074/jbc.M110.216549; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Mucha M, 2011, P NATL ACAD SCI USA, V108, P18436, DOI 10.1073/pnas.1107936108; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Owen HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE1023, DOI 10.1152/ajpendo.00586.2007; Park CR, 2008, LEARN MEMORY, V15, P271, DOI 10.1101/lm.721108; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Riihimaki-Lampen LH, 2010, J MED CHEM, V53, P514, DOI 10.1021/jm901309r; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Shimizu C, 1998, J BIOL CHEM, V273, P11189, DOI 10.1074/jbc.273.18.11189; Shors TJ, 2001, NEUROBIOL LEARN MEM, V75, P10, DOI 10.1006/nlme.1999.3956; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Vyas A, 2002, J NEUROSCI, V22, P6810	52	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61046	10.1371/journal.pone.0061046	http://dx.doi.org/10.1371/journal.pone.0061046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593384	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600077
J	Mooney, M; Bond, J; Monks, N; Eugster, E; Cherba, D; Berlinski, P; Kamerling, S; Marotti, K; Simpson, H; Rusk, T; Tembe, W; Legendre, C; Benson, H; Liang, W; Webb, CP				Mooney, Marie; Bond, Jeffrey; Monks, Noel; Eugster, Emily; Cherba, David; Berlinski, Pamela; Kamerling, Steve; Marotti, Keith; Simpson, Heather; Rusk, Tony; Tembe, Waibhav; Legendre, Christophe; Benson, Hollie; Liang, Winnie; Webb, Craig Paul			Comparative RNA-Seq and Microarray Analysis of Gene Expression Changes in B-Cell Lymphomas of Canis familiaris	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; BIOLOGY; MODELS; CHEMOTHERAPY; REGIMEN; CHOP; DOGS	Comparative oncology is a developing research discipline that is being used to assist our understanding of human neoplastic diseases. Companion canines are a preferred animal oncology model due to spontaneous tumor development and similarity to human disease at the pathophysiological level. We use a paired RNA sequencing (RNA-Seq)/microarray analysis of a set of four normal canine lymph nodes and ten canine lymphoma fine needle aspirates to identify technical biases and variation between the technologies and convergence on biological disease pathways. Surrogate Variable Analysis (SVA) provides a formal multivariate analysis of the combined RNA-Seq/microarray data set. Applying SVA to the data allows us to decompose variation into contributions associated with transcript abundance, differences between the technology, and latent variation within each technology. A substantial and highly statistically significant component of the variation reflects transcript abundance, and RNA-Seq appeared more sensitive for detection of transcripts expressed at low levels. Latent random variation among RNA-Seq samples is also distinct in character from that impacting microarray samples. In particular, we observed variation between RNA-Seq samples that reflects transcript GC content. Platform-independent variable decomposition without a priori knowledge of the sources of variation using SVA represents a generalizable method for accomplishing cross-platform data analysis. We identified genes differentially expressed between normal lymph nodes of disease free dogs and a subset of the diseased dogs diagnosed with B-cell lymphoma using each technology. There is statistically significant overlap between the RNA-Seq and microarray sets of differentially expressed genes. Analysis of overlapping genes in the context of biological systems suggests elevated expression and activity of PI3K signaling in B-cell lymphoma biopsies compared with normal biopsies, consistent with literature describing successful use of drugs targeting this pathway in lymphomas.	[Mooney, Marie; Monks, Noel; Eugster, Emily; Cherba, David; Webb, Craig Paul] Van Andel Res Inst, Lab Translat Med, Grand Rapids, MI USA; [Bond, Jeffrey] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Berlinski, Pamela; Kamerling, Steve; Marotti, Keith; Simpson, Heather] Pfizer Inc, Pfizer Anim Hlth, Kalamazoo, MI USA; [Rusk, Tony] Anim Clin Investigat, Washington, DC USA; [Tembe, Waibhav; Legendre, Christophe] Translat Genom Res Inst, Collaborat Bioinformat Ctr, Phoenix, AZ USA; [Benson, Hollie; Liang, Winnie] Translat Genom Res Inst, Collaborat Sequencing Ctr, Phoenix, AZ USA	Van Andel Institute; University of Vermont; Pfizer; Translational Genomics Research Institute; Translational Genomics Research Institute	Webb, CP (corresponding author), Van Andel Res Inst, Lab Translat Med, Grand Rapids, MI USA.	craig.webb@vai.org	Mooney, Marie/R-5068-2019; Monks, Noel/B-5886-2013	Mooney, Marie/0000-0003-3254-5139; Monks, Noel/0000-0001-6587-9827	National Institutes of Health (NIH) [1S10RR25056-01]; TGen Foundation; Van Andel Research Institute; National Science Foundation Graduate Research Fellowship; Pfizer Animal Health; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TGen Foundation; Van Andel Research Institute; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Pfizer Animal Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health (NIH) grant #1S10RR25056-01 (www.nih.gov); TGen Foundation (www.tgenfoundation.org); Van Andel Research Institute (www.vai.org); National Science Foundation Graduate Research Fellowship (www.nsf.gov); and Pfizer Animal Health (www.pfizer.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer Animal Health did participate minimally with data analysis and approved the completed manuscript for publication.	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Amadori D, 2011, EJC SUPPL, V9, P1; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; BREUNINGER LM, 1995, CANCER RES, V55, P5342; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; CHUNG EY, 2012, J CLIN INVESTIGATION; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Derrien T, 2012, MAMM GENOME, V23, P124, DOI 10.1007/s00335-011-9372-0; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dunleavy K, 2012, BLOOD, V119, P3245, DOI 10.1182/blood-2011-08-373738; Dunleavy K, 2009, BLOOD, V113, P6069, DOI 10.1182/blood-2009-01-199679; Fisher RI, 2003, LEUKEMIA, V17, P1948, DOI 10.1038/sj.leu.2403096; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Flowers CR, 2010, CA-CANCER J CLIN, V60, P393, DOI 10.3322/caac.20087; Friguet C, 2009, J AM STAT ASSOC, V104, P1406, DOI 10.1198/jasa.2009.tm08332; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Furlotte NA, 2011, BIOINFORMATICS, V27, pI288, DOI 10.1093/bioinformatics/btr221; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; HUANG SH, EVIDENCE ONCOGENIC G; Infanti L, 1996, HAEMATOLOGICA, V81, P521; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kim JY, 2011, BMB REP, V44, P238, DOI 10.5483/BMBRep.2011.44.4.238; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leek JT, 2008, P NATL ACAD SCI USA, V105, P18718, DOI 10.1073/pnas.0808709105; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marconato L, 2011, VET J, V188, P34, DOI 10.1016/j.tvjl.2010.04.027; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Milman G, 2011, VET MICROBIOL, V150, P15, DOI 10.1016/j.vetmic.2010.12.013; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pogue SL, 2000, J IMMUNOL, V165, P1300, DOI 10.4049/jimmunol.165.3.1300; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Roberts A, 2011, BIOINFORMATICS; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Schatz JH, 2011, CURR ONCOL REP, V13, P398, DOI 10.1007/s11912-011-0187-7; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; SUN Y, 2011, MULTIPLE HYPOTHESIS; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vanherberghen M, 2012, VET MICROBIOL, V157, P143, DOI 10.1016/j.vetmic.2011.12.009; Wittenburg LA, 2012, J CELL BIOCHEM, V113, P773, DOI 10.1002/jcb.23403; Witzig TE, 2010, HEMATOL-AM SOC HEMAT, P265, DOI 10.1182/asheducation-2010.1.265; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290	69	44	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61088	10.1371/journal.pone.0061088	http://dx.doi.org/10.1371/journal.pone.0061088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593398	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100074
J	Popova, S; Lange, S; Burd, L; Chudley, AE; Clarren, SK; Rehm, J				Popova, Svetlana; Lange, Shannon; Burd, Larry; Chudley, Albert E.; Clarren, Sterling K.; Rehm, Juergen			Cost of Fetal Alcohol Spectrum Disorder Diagnosis in Canada	PLOS ONE			English	Article							PRIMARY PREVENTION; BIRTH MOTHERS; SYNDROME FAS; CHILDREN; RISK; MANITOBA; PROFILE; WOMEN	Background: Fetal Alcohol Spectrum Disorder (FASD) is underdiagnosed in Canada. The diagnosis of FASD is not simple and currently, the recommendation is that a comprehensive, multidisciplinary assessment of the individual be done. The purpose of this study was to estimate the annual cost of FASD diagnosis on Canadian society. Methods: The diagnostic process breakdown was based on recommendations from the Fetal Alcohol Spectrum Disorder Canadian Guidelines for Diagnosis. The per person cost of diagnosis was calculated based on the number of hours (estimated based on expert opinion) required by each specialist involved in the diagnostic process. The average rate per hour for each respective specialist was estimated based on hourly costs across Canada. Based on the existing clinical capacity of all FASD multidisciplinary clinics in Canada, obtained from the 2005 and 2011 surveys conducted by the Canada Northwest FASD Research Network, the number of FASD cases diagnosed per year in Canada was estimated. The per person cost of FASD diagnosis was then applied to the number of cases diagnosed per year in Canada in order to calculated the overall annual cost. Results: Using the most conservative approach, it was estimated that an FASD evaluation requires 32 to 47 hours for one individual to be screened, referred, admitted, and diagnosed with an FASD diagnosis, which results in a total cost of $3,110 to $4,570 per person. The total cost of FASD diagnostic services in Canada ranges from $3.6 to $5.2 million (lower estimate), up to $5.0 to $7.3 million (upper estimate) per year. Discussion: As a result of using the most conservative approach, the cost of FASD diagnostic services presented in the current study is most likely underestimated. The reasons for this likelihood and the limitations of the study are discussed.	[Popova, Svetlana; Lange, Shannon; Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON, Canada; [Popova, Svetlana; Lange, Shannon; Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Popova, Svetlana] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Popova, Svetlana; Rehm, Juergen] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Burd, Larry] Univ N Dakota, Sch Med & Hlth Sci, Dept Pediat, Grand Forks, ND 58201 USA; [Chudley, Albert E.] Univ Manitoba, Childrens Hosp, Hlth Sci Ctr, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Chudley, Albert E.] Univ Manitoba, Childrens Hosp, Hlth Sci Ctr, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Clarren, Sterling K.] Child & Family Res Inst British Columbia, Ctr Community Child Hlth Res, Canada Fetal Alcohol Spectrum Disorder Res Networ, Vancouver, BC, Canada; [Clarren, Sterling K.] Univ British Columbia, Dept Paediat, Fac Med, BC Childrens Hosp, Vancouver, BC, Canada; [Clarren, Sterling K.] Univ Washington, Sch Med, Seattle, WA USA; [Rehm, Juergen] Tech Univ Dresden, Klin Psychol & Psychotherapie, Epidemiol Res Unit, D-01062 Dresden, Germany	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University of North Dakota Grand Forks; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; Child & Family Research Institute; BC Childrens Hospital; University of British Columbia; University of Washington; University of Washington Seattle; Technische Universitat Dresden	Popova, S (corresponding author), Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON, Canada.	lana.popova@camh.ca			Public Health Agency of Canada [4500278412]; Ontario Ministry of Health and Long-Term Care	Public Health Agency of Canada; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This work was supported by the Public Health Agency of Canada [contract # 4500278412]. In addition, support to the Centre for Addiction and Mental Health for the salaries of scientists and infrastructure has been provided by the Ontario Ministry of Health and Long-Term Care. The views expressed in this manuscript do not necessarily reflect those of the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante Centre for Fetal Alcohol Syndrome, 2010, YOUTH PROB OFF GUID; Asante K. O., 1985, REPORT SURVEY CHILDR; Astley S. J., 1999, DIAGNOSTIC GUIDE FET; Astley SJ, 2000, ALCOHOL ALCOHOLISM, V35, P499, DOI 10.1093/alcalc/35.5.499; Astley SJ, 2000, ALCOHOL ALCOHOLISM, V35, P509, DOI 10.1093/alcalc/35.5.509; Astley SJ, 2000, ALCOHOL ALCOHOLISM, V35, P400, DOI 10.1093/alcalc/35.4.400; CAPHC, 2010, NAT SCREEN TOOL KIT; Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302; Clarke ME, NATL SURVEY REGARDIN; Clarren SK, 2008, J POPUL THER CLIN PH, V15, pE223; Clarren SK, 2011, J POPUL THER CLIN PH, V18, pE494; DOWCLARKE RA, 1994, CAN J PUBLIC HEALTH, V85, P33; Goh YI, 2008, J POPUL THER CLIN PH, V15, pE344; Hermeren G, 1999, ACTA PAEDIATR, V88, P99, DOI 10.1080/080352599750029501; Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD), 2011, REC ALC REL NEUR DIS; Loock C, 2005, CAN MED ASSOC J, V172, P628, DOI 10.1503/cmaj.050135; Muckle G, 2011, ALCOHOL CLIN EXP RES, V35, P1081, DOI 10.1111/j.1530-0277.2011.01441.x; Paintner A, 2012, J CHILD NEUROL, V27, P355, DOI 10.1177/0883073811428377; Public Health Agency of Canada, 2011, ASS DIAGN FASD AD NA; Public Health Agency of Canada (PHAC), 2005, MAK EV MOTH CHILD CO; Public Health Agency of Canada (PHAC), 2003, FET ALC SPECTR DIS F; Roberts G, 2000, BEST PRACTICES FETAL; ROBINSON GC, 1987, CAN MED ASSOC J, V137, P203; Square D, 1997, CAN MED ASSOC J, V157, P59; Stratton K, 1996, FETAL ALCOHOL SYNDRO; Streissguth A, 1997, CHALLENGE OF FETAL ALCOHOL SYNDROME, P25; Streissguth AP, 2004, J DEV BEHAV PEDIATR, V25, P228, DOI 10.1097/00004703-200408000-00002; Williams RJ, 1999, CAN J PUBLIC HEALTH, V90, P192, DOI 10.1007/BF03404505	28	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60434	10.1371/journal.pone.0060434	http://dx.doi.org/10.1371/journal.pone.0060434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593216	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100042
J	Zhang, PD; Wang, W; Wang, X; Wang, X; Song, YH; Han, Y; Zhang, J; Zhao, H				Zhang, Peide; Wang, Wei; Wang, Xin; Wang, Xu; Song, Yunhu; Han, Yong; Zhang, Jing; Zhao, Hui			Protein Analysis of Atrial Fibrosis via Label-Free Proteomics in Chronic Atrial Fibrillation Patients with Mitral Valve Disease	PLOS ONE			English	Article							ANGIOTENSIN-II; TRANSFORMING GROWTH-FACTOR-BETA-1; GROWTH-FACTOR; MECHANISMS; HEART; FIBROBLASTS; MYOCARDIUM; DERMATOPONTIN; CONTRACTILE; MORTALITY	Background: Atrial fibrosis, as a hallmark of atrial structure remodeling, plays an important role in maintenance of chronic atrial fibrillation, but interrelationship of atrial fibrosis and atrial fibrillation is uncertain. Label-free proteomics can implement high throughput screening for finding and analyzing pivotal proteins related to the disease.. Therefore, we used label-free proteomics to explore and analyze differentially proteins in chronic atrial fibrillation patients with mitral valve disease. Methods: Left and right atrial appendages obtained from patients with mitral valve disease were both in chronic atrial fibrillation (CAF, AF >= 6 months, n = 6) and in sinus rhythm (SR, n = 6). One part of the sample was used for histological analysis and fibrosis quantification; other part were analyzed by label-free proteomic combining liquid chromatography with mass spectrometry (LC-MS), we utilized bioinformatics analysis to identify differential proteins. Results: Degree of atrial fibrosis was higher in CAF patients than that of SR patients. 223 differential proteins were detected between two groups. These proteins mainly had vital functions such as cell proliferation, stress response, focal adhesion apoptosis. We evaluated that serine/threonine protein kinase N2 (PKN2), dermatopontin(DP), S100 calcium binding protein B(S100B), protein tyrosine kinase 2(PTK2) and discoidin domain receptor tyrosine kinase 2(DDR2) played important roles in fibrotic process related to atrial fibrillation. Conclusion: The study presented differential proteins responsible for atrial fibrosis in chronic atrial fibrillation patients through label-free proteomic analysis. We assessed some vital proteins including their characters and roles. These findings may open up new realm for mechanism research of atrial fibrillation.	[Zhang, Peide; Wang, Wei; Wang, Xin; Wang, Xu; Song, Yunhu; Zhang, Jing; Zhao, Hui] Chinese Acad Med Sci, Peking Union Med Coll, Fuwai Hosp, Dept Cardiovasc Surg, Beijing 100730, Peoples R China; [Han, Yong] Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Peking University	Wang, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Fuwai Hosp, Dept Cardiovasc Surg, Beijing 100730, Peoples R China.	weiwang0728@gmail.com			Fuwai Hospital	Fuwai Hospital	The funding for this work was received from Fuwai Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Anyukhovsky EP, 2002, CARDIOVASC RES, V54, P462, DOI 10.1016/S0008-6363(02)00271-7; Ausma J, 1997, CIRCULATION, V96, P3157, DOI 10.1161/01.CIR.96.9.3157; Beyerbach DM, 2004, HEART RHYTHM, V1, pB8, DOI 10.1016/j.hrthm.2004.04.018; Bottiger BW, 2001, CIRCULATION, V103, P2694; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen J, 2000, CARDIOVASC RES, V48, P220, DOI 10.1016/S0008-6363(00)00177-2; Davy JM, 2010, ANN CARDIOL ANGEIOL, V59, pS4, DOI 10.1016/S0003-3928(10)70002-0; Eiras S, 2006, J MOL CELL CARDIOL, V41, P467, DOI 10.1016/j.yjmcc.2006.06.072; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hanna N, 2004, CARDIOVASC RES, V63, P236, DOI 10.1016/j.cardiores.2004.03.026; Hao JM, 2000, AM J PHYSIOL-HEART C, V279, pH3020, DOI 10.1152/ajpheart.2000.279.6.H3020; Haqqani Arsalan S., 2008, V439, P225, DOI 10.1007/978-1-59745-188-8_16; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; Kiernan J.A., 1999, HISTOLOGICAL HISTOCH, V3rd ed; Kostin S, 2002, CARDIOVASC RES, V54, P361, DOI 10.1016/S0008-6363(02)00273-0; Lachmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021732; Larn L, 2006, INT J CARDIOL, V108, P12, DOI 10.1016/j.ijcard.2206.01.002; Li JP, 2011, CLIN BIOCHEM, V44, P984, DOI 10.1016/j.clinbiochem.2011.05.014; Liao CH, 2010, J CLIN INVEST, V120, P242, DOI 10.1172/JCI39942; Lin CS, 2008, CELL MOL LIFE SCI, V65, P1489, DOI 10.1007/s00018-008-7408-8; Luo MH, 2007, CARDIOLOGY, V107, P248, DOI 10.1159/000095501; Missler U, 2002, CLIN CHIM ACTA, V321, P29, DOI 10.1016/S0009-8981(02)00061-X; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; NEAME PJ, 1989, J BIOL CHEM, V264, P5474; Okamoto O, 1999, BIOCHEM J, V337, P537, DOI 10.1042/0264-6021:3370537; Okamoto O, 2006, CONNECT TISSUE RES, V47, P177, DOI 10.1080/03008200600846564; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Park HW, 2012, CURR OPIN CARDIOL, V27, P24, DOI 10.1097/HCO.0b013e32834dc4e8; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Rucker-Martin C, 2002, CARDIOVASC RES, V55, P38, DOI 10.1016/S0008-6363(02)00338-3; Rybinski M, 2012, J THEOR BIOL, V309, P34, DOI 10.1016/j.jtbi.2012.04.031; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STODDARD MF, 1995, J AM COLL CARDIOL, V25, P452, DOI 10.1016/0735-1097(94)00396-8; Tan AY, 2011, J CARDIOVASC PHARM, V57, P625, DOI 10.1097/FJC.0b013e3182073c78; Taniyama Y, 2000, CIRCULATION, V102, P246, DOI 10.1161/01.CIR.102.2.246; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; THROSBY M, 1991, ENDOCRINOLOGY, V129, P991, DOI 10.1210/endo-129-2-991; Tsai CT, 2008, CIRCULATION, V117, P344, DOI 10.1161/CIRCULATIONAHA.107.695346; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Xiao H, 2010, CLIN CARDIOL, V33, P149, DOI 10.1002/clc.20713	45	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60210	10.1371/journal.pone.0060210	http://dx.doi.org/10.1371/journal.pone.0060210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593175	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100021
J	Abdullah, A; Deris, S; Mohamad, MS; Anwar, S				Abdullah, Afnizanfaizal; Deris, Safaai; Mohamad, Mohd Saberi; Anwar, Sohail			An Improved Swarm Optimization for ParameterA Estimation and Biological Model Selection	PLOS ONE			English	Article							DIFFERENTIAL EVOLUTION; GLOBAL OPTIMIZATION; SYSTEMS BIOLOGY; ALGORITHMS; EFFICIENT	One of the key aspects of computational systems biology is the investigation on the dynamic biological processes within cells. Computational models are often required to elucidate the mechanisms and principles driving the processes because of the nonlinearity and complexity. The models usually incorporate a set of parameters that signify the physical properties of the actual biological systems. In most cases, these parameters are estimated by fitting the model outputs with the corresponding experimental data. However, this is a challenging task because the available experimental data are frequently noisy and incomplete. In this paper, a new hybrid optimization method is proposed to estimate these parameters from the noisy and incomplete experimental data. The proposed method, called Swarm-based Chemical Reaction Optimization, integrates the evolutionary searching strategy employed by the Chemical Reaction Optimization, into the neighbouring searching strategy of the Firefly Algorithm method. The effectiveness of the method was evaluated using a simulated nonlinear model and two biological models: synthetic transcriptional oscillators, and extracellular protease production models. The results showed that the accuracy and computational speed of the proposed method were better than the existing Differential Evolution, Firefly Algorithm and Chemical Reaction Optimization methods. The reliability of the estimated parameters was statistically validated, which suggests that the model outputs produced by these parameters were valid even when noisy and incomplete experimental data were used. Additionally, Akaike Information Criterion was employed to evaluate the model selection, which highlighted the capability of the proposed method in choosing a plausible model based on the experimental data. In conclusion, this paper presents the effectiveness of the proposed method for parameter estimation and model selection problems using noisy and incomplete experimental data. This study is hoped to provide a new insight in developing more accurate and reliable biological models based on limited and low quality experimental data.	[Abdullah, Afnizanfaizal; Deris, Safaai; Mohamad, Mohd Saberi] UTM, Fac Comp, Artificial Intelligence & Bioinformat Grp AIBIG, Johor Baharu, Malaysia; [Anwar, Sohail] Penn State Univ, Altoona, PA USA	Universiti Teknologi Malaysia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Abdullah, A (corresponding author), UTM, Fac Comp, Artificial Intelligence & Bioinformat Grp AIBIG, Johor Baharu, Malaysia.	afnizanfaizal@utm.my; saberi@utm.my	MOHAMAD, MOHD SABERI/AAA-1929-2022; Abdullah, Afnizanfaizal/E-8709-2013; Mohamad, Mohd Saberi/J-3201-2014; Abdullah, Afnizanfaizal/AAI-9429-2020	MOHAMAD, MOHD SABERI/0000-0002-1079-4559; Abdullah, Afnizanfaizal/0000-0002-0280-565X; Mohamad, Mohd Saberi/0000-0002-1079-4559; Abdullah, Afnizanfaizal/0000-0002-0280-565X	Malaysia Ministry of Science, Technology and Innovation (MOSTI) [07-05-MGI-GMB011]; Research Management Centre (RMC), Universiti Teknologi Malaysia (UTM) [73744]; Universiti Teknologi Malaysia; Research University Grant (RUG) [Q.J130000.2507.04H16]	Malaysia Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Research Management Centre (RMC), Universiti Teknologi Malaysia (UTM); Universiti Teknologi Malaysia; Research University Grant (RUG)	This research was supported by a grant from Malaysia Ministry of Science, Technology and Innovation (MOSTI), organized by Malaysia Genome Institute (MGI) project number 07-05-MGI-GMB011 entitled "Design and Development of Microbial Cell Factories for Biomolecules Production and Secretion" and managed by Research Management Centre (RMC), Universiti Teknologi Malaysia (UTM) grant number 73744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express gratitude to the editor and reviewers for helpful suggestions and Universiti Teknologi Malaysia for sponsoring this research.; This research was supported by Research University Grant (RUG), project number Q.J130000.2507.04H16, and managed by Research Management Centre (RMC), Universiti Teknologi Malaysia (UTM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056310; Abdullah A, 2009, PROCEEDINGS OF THE 2009 INTERNATIONAL CONFERENCE ON COMPUTER TECHNOLOGY AND DEVELOPMENT, VOL 1, P230, DOI 10.1109/ICCTD.2009.168; Abdullahl Afnizanfaizal, 2013, International Journal of Computer Information Systems and Industrial Management Applications, V5, P571; Ashyraliyev M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-83; Balsa-Canto E, 2008, IET SYST BIOL, V2, P163, DOI 10.1049/iet-syb:20070069; Balsa-Canto E, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-26; Balsa-Canto E, 2012, ADV EXP MED BIOL, V736, P409, DOI 10.1007/978-1-4419-7210-1_24; Besozzi D, 2009, LECT NOTES COMPUT SC, V5483, P116, DOI 10.1007/978-3-642-01184-9_11; Buhry L, 2011, NEURAL COMPUT, V23, P2599, DOI 10.1162/NECO_a_00170; Bujara M, 2010, BIOTECHNOL BIOENG, V106, P376, DOI 10.1002/bit.22666; Chen Y.M., 2012, INT J COMPUT SCI ISS, V9, P1; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; COSTA PJ, 1994, IEEE T AERO ELEC SYS, V30, P525, DOI 10.1109/7.272275; Slezak DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013283; Germani A, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P886; Glover F, 2000, CONTROL CYBERN, V29, P653; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kim J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.119; Lages NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032749; Lam AYS, 2010, IEEE T EVOLUT COMPUT, V14, P381, DOI 10.1109/TEVC.2009.2033580; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lillacci G, 2012, INT J ROBUST NONLIN, V22, P1065, DOI 10.1002/rnc.2794; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Miao HY, 2009, BIOMETRICS, V65, P292, DOI 10.1111/j.1541-0420.2008.01059.x; Raue A, 2011, IET SYST BIOL, V5, P120, DOI 10.1049/iet-syb.2010.0061; Rodriguez-Fernandez M, 2006, BIOSYSTEMS, V83, P248, DOI 10.1016/j.biosystems.2005.06.016; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; Runarsson TP, 2000, IEEE T EVOLUT COMPUT, V4, P284, DOI 10.1109/4235.873238; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Sun JY, 2012, IEEE ACM T COMPUT BI, V9, P185, DOI 10.1109/TCBB.2011.63; Sun XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003758; Tashkova K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-159; Tutkun N, 2009, EXPERT SYST APPL, V36, P3342, DOI 10.1016/j.eswa.2008.01.060; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14; Zeng NY, 2012, IEEE ACM T COMPUT BI, V9, P321, DOI 10.1109/TCBB.2011.140; Zheng YT, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541609	39	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61258	10.1371/journal.pone.0061258	http://dx.doi.org/10.1371/journal.pone.0061258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593445	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200047
J	Karlsson, TE; Koczy, J; Brene, S; Olson, L; Josephson, A				Karlsson, Tobias E.; Koczy, Josefin; Brene, Stefan; Olson, Lars; Josephson, Anna			Differential Conserted Activity Induced Regulation of Nogo Receptors (1-3), LOTUS and Nogo mRNA in Mouse Brain	PLOS ONE			English	Article							OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; NEURITE OUTGROWTH; AXONAL REGENERATION; FAMILY-MEMBER; INHIBITOR; IDENTIFICATION; CORECEPTOR; INTERACTS; ANTIBODY; PROTEIN	Nogo Receptor 1 (NgR1) mRNA is downregulated in hippocampal and cortical regions by increased neuronal activity such as a kainic acid challenge or by exposing rats to running wheels. Plastic changes in cerebral cortex in response to loss of specific sensory inputs caused by spinal cord injury are also associated with downregulation of NgR1 mRNA. Here we investigate the possible regulation by neuronal activity of the homologous receptors NgR2 and NgR3 as well as the endogenous NgR1 antagonist LOTUS and the ligand Nogo. The investigated genes respond to kainic acid by gene-specific, concerted alterations of transcript levels, suggesting a role in the regulation of synaptic plasticity, Downregulation of NgR1, coupled to upregulation of the NgR1 antagonist LOTUS, paired with upregulation of NgR2 and 3 in the dentate gyrus suggest a temporary decrease of Nogo/OMgp sensitivity while CSPG and MAG sensitivity could remain. It is suggested that these activity-synchronized temporary alterations may serve to allow structural alterations at the level of local synaptic circuitry in gray matter, while maintaining white matter pathways and that subsequent upregulation of Nogo-A and NgR1 transcript levels signals the end of such a temporarily opened window of plasticity.	[Karlsson, Tobias E.; Koczy, Josefin; Olson, Lars; Josephson, Anna] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Brene, Stefan] Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Karlsson, TE (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	tobias.karlsson@ki.se		Karlsson, Tobias/0000-0002-9919-3353	Swedish Research Council [2011-4544-84355-68]; Swedish Brain Power; NIH Cutting-Edge Basic Research Awards (CEBRA); ERC [322744]; Scandia Jubileumsfond; Karolinska Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power; NIH Cutting-Edge Basic Research Awards (CEBRA); ERC(European Research Council (ERC)European Commission); Scandia Jubileumsfond; Karolinska Institute(Karolinska Institutet)	Funding provided by the Swedish Research Council (2011-4544-84355-68; http://www.vr.se, Swedish Brain Power (http://swedishbrainpower.se/), NIH Cutting-Edge Basic Research Awards (CEBRA; www.nih.gov), ERC grant no. 322744, Scandia Jubileumsfond, The Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Josephson A, 2001, EXP NEUROL, V169, P319, DOI 10.1006/exnr.2001.7659; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Lauren J, 2003, MOL CELL NEUROSCI, V24, P581, DOI 10.1016/S1044-7431(03)00199-4; Lauren J, 2007, J BIOL CHEM, V282, P5715, DOI 10.1074/jbc.M609797200; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Pernet V, 2012, CELL TISSUE RES; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Sato Y, 2011, SCIENCE, V333, P769, DOI 10.1126/science.1204144; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; SPERK G, 1985, BRAIN RES, V338, P289, DOI 10.1016/0006-8993(85)90159-3; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60892	10.1371/journal.pone.0060892	http://dx.doi.org/10.1371/journal.pone.0060892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593344	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200027
J	Nyaku, ST; Sripathi, VR; Kantety, RV; Gu, YQ; Lawrence, K; Sharma, GC				Nyaku, Seloame T.; Sripathi, Venkateswara R.; Kantety, Ramesh V.; Gu, Yong Q.; Lawrence, Kathy; Sharma, Govind C.			Characterization of the Two Intra-Individual Sequence Variants in the 18S rRNA Gene in the Plant Parasitic Nematode, Rotylenchulus reniformis	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; SECONDARY STRUCTURE; EVOLUTION; PLATYHELMINTHES	The 18S rRNA gene is fundamental to cellular and organismal protein synthesis and because of its stable persistence through generations it is also used in phylogenetic analysis among taxa. Sequence variation in this gene within a single species is rare, but it has been observed in few metazoan organisms. More frequently it has mostly been reported in the non-transcribed spacer region. Here, we have identified two sequence variants within the near full coding region of 18S rRNA gene from a single reniform nematode (RN) Rotylenchulus reniformis labeled as reniform nematode variant 1 (RN_VAR1) and variant 2 (RN_VAR2). All sequences from three of the four isolates had both RN variants in their sequences; however, isolate 13B had only RN variant 2 sequence. Specific variable base sites (96 or 5.5%) were found within the 18S rRNA gene that can clearly distinguish the two 18S rDNA variants of RN, in 11 (25.0%) and 33 (75.0%) of the 44 RN clones, for RN_VAR1 and RN_VAR2, respectively. Neighbor-joining trees show that the RN_VAR1 is very similar to the previously existing R. reniformis sequence in GenBank, while the RN_VAR2 sequence is more divergent. This is the first report of the identification of two major variants of the 18S rRNA gene in the same single RN, and documents the specific base variation between the two variants, and hypothesizes on simultaneous co-existence of these two variants for this gene.	[Nyaku, Seloame T.; Sripathi, Venkateswara R.; Kantety, Ramesh V.; Sharma, Govind C.] Alabama A&M Univ, Dept Biol & Environm Sci, Normal, AL 35762 USA; [Gu, Yong Q.] USDA ARS, Genom & Gene Discovery Res Unit, Albany, CA USA; [Lawrence, Kathy] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Alabama A&M University; United States Department of Agriculture (USDA); Auburn University System; Auburn University	Nyaku, ST (corresponding author), Alabama A&M Univ, Dept Biol & Environm Sci, Normal, AL 35762 USA.	seloame.nyaku@aamu.edu	Nyaku, Seloame/AAI-8353-2021; Lawrence, Kathy/AAA-3808-2020; Nyaku, Seloame/AFP-0999-2022	Lawrence, Kathy/0000-0002-5358-2011; 	Unites States Department of Agriculture-Cooperative State Research, Education, and Extension Service (USDA-CSREES) [2004-38814-15160]; National Science Foundation/Plant Genome Research Program (NSF/PGRP) [0703470]	Unites States Department of Agriculture-Cooperative State Research, Education, and Extension Service (USDA-CSREES); National Science Foundation/Plant Genome Research Program (NSF/PGRP)(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by Unites States Department of Agriculture-Cooperative State Research, Education, and Extension Service (USDA-CSREES) Grant # 2004-38814-15160 and National Science Foundation/Plant Genome Research Program (NSF/PGRP) award #0703470 to Dr. Ramesh V. Kantety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin VV, 1998, FEBS LETT, V429, P4, DOI 10.1016/S0014-5793(98)00550-X; Carranza S, 1996, MOL BIOL EVOL, V13, P824, DOI 10.1093/oxfordjournals.molbev.a025643; CLARK CG, 1984, NUCLEIC ACIDS RES, V12, P6197, DOI 10.1093/nar/12.15.6197; COEN ES, 1983, CELL, V33, P849, DOI 10.1016/0092-8674(83)90027-2; Davis RF, 2003, J NEMATOL, V35, P58; Deng DW, 2008, AFR J MICROBIOL RES, V2, P167; Dorris M, 1999, PARASITOL TODAY, V15, P188, DOI 10.1016/S0169-4758(99)01439-8; Dover G. A., 1982, GENOME EVOLUTION; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Gaur HS, 1998, INDIAN J NEMATOL, V18, P84; Gazaway W. S., 2003, Journal of Cotton Science, V7, P1; Gazaway WS, 2001, P BELTW COTT C AN CA; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hasegawa H, 2009, PARASITOL RES, V104, P869, DOI 10.1007/s00436-008-1269-9; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hwang Ui-Wook, 1999, Korean Journal of Parasitology, V37, P215, DOI 10.3347/kjp.1999.37.4.215; Hwang UW, 2000, ZOOL SCI, V17, P111, DOI 10.2108/zsj.17.111; Inserra RN, 1992, 199 FLOR DEP AGR CON; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Krieger J, 2006, J HERED, V97, P218, DOI 10.1093/jhered/esj035; LASSNER M, 1986, NUCLEIC ACIDS RES, V14, P5499, DOI 10.1093/nar/14.13.5499; Lawrence G. W., 1999, P BELTW COTT PROD RE, P100; Luc M, 1990, PLANT PARASITIC NEMA; Lydeard C, 2000, MOL PHYLOGENET EVOL, V15, P83, DOI 10.1006/mpev.1999.0719; McTaggart SJ, 2009, J MOL EVOL, V69, P142, DOI 10.1007/s00239-009-9257-y; Miranda LN, 2012, HARMFUL ALGAE, V16, P35, DOI 10.1016/j.hal.2012.01.002; Ohta T., 1980, EVOLUTION VARIATION, V37, DOI [10.1007/978-3-642-93138-3, DOI 10.1007/978-3-642-93138-3]; Oliveira CMG, 2004, J NEMATOL, V36, P153; Overstreet C, 1999, P BELTW COTT C ORL F, P1; QARI SH, 1994, GENE, V150, P43, DOI 10.1016/0378-1119(94)90855-9; RIUTORT M, 1992, CAN J ZOOL, V70, P1425, DOI 10.1139/z92-199; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Weaver DB, 2007, CROP SCI, V47, P19, DOI 10.2135/cropsci2006.02.0130; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111; Wu ZH, 2003, APPL ENVIRON MICROB, V69, P5389, DOI 10.1128/AEM.69.9.5389-5397.2003	41	21	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60891	10.1371/journal.pone.0060891	http://dx.doi.org/10.1371/journal.pone.0060891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593343	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200026
J	Brooks, SJ; Cedernaes, J; Schioth, HB				Brooks, Samantha J.; Cedernaes, Jonathan; Schioth, Helgi B.			Increased Prefrontal and Parahippocampal Activation with Reduced Dorsolateral Prefrontal and Insular Cortex Activation to Food Images in Obesity: A Meta-Analysis of fMRI Studies	PLOS ONE			English	Article							ANTERIOR CINGULATE; INHIBITORY CONTROL; FUTURE INCREASES; BRAIN; STIMULI; REWARD; ADDICTION; RESPONSES; CONFLICT; CUES	Background and Objectives: Obesity is emerging as the most significant health concern of the twenty-first century. A wealth of neuroimaging data suggest that weight gain might be related to aberrant brain function, particularly in prefrontal cortical regions modulating mesolimbic addictive responses to food. Nevertheless, food addiction is currently a model hotly debated. Here, we conduct a meta-analysis of neuroimaging data, examining the most common functional differences between normal-weight and obese participants in response to food stimuli. Data Source: We conducted a search using several journal databases and adhered to the 'Preferred Reporting Items for Systematic Reviews and Meta-analyses' (PRISMA) method. To this aim, 10 studies were found with a total of 126 obese participants, 129 healthy controls, equaling 184 foci (146 increased, 38 decreased activation) using the Activation Likelihood Estimation (ALE) technique. Out of the 10 studies, 7 investigated neural responses to food versus non-food images. Results: In response to food images, obese in comparison to healthy weight subjects had increased activation in the left dorsomedial prefrontal cortex, right parahippocampal gyrus, right precentral gyrus and right anterior cingulate cortex, and reduced activation in the left dorsolateral prefrontal cortex and left insular cortex. Conclusions: Prefrontal cortex areas linked to cognitive evaluation processes, such as evaluation of rewarding stimuli, as well as explicit memory regions, appear most consistently activated in response to images of food in those who are obese. Conversely, a reduced activation in brain regions associated with cognitive control and interoceptive awareness of sensations in the body might indicate a weakened control system, combined with hypo-sensitivity to satiety and discomfort signals after eating in those who are prone to overeat.	[Brooks, Samantha J.; Cedernaes, Jonathan; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Brooks, SJ (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Samantha.brooks@neuro.uu.se	Cedernaes, Jonathan/AAM-3973-2021; Brooks, Samantha/AAJ-2159-2020; Schioth, Helgi/AAQ-7239-2020	Cedernaes, Jonathan/0000-0002-9052-8372; Brooks, Samantha/0000-0002-9146-6257	Swedish Research Council; Brain Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Brain Research Foundation	The authors' work is supported by the Swedish Research Council and Brain Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bragulat V, 2008, ALCOHOL CLIN EXP RES, V32, P1124, DOI 10.1111/j.1530-0277.2008.00693.x; Brooks SJ, 2012, NEUROIMAGE, V59, P2962, DOI 10.1016/j.neuroimage.2011.09.077; Brooks SJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-179; Candeias V, 2010, CAN J PUBLIC HEALTH, V101, pS28; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Cornier MA, 2013, PHYSIOL BEHAV, V110, P122, DOI 10.1016/j.physbeh.2013.01.002; Cornier MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006310; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Davids S, 2010, INT J OBESITY, V34, P94, DOI 10.1038/ijo.2009.193; Dimitropoulos A, 2012, APPETITE, V58, P303, DOI 10.1016/j.appet.2011.10.014; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Fregni F, 2008, APPETITE, V51, P34, DOI 10.1016/j.appet.2007.09.016; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Hassenstab JJ, 2012, PSYCHIAT RES-NEUROIM, V202, P77, DOI 10.1016/j.pscychresns.2011.09.008; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Jezzard P, 2006, J MAGN RESON IMAGING, V23, P787, DOI 10.1002/jmri.20581; Johnson SC, 2000, NEUROIMAGE, V11, P179, DOI 10.1006/nimg.1999.0530; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; Knoch D, 2005, CEREB CORTEX, V15, P885, DOI 10.1093/cercor/bhh196; Leidy HJ, 2011, OBESITY, V19, P2019, DOI 10.1038/oby.2011.108; Li J, 2012, AM J CLIN NUTR, V96, P275, DOI 10.3945/ajcn.112.037440; Loeber S, 2012, INT J OBESITY, V36, P1334, DOI 10.1038/ijo.2011.184; Maayan L, 2011, OBESITY, V19, P1382, DOI 10.1038/oby.2011.15; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Martin LE, 2010, OBESITY, V18, P254, DOI 10.1038/oby.2009.220; Ochner CN, 2012, NEUROSCIENCE, V209, P128, DOI 10.1016/j.neuroscience.2012.02.030; Oltmanns KM, 2012, PSYCHOPHARMACOLOGY, V221, P693, DOI 10.1007/s00213-011-2615-7; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Shackman AJ, 2009, PSYCHOL SCI, V20, P1500, DOI 10.1111/j.1467-9280.2009.02476.x; Sperduti M, 2011, BRAIN STRUCT FUNCT, V216, P151, DOI 10.1007/s00429-010-0298-1; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stice E., 2012, NEUROSCI BIOBEHAV RE; Stice E, 2008, J ABNORM PSYCHOL, V117, P924, DOI 10.1037/a0013600; Stice E, 2013, NEUROIMAGE, V67, P322, DOI 10.1016/j.neuroimage.2012.11.028; Stice E, 2010, NEUROIMAGE, V50, P1618, DOI 10.1016/j.neuroimage.2010.01.081; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Sutin AR, 2011, J PERS SOC PSYCHOL, V101, P579, DOI 10.1037/a0024286; Szalay C, 2012, BRAIN RES, V1473, P131, DOI 10.1016/j.brainres.2012.07.051; Taghva A, 2012, NEUROSURGERY, V71, P224, DOI 10.1227/NEU.0b013e31825972ab; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Vanderhasselt MA, 2009, PSYCHON B REV, V16, P609, DOI 10.3758/PBR.16.3.609; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Yeung N, 2009, J NEUROSCI, V29, P14506, DOI 10.1523/JNEUROSCI.3615-09.2009; Yokum S, 2012, INT J OBESITY, V36, P656, DOI 10.1038/ijo.2011.175; Ziauddeen H, 2013, OBES REV, V14, P19, DOI 10.1111/j.1467-789X.2012.01046.x; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	59	170	174	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60393	10.1371/journal.pone.0060393	http://dx.doi.org/10.1371/journal.pone.0060393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593210	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000014
J	Brock, J; Board, PG; Oakley, AJ				Brock, Joseph; Board, Philip G.; Oakley, Aaron J.			Structural Insights into Omega-Class Glutathione Transferases: A Snapshot of Enzyme Reduction and Identification of a Non-Catalytic Ligandin Site	PLOS ONE			English	Article							S-TRANSFERASE; CRYSTAL-STRUCTURE; BINDING-SITE; THIOLTRANSFERASE; SYSTEM; TARGET; ONSET; AGE	Glutathione transferases (GSTs) are dimeric enzymes containing one active-site per monomer. The omega-class GSTs (hGSTO1-1 and hGSTO2-2 in humans) are homodimeric and carry out a range of reactions including the glutathione-dependant reduction of a range of compounds and the reduction of S-(phenacyl)glutathiones to acetophenones. Both types of reaction result in the formation of a mixed-disulfide of the enzyme with glutathione through the catalytic cysteine (C32). Recycling of the enzyme utilizes a second glutathione molecule and results in oxidized glutathione (GSSG) release. The crystal structure of an active-site mutant (C32A) of the hGSTO1-1 isozyme in complex with GSSG provides a snapshot of the enzyme in the process of regeneration. GSSG occupies both the G (GSH-binding) and H (hydrophobic-binding) sites and causes re-arrangement of some H-site residues. In the same structure we demonstrate the existence of a novel "ligandin" binding site deep within in the dimer interface of this enzyme, containing S-(4-nitrophenacyl)glutathione, an isozyme-specific substrate for hGSTO1-1. The ligandin site, conserved in Omega class GSTs from a range of species, is hydrophobic in nature and may represent the binding location for tocopherol esters that are uncompetitive hGSTO1-1 inhibitors.	[Brock, Joseph] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Board, Philip G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Oakley, Aaron J.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia	Australian National University; Australian National University; John Curtin School of Medical Research; University of Wollongong	Oakley, AJ (corresponding author), Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia.	aarono@uow.edu.au	Brock, Joseph/AAE-9483-2020; Brock, Joseph/P-6663-2018; Oakley, Aaron/A-9464-2013	Brock, Joseph/0000-0003-3476-9478; Brock, Joseph/0000-0003-3476-9478; Oakley, Aaron/0000-0002-4764-014X	National Health and Medical Research Council [366731]; Australian Research Council [FT0990287]; Department of Energy (DOE) Office of Biological and Environmental Research; National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) [P41GM103393]; National Institutes of Health (NIH), National Center for Research Resources (NCRR) [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Department of Energy (DOE) Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH), National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Health and Medical Research Council Project Grant 366731. AJO is supported by an Australian Research Council Future Fellowship FT0990287. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy (DOE) Office of Biological and Environmental Research, and by the National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (including P41GM103393) and the National Center for Research Resources (NCRR) (P41RR001209). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allocati N, 2008, PROTEINS, V71, P16, DOI 10.1002/prot.21835; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Board PG, 2007, CHEM RES TOXICOL, V20, P149, DOI 10.1021/tx600305y; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chen BY, 2011, J MOL BIOL, V412, P204, DOI 10.1016/j.jmb.2011.07.019; CRAWFORD MJ, 1976, XENOBIOTICA, V6, P745, DOI 10.3109/00498257609151391; De Giessen EV, 2008, AMYOTROPH LATERAL SC, V9, P81, DOI 10.1080/17482960701702553; Dulhunty AF, 2005, BIOCHEM J, V390, P333, DOI 10.1042/BJ20042113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federici L, 2007, BIOCHEM J, V403, P267, DOI 10.1042/BJ20061707; Ji XH, 1996, P NATL ACAD SCI USA, V93, P8208, DOI 10.1073/pnas.93.16.8208; KATTI SK, 1995, PROTEIN SCI, V4, P1998, DOI 10.1002/pro.5560041005; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; LITWACK G, 1971, NATURE, V234, P466, DOI 10.1038/234466a0; Mathieu Y, 2012, J BIOL CHEM, V287, P39001, DOI 10.1074/jbc.M112.402776; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Meux E, 2012, FEBS LETT, V586, P3944, DOI 10.1016/j.febslet.2012.09.036; Meux E, 2011, J BIOL CHEM, V286, P9162, DOI 10.1074/jbc.M110.194548; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Oakley AJ, 2005, CURR OPIN STRUC BIOL, V15, P716, DOI 10.1016/j.sbi.2005.10.005; Pongstaporn W, 2009, J CANCER RES CLIN, V135, P673, DOI 10.1007/s00432-008-0501-4; Reinemer P, 1996, J MOL BIOL, V255, P289, DOI 10.1006/jmbi.1996.0024; Rossjohn J, 1998, STRUCT FOLD DES, V6, P721, DOI 10.1016/S0969-2126(98)00074-4; Sampayo-Reyes A, 2006, BIOMED PHARMACOTHER, V60, P238, DOI 10.1016/j.biopha.2006.04.005; Schmuck EM, 2005, PHARMACOGENET GENOM, V15, P493, DOI 10.1097/01.fpc.0000165725.81559.e3; Washburn MP, 1999, BIOCHEM BIOPH RES CO, V257, P567, DOI 10.1006/bbrc.1999.0508; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Whitbread AK, 2003, PHARMACOGENETICS, V13, P131, DOI 10.1097/00008571-200303000-00003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhou HN, 2012, J MOL BIOL, V420, P190, DOI 10.1016/j.jmb.2012.04.014	35	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60324	10.1371/journal.pone.0060324	http://dx.doi.org/10.1371/journal.pone.0060324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593192	Green Published, gold			2022-12-27	WOS:000317909600018
J	Fukuma, A; Yoshikawa, R; Miyazawa, T; Yasuda, J				Fukuma, Aiko; Yoshikawa, Rokusuke; Miyazawa, Takayuki; Yasuda, Jiro			A New Approach to Establish a Cell Line with Reduced Risk of Endogenous Retroviruses	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; FELINE PARVOVIRUS; HIV-1 RELEASE; RD-114 VIRUS; TETHERIN; PROTEIN; RESTRICTION; PROPORTION	Endogenous retroviruses (ERVs) are integrated as DNA proviruses in the genomes of all mammalian species. Several ERVs are replication-competent and produced as fully infectious viruses from host cell. Thus, live-attenuated vaccines and biological substances have been prepared using the cell lines which may produce ERV. Indeed, we recently reported that several commercial live-attenuated vaccines for pets were contaminated with the infectious feline endogenous retrovirus, RD-114. In this study, to establish a cell line for vaccine manufacture with reduced risk of ERVs, we generated a cell line stably expressing human tetherin (Teth-CRFK cells). The release of infectious ERV from Teth-CRFK cells was suppressed to undetectable levels, while the production of parvovirus in Teth-CRFK cells was similar to that in parental CRFK cells. These observations suggest that Teth-CRFK cells will be useful as a cell line for the manufacture of live-attenuated vaccines or biological substances with reduced risk of ERV.	[Fukuma, Aiko; Yasuda, Jiro] Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Yoshikawa, Rokusuke; Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Signal Transduct, Kyoto 606, Japan	Nagasaki University; Kyoto University	Yasuda, J (corresponding author), Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med NEKKEN, Nagasaki 852, Japan.	j-yasuda@nagasaki-u.ac.jp		Yasuda, Jiro/0000-0001-9928-5621; Miyazawa, Takayuki/0000-0003-1938-9661	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett BS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002596; Baumann JG, 1998, J VIROL, V72, P7685, DOI 10.1128/JVI.72.9.7685-7687.1998; FISCHINGER PJ, 1973, J VIROL, V11, P978, DOI 10.1128/JVI.11.6.978-985.1973; Fukuma A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-540; Fukuma A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018247; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Goffinet C, 2010, J VIROL, V84, P11374, DOI 10.1128/JVI.01067-10; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Ikeda Y, 1998, J VET MED SCI, V60, P973, DOI 10.1292/jvms.60.973; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; KONISHI S, 1975, JPN J VET SCI, V37, P247; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Ma HL, 2011, J VIROL, V85, P6579, DOI 10.1128/JVI.00147-11; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Mattiuzzo G, 2010, J VIROL, V84, P2618, DOI 10.1128/JVI.01928-09; Miyazawa T, 1999, MICROBIOL IMMUNOL, V43, P609, DOI 10.1111/j.1348-0421.1999.tb02447.x; Miyazawa T, 2010, BIOLOGICALS, V38, P371, DOI 10.1016/j.biologicals.2010.03.003; Miyazawa T, 2010, J VIROL, V84, P3690, DOI 10.1128/JVI.02715-09; Nakata R, 2003, MICROBES INFECT, V5, P947, DOI 10.1016/S1286-4579(03)00180-1; Narushima R, 2011, BIOLOGICALS, V39, P89, DOI 10.1016/j.biologicals.2011.01.004; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; OKABE H, 1973, J VIROL, V12, P984, DOI 10.1128/JVI.12.5.984-994.1973; Okada M, 2011, VIRUS RES, V155, P268, DOI 10.1016/j.virusres.2010.10.020; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Sakaguchi S, 2008, J VET MED SCI, V70, P785, DOI 10.1292/jvms.70.785; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sassa Y, 2006, J VET MED SCI, V68, P1195, DOI 10.1292/jvms.68.1195; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Yoshikawa R, 2012, J VET MED SCI, V74, P347, DOI 10.1292/jvms.11-0219; Yoshikawa R, 2011, BIOLOGICALS, V39, P33, DOI 10.1016/j.biologicals.2010.11.001; Yoshikawa R, 2010, J CLIN MICROBIOL, V48, P3366, DOI 10.1128/JCM.00992-10	34	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61530	10.1371/journal.pone.0061530	http://dx.doi.org/10.1371/journal.pone.0061530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585909	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600124
J	Sandry, J; Trafimow, D; Marks, MJ; Rice, S				Sandry, Joshua; Trafimow, David; Marks, Michael J.; Rice, Stephen			Adaptive Memory: Evaluating Alternative Forms of Fitness-Relevant Processing in the Survival Processing Paradigm	PLOS ONE			English	Article							EVOLUTIONARY PSYCHOLOGY; PROXIMATE MECHANISMS; KIN RECOGNITION; ENHANCED MEMORY; ADVANTAGE; INCEST; TRUSTWORTHINESS; EXPLANATIONS; PERSPECTIVE; RETENTION	Memory may have evolved to preserve information processed in terms of its fitness-relevance. Based on the assumption that the human mind comprises different fitness-relevant adaptive mechanisms contributing to survival and reproductive success, we compared alternative fitness-relevant processing scenarios with survival processing. Participants rated words for relevancy to fitness-relevant and control conditions followed by a delay and surprise recall test (Experiment 1a). Participants recalled more words processed for their relevance to a survival situation. We replicated these findings in an online study (Experiment 2) and a study using revised fitness-relevant scenarios (Experiment 3). Across all experiments, we did not find a mnemonic benefit for alternative fitness-relevant processing scenarios, questioning assumptions associated with an evolutionary account of remembering. Based on these results, fitness-relevance seems to be too wide-ranging of a construct to account for the memory findings associated with survival processing. We propose that memory may be hierarchically sensitive to fitness-relevant processing instructions. We encourage future researchers to investigate the underlying mechanisms responsible for survival processing effects and work toward developing a taxonomy of adaptive memory.	[Sandry, Joshua; Trafimow, David; Marks, Michael J.; Rice, Stephen] New Mexico State Univ, Dept Psychol, Las Cruces, NM 88003 USA	New Mexico State University	Sandry, J (corresponding author), New Mexico State Univ, Dept Psychol, Las Cruces, NM 88003 USA.	sandry@nmsu.edu		Marks, Michael/0000-0003-1383-8948	Howard Hughes Medical Institute Scientific Teaching Fellowship [52006932]; National Science Foundation GK-12 Fellowship [DGE-0947465]	Howard Hughes Medical Institute Scientific Teaching Fellowship; National Science Foundation GK-12 Fellowship(National Science Foundation (NSF))	The first author was supported in part by a Howard Hughes Medical Institute Scientific Teaching Fellowship, under Award No. 52006932 and a National Science Foundation GK-12 Fellowship, under Award No. DGE-0947465. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan A, 2012, COGNITION, V122, P118, DOI 10.1016/j.cognition.2011.10.001; Bell R., 2009, EVOL PSYCHOL-US, V7, P317, DOI DOI 10.1177/147470490900700213; Bolhuis JJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001109; Borg JS, 2008, J COGNITIVE NEUROSCI, V20, P1529, DOI 10.1162/jocn.2008.20109; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Buchner A, 2009, EVOL HUM BEHAV, V30, P212, DOI 10.1016/j.evolhumbehav.2009.01.004; Burns DJ, 2011, J EXP PSYCHOL LEARN, V37, P206, DOI 10.1037/a0021325; Buss D. M., 2004, EVOLUTIONARY PSYCHOL; BUSS DM, 1992, PSYCHOL SCI, V3, P251, DOI 10.1111/j.1467-9280.1992.tb00038.x; Buss DM, 1998, AM PSYCHOL, V53, P533, DOI 10.1037/0003-066X.53.5.533; BUSS DM, 1995, PSYCHOL INQ, V6, P1, DOI 10.1207/s15327965pli0601_1; BUSS DM, 1990, J CROSS CULT PSYCHOL, V21, P5, DOI 10.1177/0022022190211001; Butler AC, 2009, J EXP PSYCHOL LEARN, V35, P1477, DOI 10.1037/a0017024; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Cepeda NJ, 2008, PSYCHOL SCI, V19, P1095, DOI 10.1111/j.1467-9280.2008.02209.x; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Cosmides L, 2010, P NATL ACAD SCI USA, V107, P9007, DOI 10.1073/pnas.0914623107; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Cummins D., 2005, HDB EVOLUTIONARY PSY, P676; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Ellis BJ, 2000, PSYCHOL INQ, V11, P56, DOI 10.1207/S15327965PLI1101_03; Ellis BJ, 1992, ADAPTED MIND EVOLUTI, P19; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Ermer E., 2007, ENCY SOCIAL PSYCHOL, P138, DOI [10.4135/9781412956253.n82, DOI 10.4135/9781412956253.N82]; Farrell D, 2010, SOCIOL INQ, V80, P114, DOI 10.1111/j.1475-682X.2009.00318.x; Fraley RC, 2010, PERS SOC PSYCHOL B, V36, P1202, DOI 10.1177/0146167210377180; GANGESTAD SW, 1993, ETHOL SOCIOBIOL, V14, P89, DOI 10.1016/0162-3095(93)90009-7; Geary DC, 2021, MALE, FEMALE, 3 EDITION, P1, DOI 10.1037/0000181-000; GIGERENZER G, 1992, COGNITION, V43, P127, DOI 10.1016/0010-0277(92)90060-U; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harvey PH, 1987, NATURE, V320, P575; Hintzman DL, 2011, PERSPECT PSYCHOL SCI, V6, P253, DOI 10.1177/1745691611406924; Howe ML, 2013, CURR DIR PSYCHOL SCI, V22, P16, DOI 10.1177/0963721412469397; Howe ML, 2011, CURR DIR PSYCHOL SCI, V20, P312, DOI 10.1177/0963721411416571; Howe ML, 2010, COGNITION, V115, P252, DOI 10.1016/j.cognition.2009.12.016; Kang SHK, 2008, MEM COGNITION, V36, P1151, DOI 10.3758/MC.36.6.1151; Ketelaar T, 2000, PSYCHOL INQ, V11, P1, DOI 10.1207/S15327965PLI1101_01; Klein SB, ADAPTIVE ME IN PRESS; Klein SB, 2013, MEM COGNITION, V1, P1; Klein SB, 2012, J EXP PSYCHOL LEARN, V38, P1234, DOI 10.1037/a0027636; Klein SB, 2012, J EXP PSYCHOL LEARN, V38, P240, DOI 10.1037/a0025200; Klein SB, 2011, MEMORY, V19, P121, DOI 10.1080/09658211.2010.537827; Klein SB, 2010, MEM COGNITION, V38, P13, DOI 10.3758/MC.38.1.13; Kostic B, 2012, J EXP PSYCHOL LEARN, V38, P1091, DOI 10.1037/a0026974; Kroneisen M, 2011, J EXP PSYCHOL LEARN, V37, P1553, DOI 10.1037/a0024493; Lakatos I., 1978, METHODOLOGY SCI RES, DOI 10.1017/CBO9780511621123; Lakatos I., 1976, CRITICISM GROWTH KNO, P205, DOI [10.1007/978-94-010-1863-0_14, DOI 10.1017/CBO9781139171434.009, 10.1007/ 978-94-010-1863-0_14]; Lieberman D, EVOLUTION M IN PRESS; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; MCDANIEL MA, 1986, J EXP PSYCHOL LEARN, V12, P54, DOI 10.1037/0278-7393.12.1.54; Mealey L, 1996, ETHOL SOCIOBIOL, V17, P119, DOI 10.1016/0162-3095(95)00131-X; Nairne JS, 2008, J MEM LANG, V59, P377, DOI 10.1016/j.jml.2008.06.001; Nairne JS, 2008, PSYCHOL SCI, V19, P176, DOI 10.1111/j.1467-9280.2008.02064.x; Nairne JS, 2007, J EXP PSYCHOL LEARN, V33, P263, DOI 10.1037/0278-7393.33.2.263; Nairne JS, 2012, J EXP PSYCHOL LEARN, V38, P495, DOI 10.1037/a0025728; Nairne JS, 2010, AM J PSYCHOL, V123, P381, DOI 10.5406/amerjpsyc.123.4.0381; Nairne JS, 2011, J EXP PSYCHOL LEARN, V37, P539, DOI 10.1037/a0021960; Nairne JS, 2010, PSYCHOL LEARN MOTIV, V53, P1, DOI 10.1016/S0079-7421(10)53001-9; Nairne JS, 2010, COGNITIVE PSYCHOL, V61, P1, DOI 10.1016/j.cogpsych.2010.01.005; Nairne JS, 2009, PSYCHOL SCI, V20, P740, DOI 10.1111/j.1467-9280.2009.02356.x; Nairne JS, ENCY SCI LE IN PRESS; Newell A., 1990, UNIFIED THEORIES COG; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2007, PHYSIOL BEHAV, V92, P180, DOI 10.1016/j.physbeh.2007.05.057; Otgaar H, 2011, MEM COGNITION, V39, P1033, DOI 10.3758/s13421-011-0091-2; Otgaar H, 2010, J EXP PSYCHOL LEARN, V36, P1010, DOI 10.1037/a0019402; Otgaar H, 2010, MEM COGNITION, V38, P23, DOI 10.3758/MC.38.1.23; Palmore CC, 2012, PSYCHON B REV, V19, P119, DOI 10.3758/s13423-011-0186-6; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; PETRIE M, 1994, BEHAV ECOL SOCIOBIOL, V35, P213, DOI 10.1007/s002650050090; Pinker S., 1997, MIND WORKS; Popper K., 1962, CONJECTURES REFUTAT; Popper K.R., 1959, LOGIC SCI DISCOVERY; PORTER RH, 1986, CHEM SENSES, V11, P389, DOI 10.1093/chemse/11.3.389; Porter RH, 1998, GENETICA, V104, P259, DOI 10.1023/A:1026404319384; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Savine AC, 2011, MEM COGNITION, V39, P1359, DOI 10.3758/s13421-011-0121-0; Schlinger HD, 1996, SKEPTIC, V4; Scott-Phillips TC, 2011, PERSPECT PSYCHOL SCI, V6, P38, DOI 10.1177/1745691610393528; Shackelford TK, 1999, EVOL HUM BEHAV, V20, P71, DOI 10.1016/S1090-5138(98)00036-1; Shapiro L, 2009, ROUTLEDGE ENCY PHILO; Smeets T, 2012, PSYCHON B REV, V19, P113, DOI 10.3758/s13423-011-0180-z; Soderstrom NC, 2011, PSYCHON B REV, V18, P564, DOI 10.3758/s13423-011-0060-6; Sugiyama L.S., 2005, HDB EVOLUTIONARY PSY, P292; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Tooby J., 1992, ADAPTED MIND EVOLUTI; Tse CS, 2010, MEM COGNITION, V38, P1110, DOI 10.3758/MC.38.8.1110; Weinstein Y, 2008, MEM COGNITION, V36, P913, DOI 10.3758/MC.36.5.913; Weisfeld GE, 2003, J EXP CHILD PSYCHOL, V85, P279, DOI 10.1016/S0022-0965(03)00061-4; Westermarck E, 1891, HIST HUMAN MARRIAGE; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Witt JK, 2011, CURR DIR PSYCHOL SCI, V20, P201, DOI 10.1177/0963721411408770	96	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60868	10.1371/journal.pone.0060868	http://dx.doi.org/10.1371/journal.pone.0060868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JB	23585858	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600064
J	Sobhan, PK; Seervi, M; Deb, L; Varghese, S; Soman, A; Joseph, J; Mathew, KA; Raghu, G; Thomas, G; Sreekumar, E; Manjula, S; Kumar, TRS				Sobhan, Praveen K.; Seervi, Mahendra; Deb, Lokesh; Varghese, Saneesh; Soman, Anjana; Joseph, Jeena; Mathew, Krupa Ann; Raghu, Godi; Thomas, George; Sreekumar, E.; Manjula, S.; Kumar, Santosh T. R.			Calpain and Reactive Oxygen Species Targets Bax for Mitochondrial Permeabilisation and Caspase Activation in Zerumbone Induced Apoptosis	PLOS ONE			English	Article							CANCER-CELL-PROLIFERATION; CYTOCHROME-C RELEASE; ENDOPLASMIC-RETICULUM; GINGER SESQUITERPENE; TUMOR-CELLS; DEATH; EXPRESSION; STRESS; ROS; INDUCTION	Fluorescent protein based signaling probes are emerging as valuable tools to study cell signaling because of their ability to provide spatio-temporal information in non invasive live cell mode. Previously, multiple fluorescent protein probes were employed to characterize key events of apoptosis in diverse experimental systems. We have employed a live cell image based approach to visualize the key events of apoptosis signaling induced by zerumbone, the active principle from ginger Zingiber zerumbet, in cancer cells that enabled us to analyze prominent apoptotic changes in a hierarchical manner with temporal resolution. Our studies substantiate that mitochondrial permeabilisation and cytochrome c dependent caspase activation dominate in zerumbone induced cell death. Bax activation, the essential and early event of cell death, is independently activated by reactive oxygen species as well as calpains. Zerumbone failed to induce apoptosis or mitochondrial permeabilisation in Bax knockout cells and over-expression of Bax enhanced cell death induced by zerumbone confirming the essential role of Bax for mitochondrial permeabilsation. Simultaneous inhibition of reactive oxygen species and calpain is required for preventing Bax activation and cell death. However, apoptosis induced by zerumbone was prevented in Bcl 2 and Bcl-XL over-expressing cells, whereas more protection was afforded by Bcl 2 specifically targeted to endoplasmic reticulum. Even though zerumbone treatment down-regulated survival proteins such as XIAP, Survivin and Akt, it failed to affect the pro-apoptotic proteins such as PUMA and BIM. Multiple normal diploid cell lines were employed to address cytotoxic activity of zerumbone and, in general, mammary epithelial cells, endothelial progenitor cells and smooth muscle cells were relatively resistant to zerumbone induced cell death with lesser ROS accumulation than cancer cells.	[Sobhan, Praveen K.; Seervi, Mahendra; Varghese, Saneesh; Soman, Anjana; Joseph, Jeena; Mathew, Krupa Ann; Raghu, Godi; Kumar, Santosh T. R.] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram, Kerala, India; [Deb, Lokesh] Inst Bioresource & Sustainable Dev, Imphal, Manipur, India; [Thomas, George; Manjula, S.] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India; [Sreekumar, E.] Rajiv Gandhi Ctr Biotechnol, Viral Dis Biol Program, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Institute of Bioresources & Sustainable Development (IBSD); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Kumar, TRS (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram, Kerala, India.	trsanthosh@rgcb.res.in	Deb, Lokesh/N-6226-2019; Seervi, Mahendra/K-8812-2019	Seervi, Mahendra/0000-0002-0266-2062	Department of Biotechnology, Govt. of India [BT/PR11168/NDB/51/185/2008]; Indian Council of Medical Research, Govt. of India; University Grants Commission, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research, Govt. of India(Indian Council of Medical Research (ICMR)); University Grants Commission, Govt. of India(University Grants Commission, India)	This work was supported by the Department of Biotechnology, Govt. of India, through Project NO: BT/PR11168/NDB/51/185/2008. PKS is supported by Senior Research Fellowship from Indian Council of Medical Research, Govt. of India. KAM is supported by Junior Research Fellowship from Indian Council of Medical Research, Govt. of India. GR is supported by Junior Research Fellowship from University Grants Commission, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appierto V, 2009, CARCINOGENESIS, V30, P824, DOI 10.1093/carcin/bgp067; Bairey O, 1999, CLIN CANCER RES, V5, P2860; Cha Young, 2006, Cancer Res Treat, V38, P54, DOI 10.4143/crt.2006.38.1.54; Chandrika BB, 2010, BIOCHEM PHARMACOL, V79, P1589, DOI 10.1016/j.bcp.2010.01.032; Cherukuri DP, 2008, CANCER BIOL THER, V7, P697, DOI 10.4161/cbt.7.5.6088; Fletcher JI, 2008, CELL CYCLE, V7, P39, DOI 10.4161/cc.7.1.5178; Hoffman A, 2002, CARCINOGENESIS, V23, P1961, DOI 10.1093/carcin/23.11.1961; Joseph J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020114; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Murakami A, 2002, CARCINOGENESIS, V23, P795, DOI 10.1093/carcin/23.5.795; Nakamura Y, 2004, FEBS LETT, V572, P245, DOI 10.1016/j.febslet.2004.07.042; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sakinah SAS, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-4; Seervi M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.90; Shin JW, 2011, CANCER PREV RES, V4, P860, DOI 10.1158/1940-6207.CAPR-10-0354; Sobhan PK, 2012, CANCER LETT, V317, P78, DOI 10.1016/j.canlet.2011.11.009; Sung B, 2008, CANCER RES, V68, P8938, DOI 10.1158/0008-5472.CAN-08-2155; Sung B, 2009, CANCER RES, V69, P1477, DOI 10.1158/0008-5472.CAN-08-3249; Takada Y, 2005, ONCOGENE, V24, P6957, DOI 10.1038/sj.onc.1208845; Tanaka T, 2001, LIFE SCI, V69, P1935, DOI 10.1016/S0024-3205(01)01277-2; Tzifi Flora, 2012, Adv Hematol, V2012, P524308, DOI 10.1155/2012/524308; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Xian MJ, 2007, CANCER SCI, V98, P118, DOI 10.1111/j.1349-7006.2006.00362.x; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang SY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/936030	31	49	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e59350	10.1371/journal.pone.0059350	http://dx.doi.org/10.1371/journal.pone.0059350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593137	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600006
J	von Bonin, M; Wermke, M; Cosgun, KN; Thiede, C; Bornhauser, M; Wagemaker, G; Waskow, C				von Bonin, Malte; Wermke, Martin; Cosgun, Kadriye Nehir; Thiede, Christian; Bornhauser, Martin; Wagemaker, Gerard; Waskow, Claudia			In Vivo Expansion of Co-Transplanted T Cells Impacts on Tumor Re-Initiating Activity of Human Acute Myeloid Leukemia in NSG Mice	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; VERSUS-HOST-DISEASE; AML STEM-CELLS; BONE-MARROW; NPM1 MUTATIONS; NOD/SCID MICE; MOUSE MODEL; ENGRAFTMENT; BLOOD; CHAIN	Human cells from acute myeloid leukemia (AML) patients are frequently transplanted into immune-compromised mouse strains to provide an in vivo environment for studies on the biology of the disease. Since frequencies of leukemia re-initiating cells are low and a unique cell surface phenotype that includes all tumor re-initiating activity remains unknown, the underlying mechanisms leading to limitations in the xenotransplantation assay need to be understood and overcome to obtain robust engraftment of AML-containing samples. We report here that in the NSG xenotransplantation assay, the large majority of mononucleated cells from patients with AML fail to establish a reproducible myeloid engraftment despite high donor chimerism. Instead, donor-derived cells mainly consist of polyclonal disease-unrelated expanded co-transplanted human T lymphocytes that induce xenogeneic graft versus host disease and mask the engraftment of human AML in mice. Engraftment of mainly myeloid cell types can be enforced by the prevention of T cell expansion through the depletion of lymphocytes from the graft prior transplantation.	[von Bonin, Malte; Cosgun, Kadriye Nehir; Waskow, Claudia] Tech Univ Dresden, CRTD, DFG Res Ctr, D-01062 Dresden, Germany; [von Bonin, Malte; Wermke, Martin; Thiede, Christian; Bornhauser, Martin] Tech Univ Dresden, Med Klin & Poliklin 1, Univ Klinikum Carl Gustav Carus, D-01062 Dresden, Germany; [Wagemaker, Gerard] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Erasmus University Rotterdam; Erasmus MC	Waskow, C (corresponding author), Tech Univ Dresden, CRTD, DFG Res Ctr, D-01062 Dresden, Germany.	claudia.waskow@crt-dresden.de	Waskow, Claudia/F-8146-2010; Thiede, Christian/AAS-7595-2020	Waskow, Claudia/0000-0003-3261-0922; Thiede, Christian/0000-0003-1241-2048; von Bonin, Malte/0000-0002-2995-3230; Cosgun, Kadriye/0000-0003-4181-744X; Wermke, Martin/0000-0002-4844-4087	CRTD -DFG Research Center for Regenerative Therapies Dresden, Technische Universitat Dresden, Fetscherstrasse, Dresden [105, 01307]; Deutsche Forschungsgemeinschaft (DFG) Research Center and Cluster of Excellence for Regenerative Therapies Dresden (CRTD); European Union FP7 CELL-PID;  [SFB 655]	CRTD -DFG Research Center for Regenerative Therapies Dresden, Technische Universitat Dresden, Fetscherstrasse, Dresden; Deutsche Forschungsgemeinschaft (DFG) Research Center and Cluster of Excellence for Regenerative Therapies Dresden (CRTD); European Union FP7 CELL-PID; 	CW is supported by the CRTD -DFG Research Center for Regenerative Therapies Dresden, Technische Universitat Dresden, Fetscherstrasse 105, 01307 Dresden. This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG) Research Center and Cluster of Excellence for Regenerative Therapies Dresden (CRTD) and SFB 655 (# B9, Waskow, Gerok rotation position, # B2, Bornhauser). The project was further supported by an intramural CRTD-seed grant and a grant from the European Union FP7 CELL-PID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Ailles LE, 1999, BLOOD, V94, P1761, DOI 10.1182/blood.V94.5.1761.417k23_1761_1772; Ali N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044219; Bagnara D, 2011, BLOOD, V117, P5463, DOI 10.1182/blood-2010-12-324210; Blair A, 1997, BLOOD, V89, P3104, DOI 10.1182/blood.V89.9.3104; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Bruggemann M, 2007, LEUKEMIA, V21, P215, DOI 10.1038/sj.leu.2404481; Bueno C, 2010, CYTOTHERAPY, V12, P45, DOI 10.3109/14653240903377052; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Du JW, 2007, LEUKEMIA LYMPHOMA, V48, P1618, DOI 10.1080/10428190701474357; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gorin NC, 2002, J HEMATOTH STEM CELL, V11, P277, DOI 10.1089/152581602753658466; Greenblatt MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044664; Gregoire-Gauthier J, 2012, BONE MARROW TRANSPL, V47, P439, DOI 10.1038/bmt.2011.93; HAASE D, 1995, BLOOD, V86, P2906; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kikushige Y, 2012, ANN NY ACAD SCI, V1266, P118, DOI 10.1111/j.1749-6632.2012.06550.x; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Malaise M, 2011, LEUKEMIA, V25, P1635, DOI 10.1038/leu.2011.121; Martelli MP, 2008, LEUKEMIA, V22, P195, DOI 10.1038/sj.leu.2404857; Martelli MP, 2010, BLOOD, V116, P3907, DOI 10.1182/blood-2009-08-238899; Martin MG, 2010, LEUKEMIA, V24, P1662, DOI 10.1038/leu.2010.156; Morante MP, 2006, CLIN EXP IMMUNOL, V145, P36, DOI 10.1111/j.1365-2249.2006.03104.x; Pasqualucci L, 2006, BLOOD, V108, P4146, DOI 10.1182/blood-2006-06-026716; Patel S, 2012, LEUKEMIA, V26, P2432, DOI 10.1038/leu.2012.154; Ramirez M, 1998, EXP HEMATOL, V26, P332; Risueno RM, 2011, BLOOD, V117, P7112, DOI 10.1182/blood-2011-01-329078; Rombouts WJC, 2000, LEUKEMIA, V14, P889, DOI 10.1038/sj.leu.2401777; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; SHULTZ LD, 1995, J IMMUNOL, V154, P180; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Thiede C, 2006, LEUKEMIA, V20, P1897, DOI 10.1038/sj.leu.2404367; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241; Verlinden S F, 1998, Stem Cells, V16 Suppl 1, P205; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Yoshida S, 2005, BLOOD, V106, p367A	57	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60680	10.1371/journal.pone.0060680	http://dx.doi.org/10.1371/journal.pone.0060680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585844	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600036
J	Zhao, LP; Gerdin, M; Westman, L; Rodriguez-Llanes, JM; Wu, Q; van den Oever, B; Pan, L; Albela, M; Chen, G; Zhang, DS; Guha-Sapir, D; von Schreeb, J				Zhao, Lu-Ping; Gerdin, Martin; Westman, Lina; Rodriguez-Llanes, Jose Manuel; Wu, Qi; van den Oever, Barbara; Pan, Liang; Albela, Manuel; Chen, Gao; Zhang, De-Sheng; Guha-Sapir, Debarati; von Schreeb, Johan			Hospital Stay as a Proxy Indicator for Severe Injury in Earthquakes: A Retrospective Analysis	PLOS ONE			English	Article							SCORE TRISS; TRAUMA; LENGTH; DISASTERS; ICISS	Introduction: Earthquakes are the most violent type of natural disasters and injuries are the dominant medical problem in the early phases after earthquakes. However, likely because of poor data availability, high-quality research on injuries after earthquakes is lacking. Length of hospital stay (LOS) has been validated as a proxy indicator for injury severity in high-income settings and could potentially be used in retrospective research of injuries after earthquakes. In this study, we assessed LOS as an adequate proxy indicator for severe injury in trauma survivors of an earthquake. Methods: A retrospective analysis was conducted using a database of 1,878 injured patients from the 2008 Wenchuan earthquake. Our primary outcome was severe injury, defined as a composite measure of serious injury or resource use. Secondary outcomes were serious injury and resource use, analysed separately. Non-parametric receiver operating characteristics (ROC) and area under the curve (AUC) analysis was used to test the discriminatory accuracy of LOS when used to identify severe injury. An 0.7<AUC<0.8 was defined as adequate. Results: Our study shows that LOS discriminatory accuracy is poor for the primary outcome. However, LOS discriminatory accuracy is adequate for resource use, excluding critical orthopaedic interventions and debridement. Conclusions: Length of hospital stay was not validated as a proxy indicator for severe injury in earthquake survivors. However, LOS was found to be a proxy for major nonorthopaedic surgery and blood transfusion. These findings can be useful for retrospective research on earthquake-injured patients when detailed hospital records are not available.	[Zhao, Lu-Ping; Wu, Qi; Pan, Liang; Chen, Gao; Zhang, De-Sheng] Peoples Hosp Deyang City, Deyang, Sichuan Provinc, Peoples R China; [Gerdin, Martin; Westman, Lina; von Schreeb, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Westman, Lina] Hoglandssjukhuset, Eksjo, Sweden; [Rodriguez-Llanes, Jose Manuel; van den Oever, Barbara; Albela, Manuel; Guha-Sapir, Debarati] Catholic Univ Louvain, Inst Hlth & Soc, Ctr Res Epidemiol Disasters, B-1200 Brussels, Belgium	Karolinska Institutet; Universite Catholique Louvain	Gerdin, M (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	martin.gerdin@ki.se	pan, liang/GLN-7473-2022; Rodriguez-Llanes, Jose Manuel/L-4537-2019; Wärnberg, Martin Gerdin/D-7482-2019	pan, liang/0000-0001-6610-2796; Rodriguez-Llanes, Jose Manuel/0000-0003-3736-736X; Wärnberg, Martin Gerdin/0000-0001-6069-4794	FP6 6th Framework Programme under The MICRODIS Project-Integrated Health, Social and Economic Impacts of Extreme Events: Evidence, Methods and Tools [GOCE-CT-2007-036877]; Swedish National Board of Health and Welfare through their support to the Centre for Research on Health Care in Disasters at Karolinska Institutet	FP6 6th Framework Programme under The MICRODIS Project-Integrated Health, Social and Economic Impacts of Extreme Events: Evidence, Methods and Tools; Swedish National Board of Health and Welfare through their support to the Centre for Research on Health Care in Disasters at Karolinska Institutet	This research was funded by the FP6 6th Framework Programme under The MICRODIS Project-Integrated Health, Social and Economic Impacts of Extreme Events: Evidence, Methods and Tools (Contract No. GOCE-CT-2007-036877) and by research grants from the Swedish National Board of Health and Welfare through their support to the Centre for Research on Health Care in Disasters at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolghasemi H, 2006, PREHOSP DISASTER MED, V21, P141, DOI 10.1017/S1049023X00003599; Alexander D, 1996, DISASTERS, V20, P231, DOI 10.1111/j.1467-7717.1996.tb01036.x; Bartels SA, 2012, LANCET, V379, P748, DOI 10.1016/S0140-6736(11)60887-8; BAXT WG, 1990, ANN EMERG MED, V19, P1401, DOI 10.1016/S0196-0644(05)82608-3; Birnbaum ML, 2011, PREHOSP DISASTER MED, V26, P77, DOI 10.1017/S1049023X11000173; Centre for Research on the Epidemiology of Disasters, 2012, EM DAT INT DIS DAT; Clarke Mike, 2008, J Evid Based Med, V1, P9, DOI 10.1111/j.1756-5391.2008.00007.x; Colak E, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/698320; Cryer C, 2010, INJURY PREV, V16, P254, DOI 10.1136/ip.2009.023903; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; de Goyet CDV, 2007, PREHOSP DISASTER MED, V22, P15, DOI 10.1017/S1049023X00004283; Diggs BS, 2008, J AM COLL SURGEONS, V206, P212, DOI 10.1016/j.jamcollsurg.2007.08.019; Fern KT, 1998, J TRAUMA, V45, P489, DOI 10.1097/00005373-199809000-00010; Jobe K, 2011, TRAVEL MED INFECT DI, V9, P1, DOI 10.1016/j.tmaid.2010.10.006; LETT RR, 1995, J TRAUMA, V38, P142, DOI 10.1097/00005373-199501000-00032; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Newgard CD, 2008, PREHOSP EMERG CARE, V12, P451, DOI 10.1080/10903120802290737; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Redmond AD, 2011, LANCET, V377, P1054, DOI 10.1016/S0140-6736(11)60319-X; Roy N, 2005, INJURY, V36, P927, DOI 10.1016/j.injury.2005.02.017; Rutledge R, 1998, J TRAUMA, V44, P41, DOI 10.1097/00005373-199801000-00003; Schluter PJ, 2009, NEW ZEAL MED J, V122, P65; Sharp D, 2004, LANCET, V364, P1741, DOI 10.1016/S0140-6736(04)17417-5; Stephenson S, 2003, DIAGNOSIS BASED INJU; von Schreeb J, 2008, PREHOSPITAL DISASTER, V23, P144, DOI 10.1017/S1049023X00005768; WEINGARTEN MS, 1988, ANN EMERG MED, V17, P10, DOI 10.1016/S0196-0644(88)80494-3; World Health Organization, 2008, COMM DIS RISK ASS IN; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	29	4	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61371	10.1371/journal.pone.0061371	http://dx.doi.org/10.1371/journal.pone.0061371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585897	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600111
J	Long, JR; Zhang, B; Signorello, LB; Cai, QY; Deming-Halverson, S; Shrubsole, MJ; Sanderson, M; Dennis, J; Michailiou, K; Easton, DF; Shu, XO; Blot, WJ; Zheng, W				Long, Jirong; Zhang, Ben; Signorello, Lisa B.; Cai, Qiuyin; Deming-Halverson, Sandra; Shrubsole, Martha J.; Sanderson, Maureen; Dennis, Joe; Michailiou, Kyriaki; Easton, Douglas F.; Shu, Xiao-Ou; Blot, William J.; Zheng, Wei			Evaluating Genome-Wide Association Study-Identified Breast Cancer Risk Variants in African-American Women	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; COMMON VARIANTS; CONFER SUSCEPTIBILITY; GENETIC-VARIANTS; CHROMOSOME 5P12; FGFR2; HEALTH; ADMIXTURE; ALLELES	Genome-wide association studies (GWAS), conducted mostly in European or Asian descendants, have identified approximately 67 genetic susceptibility loci for breast cancer. Given the large differences in genetic architecture between the African-ancestry genome and genomes of Asians and Europeans, it is important to investigate these loci in African-ancestry populations. We evaluated index SNPs in all 67 breast cancer susceptibility loci identified to date in our study including up to 3,300 African-American women (1,231 cases and 2,069 controls), recruited in the Southern Community Cohort Study (SCCS) and the Nashville Breast Health Study (NBHS). Seven SNPs were statistically significant (P <= 0.05) with the risk of overall breast cancer in the same direction as previously reported: rs10069690 (5p15/TERT), rs999737 (14q24/RAD51L1), rs13387042 (2q35/TNP1), rs1219648 (10q26/FGFR2), rs8170 (19p13/BABAM1), rs17817449 (16q12/FTO), and rs13329835 (16q23/DYL2). A marginally significant association (P<0.10) was found for three additional SNPs: rs1045485 (2q33/CASP8), rs4849887 (2q14/INHBB), and rs4808801 (19p13/ELL). Three additional SNPs, including rs1011970 (9p21/CDKN2A/2B), rs941764 (14q32/CCDC88C), and rs17529111 (6q14/FAM46A), showed a significant association in analyses conducted by breast cancer subtype. The risk of breast cancer was elevated with an increasing number of risk variants, as measured by quintile of the genetic risk score, from 1.00 (reference), to 1.75 (1.30-2.37), 1.56 (1.15-2.11), 2.02 (1.50-2.74) and 2.63 (1.96-3.52), respectively, (P = 7.8 x 10(-10)). Results from this study highlight the need for large genetic studies in AAs to identify risk variants impacting this population.	[Long, Jirong; Zhang, Ben; Signorello, Lisa B.; Cai, Qiuyin; Deming-Halverson, Sandra; Shrubsole, Martha J.; Shu, Xiao-Ou; Blot, William J.; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr,Dept Med,Div Epidemiol, Nashville, TN 37212 USA; [Signorello, Lisa B.; Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Sanderson, Maureen] Meharry Med Coll, Nashville, TN 37208 USA; [Dennis, Joe; Michailiou, Kyriaki; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England	Vanderbilt University; Meharry Medical College; University of Cambridge; University of Cambridge	Long, JR (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr,Dept Med,Div Epidemiol, Nashville, TN 37212 USA.	Jirong.Long@Vanderbilt.Edu	Zhang, Ben/GQP-3420-2022; zhang, weihua/GXV-1334-2022; Shrubsole, Martha J/K-5052-2015; Zheng, Wei/O-3351-2013; Michailidou, Kyriaki/ABD-5122-2020	Shrubsole, Martha J/0000-0002-5591-7575; Zheng, Wei/0000-0003-1226-070X; Michailidou, Kyriaki/0000-0001-7065-1237; Dennis, Joe/0000-0003-4591-1214; Long, Jirong/0000-0002-7433-9766	Vanderbilt-Ingram Cancer Center [P30 CA68485]; U.S. National Institutes of Health [R01CA92447]; US NIH [R01CA100374, U19 CA148065]; Ingram Professorship funds; Cancer Research UK [11022, 10118] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA092447, U19CA148065, R37CA070867, U54CA163069, R01CA100374, P30CA068485] Funding Source: NIH RePORTER	Vanderbilt-Ingram Cancer Center; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ingram Professorship funds; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Sample preparation was conducted at the Survey and Biospecimen Shared Resources, which is supported in part by Vanderbilt-Ingram Cancer Center (P30 CA68485). The SCCS dataset used for the present analyses was supported by U.S. National Institutes of Health grant R01CA92447. This project was also supported by US NIH grants R01CA100374 and U19 CA148065, as well as Ingram Professorship funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2010, NAT GENET; Barnholtz-Sloan JS, 2010, CARCINOGENESIS, V31, P1417, DOI 10.1093/carcin/bgq128; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fejerman L, 2009, CANCER EPIDEM BIOMAR, V18, P3110, DOI 10.1158/1055-9965.EPI-09-0464; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Long J, 2012, PLOS GENET IN PRESS; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Michcailidou K, 2012, NAT GENET IN PRESS; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rebbeck TR, 2009, CARCINOGENESIS, V30, P269, DOI 10.1093/carcin/bgn247; Reding KW, 2012, BREAST CANCER RES TR, V134, P801, DOI 10.1007/s10549-012-2099-0; Ruiz-Narvaez EA, 2010, BREAST CANCER RES TR, V123, P525, DOI 10.1007/s10549-010-0775-5; Ruiz-Narvaez EA, 2010, CANCER EPIDEM BIOMAR, V19, P1320, DOI 10.1158/1055-9965.EPI-09-1250; Signorello LB, 2005, J NATL MED ASSOC, V97, P972; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6; Zheng W, 2009, CANCER EPIDEM BIOMAR, V18, P2761, DOI 10.1158/1055-9965.EPI-09-0624; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	39	59	62	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e58350	10.1371/journal.pone.0058350	http://dx.doi.org/10.1371/journal.pone.0058350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593120	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000003
J	Katsumata, T; Oishi, H; Sekiguchi, Y; Nagasaki, H; Daassi, D; Tai, PH; Ema, M; Kudo, T; Takahashi, S				Katsumata, Tokio; Oishi, Hisashi; Sekiguchi, Yukari; Nagasaki, Haruka; Daassi, Dhouha; Tai, Pei-Han; Ema, Masatsugu; Kudo, Takashi; Takahashi, Satoru			Bioluminescence Imaging of beta Cells and Intrahepatic Insulin Gene Activity under Normal and Pathological Conditions	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; IN-VIVO; STEM-CELLS; MASS; MICE; PROLIFERATION; HEPATOCYTES; TRANSDIFFERENTIATION; DIFFERENTIATION; EXPRESSION	In diabetes research, bioluminescence imaging (BLI) has been applied in studies of beta-cell impairment, development, and islet transplantation. To develop a mouse model that enables noninvasive imaging of beta cells, we generated a bacterial artificial chromosome (BAC) transgenic mouse in which a mouse 200-kbp genomic fragment comprising the insulin I gene drives luciferase expression (Ins1-luc BAC transgenic mouse). BLI of mice was performed using the IVIS Spectrum system after intraperitoneal injection of luciferin, and the bioluminescence signal from the pancreatic region analyzed. When compared with MIP-Luc-VU mice [FVB/N-Tg(Ins1-luc)VUPwrs/J] expressing luciferase under the control of the 9.2-kbp mouse insulin I promoter (MIP), the bioluminescence emission from Ins1-luc BAC transgenic mice was enhanced approximately 4-fold. Streptozotocin-treated Ins1-luc BAC transgenic mice developed severe diabetes concomitant with a sharp decline in the BLI signal intensity in the pancreas. Conversely, mice fed a high-fat diet for 8 weeks showed an increase in the signal, reflecting a decrease or increase in the beta-cell mass. Although the bioluminescence intensity of the islets correlated well with the number of isolated islets in vitro, the intensity obtained from a living mouse in vivo did not necessarily reflect an absolute quantification of the beta-cell mass under pathological conditions. On the other hand, adenovirus-mediated gene transduction of beta-cell-related transcription factors in Ins1-luc BAC transgenic mice generated luminescence from the hepatic region for more than 1 week. These results demonstrate that BLI in Ins1-luc BAC transgenic mice provides a noninvasive method of imaging islet beta cells and extrapancreatic activity of the insulin gene in the liver under normal and pathological conditions.	[Katsumata, Tokio; Oishi, Hisashi; Sekiguchi, Yukari; Nagasaki, Haruka; Daassi, Dhouha; Tai, Pei-Han; Ema, Masatsugu; Kudo, Takashi; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan	University of Tsukuba	Takahashi, S (corresponding author), Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan.	satoruta@md.tsukuba.ac.jp	Daassi, Dhouha/AAM-7419-2020	Daassi, Dhouha/0000-0001-9877-2452; Kudo, Takashi/0000-0001-5477-7235; Ema, Masatsugu/0000-0003-0645-6183	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21220009]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (21220009) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bonner-Weir S, 2008, BIOCHEM SOC T, V36, P353, DOI 10.1042/BST0360353; Borot S, 2011, CURR DIABETES REP, V11, P375, DOI 10.1007/s11892-011-0215-x; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Cnop M, 2011, DIABETES OBES METAB, V13, P39, DOI 10.1111/j.1463-1326.2011.01443.x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fowler M, 2005, TRANSPLANTATION, V79, P768, DOI 10.1097/01.TP.0000152798.03204.5C; Gangalum RK, 2011, BIOTECHNIQUES, V51, P335, DOI 10.2144/000113763; Guney MA, 2011, P NATL ACAD SCI USA, V108, P15242, DOI 10.1073/pnas.1100072108; HALBAN PA, 1991, DIABETOLOGIA, V34, P767, DOI 10.1007/BF00408349; Kajihara M, 2003, BIOCHEM BIOPH RES CO, V312, P831, DOI 10.1016/j.bbrc.2003.10.196; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Park SY, 2009, HORM METAB RES, V41, P1, DOI 10.1055/s-0028-1087209; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Reiner T, 2011, P NATL ACAD SCI USA, V108, P12815, DOI 10.1073/pnas.1109859108; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Saudek Frantisek, 2008, Rev Diabet Stud, V5, P6, DOI 10.1900/RDS.2008.5.6; Sekiguchi Y, 2012, EXP ANIM TOKYO, V61, P445, DOI 10.1538/expanim.61.445; Sever D, 2011, FASEB J, V25, P676, DOI 10.1096/fj.10-158121; Smith SJ, 2006, MOL IMAGING, V5, P65, DOI 10.2310/7290.2006.00007; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Weir GC, 2011, GENOME MED, V3, DOI 10.1186/gm277; WENTWORTH BM, 1992, MOL CELL ENDOCRINOL, V86, P177, DOI 10.1016/0303-7207(92)90142-S; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Yatoh S, 2007, DIABETES-METAB RES, V23, P239, DOI 10.1002/dmrr.678; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	42	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60411	10.1371/journal.pone.0060411	http://dx.doi.org/10.1371/journal.pone.0060411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593212	gold, Green Submitted, Green Published			2022-12-27	WOS:000319108100039
J	Lobier, M; Dubois, M; Valdois, S				Lobier, Muriel; Dubois, Matthieu; Valdois, Sylviane			The Role of Visual Processing Speed in Reading Speed Development	PLOS ONE			English	Article							ATTENTION SPAN DEFICIT; SHORT-TERM-MEMORY; CHILDREN LEARN; VENTRAL STREAM; LETTER STRINGS; EYE-MOVEMENTS; WORD; MEDIATION; DYSLEXIA; CAPACITY	A steady increase in reading speed is the hallmark of normal reading acquisition. However, little is known of the influence of visual attention capacity on children's reading speed. The number of distinct visual elements that can be simultaneously processed at a glance (dubbed the visual attention span), predicts single-word reading speed in both normal reading and dyslexic children. However, the exact processes that account for the relationship between the visual attention span and reading speed remain to be specified. We used the Theory of Visual Attention to estimate visual processing speed and visual short-term memory capacity from a multiple letter report task in eight and nine year old children. The visual attention span and text reading speed were also assessed. Results showed that visual processing speed and visual short term memory capacity predicted the visual attention span. Furthermore, visual processing speed predicted reading speed, but visual short term memory capacity did not. Finally, the visual attention span mediated the effect of visual processing speed on reading speed. These results suggest that visual attention capacity could constrain reading speed in elementary school children.	[Lobier, Muriel; Valdois, Sylviane] Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France; [Dubois, Matthieu] Univ Libre Bruxelles, Lab Langage Cognit & Dev, Brussels, Belgium; [Dubois, Matthieu] Natl Fund Sci Res, FRS FNRS, Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS	Lobier, M (corresponding author), Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France.	muriel.lobier@gmail.com	Lobier, Muriel/F-4479-2010	Lobier, Muriel/0000-0003-1174-1288	Agence Nationale pour la Recherche [(VASRA N ANR_07-BLAN-0019]; Fonds National de la Recherche Scientifique, Belgium	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS)	ML was supported by a grant from the Agence Nationale pour la Recherche (VASRA N ANR_07-BLAN-0019). MD is funded by the Fonds National de la Recherche Scientifique, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JS, 2010, PSYCHOL SCI, V21, P1799, DOI 10.1177/0956797610387442; Aghababian V, 2000, J EXP CHILD PSYCHOL, V76, P123, DOI 10.1006/jecp.1999.2540; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Ans B, 1998, PSYCHOL REV, V105, P678, DOI 10.1037/0033-295X.105.4.678-723; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bosse ML, 2009, J RES READ, V32, P230, DOI 10.1111/j.1467-9817.2008.01387.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brem S, 2006, NEUROIMAGE, V29, P822, DOI 10.1016/j.neuroimage.2005.09.023; Brem S, 2010, P NATL ACAD SCI USA, V107, P7939, DOI 10.1073/pnas.0904402107; Breznitz Z, 2003, EDUC PSYCHOL REV, V15, P247, DOI 10.1023/A:1024696101081; BUNDESEN C, 1987, PSYCHOL RES-PSYCH FO, V49, P113, DOI 10.1007/BF00308676; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Carver R. P., 1990, READING RATE REV RES; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2008, NEUROIMAGE, V40, P353, DOI 10.1016/j.neuroimage.2007.11.036; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; Cornelissen PL, 1998, VISION RES, V38, P471, DOI 10.1016/S0042-6989(97)00199-5; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Croker S, 2011, CHILD DEV RES, P1, DOI [10.1155/2011/450178, DOI 10.1155/2011/450178]; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Dubois M, 2010, CORTEX, V46, P717, DOI 10.1016/j.cortex.2009.11.002; Ehri LC, 2005, SCI STUD READ, V9, P167, DOI 10.1207/s1532799xssr0902_4; Ehri LC, 2001, REV EDUC RES, V71, P393, DOI 10.3102/00346543071003393; Englund JA, 2012, VISION RES, V67, P14, DOI 10.1016/j.visres.2012.06.020; Finke K, 2005, J INT NEUROPSYCH SOC, V11, P832, DOI 10.1017/S1355617705050976; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Habekost T, 2009, SCAND J PSYCHOL, V50, P23, DOI 10.1111/j.1467-9450.2008.00681.x; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; ISHIDA T, 1989, J OPT SOC AM A, V6, P1624, DOI 10.1364/JOSAA.6.001624; Kelley K, 2010, METHODS BEHAV ED SOC; Kevan A, 2009, NEUROPSYCHOLOGIA, V47, P3174, DOI 10.1016/j.neuropsychologia.2009.07.016; Kleiner M, 2007, PERCEPTION, V36, P14; Kwon M, 2007, VISION RES, V47, P2889, DOI 10.1016/j.visres.2007.08.002; Kyllingsbaek S, 2006, BEHAV RES METHODS, V38, P123, DOI 10.3758/BF03192757; Lassus-Sangosse D, 2008, VISION RES, V48, P979, DOI 10.1016/j.visres.2008.01.025; LEFAVRAIS P, 1965, TEST ALOUETTE; Lobier M, 2012, NEUROPSYCHOLOGIA, V50, P2195, DOI 10.1016/j.neuropsychologia.2012.05.023; Lobier M, 2012, CORTEX, V48, P768, DOI 10.1016/j.cortex.2011.09.003; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Mackinnon David P, 2004, Multivariate Behav Res, V39, P99; MacKinnon DP, 2009, CURR DIR PSYCHOL SCI, V18, P16, DOI 10.1111/j.1467-8721.2009.01598.x; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Maurer U, 2006, NEUROIMAGE, V33, P749, DOI 10.1016/j.neuroimage.2006.06.025; Maurer U, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-13; Maurer U, 2011, NEUROIMAGE, V57, P714, DOI 10.1016/j.neuroimage.2010.10.055; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; RAYNER K, 1981, B PSYCHONOMIC SOC, V17, P135; SHIBUYA H, 1988, J EXP PSYCHOL HUMAN, V14, P591, DOI 10.1037/0096-1523.14.4.591; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Stenneken P, 2011, NEUROPSYCHOLOGIA, V49, P3454, DOI 10.1016/j.neuropsychologia.2011.08.021; Szwed M, 2012, DEVELOPMENTAL SCI, V15, P139, DOI 10.1111/j.1467-7687.2011.01102.x; Tydgat I, 2009, J EXP PSYCHOL HUMAN, V35, P480, DOI 10.1037/a0013027; Valdois S, 2004, DYSLEXIA, V10, P339, DOI 10.1002/dys.284; Valdois S., 2003, READ WRIT, V16, P541, DOI DOI 10.1023/A:1025501406971; Valdois S, 2012, DYSLEXIA, V18, P77, DOI 10.1002/dys.1437; Valdois S, 2011, CORTEX, V47, P1197, DOI 10.1016/j.cortex.2011.05.011; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Vinckier F, 2011, J VISION, V11, DOI 10.1167/11.6.8; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Weekes BS, 1997, Q J EXP PSYCHOL-A, V50, P439, DOI 10.1080/027249897392170	70	57	59	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e58097	10.1371/journal.pone.0058097	http://dx.doi.org/10.1371/journal.pone.0058097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RK	23593117	gold, Green Submitted, Green Published			2022-12-27	WOS:000319108100002
J	Lu, XB; Liu, YH; Yu, T; Xiao, S; Bao, XY; Pan, L; Zhu, GL; Cai, Y; Liu, QF; Jin, CH; Yang, JH; Wu, SW; An, L; van der Straaten, T				Lu, Xiaobo; Liu, Yanhua; Yu, Tao; Xiao, Sha; Bao, Xiaoyan; Pan, Liang; Zhu, Guolian; Cai, Yuan; Liu, Qiufang; Jin, Cuihong; Yang, Jinghua; Wu, Shengwen; An, Li; van der Straaten, Tahar			ERCC1 and ERCC2 Haplotype Modulates Induced BPDE-DNA Adducts in Primary Cultured Lymphocytes	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SQUAMOUS-CELL CARCINOMA; BENZO(A)PYRENE DIOL EPOXIDE; LUNG-CANCER PATIENTS; EXCISION-REPAIR GENES; CHROMOSOME 19Q13.2-3; CHINESE POPULATION; XPD POLYMORPHISMS; BREAST-CANCER; XPD/ERCC2 POLYMORPHISMS	Background: Benzo[a] pyrene(B[a] P), and its ultimate metabolite Benzo[a] pyrene 7,8-diol 9,10-epoxide (BPDE), are classic DNA damaging carcinogens. DNA damage caused by BPDE is normally repaired by Nucleotide Excision Repair (NER), of which ERCC1 and ERCC2/XPD exert an indispensable role. Genetic variations in ERCC1 and ERCC2 have been related to DNA repair efficiency. In this study we used lymphocytes from healthy individuals to show that polymorphisms in ERCC1 and ERCC2 are directly associated with decreased DNA repair efficiency. Methods: ERCC1 (rs3212986 and rs11615) and ERCC2 (rs13181, rs1799793 and rs238406) were genotyped in 818 healthy Han individuals from the northeast of China. BPDE induced DNA adducts in lymphocytes were assessed by high performance liquid chromatography (HPLC) in 282 randomly selected participants. The effect of ERCC1 rs3212986 and ERCC2 rs238406 on DNA damage caused by B[a] P was assessed with a modified comet assay. Results: We found that the variant genotypes of ERCC1 rs3212986 and ERCC2 rs238406 were associated with the high levels of BPDE-DNA adducts. Especially ERCC1 rs3212986 A-allele variant was significantly associated with the high BPDE-DNA adducts. Haplotype analysis showed that the ERCC1 haplotype AC (OR = 2.36, 95% CI = 1.84-2.97), ERCC2 haplotype AGA (OR = 1.51, 95% CI = 1.06-2.15) and haplotype block AGAAC (OR = 5.28, 95% CI = 2.95-9.43), AGCAC (OR = 1.35 95% CI = 1.13-1.60) were linked with high BPDE-DNA adducts. In addition, we found that the combined minor alleles of ERCC1 rs3212986 and ERCC2 rs238406 were associated with a reduced DNA repair capacity. Conclusions: Our results suggest that the variant genotypes of ERCC1 rs3212986 and ERCC2 rs238406 are associated with decreased repair efficiency of BPDE induced DNA damage, and may be predictive for an individual's DNA repair capacity in response to environmental carcinogens.	[Lu, Xiaobo; Liu, Yanhua; Yu, Tao; Xiao, Sha; Bao, Xiaoyan; Pan, Liang; Zhu, Guolian; Cai, Yuan; Liu, Qiufang; Jin, Cuihong; Yang, Jinghua; Wu, Shengwen; An, Li] China Med Univ, Sch Publ Hlth, Dept Toxicol, Shenyang, Peoples R China; [Lu, Xiaobo; Liu, Yanhua; Yu, Tao] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang, Peoples R China; [van der Straaten, Tahar] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, Leiden, Netherlands	China Medical University; China Medical University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lu, XB (corresponding author), China Med Univ, Sch Publ Hlth, Dept Toxicol, Shenyang, Peoples R China.	xiaobolu69@163.com	liu, yan/HCI-5542-2022		National Natural Science Foundation of China [30972506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 30972506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhamou S, 2002, MUTAGENESIS, V17, P463, DOI 10.1093/mutage/17.6.463; Benhamou S, 2005, AM J EPIDEMIOL, V161, P1, DOI 10.1093/aje/kwi018; Cao C, 2011, CHINESE MED J-PEKING, V124, P2203, DOI 10.3760/cma.j.issn.0366-6999.2011.14.022; Chang JS, 2008, INT J CANCER, V123, P2095, DOI 10.1002/ijc.23801; Chang PMH, 2009, CANCER SCI, V100, P278, DOI 10.1111/j.1349-7006.2008.01031.x; Chen PC, 2000, CANCER EPIDEM BIOMAR, V9, P843; Cheng J, 2012, J CANCER RES CLIN, V138, P231, DOI 10.1007/s00432-011-1090-1; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; Guza R, 2011, NUCLEIC ACIDS RES, V39, P3988, DOI 10.1093/nar/gkq1341; Hansen RD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-54; HAUGEN A, 1986, CANCER RES, V46, P4178; Hou SM, 2002, CARCINOGENESIS, V23, P599, DOI 10.1093/carcin/23.4.599; Hu Z, 2004, LUNG CANCER, V46, P1, DOI 10.1016/j.lungcan.2004.03.016; JERNSTROM B, 1994, BIOPHYS CHEM, V49, P185, DOI 10.1016/0301-4622(93)E0087-L; Kang S, 2006, EXP MOL MED, V38, P320, DOI 10.1038/emm.2006.38; Kiyohara Chikako, 2007, Int J Med Sci, V4, P59; Kriyak TC, 2011, GYNECOL ONCOL, V122, P121, DOI 10.1016/j.ygyno.2011.03.027; Li CY, 2009, INT J CANCER, V124, P999, DOI 10.1002/ijc.24126; Li DH, 2001, CANCER RES, V61, P1445; Li DH, 2007, CANCER RES, V67, P5628, DOI 10.1158/0008-5472.CAN-07-0983; Li YC, 2007, EUR J HUM GENET, V15, P967, DOI 10.1038/sj.ejhg.5201855; Lovatt T, 2005, HUM MUTAT, V25, P353, DOI 10.1002/humu.20158; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Malats N, 2008, SCAND J UROL NEPHROL, V42, P131, DOI 10.1080/03008880802285172; Manuguerra M, 2006, AM J EPIDEMIOL, V164, P297, DOI 10.1093/aje/kwj189; Matter B, 2004, CHEM RES TOXICOL, V17, P731, DOI 10.1021/tx049974l; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; MELIKIAN AA, 1987, CANCER RES, V47, P5354; MILLER EC, 1978, CANCER RES, V38, P1479; Mitra AK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-104; Nexo BA, 2003, CARCINOGENESIS, V24, P899, DOI 10.1093/carcin/bgg043; Pavanello S, 1999, INT ARCH OCC ENV HEA, V72, P238, DOI 10.1007/s004200050367; PELLING JC, 1984, CANCER RES, V44, P1081; Rockenbauer E, 2002, CARCINOGENESIS, V23, P1149, DOI 10.1093/carcin/23.7.1149; Ryu JS, 2004, LUNG CANCER, V44, P311, DOI 10.1016/j.lungcan.2003.11.019; Shao JF, 2007, CANCER GENET CYTOGEN, V177, P30, DOI 10.1016/j.cancergencyto.2007.05.005; Shen J, 2006, CANCER EPIDEM BIOMAR, V15, P1614, DOI 10.1158/1055-9965.EPI-06-0218; Shih MK, 1996, PHOTOCHEM PHOTOBIOL, V63, P286, DOI 10.1111/j.1751-1097.1996.tb03027.x; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-175; Spitz MR, 2001, CANCER RES, V61, P1354; Sturgis EM, 2002, ARCH OTOLARYNGOL, V128, P1084, DOI 10.1001/archotol.128.9.1084; Sturgis EM, 2000, CARCINOGENESIS, V21, P2219, DOI 10.1093/carcin/21.12.2219; Topinka J, 2007, TOXICOL LETT, V172, P85, DOI 10.1016/j.toxlet.2007.05.020; Vineis P, 2009, JNCI-J NATL CANCER I, V101, P24, DOI 10.1093/jnci/djn437; Vogel U, 2004, MUTAT RES-FUND MOL M, V546, P65, DOI 10.1016/j.mrfmmm.2003.11.001; Wei QY, 1996, CANCER RES, V56, P3975; Whitehead CM, 1997, CHROMOSOMA, V106, P493, DOI 10.1007/s004120050271; Wu WT, 2009, CLIN CANCER RES, V15, P3889, DOI 10.1158/1078-0432.CCR-08-2715; Yamazaki T, 1999, J BIOL CHEM, V274, P18173, DOI 10.1074/jbc.274.26.18173; Yang M, 2006, EUR J CANCER PREV, V15, P269, DOI 10.1097/01.cej.0000195709.79696.0c; Yin JY, 2009, BIOCHEM GENET, V47, P582, DOI 10.1007/s10528-009-9246-2; Yin JY, 2002, CANCER EPIDEM BIOMAR, V11, P1449; Yin JY, 2003, BIOCHEM GENET, V41, P27, DOI 10.1023/A:1020970428370; Yu HP, 2004, CANCER GENET CYTOGEN, V154, P10, DOI 10.1016/j.cancergencyto.2004.01.027; Zhai XD, 2009, B CANCER, V96, pE61, DOI 10.1684/bdc.2009.0952; Zhang J, 2011, MED ONCOL, V28, P655, DOI 10.1007/s12032-010-9501-8; Zhao H, 2008, CARCINOGENESIS, V29, P1560, DOI 10.1093/carcin/bgn089; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P491, DOI 10.1158/1055-9965.EPI-04-0612	58	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60006	10.1371/journal.pone.0060006	http://dx.doi.org/10.1371/journal.pone.0060006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593158	Green Submitted, Green Published, gold			2022-12-27	WOS:000319108100013
J	Zhai, JW; Zhang, GQ; Chen, LJ; Xiao, XJ; Liu, KW; Tsai, WC; Hsiao, YY; Tian, HZ; Zhu, JQ; Wang, MN; Wang, FG; Xing, FW; Liu, ZJ				Zhai, Jun-Wen; Zhang, Guo-Qiang; Chen, Li-Jun; Xiao, Xin-Ju; Liu, Ke-Wei; Tsai, Wen-Chieh; Hsiao, Yu-Yun; Tian, Huai-Zhen; Zhu, Jia-Qiang; Wang, Mei-Na; Wang, Fa-Guo; Xing, Fu-Wu; Liu, Zhong-Jian			A New Orchid Genus, Danxiaorchis, and Phylogenetic Analysis of the Tribe Calypsoeae	PLOS ONE			English	Article							CORALLORHIZINAE; POLLINATION; UTILITY	Background: Orchids have numerous species, and their speciation rates are presumed to be exceptionally high, suggesting that orchids are continuously and actively evolving. The wide diversity of orchids has attracted the interest of evolutionary biologists. In this study, a new orchid was discovered on Danxia Mountain in Guangdong, China. However, the phylogenetic clarification of this new orchid requires further molecular, morphological, and phytogeographic analyses. Methodology/Principal Findings: A new orchid possesses a labellum with a large Y-shaped callus and two sacs at the base, and cylindrical, fleshy seeds, which make it distinct from all known orchid genera. Phylogenetic methods were applied to a matrix of morphological and molecular characters based on the fragments of the nuclear internal transcribed spacer, chloroplast matK, and rbcL genes of Orchidaceae (74 genera) and Calypsoeae (13 genera). The strict consensus Bayesian inference phylogram strongly supports the division of the Calypsoeae alliance (not including Dactylostalix and Ephippianthus) into seven clades with 11 genera. The sequence data of each species and the morphological characters of each genus were combined into a single dataset. The inferred Bayesian phylogram supports the division of the 13 genera of Calypsoeae into four clades with 13 subclades (genera). Based on the results of our phylogenetic analyses, Calypsoeae, under which the new orchid is classified, represents an independent lineage in the Epidendroideae subfamily. Conclusions: Analyses of the combined datasets using Bayesian methods revealed strong evidence that Calypsoeae is a monophyletic tribe consisting of eight well-supported clades with 13 subclades (genera), which are all in agreement with the phytogeography of Calypsoeae. The Danxia orchid represents an independent lineage under the tribe Calypsoeae of the subfamily Epidendroideae. This lineage should be treated as a new genus, which we have named Danxiaorchis, that is parallel to Yoania. Both genera are placed under the subtribe Yoaniinae.	[Zhai, Jun-Wen; Wang, Fa-Guo; Xing, Fu-Wu] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhai, Jun-Wen; Zhang, Guo-Qiang; Chen, Li-Jun; Xiao, Xin-Ju; Liu, Ke-Wei; Wang, Mei-Na; Liu, Zhong-Jian] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Zhai, Jun-Wen; Zhang, Guo-Qiang; Chen, Li-Jun; Xiao, Xin-Ju; Liu, Ke-Wei; Wang, Mei-Na; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Zhai, Jun-Wen] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Tsai, Wen-Chieh; Hsiao, Yu-Yun] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Tsai, Wen-Chieh; Hsiao, Yu-Yun] Natl Cheng Kung Univ, Orchid Res Ctr, Tainan 70101, Taiwan; [Tian, Huai-Zhen] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Zhu, Jia-Qiang] Informat Ctr Renhua Cty, Shaoguan, Peoples R China; [Liu, Ke-Wei; Liu, Zhong-Jian] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Zhang, Guo-Qiang; Liu, Zhong-Jian] Fujian Agr & Forestry Univ, Landscape Coll, Fuzhou, Peoples R China; [Liu, Zhong-Jian] South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Cheng Kung University; National Cheng Kung University; East China Normal University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Fujian Agriculture & Forestry University; South China Agricultural University	Xing, FW (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	xinfw@scib.ac.cn; liuzj@sinicaorchid.org	Zhang, Guo-Qiang/AAG-6817-2019	Zhang, Guo-Qiang/0000-0001-6439-019X; Liu, Zhong-Jian/0000-0003-4390-3878	Forestry Construction of State Forestry Administration of China [2010-240]; Forestry Construction of Guangdong Province, China [2010-317]	Forestry Construction of State Forestry Administration of China; Forestry Construction of Guangdong Province, China	The work was supported by fellowships of the Forestry Construction of State Forestry Administration of China (No. 2010-240) and the Forestry Construction of Guangdong Province, China (No. 2010-317). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bougoure JJ, 2010, NEW PHYTOL, V186, P947, DOI 10.1111/j.1469-8137.2010.03246.x; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Chase M. W, 1994, P 14 WORLD ORCH C, P61; Chen SC, 1999, FLORA REIPUBLICAE PO, V18; Chen SW, 2009, J ELECTRON MATER, V38, P1, DOI 10.1007/s11664-008-0572-7; Claessens J, 2005, 18 WORLD ORCH C DIJ; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; Doyle J. J., 1987, PHYTOCHEM B, P11; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freudenstein JV, 1999, NOVON, V9, P511, DOI 10.2307/3392151; FREUDENSTEIN JV, 1994, PLANT SYST EVOL, V193, P1, DOI 10.1007/BF00983537; Freudensteinia JV, 2008, AM J BOT, V95, P498, DOI 10.3732/ajb.95.4.498; Gill DE, 1989, SPECIATION ITS CONSE, V458, P481; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; GOVAERTS R, 2012, WORLD CHECKLIST SELE; Hsue H.H., 1987, J S CHINA AGR U, V8, P1; Huang J, 1999, EC GEOGRAPHY S, V19, P31; Liu KW, 2006, NATURE, V441, P945, DOI 10.1038/441945a; Liu W., 1999, GUANGXI ZHI WU, V19, P15; LUND ID, 1988, NORD J BOT, V8, P197, DOI 10.1111/j.1756-1051.1988.tb00502.x; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Pearce N., 1997, Edinburgh Journal of Botany, V54, P289; Pridgeon AM, 2005, GENERA ORCHIDACEARUM, V4, P89; Reeves G, 2001, AM J BOT, V88, P2074, DOI 10.2307/3558433; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SULAIMAN SF, 2003, ASIA-PAC J MOL BIOL, V11, P9; Sun HQ, 2006, BOT J LINN SOC, V150, P165, DOI 10.1111/j.1095-8339.2006.00457.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiv M, 1999, PLANT SYST EVOL, V218, P299, DOI 10.1007/BF01089233	32	24	31	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60371	10.1371/journal.pone.0060371	http://dx.doi.org/10.1371/journal.pone.0060371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593204	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100035
J	Nagele, EP; Han, M; Acharya, NK; DeMarshall, C; Kosciuk, MC; Nagele, RG				Nagele, Eric P.; Han, Min; Acharya, Nimish K.; DeMarshall, Cassandra; Kosciuk, Mary C.; Nagele, Robert G.			Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and Disease	PLOS ONE			English	Article							B-CELLS; ANTIBODY REPERTOIRES; APOPTOTIC CELLS; MICE; AUTOREACTIVITY; IMMUNOGLOBULIN; INFORMATICS; CHILDHOOD; RECEPTORS; STABILITY	The presence of self-reactive IgG autoantibodies in human sera is largely thought to represent a breakdown in central tolerance and is typically regarded as a harbinger of autoimmune pathology. In the present study, immune-response profiling of human serum from 166 individuals via human protein microarrays demonstrates that IgG autoantibodies are abundant in all human serum, usually numbering in the thousands. These IgG autoantibodies bind to human antigens from organs and tissues all over the body and their serum diversity is strongly influenced by age, gender, and the presence of specific diseases. We also found that serum IgG autoantibody profiles are unique to an individual and remarkably stable over time. Similar profiles exist in rat and swine, suggesting conservation of this immunological feature among mammals. The number, diversity, and apparent evolutionary conservation of autoantibody profiles suggest that IgG autoantibodies have some important, as yet unrecognized, physiological function. We propose that IgG autoantibodies have evolved as an adaptive mechanism for debris-clearance, a function consistent with their apparent utility as diagnostic indicators of disease as already established for Alzheimer's and Parkinson's diseases.	[Nagele, Eric P.; Han, Min; Acharya, Nimish K.; DeMarshall, Cassandra; Kosciuk, Mary C.; Nagele, Robert G.] Univ Med & Dent New Jersey, Biomarker Discovery Ctr, New Jersey Inst Successful Aging, Stratford, NJ USA; [Han, Min; Acharya, Nimish K.; DeMarshall, Cassandra] Univ Med & Dent New Jersey, Sch Osteopath Med, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Nagele, Eric P.] Durin Technol Inc, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Nagele, RG (corresponding author), Univ Med & Dent New Jersey, Biomarker Discovery Ctr, New Jersey Inst Successful Aging, Stratford, NJ USA.	nagelero@umdnj.edu		Han, Min/0000-0002-7348-9121; Han, Min/0000-0002-8350-687X	Foundation Venture Capital Group "a New Jersey Health Foundation Affiliate; Foundation Venture Capital Group	Foundation Venture Capital Group "a New Jersey Health Foundation Affiliate; Foundation Venture Capital Group	This work was supported by funding from the Foundation Venture Capital Group "a New Jersey Health Foundation Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RGN is a stockholder in Durin Technologies, Inc., a small biotech company that is developing disease diagnostics using autoantibodies as biomarkers, and has filed patents on this technology. EPN is a paid consultant of Durin Technologies. This study was funded by the Foundation Venture Capital Group. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Acharya NK, 2012, J AUTOIMMUN, V38, P369, DOI 10.1016/j.jaut.2012.03.004; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Avrameas S, 2007, J AUTOIMMUN, V29, P213, DOI 10.1016/j.jaut.2007.07.010; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Bournia VK, 2012, J AUTOIMMUN, V39, P15, DOI 10.1016/j.jaut.2012.03.001; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Cocca BA, 2001, P NATL ACAD SCI USA, V98, P13826, DOI 10.1073/pnas.241510698; Fu M, 2007, APOPTOSIS, V12, P355, DOI 10.1007/s10495-006-0581-z; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Han M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032383; Hardy RR, 2005, SPRINGER SEMIN IMMUN, V26, P363, DOI 10.1007/s00281-004-0183-1; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; Heuer L, 2008, AUTISM RES, V1, P275, DOI 10.1002/aur.42; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; Koval L, 2011, J ALZHEIMERS DIS, V25, P747, DOI 10.3233/JAD-2011-101845; Lacroix-Desmazes S, 1999, J CLIN IMMUNOL, V19, P26, DOI 10.1023/A:1020510401233; Lampropoulou V, 2010, IMMUNOL REV, V233, P146, DOI 10.1111/j.0105-2896.2009.00855.x; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Madi A, 2009, P NATL ACAD SCI USA, V106, P14484, DOI 10.1073/pnas.0901528106; Marchalonis JJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0953hyp; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; Mirilas P, 1999, J CLIN IMMUNOL, V19, P109, DOI 10.1023/A:1020554500266; Mouthon L, 1996, SCAND J IMMUNOL, V44, P243, DOI 10.1046/j.1365-3083.1996.d01-306.x; MOUTHON L, 1995, P NATL ACAD SCI USA, V92, P3839, DOI 10.1073/pnas.92.9.3839; Nagele E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023112; Nagele RG, 2011, J ALZHEIMERS DIS, V25, P605, DOI 10.3233/JAD-2011-110098; Pisetsky DS, 2012, SCAND J IMMUNOL; Shoenfeld Y, 2012, J AUTOIMMUN, V38, pJ71, DOI 10.1016/j.jaut.2011.12.007; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Tarlinton DM, 1995, EUR J IMMUNOL, V25, P3388, DOI 10.1002/eji.1830251228; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tsonis LA, 2007, J AUTOIMMUN, V29, P203, DOI 10.1016/j.jaut.2007.07.009; Tuominen A, 2006, ARTERIOSCL THROM VAS, V26, P2096, DOI 10.1161/01.ATV.0000233333.07991.4a; Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107	35	188	196	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60726	10.1371/journal.pone.0060726	http://dx.doi.org/10.1371/journal.pone.0060726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23589757	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300144
J	Baltar, F; Reinthaler, T; Herndl, GJ; Pinhassi, J				Baltar, Federico; Reinthaler, Thomas; Herndl, Gerhard J.; Pinhassi, Jarone			Major Effect of Hydrogen Peroxide on Bacterioplankton Metabolism in the Northeast Atlantic	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; UV-RADIATION; PRODUCTION-RATES; DARK PRODUCTION; SINGLET OXYGEN; WATERS; COASTAL; SUPEROXIDE; SEAWATER; SURFACE	Reactive oxygen species such as hydrogen peroxide have the potential to alter metabolic rates of marine prokaryotes, ultimately impacting the cycling and bioavailability of nutrients and carbon. We studied the influence of H2O2 on prokaryotic heterotrophic production (PHP) and extracellular enzymatic activities (i.e., beta-glucosidase [BGase], leucine aminopeptidase [LAPase] and alkaline phosphatase [APase]) in the subtropical Atlantic. With increasing concentrations of H2O2 in the range of 100-1000 nM, LAPase, APase and BGase were reduced by up to 11, 23 and 62%, respectively, in the different water layers. Incubation experiments with subsurface waters revealed a strong inhibition of all measured enzymatic activities upon H2O2 amendments in the range of 10-500 nM after 24 h. H2O2 additions also reduced prokaryotic heterotrophic production by 36-100% compared to the rapid increases in production rates occurring in the unamended controls. Our results indicate that oxidative stress caused by H2O2 affects prokaryotic growth and hydrolysis of specific components of the organic matter pool. Thus, we suggest that oxidative stress may have important consequences on marine carbon and energy fluxes.	[Baltar, Federico; Pinhassi, Jarone] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden; [Reinthaler, Thomas; Herndl, Gerhard J.] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Herndl, Gerhard J.] Royal Netherlands Inst Sea Res NIOZ, Dept Biol Oceanog, Den Burg, Netherlands	Linnaeus University; University of Vienna; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Baltar, F (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden.	federico.baltar@lnu.se	Herndl, Gerhard J./S-3011-2019; Reinthaler, Thomas/E-6563-2013; Baltar, Federico/C-3260-2012; Herndl, Gerhard J./B-1513-2013; Baltar, Federico/Q-6303-2019	Herndl, Gerhard J./0000-0002-2223-2852; Reinthaler, Thomas/0000-0003-3881-3122; Baltar, Federico/0000-0001-8907-1494; Herndl, Gerhard J./0000-0002-2223-2852; Baltar, Federico/0000-0001-8907-1494	European Science Foundation (EuroEEFG project MOCA); Swedish Research Council; European Science Foundation (ESF) MOCA (Microbial Oceanography of ChemolithoAutotrophic planktonic Communities) project; Austrian Science Fund (FWF) [I486-B09, P23234-B11]; European Research Council (ERC) Advanced Grant MEDEA (Microbial Ecology of the DEep Atlantic pelagic realm); Austrian Science Fund (FWF) project PADOM (Prokaryotic Activity in Dark Ocean Mixing zones) [P23221-B11]; Austrian Science Fund (FWF) [P 23234, I 486, Z 194] Funding Source: researchfish	European Science Foundation (EuroEEFG project MOCA); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Science Foundation (ESF) MOCA (Microbial Oceanography of ChemolithoAutotrophic planktonic Communities) project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC) Advanced Grant MEDEA (Microbial Ecology of the DEep Atlantic pelagic realm); Austrian Science Fund (FWF) project PADOM (Prokaryotic Activity in Dark Ocean Mixing zones)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by projects from the European Science Foundation (EuroEEFG project MOCA) and the Swedish Research Council to JP and FB. GJH was supported by the European Science Foundation (ESF) MOCA (Microbial Oceanography of ChemolithoAutotrophic planktonic Communities) project and the Austrian Science Fund (FWF) projects I486-B09 and P23234-B11. Shiptime was provided by the European Research Council (ERC) Advanced Grant MEDEA (Microbial Ecology of the DEep Atlantic pelagic realm) to GJH. TR was supported by the Austrian Science Fund (FWF) project PADOM (Prokaryotic Activity in Dark Ocean Mixing zones) (P23221-B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 1999, ANTARCT SCI, V11, P131, DOI 10.1017/S095410209900019X; ABELEOESCHGER D, 1994, MAR ECOL PROG SER, V106, P101, DOI 10.3354/meps106101; Anesio AM, 2005, APPL ENVIRON MICROB, V71, P6267, DOI 10.1128/AEM.71.10.6267-6275.2005; Angel DL, 1999, HELGOLAND MAR RES, V53, P209; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Avery GB, 2005, MAR CHEM, V97, P236, DOI 10.1016/j.marchem.2005.03.006; Azua I, 2003, J PLANKTON RES, V25, P1451, DOI 10.1093/plankt/fbg105; Baltar F, 2010, AQUAT MICROB ECOL, V58, P287, DOI 10.3354/ame01377; Baltar F, 2009, ENVIRON MICROBIOL, V11, P1998, DOI 10.1111/j.1462-2920.2009.01922.x; Baltar F, 2009, LIMNOL OCEANOGR, V54, P182, DOI 10.4319/lo.2009.54.1.0182; Barrington DJ, 2008, ENVIRON SCI TECHNOL, V42, P8916, DOI 10.1021/es801717y; BAXTER RM, 1983, NATURE, V306, P575, DOI 10.1038/306575a0; Benner R, 1998, LIMNOL OCEANOGR, V43, P1373, DOI 10.4319/lo.1998.43.6.1373; CHROST RJ, 1991, BROCK SPR S, P29; Clark CD, 2008, MAR POLLUT BULL, V56, P397, DOI 10.1016/j.marpolbul.2007.10.017; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; COOPER WJ, 1989, ACS SYM SER, V219, P333; COOPER WJ, 1983, SCIENCE, V220, P711, DOI 10.1126/science.220.4598.711; DEAN R T, 1987, British Journal of Cancer, V55, P39; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; Farjalla VF, 2001, AQUAT MICROB ECOL, V24, P187, DOI 10.3354/ame024187; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Gasol JM, 1998, MAR ECOL PROG SER, V164, P107, DOI 10.3354/meps164107; Glaeser SP, 2010, ENVIRON MICROBIOL, V12, P3124, DOI 10.1111/j.1462-2920.2010.02285.x; Halliwell B, 1995, BIOCHEM SOC SYMP, P73, DOI 10.1042/bss0610073; HARVEY GR, 1983, MAR CHEM, V12, P119, DOI 10.1016/0304-4203(83)90075-0; Herut B, 1998, MAR POLLUT BULL, V36, P994, DOI 10.1016/S0025-326X(98)80004-0; Hoppe H-G, 1993, HDB METHODS AQUATIC, P423, DOI DOI 10.1201/9780203752746-49; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jorgensen NO, 2006, FEMS MICROBIOLOGY EC, V25, P217; Kaiser E, 1997, APPL ENVIRON MICROB, V63, P4026, DOI 10.1128/AEM.63.10.4026-4031.1997; Kieber RJ, 1997, LIMNOL OCEANOGR, V42, P1454, DOI 10.4319/lo.1997.42.6.1454; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; MALINS DC, 1991, AQUAT TOXICOL, V20, P123, DOI 10.1016/0166-445X(91)90011-W; MICINSKI E, 1993, J GEOPHYS RES-OCEANS, V98, P2299, DOI 10.1029/92JC02766; MIDDELBOE M, 1995, MICROB ECOL, V29, P231, DOI 10.1007/BF00164887; MILLER WL, 1988, ANAL CHEM, V60, P2711, DOI 10.1021/ac00175a014; Obernosterer I, 1999, LIMNOL OCEANOGR, V44, P1645, DOI 10.4319/lo.1999.44.7.1645; Obernosterer I, 2001, LIMNOL OCEANOGR, V46, P632, DOI 10.4319/lo.2001.46.3.0632; PALENIK B, 1988, LIMNOL OCEANOGR, V33, P1606, DOI 10.4319/lo.1988.33.6_part_2.1606; PETASNE RG, 1987, NATURE, V325, P516, DOI 10.1038/325516a0; Reitner B, 1997, LIMNOL OCEANOGR, V42, P950, DOI 10.4319/lo.1997.42.5.0950; Rontani JF, 2012, BIOGEOSCIENCES, V9, P4787, DOI 10.5194/bg-9-4787-2012; Scully NM, 2003, LIMNOL OCEANOGR, V48, P1818, DOI 10.4319/lo.2003.48.5.1818; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Tranvik L, 1998, AQUAT MICROB ECOL, V14, P301, DOI 10.3354/ame014301; Tranvik LJ, 2001, ECOL LETT, V4, P458, DOI 10.1046/j.1461-0248.2001.00245.x; Unanue M, 1999, MICROB ECOL, V37, P36, DOI 10.1007/s002489900128; VALENTINE RL, 1993, ENVIRON SCI TECHNOL, V27, P409, DOI 10.1021/es00039a023; Vermilyea AW, 2010, LIMNOL OCEANOGR, V55, P580, DOI 10.4319/lo.2009.55.2.0580; Weinbauer MG, 1999, AQUAT MICROB ECOL, V18, P217, DOI 10.3354/ame018217; WINSTON GW, 1991, COMP BIOCHEM PHYS C, V100, P173, DOI 10.1016/0742-8413(91)90148-M; Xenopoulos MA, 1997, PHOTOCHEM PHOTOBIOL, V66, P471, DOI 10.1111/j.1751-1097.1997.tb03175.x; Yuan JC, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000908; Yuan JC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018439; Yuan JC, 2001, DEEP-SEA RES PT II, V48, P2947, DOI 10.1016/S0967-0645(01)00026-1; ZEPP RG, 1977, NATURE, V267, P421, DOI 10.1038/267421a0	59	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61051	10.1371/journal.pone.0061051	http://dx.doi.org/10.1371/journal.pone.0061051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593386	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300045
J	Bellamy, DE; Sisterson, MS; Walse, SS				Bellamy, David E.; Sisterson, Mark S.; Walse, Spencer S.			Quantifying Host Potentials: Indexing Postharvest Fresh Fruits for Spotted Wing Drosophila, Drosophila suzukii	PLOS ONE			English	Article							OVIPOSITION BEHAVIOR; LARVAL PERFORMANCE; PREFERENCE; QUALITY; MODEL; MELANOGASTER; POPULATIONS; SUITABILITY; FECUNDITY; SELECTION	Novel methodology is presented for indexing the relative potential of hosts to function as resources. A Host Potential Index (HPI) was developed as a practical framework to express relative host potential based on combining results from one or more independent studies, such as those examining host selection, utilization, and physiological development of the organism resourcing the host. Several aspects of the HPI are addressed including: 1) model derivation; 2) influence of experimental design on establishing host rankings for a study type (no choice, two-choice, and multiple-choice); and, 3) variable selection and weighting associated with combining multiple studies. To demonstrate application of the HPI, results from the interactions of spotted wing drosophila (SWD), Drosophila suzukii Matsumura (Diptera: Drosophilidae), with seven "reported" hosts (blackberries, blueberries, sweet cherries, table grapes, peaches, raspberries, and strawberries) in a postharvest scenario were analyzed. Four aspects of SWD-host interaction were examined: attraction to host volatiles; population-level oviposition performance; individual-level oviposition performance; and key developmental factors. Application of HPI methodology indicated that raspberries ((HPIvaried)-H-mean = 301.9 +/- 8.39; rank 1 of 7) have the greatest potential to serve as a postharvest host for SWD relative to the other fruit hosts, with grapes ((HPIvaried)-H-mean = 232.4 +/- 3.21; rank 7 of 7) having the least potential.	[Bellamy, David E.; Sisterson, Mark S.; Walse, Spencer S.] ARS, San Joaquin Valley Agr Sci Ctr, USDA, Parlier, CA USA	United States Department of Agriculture (USDA)	Walse, SS (corresponding author), ARS, San Joaquin Valley Agr Sci Ctr, USDA, Parlier, CA USA.	spencer.walse@ars.usda.gov	Bellamy, David E/O-9800-2018	Bellamy, David E/0000-0002-2879-8419	U.S. Department of Agriculture-Agricultural Research Service	U.S. Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was supported through the U.S. Department of Agriculture-Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; Alpatov WW, 1929, J EXP ZOOL, V52, P407, DOI 10.1002/jez.1400520303; [Anonymous], 1999, DES EXP 8 0 3; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; CHIAVELLI DA, 1993, LIMNOL OCEANOGR, V38, P574, DOI 10.4319/lo.1993.38.3.0574; COOK WD, 1990, MANAGE SCI, V36, P1302, DOI 10.1287/mnsc.36.11.1302; COURTNEY SP, 1989, OIKOS, V55, P55, DOI 10.2307/3565872; Cunningham JP, 2008, J THEOR BIOL, V251, P404, DOI 10.1016/j.jtbi.2007.11.009; Elo A. E., 1978, RATING CHESSPLAYERS; FRANSEN JJ, 1993, ENTOMOL EXP APPL, V69, P239, DOI 10.1007/BF02381996; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; Gripenberg S, 2005, ANN ZOOL FENN, V42, P335; Hassan HK, 2003, AM J TROP MED HYG, V69, P641, DOI 10.4269/ajtmh.2003.69.641; HAUKIOJA E, 1985, ECOL ENTOMOL, V10, P267, DOI 10.1111/j.1365-2311.1985.tb00723.x; HEATH RR, 1992, J CHEM ECOL, V18, P1209, DOI 10.1007/BF00980075; Jameson KA, 1999, ANIM BEHAV, V57, P991, DOI 10.1006/anbe.1998.1077; Kanzawa T, 1939, STUDIES DROSOPHILA S; KAREIVA P, 1982, ECOL MONOGR, V52, P261, DOI 10.2307/2937331; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; KAY BH, 1979, MOSQ NEWS, V39, P68; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Leskey TC, 2007, ENTOMOL EXP APPL, V123, P217, DOI 10.1111/j.1570-7458.2007.00545.x; LYNCH R E, 1981, Peanut Science, V8, P106, DOI 10.3146/i0095-3679-8-2-7; Mayhew PJ, 2001, TRENDS ECOL EVOL, V16, P165, DOI 10.1016/S0169-5347(00)02099-1; MCCLURE MS, 1980, ECOLOGY, V61, P72, DOI 10.2307/1937157; McSorley R, 1999, J NEMATOL, V31, P619; MESSINA FJ, 1982, OECOLOGIA, V55, P342, DOI 10.1007/BF00376922; Mitsui H, 2010, ENTOMOL SCI, V13, P60, DOI 10.1111/j.1479-8298.2010.00372.x; Papaj DR, 2000, ANNU REV ENTOMOL, V45, P423, DOI 10.1146/annurev.ento.45.1.423; Pappers SM, 2002, OECOLOGIA, V130, P433, DOI 10.1007/s00442-001-0822-3; Peters TM, 1997, ANNU REV ENTOMOL, V22, P431; Robertson FW., 1957, J GENET, V55, P428, DOI [10.1007/BF02984061, DOI 10.1007/BF02984061]; ROININEN H, 1989, ECOLOGY, V70, P129, DOI 10.2307/1938419; Rusu AS, 2004, BEHAV ECOL SOCIOBIOL, V56, P298, DOI 10.1007/s00265-004-0787-4; Salt G, 1935, PROC R SOC SER B-BIO, V117, P413, DOI 10.1098/rspb.1935.0037; SAS Institute Inc, 1989, JMP; Scheirs J, 2002, OIKOS, V96, P187, DOI 10.1034/j.1600-0706.2002.960121.x; Schuler TH, 1999, NATURE, V400, P825, DOI 10.1038/23605; SINGER MC, 1982, OECOLOGIA, V52, P224, DOI 10.1007/BF00363841; SKINNER JE, 1994, BIO-TECHNOL, V12, P596, DOI 10.1038/nbt0694-596; Solarz SL, 2001, OECOLOGIA, V126, P66, DOI 10.1007/s004420000484; TANTAWY AO, 1960, AM NAT, V94, P395, DOI 10.1086/282143; TANTAWY AO, 1964, GENETICS, V50, P1349; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; TURLINGS TCJ, 1992, P NATL ACAD SCI USA, V89, P8399, DOI 10.1073/pnas.89.17.8399; Walse SS, 2012, J ASIA-PAC ENTOMOL, V15, P451, DOI 10.1016/j.aspen.2012.05.003; Walsh DB, 2011, J INTEGRATE PEST MAN, V67, P1358	50	154	160	0	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61227	10.1371/journal.pone.0061227	http://dx.doi.org/10.1371/journal.pone.0061227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593439	Green Submitted, Green Published, gold			2022-12-27	WOS:000317385300064
J	Calligaris, SD; Lecanda, M; Solis, F; Ezquer, M; Gutierrez, J; Brandan, E; Leiva, A; Sobrevia, L; Conget, P				Calligaris, Sebastian D.; Lecanda, Manuel; Solis, Felipe; Ezquer, Marcelo; Gutierrez, Jaime; Brandan, Enrique; Leiva, Andrea; Sobrevia, Luis; Conget, Paulette			Mice Long-Term High-Fat Diet Feeding Recapitulates Human Cardiovascular Alterations: An Animal Model to Study the Early Phases of Diabetic Cardiomyopathy	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; C57BL/6 MICE; GLUCOSE-INTOLERANCE; INDUCED OBESITY; RISK-FACTORS; EXPRESSION; HEART; DISEASE; STRESS	Background/Aim: Hypercaloric diet ingestion and sedentary lifestyle result in obesity. Metabolic syndrome is a cluster clinical features secondary to obesity, considered as a pre-diabetic condition and recognized as an independent risk factor for cardiovascular diseases. To better understand the relationship between obesity, metabolic syndrome and cardiovascular disease as well as for the development of novel therapeutic strategies, animal models that reproduce the etiology, course and outcomes of these pathologies are required. The aim of this work was to characterize the long-term effects of high-fat diet-induced obesity on the mice cardiovascular system, in order to make available a new animal model for diabetic cardiomyopathy. Methods/Results: Male C57BL/6 mice were fed with a standardized high-fat diet (obese) or regular diet (normal) for 16 months. Metabolic syndrome was evaluated testing plasma glucose, triglycerides, cholesterol, insulin, and glucose tolerance. Arterial pressure was measured using a sphygmomanometer (non invasive method) and by hemodynamic parameters (invasive method). Cardiac anatomy was described based on echocardiography and histological studies. Cardiac function was assessed by cardiac catheterization under a stress test. Cardiac remodelling and metabolic biomarkers were assessed by RT-qPCR and immunoblotting. As of month eight, the obese mice were overweight, hyperglycaemic, insulin resistant, hyperinsulinemic and hypercholesterolemic. At month 16, they also presented normal arterial pressure but altered vascular reactivity (vasoconstriction), and cardiac contractility reserve reduction, heart mass increase, cardiomyocyte hypertrophy, cardiac fibrosis, and heart metabolic compensations. By contrast, the normal mice remained healthy throughout the study. Conclusions: Mice fed with a high-fat diet for prolonged time recapitulates the etiology, course and outcomes of the early phases of human diabetic cardiomyopathy.	[Calligaris, Sebastian D.; Lecanda, Manuel; Solis, Felipe; Ezquer, Marcelo; Conget, Paulette] Univ Desarrollo, Fac Med, Clin Alemana, Inst Ciencias, Santiago, Chile; [Gutierrez, Jaime; Brandan, Enrique] Pontificia Univ Catolica Chile, MIFAB, Ctr Regulac Celular & Patol, Dept Biol Celular & Mol, Santiago, Chile; [Leiva, Andrea; Sobrevia, Luis] Pontificia Univ Catolica Chile, Sch Med, Fac Med, Div Obstet & Gynecol,CMPL, Santiago, Chile; [Sobrevia, Luis] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia	Clinica Alemana; Universidad del Desarrollo; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Queensland	Calligaris, SD (corresponding author), Univ Desarrollo, Fac Med, Clin Alemana, Inst Ciencias, Santiago, Chile.	scalligaris@udd.cl	Sobrevia, Luis/H-9608-2016; Brandan, Enrique/A-7063-2017	Sobrevia, Luis/0000-0001-5802-2243; Brandan, Enrique/0000-0002-6820-5059; Conget, Paulette/0000-0002-2530-7936; Ezquer, Marcelo/0000-0002-2064-3041	FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico) [11090114]	FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico) grant No 11090114 to S.D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Asghar O, 2009, CLIN SCI, V116, P741, DOI 10.1042/CS20080500; Bernardi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/872504; Black BL, 1998, METABOLISM, V47, P1354, DOI 10.1016/S0026-0495(98)90304-3; Bonora E, 2003, INT J OBESITY, V27, P1283, DOI 10.1038/sj.ijo.0802381; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Conget P, 2013, JOVE-J VIS EXP, V72, P1; Dailey G, 2011, CLIN THER, V33, P665, DOI 10.1016/j.clinthera.2011.04.025; Daniels A, 2010, ACTA PHYSIOL, V200, P11, DOI 10.1111/j.1748-1716.2010.02102.x; de Chantemele EJB, 2011, HYPERTENSION, V58, P271, DOI 10.1161/HYPERTENSIONAHA.110.168427; Drosatos K, 2011, AM J PHYSIOL-ENDOC M, V300, pE489, DOI 10.1152/ajpendo.00569.2010; Ezquer M, 2011, J HEPATOL, V55, P1112, DOI 10.1016/j.jhep.2011.02.020; Fan X, 2012, CURRENT MOL MED; Farah V, 2006, AUTON NEUROSCI-BASIC, V130, P41, DOI 10.1016/j.autneu.2006.05.006; FEIN FS, 1990, DIABETES CARE, V13, P1169, DOI 10.2337/diacare.13.11.1169; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Guzman-Gutierrez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041705; Harte RA, 1999, HORM METAB RES, V31, P570, DOI 10.1055/s-2007-978797; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; Jimenez-Altayo F., 2012, AGE; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Mattson DL, 1998, AM J PHYSIOL-REG I, V274, pR564, DOI 10.1152/ajpregu.1998.274.2.R564; Mundy AL, 2007, CARDIOVASC RES, V73, P368, DOI 10.1016/j.cardiores.2006.11.019; Neuhaus B, 2012, EXP DERMATOL, V21, P712, DOI 10.1111/j.1600-0625.2012.01558.x; Nishikawa S, 2007, EXP ANIM TOKYO, V56, P263, DOI 10.1538/expanim.56.263; NISHINA PM, 1990, J LIPID RES, V31, P859; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; REAVEN GM, 1988, DIABETES METAB REV, V4, P639, DOI 10.1002/dmr.5610040703; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Sumiyoshi M, 2006, J NUTR, V136, P582, DOI 10.1093/jn/136.3.582; Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155; Wiesmann F, 2001, CIRC RES, V88, P563, DOI 10.1161/01.RES.88.6.563; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Yu Qianli, 2004, Cardiovasc Toxicol, V4, P37; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841; Zibadi S, 2009, AM J PHYSIOL-HEART C, V297, pH976, DOI 10.1152/ajpheart.00398.2009	58	100	102	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60931	10.1371/journal.pone.0060931	http://dx.doi.org/10.1371/journal.pone.0060931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593350	Green Submitted, Green Published, gold			2022-12-27	WOS:000317383200029
J	de Tullio, MB; Castelletto, V; Hamley, IW; Adami, PVM; Morelli, L; Castano, EM				de Tullio, Matias B.; Castelletto, Valeria; Hamley, Ian W.; Martino Adami, Pamela V.; Morelli, Laura; Castano, Eduardo M.			Proteolytically Inactive Insulin-Degrading Enzyme Inhibits Amyloid Formation Yielding Non-Neurotoxic A beta Peptide Aggregates	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CHAPERONE-LIKE ACTIVITY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; EXTRACELLULAR CHAPERONE; PLAQUE-FORMATION; CULTURED-CELLS; IN-VIVO; BRAIN; CLUSTERIN	Insulin-degrading enzyme (IDE) is a neutral Zn2+ peptidase that degrades short peptides based on substrate conformation, size and charge. Some of these substrates, including amyloid beta (A beta) are capable of self-assembling into cytotoxic oligomers. Based on IDE recognition mechanism and our previous report of the formation of a stable complex between IDE and intact Ab in vitro and in vivo, we analyzed the possibility of a chaperone-like function of IDE. A proteolytically inactive recombinant IDE with Glu111 replaced by Gln (IDEQ) was used. IDEQ blocked the amyloidogenic pathway of A beta yielding non-fibrillar structures as assessed by electron microscopy. Measurements of the kinetics of A beta aggregation by light scattering showed that 1) IDEQ effect was promoted by ATP independent of its hydrolysis, 2) end products of A beta-IDEQ co-incubation were incapable of "seeding" the assembly of monomeric A beta and 3) IDEQ was ineffective in reversing A beta aggregation. Moreover, Ab aggregates formed in the presence of IDEQ were non-neurotoxic. IDEQ had no conformational effects upon insulin (a non-amyloidogenic protein under physiological conditions) and did not disturb insulin receptor activation in cultured cells. Our results suggest that IDE has a chaperone-like activity upon amyloid-forming peptides. It remains to be explored whether other highly conserved metallopeptidases have a dual protease-chaperone function to prevent the formation of toxic peptide oligomers from bacteria to mammals.	[de Tullio, Matias B.; Martino Adami, Pamela V.; Morelli, Laura; Castano, Eduardo M.] Consejo Nacl Invest Cient & Tecn CONICET, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [de Tullio, Matias B.; Martino Adami, Pamela V.; Morelli, Laura; Castano, Eduardo M.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Bioquim Buenos Aires, Buenos Aires, DF, Argentina; [Castelletto, Valeria; Hamley, Ian W.] Univ Reading, Dept Chem, Reading RG6 2AD, Berks, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Reading	Castano, EM (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Fdn Inst Leloir, Buenos Aires, DF, Argentina.	ecastano@leloir.org.ar	Hamley, Ian/D-1643-2009	Hamley, Ian/0000-0002-4549-0926	John Simon Guggenheim Foundation; Alzheimer's Association [IIRG-03-5312]; CONICET [PIP2009-693]; EPSRC [EP/F048114/1, EP/G030952/1, EP/G026203/1]; Engineering and Physical Sciences Research Council [EP/G030952/1, EP/F048114/1, EP/G026203/1] Funding Source: researchfish	John Simon Guggenheim Foundation; Alzheimer's Association(Alzheimer's Association); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a John Simon Guggenheim Foundation fellowship, Alzheimer's Association grant IIRG-03-5312 (to EMC), a CONICET grant PIP2009-693 (to LM), and EPSRC grants EP/F048114/1, EP/G030952/1 and EP/G026203/1 (to IWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bruinsma IB, 2011, J NEUROSCI, V31, P11992, DOI 10.1523/JNEUROSCI.0945-11.2011; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; CACERES A, 1986, J NEUROSCI, V6, P714; Calero M, 2005, SUB CELL BIOCHEM, V38, P273; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chow KM, 2009, BIOCHEMISTRY-US, V48, P2868, DOI 10.1021/bi8016125; Cordes CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018138; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Gau JT, 2002, AM J PATHOL, V160, P731, DOI 10.1016/S0002-9440(10)64893-6; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Hulko M, 2007, PROTEIN SCI, V16, P644, DOI 10.1110/ps.062478607; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Johnson KA, 2006, EMBO J, V25, P1977, DOI 10.1038/sj.emboj.7601080; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee S, 2006, BIOCHEM BIOPH RES CO, V347, P527, DOI 10.1016/j.bbrc.2006.06.128; LI D, 1992, J BIOL CHEM, V267, P2414; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Llovera RE, 2008, J BIOL CHEM, V283, P17039, DOI 10.1074/jbc.M706316200; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Martin-Rehrmann MD, 2005, NEUROTOX RES, V7, P231, DOI 10.1007/BF03036452; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Morelli L, 2005, BIOCHEM BIOPH RES CO, V332, P808, DOI 10.1016/j.bbrc.2005.05.020; Morelli L, 2004, J BIOL CHEM, V279, P56004, DOI 10.1074/jbc.M407283200; Mzhavia N, 1999, DNA CELL BIOL, V18, P369, DOI 10.1089/104454999315268; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Noinaj N, 2012, J BIOL CHEM, V287, P48, DOI 10.1074/jbc.M111.264614; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Schumann W, 1999, FEMS MICROBIOL REV, V23, P1; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Shinall H, 2005, BIOCHEMISTRY-US, V44, P15345, DOI 10.1021/bi050650l; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Wang CC, 1998, FEBS LETT, V425, P382, DOI 10.1016/S0014-5793(98)00272-5; Wang YQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208934; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	70	36	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e59113	10.1371/journal.pone.0059113	http://dx.doi.org/10.1371/journal.pone.0059113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593132	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200002
J	Ansbro, MR; Shukla, S; Ambudkar, SV; Yuspa, SH; Li, LW				Ansbro, Megan R.; Shukla, Suneet; Ambudkar, Suresh V.; Yuspa, Stuart H.; Li, Luowei			Screening Compounds with a Novel High-Throughput ABCB1-Mediated Efflux Assay Identifies Drugs with Known Therapeutic Targets at Risk for Multidrug Resistance Interference	PLOS ONE			English	Article							P-GLYCOPROTEIN; ABC TRANSPORTERS; INHIBITORS; CARCINOMA; BINDING; EXPRESSION; PROTEIN; DOXORUBICIN; VINBLASTINE; MECHANISMS	ABCB1, also known as P-glycoprotein (P-gp) or multidrug resistance protein 1 (MDR1), is a membrane-associated multidrug transporter of the ATP-binding cassette (ABC) transporter family. It is one of the most widely studied transporters that enable cancer cells to develop drug resistance. Reliable high-throughput assays that can identify compounds that interact with ABCB1 are crucial for developing new therapeutic drugs. A high-throughput assay for measuring ABCB1-mediated calcein AM efflux was developed using a fluorescent and phase-contrast live cell imaging system. This assay demonstrated the time- and dose-dependent accumulation of fluorescent calcein in ABCB1-overexpressing KB-V1 cells. Validation of the assay was performed with known ABCB1 inhibitors, XR9576, verapamil, and cyclosporin A, all of which displayed dose-dependent inhibition of ABCB1-mediated calcein AM efflux in this assay. Phase-contrast and fluorescent images taken by the imaging system provided additional opportunities for evaluating compounds that are cytotoxic or produce false positive signals. Compounds with known therapeutic targets and a kinase inhibitor library were screened. The assay identified multiple agents as inhibitors of ABCB1-mediated efflux and is highly reproducible. Among compounds identified as ABCB1 inhibitors, BEZ235, BI 2536, IKK 16, and ispinesib were further evaluated. The four compounds inhibited calcein AM efflux in a dose-dependent manner and were also active in the flow cytometry-based calcein AM efflux assay. BEZ235, BI 2536, and IKK 16 also successfully inhibited the labeling of ABCB1 with radiolabeled photoaffinity substrate [I-125]iodoarylazidoprazosin. Inhibition of ABCB1 with XR9576 and cyclosporin A enhanced the cytotoxicity of BI 2536 to ABCB1-overexpressing cancer cells, HCT-15-Pgp, and decreased the IC50 value of BI 2536 by several orders of magnitude. This efficient, reliable, and simple high-throughput assay has identified ABCB1 substrates/inhibitors that may influence drug potency or drug-drug interactions and predict multidrug resistance in clinical treatment.	[Ansbro, Megan R.; Yuspa, Stuart H.; Li, Luowei] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Shukla, Suneet; Ambudkar, Suresh V.] NCI, Cell Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Li, LW (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	lilu@mail.nih.gov	Ambudkar, Suresh V/L-1317-2016	Ansbro, Megan/0000-0002-7131-1610	intramural program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER	intramural program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Aszalos A, 2007, DRUG DISCOV TODAY, V12, P838, DOI 10.1016/j.drudis.2007.07.021; Bauer B, 2003, PHARM RES-DORDR, V20, P1170, DOI 10.1023/A:1025040712857; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bushway PJ, 2008, ASSAY DRUG DEV TECHN, V6, P557, DOI 10.1089/adt.2008.139; Calcagno Anna Maria, 2007, Current Drug Delivery, V4, P324, DOI 10.2174/156720107782151241; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; Crowley E, 2010, FEBS J, V277, P530, DOI 10.1111/j.1742-4658.2009.07484.x; DALTON WS, 1988, CANCER RES, V48, P1882; Degenhardt Y, 2010, CLIN CANCER RES, V16, P384, DOI 10.1158/1078-0432.CCR-09-1380; Forster F, 2008, EUR J PHARM BIOPHARM, V69, P396, DOI 10.1016/j.ejpb.2007.10.003; Ghosh RD, 2012, MOL CELL BIOCHEM, V364, P309, DOI 10.1007/s11010-012-1232-z; Gillet JP, 2011, CURR PHARM BIOTECHNO, V12, P686, DOI 10.2174/138920111795163931; Glavinas H, 2011, XENOBIOTICA, V41, P712, DOI 10.3109/00498254.2011.587033; GOLDBERG H, 1988, BIOCHEM BIOPH RES CO, V152, P552, DOI 10.1016/S0006-291X(88)80073-1; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Haupenthal J, 2012, NEOPLASIA, V14, P410, DOI 10.1596/neo.111366; Henrich CJ, 2006, J BIOMOL SCREEN, V11, P176, DOI 10.1177/1087057105284576; Henrich CJ, 2007, MOL CANCER THER, V6, P3271, DOI 10.1158/1535-7163.MCT-07-0352; Homolya L, 1996, BRIT J CANCER, V73, P849, DOI 10.1038/bjc.1996.151; Ivnitski-Steele I, 2008, ASSAY DRUG DEV TECHN, V6, P263, DOI 10.1089/adt.2007.107; Kannan P, 2010, DRUG METAB DISPOS, V38, P917, DOI 10.1124/dmd.109.031161; Katayama K, 2007, MOL CANCER THER, V6, P2092, DOI 10.1158/1535-7163.MCT-07-0148; KESSEL D, 1991, CANCER RES, V51, P4665; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maki N, 2003, J BIOL CHEM, V278, P18132, DOI 10.1074/jbc.M210413200; Mandal D, 2012, BIOCHEMISTRY-US, V51, P2852, DOI 10.1021/bi201479k; Marques-Santos LF, 2003, BIOSCIENCE REP, V23, P199, DOI 10.1023/B:BIRE.0000007693.33521.18; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; Roe M, 1999, BIOORG MED CHEM LETT, V9, P595, DOI 10.1016/S0960-894X(99)00030-X; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; SARKADI B, 1992, J BIOL CHEM, V267, P4854; SCARBOROUGH GA, 1995, J BIOENERG BIOMEMBR, V27, P37, DOI 10.1007/BF02110329; SHEN DW, 1988, CANCER RES, V48, P4334; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Shen Y, 2012, ONCOL REP, V27, P1535, DOI 10.3892/or.2012.1671; Shukla S, 2012, DRUG METAB DISPOS, V40, P304, DOI 10.1124/dmd.111.042721; SLOVAK ML, 1988, CANCER RES, V48, P2793; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tachibana T, 2010, CURR DRUG METAB, V11, P762, DOI 10.2174/138920010794328922; TAMAI I, 1991, J BIOL CHEM, V266, P16796; Tiberghien F, 1996, ANTI-CANCER DRUG, V7, P568, DOI 10.1097/00001813-199607000-00012; Vizler C, 2002, CYTOMETRY, V47, P158, DOI 10.1002/cyto.10066; Wang EJ, 2001, BIOCHEM BIOPH RES CO, V289, P580, DOI 10.1006/bbrc.2001.6000; WEAVER JL, 1991, EXP CELL RES, V196, P323, DOI 10.1016/0014-4827(91)90267-X; Xiao YL, 2006, MOL PHARMACEUT, V3, P45, DOI 10.1021/mp050088t; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	50	35	35	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60334	10.1371/journal.pone.0060334	http://dx.doi.org/10.1371/journal.pone.0060334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593196	Green Submitted, gold, Green Published			2022-12-27	WOS:000317382000012
J	Goforth, JB; Walter, NE; Karatan, E				Goforth, John Bradley; Walter, Nicholas Emmanuel; Karatan, Ece			Effects of Polyamines on Vibrio cholerae Virulence Properties	PLOS ONE			English	Article							MEDIATED MICROCOLONY FORMATION; COLONIZATION FACTOR; BIOFILM FORMATION; GENE-EXPRESSION; INFANT MOUSE; TOXIN; PILUS; INFECTION; PATHOGENESIS; CADAVERINE	Vibrio cholerae is the causative agent of the severe enteric disease cholera. To cause cholera the bacterium must be able to synthesize both cholera toxin (CT) and toxin-coregulated pilus (TCP) which mediates autoagglutination and is required for colonization of the small intestine. Only a few environmental signals have been shown to regulate V. cholerae virulence gene expression. Polyamines, which are ubiquitous in nature, and have been implicated in regulating virulence gene expression in other bacteria, have not been extensively studied for their effect on V. cholerae virulence properties. The objective of this study was to test the effect of several polyamines that are abundant in the human intestine on V. cholerae virulence properties. All of the polyamines tested inhibited autoagglutination of V. cholerae O1 classical strain in a concentration dependent manner. Putrescine and cadaverine decreased the synthesis of the major pilin subunit, TcpA, spermidine increased its production, and spermine had no effect. Putrescine and spermidine led to a decrease and increase, respectively, on the relative abundance of TCP found on the cell surface. Spermine led to a small reduction in cholera toxin synthesis whereas none of the other polyamines had an effect. The polyamines did not affect pili bundling morphology, but caused a small reduction in CTX phi transduction, indicating that the TCP present on the cell surface may not be fully functional. We hypothesize the inhibition of autoagglutination is likely to be caused by the positively charged amine groups on the polyamines electrostatically disrupting the pili-pili interactions which mediate autoagglutination. Our results implicate that polyamines may have a protective function against colonization of the small intestine by V. cholerae.	[Goforth, John Bradley; Walter, Nicholas Emmanuel; Karatan, Ece] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA	University of North Carolina; Appalachian State University	Karatan, E (corresponding author), Appalachian State Univ, Dept Biol, Boone, NC 28608 USA.	karatane@appstate.edu			NIH [AI096358]; Appalachian State University Department of Biology; Office of Student Research; Graduate Student Association Senate at Appalachian State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI096358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Appalachian State University Department of Biology; Office of Student Research; Graduate Student Association Senate at Appalachian State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the following sources: Appalachian State University Department of Biology, the Office of Student Research and the Graduate Student Association Senate at Appalachian State University and and by NIH (Grant number AI096358 to E.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Alam A, 2005, INFECT IMMUN, V73, P6674, DOI 10.1128/IAI.73.10.6674-6679.2005; Angelichio MJ, 1999, INFECT IMMUN, V67, P3733, DOI 10.1128/IAI.67.8.3733-3739.1999; Bardocz S., 1999, POLYAMINES HLTH NUTR, VVII; Benamouzig R, 1997, AM J CLIN NUTR, V65, P766, DOI 10.1093/ajcn/65.3.766; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; CLARKE ECW, 1985, J PHYS CHEM REF DATA, V14, P489, DOI 10.1063/1.555730; Cotter PA, 2000, ANNU REV MICROBIOL, V54, P519, DOI 10.1146/annurev.micro.54.1.519; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Fujiwara K, 1996, HISTOCHEM CELL BIOL, V106, P465, DOI 10.1007/s004180050065; GERLACH GF, 1989, INFECT IMMUN, V57, P219, DOI 10.1128/IAI.57.1.219-224.1989; Gupta S, 1997, INFECT IMMUN, V65, P1131, DOI 10.1128/IAI.65.3.1131-1134.1997; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; HAWEL L, 1994, J BIOL CHEM, V269, P7412; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Jude BA, 2011, J STRUCT BIOL, V175, P1, DOI 10.1016/j.jsb.2011.04.008; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11; Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006; Laux DC, 2005, ROLE MUCOSAL LAYER B; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Lim MS, 2010, MOL MICROBIOL, V77, P755, DOI 10.1111/j.1365-2958.2010.07244.x; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P25, DOI 10.1111/j.1348-0421.2007.tb03887.x; MCEVOY FA, 1975, PEDIATR RES, V9, P721, DOI 10.1203/00006450-197509000-00007; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milovic V, 2001, EUR J GASTROEN HEPAT, V13, P1021, DOI 10.1097/00042737-200109000-00004; Morgan DML, 1999, MOL BIOTECHNOL, V11, P229, DOI 10.1007/BF02788682; Murphy GM, 2001, EUR J GASTROEN HEPAT, V13, P1011, DOI 10.1097/00042737-200109000-00002; Nielsen AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001102; Noack J, 1998, J NUTR, V128, P1385, DOI 10.1093/jn/128.8.1385; Ritchie JM, 2009, CURR TOP MICROBIOL, V337, P37, DOI 10.1007/978-3-642-01846-6_2; Russo BC, 2011, INFECT IMMUN, V79, P3665, DOI 10.1128/IAI.00135-11; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Seiler N, 2007, CRIT REV CL LAB SCI, V44, P365, DOI 10.1080/10408360701250016; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; WALLACE HM, 1990, BIOCHEM SOC T, V18, P1079, DOI 10.1042/bst0181079; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x	50	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60765	10.1371/journal.pone.0060765	http://dx.doi.org/10.1371/journal.pone.0060765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593304	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000025
J	Centola, M; Cavet, G; Shen, YJ; Ramanujan, S; Knowlton, N; Swan, KA; Turner, M; Sutton, C; Smith, DR; Haney, DJ; Chernoff, D; Hesterberg, LK; Carulli, JP; Taylor, PC; Shadick, NA; Weinblatt, ME; Curtis, JR				Centola, Michael; Cavet, Guy; Shen, Yijing; Ramanujan, Saroja; Knowlton, Nicholas; Swan, Kathryn A.; Turner, Mary; Sutton, Chris; Smith, Dustin R.; Haney, Douglas J.; Chernoff, David; Hesterberg, Lyndal K.; Carulli, John P.; Taylor, Peter C.; Shadick, Nancy A.; Weinblatt, Michael E.; Curtis, Jeffrey R.			Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; ACTIVITY SCORE; THERAPY; RECOMMENDATIONS; METHOTREXATE; FIBROMYALGIA; CALPROTECTIN; ASSOCIATION; INFLIXIMAB	Background: Disease activity measurement is a key component of rheumatoid arthritis (RA) management. Biomarkers that capture the complex and heterogeneous biology of RA have the potential to complement clinical disease activity assessment. Objectives: To develop a multi-biomarker disease activity (MBDA) test for rheumatoid arthritis. Methods: Candidate serum protein biomarkers were selected from extensive literature screens, bioinformatics databases, mRNA expression and protein microarray data. Quantitative assays were identified and optimized for measuring candidate biomarkers in RA patient sera. Biomarkers with qualifying assays were prioritized in a series of studies based on their correlations to RA clinical disease activity (e. g. the Disease Activity Score 28-C-Reactive Protein [DAS28-CRP], a validated metric commonly used in clinical trials) and their contributions to multivariate models. Prioritized biomarkers were used to train an algorithm to measure disease activity, assessed by correlation to DAS and area under the receiver operating characteristic curve for classification of low vs. moderate/high disease activity. The effect of comorbidities on the MBDA score was evaluated using linear models with adjustment for multiple hypothesis testing. Results: 130 candidate biomarkers were tested in feasibility studies and 25 were selected for algorithm training. Multibiomarker statistical models outperformed individual biomarkers at estimating disease activity. Biomarker-based scores were significantly correlated with DAS28-CRP and could discriminate patients with low vs. moderate/high clinical disease activity. Such scores were also able to track changes in DAS28-CRP and were significantly associated with both joint inflammation measured by ultrasound and damage progression measured by radiography. The final MBDA algorithm uses 12 biomarkers to generate an MBDA score between 1 and 100. No significant effects on the MBDA score were found for common comorbidities. Conclusion: We followed a stepwise approach to develop a quantitative serum-based measure of RA disease activity, based on 12-biomarkers, which was consistently associated with clinical disease activity levels.	[Centola, Michael; Turner, Mary; Sutton, Chris; Smith, Dustin R.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Cavet, Guy; Ramanujan, Saroja; Swan, Kathryn A.; Haney, Douglas J.] Crescendo Biosci Inc, Dept Informat, San Francisco, CA USA; [Shen, Yijing] Crescendo Biosci Inc, Dept Biostat & Bioinformat, San Francisco, CA USA; [Knowlton, Nicholas] Oklahoma Med Res Fdn, Biomarker & Prote Core Facil, Oklahoma City, OK 73104 USA; [Chernoff, David] Crescendo Biosci Inc, Dept Med, San Francisco, CA USA; [Hesterberg, Lyndal K.] Crescendo Biosci Inc, Dept Dev, San Francisco, CA USA; [Carulli, John P.] Biogen Idec Inc, Genet & Genom Grp, Cambridge, MA USA; [Taylor, Peter C.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Shadick, Nancy A.; Weinblatt, Michael E.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Curtis, Jeffrey R.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; Biogen; University of Oxford; Harvard University; Brigham & Women's Hospital; University of Alabama System; University of Alabama Birmingham	Cavet, G (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	glcavet@gmail.com		Knowlton, Nicholas/0000-0002-7022-3352	Crescendo Bioscience; Biogen Idec	Crescendo Bioscience; Biogen Idec(Biogen)	This work was partly supported by Crescendo Bioscience and Biogen Idec. Crescendo Bioscience was partly responsible for study design, data collection, data analysis and preparation of the manuscript. No additional external funding received for this study.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bakker M, 2012, ANN RHEUMATIC DIS; Bakker MF, 2007, ANN RHEUM DIS, V66, P56, DOI 10.1136/ard.2007.078360; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L, 1997, J ROY STAT SOC B MET, V59, P3, DOI 10.1111/1467-9868.00054; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Curtis J.R., 2012, ARTHRITIS CARE RES; Eastman PS, 2012, J PHARMACEUT BIOMED, V70, P415, DOI 10.1016/j.jpba.2012.06.003; Eastman PS, 2012, J PHARM BIOMEDICAL A; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fleischmann RM, 2010, ANN RHEUM DIS, V69, P657; Fransen J, CLIN EXPT RHEUMATOLO, V23, pS93; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Hastie T., 2009, UNSUPERVISED LEARNIN; Iannaccone CK, 2011, RHEUMATOLOGY, V50, P40, DOI 10.1093/rheumatology/keq263; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Karlson EW, 2008, ANN RHEUM DIS, V67, P358, DOI 10.1136/ard.2007.071662; Keenan RT, 2008, CLIN EXP RHEUMATOL, V26, P814; Klimiuk PA, 2002, ANN RHEUM DIS, V61, P804, DOI 10.1136/ard.61.9.804; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Lavie F, 2007, ANN RHEUM DIS, V66, P700, DOI 10.1136/ard.2006.060772; Leeb BF, 2004, RHEUMATOLOGY, V43, P1504, DOI 10.1093/rheumatology/keh322; Marhadour T, 2010, J RHEUMATOL, V37, P932, DOI 10.3899/jrheum.090879; Mease PJ, 2010, J RHEUMATOL, V37, P1570, DOI 10.3899/jrheum.091064; Mease PJ, 1998, CLIN EXPT RHEUMATOLO, V29, P567; Melis L, 2010, ANN RHEUM DIS, V69, P618, DOI 10.1136/ard.2009.107649; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Park M-C, 2004, SCANDINAVIAN J RHEUM, V37, P173; Pincus T, 2008, J RHEUMATOL, V35, P2136, DOI 10.3899/jrheum.080182; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ranzolin A, 2009, ARTHRIT RHEUM-ARTHR, V61, P794, DOI 10.1002/art.24430; Rhodes B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000341; Rioja I, 2008, ARTHRITIS RHEUM-US, V58, P2257, DOI 10.1002/art.23667; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Sokka T, 2009, J RHEUMATOL, V36, P1387, DOI 10.3899/jrheum.080770; Targonska-Stepniak B, 2008, RHEUMATOL INT, V28, P585, DOI 10.1007/s00296-007-0480-9; Taylor PC, 2006, ARTHRITIS RHEUM-US, V54, P47, DOI 10.1002/art.21544; Taylor PC, 2004, ARTHRITIS RHEUM, V50, P1107, DOI 10.1002/art.20123; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Todd DJ, 2011, ARTHRITIS RHEUM-US, V63, P894, DOI 10.1002/art.30213; Uhlig T, 2009, ANN RHEUM DIS, V68, P972, DOI 10.1136/ard.2008.097345; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Wren JD, 2004, BIOINFORMATICS, V20, P191, DOI 10.1093/bioinformatics/btg390; Zatarain E, 2006, NAT CLIN PRACT RHEUM, V2, P611, DOI 10.1038/ncprheum0246; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	48	129	137	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60635	10.1371/journal.pone.0060635	http://dx.doi.org/10.1371/journal.pone.0060635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585841	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600031
J	Jiang, ZX; Liang, K; Ding, BQ; Tan, W; Wang, J; Lu, YX; Xu, YX; Tao, LM				Jiang, Zhengxuan; Liang, Kun; Ding, Biqing; Tan, Wei; Wang, Jing; Lu, Yunxia; Xu, Yuxin; Tao, Liming			Hepatocyte Growth Factor Genetic Variations and Primary Angle-Closure Glaucoma in the Han Chinese Population	PLOS ONE			English	Article							CAUCASIAN POPULATION; ASSOCIATION; POLYMORPHISMS; PARAMETERS; RECEPTOR; HGF	Purpose: The aim of this study is to examine whether or not hepatocyte growth factor (HGF) genetic variations are associated with susceptibility to primary angle-closure glaucoma (PACG) in the Han Chinese population. Methods: Three single-nucleotide polymorphisms (SNPs)-rs5745718, rs17427817, and rs3735520-in the HGF gene were genotyped in 238 adult patients with PACG and 287 age-, sex-, and ethnically matched healthy controls by using a polymerase chain reaction restriction fragment length polymorphism assay. Data was analyzed by x 2 analysis. Results: The three tested analyzed polymorphisms in the HGF gene were in Hardy-Weinberg equilibrium, in all the subjects. The frequencies of the genotype and allele of rs5745718 and rs1742817 in the HGF gene were significantly different between the PACG patients and the controls. On one hand, the frequencies of the CC genotype and C allele of rs5745718 were significantly decreased in PACG patients compared with controls (P-c = 1.40x10(-3); P-c = 3.21x10(-4), respectively); however, on the other hand, significantly decreased frequencies of the GG genotype and the G allele of rs17427817 were observed in PACG patients compared with the controls (P-c = 0.006,; P-c = 6.06x10(-4), respectively). A comparison of the distributions of the genotypes and alleles of rs3735520 showed no statistically significant differences between the PACG patients and the controls (P-c > 0.05). The haplotype analysis results showed that the CGC haplotype frequency was significantly decreased in the patients with PACG compared with the controls (P-c < 0.001). No difference was detected between the patients and the controls with regard to the other haplotypes. Conclusions: Our study suggests that rs5745718 and rs17427817 are associated with a decreased risk of PACG in the Chinese Han population. The CGC haplotype was demonstrated to possibly play a protective role against PACG in this population.	[Jiang, Zhengxuan; Liang, Kun; Ding, Biqing; Wang, Jing; Xu, Yuxin; Tao, Liming] Anhui Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Hefei, Anhui, Peoples R China; [Tan, Wei] Zunyi Med Univ, Affiliated Hosp 3, Peoples Hosp Zunyi 1, Dept Ophthalmol, Zunyi, Guizhou, Peoples R China; [Lu, Yunxia] Anhui Med Univ, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China	Anhui Medical University; Zunyi Medical University; Anhui Medical University	Tao, LM (corresponding author), Anhui Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Hefei, Anhui, Peoples R China.	taolimingchina@yahoo.cn	TAO, Li/HIR-4254-2022; Lu, Yunxia/AAU-6408-2021	Lu, Yunxia/0000-0002-8739-7789	Anhui Provincial Natural Science Foundation [1208085MH178]; Natural Science Foundation of Higher Educational Bureau of Anhui Province [kj2011z189]; Talent Foundation of the Department of Personnel Anhui Province [2010-45]; Foundation of Anhui Medical University [2012xkj053]; Governor Foundation of Special Research of Clinical Application in Guizhou Province [[2012]131]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Natural Science Foundation of Higher Educational Bureau of Anhui Province; Talent Foundation of the Department of Personnel Anhui Province; Foundation of Anhui Medical University; Governor Foundation of Special Research of Clinical Application in Guizhou Province	This work was supported in part by the Anhui Provincial Natural Science Foundation (1208085MH178), the Natural Science Foundation of Higher Educational Bureau of Anhui Province (kj2011z189), the Talent Foundation of the Department of Personnel Anhui Province (2010-45), the Foundation of Anhui Medical University (2012xkj053) and Governor Foundation of Special Research of Clinical Application in Guizhou Province ([2012]131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2007, INVEST OPHTH VIS SCI, V48, P5591, DOI 10.1167/iovs.07-0780; Amerasinghe N, 2011, OPHTHALMOLOGY, V118, P480, DOI 10.1016/j.ophtha.2010.06.043; Awadalla MS, 2011, MOL VIS, V17, P2248; Awadalla MS, 2011, MOL VIS, V17, P1420; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Casson RJ, 2008, CLIN EXP OPHTHALMOL, V36, P70, DOI 10.1111/j.1442-9071.2008.01672.x; Chen JH, 2012, MOL VIS, V18, P765; Cong YH, 2009, MOL VIS, V15, P1412; CONGDON N, 1992, SURV OPHTHALMOL, V36, P411, DOI 10.1016/S0039-6257(05)80022-0; Congdon NG, 1996, ACTA OPHTHALMOL SCAN, V74, P113; Dai Xiaohua, 2008, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V25, P493; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235, DOI 10.1001/archopht.1996.01100140435011; He PM, 1998, BIOCHEM BIOPH RES CO, V249, P253, DOI 10.1006/bbrc.1998.9087; Hu DN, 2001, J GLAUCOMA, V10, P152, DOI 10.1097/00061198-200106000-00002; Jiang ZX, 2010, HUM IMMUNOL, V71, P414, DOI 10.1016/j.humimm.2010.01.026; Li Q, 1996, INVEST OPHTH VIS SCI, V37, P727; Lin YW, 1997, J FORMOS MED ASSOC, V96, P908; Mengkegale M, 2008, MOL VIS, V14, P413; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sihota R, 2000, CLIN EXP OPHTHALMOL, V28, P253, DOI 10.1046/j.1442-9071.2000.00324.x; Veerappan S, 2010, OPHTHALMOLOGY, V117, P239, DOI 10.1016/j.ophtha.2009.07.002; Wang CY, 2012, MOL VIS, V18, P779; Wang NL, 2002, CHINESE MED J-PEKING, V115, P1706; Wilson SE, 1999, EXP EYE RES, V68, P377, DOI 10.1006/exer.1998.0603; Wordinger RJ, 1998, INVEST OPHTH VIS SCI, V39, P1575; Yanovitch T, 2009, MOL VIS, V15, P1028; Zhou HY, 2010, MOL VIS, V16, P2585	29	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60950	10.1371/journal.pone.0060950	http://dx.doi.org/10.1371/journal.pone.0060950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585864	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600071
J	Ledda, M; Megiorni, F; Pozzi, D; Giuliani, L; D'Emilia, E; Piccirillo, S; Mattei, C; Grimaldi, S; Lisi, A				Ledda, Mario; Megiorni, Francesca; Pozzi, Deleana; Giuliani, Livio; D'Emilia, Enrico; Piccirillo, Sara; Mattei, Cristiana; Grimaldi, Settimio; Lisi, Antonella			Non Ionising Radiation as a Non Chemical Strategy in Regenerative Medicine: Ca2+-ICR "In Vitro" Effect on Neuronal Differentiation and Tumorigenicity Modulation in NT2 Cells	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; RETINOIC ACID; STEM-CELLS; GENE-EXPRESSION; AURORA KINASES; TGF-ALPHA; GROWTH; PROTEINS; FIELDS; CANCER	In regenerative medicine finding a new method for cell differentiation without pharmacological treatment or gene modification and minimal cell manipulation is a challenging goal. In this work we reported a neuronal induced differentiation and consequent reduction of tumorigenicity in NT2 human pluripotent embryonal carcinoma cells exposed to an extremely low frequency electromagnetic field (ELF-EMF), matching the cyclotron frequency corresponding to the charge/ mass ratio of calcium ion (Ca2+-ICR). These cells, capable of differentiating into post-mitotic neurons following treatment with Retinoic Acid (RA), were placed in a solenoid and exposed for 5 weeks to Ca2+-ICR. The solenoid was installed in a m-metal shielded room to avoid the effect of the geomagnetic field and obtained totally controlled and reproducible conditions. Contrast microscopy analysis reveled, in the NT2 exposed cells, an important change in shape and morphology with the outgrowth of neuritic-like structures together with a lower proliferation rate and metabolic activity alike those found in the RA treated cells. A significant up-regulation of early and late neuronal differentiation markers and a significant down-regulation of the transforming growth factor-alpha (TGF-alpha) and the fibroblast growth factor-4 (FGF-4) were also observed in the exposed cells. The decreased protein expression of the transforming gene Cripto-1 and the reduced capability of the exposed NT2 cells to form colonies in soft agar supported these last results. In conclusion, our findings demonstrate that the Ca2+-ICR frequency is able to induce differentiation and reduction of tumorigenicity in NT2 exposed cells suggesting a new potential therapeutic use in regenerative medicine.	[Ledda, Mario; Pozzi, Deleana; Piccirillo, Sara; Mattei, Cristiana; Grimaldi, Settimio; Lisi, Antonella] CNR, Inst Translat Pharmacol, Rome, Italy; [Megiorni, Francesca; Pozzi, Deleana] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Giuliani, Livio; D'Emilia, Enrico] Natl Inst Occupat Safety & Prevent, Dept Product Plants & Interact Environm, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); Sapienza University Rome	Lisi, A (corresponding author), CNR, Inst Translat Pharmacol, Rome, Italy.	antonella.lisi@ift.cnr.it	Megiorni, Francesca/AAC-1597-2019; Ledda, Mario/B-5656-2015; Ledda, Mario/AAP-2356-2021; Ledda, Mario/ABA-8685-2021; Lisi, Antonella/C-7024-2015	Megiorni, Francesca/0000-0003-3705-3248; Ledda, Mario/0000-0002-0349-8938; Ledda, Mario/0000-0002-0349-8938; Lisi, Antonella/0000-0002-5465-9500				Adamson ED, 2002, J CELL PHYSIOL, V190, P267, DOI 10.1002/jcp.10072; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Andrews PW, 1998, APMIS, V106, P158, DOI 10.1111/j.1699-0463.1998.tb01331.x; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Andrews PW, 2001, COLD SPRING HARBOR M, P231; Baldini E, 2010, ANDROLOGIA, V42, P260, DOI 10.1111/j.1439-0272.2009.00987.x; BASELGA J, 1993, ONCOGENE, V8, P3257; Bevort M, 2000, DIFFERENTIATION, V66, P81, DOI 10.1046/j.1432-0436.2000.660203.x; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Cheung WMW, 1999, BIOTECHNIQUES, V26, P946, DOI 10.2144/99265rr04; Chieffi P, 2004, J ENDOCRINOL, V181, P263, DOI 10.1677/joe.0.1810263; CIARDIELLO F, 1991, CANCER RES, V51, P1051; CIARDIELLO F, 1991, P NATL ACAD SCI USA, V88, P7792, DOI 10.1073/pnas.88.17.7792; CIARDIELLO F, 1991, ANN ONCOL, V2, P169; COSSARIZZA A, 1989, BIOCHEM BIOPH RES CO, V160, P692, DOI 10.1016/0006-291X(89)92488-1; Coyle DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016174; Croitoru-Lamoury J, 2006, CYTOTHERAPY, V8, P445, DOI 10.1080/14653240600879152; De Carlo F, 2012, TISSUE ENG A, V18; DMITROVSKY E, 1990, ONCOGENE RES, V5, P233; Fennerf MH, 2008, EXPERT OPIN INV DRUG, V17, P511, DOI [10.1517/13543784.17.4.511, 10.1517/13543784.17.4.511 ]; Gaetani R, 2009, CARDIOVASC RES, V82, P411, DOI 10.1093/cvr/cvp067; Gao ZY, 1998, BIOCHEM BIOPH RES CO, V247, P407, DOI 10.1006/bbrc.1998.8826; Hara K, 2007, J NEUROSCI RES, V85, P1240, DOI 10.1002/jnr.21234; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Jain P, 2007, J NEUROSCI RES, V85, P83, DOI 10.1002/jnr.21094; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDNEV VV, 1991, BIOELECTROMAGNETICS, V12, P71, DOI 10.1002/bem.2250120202; LIBOFF A R, 1985, Journal of Biological Physics, V13, P99, DOI 10.1007/BF01878387; Liboff AR, 1985, INTERACTIONS ELECT F, P281; Lisi A, 2005, J CELL PHYSIOL, V204, P532, DOI 10.1002/jcp.20322; Lisi A, 2008, ELECTROMAGN BIOL MED, V27, P127, DOI 10.1080/15368370802072117; Lisi A, 2006, BIOELECTROMAGNETICS, V27, P641, DOI 10.1002/bem.20255; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maerz WJ, 1998, ONCOGENE, V17, P761, DOI 10.1038/sj.onc.1201992; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Matthews N, 2006, EXPERT REV ANTICANC, V6, P109, DOI 10.1586/14737140.6.1.109; Megiorni F, 2005, NEUROSCI LETT, V373, P105, DOI 10.1016/j.neulet.2004.09.070; Meland MN, 2010, J NEUROSCI RES, V88, P222, DOI 10.1002/jnr.22171; MIYAZONO M, 1995, LAB INVEST, V73, P273; Neelands TR, 2000, J NEUROPHYSIOL, V84, P2933, DOI 10.1152/jn.2000.84.6.2933; Newman MB, 2005, STEM CELLS DEV, V14, P29, DOI 10.1089/scd.2005.14.29; Noel EE, 2008, GENE CHROMOSOME CANC, V47, P604, DOI 10.1002/gcc.20564; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Przyborski SA, 2004, STEM CELLS DEV, V13, P400, DOI 10.1089/1547328041797507; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; SAEKI T, 1991, MOL ENDOCRINOL, V5, P1955, DOI 10.1210/mend-5-12-1955; Stanke M, 2004, MOL CELL NEUROSCI, V25, P374, DOI 10.1016/j.mcn.2003.10.021; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Ulisse S, 2010, J ENDOCRINOL, V204, P135, DOI 10.1677/JOE-09-0257; Ventura C, 2004, FASEB J, V18, P155, DOI 10.1096/fj.04-2695fje	52	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61535	10.1371/journal.pone.0061535	http://dx.doi.org/10.1371/journal.pone.0061535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585910	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600125
J	Lew, WYW; Bayna, E; Molle, ED; Dalton, ND; Lai, NC; Bhargava, V; Mendiola, V; Clopton, P; Tang, T				Lew, Wilbur Y. W.; Bayna, Evelyn; Molle, Erminia Dalle; Dalton, Nancy D.; Lai, N. Chin; Bhargava, Valmik; Mendiola, Vincent; Clopton, Paul; Tang, Tong			Recurrent Exposure to Subclinical Lipopolysaccharide Increases Mortality and Induces Cardiac Fibrosis in Mice	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; DIASTOLIC DYSFUNCTION; VENTRICULAR MYOCYTES; PERIODONTAL-DISEASE; INNATE IMMUNITY; ENDOTOXEMIA; FIBROBLAST; EXPRESSION; OBESITY	Background: Circulating subclinical lipopolysaccharide (LPS) occurs in health and disease. Ingesting high fatty meals increases LPS that cause metabolic endotoxemia. Subclinical LPS in periodontal disease may impair endothelial function. The heart may be targeted as cardiac cells express TLR4, the LPS receptor. It was hypothesized that recurrent exposure to subclinical LPS increases mortality and causes cardiac fibrosis. Methods: C57Bl/6 mice were injected with intraperitoneal saline (control), low dose LPS (0.1 or 1 mg/kg), or moderate dose LPS (10 or 20 mg/kg), once a week for 3 months. Left ventricular (LV) function (echocardiography), hemodynamics (tail cuff pressure) and electrocardiograms (telemetry) were measured. Cardiac fibrosis was assessed by picrosirius red staining and LV expression of fibrosis related genes (QRT-PCR). Adult cardiac fibroblasts were isolated and exposed to LPS. Results: LPS injections transiently increased heart rate and blood pressure (<6 hours) and mildly decreased LV function with full recovery by 24 hours. Mice tolerated weekly LPS for 2-3 months with no change in activity, appearance, appetite, weight, blood pressure, LV function, oximetry, or blood chemistries. Mortality increased after 60-90 days with moderate, but not low dose LPS. Arrhythmias occurred a few hours before death. LV collagen fraction area increased dose-dependently from 3.0 +/- 0.5% (SEM) in the saline control group, to 5.6 +/- 0.5% with low dose LPS and 9.7 +/- 0.9% with moderate dose LPS (P<0.05 moderate vs low dose LPS, and each LPS dose vs control). LPS increased LV expression of collagen I alpha 1, collagen III alpha 1, MMP2, MMP9, TIMP1, periostin and IL-6 (P<0.05 moderate vs low dose LPS and vs control). LPS increased alpha-SMA immunostaining of myofibroblasts. LPS dose-dependently increased IL-6 in isolated adult cardiac fibroblasts. Conclusions: Recurrent exposure to subclinical LPS increases mortality and induces cardiac fibrosis.	[Lew, Wilbur Y. W.] Vet Adm San Diego Healthcare Syst, Dept Med, Cardiol Sect, San Diego, CA USA; Vet Adm San Diego Healthcare Syst, Res Serv, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California San Diego	Lew, WYW (corresponding author), Vet Adm San Diego Healthcare Syst, Dept Med, Cardiol Sect, San Diego, CA USA.	wlew@ucsd.edu		Mendiola, Vincent Louie/0000-0001-5287-0743	Medical Research Service, Department of Veterans Affairs [0007]; Veterans Medical Research Foundation, San Diego, California [08254]; American Heart Association [11GRNT7610059]	Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Medical Research Foundation, San Diego, California; American Heart Association(American Heart Association)	This research was supported by the Medical Research Service, Department of Veterans Affairs (0007, P. I. WYWL) [www.research.va.gov], the Veterans Medical Research Foundation, San Diego, California (08254, P. I. WYWL) [www.vmrf.org], and the American Heart Association (11GRNT7610059, P. I. TT) [www.heart.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Amar S, 2003, ARTERIOSCL THROM VAS, V23, P1245, DOI 10.1161/01.ATV.0000078603.90302.4A; Beck JD, 2001, ARTERIOSCL THROM VAS, V21, P1816, DOI 10.1161/hq1101.097803; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Blyszczuk P, 2009, CIRC RES, V105, P912, DOI 10.1161/CIRCRESAHA.109.199802; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Geerts SO, 2002, J PERIODONTOL, V73, P73, DOI 10.1902/jop.2002.73.1.73; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Li HL, 2002, AM J PHYSIOL-HEART C, V283, pH461, DOI 10.1152/ajpheart.00701.2001; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; O'Reilly S, 2012, CYTOKINE GROWTH F R, V23, P99, DOI 10.1016/j.cytogfr.2012.04.003; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Roth DM, 2003, BASIC RES CARDIOL, V98, P380, DOI 10.1007/s00395-003-0429-4; Sciarretta S, 2009, CLIN SCI, V116, P467, DOI 10.1042/CS20080390; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Selkirk GA, 2008, AM J PHYSIOL-REG I, V295, pR611, DOI 10.1152/ajpregu.00917.2007; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; Suzuki J, 2003, J AM COLL CARDIOL, V41, P482, DOI 10.1016/S0735-1097(02)02820-6; Suzuki J, 2007, J AM COLL CARDIOL, V49, P491, DOI 10.1016/j.jacc.2006.10.043; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Warren HS, 2010, J INFECT DIS, V201, P223, DOI 10.1086/649557; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Yasuda S, 1997, CIRC RES, V81, P1011	39	63	64	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61057	10.1371/journal.pone.0061057	http://dx.doi.org/10.1371/journal.pone.0061057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585870	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600078
J	Pedchenko, T; Mernaugh, R; Parekh, D; Li, M; Massion, PP				Pedchenko, Tetyana; Mernaugh, Ray; Parekh, Dipti; Li, Ming; Massion, Pierre P.			Early Detection of NSCLC with scFv Selected against IgM Autoantibody	PLOS ONE			English	Article							LUNG-CANCER; TUMOR-ANTIGENS; BREAST-CANCER; ANTIBODIES; REPERTOIRE; BIOMARKERS; DIAGNOSIS; SERUM	Survival of patients with lung cancer could be significantly prolonged should the disease be diagnosed early. Growing evidence indicates that the immune response in the form of autoantibodies to developing cancer is present before clinical presentation. We used a phage-displayed antibody library to select for recombinant scFvs that specifically bind to lung cancer-associated IgM autoantibodies. We selected for scFv recombinant antibodies reactive with circulating IgM autoantibodies found in the serum of patients with early stage lung adenocarcinoma but not matched controls. Discriminatory performance of 6 selected scFvs was validated in an independent set of serum from stage 1 adenocarcinoma and matching control groups using two independent novel methods developed for this application. The panel of 6 selected scFvs predicted cancer based on seroreactivity value with sensitivity of 0.8 and specificity of 0.87. Receiver Operative Characteristic curve (ROC) for combined 6 scFv has an AUC of 0.88 (95% CI, 0.76-1.0) as determined by fluorometric microvolume assay technology (FMAT) The ROC curve generated using a homogeneous bridging Mesa Scale Discovery (MSD) assay had an AUC of 0.72 (95% CI, 0.59-0.85). The panel of all 6 antibodies demonstrated better discriminative power than any single scFv alone. The scFv panel also demonstrated the association between a high score - based on seroreactivity - with poor survival. Selected scFvs were able to recognize lung cancer associated IgM autoantibodies in patient serum as early as 21 months before the clinical presentation of disease. The panel of antibodies discovered represents a potential unique non-invasive molecular tool to detect an immune response specific to lung adenocarcinoma at an early stage of disease.	[Pedchenko, Tetyana; Massion, Pierre P.] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37212 USA; [Mernaugh, Ray; Parekh, Dipti] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Li, Ming] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Massion, Pierre P.] Tennessee Valley Hlth Care Syst, Vet Affairs, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Pedchenko, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37212 USA.	tetyana.v.pedchenko@vanderbilt.edu	Li, Ming/P-9514-2019	Li, Ming/0000-0001-8270-2070	ASCO Advanced Career Research Award; Vanderbilt SPORE in lung cancer Project [1 CA 090949]; Vanderbilt Institute of Chemical Biology; NATIONAL CANCER INSTITUTE [P50CA090949, U01CA152662] Funding Source: NIH RePORTER	ASCO Advanced Career Research Award; Vanderbilt SPORE in lung cancer Project; Vanderbilt Institute of Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an ASCO Advanced Career Research Award to Pierre P. Massion and the Vanderbilt SPORE in lung cancer Project 1 CA 090949. Ray Mernaugh was supported in part by the Vanderbilt Institute of Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastarache JA, 2011, J IMMUNOL METHODS, V367, P33, DOI 10.1016/j.jim.2011.01.005; Bradley C, 2007, CARCINOGENESIS, V28, P2184, DOI 10.1093/carcin/bgm100; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; Davies SS, 2004, FREE RADICAL BIO MED, V36, P1163, DOI 10.1016/j.freeradbiomed.2004.02.014; Dawling S, 2001, CANCER RES, V61, P6716; Draghici S, 2005, EXPERT REV MOL DIAGN, V5, P735, DOI 10.1586/14737159.5.5.735; Du LP, 2005, ARCH BIOCHEM BIOPHYS, V435, P125, DOI 10.1016/j.abb.2004.11.023; Edl J, 2005, METH MOL B, V303, P113; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Hennig EE, 2004, INFECT IMMUN, V72, P3429, DOI 10.1128/IAI.72.6.3429-3435.2004; Imafuku Y, 2004, DIS MARKERS, V20, P149, DOI 10.1155/2004/829450; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; POPE T, 1996, ANTIBODY ENG PRACTIC; Qiu J, 2008, J CLIN ONCOL, V26, P5060, DOI 10.1200/JCO.2008.16.2388; Shin BK, 2002, J MAMMARY GLAND BIOL, V7, P407, DOI 10.1023/A:1024038132381; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Travis WD, 2008, J THORAC ONCOL, V3, P1213, DOI 10.1097/JTO.0b013e31818b06e3; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Wardwell NR, 2005, SEMIN ONCOL, V32, P259, DOI 10.1053/j.seminoncol.2005.02.009; Zhang JY, 2004, CANCER DETECT PREV, V28, P114, DOI 10.1016/j.cdp.2003.12.006; Zhong L, 2006, J THORAC ONCOL, V1, P513, DOI 10.1097/01243894-200607000-00003	23	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60934	10.1371/journal.pone.0060934	http://dx.doi.org/10.1371/journal.pone.0060934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585862	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600069
J	Abdi, J; Mutis, T; Garssen, J; Redegeld, F				Abdi, Jahangir; Mutis, Tuna; Garssen, Johan; Redegeld, Frank			Characterization of the Toll-like Receptor Expression Profile in Human Multiple Myeloma Cells	PLOS ONE			English	Article							SIGNALING PATHWAY; PLASMA-CELLS; KAPPA-B; CANCER; IMMUNOTHERAPY; SURVIVAL; INFLAMMATION; ACTIVATION; LIGANDS; GROWTH	Expression and function of Toll-like receptors (TLRs) in multiple myeloma (MM) has recently become the focus of several studies. Knowledge of expression and biology of these receptors in MM will provide us with a new insight into the role of an inflammatory environment in disease progression or pathogenesis of MM. However, to date a quite heterogeneous expression pattern of TLRs in MM particularly at gene level has been described while information on the TLR expression at the protein level is largely unavailable. In this study, we investigated the TLR expression in human myeloma cell lines (HMCLs) Fravel, L363, UM6, UM9, OPM1, OPM2, U266, RPMI 8226, XG1, and NCI H929 and primary cells from MM patients at both mRNA and protein level (western blot and flow cytometry). We found that all cell lines and primary cells expressed TLR1, TLR3, TLR4, TLR7, TLR8, and TLR9 mRNA and protein. TLR2 and TLR5 were expressed by the majority of HMCLs at mRNA but were not detectable at protein level, while primary samples showed a low level of TLR2, TLR3 and TLR5 protein expression. Our results indicate that MM cells express a broad range of TLRs with a degree of disparity between gene and protein expression pattern. The clear expression of TLRs in MM cells indicates a propensity for responding to tumor-induced inflammatory signals, which seem inevitable in the MM bone marrow environment.	[Abdi, Jahangir; Garssen, Johan; Redegeld, Frank] Univ Utrecht, Div Pharmacol, Fac Sci, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Mutis, Tuna] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Redegeld, F (corresponding author), Univ Utrecht, Div Pharmacol, Fac Sci, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	f.a.m.redegeld@uu.nl	Abdi, Jahangir/ABF-9317-2020; garssen, johan/I-7159-2016; Redegeld, Frank A/O-6534-2016	Redegeld, Frank A/0000-0001-8830-7960; Abdi, Jahangir/0000-0001-5857-7281	Utrecht University	Utrecht University	This research has been funded by the Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi J, 2011, CRIT REV ONCOL HEMAT, V80, P225, DOI 10.1016/j.critrevonc.2010.12.001; Arvaniti E, 2011, HAEMATOL-HEMATOL J, V96, P1644, DOI 10.3324/haematol.2011.044792; Bohnhorst J, 2006, LEUKEMIA, V20, P1138, DOI 10.1038/sj.leu.2404225; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Brown LM, 2008, BLOOD, V111, P3388, DOI 10.1182/blood-2007-10-121285; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Chiron D, 2008, BLOOD, V112, P2205, DOI 10.1182/blood-2008-02-140673; Chiron D, 2009, J IMMUNOL, V182, P4471, DOI 10.4049/jimmunol.0803113; Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Jeannin P, 2008, CURR OPIN IMMUNOL, V20, P530, DOI 10.1016/j.coi.2008.04.013; Jego G, 2006, LEUKEMIA, V20, P1130, DOI 10.1038/sj.leu.2404226; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Paradisi F, 2001, INFECT DIS CLIN N AM, V15, P373, DOI 10.1016/S0891-5520(05)70151-3; Prabhala RH, 2006, BLOOD, V107, P301, DOI 10.1182/blood-2005-08-3101; Pratt G, 2007, BRIT J HAEMATOL, V138, P563, DOI 10.1111/j.1365-2141.2007.06705.x; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rozkova D, 2010, INT J CANCER, V126, P1132, DOI 10.1002/ijc.24832; van de Donk NWCJ, 2002, LEUKEMIA, V16, P1362, DOI 10.1038/sj.leu.2402501; van der Veer MS, 2011, HAEMATOL-HEMATOL J, V96, P284, DOI 10.3324/haematol.2010.030759; Wang SQ, 2006, BLOOD, V108, P4071, DOI 10.1182/blood-2006-04-016980; Xu Y, 2010, BRIT J HAEMATOL, V150, P543, DOI 10.1111/j.1365-2141.2010.08284.x	25	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60671	10.1371/journal.pone.0060671	http://dx.doi.org/10.1371/journal.pone.0060671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593278	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000049
J	Hojjat-Farsangi, M; Ghaemimanesh, F; Daneshmanesh, AH; Bayat, AA; Mahmoudian, J; Jeddi-Tehrani, M; Rabbani, H; Mellstedt, H				Hojjat-Farsangi, Mohammad; Ghaemimanesh, Fatemeh; Daneshmanesh, Amir Hossein; Bayat, Ali-Ahmad; Mahmoudian, Jafar; Jeddi-Tehrani, Mahmood; Rabbani, Hodjatallah; Mellstedt, Hakan			RETRACTED: Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							CHRONIC LYMPHOCYTIC-LEUKEMIA; REGION GENE USAGE; POSTTRANSLATIONAL MODIFICATIONS; BREAST-CANCER; AUTOPHOSPHORYLATION; FAMILY; GLYCOSYLATION; EXPRESSION; PHOSPHORYLATION; AMPLIFICATION	The receptor tyrosine kinase (RTK) ROR1 is overexpressed and of importance for the survival of various malignancies, including lung adenocarcinoma, breast cancer and chronic lymphocytic leukemia (CLL). There is limited information however on ROR1 in melanoma. In the present study we analysed in seven melanoma cell lines ROR1 expression and phosphorylation as well as the effects of anti-ROR1 monoclonal antibodies (mAbs) and ROR1 suppressing siRNA on cell survival. ROR1 was overexpressed at the protein level to a varying degree and phosphorylated at tyrosine and serine residues. Three of our four self-produced anti-ROR1 mAbs (clones 3H9, 5F1 and 1A8) induced a significant direct apoptosis of the ESTDAB049, ESTDAB112, DFW and A375 cell lines as well as cell death in complement dependent cytotoxicity (CDC) and antibody dependent cellular cytotoxicity (ADCC). The ESTDAB081 and 094 cell lines respectively were resistant to direct apoptosis of the four anti-ROR1 mAbs alone but not in CDC or ADCC. ROR1 siRNA transfection induced downregulation of ROR1 expression both at mRNA and protein levels proceeded by apoptosis of the melanoma cells (ESTDAB049, ESTDAB112, DFW and A375) including ESTDAB081, which was resistant to the direct apoptotic effect of the mAbs. The results indicate that ROR1 may play a role in the survival of melanoma cells. The surface expression of ROR1 on melanoma cells may support the notion that ROR1 might be a suitable target for mAb therapy.	[Hojjat-Farsangi, Mohammad; Daneshmanesh, Amir Hossein; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Oncol Pathol, Immune & Gene Therapy Lab, Canc Ctr Karolinska CCK, Stockholm, Sweden; [Hojjat-Farsangi, Mohammad; Daneshmanesh, Amir Hossein; Mellstedt, Hakan] Karolinska Inst, Stockholm, Sweden; [Hojjat-Farsangi, Mohammad] Bushehr Univ Med Sci, Sch Med, Dept Immunol, Bushehr, Iran; [Ghaemimanesh, Fatemeh; Bayat, Ali-Ahmad; Mahmoudian, Jafar; Jeddi-Tehrani, Mahmood; Rabbani, Hodjatallah] ACECR, Avicenna Res Inst, Monoclonal Antibody Res Ctr, Tehran, Iran	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Academic Center for Education, Culture & Research (ACECR)	Hojjat-Farsangi, M (corresponding author), Karolinska Univ Hosp Solna, Dept Oncol Pathol, Immune & Gene Therapy Lab, Canc Ctr Karolinska CCK, Stockholm, Sweden.	mohammad.hojat-farsangi@ki.se	Jeddi-Tehrani, Mahmood/HDM-1013-2022; Ghaemimanesh, Fatemeh/Q-9959-2017; Hojjat-Farsangi, Mohammad/E-8171-2018; Mahmoudian, Jafar/ABA-3206-2021	Ghaemimanesh, Fatemeh/0000-0002-0386-1717; Hojjat-Farsangi, Mohammad/0000-0002-0589-5523; Jeddi-Tehrani, Mahmood/0000-0002-8831-4711; Mahmoudian, Jafar/0000-0001-7048-159X	CLL Global Research Foundation; VINNOVA; Swedish Research Council; Cancer and Allergy Foundation; Swedish Cancer Society; Cancer Society in Stockholm; King Gustaf Vth Jubilee Fund; Karolinska Institute Foundations; Stockholm County Council; Avicenna Research Institute, ACECR, Tehran, Iran	CLL Global Research Foundation; VINNOVA(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer and Allergy Foundation; Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; King Gustaf Vth Jubilee Fund; Karolinska Institute Foundations(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Avicenna Research Institute, ACECR, Tehran, Iran	This study was supported by grants from the CLL Global Research Foundation, VINNOVA, the Swedish Research Council, the Cancer and Allergy Foundation, the Swedish Cancer Society, the Cancer Society in Stockholm, the King Gustaf Vth Jubilee Fund, the Karolinska Institute Foundations, the Stockholm County Council and Avicenna Research Institute, ACECR, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Bennasroune A, 2004, CRIT REV ONCOL HEMAT, V50, P23, DOI 10.1016/j.critrevonc.2003.08.004; Butenas Saulius, 2012, Front Biosci (Elite Ed), V4, P381; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Choudhury A, 2010, BRIT J HAEMATOL, V151, P327, DOI 10.1111/j.1365-2141.2010.08362.x; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Cronwright G, 2005, CANCER RES, V65, P2207, DOI 10.1158/0008-5472.CAN-04-1882; Daneshmanesh AH, 2012, LEUKEMIA, V26, P1348, DOI 10.1038/leu.2011.362; Daneshmanesh AH, 2012, 54 AM SOC HEM ASH AT; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Daneshmanesh AH, 2013, LEUKEMIA LYMPHOMA, V54, P843, DOI 10.3109/10428194.2012.731599; Endo M, 2012, J CELL SCI, V125, P2017, DOI 10.1242/jcs.097782; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; GOTTLINGER HG, 1986, INT J CANCER, V38, P47; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; GULLICK WJ, 1991, BRIT J CANCER, V63, P434, DOI 10.1038/bjc.1991.100; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Hojjat Farsangi Mohammad, 2008, Iran J Immunol, V5, P25, DOI IJIv5i1A2; Hojjat-Farsangi M, 2009, CANCER SCI, V100, P2346, DOI 10.1111/j.1349-7006.2009.01341.x; Hu QX, 2007, VIROLOGY, V368, P145, DOI 10.1016/j.virol.2007.06.029; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kaucka M, 2011, ACTA PHYSIOL, V203, P351, DOI 10.1111/j.1748-1716.2011.02306.x; Khoury H, 2001, ONCOGENE, V20, P788, DOI 10.1038/sj.onc.1204166; Laidler P, 2006, CANCER IMMUNOL IMMUN, V55, P112, DOI 10.1007/s00262-005-0019-4; Leeming DJ, 2011, BIOMARKERS, V16, P193, DOI 10.3109/1354750X.2011.557440; Lethe B, 1998, INT J CANCER, V76, P903, DOI 10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Mellstedt H, 2011, 53 AM SOC HEM ASH SA; Mendez R, 2008, CANCER IMMUNOL IMMUN, V57, P719, DOI 10.1007/s00262-007-0411-3; Mendez R, 2009, CANCER IMMUNOL IMMUN, V58, P1507, DOI 10.1007/s00262-009-0701-z; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PATERSON MC, 1991, CANCER RES, V51, P556; Paulitschke V, 2009, J PROTEOME RES, V8, P2501, DOI 10.1021/pr8010827; Pawelec G, 2006, CANCER IMMUNOL IMMUN, V55, P623, DOI 10.1007/s00262-005-0117-3; Poehlein Christian H, 2005, Curr Oncol Rep, V7, P383, DOI 10.1007/s11912-005-0066-1; Rabbani Hodjattallah, 2010, Iranian Biomedical Journal, V14, P77; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; SENSI M, 1995, P NATL ACAD SCI USA, V92, P5674, DOI 10.1073/pnas.92.12.5674; Singh G, 2011, CURR CANCER DRUG TAR, V11, P536, DOI 10.2174/156800911795655930; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Staff C, 2012, J CLIN IMMUNOL, V32, P855, DOI 10.1007/s10875-012-9662-7; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yoda A, 2003, J RECEPT SIG TRANSD, V23, P1, DOI 10.1081/RRS-120018757; Zhang SP, 2012, AM J PATHOL, V181, P1903, DOI 10.1016/j.ajpath.2012.08.024; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]	52	36	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61167	10.1371/journal.pone.0061167	http://dx.doi.org/10.1371/journal.pone.0061167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593420	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000108
J	Jang, SI; Kim, DK; Lillehoj, HS; Lee, SH; Lee, KW; Bertrand, F; Dupuis, L; Deville, S; Ben Arous, J; Lillehoj, EP				Jang, Seung I.; Kim, Duk Kyung; Lillehoj, Hyun S.; Lee, Sung Hyen; Lee, Kyung Woo; Bertrand, Francois; Dupuis, Laurent; Deville, Sebastien; Ben Arous, Juliette; Lillehoj, Erik P.			Evaluation of Montanide (TM) ISA 71 VG Adjuvant during Profilin Vaccination against Experimental Coccidiosis	PLOS ONE			English	Article							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; EIMERIA-ACERVULINA; GENE-EXPRESSION; IMMUNE-RESPONSES; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; ANTIGEN VACCINATION; IMMUNIZATION; INFECTION; CYTOKINE	Chickens were immunized subcutaneously with an Eimeria recombinant profilin protein plus Montanide (TM) ISA 70 VG (ISA 70) or Montanide (TM) ISA 71 VG (ISA 71) water-in-oil adjuvants, or with profilin alone, and comparative RNA microarray hybridizations were performed to ascertain global transcriptome changes induced by profilin/ISA 70 vs. profilin alone and by profilin/ISA 71 vs. profilin alone. While immunization with profilin/ISA 70 vs. profilin alone altered the levels of more total transcripts compared with profilin/ISA 71 vs. profilin alone (509 vs. 296), the latter was associated with a greater number of unique biological functions, and a larger number of genes within these functions, compared with the former. Further, canonical pathway analysis identified 10 pathways that were associated with genes encoding the altered transcripts in animals immunized with profilin/ISA 71 vs. profilin alone, compared with only 2 pathways in profilin/ISA 70 vs. profilin alone. Therefore, ISA 71 was selected as a candidate adjuvant in conjunction with profilin vaccination for in vivo disease protection studies. Vaccination with profilin/ISA 71 was associated with greater body weight gain following E. acervulina infection, and decreased parasite fecal shedding after E. maxima infection, compared with profilin alone. Anti-profilin antibody levels were higher in sera of E. maxima- and E. tenella-infected chickens vaccinated with profilin/ISA 71 compared with profilin alone. Finally, the levels of transcripts encoding interferon-gamma, interleukin (IL)-2, IL-10, and IL-17A were increased in intestinal lymphocytes from E. acervulina-, E. maxima-, and/or E. tenella-infected chickens vaccinated with profilin/ISA 71 compared with profilin alone. None of these effects were seen in chickens injected with ISA 71 alone indicating that the adjuvant was not conferring non-specific immune stimulation. These results suggest that profilin plus ISA 71 augments protective immunity against selective Eimeria species in chickens.	[Jang, Seung I.; Kim, Duk Kyung; Lillehoj, Hyun S.; Lee, Sung Hyen; Lee, Kyung Woo] USDA ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, Beltsville, MD USA; [Bertrand, Francois; Dupuis, Laurent; Deville, Sebastien; Ben Arous, Juliette] SEPPIC, F-92800 Puteaux La Defense, France; [Lillehoj, Erik P.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland Baltimore	Lillehoj, HS (corresponding author), USDA ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, Beltsville, MD USA.	Hyun.Lillehoj@ars.usda.gov	Lee, Kyung-Woo/D-5494-2019	Lee, Kyung-Woo/0000-0002-3533-7979; Lillehoj, Erik/0000-0002-2710-1704	ARS-USDA; Seppic, Inc. (Puteaux, France); World Class University Program of the Ministry of Education, Science and Technology of South Korea [R33-10013]; trust from Seppic, Inc.	ARS-USDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Seppic, Inc. (Puteaux, France); World Class University Program of the Ministry of Education, Science and Technology of South Korea; trust from Seppic, Inc.	This project was supported, in part, by a Trust agreement established between ARS-USDA and Seppic, Inc. (Puteaux, France), between ARS-USDA and the World Class University Program (R33-10013) of the Ministry of Education, Science and Technology of South Korea. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest. The study was supported in part by a trust from Seppic, Inc. and authors FB, LD, SD and JBA are employees of SEPPIC. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allen PC, 2002, CLIN MICROBIOL REV, V15, P58, DOI 10.1128/CMR.15.1.58-65.2002; Aucouturier J, 2006, VACCINE, V24, pS44, DOI 10.1016/j.vaccine.2005.01.116; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Belloc C, 2008, REV MED VET-TOULOUSE, V159, P371; Bowersock TL, 1999, ADV DRUG DELIVER REV, V38, P167, DOI 10.1016/S0169-409X(99)00015-0; De Gregorio E, 2008, EUR J IMMUNOL, V38, P2068, DOI 10.1002/eji.200838648; Ding XC, 2004, INFECT IMMUN, V72, P6939, DOI 10.1128/IAI.72.12.6939-6944.2004; Dupuis L, 2006, ANN NY ACAD SCI, V1081, P202, DOI 10.1196/annals.1373.024; Heegaard PMH, 2011, ARCH VIROL, V156, P183, DOI 10.1007/s00705-010-0863-1; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P259, DOI 10.1016/j.vetimm.2006.08.006; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P209, DOI 10.1016/j.vetimm.2006.07.007; Jang SI, 2011, EXP PARASITOL, V129, P36, DOI 10.1016/j.exppara.2011.05.021; Jang SI, 2011, EXP PARASITOL, V127, P178, DOI 10.1016/j.exppara.2010.07.021; Jang SI, 2010, VET PARASITOL, V172, P221, DOI 10.1016/j.vetpar.2010.04.042; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Kim DK, 2010, POULTRY SCI, V89, P68, DOI 10.3382/ps.2009-00275; Kim DK, 2012, BR J NUTR, V13, P1; Kim DK, 2012, AVIAN DIS, V56, P97, DOI 10.1637/9720-031711-Reg.1; Kim DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027712; Lee SH, 2007, POULTRY SCI, V86, P63, DOI 10.1093/ps/86.1.63; Lillehoj HS, 2007, POULTRY SCI, V86, P1491, DOI 10.1093/ps/86.7.1491; Lillehoj HS, 1998, AVIAN DIS, V42, P307, DOI 10.2307/1592481; Lillehoj HS, 2005, AVIAN DIS, V49, P112, DOI 10.1637/7249-073004R; Lillehoj HS, 2004, POULTRY SCI, V83, P611, DOI 10.1093/ps/83.4.611; Lillehoj HS, 2001, VET IMMUNOL IMMUNOP, V82, P229, DOI 10.1016/S0165-2427(01)00360-9; Lillehoj HS, 2000, AVIAN DIS, V44, P379, DOI 10.2307/1592553; Mata E, 2007, VACCINE, V25, P877, DOI 10.1016/j.vaccine.2006.09.036; McShane LM, 2003, J MAMMARY GLAND BIOL, V8, P359, DOI 10.1023/B:JOMG.0000010035.57912.5a; Min WG, 2005, MOL BIOTECHNOL, V30, P143, DOI 10.1385/MB:30:2:143; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Ren JL, 2011, VACCINE, V29, P7960, DOI 10.1016/j.vaccine.2011.08.072; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Shirley MW, 2012, AVIAN PATHOL, V41, P111, DOI 10.1080/03079457.2012.666338; Song KD, 2000, VACCINE, V19, P243, DOI 10.1016/S0264-410X(00)00169-9; Toledo H, 2001, VACCINE, V19, P4328, DOI 10.1016/S0264-410X(01)00111-6; Waghmare A, 2009, VACCINE, V27, P1067, DOI 10.1016/j.vaccine.2008.11.103; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yun CH, 2000, AVIAN DIS, V44, P305, DOI 10.2307/1592544	39	21	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59786	10.1371/journal.pone.0059786	http://dx.doi.org/10.1371/journal.pone.0059786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593150	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000014
J	Lei, JP; Xiao, WF; Liu, JF; Xiong, DP; Wang, PC; Pan, L; Jiang, Y; Li, MH				Lei, Jing-Pin; Xiao, Wenfa; Liu, Jian-Feng; Xiong, Dingpeng; Wang, Pengcheng; Pan, Lei; Jiang, Yong; Li, Mai-He			Responses of Nutrients and Mobile Carbohydrates in Quercus variabilis Seedlings to Environmental Variations Using In Situ and Ex Situ Experiments	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; PINUS-SYLVESTRIS POPULATIONS; LEAF-TRAIT RELATIONSHIPS; POPULUS-BALSAMIFERA L.; WATER-USE EFFICIENCY; GENETIC-VARIATION; SOIL-TEMPERATURE; STOMATAL CONDUCTANCE; GEOGRAPHIC-VARIATION; ECOPHYSIOLOGICAL TRAITS	Forest tree species distributed across a wide range of geographical areas are subjected to differential climatic and edaphic conditions and long-term selection, leading to genotypes with morphological and physiological adaptation to the local environment. To test the ability of species to cope with changing environmental conditions, we studied the ecophysiological features of Quercus variabilis using seedlings grown in geographically widely isolated populations (Exp. I, in situ) and in a common garden (Exp. II, ex situ) using seedlings originating from those populations. We found that Q. variabilis plants grown in different locations along a south-north gradient had different levels of nutrients (N, P, K) and carbon-physiological performance (photosynthesis, non-structural carbohydrates, such as soluble sugars and starch), and that these physiological differences were not correlated with local soil properties. These geographic variations of plant physiology disappeared when plants from different locations were grown in the same environment. Our results indicate that the physiological performance of Q. variabilis plants is mainly determined by the climatic variations across latitude rather than by their soils or by genetic differentiation. The adaptive ability of Q. variabilis found in the present study suggests that this species has the potential to cope, at least to some extent, with changing environmental conditions.	[Lei, Jing-Pin; Liu, Jian-Feng] Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat, State Forestry Adm, Beijing, Peoples R China; [Xiao, Wenfa] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Xiong, Dingpeng; Wang, Pengcheng] Huazhong Agr Univ, Coll Hort & Forestry, Wuhan, Peoples R China; [Pan, Lei] Hubei Acad Forestry, Wuhan, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Jiang, Yong; Li, Mai-He] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Huazhong Agricultural University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Xiao, WF (corresponding author), Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.	Xiaowenf@caf.ac.cn; Liujf2000cn@163.com	Jiang, Yong/A-2263-2012; Li, Mai-He/L-6390-2013	Jiang, Yong/0000-0001-7518-5810; Li, Mai-He/0000-0002-7029-2841; Liu, Jianfeng/0000-0002-5502-0872	Special Research Programme In Forestry Industry, State Forestry Administration of China [200804001]; Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry [CAFIFEEPYBB2007001]	Special Research Programme In Forestry Industry, State Forestry Administration of China; Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry	This work was supported by the Special Research Programme In Forestry Industry, State Forestry Administration of China (contract: 200804001), and by the Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry (CAFIFEEPYBB2007001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERAR M, 1991, ANN SCI FOREST, V48, P561, DOI 10.1051/forest:19910506; Benowicz A, 2000, OECOLOGIA, V123, P168, DOI 10.1007/s004420051002; Bolstad PV, 2003, TREE PHYSIOL, V23, P969, DOI 10.1093/treephys/23.14.969; Canham CD, 1999, OECOLOGIA, V121, P1, DOI 10.1007/s004420050900; CastroDiez P, 1997, TREES-STRUCT FUNCT, V11, P127, DOI 10.1007/s004680050068; CEULEMANS R, 1992, CAN J FOREST RES, V22, P1937, DOI 10.1139/x92-253; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Coops NC, 2011, ECOL MODEL, V222, P2119, DOI 10.1016/j.ecolmodel.2011.03.033; Cregg BM, 2000, CAN J FOREST RES, V30, P428, DOI 10.1139/cjfr-30-3-428; Crescente MF, 2002, FLORA, V197, P2, DOI 10.1078/0367-2530-00007; DANG QL, 1994, CAN J FOREST RES, V24, P2150, DOI 10.1139/x94-277; Domisch T, 2002, PLANT SOIL, V246, P75, DOI 10.1023/A:1021527716616; Domisch T, 2002, PLANT SOIL, V239, P173, DOI 10.1023/A:1015037127126; Ehleringer JR, 1996, ANN SCI FOREST, V53, P291, DOI 10.1051/forest:19960212; Fang JY, 2006, J BIOGEOGR, V33, P1804, DOI 10.1111/j.1365-2699.2006.01533.x; Fang KY, 2009, TREES-STRUCT FUNCT, V23, P1321, DOI 10.1007/s00468-009-0373-5; Figueroa JA, 2010, TREE PHYSIOL, V30, P574, DOI 10.1093/treephys/tpq016; FOULDS W, 1993, NEW PHYTOL, V125, P529, DOI 10.1111/j.1469-8137.1993.tb03901.x; Genet M, 2011, ANN BOT-LONDON, V107, P311, DOI 10.1093/aob/mcq237; Gornall JL, 2007, CAN J BOT, V85, P1202, DOI 10.1139/B07-079; GRIMSHAW HM, 1989, CHEM ANAL ECOLOGICAL; Grossnickle SC, 2005, TREES-STRUCT FUNCT, V19, P32, DOI 10.1007/s00468-004-0360-9; Gunderson CA, 2000, TREE PHYSIOL, V20, P87; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hoch G, 2003, PLANT CELL ENVIRON, V26, P1067, DOI 10.1046/j.0016-8025.2003.01032.x; Hoch G, 2003, OECOLOGIA, V135, P10, DOI 10.1007/s00442-002-1154-7; Hoch G, 2002, OIKOS, V98, P361, DOI 10.1034/j.1600-0706.2002.980301.x; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Ito M, 2009, J FOREST RES-JPN, V14, P240, DOI 10.1007/s10310-009-0121-0; Jonas CS, 1999, AM J BOT, V86, P333, DOI 10.2307/2656755; Karenlampi L, 1998, CHEMOSPHERE, V36, P675, DOI 10.1016/S0045-6535(97)10106-0; Keller SR, 2011, AM J BOT, V98, P99, DOI 10.3732/ajb.1000317; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Klumpp R, 2011, SCAND J FOREST RES, V26, P294, DOI 10.1080/02827581.2011.566888; Knox KJE, 2005, FUNCT ECOL, V19, P690, DOI 10.1111/j.1365-2435.2005.01006.x; Kobe RK, 2010, ECOLOGY, V91, P166, DOI 10.1890/09-0027.1; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Lee TD, 2005, FUNCT ECOL, V19, P640, DOI 10.1111/j.1365-2435.2005.01023.x; Li MH, 2013, PLANT BIOLOGY, V15, P177, DOI 10.1111/j.1438-8677.2012.00579.x; Li MH, 2008, PLANT CELL ENVIRON, V31, P1377, DOI 10.1111/j.1365-3040.2008.01848.x; Li MH, 2008, TREE PHYSIOL, V28, P1287, DOI 10.1093/treephys/28.8.1287; Li MH, 2006, TREES-STRUCT FUNCT, V20, P611, DOI 10.1007/s00468-006-0076-0; Li MH, 2006, J INTEGR PLANT BIOL, V48, P255, DOI 10.1111/j.1744-7909.2006.00232.x; Li MH, 2002, TREES-STRUCT FUNCT, V16, P331, DOI 10.1007/s00468-002-0172-8; Lopez R, 2009, TREES-STRUCT FUNCT, V23, P509, DOI 10.1007/s00468-008-0297-5; Luoma S, 1997, FUNCT ECOL, V11, P273, DOI 10.1046/j.1365-2435.1997.00089.x; Miyazawa K, 2004, ANN BOT-LONDON, V94, P635, DOI 10.1093/aob/mch184; Mollo L, 2011, PLANT CELL TISS ORG, V107, P141, DOI 10.1007/s11240-011-9966-y; Newton AC, 2008, SILVAE GENET, V57, P348, DOI 10.1515/sg-2008-0049; Nielsen CN, 2003, FOREST ECOL MANAG, V174, P233, DOI 10.1016/S0378-1127(02)00042-7; OLEKSYN J, 1992, TREES-STRUCT FUNCT, V6, P225, DOI 10.1007/BF00224340; Oleksyn J, 2000, TREE PHYSIOL, V20, P837; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Oleksyn J, 2003, OECOLOGIA, V136, P220, DOI 10.1007/s00442-003-1265-9; Oleksyn J, 2002, ANN FOR SCI, V59, P1, DOI 10.1051/forest:2001001; OSAKI M, 1991, SOIL SCI PLANT NUTR, V37, P117, DOI 10.1080/00380768.1991.10415017; PRIOUL JL, 1977, ANN BOT-LONDON, V41, P789, DOI 10.1093/oxfordjournals.aob.a085354; Qi J, 2009, ECOL RES, V24, P1243, DOI 10.1007/s11284-009-0608-3; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Reich PB, 1996, FUNCT ECOL, V10, P768, DOI 10.2307/2390512; Reich PB, 1997, ECOLOGY, V78, P335, DOI 10.1890/0012-9658(1997)078[0335:NMAPIH]2.0.CO;2; Reich PB, 1998, FUNCT ECOL, V12, P948, DOI 10.1046/j.1365-2435.1998.00274.x; Rennenberg H, 2009, PLANT BIOLOGY, V11, P4, DOI 10.1111/j.1438-8677.2009.00241.x; Repo T, 2004, PHYSIOL PLANTARUM, V121, P93, DOI 10.1111/j.0031-9317.2004.00307.x; Perez VS, 2007, ANN FOREST SCI, V64, P201, DOI 10.1051/forest:2006104; Scarano F, 2005, TREES-STRUCT FUNCT, V19, P497, DOI 10.1007/s00468-005-0421-8; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; Shi P, 2008, FUNCT ECOL, V22, P213, DOI 10.1111/j.1365-2435.2007.01370.x; Shi PL, 2006, BASIC APPL ECOL, V7, P370, DOI 10.1016/j.baae.2005.06.005; Singh B., 2010, J AM SCI, V6, P108; Soethe N, 2008, J TROP ECOL, V24, P397, DOI 10.1017/S026646740800504X; Soolanayakanahally RY, 2009, PLANT CELL ENVIRON, V32, P1821, DOI 10.1111/j.1365-3040.2009.02042.x; St Hilaire R, 1999, J AM SOC HORTIC SCI, V124, P605; Swenson JJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P470, DOI 10.1111/j.1466-822x.2006.00242.x; Teskey RO, 1999, TREE PHYSIOL, V19, P519, DOI 10.1093/treephys/19.8.519; Tjoelker MG, 2008, GLOBAL CHANGE BIOL, V14, P782, DOI 10.1111/j.1365-2486.2008.01548.x; Tognetti R, 2000, CAN J FOREST RES, V30, P1682, DOI 10.1139/cjfr-30-11-1682; Turna I, 2004, BIOLOGIA, V59, P519; Villar R, 1998, NEW PHYTOL, V140, P425, DOI [10.1046/j.1469-8137.1998.00286.x, 10.1111/j.1469-8137.1998.00286.x]; Wahid N, 2006, ANN FOREST SCI, V63, P83, DOI 10.1051/forest:20050100; Weih M, 2001, NEW PHYTOL, V150, P147, DOI 10.1046/j.1469-8137.2001.00078.x; WEINSTEIN A, 1989, FOREST ECOL MANAG, V27, P99, DOI 10.1016/0378-1127(89)90032-7; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xu XA, 2010, AUST J BOT, V58, P519, DOI 10.1071/BT10108; ZHU W, 2012, PLOS ONE, V7; Zhu WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034213	92	6	7	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61192	10.1371/journal.pone.0061192	http://dx.doi.org/10.1371/journal.pone.0061192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593429	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000111
J	Rollag, H; Ueland, T; Asberg, A; Hartmann, A; Jardine, AG; Humar, A; Pescovitz, MD; Bignamini, AA; Aukrust, P				Rollag, Halvor; Ueland, Thor; Asberg, Anders; Hartmann, Anders; Jardine, Alan G.; Humar, Atul; Pescovitz, Mark D.; Bignamini, Angelo A.; Aukrust, Pal			Characterization of Cytomegalovirus Disease in Solid Organ Transplant Recipients by Markers of Inflammation in Plasma	PLOS ONE			English	Article							DENDRITIC CELLS; INFECTION; CXCL10; CCL21; CCL19; CMV; VALGANCICLOVIR; REACTIVATION; GANCICLOVIR; CHEMOKINES	Background: While several studies have examined the general inflammatory responses in relation to cytomegalovirus infection, the identification of the various inflammatory mediators as well as their relative importance is far from clear. Patients and Methods: Solid organ recipients enrolled in an international multicenter trial of cytomegalovirus disease treatment (the VICTOR study) were analyzed (n = 289) (ClinicalTrials.gov NCT00431353). Plasma markers of inflammation and endothelial cell activation were assessed at baseline by enzyme immunoassays. Results: The major findings were: (i) Plasma levels of the CXC-chemokine interferon-inducible protein-10 (P<0.001) and C-reactive protein (P = 0.046) were independently associated with the presence of cytomegalovirus DNAemia above lower level of quantification. (ii) High levels of CC-chemokine ligand 21 (P = 0.027) and pentraxin 3 (P = 0.033) were independently associated with tissue invasive cytomegalovirus disease as opposed to cytomegalovirus syndrome. Conclusion: Our findings illustrate the complex interaction between cytomegalovirus and the immune system, involving a wide range of inflammatory mediators that could be associated to disease manifestations in cytomegalovirus related disease.	[Rollag, Halvor] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Microbiol, N-0027 Oslo, Norway; [Ueland, Thor; Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Asberg, Anders] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, N-0027 Oslo, Norway; [Asberg, Anders; Aukrust, Pal] Univ Oslo, Rikshosp, Dept Organ Transplantat Gastroenterol & Nephrol, Sect Nephrol,Oslo Univ Hosp, N-0027 Oslo, Norway; [Ueland, Thor; Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Rollag, Halvor; Hartmann, Anders] Univ Oslo, Fac Med, N-0027 Oslo, Norway; [Jardine, Alan G.] Univ Glasgow, Dept Med, Glasgow, Lanark, Scotland; [Humar, Atul] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Pescovitz, Mark D.] Indiana Univ, Dept Surg, Indianapolis, IN 46204 USA; [Pescovitz, Mark D.] Indiana Univ, Dept Microbiol & Immunol, Indianapolis, IN 46204 USA; [Bignamini, Angelo A.] Univ Milan, Sch Specializat Hosp Pharm, Milan, Italy	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Glasgow; University of Alberta; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Milan	Rollag, H (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Microbiol, N-0027 Oslo, Norway.	halvor.rollag@rr-research.no	Jardine, Alan/L-5770-2019	Jardine, Alan/0000-0001-5815-9370				Asberg A, 2007, AM J TRANSPLANT, V7, P2106, DOI 10.1111/j.1600-6143.2007.01910.x; Asberg A, 2009, AM J TRANSPLANT, V9, P1205, DOI 10.1111/j.1600-6143.2009.02617.x; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Bollerslev J, 2006, EUR J ENDOCRINOL, V154, P537, DOI 10.1530/eje.1.02125; Bozza S, 2006, BLOOD, V108, P3387, DOI 10.1182/blood-2006-03-009266; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Cinque P, 2005, J NEUROIMMUNOL, V168, P154, DOI 10.1016/j.jneuroim.2005.07.002; D'Angelo C, 2009, J IMMUNOL, V183, P4609, DOI 10.4049/jimmunol.0900345; Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c; Deban L, 2011, CELL TISSUE RES, V343, P237, DOI 10.1007/s00441-010-1018-0; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Humar A, 2009, AM J TRANSPLANT, V9, P374, DOI 10.1111/j.1600-6143.2008.02501.x; Humar A, 1999, J INFECT DIS, V179, P484, DOI 10.1086/314602; Hummel M, 2002, J CLIN VIROL, V25, pS123; Kotton CN, 2010, TRANSPLANTATION, V89, P779, DOI 10.1097/TP.0b013e3181cee42f; Lazzeri E., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P109, DOI 10.2174/1568008053174723; Manuel O, 2009, CLIN INFECT DIS, V49, P1160, DOI 10.1086/605633; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Middel P, 2006, GUT, V55, P220, DOI 10.1136/gut.2004.063008; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P914, DOI 10.1002/art.30232; Preiksaitis JK, 2005, AM J TRANSPLANT, V5, P218, DOI 10.1111/j.1600-6143.2004.00692.x; Rollag H, 2012, TRANSPLANTATION, V94, P1060, DOI 10.1097/TP.0b013e31826c39de; Sagedal S, 2000, TRANSPLANTATION, V70, P1166, DOI 10.1097/00007890-200010270-00007; Sumino KC, 2010, THORAX, V65, P639, DOI 10.1136/thx.2009.132480; van Leeuwen EMM, 2005, INT IMMUNOL, V17, P713, DOI 10.1093/intimm/dxh251; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60767	10.1371/journal.pone.0060767	http://dx.doi.org/10.1371/journal.pone.0060767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593305	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000063
J	Huertas-Vazquez, A; Nelson, CP; Guo, XQ; Reinier, K; Uy-Evanado, A; Teodorescu, C; Ayala, J; Jerger, K; Chugh, H; Braund, PS; Deloukas, P; Hall, AS; Balmforth, AJ; Jones, M; Taylor, KD; Pulit, SL; Newton-Cheh, C; Gunson, K; Jui, J; Rotter, JI; Albert, CM; Samani, NJ; Chugh, SS				Huertas-Vazquez, Adriana; Nelson, Christopher P.; Guo, Xiuqing; Reinier, Kyndaron; Uy-Evanado, Audrey; Teodorescu, Carmen; Ayala, Jo; Jerger, Katherine; Chugh, Harpriya; Braund, Peter S.; Deloukas, Panos; Hall, Alistair S.; Balmforth, Anthony J.; Jones, Michelle; Taylor, Kent D.; Pulit, Sara L.; Newton-Cheh, Christopher; Gunson, Karen; Jui, Jonathan; Rotter, Jerome I.; Albert, Christine M.; Samani, Nilesh J.; Chugh, Sumeet S.		WTCCC	Novel Loci Associated with Increased Risk of Sudden Cardiac Death in the Context of Coronary Artery Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACUTE MYOCARDIAL-INFARCTION; COMMON VARIANTS; UNEXPECTED DEATH; SUSCEPTIBILITY LOCI; BINDING PROTEIN; HEART-DISEASE; QRS DURATION; PR INTERVAL; POPULATION	Background: Recent genome-wide association studies (GWAS) have identified novel loci associated with sudden cardiac death (SCD). Despite this progress, identified DNA variants account for a relatively small portion of overall SCD risk, suggesting that additional loci contributing to SCD susceptibility await discovery. The objective of this study was to identify novel DNA variation associated with SCD in the context of coronary artery disease (CAD). Methods and Findings: Using the MetaboChip custom array we conducted a case-control association analysis of 119,117 SNPs in 948 SCD cases (with underlying CAD) from the Oregon Sudden Unexpected Death Study (Oregon-SUDS) and 3,050 controls with CAD from the Wellcome Trust Case-Control Consortium (WTCCC). Two newly identified loci were significantly associated with increased risk of SCD after correction for multiple comparisons at: rs6730157 in the RAB3GAP1 gene on chromosome 2 (P = 4.93 x 10(-12), OR = 1.60) and rs2077316 in the ZNF365 gene on chromosome 10 (P = 3.64 x 10(-8), OR = 2.41). Conclusions: Our findings suggest that RAB3GAP1 and ZNF365 are relevant candidate genes for SCD and will contribute to the mechanistic understanding of SCD susceptibility.	[Huertas-Vazquez, Adriana; Reinier, Kyndaron; Uy-Evanado, Audrey; Teodorescu, Carmen; Ayala, Jo; Jerger, Katherine; Chugh, Harpriya; Chugh, Sumeet S.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Nelson, Christopher P.; Braund, Peter S.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Nelson, Christopher P.; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit Cardiov, Leicester, Leics, England; [Guo, Xiuqing; Taylor, Kent D.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Hall, Alistair S.; Balmforth, Anthony J.] Univ Leeds, Dept Clin Cardiol, Leeds, W Yorkshire, England; [Jones, Michelle] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol & Metab, Los Angeles, CA 90048 USA; [Pulit, Sara L.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Gunson, Karen] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Jui, Jonathan] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Albert, Christine M.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Div Prevent Med,Ctr Arrhyth, Boston, MA USA	Cedars Sinai Medical Center; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Cedars Sinai Medical Center; Wellcome Trust Sanger Institute; University of Leeds; Cedars Sinai Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Oregon Health & Science University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Samani, NJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	njs@le.ac.uk; sumeet.chugh@cshs.org	Breen, Gerome/Y-2706-2019; O'Donovan, Michael C/P-7005-2018; Dominiczak, Anna F/P-9390-2017; Deloukas, Panos/B-2922-2013; Hall, Alistair/K-1953-2019; Rotter, Jerome/AAY-6598-2021; eyre, stephen/K-3776-2017; Prescott, Natalie/F-6490-2011; Myers, Simon/A-6792-2015; McCarthy, Mark/M-3763-2015; Evans, David/H-6325-2013	Breen, Gerome/0000-0003-2053-1792; O'Donovan, Michael C/0000-0001-7073-2379; Dominiczak, Anna F/0000-0003-4913-3608; Deloukas, Panos/0000-0001-9251-070X; eyre, stephen/0000-0002-1251-6974; Evans, Gareth/0000-0002-8482-5784; Zeggini, Eleftheria/0000-0003-4238-659X; Prescott, Natalie/0000-0002-5901-7371; Newman, William/0000-0002-6382-4678; Pulit, Sara/0000-0002-2502-3669; Martin, Paul/0000-0002-1016-6851; Barnes, Chris/0000-0002-9459-1395; Maller, Julian/0000-0002-1565-9559; Myers, Simon/0000-0002-2585-9626; McCarthy, Mark/0000-0002-4393-0510; Parkes, Miles/0000-0002-6467-0631; Lango Allen, Hana/0000-0002-7803-8688; Wain, Louise/0000-0003-4951-1867; Mentzer, Alexander/0000-0002-4502-2209; Morgan, Ann/0000-0003-1109-624X; Tobin, Martin/0000-0002-3596-7874; Lee, James/0000-0001-5711-9385; Isaacs, John/0000-0002-6103-7056; Aerts, Jan/0000-0002-6416-2717; Grozeva, Detelina/0000-0003-3239-8415; Ouwehand, Willem/0000-0002-7744-1790; Young, Allan/0000-0003-2291-6952; bennett, amanda/0000-0003-2140-8710; Caulfield, Mark/0000-0001-9295-3594; Bruce, Ian/0000-0003-3047-500X; Munroe, Patricia/0000-0002-4176-2947; Lindgren, Cecilia/0000-0002-4903-9374; Evans, David/0000-0003-0663-4621; Giannoulatou, Eleni/0000-0002-7084-6736; Harrison, Pille/0000-0003-4117-6910; Hall, Alistair/0000-0003-0306-7887; Hocking, Lynne J/0000-0002-2414-2826; Weedon, Michael/0000-0002-6174-6135; Hattersley, Andrew/0000-0001-5620-473X; Wallace, Chris/0000-0001-9755-1703; Turnbull, Clare/0000-0002-1734-5772; Albert, Christine/0000-0002-2081-1121; Howson, Joanna/0000-0001-7618-0050; Jones, Lisa/0000-0002-5122-8334; Nelson, Christopher/0000-0001-8025-2897	British Heart Foundation (BHF); British Cardiovascular Society; MRC [G0800759, G0600329, G0800675] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; Medical Research Council [G0800675, G0600329, G0800759] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/137, ETM/75] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); British Cardiovascular Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The Oregon Sudden Unexpected Death Study acknowledges the significant contribution of American Medical Response and the Portland/Gresham fire departments. SSC holds the Pauline and Harold Price Chair in Cardiac Electrophysiology at the Cedars-Sinai Heart Institute. Recruitment of the British Heart Foundation Heart Family Heart Study was funded by the British Heart Foundation (BHF) and the PRAMIS Study by the British Cardiovascular Society. NJS holds a Chair funded by the BHF and is a UK National Institute for Health Research (NIHR) Senior Investigator. This work falls under the portfolio of research conducted within the NIHR Leicester Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabag AS, 2010, NAT REV CARDIOL, V7, P216, DOI 10.1038/nrcardio.2010.3; Adabag AS, 2010, AM HEART J, V159, P33, DOI 10.1016/j.ahj.2009.10.019; Albert CM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P222, DOI 10.1161/CIRCEP.110.944934; Aligianis IA, 2006, AM J HUM GENET, V78, P702, DOI 10.1086/502681; Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; Arking DE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002158; Arking DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009879; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Chugh SS, 2009, J AM COLL CARDIOL, V54, P2006, DOI 10.1016/j.jacc.2009.07.038; Chugh SS, 2009, CIRCULATION, V119, P663, DOI 10.1161/CIRCULATIONAHA.108.797035; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Friedlander Y, 2002, ATHEROSCLEROSIS, V162, P211, DOI 10.1016/S0021-9150(01)00701-8; Hall AS, 2009, EUR J CARDIOV PREV R, V16, P712, DOI 10.1097/HJR.0b013e3283316ce8; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Illumina Inc, 2005, TECHN SPOTL; Illumina Inc, 2009, TECHN NOT DNA AN; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Kaikkonen KS, 2006, CIRCULATION, V114, P1462, DOI 10.1161/CIRCULATIONAHA.106.624593; Malik-Hall M, 2003, MOL BRAIN RES, V110, P298, DOI 10.1016/S0169-328X(02)00661-7; Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846; Pearson IR, 2011, HEART, V97, pA17, DOI 10.1136/heartjnl-2011-300198.22; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stecker EC, 2006, J AM COLL CARDIOL, V47, P1161, DOI 10.1016/j.jacc.2005.11.045; Takai Y, 1996, GENES CELLS, V1, P615, DOI 10.1046/j.1365-2443.1996.00257.x; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westaway SK, 2011, CIRC-CARDIOVASC GENE, V4, P397, DOI 10.1161/CIRCGENETICS.111.959916; World Health Organization, 1985, WHO TECH REP SER, V726, P5	39	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e59905	10.1371/journal.pone.0059905	http://dx.doi.org/10.1371/journal.pone.0059905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593153	Green Published, gold			2022-12-27	WOS:000319108100011
J	Liu, Y; Zhang, YJ; Wang, LL; Guo, Y; Xiao, SQ				Liu, Yi; Zhang, Yujie; Wang, Lili; Guo, Yang; Xiao, Shuiqing			Prevalence of Porphyromonas gingivalis Four rag Locus Genotypes in Patients of Orthodontic Gingivitis and Periodontitis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SUBGINGIVAL PLAQUE; FIMA GENOTYPES; VIRULENCE; GINGIPAINS; PATHOGENICITY; RESPONSES; STRAINS; W83; W50	Porphyromonas gingivalis is considered as a major etiological agent in periodontal diseases and implied to result in gingival inflammation under orthodontic appliance. rag locus is a pathogenicity island found in Porphyromonas gingivalis. Four rag locus variants are different in pathogenicity of Porphyromonas gingivalis. Moreover, there are different racial and geographic differences in distribution of rag locus genotypes. In this study, we assessed the prevalence of Porphyromonas gingivalis and rag locus genotypes in 102 gingival crevicular fluid samples from 57 cases of gingivitis patients with orthodontic appliances, 25 cases of periodontitis patients and 20 cases of periodontally healthy people through a 16S rRNA-based PCR and a multiplex PCR. The correlations between Porphyromona.gingivalis/rag locus and clinical indices were analyzed. The prevalence of Porphyromonas gingivalis and rag locus genes in periodontitis group was the highest among three groups and higher in orthodontic gingivitis than healthy people (p<0.01). An obviously positive correlation was observed between the prevalence of Porphyromonas gingivalis/rag locus and gingival index. rag-3 and rag-4 were the predominant genotypes in the patients of orthodontic gingivitis and mild-to-moderate periodontitis in Shandong. Porphyromonas. gingivalis carrying rag-1 has the strong virulence and could be associated with severe periodontitis.	[Liu, Yi] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250100, Shandong, Peoples R China; [Zhang, Yujie; Guo, Yang; Xiao, Shuiqing] Jinan Stomatol Hosp, Dept Orthodont, Jinan, Shandong, Peoples R China; [Wang, Lili] Shandong Univ, Jinan Cent Hosp, Clin Lab, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Xiao, SQ (corresponding author), Jinan Stomatol Hosp, Dept Orthodont, Jinan, Shandong, Peoples R China.	shqxiao@126.com	wang, lili/HDL-7210-2022		Jinan Science and Technology Research Project from Jinan Science and Technology Committee [JK200905034]	Jinan Science and Technology Research Project from Jinan Science and Technology Committee	This work was funded by Jinan Science and Technology Research Project (JK200905034) from Jinan Science and Technology Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Bollen AM, 2008, J AM DENT ASSOC, V139, P413, DOI 10.14219/jada.archive.2008.0184; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Cardoso-Silva C, 2011, EUR J PAEDIATR DENT, V12, P210; CHEN JP, 2011, J ANHUI MED, V32, P604; Curtis MA, 1999, J PERIODONTAL RES, V34, P400, DOI 10.1111/j.1600-0765.1999.tb02273.x; Decaillet Fabien, 2012, Schweiz Monatsschr Zahnmed, V122, P198; EVANS RT, 1992, ARCH ORAL BIOL, V37, P813, DOI 10.1016/0003-9969(92)90115-O; Fitzpatrick RE, 2009, J INNATE IMMUN, V1, P109, DOI 10.1159/000181145; [傅民魁 Fu Minku], 2002, [中华口腔医学杂志, Chinese Journal of Stomatology], V37, P371; Gibson FC, 2001, INFECT IMMUN, V69, P7959, DOI 10.1128/IAI.69.12.7959-7963.2001; Grenier D, 2010, TOXINS, V2, P341, DOI 10.3390/toxins2030341; Guentsch A, 2011, J PERIODONTOL, V82, P1051, DOI 10.1902/jop.2011.100565; HACKER J, 1992, ZBL BAKT-INT J MED M, V276, P165; Hall LMC, 2005, INFECT IMMUN, V73, P4253, DOI 10.1128/IAI.73.7.4253-4262.2005; Hanley SA, 1999, INFECT IMMUN, V67, P1157, DOI 10.1128/IAI.67.3.1157-1171.1999; Haruyama K, 2009, INFECT IMMUN, V77, P4414, DOI 10.1128/IAI.00140-09; Hasturk H, 2007, J PERIODONTOL, V78, P924, DOI 10.1902/jop.2007.060293; Hayashi F, 2012, J ORAL SCI, V54, P77, DOI 10.2334/josnusd.54.77; HUANG X, 2010, CHINA CLIN PRAC MED, V4, P26; Igboin CO, 2011, INFECT IMMUN, V79, P439, DOI 10.1128/IAI.00784-10; Perez-Chaparro PJ, 2009, BIOMEDICA, V29, P298; Katz J, 1996, ORAL MICROBIOL IMMUN, V11, P309, DOI 10.1111/j.1399-302X.1996.tb00187.x; Klein MI, 2003, J PERIODONTOL, V74, P798, DOI 10.1902/jop.2003.74.6.798; Lara-Carrillo E, 2010, MED ORAL PATOL ORAL, V15, pE924, DOI 10.4317/medoral.15.e924; Lee SM, 2005, J MICROBIOL, V43, P260; LIN L, 2006, CHIN J STOMATOL, V41, P734; Lin L, 2009, ACTA ODONTOL SCAND, V67, P258, DOI 10.1080/00016350902841890; Liu HY, 2011, ANGLE ORTHOD, V81, P609, DOI 10.2319/082310-352.1; LOPEZ N, 2000, J PERIODONTOL, V71, P48954; Naranjo AA., 2006, AM J ORTHOD DENTOFAC, V130, p275., DOI 10.1016/j.ajodo.2005.10.022; O'Brien-Simpson NM, 2001, INFECT IMMUN, V69, P7527, DOI 10.1128/IAI.69.12.7527-7534.2001; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Ristic M, 2007, ORTHOD CRANIOFAC RES, V10, P187, DOI 10.1111/j.1601-6343.2007.00396.x; RUDIN HJ, 1970, HELV ODONTOL ACTA, V14, P21; Sallum EJ, 2004, AM J ORTHOD DENTOFAC, V126, P363, DOI 10.1016/j.ajodo.2004.04.017; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; Shi XJ, 2007, INFECT IMMUN, V75, P2071, DOI 10.1128/IAI.01785-06; Su Z, 2010, EUR J CLIN MICROBIOL, V29, P429, DOI 10.1007/s10096-010-0880-8; Wang Guan-Hua, 2009, Hua Xi Kou Qiang Yi Xue Za Zhi, V27, P168; WANG J, 2011, STOMATOLOGY, V31, P531	41	16	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61028	10.1371/journal.pone.0061028	http://dx.doi.org/10.1371/journal.pone.0061028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593379	gold, Green Submitted, Green Published			2022-12-27	WOS:000319108100071
J	Medina-Sanchez, JM; Delgado-Molina, JA; Bratbak, G; Bullejos, FJ; Villar-Argaiz, M; Carrillo, P				Manuel Medina-Sanchez, Juan; Antonio Delgado-Molina, Jose; Bratbak, Gunnar; Jose Bullejos, Francisco; Villar-Argaiz, Manuel; Carrillo, Presentacion			Maximum in the Middle: Nonlinear Response of Microbial Plankton to Ultraviolet Radiation and Phosphorus	PLOS ONE			English	Article							SOLAR UV-RADIATION; HIGH-MOUNTAIN LAKE; CLIMATE-CHANGE; BACTERIAL-ACTIVITY; ORGANIC-MATTER; ALGAL CONTROL; ALPINE LAKE; B RADIATION; DUST INPUTS; PHYTOPLANKTON	The responses of heterotrophic microbial food webs (HMFW) to the joint action of abiotic stressors related to global change have been studied in an oligotrophic high-mountain lake. A 2x5 factorial design field experiment performed with large mesocosms for >2 months was used to quantify the dynamics of the entire HMFW (bacteria, heterotrophic nanoflagellates, ciliates, and viruses) after an experimental P-enrichment gradient which approximated or surpassed current atmospheric P pulses in the presence vs. absence of ultraviolet radiation. HMFW underwent a mid-term (<20 days) acute development following a noticeable unimodal response to P enrichment, which peaked at intermediate P-enrichment levels and, unexpectedly, was more accentuated under ultraviolet radiation. However, after depletion of dissolved inorganic P, the HMFW collapsed and was outcompeted by a low-diversity autotrophic compartment, which constrained the development of HMFW and caused a significant loss of functional biodiversity. The dynamics and relationships among variables, and the response patterns found, suggest the importance of biotic interactions (predation/parasitism and competition) in restricting HMFW development, in contrast to the role of abiotic factors as main drivers of autotrophic compartment. The response of HMFW may contribute to ecosystem resilience by favoring the maintenance of the peculiar paths of energy and nutrient-mobilization in these pristine ecosystems, which are vulnerable to threats by the joint action of abiotic stressors related to global change.	[Manuel Medina-Sanchez, Juan; Antonio Delgado-Molina, Jose; Jose Bullejos, Francisco; Villar-Argaiz, Manuel] Univ Granada, Fac Ciencias, Dept Ecol, Granada, Spain; [Bratbak, Gunnar] Univ Bergen, Dept Biol, Bergen, Norway; [Carrillo, Presentacion] Univ Granada, Inst Agua, Granada, Spain	University of Granada; University of Bergen; University of Granada	Medina-Sanchez, JM (corresponding author), Univ Granada, Fac Ciencias, Dept Ecol, Granada, Spain.	jmmedina@ugr.es	Bullejos Carrillo, Francisco José/K-4971-2015; Villar-Argaiz, Manuel/L-9085-2014; Bratbak, Gunnar/N-8786-2015; Medina-Sánchez, Juan Manuel/A-4703-2013; Carrillo, Presentación/I-1601-2015	Bullejos Carrillo, Francisco José/0000-0002-0335-3923; Villar-Argaiz, Manuel/0000-0002-3288-8900; Bratbak, Gunnar/0000-0001-8388-4945; Medina-Sánchez, Juan Manuel/0000-0003-0991-9331; Carrillo, Presentación/0000-0003-3794-4294	Junta de Andalucia (Excelencia) [P07-CVI-02598, P09-RNM-5376]; Spanish Ministries of Medio Ambiente; Rural y Marino [PN2009/067]; Ciencia e Innovacion [GLC2008-01127/BOS, CGL2011-23681]; ERC [250254]; Spanish government	Junta de Andalucia (Excelencia)(Junta de Andalucia); Spanish Ministries of Medio Ambiente; Rural y Marino; Ciencia e Innovacion; ERC(European Research Council (ERC)European Commission); Spanish government(Spanish GovernmentEuropean Commission)	This research was supported by Junta de Andalucia (Excelencia P07-CVI-02598 to PC, and P09-RNM-5376 to JMMS), the Spanish Ministries of Medio Ambiente, Rural y Marino (PN2009/067 to PC) and Ciencia e Innovacion (GLC2008-01127/BOS and CGL2011-23681 to PC), the ERC Advanced Grant project number 250254 "MINOS'' (to GB), and two Spanish government grants (to JADM and FJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association, 1992, STANDARD METHODS EXA; Delgado-Molina JA, 2009, J PLANKTON RES, V31, P619, DOI 10.1093/plankt/fbp018; Bergeron M, 1997, AQUAT MICROB ECOL, V12, P239, DOI 10.3354/ame012239; Biddanda B, 2001, LIMNOL OCEANOGR, V46, P730, DOI 10.4319/lo.2001.46.3.0730; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Bouvy M, 2011, ENVIRON MICROBIOL, V13, P1842, DOI 10.1111/j.1462-2920.2011.02498.x; BRATBAK G, 1992, MAR ECOL PROG SER, V83, P273, DOI 10.3354/meps083273; Bratbak G, 1990, APPL ENVIRON MICROB, V56, P100; Carrillo P, 2008, GLOBAL CHANGE BIOL, V14, P423, DOI 10.1111/j.1365-2486.2007.01496.x; Carrillo P, 2002, LIMNOL OCEANOGR, V47, P1294, DOI 10.4319/lo.2002.47.5.1294; Carrillo P, 2008, MICROB ECOL, V56, P350, DOI 10.1007/s00248-007-9353-8; Caston CB, 2009, LIMNOL OCEANOGR, V54, P2143, DOI 10.4319/lo.2009.54.6.2143; Catalan J., 2006, LIMNETICA, V25, P551, DOI DOI 10.23818/LIMN.25.38; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; de Castro F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008465; Duarte CM, 2005, LIMNOL OCEANOGR, V50, P1844, DOI 10.4319/lo.2005.50.6.1844; Escudero M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004731; Ferreyra GA, 2006, PHOTOCHEM PHOTOBIOL, V82, P887, DOI 10.1562/2006-02-23-RA-810; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hall EK, 2007, AQUAT MICROB ECOL, V49, P35, DOI 10.3354/ame01124; Helton RR, 2005, AQUAT MICROB ECOL, V41, P209, DOI 10.3354/ame041209; Hofer JS, 2001, AQUAT MICROB ECOL, V26, P1, DOI 10.3354/ame026001; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Bullejos FJ, 2010, LIMNOL OCEANOGR, V55, P2549, DOI 10.4319/lo.2010.55.6.2549; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; Keil M, 2007, ATMOS CHEM PHYS, V7, P961, DOI 10.5194/acp-7-961-2007; Kirchman DL, 2005, DEEP-SEA RES PT II, V52, P3386, DOI 10.1016/j.dsr2.2005.09.005; Medina-Sanchez JM, 2010, FEMS MICROBIOL ECOL, V74, P554, DOI 10.1111/j.1574-6941.2010.00969.x; Maranger R, 2002, AQUAT MICROB ECOL, V28, P213, DOI 10.3354/ame028213; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; Medina-Sanchez JM, 2006, LIMNOL OCEANOGR, V51, P913; Medina-Sanchez JM, 2004, LIMNOL OCEANOGR, V49, P1722, DOI 10.4319/lo.2004.49.5.1722; Medina-Sanchez JM, 2002, FRESHWATER BIOL, V47, P2191, DOI 10.1046/j.1365-2427.2002.00969.x; Medina-Sanchez Juan Manuel, 1999, Journal of Limnology, V58, P213; Miki T, 2008, AQUAT MICROB ECOL, V51, P195, DOI 10.3354/ame01190; Mladenov N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1411; Modenutti BE, 2005, LIMNOL OCEANOGR, V50, P864, DOI 10.4319/lo.2005.50.3.0864; Morales-Baquero R, 2006, LIMNOL OCEANOGR, V51, P830, DOI 10.4319/lo.2006.51.2.0830; Mostajir B, 1999, LIMNOL OCEANOGR, V44, P586, DOI 10.4319/lo.1999.44.3.0586; Motulsky Harvey J., 2004, P1; Nelson CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018320; Parker BR, 2008, P NATL ACAD SCI USA, V105, P12927, DOI 10.1073/pnas.0806481105; Paterson H, 2012, POLAR BIOL, V35, P491, DOI 10.1007/s00300-011-1093-z; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pedros-Alio C, 2000, FEMS MICROBIOL ECOL, V32, P157; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Rae R, 1998, FRESHWATER BIOL, V40, P747, DOI 10.1046/j.1365-2427.1998.00361.x; Reche I, 2009, LIMNOL OCEANOGR, V54, P869, DOI 10.4319/lo.2009.54.3.0869; Sawstrom C, 2008, EXTREMOPHILES, V12, P167, DOI 10.1007/s00792-007-0134-6; Sawstrom C, 2008, FEMS MICROBIOL ECOL, V63, P12, DOI 10.1111/j.1574-6941.2007.00407.x; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Sommaruga R, 1999, J PLANKTON RES, V21, P859, DOI 10.1093/plankt/21.5.859; Straskrabova V, 2009, ADV LIMNOL, V62, P19; Straskrabova Viera, 1999, Journal of Limnology, V58, P77; Tadonleke RD, 2005, MICROB ECOL, V49, P325, DOI 10.1007/s00248-004-0232-2; Thingstad TF, 2008, NATURE, V455, P387, DOI 10.1038/nature07235; THOMAS WH, 1991, ARCTIC ALPINE RES, V23, P287, DOI 10.2307/1551606; Urabe J, 2002, ECOLOGY, V83, P619, DOI 10.2307/3071868; Vadstein O, 2004, MAR ECOL PROG SER, V270, P199, DOI 10.3354/meps270199; Villar-Argaiz M, 2002, AQUAT MICROB ECOL, V29, P253, DOI 10.3354/ame029253; Villar-Argaiz M, 2001, FRESHWATER BIOL, V46, P1017, DOI 10.1046/j.1365-2427.2001.00734.x; Weisse T, 2002, LIMNOL OCEANOGR, V47, P1447, DOI 10.4319/lo.2002.47.5.1447; Williamson CE, 2009, SCIENCE, V323, P887, DOI 10.1126/science.1169443; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236	71	17	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60223	10.1371/journal.pone.0060223	http://dx.doi.org/10.1371/journal.pone.0060223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593178	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100024
J	Senior, JK; Schweitzer, JA; O'Reilly-Wapstra, J; Chapman, SK; Steane, D; Langley, A; Bailey, JK				Senior, John K.; Schweitzer, Jennifer A.; O'Reilly-Wapstra, Julianne; Chapman, Samantha K.; Steane, Dorothy; Langley, Adam; Bailey, Joseph K.			Phylogenetic Responses of Forest Trees to Global Change	PLOS ONE			English	Article							ELEVATED ATMOSPHERIC CO2; TERRESTRIAL CARBON-CYCLE; CLIMATE-CHANGE; NITROGEN LIMITATION; ECOSYSTEM RESPONSE; BIOMASS ALLOCATION; GROWTH; VEGETATION; IMPACTS; MODELS	In a rapidly changing biosphere, approaches to understanding the ecology and evolution of forest species will be critical to predict and mitigate the effects of anthropogenic global change on forest ecosystems. Utilizing 26 forest species in a factorial experiment with two levels each of atmospheric CO2 and soil nitrogen, we examined the hypothesis that phylogeny would influence plant performance in response to elevated CO2 and nitrogen fertilization. We found highly idiosyncratic responses at the species level. However, significant, among-genetic lineage responses were present across a molecularly determined phylogeny, indicating that past evolutionary history may have an important role in the response of whole genetic lineages to future global change. These data imply that some genetic lineages will perform well and that others will not, depending upon the environmental context.	[Senior, John K.; Schweitzer, Jennifer A.; O'Reilly-Wapstra, Julianne; Steane, Dorothy; Bailey, Joseph K.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [O'Reilly-Wapstra, Julianne] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas, Australia; [Chapman, Samantha K.; Langley, Adam] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Steane, Dorothy] Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia	University of Tasmania; University of Tennessee System; University of Tennessee Knoxville; University of Tasmania; Villanova University; University of the Sunshine Coast	Bailey, JK (corresponding author), Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia.	Joe.Bailey@utk.edu	Steane, Dorothy/N-9940-2013; O'Reilly-Wapstra, Julianne M/J-7275-2014	O'Reilly-Wapstra, Julianne M/0000-0003-4801-4412; Steane, Dorothy/0000-0002-8061-8454				Atwell BJ, 2009, PLANT CELL ENVIRON, V32, P553, DOI 10.1111/j.1365-3040.2009.01949.x; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cao B, 2008, FOREST ECOL MANAG, V254, P217, DOI 10.1016/j.foreco.2007.08.002; CONROY JP, 1992, PLANT CELL ENVIRON, V15, P843, DOI 10.1111/j.1365-3040.1992.tb02152.x; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; Davis CC, 2010, PHILOS T R SOC B, V365, P3201, DOI 10.1098/rstb.2010.0130; DUFF GA, 1994, FUNCT ECOL, V8, P502, DOI 10.2307/2390075; Edwards EJ, 2007, TRENDS ECOL EVOL, V22, P243, DOI 10.1016/j.tree.2007.02.002; Esther A, 2010, J VEG SCI, V21, P447, DOI 10.1111/j.1654-1103.2009.01155.x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gillon J, 2001, SCIENCE, V291, P2584, DOI 10.1126/science.1056374; Gleadow RM, 1998, PLANT CELL ENVIRON, V21, P12, DOI 10.1046/j.1365-3040.1998.00258.x; GRIFFIN KL, 1995, NEW PHYTOL, V129, P547, DOI 10.1111/j.1469-8137.1995.tb03022.x; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; IPCC, 2007, CLIM CHANG PHYS SCI; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Lawler IR, 1997, OECOLOGIA, V109, P59, DOI 10.1007/s004420050058; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; May B., 2009, RC0720708 FOR WOOD P; McKiernan AB, 2012, J CHEM ECOL, V38, P204, DOI 10.1007/s10886-012-0071-4; McKinnon GE, 2008, AM J BOT, V95, P368, DOI 10.3732/ajb.95.3.368; MOLNAR AV, J ECOL, V100, P1141; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Prentice IC, 2011, NEW PHYTOL, V189, P988, DOI 10.1111/j.1469-8137.2010.03620.x; Pryor LD, 1971, CLASSIFICATION EUCAL; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Spinnler D, 2002, TREES-STRUCT FUNCT, V16, P423, DOI 10.1007/s00468-002-0179-1; Steane DA, 2011, MOL PHYLOGENET EVOL, V59, P206, DOI 10.1016/j.ympev.2011.02.003; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Williams J. E., 1997, EUCALYPT ECOLOGY IND; Williams K. J., 1996, Tasforests, V8, P39; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; WONG SC, 1992, AUST J BOT, V40, P457, DOI 10.1071/BT9920457; Woodhams M, 2013, SYST BIOL, V62, P62, DOI 10.1093/sysbio/sys071; Zak DR, 2000, ECOL APPL, V10, P34, DOI 10.1890/1051-0761(2000)010[0034:ACSNAA]2.0.CO;2	47	10	10	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60088	10.1371/journal.pone.0060088	http://dx.doi.org/10.1371/journal.pone.0060088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593164	Green Published, gold			2022-12-27	WOS:000319108100016
J	Steffen, RE; Caetano, R; Pinto, M; Chaves, D; Ferrari, R; Bastos, M; de Abreu, ST; Menzies, D; Trajman, A				Steffen, Ricardo Ewbank; Caetano, Rosangela; Pinto, Marcia; Chaves, Diogo; Ferrari, Rossini; Bastos, Mayara; de Abreu, Sandra Teixeira; Menzies, Dick; Trajman, Anete			Cost-Effectiveness of Quantiferon (R)- TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil	PLOS ONE			English	Article							GAMMA RELEASE ASSAY; INCOME COUNTRIES; DIAGNOSIS; REACTIVITY; PREVALENCE; STRATEGIES; RISK	Background: Latent tuberculosis infection (LTBI) is a reservoir for new TB cases. Isoniazid preventive therapy (IPT) reduces the risk of active TB by as much as 90%, but LTBI screening has limitations. Unlike tuberculin skin testing (TST), interferongamma release assays are not affected by BCG vaccination, and have been reported to be cost-effective in low-burden countries. The goal of this study was to perform a cost-effectiveness analysis from the health system perspective, comparing three strategies for LTBI diagnosis in TB contacts: tuberculin skin testing (TST), QuantiFERON (R)-TB Gold-in-Tube (QFT-GIT) and TST confirmed by QFT-GIT if positive (TSTQFT-GIT) in Brazil, a middle-income, high-burden country with universal BCG coverage. MethodologyPrincipal Findings: Costs for LTBI diagnosis and treatment of a hypothetical cohort of 1,000 adult immunocompetent close contacts were considered. The effectiveness measure employed was the number of averted TB cases in two years. Health system costs were US$ 105,096 for TST, US$ 121,054 for QFT-GIT and US$ 101,948 for TSTQFTGIT; these strategies averted 6.56, 6.63 and 4.59 TB cases, respectively. The most cost-effective strategy was TST (US$ 16,021/ averted case). The incremental cost-effectiveness ratio was US$ 227,977averted TB case for QFT-GIT. TSTQFT-GIT was dominated. Conclusions: Unlike previous studies, TST was the most cost-effective strategy for averting new TB cases in the short term. QFT-GIT would be more cost-effective if its costs could be reduced to US$ 26.95, considering a TST specificity of 59% and US$ 18 considering a more realistic TST specificity of 80%. Nevertheless, with TST, 207.4 additional people per 1,000 will be prescribed IPT compared with QFT.	[Steffen, Ricardo Ewbank] Univ Fed Rio de Janeiro, Internal Med Postgrad Program, Rio De Janeiro, Brazil; [Caetano, Rosangela] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil; [Pinto, Marcia] Fiocruz MS, Fernandes Figueira Inst, BR-21045900 Rio De Janeiro, Brazil; [Chaves, Diogo; Ferrari, Rossini; Bastos, Mayara; Trajman, Anete] Univ Gama Filho, Rio De Janeiro, Brazil; [de Abreu, Sandra Teixeira] Santa Casa de Misericordia Rio de Janeiro Hosp, Paschoal Granato Lab, Rio De Janeiro, Brazil; [Menzies, Dick; Trajman, Anete] McGill Univ, Montreal Chest Inst, Montreal, PQ, Canada	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Gama Filho; McGill University	Steffen, RE (corresponding author), Univ Fed Rio de Janeiro, Internal Med Postgrad Program, Rio De Janeiro, Brazil.	ricardo.steffen@gmail.com	Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [558383/2009-2]; Fundacao de Amparo a Pesquisa do Rio de Janeiro - FAPERJ [E-26/102.712/2008]; International Clinical, Operational and Health Services Research Training Award grant - ICOHRTA [5U 2R TW006883-02]; CNPq/PIBIC UGF; Canadian Institute of Health Research; FOGARTY INTERNATIONAL CENTER [U2RTW006883, U2RTW006885] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); International Clinical, Operational and Health Services Research Training Award grant - ICOHRTA; CNPq/PIBIC UGF; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [558383/2009-2]; Fundacao de Amparo a Pesquisa do Rio de Janeiro - FAPERJ [E-26/102.712/2008]; and by the International Clinical, Operational and Health Services Research Training Award grant - ICOHRTA [5U 2R TW006883-02]. DC, RF and MB have a grant by CNPq/PIBIC UGF. The parental 4R vs 9H RCT is funded by the Canadian Institute of Health Research. None of the funding agencies is responsible for the statements in this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierrenbach AL, 2001, INT J TUBERC LUNG D, V5, P656; Burgos JL, 2009, INT J TUBERC LUNG D, V13, P962; Cobelens FGJ, 2007, INT J TUBERC LUNG D, V11, P934; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; DASAUDE M, BRASIL REGIOES UNIDA; de Perio MA, 2009, ARCH INTERN MED, V169, P179, DOI 10.1001/archinternmed.2008.524; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Deuffic-Burban S, 2010, INT J TUBERC LUNG D, V14, P471; Diel R, 2007, EUR RESPIR J, V30, P321, DOI 10.1183/09031936.00145906; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2007, CHEST, V131, P1424, DOI 10.1378/chest.06-2728; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; EDEJER TTT, 2003, MAKING CHOICES HLTH, V13, P312; GOLD MR, 1996, COST EFFECTIVENESS H, V23; Hardy AB, 2010, THORAX, V65, P178, DOI 10.1136/thx.2009.119677; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; *INT UN AG TUB COM, 1982, B WORLD HEALTH ORGAN, P555; KOCH R, 1982, REV INFECT DIS, V4, P1270; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Kowada A, 2008, MOL DIAGN THER, V12, P235, DOI 10.1007/BF03256289; Kowada A, 2010, MOL DIAGN THER, V14, P367, DOI 10.2165/11586190-000000000-00000; Kowada A, 2010, MOL DIAGN THER, V14, P229, DOI 10.2165/11538610-000000000-00000; Lemos Antonio Carlos, 2004, Braz J Infect Dis, V8, P424, DOI 10.1590/S1413-86702004000600006; Linas BP, 2011, AM J RESP CRIT CARE, V183; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Mancuso JD, 2011, INT J TUBERC LUNG D, V15, P1223, DOI 10.5588/ijtld.10.0542; MANTOUX MC, 1912, PRESSE MED, V20, P146; Marra F, 2008, INT J TUBERC LUNG D, V12, P1414; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Nolan CM, 2003, AM J RESP CRIT CARE, V168, P412, DOI 10.1164/rccm.2306004; Oxlade O, 2007, INT J TUBERC LUNG D, V11, P16; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; PAREEK M, 2011, LANCET INFECT DIS; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; *PROGR NAC CONTR T, 2010, MAN REC CONTR TUB BR; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Slowiak P F, 1985, Hosp Top, V63, P31; Steffen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014014; Trajman A, 2010, INT J TUBERC LUNG D, V14, P551; TSEVAT J, 1988, AM REV RESPIR DIS, V137, P215, DOI 10.1164/ajrccm/137.1.215; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	50	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e59546	10.1371/journal.pone.0059546	http://dx.doi.org/10.1371/journal.pone.0059546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593145	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100008
J	Yeh, E; Fanganiello, RD; Sunaga, DY; Zhou, XY; Holmes, G; Rocha, KM; Alonso, N; Matushita, H; Wang, YL; Jabs, EW; Passos-Bueno, MR				Yeh, Erika; Fanganiello, Roberto D.; Sunaga, Daniele Y.; Zhou, Xueyan; Holmes, Gregory; Rocha, Katia M.; Alonso, Nivaldo; Matushita, Hamilton; Wang, Yingli; Jabs, Ethylin W.; Passos-Bueno, Maria Rita			Novel Molecular Pathways Elicited by Mutant FGFR2 May Account for Brain Abnormalities in Apert Syndrome	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; CHONDROCYTE PROLIFERATION; FACTOR RECEPTOR-2; BONE-DEVELOPMENT; CROUZON SYNDROME; MUTATIONS; ACTIVATION; EXPRESSION; MANAGEMENT	Apert syndrome (AS), the most severe form craniosynostosis, is characterized by premature fusion of coronal sutures. Approximately 70% of AS patients carry S252W gain-of-function mutation in FGFR2. Besides the cranial phenotype, brain dysmorphologies are present and are not seen in other FGFR2-asociated craniosynostosis, such as Crouzon syndrome (CS). Here, we hypothesized that S252W mutation leads not only to overstimulation of FGFR2 downstream pathway, but likewise induces novel pathological signaling. First, we profiled global gene expression of wild-type and S252W periosteal fibroblasts stimulated with FGF2 to activate FGFR2. The great majority (92%) of the differentially expressed genes (DEGs) were divergent between each group of cell populations and they were regulated by different transcription factors. We than compared gene expression profiles between AS and CS cell populations and did not observe correlations. Therefore, we show for the first time that S252W mutation in FGFR2 causes a unique cell response to FGF2 stimulation. Since our gene expression results suggested that novel signaling elicited by mutant FGFR2 might be associated with central nervous system (CNS) development and maintenance, we next investigated if DEGs found in AS cells were also altered in the CNS of an AS mouse model. Strikingly, we validated Strc (stereocilin) in newborn Fgfr2(S252W/+) mouse brain. Moreover, immunostaining experiments suggest a role for endothelial cells and cerebral vasculature in the establishment of characteristic CNS dysmorphologies in AS that has not been proposed by previous literature. Our approach thus led to the identification of new target genes directly or indirectly associated with FGFR2 which are contributing to the pathophysiology of AS.	[Yeh, Erika; Fanganiello, Roberto D.; Sunaga, Daniele Y.; Rocha, Katia M.; Passos-Bueno, Maria Rita] Univ Sao Paulo, Ctr Human Genome, Dept Genet & Evolut Biol, Inst Biosci, Sao Paulo, Brazil; [Zhou, Xueyan; Holmes, Gregory; Wang, Yingli; Jabs, Ethylin W.] Mt Sinai Med Ctr, Dept Genet & Genom Sci, New York, NY 10029 USA; [Alonso, Nivaldo] Univ Sao Paulo, Fac Med, Dept Plast Surg, Sao Paulo, Brazil; [Matushita, Hamilton] Univ Sao Paulo, Fac Med, Dept Neurol, Sao Paulo, Brazil	Universidade de Sao Paulo; Icahn School of Medicine at Mount Sinai; Universidade de Sao Paulo; Universidade de Sao Paulo	Passos-Bueno, MR (corresponding author), Univ Sao Paulo, Ctr Human Genome, Dept Genet & Evolut Biol, Inst Biosci, Sao Paulo, Brazil.	passos@ib.usp.br	Fanganiello, Roberto D./GPP-1411-2022; Alonso, Nivaldo/AAB-4570-2021; Alonso, Nivaldo/D-2711-2012; Passos-Bueno, Maria Rita/I-6796-2016	Fanganiello, Roberto D./0000-0002-5355-255X; Alonso, Nivaldo/0000-0003-1532-9610; Alonso, Nivaldo/0000-0003-1532-9610; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Yeh, Erika/0000-0002-2374-1528; Jabs, Ethylin/0000-0001-8983-5466; Sunaga-Franze, Daniele Yumi/0000-0002-6851-9162	CEPID/Sao Paulo Research Foundation (FAPESP); National Council for Scientific and Technological Development (CNPq); National Institutes of Health [5 R01 DE018500]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018500] Funding Source: NIH RePORTER	CEPID/Sao Paulo Research Foundation (FAPESP); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by grants from CEPID/Sao Paulo Research Foundation (FAPESP), National Council for Scientific and Technological Development (CNPq) and in part by National Institutes of Health 5 R01 DE018500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agochukwu NB, 2012, CHILD NERV SYST, V28, P1447, DOI 10.1007/s00381-012-1756-2; Aldridge K, 2010, DEV DYNAM, V239, P987, DOI 10.1002/dvdy.22218; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; CHADI G, 1993, EXP BRAIN RES, V97, P145; Cohen M M Jr, 1991, Neurosurg Clin N Am, V2, P565; COHEN MM, 1992, CLIN GENET, V41, P12; COHEN MM, 1994, J CRAN GENET DEV BIO, V14, P153; COHEN MM, 1990, AM J MED GENET, V35, P36, DOI 10.1002/ajmg.1320350108; COHEN MM, 1993, AM J MED GENET, V45, P758, DOI 10.1002/ajmg.1320450618; Cohen MM, 2000, CRANIOSYNOSTOSIS DIA, V2nd; DELEON DD, 1987, BIOL REPROD, V37, P1066, DOI 10.1095/biolreprod37.5.1066; ECKENSTEIN F, 1991, ANN NY ACAD SCI, V638, P348, DOI 10.1111/j.1749-6632.1991.tb49045.x; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; Emoto N, 1989, GROWTH FACTORS, V2, P21, DOI 10.3109/08977198909069078; Fanganiello RD, 2007, MOL MED, V13, P422, DOI 10.2119/2007-00027.Fanganiello; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Mangasarian K, 1997, J CELL PHYSIOL, V172, P117, DOI 10.1002/(SICI)1097-4652(199707)172:1<117::AID-JCP13>3.3.CO;2-S; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; NEILSON KM, 1995, J BIOL CHEM, V270, P26037, DOI 10.1074/jbc.270.44.26037; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Quintero-Rivera F, 2006, AM J MED GENET A, V140A, P1337, DOI 10.1002/ajmg.a.31277; Raybaud C, 2007, CHILD NERV SYST, V23, P1379, DOI 10.1007/s00381-007-0474-7; Renier D, 2000, CHILD NERV SYST, V16, P645, DOI 10.1007/s003810000320; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; Verpy E, 2008, NATURE, V456, P255, DOI 10.1038/nature07380; Verpy E, 2011, J COMP NEUROL, V519, P194, DOI 10.1002/cne.22509; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yacubian-Fernandes A, 2004, J NEURORADIOLOGY, V31, P116, DOI 10.1016/S0150-9861(04)96978-7; Yeh E, STEM CELL REV; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536; Zechel S, 2010, NEUROSCIENTIST, V16, P357, DOI 10.1177/1073858410371513	42	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60439	10.1371/journal.pone.0060439	http://dx.doi.org/10.1371/journal.pone.0060439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593218	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100044
J	Ogara, MF; Sirkin, PF; Carcagno, AL; Marazita, MC; Sonzogni, SV; Ceruti, JM; Canepa, ET				Ogara, Maria F.; Sirkin, Pablo F.; Carcagno, Abel L.; Marazita, Mariela C.; Sonzogni, Silvina V.; Ceruti, Julieta M.; Canepa, Eduardo T.			Chromatin Relaxation-Mediated Induction of p19INK4d Increases the Ability of Cells to Repair Damaged DNA	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; NUCLEOTIDE EXCISION-REPAIR; CHECKPOINT CONTROL; CYCLE CHECKPOINTS; GENOTOXIC STRESS; INK4 PROTEINS; UP-REGULATION; ATM; CANCER	The maintenance of genomic integrity is of main importance to the survival and health of organisms which are continuously exposed to genotoxic stress. Cells respond to DNA damage by activating survival pathways consisting of cell cycle checkpoints and repair mechanisms. However, the signal that triggers the DNA damage response is not necessarily a direct detection of the primary DNA lesion. In fact, chromatin defects may serve as initiating signals to activate those mechanisms. If the modulation of chromatin structure could initiate a checkpoint response in a direct manner, this supposes the existence of specific chromatin sensors. p19INK4d, a member of the INK4 cell cycle inhibitors, plays a crucial role in regulating genomic stability and cell viability by enhancing DNA repair. Its expression is induced in cells injured by one of several genotoxic treatments like cis-platin, UV light or neocarzinostatin. Nevertheless, when exogenous DNA damaged molecules are introduced into the cell, this induction is not observed. Here, we show that p19INK4d is enhanced after chromatin relaxation even in the absence of DNA damage. This induction was shown to depend upon ATM/ATR, Chk1/Chk2 and E2F activity, as is the case of p19INK4d induction by endogenous DNA damage. Interestingly, p19INK4d improves DNA repair when the genotoxic damage is caused in a relaxed-chromatin context. These results suggest that changes in chromatin structure, and not DNA damage itself, is the actual trigger of p19INK4d induction. We propose that, in addition to its role as a cell cycle inhibitor, p19INK4d could participate in a signaling network directed to detecting and eventually responding to chromatin anomalies.	[Ogara, Maria F.; Sirkin, Pablo F.; Carcagno, Abel L.; Marazita, Mariela C.; Sonzogni, Silvina V.; Ceruti, Julieta M.; Canepa, Eduardo T.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Mol Biol Lab, Buenos Aires, DF, Argentina	University of Buenos Aires	Canepa, ET (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Mol Biol Lab, Ciudad Univ Pabellon 2, Buenos Aires, DF, Argentina.	ecanepa@qb.fcen.uba.ar		Sonzogni, Silvina/0000-0002-6237-6594; Canepa, Eduardo T./0000-0002-4322-1650	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT); Universidad de Buenos Aires	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT)(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by research grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT) and Universidad de Buenos Aires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Baure J, 2009, MUTAGENESIS, V24, P161, DOI 10.1093/mutage/gen064; Bilsland E, 2005, MUTAGENESIS, V20, P153, DOI 10.1093/mutage/gei031; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Carcagno AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021938; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Ceruti JM, 2005, ONCOGENE, V24, P4065, DOI 10.1038/sj.onc.1208570; Ceruti JM, 2009, INT J BIOCHEM CELL B, V41, P1344, DOI 10.1016/j.biocel.2008.12.005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2005, CELL CYCLE, V4, P1373, DOI 10.4161/cc.4.10.2108; Eller MS, 1997, P NATL ACAD SCI USA, V94, P12627, DOI 10.1073/pnas.94.23.12627; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Forget A, 2008, CELL CYCLE, V7, P3737, DOI 10.4161/cc.7.23.7187; Fuse T, 1996, BIOCHEM BIOPH RES CO, V225, P759, DOI 10.1006/bbrc.1996.1247; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hunt CR, 2007, CANCER RES, V67, P3010, DOI 10.1158/0008-5472.CAN-06-4328; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; KONGRUTTANACHOK N, MOL CANC, V9, P70; Koundrioukoff S, 2004, DNA REPAIR, V3, P969, DOI 10.1016/j.dnarep.2004.03.010; Kuo LJ, 2008, IN VIVO, V22, P305; Lee Jong-Soo, 2007, Cancer Res Treat, V39, P125, DOI 10.4143/crt.2007.39.3.125; Lin WC, 2001, GENE DEV, V15, P1833; LOEKEN MR, 1989, J BIOL CHEM, V264, P6572; Loizou JI, 2006, CELL CYCLE, V5, P696, DOI 10.4161/cc.5.7.2616; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Misri Sandeep, 2009, V523, P395, DOI 10.1007/978-1-59745-190-1_26; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sarkaria JN, 1999, CANCER RES, V59, P4375; Scassa ME, 2007, DNA REPAIR, V6, P626, DOI 10.1016/j.dnarep.2006.12.003; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Varone CL, 1999, ARCH BIOCHEM BIOPHYS, V372, P261, DOI 10.1006/abbi.1999.1470; Weizman N, 2003, J BIOL CHEM, V278, P6741, DOI 10.1074/jbc.M211168200; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020	52	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61143	10.1371/journal.pone.0061143	http://dx.doi.org/10.1371/journal.pone.0061143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593412	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300052
J	Debray, TPA; Moons, KGM; Abo-Zaid, GMA; Koffijberg, H; Riley, RD				Debray, Thomas P. A.; Moons, Karel G. M.; Abo-Zaid, Ghada Mohammed Abdallah; Koffijberg, Hendrik; Riley, Richard David			Individual Participant Data Meta-Analysis for a Binary Outcome: One-Stage or Two-Stage?	PLOS ONE			English	Article							RANDOM-EFFECTS MODELS; PATIENT DATA; SYSTEMATIC REVIEWS; LOGISTIC-REGRESSION; STATISTICAL-METHODS; PROGNOSTIC MARKERS; METHODOLOGY; SEPARATION; QUALITY; TRIALS	Background: A fundamental aspect of epidemiological studies concerns the estimation of factor-outcome associations to identify risk factors, prognostic factors and potential causal factors. Because reliable estimates for these associations are important, there is a growing interest in methods for combining the results from multiple studies in individual participant data meta-analyses (IPD-MA). When there is substantial heterogeneity across studies, various random-effects meta-analysis models are possible that employ a one-stage or two-stage method. These are generally thought to produce similar results, but empirical comparisons are few. Objective: We describe and compare several one-and two-stage random-effects IPD-MA methods for estimating factor-outcome associations from multiple risk-factor or predictor finding studies with a binary outcome. One-stage methods use the IPD of each study and meta-analyse using the exact binomial distribution, whereas two-stage methods reduce evidence to the aggregated level (e. g. odds ratios) and then meta-analyse assuming approximate normality. We compare the methods in an empirical dataset for unadjusted and adjusted risk-factor estimates. Results: Though often similar, on occasion the one-stage and two-stage methods provide different parameter estimates and different conclusions. For example, the effect of erythema and its statistical significance was different for a one-stage (OR = 1.35, p = 0: 03) and univariate two-stage (OR = 1.55, p = 0: 12). Estimation issues can also arise: two-stage models suffer unstable estimates when zero cell counts occur and one-stage models do not always converge. Conclusion: When planning an IPD-MA, the choice and implementation (e.g. univariate or multivariate) of a one-stage or two-stage method should be prespecified in the protocol as occasionally they lead to different conclusions about which factors are associated with outcome. Though both approaches can suffer from estimation challenges, we recommend employing the one-stage method, as it uses a more exact statistical approach and accounts for parameter correlation.	[Debray, Thomas P. A.; Moons, Karel G. M.; Koffijberg, Hendrik] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Abo-Zaid, Ghada Mohammed Abdallah] Univ Exeter, European Ctr Environm & Human Hlth, Peninsula Coll Med & Dent, Knowledge Spa,Royal Cornwall Hosp, Truro, Cornwall, England; [Riley, Richard David] Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Riley, Richard David] Univ Birmingham, Coll Med & Dent Sci, Sch Math Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England	Utrecht University; Utrecht University Medical Center; Royal Cornwall Hospital; University of Exeter; University of Plymouth; University of Birmingham; University of Birmingham	Debray, TPA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	T.Debray@umcutrecht.nl	Debray, Thomas/J-7413-2012; Riley, Richard David/ABE-5877-2020; Abo-Zaid, Ghada/AAY-7516-2020; Riley, Richard/G-2406-2011	Debray, Thomas/0000-0002-1790-2719; Riley, Richard David/0000-0001-8699-0735; Koffijberg, Hendrik/0000-0002-1753-0652	MRC Midlands Hub for Trials Methodology Research (Medical Research Council), at the University of Birmingham in the United Kingdom [G0800808]; Netherlands Organization for Scientific Research [9120.8004, 918.10.615, 916.11.126]; MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: researchfish	MRC Midlands Hub for Trials Methodology Research (Medical Research Council), at the University of Birmingham in the United Kingdom; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Whilst undertaking this work, TPD, GAZ and RDR were supported by the MRC Midlands Hub for Trials Methodology Research (Medical Research Council Grant ID G0800808), at the University of Birmingham in the United Kingdom. The authors also gratefully acknowledge the financial support by The Netherlands Organization for Scientific Research (9120.8004, 918.10.615 and 916.11.126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Abo-Zaid GMA, 2012, J CLIN EPIDEMI UNPUB; ALBERT A, 1984, BIOMETRIKA, V71, P1; Altman DG, 2005, NAT CLIN PRACT ONCOL, V2, P466, DOI 10.1038/ncponc0287; Altman DG, 2001, BRIT MED J, V323; [Anonymous], 2009, STAT MED, V28, P1218, DOI 10.1002/sim.3540; Austin PC, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1195; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Brostrom G, 2011, COMPUT STAT DATA AN, V55, P3123, DOI 10.1016/j.csda.2011.06.011; Brotman DJ, 2005, ARCH INTERN MED, V165, P138, DOI 10.1001/archinte.165.2.138; Browne WJ, 2006, BAYESIAN ANAL, V1, P473, DOI 10.1214/06-BA117; Chen H, 2012, BIOMETRICS IN PRESS; Crowther MJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-34; Debray TPA, 2012, STAT MED, V31, P2697, DOI 10.1002/sim.5412; Debray TPA, 2013, STAT MED IN PRESS; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dutton MT, 2010, THESIS FLORIDA STATE; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Geersing GJ, 2011, THESIS UTRECHT U UTR; Guo G, 2000, ANNU REV SOCIOL, V26, P441, DOI 10.1146/annurev.soc.26.1.441; Hall PA, 1999, HISTOPATHOLOGY, V35, P489; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Hastie T., 2009, ELEMENTS STAT LEARNI, P139; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hemingway H, 2012, BRIT MED J IN PRESS; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; Jackson D, 2011, STAT MED, V30, P2481, DOI 10.1002/sim.4172; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Jackson D, 2010, J STAT PLAN INFER, V140, P961, DOI 10.1016/j.jspi.2009.09.017; Jones AP, 2009, CLIN TRIALS, V6, P16, DOI 10.1177/1740774508100984; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Lesaffre E, 2001, J ROY STAT SOC C-APP, V50, P325, DOI 10.1111/1467-9876.00237; LESAFFRE E, 1989, J ROY STAT SOC B MET, V51, P109; Mathew T, 1999, BIOMETRICS, V55, P1221, DOI 10.1111/j.0006-341X.1999.01221.x; Mathew T, 2010, BIOMETRICAL J, V52, P271, DOI 10.1002/bimj.200900143; Mavridis D, 2012, STAT METHODS MED RES, DOI 10.1177/0962280211432219; Montori VM, 2003, CLIN ORTHOP RELAT R, P43, DOI 10.1097/01.blo.0000079322.41006.5b; Moons KGM, 2010, CLIN CHEM, V56, P537, DOI 10.1373/clinchem.2009.134155; Moons Karel G M, 2009, BMJ-BRIT MED J, P338; Nia VP, 2006, GAUSS HERMITE QUADRA; Noh M, 2007, J MULTIVARIATE ANAL, V98, P896, DOI 10.1016/j.jmva.2006.11.009; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Olkin I, 1998, BIOMETRICS, V54, P317, DOI 10.2307/2534018; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Riley RD, 2007, STAT MED, V26, P78, DOI 10.1002/sim.2524; Riley RD, 2003, BRIT J CANCER, V88, P1191, DOI 10.1038/sj.bjc.6600886; Riley RD, 2012, PLOS MED IN PRESS; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Riley RD, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-3; Riley RD, 2007, STAT IND TECHNOL, P39, DOI 10.1007/978-0-8176-4542-7_3; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P863, DOI 10.1016/j.jclinepi.2007.02.004; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Riley RD, 2010, RES SYNTH METHODS, V1, P2, DOI 10.1002/jrsm.4; Riley RD, 2009, J R STAT SOC A STAT, V172, P789, DOI 10.1111/j.1467-985X.2008.00593.x; Sauerbrei W, 2005, ADV OTO-RHINO-LARYNG, V62, P184; Sauerbrei W, 2006, COMMUNICATIONS STAT, V35; Shrier I, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-19; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Simon R, 1994, BRIT J CANCER, V69, P979; Stewart GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046042; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Steyerberg EW, 2000, STAT MED, V19, P141, DOI 10.1002/(SICI)1097-0258(20000130)19:2<141::AID-SIM334>3.0.CO;2-O; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Sutton AJ, 2008, STAT MED, V27, P651, DOI 10.1002/sim.2916; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Walter SD, 1997, STAT MED, V16, P2883, DOI 10.1002/(SICI)1097-0258(19971230)16:24<2883::AID-SIM825>3.0.CO;2-B	86	131	130	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60650	10.1371/journal.pone.0060650	http://dx.doi.org/10.1371/journal.pone.0060650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585842	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600032
J	Di Palo, B; Rippa, V; Santi, I; Brettoni, C; Muzzi, A; Metruccio, MME; Grifantini, R; Telford, JL; Paccani, SR; Soriani, M				Di Palo, Benedetta; Rippa, Valentina; Santi, Isabella; Brettoni, Cecilia; Muzzi, Alessandro; Metruccio, Matteo Maria Emiliano; Grifantini, Renata; Telford, John L.; Paccani, Silvia Rossi; Soriani, Marco			Adaptive Response of Group B Streptococcus to High Glucose Conditions: New Insights on the CovRS Regulation Network	PLOS ONE			English	Article							GENE-EXPRESSION; VIRULENCE; SYSTEM; DISEASE; PROTEIN; METABOLISM; AGALACTIAE; TRANSPORT; ADULTS; FAMILY	Although the contribution of carbohydrate catabolism to bacterial colonization and infection is well recognized, the transcriptional changes during these processes are still unknown. In this study, we have performed comparative global gene expression analysis of GBS in sugar-free versus high glucose milieu. The analysis revealed a differential expression of genes involved in metabolism, transport and host-pathogen interaction. Many of them appeared to be among the genes previously reported to be controlled by the CovRS two-component system. Indeed, the transcription profile of a Delta covRS strain grown in high-glucose conditions was profoundly affected. In particular, of the total genes described to be regulated by glucose, similar to 27% were under CovRS control with a functional role in protein synthesis, transport, energy metabolism and regulation. Among the CovRS dependent genes, we found bibA, a recently characterized adhesin involved in bacterial serum resistance and here reported to be down-regulated by glucose. ChIP analysis revealed that in the presence of glucose, CovR binds bibA promoter in vivo, suggesting that CovR may act as a negative regulator or a repressor. We also demonstrated that, as for other target promoters, chemical phosphorylation of CovR in aspartic acid increases its affinity for the bibA promoter region. The data reported in this study contribute to the understanding of the molecular mechanisms modulating the adaptation of GBS to glucose.	[Di Palo, Benedetta; Rippa, Valentina; Brettoni, Cecilia; Muzzi, Alessandro; Metruccio, Matteo Maria Emiliano; Telford, John L.; Paccani, Silvia Rossi; Soriani, Marco] Novartis Vaccines & Diagnost, Siena, Italy; [Santi, Isabella] Swiss Fed Inst Technol, CH-1015 Lausanne, Switzerland; [Grifantini, Renata] Externautics Spa, Siena, Italy	Novartis; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Paccani, SR (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	silvia.rossi_paccani@novartis.com; marco.soriani@novartis.com	Telford, John Laird/ABG-8144-2020; Renata, Grifantini/AAB-9969-2022; Muzzi, Alessandro/J-6200-2012; Metruccio, Matteo/I-1467-2019	Renata, Grifantini/0000-0003-0024-3355; Metruccio, Matteo/0000-0002-2456-2652; SORIANI, Marco/0000-0002-9752-5844	Novartis Vaccines and Diagnostics Srl	Novartis Vaccines and Diagnostics Srl	Internal funding from Novartis Vaccines and Diagnostics Srl supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almengor AC, 2007, J BACTERIOL, V189, P8405, DOI 10.1128/JB.01038-07; Alteri CJ, 2012, CURR OPIN MICROBIOL, V15, P3, DOI 10.1016/j.mib.2011.12.004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Domingo P, 1997, CLIN INFECT DIS, V25, P1180, DOI 10.1086/516094; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; Gruening P, 2006, J BACTERIOL, V188, P361, DOI 10.1128/JB.188.2.361-369.2006; Hoffmann T, 2002, J BACTERIOL, V184, P718, DOI 10.1128/JB.184.3.718-727.2002; Hoffmann T, 2011, J BACTERIOL, V193, P1552, DOI 10.1128/JB.01319-10; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; JACKSON LA, 1995, ANN INTERN MED, V123, P415, DOI 10.7326/0003-4819-123-6-199509150-00003; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Jones AL, 2000, MOL MICROBIOL, V37, P1444, DOI 10.1046/j.1365-2958.2000.02099.x; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003; Mazade MA, 2001, MOL GENET METAB, V73, P259, DOI 10.1006/mgme.2001.3185; Mereghetti L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007145; Obis D, 1999, J BACTERIOL, V181, P6238, DOI 10.1128/JB.181.20.6238-6246.1999; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Samen U, 2004, J BACTERIOL, V186, P1398, DOI 10.1128/JB.186.5.1398-1408.2004; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Santi I, 2009, J BACTERIOL, V191, P5387, DOI 10.1128/JB.00370-09; Santi I, 2009, J INFECT DIS, V200, P564, DOI 10.1086/603540; SCHWARTZ B, 1991, JAMA-J AM MED ASSOC, V266, P1112, DOI 10.1001/jama.266.8.1112; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Sitkiewicz I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006114; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Stroeher UH, 2007, J INFECT DIS, V196, P1820, DOI 10.1086/523107; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Ueda T, 2011, MICROB PATHOGENESIS, V51, P178, DOI 10.1016/j.micpath.2011.04.003; Warren MA, 2004, J BACTERIOL, V186, P4605, DOI 10.1128/JB.186.14.4605-4612.2004; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x; Yanai H., 2012, Journal of Microbiology and Antimicrobials, V4, P1	52	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61294	10.1371/journal.pone.0061294	http://dx.doi.org/10.1371/journal.pone.0061294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585887	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600100
J	Milne, GJ; Halder, N; Kelso, JK				Milne, George J.; Halder, Nilimesh; Kelso, Joel K.			The Cost Effectiveness of Pandemic Influenza Interventions: A Pandemic Severity Based Analysis	PLOS ONE			English	Article							SCHOOL CLOSURE; MITIGATION STRATEGIES; ANTIVIRAL RESISTANCE; REPRODUCTION NUMBER; VIRUS; TRANSMISSION; EPIDEMIC; DESIGN; IMPACT; H1N1	Background: The impact of a newly emerged influenza pandemic will depend on its transmissibility and severity. Understanding how these pandemic features impact on the effectiveness and cost effectiveness of alternative intervention strategies is important for pandemic planning. Methods: A cost effectiveness analysis of a comprehensive range of social distancing and antiviral drug strategies intended to mitigate a future pandemic was conducted using a simulation model of a community of similar to 30,000 in Australia. Six pandemic severity categories were defined based on case fatality ratio (CFR), using data from the 2009/2010 pandemic to relate hospitalisation rates to CFR. Results: Intervention strategies combining school closure with antiviral treatment and prophylaxis are the most cost effective strategies in terms of cost per life year saved (LYS) for all severity categories. The cost component in the cost per LYS ratio varies depending on pandemic severity: for a severe pandemic (CFR of 2.5%) the cost is similar to$9 k per LYS; for a low severity pandemic (CFR of 0.1%) this strategy costs similar to$58 k per LYS; for a pandemic with very low severity similar to the 2009 pandemic (CFR of 0.03%) the cost is similar to$155 per LYS. With high severity pandemics (CFR >0.75%) the most effective attack rate reduction strategies are also the most cost effective. During low severity pandemics costs are dominated by productivity losses due to illness and social distancing interventions, while for high severity pandemics costs are dominated by hospitalisation costs and productivity losses due to death. Conclusions: The most cost effective strategies for mitigating an influenza pandemic involve combining sustained social distancing with the use of antiviral agents. For low severity pandemics the most cost effective strategies involve antiviral treatment, prophylaxis and short durations of school closure; while these are cost effective they are less effective than other strategies in reducing the infection rate.	[Milne, George J.; Halder, Nilimesh; Kelso, Joel K.] Univ Western Australia, Simulat & Modelling Res Unit, Perth, WA 6009, Australia	University of Western Australia	Milne, GJ (corresponding author), Univ Western Australia, Simulat & Modelling Res Unit, Perth, WA 6009, Australia.	milne@csse.uwa.edu.au	Milne, George/C-6839-2013	Kelso, Joel/0000-0001-9814-6435; Milne, George/0000-0002-9796-0600	National Health and Medical Research Council, Australia [10004415]; GlaxoSmithKline	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); GlaxoSmithKline(GlaxoSmithKline)	This study has been funded by a project grant to GJM from the National Health and Medical Research Council, Australia (number 10004415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GJM has received a travel grant from GlaxoSmithKline to attend an expert meeting in Boston, USA.	Arinaminpathy N, 2008, J R SOC INTERFACE, V5, P545, DOI 10.1098/rsif.2007.1152; Arino J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-8; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Drummond MF, 2015, METHODS EC EVALUATIO; ECDC, 2009, ECDC RISK ASS 2009 I; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Godlee F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7304; Halder N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022087; Halder N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-221; Halder N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-168; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Kelso JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013797; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007108; Lee VJ, 2006, EMERG INFECT DIS, V12, P95; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; McCaw J.M., 2011, INFLUENZA OTHER RESP, V5, P202; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Milne G, 2012, BRIT MED J, pe7304; Milne G, 2010, J R SOC INTERFACE, V7, P573, DOI 10.1098/rsif.2009.0312; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014505; Newall AT, 2010, EMERG INFECT DIS, V16, P224, DOI 10.3201/eid1602.090571; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Phillip C, 2011, NATURE S, V480, pS1; Presanis AM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5408; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reddy D, 2010, J ANTIMICROB CHEMOTH, V65, pII35, DOI 10.1093/jac/dkq014; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Sypsa V, 2009, EUROSURVEILLANCE, V14; US CDC, 2007, INT PREP PLANN GUID; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; WHO, 2003, MAKING CHOICES HLTH; World Health Organization, 2011, REP REV COMM FUNCT I; World Health Organization, 2009, PAND INFL PREP RESP; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x	70	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61504	10.1371/journal.pone.0061504	http://dx.doi.org/10.1371/journal.pone.0061504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585906	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600121
J	Ferretti, L; Disanto, F; Wiehe, T				Ferretti, Luca; Disanto, Filippo; Wiehe, Thomas			The Effect of Single Recombination Events on Coalescent Tree Height and Shape	PLOS ONE			English	Article							HITCHHIKING; SIMULATION; INFERENCE; SELECTION; SAMPLES; MODELS	The coalescent with recombination is a fundamental model to describe the genealogical history of DNA sequence samples from recombining organisms. Considering recombination as a process which acts along genomes and which creates sequence segments with shared ancestry, we study the influence of single recombination events upon tree characteristics of the coalescent. We focus on properties such as tree height and tree balance and quantify analytically the changes in these quantities incurred by recombination in terms of probability distributions. We find that changes in tree topology are often relatively mild under conditions of neutral evolution, while changes in tree height are on average quite large. Our results add to a quantitative understanding of the spatial coalescent and provide the neutral reference to which the impact by other evolutionary scenarios, for instance tree distortion by selective sweeps, can be compared.	[Ferretti, Luca; Disanto, Filippo; Wiehe, Thomas] Univ Cologne, Inst Genet, Cologne, Germany; [Ferretti, Luca] Ctr Res AgriGenom, Barcelona, Spain	University of Cologne; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Wiehe, T (corresponding author), Univ Cologne, Inst Genet, Cologne, Germany.	twiehe@uni-koeln.de	Ferretti, Luca/B-4340-2019	Ferretti, Luca/0000-0001-7578-7301	German Research Foundation [DFG-SFB680, DFG-SPP1590]; MICINN, Spain [AGL2010-14822]; Consolider Grant from the Spanish Ministry of Research [CSD2007- 00036]; CSIC (Spain) under the JAE-doc program;  [SFB680]	German Research Foundation(German Research Foundation (DFG)); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider Grant from the Spanish Ministry of Research; CSIC (Spain) under the JAE-doc program; 	This work was supported by grants from the German Research Foundation (DFG-SFB680 and DFG-SPP1590) to TW, grant AGL2010-14822 (MICINN, Spain) to Miguel Perez-Enciso and by a Consolider Grant from the Spanish Ministry of Research, CSD2007- 00036 "Centre for Research in Agrigenomics." LF acknowledges support from CSIC (Spain) under the JAE-doc program, and by a visiting scholar grant from SFB680. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Angel O, 2012, PROBAB THEORY REL, V152, P625, DOI 10.1007/s00440-010-0332-5; [Anonymous], 2011, PHYLOGENETIC NETWORK; Bhaskar A, 2012, ADV APPL PROBAB, V44, P408, DOI 10.1239/aap/1339878718; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Disanto F, 2013, MATH BIOSCI, V242, P195, DOI 10.1016/j.mbs.2013.01.010; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Fay JC, 2000, GENETICS, V155, P1405; Greven A, 2009, PROBAB THEORY REL, V145, P285, DOI 10.1007/s00440-008-0169-3; Griffiths R, 2003, HIGHLY STRUCTURED ST, P393; Griffiths R., 1997, PROGR POPULATION GEN, P257; GRIFFITHS RC, 1984, J MATH BIOL, V21, P67, DOI 10.1007/BF00275223; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; KAPLAN NL, 1989, GENETICS, V123, P887; Kim Y, 2009, BRIEF BIOINFORM, V10, P84, DOI 10.1093/bib/bbn048; KIMURA M, 1987, J MOL EVOL, V26, P24, DOI 10.1007/BF02111279; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Li H, 2012, COALESCENT IN PRESS; Li HP, 2011, MOL BIOL EVOL, V28, P365, DOI 10.1093/molbev/msq211; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; MURTAGH F, 1984, DISCRETE APPL MATH, V7, P191, DOI 10.1016/0166-218X(84)90066-0; Paul JS, 2011, GENETICS, V187, P1115, DOI 10.1534/genetics.110.125534; Rasmussen MD, 2012, GENOME RES, V22, P755, DOI 10.1101/gr.123901.111; Sagitov S, 1999, J APPL PROBAB, V36, P1116, DOI 10.1239/jap/1032374759; Semple C, 2006, IEEE ACM T COMPUT BI, V3, P84, DOI 10.1109/TCBB.2006.14; TAJIMA F, 1983, GENETICS, V105, P437; Wakeley J., 2009, COALESCENT THEORY; Wiuf C, 1999, THEOR POPUL BIOL, V55, P248, DOI 10.1006/tpbi.1998.1403; Wiuf C, 2006, J MATH BIOL, V53, P821, DOI 10.1007/s00285-006-0031-0; Zivkovic D, 2008, GENETICS, V180, P341, DOI 10.1534/genetics.108.091231	32	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60123	10.1371/journal.pone.0060123	http://dx.doi.org/10.1371/journal.pone.0060123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593168	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000021
J	Lin, L; Sun, Y; Luo, BJ; Yang, Y; He, X; Su, WL; Sun, ZN; Guo, DY; Zhu, QY; Liu, JM; Chang, GH				Lin Lei; Sun Ying; Luo Baojun; Yang Yi; He Xiang; Su Wenli; Sun Zounan; Guo Deyin; Zhu Qingyu; Liu Jingmei; Chang Guohui			Attenuation of Mouse Hepatitis Virus by Deletion of the LLRKxGxKG Region of Nsp1	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; HOST GENE-EXPRESSION; SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; IN-VITRO; VIRAL REPLICATION; PROTEIN; GENOME; PATHOGENESIS; DISEASE	Coronaviruses are a family of large positive-sense RNA viruses that are responsible for a wide range of important veterinary and human diseases. Nsp1 has been shown to have an important role in the pathogenetic mechanisms of coronaviruses in vivo. To assess the function of a relatively conserved domain (LLRKxGxKG) of MHV nsp1, a mutant virus, MHV-nsp1-27D, with a 27 nts (LLRKxGxKG) deletion in nsp1, was constructed using a reverse genetic system with a vaccinia virus vector. The mutant virus had similar growth kinetics to MHV-A59 wild-type virus in 17CI-1 cells, but was highly attenuated in vivo. Moreover, the mutant virus completely protected C57BL/6 mice from a lethal MHV-A59 challenge. To further analyze the mechanism of the attenuation of the mutant virus, changes in reporter gene expression were measured in nsp1- or nsp1-27D-expressing cells; the results showed that nsp1 inhibited reporter gene expression controlled by different promoters, but that this inhibition was reduced for nsp1-27D. The research in vivo and in vitro suggests that the LLRKxGxKG region of nsp1 may play an important role in this process.	[Lin Lei; Luo Baojun; Zhu Qingyu; Chang Guohui] Acad Mil Med Sci, Inst Epidemiol & Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Yang Yi; He Xiang; Su Wenli; Sun Zounan; Liu Jingmei; Chang Guohui] Acad Mil Med Sci, Inst Dis Prevent & Control, Beijing, Peoples R China; [Sun Ying; Guo Deyin] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [Sun Ying; Guo Deyin] Wuhan Univ, Modern Virol Res Ctr, Coll Life Sci, Wuhan 430072, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Academy of Military Medical Sciences - China; Wuhan University; Wuhan University	Liu, JM (corresponding author), Acad Mil Med Sci, Inst Dis Prevent & Control, Beijing, Peoples R China.	amay_l@163.com; changguohui999@yahoo.com.cn			National Natural Science Foundation of China [31100122]; State Key Laboratory of Pathogen and Biosecurity Foundation of China [SKLPBS1109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pathogen and Biosecurity Foundation of China	This work was supported by the National Natural Science Foundation of China (No. 31100122) and State Key Laboratory of Pathogen and Biosecurity Foundation of China (No. SKLPBS1109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MS, 2007, J VIROL, V81, P3151, DOI 10.1128/JVI.01939-06; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Brockway SM, 2005, VIROLOGY, V340, P209, DOI 10.1016/j.virol.2005.06.035; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Coley SE, 2005, J VIROL, V79, P3097, DOI 10.1128/JVI.79.5.3097-3106.2005; Connor RF, 2007, TRENDS MICROBIOL, V15, P51, DOI 10.1016/j.tim.2006.12.005; De Groot-Mijnes JDF, 2005, J VIROL, V79, P1036, DOI 10.1128/JVI.79.2.1036-1044.2005; de Haan CAM, 2002, VIROLOGY, V296, P177, DOI 10.1006/viro.2002.1412; Dijkman R, 2009, J FORMOS MED ASSOC, V108, P270, DOI 10.1016/S0929-6646(09)60066-8; Elankumaran S, 2010, J VIROL, V84, P3835, DOI 10.1128/JVI.01553-09; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Graham RL, 2005, J VIROL, V79, P13399, DOI 10.1128/JVI.79.21.13399-13411.2005; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Roth-Cross JK, 2007, J VIROL, V81, P7189, DOI 10.1128/JVI.00013-07; Schelle B, 2006, ADV EXP MED BIOL, V581, P43; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Thiel V, 2003, J VIROL, V77, P9790, DOI 10.1128/JVI.77.18.9790-9798.2003; Thiel V, 2001, J GEN VIROL, V82, P1273, DOI 10.1099/0022-1317-82-6-1273; Tohya Y, 2009, J VIROL, V83, P5282, DOI 10.1128/JVI.02485-08; Vijgen L, 2005, VIROLOGY, V337, P85, DOI 10.1016/j.virol.2005.04.010; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	30	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61166	10.1371/journal.pone.0061166	http://dx.doi.org/10.1371/journal.pone.0061166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593419	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000107
J	Santana-Mora, U; Lopez-Cedrun, J; Mora, MJ; Otero, XL; Santana-Penin, U				Santana-Mora, Urbano; Lopez-Cedrun, Jose; Mora, Maria J.; Otero, Xose L.; Santana-Penin, Urbano			Temporomandibular Disorders: The Habitual Chewing Side Syndrome	PLOS ONE			English	Article							ARTICULAR EMINENCE; JOINT; OCCLUSAL; DYSFUNCTION; GROWTH; MODEL	Background: Temporomandibular disorders are the most common cause of chronic orofacial pain, but, except where they occur subsequent to trauma, their cause remains unknown. This cross-sectional study assessed chewing function (habitual chewing side) and the differences of the chewing side and condylar path and lateral anterior guidance angles in participants with chronic unilateral temporomandibular disorder. This is the preliminary report of a randomized trial that aimed to test the effect of a new occlusal adjustment therapy. Methods: The masticatory function of 21 randomly selected completely dentate participants with chronic temporomandibular disorders (all but one with unilateral symptoms) was assessed by observing them eat almonds, inspecting the lateral horizontal movement of the jaw, with kinesiography, and by means of interview. The condylar path in the sagittal plane and the lateral anterior guidance angles with respect to the Frankfort horizontal plane in the frontal plane were measured on both sides in each individual. Results: Sixteen of 20 participants with unilateral symptoms chewed on the affected side; the concordance (Fisher's exact test, P = .003) and the concordance-symmetry level (Kappa coefficient kappa = 0.689; 95% confidence interval [CI], 0.38 to 0.99; P = .002) were significant. The mean condylar path angle was steeper (53.47(10.88) degrees versus 46.16(7.25) degrees; P = .001), and the mean lateral anterior guidance angle was flatter (41.63(13.35) degrees versus 48.32(9.53) degrees P = .036) on the symptomatic side. Discussion: The results of this study support the use of a new term based on etiology, "habitual chewing side syndrome", instead of the nonspecific symptom-based "temporomandibular joint disorders"; this denomination is characterized in adults by a steeper condylar path, flatter lateral anterior guidance, and habitual chewing on the symptomatic side.	[Santana-Mora, Urbano; Mora, Maria J.; Santana-Penin, Urbano] Univ Santiago Compostela, Fac Med & Odontol, Dept Stomatol, La Coruna, Spain; [Lopez-Cedrun, Jose] Univ Hosp La Coruna, Oral & Maxillofacial Surg Serv, La Coruna, Spain; [Otero, Xose L.] Univ Santiago Compostela, Fac Med & Odontol, Dept Stat, La Coruna, Spain	Universidade de Santiago de Compostela; Complejo Hospitalario Universitario A Coruna; Universidade de Santiago de Compostela	Santana-Penin, U (corresponding author), Univ Santiago Compostela, Fac Med & Odontol, Dept Stomatol, La Coruna, Spain.	urbano.santana@usc.es	Mora, Urbano Alejandro Santana/ABH-2032-2020	Mora, Urbano Alejandro Santana/0000-0002-8053-0014; Santana-Penin, Urbano/0000-0002-9322-4120	Institute of Health Carlos III of the Ministry of Science and Innovation of the Government of Spain [PI11/02507]; General Directorate of Universities and Research; Department of Education and University	Institute of Health Carlos III of the Ministry of Science and Innovation of the Government of Spain; General Directorate of Universities and Research; Department of Education and University	This study was financed with a grant PI11/02507 from the Institute of Health Carlos III of the Ministry of Science and Innovation of the Government of Spain. It was completed with the equipment granted by the General Directorate of Universities and Research; Department of Education and University. Xunta de Galicia. Official Journal No. 143 Galicia, July 22, 1996. And the Department of Innovation, Industry and Commerce. Xunta de Galicia, April 30, 2004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt O, 2007, ANN ANAT, V189, P342, DOI 10.1016/j.aanat.2007.02.008; Cantor AB, 1996, PSYCHOL METHODS, V1, P150, DOI 10.1037/1082-989X.1.2.150; De Leeuw R., 2008, OROFACIAL PAIN GUIDE, V4th; De Wijer Anton, 1995, Journal of Orofacial Pain, V9, P181; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Diernberger S, 2008, J ORAL REHABIL, V35, P613, DOI 10.1111/j.1365-2842.2007.01790.x; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Ferrario VF, 1996, J PROSTHET DENT, V75, P534, DOI 10.1016/S0022-3913(96)90459-X; Gysi A., 1910, DENT COSMOS, V52, P403; Hildebrand Y., 1936, DENT COSMOS, V78, P449; HINTON RJ, 1981, AM J PHYS ANTHROPOL, V54, P439, DOI 10.1002/ajpa.1330540402; Hoogmartens M J, 1987, Electromyogr Clin Neurophysiol, V27, P7; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; HYLANDER WL, 1979, AM J PHYS ANTHROPOL, V51, P433, DOI 10.1002/ajpa.1330510317; KOOLSTRA JH, 1988, J BIOMECH, V21, P563, DOI 10.1016/0021-9290(88)90219-9; Miyawaki S, 2001, J DENT RES, V80, P437, DOI 10.1177/00220345010800020701; Nitzan DW, 2001, J ORAL MAXIL SURG, V59, P36, DOI 10.1053/joms.2001.19278; Del Palomar AP, 2008, ANN BIOMED ENG, V36, P1014, DOI 10.1007/s10439-008-9487-y; Poikela A, 1997, EUR J ORAL SCI, V105, P331, DOI 10.1111/j.1600-0722.1997.tb00249.x; POND LH, 1986, J PROSTHET DENT, V55, P498, DOI 10.1016/0022-3913(86)90186-1; PRETI G, 1982, J PROSTHET DENT, V48, P461, DOI 10.1016/0022-3913(82)90086-5; PULLINGER AG, 1993, J DENT RES, V72, P968, DOI 10.1177/00220345930720061301; Reinhardt R, 2006, CRANIO, V24, P166, DOI 10.1179/crn.2006.027; REN YF, 1995, ORAL SURG ORAL MED O, V80, P258, DOI 10.1016/S1079-2104(05)80380-4; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Shinagawa H, 2003, J DENT RES, V82, P278, DOI 10.1177/154405910308200407; Smartt JM, 2005, PLAST RECONSTR SURG, V116, p14E, DOI 10.1097/01.PRS.0000169940.69315.9C; SMITH DM, 1986, J DENT RES, V65, P1046, DOI 10.1177/00220345860650080201; SZENTPETERY A, 1987, COMMUNITY DENT ORAL, V15, P164, DOI 10.1111/j.1600-0528.1987.tb00507.x; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; Varela JMF, 2003, J ORAL REHABIL, V30, P990, DOI 10.1046/j.1365-2842.2003.01085.x	31	41	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59980	10.1371/journal.pone.0059980	http://dx.doi.org/10.1371/journal.pone.0059980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593156	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000017
J	Ellinger, P; Kluth, M; Stindt, J; Smits, SHJ; Schmitt, L				Ellinger, Philipp; Kluth, Marianne; Stindt, Jan; Smits, Sander H. J.; Schmitt, Lutz			Detergent Screening and Purification of the Human Liver ABC Transporters BSEP (ABCB11) and MDR3 (ABCB4) Expressed in the Yeast Pichia pastoris	PLOS ONE			English	Article							SALT EXPORT PUMP; FAMILIAL INTRAHEPATIC CHOLESTASIS; RESISTANCE PROTEIN BCRP/ABCG2; SIZE-EXCLUSION CHROMATOGRAPHY; INTEGRAL MEMBRANE-PROTEINS; P-GLYCOPROTEIN; NUCLEOTIDE-BINDING; CANALICULAR MEMBRANE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION	The human liver ATP-binding cassette (ABC) transporters bile salt export pump (BSEP/ABCB11) and the multidrug resistance protein 3 (MDR3/ABCB4) fulfill the translocation of bile salts and phosphatidylcholine across the apical membrane of hepatocytes. In concert with ABCG5/G8, these two transporters are responsible for the formation of bile and mutations within these transporters can lead to severe hereditary diseases. In this study, we report the heterologous overexpression and purification of human BSEP and MDR3 as well as the expression of the corresponding C-terminal GFP-fusion proteins in the yeast Pichia pastoris. Confocal laser scanning microscopy revealed that BSEP-GFP and MDR3-GFP are localized in the plasma membrane of P. pastoris. Furthermore, we demonstrate the first purification of human BSEP and MDR3 yielding,1 mg and,6 mg per 100 g of wet cell weight, respectively. By screening over 100 detergents using a dot blot technique, we found that only zwitterionic, lipid-like detergents such as Fos-cholines or Cyclofos were able to extract both transporters in sufficient amounts for subsequent functional analysis. For MDR3, fluorescence-detection size exclusion chromatography (FSEC) screens revealed that increasing the acyl chain length of Fos-Cholines improved monodispersity. BSEP purified in n-dodecyl-beta-D-maltoside or Cymal-5 after solubilization with Fos-choline 16 from P. pastoris membranes showed binding to ATP-agarose. Furthermore, detergent-solubilized and purified MDR3 showed a substrate-inducible ATPase activity upon addition of phosphatidylcholine lipids. These results form the basis for further biochemical analysis of human BSEP and MDR3 to elucidate the function of these clinically relevant ABC transporters.	[Ellinger, Philipp; Kluth, Marianne; Stindt, Jan; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany.	Lutz.Schmitt@hhu.de		Stindt, Jan/0000-0002-8760-1989	Clinic Research Unit 217 (KFO 217) [TP3]	Clinic Research Unit 217 (KFO 217)	This work was supported by the Clinic Research Unit 217 (KFO 217) "Hepatobiliary transport and liver diseases" (project TP3 to L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Bai J, PLOS ONE, V6; Beaudet L, 1998, BIOCHEMISTRY-US, V37, P9073, DOI 10.1021/bi972656j; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Cai J, 2002, BIOCHEMISTRY-US, V41, P8058, DOI 10.1021/bi012082p; Cai J, 2001, BIOCHEMISTRY-US, V40, P8307, DOI 10.1021/bi010093c; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deleuze JF, 1996, HEPATOLOGY, V23, P904, DOI 10.1002/hep.510230435; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Dzagania T, 2012, GENE, V506, P141, DOI 10.1016/j.gene.2012.06.029; Elferink RPJO, 2007, PFLUG ARCH EUR J PHY, V453, P601, DOI 10.1007/s00424-006-0062-9; Eshaghi Said, 2009, V498, P265, DOI 10.1007/978-1-59745-196-3_17; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Gonzales E, 2012, J HEPATOL, V57, P695, DOI 10.1016/j.jhep.2012.04.017; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Groen A, 2011, GASTROENTEROLOGY, V141, P1927, DOI 10.1053/j.gastro.2011.07.042; Gutmann DAP, 2007, PROTEIN SCI, V16, P1422, DOI 10.1110/ps.072759907; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hayashi H, 2005, HEPATOLOGY, V41, P916, DOI 10.1002/hep.20627; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Infed N, 2011, BBA-BIOMEMBRANES, V1808, P2313, DOI 10.1016/j.bbamem.2011.05.016; Jacquemin E, 2012, CLIN RES HEPATOL GAS, V36, pS26, DOI 10.1016/S2210-7401(12)70018-9; Johnson BJH, 2010, BIOCHEMISTRY-US, V49, P3403, DOI 10.1021/bi902064g; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kis E, 2009, DRUG METAB DISPOS, V37, P1878, DOI 10.1124/dmd.108.024778; Kubitz R, 2004, GASTROENTEROLOGY, V126, P541, DOI 10.1053/j.gastro.2003.11.003; Kubitz R, 2012, CLIN RES HEPATOLOGY; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; McDevitt CA, 2009, ADV DRUG DELIVER REV, V61, P57, DOI 10.1016/j.addr.2008.07.004; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Mita S, 2006, AM J PHYSIOL-GASTR L, V290, pG550, DOI 10.1152/ajpgi.00364.2005; Mizutani K, 2011, PROTEIN EXPRES PURIF, V77, P1, DOI 10.1016/j.pep.2010.12.009; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Ni ZL, 2010, CURR DRUG METAB, V11, P603, DOI 10.2174/138920010792927325; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Paulusma CC, 2009, J BIOL CHEM, V284, P9947, DOI 10.1074/jbc.M808667200; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2010, STRUCTURE, V18, P482, DOI 10.1016/j.str.2010.01.017; Rosmorduc O, 2001, GASTROENTEROLOGY, V120, P1459, DOI 10.1053/gast.2001.23947; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Small DM, 2003, P NATL ACAD SCI USA, V100, P4, DOI 10.1073/pnas.0237205100; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; Stindt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020562; Strautnieks SS, 1997, AM J HUM GENET, V61, P630, DOI 10.1086/515501; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; Van Mil SWC, 2004, GASTROENTEROLOGY, V127, P379, DOI 10.1053/j.gastro.2004.04.065; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Vergis JM, 2010, ANAL BIOCHEM, V407, P1, DOI 10.1016/j.ab.2010.07.019; Wang RX, 2009, HEPATOLOGY, V50, P948, DOI 10.1002/hep.23089; Zeder-Lutz G, 2006, PROTEIN EXPRES PURIF, V50, P118, DOI 10.1016/j.pep.2006.05.017	61	29	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60620	10.1371/journal.pone.0060620	http://dx.doi.org/10.1371/journal.pone.0060620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593265	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100059
J	Flynn, SM; Shaw, JJ; Abel, KM				Flynn, Sandra M.; Shaw, Jenny J.; Abel, Kathryn M.			Filicide: Mental Illness in Those Who Kill Their Children	PLOS ONE			English	Article							PATERNAL FILICIDE; MATERNAL FILICIDE; PHYSICAL ABUSE; RISK-FACTORS; HOMICIDE; MOTHERS; KNOWLEDGE; THOUGHTS; INFANTS; PARENTS	Background: Most child victims of homicide are killed by a parent or step-parent. This large population study provides a contemporary and detailed description of filicide perpetrators. We examined the relationship between filicide and mental illness at the time of the offence, and care received from mental health services in the past. Method: All filicide and filicide-suicide cases in England and Wales (1997-2006) were drawn from a national index of homicide perpetrators. Data on people in contact with mental health services were obtained via a questionnaire from mental health teams. Additional clinical information was collected from psychiatric reports. Results: 6144 people were convicted of homicide, 297 were filicides, and 45 cases were filicide-suicides. 195 (66%) perpetrators were fathers. Mothers were more likely than fathers to have a history of mental disorder (66% v 27%) and symptoms at the time of the offence (53% v 23%), most often affective disorder. 17% of mothers had schizophrenia or other delusional disorders. Overall 8% had schizophrenia. 37% were mentally ill at the time of the offence. 20% had previously been in contact with mental health services, 12% within a year of the offence. Conclusion: In the majority of cases, mental illness was not a feature of filicide. However, young mothers and parents with severe mental illness, especially affective and personality disorder who are providing care for children, require careful monitoring by mental health and other support services. Identifying risk factors for filicide requires further research.	[Flynn, Sandra M.; Shaw, Jenny J.] Univ Manchester, Ctr Mental Hlth & Risk, Manchester, Lancs, England; [Abel, Kathryn M.] Univ Manchester, Ctr Womens Mental Hlth, Manchester, Lancs, England	University of Manchester; University of Manchester	Flynn, SM (corresponding author), Univ Manchester, Ctr Mental Hlth & Risk, Manchester, Lancs, England.	sandra.m.flynn@manchester.ac.uk		Flynn, Sandra/0000-0003-1413-0992; shaw, jennifer/0000-0003-2569-7687; Abel, Kathryn M/0000-0003-3538-8896	Healthcare Quality Improvement Partnership, Department of Health, UK Government	Healthcare Quality Improvement Partnership, Department of Health, UK Government	The study was funded by the Healthcare Quality Improvement Partnership, Department of Health, UK Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K. M., 2011, Textbook in psychiatric epidemiology, P483; Abel KM, 2005, J CLIN PSYCHIAT, V66, P781, DOI 10.4088/JCP.v66n0618; Appleby L, 2001, SAFETY 1 REPORT NATL; Black DA, 2001, AGGRESS VIOLENT BEH, V6, P121, DOI 10.1016/S1359-1789(00)00021-5; Bourget D, 2005, J AM ACAD PSYCHIATRY, V33, P354; Bourget D, 2002, J AM ACAD PSYCHIATRY, V30, P345; Bourget D, 2007, J AM ACAD PSYCHIATRY, V35, P74; Cavanagh K, 2007, CHILD ABUSE NEGLECT, V31, P731, DOI 10.1016/j.chiabu.2006.12.016; Centre for Disease Control and Prevention (CDC), MMRW MORBIDITY MORTA, V59, P710; CONNELLY CD, 1992, CHILD ABUSE NEGLECT, V16, P709, DOI 10.1016/0145-2134(92)90107-3; Flynn SM, 2007, J CLIN PSYCHIAT, V68, P1501, DOI 10.4088/JCP.v68n1005; Friedman SH, 2005, J AM ACAD PSYCHIATRY, V33, P496; Friedman SH, 2005, AM J PSYCHIAT, V162, P1578, DOI 10.1176/appi.ajp.162.9.1578; Friedman SH, 2008, COMPR PSYCHIAT, V49, P106, DOI 10.1016/j.comppsych.2007.07.001; Jennings KD, 1999, J AFFECT DISORDERS, V54, P21; King-Hele SA, 2007, ARCH GEN PSYCHIAT, V64, P1323, DOI 10.1001/archpsyc.64.11.1323; Laursen TM, 2011, J CLIN PSYCHIAT, V72, P698, DOI 10.4088/JCP.09m05508gre; Liem Marieke, 2008, Crim Behav Ment Health, V18, P166, DOI 10.1002/cbm.695; McKee GR, 1998, J CLIN PSYCHOL, V54, P679, DOI 10.1002/(SICI)1097-4679(199808)54:5<679::AID-JCLP14>3.0.CO;2-A; National Centre for Social Research, 2009, AD PSYCH MORB ENGL 2; National Confidential Inquiry into Suicide and Homicide by People with Mental Illness, 2011, ANN REP ENGL WAL SCO; Office for National Statistics, 2010, SOC TRENDS; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; SOMANDER LKH, 1991, CHILD ABUSE NEGLECT, V15, P45, DOI 10.1016/0145-2134(91)90089-V; StataCorp Stata Statistical Software, 2007, STATACORP STAT STAT; Stroud J, 2008, CRIT SOC POLICY, V28, P482, DOI 10.1177/0261018308095281; Unicef, 2003, 5 UNICEF; Webb RT, 2011, PSYCHOL MED, V41, P1867, DOI 10.1017/S0033291711000055; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yasumi K, 2009, J FORENSIC LEG MED, V16, P70, DOI 10.1016/j.jflm.2008.07.007	30	42	42	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e58981	10.1371/journal.pone.0058981	http://dx.doi.org/10.1371/journal.pone.0058981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RK	23593128	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100006
J	Ran, S; Pei, YF; Liu, YJ; Zhang, L; Han, YY; Hai, R; Tian, Q; Lin, Y; Yang, TL; Guo, YF; Shen, H; Thethi, IS; Zhu, XZ; Deng, HW				Ran, Shu; Pei, Yu-Fang; Liu, Yong-Jun; Zhang, Lei; Han, Ying-Ying; Hai, Rong; Tian, Qing; Lin, Yong; Yang, Tie-Lin; Guo, Yan-Fang; Shen, Hui; Thethi, Inderpal S.; Zhu, Xue-Zhen; Deng, Hong-Wen			Bivariate Genome-Wide Association Analyses Identified Genes with Pleiotropic Effects for Femoral Neck Bone Geometry and Age at Menarche	PLOS ONE			English	Article							CROSS-SECTIONAL GEOMETRY; MUCOPOLYSACCHARIDOSIS TYPE-II; QUANTITATIVE-TRAIT LOCI; RISK-FACTORS; FRACTURE; STRENGTH; MEN; POLYMORPHISMS; OSTEOPOROSIS; PHENOTYPES	Femoral neck geometric parameters (FNGPs), which include cortical thickness (CT), periosteal diameter (W), buckling ratio (BR), cross-sectional area (CSA), and section modulus (Z), contribute to bone strength and may predict hip fracture risk. Age at menarche (AAM) is an important risk factor for osteoporosis and bone fractures in women. Some FNGPs are genetically correlated with AAM. In this study, we performed a bivariate genome-wide association study (GWAS) to identify new candidate genes responsible for both FNGPs and AAM. In the discovery stage, we tested 760,794 SNPs in 1,728 unrelated Caucasian subject, followed by replication analyses in independent samples of US Caucasians (with 501 subjects) and Chinese (with 826 subjects). We found six SNPs that were associated with FNGPs and AAM. These SNPs are located in three genes (i.e. NRCAM, IDS and LOC148145), suggesting these three genes may co-regulate FNGPs and AAM. Our findings may help improve the understanding of genetic architecture and pathophysiological mechanisms underlying both osteoporosis and AAM.	[Liu, Yong-Jun; Tian, Qing; Shen, Hui; Thethi, Inderpal S.; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Ran, Shu; Pei, Yu-Fang; Zhang, Lei; Han, Ying-Ying; Lin, Yong; Zhu, Xue-Zhen; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Sch Med Instrument & Food Engn, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Hai, Rong] Inner Mongolia Peoples Hosp, Hohhot, Peoples R China; [Yang, Tie-Lin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Shanxi, Peoples R China; [Guo, Yan-Fang] Southern Med Univ, Inst Bioinformat, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China	Tulane University; University of Shanghai for Science & Technology; Xi'an Jiaotong University; Southern Medical University - China	Deng, HW (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.	hdeng2@tulane.edu	Yang, Tie-Lin/G-8365-2014; Zhang, Lei/L-1016-2016; Liu, Yong/GWQ-6163-2022	Yang, Tie-Lin/0000-0001-7062-3025; Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	Shanghai University of Science and Technology; Shanghai Leading Academic Discipline Project [S30501]; NIH [R01AG026564, RC2DE020756, R01AR057049, R01AR050496, R03TW008221]; SCOR (Specialized Center of Research) [P50AR055081]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Office of Research on Women's Health (ORWH); Edward G. Schlieder Endowment; Franklin D. Dickson/Missouri Endowment; National Natural Science Foundation of China [31100902]; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496, R01AR057049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	Shanghai University of Science and Technology; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCOR (Specialized Center of Research); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Edward G. Schlieder Endowment; Franklin D. Dickson/Missouri Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was partially supported by startup funds from Shanghai University of Science and Technology and Shanghai Leading Academic Discipline Project (S30501). The investigators of this work were partially supported by grants from NIH (R01AG026564, RC2DE020756, R01AR057049, R01AR050496 and R03TW008221), a SCOR (Specialized Center of Research) grant (P50AR055081) supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Office of Research on Women's Health (ORWH), and the Edward G. Schlieder Endowment and the Franklin D. Dickson/Missouri Endowment. Lei Zhang was also supported by the National Natural Science Foundation of China project (31100902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2007, BEHAV GENET, V37, P668, DOI 10.1007/s10519-007-9163-2; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck T, 2003, OSTEOPOROSIS INT, V14, pS81, DOI 10.1007/s00198-003-1478-0; Bhattacharyya S, 2007, J STEROID BIOCHEM, V103, P20, DOI 10.1016/j.jsbmb.2006.08.002; Chen Y, 2010, BONE, V46, P129, DOI 10.1016/j.bone.2009.09.025; Danielson ME, 2012, OSTEOPOROS INT; Demissie S, 2007, BONE, V40, P743, DOI 10.1016/j.bone.2006.09.020; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Hsu YS, 2011, IBMS BONEKEY, V8, P112; Jiang H, 2007, ACTA PHARMACOL SIN, V28, P375, DOI 10.1111/j.1745-7254.2007.00522.x; Kannus P, 1996, BONE, V18, pS57, DOI 10.1016/8756-3282(95)00381-9; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Liu YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000420; Marucha J, 2012, ACTA PAEDIATR, V101, pE183, DOI 10.1111/j.1651-2227.2011.02522.x; Marui T, 2009, INT J NEUROPSYCHOPH, V12, P1, DOI 10.1017/S1461145708009127; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Melton LJ, 2005, OSTEOPOROSIS INT, V16, P460, DOI 10.1007/s00198-004-1820-1; Moffett SP, 2005, J CLIN ENDOCR METAB, V90, P3491, DOI 10.1210/jc.2004-2235; Morini SR, 2010, J PEDIATR ORTHOP B, V19, P313, DOI 10.1097/BPB.0b013e3283317b7a; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Petit MA, 2004, BONE, V35, P750, DOI 10.1016/j.bone.2004.05.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qureshi AM, 2001, CALCIFIED TISSUE INT, V69, P67, DOI 10.1007/s002230010037; Rauch F, 1999, BONE, V25, P69, DOI 10.1016/S8756-3282(99)00104-0; Rivadeneira F, 2004, J BONE MINER RES, V19, P1280, DOI 10.1359/JBMR.040405; Roy DK, 2003, OSTEOPOROSIS INT, V14, P19, DOI 10.1007/s00198-002-1317-8; Serafica MD, 2005, HUM REPROD, V20, P2074, DOI 10.1093/humrep/dei030; Shen H, 2005, J BONE MINER RES, V20, P1973, DOI 10.1359/JBMR.050715; Silman AJ, 2003, OSTEOPOROSIS INT, V14, P213, DOI 10.1007/s00198-002-1364-1; Tobacman JK, 2005, AACR M; Turner CH, 2000, J BONE MINER RES, V15, P1126, DOI 10.1359/jbmr.2000.15.6.1126; Tuschl K, 2005, PEDIATR NEUROL, V32, P270, DOI 10.1016/j.pediatrneurol.2004.10.009; van den Berg SM, 2007, BEHAV GENET, V37, P661, DOI 10.1007/s10519-007-9161-4; WELLENS R, 1992, AM J HUM BIOL, V4, P783, DOI 10.1002/ajhb.1310040610; Xiong DH, 2006, J BONE MINER RES, V21, P424, DOI 10.1359/JBMR.051202; Xiong DH, 2005, OSTEOPOROSIS INT, V16, P2113, DOI 10.1007/s00198-005-2011-4; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang F, 2010, OSTEOPOROSIS INT, V21, P1205, DOI 10.1007/s00198-009-1057-0; Zhao LJ, 2010, J BONE MINER RES, V25, P320, DOI 10.1359/jbmr.090726; Zuo LJ, 2012, NEUROPSYCHOPHARMACOL, V37, P557, DOI 10.1038/npp.2011.229	45	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60362	10.1371/journal.pone.0060362	http://dx.doi.org/10.1371/journal.pone.0060362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593202	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100033
J	Agarwal, R; Maskey, D; Aggarwal, AN; Saikia, B; Garg, M; Gupta, D; Chakrabarti, A				Agarwal, Ritesh; Maskey, Dipesh; Aggarwal, Ashutosh Nath; Saikia, Biman; Garg, Mandeep; Gupta, Dheeraj; Chakrabarti, Arunaloke			Diagnostic Performance of Various Tests and Criteria Employed in Allergic Bronchopulmonary Aspergillosis: A Latent Class Analysis	PLOS ONE			English	Article							SEVERE ASTHMA; CLINICAL-SIGNIFICANCE; BRONCHIAL-ASTHMA; NORTH-INDIA; CT; HYPERSENSITIVITY; FUMIGATUS; DISEASE; LUNG; IGE	Aim: The efficiency of various investigations and diagnostic criteria used in diagnosis of allergic bronchopulmonary aspergillosis (ABPA) remain unknown, primarily because of the lack of a gold standard. Latent class analysis (LCA) can provide estimates of sensitivity and specificity in absence of gold standard. Herein, we report the performance of various investigations and criteria employed in diagnosis of ABPA. Methods: Consecutive subjects with asthma underwent all the following investigations Aspergillus skin test, IgE levels (total and A. fumigatus specific), Aspergillus precipitins, eosinophil count, chest radiograph, and high-resolution computed tomography (HRCT) of the chest. We used LCA to estimate the performance of various diagnostic tests and criteria in identification of ABPA. Results: There were 372 asthmatics with a mean age of 35.9 years. The prevalence of Aspergillus sensitization was 53.2%. The sensitivity and specificity of various tests were Aspergillus skin test positivity (94.7%, 79.7%); IgE levels>1000 IU/mL (97.1%, 37.7%); A.fumigatus specific IgE levels>0.35 kUA/L (100%, 69.3%); Aspergillus precipitins (42.7%, 97.1%); eosinophil count>1000 cells/mu L (29.5%, 93.1%); chest radiographic opacities (36.1%, 92.5%); bronchiectasis (91.9%, 80.9%); and, high-attenuation mucus (39.7%, 100%). The most accurate criteria was the Patterson criteria using six components followed by the Agarwal criteria. However, there was substantial decline in accuracy of the Patterson criteria if components of the criteria were either increased or decreased from six. Conclusions: A.fumigatus specific IgE levels and high-attenuation mucus were found to be the most sensitive and specific test respectively in diagnosis of ABPA. The Patterson criteria remain the best diagnostic criteria however they have good veridicality only if six criteria are used.	[Agarwal, Ritesh; Maskey, Dipesh; Aggarwal, Ashutosh Nath; Gupta, Dheeraj] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India; [Saikia, Biman] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India; [Garg, Mandeep] Postgrad Inst Med Educ & Res, Dept Radiodiagnosis & Imaging, Chandigarh 160012, India; [Chakrabarti, Arunaloke] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Agarwal, R (corresponding author), Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India.	riteshpgi@gmail.com	Agarwal, Ritesh/A-3063-2009	Agarwal, Ritesh/0000-0003-2547-7668; Garg, Mandeep/0000-0002-4714-6299; Maskey, Dipesh/0000-0003-0946-7195				Agarwal R, 2006, AM J ROENTGENOL, V186, P904, DOI 10.2214/AJR.05.0125; Agarwal R, 2009, INT J TUBERC LUNG D, V13, P936; Agarwal R., 2010, INT J RESP CARE, V6, P53; Agarwal R, 2010, INT J RESP CARE, V6, P56; Agarwal R, 2006, CHEST, V130, P442, DOI 10.1378/chest.130.2.442; Agarwal R, 2007, CHEST, V132, P1183, DOI 10.1378/chest.07-0808; Agarwal Ritesh, 2011, Indian J Radiol Imaging, V21, P242, DOI 10.4103/0971-3026.90680; Agarwal R, 2011, MYCOSES, V54, pE531, DOI 10.1111/j.1439-0507.2010.01971.x; Agarwal R, 2011, CURR ALLERGY ASTHM R, V11, P403, DOI 10.1007/s11882-011-0217-4; Agarwal R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015346; Agarwal R, 2010, WORLD J RADIOL, V2, P41, DOI 10.4329/wjr.v2.i1.41; Agarwal R, 2010, MED MYCOL, V48, P988, DOI 10.3109/13693781003743148; Agarwal R, 2010, MYCOSES, V53, P138, DOI 10.1111/j.1439-0507.2008.01680.x; Agarwal R, 2010, RESP MED, V104, P204, DOI 10.1016/j.rmed.2009.09.005; Agarwal R, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P707, DOI 10.1007/978-90-481-2408-4_42; Agarwal R, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P671, DOI 10.1007/978-90-481-2408-4_39; Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; Aggarwal A N, 2002, J Assoc Physicians India, V50, P567; ANGUS RM, 1994, THORAX, V49, P586, DOI 10.1136/thx.49.6.586; [Anonymous], 2004, GLOB STRAT ASTHM MAN; Boelaert M, 1999, TROP MED INT HEALTH, V4, P395, DOI 10.1046/j.1365-3156.1999.00421.x; Denning DW, 2013, MED MYCOL IN PRESS, DOI [10.3109/13693786.13692012.13738312, DOI 10.3109/13693786.13692012.13738312]; Eaton T, 2000, CHEST, V118, P66, DOI 10.1378/chest.118.1.66; Fairs A, 2010, AM J RESP CRIT CARE, V182, P1362, DOI 10.1164/rccm.201001-0087OC; Ghosh Tapashi, 2010, J Indian Med Assoc, V108, P863; Girardi E., 2009, EURO SURVEILLANCE, V14; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; Global Initiative for Asthma (GINA), 2012, GLOB STRAT ASTHM MAN; GREENBERGER PA, 1988, J ALLERGY CLIN IMMUN, V81, P646, DOI 10.1016/0091-6749(88)91034-2; Grenier P, 1996, EUR RADIOL, V6, P199; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; Hamburger RN, 2005, ALLERG IMMUNOL, V18, P46; Harmanci E, 2002, RESPIRATION, V69, P420, DOI 10.1159/000064018; Hogan C, 2011, SEMIN RESP CRIT CARE, V32, P682, DOI 10.1055/s-0031-1295716; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Jensen SP, 2002, CLIN RADIOL, V57, P1078, DOI 10.1053/crad.2002.1104; Kumar R, 2000, ASIAN PAC J ALLERGY, V18, P181; LONGBOTTOM JL, 1964, J PATHOL BACTERIOL, V88, P141, DOI 10.1002/path.1700880119; de Assis TSM, 2012, TROP MED INT HEALTH, V17, P1202, DOI 10.1111/j.1365-3156.2012.03064.x; MALO JL, 1977, THORAX, V32, P269, DOI 10.1136/thx.32.3.269; Menzies D, 2011, ALLERGY, V66, P679, DOI 10.1111/j.1398-9995.2010.02542.x; Nascimento MC, 2007, J CLIN MICROBIOL, V45, P715, DOI 10.1128/JCM.01264-06; PATTERSON R, 1986, ARCH INTERN MED, V146, P916, DOI 10.1001/archinte.146.5.916; Pouillot R, 2002, PREV VET MED, V53, P67, DOI 10.1016/S0167-5877(01)00272-0; REIFF DB, 1995, AM J ROENTGENOL, V165, P261, DOI 10.2214/ajr.165.2.7618537; RINDSKOPF D, 1986, STAT MED, V5, P21, DOI 10.1002/sim.4780050105; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; SHEPS SB, 1984, JAMA-J AM MED ASSOC, V252, P2418, DOI 10.1001/jama.252.17.2418; Tillie-Leblond I, 2005, ALLERGY, V60, P1004, DOI 10.1111/j.1398-9995.2005.00887.x; Ward S, 1999, AM J ROENTGENOL, V173, P937, DOI 10.2214/ajr.173.4.10511153	51	108	117	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61105	10.1371/journal.pone.0061105	http://dx.doi.org/10.1371/journal.pone.0061105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593402	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300049
J	Jaffres, JBD				Jaffres, Jasmine B. D.			Mixed Layer Depth Seasonality within the Coral Sea Based on Argo Data	PLOS ONE			English	Article							TROPICAL PACIFIC; NORTH PACIFIC; GLOBAL OCEAN; SURFACE; VARIABILITY; CHLOROPHYLL	The worldwide deployment of Argo floats has enabled much more detailed studies of global and regional seas over the last decade. Here, the seasonal variability of the mixed layer depth (MLD) within the Coral Sea was examined with CTD profiles from Argo floats. Multiple threshold values for both temperature and density have been employed to determine the most suitable threshold values for the Coral Sea. A threshold value of 0.04 kg/m(3) for density and 0.2 degrees C for temperature appear the most fitting for this region. Although MLD and isothermal layer depth (ILD) coincide quite well in most cases, the relatively common presence of temporary, non-seasonal barrier layers induces an ILD that is significantly deeper than the MLD. Consequently, an MLD estimation based on density is more appropriate. A distinct seasonality in the MLD is evident throughout the Coral Sea, but is generally more pronounced in higher southern latitudes (20-30 degrees S). Salinity inversions are rare and mainly occur in the south-eastern Coral Sea, while barrier layers are more commonly associated with the north-eastern Coral Sea, a region characterised by high rainfall. The significance of regional currents is evident in the north-western Coral Sea, where temperature and ocean heat content is relatively low due to a northward moving boundary current. Shallow bathymetry, in turn, is linked to the absence of Argo data on the continental shelf and in the central Coral Sea.	[Jaffres, Jasmine B. D.] James Cook Univ, AIMS, Townsville, Qld 4811, Australia; [Jaffres, Jasmine B. D.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia	Australian Institute of Marine Science; James Cook University; James Cook University	Jaffres, JBD (corresponding author), James Cook Univ, AIMS, Townsville, Qld 4811, Australia.	jasmine.jaffres@jcu.edu.au	Jaffrés, Jasmine B. D./B-4607-2011	Jaffrés, Jasmine B. D./0000-0003-2567-539X	Australian Research Council Research Network for Earth System Science (ARC NESS)	Australian Research Council Research Network for Earth System Science (ARC NESS)(Australian Research Council)	This work was financially supported by the Australian Research Council Research Network for Earth System Science (ARC NESS; http://www.arcness.mq.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAINERD KE, 1995, DEEP-SEA RES PT I, V42, P1521, DOI 10.1016/0967-0637(95)00068-H; CHEN D, 1994, J GEOPHYS RES-OCEANS, V99, P20345, DOI 10.1029/94JC01621; Choukroun S, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005761; Condie SA, 2006, MAR FRESHWATER RES, V57, P569, DOI 10.1071/MF06009; Cravatte S, 2011, PROG OCEANOGR, V88, P116, DOI 10.1016/j.pocean.2010.12.015; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Ganachaud A, 2007, SW PACIFIC OCEAN CIR; Gardner WD, 1999, DEEP-SEA RES PT II, V46, P1833, DOI 10.1016/S0967-0645(99)00046-6; Kako S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030362; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Kara AB, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000736; Kraus E. B., 1994, ATMOSPHERE OCEAN INT; Lorbacher K, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2003JC002157; LUKAS R, 1991, J GEOPHYS RES-OCEANS, V96, P3343, DOI 10.1029/90JC01951; Messie M, 2006, DEEP-SEA RES PT I, V53, P1581, DOI 10.1016/j.dsr.2006.06.007; Mignot J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003954; Ohno Y, 2009, J OCEANOGR, V65, P1, DOI 10.1007/s10872-009-0001-4; Polovina JJ, 1995, DEEP-SEA RES PT I, V42, P1701, DOI 10.1016/0967-0637(95)00075-H; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; ROEMMICH D, 2000, OCEANOGRAPHY, V13, P45, DOI DOI 10.5670/OCEANOG.2000.33; Roemmich D, 2009, OCEANOGRAPHY, V22, P34, DOI 10.5670/oceanog.2009.36; Rotschi H., 1967, OCEANOGRAPHY MARINE, V5, P49; SPRINTALL J, 1992, J GEOPHYS RES-OCEANS, V97, P7305, DOI 10.1029/92JC00407; Thomson RE, 2003, J ATMOS OCEAN TECH, V20, P319, DOI 10.1175/1520-0426(2003)020<0319:EMLDFO>2.0.CO;2; UNESCO, 1983, ALG COMP FUND PROP S; WOLANSKI E, 1988, ESTUAR COAST SHELF S, V26, P169, DOI 10.1016/0272-7714(88)90049-2	27	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60985	10.1371/journal.pone.0060985	http://dx.doi.org/10.1371/journal.pone.0060985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593368	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000317383200032
J	Santiago, PN; Ursano, RJ; Gray, CL; Pynoos, RS; Spiegel, D; Lewis-Fernandez, R; Friedman, MJ; Fullerton, CS				Santiago, Patcho N.; Ursano, Robert J.; Gray, Christine L.; Pynoos, Robert S.; Spiegel, David; Lewis-Fernandez, Roberto; Friedman, Matthew J.; Fullerton, Carol S.			A Systematic Review of PTSD Prevalence and Trajectories in DSM-5 Defined Trauma Exposed Populations: Intentional and Non-Intentional Traumatic Events	PLOS ONE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; DISASTER VICTIMS SPEAK; MENTAL-HEALTH PROBLEMS; FOLLOW-UP; RESILIENCE; SURVIVORS; SYMPTOMS; RISK	Objective: We conducted a systematic review of the literature to explore the longitudinal course of PTSD in DSM-5-defined trauma exposed populations to identify the course of illness and recovery for individuals and populations experiencing PTSD. Methods: We reviewed the published literature from January 1, 1998 to December 31, 2010 for longitudinal studies of directly exposed trauma populations in order to: (1) review rates of PTSD in the first year after a traumatic event; (2) examine potential types of proposed DSM-5 direct trauma exposure (intentional and non-intentional); and (3) identify the clinical course of PTSD (early onset, later onset, chronicity, remission, and resilience). Of the 2537 identified articles, 58 articles representing 35 unique subject populations met the proposed DSM-5 criteria for experiencing a traumatic event, and assessed PTSD at two or more time points within 12 months of the traumatic event. Results: The mean prevalence of PTSD across all studies decreases from 28.8% (range = 3.1-87.5%) at 1 month to 17.0% (range = 0.6-43.8%) at 12 months. However, when traumatic events are classified into intentional and non-intentional, the median prevalences trend down for the non-intentional trauma exposed populations, while the median prevalences in the intentional trauma category steadily increase from 11.8% to 23.3%. Across five studies with sufficient data, 37.1% of those exposed to intentional trauma develop PTSD. Among those with PTSD, about one third (34.8%) remit after 3 months. Nearly 40% of those with PTSD (39.1%) have a chronic course, and only a very small fraction (3.5%) of new PTSD cases appears after three months. Conclusions: Understanding the trajectories of PTSD over time, and how it may vary by type of traumatic event (intentional vs. non-intentional) will assist public health planning and treatment.	[Santiago, Patcho N.; Ursano, Robert J.; Gray, Christine L.; Fullerton, Carol S.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD 20814 USA; [Pynoos, Robert S.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Spiegel, David] Stanford Univ, Sch Med, Ctr Stress & Hlth, Stanford, CA 94305 USA; [Lewis-Fernandez, Roberto] Columbia Univ, Dept Psychiat, New York, NY USA; [Lewis-Fernandez, Roberto] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Friedman, Matthew J.] Natl Ctr Posttraumat Stress Disorder, Dept Vet Affairs, White River Jct, VT USA; [Friedman, Matthew J.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Friedman, Matthew J.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA	Uniformed Services University of the Health Sciences - USA; University of California System; University of California Los Angeles; Stanford University; Columbia University; New York State Psychiatry Institute; Dartmouth College; Dartmouth College	Santiago, PN (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD 20814 USA.	patcho.santiago@usuhs.edu	Ursano, Robert J/ABE-6533-2020	Ursano, Robert/0000-0002-1861-9173; Santiago, Patcho/0000-0003-0805-4313; Spiegel, David/0000-0002-9476-9173				Alcantara C, 2013, CLIN PSYCHOL REV, V33, P107, DOI 10.1016/j.cpr.2012.10.005; American Psychiatric Association, 2010, DSM5 FUT PSYCH DIAGN; Bonanno GA, 2008, PEDIATRICS, V121, P369, DOI 10.1542/peds.2007-1648; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hinton DE, 2011, DEPRESS ANXIETY, V28, P783, DOI 10.1002/da.20753; Hobfoll SE, 2009, J CONSULT CLIN PSYCH, V77, P138, DOI 10.1037/a0014360; Johansen VA, 2007, SOC PSYCH PSYCH EPID, V42, P583, DOI 10.1007/s00127-007-0205-0; Johnson SD, 2002, COMMUNITY MENT HLT J, V38, P181, DOI 10.1023/A:1015269521969; Jones C, 2007, BEHAV RES THER, V45, P151, DOI 10.1016/j.brat.2006.02.004; Karamustafalioglu OK, 2006, J CLIN PSYCHIAT, V67, P882, DOI 10.4088/JCP.v67n0604; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Lange A, 2003, J CONSULT CLIN PSYCH, V71, P901, DOI 10.1037/0022-006X.71.5.901; Lauterbach D., 1996, ASSESSMENT, V3, P17, DOI [DOI 10.1177/107319119600300102, 10.1177/107319119600300102]; Marchand Andre, 2006, BRIEF TREATMENT CRIS, V6, P122, DOI DOI 10.1093/BRIEF-TREATMENT/MHJ007; Matthieu M, 2006, J INTERPERS VIOLENCE, V21, P1654, DOI 10.1177/0886260506294243; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2002, PSYCHIATRY, V65, P240, DOI 10.1521/psyc.65.3.240.20169; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; North C S, 2001, Ann Clin Psychiatry, V13, P81, DOI 10.3109/10401230109148952; North CS, 2012, AM J PUBLIC HEALTH, V102, pE40, DOI 10.2105/AJPH.2012.300689; North CS, 1997, AM J PSYCHIAT, V154, P1696, DOI 10.1176/ajp.154.12.1696; Phelps LF, 2008, REHABIL PSYCHOL, V53, P28, DOI 10.1037/0090-5550.53.1.28; Roth G, 2006, EUR PSYCHIAT, V21, P152, DOI 10.1016/j.eurpsy.2005.11.004; Roy-Byrne PP, 2004, DEPRESS ANXIETY, V19, P77, DOI 10.1002/da.10132; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Spitzer RL, 2007, J ANXIETY DISORD, V21, P233, DOI 10.1016/j.janxdis.2006.09.006; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Ursano RJ, 2007, TEXTBOOK OF DISASTER PSYCHIATRY, P3; Van der Velden PG, 2006, ADM POLICY MENT HLTH, V33, P279, DOI 10.1007/s10488-005-0027-x; Vojvoda D, 2008, J REHABIL RES DEV, V45, P421, DOI 10.1682/JRRD.2007.06.0083; Wikman A, 2008, PSYCHOSOM MED, V70, P764, DOI 10.1097/PSY.0b013e3181835c07	34	261	265	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e59236	10.1371/journal.pone.0059236	http://dx.doi.org/10.1371/journal.pone.0059236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123JA	23593134	gold, Green Submitted, Green Published			2022-12-27	WOS:000317383200003
J	Barbraud, C; Tuck, GN; Thomson, R; Delord, K; Weimerskirch, H				Barbraud, Christophe; Tuck, Geoffrey N.; Thomson, Robin; Delord, Karine; Weimerskirch, Henri			Fisheries Bycatch as an Inadvertent Human-Induced Evolutionary Mechanism	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; ALBATROSS DIOMEDEA-EXULANS; POPULATION-DYNAMICS; WANDERING ALBATROSS; LONGLINE FISHERY; SOUTHERN-OCEAN; INDIAN-OCEAN; CONSEQUENCES; SELECTION; HETEROGENEITY	Selective harvesting of animals by humans can affect the sustainability and genetics of their wild populations. Bycatch - the accidental catch of non-target species - spans the spectrum of marine fauna and constitutes a harvesting pressure. Individual differences in attraction to fishing vessels and consequent susceptibility to bycatch exist, but few studies integrate this individual heterogeneity with demography. Here, we tested for the evidence and consequences of individual heterogeneity on the demography of the wandering albatross, a seabird heavily affected by fisheries bycatch. We found strong evidence for heterogeneity in survival with one group of individuals having a 5.2% lower annual survival probability than another group, and a decrease in the proportion of those individuals with the lowest survival in the population coinciding with a 7.5 fold increase in fishing effort in the foraging areas. Potential causes for the heterogeneity in survival are discussed and we suggest that bycatch removed a large proportion of individuals attracted by fishing vessels and had significant phenotypic and population consequences.	[Barbraud, Christophe; Delord, Karine; Weimerskirch, Henri] CEBC CNRS, UPR 1934, F-79360 Villiers En Bois, France; [Barbraud, Christophe; Tuck, Geoffrey N.; Thomson, Robin] CSIRO Wealth Oceans Flagship, Div Marine & Atmospher Res, Hobart, Tas, Australia	Centre National de la Recherche Scientifique (CNRS); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Barbraud, C (corresponding author), CEBC CNRS, UPR 1934, F-79360 Villiers En Bois, France.	barbraud@cebc.cnrs.fr	Weimerskirch, Henri/F-5562-2013; Thomson, Robin/G-2882-2015; Barbraud, Christophe/A-5870-2012; Tuck, Geoffrey/E-2356-2012; Weimerskirch, Henri/K-7306-2019	Thomson, Robin/0000-0001-8499-2059; Barbraud, Christophe/0000-0003-0146-212X; Tuck, Geoffrey/0000-0002-3640-6147; Weimerskirch, Henri/0000-0002-0457-586X	CSIRO Frohlich Fellowship	CSIRO Frohlich Fellowship	Christophe Barbraud was partly supported during this work by a 2011 CSIRO Frohlich Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Grateful thanks to all the field workers involved in the demographic study on Possession Island over the past 50 years and Dominique Besson for data management. We thank the "Comparative Evolutionary Demography" French working group for fruitful statistical and bibliographical help. Christophe Barbraud was partly supported during this work by a 2011 CSIRO Frohlich Fellowship. No additional external funding received for this study. Malcolm Haddon and Barry Bruce (CSIRO), Vivienne Mawson and two anonymous reviewers are thanked for their helpful comments on earlier drafts of this paper.	Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Barbraud C, 2012, J ORNITHOL, V152, pS605, DOI 10.1007/s10336-011-0686-1; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Brown C, 2007, BEHAV ECOL SOCIOBIOL, V62, P237, DOI 10.1007/s00265-007-0458-3; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caswell, 2000, MATRIX POPULATION MO; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Cooke SJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P480, DOI 10.1086/520618; Croxall JP, 2004, ANTARCT SCI, V16, P569, DOI 10.1017/S0954102004002330; Davies RWD, 2009, MAR POLICY, V33, P661, DOI 10.1016/j.marpol.2009.01.003; Delord K, 2008, BIOL CONSERV, V141, P1840, DOI 10.1016/j.biocon.2008.05.001; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Fenberg PB, 2008, MOL ECOL, V17, P209, DOI 10.1111/j.1365-294X.2007.03522.x; Fox GA, 2006, J ANIM ECOL, V75, P921, DOI 10.1111/j.1365-2656.2006.01110.x; Gales R, 1998, BIOL CONSERV, V86, P37, DOI 10.1016/S0006-3207(98)00011-1; Garamszegi LZ, 2009, ANIM BEHAV, V77, P803, DOI 10.1016/j.anbehav.2008.12.012; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Granadeiro JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017467; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; HINES J E, 1989, U S Fish and Wildlife Service Fish and Wildlife Technical Report, P1; Huang HW, 2010, FISH RES, V106, P261, DOI 10.1016/j.fishres.2010.08.005; JACHMANN H, 1995, AFR J ECOL, V33, P230, DOI 10.1111/j.1365-2028.1995.tb00800.x; Johnson D. H., 1986, P INT BIOM C, V13, P1; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; MYERS RA, 1995, SCIENCE, V269, P1106, DOI 10.1126/science.269.5227.1106; Nel DC, 2003, AFR J MAR SCI, V25, P503, DOI 10.2989/18142320309504039; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Pradel R, 2009, ENVIRON ECOL STAT SE, V3, P781, DOI 10.1007/978-0-387-78151-8_36; R Development Core Team, 2001, R LANG ENV STAT COMP; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Rivalan P, 2010, IBIS, V152, P6, DOI 10.1111/j.1474-919X.2009.00977.x; Rolland V, 2010, GLOBAL CHANGE BIOL, V16, P1910, DOI 10.1111/j.1365-2486.2009.02070.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Terauds A, 2006, EMU, V106, P211, DOI 10.1071/MU06007; Torres LG, 2011, MAR ECOL PROG SER, V428, P289, DOI 10.3354/meps09068; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Weimerskirch H, 2000, NATURE, V406, P955, DOI 10.1038/35023068; WEIMERSKIRCH H, 1987, OIKOS, V49, P315, DOI 10.2307/3565767; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; Weimerskirch H, 2011, NATL PLAN ACTION CON; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wilson ADM, 2011, CAN J FISH AQUAT SCI, V68, P749, DOI 10.1139/F2011-019; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250	58	28	28	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60353	10.1371/journal.pone.0060353	http://dx.doi.org/10.1371/journal.pone.0060353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593199	Green Published, gold			2022-12-27	WOS:000317382000013
J	Metaferia, B; Wei, JS; Song, YK; Evangelista, J; Aschenbach, K; Johansson, P; Wen, XY; Chen, QR; Lee, A; Hempel, H; Gheeya, JS; Getty, S; Gomez, R; Khan, J				Metaferia, Belhu; Wei, Jun S.; Song, Young K.; Evangelista, Jennifer; Aschenbach, Konrad; Johansson, Peter; Wen, Xinyu; Chen, Qingrong; Lee, Albert; Hempel, Heidi; Gheeya, Jinesh S.; Getty, Stephanie; Gomez, Romel; Khan, Javed			Development of Peptide Nucleic Acid Probes for Detection of the HER2 Oncogene	PLOS ONE			English	Article							HYBRIDIZATION; DNA; PNA; IMMOBILIZATION; STABILITY; PNA/DNA	Peptide nucleic acids (PNAs) have gained much interest as molecular recognition tools in biology, medicine and chemistry. This is due to high hybridization efficiency to complimentary oligonucleotides and stability of the duplexes with RNA or DNA. We have synthesized 15/16-mer PNA probes to detect the HER2 mRNA. The performance of these probes to detect the HER2 target was evaluated by fluorescence imaging and fluorescence bead assays. The PNA probes have sufficiently discriminated between the wild type HER2 target and the mutant target with single base mismatches. Furthermore, the probes exhibited excellent linear concentration dependence between 0.4 to 400 fmol for the target gene. The results demonstrate potential application of PNAs as diagnostic probes with high specificity for quantitative measurements of amplifications or over-expressions of oncogenes.	[Metaferia, Belhu; Wei, Jun S.; Song, Young K.; Johansson, Peter; Wen, Xinyu; Chen, Qingrong; Lee, Albert; Hempel, Heidi; Gheeya, Jinesh S.; Khan, Javed] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Wen, Xinyu] NCI, Adv Biomed Comp Ctr, SAIC Frederick Inc, Frederick, MD 21701 USA; [Evangelista, Jennifer; Aschenbach, Konrad; Gomez, Romel] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA; [Getty, Stephanie] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Khan, J (corresponding author), NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA.	khanjav@mail.nih.gov	Getty, Stephanie A/D-7037-2012; Johansson, Peter A/K-1053-2014; Khan, Javed/P-9157-2014	Johansson, Peter A/0000-0001-7015-5452; Gheeya, Jinesh/0000-0002-5246-6262	National Institutes of Health, National Cancer Institute, Center for Cancer Research	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen L, 1995, J Pept Sci, V1, P175; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; EGHOLM M, 1992, J AM CHEM SOC, V114, P1895, DOI 10.1021/ja00031a062; Giesen U, 1998, NUCLEIC ACIDS RES, V26, P5004, DOI 10.1093/nar/26.21.5004; Jang H, 2010, J CLIN MICROBIOL, V48, P3127, DOI 10.1128/JCM.02058-09; Jensen KK, 1997, BIOCHEMISTRY-US, V36, P5072, DOI 10.1021/bi9627525; Kaihatsu K, 2002, BIOCHEMISTRY-US, V41, P11118, DOI 10.1021/bi0263659; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Lee M, 2005, ORG LETT, V7, P4269, DOI 10.1021/ol051753z; Lesaicherre ML, 2002, BIOORG MED CHEM LETT, V12, P2079, DOI 10.1016/S0960-894X(02)00379-7; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Noske A, 2011, BREAST CANCER RES TR, V126, P109, DOI 10.1007/s10549-010-1316-y; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Pandana H, 2008, IEEE SENS J, V8, P655, DOI 10.1109/JSEN.2008.922724; Pellestor F, 2004, EUR J HUM GENET, V12, P694, DOI 10.1038/sj.ejhg.5201226; Rasooly A, 2006, BIOSENS BIOELECTRON, V21, P1851, DOI 10.1016/j.bios.2006.01.003; Robertson KL, 2006, BIOCHEMISTRY-US, V45, P6066, DOI 10.1021/bi052050s; Schwarz FP, 1999, NUCLEIC ACIDS RES, V27, P4792, DOI 10.1093/nar/27.24.4792; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stark A, 2000, J CLIN ONCOL, V18, P267, DOI 10.1200/JCO.2000.18.2.267; Takiya Toshiyuki, 2004, Nucleic Acids Symp Ser (Oxf), P131, DOI 10.1093/nass/48.1.131; Uno T, 2007, ANAL CHEM, V79, P52, DOI 10.1021/ac060273y; Winston Janet S, 2004, Am J Clin Pathol, V121 Suppl, pS33; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175; Yu DH, 1998, ONCOGENE, V16, P2087, DOI 10.1038/sj.onc.1201729; Zhang N, 2007, J AM CHEM SOC, V129, P8424, DOI 10.1021/ja072744j	31	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e58870	10.1371/journal.pone.0058870	http://dx.doi.org/10.1371/journal.pone.0058870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593123	Green Published, gold, Green Submitted			2022-12-27	WOS:000317382000002
J	Padysakova, E; Bartos, M; Tropek, R; Janecek, S				Padysakova, Eliska; Bartos, Michael; Tropek, Robert; Janecek, Stepan			Generalization versus Specialization in Pollination Systems: Visitors, Thieves, and Pollinators of Hypoestes aristata (Acanthaceae)	PLOS ONE			English	Article							FLORAL VISITORS; REPRODUCTIVE-BIOLOGY; SOUTHERN-AFRICA; GEOGRAPHIC PATTERNS; BAMENDA HIGHLANDS; FORAGING BEHAVIOR; BEES HYMENOPTERA; FLY POLLINATION; VACCINIUM-ASHEI; POLLEN TRANSFER	Many recent studies have suggested that the majority of animal-pollinated plants have a higher diversity of pollinators than that expected according to their pollination syndrome. This broad generalization, often based on pollination web data, has been challenged by the fact that some floral visitors recorded in pollination webs are ineffective pollinators. To contribute to this debate, and to obtain a contrast between visitors and pollinators, we studied insect and bird visitors to virgin flowers of Hypoestes aristata in the Bamenda Highlands, Cameroon. We observed the flowers and their visitors for 2-h periods and measured the seed production as a metric of reproductive success. We determined the effects of individual visitors using 2 statistical models, single-visit data that were gathered for more frequent visitor species, and frequency data. This approach enabled us to determine the positive as well as neutral or negative impact of visitors on H. aristata's reproductive success. We found that (i) this plant is not generalized but rather specialized; although we recorded 15 morphotaxa of visitors, only 3 large bee species seemed to be important pollinators; (ii) the carpenter bee Xylocopa cf. inconstans was both the most frequent and the most effective pollinator; (iii) the honey bee Apis mellifera acted as a nectar thief with apparent negative effects on the plant reproduction; and (iv) the close relationship between H. aristata and carpenter bees was in agreement with the large-bee pollination syndrome of this plant. Our results highlight the need for studies detecting the roles of individual visitors. We showed that such an approach is necessary to evaluate the pollination syndrome hypothesis and create relevant evolutionary and ecological hypotheses.	[Padysakova, Eliska; Bartos, Michael; Tropek, Robert] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Padysakova, Eliska; Bartos, Michael; Janecek, Stepan] Acad Sci Czech Republic, Inst Bot, Trebon, Czech Republic; [Tropek, Robert] Acad Sci Czech Republic, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Padysakova, E (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	paddysek@gmail.com	Tropek, Robert/AAD-4638-2022; Bartoš, Michael/AAP-1336-2020; Bartoš, Michael/H-1580-2014; Janeček, Štěpán/H-1594-2014; Padyšáková, Eliška/I-5146-2016; Bartoš, Michael/ABB-7887-2021; Tropek, Robert/G-6564-2014	Tropek, Robert/0000-0001-7499-6259; Bartoš, Michael/0000-0002-1415-3724; Bartoš, Michael/0000-0002-1415-3724; Janeček, Štěpán/0000-0003-1285-6490; Padyšáková, Eliška/0000-0003-3994-2161; Tropek, Robert/0000-0001-7499-6259	Czech Science Foundation [P505/11/1617]; Grant Agency of the University of South Bohemia [136/2010/P, 156/2013/P]; long-term research development [67985939]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the University of South Bohemia; long-term research development	This work was supported by the projects of Czech Science Foundation P505/11/1617, Grant Agency of the University of South Bohemia 136/2010/P and 156/2013/P, institutional support RVO:60077344 and the long-term research development project no. 67985939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2006, ANN BOT-LONDON, V97, P141, DOI 10.1093/aob/mcj012; Anderson M.J., 2008, PERMANOVA PRIMER GUI; BALKWILL K, 1985, S AFR J BOT, V51, P133, DOI 10.1016/S0254-6299(16)31685-4; Bartos M, 2012, S AFR J BOT, V78, P63, DOI 10.1016/j.sajb.2011.05.015; BEATTIE AJ, 1971, NEW PHYTOL, V70, P343, DOI 10.1111/j.1469-8137.1971.tb02533.x; BULLOCK SH, 1989, OECOLOGIA, V78, P389, DOI 10.1007/BF00379114; CANE JH, 1993, ANN ENTOMOL SOC AM, V86, P577, DOI 10.1093/aesa/86.5.577; Castellanos MC, 2003, EVOLUTION, V57, P2742, DOI 10.1111/j.0014-3820.2003.tb01516.x; Castro S, 2008, PLANT ECOL, V199, P201, DOI 10.1007/s11258-008-9424-z; Celebrezze T, 2004, AUSTRAL ECOL, V29, P129, DOI 10.1111/j.1442-9993.2003.01328.x; Cheek M, 2000, PLANTS MOUNT OKU IJI; Darwin C, 1859, ORIGIN SPECIES MEANS; Dedej S, 2004, ENVIRON ENTOMOL, V33, P100, DOI 10.1603/0046-225X-33.1.100; Eberly LE, 2007, MULTIPLE LINEAR REGR; ECKHART VM, 1992, OIKOS, V64, P573, DOI 10.2307/3545177; Escaravage N, 2004, PLANT BIOLOGY, V6, P606, DOI 10.1055/s-2004-821143; Faegri K., 1979, PRINCIPLES POLLINATI; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fumero-Caban JJ, 2007, AM J BOT, V94, P419, DOI 10.3732/ajb.94.3.419; GRANT V, 1979, PLANT SYST EVOL, V133, P29, DOI 10.1007/BF00985877; Hansen DM, 2002, J BIOGEOGR, V29, P721, DOI 10.1046/j.1365-2699.2002.00720.x; HEITHAUS ER, 1974, ANN MO BOT GARD, V61, P675, DOI 10.2307/2395023; Hepper JMe, 1963, FLORA W TROPICAL AFR, V2; HERRERA CM, 1995, ECOLOGY, V76, P1516, DOI 10.2307/1938153; HERRERA CM, 1988, BIOL J LINN SOC, V35, P95, DOI 10.1111/j.1095-8312.1988.tb00461.x; HERRERA CM, 1989, OECOLOGIA, V80, P241, DOI 10.1007/BF00380158; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; INOUYE DW, 1994, AM J BOT, V81, P1517, DOI 10.2307/2445328; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; Janecek S, 2007, AFR J ECOL, V45, P607, DOI 10.1111/j.1365-2028.2007.00779.x; Janecek S, 2012, BIOL J LINN SOC, V107, P355, DOI 10.1111/j.1095-8312.2012.01943.x; Janecek S, 2011, OIKOS, V120, P178, DOI 10.1111/j.1600-0706.2010.18612.x; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kishore K, 2011, SCI HORTIC-AMSTERDAM, V129, P735, DOI 10.1016/j.scienta.2011.05.031; Lara C, 2001, OECOLOGIA, V128, P263, DOI 10.1007/s004420100640; Larsen MW, 2008, BOT J LINN SOC, V156, P65, DOI 10.1111/j.1095-8339.2007.00725.x; Littell RC, 2002, SAS LINEAR MODELS; Maloof JE, 2000, ECOLOGY, V81, P2651, DOI 10.1890/0012-9658(2000)081[2651:ANRCOM]2.0.CO;2; Manning JC, 1997, PLANT SYST EVOL, V206, P51, DOI 10.1007/BF00987941; Mayfield MM, 2001, ANN BOT-LONDON, V88, P591, DOI 10.1006/anbo.2001.1500; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Nassar JM, 2004, PLANT SYST EVOL, V248, P31, DOI 10.1007/s00606-004-0193-4; Ne'eman G, 2010, BIOL REV, V85, P435, DOI 10.1111/j.1469-185X.2009.00108.x; Niemirski R, 2011, PLANT SYST EVOL, V294, P147, DOI 10.1007/s00606-011-0454-y; Olesen JN, 2007, TAXON, V56, P729, DOI 10.2307/25065857; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Ollerton J, 1996, J ECOL, V84, P767, DOI 10.2307/2261338; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Olsen KM, 1997, OECOLOGIA, V109, P114, DOI [10.1007/s004420050065, 10.1007/PL00008811]; Potgieter CJ, 2005, ANN MO BOT GARD, V92, P254; PRIMACK RB, 1979, NEW ZEAL J BOT, V17, P9, DOI 10.1080/0028825X.1979.10425156; Quinn GP, 2003, EXPT DESIGN DATA ANA; Raju AJS, 2006, CURR SCI INDIA, V90, P1210; Reif J, 2007, OSTRICH, V78, P31, DOI 10.2989/OSTRICH.2007.78.1.5.49; RENNER SS, 1989, ANN MO BOT GARD, V76, P496, DOI 10.2307/2399497; RENNER SS, 1993, AM J BOT, V80, P1100, DOI 10.2307/2445757; Riegert J, 2011, J ORNITHOL, V152, P819, DOI 10.1007/s10336-011-0650-0; Robertson IC, 2011, ARTHROPOD-PLANT INTE, V5, P379, DOI 10.1007/s11829-011-9142-7; ROUBIK DW, 1982, ECOLOGY, V63, P354, DOI 10.2307/1938953; Sahli HF, 2007, AM J BOT, V94, P203, DOI 10.3732/ajb.94.2.203; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; Searle S. R., 1992, VARIANCE COMPONENTS; Silva-Montellano A, 2003, AM J BOT, V90, P377, DOI 10.3732/ajb.90.3.377; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Stone JL, 1996, OECOLOGIA, V107, P504, DOI 10.1007/BF00333942; Strauss SY, 2005, NEW PHYTOL, V165, P81, DOI 10.1111/j.1469-8137.2004.01228.x; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Tropek R, 2010, AFR J ECOL, V48, P428, DOI 10.1111/j.1365-2028.2009.01129.x; VANDERPIJL L, 1960, EVOLUTION, V14, P403, DOI 10.2307/2405990; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Willmer P., 2011, POLLINATION FLORAL E; Young HJ, 2007, AM J BOT, V94, P1267, DOI 10.3732/ajb.94.7.1267	77	23	24	2	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e59299	10.1371/journal.pone.0059299	http://dx.doi.org/10.1371/journal.pone.0059299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593135	gold, Green Submitted, Green Published			2022-12-27	WOS:000317382000004
J	Colomer, MA; Margalida, A; Perez-Jimenez, MJ				Angels Colomer, Ma; Margalida, Antoni; Perez-Jimenez, Mario J.			Population Dynamics P System (PDP) Models: A Standardized Protocol for Describing and Applying Novel Bio-Inspired Computing Tools	PLOS ONE			English	Article							INTERACTION STRENGTH; ECOSYSTEM; SANITARY; VULTURE; PREDATION; NETWORKS; POLICIES	Today, the volume of data and knowledge of processes necessitates more complex models that integrate all available information. This handicap has been solved thanks to the technological advances in both software and hardware. Computational tools available today have allowed developing a new family of models, known as computational models. The description of these models is difficult as they can not be expressed analytically, and it is therefore necessary to create protocols that serve as guidelines for future users. The Population Dynamics P systems models (PDP) are a novel and effective computational tool to model complex problems, are characterized by the ability to work in parallel (simultaneously interrelating different processes), are modular and have a high computational efficiency. However, the difficulty of describing these models therefore requires a protocol to unify the presentation and the steps to follow. We use two case studies to demonstrate the use and implementation of these computational models for population dynamics and ecological process studies, discussing briefly their potential applicability to simulate complex ecosystem dynamics.	[Angels Colomer, Ma] Univ Lleida, Dept Math, Lleida, Spain; [Margalida, Antoni] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Perez-Jimenez, Mario J.] Univ Seville, Dept Comp Sci & Artificial Intelligence, Res Grp Nat Comp, Seville, Spain	Universitat de Lleida; University of Bern; University of Sevilla	Margalida, A (corresponding author), Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland.	antoni.margalida@iee.unibe.ch	Margalida, Antoni/AAG-5337-2020; Cugat, Maria Angeles Colomer/O-2909-2015; Margalida, Antoni/A-2723-2011; Perez Jimenez, Mario J./B-2114-2008; Margalida, Antoni/A-2723-2011	Cugat, Maria Angeles Colomer/0000-0003-4469-9178; Margalida, Antoni/0000-0002-0576-3993; Perez Jimenez, Mario J./0000-0002-5055-0102; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212	Spanish Network on Biomolecular and Biocellular Computing of the Ministerio de Ciencia e Inovacion of Spain [TIN2008-04487-E]	Spanish Network on Biomolecular and Biocellular Computing of the Ministerio de Ciencia e Inovacion of Spain	The authors acknowledge the support of the Spanish Network on Biomolecular and Biocellular Computing TIN2008-04487-E of the Ministerio de Ciencia e Inovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colomer MA, 2012, NAT COMPUT, V11, P369, DOI 10.1007/s11047-011-9289-2; Colomer MA, 2011, ECOL MODEL, V222, P33, DOI 10.1016/j.ecolmodel.2010.09.012; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bousquet F, 2004, ECOL MODEL, V176, P313, DOI 10.1016/j.ecolmodel.2004.01.011; Brook BW, 1999, ANIM CONSERV, V2, P23, DOI 10.1111/j.1469-1795.1999.tb00045.x; Cardona M, 2010, LECT NOTES COMPUT SC, V5957, P182, DOI 10.1007/978-3-642-11467-0_14; Cardona M, 2009, LECT NOTES COMPUT SC, V5391, P137; Diaz-Pernil D, 2009, LECT NOTES COMPUT SC, V5391, P187; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Fisher J, 2007, NAT BIOTECHNOL, V25, P1279; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Kendall BE, 2000, AM NAT, V155, P628, DOI 10.1086/303350; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2012, SCIENCE, V335, P284, DOI 10.1126/science.335.6066.284-a; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; Martinez-del-Amor M A., 2012, 13 INT C MEMBR COMP, P291; McGowan CP, 2011, BIOL CONSERV, V144, P1400, DOI 10.1016/j.biocon.2011.01.005; Mullon Christian, 2004, Natural Resource Modeling, V17, P71; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; PAINE RT, 1980, J ANIM ECOL, V49, P667; Paun G, 2000, J COMPUT SYST SCI, V61, P108, DOI 10.1006/jcss.1999.1693; Perez-Hurtado I., 2010, 2010 IEEE Fifth International Conference on Bio-Inspired Computing: Theories and Applications (BIC-TA), P637, DOI 10.1109/BICTA.2010.5645199; Pun G., 2010, OXFORD HDB MEMBRANE; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Russell JC, 2009, ECOL MODEL, V220, P1098, DOI 10.1016/j.ecolmodel.2009.01.017; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934	32	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60698	10.1371/journal.pone.0060698	http://dx.doi.org/10.1371/journal.pone.0060698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593284	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600037
J	Chung, BH; Yu, JH; Cho, HJ; Kim, JI; Moon, IS; Park, CW; Yang, CW; Kim, YS; Choi, BS				Chung, Byung Ha; Yu, Jee Hyun; Cho, Hyuk Jin; Kim, Ji-Il; Moon, In Sung; Park, Cheol Whee; Yang, Chul Woo; Kim, Yong-Soo; Choi, Bum Soon			Comparison of Estimating Equations for the Prediction of Glomerular Filtration Rate in Kidney Donors before and after Kidney Donation	PLOS ONE			English	Article							SERUM CREATININE; RENAL-DISEASE; CKD-EPI; COCKCROFT-GAULT; PERFORMANCE; DIET; GFR; EPIDEMIOLOGY; VALIDATION; FORMULA	The aim of this study is to investigate the usefulness of the GFR-estimating equations to predict renal function in kidney donors before and after transplantation. We compared the performance of 24-hour-urine-based creatinine clearance (24 hr urine-CrCI), the Cockcroft-Gault formula (eGFR(CG)), the Modification of Diet in Renal Disease equation (eGFR(MDRD)), and the Chronic Kidney Disease Epidemiology Collaboration equation (eGFR(CKD-EPI)) with technetium-diethylenetriaminepentaacetic acid (Tc-99m-DTPA) clearance (mGFR) in 207 potential kidney donors and 108 uninephric donors. Before donation, eGFR(CKD-EPI) showed minimal bias and did not show a significant difference from mGFR (P = 0.65, respectively) while 24 hr urine-CrCl and eGFR(MDRD) significantly underestimated mGFR (P<0.001 for each). Precision and accuracy was highest in eGFR(CKD-EPI) and this better performance was more dominant when renal function is higher than 90 mL center dot min(-1)center dot 1.73 m(-2). After kidney donation, eGFR(MDRD) was superior to other equations in precision and accuracy in contrast to before donation. Within individual analysis, eGFR(MDRD) showed better performance at post-donation compared to pre-donation, but eGFR(CKD-EPI) and eGFR(CG) showed inferior performance at post-donation. In conclusion, eGFR(CKD-EPI) showed better performance compared to other equations before donation. In a uninephric donor, however, eGFR(MDRD) is more appropriate for the estimation of renal function than eGFR(CKD-EPI).	[Chung, Byung Ha; Yu, Jee Hyun; Park, Cheol Whee; Yang, Chul Woo; Kim, Yong-Soo; Choi, Bum Soon] Catholic Univ Korea, Transplant Res Ctr, Seoul St Marys Hosp, Coll Med, Seoul, South Korea; [Chung, Byung Ha; Yu, Jee Hyun; Park, Cheol Whee; Yang, Chul Woo; Kim, Yong-Soo; Choi, Bum Soon] Catholic Univ Korea, Div Nephrol, Seoul St Marys Hosp, Dept Internal Med,Coll Med, Seoul, South Korea; [Cho, Hyuk Jin] Catholic Univ Korea, Dept Urol, Seoul St Marys Hosp, Coll Med, Seoul, South Korea; [Kim, Ji-Il; Moon, In Sung] Catholic Univ Korea, Dept Surg, Seoul St Marys Hosp, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Choi, BS (corresponding author), Catholic Univ Korea, Transplant Res Ctr, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	sooncb@catholic.ac.kr	Cho, Hyuk Jin/AAU-7753-2020	Cho, Hyuk Jin/0000-0003-2599-2950	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0023126]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant (A092258) from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0023126). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Khader AA, 2008, RENAL FAILURE, V30, P205, DOI 10.1080/08860220701810554; BRENNER BM, 1985, AM J PHYSIOL, V249, pF324, DOI 10.1152/ajprenal.1985.249.3.F324; Carter JL, 2011, QJM-INT J MED, V104, P839, DOI 10.1093/qjmed/hcr077; CHEN L, 1995, EUR HEART J, V16, P1085, DOI 10.1093/oxfordjournals.eurheartj.a061051; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Hsu CY, 2002, KIDNEY INT, V61, P1567, DOI 10.1046/j.1523-1755.2002.00299.x; Issa N, 2008, TRANSPLANTATION, V86, P223, DOI 10.1097/TP.0b013e318176aefc; Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100; KAMPMANN J, 1974, ACTA MED SCAND, V196, P517; Kang KY, 2007, NEPHROL DIAL TRANSPL, V22, P2322, DOI 10.1093/ndt/gfm192; Kang YS, 2005, CLIN NEPHROL, V63, P258; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mahajan S, 2005, J NEPHROL, V18, P257; Michels WM, 2010, CLIN J AM SOC NEPHRO, V5, P1003, DOI 10.2215/CJN.06870909; Poge U, 2011, NEPHROL DIAL TRANSPL, V26, P4104, DOI 10.1093/ndt/gfr183; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; RUSSELL CD, 1983, J NUCL MED, V24, P722; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Srinivas S, 2008, NEPHROLOGY, V13, P440, DOI 10.1111/j.1440-1797.2008.00967.x; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Tan JC, 2010, CLIN J AM SOC NEPHRO, V5, P497, DOI 10.2215/CJN.05280709; Tent H, 2010, CLIN J AM SOC NEPHRO, V5, P1960, DOI 10.2215/CJN.08761209; Teo BW, 2011, AM J KIDNEY DIS, V58, P56, DOI 10.1053/j.ajkd.2011.02.393; Briones JLT, 2011, NEFROLOGIA, V31, P677, DOI 10.3265/Nefrologia.pre2011.Sep.11014; United Network for Organ Sharing, US TRANSPL DAT; Walser M, 1998, AM J KIDNEY DIS, V32, P23, DOI 10.1053/ajkd.1998.v32.pm9669420; White CA, 2008, AM J KIDNEY DIS, V51, P1005, DOI 10.1053/j.ajkd.2008.02.308; White CA, 2010, CLIN CHEM, V56, P474, DOI 10.1373/clinchem.2009.135111; Zhao WY, 2009, CLIN TRANSPLANT, V23, P469, DOI 10.1111/j.1399-0012.2009.01027.x	35	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60720	10.1371/journal.pone.0060720	http://dx.doi.org/10.1371/journal.pone.0060720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585845	Green Submitted, gold, Green Published			2022-12-27	WOS:000317909600041
J	He, F; Wu, XF; Xia, X; Peng, FF; Huang, FX; Yu, XQ				He, Feng; Wu, Xianfeng; Xia, Xi; Peng, Fenfen; Huang, Fengxian; Yu, Xueqing			Pneumonia and Mortality Risk in Continuous Ambulatory Peritoneal Dialysis Patients with Diabetic Nephropathy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; RENAL-DISEASE; UNITED-STATES; SURVIVAL; OBESITY; ATHEROSCLEROSIS; HOSPITALIZATION; EPIDEMIOLOGY; INFLAMMATION	Background: Although clinical experience suggests that patients with diabetes mellitus are more susceptible to several types of infections, the overall scope of pneumonia in continuous ambulatory peritoneal dialysis (CAPD) patients with diabetic nephropathy (DN) has received little attention. Methods: This was a prospective observational cohort study in CAPD patients in which prognostic risks of pneumonia were evaluated in DN and non-DN patients by Cox regression analysis. Hazard ratios of pneumonia events, all-cause and pneumonia-related mortality were calculated by Kaplan-Meier curves and the Cox proportional hazards model for DN versus non-DN patients. Results: A total of 1148 patients (58.6% male, 48.34 +/- 15.78 years) had a median follow-up of 23.8 months and a maximum follow-up of 72.0 months. The pneumonia incidence rate of 62.3/1,000 patient-years in CAPD patients with DN was significantly higher than that of 28.5/1,000 patient-years in non-DN patients. On multivariate analysis, independent predictors of pneumonia occurrence in CAPD patients with DN were high body mass index (hazard ratio [HR], 1.15; 95% confidence interval [CI], 1.01-1.31; P = 0.037) and low serum albumin level (HR, 0.87; 95% CI, 0.78-0.98; P = 0.014). Older age (HR, 1.63; 95% CI, 1.35-1.96; P<0.001) was an independent risk factor for the presence of pneumonia in non-DN patients. CAPD patients with DN had higher pneumonia-related mortality (HR, 4.424; 95% CI, 1.871-10.461; P<0.001) and all-cause mortality (HR, 2.608; 95% CI, 1.890-3.599; P<0.001) hazards than their non-DN counterparts, even when extensive demographics, comorbidities, and lab adjustments were made. Conclusions: The pneumonia and all-cause mortality risks were strikingly higher in CAPD patients with DN than in non-DN counterparts, which may warrant further investigation and therapeutic care intensification.	[He, Feng; Wu, Xianfeng; Xia, Xi; Peng, Fenfen; Huang, Fengxian; Yu, Xueqing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	He, F (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	hfxyl@163.net; yuxq@mail.sysu.edu.cn		, xianfeng/0000-0001-7447-5189	National Key Basic Research Program of China [2011CB504005]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI10B05]; National Natural Science Foundation of China [81170765]; Guangdong Natural Science Foundation [S2011020002359]	National Key Basic Research Program of China(National Basic Research Program of China); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by the grants from the National Key Basic Research Program of China (grant number 2011CB504005), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (grant number 2011BAI10B05), the National Natural Science Foundation of China (grant number 81170765), and the Guangdong Natural Science Foundation (grant number S2011020002359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; [Anonymous], 1989, Stroke, V20, P1407; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; Benfield T, 2007, DIABETOLOGIA, V50, P549, DOI 10.1007/s00125-006-0570-3; Bethesda, 2006, USRDS 2006 ANN DAT R; D'Agata EMC, 2000, AM J KIDNEY DIS, V35, P1083, DOI 10.1016/S0272-6386(00)70044-8; de Mutsert R, 2007, J AM SOC NEPHROL, V18, P967, DOI 10.1681/ASN.2006091050; Guo HF, 2008, NEPHROL DIAL TRANSPL, V23, P680, DOI 10.1093/ndt/gfm474; Hoogeveen EK, 2012, CLIN J AM SOC NEPHRO, V7, P280, DOI 10.2215/CJN.05700611; Kaparianos A, 2008, Chron Respir Dis, V5, P101, DOI 10.1177/1479972307086313; Kuriyama S, 2007, PERITON DIALYSIS INT, V27, pS190; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; Miyamoto T, 2011, CURR OPIN NEPHROL HY, V20, P662, DOI 10.1097/MNH.0b013e32834ad504; Navab KD, 2011, CURR PHARM DESIGN, V17, P17; O'Meara ES, 2005, J AM GERIATR SOC, V53, P1108, DOI 10.1111/j.1532-5415.2005.53352.x; Piroddi M, 2007, AMINO ACIDS, V32, P573, DOI 10.1007/s00726-006-0433-8; Praga M, 2002, NEPHROL DIAL TRANSPL, V17, P1157, DOI 10.1093/ndt/17.7.1157; Remuzzi G, 2006, J AM SOC NEPHROL, V17, pS90, DOI 10.1681/ASN.2005121324; Sarnak MJ, 2001, CHEST, V120, P1883, DOI 10.1378/chest.120.6.1883; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Slinin Y, 2006, KIDNEY INT, V70, P1135, DOI 10.1038/sj.ki.5001714; Stack AG, 2004, KIDNEY INT, V65, P2398, DOI 10.1111/j.1523-1755.2004.00654.x; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Vardakas KZ, 2007, DIABETIC MED, V24, P1168, DOI 10.1111/j.1464-5491.2007.02234.x; Xie YS, 2008, AM J NEPHROL, V28, P1, DOI 10.1159/000108755; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x	26	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61497	10.1371/journal.pone.0061497	http://dx.doi.org/10.1371/journal.pone.0061497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585903	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600118
J	Lin, J; Zhang, LL; Zhao, GQ; Su, ZT; Deng, RZ; Pflugfelder, SC; Li, DQ				Lin, Jing; Zhang, Lili; Zhao, Guiqiu; Su, Zhitao; Deng, Ruzhi; Pflugfelder, Stephen C.; Li, De-Quan			A Novel Interleukin 33/ST2 Signaling Regulates Inflammatory Response in Human Corneal Epithelium	PLOS ONE			English	Article							SOLUBLE ST2 PROTEIN; CYTOKINE PRODUCTION; INDUCED ARTHRITIS; HUMAN BASOPHILS; MAST-CELLS; IL-33; EXPRESSION; RECEPTOR; GENE; ASTHMA	Interleukin (IL) 33, a member of IL-1 cytokine family, is well known to promote Th2 type immune responses by signaling through its receptor ST2. However, it is not clear whether ST2 is expressed by mucosal epithelium, and how it responds to IL-33 to induce inflammatory mediators. This study was to identify the presence and function of ST2 and explore the role of IL-33/ST2 signaling in regulating the inflammatory cytokine production in corneal epithelial cells. Human corneal tissues and cultured primary human corneal epithelial cells (HCECs) were treated with IL-33 in different concentrations without or with different inhibitors to evaluate the expression, location and signaling pathways of ST2 in regulating production of inflammatory cytokine and chemokine. The mRNA expression was determined by reverse transcription and real time PCR, and protein production was measured by enzyme-linked immunosorbent assay (ELISA), immunohistochemical and immunofluorescent staining. ST2 mRNA and protein were detected in donor corneal epithelium and cultured HCECs, and ST2 signal was enhanced by exposure to IL-33. IL-33 significantly stimulated the production of inflammatory cytokines (TNF-alpha, IL-1 beta and IL-6) and chemokine IL-8 by HCECs at both mRNA and protein levels. The stimulated production of inflammatory mediators by IL-33 was blocked by ST2 antibody or soluble ST2 protein. Interestingly, the I kappa B-alpha inhibitor BAY11-7082 or NF-kappa B activation inhibitor quinazoline blocked NF-kappa B p65 protein phosphorylation and nuclear translocation, and also suppressed the production of these inflammatory cytokines and chemokine induced by IL-33. These findings demonstrate that ST2 is present in human corneal epithelial cells, and IL-33/ST2 signaling plays an important role in regulating IL-33 induced inflammatory responses in ocular surface.	[Lin, Jing; Zhang, Lili; Zhao, Guiqiu] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Ophthalmol, Qingdao 266071, Peoples R China; [Lin, Jing; Zhang, Lili; Su, Zhitao; Deng, Ruzhi; Pflugfelder, Stephen C.; Li, De-Quan] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Su, Zhitao; Deng, Ruzhi] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China	Qingdao University; Baylor College of Medicine; Wenzhou Medical University	Zhao, GQ (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, Dept Ophthalmol, Qingdao 266071, Peoples R China.	guiqiuzhao@126.com; dequanl@bcm.edu			National Eye Institute, National Institutes of Health [EY11915]; Alkek Foundation; National Natural Science Foundation of China [81170825]; Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Alkek Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oshman Foundation; William Stamps Farish Fund	This study was supported by National Eye Institute, National Institutes of Health grant EY11915 (SCP), Alkek Foundation (DQL), National Natural Science Foundation of China (81170825), an unrestricted grant from Research to Prevent Blindness, the Oshman Foundation and the William Stamps Farish Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra A, 2008, CYTOKINE, V41, P114, DOI 10.1016/j.cyto.2007.11.001; Bian F, 2010, STEM CELLS, V28, P2172, DOI 10.1002/stem.539; BONANNO JA, 1987, OPHTHALMOLOGY, V94, P1305; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Jones LA, 2010, EUR J IMMUNOL, V40, P426, DOI 10.1002/eji.200939705; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; KUMAR S, 1995, J BIOL CHEM, V270, P27905, DOI 10.1074/jbc.270.46.27905; Kurokawa M, 2011, INT ARCH ALLERGY IMM, V155, P12, DOI 10.1159/000327259; Leung BP, 2004, J IMMUNOL, V173, P145, DOI 10.4049/jimmunol.173.1.145; Li DQ, 2010, INVEST OPHTH VIS SCI, V51, P5623, DOI 10.1167/iovs.09-4992; Liu XC, 2012, INFLAMMATION, V35, P776, DOI 10.1007/s10753-011-9379-4; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Ma P, 2010, EXP EYE RES, V90, P130, DOI 10.1016/j.exer.2009.09.021; Matsuda A, 2009, INVEST OPHTH VIS SCI, V50, P4646, DOI 10.1167/iovs.08-3365; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Moritz DR, 1998, J IMMUNOL, V161, P4866; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Oshikawa K, 2002, CLIN EXP ALLERGY, V32, P1520, DOI 10.1046/j.1365-2745.2002.01494.x; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Szerafin T, 2009, THORAC CARDIOV SURG, V57, P25, DOI 10.1055/s-2008-1039044; Tajima S, 2007, EXP LUNG RES, V33, P81, DOI 10.1080/01902140701198583; Tominaga S, 1999, BIOCHEM BIOPH RES CO, V264, P14, DOI 10.1006/bbrc.1999.1469; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; TOMINAGA S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P1, DOI 10.1016/0167-4781(91)90029-L; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685; Yin H, 2006, BIOCHEM BIOPH RES CO, V351, P940, DOI 10.1016/j.bbrc.2006.10.166; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003	50	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60963	10.1371/journal.pone.0060963	http://dx.doi.org/10.1371/journal.pone.0060963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585867	gold, Green Submitted, Green Published			2022-12-27	WOS:000317909600074
J	Myung, S; Zhang, YHP				Myung, Suwan; Zhang, Y-H Percival			Non-Complexed Four Cascade Enzyme Mixture: Simple Purification and Synergetic Co-stabilization	PLOS ONE			English	Article							HYDROGEN; GLUCOSE; STABILITY; ISOMERASE; PATHWAY; CLONING; WATER	Cell-free biosystems comprised of synthetic enzymatic pathways would be a promising biomanufacturing platform due to several advantages, such as high product yield, fast reaction rate, easy control and access, and so on. However, it was essential to produce (purified) enzymes at low costs and stabilize them for a long time so to decrease biocatalyst costs. We studied the stability of the four recombinant enzyme mixtures, all of which originated from thermophilic microorganisms: triosephosphate isomerase (TIM) from Thermus thermophiles, fructose bisphosphate aldolase (ALD) from Thermotoga maritima, fructose bisphosphatase (FBP) from T. maritima, and phosphoglucose isomerase (PGI) from Clostridium thermocellum. It was found that TIM and ALD were very stable at evaluated temperature so that they were purified by heat precipitation followed by gradient ammonia sulfate precipitation. In contrast, PGI was not stable enough for heat treatment. In addition, the stability of a low concentration PGI was enhanced by more than 25 times in the presence of 20 mg/L bovine serum albumin or the other three enzymes. At a practical enzyme loading of 1000 U/L for each enzyme, the half-life time of free PGI was prolong to 433 h in the presence of the other three enzymes, resulting in a great increase in the total turn-over number of PGI to 6.2 x 10(9) mole of product per mole of enzyme. This study clearly suggested that the presence of other proteins had a strong synergetic effect on the stabilization of the thermolabile enzyme PGI due to in vitro macromolecular crowding effect. Also, this result could be used to explain why not all enzymes isolated from thermophilic microorganisms are stable in vitro because of a lack of the macromolecular crowding environment.	[Myung, Suwan; Zhang, Y-H Percival] Virginia Polytech Inst & State Univ, Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Myung, Suwan; Zhang, Y-H Percival] Virginia Polytech Inst & State Univ, Inst Crit Technol & Appl Sci ICTAS, Blacksburg, VA 24061 USA; [Zhang, Y-H Percival] Cell Free Bioinnovat Inc, Blacksburg, VA USA; [Zhang, Y-H Percival] Gate Fuels Inc, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Zhang, YHP (corresponding author), Virginia Polytech Inst & State Univ, Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	ypzhang@vt.edu			Biological Systems Engineering Department of Virginia Tech; Shell; CALS Biodesign and Bioprocessing Research Center; NSF SBIR I grant; ICTAS Scholar Program	Biological Systems Engineering Department of Virginia Tech; Shell(Royal Dutch Shell); CALS Biodesign and Bioprocessing Research Center; NSF SBIR I grant; ICTAS Scholar Program	This work was supported by the Biological Systems Engineering Department of Virginia Tech, and partially supported Shell by GameChanger Program, the CALS Biodesign and Bioprocessing Research Center, and NSF SBIR I grant to PZ. SM was partially supported by the ICTAS Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Banki MR, 2005, NAT METHODS, V2, P659, DOI 10.1038/nmeth787; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Bruggink A, 2003, ORG PROCESS RES DEV, V7, P622, DOI 10.1021/op0340311; Cao LQ, 2003, CURR OPIN BIOTECH, V14, P387, DOI 10.1016/S0958-1669(03)00096-X; CHANG BS, 1995, BIOTECHNOL APPL BIOC, V22, P203; del Campo JSM, 2013, ANGEW CHEM INT EDIT, DOI [10.1002/ange.201300766, DOI 10.1002/ANGE.201300766]; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Forster AC, 2007, GENOME RES, V17, P1, DOI 10.1101/gr.5776007; Gouda MD, 2002, BIOSENS BIOELECTRON, V17, P503, DOI 10.1016/S0956-5663(02)00021-0; Guterl JK, 2012, CHEMSUSCHEM, V5, P2165, DOI 10.1002/cssc.201200365; Huang SY, 2012, APPL MICROBIOL BIOT, V93, P2403, DOI 10.1007/s00253-011-3578-7; Iyer RB, 2002, EXTREMOPHILES, V6, P283, DOI 10.1007/s00792-001-0255-2; Meyer A, 2007, CURR OPIN MICROBIOL, V10, P246, DOI 10.1016/j.mib.2007.05.009; Myung S, 2011, BIOTECHNOL PROGR, V27, P969, DOI 10.1002/btpr.606; Myung S, 2010, PROCESS BIOCHEM, V45, P1882, DOI 10.1016/j.procbio.2010.03.017; Rogers TA, 2010, CHEM ENG SCI, V65, P2118, DOI 10.1016/j.ces.2009.12.005; SHULER ML, 2001, BIOPROCESS ENG BASIC; Sun FF, 2012, PROTEIN EXPRES PURIF, V82, P302, DOI 10.1016/j.pep.2012.01.017; Swartz JR, 2012, AICHE J, V58, P5, DOI 10.1002/aic.13701; Tong XD, 2011, BIOTECHNOL BIOENG, V108, P465, DOI 10.1002/bit.22938; Wang Y, 2010, J APPL MICROBIOL, V108, P39, DOI 10.1111/j.1365-2672.2009.04396.x; Wang YR, 2011, CHEM BIOL, V18, P372, DOI 10.1016/j.chembiol.2010.12.019; Wang YR, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-30; Xu S, 2012, ACS CATAL, V2, P91, DOI 10.1021/cs200523s; Ye XT, 2013, J BIOTECHNOL, V164, P34, DOI 10.1016/j.jbiotec.2012.11.011; Ye XT, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-120; Ye XH, 2009, CHEMSUSCHEM, V2, P149, DOI 10.1002/cssc.200900017; You C, 2013, ACS SYNTH BIOL, V2, P102, DOI 10.1021/sb300068g; You C, 2012, ANGEW CHEM INT EDIT, V51, P8787, DOI 10.1002/anie.201202441; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhang YHP, 2012, TRENDS BIOTECHNOL, V30, P301, DOI 10.1016/j.tibtech.2012.02.006; Zhang YHP, 2011, BIOTECHNOL ADV, V29, P715, DOI 10.1016/j.biotechadv.2011.05.020; Zhang YHP, 2010, BIOTECHNOL BIOENG, V105, P663, DOI 10.1002/bit.22630; Zhang YHP, 2011, J MATER CHEM, V21, P18877, DOI 10.1039/c1jm12078f; Zhang YHP, 2010, CURR OPIN BIOTECH, V21, P663, DOI 10.1016/j.copbio.2010.05.005; Zhu ZG, 2012, BIOSENS BIOELECTRON, V36, P110, DOI 10.1016/j.bios.2012.04.001	37	23	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61500	10.1371/journal.pone.0061500	http://dx.doi.org/10.1371/journal.pone.0061500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585905	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600120
J	Parikh, UM; Kiepiela, P; Ganesh, S; Gomez, K; Horn, S; Eskay, K; Kelly, C; Mensch, B; Gorbach, P; Soto-Torres, L; Ramjee, G; Mellors, JW				Parikh, Urvi M.; Kiepiela, Photini; Ganesh, Shayhana; Gomez, Kailazarid; Horn, Stephanie; Eskay, Krista; Kelly, Cliff; Mensch, Barbara; Gorbach, Pamina; Soto-Torres, Lydia; Ramjee, Gita; Mellors, John W.		MTN-Protocol Team	Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009)	PLOS ONE			English	Article							SURVEILLANCE; WORLD; MUTATIONS; ADHERENCE; ROLLOUT; UPDATE	Background: A major concern with using antiretroviral (ARV)-based products for HIV prevention is the potential spread of drug resistance, particularly from individuals who are HIV-infected but unaware of their status. Limited data exist on the prevalence of HIV infection or drug resistance among potential users of ARV-based prevention products. Methods: A cross-sectional study of reproductive-aged women who presented to screen for an HIV prevention trial was conducted at 7 clinical sites in Durban, South Africa. CD4+ T cell counts, HIV-1 RNA levels and population sequencing of the protease and reverse transcriptase genes were performed for all women with 2 positive HIV rapid tests. Resistance mutations were identified using the Stanford Calibrated Population Resistance Tool. Results: Of the 1073 evaluable women, 400(37%) were confirmed as HIV-infected. Of those, plasma HIV-1 RNA was detectable in 365/400(91%) and undetectable(<40 copies/ml) in 35/400(9%) women. 156 women(39%) were eligible for antiretroviral therapy (CD4+ T cell counts<350 cells/mm(3)) and 50(13%) met criteria for AIDS(CD4<200 cells/mm(3)). Of 352 plasma samples(>200 copies/ml) analyzed for drug resistance, 26(7.4%) had nucleoside reverse transcriptase inhibitor (NRTI), non-nucleoside reverse transcriptase inhibitor (NNRTI) or protease inhibitor (PI) drug resistance mutations. Among those with resistance, 18/26 participants(62%) had single-class NNRTI resistance and 5/26(19%) had dual-class NRTI/NNRTI. Major mutations in reverse transcriptase included K65R(n = 1), L74I(n = 1), K103N(n = 19), V106M(n = 4), Y181C(n = 2), M184V(n = 4), and K219E/R(n = 2). Major PI-resistance mutations were rare: M46L(n = 1) and I85V(n = 1). All participants were infected with subtype C virus, except one infected with subtype A. Conclusions: In women from Durban, South Africa screening for an HIV prevention trial, the HIV prevalence was high (37%) and HIV drug resistance prevalence was above 5%. This study highlights the potential challenges faced when implementing an ARV-based prevention product that overlaps with first-line antiretroviral therapy. Effective screening to exclude HIV infection among women interested in uptake of ARV-based HIV prevention will be essential in limiting the spread of ARV resistance.	[Parikh, Urvi M.; Eskay, Krista; Mellors, John W.] Univ Pittsburgh, Sch Med, Dept Infect Dis, Pittsburgh, PA 15260 USA; [Kiepiela, Photini; Ganesh, Shayhana; Ramjee, Gita] MRC, HIV Prevent Res Unit, Durban, South Africa; [Gomez, Kailazarid; Horn, Stephanie] FHI 360, Res Triangle Pk, NC USA; [Kelly, Cliff] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Mensch, Barbara] Populat Council, New York, NY 10021 USA; [Gorbach, Pamina] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Soto-Torres, Lydia] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; FHI 360; Fred Hutchinson Cancer Center; Population Council; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Parikh, UM (corresponding author), Univ Pittsburgh, Sch Med, Dept Infect Dis, Pittsburgh, PA 15260 USA.	ump3@pitt.edu			National Institute of Allergy and Infectious Diseases, component of the U.S. National Institutes of Health [5UM1AI068633]; National Institute of Child Health and Human Development, component of the U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068633, U01AI068633] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, component of the U.S. National Institutes of Health; National Institute of Child Health and Human Development, component of the U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Microbicide Trials Network is funded by the National Institute of Allergy and Infectious Diseases (5UM1AI068633), with co-funding from the National Institute of Child Health and Human Development, all components of the U.S. National Institutes of Health. As a US Public Health Service Commissioned Corps Officer in the Division of AIDS (DAIDS) at the National Institute of Allergy and Infectious Diseases (NIAID), Dr. Soto-Torres represents the funder (NIAID). However, she has no official oversight of MTN funding or budgetary issues. Her responsibilities as a DAIDS Medical Officer are to oversee the design and conduct of MTN-009 as well as monitor participant safety in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018165; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bennett DE, 2006, CURR OPIN INFECT DIS, V19, P607, DOI 10.1097/QCO.0b013e3280109ff1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Castro H, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-30; Castro KG, 1992, MORBIDITY MORTALITY, P4; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Gorbach PM, 2012, AIDS BEHAV; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Horwood C, 2010, TROP MED INT HLTH; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Jordan MR, 2012, CLIN INFECT DIS, V54, pS245, DOI 10.1093/cid/cis206; Jordan MR, 2008, ANTIVIR THER, V13, P15; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Li JF, 2011, J INFECT DIS, V203, P798, DOI 10.1093/infdis/jiq126; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Mensch BS, 2011, AIDS BEHAV, V15, P407, DOI 10.1007/s10461-010-9791-z; Motsoaledi A, 2010, CLIN GUIDELINES MANA; Nel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035278; Nel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021528; Nwobegahay JM, 2011, J HEALTH POPUL NUTR, V29, P303, DOI 10.3329/jhpn.v29i4.8444; Okulicz JF, 2011, CURR OPIN HIV AIDS, V6, P163, DOI 10.1097/COH.0b013e328344f35e; Parboosing R, 2011, J MED VIROL, V83, P1508, DOI 10.1002/jmv.22143; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Welker R, 2005, JAMA-J AM MED ASSOC, V293, P281, DOI 10.1001/jama.293.3.281; WHO/UNAIDS, 2010, GLOB REP UNAIDS REP; Woodsong C, 2012, AIDS BEHAV, V16, P785, DOI 10.1007/s10461-011-0027-7	33	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e59787	10.1371/journal.pone.0059787	http://dx.doi.org/10.1371/journal.pone.0059787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585827	Green Published, gold, Green Accepted			2022-12-27	WOS:000317909600009
J	Qu, QM; Zhu, M; Wang, W				Qu, Qingming; Zhu, Min; Wang, Wei			Scales and Dermal Skeletal Histology of an Early Bony Fish Psarolepis romeri and Their Bearing on the Evolution of Rhombic Scales and Hard Tissues	PLOS ONE			English	Article							ORIGIN; FOSSIL; INTERRELATIONSHIPS; SARCOPTERYGII; COSMINE; JAWS	Recent discoveries of early bony fishes from the Silurian and earliest Devonian of South China (e. g. Psarolepis, Achoania, Meemannia, Styloichthys and Guiyu) have been crucial in understanding the origin and early diversification of the osteichthyans (bony fishes and tetrapods). All these early fishes, except Guiyu, have their dermal skeletal surface punctured by relatively large pore openings. However, among these early fishes little is known about scale morphology and dermal skeletal histology. Here we report new data about the scales and dermal skeletal histology of Psarolepis romeri, a taxon with important implications for studying the phylogeny of early gnathostomes and early osteichthyans. Seven subtypes of rhombic scales with similar histological composition and surface sculpture are referred to Psarolepis romeri. They are generally thick and show a faint antero-dorsal process and a broad peg-and-socket structure. In contrast to previously reported rhombic scales of osteichthyans, these scales bear a neck between crown and base as in acanthodian scales. Histologically, the crown is composed of several generations of odontodes and an irregular canal system connecting cylindrical pore cavities. Younger odontodes are deposited on older ones both superpositionally and areally. The bony tissues forming the keel of the scale are shown to be lamellar bone with plywood-like structure, whereas the other parts of the base are composed of pseudo-lamellar bone with parallel collagen fibers. The unique tissue combination in the keel (i.e., extrinsic Sharpey's fibers orthogonal to the intrinsic orthogonal sets of collagen fibers) has rarely been reported in the keel of other rhombic scales. The new data provide insights into the early evolution of rhombic (ganoid and cosmoid) scales in osteichthyans, and add to our knowledge of hard tissues of early vertebrates.	[Qu, Qingming] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Subdept Evolut & Dev, Uppsala, Sweden; [Qu, Qingming; Zhu, Min; Wang, Wei] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China	Uppsala University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Qu, QM (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Subdept Evolut & Dev, Uppsala, Sweden.	quqingming@hotmail.com; zhumin@ivpp.ac.cn	Qu, Qingming/R-7194-2016; min, zhu/AAL-6712-2021; Zhu, Min/E-8728-2012	Qu, Qingming/0000-0002-8291-8493; Zhu, Min/0000-0002-4786-0898	MST of China [2012CB821902]; National Nature Science Foundation of China [40930208]; Chinese Academy of Sciences [KZCX2-YW-156]; ERC [233111]	MST of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); ERC(European Research Council (ERC)European Commission)	Funding was provided by the Major Basic Research Projects (2012CB821902) of MST of China, the National Nature Science Foundation of China (40930208), the Chinese Academy of Sciences (KZCX2-YW-156), and ERC Advanced Investigator Grant 233111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; BORGEN UJ, 1989, LETHAIA, V22, P413, DOI 10.1111/j.1502-3931.1989.tb01444.x; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow Carole, 1994, Records of the South Australian Museum (Adelaide), V27, P175; Burrow Carole J., 1995, Geobios Memoire Special (Villeurbanne), V19, P319; Burrow CJ, 1999, J VERTEBR PALEONTOL, V19, P204, DOI 10.1080/02724634.1999.10011135; Chang M., 1981, SCI SINICA, V24, P89; Chang M.M., 1984, Proceedings of the Linnean Society of New South Wales, V107, P171; Chang MM, 1992, J VERTEBR PALEONTOL, V12, P294, DOI 10.1080/02724634.1992.10011461; Choo B, 2011, EARTH ENV SCI T R SO, V102, P77, DOI 10.1017/S1755691011011029; Daget J, 2001, FISH FISH, V2, P113, DOI 10.1046/j.1467-2960.2001.00046.x; Denison, 1979, ACANTHODII; DENISON R H, 1968, Fieldiana Geology, V17, P353; Denison R. H., 1968, P247; Donoghue PCJ, 2001, T ROY SOC EDIN-EARTH, V92, P15, DOI 10.1017/S026359330000002X; Esi D.N.., 1990, PALEONTOL J+, V1990, P90; Francillon-Vieillot H., 1990, P471; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; GROSS W, 1968, Palaeontologische Zeitschrift, V42, P73; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; Gross W., 1971, Palaeontographica A, V136, P1; Gross W., 1947, PALAEONTOGR ABT A, V96, P91; GROSS WALTER, 1956, K SVENSKA VETENSKAPSAKAD HANDL, V5, P1; Janvier P., 1978, EESTI NSV TEADUSTE A, V27, P88; Janvier P., 1996, EARLY VERTEBRATES; Janvier P, 2010, P NATL ACAD SCI USA, V107, P19137, DOI 10.1073/pnas.1014583107; Jessen H., 1968, Palaeontographica, V128A, P87; KERR T, 1952, P ZOOL SOC LOND, V122, P55, DOI 10.1111/j.1469-7998.1952.tb06313.x; Lu Jing, 2008, Vertebrata Palasiatica, V46, P161; Meinke D.K., 1984, Journal of Vertebrate Paleontology, V4, P457; MEUNIER FJ, 1984, AM ZOOL, V24, P953; MEUNIER FJ, 1980, ARCH ZOOL EXP GEN, V121, P279; MEUNIER FJ, 1980, ANN BIOL-PARIS, V19, P1; Meunier FJ, 2011, CR PALEVOL, V10, P347, DOI 10.1016/j.crpv.2011.04.005; Min Z, 1997, LETHAIA, V30, P293; Min Z., 2007, FRONTIERS BIOL CHINA, V2, P1; Mondejar-Fernandez J, 2012, J VERTEBR PALEONTOL, V32, P267, DOI 10.1080/02724634.2012.646836; ORVIG T, 1969, LETHAIA, V2, P241, DOI 10.1111/j.1502-3931.1969.tb01850.x; ORVIG T, 1967, ARK ZOOL, V19, P1; Orvig T., 1967, STRUCTURAL CHEMICAL, P45; Pander CH., 1856, MONOGRAPHIE FOSSILEN; Qiao T, 2010, SCI CHINA EARTH SCI, V53, P1836, DOI 10.1007/s11430-010-4089-6; RICHTER M, 1995, ZOOL J LINN SOC-LOND, V114, P173, DOI 10.1006/zjls.1995.0023; SCHULTZE H-P, 1977, Palaeontologische Zeitschrift, V51, P152; SCHULTZE H-P, 1968, Bulletin of the British Museum (Natural History) Geology, V16, P343; Sire JY, 2009, J ANAT, V214, P409, DOI 10.1111/j.1469-7580.2009.01046.x; Smith M.M., 1989, Historical Biology, V3, P97; Thanh TD, 1997, CR ACAD SCI II A, V324, P1023; Thomson K.S., 1975, Bulletin Peabody Mus nat Hist, VNo. 40, P1; Trinajstic K, 1999, ALCHERINGA, V23, P9, DOI 10.1080/03115519908619335; Wang N.Z., 1984, J LINNEAN SOC NEW S, V107, P419; Wang Nianzhong, 1997, Vertebrata Palasiatica, V35, P1; Wang NZ, 2005, J VERTEBR PALEONTOL, V25, P745, DOI 10.1671/0272-4634(2005)025[0745:HOTGDA]2.0.CO;2; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M., 2004, RECENT ADV ORIGIN EA, P271; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035103; Zhu Min, 2010, P199; Zhu M, 2009, BIOL LETTERS, V5, P372, DOI 10.1098/rsbl.2008.0784; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	66	30	31	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61485	10.1371/journal.pone.0061485	http://dx.doi.org/10.1371/journal.pone.0061485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585902	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600117
J	Whited, BM; Hofmann, MC; Lu, P; Xu, Y; Rylander, CG; Wang, G; Sapoznik, E; Criswell, T; Lee, SJ; Soker, S; Rylander, MN				Whited, Bryce M.; Hofmann, Matthias C.; Lu, Peng; Xu, Yong; Rylander, Christopher G.; Wang, Ge; Sapoznik, Etai; Criswell, Tracy; Lee, Sang Jin; Soker, Shay; Rylander, Marissa Nichole			Dynamic, Nondestructive Imaging of a Bioengineered Vascular Graft Endothelium	PLOS ONE			English	Article							SHEAR-STRESS; APOPTOSIS; BIOMATERIALS; CELLS; FLOW; PROLIFERATION; ALLOGRAFT; SCAFFOLD; VESSEL	Bioengineering of vascular grafts holds great potential to address the shortcomings associated with autologous and conventional synthetic vascular grafts used for small diameter grafting procedures. Lumen endothelialization of bioengineered vascular grafts is essential to provide an antithrombogenic graft surface to ensure long-term patency after implantation. Conventional methods used to assess endothelialization in vitro typically involve periodic harvesting of the graft for histological sectioning and staining of the lumen. Endpoint testing methods such as these are effective but do not provide real-time information of endothelial cells in their intact microenvironment, rather only a single time point measurement of endothelium development. Therefore, nondestructive methods are needed to provide dynamic information of graft endothelialization and endothelium maturation in vitro. To address this need, we have developed a nondestructive fiber optic based (FOB) imaging method that is capable of dynamic assessment of graft endothelialization without disturbing the graft housed in a bioreactor. In this study we demonstrate the capability of the FOB imaging method to quantify electrospun vascular graft endothelialization, EC detachment, and apoptosis in a nondestructive manner. The electrospun scaffold fiber diameter of the graft lumen was systematically varied and the FOB imaging system was used to noninvasively quantify the affect of topography on graft endothelialization over a 7-day period. Additionally, results demonstrated that the FOB imaging method had a greater imaging penetration depth than that of two-photon microscopy. This imaging method is a powerful tool to optimize vascular grafts and bioreactor conditions in vitro, and can be further adapted to monitor endothelium maturation and response to fluid flow bioreactor preconditioning.	[Whited, Bryce M.; Rylander, Christopher G.; Wang, Ge; Rylander, Marissa Nichole] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA USA; [Hofmann, Matthias C.; Lu, Peng; Xu, Yong] Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Blacksburg, VA 24061 USA; [Rylander, Christopher G.; Rylander, Marissa Nichole] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA; [Sapoznik, Etai; Criswell, Tracy; Lee, Sang Jin; Soker, Shay] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA	Virginia Polytechnic Institute & State University; Wake Forest University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Wake Forest University; Wake Forest Baptist Medical Center	Soker, S (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.	ssoker@wakehealth.edu; mnr@vt.edu	Rylander, Chris/F-2454-2014; Wang, Ge/AAH-8592-2020; Rylander, Marissa Nichole/F-2455-2014; Lee, Sang Jin/S-4056-2019; Lu, Peng/R-8753-2018	Wang, Ge/0000-0002-2656-7705; Lee, Sang Jin/0000-0002-3899-1909; Lu, Peng/0000-0003-4732-9519	National Institutes of Health [NIBIB HL098912]; National Science Foundation CAREER Award [CBET 0955072]; Institute for Critical Technology and Applied Science (Virginia Tech); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Award(National Science Foundation (NSF)); Institute for Critical Technology and Applied Science (Virginia Tech); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by a grant from the National Institutes of Health (NIBIB HL098912), the National Science Foundation CAREER Award (CBET 0955072), and a grant from the Institute for Critical Technology and Applied Science (Virginia Tech). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt D, 2002, AM J CARDIOL, V90, p40L, DOI 10.1016/S0002-9149(02)02963-6; Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002; Bran GM, 2008, ARCH MED RES, V39, P467, DOI 10.1016/j.arcmed.2008.02.007; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Coyle CH, 2007, J BIOMATER APPL, V22, P55, DOI 10.1177/0885328206069152; Dardik A, 1999, J VASC SURG, V29, P157, DOI 10.1016/S0741-5214(99)70357-5; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Engbers-Buijtenhuijs P, 2005, TISSUE ENG, V11, P1631, DOI 10.1089/ten.2005.11.1631; Estrada R, 2011, ANAL CHEM, V83, P3170, DOI 10.1021/ac2002998; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248; Heath DE, 2010, J BIOMED MATER RES A, V94A, P1195, DOI 10.1002/jbm.a.32802; Heyligers JMM, 2005, ANN VASC SURG, V19, P448, DOI 10.1007/s10016-005-0026-0; Hofmann MC, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.066010; Hofmann MC, 2012, TISSUE ENG C; Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020; Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002; Kader KN, 2008, MAT SCI ENG C-BIO S, V28, P387, DOI 10.1016/j.msec.2007.04.027; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Lamm P, 2001, CIRCULATION, V104, pI108; Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032; Li S, 2011, ANNU REV BIOMED ENG, V13, P451, DOI 10.1146/annurev-bioeng-071910-124733; Minino A.M., 2011, NATL VITAL STAT REPO, V59; Mueller RL, 1997, ANN THORAC SURG, V63, P869, DOI 10.1016/S0003-4975(96)01375-6; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; OTT MJ, 1995, SURGERY, V117, P334, DOI 10.1016/S0039-6060(05)80210-7; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x; Thomas AC, 2003, CARDIOVASC PATHOL, V12, P271, DOI 10.1016/S1054-8807(03)00086-3; Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006; Williams C, 2004, TISSUE ENG, V10, P930, DOI 10.1089/1076327041348536; Wu GD, 2002, J HEART LUNG TRANSPL, V21, P1174, DOI 10.1016/S1053-2498(02)00457-6; Yazdani SK, 2010, J VASC SURG, V51, P174, DOI 10.1016/j.jvs.2009.08.074; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	39	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61275	10.1371/journal.pone.0061275	http://dx.doi.org/10.1371/journal.pone.0061275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585885	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600097
J	Furnari, MA; Jobes, ML; Nekrasova, T; Minden, A; Wagner, GC				Furnari, Melody A.; Jobes, Michelle L.; Nekrasova, Tanya; Minden, Audrey; Wagner, George C.			Functional Deficits in Pak5, Pak6 and Pak5/Pak6 Knockout Mice	PLOS ONE			English	Article							P21-ACTIVATED PROTEIN-KINASE; TARGETED DISRUPTION; ACTIN CYTOSKELETON; BRAIN	The p21-activated kinases are effector proteins for Rho-family GTPases. PAK4, PAK5, and PAK6 are the group II PAKs associated with neurite outgrowth, filopodia formation, and cell survival. Pak4 knockout mice are embryonic lethal, while Pak5, Pak6, and Pak5/Pak6 double knockout mice are viable and fertile. Our previous work found that the double knockout mice exhibit locomotor changes and learning and memory deficits. We also found some differences with Pak5 and Pak6 single knockout mice and the present work further explores the potential differences of the Pak5 knockout and Pak6 knockout mice in comparison with wild type mice. The Pak6 knockout mice were found to weigh significantly more than the other genotypes. The double knockout mice were found to be less active than the other genotypes. The Pak5 knockout mice and the double knockout mice performed worse on the rotorod test. All the knockout genotypes were found to be less aggressive in the resident intruder paradigm. The double knockout mice were, once again, found to perform worse in the active avoidance assay. These results indicate, that although some behavioral differences are seen in the Pak5 and Pak6 single knockout mice, the double knockout mice exhibit the greatest changes in locomotion and learning and memory.	[Furnari, Melody A.; Jobes, Michelle L.] Rutgers State Univ, Joint Program Toxicol, Piscataway, NJ USA; [Nekrasova, Tanya; Minden, Audrey] Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernesto Mario Sch Pharm, Piscataway, NJ USA; [Wagner, George C.] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Wagner, GC (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.	gcwagner@rci.rutgers.edu			 [ES007148];  [ES05022]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007148] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported in part by ES007148 and ES05022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Fan WQ, 2005, DIABETES, V54, P1000, DOI 10.2337/diabetes.54.4.1000; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Li XF, 2003, MOL CELL BIOL, V23, P7134, DOI 10.1128/MCB.23.20.7134-7142.2003; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vadlamudi RK, 2003, CANCER METAST REV, V22, P385, DOI 10.1023/A:1023729130497; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	21	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61321	10.1371/journal.pone.0061321	http://dx.doi.org/10.1371/journal.pone.0061321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593460	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000124
J	Baragetti, I; Norata, GD; Sarcina, C; Baragetti, A; Rastelli, F; Buzzi, L; Grigore, L; Garlaschelli, K; Pozzi, C; Catapano, AL				Baragetti, Ivano; Norata, Giuseppe Danilo; Sarcina, Cristina; Baragetti, Andrea; Rastelli, Francesco; Buzzi, Laura; Grigore, Liliana; Garlaschelli, Katia; Pozzi, Claudio; Catapano, Alberico Luigi			-374 T/A RAGE Polymorphism Is Associated with Chronic Kidney Disease Progression in Subjects Affected by Nephrocardiovascular Disease	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; TYPE-1 DIABETIC-PATIENTS; COMMON CAROTID-ARTERY; CHRONIC-RENAL-FAILURE; GENE-EXPRESSION; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE	Background: Chronic kidney disease (CKD) patients present elevated advanced glycation end products (AGEs) blood levels. AGEs promote inflammation through binding to their receptor (RAGE), located on the membrane of mesangial cells, endothelial cells and macrophages. Several genetic polymorphisms influence RAGE transcription, expression and activity, including the substitution of a thymine with an adenine (T/A) in the position -374 of the gene promoter of RAGE. Our study investigates the role of -374 T/A RAGE polymorphism in CKD progression in subjects affected by nephrocardiovascular disease. Methods: 174 patients (119 males (68.4%) mean age 67.2 +/- 0.88 years; 55 females (31.6%): mean age 65.4 +/- 1.50 years) affected by mild to moderate nephrocardiovascular CKD were studied. Each subject was prospectively followed for 84 months, every 6-9 months. The primary endpoint of the study was a rise of serum creatinine concentrations above 50% of basal values or end stage renal disease. Results: Carriers of the A/A and T/A genotype presented higher plasma levels of interleukin 6 (A/A 29.5 +/- 15.83; T/A 30.0 +/- 7.89, vs T/T 12.3 +/- 5.04 p = 0.01 for both) and Macrophages chemoattractant protein 1 (A/A 347.1 +/- 39.87; T/A 411.8 +/- 48.41, vs T/T 293.5 +/- 36.20, p = 0.04 for both) than T/T subjects. Carriers of the A allele presented a faster CKD progression than wild type patients (Log-Rank test: Chi square = 6.84, p = 0,03). Cox regression showed that -374 T/A RAGE polymorphism (p = 0.037), albuminuria (p = 0.01) and LDL cholesterol (p = 0.038) were directly associated with CKD progression. HDL cholesterol (p = 0.022) and BMI (p = 0.04) were inversely related to it. No relationship was found between circulating RAGE and renal function decline. Conclusions: -374 T/A RAGE polymorphism could be associated with CKD progression and inflammation. Further studies should confirm this finding and address whether inhibiting RAGE downstream signalling would be beneficial for CKD progression.	[Baragetti, Ivano; Sarcina, Cristina; Rastelli, Francesco; Buzzi, Laura; Pozzi, Claudio] Bassini Hosp, Nephrol & Dialysis Unit, Milan, Italy; [Norata, Giuseppe Danilo; Baragetti, Andrea; Catapano, Alberico Luigi] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Norata, Giuseppe Danilo; Baragetti, Andrea; Grigore, Liliana; Garlaschelli, Katia] Bassini Hosp, Ctr Study Atherosclerosis, Italian Soc Study Atherosclerosis SISA Lombard Ch, Milan, Italy; [Norata, Giuseppe Danilo] Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Grigore, Liliana; Catapano, Alberico Luigi] Multimed IRCCS, Milan, Italy	University of Milan; University of London; Queen Mary University London; IRCCS Multimedica	Baragetti, I (corresponding author), Bassini Hosp, Nephrol & Dialysis Unit, Milan, Italy.	ivano.baragetti@icp.mi.it; danilo.norata@unimi.it	Norata, Giuseppe Danilo/AAC-2863-2019; Catapano, alberico/AAC-2827-2019	Catapano, alberico/0000-0002-7593-2094; Norata, Giuseppe Danilo/0000-0002-6081-1257				Abdel-Azeez Hala A, 2009, Egypt J Immunol, V16, P95; Ammirati E, 2012, J AM HEART ASSOC, V1, P27, DOI 10.1161/JAHA.111.000125; Ammirati E, 2010, ARTERIOSCL THROM VAS, V30, P1832, DOI 10.1161/ATVBAHA.110.206813; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bianchi S, 2010, AM J KIDNEY DIS, V55, P671, DOI 10.1053/j.ajkd.2009.11.006; Bohlender JM, 2005, AM J PHYSIOL-RENAL, V289, pF645, DOI 10.1152/ajprenal.00398.2004; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Burton JO, 2012, NEPHROL DIAL TRANSPL, V27, P1860, DOI 10.1093/ndt/gfr574; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; dos Santos KG, 2005, MOL GENET METAB, V85, P149, DOI 10.1016/j.ymgme.2005.02.010; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; Falcone C, 2005, ARTERIOSCL THROM VAS, V25, P1032, DOI 10.1161/01.ATV.0000160342.20342.00; Falcone C, 2008, ARCH MED RES, V39, P320, DOI 10.1016/j.arcmed.2007.11.003; Fukami K, 2004, KIDNEY INT, V66, P2137, DOI 10.1111/j.1523-1755.2004.66004.x; Goolsby Mary Jo, 2002, J Am Acad Nurse Pract, V14, P238, DOI 10.1111/j.1745-7599.2002.tb00119.x; Grossin N, 2008, DIABETES METAB, V34, P392, DOI 10.1016/j.diabet.2008.04.003; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; IMANI F, 1993, J EXP MED, V178, P2165, DOI 10.1084/jem.178.6.2165; Kalea AZ, 2011, FRONT BIOSCI-LANDMRK, V16, P2756, DOI 10.2741/3884; Kang PP, 2012, GENE, V500, P1, DOI 10.1016/j.gene.2012.03.056; Kirbis J, 2004, COLLEGIUM ANTROPOL, V28, P611; KIRSTEIN M, 1992, J CLIN INVEST, V90, P439, DOI 10.1172/JCI115879; Kucukhuseyin O, 2009, IN VIVO, V23, P949; Lindholm E, 2006, DIABETOLOGIA, V49, P2745, DOI 10.1007/s00125-006-0412-3; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; MIMICOKA J, 1995, CLIN NEPHROL, V44, P44; Norata GD, 2010, NUTR METAB CARDIOVAS, V20, P56, DOI 10.1016/j.numecd.2009.01.011; Norata GD, 2006, STROKE, V37, P1558, DOI 10.1161/01.STR.0000221803.16897.22; Norata GD, 2005, CIRCULATION, V111, P2805, DOI 10.1161/CIRCULATIONAHA.104.472886; Norata GD, 2007, STROKE, V38, P2844, DOI 10.1161/STROKEAHA.107.485540; Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015; Norata GD, 2010, ATHEROSCLEROSIS, V208, P177, DOI 10.1016/j.atherosclerosis.2009.06.023; Norata GD, 2009, ATHEROSCLEROSIS, V206, P556, DOI 10.1016/j.atherosclerosis.2009.03.017; Norata GD, 2009, NUTR METAB CARDIOVAS, V19, P129, DOI 10.1016/j.numecd.2008.03.004; Pettersson-Fernholm K, 2003, DIABETES, V52, P891, DOI 10.2337/diabetes.52.3.891; Predazzi IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031086; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Rashid G, 2004, KIDNEY INT, V66, P1099, DOI 10.1111/j.1523-1755.2004.00860.x; REAICH D, 1995, AM J KIDNEY DIS, V26, P242, DOI 10.1016/0272-6386(95)90179-5; Vaziri ND, 2003, KIDNEY INT, V63, P179, DOI 10.1046/j.1523-1755.2003.00702.x; VLASSARA H, 1994, P NATL ACAD SCI USA, V91, P11704, DOI 10.1073/pnas.91.24.11704; WENDELHAG I, 1993, ARTERIOSCLER THROMB, V13, P1404, DOI 10.1161/01.ATV.13.10.1404; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Yamagishi S, 2003, KIDNEY INT, V63, P464, DOI 10.1046/j.1523-1755.2003.00752.x; Yamagishi SI, 2008, CURR PHARM DESIGN, V14, P487, DOI 10.2174/138161208783597416; Yamagishi SI, 2007, CURR DRUG TARGETS, V8, P952; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; YANG CW, 1994, P NATL ACAD SCI USA, V91, P9436, DOI 10.1073/pnas.91.20.9436; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	51	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60089	10.1371/journal.pone.0060089	http://dx.doi.org/10.1371/journal.pone.0060089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593165	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100017
J	Hu, YL; Tan, PT; Tan, TW; August, JT; Khan, AM				Hu, Yongli; Tan, Paul ThiamJoo; Tan, Tin Wee; August, J. Thomas; Khan, Asif M.			Dissecting the Dynamics of HIV-1 Protein Sequence Diversity	PLOS ONE			English	Article							ALTERED PEPTIDE LIGANDS; T-LYMPHOCYTE RESPONSES; ELITE CONTROLLERS; CELL RESPONSES; INFLUENZA-A; AIDS VIRUS; REPLICATION; EVOLUTION; IMMUNOGENS; EPITOPES	The rapid mutation of human immunodeficiency virus-type 1 (HIV-1) and the limited characterization of the composition and incidence of the variant population are major obstacles to the development of an effective HIV-1 vaccine. This issue was addressed by a comprehensive analysis of over 58,000 clade B HIV-1 protein sequences reported over at least 26 years. The sequences were aligned and the 2,874 overlapping nonamer amino acid positions of the viral proteome, each a possible core binding domain for human leukocyte antigen molecules and T-cell receptors, were quantitatively analyzed for four patterns of sequence motifs: (1) "index'', the most prevalent sequence; (2) "major'' variant, the most common variant sequence; (3) "minor'' variants, multiple different sequences, each with an incidence less than that of the major variant; and (4) "unique'' variants, each observed only once in the alignment. The collective incidence of the major, minor, and unique variants at each nonamer position represented the total variant population for the position. Positions with more than 50% total variants contained correspondingly reduced incidences of index and major variant sequences and increased minor and unique variants. Highly diverse positions, with 80 to 98% variant nonamer sequences, were present in each protein, including 5% of Gag, and 27% of Env and Nef, each. The multitude of different variant nonamer sequences (i.e. nonatypes; up to 68%) at the highly diverse positions, represented by the major, multiple minor, and multiple unique variants likely supported variants function both in immune escape and as altered peptide ligands with deleterious T-cell responses. The patterns of mutational change were consistent with the sequences of individual HXB2 and C1P viruses and can be considered applicable to all HIV-1 viruses. This characterization of HIV-1 protein mutation provides a foundation for the design of peptide-based vaccines and therapeutics.	[Hu, Yongli; August, J. Thomas; Khan, Asif M.] Perdana Univ, Grad Sch Med, Selangor Darul Ehsan, Malaysia; [Tan, Paul ThiamJoo; August, J. Thomas; Khan, Asif M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Hu, Yongli; Tan, Tin Wee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Tan, Paul ThiamJoo] Minist Hlth, Communicable Dis Div, Natl Publ Hlth Lab, Singapore, Singapore	Johns Hopkins University; National University of Singapore; Ministry of Health-Singapore	August, JT (corresponding author), Perdana Univ, Grad Sch Med, Selangor Darul Ehsan, Malaysia.	taugust@jhmi.edu; asif@perdanauniversity.edu.my	Khan, M. Asif/ABE-7839-2021; Tan, Tin Wee/B-8963-2009; Khan, Mohammad Asif/F-4663-2010	Khan, M. Asif/0000-0001-9202-279X; Tan, Tin Wee/0000-0002-4062-2854; Khan, Mohammad Asif/0000-0001-9202-279X	National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States of America [R37-AI41908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI041908] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grant R37-AI41908 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Almeida RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045267; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1998, NUMBERING POSITIONS; Autran B, 2011, CURR OPIN HIV AIDS, V6, P181, DOI 10.1097/COH.0b013e328345a328; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; BATSCHELET E, 1976, GENE, V1, P27, DOI 10.1016/0378-1119(76)90004-4; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; Blankson JN, 2010, DISCOV MED, V9, P261; Bouhdoud L, 2000, J VIROL, V74, P2121, DOI 10.1128/JVI.74.5.2121-2130.2000; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Brusic V, 1999, LETT PEPT SCI, V6, P313; Domingo E, 1997, REV MED VIROL, V7, P87, DOI 10.1002/(SICI)1099-1654(199707)7:2<87::AID-RMV188>3.0.CO;2-0; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Khan AM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S4; Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272; Kirksey TJ, 1999, J BIOL CHEM, V274, P37259, DOI 10.1074/jbc.274.52.37259; KLENERMAN P, 1995, EUR J IMMUNOL, V25, P1927, DOI 10.1002/eji.1830250720; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Koo QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005352; Kothe DL, 2006, VIROLOGY, V352, P438, DOI 10.1016/j.virol.2006.05.011; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Leitner T, 2005, HIV 1 SUBTYPE CIRCUL; Liu Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015639, 10.1371/journal.pone.0022241]; Malm M, 2005, VIRAL IMMUNOL, V18, P678, DOI 10.1089/vim.2005.18.678; McBurney SP, 2008, EXPERT REV VACCINES, V7, P1405, DOI 10.1586/14760584.7.9.1405; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Moschella F, 2003, HUM IMMUNOL, V64, P1, DOI 10.1016/S0198-8859(02)00783-8; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Purbhoo MA, 1998, P NATL ACAD SCI USA, V95, P4527, DOI 10.1073/pnas.95.8.4527; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; Sahu GK, 2010, J VIROL, V84, P8348, DOI 10.1128/JVI.00362-10; Sauce D, 2011, BLOOD, V117, P5142, DOI 10.1182/blood-2011-01-331306; Sewell AK, 1997, EUR J IMMUNOL, V27, P2323, DOI 10.1002/eji.1830270929; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson SA, 2005, VACCINE, V23, P4647, DOI 10.1016/j.vaccine.2005.04.045; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Tsukamoto T, 2009, J VIROL, V83, P9339, DOI 10.1128/JVI.01120-09; WAINHOBSON S, 1993, CURR OPIN GENET DEV, V3, P878, DOI 10.1016/0959-437X(93)90008-D; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Wucherpfennig KW, 2009, CURR OPIN IMMUNOL, V21, P590, DOI 10.1016/j.coi.2009.07.008; YOKOYAMA S, 1987, J MOL EVOL, V24, P330, DOI 10.1007/BF02134131	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e59994	10.1371/journal.pone.0059994	http://dx.doi.org/10.1371/journal.pone.0059994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593157	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100012
J	Barone, P; Lacassagne, L; Kral, A				Barone, Pascal; Lacassagne, Ludovic; Kral, Andrej			Reorganization of the Connectivity of Cortical Field DZ in Congenitally Deaf Cat	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; CROSS-MODAL PLASTICITY; POSTERIOR-PULVINAR COMPLEX; MEDIAL GENICULATE-BODY; POSITRON-EMISSION-TOMOGRAPHY; PRIMATE INFERIOR COLLICULUS; STRIATE-RECIPIENT ZONE; PRIMARY VISUAL-CORTEX; RETINOTOPIC ORGANIZATION; THALAMOCORTICAL CONNECTIONS	Psychophysics and brain imaging studies in deaf patients have revealed a functional crossmodal reorganization that affects the remaining sensory modalities. Similarly, the congenital deaf cat (CDC) shows supra-normal visual skills that are supported by specific auditory fields (DZ-dorsal zone and P-posterior auditory cortex) but not the primary auditory cortex (A1). To assess the functional reorganization observed in deafness we analyzed the connectivity pattern of the auditory cortex by means of injections of anatomical tracers in DZ and A1 in both congenital deaf and normally hearing cats. A quantitative analysis of the distribution of the projecting neurons revealed the presence of non-auditory inputs to both A1 and DZ of the CDC which were not observed in the hearing cats. Firstly, some visual (areas 19/20) and somatosensory (SIV) areas were projecting toward DZ of the CDC but not in the control. Secondly, A1 of the deaf cat received a weak projection from the visual lateral posterior nuclei (LP). Most of these abnormal projections to A1 and DZ represent only a small fraction of the normal inputs to these areas. In addition, most of the afferents to DZ and A1 appeared normal in terms of areal specificity and strength of projection, with preserved but smeared nucleotopic gradient of A1 in CDCs. In conclusion, while the abnormal projections revealed in the CDC can participate in the crossmodal compensatory mechanisms, the observation of a limited reorganization of the connectivity pattern of the CDC implies that functional reorganization in congenital deafness is further supported also by normal cortico-cortical connectivity.	[Barone, Pascal; Lacassagne, Ludovic] Univ Toulouse 3, CerCo, Univ Toulouse, F-31062 Toulouse, France; [Barone, Pascal; Lacassagne, Ludovic] CNRS, UMR 5549, Toulouse, France; [Kral, Andrej] Hannover Med Sch, Dept Expt Otol, Inst Audioneurotechnol, Lab Auditory Neurosci, Hannover, Germany; [Kral, Andrej] Univ Clin Hamburg Eppendorf, Lab Auditory Neurosci, Inst Neurophysiol, Hamburg, Germany	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Barone, P (corresponding author), Univ Toulouse 3, CerCo, Univ Toulouse, F-31062 Toulouse, France.	pascal.barone@cerco.ups-tlse.fr	BARONE, Pascal/AHE-2323-2022; Barone, Pascal/A-4008-2009	BARONE, Pascal/0000-0003-0125-7468; Kral, Andrej/0000-0002-7762-4642	ANR Hearing Loss [ANR-06-Neuro-021-04]; la Federation pour la Recherche sur le Cerveau; BQR ATUPS program of the Universite P. Sabatier; CNRS; Deutsche Forschungsgemeinschaft [Kr 3370]	ANR Hearing Loss(French National Research Agency (ANR)); la Federation pour la Recherche sur le Cerveau; BQR ATUPS program of the Universite P. Sabatier; CNRS(Centre National de la Recherche Scientifique (CNRS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the the ANR Hearing Loss (ANR-06-Neuro-021-04) to LL and PB, la Federation pour la Recherche sur le Cerveau (to BP), the BQR ATUPS program of the Universite P. Sabatier (to LL), the recurrent funding of the CNRS (BP) and Deutsche Forschungsgemeinschaft (Kr 3370 and cluster of excellence Hearing4all to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman BL, 2009, P NATL ACAD SCI USA, V106, P5925, DOI 10.1073/pnas.0809483106; ANDERSEN RA, 1980, J COMP NEUROL, V194, P663, DOI 10.1002/cne.901940312; ASANUMA C, 1990, NEUROSCIENCE, V39, P533, DOI 10.1016/0306-4522(90)90241-U; Auer ET, 2007, NEUROREPORT, V18, P645, DOI 10.1097/WNR.0b013e3280d943b9; Banks MI, 2011, AUDITORY CORTEX, P75, DOI 10.1007/978-1-4419-0074-6_3; Barone P., 1996, Society for Neuroscience Abstracts, V22, P1016; Barone P, 2000, J NEUROSCI, V20, P3263, DOI 10.1523/JNEUROSCI.20-09-03263.2000; BARONE P, 1995, CEREB CORTEX, V5, P22, DOI 10.1093/cercor/5.1.22; Barone P, 1996, J COMP NEUROL, V374, P1, DOI 10.1002/(SICI)1096-9861(19961007)374:1<1::AID-CNE1>3.0.CO;2-7; Barone P., 1997, Society for Neuroscience Abstracts, V23, P1993; Batardiere A, 2002, CEREB CORTEX, V12, P453, DOI 10.1093/cercor/12.5.453; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; BERSON DM, 1983, NEUROSCIENCE, V9, P337, DOI 10.1016/0306-4522(83)90299-3; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; BRANDNER S, 1990, J NEUROSCI, V10, P50; CAMPBELL A, 1978, J COMP PHYSIOL PSYCH, V92, P45, DOI 10.1037/h0077442; Capek CM, 2008, NEUROPSYCHOLOGIA, V46, P1233, DOI 10.1016/j.neuropsychologia.2007.11.026; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; CATALANAHUMADA M, 1993, BRAIN RES, V623, P287, DOI 10.1016/0006-8993(93)91439-Y; CAVADA C, 1983, BRAIN RES, V270, P319, DOI 10.1016/0006-8993(83)90606-6; Chabot N, 2008, NEUROSCI LETT, V433, P129, DOI 10.1016/j.neulet.2008.01.003; CHALUPA LM, 1991, J COGNITIVE NEUROSCI, V3, P209, DOI 10.1162/jocn.1991.3.3.209; CHALUPA LM, 1989, J NEUROSCI, V9, P347; CHALUPA LM, 1978, EXP NEUROL, V61, P96, DOI 10.1016/0014-4886(78)90184-X; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CLAREY JC, 1990, J COMP NEUROL, V301, P289, DOI 10.1002/cne.903010211; Clarey JC, 1992, MAMMALIAN AUDITORY P, P232, DOI [10.1007/978-1-4612-2838-7_5, DOI 10.1007/978-1-4612-2838-7_5]; Clemo HR, 2004, SOMATOSENS MOT RES, V21, P199, DOI 10.1080/08990220400012505; CLEMO HR, 1983, J NEUROPHYSIOL, V50, P910, DOI 10.1152/jn.1983.50.4.910; CLEMO HR, 1982, BRAIN RES, V235, P162; Codina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020417; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Collignon O, 2011, PROG BRAIN RES, V191, P211, DOI 10.1016/B978-0-444-53752-2.00003-5; CORNWELL P, 1981, J COMP PHYSIOL PSYCH, V95, P603, DOI 10.1037/h0077799; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; DEGGOUJ N, 1995, ADV OTO-RHINO-LARYNG, V50, P31; Dehay C, 1996, J COMP NEUROL, V376, P386, DOI 10.1002/(SICI)1096-9861(19961216)376:3<386::AID-CNE3>3.0.CO;2-Z; Dehay C, 1996, J COMP NEUROL, V367, P70, DOI 10.1002/(SICI)1096-9861(19960325)367:1<70::AID-CNE6>3.0.CO;2-G; Doubell TP, 2000, EUR J NEUROSCI, V12, P4290, DOI 10.1046/j.1460-9568.2000.01337.x; Falchier A, 2010, CEREB CORTEX, V20, P1529, DOI 10.1093/cercor/bhp213; Fallon JB, 2009, J COMP NEUROL, V512, P101, DOI 10.1002/cne.21886; FALLON JH, 1977, NEUROSCI LETT, V6, P143, DOI 10.1016/0304-3940(77)90009-X; Finney EM, 2003, NEUROREPORT, V14, P1425, DOI 10.1097/00001756-200308060-00004; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Fonta C, 2004, CEREB CORTEX, V14, P595, DOI 10.1093/cercor/bhh021; GRANT S, 1991, VISUAL NEUROSCI, V6, P315, DOI 10.1017/S0952523800006568; GRAYBIEL AM, 1980, NEUROSCIENCE, V5, P1175, DOI 10.1016/0306-4522(80)90196-7; Groh JM, 2001, NEURON, V29, P509, DOI 10.1016/S0896-6273(01)00222-7; Hamilton R, 2000, NEUROREPORT, V11, P237, DOI 10.1097/00001756-200002070-00003; Hartmann R, 1997, HEARING RES, V112, P115, DOI 10.1016/S0378-5955(97)00114-7; He JF, 1997, J NEUROSCI, V17, P2615; He JF, 1998, J COMP NEUROL, V400, P334, DOI 10.1002/(SICI)1096-9861(19981026)400:3<334::AID-CNE4>3.0.CO;2-9; Horng SH, 2006, PROG BRAIN RES, V157, P3, DOI 10.1016/S0079-6123(06)57001-3; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Huberman AD, 2005, J NEUROSCI, V25, P4014, DOI 10.1523/JNEUROSCI.4292-04.2005; Hunt DL, 2006, NEUROSCIENCE, V139, P1507, DOI 10.1016/j.neuroscience.2006.01.023; IMIG TJ, 1984, J COMP NEUROL, V227, P511, DOI 10.1002/cne.902270405; IMIG TJ, 1985, J NEUROPHYSIOL, V53, P309, DOI 10.1152/jn.1985.53.1.309; IMIG TJ, 1980, J COMP NEUROL, V192, P293, DOI 10.1002/cne.901920208; INNOCENTI GM, 1988, J COMP NEUROL, V272, P242, DOI 10.1002/cne.902720207; ITAYA SK, 1982, BRAIN RES, V233, P45, DOI 10.1016/0006-8993(82)90928-3; JIANG H, 1994, EXP BRAIN RES, V97, P404; JOSEPH JP, 1986, EXP BRAIN RES, V62, P355; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; KAWAMURA K, 1971, ACTA ANAT, V80, P204; Klinge C, 2010, J NEUROSCI, V30, P12798, DOI 10.1523/JNEUROSCI.2384-10.2010; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kok MA, 2012, AMPLIFIED EXTRASTRIA; KORTE M, 1993, J NEUROPHYSIOL, V70, P1717, DOI 10.1152/jn.1993.70.4.1717; Kral A, 2005, CEREB CORTEX, V15, P552, DOI 10.1093/cercor/bhh156; Kral A, 2003, EXP BRAIN RES, V153, P605, DOI 10.1007/s00221-003-1609-z; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; Kral A, 2002, CEREB CORTEX, V12, P797, DOI 10.1093/cercor/12.8.797; Kral A, 2006, PROG BRAIN RES, V157, P283, DOI 10.1016/S0079-6123(06)57018-9; Kral A, 2009, J NEUROSCI, V29, P811, DOI 10.1523/JNEUROSCI.2424-08.2009; KUCHIIWA S, 1985, EXP BRAIN RES, V60, P179; Kujala T, 2000, TRENDS NEUROSCI, V23, P115, DOI 10.1016/S0166-2236(99)01504-0; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Lee CC, 2004, NEUROSCIENCE, V128, P871, DOI 10.1016/j.neuroscience.2004.06.062; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Lee CC, 2008, J COMP NEUROL, V507, P1920, DOI 10.1002/cne.21613; Lee CC, 2013, JARO-J ASSOC RES OTO, V14, P61, DOI 10.1007/s10162-012-0357-9; Lomber SG, 1996, CEREB CORTEX, V6, P673, DOI 10.1093/cercor/6.5.673; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; MAIRELEPOIVRE E, 1986, BEHAV BRAIN RES, V22, P53, DOI 10.1016/0166-4328(86)90080-X; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Markov NT, 2010, PRENATAL ENUCLEATION; Mellott JG, 2010, HEARING RES, V267, P119, DOI 10.1016/j.heares.2010.04.003; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; Meredith MA, 2011, P NATL ACAD SCI USA, V108, P8856, DOI 10.1073/pnas.1018519108; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; MIDDLEBROOKS JC, 1983, J NEUROSCI, V3, P203; MOREL A, 1987, J COMP NEUROL, V265, P119, DOI 10.1002/cne.902650109; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; OLSON CR, 1987, J COMP NEUROL, V261, P277, DOI 10.1002/cne.902610209; PALLAS SL, 1990, J COMP NEUROL, V298, P50, DOI 10.1002/cne.902980105; PALMER LA, 1978, J COMP NEUROL, V177, P237, DOI 10.1002/cne.901770205; PALOFF AM, 1985, NEUROSCI LETT, V54, P339, DOI 10.1016/S0304-3940(85)80101-4; Park MH, 2010, BRAIN RES, V1354, P85, DOI 10.1016/j.brainres.2010.07.105; Pavani F, 2011, FRONTIERS N IN PRESS; Porter KK, 2006, J NEUROPHYSIOL, V95, P1826, DOI 10.1152/jn.00857.2005; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Ptito M, 2001, PROG BRAIN RES, V134, P447; Raggio MW, 2003, J NEUROPHYSIOL, V89, P3190, DOI 10.1152/jn.00341.2002; RAUSCHECKER JP, 1987, EXP BRAIN RES, V67, P100, DOI 10.1007/BF00269458; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Read HL, 2011, HEARING RES, V274, P95, DOI 10.1016/j.heares.2010.11.010; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; REBILLARD G, 1977, BRAIN RES, V129, P162, DOI 10.1016/0006-8993(77)90980-5; Roder B., 2004, HDB MULTISENSORY PRO, P719; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Scannell JW, 2000, PHILOS T ROY SOC B, V355, P21, DOI 10.1098/rstb.2000.0547; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Schofield BR, 2007, NEUROSCIENCE, V146, P773, DOI 10.1016/j.neuroscience.2007.02.026; Sharpee TO, 2011, CURR OPIN NEUROBIOL, V21, P761, DOI 10.1016/j.conb.2011.05.027; Stanton SG, 2000, J COMP NEUROL, V426, P117, DOI 10.1002/1096-9861(20001009)426:1<117::AID-CNE8>3.0.CO;2-S; Stecker GC, 2005, J NEUROPHYSIOL, V94, P1267, DOI 10.1152/jn.00104.2005; Steriade M, 1997, THALAMUS, VI; STEWART DL, 1970, EXP NEUROL, V28, P525, DOI 10.1016/0014-4886(70)90190-1; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; SYMONDS LL, 1984, J COMP NEUROL, V229, P1, DOI 10.1002/cne.902290103; TUSA RJ, 1980, J COMP NEUROL, V193, P147, DOI 10.1002/cne.901930110; UPDYKE BV, 1981, J COMP NEUROL, V201, P477, DOI 10.1002/cne.902010403; UPDYKE BV, 1986, J COMP NEUROL, V246, P265, DOI 10.1002/cne.902460210; Van der Gucht E, 2001, J COMP NEUROL, V441, P345, DOI 10.1002/cne.1416; Velenovsky DS, 2003, J NEUROSCI, V23, P308; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Winer JA, 2007, HEARING RES, V229, P3, DOI 10.1016/j.heares.2007.01.017; Wong M, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00052; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; YIN TCT, 1992, EXP BRAIN RES, V88, P15, DOI 10.1007/BF02259125; Zwiers MP, 2004, J NEUROSCI, V24, P4145, DOI 10.1523/JNEUROSCI.0199-04.2004	139	73	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60093	10.1371/journal.pone.0060093	http://dx.doi.org/10.1371/journal.pone.0060093			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593166	gold, Green Submitted, Green Published			2022-12-27	WOS:000317385300010
J	Tang, XY; Liu, G; Kang, J; Hou, Y; Jiang, FG; Yuan, W; Shi, JG				Tang, Xianye; Liu, Gang; Kang, Jian; Hou, Yang; Jiang, Fungui; Yuan, Wen; Shi, Jiangang			Obesity and Risk of Hip Fracture in Adults: A Meta-Analysis of Prospective Cohort Studies	PLOS ONE			English	Article							BODY-MASS-INDEX; BONE-MINERAL DENSITY; PHYSICAL-ACTIVITY; NORWEGIAN WOMEN; OLDER; ASSOCIATION; OUTCOMES; MEN; BMD	Background: Many observational studies assessed the association between obesity and risk of hip fracture in adults, but reported controversial results. Our goal was to evaluate the association between obesity and risk of hip fracture in adults by conducting a meta-analysis of prospective cohort studies. Methods: Three databases, PubMed, Embase and Web of Science, were searched through May 2012 to identify eligible cohort studies. Either a fixed-or a random-effects model was used to calculate the pooled relative risk (RR) with its 95% confidence interval (95% CI). Results: Fifteen prospective cohort studies involving a total 3,126,313 participants were finally included into this meta-analysis. Overall, adults with obesity compared with the normal weight group had a significantly decreased risk of hip fracture (RR: 0.66, 95% CI 0.57 to 0.77, P<0.001). Meta-analyses by the adjusted status of RRs also suggested adults with obesity compared with the reference group had a significantly decreased risk of hip fracture (adjusted RR: 0.48, 95% CI 0.39 to 0.58, P<0.001; unadjusted RR: 0.66, 95% CI 0.56 to 0.78, P<0.001). Subgroup analyses by gender suggested individuals with obesity had a significantly decreased risk for developing hip fracture compared with the reference group in both men (RR 0.54, 95% CI 0.48 to 0.60, P<0.001) and women (RR 0.70, 95% CI 0.58 to 0.84, P, <0.001). No evidence of publication bias was observed in this meta-analysis. Conclusions: This meta-analysis of prospective cohort studies suggests that obesity significantly decreases the risk of hip fracture in adults, and obesity is probably a protective factor of hip fracture in adults.	[Tang, Xianye; Liu, Gang; Kang, Jian; Hou, Yang; Yuan, Wen; Shi, Jiangang] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed, Shanghai, Peoples R China; [Jiang, Fungui] Peoples Hosp Wujiang City, Dept Orthopaed, Wujiang, Peoples R China	Naval Medical University	Yuan, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed, Shanghai, Peoples R China.	wenyuancz19@yahoo.com; fuguidoctor@yahoo.com						Armstrong MEG, 2011, J BONE MINER RES, V26, P1330, DOI 10.1002/jbmr.315; Beck TJ, 2009, J BONE MINER RES, V24, P1369, DOI [10.1359/JBMR.090307, 10.1359/jbmr.090307]; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benetou V, 2011, INJURY, V42, P188, DOI 10.1016/j.injury.2010.08.022; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Chudyk AM, 2012, CLIN RHEUMATOL, V31, P749, DOI 10.1007/s10067-012-1970-z; Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimitri P, 2012, BONE, V50, P457, DOI 10.1016/j.bone.2011.05.011; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fernandez-Ruiz M, 2011, INTERN EMERG MED; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Haara M, 2006, ACTA ORTHOP, V77, P9, DOI 10.1080/17453670610045632; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hartholt KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022227; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; LaFleur J, 2011, J BONE MINER METAB, V29, P193, DOI 10.1007/s00774-010-0207-y; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; MEYER HE, 1995, EPIDEMIOLOGY, V6, P299, DOI 10.1097/00001648-199505000-00019; MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nasser KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028042; Nielson CM, 2011, J BONE MINER RES, V26, P496, DOI 10.1002/jbmr.235; Orwig DL, 2006, ORTHOP CLIN N AM, V37, P611, DOI 10.1016/j.ocl.2006.08.003; Ottenbacher KJ, 2002, J GERONTOL A-BIOL, V57, pM648, DOI 10.1093/gerona/57.10.M648; Plourde G, 2012, CAN MED ASSOC J, V184, P1039, DOI 10.1503/cmaj.111640; Prieto-Alhambra D, 2012, J BONE MINER RES, V27, P294, DOI 10.1002/jbmr.1466; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Shapses SA, 2012, ANNU REV NUTR, V32, P287, DOI 10.1146/annurev.nutr.012809.104655; Sienkiewicz E, 2011, METABOLISM, V60, P1211, DOI 10.1016/j.metabol.2011.05.016; Stolee P, 2009, J GERONTOL A-BIOL, V64, P403, DOI 10.1093/gerona/gln035; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Visschedijk J, 2010, J AM GERIATR SOC, V58, P1739, DOI 10.1111/j.1532-5415.2010.03036.x; Wells G, 2012, NEWSCASTLE OTTAWA SC; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	42	97	100	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e55077	10.1371/journal.pone.0055077	http://dx.doi.org/10.1371/journal.pone.0055077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593112	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300001
J	Vahl, WK; Boiteau, G; de Heij, ME; MacKinley, PD; Kokko, H				Vahl, Wouter K.; Boiteau, Gilles; de Heij, Maaike E.; MacKinley, Pamela D.; Kokko, Hanna			Female Fertilization: Effects of Sex-Specific Density and Sex Ratio Determined Experimentally for Colorado Potato Beetles and Drosophila Fruit Flies	PLOS ONE			English	Article							MATING KINETICS; COLEOPTERA; CHRYSOMELIDAE; REPRODUCTION; SELECTION; POPULATIONS; HARASSMENT; DISPERSAL; EVOLUTION; CONFLICT	If males and females affect reproduction differentially, understanding and predicting sexual reproduction requires specification of response surfaces, that is, two-dimensional functions that relate reproduction to the (numeric) densities of both sexes. Aiming at rigorous measurement of female per capita fertilization response surfaces, we conducted a multifactorial experiment and reanalyzed an extensive data set. In our experiment, we varied the density of male and female Leptinotarsa decemlineata (Colorado potato beetles) by placing different numbers of the two sexes on enclosed Solanum tuberosum (potato plants) to determine the proportion of females fertilized after 3 or 22 hours. In the reanalysis, we investigated how the short-term fertilization probability of three Drosophila strains (melanogaster ebony, m. sepia, and simulans) depended on adult sex ratio (proportion of males) and total density. The fertilization probability of female Leptinotarsa decemlineata increased logistically with male density, but not with female density. These effects were robust to trial duration. The fertilization probability of female Drosophila increased logistically with both sex ratio and total density. Treatment effects interacted in m. sepia, and simulans. These findings highlight the importance of well-designed, multifactorial experiments and strengthen previous experimental evidence for the relevance of sex-specific densities to understanding and prediction of female fertilization probability.	[Vahl, Wouter K.; Kokko, Hanna] Univ Helsinki, Dept Biosci, Lab Ecol & Evolutionary Dynam, Helsinki, Finland; [Kokko, Hanna] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Boiteau, Gilles; MacKinley, Pamela D.] Agr & Agri Food Canada, Fredericton, NB, Canada; [de Heij, Maaike E.] Univ Helsinki, Dept Biosci, Bird Ecol Unit, Helsinki, Finland	University of Helsinki; Australian National University; Agriculture & Agri Food Canada; University of Helsinki	Vahl, WK (corresponding author), Univ Helsinki, Dept Biosci, Lab Ecol & Evolutionary Dynam, Helsinki, Finland.	w.k.vahl@gmail.com	Kokko, Hanna/C-7861-2009	Kokko, Hanna/0000-0002-5772-4881	Academy of Finland; Agriculture and Agri-Food Canada	Academy of Finland(Academy of Finland); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	WKV, MEH, and HK acknowledge financial support from the Academy of Finland. GB and PM acknowledge financial support from Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin AV, 1999, ENVIRON ENTOMOL, V28, P425, DOI 10.1093/ee/28.3.425; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; ARNQVIST G, 1992, ANIM BEHAV, V43, P559, DOI 10.1016/S0003-3472(05)81016-4; Ashman TL, 2001, AM NAT, V157, P334, DOI 10.1086/319192; Bates D, 2012, LME4 LINEAR MIXED EF; BOITEAU G, 1986, ENVIRON ENTOMOL, V15, P311, DOI 10.1093/ee/15.2.311; Boiteau G, 2005, ENVIRON ENTOMOL, V34, P446, DOI 10.1603/0046-225X-34.2.446; Boiteau G, 2001, ENVIRON ENTOMOL, V30, P306, DOI 10.1603/0046-225X-30.2.306; BOITEAU G, 1988, ENTOMOL EXP APPL, V47, P183, DOI 10.1007/BF00367485; Boiteau G., 1992, AGR CANADA PUBLICATI, V1878/ E; BROWER JH, 1975, ANN ENTOMOL SOC AM, V68, P847, DOI 10.1093/aesa/68.5.847; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Castillo RA, 2002, J EVOLUTION BIOL, V15, P544, DOI 10.1046/j.1420-9101.2002.00425.x; Caswell H, 2001, MATRIX POPULATION MO, P568; Collett D, 2003, C&H TEXT STAT SCI, P45; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Cox D. R., 1958, PLANNING EXPT; Dennis B, 1989, NAT RESOUR MODEL, V3, P418; DOWSE HB, 1986, J THEOR BIOL, V121, P173, DOI 10.1016/S0022-5193(86)80091-1; Dreiss AN, 2010, BEHAV ECOL, V21, P356, DOI 10.1093/beheco/arp198; Gibson A, 1925, BULLETIN, V52; HU C, 1986, J APPL ENTOMOL, V101, P525, DOI 10.1111/j.1439-0418.1986.tb00886.x; Inouye BD, 2001, ECOLOGY, V82, P2696, DOI 10.2307/2679954; Khalfalla M. M., 2008, From the pharaohs to the future. Eighth International Symposium on Tilapia in Aquaculture. Proceedings. Cairo, Egypt, 12-14 October, 2008, P115; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; McCauley DE, 1998, EVOLUTION, V52, P30, DOI 10.1111/j.1558-5646.1998.tb05135.x; Meier CM, 2011, OIKOS, V120, P1459, DOI 10.1111/j.1600-0706.2011.19487.x; Michalczyk L, 2011, EVOLUTION, V65, P713, DOI 10.1111/j.1558-5646.2010.01174.x; Miller TEX, 2011, ECOLOGY, V92, P2141, DOI 10.1890/11-0028.1; Montgomery D., 2001, DESIGN ANAL EXPT, V5th; Noronha C, 1999, CAN ENTOMOL, V131, P521, DOI 10.4039/Ent131521-4; Park T, 1933, J EXP ZOOL, V65, P17, DOI 10.1002/jez.1400650103; Peckarsky Barbara L., 1998, P311; Powell Jeff R., 2003, Proceedings of the Entomological Society of Manitoba, V59, P16; Proell J.M., 2009, THESIS KENT STATE U; R Development Core Team, 2012, R LANG ENV STAT; Radtke MG, 2002, J INSECT PHYSIOL, V48, P1087, DOI 10.1016/S0022-1910(02)00201-9; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Rhainds M, 2013, ENTOMOL EXP APPL, V146, P123, DOI 10.1111/j.1570-7458.2012.01224.x; Rhainds M, 2010, ENTOMOL EXP APPL, V136, P211, DOI 10.1111/j.1570-7458.2010.01032.x; ROBINSON AS, 1980, Z ANGEW ENTOMOL, V90, P82; Rossi BH, 2010, ANIM BEHAV, V79, P165, DOI 10.1016/j.anbehav.2009.10.023; Sandeson PD, 2004, ENVIRON ENTOMOL, V33, P1421, DOI 10.1603/0046-225X-33.5.1421; Sandeson PD, 2002, ENVIRON ENTOMOL, V31, P533, DOI 10.1603/0046-225X-31.3.533; SIH A, 1995, BEHAV ECOL, V6, P316, DOI 10.1093/beheco/6.3.316; Smith CC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1349, DOI 10.1007/s00265-007-0365-7; TILBROOK AJ, 1987, APPL ANIM BEHAV SCI, V18, P173, DOI 10.1016/0168-1591(87)90191-2; Tobin PC, 2013, ENTOMOL EXP APPL, V146, P103, DOI 10.1111/j.1570-7458.2012.01299.x; Tu YK, 2005, BRIT DENT J, V199, P457, DOI 10.1038/sj.bdj.4812743; Underwood N, 2005, OECOLOGIA, V145, P177, DOI 10.1007/s00442-005-0057-9; Utida S., 1947, Seiri-Seitai (Phys & Ecol) Kyoto, V1, P67; Valosaari KR, 2008, ANN ZOOL FENN, V45, P1; WALLACE B, 1985, BEHAV SCI, V30, P149, DOI 10.1002/bs.3830300305; WALLACE B, 1990, BEHAV GENET, V20, P405, DOI 10.1007/BF01065566	54	9	9	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60381	10.1371/journal.pone.0060381	http://dx.doi.org/10.1371/journal.pone.0060381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593206	Green Submitted, gold, Green Published			2022-12-27	WOS:000317385300015
J	Griguer, CE; Cantor, AB; Fathallah-Shaykh, HM; Gillespie, GY; Gordon, AS; Markert, JM; Radovanovic, I; Clement-Schatlo, V; Shannon, CN; Oliva, CR				Griguer, Corinne E.; Cantor, Alan B.; Fathallah-Shaykh, Hassan M.; Gillespie, G. Yancey; Gordon, Amber S.; Markert, James M.; Radovanovic, Ivan; Clement-Schatlo, Virginie; Shannon, Chevis N.; Oliva, Claudia R.			Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; MOLECULAR EVOLUTION; MITOCHONDRIAL-FUNCTION; SUBUNIT; GENE; CELL; METHYLTRANSFERASE; TEMOZOLOMIDE; CAPACITY; GLIOMAS	Patients with primary glioblastoma multiforme (GBM) have one of the lowest overall survival rates among cancer patients, and reliable biomarkers are necessary to predict patient outcome. Cytochrome c oxidase (CcO) promotes the switch from glycolytic to OXPHOS metabolism, and increased CcO activity in tumors has been associated with tumor progression after chemotherapy failure. Thus, we investigated the relationship between tumor CcO activity and the survival of patients diagnosed with primary GBM. A total of 84 patients with grade IV glioma were evaluated in this retrospective cohort study. Cumulative survival was calculated by the Kaplan-Meier method and analyzed by the log-rank test, and univariate and multivariate analyses were performed with the Cox regression model. Mitochondrial CcO activity was determined by spectrophotometrically measuring the oxidation of cytochrome c. High CcO activity was detected in a subset of glioma tumors (similar to 30%), and was an independent prognostic factor for shorter progression-free survival and overall survival [P = 0.0087 by the log-rank test, hazard ratio = 3.57 for progression-free survival; P < 0.001 by the log-rank test, hazard ratio = 10.75 for overall survival]. The median survival time for patients with low tumor CcO activity was 14.3 months, compared with 6.3 months for patients with high tumor CcO activity. High CcO activity occurs in a significant subset of high-grade glioma patients and is an independent predictor of poor outcome. Thus, CcO activity may serve as a useful molecular marker for the categorization and targeted therapy of GBMs.	[Griguer, Corinne E.; Gillespie, G. Yancey; Gordon, Amber S.; Markert, James M.; Shannon, Chevis N.; Oliva, Claudia R.] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA; [Cantor, Alan B.] Univ Alabama Birmingham, Dept Med, Div Preventat Med, Birmingham, AL 35294 USA; [Radovanovic, Ivan; Clement-Schatlo, Virginie] Univ Hosp Geneva, Div Neurosurg, Geneva, Switzerland; [Radovanovic, Ivan; Clement-Schatlo, Virginie] Univ Geneva, Geneva, Switzerland	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Geneva; University of Geneva	Griguer, CE (corresponding author), Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA.	cgriguer@uab.edu		Fathallah-Shaykh, Hassan/0000-0002-2690-7685; Gillespie, George/0000-0001-6436-9542; , Corinne/0000-0003-3877-5031; Oliva, Claudia/0000-0003-0624-5490	National Cancer Institute; National Institute of General Medical Sciences, National Institutes of Health [HHSN261200800001E, R21CA139290, R01CA160821, P50 CA097247, P20 CA151129, R01GM096191]; Alabama Drug Discovery Alliance; University of Alabama at Birmingham Center for Clinical and Translational Science from the National Center for Advancing Translational Sciences [UL1TR000165]; National Center for Research Resources; NATIONAL CANCER INSTITUTE [R01CA160821, P20CA151129, P50CA097247, R21CA139290] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096191] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alabama Drug Discovery Alliance; University of Alabama at Birmingham Center for Clinical and Translational Science from the National Center for Advancing Translational Sciences; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in whole or in part with Federal Funds from the National Cancer Institute and National Institute of General Medical Sciences, National Institutes of Health, under Contract No. HHSN261200800001E (GYG) and Award Numbers R21CA139290 and R01CA160821 (CEG), Award Numbers P50 CA097247 and P20 CA151129 (GYG), R01GM096191 (HF-S), Award from Alabama Drug Discovery Alliance and the University of Alabama at Birmingham Center for Clinical and Translational Science UL1TR000165 from the National Center for Advancing Translational Sciences and National Center for Research Resources (CEG). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health and the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Campian JL, 2007, J BIOL CHEM, V282, P12430, DOI 10.1074/jbc.M604547200; Esteller M, 1999, CANCER RES, V59, P793; Fern R, 2003, J NEUROSCI RES, V71, P759, DOI 10.1002/jnr.10553; Grossman LI, 1997, BBA-GENE STRUCT EXPR, V1352, P174, DOI 10.1016/S0167-4781(97)00025-0; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Huttemann M, 2000, BBA-GENE STRUCT EXPR, V1492, P252, DOI 10.1016/S0167-4781(00)00087-7; JONES DP, 1979, BIOCHIM BIOPHYS ACTA, V576, P17, DOI 10.1016/0005-2795(79)90480-X; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; KENNEDY FG, 1986, AM J PHYSIOL, V250, pC374, DOI 10.1152/ajpcell.1986.250.3.C374; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Oliva CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024665; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Santandreu FM, 2008, CELL PHYSIOL BIOCHEM, V22, P757, DOI 10.1159/000185559; Schmidt TR, 1997, MOL BIOL EVOL, V14, P595, DOI 10.1093/oxfordjournals.molbev.a025798; Seelan RS, 1997, J BIOL CHEM, V272, P10175, DOI 10.1074/jbc.272.15.10175; Shi J, 2012, AM J CANCER RES, V2, P116; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Wu W, 1997, J MOL EVOL, V44, P477, DOI 10.1007/PL00006172; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	23	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61035	10.1371/journal.pone.0061035	http://dx.doi.org/10.1371/journal.pone.0061035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593382	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000039
J	Han, NY; Mu, YG				Han, Nanyu; Mu, Yuguang			Plasticity of 150-Loop in Influenza Neuraminidase Explored by Hamiltonian Replica Exchange Molecular Dynamics Simulations	PLOS ONE			English	Article							RATIONAL DESIGN; POTENT; INHIBITORS; EVOLUTION; DISCOVERY; PROTEINS	Neuraminidase (NA) of influenza is a key target for antiviral inhibitors, and the 150-cavity in group-1 NA provides new insight in treating this disease. However, NA of 2009 pandemic influenza (09N1) was found lacking this cavity in a crystal structure. To address the issue of flexibility of the 150-loop, Hamiltonian replica exchange molecular dynamics simulations were performed on different groups of NAs. Free energy landscape calculated based on the volume of 150-cavity indicates that 09N1 prefers open forms of 150-loop. The turn A (residues 147-150) of the 150-loop is discovered as the most dynamical motif which induces the inter-conversion of this loop among different conformations. In the turn A, the backbone dynamic of residue 149 is highly related with the shape of 150-loop, thus can function as a marker for the conformation of 150-loop. As a contrast, the closed conformation of 150-loop is more energetically favorable in N2, one of group-2 NAs. The D147-H150 salt bridge is found having no correlation with the conformation of 150-loop. Instead the intimate salt bridge interaction between the 150 and 430 loops in N2 variant contributes the stabilizing factor for the closed form of 150-loop. The clustering analysis elaborates the structural plasticity of the loop. This enhanced sampling simulation provides more information in further structural-based drug discovery on influenza virus.	[Han, Nanyu; Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mu, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	ygmu@ntu.edu.sg			IDA Cloud Computing Call for Project Proposals; MOE NTU Tier 1 grant [RG23/11]	IDA Cloud Computing Call for Project Proposals; MOE NTU Tier 1 grant	This work is partially supported by the IDA Cloud Computing Call for Project Proposals 2012 and MOE NTU Tier 1 grant RG23/11. We also thank Ping Jiang for her helpful discussions.	Amaro RE, 2007, J AM CHEM SOC, V129, P7764, DOI 10.1021/ja0723535; Amaro RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1390; Amaro RE, 2009, J AM CHEM SOC, V131, P4702, DOI 10.1021/ja8085643; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Bu ZM, 2011, ADV PROTEIN CHEM STR, V83, P163, DOI 10.1016/B978-0-12-381262-9.00005-7; Chachra R, 2008, J CHEM THEORY COMPUT, V4, P1526, DOI 10.1021/ct800068v; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Duan S, 2011, ANTIMICROB AGENTS CH, V55, P4718, DOI 10.1128/AAC.00316-11; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Fauci AS, 2006, EMERG INFECT DIS, V12, P73; Grienke U, 2010, J MED CHEM, V53, P778, DOI 10.1021/jm901440f; Han NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044057; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Landon MR, 2008, CHEM BIOL DRUG DES, V71, P106, DOI 10.1111/j.1747-0285.2007.00614.x; Li QL, 2010, CONSTRUCTIVE COMPUTATION IN STOCHASTIC MODELS WITH APPLICATIONS: THE RG-FACTORIZATION, P1; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Mu YG, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3120483; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nistal-Villan E, 2009, NAT MED, V15, P1253, DOI 10.1038/nm1109-1253; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rudrawar S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1114; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Simmerling C, 1998, J AM CHEM SOC, V120, P5771, DOI 10.1021/ja972457n; van der Vries E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002914; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang MY, 2011, J VIROL, V85, P8431, DOI 10.1128/JVI.00638-11; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu WX, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2911693; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08	41	22	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60995	10.1371/journal.pone.0060995	http://dx.doi.org/10.1371/journal.pone.0060995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593372	Green Published, gold			2022-12-27	WOS:000317382000036
J	Pripuzova, NS; Gmyl, LV; Romanova, LI; Tereshkina, NV; Rogova, YV; Terekhina, LL; Kozlovskaya, LI; Vorovitch, MF; Grishina, KG; Timofeev, AV; Karganova, GG				Pripuzova, Natalia S.; Gmyl, Larissa V.; Romanova, Lidiya Iu.; Tereshkina, Natalia V.; Rogova, Yulia V.; Terekhina, Liubov L.; Kozlovskaya, Liubov I.; Vorovitch, Mikhail F.; Grishina, Karina G.; Timofeev, Andrey V.; Karganova, Galina G.			Exploring of Primate Models of Tick-Borne Flaviviruses Infection for Evaluation of Vaccines and Drugs Efficacy	PLOS ONE			English	Article							ENCEPHALITIS-VIRUS; ATTENUATED VACCINE; IMMUNE-RESPONSE; RHESUS-MONKEYS; LANGAT VIRUS; IMMUNIZATION; NEUROVIRULENCE; LIVE; NEUROINVASIVENESS; REPLICATION	Tick-borne encephalitis virus (TBEV) is one of the most prevalent and medically important tick-borne arboviruses in Eurasia. There are overlapping foci of two flaviviruses: TBEV and Omsk hemorrhagic fever virus (OHFV) in Russia. Inactivated vaccines exist only against TBE. There are no antiviral drugs for treatment of both diseases. Optimal animal models are necessary to study efficacy of novel vaccines and treatment preparations against TBE and relative flaviviruses. The models for TBE and OHF using subcutaneous inoculation were tested in Cercopithecus aethiops and Macaca fascicularis monkeys with or without prior immunization with inactivated TBE vaccine. No visible clinical signs or severe pathomorphological lesions were observed in any monkey infected with TBEV or OHFV. C. aethiops challenged with OHFV showed massive hemolytic syndrome and thrombocytopenia. Infectious virus or viral RNA was revealed in visceral organs and CNS of C. aethiops infected with both viruses; however, viremia was low. Inactivated TBE vaccines induced high antibody titers against both viruses and expressed booster after challenge. The protective efficacy against TBE was shown by the absence of virus in spleen, lymph nodes and CNS of immunized animals after challenge. Despite the absence of expressed hemolytic syndrome in immunized C. aethiops TBE vaccine did not prevent the reproduction of OHFV in CNS and visceral organs. Subcutaneous inoculation of M. fascicularis with two TBEV strains led to a febrile disease with well expressed viremia, fever, and virus reproduction in spleen, lymph nodes and CNS. The optimal terms for estimation of the viral titers in CNS were defined as 8-16 days post infection. We characterized two animal models similar to humans in their susceptibility to tick-borne flaviviruses and found the most optimal scheme for evaluation of efficacy of preventive and therapeutic preparations. We also identified M. fascicularis to be more susceptible to TBEV than C. aethiops.	[Pripuzova, Natalia S.; Gmyl, Larissa V.; Romanova, Lidiya Iu.; Tereshkina, Natalia V.; Rogova, Yulia V.; Terekhina, Liubov L.; Kozlovskaya, Liubov I.; Vorovitch, Mikhail F.; Grishina, Karina G.; Timofeev, Andrey V.; Karganova, Galina G.] FSBI Chumakov Inst Poliomyelitis & Viral Encephal, Moscow, Russia		Karganova, GG (corresponding author), FSBI Chumakov Inst Poliomyelitis & Viral Encephal, Moscow, Russia.	karganova@bk.ru	Gmyl, Larissa/D-8740-2014; Karganova, Galina G/D-8601-2014; Romanova, Lidiya/S-6419-2019; Romanova, Lidiya/D-4874-2014; Kozlovskaya, Liubov/E-2368-2014; Vorovitch, Mikhail/S-1092-2016; Rogova, Yulia/ABE-1629-2021; Chernokhaeva, Liubov/D-8596-2014	Karganova, Galina G/0000-0002-8901-6206; Romanova, Lidiya/0000-0002-8360-818X; Romanova, Lidiya/0000-0002-8360-818X; Kozlovskaya, Liubov/0000-0002-3029-1035; Vorovitch, Mikhail/0000-0002-7367-6357; Rogova, Yulia/0000-0002-4655-5330; Chernokhaeva, Liubov/0000-0002-6888-6691	FSBI (Federal State Budgetary Institution) Chumakov Institute of Poliomyelitis and Viral Encephalitides (IPVE) RAMS (Russian Academy of Medical Sciences), Moscow, Russia	FSBI (Federal State Budgetary Institution) Chumakov Institute of Poliomyelitis and Viral Encephalitides (IPVE) RAMS (Russian Academy of Medical Sciences), Moscow, Russia	The work was funded by the FSBI (Federal State Budgetary Institution) Chumakov Institute of Poliomyelitis and Viral Encephalitides (IPVE) RAMS (Russian Academy of Medical Sciences), Moscow, Russia itself. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 2005, J VIROL, V79, P15107, DOI 10.1128/JVI.79.24.15107-15113.2005; Achazi K, 2012, ANTIVIR RES, V93, P94, DOI 10.1016/j.antiviral.2011.10.023; Andersson CR, 2010, VACCINE, V28, P2827, DOI 10.1016/j.vaccine.2010.02.001; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Dubov A, 1969, LINE VACCINE TICK BO; Dubov A, 1971, TRYING OUT EXPERIENC; Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; ELBERT LB, 1980, VOP VIRUSOL+, P341; Engel AR, 2011, VECTOR-BORNE ZOONOT, V11, P665, DOI 10.1089/vbz.2010.0179; Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014; FROLOVA MP, 1984, ACTA VIROL, V28, P232; HAMBLETON P, 1983, INFECT IMMUN, V40, P995, DOI 10.1128/IAI.40.3.995-1003.1983; Heiss BL, 2012, J VIROL, V86, P5647, DOI 10.1128/JVI.07125-11; ILYENKO V I, 1960, Acta Virol, V4, P75; Koller RM, 2004, ARCH VIROL, P191; Kozlovskaya LI, 2010, VIROLOGY, V398, P262, DOI 10.1016/j.virol.2009.12.012; Levanov LN, 2010, VACCINE, V28, P5265, DOI 10.1016/j.vaccine.2010.05.060; LEVENBOOK IS, 1987, J BIOL STAND, V15, P305, DOI 10.1016/S0092-1157(87)80003-3; Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007; Mandl CW, 2004, VIRAL IMMUNOL, V17, P461, DOI 10.1089/vim.2004.17.461; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Monath TP, 1999, VACCINE, V17, P1869, DOI 10.1016/S0264-410X(98)00487-3; MORRIS JA, 1955, AM J HYG, V62, P327, DOI 10.1093/oxfordjournals.aje.a119782; NATHANSON N, 1966, AM J EPIDEMIOL, V84, P541, DOI 10.1093/oxfordjournals.aje.a120665; NATHANSON N, 1965, AM J EPIDEMIOL, V82, P359, DOI 10.1093/oxfordjournals.aje.a120556; Omori-Urabe Y, 2011, MICROBIOL IMMUNOL, V55, P893, DOI 10.1111/j.1348-0421.2011.00389.x; Onishchenko G. G., 2007, Voprosy Virusologii, V52, P8; Pattnaik P, 2006, REV MED VIROL, V16, P151, DOI 10.1002/rmv.495; PLETNEV AG, 1992, P NATL ACAD SCI USA, V89, P10532, DOI 10.1073/pnas.89.21.10532; Pletnev AG, 2001, J VIROL, V75, P8259, DOI 10.1128/JVI.75.17.8259-8267.2001; POGODINA VV, 1981, ACTA VIROL, V25, P337; Pripuzova NS, 2009, J MED VIROL, V81, P1777, DOI 10.1002/jmv.21587; PuchhammerStockl E, 1995, CLIN DIAGN VIROL, V4, P321, DOI 10.1016/0928-0197(95)00022-4; REED L. J., 1938, AMER JOUR HYG, V27, P493; Romanova L. Yu., 2006, Voprosy Virusologii, V51, P31; Rumyantsev AA, 2006, J VIROL, V80, P1427, DOI 10.1128/JVI.80.3.1427-1439.2006; Rurayantsev AA, 2006, VACCINE, V24, P133, DOI 10.1016/j.vaccine.2005.07.067; Ruzek D, 2010, LANCET, V376, P2104, DOI 10.1016/S0140-6736(10)61120-8; SLONIM D, 1966, ACTA VIROL, V10, P413; Smorodintsev AA, 1986, TICK BORNE EXCEPHALI; Suss J, 2007, EMERG INFECT DIS, V13, P905, DOI 10.3201/eid1306.061173; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Vorobyeva M. S., 2007, Voprosy Virusologii, V52, P30; ZLOTNIK I, 1970, BRIT J EXP PATHOL, V51, P434; ZLOTNIK I, 1976, BRIT J EXP PATHOL, V57, P200	48	15	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61094	10.1371/journal.pone.0061094	http://dx.doi.org/10.1371/journal.pone.0061094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585873	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600082
J	Khraiwesh, B; Pugalenthi, G; Fedoroff, NV				Khraiwesh, Basel; Pugalenthi, Ganesan; Fedoroff, Nina V.			Identification and Analysis of Red Sea Mangrove (Avicennia marina) microRNAs by High-Throughput Sequencing and Their Association with Stress Responses	PLOS ONE			English	Article							SMALL RNAS; GENE-EXPRESSION; NONCODING RNAS; ARABIDOPSIS; BIOGENESIS; SPECIALIZATION; RIBONUCLEASE; PRECURSORS; MECHANISM; PROTEIN	Although RNA silencing has been studied primarily in model plants, advances in high-throughput sequencing technologies have enabled profiling of the small RNA components of many more plant species, providing insights into the ubiquity and conservatism of some miRNA-based regulatory mechanisms. Small RNAs of 20 to 24 nucleotides (nt) are important regulators of gene transcript levels by either transcriptional or by posttranscriptional gene silencing, contributing to genome maintenance and controlling a variety of developmental and physiological processes. Here, we used deep sequencing and molecular methods to create an inventory of the small RNAs in the mangrove species, Avicennia marina. We identified 26 novel mangrove miRNAs and 193 conserved miRNAs belonging to 36 families. We determined that 2 of the novel miRNAs were produced from known miRNA precursors and 4 were likely to be species-specific by the criterion that we found no homologs in other plant species. We used qRT-PCR to analyze the expression of miRNAs and their target genes in different tissue sets and some demonstrated tissue-specific expression. Furthermore, we predicted potential targets of these putative miRNAs based on a sequence homology and experimentally validated through endonucleolytic cleavage assays. Our results suggested that expression profiles of miRNAs and their predicted targets could be useful in exploring the significance of the conservation patterns of plants, particularly in response to abiotic stress. Because of their well-developed abilities in this regard, mangroves and other extremophiles are excellent models for such exploration.	[Khraiwesh, Basel; Fedoroff, Nina V.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Ctr Desert Agr, Thuwal, Saudi Arabia; [Pugalenthi, Ganesan] King Abdullah Univ Sci & Technol, Biosci Core Lab, Thuwal, Saudi Arabia; [Fedoroff, Nina V.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Khraiwesh, B (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Ctr Desert Agr, Thuwal, Saudi Arabia.	Basel.Khraiwesh@kaust.edu.sa	Khraiwesh, Basel/G-7509-2015; Ganesan, Pugalenthi/H-3566-2019	Khraiwesh, Basel/0000-0001-7026-1263; Ganesan, Pugalenthi/0000-0002-5234-5700				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arif MA, 2013, INT J MOL SCI, V14, P1516, DOI 10.3390/ijms14011516; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; CHEESEMAN JM, 1991, PHOTOSYNTH RES, V29, P11, DOI 10.1007/BF00035202; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Dassanayake M, 2010, FUNCT INTEGR GENOMIC, V10, P523, DOI 10.1007/s10142-009-0156-5; DECARVALHO F, 1992, EMBO J, V11, P2595, DOI 10.1002/j.1460-2075.1992.tb05324.x; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Donaire L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027916; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Khraiwesh B, 2011, METHODS MOL BIOL, V744, P57, DOI 10.1007/978-1-61779-123-9_5; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee WS, 2011, BOT MAR, V54, P313, DOI 10.1515/BOT.2011.031; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Matzke MA, 2004, PLOS BIOL, V2, P582, DOI 10.1371/journal.pbio.0020133; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Schramke V, 2004, CURR OPIN GENET DEV, V14, P174, DOI 10.1016/j.gde.2004.02.006; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	76	28	31	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60774	10.1371/journal.pone.0060774	http://dx.doi.org/10.1371/journal.pone.0060774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593307	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000065
J	Moriguchi, S; Shinoda, Y; Yamamoto, Y; Sasaki, Y; Miyajima, K; Tagashira, H; Fukunaga, K				Moriguchi, Shigeki; Shinoda, Yasuharu; Yamamoto, Yui; Sasaki, Yuzuru; Miyajima, Kosuke; Tagashira, Hideaki; Fukunaga, Kohji			Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; DEHYDROEPIANDROSTERONE-SULFATE; CELL-PROLIFERATION; AMPA RECEPTORS; ANIMAL-MODEL; BINDING-SITE; RAT; ACTIVATION; ALZHEIMERS	Dehydroepiandrosterone (DHEA) is the most abundant neurosteroid synthesized de novo in the central nervous system. We previously reported that stimulation of the sigma-1 receptor by DHEA improves cognitive function by activating calcium/calmodulin-dependent protein kinase II (CaMKII), protein kinase C and extracellular signal-regulated kinase in the hippocampus in olfactory bulbectomized (OBX) mice. Here, we asked whether DHEA enhances neurogenesis in the subgranular zone of the hippocampal dentate gyrus (DG) and improves depressive-like behaviors observed in OBX mice. Chronic treatment with DHEA at 30 or 60 mg/kg p.o. for 14 days significantly improved hippocampal LTP impaired in OBX mice concomitant with increased CaMKII autophosphorylation and GluR1 (Ser-831) phosphorylation in the DG. Chronic DHEA treatment also ameliorated depressive-like behaviors in OBX mice, as assessed by tail suspension and forced swim tests, while a single DHEA treatment had no affect. DHEA treatment also significantly increased the number of BrdU-positive neurons in the subgranular zone of the DG of OBX mice, an increase inhibited by treatment with NE-100, a sigma-1 receptor antagonist. DHEA treatment also significantly increased phosphorylation of Akt (Ser-473), Akt (Ser-308) and ERK in the DG. Furthermore, GSK-3 beta (Ser-9) phosphorylation increased in the DG of OBX mice possibly accounting for increased neurogenesis through Akt activation. Finally, we confirmed that DHEA treatment of OBX mice increases the number of BrdU-positive neurons co-expressing beta-catenin, a downstream GSK-3 beta target. Overall, we conclude that sigma-1 receptor stimulation by DHEA ameliorates OBX-induced depressive-like behaviors by increasing neurogenesis in the DG through activation of the Akt/GSK-3 beta/beta-catenin pathway.	[Moriguchi, Shigeki; Shinoda, Yasuharu; Yamamoto, Yui; Sasaki, Yuzuru; Miyajima, Kosuke; Tagashira, Hideaki; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan	Tohoku University	Moriguchi, S (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan.	shigeki@m.tohoku.ac.jp; kfukunaga@m.tohoku.ac.jp	Fukunaga, Kohji/AAI-8811-2021; Shinoda, Yasuharu/AAE-6135-2019	Shinoda, Yasuharu/0000-0001-9910-048X; Fukunaga, Kohji/0000-0001-8526-2824	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health and Welfare of Japan [22390109, 20790398]; Pharmacological Research Foundation, Tokyo; Research Foundation for Pharmaceutical Sciences; Smoking Research Foundation; Takeda Science Foundation; NISHINOMIYA Basic Research Fund; Suzuken Memorial Foundation; HIROMI Medical Research Foundation; Tohoku University; Grants-in-Aid for Scientific Research [12J04360, 24659024] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo); Research Foundation for Pharmaceutical Sciences; Smoking Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); NISHINOMIYA Basic Research Fund; Suzuken Memorial Foundation; HIROMI Medical Research Foundation; Tohoku University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health and Welfare of Japan (22390109 to K. F.; 20790398 to S. M.) and the Pharmacological Research Foundation, Tokyo (to S. M.), the Research Foundation for Pharmaceutical Sciences (to S. M.), the Smoking Research Foundation (to K. F.), the Takeda Science Foundation (to S. M.), the NISHINOMIYA Basic Research Fund (Japan) (to S. M.), the Suzuken Memorial Foundation (to S. M.), the HIROMI Medical Research Foundation (to S. M.). Funding was provided by the Tohoku University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Baulieu EE, 1998, P NATL ACAD SCI USA, V95, P4089, DOI 10.1073/pnas.95.8.4089; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CAIN DP, 1974, PSYCHOL BULL, V81, P654, DOI 10.1037/h0036954; Chatterjee S, 2012, AM J PHYSIOL-HEART C, V302, pH105, DOI 10.1152/ajpheart.00298.2011; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; CORWIN J, 1985, IRCS MED SCI-BIOCHEM, V13, P260; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; Fukunaga K, 2002, J NEUROSCI RES, V70, P799, DOI 10.1002/jnr.10400; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Han F, 2008, NEUROSCIENCE, V151, P671, DOI 10.1016/j.neuroscience.2007.11.011; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; HELLEWELL SB, 1990, BRAIN RES, V527, P244, DOI 10.1016/0006-8993(90)91143-5; HELLEWELL SB, 1994, EUR J PHARM-MOLEC PH, V268, P9, DOI 10.1016/0922-4106(94)90115-5; Hozumi S, 2003, BEHAV BRAIN RES, V138, P9, DOI 10.1016/S0166-4328(02)00183-3; Huddleston AT, 2008, J NEUROPHYSIOL, V99, P1565, DOI 10.1152/jn.00659.2007; IRWIN RP, 1994, J PHARMACOL EXP THER, V271, P677; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P4050, DOI 10.1073/pnas.88.9.4050; JUNIEN JL, 1991, EUR J PHARMACOL, V200, P343, DOI 10.1016/0014-2999(91)90593-F; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; Koss E, 1986, DEV NEUROPSYCHOL, V2, P89, DOI 10.1080/87565648609540332; Kovacs T, 2001, NEUROREPORT, V12, P285, DOI 10.1097/00001756-200102120-00021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li BS, 2001, J NEUROSCI, V21, P1569, DOI 10.1523/JNEUROSCI.21-05-01569.2001; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Ma T, 2011, J NEUROSCI, V31, P17537, DOI 10.1523/JNEUROSCI.4761-11.2011; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; MATSUNO K, 1993, J PHARMACOL EXP THER, V265, P851; Maurice T, 2001, EUR J PHARMACOL, V431, P223, DOI 10.1016/S0014-2999(01)01436-4; MIYANO O, 1992, J BIOL CHEM, V267, P1198; Moriguchi S, 2006, J NEUROCHEM, V97, P22, DOI 10.1111/j.1471-4159.2006.03710.x; Moriguchi S, 2008, J NEUROCHEM, V106, P1092, DOI 10.1111/j.1471-4159.2008.05440.x; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; ORENTREICH N, 1992, J CLIN ENDOCR METAB, V75, P1002, DOI 10.1210/jc.75.4.1002; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Palacios G, 2003, BRAIN RES, V961, P92, DOI 10.1016/S0006-8993(02)03892-1; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Sabino V, 2009, BEHAV BRAIN RES, V198, P472, DOI 10.1016/j.bbr.2008.11.036; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shioda N, 2012, J BIOL CHEM, V287, P23318, DOI 10.1074/jbc.M112.349142; Shioda N, 2010, J PHARMACOL EXP THER, V333, P43, DOI 10.1124/jpet.109.163535; SIECK MH, 1972, PHYSIOL BEHAV, V8, P705, DOI 10.1016/0031-9384(72)90099-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; SUNDERLAND T, 1989, LANCET, V2, P570; Tian HP, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-139; Tizabi Y, 1999, PSYCHOPHARMACOLOGY, V142, P193, DOI 10.1007/s002130050879; Vermeulen A, 1995, ANN NY ACAD SCI, V774, P121, DOI 10.1111/j.1749-6632.1995.tb17376.x; WARNER MD, 1986, BIOL PSYCHIAT, V21, P116, DOI 10.1016/0006-3223(86)90013-2; Yamagata Y, 2003, J PHARMACOL SCI, V93, P22, DOI 10.1254/jphs.93.22; Yamamoto T, 1997, BEHAV BRAIN RES, V83, P57, DOI 10.1016/S0166-4328(97)86046-9	70	63	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60863	10.1371/journal.pone.0060863	http://dx.doi.org/10.1371/journal.pone.0060863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593332	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000079
J	Yang, B; Larson, DF; Ranger-Moore, J				Yang, Bo; Larson, Douglas F.; Ranger-Moore, James			Biphasic Change of Tau (tau) in Mice as Arterial Load Acutely Increased with Phenylephrine Injection	PLOS ONE			English	Article							LEFT-VENTRICULAR RELAXATION; CANINE LEFT-VENTRICLE; ISOVOLUMIC RELAXATION; MYOCARDIAL RELAXATION; TIME CONSTANT; HEMODYNAMIC DETERMINANTS; CONTRACTILE STATE; HEART-FAILURE; PRESSURE; AFTERLOAD	Background: Diastolic dysfunction is the hemodynamic hallmark of hypertensive heart disease. Tau (tau) has been used to describe left ventricle relaxation. The relationship between tau and afterload has been controversial. Our goal was to demonstrate this relationship in mice, because genetically-modified mouse models have been used extensively for studies in cardiovascular diseases. Methods: Increased arterial load was produced by phenylephrine administration (50 mu g/kg iv) (n = 10). A series of pressure-volume loops was recorded with a Millar conductance catheter in vivo as the left ventricle pressure reached the maximum. The arterial load was expressed as Ea (effective arterial elastance). Tau values were computed using three mathematical methods: tau(Weiss), tau(Glantz), and tau(Logistic). Results: A correlation plot between tau and Ea showed a biphasic relationship a flat phase I and an inclined phase II. The existence of an inflection point was proved mathematically with biphasic linear regression. Pressure-volume area (PVA), a parameter linearly related to myocardial O-2 consumption (MVO2), was found to be directly proportional to Ea. The plot of tau versus PVA was also biphasic. Conclusion: We concluded that a small increase of the arterial load by phenylephrine increased PVA (index of MVO2) but had little effect on tau. However, after an inflection point, further increase of arterial load and PVA resulted in the linear increase of tau.	[Yang, Bo] Univ Michigan, Dept Cardiac Surg, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Larson, Douglas F.] Univ Arizona, Coll Med, Sarver Heart Ctr, Tucson, AZ USA; [Larson, Douglas F.] Univ Arizona, Coll Med, Dept Med Pharmacol, Tucson, AZ USA; [Ranger-Moore, James] Univ Arizona, Div Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA	University of Michigan System; University of Michigan; University of Arizona; University of Arizona; University of Arizona	Yang, B (corresponding author), Univ Michigan, Dept Cardiac Surg, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.	boya@med.umich.edu		Yang, Bo/0000-0002-2158-9155	National Institutes of Health [R01 HL079206-01]; James and Linda Lee Heart Failure Research Award; Steinbronn Donation for Heart Failure Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Linda Lee Heart Failure Research Award; Steinbronn Donation for Heart Failure Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health R01 HL079206-01, the James and Linda Lee Heart Failure Research Award, and the Steinbronn Donation for Heart Failure Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger DS, 1997, AM J PHYSIOL-HEART C, V273, pH2696, DOI 10.1152/ajpheart.1997.273.6.H2696; CHENG CP, 1990, CIRC RES, V66, P814, DOI 10.1161/01.RES.66.3.814; Davis KL, 1999, BASIC RES CARDIOL, V94, P41, DOI 10.1007/s003950050125; GAASCH WH, 1980, AM J PHYSIOL, V239, pH1, DOI 10.1152/ajpheart.1980.239.1.H1; GAASCH WH, 1986, CIRCULATION, V73, P1037, DOI 10.1161/01.CIR.73.5.1037; GILBERT JC, 1989, CIRC RES, V64, P827, DOI 10.1161/01.RES.64.5.827; Gillebert TC, 1997, CIRCULATION, V95, P745, DOI 10.1161/01.CIR.95.3.745; GLANTZ SA, 1975, CIRC RES, V37, P787, DOI 10.1161/01.RES.37.6.787; KARLINER JS, 1977, J CLIN INVEST, V60, P511, DOI 10.1172/JCI108803; Klapholz M, 2004, J AM COLL CARDIOL, V43, P1432, DOI 10.1016/j.jacc.2003.11.040; Langer SFJ, 1998, INT J CARDIAC IMAG, V14, P229, DOI 10.1023/A:1006083306901; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; LEITEMOREIRA AF, 1994, CIRCULATION, V90, P2481, DOI 10.1161/01.CIR.90.5.2481; MATSUBARA H, 1995, CIRCULATION, V92, P2318, DOI 10.1161/01.CIR.92.8.2318; MIURA T, 1993, J APPL PHYSIOL, V75, P389, DOI 10.1152/jappl.1993.75.1.389; O'Connor CM, 2000, AM J CARDIOL, V86, P863, DOI 10.1016/S0002-9149(00)01107-3; RAFF GL, 1981, CIRC RES, V48, P813, DOI 10.1161/01.RES.48.6.813; Sagawa K, 1988, CARDIAC CONTRACTION, P171; SCHAFER S, 1992, CARDIOVASC RES, V26, P631, DOI 10.1093/cvr/26.6.631; SCHIERECK P, 1987, AM J PHYSIOL, V253, pH512, DOI 10.1152/ajpheart.1987.253.3.H512; STARLING MR, 1987, CIRCULATION, V76, P1274, DOI 10.1161/01.CIR.76.6.1274; SUNAGAWA K, 1983, AM J PHYSIOL, V245, pH773, DOI 10.1152/ajpheart.1983.245.5.H773; SUNAGAWA K, 1985, CIRC RES, V56, P586, DOI 10.1161/01.RES.56.4.586; TOBIAS AH, 1995, AM J PHYSIOL-HEART C, V268, pH170, DOI 10.1152/ajpheart.1995.268.1.H170; WEISS JL, 1976, J CLIN INVEST, V58, P751, DOI 10.1172/JCI108522; Yang B, 2001, J INVEST SURG, V14, P341, DOI 10.1080/089419301753435710; Yang B, 1999, AM J PHYSIOL-HEART C, V277, pH1906, DOI 10.1152/ajpheart.1999.277.5.H1906; Yang B, 2000, CARDIOVASC ENG, V5, P57	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60580	10.1371/journal.pone.0060580	http://dx.doi.org/10.1371/journal.pone.0060580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593252	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000039
J	Emig, D; Ivliev, A; Pustovalova, O; Lancashire, L; Bureeva, S; Nikolsky, Y; Bessarabova, M				Emig, Dorothea; Ivliev, Alexander; Pustovalova, Olga; Lancashire, Lee; Bureeva, Svetlana; Nikolsky, Yuri; Bessarabova, Marina			Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach	PLOS ONE			English	Article							GENE-EXPRESSION OMNIBUS; MYC; CANCER; REGRESSION; PRIORITIZATION; INTERLEUKIN-2; INACTIVATION; INTERACTOME; SUPPRESSION; SCLERODERMA	The discovery of novel drug targets is a significant challenge in drug development. Although the human genome comprises approximately 30,000 genes, proteins encoded by fewer than 400 are used as drug targets in the treatment of diseases. Therefore, novel drug targets are extremely valuable as the source for first in class drugs. On the other hand, many of the currently known drug targets are functionally pleiotropic and involved in multiple pathologies. Several of them are exploited for treating multiple diseases, which highlights the need for methods to reliably reposition drug targets to new indications. Network-based methods have been successfully applied to prioritize novel disease-associated genes. In recent years, several such algorithms have been developed, some focusing on local network properties only, and others taking the complete network topology into account. Common to all approaches is the understanding that novel disease-associated candidates are in close overall proximity to known disease genes. However, the relevance of these methods to the prediction of novel drug targets has not yet been assessed. Here, we present a network-based approach for the prediction of drug targets for a given disease. The method allows both repositioning drug targets known for other diseases to the given disease and the prediction of unexploited drug targets which are not used for treatment of any disease. Our approach takes as input a disease gene expression signature and a high-quality interaction network and outputs a prioritized list of drug targets. We demonstrate the high performance of our method and highlight the usefulness of the predictions in three case studies. We present novel drug targets for scleroderma and different types of cancer with their underlying biological processes. Furthermore, we demonstrate the ability of our method to identify non-suspected repositioning candidates using diabetes type 1 as an example.	[Emig, Dorothea; Ivliev, Alexander; Pustovalova, Olga; Lancashire, Lee; Bureeva, Svetlana; Nikolsky, Yuri; Bessarabova, Marina] Thomson Reuters, IP & Sci, Carlsbad, CA USA	Clarivate	Bessarabova, M (corresponding author), Thomson Reuters, IP & Sci, Carlsbad, CA USA.	marina.bessarabova@thomsonreuters.com	Crozier, Laura/A-7950-2013	Lancashire, Lee/0000-0003-4835-4847	Thomson Reuters	Thomson Reuters	All authors are employees of Thomson Reuters. This research was funded by Thomson Reuters. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DJ, 2009, RHEUMATOLOGY, V48, P3, DOI 10.1093/rheumatology/ken481; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; [Anonymous], 2008, SCI DAILY; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bending D, 2012, INT IMMUNOL, V24, P339, DOI 10.1093/intimm/dxs049; Bodor J, 2000, J LEUKOCYTE BIOL, V67, P774, DOI 10.1002/jlb.67.6.774; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bureeva S, 2009, METHODS MOL BIOL, V563, P75, DOI 10.1007/978-1-60761-175-2_5; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Chizzolini C, 2007, ANN MED, V39, P42, DOI 10.1080/07853890601098152; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Dickson M, 2004, NAT REV DRUG DISCOV, V3, P417, DOI 10.1038/nrd1382; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; GONZALEZAMARO R, 1988, CLIN IMMUNOL IMMUNOP, V46, P412, DOI 10.1016/0090-1229(88)90060-8; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hermeking H, 2003, CURR CANCER DRUG TAR, V3, P163, DOI 10.2174/1568009033481949; Hsu CL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S25; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Hulme MA, 2012, DIABETES, V61, P14, DOI 10.2337/db11-1213; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim D, 2008, ARTHRITIS RHEUM-US, V58, P2163, DOI 10.1002/art.23486; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Leask A, 2012, EXPERT OPIN EMERG DR, V17, P173, DOI 10.1517/14728214.2012.678833; Litherland SA, 1999, J CLIN INVEST, V104, P515, DOI 10.1172/JCI4852; MANTEL N, 1967, CANCER RES, V27, P209; Motavaf M, 2012, J VIRAL HEPATITIS, V19, P757, DOI 10.1111/jvh.12006; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Nitsch D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-460; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pache L, 2011, METHODS, V53, P3, DOI 10.1016/j.ymeth.2010.07.009; Patrussi L, 2011, CURR MED CHEM, V18, P497, DOI 10.2174/092986711794480159; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Pollard Jack Jr, 2005, Diabetes Technol Ther, V7, P323, DOI 10.1089/dia.2005.7.323; Prochownik Edward V, 2004, Expert Rev Anticancer Ther, V4, P289, DOI 10.1586/14737140.4.2.289; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; RINCON M, 1988, EUR J IMMUNOL, V18, P1791, DOI 10.1002/eji.1830181121; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Skyler JS, 2011, INT J CLIN PRACT, V65, P61, DOI 10.1111/j.1742-1241.2010.02580.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Tabatabaie T, 2000, BIOCHEM BIOPH RES CO, V273, P699, DOI 10.1006/bbrc.2000.2959; Uddin S, 2004, J BIOCHEM MOL BIOL, V37, P635; ULITSKY I, 2010, PLOS ONE, V0005; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104	60	149	154	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60618	10.1371/journal.pone.0060618	http://dx.doi.org/10.1371/journal.pone.0060618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593264	gold, Green Submitted, Green Published			2022-12-27	WOS:000319108100058
J	Ghebremariam, YT; Yamada, K; Lee, JC; Johnson, CLC; Atzler, D; Anderssohn, M; Agrawal, R; Higgins, JP; Patterson, AJ; Boger, RH; Cooke, JP				Ghebremariam, Yohannes T.; Yamada, Keisuke; Lee, Jerry C.; Johnson, Christine L. C.; Atzler, Dorothee; Anderssohn, Maike; Agrawal, Rani; Higgins, John P.; Patterson, Andrew J.; Boeger, Rainer H.; Cooke, John P.			FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FARNESOID-X-RECEPTOR; DIMETHYLARGININE DIMETHYLAMINOHYDROLASE DDAH; TYPE-2 DIABETES-MELLITUS; ASYMMETRIC DIMETHYLARGININE; BLOOD-PRESSURE; DIETARY-SODIUM; EXPERIMENTAL-HYPERTENSION; SYNTHESIS INHIBITION; RESISTANCE	Aims: Genetic and pharmacological studies have shown that impairment of the nitric oxide (NO) synthase (NOS) pathway is associated with hypertension and insulin-resistance (IR). In addition, inhibition of NOS by the endogenous inhibitor, asymmetric dimethylarginine (ADMA), may also result in hypertension and IR. On the other hand, overexpression of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme that metabolizes ADMA, in mice is associated with lower ADMA, increased NO and enhanced insulin sensitivity. Since DDAH carries a farnesoid X receptor (FXR)-responsive element, we aimed to upregulate its expression by an FXR-agonist, INT-747, and evaluate its effect on blood pressure and insulin sensitivity. Methods and Results: In this study, we evaluated the in vivo effect of INT-747 on tissue DDAH expression and insulin sensitivity in the Dahl rat model of salt-sensitive hypertension and IR (Dahl-SS). Our data indicates that high salt (HS) diet significantly increased systemic blood pressure. In addition, HS diet downregulated tissue DDAH expression while INT-747 protected the loss in DDAH expression and enhanced insulin sensitivity compared to vehicle controls. Conclusion: Our study may provide the basis for a new therapeutic approach for IR by modulating DDAH expression and/or activity using small molecules.	[Ghebremariam, Yohannes T.; Yamada, Keisuke; Lee, Jerry C.; Cooke, John P.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Johnson, Christine L. C.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Atzler, Dorothee; Anderssohn, Maike; Patterson, Andrew J.; Boeger, Rainer H.] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Agrawal, Rani] Stanford Univ, Div Anesthesia, Stanford, CA 94305 USA; [Higgins, John P.] Stanford Univ, Div Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Stanford University	Cooke, JP (corresponding author), Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.	john.cooke@stanford.edu		Atzler, Dorothee/0000-0002-6551-1544; Cooke, John/0000-0003-0033-9138; Lee, Jerry/0000-0002-0354-5247	National Institutes of Health (NIH) [RC2HL103400, 1U01HL100397, K12HL087746, 1R01EY02060901A1]; American Heart Association (AHA) [11IRG5180026]; Stanford SPARK Translational Research Program; Tobacco-Related Disease Research Program of the University of California [18XT-0098, 20FT-0090]; Stanford School of Medicine Dean's fellowship [1049528-149-KAVFB]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL103400, K12HL087746, U01HL100397] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Stanford SPARK Translational Research Program; Tobacco-Related Disease Research Program of the University of California(University of California System); Stanford School of Medicine Dean's fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants to JPC from the National Institutes of Health (NIH) (grant numbers RC2HL103400, 1U01HL100397, K12HL087746 and 1R01EY02060901A1); the American Heart Association (AHA) (grant number 11IRG5180026); Stanford SPARK Translational Research Program; and by the Tobacco-Related Disease Research Program of the University of California (grant number 18XT-0098). YTG was a recipient of the Stanford School of Medicine Dean's fellowship (grant number 1049528-149-KAVFB); and is currently supported by Tobacco-Related Disease Research Program of the University of California (grant number 20FT-0090). Other than the listed authors, no individual employed or contracted by the sponsors played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron AD, 1999, AM J CARDIOL, V84, p25J; Baron AD, 1996, J INVEST MED, V44, P406; BURG MB, 1982, KIDNEY INT, V22, P454, DOI 10.1038/ki.1982.198; Cariou B, 2005, ENDOCRINOLOGY, V146, P981, DOI 10.1210/en.2004-1595; CHEN PY, 1991, J CLIN INVEST, V88, P1559, DOI 10.1172/JCI115467; Chitturi Shivakumar, 2003, Curr Gastroenterol Rep, V5, P18, DOI 10.1007/s11894-003-0005-y; Cianciaruso B, 1998, MINER ELECTROL METAB, V24, P296, DOI 10.1159/000057385; Cooke JP, 2011, J CLIN INVEST, V121, P1258, DOI 10.1172/JCI57193; Cooke JP, 2010, VASC MED, V15, P235, DOI 10.1177/1358863X10362605; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Cooke JP, 2000, VASC MED, V5, P49, DOI 10.1177/1358836X0000500108; DAHL LK, 1962, J EXP MED, V115, P1173, DOI 10.1084/jem.115.6.1173; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dengel DR, 2007, PHYSIOL RES, V56, P393, DOI 10.33549/physiolres.931002; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Fang Y, 2006, HYPERTENSION, V48, P724, DOI 10.1161/01.HYP.0000238159.19614.ce; Fujiwara N, 2000, CIRCULATION, V101, P856, DOI 10.1161/01.CIR.101.8.856; Ghebremariam YT, 2012, J BIOMOL SCREEN, V17, P651, DOI 10.1177/1087057112441521; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; Hodge G, 2002, EXP PHYSIOL, V87, P1, DOI 10.1113/eph8702322; Hu TH, 2006, J BIOL CHEM, V281, P39831, DOI 10.1074/jbc.M606779200; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Hyndman ME, 2002, HYPERTENSION, V39, P919, DOI 10.1161/01.HYP.0000013703.07316.7F; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Li J, 2009, J PHARMACOL EXP THER, V331, P234, DOI 10.1124/jpet.109.153510; Li J, 2009, J NUTR, V139, P447, DOI 10.3945/jn.108.097451; Maas R, 2007, J CHROMATOGR B, V851, P220, DOI 10.1016/j.jchromb.2007.01.020; Matsuoka H, 1997, HYPERTENSION, V29, P242, DOI 10.1161/01.HYP.29.1.242; Miyaki K, 2005, AM J HYPERTENS, V18, P1556, DOI 10.1016/j.amjhyper.2005.06.012; Miyazaki-Anzai S, 2010, CIRC RES, V106, P1807, DOI 10.1161/CIRCRESAHA.109.212969; MONDON CE, 1981, AM J PHYSIOL, V240, pE482, DOI 10.1152/ajpendo.1981.240.5.E482; Mookerjee RP, 2011, CURR OPIN CRIT CARE, V17, P170, DOI 10.1097/MCC.0b013e328344a076; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Ogihara T, 2002, HYPERTENSION, V40, P83, DOI 10.1161/01.HYP.0000022880.45113.C9; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; RAPP JP, 1985, HYPERTENSION, V7, P340, DOI 10.1161/01.HYP.7.3_Pt_1.340; Reaven G, 2005, CIRCULATION, V112, P3030, DOI 10.1161/CIRCULATIONAHA.105.504670; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SALAZAR FJ, 1993, HYPERTENSION, V22, P49, DOI 10.1161/01.HYP.22.1.49; SALAZAR FJ, 1992, HYPERTENSION, V20, P113, DOI 10.1161/01.HYP.20.1.113; Sanada H, 2011, CURR HYPERTENS REP, V13, P55, DOI 10.1007/s11906-010-0167-6; Schulze F, 2004, CLIN CHEM LAB MED, V42, P1377, DOI 10.1515/CCLM.2004.257; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Shehata M, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-7; Siekmeier R, 2008, J CARDIOVASC PHARM T, V13, P279, DOI 10.1177/1074248408326488; Staels B, 2007, DRUGS, V67, P1383, DOI 10.2165/00003495-200767100-00001; STOOS BA, 1995, J AM SOC NEPHROL, V6, P89; Strazzullo Pasquale, 2009, BMJ, V339, pb4567, DOI 10.1136/bmj.b4567; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Sydow K, 2008, ARTERIOSCL THROM VAS, V28, P692, DOI 10.1161/ATVBAHA.108.162073; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tzemos N, 2008, HYPERTENSION, V51, P1525, DOI 10.1161/HYPERTENSIONAHA.108.109868; Vairappan B, 2009, 60 ANN M AM ASS FOR; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Wang D, 2009, AM J PHYSIOL-REG I, V296, pR195, DOI 10.1152/ajpregu.90506.2008; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009	61	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60653	10.1371/journal.pone.0060653	http://dx.doi.org/10.1371/journal.pone.0060653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593273	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100062
J	Volkov, A; Hagner, S; Loser, S; Alnahas, S; Raifer, H; Hellhund, A; Garn, H; Steinhoff, U				Volkov, Anton; Hagner, Stefanie; Loeser, Stephan; Alnahas, Safa; Raifer, Hartmann; Hellhund, Anne; Garn, Holger; Steinhoff, Ulrich			beta 5i Subunit Deficiency of the Immunoproteasome Leads to Reduced Th2 Response in OVA Induced Acute Asthma	PLOS ONE			English	Article							DENDRITIC CELLS; EXPERIMENTAL COLITIS; SELECTIVE INHIBITOR; PROTEASOME; INFLAMMATION; DEGRADATION; ANTIGEN; ACTIVATION; EXPRESSION; MATURATION	The immunoproteasome subunit beta 5i has been shown to play an important role in Th1/Th17 driven models of colitis and arthritis. However, the function of beta 5i in Th2 dependent diseases remains enigmatic. To study the role of beta 5i in Th2-driven pathology, beta 5i knockout (KO) and control mice were tested in different models of experimental allergic asthma. beta 5i-deficient mice showed reduced OVA/Alum-and subcutaneous/OVA-induced acute asthma with decreased eosinophilia in the bronchoalveolar lavage (BAL), low OVA-specific IgG1 and reduced local and systemic Th2 cytokines. While Th2 cells in the lungs were reduced, Tregs and Th1 cells were not affected. Attenuated asthma in beta 5i KO mice could not be attributed to defects in OVA uptake or maturation of dendritic cells in the lung. Surprisingly, beta 5i deficient mice developed HDM asthma which was comparable to control mice. Here, we present novel evidence for the requirement of the beta 5i immunosubunit to generate a strong Th2 response during OVA-but not HDM-induced acute asthma. The unexpected role of beta 5i in OVA asthma remains to be clarified.	[Volkov, Anton; Loeser, Stephan; Alnahas, Safa; Raifer, Hartmann; Hellhund, Anne; Steinhoff, Ulrich] Univ Marburg, Inst Med Microbiol & Hyg, Marburg, Germany; [Hagner, Stefanie; Garn, Holger] Univ Marburg, Inst Lab Med & Pathobiochem, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Steinhoff, U (corresponding author), Univ Marburg, Inst Med Microbiol & Hyg, Marburg, Germany.	ulrich.steinhoff@staff.uni-marburg.de		Steinhoff, Ulrich/0000-0003-2141-7756; Garn, Holger/0000-0002-5178-4023	University of Giessen and Marburg Lung Center (UGMLC); DFG [SFB/TR22]	University of Giessen and Marburg Lung Center (UGMLC); DFG(German Research Foundation (DFG))	The work was supported by the University of Giessen and Marburg Lung Center (UGMLC) and by the collaborative research grant (DFG) SFB/TR22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Broide DH, 2001, J ALLERGY CLIN IMMUN, V108, pS65, DOI 10.1067/mai.2001.116436; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Conrad ML, 2009, CLIN EXP ALLERGY, V39, P1246, DOI 10.1111/j.1365-2222.2009.03260.x; Ebstein F, 2009, INT J BIOCHEM CELL B, V41, P1205, DOI 10.1016/j.biocel.2008.10.023; Elliott PJ, 1999, J ALLERGY CLIN IMMUN, V104, P294, DOI 10.1016/S0091-6749(99)70369-6; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Fujihara S, 2002, EUR J IMMUNOL, V32, P457, DOI 10.1002/1521-4141(200202)32:2<457::AID-IMMU457>3.0.CO;2-1; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1996, IMMUNOL TODAY, V17, P429, DOI 10.1016/0167-5699(96)10051-7; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Kalim KW, 2012, J IMMUNOL, V189, P4182, DOI 10.4049/jimmunol.1201183; Keller AC, 2006, J ALLERGY CLIN IMMUN, V117, P283, DOI 10.1016/j.jaci.2005.10.019; Kruger E, 2012, CURR OPIN IMMUNOL, V24, P77, DOI 10.1016/j.coi.2012.01.005; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lutz MB, 1996, EUR J IMMUNOL, V26, P586, DOI 10.1002/eji.1830260313; Macagno A, 1999, EUR J IMMUNOL, V29, P4037, DOI 10.1002/(SICI)1521-4141(199912)29:12<4037::AID-IMMU4037>3.0.CO;2-T; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Taube C, 2004, INT ARCH ALLERGY IMM, V135, P173, DOI 10.1159/000080899; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Van Hove CL, 2007, AM J RESP CELL MOL, V36, P573, DOI 10.1165/rcmb.2006-0385OC; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Visekruna A, 2009, INFLAMM BOWEL DIS, V15, P526, DOI 10.1002/ibd.20805; Wegmann M, 2012, INT ARCH ALLERGY IMM, V158, P43, DOI 10.1159/000330103	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60565	10.1371/journal.pone.0060565	http://dx.doi.org/10.1371/journal.pone.0060565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593249	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100054
J	Bachet, JB; Tabone-Eglinger, S; Dessaux, S; Besse, A; Brahimi-Adouane, S; Emile, JF; Blay, JY; Alberti, L				Bachet, Jean-Baptiste; Tabone-Eglinger, Severine; Dessaux, Sophie; Besse, Anthony; Brahimi-Adouane, Sabrina; Emile, Jean-Francois; Blay, Jean-Yves; Alberti, Laurent			Gene Expression Patterns of Hemizygous and Heterozygous KIT Mutations Suggest Distinct Oncogenic Pathways: A Study in NIH3T3 Cell Lines and GIST Samples	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; RECEPTOR TYROSINE KINASE; C-KIT; JUXTAMEMBRANE DOMAIN; SIGNAL-TRANSDUCTION; COLORECTAL-CANCER; PANCREATIC-CANCER; IMATINIB MESYLATE; EXON-11 MUTATIONS; BONE-MARROW	Objective: Most gain of function mutations of tyrosine kinase receptors in human tumours are hemizygous. Gastrointestinal stromal tumours ( GIST) with homozygous mutations have a worse prognosis. We aimed to identify genes differentially regulated by hemizygous and heterozygous KIT mutations. Materials and Methods: Expression of 94 genes and 384 miRNA was analysed with low density arrays in five NIH3T3 cell lines expressing the full-length human KIT cDNA wild-type (WT), hemizygous KIT mutation with del557-558 (D6) or del564-581 (D54) and heterozygous WT/D6 or WT/D54. Expression of 5 of these genes and 384 miRNA was then analysed in GISTs samples. Results: Unsupervised and supervised hierarchical clustering of the mRNA and miRNA profiles showed that heterozygous mutants clustered with KIT WT expressing cells while hemizygous mutants were distinct. Among hemizygous cells, D6 and D54 expressing cells clustered separately. Most deregulated genes have been reported as potentially implicated in cancer and severals, as ANXA8 and FBN1, are highlighted by both, mRNA and miRNA analyses. MiRNA and mRNA analyses in GISTs samples confirmed that their expressions varied according to the mutation of the alleles. Interestingly, RGS16, a membrane protein of the regulator of G protein family, correlate with the subcellular localization of KIT mutants and might be responsible for regulation of the PI3K/AKT signalling pathway. Conclusion: Patterns of mRNA and miRNA expression in cells and tumours depend on heterozygous/hemizygous status of KIT mutations, and deletion/presence of TYR568 & TYR570 residues. Thus each mutation of KIT may drive specific oncogenic pathways.	[Bachet, Jean-Baptiste; Brahimi-Adouane, Sabrina; Emile, Jean-Francois] UVSQ, Fac Med PIFO, Epidemiol & Oncogenese Tumeurs Digest EA4340, Guyancourt, France; [Bachet, Jean-Baptiste] Grp Hosp Pitie Salpetriere, APHP, Hepatogastroenterol Dept, F-75634 Paris, France; [Bachet, Jean-Baptiste] UFR Paris VI, Fac Med Pierre & Marie Curie, Paris, France; [Tabone-Eglinger, Severine; Dessaux, Sophie; Besse, Anthony; Blay, Jean-Yves; Alberti, Laurent] Univ Lyon, Lyon, France; [Brahimi-Adouane, Sabrina; Emile, Jean-Francois] Hop Ambroise Pare, APHP, Dept Pathol, Boulogne, France; [Blay, Jean-Yves] Ctr Leon Berard, Dept Oncol, F-69373 Lyon, France; [Alberti, Laurent] Ctr Leon Berard, Biopathol Dept, F-69373 Lyon, France; [Tabone-Eglinger, Severine; Dessaux, Sophie; Besse, Anthony] Univ Lyon 1, ISPB, F-69365 Lyon, France; [Tabone-Eglinger, Severine; Dessaux, Sophie; Besse, Anthony] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France; [Tabone-Eglinger, Severine; Dessaux, Sophie; Besse, Anthony] Ctr Rech Cancerol Lyon, CNRS, UMR5286, Lyon, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard	Alberti, L (corresponding author), Univ Lyon, Lyon, France.	laurent.alberti@lyon.unicancer.fr	BACHET, Jean-Baptiste/N-6943-2017; Blay, Jean-Yves/N-3966-2016; Alberti, Laurent/HHZ-3296-2022	BACHET, Jean-Baptiste/0000-0003-4337-286X; Blay, Jean-Yves/0000-0001-7190-120X; Alberti, Laurent/0000-0002-7686-1750; TABONE-eglinger, Severine/0000-0003-4247-1321	Conticanet [FP6-018806]; AREP	Conticanet; AREP	This work was supported in part by Conticanet (FP6-018806, INCA) and non profit organism AREP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albig AR, 2008, MICROVASC RES, V76, P7, DOI 10.1016/j.mvr.2008.01.001; Bachet JB, 2009, BRIT J CANCER, V101, P7, DOI 10.1038/sj.bjc.6605117; Bachet JB, 2010, APPL CLIN GENET, V3, P85, DOI 10.2147/TACG.S7191; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; BLUMEJENSEN P, 1991, EMBO J, V10, P4121, DOI 10.1002/j.1460-2075.1991.tb04989.x; Brahimi-Adouane S, 2012, MOL ONCOL IN PRESS; Buus R, 2009, CURR BIOL, V19, P1463, DOI 10.1016/j.cub.2009.07.040; Casali PG, 2008, ANN ONCOL, V19, P35, DOI 10.1093/annonc/mdn080; Cassier PA, 2010, BRIT J CANCER, V103, P165, DOI 10.1038/sj.bjc.6605743; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Ceder R, 2012, AM J PATHOL, V180, P457, DOI 10.1016/j.ajpath.2011.10.016; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560; Davies SR, 2010, INT J ONCOL, V36, P1129, DOI 10.3892/ijo_00000595; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Denk AE, 2011, INT J MOL MED, V28, P721, DOI 10.3892/ijmm.2011.742; Dumont AG, 2012, CARCINOGENESIS, V33, P1674, DOI 10.1093/carcin/bgs221; Emile JF, 2008, LAB INVEST, V88, P456, DOI 10.1038/labinvest.2008.13; Emile JF, 2004, CLIN GASTROENTEROL H, V2, P597, DOI 10.1016/S1542-3565(04)00243-5; Emile JF, 2009, AM J SURG PATHOL, V33, P157, DOI 10.1097/PAS.0b013e3181883765; Emile JF, 2002, DIAGN MOL PATHOL, V11, P107, DOI 10.1097/00019606-200206000-00007; Goebeler V, 2008, MOL BIOL CELL, V19, P5267, DOI 10.1091/mbc.E08-04-0383; Gougelet Angelique, 2011, Sarcoma, V2011, P460650, DOI 10.1155/2011/460650; Haferlach C, 2011, LEUKEMIA, V25, P874, DOI 10.1038/leu.2011.5; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hou CH, 2011, BIOCHEM PHARMACOL, V81, P1286, DOI 10.1016/j.bcp.2011.03.016; Jiang S, 2011, CANCER SCI, V102, P1568, DOI 10.1111/j.1349-7006.2011.01964.x; Karanjawala ZE, 2008, AM J SURG PATHOL, V32, P188, DOI 10.1097/PAS.0b013e31815701f3; Kim JH, 2010, TUMOR BIOL, V31, P541, DOI 10.1007/s13277-010-0067-z; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Lasota J, 2007, LAB INVEST, V87, P1029, DOI 10.1038/labinvest.3700628; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Lind GE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-85; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nagai Y, 2011, ANTICANCER RES, V31, P991; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Price DJ, 1997, J BIOL CHEM, V272, P5915, DOI 10.1074/jbc.272.9.5915; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Scholl S, 2004, J CANCER RES CLIN, V130, P711, DOI 10.1007/s00432-004-0602-7; Shivakrupa R, 2005, CELL SIGNAL, V17, P103, DOI 10.1016/j.cellsig.2004.06.004; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Tabone-Eglinger S, 2008, CLIN CANCER RES, V14, P2285, DOI 10.1158/1078-0432.CCR-07-4102; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Vijayakumar S, 2011, CANCER CELL, V19, P601, DOI 10.1016/j.ccr.2011.03.010; Wallander ML, 2011, APPL IMMUNOHISTO M M, V19, P21, DOI 10.1097/PAI.0b013e3181ec4f95; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Wollberg P, 2003, BIOCHEM J, V370, P1033, DOI 10.1042/BJ20020716; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06; Yan GR, 2011, PROTEOMICS, V11, P912, DOI 10.1002/pmic.201000539	64	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61103	10.1371/journal.pone.0061103	http://dx.doi.org/10.1371/journal.pone.0061103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593401	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300048
J	Brown, PL; Shepard, PD				Brown, Paul Leon; Shepard, Paul D.			Lesions of the Fasciculus Retroflexus Alter Footshock-Induced cFos Expression in the Mesopontine Rostromedial Tegmental Area of Rats	PLOS ONE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; LATERAL HABENULAR NUCLEUS; MIDBRAIN DOPAMINE NEURONS; FOS-LIKE IMMUNOREACTIVITY; NEGATIVE REWARD SIGNALS; SUBSTANTIA-NIGRA; ELECTRICAL-STIMULATION; NOCICEPTIVE RESPONSES; PARS COMPACTA; BASAL GANGLIA	Midbrain dopamine neurons are an essential part of the circuitry underlying motivation and reinforcement. They are activated by rewards or reward-predicting cues and inhibited by reward omission. The lateral habenula (lHb), an epithalamic structure that forms reciprocal connections with midbrain dopamine neurons, shows the opposite response being activated by reward omission or aversive stimuli and inhibited by reward-predicting cues. It has been hypothesized that habenular input to midbrain dopamine neurons is conveyed via a feedforward inhibitory pathway involving the GABAergic mesopontine rostromedial tegmental area. Here, we show that exposing rats to low-intensity footshock (four, 0.5 mA shocks over 20 min) induces cFos expression in the rostromedial tegmental area and that this effect is prevented by lesions of the fasciculus retroflexus, the principal output pathway of the habenula. cFos expression is also observed in the medial portion of the lateral habenula, an area that receives dense DA innervation via the fr and the paraventricular nucleus of the thalamus, a stress sensitive area that also receives dopaminergic input. High-intensity footshock (120, 0.8 mA shocks over 40 min) also elevates cFos expression in the rostromedial tegmental area, medial and lateral aspects of the lateral habenula and the paraventricular thalamus. In contrast to low-intensity footshock, increases in cFos expression within the rostromedial tegmental area are not altered by fr lesions suggesting a role for non-habenular inputs during exposure to highly aversive stimuli. These data confirm the involvement of the lateral habenula in modulating the activity of rostromedial tegmental area neurons in response to mild aversive stimuli and suggest that dopamine input may contribute to footshock-induced activation of cFos expression in the lateral habenula.	[Brown, Paul Leon; Shepard, Paul D.] Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Brown, Paul Leon; Shepard, Paul D.] Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Brown, PL (corresponding author), Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA.	lbrown@mprc.umaryland.edu	Brown, P. Leon/ABD-6581-2021; Shepard, Paul/AAF-1533-2021	Brown, P. Leon/0000-0001-5778-3921	National Association for Research on Schizophrenia and Affective Disorders Independent Investigator Award; National Institutes of Mental Health [R01MH094489]; Ruth L. Kirschstein NRSA Award from the National Institute On Drug Abuse [F31DA030893]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA030893] Funding Source: NIH RePORTER	National Association for Research on Schizophrenia and Affective Disorders Independent Investigator Award; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ruth L. Kirschstein NRSA Award from the National Institute On Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a National Association for Research on Schizophrenia and Affective Disorders Independent Investigator Award (to PDS; bbrfoundation.org), a National Institutes of Mental Health grant (R01MH094489 to PDS; nimh.nih.gov), and a Ruth L. Kirschstein NRSA Award from the National Institute On Drug Abuse (F31DA030893 to PLB; drugabuse.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Brain and Behavior Research Foundation, the National Institute of Mental Health, the National Institute On Drug Abuse, or the National Institutes of Health (nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER H, 1986, NEUROSCIENCE, V17, P469, DOI 10.1016/0306-4522(86)90260-5; Barrot M, 2012, J NEUROSCI, V32, P14094, DOI 10.1523/JNEUROSCI.3370-12.2012; BENABID AL, 1989, NEUROSCI LETT, V96, P289, DOI 10.1016/0304-3940(89)90393-5; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Brinschwitz K, 2010, NEUROSCIENCE, V168, P463, DOI 10.1016/j.neuroscience.2010.03.050; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; BROWN EE, 1992, J NEUROSCI, V12, P4112; CHASTRETTE N, 1991, BRAIN RES, V563, P339, DOI 10.1016/0006-8993(91)91559-J; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; DONG WQ, 1992, NEUROSCIENCE, V48, P933, DOI 10.1016/0306-4522(92)90281-6; Engber TM, 1998, NEUROSCI LETT, V241, P95, DOI 10.1016/S0304-3940(97)00962-2; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; GAO DM, 1990, BRAIN RES, V529, P315, DOI 10.1016/0006-8993(90)90843-Z; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; Garcia-Cabezas MA, 2009, CEREB CORTEX, V19, P424, DOI 10.1093/cercor/bhn093; Geisler S, 2003, J COMP NEUROL, V458, P78, DOI 10.1002/cne.10566; Geisler S, 2008, CNS SPECTRUMS, V13, P484, DOI 10.1017/S1092852900016710; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Goncalves L, 2012, J COMP NEUROL, V520, P1278, DOI 10.1002/cne.22787; GOTTESFELD Z, 1983, BRAIN RES, V275, P299, DOI 10.1016/0006-8993(83)90990-3; Greenwood BN, 2005, BRAIN RES, V1033, P164, DOI 10.1016/j.brainres.2004.11.037; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hamamura T, 1997, BRAIN RES, V767, P140, DOI 10.1016/S0006-8993(97)00697-5; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; KITAHAMA K, 1989, BRAIN RES, V478, P156, DOI 10.1016/0006-8993(89)91489-3; Klemm WR, 2004, MED SCI MONITOR, V10, pRA261; Kowski AB, 2009, NEUROSCIENCE, V161, P1154, DOI 10.1016/j.neuroscience.2009.04.026; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Le Masurier M, 2004, PSYCHOPHARMACOLOGY, V171, P435, DOI 10.1007/s00213-003-1607-7; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; LI YQ, 1993, J COMP NEUROL, V333, P118, DOI 10.1002/cne.903330110; Liu ZH, 2008, NEUROPSYCHOPHARMACOL, V33, P3010, DOI 10.1038/npp.2008.4; MAHIEUX G, 1987, BRAIN RES, V406, P118, DOI 10.1016/0006-8993(87)90776-1; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; MCCULLOCH J, 1980, BRAIN RES, V194, P117, DOI 10.1016/0006-8993(80)91322-0; MCKITRICK DJ, 1993, BRAIN RES, V632, P127, DOI 10.1016/0006-8993(93)91147-K; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; Omelchenko N, 2007, NEUROSCIENCE, V146, P1259, DOI 10.1016/j.neuroscience.2007.02.016; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PHILLIPSON OT, 1982, EXP BRAIN RES, V45, P89; Salas R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00036; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shen XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034323; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SKAGERBERG G, 1984, BRAIN RES, V307, P99, DOI 10.1016/0006-8993(84)90465-7; Stephenson CP, 1999, NEUROSCIENCE, V92, P1011, DOI 10.1016/S0306-4522(99)00049-4; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017047; WECHSLER LR, 1979, J NEUROCHEM, V32, P15, DOI 10.1111/j.1471-4159.1979.tb04504.x; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WOOTEN GF, 1982, P NATL ACAD SCI-BIOL, V79, P3360, DOI 10.1073/pnas.79.10.3360; Zahm DS, 2010, NEUROPSYCHOPHARMACOL, V35, P445, DOI 10.1038/npp.2009.149; Zhu L, 2011, NEUROSCI LETT, V488, P81, DOI 10.1016/j.neulet.2010.11.007	72	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60678	10.1371/journal.pone.0060678	http://dx.doi.org/10.1371/journal.pone.0060678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593280	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300025
J	Granic, A; Potter, H				Granic, Antoneta; Potter, Huntington			Mitotic Spindle Defects and Chromosome Mis-Segregation Induced by LDL/Cholesterol-Implications for Niemann-Pick C1, Alzheimer's Disease, and Atherosclerosis	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; SMOOTH-MUSCLE-CELLS; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E; CHOLESTEROL TRAFFICKING; MOSAIC TRISOMY-21; DNA-REPLICATION; ALCOHOL INTAKE; CYCLE EVENTS; ANEUPLOIDY	Elevated low-density lipoprotein (LDL)-cholesterol is a risk factor for both Alzheimer's disease (AD) and Atherosclerosis (CVD), suggesting a common lipid-sensitive step in their pathogenesis. Previous results show that AD and CVD also share a cell cycle defect: chromosome instability and up to 30% aneuploidy-in neurons and other cells in AD and in smooth muscle cells in atherosclerotic plaques in CVD. Indeed, specific degeneration of aneuploid neurons accounts for 90% of neuronal loss in AD brain, indicating that aneuploidy underlies AD neurodegeneration. Cell/mouse models of AD develop similar aneuploidy through amyloid-beta (A beta) inhibition of specific microtubule motors and consequent disruption of mitotic spindles. Here we tested the hypothesis that, like upregulated A beta, elevated LDL/cholesterol and altered intracellular cholesterol homeostasis also causes chromosomal instability. Specifically we found that: 1) high dietary cholesterol induces aneuploidy in mice, satisfying the hypothesis' first prediction, 2) Niemann-Pick C1 patients accumulate aneuploid fibroblasts, neurons, and glia, demonstrating a similar aneugenic effect of intracellular cholesterol accumulation in humans 3) oxidized LDL, LDL, and cholesterol, but not high-density lipoprotein (HDL), induce chromosome mis-segregation and aneuploidy in cultured cells, including neuronal precursors, indicating that LDL/cholesterol directly affects the cell cycle, 4) LDL-induced aneuploidy requires the LDL receptor, but not A beta, showing that LDL works differently than A beta, with the same end result, 5) cholesterol treatment disrupts the structure of the mitotic spindle, providing a cell biological mechanism for its aneugenic activity, and 6) ethanol or calcium chelation attenuates lipoprotein-induced chromosome mis-segregation, providing molecular insights into cholesterol's aneugenic mechanism, specifically through its rigidifying effect on the cell membrane, and potentially explaining why ethanol consumption reduces the risk of developing atherosclerosis or AD. These results suggest a novel, cell cycle mechanism by which aberrant cholesterol homeostasis promotes neurodegeneration and atherosclerosis by disrupting chromosome segregation and potentially other aspects of microtubule physiology.	[Granic, Antoneta; Potter, Huntington] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Granic, Antoneta; Potter, Huntington] Univ Colorado, Sch Med, Linda Crnic Inst Syndrome, Aurora, CO USA; [Granic, Antoneta] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Newcastle University - UK	Potter, H (corresponding author), Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA.	huntington.potter@ucdenver.edu		Potter, Huntington/0000-0002-4051-2516; Granic, Antoneta/0000-0001-9247-899X	Byrd Alzheimer's Institute; Eric Pfeiffer Chair for Research on Alzheimer's Disease; University of Colorado, Denver; NIA [AG025711, AG037942]; NIH/NCRR Colorado CTSI [UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037942, P50AG025711] Funding Source: NIH RePORTER	Byrd Alzheimer's Institute; Eric Pfeiffer Chair for Research on Alzheimer's Disease; University of Colorado, Denver; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Byrd Alzheimer's Institute, the Eric Pfeiffer Chair for Research on Alzheimer's Disease, The University of Colorado, Denver and the NIA (AG025711; AG037942). Some imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advanced Light Microscopy Core supported in part by NIH/NCRR Colorado CTSI Grant Number UL1 RR025780. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abisambra JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008556; Abramov AY, 2011, AGING CELL, V10, P595, DOI 10.1111/j.1474-9726.2011.00685.x; ADICKES ED, 1988, ALCOHOL ALCOHOLISM, V23, P377, DOI 10.1093/oxfordjournals.alcalc.a044832; Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO;2-M; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Arendt T, 1996, NEUROREPORT, V7, P3047; Arendt T, 2012, MOL NEUROBIOL, V46, P125, DOI 10.1007/s12035-012-8262-0; Arendt T, 2010, AM J PATHOL, V177, P15, DOI 10.2353/ajpath.2010.090955; Badea M G, 1989, Physiologie, V26, P95; Bae MK, 2005, MOL CELLS, V19, P356; Beach TG, 2007, ACTA NEUROPATHOL, V113, P13, DOI 10.1007/s00401-006-0136-y; BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bloch K., 1991, NEW COMPREHENSIVE BI, V20, P363; Boeras DI, 2008, NEUROBIOL AGING, V29, P319, DOI 10.1016/j.neurobiolaging.2006.10.027; Borysov SI, 2011, CELL CYCLE, V10, P1397, DOI 10.4161/cc.10.9.15478; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brust JCM, 2010, INT J ENV RES PUB HE, V7, P1540, DOI 10.3390/ijerph7041540; Burns M, 2002, ANN NY ACAD SCI, V977, P367, DOI 10.1111/j.1749-6632.2002.tb04839.x; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; CASALONE R, 1991, HUM GENET, V87, P139, DOI 10.1007/BF00204169; Christian AE, 1997, J LIPID RES, V38, P2264; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Dashti N, 1996, J LIPID RES, V37, P810; DEMEL RA, 1976, BIOCHIM BIOPHYS ACTA, V457, P109, DOI 10.1016/0304-4157(76)90008-3; Di Castelnuovo A, 2010, INTERN EMERG MED, V5, P291, DOI 10.1007/s11739-010-0346-0; Dolan H, 2010, ANN NEUROL, V68, P231, DOI 10.1002/ana.22055; Duesberg P, 2003, CELL CYCLE, V2, P202, DOI 10.4161/cc.2.3.382; Eckert GP, 2005, SUB CELL BIOCHEM, V38, P319; EPSTEIN CJ, 1990, AM J MED GENET, P31; Geller LN, 1999, NEUROBIOL DIS, V6, P167, DOI 10.1006/nbdi.1999.0236; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Granic A, 2011, GENETICS ETIOLOGY SY, P159; Granic A, 2010, MOL BIOL CELL, V21, P511, DOI 10.1091/mbc.E09-10-0850; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Guizzetti M, 2007, J BIOL CHEM, V282, P18740, DOI 10.1074/jbc.M702398200; HARDY J, 1989, LANCET, V2, P743; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Hartel S, 1998, ANAL BIOCHEM, V258, P277, DOI 10.1006/abio.1998.2594; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Honig LS, 2005, NEUROLOGY, V64, P494, DOI 10.1212/01.WNL.0000150886.50187.30; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Iourov IY, 2009, NEUROBIOL DIS, V34, P212, DOI 10.1016/j.nbd.2009.01.003; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kai Y, 2009, CELL RES, V19, P247, DOI 10.1038/cr.2008.305; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; King RW, 2008, BBA-REV CANCER, V1786, P4, DOI 10.1016/j.bbcan.2008.07.007; Kingsbury MA, 2006, CELL MOL LIFE SCI, V63, P2626, DOI 10.1007/s00018-006-6169-5; Lee VMY, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P257; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Li JH, 1997, CELL, V90, P917, DOI 10.1016/S0092-8674(00)80356-6; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Lopes JP, 2009, J ALZHEIMERS DIS, V16, P541, DOI 10.3233/JAD-2009-0993; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marchenko Steven, 2007, J Vis Exp, P263, DOI 10.3791/263; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Matturri L, 1997, Cardiologia, V42, P833; Matturri L, 2001, ATHEROSCLEROSIS, V154, P755, DOI 10.1016/S0021-9150(00)00488-3; McConnell MJ, 2004, J NEUROSCI, V24, P8090, DOI 10.1523/JNEUROSCI.2263-04.2004; Migliore L, 2006, NEUROBIOL AGING, V27, P710, DOI 10.1016/j.neurobiolaging.2005.03.025; Migliore L, 1999, CYTOGENET CELL GENET, V87, P41, DOI 10.1159/000015389; Migliore L, 1997, HUM GENET, V101, P299, DOI 10.1007/s004390050632; Migliore L, 2011, MUTAGENESIS, V26, P85, DOI 10.1093/mutage/geq067; Miniati P, 2001, INT J BIOL MARKER, V16, P167, DOI 10.1177/172460080101600302; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Murry CE, 1997, AM J PATHOL, V151, P697; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; Pacey L., 2006, PROTOC EXCH, DOI [10.1038/nprot.2006.215, DOI 10.1038/NPROT.2006.215]; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Peake KB, 2010, FEBS LETT, V584, P2731, DOI 10.1016/j.febslet.2010.04.047; Peterson Suzanne E., 2008, V438, P197, DOI 10.1007/978-1-59745-133-8_16; POTTER H, 1995, RESEARCH ADVANCES IN ALZHEIMER'S DISEASE AND RELATED DISORDERS, P643; POTTER H, 1991, AM J HUM GENET, V48, P1192; Potter Huntington, 2012, Int J Alzheimers Dis, V2012, P489428, DOI 10.1155/2012/489428; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ringman JM, 2008, ARCH NEUROL-CHICAGO, V65, P412, DOI 10.1001/archneur.65.3.412; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Rossi G, 2008, CELL CYCLE, V7, P1788, DOI 10.4161/cc.7.12.6012; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; ROWE IF, 1989, LANCET, V2, P229; SCHAPIRO M B, 1989, Neurology, V39, P169; SCHROEDER F, 1988, BIOCHIM BIOPHYS ACTA, V946, P85, DOI 10.1016/0005-2736(88)90460-9; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; SMITH TW, 1995, J NEUROPATH EXP NEUR, V54, P297, DOI 10.1097/00005072-199505000-00002; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Sparks DL, 1997, ANN NY ACAD SCI, V826, P128, DOI 10.1111/j.1749-6632.1997.tb48466.x; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Thomas P, 2008, MUTAGENESIS, V23, P57, DOI 10.1093/mutage/gem044; Trippi F, 2001, MUTAGENESIS, V16, P323, DOI 10.1093/mutage/16.4.323; Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124; VANNI R, 1991, DIS MARKERS, V9, P81; Varvel NH, 2008, J NEUROSCI, V28, P10786, DOI 10.1523/JNEUROSCI.2441-08.2008; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Westra JW, 2009, NEURODEGENER DIS, V6, P221, DOI 10.1159/000236901; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7; Woods NK, 2012, ADV EXP MED BIOL, V740, P1193, DOI 10.1007/978-94-007-2888-2_54; Yang AH, 2003, J NEUROSCI, V23, P10454; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558; Yurov YB, 2011, THESCIENTIFICWORLDJO, V11, P2602, DOI 10.1100/2011/625690; Zhang JR, 2008, J CLIN INVEST, V118, P2281, DOI [10.1172/JCI32561, 10.1172/JC132561]; Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0; Zhang M, 2010, BRAIN PATHOL, V20, P367, DOI 10.1111/j.1750-3639.2009.00286.x; Zivkovic L, 2006, MECH AGEING DEV, V127, P892, DOI 10.1016/j.mad.2006.09.004	114	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60718	10.1371/journal.pone.0060718	http://dx.doi.org/10.1371/journal.pone.0060718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593294	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300029
J	Langenfeld, E; Hong, CC; Lanke, G; Langenfeld, J				Langenfeld, Elaine; Hong, Charles C.; Lanke, Gandhi; Langenfeld, John			Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; OVARIAN-CANCER; TUMOR-GROWTH; CYCLE ARREST; EXPRESSION; ACTIVATION; CARCINOMA; APOPTOSIS; DIFFERENTIATION; BMP-2	Bone morphogenetic proteins (BMPs) are highly conserved morphogens that are essential for normal development. BMP-2 is highly expressed in the majority of non-small cell lung carcinomas (NSCLC) but not in normal lung tissue or benign lung tumors. The effects of the BMP signaling cascade on the growth and survival of cancer cells is poorly understood. We show that BMP signaling is basally active in lung cancer cell lines, which can be effectively inhibited with selective antagonists of the BMP type I receptors. Lung cancer cell lines express alk2, alk3, and alk6 and inhibition of a single BMP receptor was not sufficient to decrease signaling. Inhibition of more than one type I receptor was required to decrease BMP signaling in lung cancer cell lines. BMP receptor antagonists and silencing of BMP type I receptors with siRNA induced cell death, inhibited cell growth, and caused a significant decrease in the expression of inhibitor of differentiation (Id1, Id2, and Id3) family members, which are known to regulate cell growth and survival in many types of cancers. BMP receptor antagonists also decreased clonogenic cell growth. Knockdown of Id3 significantly decreased cell growth and induced cell death of lung cancer cells. H1299 cells stably overexpressing Id3 were resistant to growth suppression and induction of cell death induced by the BMP antagonist DMH2. These studies suggest that BMP signaling promotes cell growth and survival of lung cancer cells, which is mediated through its regulation of Id family members. Selective antagonists of the BMP type I receptors represents a potential means to pharmacologically treat NSCLC and other carcinomas with an activated BMP signaling cascade.	[Langenfeld, Elaine; Lanke, Gandhi; Langenfeld, John] UMDNJ Robert Wood Johnson Med Sch, Div Thorac Surg, Dept Surg, New Brunswick, NJ USA; [Langenfeld, Elaine; Lanke, Gandhi; Langenfeld, John] UMDNJ Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Vet Affairs TVHS, Nashville, TN 37212 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Vanderbilt University; Vanderbilt University	Langenfeld, J (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Div Thorac Surg, Dept Surg, New Brunswick, NJ USA.	langenje@umdnj.edu	Lanke, Gandhi/T-5727-2019	Lanke, Gandhi/0000-0002-5577-2257	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL104040] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Beck SE, 2007, CELL SIGNAL, V19, P1465, DOI 10.1016/j.cellsig.2007.01.017; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen SS, 2011, BLOOD, V117, P862, DOI 10.1182/blood-2010-05-284638; Gray MJ, 2008, ONCOGENE, V27, P7192, DOI 10.1038/onc.2008.356; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Izumi M, 2001, J BIOL CHEM, V276, P31133, DOI 10.1074/jbc.M101463200; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Kiesslich T, 2011, CURR PHARM BIOTECHNO, P24; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Langenfeld EM, 2005, MOL CANCER RES, V3, P679, DOI 10.1158/1541-7786.MCR-05-0124; Langenfeld EM, 2005, ANN THORAC SURG, V80, P1028, DOI 10.1016/j.athoracsur.2005.03.094; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Langenfeld EM, 2005, ONCOGENE; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Leite M, 1999, ANAL CELL PATHOL, V19, P139, DOI 10.1155/1999/176515; Li B, 2009, INT J CANCER, V125, P2576, DOI 10.1002/ijc.24675; Lin JZ, 2010, CLIN CANCER RES, V16, P77, DOI 10.1158/1078-0432.CCR-08-2362; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Mern DS, 2010, BRIT J CANCER, V103, P1237, DOI 10.1038/sj.bjc.6605897; Mern DS, 2010, BREAST CANCER RES TR, V124, P623, DOI 10.1007/s10549-010-0810-6; Miyazaki H, 2004, ONCOGENE, V23, P9326, DOI 10.1038/sj.onc.1208127; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Noetzel E, 2008, Pathologe, V29 Suppl 2, P319, DOI 10.1007/s00292-008-1038-7; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Park Y, 2010, MED ONCOL, V27, P1192, DOI 10.1007/s12032-009-9358-x; Pizette S, 2001, DEVELOPMENT, V128, P4463; Ponz-Sarvise M, 2011, CLIN CANCER RES, V17, P4155, DOI 10.1158/1078-0432.CCR-10-3381; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Raida M, 2005, INT J ONCOL, V26, P1465; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rollin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004158; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Rothschild SI, LUNG, V71, P306; Shepherd TG, 2008, GENE, V414, P95, DOI 10.1016/j.gene.2008.02.015; Soda H, 1998, ANTI-CANCER DRUG, V9, P327, DOI 10.1097/00001813-199804000-00006; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; Sugimori K, 2005, J BONE MINER METAB, V23, P411, DOI 10.1007/s00774-005-0622-7; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tada A, 1998, ONCOL REP, V5, P1137; Umetani N, 2005, ONCOGENE, V24, P4721, DOI 10.1038/sj.onc.1208538; Yang X, 1999, DEVELOPMENT, V126, P1571; Ye L, FRONT, V16, P865; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yuen HF, 2008, MODERN PATHOL, V21, P1436, DOI 10.1038/modpathol.2008.94; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	60	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61256	10.1371/journal.pone.0061256	http://dx.doi.org/10.1371/journal.pone.0061256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593444	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300067
J	Peng, T; Du, YX; Zhang, J; Li, JZ; Liu, YX; Zhao, YF; Sun, HZ; Zhao, QZ				Peng, Ting; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Liu, Yanxia; Zhao, Yafan; Sun, Hongzheng; Zhao, Quanzhi			Genome-Wide Analysis of 24-nt siRNAs Dynamic Variations during Rice Superior and Inferior Grain Filling	PLOS ONE			English	Article							SMALL RNAS; POSTANTHESIS DEVELOPMENT; ABSCISIC-ACID; EXPRESSION; MICRORNAS; PLANT; MIR172; BIOGENESIS; SPIKELETS; METHYLATION	24 nt-siRNAs are the most abundant small interfering RNAs in rice grains aside from microRNAs. To investigate the roles that 24 nt-siRNAs played in the poor grain filling of rice inferior grains, dynamic variations of 24 nt-siRNAs in inferior grains were compared with those of superior grains by using small RNA deep sequencing technology. The results showed that 24 nt-siRNAs derived from multiple regions of rice genome, and the maintenance of the two strands of 24 nt-siRNA duplex was a non-random process. The amounts of 24 nt-siRNAs declined with the process of grain filling in both superior and inferior grains, but 24 nt-siRNAs in inferior grains was much higher than that of superior grains in each period we sampled. Bioinformatics prediction indicated that 24 nt-siRNAs targeted on more genes involved in most of the known KEGG rice pathways, such as the starch and sucrose biosynthesis pathway. Combined with digital gene expression profiling of target genes, 24 nt-siRNAs mapped on the antisense strands of exons were specifically investigated, but the abundance of 24 nt-siRNAs did not show negative correlations with their corresponding target genes. The results indicated that 24 nt-siRNAs were not involved in down-regulation of target genes. The potential biological meanings for this inconsistency were probably the results of methylation directed gene expression activation, or competition for small RNA stability methylation.	[Sun, Hongzheng] Henan Agr Univ, Henan Engn Lab Rice, Zhengzhou, Peoples R China; Henan Agr Univ, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Agricultural University	Sun, HZ (corresponding author), Henan Agr Univ, Henan Engn Lab Rice, Zhengzhou, Peoples R China.	sunhongzheng@foxmail.com; qzzhaoh@126.com			National Natural Science Foundation of China [31200973, 31271651]; Supported Program for Innovative Research Team (in Science and Technology) in University of Henan Province [2010IRTSTHN005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supported Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This work was supported by the National Natural Science Foundation of China (grant No. 31200973to HS), National Natural Science Foundation of China (grant No. 31271651 to QZ), and Supported Program for Innovative Research Team (in Science and Technology) in University of Henan Province (grant No 2010IRTSTHN005 to QZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bonnet E, 2006, NEW PHYTOL, V171, P451, DOI 10.1111/j.1469-8137.2006.01806.x; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cho HJ, 2012, FEBS LETT, V586, P2332, DOI 10.1016/j.febslet.2012.05.035; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Grigorova B, 2011, DEVELOPMENT, V138, P2451, DOI 10.1242/dev.058362; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Jung JH, 2011, PLANT MOL BIOL, V76, P35, DOI 10.1007/s11103-011-9759-z; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim VN, 2005, MOL CELLS, V19, P1; Lee JH, 2012, PLANT SIGNAL BEHAV, V7, P1151, DOI 10.4161/psb.21366; Liu B, 2007, PLANT CELL, V19, P2705, DOI 10.1105/tpc.107.052209; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Seitz H, 2010, CURR BIOL, V20, pR108, DOI 10.1016/j.cub.2009.12.027; Snead NM, 2010, WIRES RNA, V1, P117, DOI 10.1002/wrna.14; Song X, 2011, PLANT J; Sun X, 2012, MOL BIOL REP, V39, P9463, DOI 10.1007/s11033-012-1811-9; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wollmann H, 2010, DEVELOPMENT, V137, P3633, DOI 10.1242/dev.036673; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xu GR, 2010, RNA, V16, P1610, DOI 10.1261/rna.2194910; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu B, 2010, NUCLEIC ACIDS RES, V38, P5844, DOI 10.1093/nar/gkq348; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61029	10.1371/journal.pone.0061029	http://dx.doi.org/10.1371/journal.pone.0061029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593380	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300043
J	Rakotosamimanana, N; Doherty, TM; Andriamihantasoa, LH; Richard, V; Gicquel, B; Soares, JL; Zumla, A; Razanamparany, VR				Rakotosamimanana, Niaina; Doherty, T. Mark; Andriamihantasoa, Lova H.; Richard, Vincent; Gicquel, Brigitte; Soares, Jean-Louis; Zumla, Alimuddin; Razanamparany, Voahangy Rasolofo			Expression of TNF-Alpha-Dependent Apoptosis-Related Genes in the Peripheral Blood of Malagasy Subjects with Tuberculosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; MACROPHAGE APOPTOSIS; T-CELLS; MECHANISMS; INFECTION; PATHWAY; STRAINS; RELEASE	The majority of Mycobacterium tuberculosis (Mtb) infections remain asymptomatic with only up to 10% progressing to clinical tuberculosis. However, the constituents of the effective "protective immunity'' against tuberculosis responsible for containing most infections remain unknown. Evaluating gene transcriptional profiles in tuberculosis clinical cohorts is one approach to understanding the spectrum of tuberculosis progression. It is clear that apoptosis plays a role in the control of tuberculosis but the utility of apoptosis-related genes as surrogate markers of protection against tuberculosis has not been well investigated. To characterize potential surrogate markers that could discriminate different phases of the clinical tuberculosis spectrum, we investigated gene expression of several TNF-alpha dependent apoptotic genes (TNFR1, TNFR2, FLICE, FLIPs) by real-time RT-PCR of peripheral blood cells from cohorts of individuals with active tuberculosis or potential exposure to tuberculosis. Newly diagnosed tuberculosis patients (n = 23), their close household contacts (n = 80), and community controls (n = 46) were tested at intervals over a period of up to two years. Latent infection or previous Mtb contact was assessed by ELISPOT and TST and complete blood counts were performed during the follow up. Results showed significant upregulation of FLIPs expression by infected individuals regardless of clinical status at entry to the study. A higher percentage of lymphocytes was found in the infected household contacts that remained healthy. In contrast, in individuals with active TB, a significant upregulation of TNFR2 expression, a significantly higher percentage of monocytes and a significantly decreased lymphocyte count were seen, compared to subjects that remained healthy. Moreover, the household contacts who subsequently developed signs of TB also had a significantly high number of monocytes. These data suggest tuberculosis may be associated with decreased T-cell survival (perhaps due to apoptosis) while inhibition of apoptosis in monocytes could lead to a relative increase in these cells: a situation predicted to favour Mtb.	[Rakotosamimanana, Niaina; Andriamihantasoa, Lova H.; Razanamparany, Voahangy Rasolofo] Inst Pasteur Madagascar, Unite Mycobacteries, Antananarivo, Madagascar; [Doherty, T. Mark] Staten Serum Inst, Copenhagen, Denmark; [Richard, Vincent; Soares, Jean-Louis] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Statens Serum Institut; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London	Razanamparany, VR (corresponding author), Inst Pasteur Madagascar, Unite Mycobacteries, Antananarivo, Madagascar.	vrasolof@pasteur.mg	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735; Vincent, RICHARD/0000-0002-6961-1753; Rakotosamimanana, Niaina/0000-0002-2352-9797	Institut Pasteur de Madagascar core budget; VACSIS project; European Commission through the EU INCO [ICA4-CT-2002-10052]	Institut Pasteur de Madagascar core budget; VACSIS project; European Commission through the EU INCO	This work was funded by the Institut Pasteur de Madagascar core budget and was part of the VACSIS project, which was funded by the European Commission through the EU INCO contract ICA4-CT-2002-10052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/678570; Abebe M, 2010, EUR J IMMUNOL, V40, P291, DOI 10.1002/eji.200939856; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Hirsch CS, 2005, J CLIN IMMUNOL, V25, P353, DOI 10.1007/s10875-005-4841-4; Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Hoft DF, 2002, J INFECT DIS, V186, P1448, DOI 10.1086/344359; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Kundu M, 2009, NAT IMMUNOL, V10, P918, DOI 10.1038/ni.1754; Li BQ, 1998, J IMMUNOL, V161, P1558; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Mohan AK, 2004, CLIN INFECT DIS, V39, P295, DOI 10.1086/421494; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oddo M, 1998, J IMMUNOL, V160, P5448; Perskvist N, 2002, J IMMUNOL, V168, P6358, DOI 10.4049/jimmunol.168.12.6358; Rakotosamimanana N, 2010, CLIN VACCINE IMMUNOL, V17, P1094, DOI 10.1128/CVI.00049-10; Rook GAW, 2005, VACCINE, V23, P2115, DOI 10.1016/j.vaccine.2005.01.069; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; Sutherland JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025230; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; Turner J, 2001, AM J RESP CELL MOL, V24, P203, DOI 10.1165/ajrcmb.24.2.4370; Uriz J, 2007, AN SIST SANIT NAVAR, V30, P131; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	31	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61154	10.1371/journal.pone.0061154	http://dx.doi.org/10.1371/journal.pone.0061154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593415	Green Submitted, Green Published, gold			2022-12-27	WOS:000317385300053
J	Tang, Y; Jiang, WX; Liao, J; Wang, W; Luo, AJ				Tang, Yan; Jiang, Weixiong; Liao, Jian; Wang, Wei; Luo, Aijing			Identifying Individuals with Antisocial Personality Disorder Using Resting-State fMRI	PLOS ONE			English	Article							INFERIOR FRONTAL-CORTEX; SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; PARIETAL CORTEX; DISCRIMINATIVE ANALYSIS; RESPONSE-INHIBITION; PREFRONTAL CORTEX; PERMUTATION TESTS; HUMAN CEREBELLUM; DEFAULT NETWORK	Antisocial personality disorder (ASPD) is closely connected to criminal behavior. A better understanding of functional connectivity in the brains of ASPD patients will help to explain abnormal behavioral syndromes and to perform objective diagnoses of ASPD. In this study we designed an exploratory data-driven classifier based on machine learning to investigate changes in functional connectivity in the brains of patients with ASPD using resting state functional magnetic resonance imaging (fMRI) data in 32 subjects with ASPD and 35 controls. The results showed that the classifier achieved satisfactory performance (86.57% accuracy, 77.14% sensitivity and 96.88% specificity) and could extract stabile information regarding functional connectivity that could be used to discriminate ASPD individuals from normal controls. More importantly, we found that the greatest change in the ASPD subjects was uncoupling between the default mode network and the attention network. Moreover, the precuneus, superior parietal gyrus and cerebellum exhibited high discriminative power in classification. A voxel-based morphometry analysis was performed and showed that the gray matter volumes in the parietal lobule and white matter volumes in the precuneus were abnormal in ASPD compared to controls. To our knowledge, this study was the first to use resting-state fMRI to identify abnormal functional connectivity in ASPD patients. These results not only demonstrated good performance of the proposed classifier, which can be used to improve the diagnosis of ASPD, but also elucidate the pathological mechanism of ASPD from a resting-state functional integration viewpoint.	[Tang, Yan; Jiang, Weixiong; Liao, Jian; Wang, Wei] Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China; [Tang, Yan; Jiang, Weixiong] Cent S Univ, Sch Geosci & Infophys, Biomed Engn Lab, Changsha, Hunan, Peoples R China; [Jiang, Weixiong] Hunan First Normal Univ, Dept Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Wang, Wei; Luo, Aijing] Cent S Univ, Coll Hunan Prov, Key Lab Med Informat Res, Changsha, Hunan, Peoples R China	Central South University; Central South University; Hunan First Normal University; Central South University	Jiang, WX (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China.	wawe01cn@yahoo.com.cn			Science and Technology Plan Funded of Hunan Province [2009JT3014]	Science and Technology Plan Funded of Hunan Province	This study was supported by Science and Technology Plan Funded of Hunan Province (NO: 2009JT3014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Bellebaum C, 2007, CEREBELLUM, V6, P184, DOI 10.1080/14734220601169707; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 2011, COGNITIVE NEUROSCIEN, V89; Caspers S, 2012, CEREB CORTEX; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Cutini S, 2008, NEUROIMAGE, V42, P945, DOI 10.1016/j.neuroimage.2008.05.013; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Dolan RJ, 1998, BRAIN, V121, P545, DOI 10.1093/brain/121.4.545; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Exner C, 2004, NEUROLOGY, V63, P2132, DOI 10.1212/01.WNL.0000146197.44568.CD; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Forstmann BU, 2008, J NEUROSCI, V28, P9790, DOI 10.1523/JNEUROSCI.1465-08.2008; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Govindarajulu Z., 1992, TECHNOMETRICS, V34, P108, DOI [10.1080/00401706.1992.10485252, DOI 10.2307/1269571]; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hawkins KM, 2012, J COGN NEUROSCI; Jastorff J, 2011, CEREB CORTEX, V21, P318, DOI 10.1093/cercor/bhq098; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Kolb B., 2015, FUNDAMENTALS HUMAN N; Lindner A, 2010, J NEUROSCI, V30, P11715, DOI 10.1523/JNEUROSCI.2849-09.2010; Liu CL, 2006, NEUROREPORT, V17, P1397, DOI 10.1097/01.wnr.0000233090.00463.35; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lopez-Caneda E, 2012, ADDICTION, V107, P1796, DOI 10.1111/j.1360-0443.2012.03908.x; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Meriaux S, 2006, HUM BRAIN MAPP, V27, P402, DOI 10.1002/hbm.20251; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Partridge J, 2010, BRIT J HOSP MED, V71, P712, DOI 10.12968/hmed.2010.71.12.712; Pedersen JR, 1998, NEUROIMAGE, V8, P214, DOI 10.1006/nimg.1998.0362; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Peterson, 1989, ATTENTION SYSTEM HUM; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rothbart M.K., 2011, BECOMING WHO WE ARE; Rothbart MK, 2011, EMOT REV, V3, P207, DOI 10.1177/1754073910387943; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Samuel DB, 2010, J PERS DISORD, V24, P721, DOI 10.1521/pedi.2010.24.6.721; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schoch B, 2006, NEUROIMAGE, V30, P36, DOI 10.1016/j.neuroimage.2005.09.018; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Tang Y, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-50; Tao H, 2011, MOL PSYCHIAT; Tavano A, 2007, BRAIN, V130, P2646, DOI 10.1093/brain/awm201; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vince G, 2006, NEWSCIENTIST; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Wang QF, 2012, NEUROIMAGE, V59, P1085, DOI 10.1016/j.neuroimage.2011.09.035; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; WIDIGER TA, 1994, J ABNORM PSYCHOL, V103, P78, DOI 10.1037/0021-843X.103.1.78; Wolf U, 2009, J NEUROPSYCH CLIN N, V21, P245, DOI 10.1176/appi.neuropsych.21.3.245; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	79	50	51	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60652	10.1371/journal.pone.0060652	http://dx.doi.org/10.1371/journal.pone.0060652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593272	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300024
J	Zhao, DS; Wu, SH; Yin, YH				Zhao, Dongsheng; Wu, Shaohong; Yin, Yunhe			Responses of Terrestrial Ecosystems' Net Primary Productivity to Future Regional Climate Change in China	PLOS ONE			English	Article							CARBON BALANCE; NATURAL ECOSYSTEMS; VARIATION TRENDS; TIBETAN PLATEAU; TREE GROWTH; DYNAMICS; VEGETATION; MONSOON; FORESTS; DRIVEN	The impact of regional climate change on net primary productivity (NPP) is an important aspect in the study of ecosystems' response to global climate change. China's ecosystems are very sensitive to climate change owing to the influence of the East Asian monsoon. The Lund-Potsdam-Jena Dynamic Global Vegetation Model for China (LPJ-CN), a global dynamical vegetation model developed for China's terrestrial ecosystems, was applied in this study to simulate the NPP changes affected by future climate change. As the LPJ-CN model is based on natural vegetation, the simulation in this study did not consider the influence of anthropogenic activities. Results suggest that future climate change would have adverse effects on natural ecosystems, with NPP tending to decrease in eastern China, particularly in the temperate and warm temperate regions. NPP would increase in western China, with a concentration in the Tibetan Plateau and the northwest arid regions. The increasing trend in NPP in western China and the decreasing trend in eastern China would be further enhanced by the warming climate. The spatial distribution of NPP, which declines from the southeast coast to the northwest inland, would have minimal variation under scenarios of climate change.	[Zhao, Dongsheng; Wu, Shaohong; Yin, Yunhe] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Wu, SH (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	wush@igsnrr.ac.cn			National Scientific Technical Supporting Programs during the 12th Five-year Plan of China [2012BAC19B04, 2012BAC19B10]	National Scientific Technical Supporting Programs during the 12th Five-year Plan of China	This study was supported by the National Scientific Technical Supporting Programs during the 12th Five-year Plan of China (2012BAC19B04, 2012BAC19B10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelet D, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001508; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Ding YH, 2005, METEOROL ATMOS PHYS, V89, P117, DOI 10.1007/s00703-005-0125-z; Doherty RM, 2010, GLOBAL CHANGE BIOL, V16, P617, DOI 10.1111/j.1365-2486.2009.01997.x; Gerten D, 2004, J HYDROL, V286, P249, DOI 10.1016/j.jhydrol.2003.09.029; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hou Ying-Yu, 2007, Yingyong Shengtai Xuebao, V18, P1546; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Ji JJ, 2008, SCI CHINA SER D, V51, P885, DOI 10.1007/s11430-008-0039-y; Jones RG, 2004, GENERATING HIGH RESO, P40; Ju WM, 2007, J ENVIRON MANAGE, V85, P538, DOI 10.1016/j.jenvman.2006.04.028; Koca D, 2006, CLIMATIC CHANGE, V78, P381, DOI 10.1007/s10584-005-9030-1; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Liang EY, 2003, ANN FOREST SCI, V60, P145, DOI 10.1051/forest:2003007; Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012; McGregor JL, 1997, METEOROL ATMOS PHYS, V63, P105, DOI 10.1007/BF01025367; Morales P, 2007, GLOBAL CHANGE BIOL, V13, P108, DOI 10.1111/j.1365-2486.2006.01289.x; Nakicenovic, 2000, SPEC REP EM SCEN SRE; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Ni J, 2000, MT RES DEV, V20, P80, DOI 10.1659/0276-4741(2000)020[0080:ASOBOT]2.0.CO;2; Ni J, 2003, FOREST ECOL MANAG, V176, P485, DOI 10.1016/S0378-1127(02)00312-2; Ni J, 2000, GLOBAL ECOL BIOGEOGR, V9, P463, DOI 10.1046/j.1365-2699.2000.00206.x; ODUM E P, 1971, P574; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; [许吟隆 Xu Yinlong], 2004, [中国农业气象, Agricultural Meteorology of China], V25, P5; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Taskforce on China's National Assessment Report on Climate Change, 2007, CHIN NAT ASS REP CLI; Tian HQ, 2003, GLOBAL PLANET CHANGE, V37, P201, DOI 10.1016/S0921-8181(02)00205-9; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Wu SH, 2010, INT J CLIMATOL, V30, P866, DOI 10.1002/joc.1938; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395; [张时煌 Zhang Shihuang], 2004, [气候与环境研究, Climatic and environmental research], V9, P65; Zhao Dong-sheng, 2011, Yingyong Shengtai Xuebao, V22, P897; Zhao DS, 2011, REG ENVIRON CHANGE, V11, P905, DOI 10.1007/s10113-011-0228-7; Zheng D, 1996, SCI CHINA SER D, V39, P410	40	58	65	7	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60849	10.1371/journal.pone.0060849	http://dx.doi.org/10.1371/journal.pone.0060849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593325	Green Published, gold			2022-12-27	WOS:000317383200021
J	Anantha, RW; Alcivar, AL; Ma, JL; Cai, H; Simhadri, S; Ule, J; Konig, J; Xia, B				Anantha, Rachel W.; Alcivar, Allen L.; Ma, Jianglin; Cai, Hong; Simhadri, Srilatha; Ule, Jernej; Koenig, Julian; Xia, Bing			Requirement of Heterogeneous Nuclear Ribonucleoprotein C for BRCA Gene Expression and Homologous Recombination	PLOS ONE			English	Article							HNRNP C; FANCONI-ANEMIA; DNA-DAMAGE; PROTEINS; PALB2; RNA; CANCER; REPAIR; PATHWAY; RAD51	Background: Heterogeneous nuclear ribonucleoprotein C1/C2 (hnRNP C) is a core component of 40S ribonucleoprotein particles that bind pre-mRNAs and influence their processing, stability and export. Breast cancer tumor suppressors BRCA1, BRCA2 and PALB2 form a complex and play key roles in homologous recombination (HR), DNA double strand break (DSB) repair and cell cycle regulation following DNA damage. Methods: PALB2 nucleoprotein complexes were isolated using tandem affinity purification from nuclease-solubilized nuclear fraction. Immunofluorescence was used for localization studies of proteins. siRNA-mediated gene silencing and flow cytometry were used for studying DNA repair efficiency and cell cycle distribution/checkpoints. The effect of hnRNP C on mRNA abundance was assayed using quantitative reverse transcriptase PCR. Results and Significance: We identified hnRNP C as a component of a nucleoprotein complex containing breast cancer suppressor proteins PALB2, BRCA2 and BRCA1. Notably, other components of the 40S ribonucleoprotein particle were not present in the complex. hnRNP C was found to undergo significant changes of sub-nuclear localization after ionizing radiation (IR) and to partially localize to DNA damage sites. Depletion of hnRNP C substantially altered the normal balance of repair mechanisms following DSB induction, reducing HR usage in particular, and impaired S phase progression after IR. Moreover, loss of hnRNP C strongly reduced the abundance of key HR proteins BRCA1, BRCA2, RAD51 and BRIP1, which can be attributed, at least in part, to the downregulation of their mRNAs due to aberrant splicing. Our results establish hnRNP C as a key regulator of BRCA gene expression and HR-based DNA repair. They also suggest the existence of an RNA regulatory program at sites of DNA damage, which involves a unique function of hnRNP C that is independent of the 40S ribonucleoprotein particles and most other hnRNP proteins.	[Anantha, Rachel W.; Alcivar, Allen L.; Ma, Jianglin; Cai, Hong; Simhadri, Srilatha; Xia, Bing] Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA; [Anantha, Rachel W.; Alcivar, Allen L.; Ma, Jianglin; Cai, Hong; Simhadri, Srilatha; Xia, Bing] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Ule, Jernej; Koenig, Julian] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; MRC Laboratory Molecular Biology	Xia, B (corresponding author), Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA.	xiabi@umdnj.edu	Ule, Jernej/C-6315-2013	Ule, Jernej/0000-0002-2452-4277; Ma, jianglin/0000-0003-1135-6339; Konig, Julian/0000-0002-9398-5421	National Cancer Institute [R01CA138804]; American Cancer Society [RSG TBG-119822]; Cancer Institute of New Jersey; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0486]; MRC [MC_U105185858] Funding Source: UKRI; Medical Research Council [MC_U105185858] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA138804] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Cancer Institute of New Jersey; Department of Defense Breast Cancer Research Program(United States Department of Defense); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Cancer Institute (R01CA138804 to BX), the American Cancer Society (RSG TBG-119822 to BX), and the Cancer Institute of New Jersey (BX). RWA is supported by a postdoctoral fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-10-1-0486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hayakawa T, 2010, J CELL SCI, V123, P1124, DOI 10.1242/jcs.060178; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Hossain MN, 2007, MOL CELL BIOCHEM, V296, P151, DOI 10.1007/s11010-006-9308-2; HUANG M, 1994, MOL CELL BIOL, V14, P518, DOI 10.1128/MCB.14.1.518; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P1212, DOI 10.1021/bi951974k; Menzel T, 2011, EMBO REP, V12, P705, DOI 10.1038/embor.2011.99; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Soltaninassab SR, 1998, NUCLEIC ACIDS RES, V26, P3410, DOI 10.1093/nar/26.14.3410; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Sy SMH, 2009, J BIOL CHEM, V284, P21127, DOI 10.1074/jbc.C109.023937; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Thakur S, 2003, MOL CELL BIOL, V23, P3774, DOI 10.1128/MCB.23.11.3774-3787.2003; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Williamson DJ, 2000, MOL CELL BIOL, V20, P4094, DOI 10.1128/MCB.20.11.4094-4105.2000; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	44	51	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61368	10.1371/journal.pone.0061368	http://dx.doi.org/10.1371/journal.pone.0061368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585894	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600108
J	Deming, DA; Leystra, AA; Farhoud, M; Nettekoven, L; Clipson, L; Albrecht, D; Washington, MK; Sullivan, R; Weichert, JP; Halberg, RB				Deming, Dustin A.; Leystra, Alyssa A.; Farhoud, Mohammed; Nettekoven, Laura; Clipson, Linda; Albrecht, Dawn; Washington, Mary Kay; Sullivan, Ruth; Weichert, Jamey P.; Halberg, Richard B.			mTOR Inhibition Elicits a Dramatic Response in PI3K-Dependent Colon Cancers	PLOS ONE			English	Article							PREDICT RESPONSE; MUTATIONS; PATHWAY; GROWTH; PI3K; GENE; MEK; PI3K/AKT/MTOR; ACTIVATION; BREAST	The phosphatidylinositide-3-kinase (PI3K) signaling pathway is critical for multiple cellular functions including metabolism, proliferation, angiogenesis, and apoptosis, and is the most commonly altered pathway in human cancers. Recently, we developed a novel mouse model of colon cancer in which tumors are initiated by a dominant active PI3K (FC PIK3ca*). The cancers in these mice are moderately differentiated invasive mucinous adenocarcinomas of the proximal colon that develop by 50 days of age. Interestingly, these cancers form without a benign intermediary or aberrant WNT signaling, indicating a non-canonical mechanism of tumorigenesis. Since these tumors are dependent upon the PI3K pathway, we investigated the potential for tumor response by the targeting of this pathway with rapamycin, an mTOR inhibitor. A cohort of FC PIK3ca* mice were treated with rapamycin at a dose of 6 mg/kg/day or placebo for 14 days. FDG dual hybrid PET/CT imaging demonstrated a dramatic tumor response in the rapamycin arm and this was confirmed on necropsy. The tumor tissue remaining after treatment with rapamycin demonstrated increased pERK1/2 or persistent phosphorylated ribosomal protein S6 (pS6), indicating potential resistance mechanisms. This unique model will further our understanding of human disease and facilitate the development of therapeutics through pharmacologic screening and biomarker identification.	[Deming, Dustin A.] Univ Wisconsin, Dept Med, Div Hematol & Oncol, Madison, WI USA; [Leystra, Alyssa A.; Clipson, Linda] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Washington, Mary Kay] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Nettekoven, Laura; Albrecht, Dawn; Halberg, Richard B.] Univ Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Madison, WI 53706 USA; [Washington, Mary Kay] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Washington, Mary Kay] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Sullivan, Ruth] Univ Wisconsin, Res Anim Resources Ctr, Madison, WI USA; [Weichert, Jamey P.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Halberg, RB (corresponding author), Univ Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Madison, WI 53706 USA.	rbhalberg@medicine.wisc.edu			Conquer Cancer Foundation of the American Society of Clinical Oncology through a Young Investigator Award; National Cancer Institute of the U.S. National Institutes of Health [T32 CA009614, P50 CA095103, R01 CA123438, P30 CA014520]; UW Division of Gastroenterology and Hepatology, the UW Department of Medicine; UW School of Medicine and Public Health; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA123438, T32CA009614, P30CA014520] Funding Source: NIH RePORTER	Conquer Cancer Foundation of the American Society of Clinical Oncology through a Young Investigator Award; National Cancer Institute of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UW Division of Gastroenterology and Hepatology, the UW Department of Medicine; UW School of Medicine and Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project was supported by the Conquer Cancer Foundation of the American Society of Clinical Oncology through a Young Investigator Award (to DAD); the National Cancer Institute of the U.S. National Institutes of Health through T32 CA009614 (to DAD), P50 CA095103 Gastrointestinal Specialized Program of Research Excellence Grant, Vanderbilt Ingram Cancer Center), R01 CA123438 (to RBH), P30 CA014520 (Core Grant, University of Wisconsin (UW) Carbone Cancer Center); and start-up funds (to RBH) from the UW Division of Gastroenterology and Hepatology, the UW Department of Medicine, and the UW School of Medicine and Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; American Cancer Society, 2011, CANC FACTS FIG 2011; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chabner BA, 2011, NEW ENGL J MED, V364, P1087, DOI 10.1056/NEJMp1100548; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Durkee BY, 2008, ACAD RADIOL, V15, P334, DOI 10.1016/j.acra.2007.10.005; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Haagensen EJ, 2012, BRIT J CANCER, V106, P1386, DOI 10.1038/bjc.2012.70; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Hernandez-Aya LF, 2011, ONCOLOGIST, V16, P404, DOI 10.1634/theoncologist.2010-0402; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Juric D, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P8-10-07; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leystra AA, 2012, CANCER RES, V72, P2931, DOI 10.1158/0008-5472.CAN-11-4097; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Pal SK, 2010, MOL CANCER THER, V9, P1931, DOI 10.1158/1535-7163.MCT-10-0239; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sartore-Bianchi A, 2010, TARGET ONCOL, V5, P19, DOI 10.1007/s11523-010-0138-5; Schmidt-Kittler O, 2010, ONCOTARGET, V1, P339; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stelzer MK, 2010, CANCER PREV RES, V3, P1542, DOI 10.1158/1940-6207.CAPR-10-0228; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Zhao L, 2010, CELL CYCLE, V9, P596, DOI 10.4161/cc.9.3.10599	33	17	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60709	10.1371/journal.pone.0060709	http://dx.doi.org/10.1371/journal.pone.0060709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593290	gold, Green Submitted, Green Published			2022-12-27	WOS:000317909600039
J	Ledikwe, JH; Kejelepula, M; Maupo, K; Sebetso, S; Thekiso, M; Smith, M; Mbayi, B; Houghton, N; Thankane, K; O'Malley, G; Semo, B				Ledikwe, Jenny H.; Kejelepula, Mable; Maupo, Kabelo; Sebetso, Siwulani; Thekiso, Mothwana; Smith, Monica; Mbayi, Bagele; Houghton, Nankie; Thankane, Kabo; O'Malley, Gabrielle; Semo, Bazghinawerq			Evaluation of a Well-Established Task-Shifting Initiative: The Lay Counselor Cadre in Botswana	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; NONPHYSICIAN CLINICIAN; ANTIRETROVIRAL THERAPY; HIV/AIDS CARE; TESTING SERVICES; RAPID EXPANSION; HIV TREATMENT; SOUTH-AFRICA; PROGRAM; ZAMBIA	Background: Evidence supports the implementation of task shifting to address health worker shortages that are common in resource-limited settings. However, there is need to learn from established programs to identify ways to achieve the strongest, most sustainable impact. This study examined the Botswana lay counselor cadre, a task shifting initiative, to explore effectiveness and contribution to the health workforce. Methods: This evaluation used multiple methods, including a desk review, a national lay counselor survey (n = 385; response = 94%), in-depth interviews (n = 79), lay counselors focus group discussions (n = 7), lay counselors observations (n = 25), and client exit interviews (n = 47). Results: Interview and focus group data indicate that lay counselors contribute to essentially all HIV-related programs in Botswana and they conduct the majority of HIV tests and related counseling at public health facilities throughout the country. Interviews showed that the lay counselor cadre is making the workload of more skilled health workers more manageable and increasing HIV acceptance in communities. The average score on a work-related knowledge test was 74.5%. However for 3 questions, less than half answered correctly. During observations, lay counselors demonstrated average competence for most skills assessed and clients (97.9%) were satisfied with services received. From the survey, lay counselors generally reported being comfortable with their duties; however, some reported clinical duties that extended beyond their training and mandate. Multiple factors affecting the performance of the lay counselors were identified, including insufficient resources, such as private counseling space and HIV test kits; and technical, administrative, and supervisory support. Conclusion: Lay counselors are fulfilling an important role in Botswana's healthcare system, serving as the entry point into HIV care, support, and treatment services. Recommendation: For this and other similar task shifting initiatives, it is important that lay counselors' responsibilities are clear and that training and support are adequate to optimize their effectiveness.	[Ledikwe, Jenny H.; O'Malley, Gabrielle; Semo, Bazghinawerq] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Ledikwe, Jenny H.; Houghton, Nankie; Thankane, Kabo; Semo, Bazghinawerq] Botswana Int Training & Educ Ctr Hlth I TECH, Gaborone, Botswana; [Kejelepula, Mable; Maupo, Kabelo; Sebetso, Siwulani; Thekiso, Mothwana] Botswana Minist Hlth, Gaborone, Botswana; [Smith, Monica; Mbayi, Bagele] US Ctr Dis Control & Prevent, Gaborone, Botswana	University of Washington; University of Washington Seattle	Ledikwe, JH (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	Ledikwe@UW.edu		O&apos;Malley, Gabrielle/0000-0002-7514-8240; Ledikwe, Jenny/0000-0001-8658-2993; Ramabu, Nankie M/0000-0001-9355-5547	U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) [U91HA06801]; President's Emergency Plan for AIDS Relief (PEPFAR)	U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This evaluation was conducted by the University of Washington and the International Training and Education Center for Health (I-TECH) with funding from Cooperative Agreement U91HA06801 from the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA). It was supported by the President's Emergency Plan for AIDS Relief (PEPFAR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babigumira JB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-192; Baiden F, 2007, J BIOSOC SCI, V39, P721, DOI 10.1017/S0021932006001829; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Bland RM, 2008, AIDS, V22, P883, DOI 10.1097/QAD.0b013e3282f768de; Brentlinger PE, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-23; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chibanda D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-828; Chu K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000078; Chu Kathryn M, 2011, Confl Health, V5, P12, DOI 10.1186/1752-1505-5-12; Creek T, 2009, AIDS BEHAV, V13, P356, DOI 10.1007/s10461-007-9322-8; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Dawad S, 2011, DISABIL REHABIL, V33, P1997, DOI 10.3109/09638288.2011.553710; De Brouwere V, 2009, REPROD HEALTH MATTER, V17, P32, DOI 10.1016/S0968-8080(09)33437-0; de Wet K, 2011, J PUBLIC HEALTH POL, V32, pS94, DOI 10.1057/jphp.2011.30; Ford N, 2011, AIDS; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Gabriel AP, 2011, THESCIENTIFICWORLDJO, V11, P2178, DOI 10.1100/2011/984321; Ginwalla SK, 2002, AIDS CARE, V14, P707, DOI 10.1080/0954012021000005533; Government of Botswana, 2009, NAT GUID HIV TEST CO; Grinstead OA, 2000, AIDS CARE, V12, P625, DOI 10.1080/095401200750003806; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Ivers LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019276; Kengne AP, 2010, EPILEPSIA, V51, P931, DOI 10.1111/j.1528-1167.2009.02414.x; Kilminster SM, 2000, MED EDUC, V34, P827, DOI 10.1046/j.1365-2923.2000.00758.x; Labhardt ND, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-339; Lekoubou A, 2010, INT J ENV RES PUB HE, V7, P353, DOI 10.3390/ijerph7020353; Mafigiri DK, 2012, GLOB PUBLIC HEALTH, V7, P270, DOI 10.1080/17441692.2011.552067; McCollum ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009626; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Petersen I, 2011, HLTH POLICY PLAN; Petersen I, 2011, COMMUNITY MENT HLTH; Rohleder P, 2005, AIDS CARE, V17, P397, DOI 10.1080/09540120512331314376; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Sanjana P, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-44; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Sherr K, 2009, JAIDS-J ACQ IMM DEF, V52, pS20, DOI 10.1097/QAI.0b013e3181bbc9c0; Shetty AK, 2005, INT J STD AIDS, V16, P755, DOI 10.1258/095646205774763090; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Steen TW, 2007, JAIDS-J ACQ IMM DEF, V44, P484, DOI 10.1097/QAI.0b013e318030ffa9; Stekelenburg J, 2003, HEALTH POLICY, V65, P109, DOI 10.1016/S0168-8510(02)00207-5; Swider SM, 2002, PUBLIC HEALTH NURS, V19, P11, DOI 10.1046/j.1525-1446.2002.19003.x; Tebatso P, 2010, SURVEY PERCEPTIONS H; Torpey KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002204; UNAIDS, 2000, TOOLS EV HIV VOL COU; Wester CW, 2005, CLIN INFECT DIS, V40, P1041, DOI 10.1086/428352; WHO, 2006, TASK SHIFT TACKL HLT; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organisation, 2008, TASK SHIFT GLOB REC; Yakam JCYT, 2009, INT NURS REV, V56, P50, DOI 10.1111/j.1466-7657.2008.00680.x; Yong CS, 2006, MED J AUSTRALIA, V185, P27, DOI 10.5694/j.1326-5377.2006.tb00446.x	51	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61601	10.1371/journal.pone.0061601	http://dx.doi.org/10.1371/journal.pone.0061601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JB	23585912	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600127
J	Meriweather, M; Matthews, S; Rio, R; Baucom, RS				Meriweather, Matthew; Matthews, Sara; Rio, Rita; Baucom, Regina S.			A 454 Survey Reveals the Community Composition and Core Microbiome of the Common Bed Bug (Cimex lectularius) across an Urban Landscape	PLOS ONE			English	Article							PHYLOGENETIC CHARACTERIZATION; WOLBACHIA INFECTIONS; NATURAL-POPULATIONS; BACTERIAL DIVERSITY; PUBLIC-HEALTH; EVOLUTION; PARASITE; GENOME; HETEROPTERA; MANAGEMENT	Elucidating the spatial dynamic and core constituents of the microbial communities found in association with arthropod hosts is of crucial importance for insects that may vector human or agricultural pathogens. The hematophagous Cimex lectularius (Hemiptera: Cimicidae), known as the human bed bug, has made a recent resurgence in North America, as well as worldwide, potentially owing to increased travel, climate change and resistance to insecticides. A comprehensive survey of the bed bug microbiome has not been performed to date, nor has an assessment of the spatial dynamics of its microbiome. Here we present a survey of internal and external bed bug microbial communities by amplifying the V4-V6 hypervariable region of the 16S rDNA gene region followed by 454 Titanium sequencing using 31 individuals from eight distinct collection locations obtained from residences in Cincinnati, OH. Across all samples, 97% of the microbial community is made up of two dominant OTUs, previously identified as the alpha-proteobacterium Wolbachia and an unnamed gamma-proteobacterium from the Enterobacteriaceae. Microbial communities varied among host locations for measures of community diversity and exhibited structure according to collection location. This broad survey represents the most in-depth assessment, to date, of the microbes that associate with bed bugs.	[Meriweather, Matthew; Matthews, Sara; Baucom, Regina S.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Rio, Rita] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	University System of Ohio; University of Cincinnati; West Virginia University	Baucom, RS (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.	gina.baucom@gmail.com		Baucom, Regina/0000-0001-7960-498X	University of Cincinnati	University of Cincinnati	Funding was provided by the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; [Anonymous], 2011, OHIO BEDBUG WORKGROU; ARKWRIGHT J. A., 1921, Parasitology, V13, P27, DOI 10.1017/S0031182000012270; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Boase Clive J., 2004, Biologist (London), V51, P9; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; CAMPBELL BC, 1993, CURR MICROBIOL, V26, P37, DOI 10.1007/BF01577240; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CHANG KP, 1974, J INVERTEBR PATHOL, V23, P333, DOI 10.1016/0022-2011(74)90098-6; Clay K, 2008, MOL ECOL, V17, P4371, DOI 10.1111/j.1365-294X.2008.03914.x; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Degnan PH, 2011, CURR MICROBIOL, V62, P1565, DOI 10.1007/s00284-011-9893-5; Delaunay P, 2011, CLIN INFECT DIS, V52, P200, DOI 10.1093/cid/ciq102; DEMEILLON B, 1947, J EXP BIOL, V24, P41; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Eddy C, 2011, J ENVIRON HEALTH, V73, P8; Estes AM, 2012, ENVIRON ENTOMOL, V41, P265, DOI 10.1603/EN11245; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Gai CS, 2009, J MICROBIOL, V47, P448, DOI 10.1007/s12275-008-0303-z; Gangloff-Kaufmann J., 2006, American Entomologist, V52, P105; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Hail D, 2011, ENVIRON ENTOMOL, V40, P23, DOI 10.1603/EN10115; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Hypsa V, 1997, INSECT MOL BIOL, V6, P301, DOI 10.1046/j.1365-2583.1997.00178.x; Ishak HD, 2011, SCI REP-UK, V1, DOI 10.1038/srep00204; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Lee IY, 2008, KOREAN J PARASITOL, V46, P269, DOI 10.3347/kjp.2008.46.4.269; Novakova E, 2007, FEMS MICROBIOL LETT, V269, P131, DOI 10.1111/j.1574-6968.2006.00620.x; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Park HJ, 2011, J CLIN MICROBIOL, V49, P1598, DOI 10.1128/JCM.01842-10; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Pinto L. J., 2007, BED BUG HDB COMPLETE; Potter M. F., 2005, Pest Control Technology, V33, P82; Rasgon JL, 2004, J MED ENTOMOL, V41, P1175, DOI 10.1603/0022-2585-41.6.1175; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Rossi L, 2010, J ENVIRON HEALTH, V72, P34; Saenz VL, 2012, J MED ENTOMOL, V49, P865, DOI 10.1603/ME11202; Sakamoto JM, 2006, J MED ENTOMOL, V43, P696, DOI 10.1603/0022-2585(2006)43[696:GDOWII]2.0.CO;2; Sakamoto JM, 2006, APPL ENVIRON MICROB, V72, P3161, DOI 10.1128/AEM.72.5.3161-3167.2006; Sakamoto Joyce M., 2006, American Entomologist, V52, P119; Schloss PD, 2006, ENVIRON ENTOMOL, V35, P625, DOI 10.1603/0046-225X-35.3.625; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Swayne DF, 2003, COMPUT STAT DATA AN, V43, P423, DOI 10.1016/S0167-9473(02)00286-4; Takano-Lee M, 2003, J MED ENTOMOL, V40, P795, DOI 10.1603/0022-2585-40.6.795; Terenius O, 2012, FEMS MICROBIOL ECOL, V80, P556, DOI 10.1111/j.1574-6941.2012.01317.x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; White DC, 1996, CURR OPIN BIOTECH, V7, P301, DOI 10.1016/S0958-1669(96)80034-6; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	63	38	41	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61465	10.1371/journal.pone.0061465	http://dx.doi.org/10.1371/journal.pone.0061465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585900	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600115
J	Nadin, BM; Pfaffinger, PJ				Nadin, Brian M.; Pfaffinger, Paul J.			A New TASK for Dipeptidyl Peptidase-like Protein 6	PLOS ONE			English	Article							CEREBELLAR GRANULE NEURONS; DOMAIN POTASSIUM CHANNEL; CA1 PYRAMIDAL NEURONS; LONG-TERM POTENTIATION; KV4.2 KNOCKOUT MICE; A-TYPE; K+ CHANNELS; ION-CHANNEL; DPP6; SUBUNITS	Dipeptidyl Peptidase-like Protein 6 (DPP6) is widely expressed in the brain where it co-assembles with Kv4 channels and KChIP auxiliary subunits to regulate the amplitude and functional properties of the somatodendritic A-current, I-SA. Here we show that in cerebellar granule (CG) cells DPP6 also regulates resting membrane potential and input resistance by increasing the amplitude of the I-kappa(SO) resting membrane current. Pharmacological analysis shows that DPP6 acts through the control of a channel with properties matching the K-2P channel TASK-3. Heterologous expression and co-immunoprecipitation shows that DPP6 co-expression with TASK-3 results in the formation of a protein complex that enhances resting membrane potassium conductance. The co-regulation of resting and voltage-gated channels by DPP6 produces coordinate shifts in resting membrane potential and A-current gating that optimize the sensitivity of I-SA inactivation gating to subthreshold fluctuations in resting membrane potential.	[Nadin, Brian M.; Pfaffinger, Paul J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Pfaffinger, PJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	paulp@bcm.edu			National Institutes of Health [P01 NS37444, R01 GM090029, P30HD024064, T32GM008507]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008507, R01GM090029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants P01 NS37444, R01 GM090029, P30HD024064, and T32GM008507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alders M, 2009, AM J HUM GENET, V84, P468, DOI 10.1016/j.ajhg.2009.02.009; Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Aller MI, 2008, NEUROSCIENCE, V151, P1154, DOI 10.1016/j.neuroscience.2007.12.011; Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; Anderson D, 2010, CHANNELS, V4, P163, DOI 10.4161/chan.4.3.11955; Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Ashmole I, 2009, J PHYSIOL-LONDON, V587, P4769, DOI 10.1113/jphysiol.2009.175430; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Clarke CE, 2004, J PHYSIOL-LONDON, V560, P51, DOI 10.1113/jphysiol.2004.070292; Cotten JF, 2004, MOL BRAIN RES, V128, P112, DOI 10.1016/j.molbrainres.2004.06.007; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; Dougherty K, 2006, J GEN PHYSIOL, V128, P745, DOI 10.1085/jgp.200609668; Du J, 2011, ACTA HISTOCHEM, V113, P636, DOI 10.1016/j.acthis.2010.08.001; Duguid I, 2012, J NEUROSCI, V32, P11132, DOI 10.1523/JNEUROSCI.0460-12.2012; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Es-Salah-Lamoureux Z, 2010, TRENDS PHARMACOL SCI, V31, P587, DOI 10.1016/j.tips.2010.09.001; Fan ZP, 2009, AM J MED GENET A, V149A, P521, DOI 10.1002/ajmg.a.32647; Foeger NC, 2012, J BIOL CHEM, V287, P9640, DOI 10.1074/jbc.M111.324574; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Jerng HH, 2007, MOL CELL NEUROSCI, V35, P604, DOI 10.1016/j.mcn.2007.03.008; Jerng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038205; Jerng HH, 2009, CHANNELS, V3, P448, DOI 10.4161/chan.3.6.10216; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kim J, 2008, J NEUROPHYSIOL, V100, P1835, DOI 10.1152/jn.90261.2008; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; Lazarenko RM, 2010, J NEUROSCI, V30, P7691, DOI 10.1523/JNEUROSCI.1655-10.2010; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Lugo JN, 2012, LEARN MEMORY, V19, P182, DOI 10.1101/lm.023614.111; Maffie J, 2009, NEUROSCI LETT, V449, P189, DOI 10.1016/j.neulet.2008.10.098; Marionneau C, 2012, J NEUROSCI, V32, P5716, DOI 10.1523/JNEUROSCI.6450-11.2012; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; Schade J, 2008, J HISTOCHEM CYTOCHEM, V56, P147, DOI 10.1369/jhc.7A7319.2007; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; Soh H, 2008, J BIOL CHEM, V283, P15072, DOI 10.1074/jbc.M706964200; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Watkins CS, 1996, J PHYSIOL-LONDON, V491, P401, DOI 10.1113/jphysiol.1996.sp021224; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zheng J, 2003, J NEUROSCI, V23, P8167	73	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60831	10.1371/journal.pone.0060831	http://dx.doi.org/10.1371/journal.pone.0060831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593319	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600054
J	Robol, V; Tibber, MS; Anderson, EJ; Bobin, T; Carlin, P; Shergill, SS; Dakin, SC				Robol, Valentina; Tibber, Marc S.; Anderson, Elaine J.; Bobin, Tracy; Carlin, Patricia; Shergill, Sukhwinder S.; Dakin, Steven C.			Reduced Crowding and Poor Contour Detection in Schizophrenia Are Consistent with Weak Surround Inhibition	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; PERCEPTUAL ORGANIZATION; VISUAL-CORTEX; ORIENTATION SELECTIVITY; GAMMA-HYDROXYBUTYRATE; OBJECT-RECOGNITION; GABA CONCENTRATION; INTEGRATION; DOPAMINE; CONTRAST	Background: Detection of visual contours (strings of small oriented elements) is markedly poor in schizophrenia. This has previously been attributed to an inability to group local information across space into a global percept. Here, we show that this failure actually originates from a combination of poor encoding of local orientation and abnormal processing of visual context. Methods: We measured the ability of observers with schizophrenia to localise contours embedded in backgrounds of differently oriented elements (either randomly oriented, near-parallel or near-perpendicular to the contour). In addition, we measured patients' ability to process local orientation information (i.e., report the orientation of an individual element) for both isolated and crowded elements (i.e., presented with nearby distractors). Results: While patients are poor at detecting contours amongst randomly oriented elements, they are proportionally less disrupted (compared to unaffected controls) when contour and surrounding elements have similar orientations (near-parallel condition). In addition, patients are poor at reporting the orientation of an individual element but, again, are less prone to interference from nearby distractors, a phenomenon known as visual crowding. Conclusions: We suggest that patients' poor performance at contour perception arises not as a consequence of an "integration deficit" but from a combination of reduced sensitivity to local orientation and abnormalities in contextual processing. We propose that this is a consequence of abnormal gain control, a phenomenon that has been implicated in orientation-selectivity as well as surround suppression.	[Robol, Valentina] Univ Padua, Dept Gen Psychol, Padua, Italy; [Tibber, Marc S.; Anderson, Elaine J.; Dakin, Steven C.] UCL, Inst Ophthalmol, London, England; [Anderson, Elaine J.] UCL, Inst Cognit Neurosci, London, England; [Bobin, Tracy; Carlin, Patricia; Shergill, Sukhwinder S.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of Padua; University of London; University College London; University of London; University College London; University of London; King's College London	Robol, V (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	valentina.robol@gmail.com	Dakin, Steven C/B-7610-2008	Dakin, Steven C/0000-0002-3548-9104; shergill, sukhi/0000-0003-4928-9100; Collier, Tracy/0000-0001-7067-8616	Wellcome Trust; MRC [G0901868] Funding Source: UKRI; Medical Research Council [G0901868] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil M, 2003, J NEUROSCI, V23, P2008; Alitto HJ, 2010, CURR OPIN NEUROBIOL, V20, P340, DOI 10.1016/j.conb.2010.02.012; ANDRIESSEN JJ, 1976, VISION RES, V16, P71, DOI 10.1016/0042-6989(76)90078-X; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; ANGRIST B, 1984, TRENDS NEUROSCI, V7, P388, DOI 10.1016/S0166-2236(84)80062-4; Barch DM, 2012, SCHIZOPHRENIA BULL, V38, P135, DOI 10.1093/schbul/sbr154; BJORK EL, 1977, PSYCHOL REV, V84, P472, DOI 10.1037/0033-295X.84.5.472; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Butler PD, 2007, BRAIN, V130, P417, DOI 10.1093/brain/awl233; Butler PD, 2005, ARCH GEN PSYCHIAT, V62, P495, DOI 10.1001/archpsyc.62.5.495; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Chapman L.J., 1973, DISORDERED THOUGHT S; Chen Y, 2011, SCHIZOPHRENIA BULL, V37, P709, DOI 10.1093/schbul/sbr020; CHERAMY A, 1977, J PHARMACOL EXP THER, V203, P283; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; CROOK JM, 1992, J NEUROSCI, V12, P1816; Dakin S, 2005, CURR BIOL, V15, pR822, DOI 10.1016/j.cub.2005.10.015; Dakin SC, 1998, J OPT SOC AM A, V15, P1486, DOI 10.1364/JOSAA.15.001486; Dakin SC, 2010, J VISION, V10, DOI [10.1167/10.10.14, 10.1167/10.11.5]; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Doniger GM, 2001, AM J PSYCHIAT, V158, P1818, DOI 10.1176/appi.ajp.158.11.1818; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Epstein J, 1999, ANN NY ACAD SCI, V877, P562, DOI 10.1111/j.1749-6632.1999.tb09289.x; Feigenbaum JJ, 1996, INT J NEUROSCI, V88, P53, DOI 10.3109/00207459608999812; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; FOX K, 1990, J NEUROPHYSIOL, V64, P1413, DOI 10.1152/jn.1990.64.5.1413; FRITH CD, 1979, BRIT J PSYCHIAT, V134, P225, DOI 10.1192/bjp.134.3.225; Goto N, 2009, SCHIZOPHR RES, V112, P192, DOI 10.1016/j.schres.2009.04.026; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; HEMSLEY DR, 1993, BEHAV RES THER, V31, P633, DOI 10.1016/0005-7967(93)90116-C; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; Hess RF, 1999, VISION RES, V39, P947, DOI 10.1016/S0042-6989(98)00152-7; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keri S, 2002, J NEUROPSYCH CLIN N, V14, P190, DOI 10.1176/appi.neuropsych.14.2.190; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019971; Kimhy D, 2007, SCHIZOPHR RES, V97, P25, DOI 10.1016/j.schres.2007.08.022; Kovacs I, 2000, VISION RES, V40, P1775, DOI 10.1016/S0042-6989(00)00008-0; Kozma-Wiebe P, 2006, COMPUT HUM BEHAV, V22, P971, DOI 10.1016/j.chb.2004.03.017; KWON YH, 1992, J NEUROPHYSIOL, V68, P182, DOI 10.1152/jn.1992.68.1.182; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Li G, 2008, NEUROSCIENCE, V155, P914, DOI 10.1016/j.neuroscience.2008.06.032; LIEBERMAN JA, 1987, PSYCHOPHARMACOLOGY, V91, P415, DOI 10.1007/BF00216006; Livne T, 2007, J VISION, V7, DOI 10.1167/7.2.4; Livne T, 2010, J VISION, V10, DOI 10.1167/10.3.1; Lopez LM, 2004, NEUROPSYCHOPHARMACOL, V29, P1217, DOI 10.1038/sj.npp.1300461; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; May KA, 2007, J VISION, V7, DOI 10.1167/7.13.9; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Nelson HE., 1991, REVISED NATL ADULT R; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Phillips WA, 2003, BEHAV BRAIN SCI, V26, P65, DOI 10.1017/S0140525X03000025; PLACE EJS, 1980, J ABNORM PSYCHOL, V89, P409; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Robol V, 2012, J VISION, V12, DOI 10.1167/12.7.3; Rokem A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00127; Schenkel LS, 2005, SCHIZOPHR RES, V76, P273, DOI 10.1016/j.schres.2005.03.003; Schenkel LS, 2005, J PSYCHIATR RES, V39, P499, DOI 10.1016/j.jpsychires.2005.01.001; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; SILLITO AM, 1980, BRAIN RES, V194, P517, DOI 10.1016/0006-8993(80)91234-2; Silverstein SM, 2000, SCHIZOPHR RES, V43, P11, DOI 10.1016/S0920-9964(99)00180-2; Silverstein Steven M, 2006, Cogn Neuropsychiatry, V11, P112, DOI 10.1080/13546800444000209; Silverstein SM, 2009, J INTEGR NEUROSCI, V8, P175, DOI 10.1142/S0219635209002113; Skottun BC, 2011, SCHIZOPHRENIA BULL, V37, P23, DOI 10.1093/schbul/sbq114; Slaghuis WL, 1998, J ABNORM PSYCHOL, V107, P49, DOI 10.1037/0021-843X.107.1.49; Smith MA, 2006, J NEUROSCI, V26, P4826, DOI 10.1523/JNEUROSCI.5542-06.2006; Tadin D, 2006, J NEUROSCI, V26, P11403, DOI 10.1523/JNEUROSCI.2592-06.2006; Tibber MS, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00088, 10.3389/fpsyt.2013.00027]; Uhlhaas Peter J, 2006, Cogn Neuropsychiatry, V11, P416, DOI 10.1080/13546800444000272; Uhlhaas PJ, 2006, PSYCHIAT RES, V145, P105, DOI 10.1016/j.psychres.2005.10.016; Uhlhaas PJ, 2005, PSYCHOL BULL, V131, P618, DOI 10.1037/0033-2909.131.4.618; Uhlhaas PJ, 2005, SCHIZOPHR RES, V75, P183, DOI 10.1016/j.schres.2004.11.005; Volz A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006391; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Watt R, 2008, J VISION, V8, DOI 10.1167/8.7.23; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Wilkinson F, 1997, J OPT SOC AM A, V14, P2057, DOI 10.1364/JOSAA.14.002057; WOLFORD G, 1975, PSYCHOL REV, V82, P184, DOI 10.1037/0033-295X.82.3.184; Yen SC, 1998, VISION RES, V38, P719, DOI 10.1016/S0042-6989(97)00197-1; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; Yoon JH, 2009, SCHIZOPHRENIA BULL, V35, P1078, DOI 10.1093/schbul/sbp064; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	95	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60951	10.1371/journal.pone.0060951	http://dx.doi.org/10.1371/journal.pone.0060951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JB	23585865	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600072
J	Tran, V; Zhang, XD; Cao, L; Li, HQ; Lee, B; So, M; Sun, YH; Chen, W; Zhao, M				Vu Tran; Zhang, Xiaodong; Cao, Lin; Li, Hanqing; Lee, Benjamin; So, Michelle; Sun, Yaohui; Chen, Wei; Zhao, Min			Synchronization Modulation Increases Transepithelial Potentials in MDCK Monolayers through Na/K Pumps	PLOS ONE			English	Article							ENDOGENOUS ELECTRIC-FIELDS; VOLTAGE-DEPENDENCE; CELL-DIVISION; K-ATPASE; TRANSPORT; OUABAIN; NA,K-ATPASE; ACTIVATION; DIFFERENCE; SIGNALS	Transepithelial potential (TEP) is the voltage across a polarized epithelium. In epithelia that have active transport functions, the force for transmembrane flux of an ion is dictated by the electrochemical gradient in which TEP plays an essential role. In epithelial injury, disruption of the epithelial barrier collapses the TEP at the wound edge, resulting in the establishment of an endogenous wound electric field (similar to 100 mV/mm) that is directed towards the center of the wound. This endogenous electric field is implicated to enhance wound healing by guiding cell migration. We thus seek techniques to enhance the TEP, which may increase the wound electric fields and enhance wound healing. We report a novel technique, termed synchronization modulation (SM) using a train of electric pulses to synchronize the Na/K pump activity, and then modulating the pumping cycles to increase the efficiency of the Na/K pumps. Kidney epithelial monolayers (MDCK cells) maintain a stable TEP and transepithelial resistance (TER). SM significantly increased TEP over four fold. Either ouabain or digoxin, which block Na/K pump, abolished SM-induced TEP increases. In addition to the pump activity, basolateral distribution of Na/K pumps is essential for an increase in TEP. Our study for the first time developed an electrical approach to significantly increase the TEP. This technique targeting the Na/K pump may be used to modulate TEP, and may have implication in wound healing and in diseases where TEP needs to be modulated.	[Vu Tran; Zhang, Xiaodong; Cao, Lin; Li, Hanqing; Lee, Benjamin; So, Michelle; Sun, Yaohui; Zhao, Min] Univ Calif Davis, Inst Regenerat Cures, Dept Dermatol, Davis, CA 95616 USA; [Vu Tran; Zhang, Xiaodong; Cao, Lin; Li, Hanqing; Lee, Benjamin; So, Michelle; Sun, Yaohui; Zhao, Min] Univ Calif Davis, Dept Ophthalmol, Davis, CA 95616 USA; [Chen, Wei] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Zhao, Min] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; State University System of Florida; University of South Florida; University of California System; University of California Davis	Chen, W (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	wchen@usf.edu; minzhao@ucdavis.edu			NIH [1R01EY019101]; California Institute of Regenerative Medicine [RB1-01417]; NSF [MCB-0951199]; Research to Prevent Blindness, NY; UC Davis Ophthalmology; Div Of Molecular and Cellular Bioscience [0951199] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [R01EY019101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Research to Prevent Blindness, NY(Research to Prevent Blindness (RPB)); UC Davis Ophthalmology; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by an NIH grant (1R01EY019101) to MZ. Work in MZ's lab is also supported by grants from California Institute of Regenerative Medicine RB1-01417, NSF MCB-0951199. This study was also supported in part by an unrestricted grant from Research to Prevent Blindness, NY, and UC Davis Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; BIBER TUL, 1973, J GEN PHYSIOL, V61, P529, DOI 10.1085/jgp.61.5.529; BLANK M, 1989, BIOELECTROCH BIOENER, V22, P313, DOI 10.1016/0302-4598(89)87048-5; BLANK M, 1990, BIOELECTROCH BIOENER, V24, P51, DOI 10.1016/0302-4598(80)85006-9; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; CANDIA OA, 1968, INVEST OPHTH VISUAL, V7, P405; Chen W, 2002, BIOELECTROCHEMISTRY, V56, P199, DOI 10.1016/S1567-5394(02)00046-4; Chen W, 2008, J PHYS CHEM B, V112, P10064, DOI 10.1021/jp0754637; Chen W, 2008, J MEMBRANE BIOL, V221, P165, DOI 10.1007/s00232-008-9094-8; Chen W, 2007, J BIOENERG BIOMEMBR, V39, P117, DOI 10.1007/s10863-006-9068-4; Chen W, 2007, J BIOENERG BIOMEMBR, V39, P331, DOI 10.1007/s10863-007-9096-8; Chen W, 2006, J BIOENERG BIOMEMBR, V38, P319, DOI 10.1007/s10863-006-9049-7; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; CHINET TC, 1994, EUR RESPIR J, V7, P1917; Dando R, 2012, J MEMBRANE BIOL, V245, P97, DOI 10.1007/s00232-012-9418-6; Dube J, 2010, TISSUE ENG PT A, V16, P3055, DOI [10.1089/ten.tea.2010.0030, 10.1089/ten.TEA.2010.0030]; FESTEN CMAW, 1979, EXP EYE RES, V28, P413, DOI 10.1016/0014-4835(79)90116-7; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; HAY JG, 1985, THORAX, V40, P493, DOI 10.1136/thx.40.7.493; Huttenlocher A, 2007, NEW ENGL J MED, V356, P303, DOI 10.1056/NEJMcibr066496; KLYCE SD, 1972, J PHYSIOL-LONDON, V226, P407, DOI 10.1113/jphysiol.1972.sp009991; KNOWLES MR, 1985, PEDIATR RES, V19, P676, DOI 10.1203/00006450-198507000-00008; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; Kucerova R, 2011, J CELL PHYSIOL, V226, P1544, DOI 10.1002/jcp.22488; Larsen EH, 2006, ACTA PHYSIOL, V187, P177, DOI 10.1111/j.1748-1716.2006.01580.x; Laughery MD, 2007, AM J PHYSIOL-RENAL, V292, pF1718, DOI 10.1152/ajprenal.00360.2006; Lavelle JP, 1997, AM J PHYSIOL-RENAL, V273, pF67, DOI 10.1152/ajprenal.1997.273.1.F67; Leschelle X, 2000, EUR J BIOCHEM, V267, P6435, DOI 10.1046/j.1432-1327.2000.01731.x; Ljubimov AV, 2002, CORNEA, V21, P74, DOI 10.1097/00003226-200201000-00016; Luquet CM, 2002, J EXP BIOL, V205, P71; MADSEN KM, 1986, AM J PHYSIOL, V250, pF1, DOI 10.1152/ajprenal.1986.250.1.F1; MARKIN VS, 1992, BIOPHYS J, V61, P1045, DOI 10.1016/S0006-3495(92)81913-6; MARSHALL WS, 1977, J COMP PHYSIOL, V114, P157, DOI 10.1007/BF00688966; MAURICE DM, 1967, EXP EYE RES, V6, P138, DOI 10.1016/S0014-4835(67)80065-4; MAYHEW E, 1968, J CELL PHYSIOL, V72, P73, DOI 10.1002/jcp.1040720112; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2009, J CELL SCI, V122, P4267, DOI 10.1242/jcs.023564; Montalbetti N, 2009, BIOPHYS J, V97, P1530, DOI 10.1016/j.bpj.2009.05.063; NAKAO M, 1989, J GEN PHYSIOL, V94, P539, DOI 10.1085/jgp.94.3.539; Nieves-Gonzales A, 2012, AM J PHYSL RENAL PHY; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; Nuccitelli R, 2003, RADIAT PROT DOSIM, V106, P375, DOI 10.1093/oxfordjournals.rpd.a006375; Palmer LG, 2008, J GEN PHYSIOL, V132, P607, DOI 10.1085/jgp.200810149; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; RAKOWSKI RF, 1989, J GEN PHYSIOL, V93, P903, DOI 10.1085/jgp.93.5.903; Rakowski RF, 1997, J MEMBRANE BIOL, V155, P105, DOI 10.1007/s002329900162; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; ROBERTSON B, 1991, J CHEM PHYS, V94, P7414, DOI 10.1063/1.460173; SERPERSU EH, 1983, J MEMBRANE BIOL, V74, P191, DOI 10.1007/BF02332123; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Taylor CJ, 2009, PAEDIATR RESPIR REV, V10, P220, DOI 10.1016/j.prrv.2009.05.002; TEISSIE J, 1980, J MEMBRANE BIOL, V55, P133, DOI 10.1007/BF01871155; Valente RC, 2003, FASEB J, V17, P1700, DOI 10.1096/fj.02-0937fje; Vanhaesebroeck B, 2006, NAT CHEM BIOL, V2, P453, DOI 10.1038/nchembio0906-453; Vieira AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017411; Wilson PD, 2000, AM J PATHOL, V156, P253, DOI 10.1016/S0002-9440(10)64726-8; Xie TD, 1997, BIOPHYS J, V72, P2496, DOI 10.1016/S0006-3495(97)78894-5; Yu DF, 2012, AM J PHYSIOL-CELL PH, V303, pC767, DOI 10.1152/ajpcell.00195.2012; Zak J, 2000, PFLUG ARCH EUR J PHY, V440, P179, DOI 10.1007/s004240000282; Zhang LP, 2012, J BIOENERG BIOMEMBR, V44, P385, DOI 10.1007/s10863-012-9432-5; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2012, PROG RETIN EYE RES, V31, P65, DOI 10.1016/j.preteyeres.2011.10.001; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	65	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61509	10.1371/journal.pone.0061509	http://dx.doi.org/10.1371/journal.pone.0061509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585907	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600122
J	Wei, GX; Xu, T; Fan, FM; Dong, HM; Jiang, LL; Li, HJ; Yang, Z; Luo, J; Zuo, XN				Wei, Gao-Xia; Xu, Ting; Fan, Feng-Mei; Dong, Hao-Ming; Jiang, Li-Li; Li, Hui-Jie; Yang, Zhi; Luo, Jing; Zuo, Xi-Nian			Can Taichi Reshape the Brain? A Brain Morphometry Study	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; EXERCISE INDUCES ANGIOGENESIS; LONG-TERM MEDITATION; PRIMARY MOTOR CORTEX; CORTICAL THICKNESS; GEOMETRICALLY ACCURATE; PHYSICAL-ACTIVITY; CHI CHUAN; GRAY; VOLUME	Although research has provided abundant evidence for Taichi-induced improvements in psychological and physiological well-being, little is known about possible links to brain structure of Taichi practice. Using high-resolution MRI of 22 Tai Chi Chuan (TCC) practitioners and 18 controls matched for age, sex and education, we set out to examine the underlying anatomical correlates of long-term Taichi practice at two different levels of regional specificity. For this purpose, parcel-wise and vertex-wise analyses were employed to quantify the difference between TCC practitioners and the controls based on cortical surface reconstruction. We also adopted the Attention Network Test (ANT) to explore the effect of TCC on executive control. TCC practitioners, compared with controls, showed significantly thicker cortex in precentral gyrus, insula sulcus and middle frontal sulcus in the right hemisphere and superior temporal gyrus and medial occipito-temporal sulcus and lingual sulcus in the left hemisphere. Moreover, we found that thicker cortex in left medial occipito-temporal sulcus and lingual sulcus was associated with greater intensity of TCC practice. These findings indicate that long-term TCC practice could induce regional structural change and also suggest TCC might share similar patterns of neural correlates with meditation and aerobic exercise.	[Wei, Gao-Xia; Xu, Ting; Fan, Feng-Mei; Dong, Hao-Ming; Jiang, Li-Li; Li, Hui-Jie; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Magnet Resonance Imaging Res Ctr, Lab Funct Connectome & Dev,Key Lab Behav Sci, Beijing 100101, Peoples R China; [Wei, Gao-Xia; Luo, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Fan, Feng-Mei] Beijing Huilongguan Hosp, Psychiat Res Ctr, Beijing, Peoples R China; [Luo, Jing] Capital Normal Univ, Dept Psychol, Beijing Key Lab Learning & Cognit, Beijing, Peoples R China; [Dong, Hao-Ming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Capital Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zuo, XN (corresponding author), Chinese Acad Sci, Inst Psychol, Magnet Resonance Imaging Res Ctr, Lab Funct Connectome & Dev,Key Lab Behav Sci, Beijing 100101, Peoples R China.	luoj@psych.ac.cn; zuoxn@psych.ac.cn	Zuo, Xi-Nian/A-7273-2009; Yang, Zhi/W-6459-2019	Zuo, Xi-Nian/0000-0001-9110-585X; Yang, Zhi/0000-0002-2222-2312; Wei, Gao-Xia/0000-0002-6350-9096	National Natural Science Foundation of China [31200794, 91132728, 81171409, 81030028]; Key Laboratory of Mental Health, the Knowledge Innovation Program from Institute of Psychology, Chinese Academy of Sciences (CAS) [KSCX2-EW-J-8]; Hundred Talents Program [Y2CX112006]; Key Research Program of CAS [KSZD-EW-TZ-002]; Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation [81220108014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Mental Health, the Knowledge Innovation Program from Institute of Psychology, Chinese Academy of Sciences (CAS); Hundred Talents Program(Chinese Academy of Sciences); Key Research Program of CAS; Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation	This work was supported by the National Natural Science Foundation of China (31200794, 91132728, 81171409, 81030028) and the Open Research Fund of the Key Laboratory of Mental Health, the Knowledge Innovation Program (KSCX2-EW-J-8) from Institute of Psychology, Chinese Academy of Sciences (CAS). The senior author Prof. Xi-Nian Zuo acknowledges the Hundred Talents Program (Y2CX112006) and the Key Research Program (KSZD-EW-TZ-002) of CAS and the Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation (81220108014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Bernal-Rusiel JL, 2010, NEUROIMAGE, V52, P158, DOI 10.1016/j.neuroimage.2010.03.074; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Booth FW, 2006, MED SCI SPORT EXER, V38, P405, DOI 10.1249/01.mss.0000205117.11882.65; Caldwell K, 2009, J BODYW MOV THER, V13, P155, DOI 10.1016/j.jbmt.2007.12.001; Chang YK, 2010, J AGING PHYS ACTIV, V18, P451, DOI 10.1123/japa.18.4.451; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dechamps A, 2009, J AGING PHYS ACTIV, V17, P236, DOI 10.1123/japa.17.2.236; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Eskildsen SF, 2007, LECT NOTES COMPUT SC, V4791, P409; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Grant JA, 2010, EMOTION, V10, P43, DOI 10.1037/a0018334; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; Jang JH, 2011, NEUROSCI LETT, V487, P358, DOI 10.1016/j.neulet.2010.10.056; Kang DH, 2013, SOC COGN AFFECT NEUR, V8, P27, DOI 10.1093/scan/nss056; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 2002, BRAIN RES, V934, P1, DOI 10.1016/S0006-8993(02)02239-4; Klein Penelope J, 2006, J Neurol Phys Ther, V30, P22; Kolb B, 2008, NEUROBIOL LEARN MEM, V90, P295, DOI 10.1016/j.nlm.2008.04.012; Lan C, 1998, MED SCI SPORT EXER, V30, P345, DOI 10.1097/00005768-199803000-00003; Lan C, 2000, ARCH PHYS MED REHAB, V81, P604, DOI 10.1053/mr.2000.3849; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lee JK, 2006, NEUROIMAGE, V31, P572, DOI 10.1016/j.neuroimage.2005.12.044; Lee MS, 2008, PARKINSONISM RELAT D, V14, P589, DOI 10.1016/j.parkreldis.2008.02.003; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Makris N, 2006, NEUROIMAGE, V33, P139, DOI 10.1016/j.neuroimage.2006.04.220; Matthews Margaret M, 2008, J S C Med Assoc, V104, P255; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Paw MJMCA, 2008, SPORTS MED, V38, P781, DOI 10.2165/00007256-200838090-00006; Pienaar R, 2008, INT J IMAG SYST TECH, V18, P42, DOI 10.1002/ima.20138; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Redick TS, 2006, APPL COGNITIVE PSYCH, V20, P713, DOI 10.1002/acp.1224; Rejbi Imen Ben Cheikh, 2010, Int J Chron Obstruct Pulmon Dis, V5, P209; Rogers CE, 2009, WESTERN J NURS RES, V31, P245, DOI 10.1177/0193945908327529; Sandlund ES, 2000, INT J STRESS MANAGE, V7, P139, DOI 10.1023/A:1009536319034; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Tai'Wang Yong, 2008, V52, P135, DOI 10.1159/000134294; Taubert M, 2012, NEUROSCIENTIST, V18, P320, DOI 10.1177/1073858411419048; Taylor D, 2012, J AM GERIATR SOC, V60, P841, DOI 10.1111/j.1532-5415.2012.03928.x; Taylor-Piliae RE, 2006, J ADV NURS, V54, P313, DOI 10.1111/j.1365-2648.2006.03809.x; Taylor-Piliae Ruth E, 2004, J Cardiovasc Nurs, V19, P48; Tsang WWN, 2004, MED SCI SPORT EXER, V36, P648, DOI 10.1249/01.MSS.0000121941.57669.BF; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Wang WC, 2009, J ACUPUNCT MERIDIAN, V2, P171, DOI 10.1016/S2005-2901(09)60052-2; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P191, DOI 10.1089/acm.2007.7170B; Weinberg RS, 2007, EXERCISE BEHAV ADHER; Weinstein AM, 2012, BRAIN BEHAV IMMUN, V26, P811, DOI 10.1016/j.bbi.2011.11.008; Wong Alice M. K., 2008, V52, P115, DOI 10.1159/000134291; Xing XX, 2011, MAGN RESON IMAGING, V29, P731, DOI 10.1016/j.mri.2011.02.007; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhu WM, 2010, AM J LIFESTYLE MED, V4, P418, DOI 10.1177/1559827610368777; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703	76	92	101	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61038	10.1371/journal.pone.0061038	http://dx.doi.org/10.1371/journal.pone.0061038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585869	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600076
J	Hu, AH; Josephson, MB; Diener, BL; Nino, G; Xu, SY; Paranjape, C; Orange, JS; Grunstein, MM				Hu, Aihua y; Josephson, Maureen B.; Diener, Barry L.; Nino, Gustavo; Xu, Shuyun; Paranjape, Chinmay; Orange, Jordan S.; Grunstein, Michael M.			Pro-Asthmatic Cytokines Regulate Unliganded and Ligand-Dependent Glucocorticoid Receptor Signaling in Airway Smooth Muscle	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; N-TERMINAL KINASE; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; ALTERED RESPONSIVENESS; INDEPENDENT ACTIVATION; INFLAMMATORY-RESPONSE; BINDING AFFINITY; NUCLEAR EXPORT; TNF-ALPHA	To elucidate the regulation of glucocorticoid receptor (GR) signaling under pro-asthmatic conditions, cultured human airway smooth muscle (HASM) cells were treated with proinflammatory cytokines or GR ligands alone and in combination, and then examined for induced changes in ligand-dependent and -independent GR activation and downstream signaling events. Ligand stimulation with either cortisone or dexamethsone (DEX) acutely elicited GR translocation to the nucleus and, comparably, ligand-independent stimulation either with the Th2 cytokine, IL-13, or the pleiotropic cytokine combination, IL-1 beta/TNF alpha, also acutely evoked GR translocation. The latter response was potentiated by combined exposure of cells to GR ligand and cytokine. Similarly, treatment with either DEX or IL-13 alone induced GR phosphorylation at its serine-211 residue (GR(Ser211)), denoting its activated state, and combined treatment with DEX+IL-13 elicited heightened and sustained GR(Ser211) phosphorylation. Interestingly, the above ligand-independent GR responses to IL-13 alone were not associated with downstream GR binding to its consensus DNA sequence or GR transactivation, whereas both DEX-induced GR:DNA binding and transcriptional activity were significantly heightened in the presence of IL-13, coupled to increased recruitment of the transcriptional co-factor, MED14. The stimulated GR signaling responses to DEX were prevented in IL-13-exposed cells wherein GR(Ser211) phosphorylation was suppressed either by transfection with specific serine phosphorylation-deficient mutant GRs or treatment with inhibitors of the MAPKs, ERK1/2 and JNK. Collectively, these novel data highlight a heretofore-unidentified homeostatic mechanism in HASM cells that involves pro-asthmatic cytokine-driven, MAPK-mediated, non-ligand-dependent GR activation that confers heightened glucocorticoid ligand-stimulated GR signaling. These findings raise the consideration that perturbations in this homeostatic cytokine-driven GR signaling mechanism may be responsible, at least in part, for the insensirtivity to glucocorticoid therapy that is commonly seen in individuals with severe asthma.	[Hu, Aihua y; Josephson, Maureen B.; Diener, Barry L.; Nino, Gustavo; Xu, Shuyun; Paranjape, Chinmay; Grunstein, Michael M.] Univ Penn, Perlman Sch Med, Div Pulm Med, Childrens Hosp Philadelphia Res Inst, Philadelphia, PA 19104 USA; [Nino, Gustavo] George Washington Univ, Med Genet Res Ctr, Childrens Natl Med Ctr, Dept Integrat Syst Biol, Washington, DC USA; [Nino, Gustavo] George Washington Univ, Med Genet Res Ctr, Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC USA; [Orange, Jordan S.] Texas Childrens Hosp, Baylor Coll Med, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's National Health System; George Washington University; Children's National Health System; George Washington University; Baylor College of Medicine	Grunstein, MM (corresponding author), Univ Penn, Perlman Sch Med, Div Pulm Med, Childrens Hosp Philadelphia Res Inst, Philadelphia, PA 19104 USA.	grunstein@email.chop.edu	Xu, Shuyun/G-7081-2014	orange, jordan/0000-0001-7117-7725	National Institutes of Health HLBI [HL-061038, HL-097739]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061038, R01HL097739] Funding Source: NIH RePORTER	National Institutes of Health HLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health HLBI grants HL-061038 and HL-097739 to MMG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2008, BRIT J PHARMACOL, V155, P84, DOI 10.1038/bjp.2008.232; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Bouazza B, 2012, AM J RESP CELL MOL, V47, P464, DOI 10.1165/rcmb.2011-0364OC; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; BURNSTEIN KL, 1994, MOL ENDOCRINOL, V8, P1764, DOI 10.1210/me.8.12.1764; Cadepond F, 1997, ANNU REV MED, V48, P129; Cai TQ, 2001, J STEROID BIOCHEM, V77, P117, DOI 10.1016/S0960-0760(01)00041-3; Chapman KE, 2006, ANN NY ACAD SCI, V1088, P265, DOI 10.1196/annals.1366.030; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Cooper MS, 2001, J BONE MINER RES, V16, P1037, DOI 10.1359/jbmr.2001.16.6.1037; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; DAMON M, 1986, AGENTS ACTIONS, V17, P478, DOI 10.1007/BF01965517; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Freeman L, 2005, BLOOD, V106, P2042, DOI 10.1182/blood-2005-01-0186; Galliher-Beckley AJ, 2011, MOL CELL BIOL, V31, P4663, DOI 10.1128/MCB.05866-11; GLADMAN DD, 1991, J RHEUMATOL, V18, P681; Grunstein MM, 2002, AM J PHYSIOL-LUNG C, V282, pL520, DOI 10.1152/ajplung.00343.2001; Hakonarson H, 2001, AM J RESP CELL MOL, V25, P761, DOI 10.1165/ajrcmb.25.6.4628; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hirst SJ, 1998, AM J RESP CRIT CARE, V158, pS201, DOI 10.1164/ajrccm.158.supplement_2.13tac190; Hu AH, 2009, AM J PHYSIOL-LUNG C, V296, pL790, DOI 10.1152/ajplung.90572.2008; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Josephson MB, 2012, AM J PHYSIOL-LUNG C, V303, pL382, DOI 10.1152/ajplung.00125.2012; KAM JC, 1993, J IMMUNOL, V151, P3460; Kino T, 2003, J STEROID BIOCHEM, V85, P457, DOI 10.1016/S0960-0760(03)00218-8; Kotitschke A, 2009, MOL ENDOCRINOL, V23, P1726, DOI 10.1210/me.2008-0462; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; Kumar R, 2008, BIOL-TARGETS THER, V2, P845; Laporte JC, 2001, AM J RESP CRIT CARE, V164, P141, DOI 10.1164/ajrccm.164.1.2008060; Liu JM, 2000, MOL ENDOCRINOL, V14, P40, DOI 10.1210/me.14.1.40; Miller AL, 2007, CANC CELL INT, V7; Nino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032078; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; ORTI E, 1993, J BIOL CHEM, V268, P7779; Panettieri Reynold A Jr, 2004, Proc Am Thorac Soc, V1, P231, DOI 10.1513/pats.200402-021MS; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Rogatsky I, 1998, J BIOL CHEM, V273, P14315, DOI 10.1074/jbc.273.23.14315; Schottelius A, 2000, AM J GASTROENTEROL, V95, P1994; SHER ER, 1994, J CLIN INVEST, V93, P33, DOI 10.1172/JCI116963; Spahn JD, 1996, J IMMUNOL, V157, P2654; Tanaka H, 1996, J IMMUNOL, V156, P1601; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Verheggen MM, 1996, EUR RESPIR J, V9, P2036, DOI 10.1183/09031936.96.09102036; Verhoog NJD, 2011, J BIOL CHEM, V286, P19297, DOI 10.1074/jbc.M110.193672; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Webster JC, 1999, TRENDS ENDOCRIN MET, V10, P396, DOI 10.1016/S1043-2760(99)00186-1; Weigel Nancy L, 2007, Nucl Recept Signal, V5, pe005; Zhang TY, 2005, J IMMUNOL, V174, P879, DOI 10.4049/jimmunol.174.2.879; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	52	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60452	10.1371/journal.pone.0060452	http://dx.doi.org/10.1371/journal.pone.0060452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593222	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100046
J	Yeh, WL; Shioda, K; Coser, KR; Rivizzigno, D; McSweeney, KR; Shioda, T				Yeh, Wei-Lan; Shioda, Keiko; Coser, Kathryn R.; Rivizzigno, Danielle; McSweeney, Kristen R.; Shioda, Toshi			Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor alpha Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase	PLOS ONE			English	Article							BREAST-CANCER CELLS; E-SCREEN ASSAY; ER-ALPHA; ENDOCRINE THERAPY; PROSTATE-CANCER; GENE-EXPRESSION; RESISTANCE; TAMOXIFEN; INHIBITION; PATHWAYS	Fulvestrant is a representative pure antiestrogen and a Selective Estrogen Receptor Down-regulator (SERD). In contrast to the Selective Estrogen Receptor Modulators (SERMs) such as 4-hydroxytamoxifen that bind to estrogen receptor alpha (ER alpha) as antagonists or partial agonists, fulvestrant causes proteasomal degradation of ERa protein, shutting down the estrogen signaling to induce proliferation arrest and apoptosis of estrogen-dependent breast cancer cells. We performed genome-wide RNAi knockdown screenings for protein kinases required for fulvestrant-induced apoptosis of the MCF-7 estrogendependent human breast caner cells and identified the c-Src tyrosine kinase (CSK), a negative regulator of the oncoprotein c-Src and related protein tyrosine kinases, as one of the necessary molecules. Whereas RNAi knockdown of CSK in MCF-7 cells by shRNA-expressing lentiviruses strongly suppressed fulvestrant-induced cell death, CSK knockdown did not affect cytocidal actions of 4-hydroxytamoxifen or paclitaxel, a chemotherapeutic agent. In the absence of CSK, fulvestrant-induced proteasomal degradation of ER alpha protein was suppressed in both MCF-7 and T47D estrogen-dependent breast cancer cells whereas the TP53-mutated T47D cells were resistant to the cytocidal action of fulvestrant in the presence or absence of CSK. MCF-7 cell sensitivities to fulvestrant-induced cell death or ERa protein degradation was not affected by small-molecular-weight inhibitors of the tyrosine kinase activity of c-Src, suggesting possible involvement of other signaling molecules in CSK-dependent MCF-7 cell death induced by fulvestrant. Our observations suggest the importance of CSK in the determination of cellular sensitivity to the cytocidal action of fulvestrant.	[Shioda, Toshi] Massachusetts Gen Hosp, Ctr Canc, Ctr Canc Res, Charlestown, MA USA; Harvard Univ, Sch Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University	Shioda, T (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Ctr Canc Res, Charlestown, MA USA.	tshioda@partners.org			Susan G. Komen for Cure grant [FAS0703860, KG090515]; AstraZeneca [IRUSFULV0066]	Susan G. Komen for Cure grant(Susan G. Komen Breast Cancer Foundation); AstraZeneca(AstraZeneca)	This research was supported by Susan G. Komen for Cure grants FAS0703860 and KG090515, and AstraZeneca Preclinical Study Support IRUSFULV0066, awarded to T. Shioda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Baselga J, 2010, CLIN CANCER RES, V16, P4876, DOI 10.1158/1078-0432.CCR-10-0748; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; BORGNA JL, 1980, MOL CELL ENDOCRINOL, V20, P71, DOI 10.1016/0303-7207(80)90095-7; Brunner N, 1997, CANCER RES, V57, P3486; Butt AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1779; Callige Mathilde, 2006, Nucl Recept Signal, V4, pe004; CASTORIA G, 2012, ONCOGENE; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chu I, 2007, J CLIN INVEST, V117, P2205, DOI 10.1172/JCI21739; Chung YL, 2002, INT J CANCER, V97, P306, DOI 10.1002/ijc.1614; Clarke M, 1998, LANCET, V351, P1451; Cook KL, 2011, EXPERT REV ANTICANC, V11, P1283, DOI [10.1586/ERA.11.111, 10.1586/era.11.111]; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; D'Arco M, 2009, J BIOL CHEM, V284, P21393, DOI 10.1074/jbc.M109.023051; Diel P, 1999, BREAST CANCER RES TR, V58, P87, DOI 10.1023/A:1006338123126; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Fan MY, 2003, MOL ENDOCRINOL, V17, P356, DOI 10.1210/me.2002-0323; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Gururaj AE, 2006, CLIN CANCER RES, V12, p1001S, DOI 10.1158/1078-0432.CCR-05-2110; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Hiscox S, 2006, ENDOCR-RELAT CANCER, V13, P1085, DOI 10.1677/erc.1.01270; Howell A, 2004, J CLIN ONCOL, V22, P1605, DOI 10.1200/JCO.2004.02.112; HOWELL A, 1995, LANCET, V345, P29, DOI 10.1016/S0140-6736(95)91156-1; Howell A, 2006, ENDOCR-RELAT CANCER, V13, P689, DOI 10.1677/erc.1.00846; Hur J, 2006, CANCER RES, V66, P10153, DOI 10.1158/0008-5472.CAN-05-3696; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Ia KK, 2010, GROWTH FACTORS, V28, P329, DOI 10.3109/08977194.2010.484424; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Ishii Y, 2011, CLIN CANCER RES, V17, P2292, DOI 10.1158/1078-0432.CCR-10-1745; Jones C, 2000, CANCER GENET CYTOGEN, V117, P153, DOI 10.1016/S0165-4608(99)00158-2; Jordan VC, 2006, EUR J CANCER, V42, P2909, DOI 10.1016/j.ejca.2006.09.012; Jordan VC, 2007, STEROIDS, V72, P7, DOI 10.1016/j.steroids.2006.10.009; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kocanova S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-98; Kurebayashi Junichi, 2007, Breast Cancer, V14, P200, DOI 10.2325/jbcs.954; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Levenson AS, 1997, CANCER RES, V57, P3071; Lin NU, 2008, J CLIN ONCOL, V26, P798, DOI 10.1200/JCO.2007.15.0946; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Long XH, 2006, J BIOL CHEM, V281, P9607, DOI 10.1074/jbc.M510809200; Long XH, 2010, CANCER BIOL THER, V9, P389, DOI 10.4161/cbt.9.5.10926; MADAKERDOGAN Z, 2008, MOL ENDOCRINOL; Marsaud V, 2003, MOL ENDOCRINOL, V17, P2013, DOI 10.1210/me.2002-0269; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Migliaccio A, 2002, ANN NY ACAD SCI, V963, P185; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nicholson RI, 2004, CLIN CANCER RES, V10, p346S, DOI 10.1158/1078-0432.CCR-031206; Nicholson RI, 2003, BREAST CANCER RES TR, V80, pS29; Ning YX, 2010, MOL CANCER THER, V9, P1274, DOI 10.1158/1535-7163.MCT-09-1169; NIRMALA PB, 1995, BIOCHEM BIOPH RES CO, V213, P24, DOI 10.1006/bbrc.1995.2093; Nugoli M, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-13; OSBORNE CK, 1987, BREAST CANCER RES TR, V9, P111, DOI 10.1007/BF01807363; Powers GL, 2010, ONCOGENE, V29, P1509, DOI 10.1038/onc.2009.434; Rayala SK, 2005, EMBO REP, V6, P538, DOI 10.1038/sj.embor.7400417; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rengifo-Cam W, 2004, ONCOGENE, V23, P289, DOI 10.1038/sj.onc.1207041; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; SABE H, 1992, P NATL ACAD SCI USA, V89, P2190, DOI 10.1073/pnas.89.6.2190; SABE H, 1992, MOL CELL BIOL, V12, P4706, DOI 10.1128/MCB.12.10.4706; Santen RJ, 2004, CLIN CANCER RES, V10, p337S, DOI 10.1158/1078-0432.CCR-031207; SEIBERT K, 1983, CANCER RES, V43, P2223; Shah YM, 2005, MOL ENDOCRINOL, V19, P732, DOI 10.1210/me.2004-0298; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shupnik MA, 2004, ONCOGENE, V23, P7979, DOI 10.1038/sj.onc.1208076; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Sun M, 2001, CANCER RES, V61, P5985; Tatton L, 2003, J BIOL CHEM, V278, P4847, DOI 10.1074/jbc.M209321200; Tsai HW, 2004, ENDOCRINOLOGY, V145, P2730, DOI 10.1210/en.2003-1470; Utsumi Toshiaki, 2007, Breast Cancer, V14, P194, DOI 10.2325/jbcs.959; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; VILLALOBOS M, 1995, ENVIRON HEALTH PERSP, V103, P844, DOI 10.2307/3432398; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; WHANGPENG J, 1983, J NATL CANCER I, V71, P687; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Wong CW, 2002, P NATL ACAD SCI USA, V99, P14783, DOI 10.1073/pnas.192569699; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Yahata T, 2001, GENE DEV, V15, P2598, DOI 10.1101/gad.906301; Zhu F, 2006, CANCER RES, V66, P5729, DOI 10.1158/0008-5472.CAN-05-4466	98	52	53	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60889	10.1371/journal.pone.0060889	http://dx.doi.org/10.1371/journal.pone.0060889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593342	Green Submitted, Green Published, gold			2022-12-27	WOS:000319108100068
J	Alisson-Silva, F; Freire-de-Lima, L; Donadio, JL; Lucena, MC; Penha, L; Sa-Diniz, JN; Dias, WB; Todeschini, AR				Alisson-Silva, Frederico; Freire-de-Lima, Leonardo; Donadio, Joana L.; Lucena, Miguel C.; Penha, Luciana; Sa-Diniz, Julliana N.; Dias, Wagner B.; Todeschini, Adriane R.			Increase of O-Glycosylated Oncofetal Fibronectin in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Epithelial Cells	PLOS ONE			English	Article							ALPHA-D-GALACTOSAMINE; DIABETES-MELLITUS; METABOLISM; ACTIVATION; VARIANTS; FIBROSIS; MOTILITY; ADHESION; BETA-1; GROWTH	Growing evidences indicate that aberrant glycosylation can modulate tumor cell invasion and metastasis. The process termed "epithelial-mesenchymal transition" (EMT) provides a basic experimental model to shed light on this complex process. The EMT involves a striking decline in epithelial markers, accompanied by enhanced expression of mesenchymal markers, culminating in cell morphology change and increased cell motility. Few recent studies have established the participation glycosylation during EMT. Studies now come into knowledge brought to light the involvement of a site-specific O-glycosylation in the IIICS domain of human oncofetal fibronectin (onfFN) during the EMT process. Herein we show that high glucose induces EMT in A549 cells as demonstrated by TGF-beta secretion, cell morphology changes, increased cellular motility and the emergence of mesenchymal markers. The hyperglycemic conditions increased onfFN protein levels, promoted an up regulation of mRNA levels for ppGalNAc-T6 and FN IIICS domain, which contain the hexapeptide (VTHPGY) required for onfFN biosynthesis. Glucose effect involves hexosamine (HBP) biosynthetic pathway as overexpression of glutamine: fructose-6-phosphate amidotransferase increases mesenchymal markers, onfFN levels and mRNA levels for FN IIICS domain. In summary, our results demonstrate, for the first time that the metabolism of glucose through HBP promotes O-glycosylation of the oncofetal form of FN during EMT modulating tumorogenesis.	[Alisson-Silva, Frederico; Freire-de-Lima, Leonardo; Donadio, Joana L.; Lucena, Miguel C.; Penha, Luciana; Sa-Diniz, Julliana N.; Dias, Wagner B.; Todeschini, Adriane R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Todeschini, AR (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	adrianet@biof.ufrj.br	da Silva, Frederico/X-7822-2018; Dias, Wagner/B-1401-2016; Todeschini, Adriane Regina/ABC-9165-2020; da Silva, Frederico/AAY-4758-2021; Freire-de-Lima, Leonardo/I-1894-2012; Todeschini, Adriane/AAG-8128-2020	da Silva, Frederico/0000-0001-6717-2518; Todeschini, Adriane Regina/0000-0002-6049-2751; da Silva, Frederico/0000-0001-6717-2518; Freire-de-Lima, Leonardo/0000-0003-3013-3173; Dias, Wagner/0000-0002-8378-8846	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCT-V)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCT-V)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and the Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCT-V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dias WB, 2012, BIOCHEM BIOPH RES CO, V422, P224, DOI 10.1016/j.bbrc.2012.04.124; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Ding Y, 2012, FEBS LETT, V586, P1813, DOI 10.1016/j.febslet.2012.05.020; Freeze H.H., 2009, GLYCOSYLATION PRECUR; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Gribbin J, 2009, RESP MED, V103, P927, DOI 10.1016/j.rmed.2008.11.001; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang SP, 2010, J PANCREAS, V11, P334; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; Labat-Robert J, 2012, PATHOL BIOL, V60, P15, DOI 10.1016/j.patbio.2011.10.003; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; MATSUURA H, 1985, P NATL ACAD SCI USA, V82, P6517, DOI 10.1073/pnas.82.19.6517; MATSUURA H, 1989, J BIOL CHEM, V264, P10472; Mosher DF, 2001, NAT MED, V7, P290, DOI 10.1038/85426; Nomoto M, 1999, CANCER RES, V59, P6214; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Schofield KP, 1999, BLOOD, V93, P410, DOI 10.1182/blood.V93.1.410; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Todeschini AR, 2008, P NATL ACAD SCI USA, V105, P1925, DOI 10.1073/pnas.0709619104; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Vigneri R, 2009, NAT REV ENDOCRINOL, V5, P651, DOI 10.1038/nrendo.2009.219; WARBURG O, 1956, SCIENCE, V124, P269; Weigert C, 2004, J BIOL CHEM, V279, P15908, DOI 10.1074/jbc.M313524200; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; White ES, 2011, IUBMB LIFE, V63, P538, DOI 10.1002/iub.493; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414; Zhou L, 2010, CLIN EXP PHARMACOL P, V37, pe152, DOI 10.1111/j.1440-1681.2010.05421.x	43	52	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60471	10.1371/journal.pone.0060471	http://dx.doi.org/10.1371/journal.pone.0060471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593224	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300017
J	Yagasaki, Y; Hayashi, M; Tamura, N; Kawakami, Y				Yagasaki, Yuki; Hayashi, Motohiro; Tamura, Noriko; Kawakami, Yoriko			Gamma Knife Irradiation of Injured Sciatic Nerve Induces Histological and Behavioral Improvement in the Rat Neuropathic Pain Model	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TRIGEMINAL NEURALGIA; AXONAL REGENERATION; WALLERIAN DEGENERATION; MYELIN PHAGOCYTOSIS; X-IRRADIATION; RADIOSURGERY; BRAIN; SURGERY; MACROPHAGES	We examined the effects of gamma knife (GK) irradiation on injured nerves using a rat partial sciatic nerve ligation (PSL) model. GK irradiation was performed at one week after ligation and nerve preparations were made three weeks after ligation. GK irradiation is known to induce immune responses such as glial cell activation in the central nervous system. Thus, we determined the effects of GK irradiation on macrophages using immunoblot and histochemical analyses. Expression of Iba-1 protein, a macrophage marker, was further increased in GK-treated injured nerves as compared with non-irradiated injured nerves. Immunohistochemical study of Iba-1 in GK-irradiated injured sciatic nerves demonstrated Iba-1 positive macrophage accumulation to be enhanced in areas distal to the ligation point. In the same area, myelin debris was also more efficiently removed by GK-irradiation. Myelin debris clearance by macrophages is thought to contribute to a permissive environment for axon growth. In the immunoblot study, GK irradiation significantly increased expressions of beta III-tubulin protein and myelin protein zero, which are markers of axon regeneration and re-myelination, respectively. Toluidine blue staining revealed the re-myelinated fiber diameter to be larger at proximal sites and that the re-myelinated fiber number was increased at distal sites in GK-irradiated injured nerves as compared with non-irradiated injured nerves. These results suggest that GK irradiation of injured nerves facilitates regeneration and re-myelination. In a behavior study, early alleviation of allodynia was observed with GK irradiation in PSL rats. When GK-induced alleviation of allodynia was initially detected, the expression of glial cell line-derived neurotrophic factor (GDNF), a potent analgesic factor, was significantly increased by GK irradiation. These results suggested that GK irradiation alleviates allodynia via increased GDNF. This study provides novel evidence that GK irradiation of injured peripheral nerves may have beneficial effects.	[Yagasaki, Yuki; Kawakami, Yoriko] Tokyo Womens Med Univ, Dept Physiol, Sch Med, Tokyo, Japan; [Hayashi, Motohiro; Tamura, Noriko] Tokyo Womens Med Univ, Dept Neurosurg, Neurol Inst, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Yagasaki, Y (corresponding author), Tokyo Womens Med Univ, Dept Physiol, Sch Med, Tokyo, Japan.	yagasaki@research.twmu.ac.jp			Japan Society for the Promotion of Science (JSPS) [19791015, 19603017, 22791358]; Grants-in-Aid for Scientific Research [22791358] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research 19791015 to YY, 19603017 to YK, and 22791358 to YY from the Japan Society for the Promotion of Science (JSPS), http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomei F, 2008, NEUROLOGY, V70, P1658, DOI 10.1212/01.wnl.0000294326.05118.d8; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Cui Q, 2009, NEUROSCIENCE, V158, P1039, DOI 10.1016/j.neuroscience.2008.07.036; Da Silva AN, 2009, J NEUROSURG, V111, P423, DOI 10.3171/2008.9.JNS08281; Filbin MT, 2006, NAT NEUROSCI, V9, P715, DOI 10.1038/nn0606-715; FLICKINGER JC, 1994, INT J RADIAT ONCOL, V28, P797, DOI 10.1016/0360-3016(94)90098-1; Flickinger JC, 2001, J NEUROSURG, V94, P1, DOI 10.3171/jns.2001.94.1.0001; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Hayashi M, 2002, J NEUROSURG, V97, P433, DOI 10.3171/jns.2002.97.supplement_5.0433; Hayashi M, 2009, PROG NEUROL SURG, V22, P182, DOI 10.1159/000163431; Hillard VH, 2007, J NEUROSURG-SPINE, V6, P337, DOI 10.3171/spi.2007.6.4.337; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Hoffman PN, 1996, BRAIN RES, V742, P329, DOI 10.1016/S0006-8993(96)00980-8; HOFFMAN PN, 1988, P NATL ACAD SCI USA, V85, P4530, DOI 10.1073/pnas.85.12.4530; Hoke A, 2003, J NEUROSCI, V23, P561; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kalderon N, 2001, BRAIN RES, V904, P199, DOI 10.1016/S0006-8993(01)02402-7; Kalderon N, 1996, P NATL ACAD SCI USA, V93, P11179, DOI 10.1073/pnas.93.20.11179; Kamiryo T, 1996, ACTA NEUROCHIR, V138, P451, DOI 10.1007/BF01420308; Kondziolka D, 2000, NEUROSURGERY, V46, P971, DOI 10.1097/00006123-200004000-00038; KONDZIOLKA D, 1992, NEUROSURGERY, V31, P271, DOI 10.1227/00006123-199208000-00012; MILDENBERGER M, 1990, INT J RADIAT ONCOL, V18, P1051, DOI 10.1016/0360-3016(90)90440-U; MOSKOWITZ PF, 1995, J NEUROSCI, V15, P1545; Myers RR, 1996, EXP NEUROL, V141, P94, DOI 10.1006/exnr.1996.0142; Nagano M, 2003, BRIT J PHARMACOL, V140, P1252, DOI 10.1038/sj.bjp.0705550; NAKATA H, 1995, ACTA NEUROCHIR, V136, P82, DOI 10.1007/BF01411440; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; Regis J, 2002, ACT NEUR S, V84, P37; Regis J, 2006, J NEUROSURG, V104, P913, DOI 10.3171/jns.2006.104.6.913; Regis J, 2010, J NEURO-ONCOL, V98, P155, DOI 10.1007/s11060-010-0226-5; Reinacher PC, 1999, EXP NEUROL, V160, P117, DOI 10.1006/exnr.1999.7177; Salegio EAA, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-11; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215, DOI 10.1016/0360-3016(80)90175-3; Shi JY, 2011, HUM GENE THER, V22, P721, DOI 10.1089/hum.2010.036; Song XY, 2006, J NEUROCHEM, V96, P833, DOI 10.1111/j.1471-4159.2005.03564.x; Stafford SL, 2001, NEUROSURGERY, V49, P1029, DOI 10.1097/00006123-200111000-00001; Tokumaru O, 2005, J NEUROSURG, V102, P42, DOI 10.3171/jns.2005.102.s_supplement.0042; Tokumaru O, 2007, STEREOT FUNCT NEUROS, V85, P135, DOI 10.1159/000099071; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; Yang T, 2000, NEUROSURGERY, V47, P407, DOI 10.1097/00006123-200008000-00026; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yuan QJ, 2000, NEUROREPORT, V11, P2237, DOI 10.1097/00001756-200007140-00035; Zerris VA, 2002, ACT NEUR S, V84, P99; Zhang LQ, 2009, GLIA, V57, P1178, DOI 10.1002/glia.20840; Zhao ZF, 2010, J NEUROSURG, V113, P39, DOI 10.3171/2010.1.JNS091116	47	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61010	10.1371/journal.pone.0061010	http://dx.doi.org/10.1371/journal.pone.0061010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593377	Green Submitted, gold, Green Published			2022-12-27	WOS:000317385300042
J	Zhang, QC; Tian, MJ; Feng, Y; Zhao, K; Xu, J; Liu, Y; Shao, YM				Zhang, Qicheng; Tian, Meijuan; Feng, Yi; Zhao, Kai; Xu, Jing; Liu, Ying; Shao, Yiming			Genomic Sequence and Virulence of Clonal Isolates of Vaccinia Virus Tiantan, the Chinese Smallpox Vaccine Strain	PLOS ONE			English	Article							CELL-CULTURE; GLYCOPROTEIN; PROTECTION; INFECTION; ACAM2000; PROTEIN	Despite the worldwide eradication of smallpox in 1979, the potential bioterrorism threat from variola virus and the ongoing use of vaccinia virus (VACV) as a vector for vaccine development argue for continued research on VACV. In China, the VACV Tiantan strain (TT) was used in the smallpox eradication campaign. Its progeny strain is currently being used to develop a human immunodeficiency virus (HIV) vaccine. Here we sequenced the full genomes of five TT clones isolated by plaque purification from the TT (752-1) viral stock. Phylogenetic analysis with other commonly used VACV strains showed that TT (752-1) and its clones clustered and exhibited higher sequence diversity than that found in Dryvax clones. The similar to 190 kbp genomes of TT appeared to encode 273 open reading frames (ORFs). ORFs located in the middle of the genome were more conserved than those located at the two termini, where many virulence and immunomodulation associated genes reside. Several patterns of nucleotide changes including point mutations, insertions and deletions were identified. The polymorphisms in seven virulence-associated proteins and six immunomodulation-related proteins were analyzed. We also investigated the neuro- and skin-virulence of TT clones in mice and rabbits, respectively. The TT clones exhibited significantly less virulence than the New York City Board of Health (NYCBH) strain, as evidenced by less extensive weight loss and morbidity in mice as well as produced smaller skin lesions and lower incidence of putrescence in rabbits. The complete genome sequences, ORF annotations, and phenotypic diversity yielded from this study aid our understanding of the Chinese historic TT strain and are useful for HIV vaccine projects employing TT as a vector.	[Zhang, Qicheng; Feng, Yi; Liu, Ying; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China; [Zhang, Qicheng; Shao, Yiming] Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Biotechnol, Minist Educ, Tianjin 300071, Peoples R China; [Zhang, Qicheng; Shao, Yiming] Nankai Univ, Coll Life Sci, Key Lab Microbial Funct Genom Tianjin, Tianjin 300071, Peoples R China; [Tian, Meijuan] Case Western Reserve Univ, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Zhao, Kai; Xu, Jing] Natl Vaccine & Serum Inst, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Nankai University; Nankai University; Case Western Reserve University	Liu, Y (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China.	yingliu@chinaaids.cn; yshao08@gmail.com		zhang, qicheng/0000-0001-7277-0280	national major projects for Infectious Diseases Control and Prevention [2012ZX10001008]; National Natural Science Foundation of China [81020108030]; State Key Laboratory for Infectious Disease Prevention and Control (SKLID) Development grant [2012SKLID103]	national major projects for Infectious Diseases Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Disease Prevention and Control (SKLID) Development grant	Funding was provided by national major projects for Infectious Diseases Control and Prevention 2012ZX10001008 (http://www.nmp.gov.cn/), National Natural Science Foundation of China 81020108030 (http://www.nsfc.gov.cn/Portal0/default152.htm), and State Key Laboratory for Infectious Disease Prevention and Control (SKLID) Development grant 2012SKLID103(http://sklid.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1975, VACC EXP EXCH C; [Anonymous], 1980, GLOBAL ERADICATION S; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Brodie R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-96; Dong S, 2009, WEISHENGWUXUE MIANYI, V37, P1; Earl PL, 2008, P NATL ACAD SCI USA, V105, P10889, DOI 10.1073/pnas.0804985105; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Esteban D, 2005, PHARMACOGENOMICS, V6, P271, DOI 10.1517/14622416.6.3.271; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P241, DOI 10.1086/375824; Garcel A, 2009, VACCINE, V27, P708, DOI 10.1016/j.vaccine.2008.11.063; Garcel A, 2007, J GEN VIROL, V88, P1906, DOI 10.1099/vir.0.82708-0; Gardner JD, 2001, J GEN VIROL, V82, P2083, DOI 10.1099/0022-1317-82-9-2083; HENDERSON D, 1999, SMALLPOX VACCINIA; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; ISAACS SN, 1992, J VIROL, V66, P7217, DOI 10.1128/JVI.66.12.7217-7224.1992; Jezek Z, 1988, HUMAN MONKEYPOX; Levy-Bruhl D, 2001, Euro Surveill, V6, P171; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu LX, 2012, VACCINE, V30, P4135, DOI 10.1016/j.vaccine.2012.04.075; Lu B, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970424; Mahalingam S, 2004, TRENDS IMMUNOL, V25, P636, DOI 10.1016/j.it.2004.10.002; Marennikova SS, 1969, P S SMALLP ZAGR YUG; Monath TP, 2004, INT J INFECT DIS, V8, pS31, DOI 10.1016/j.ijid.2004.09.002; Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005; Ng A, 2001, J GEN VIROL, V82, P2095, DOI 10.1099/0022-1317-82-9-2095; Osborne JD, 2007, VACCINE, V25, P8807, DOI 10.1016/j.vaccine.2007.10.040; Parker RF, 1941, J EXP MED, V74, P263, DOI 10.1084/jem.74.3.263; POLAK MF, 1963, B WORLD HEALTH ORGAN, V29, P311; Qin L, 2011, J VIROL, V85, P13049, DOI 10.1128/JVI.05779-11; RICE CM, 1985, J VIROL, V56, P227, DOI 10.1128/JVI.56.1.227-239.1985; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Upton C, 2000, VIRUS RES, V70, P55, DOI 10.1016/S0168-1702(00)00210-0; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916; Yu WB, 2010, VACCINE, V28, P2088, DOI 10.1016/j.vaccine.2009.12.038; Zhao Kai, 2007, MED BIOLOGICOLOGY, P963	41	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60557	10.1371/journal.pone.0060557	http://dx.doi.org/10.1371/journal.pone.0060557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593246	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300020
J	Brauchle, M; Yao, ZP; Arora, R; Thigale, S; Clay, I; Inverardi, B; Fletcher, J; Taslimi, P; Acker, MG; Gerrits, B; Voshol, J; Bauer, A; Schubeler, D; Bouwmeester, T; Ruffner, H				Brauchle, Michael; Yao, Zhiping; Arora, Rishi; Thigale, Sachin; Clay, Ieuan; Inverardi, Bruno; Fletcher, Joy; Taslimi, Paul; Acker, Michael G.; Gerrits, Bertran; Voshol, Johannes; Bauer, Andreas; Schuebeler, Dirk; Bouwmeester, Tewis; Ruffner, Heinz			Protein Complex Interactor Analysis and Differential Activity of KDM3 Subfamily Members Towards H3K9 Methylation	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; HISTONE DEMETHYLASE; JMJC-DOMAIN; GENE-EXPRESSION; SUBSTRATE-SPECIFICITY; MOLECULAR-MECHANISMS; LYSINE METHYLATION; TARGET GENES; FAMILY; CHROMATIN	Histone modifications play an important role in chromatin organization and gene regulation, and their interpretation is referred to as epigenetic control. The methylation levels of several lysine residues in histone tails are tightly controlled, and JmjC domain-containing proteins are one class of broadly expressed enzymes catalyzing methyl group removal. However, several JmjC proteins remain uncharacterized, gaps persist in understanding substrate recognition, and the integration of JmjC proteins into signaling pathways is just emerging. The KDM3 subfamily is an evolutionarily conserved group of histone demethylase proteins, thought to share lysine substrate specificity. Here we use a systematic approach to compare KDM3 subfamily members. We show that full-length KDM3A and KDM3B are H3K9me1/2 histone demethylases whereas we fail to observe histone demethylase activity for JMJD1C using immunocytochemical and biochemical approaches. Structure-function analyses revealed the importance of a single amino acid in KDM3A implicated in the catalytic activity towards H3K9me1/2 that is not conserved in JMJD1C. Moreover, we use quantitative proteomic analyses to identify subsets of the interactomes of the 3 proteins. Specific interactor candidates were identified for each of the three KDM3 subfamily members. Importantly, we find that SCAI, a known transcriptional repressor, interacts specifically with KDM3B. Taken together, we identify substantial differences in the biology of KDM3 histone demethylases, namely enzymatic activity and protein-protein interactions. Such comparative approaches pave the way to a better understanding of histone demethylase specificity and protein function at a systems level and are instrumental in identifying the more subtle differences between closely related proteins.	[Brauchle, Michael; Clay, Ieuan; Inverardi, Bruno; Gerrits, Bertran; Voshol, Johannes; Bauer, Andreas; Bouwmeester, Tewis; Ruffner, Heinz] Novartis Inst Biomed Res, Basel, Switzerland; [Yao, Zhiping; Arora, Rishi; Thigale, Sachin; Fletcher, Joy; Taslimi, Paul; Acker, Michael G.] Novartis Inst Biomed Res, Ctr Prote Chem, Cambridge, MA USA; [Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Novartis; Novartis; Friedrich Miescher Institute for Biomedical Research	Brauchle, M (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	brauchle@nyu.edu; heinz.ruffner@novartis.com	Thigale, Sachin/ABF-4357-2021	Acker, Michael/0000-0002-3565-9601; Thigale, Sachin/0000-0002-9700-7406; Clay, Ieuan/0000-0001-9722-8834	Novartis AG	Novartis AG	Michael Brauchle, Zhiping Yao, Rishi Arora, Sachin Thigale, Ieuan Clay, Bruno Inverardi, Joy Fletcher, Paul Taslimi, Michael G. Acker, Bertran Gerrits, Johannes Voshol, Andreas Bauer, Tewis Bouwmeester and Heinz Ruffner are all employees of Novartis AG. Dirk Schubeler is an employee of FMI, largely funded by Novartis AG. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Curtis BJ, 2011, DEV BIOL, V350, P534, DOI 10.1016/j.ydbio.2010.12.001; Hahn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013769; Hata K, 2002, DEVELOPMENT, V129, P1983; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Hu ZB, 2001, ONCOGENE, V20, P6946, DOI 10.1038/sj.onc.1204850; Inagaki S, 2010, EMBO J, V29, P3496, DOI 10.1038/emboj.2010.227; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim JY, 2012, MOL CELL BIOL, V32, P2917, DOI 10.1128/MCB.00133-12; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Lu FL, 2008, J INTEGR PLANT BIOL, V50, P886, DOI 10.1111/j.1744-7909.2008.00692.x; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wolf SS, 2007, ARCH BIOCHEM BIOPHYS, V460, P56, DOI 10.1016/j.abb.2007.01.017; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	51	51	53	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60549	10.1371/journal.pone.0060549	http://dx.doi.org/10.1371/journal.pone.0060549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593242	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200010
J	Kotkova, M; Sak, B; Kvetonova, D; Kvac, M				Kotkova, Michaela; Sak, Bohumil; Kvetonova, Dana; Kvac, Martin			Latent Microsporidiosis Caused by Encephalitozoon cuniculi in Immunocompetent Hosts: A Murine Model Demonstrating the Ineffectiveness of the Immune System and Treatment with Albendazole	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; SCID MICE; ENTEROCYTOZOON-BIENEUSI; PATIENT; LYMPHOCYTES; EPIDEMIOLOGY; INTESTINALIS; CONFIRMATION; MACROPHAGES; ANTIBODIES	Background: Microsporidia are obligate intracellular parasites causing severe infections with lethal outcome in immunocompromised hosts. However, these pathogens are more frequently reported as latent infections in immunocompetent individuals and raises questions about the potential risk of reactivation following induced immunosuppression. Aims: To evaluate the possibility latent microsporidiosis, efficacy or albendazole, and reactivation, the authors monitored the course of E. cuniculi infection in immunocompetent BALB/c mice and immunodeficient SCID mice using molecular methods. Methods: Mice were per orally infected with 10(7) spores of E. cuniculi. Selected groups were treated with albendazole, re-infected or chemically immunosuppressed by dexamethasone. The presence of microsporidia in the host's organs and feces were determined using PCR methods. Changes in numbers of lymphocytes in blood and in spleen after induction of immunosuppression were confirmed using flow cytometry analysis. Results: Whereas E. cuniculi caused lethal microsporidiosis in SCID mice, the infection in BABL/c mice remained asymptomatic despite parasite dissemination into many organs during the acute infection phase. Albendazole treatment led to microsporidia elimination from organs in BALB/c mice. In SCID mice, however, only a temporary reduction in number of affected organs was observed and infection re-established post-treatment. Dexamethasone treatment resulted in a chronic microsporidia infection disseminating into most organs in BALB/c mice. Although the presence of E. cuniculi in organs of albendazole- treated mice was undetectable by PCR, it was striking that infection was reactivated by immunosuppression treatment. Conclusion: Our results demonstrated that microsporidia can successfully survive in organs of immunocompetent hosts and are able to reactivate from undetectable levels and spread within these hosts after induction of immunosuppression. These findings stress the danger of latent microsporidiosis as a life-threatening risk factor especially for individuals undergoing chemotherapy and in transplant recipients of organs originating from infected donors.	[Kotkova, Michaela; Sak, Bohumil; Kvetonova, Dana; Kvac, Martin] Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic; [Kvac, Martin] Univ South Bohemia Ceske Budejovice, Fac Agr, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Sak, B (corresponding author), Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, Vvi, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	casio@paru.cas.cz	Kvac, Martin/AAT-9533-2020; Kvac, Martin/G-7299-2014; Sak, Bohumil/G-9262-2014	Kvac, Martin/0000-0003-0013-6090; 	Grant Agency of Faculty of Science, University of South Bohemia in Ceske Budejovice [SGA2010/005]; Grant Agency of University of South Bohemia [022/2010/Z]; Ministry of Education, Youth and Sports of the Czech Republic [LH11061]; Grant Agency of the Czech Republic [P505/11/1163]	Grant Agency of Faculty of Science, University of South Bohemia in Ceske Budejovice; Grant Agency of University of South Bohemia; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This study was supported by projects from Grant Agency of Faculty of Science, University of South Bohemia in Ceske Budejovice (SGA2010/005), Grant Agency of University of South Bohemia (022/2010/Z), the Ministry of Education, Youth and Sports of the Czech Republic (LH11061), and Grant Agency of the Czech Republic (P505/11/1163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braunfuchsova P, 2001, INT J PARASITOL, V31, P681, DOI 10.1016/S0020-7519(01)00134-5; Breitenmoser AC, 1999, PARASITOLOGY, V118, P447, DOI 10.1017/S0031182099004229; Bryan RT, 1999, MICROSPORIDIA MICROS, P502; CANNING EU, 1991, J PROTOZOOL, V38, P631; CANNING EU, 1986, MICROSPORIDIA VERTEB; Canning EU, 1992, REV MED MICROBIOL, V2, P35; Cotte L, 1999, J INFECT DIS, V180, P2003, DOI 10.1086/315112; De Bosschere H, 2007, ZOONOSES PUBLIC HLTH, V54, P131, DOI 10.1111/j.1863-2378.2007.01034.x; DEGROOTE MA, 1995, J INFECT DIS, V171, P1375, DOI 10.1093/infdis/171.5.1375; Deplazes P, 2000, CONTRIB MICROBIOL, V6, P236, DOI 10.1159/000060363; DIDIER ES, 1995, PARASITE IMMUNOL, V17, P405, DOI 10.1111/j.1365-3024.1995.tb00908.x; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Didier ES, 1998, ADV PARASIT, V40, P283, DOI 10.1016/S0065-308X(08)60125-6; Didier ES, 1994, J EUKARYOT MICROBIOL, V41, P43; Ditrich O, 2011, J CLIN MICROBIOL, V49, P2769, DOI 10.1128/JCM.00620-11; Dowd SE, 1998, APPL ENVIRON MICROB, V64, P3332; Fournier S, 2000, FEMS IMMUNOL MED MIC, V29, P95, DOI 10.1111/j.1574-695X.2000.tb01510.x; Franzen C, 2005, EXP PARASITOL, V109, P1, DOI 10.1016/j.exppara.2004.10.001; GANNON J, 1980, LAB ANIM, V14, P189, DOI 10.1258/002367780780937652; HOLLISTER WS, 1991, PARASITOLOGY, V102, P33, DOI 10.1017/S0031182000060315; Jalovecka M, 2010, PARASITOL RES, V106, P1159, DOI 10.1007/s00436-010-1785-2; Kakrania R, 2006, EYE, V20, P1314, DOI 10.1038/sj.eye.6702178; KatzwinkelWladarsch S, 1996, TROP MED INT HEALTH, V1, P373, DOI 10.1046/j.1365-3156.1996.d01-51.x; Khan IA, 1999, J IMMUNOL, V162, P6086; Khan IA, 2001, MICROBES INFECT, V3, P401, DOI 10.1016/S1286-4579(01)01397-1; KOUDELA B, 1993, FOLIA PARASIT, V40, P279; KOUDELA B, 1994, J EUKARYOT MICROBIOL, V41, P49; Lallo MA, 2012, EXP PARASITOL, V131, P339, DOI 10.1016/j.exppara.2012.04.019; Levaditi C, 1923, ANN I PASTEUR PARIS, V38, P675; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; MATSUBAYASHI H, 1959, ARCH PATHOL, V67, P181; Mertens RB, 1997, MODERN PATHOL, V10, P68; Moretto M, 2000, INFECT IMMUN, V68, P6223, DOI 10.1128/IAI.68.11.6223-6232.2000; ORENSTEIN JM, 1991, J PARASITOL, V77, P843, DOI 10.2307/3282733; Pozio E, 2005, TRENDS PARASITOL, V21, P58, DOI 10.1016/j.pt.2004.11.003; Sak B, 2006, PARASITE IMMUNOL, V28, P95, DOI 10.1111/j.1365-3024.2005.00813.x; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2010, VET PARASITOL, V168, P196, DOI 10.1016/j.vetpar.2009.11.012; Salat J, 2006, PARASITOL RES, V99, P682, DOI 10.1007/s00436-006-0208-x; SCHMIDT EC, 1983, INFECT IMMUN, V40, P936, DOI 10.1128/IAI.40.3.936-942.1983; SHADDUCK JA, 1969, SCIENCE, V166, P516, DOI 10.1126/science.166.3904.516; Sinski Edward, 2003, Acta Microbiologica Polonica, V52, P97; Valencakova A, 2012, COMP IMMUNOL MICROB, V35, P1, DOI 10.1016/j.cimid.2011.11.004; vanGool T, 1997, J INFECT DIS, V175, P1020, DOI 10.1086/513963; Waywa D, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P151; Weber R, 1997, NEW ENGL J MED, V336, P474, DOI 10.1056/NEJM199702133360704; WEBER R, 1994, CLIN MICROBIOL REV, V7, P426, DOI 10.1128/CMR.7.4.426-461.1994; Wright JH, 1922, J EXP MED, V36, P135, DOI 10.1084/jem.36.1.135	50	52	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60941	10.1371/journal.pone.0060941	http://dx.doi.org/10.1371/journal.pone.0060941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593356	Green Submitted, gold, Green Published			2022-12-27	WOS:000317383200031
J	Selig, ER; Longo, C; Halpern, BS; Best, BD; Hardy, D; Elfes, CT; Scarborough, C; Kleisner, KM; Katona, SK				Selig, Elizabeth R.; Longo, Catherine; Halpern, Benjamin S.; Best, Benjamin D.; Hardy, Darren; Elfes, Cristiane T.; Scarborough, Courtney; Kleisner, Kristin M.; Katona, Steven K.			Assessing Global Marine Biodiversity Status within a Coupled Socio-Ecological Perspective	PLOS ONE			English	Article							EXTINCTION RISK; CONSERVATION; CONSEQUENCES; RECOVERY; DECLINE; INDEXES; TARGETS; HEALTH; FUTURE; EXTENT	People value the existence of a variety of marine species and habitats, many of which are negatively impacted by human activities. The Convention on Biological Diversity and other international and national policy agreements have set broad goals for reducing the rate of biodiversity loss. However, efforts to conserve biodiversity cannot be effective without comprehensive metrics both to assess progress towards meeting conservation goals and to account for measures that reduce pressures so that positive actions are encouraged. We developed an index based on a global assessment of the condition of marine biodiversity using publically available data to estimate the condition of species and habitats within 151 coastal countries. Our assessment also included data on social and ecological pressures on biodiversity as well as variables that indicate whether good governance is in place to reduce them. Thus, our index is a social as well as ecological measure of the current and likely future status of biodiversity. As part of our analyses, we set explicit reference points or targets that provide benchmarks for success and allow for comparative assessment of current conditions. Overall country-level scores ranged from 43 to 95 on a scale of 1 to 100, but countries that scored high for species did not necessarily score high for habitats. Although most current status scores were relatively high, likely future status scores for biodiversity were much lower in most countries due to negative trends for both species and habitats. We also found a strong positive relationship between the Human Development Index and resilience measures that could promote greater sustainability by reducing pressures. This relationship suggests that many developing countries lack effective governance, further jeopardizing their ability to maintain species and habitats in the future.	[Selig, Elizabeth R.; Katona, Steven K.] Conservat Int, Betty & Gordon Moore Ctr Ecosyst Sci & Econ, Arlington, VA USA; [Longo, Catherine; Halpern, Benjamin S.; Best, Benjamin D.; Hardy, Darren; Scarborough, Courtney] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Ctr Marine Assessment & Planning, Santa Barbara, CA 93106 USA; [Best, Benjamin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Elfes, Cristiane T.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Elfes, Cristiane T.] Conservat Int, Biodivers Assessment Unit, IUCN Global Species Programme, Arlington, VA USA; [Kleisner, Kristin M.] Univ British Columbia, Fisheries Ctr, Sea Us Project, Vancouver, BC V5Z 1M9, Canada	Conservation International; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Duke University; University of California System; University of California Santa Barbara; Conservation International; University of British Columbia	Selig, ER (corresponding author), Conservat Int, Betty & Gordon Moore Ctr Ecosyst Sci & Econ, Arlington, VA USA.	eselig@conservation.org		Scarborough, Courtney/0000-0001-7270-9228	Beau; Heather Wrigley; Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic; National Center for Ecological Analysis and Synthesis; David and Lucile Packard Foundation	Beau; Heather Wrigley; Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic(National Geographic Society); National Center for Ecological Analysis and Synthesis; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beau and Heather Wrigley provided the founding grant for the original Ocean Health Index work and the Pacific Life Foundation is the Founding Presenting Sponsor. Additional financial and in-kind support was provided by the Thomas W. Haas Fund of the New Hampshire Charitable Foundation, the Oak Foundation, Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation, Darden Restaurants Inc. Foundation, Conservation International, New England Aquarium, National Geographic, and the National Center for Ecological Analysis and Synthesis, which supported the Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project funded by the David and Lucile Packard Foundation.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Angermeier PL, 2000, CONSERV BIOL, V14, P373, DOI 10.1046/j.1523-1739.2000.98362.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Beaumont NJ, 2008, MAR POLLUT BULL, V56, P386, DOI 10.1016/j.marpolbul.2007.11.013; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Brito D, 2010, BIOL CONSERV, V143, P1154, DOI 10.1016/j.biocon.2010.02.015; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Dahl T.E., 2000, STATUS TRENDS WETLAN; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FETTERER F, 2009, SEA ICE INDEX; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Habel JC, 2011, BIODIVERSITY HOTSPOT; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; IUCN, 2001, IUCN RED LIST CAT CR; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jackson JBC, 2010, PHILOS T R SOC B, V365, P3765, DOI 10.1098/rstb.2010.0278; Justus J, 2009, TRENDS ECOL EVOL, V24, P187, DOI 10.1016/j.tree.2008.11.011; Kaschner K, 2010, PREDICTED RANGE MAPS; Knapp L, 2011, AQUAT CONSERV, V21, P401, DOI 10.1002/aqc.1202; Loh J, 2005, ECOL INDIC, V5, P231, DOI 10.1016/j.ecolind.2005.02.005; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McClanahan TR, 1999, CORAL REEFS, V18, P321, DOI 10.1007/s003380050205; McClenachan L, 2012, CONSERV LETT, V5, P73, DOI 10.1111/j.1755-263X.2011.00206.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Ministry for the Environment, 2007, ENV NZ 2007; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Perrings C, 2011, FRONT ECOL ENVIRON, V9, P512, DOI 10.1890/100212; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sadovy de Mitcheson Y, 2012, FISH FISHERIES; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Secretariat of the Convention on Biological Diversity, 2010, STRAT PALN BIOD 2011; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; *UN FAO, 2007, WORLDS MANGR 1980 20; Vackar D, 2012, ECOL INDIC, V17, P58, DOI 10.1016/j.ecolind.2011.04.024; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; World Wildlife Fund, 2010, LIV PLAN REP 2010 BI; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	57	18	18	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60284	10.1371/journal.pone.0060284	http://dx.doi.org/10.1371/journal.pone.0060284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593188	gold, Green Published, Green Submitted			2022-12-27	WOS:000317383200004
J	Bacon, KL; Belcher, CM; Haworth, M; McElwain, JC				Bacon, Karen L.; Belcher, Claire M.; Haworth, Matthew; McElwain, Jennifer C.			Increased Atmospheric SO2 Detected from Changes in Leaf Physiognomy across the Triassic-Jurassic Boundary Interval of East Greenland	PLOS ONE			English	Article							TRIASSIC/JURASSIC BOUNDARY; CO2; CLIMATE; RESPONSES; RECORD; SHAPE; PHOTOSYNTHESIS; TERRESTRIAL; SENSITIVITY; FUMIGATION	The Triassic-Jurassic boundary (Tr-J; similar to 201 Ma) is marked by a doubling in the concentration of atmospheric CO2, rising temperatures, and ecosystem instability. This appears to have been driven by a major perturbation in the global carbon cycle due to massive volcanism in the Central Atlantic Magmatic Province. It is hypothesized that this volcanism also likely delivered sulphur dioxide (SO2) to the atmosphere. The role that SO2 may have played in leading to ecosystem instability at the time has not received much attention. To date, little direct evidence has been presented from the fossil record capable of implicating SO2 as a cause of plant extinctions at this time. In order to address this, we performed a physiognomic leaf analysis on well-preserved fossil leaves, including Ginkgoales, bennettites, and conifers from nine plant beds that span the Tr-J boundary at Astartekloft, East Greenland. The physiognomic responses of fossil taxa were compared to the leaf size and shape variations observed in nearest living equivalent taxa exposed to simulated palaeoatmospheric treatments in controlled environment chambers. The modern taxa showed a statistically significant increase in leaf roundness when fumigated with SO2. A similar increase in leaf roundness was also observed in the Tr-J fossil taxa immediately prior to a sudden decrease in their relative abundances at Astartekloft. This research reveals that increases in atmospheric SO2 can likely be traced in the fossil record by analyzing physiognomic changes in fossil leaves. A pattern of relative abundance decline following increased leaf roundness for all six fossil taxa investigated supports the hypothesis that SO2 had a significant role in Tr-J plant extinctions. This finding highlights that the role of SO2 in plant biodiversity declines across other major geological boundaries coinciding with global scale volcanism should be further explored using leaf physiognomy.	[Bacon, Karen L.; McElwain, Jennifer C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Belcher, Claire M.] Univ Exeter, Coll Life & Environm Sci, Hatherly Labs, Exeter, Devon, England; [Haworth, Matthew] CNR Ist Biometeorol IBIMET, Florence, Italy	University College Dublin; University of Exeter; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR)	Bacon, KL (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	karenl.bacon@gmail.com	McElwain, Jennifer/AAX-1605-2020; McElwain, Jennifer/B-1735-2009; Haworth, Matthew/B-7817-2013	McElwain, Jennifer/0000-0002-1729-6755; Bacon, Karen/0000-0002-8944-5107; Haworth, Matthew/0000-0002-3225-6620	UCD Research Demonstratorship and Science Foundation Ireland [SFI 11/PI/1103]; European Union [PIEF-GA-2009-253780, PCIG10-GA-2011-303610]; European Research Council Starting Investigator Grant [ERC-2001-StG_ 279962];  [PEA-IEF-2010-275626];  [MEXT-CT-2006-042531]	UCD Research Demonstratorship and Science Foundation Ireland(Science Foundation Ireland); European Union(European Commission); European Research Council Starting Investigator Grant(European Research Council (ERC)); ; 	KLB acknowledges funding through a UCD Research Demonstratorship and Science Foundation Ireland (SFI 11/PI/1103). CMB acknowledges funding through a European Union Marie Curie Intra-European Fellowship FILE PIEF-GA-2009-253780 and a Marie Curie Career Integration Grant PyroMap PCIG10-GA-2011-303610. MH acknowledges funding though PEA-IEF-2010-275626. JMC acknowledges funding through Science Foundation Ireland (SFI 11/PI/1103) and a European Research Council Starting Investigator Grant (ERC-2001-StG_ 279962). JMC, CMB, and MH acknowledge funding through a Marie Curie research grant (MEXT-CT-2006-042531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; [Anonymous], 1937, MEDDELELSER GRONLAND; Bacon KL, 2011, PALAIOS, V26, P461, DOI 10.2110/palo.2010.p10-120r; Bartiromo A, 2013, ENVIRON EXP BOT, V87, P197, DOI 10.1016/j.envexpbot.2012.10.006; Bartiromo A, 2012, J VOLCANOL GEOTH RES, V233, P1, DOI 10.1016/j.jvolgeores.2012.04.002; Belcher CM, 2010, NAT GEOSCI, V3, P426, DOI 10.1038/NGEO871; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Bonis NR, 2010, PALAEOGEOGR PALAEOCL, V295, P146, DOI 10.1016/j.palaeo.2010.05.034; Bytnerowicz A, 2007, ENVIRON POLLUT, V147, P438, DOI 10.1016/j.envpol.2006.08.028; DAM G, 1992, GEOLOGY, V20, P749, DOI 10.1130/0091-7613(1992)020<0749:FRIALW>2.3.CO;2; DARRALL NM, 1986, J EXP BOT, V37, P1313, DOI 10.1093/jxb/37.9.1313; Deenen MHL, 2010, EARTH PLANET SC LETT, V291, P113, DOI 10.1016/j.epsl.2010.01.003; Haworth M, 2013, OECOLOGIA, V171, P71, DOI 10.1007/s00442-012-2406-9; Haworth M, 2012, REV PALAEOBOT PALYNO, V182, P44, DOI 10.1016/j.revpalbo.2012.06.006; Haworth M, 2010, NEW PHYTOL, V188, P845, DOI 10.1111/j.1469-8137.2010.03403.x; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hirano A, 2012, LANDSC ECOL ENG, V8, P59, DOI 10.1007/s11355-011-0149-0; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Kim Y.S., 1997, GINKGO BILOBA GLOBAL, P233, DOI DOI 10.1007/978-4-431-68416-9_18; Mander L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049153; Mander L, 2013, J GEOL SOC LONDON, V170, P37, DOI 10.1144/jgs2012-018; Mander L, 2010, P NATL ACAD SCI USA, V107, P15351, DOI 10.1073/pnas.1004207107; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McElwain JC, 2007, PALEOBIOLOGY, V33, P547, DOI 10.1666/06026.1; McElwain JC, 2009, SCIENCE, V324, P1554, DOI 10.1126/science.1171706; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007653; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Ruhl M, 2009, EARTH PLANET SC LETT, V281, P169, DOI 10.1016/j.epsl.2009.02.020; Schaller MF, 2011, SCIENCE, V331, P1404, DOI 10.1126/science.1199011; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Spicer RA, 2009, PALAEOGEOGR PALAEOCL, V283, P91, DOI 10.1016/j.palaeo.2009.09.009; Steinthorsdottir M, 2011, PALAEOGEOGR PALAEOCL, V308, P418, DOI 10.1016/j.palaeo.2011.05.050; Tanner LH, 2004, EARTH-SCI REV, V65, P103, DOI 10.1016/S0012-8252(03)00082-5; Tanner LH, 2001, NATURE, V411, P675, DOI 10.1038/35079548; van de Schootbrugge B, 2007, PALAEOGEOGR PALAEOCL, V244, P126, DOI 10.1016/j.palaeo.2006.06.026; van de Schootbrugge B, 2009, NAT GEOSCI, V2, P589, DOI 10.1038/NGEO577; Ward PD, 2007, PALAEOGEOGR PALAEOCL, V244, P281, DOI 10.1016/j.palaeo.2006.06.042; Whiteside JH, 2010, P NATL ACAD SCI USA, V107, P6721, DOI 10.1073/pnas.1001706107; Williford KH, 2007, PALAEOGEOGR PALAEOCL, V244, P290, DOI 10.1016/j.palaeo.2006.06.032; WINNER WE, 1985, OECOLOGIA, V66, P387, DOI 10.1007/BF00378304; WOLFE JA, 1995, ANNU REV EARTH PL SC, V23, P119, DOI 10.1146/annurev.earth.23.1.119; Yang J, 2007, AM J BOT, V94, P599, DOI 10.3732/ajb.94.4.599	43	41	42	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60614	10.1371/journal.pone.0060614	http://dx.doi.org/10.1371/journal.pone.0060614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593262	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000021
J	DeGutis, J; Mercado, RJ; Wilmer, J; Rosenblatt, A				DeGutis, Joseph; Mercado, Rogelio J.; Wilmer, Jeremy; Rosenblatt, Andrew			Individual Differences in Holistic Processing Predict the Own-Race Advantage in Recognition Memory	PLOS ONE			English	Article							FACE RECOGNITION; CATEGORIZATION; ATTENTION; PROSOPAGNOSIA; PERCEPTION; FEATURES; ACCOUNT; PARTS; BIAS	Individuals are consistently better at recognizing own-race faces compared to other-race faces (other-race effect, ORE). One popular hypothesis is that this recognition memory ORE is caused by differential own- and other-race holistic processing, the simultaneous integration of part and configural face information into a coherent whole. Holistic processing may create a more rich, detailed memory representation of own-race faces compared to other-race faces. Despite several studies showing that own-race faces are processed more holistically than other-race faces, studies have yet to link the holistic processing ORE and the recognition memory ORE. In the current study, we sought to use a more valid method of analyzing individual differences in holistic processing by using regression to statistically remove the influence of the control condition (part trials in the part-whole task) from the condition of interest (whole trials in the part-whole task). We also employed regression to separately examine the two components of the ORE: own-race advantage (regressing other-race from own-race performance) and other-race decrement (regressing own-race from other-race performance). First, we demonstrated that own-race faces were processed more holistically than other-race faces, particularly the eye region. Notably, using regression, we showed a significant association between the own-race advantage in recognition memory and the own-race advantage in holistic processing and that these associations were weaker when examining the other-race decrement. We also demonstrated that performance on own- and other-race faces across all of our tasks was highly correlated, suggesting that the differences we found between own- and other-race faces are quantitative rather than qualitative. Together, this suggests that own- and other-race faces recruit largely similar mechanisms, that own-race faces more thoroughly engage holistic processing, and that this greater engagement of holistic processing is significantly associated with the own-race advantage in recognition memory.	[DeGutis, Joseph; Rosenblatt, Andrew] Boston Div VA Healthcare Syst, Ctr Geriatr Res Educ & Clin, Jamaica Plain, MA USA; [DeGutis, Joseph] Harvard Univ, Dept Psychol, Vis Sci Lab, Cambridge, MA 02138 USA; [Mercado, Rogelio J.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Wilmer, Jeremy] Wellesley Coll, Dept Psychol, Wellesley, MA 02181 USA	Geriatric Research Education & Clinical Center; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Wellesley College	DeGutis, J (corresponding author), Boston Div VA Healthcare Syst, Ctr Geriatr Res Educ & Clin, Jamaica Plain, MA USA.	degutis@wjh.harvard.edu			Veterans Affairs Career Development Award	Veterans Affairs Career Development Award	The authors would like to acknowledge funding support from a Veterans Affairs Career Development Award for JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; Brett MT, 2004, OIKOS, V105, P647, DOI 10.1111/j.0030-1299.2004.12777.x; Brewer M.B., 2001, SOCIAL IDENTITY INTE, P17; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Bukach CM, 2012, COGNITION, V123, P319, DOI 10.1016/j.cognition.2012.02.007; Butler S, 2010, ATTEN PERCEPT PSYCHO, V72, P1444, DOI 10.3758/APP.72.6.1444; Caldara R, 2005, J COGNITIVE NEUROSCI, V17, P1652, DOI 10.1162/089892905774597254; DeGutis J, COGNITIVE N IN PRESS; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Eimer M, 2011, BRAIN RES, V1376, P76, DOI 10.1016/j.brainres.2010.12.046; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Hancock KJ, 2008, BRIT J PSYCHOL, V99, P45, DOI 10.1348/000712607X199981; Hayward WG, 2008, COGNITION, V106, P1017, DOI 10.1016/j.cognition.2007.04.002; Herzmann G, 2011, NEUROPSYCHOLOGIA, V49, P3103, DOI 10.1016/j.neuropsychologia.2011.07.019; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Hugenberg K, 2007, J EXP SOC PSYCHOL, V43, P334, DOI 10.1016/j.jesp.2006.02.010; Hugenberg K, 2010, PSYCHOL REV, V117, P1168, DOI 10.1037/a0020463; Hugenberg K, 2009, COGNITIVE SCI, V33, P1173, DOI 10.1111/j.1551-6709.2009.01048.x; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Konar Y, 2010, FACE IDENTIFICATION; Konar Y, 2010, PSYCHOL SCI, V21, P38, DOI 10.1177/0956797609356508; Lebrecht S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004215; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Lewis GJ, 2010, PSYCHOL SCI, V21, P1623, DOI 10.1177/0956797610387439; McKone E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047956; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Michel C, 2006, VIS COGN, V14, P55, DOI 10.1080/13506280500158761; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Phelps EA, 2001, NAT NEUROSCI, V4, P775, DOI 10.1038/90467; REINITZ MT, 1992, MEM COGNITION, V20, P1, DOI 10.3758/BF03208247; Rhodes G, 2009, PERCEPTION, V38, P232, DOI 10.1068/p6110; Richler JJ, 2008, J EXP PSYCHOL LEARN, V34, P1356, DOI 10.1037/a0013080; RODIN MJ, 1987, SOC COGNITION, V5, P144, DOI 10.1521/soco.1987.5.2.144; Rossion B., 2011, OXFORD HDB FACE PERC, P215; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Rossion B, 2009, J NEUROPSYCHOL, V3, P69, DOI 10.1348/174866408X289944; Russell R, 2009, PSYCHON B REV, V16, P252, DOI 10.3758/PBR.16.2.252; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Sidanius J., 1999, SOCIAL DOMINANCE INT; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Tanaka JW, 2009, COGN AFFECT BEHAV NE, V9, P122, DOI 10.3758/CABN.9.1.122; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Walker PM, 2003, PERCEPTION, V32, P1117, DOI 10.1068/p5098; Wang R, 2012, PSYCHOL SCI; Wiese H., CEREBRAL CO IN PRESS; Wiese H, 2009, BIOL PSYCHOL, V81, P103, DOI 10.1016/j.biopsycho.2009.03.002; Wilmer J, COGNITIVE N IN PRESS; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; Yovel G, 2012, J EXP PSYCHOL HUMAN, V38, P285, DOI 10.1037/a0027077	58	43	44	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e58253	10.1371/journal.pone.0058253	http://dx.doi.org/10.1371/journal.pone.0058253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123IQ	23593119	Green Published, gold, Green Submitted			2022-12-27	WOS:000317382000001
J	Osawa, S; Iwasaki, M; Hosaka, R; Matsuzaka, Y; Tomita, H; Ishizuka, T; Sugano, E; Okumura, E; Yawo, H; Nakasato, N; Tominaga, T; Mushiake, H				Osawa, Shin-ichiro; Iwasaki, Masaki; Hosaka, Ryosuke; Matsuzaka, Yoshiya; Tomita, Hiroshi; Ishizuka, Toru; Sugano, Eriko; Okumura, Eiichi; Yawo, Hiromu; Nakasato, Nobukazu; Tominaga, Teiji; Mushiake, Hajime			Optogenetically Induced Seizure and the Longitudinal Hippocampal Network Dynamics	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GRANGER CAUSALITY; BRAIN STRUCTURES; RAT HIPPOCAMPUS; DENTATE GYRUS; IN-VITRO; MODELS; CHANNELRHODOPSIN-2; AFTERDISCHARGE; STIMULATION	Epileptic seizure is a paroxysmal and self-limited phenomenon characterized by abnormal hypersynchrony of a large population of neurons. However, our current understanding of seizure dynamics is still limited. Here we propose a novel in vivo model of seizure-like afterdischarges using optogenetics, and report on investigation of directional network dynamics during seizure along the septo-temporal (ST) axis of hippocampus. Repetitive pulse photostimulation was applied to the rodent hippocampus, in which channelrhodopsin-2 (ChR2) was expressed, under simultaneous recording of local field potentials (LFPs). Seizure-like afterdischarges were successfully induced after the stimulation in both W-TChR2V4 transgenic (ChR2V-TG) rats and in wild type rats transfected with adeno-associated virus (AAV) vectors carrying ChR2. Pulse frequency at 10 and 20 Hz, and a 0.05 duty ratio were optimal for afterdischarge induction. Immunohistochemical c-Fos staining after a single induced afterdischarge confirmed neuronal activation of the entire hippocampus. LFPs were recorded during seizure-like afterdischarges with a multi-contact array electrode inserted along the ST axis of hippocampus. Granger causality analysis of the LFPs showed a bidirectional but asymmetric increase in signal flow along the ST direction. State space presentation of the causality and coherence revealed three discrete states of the seizure-like afterdischarge phenomenon: 1) resting state; 2) afterdischarge initiation with moderate coherence and dominant septal-to-temporal causality; and 3) afterdischarge termination with increased coherence and dominant temporal-to-septal causality. A novel in vivo model of seizure-like afterdischarge was developed using optogenetics, which was advantageous in its reproducibility and artifact-free electrophysiological observations. Our results provide additional evidence for the potential role of hippocampal septo-temporal interactions in seizure dynamics in vivo. Bidirectional networks work hierarchically along the ST hippocampus in the genesis and termination of epileptic seizures.	[Osawa, Shin-ichiro; Iwasaki, Masaki; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan; [Hosaka, Ryosuke] Fukuoka Univ, Dept Appl Math, Fukuoka 81401, Japan; [Matsuzaka, Yoshiya] Tohoku Univ, Grad Sch Med, Dept Physiol, Sendai, Miyagi 980, Japan; [Tomita, Hiroshi; Sugano, Eriko] Iwate Univ, Grad Sch Sci & Engn, Fac Engn, Dept Chem & Bioengn, Morioka, Iwate 020, Japan; [Matsuzaka, Yoshiya; Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Okumura, Eiichi; Nakasato, Nobukazu] Tohoku Univ, Grad Sch Med, Dept Epileptol, Sendai, Miyagi 980, Japan; [Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Ctr Neurosci, Sendai, Miyagi 980, Japan; [Osawa, Shin-ichiro; Iwasaki, Masaki; Matsuzaka, Yoshiya; Ishizuka, Toru; Yawo, Hiromu; Mushiake, Hajime] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Tohoku University; Fukuoka University; Tohoku University; Iwate University; Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST)	Iwasaki, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan.	epinetmi@gmail.com	Nakasato, Nobukazu/AAC-3650-2019; Yawo, Hiromu/I-4871-2015; Iwasaki, Masaki/AAH-4985-2020; Ishizuka, Toru/L-8191-2017; Tomita, Hiroshi/O-2135-2018	Yawo, Hiromu/0000-0002-4299-3288; Iwasaki, Masaki/0000-0002-4204-7144; Ishizuka, Toru/0000-0003-4405-8792; Tomita, Hiroshi/0000-0003-1051-2301; Mushiake, Hajime/0000-0002-5130-4720	Core Research of Evolutional Science & Technology (CREST); Japan Science and Technology Agency (JST), Tokyo, Japan; Ministry of Education, Science, Sports and Culture of Japan; Japan Epilepsy Research Foundation	Core Research of Evolutional Science & Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST), Tokyo, Japan; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Epilepsy Research Foundation	This study was supported by grants from Core Research of Evolutional Science & Technology (CREST), Japan Science and Technology Agency (JST), Tokyo, Japan and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan. One author (MI) was supported by the Japan Epilepsy Research Foundation. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Albus K, 2012, EPILEPSIA, V53, P1928, DOI 10.1111/j.1528-1167.2012.03597.x; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Avoli M, 2012, NEUROPHARMACOLOGY, P1; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bertram EH, 1997, EPILEPSIA, V38, P95, DOI 10.1111/j.1528-1157.1997.tb01083.x; Cadotte AJ, 2010, J NEUROSCI METH, V189, P121, DOI 10.1016/j.jneumeth.2010.03.007; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; de Curtis M, 2009, EPILEPSIA, V50, P2514, DOI 10.1111/j.1528-1167.2009.02249.x; Derchansky M, 2006, NEUROBIOL DIS, V23, P312, DOI 10.1016/j.nbd.2006.03.014; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FILIPE CN, 1989, ELECTROEN CLIN NEURO, V73, P172, DOI 10.1016/0013-4694(89)90198-3; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Foutz TJ, 2012, J NEUROPHYSIOL, V107, P3235, DOI 10.1152/jn.00501.2011; GAARSKJAER FB, 1986, BRAIN RES REV, V11, P335, DOI 10.1016/0165-0173(86)90004-4; GODDARD GV, 1967, NATURE, V214, P1020, DOI 10.1038/2141020a0; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; Iasemidis LD, 2004, IEEE T BIO-MED ENG, V51, P493, DOI 10.1109/TBME.2003.821013; Inoue T, 2009, NEURO-ONCOLOGY, V11, P151, DOI 10.1215/15228517-2008-068; JEFFERYS JGR, 1990, EXP PHYSIOL, V75, P127, DOI 10.1113/expphysiol.1990.sp003390; Ji ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032699; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Ledri M, 2012, EUR J NEUROSCI, V36, P1971, DOI 10.1111/j.1460-9568.2012.08080.x; LOTHMAN EW, 1992, EPILEPSY RES, V13, P205, DOI 10.1016/0920-1211(92)90054-W; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Pallud J, 2011, HIPPOCAMPUS, V21, P334, DOI 10.1002/hipo.20795; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Raol YH, 2012, PROG MOL BIOL TRANSL, V105, P57, DOI 10.1016/B978-0-12-394596-9.00003-2; Sander JWAS, 1996, J NEUROL NEUROSUR PS, V61, P433, DOI 10.1136/jnnp.61.5.433; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Shigeto H, 2012, EPILEPSY RES, P1; Sitnikova E, 2008, J NEUROSCI METH, V170, P245, DOI 10.1016/j.jneumeth.2008.01.017; SPENCER SS, 1992, EPILEPSIA, V33, P537, DOI 10.1111/j.1528-1157.1992.tb01706.x; STRINGER JL, 1989, J NEUROPHYSIOL, V62, P126, DOI 10.1152/jn.1989.62.1.126; Sugano E, 2011, GENE THER, V18, P266, DOI 10.1038/gt.2010.140; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieser HG, 2004, EPILEPSIA, V45, P32; Xiong WH, 2012, J NEUROSCI METH, V210, P119, DOI 10.1016/j.jneumeth.2012.07.019; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	49	59	59	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60928	10.1371/journal.pone.0060928	http://dx.doi.org/10.1371/journal.pone.0060928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593349	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000028
J	Wilson, BM; Stolarz-Fantino, S; Fantino, E				Wilson, Brent M.; Stolarz-Fantino, Stephanie; Fantino, Edmund			Regulating the Way to Obesity: Unintended Consequences of Limiting Sugary Drink Sizes	PLOS ONE			English	Article							PORTION SIZES; ENERGY-INTAKE; FOOD; CONSUMPTION; VOLUME; PRICE	Objectives: We examined whether a sugary drink limit would still be effective if larger-sized drinks were converted into bundles of smaller-sized drinks. Methods: In a behavioral simulation, participants were offered varying food and drink menus. One menu offered 16 oz, 24 oz, or 32 oz drinks for sale. A second menu offered 16 oz drinks, a bundle of two 12 oz drinks, or a bundle of two 16 oz drinks. A third menu offered only 16 oz drinks for sale. The method involved repeated elicitation of choices, and the instructions did not mention a limit on drink size. Results: Participants bought significantly more ounces of soda with bundles than with varying-sized drinks. Total business revenue was also higher when bundles rather than only small-sized drinks were sold. Conclusions: Our research suggests that businesses have a strong incentive to offer bundles of soda when drink size is limited. Restricting larger-sized drinks may have the unintended consequence of increasing soda consumption rather than decreasing it.	[Wilson, Brent M.; Stolarz-Fantino, Stephanie; Fantino, Edmund] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wilson, BM (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	b6wilson@ucsd.edu						Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687; City of New York, 2012, MAYOR BLOOMB DEP MAY; Downs JS, 2009, AM ECON REV, V99, P159, DOI 10.1257/aer.99.2.159; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Grynbaum MM, 2012, NY TIMES; Harnack LJ, 2000, AM J CLIN NUTR, V71, P1478; Just DR, 2009, CHOICES, V24, P19; Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450; Rolls BJ, 2002, AM J CLIN NUTR, V76, P1207, DOI 10.1093/ajcn/76.6.1207; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wansink B, 1996, J MARKETING, V60, P1, DOI 10.2307/1251838; Wansink B, 2005, J NUTR EDUC BEHAV, V37, P242, DOI 10.1016/S1499-4046(06)60278-9; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Young LR, 2007, J PUBLIC HEALTH POL, V28, P238, DOI 10.1057/palgrave.jphp.3200127; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246	16	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61081	10.1371/journal.pone.0061081	http://dx.doi.org/10.1371/journal.pone.0061081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123IQ	23593397	Green Published, gold, Green Submitted			2022-12-27	WOS:000317382000043
J	Amir, S; Ma, AH; Shi, XB; Xue, LR; Kung, HJ; White, RWD				Amir, Sumaira; Ma, Ai-Hong; Shi, Xu-Bao; Xue, Lingru; Kung, Hsing-Jien; White, Ralph W. deVere			Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer	PLOS ONE			English	Article							P53; MICRORNAS; PATHWAY; PROTEIN; INHIBITION; EXPRESSION; THERAPIES; DNA	MicroRNAs are a class of naturally occurring small non-coding RNAs that target protein-coding mRNAs at the post-transcriptional level and regulate complex patterns of gene expression. Our previous studies demonstrated that in human prostate cancer the miRNA miR-125b is highly expressed, leading to a negative regulation of some tumor suppressor genes. In this study, we further extend our studies by showing that miR-125b represses the protein product of the ink4a/ARF locus, p14(ARF), in two prostate cancer cell lines, LNCaP (wild type-p53) and 22Rv1 (both wild type and mutant p53), as well as in the PC-346C prostate cancer xenograft model that lentivirally overexpressed miR-125b. Our results highlight that miR-125b modulates the p53 network by hindering the down-regulation of Mdm2, thereby affecting p53 and its target genes p21 and Puma to a degree sufficient to inhibit apoptosis. Conversely, treatment of prostate cancer cells with an inhibitor of miR-125b (anti-miR-125b) resulted in increased expression of p14(ARF), decreased level of Mdm2, and induction of apoptosis. In addition, overexpression of miR-125b in p53-deficient PC3 cells induced down-regulation of p14(ARF), which leads to increased cell proliferation through a p53-independent manner. Thus, we conclude that miR-125b acts as an oncogene which regulates p14(ARF)/Mdm2 signaling, stimulating proliferation of prostate cancer cells through a p53-dependent or p53-independent function. This reinforces our belief that miR-125b has potential as a therapeutic target for the management of patients with metastatic prostate cancer.	[Amir, Sumaira; Ma, Ai-Hong; Shi, Xu-Bao; Xue, Lingru; White, Ralph W. deVere] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA; [Kung, Hsing-Jien] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	White, RWD (corresponding author), Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA.	rwdeverewhite@ucdavis.edu			NCI [CA136597]; Department of Defense [PC080488]; NATIONAL CANCER INSTITUTE [R01CA136597] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NCI grant CA136597 and Department of Defense grant PC080488. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2006, EXP MOL PATHOL, V81, P115, DOI 10.1016/j.yexmp.2006.07.001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; CHI SG, 1994, J NATL CANCER I, V86, P926, DOI 10.1093/jnci/86.12.926; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Cong F, 1999, ONCOGENE, V18, P7731, DOI 10.1038/sj.onc.1203290; Dimri GP, 2000, MOL CELL BIOL, V20, P273; Gumerlock PH, 1997, J NATL CANCER I, V89, P66, DOI 10.1093/jnci/89.1.66; Hassan O, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-9; HEIDENBERG HB, 1995, J UROLOGY, V154, P414, DOI 10.1016/S0022-5347(01)67065-4; Ichimura K, 2000, CANCER RES, V60, P417; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Konishi N, 2002, AM J PATHOL, V160, P1207, DOI 10.1016/S0002-9440(10)62547-3; Lassi K, 2009, CURR OPIN ONCOL, V21, P260, DOI 10.1097/CCO.0b013e32832a1868; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Meyers FJ, 1998, CANCER, V83, P2534, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2534::AID-CNCR19>3.3.CO;2-M; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Muer A, 2012, J BIOL CHEM, V287, P17343, DOI 10.1074/jbc.M111.314898; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Osanto S, 2012, THER ADV UROL, V4, P3, DOI 10.1177/1756287211432777; Pezaro C, 2012, NAT REV UROL, V9, P63, DOI 10.1038/nrurol.2011.235; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; SAOTOME K, 1989, TOXICOL IN VITRO, V3, P317, DOI 10.1016/0887-2333(89)90039-8; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	38	62	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61064	10.1371/journal.pone.0061064	http://dx.doi.org/10.1371/journal.pone.0061064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585871	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600079
J	Chheng, K; Carter, MJ; Emary, K; Chanpheaktra, N; Moore, CE; Stoesser, N; Putchhat, H; Sona, S; Reaksmey, S; Kitsutani, P; Sar, B; van Doorn, HR; Uyen, NH; Tan, LV; Paris, D; Blacksell, SD; Amornchai, P; Wuthiekanun, V; Parry, CM; Day, NPJ; Kumar, V				Chheng, Kheng; Carter, Michael J.; Emary, Kate; Chanpheaktra, Ngoun; Moore, Catrin E.; Stoesser, Nicole; Putchhat, Hor; Sona, Soeng; Reaksmey, Sin; Kitsutani, Paul; Sar, Borann; van Doorn, H. Rogier; Nguyen Hanh Uyen; Le Van Tan; Paris, Daniel; Blacksell, Stuart D.; Amornchai, Premjit; Wuthiekanun, Vanaporn; Parry, Christopher M.; Day, Nicholas P. J.; Kumar, Varun			A Prospective Study of the Causes of Febrile Illness Requiring Hospitalization in Children in Cambodia	PLOS ONE			English	Article							REAL-TIME PCR; SOUTHERN VIETNAM; CLINICAL-SAMPLES; RAPID DETECTION; MURINE TYPHUS; SCRUB TYPHUS; HEALTH-CARE; SIEM REAP; INFECTIONS; DIAGNOSIS	Background: Febrile illnesses are pre-eminent contributors to morbidity and mortality among children in South-East Asia but the causes are poorly understood. We determined the causes of fever in children hospitalised in Siem Reap province, Cambodia. Methods and Findings: A one-year prospective study of febrile children admitted to Angkor Hospital for Children, Siem Reap. Demographic, clinical, laboratory and outcome data were comprehensively analysed. Between October 12th 2009 and October 12th 2010 there were 1225 episodes of febrile illness in 1180 children. Median (IQR) age was 2.0 (0.8-6.4) years, with 850 (69%) episodes in children,5 years. Common microbiological diagnoses were dengue virus (16.2%), scrub typhus (7.8%), and Japanese encephalitis virus (5.8%). 76 (6.3%) episodes had culture-proven bloodstream infection, including Salmonella enterica serovar Typhi (22 isolates, 1.8%), Streptococcus pneumoniae (13, 1.1%), Escherichia coli (8, 0.7%), Haemophilus influenzae (7, 0.6%), Staphylococcus aureus (6, 0.5%) and Burkholderia pseudomallei (6, 0.5%). There were 69 deaths (5.6%), including those due to clinically diagnosed pneumonia (19), dengue virus (5), and melioidosis (4). 10 of 69 (14.5%) deaths were associated with culture-proven bloodstream infection in logistic regression analyses (odds ratio for mortality 3.4, 95% CI 1.6-6.9). Antimicrobial resistance was prevalent, particularly in S. enterica Typhi, (where 90% of isolates were resistant to ciprofloxacin, and 86% were multi-drug resistant). Comorbid undernutrition was present in 44% of episodes and a major risk factor for acute mortality (OR 2.1, 95% CI 1.1-4.2), as were HIV infection and cardiac disease. Conclusion: We identified a microbiological cause of fever in almost 50% of episodes in this large study of community-acquired febrile illness in hospitalized children in Cambodia. The range of pathogens, antimicrobial susceptibility, and comorbidities associated with mortality described will be of use in the development of rational guidelines for infectious disease treatment and control in Cambodia and South-East Asia.	[Chheng, Kheng; Chanpheaktra, Ngoun; Moore, Catrin E.; Putchhat, Hor; Sona, Soeng; Reaksmey, Sin; Kumar, Varun] Angkor Hosp Children, Siem Reap, Cambodia; [Carter, Michael J.; Emary, Kate; Moore, Catrin E.; Stoesser, Nicole; Paris, Daniel; Blacksell, Stuart D.; Amornchai, Premjit; Wuthiekanun, Vanaporn; Parry, Christopher M.; Day, Nicholas P. J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Emary, Kate; Moore, Catrin E.; Stoesser, Nicole; van Doorn, H. Rogier; Paris, Daniel; Blacksell, Stuart D.; Parry, Christopher M.; Day, Nicholas P. J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Carter, Michael J.] UCL, Inst Child Hlth, London, England; [van Doorn, H. Rogier; Nguyen Hanh Uyen; Le Van Tan] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Kitsutani, Paul; Sar, Borann] US Ctr Dis Control & Prevent, Cambodia Off, Influenza Program, Phnom Penh, Cambodia	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of London; University College London; University of Oxford	Carter, MJ (corresponding author), Angkor Hosp Children, Siem Reap, Cambodia.	michael.james.carter@gmail.com; varun@angkorhospital.org	Blacksell, Stuart/D-5530-2018; Moore, Catrin/K-1980-2017; van Doorn, H. Rogier/H-3080-2019; Paris, Daniel/GLN-7566-2022; Paris, Daniel/AFV-4762-2022; Stoesser, Nicole/H-3421-2019	Blacksell, Stuart/0000-0001-6576-726X; Moore, Catrin/0000-0002-8639-9846; van Doorn, H. Rogier/0000-0002-9807-1821; Stoesser, Nicole/0000-0002-4508-7969; CARTER, Michael/0000-0003-3403-4746; , Varun/0000-0003-4976-6229; Le Van, Tan/0000-0002-1791-3901; PARIS, Daniel/0000-0003-4743-5987	Wellcome Trust of Great Britain; Li Ka Shing-University of Oxford Global Health Programme; EMPERIE (European Management Platform for Emerging and Re-emerging Infectious Disease Entities); Influenza Division, US Centers for Communicable Disease Control as part of ongoing public health surveillance for severe acute respiratory infection; UK National Institute of Health Research through the University of Oxford; University College London	Wellcome Trust of Great Britain(Wellcome Trust); Li Ka Shing-University of Oxford Global Health Programme; EMPERIE (European Management Platform for Emerging and Re-emerging Infectious Disease Entities); Influenza Division, US Centers for Communicable Disease Control as part of ongoing public health surveillance for severe acute respiratory infection; UK National Institute of Health Research through the University of Oxford; University College London(General Electric)	This study was supported by the Wellcome Trust of Great Britain, the Li Ka Shing-University of Oxford Global Health Programme, EMPERIE (European Management Platform for Emerging and Re-emerging Infectious Disease Entities). Respiratory virus assays were supported by the Influenza Division, US Centers for Communicable Disease Control as part of ongoing public health surveillance for severe acute respiratory infection (PK and BS). UK National Institute of Health Research provided grants for academic clinical fellowships to KE and MJC through the University of Oxford, and University College London, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, HDB INT MAN CHILDH I; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Benschop K, 2008, J CLIN VIROL, V41, P69, DOI 10.1016/j.jcv.2007.10.004; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Blacksell SD, 2008, DIAGN MICR INFEC DIS, V60, P43, DOI 10.1016/j.diagmicrobio.2007.07.011; Blacksell SD, 2007, CLIN INFECT DIS, V44, P391, DOI 10.1086/510585; Blacksell SD, 2010, AM J TROP MED HYG, V83, P365, DOI 10.4269/ajtmh.2010.09-0534; Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9; Chheng K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006630; Chhour YM, 2002, EMERG INFECT DIS, V8, P485, DOI 10.3201/eid0805.010236; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; de Jong MD, 2000, J CLIN MICROBIOL, V38, P2568, DOI 10.1128/JCM.38.7.2568-2573.2000; Deen J, 2012, LANCET INFECT DIS, V12, P480, DOI 10.1016/S1473-3099(12)70028-2; Echevarria JE, 1998, J CLIN MICROBIOL, V36, P1388; Emary K, 2012, T ROY SOC TROP MED H, V106, P718, DOI 10.1016/j.trstmh.2012.08.007; Gueudin M, 2003, J VIROL METHODS, V109, P39, DOI 10.1016/S0166-0934(03)00042-9; Henry KM, 2007, MOL CELL PROBE, V21, P17, DOI 10.1016/j.mcp.2006.06.002; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; KARRON RA, 1994, J CLIN MICROBIOL, V32, P484, DOI 10.1128/JCM.32.2.484-488.1994; Kasper MR, 2012, AM J TROP MED HYG, V86, P246, DOI 10.4269/ajtmh.2012.11-0409; Kasper MR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-320; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Leelarasamee Amorn, 2004, Journal of the Medical Association of Thailand, V87, P464; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; National Institute of Statistics, 2011, CAMB DEM HLTH SURV 2; Pagnarith Y, 2010, AM J TROP MED HYG, V82, P1106, DOI 10.4269/ajtmh.2010.10-0030; Peacock SJ, 2008, T ROY SOC TROP MED H, V102, P5, DOI 10.1016/j.trstmh.2007.06.004; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Punjabi NH, 2012, AM J TROP MED HYG, V86, P46, DOI 10.4269/ajtmh.2012.10-0497; Thaipadunpanit J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016236; Tran VTN, 2012, T ROY SOC TROP MED H, V106, P26, DOI 10.1016/j.trstmh.2011.10.004; Khanh TH, 2012, EMERG INFECT DIS, V18, P2002, DOI 10.3201/eid1812.120929; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; Vong S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000903; WHO Collaborating Centre for Influenza, 2009, I00705 CDC WHO COLL; Wijedoru LPM, 2012, J TROP PEDIATRICS, V58, P68, DOI 10.1093/tropej/fmr032; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Wuthiekanun V, 2007, J CLIN MICROBIOL, V45, P1363, DOI 10.1128/JCM.02430-06	39	69	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60634	10.1371/journal.pone.0060634	http://dx.doi.org/10.1371/journal.pone.0060634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593267	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000317909600030
J	Chiu, YC; Kocagoz, S; Larson, JC; Brey, EM				Chiu, Yu-Chieh; Kocagoez, Sevi; Larson, Jeffery C.; Brey, Eric M.			Evaluation of Physical and Mechanical Properties of Porous Poly (Ethylene Glycol)-co-(L-Lactic Acid) Hydrogels during Degradation	PLOS ONE			English	Article							B-PLA HYDROGEL; POLY(ETHYLENE GLYCOL) HYDROGELS; STATISTICAL KINETIC-MODEL; IN-VITRO DEGRADATION; BULK DEGRADATION; CROSS-LINKING; CELL; DELIVERY; REGENERATION; SCAFFOLDS	Porous hydrogels of poly(ethylene glycol) (PEG) have been shown to facilitate vascularized tissue formation. However, PEG hydrogels exhibit limited degradation under physiological conditions which hinders their ultimate applicability for tissue engineering therapies. Introduction of poly((L)-lactic acid) (PLLA) chains into the PEG backbone results in copolymers that exhibit degradation via hydrolysis that can be controlled, in part, by the copolymer conditions. In this study, porous, PEG-PLLA hydrogels were generated by solvent casting/particulate leaching and photopolymerization. The influence of polymer conditions on hydrogel architecture, degradation and mechanical properties was investigated. Autofluorescence exhibited by the hydrogels allowed for three-dimensional, non-destructive monitoring of hydrogel structure under fully swelled conditions. The initial pore size depended on particulate size but not polymer concentration, while degradation time was dependent on polymer concentration. Compressive modulus was a function of polymer concentration and decreased as the hydrogels degraded. Interestingly, pore size did not vary during degradation contrary to what has been observed in other polymer systems. These results provide a technique for generating porous, degradable PEG-PLLA hydrogels and insight into how the degradation, structure, and mechanical properties depend on synthesis conditions.	[Chiu, Yu-Chieh; Kocagoez, Sevi; Larson, Jeffery C.; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Larson, Jeffery C.; Brey, Eric M.] Edward Hines Vet Adm Med Ctr, Res Serv, Hines, IL USA	Illinois Institute of Technology; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Brey, EM (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	brey@iit.edu			Veterans Administration; National Science Foundation [IIS 1125412, CBET 0854430]; Direct For Computer & Info Scie & Enginr [1125412] Funding Source: National Science Foundation	Veterans Administration(US Department of Veterans Affairs); National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors would like to acknowledge support from the Veterans Administration and the National Science Foundation (IIS 1125412 and CBET 0854430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz MW, 2010, BIOMACROMOLECULES, V11, P1160, DOI 10.1021/bm100061z; Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca; Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5; Chiu YC, 2012, J FLUORESC; Chiu YC, 2011, BIOMATERIALS; Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]; Chiu YC, 2009, CHEM MATER, V21, P1677, DOI 10.1021/cm803520j; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Eskandari M, 2011, BIOTECHNOL BIOENG, V108, P435, DOI 10.1002/bit.22889; Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1; Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296; Francis-Sedlak ME, 2010, MICROVASC RES, V80, P3, DOI 10.1016/j.mvr.2009.12.005; Francis-Sedlak ME, 2009, BIOMATERIALS, V30, P1851, DOI 10.1016/j.biomaterials.2008.12.014; Goraltchouk A, 2005, BIOMATERIALS, V26, P7555, DOI 10.1016/j.biomaterials.2005.05.026; Hattori K, 2001, MAT SCI ENG C-BIO S, V17, P27, DOI 10.1016/S0928-4931(01)00331-9; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133; Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054; Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083; Lovett M, 2010, TISSUE ENG PART C-ME, V16, P1565, DOI [10.1089/ten.tec.2010.0241, 10.1089/ten.TEC.2010.0241]; Metters AT, 2000, J PHYS CHEM B, V104, P7043, DOI 10.1021/jp000523t; Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1; Metters AT, 2001, J PHYS CHEM B, V105, P8069, DOI 10.1021/jp004083h; Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104; Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574; Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006; Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002; Saito T, 2004, ANN THORAC SURG, V77, P684, DOI 10.1016/S0003-4975(03)01341-9; Sokic S, 2012, TISSUE ENG PT A, V18, P2477, DOI [10.1089/ten.tea.2012.0173, 10.1089/ten.TEA.2012.0173]; Sokic S, 2012, ACTA BIOMATER, V8, P2213, DOI 10.1016/j.actbio.2012.03.017; VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044; Vila A, 2004, J AEROSOL MED, V17, P174, DOI 10.1089/0894268041457183; Wachiralarpphaithoon C, 2007, BIOMATERIALS, V28, P984, DOI 10.1016/j.biomaterials.2006.10.024; Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613	36	48	49	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60728	10.1371/journal.pone.0060728	http://dx.doi.org/10.1371/journal.pone.0060728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593296	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600042
J	Ding, WX; Zhou, DL; Jiang, X; Lu, LS				Ding, Weixing; Zhou, Dong-lei; Jiang, Xun; Lu, Lie-sheng			Methionine Synthase A2756G Polymorphism and Risk of Colorectal Adenoma and Cancer: Evidence Based on 27 Studies	PLOS ONE			English	Article							ONE-CARBON METABOLISM; CPG ISLAND METHYLATION; PLASMA HOMOCYSTEINE LEVELS; COLON-CANCER; GENE POLYMORPHISMS; FOLATE METABOLISM; NURSES HEALTH; METHYLENETETRAHYDROFOLATE REDUCTASE; CARCINOMA SEQUENCE; D919G POLYMORPHISM	Methionine synthase (MTR), which plays a central role in maintaining adequate intracellular folate, methionine and normal homocysteine concentrations, was thought to be involved in the development of colorectal cancer (CRC) and colorectal adenoma (CRA) by affecting DNA methylation. However, studies on the association between MTR A2756G polymorphism and CRC/CRA remain conflicting. We conducted a meta-analysis of 27 studies, including 13465 cases and 20430 controls for CRC, and 4844 cases and 11743 controls for CRA. Potential sources of heterogeneity and publication bias were also systematically explored. Overall, the summary odds ratio of G variant for CRC was 1.03 (95% CI: 0.96-1.09) and 1.05 (95% CI: 0.99-1.12) for CRA. No significant results were observed in heterozygous and homozygous when compared with wild genotype for these polymorphisms. In the stratified analyses according to ethnicity, source of controls, sample size, sex, and tumor site, no evidence of any gene-disease association was obtained. Results from the meta-analysis of four studies on MTR stratified according to smoking and alcohol drinking status showed an increased CRC risk in heavy smokers (OR = 2.06, 95% CI: 1.32-3.20) and heavy drinkers (OR = 2.00, 95% CI: 1.28-3.09) for G allele carriers. This meta-analysis suggests that the MTR A2756G polymorphism is not associated with CRC/CRA susceptibility and that gene-environment interaction may exist.	[Ding, Weixing; Zhou, Dong-lei; Jiang, Xun; Lu, Lie-sheng] Tongji Univ, Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China	Tongji University	Ding, WX (corresponding author), Tongji Univ, Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China.	Weixing_Ding@163.com; liesheng_lu@163.com						BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; Chen J, 2004, INT J CANCER, V110, P617, DOI 10.1002/ijc.20148; Chen J, 1996, CANCER RES, V56, P4862; Chen J, 2001, ATHEROSCLEROSIS, V154, P667, DOI 10.1016/S0021-9150(00)00469-X; Chen Kun, 2006, Zhonghua Zhongliu Zazhi, V28, P429; Cotton S, 1996, CRIT REV ONCOGENESIS, V7, P293, DOI 10.1615/CritRevOncog.v7.i5-6.10; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; de Jong MM, 2002, CANCER EPIDEM BIOMAR, V11, P1332; de Vogel S, 2011, CANCER EPIDEM BIOMAR, V20, P1726, DOI 10.1158/1055-9965.EPI-11-0359; de Vogel S, 2009, CANCER EPIDEM BIOMAR, V18, P3086, DOI 10.1158/1055-9965.EPI-09-0289; Dekou V, 2001, THROMB HAEMOSTASIS, V85, P67, DOI 10.1055/s-0037-1612906; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desai TK, 2008, GASTROENTEROL CLIN N, V37, P47, DOI 10.1016/j.gtc.2007.12.006; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EICHNER ER, 1973, J CLIN INVEST, V52, P584, DOI 10.1172/JCI107219; Eussen SJPM, 2010, CANCER EPIDEM BIOMAR, V19, P1328, DOI 10.1158/1055-9965.EPI-09-0841; Friso S, 2005, CURR DRUG METAB, V6, P37, DOI 10.2174/1389200052997339; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Giovannucci E, 2004, J NUTR, V134, p2475S, DOI 10.1093/jn/134.9.2475S; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Goode EL, 2004, CANCER EPIDEM BIOMAR, V13, P157, DOI 10.1158/1055-9965.EPI-03-0097; Guerreiro CS, 2008, AM J CLIN NUTR, V88, P1413, DOI 10.3945/ajcn.2008.25877; Han SS, 2012, CANCER EPIDEM BIOMAR, V21, P417, DOI 10.1158/1055-9965.EPI-11-0782; Hawkins N, 2002, GASTROENTEROLOGY, V122, P1376, DOI 10.1053/gast.2002.32997; Hazra A, 2007, CARCINOGENESIS, V28, P1510, DOI 10.1093/carcin/bgm062; HILLMAN RS, 1982, ANNU REV MED, V33, P345, DOI 10.1146/annurev.me.33.020182.002021; Jokic M, 2011, DNA CELL BIOL, V30, P771, DOI 10.1089/dna.2010.1189; Kim HC, 2005, J GASTROEN HEPATOL, V20, P1920, DOI 10.1111/j.1440-1746.2005.03943.x; Kim JW, 2011, ONCOL REP, V25, P167, DOI 10.3892/or_00001057; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Koushik A, 2006, CANCER EPIDEM BIOMAR, V15, P2408, DOI 10.1158/1055-9965.EPI-06-0624; Kury S, 2007, CANCER EPIDEM BIOMAR, V16, P1460, DOI 10.1158/1055-9965.EPI-07-0236; Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P1812, DOI 10.1158/1055-9965.EPI-10-0151; Ma J, 1999, CANCER EPIDEM BIOMAR, V8, P825; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; Marchand LL, 2002, CANCER CAUSE CONTROL, V13, P239, DOI 10.1023/A:1015057614870; Martinelli M, 2012, BR J NUTR, P1; Matsuo K, 2005, CARCINOGENESIS, V26, P2164, DOI 10.1093/carcin/bgi196; Matsuo Keitaro, 2002, Asian Pac J Cancer Prev, V3, P353; Guimaraes JLM, 2011, TUMOR BIOL, V32, P853, DOI 10.1007/s13277-011-0185-2; MULDER JWR, 1992, AM J PATHOL, V141, P797; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pufulete M, 2003, P NUTR SOC, V62, P437, DOI 10.1079/PNS2003265; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Sanjoaquin MA, 2005, INT J CANCER, V113, P825, DOI 10.1002/ijc.20648; Steck SE, 2008, J NUTRIGENET NUTRIGE, V1, P196, DOI 10.1159/000136651; Theodoratou E, 2008, CANCER EPIDEM BIOMAR, V17, P171, DOI 10.1158/1055-9965.EPI-07-0621; Tranah GJ, 2005, MOL CARCINOGEN, V44, P21, DOI 10.1002/mc.20112; Tsai MY, 2000, ATHEROSCLEROSIS, V149, P131, DOI 10.1016/S0021-9150(99)00297-X; Tseng M, 1996, AM J EPIDEMIOL, V144, P1005, DOI 10.1093/oxfordjournals.aje.a008871; Ulrich CM, 2005, CANCER EPIDEM BIOMAR, V14, P2509, DOI 10.1158/1055-9965.EPI-05-0261; Ulvik A, 2004, CANCER EPIDEM BIOMAR, V13, P2175; van Rijnsoever M, 2002, GUT, V51, P797, DOI 10.1136/gut.51.6.797; Wasson GR, 2006, J NUTR, V136, P2748, DOI 10.1093/jn/136.11.2748; Yamaji T, 2009, CANCER EPIDEM BIOMAR, V18, P267, DOI 10.1158/1055-9965.EPI-08-0702; Zhang YL, 2009, ZHONGHUA ZHONG LIU F, V16, P568; Zhang YL, 2008, ZHONGHUA ZHONG LIU F, V15, P1298	57	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60508	10.1371/journal.pone.0060508	http://dx.doi.org/10.1371/journal.pone.0060508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593229	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600025
J	Groessl, F; Jeong, JH; Talmage, DA; Role, LW; Jo, YH				Groessl, Florian; Jeong, Jae Hoon; Talmage, David A.; Role, Lorna W.; Jo, Young-Hwan			Overnight Fasting Regulates Inhibitory Tone to Cholinergic Neurons of the Dorsomedial Nucleus of the Hypothalamus	PLOS ONE			English	Article							FOOD-INTAKE; ENERGY-BALANCE; POMC NEURONS; PROOPIOMELANOCORTIN NEURONS; CIRCADIAN-RHYTHMS; LEPTIN; OBESITY; RECEPTOR; MICE; RAT	The dorsomedial nucleus of the hypothalamus (DMH) contributes to the regulation of overall energy homeostasis by modulating energy intake as well as energy expenditure. Despite the importance of the DMH in the control of energy balance, DMH-specific genetic markers or neuronal subtypes are poorly defined. Here we demonstrate the presence of cholinergic neurons in the DMH using genetically modified mice that express enhanced green florescent protein (eGFP) selectively in choline acetyltransferase (Chat)-neurons. Overnight food deprivation increases the activity of DMH cholinergic neurons, as shown by induction of fos protein and a significant shift in the baseline resting membrane potential. DMH cholinergic neurons receive both glutamatergic and GABAergic synaptic input, but the activation of these neurons by an overnight fast is due entirely to decreased inhibitory tone. The decreased inhibition is associated with decreased frequency and amplitude of GABAergic synaptic currents in the cholinergic DMH neurons, while glutamatergic synaptic transmission is not altered. As neither the frequency nor amplitude of miniature GABAergic or glutamatergic postsynaptic currents is affected by overnight food deprivation, the fasting-induced decrease in inhibitory tone to cholinergic neurons is dependent on superthreshold activity of GABAergic inputs. This study reveals that cholinergic neurons in the DMH readily sense the availability of nutrients and respond to overnight fasting via decreased GABAergic inhibitory tone. As such, altered synaptic as well as neuronal activity of DMH cholinergic neurons may play a critical role in the regulation of overall energy homeostasis.	[Groessl, Florian; Talmage, David A.; Role, Lorna W.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Jeong, Jae Hoon; Jo, Young-Hwan] Yeshiva Univ, Dept Med, Albert Einstein Coll Med, Bronx, NY USA; [Jeong, Jae Hoon; Jo, Young-Hwan] Yeshiva Univ, Dept Mol Pharmacol, Albert Einstein Coll Med, Bronx, NY USA; [Groessl, Florian] Vienna Bioctr, Res Inst Mol Pathol IMP, Vienna, Austria	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Jo, YH (corresponding author), Yeshiva Univ, Dept Med, Albert Einstein Coll Med, Bronx, NY USA.	young-hwan.jo@einstein.yu.edu	Role, LW/Q-7371-2018; Groessl, Florian/ABE-5967-2020	Role, LW/0000-0001-5851-212X; Groessl, Florian/0000-0002-1820-383X; Talmage, David/0000-0003-4627-3007; Jo, Young-Hwan/0000-0001-6939-8000	National Institute of Diabetes and Digestive and Kidney Diseases [RO1DK092246];  [NS22061]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092246, P30DK026687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010266] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by The National Institute of Diabetes and Digestive and Kidney Diseases (RO1DK092246) to YHJ and NS22061 to LWR. We also acknowledge R01DA10266 to Dr. S Vijayaraghavan for the generation and characterization of the Chat-tauGFP transgenic line. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellinger LL, 2002, PHYSIOL BEHAV, V76, P431, DOI 10.1016/S0031-9384(02)00756-4; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; Chou TC, 2003, J NEUROSCI, V23, P10691; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Crosby KM, 2011, NEURON, V71, P529, DOI 10.1016/j.neuron.2011.06.006; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Donato J, 2010, ENDOCRINOLOGY, V151, P5415, DOI 10.1210/en.2010-0651; Gautron L, 2010, J COMP NEUROL, V518, P2090, DOI 10.1002/cne.22323; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Grybko MJ, 2011, EUR J NEUROSCI, V33, P1786, DOI 10.1111/j.1460-9568.2011.07671.x; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Huang H, 2011, J NEUROPHYSIOL, V106, P1191, DOI 10.1152/jn.00740.2010; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Lee S, 2012, J COMP NEUROL, V520, P3617, DOI 10.1002/cne.23116; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; TAGO H, 1987, BRAIN RES, V415, P49, DOI 10.1016/0006-8993(87)90268-X; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Thompson RH, 1998, BRAIN RES REV, V27, P89, DOI 10.1016/S0165-0173(98)00010-1; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Zhang Y, 2011, J NEUROSCI, V31, P1873, DOI 10.1523/JNEUROSCI.3223-10.2011	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60828	10.1371/journal.pone.0060828	http://dx.doi.org/10.1371/journal.pone.0060828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585854	gold, Green Submitted, Green Published			2022-12-27	WOS:000317909600052
J	Knowles, CJ; Cebova, M; Pinz, IM				Knowles, Catherine J.; Cebova, Martina; Pinz, Ilka M.			Palmitate Diet-induced Loss of Cardiac Caveolin-3: A Novel Mechanism for Lipid-induced Contractile Dysfunction	PLOS ONE			English	Article							T-TUBULES; APOPTOSIS; HEART; MUSCLE; EXPRESSION; MUTATIONS; CERAMIDE; COMPLEX; DEVELOP; MICE	Obesity is associated with an increased risk of cardiomyopathy, and mechanisms linking the underlying risk and dietary factors are not well understood. We tested the hypothesis that dietary intake of saturated fat increases the levels of sphingolipids, namely ceramide and sphingomyelin in cardiac cell membranes that disrupt caveolae, specialized membrane micro-domains and important for cellular signaling. C57BL/6 mice were fed two high-fat diets: palmitate diet (21% total fat, 47% is palmitate), and MCT diet (21% medium-chain triglycerides, no palmitate). We established that high-palmitate feeding for 12 weeks leads to 40% and 50% increases in ceramide and sphingomyelin, respectively, in cellular membranes. Concomitant with sphingolipid accumulation, we observed a 40% reduction in systolic contractile performance. To explore the relationship of increased sphingolipids with caveolins, we analyzed caveolin protein levels and intracellular localization in isolated cardiomyocytes. In normal cardiomyocytes, caveolin-1 and caveolin-3 co-localize at the plasma membrane and the T-tubule system. However, mice maintained on palmitate lost 80% of caveolin-3, mainly from the T-tubule system. Mice maintained on MCT diet had a 90% reduction in caveolin-1. These data show that caveolin isoforms are sensitive to the lipid environment. These data are further supported by similar findings in human cardiac tissue samples from non-obese, obese, non-obese cardiomyopathic, and obese cardiomyopathic patients. To further elucidate the contractile dysfunction associated with the loss of caveolin-3, we determined the localization of the ryanodine receptor and found lower expression and loss of the striated appearance of this protein. We suggest that palmitate-induced loss of caveolin-3 results in cardiac contractile dysfunction via a defect in calcium-induced calcium release.	[Knowles, Catherine J.; Cebova, Martina; Pinz, Ilka M.] Maine Med Ctr, Res Inst, Scarborough, ME USA	Maine Medical Center	Pinz, IM (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ME USA.	pinzi@mmc.org	Cebova, Martina/V-9501-2018	Cebova, Martina/0000-0003-0132-670X	American Heart Association, SDG [0930260N]; National Institutes of Health (NIH) [P30GM103392]; NIH [P20GM103465/P30GM103392]; National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR018823]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103465, P30GM103392] Funding Source: NIH RePORTER	American Heart Association, SDG(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Heart Association, SDG award 0930260N to IMP, and this work was supported in part by the protein, nucleic acid analysis and cell imaging core facility supported by National Institutes of Health (NIH) grant P30GM103392 (R. Friesel, PI), Phase III COBRE in Vascular Biology and the histopathology core facility supported by NIH grants P20GM103465/P30GM103392. Human heart tissue samples were obtained from the MMC BioBank, a core facility at Maine Medical Center Research Institute. LC-MS/MS analysis of sphingolipids was performed by Lipidomics Shared Resource, Medical University of South Carolina, MUSC. This work was conducted in a facility constructed with support from the National Institutes of Health, Grant Number C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Augustus AS, 2008, CELL CYCLE, V7, P2509, DOI 10.4161/cc.7.16.6421; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BRUNS RR, 1968, J CELL BIOL, V37, P244, DOI 10.1083/jcb.37.2.244; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; CAMPBELL PJ, 1994, AM J PHYSIOL, V266, pE600, DOI 10.1152/ajpendo.1994.266.4.E600; Carrer DC, 2006, BIOPHYS J, V90, P2394, DOI 10.1529/biophysj.105.074252; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Couchoux H, 2011, INT J BIOCHEM CELL B, V43, P713, DOI 10.1016/j.biocel.2011.01.011; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; Cronk LB, 2007, HEART RHYTHM, V4, P161, DOI 10.1016/j.hrthm.2006.11.030; Fauconnier J, 2007, DIABETES, V56, P1136, DOI 10.2337/db06-0739; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; HALLGREN B, 1960, J CLIN INVEST, V39, P1424, DOI 10.1172/JCI104162; Hayashi T, 2004, BIOCHEM BIOPH RES CO, V313, P178, DOI 10.1016/j.bbrc.2003.11.101; Hnasko Robert, 2003, Mol Interv, V3, P445, DOI 10.1124/mi.3.8.445; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kong JY, 2004, MOL CELL BIOCHEM, V258, P1, DOI 10.1023/B:MCBI.0000012811.89386.a8; Kong JY, 2003, ARCH BIOCHEM BIOPHYS, V412, P196, DOI 10.1016/S0003-9861(03)00008-0; LAAKSO M, 1985, ATHEROSCLEROSIS, V56, P271, DOI 10.1016/0021-9150(85)90003-6; Lessard SJ, 2007, DIABETES, V56, P1856, DOI 10.2337/db06-1065; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Okere IC, 2006, AM J PHYSIOL-HEART C, V291, pH38, DOI 10.1152/ajpheart.01295.2005; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; Peterson JM, 2008, AM J PHYSIOL-ENDOC M, V295, pE1307, DOI 10.1152/ajpendo.00738.2007; Pinz I, 2011, CELL BIOCH BIOPHYS; Pinz I, 2008, J CELL BIOCHEM, V105, P99, DOI 10.1002/jcb.21798; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Shankar Sudha S, 2005, Curr Diab Rep, V5, P30, DOI 10.1007/s11892-005-0064-6; Smith G, 2007, EXP PHYSIOL, V92, P973, DOI 10.1113/expphysiol.2007.034314; Smythe GM, 2003, J CELL SCI, V116, P4739, DOI 10.1242/jcs.00806; Sotgia F, 2003, AM J PHYSIOL-CELL PH, V285, pC1150, DOI 10.1152/ajpcell.00166.2003; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Tsang MYC, 2004, NITRIC OXIDE-BIOL CH, V10, P11, DOI 10.1016/j.niox.2004.01.005; Vassilopoulos S, 2010, BIOCHEMISTRY-US, V49, P6130, DOI 10.1021/bi100796v; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu HQ, 2011, CARDIOVASC RES, V92, P75, DOI 10.1093/cvr/cvr145; ZUNIGAGUAJARDO S, 1985, METABOLISM, V34, P926, DOI 10.1016/0026-0495(85)90140-4	54	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61369	10.1371/journal.pone.0061369	http://dx.doi.org/10.1371/journal.pone.0061369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585895	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600109
J	Shamnamole, K; Jalali, S; Scaria, V; Bhardwaj, A				Shamnamole, K.; Jalali, Saakshi; Scaria, Vinod; Bhardwaj, Anshu			MitoLSDB: A Comprehensive Resource to Study Genotype to Phenotype Correlations in Human Mitochondrial DNA Variations	PLOS ONE			English	Article							SEQUENCE VARIATION; MTDNA MUTATION; DISEASE; DATABASE; POPULATION; PENETRANCE; PHYLOGENY; GENOMES; COMMON; INDIA	Human mitochondrial DNA (mtDNA) encodes a set of 37 genes which are essential structural and functional components of the electron transport chain. Variations in these genes have been implicated in a broad spectrum of diseases and are extensively reported in literature and various databases. In this study, we describe MitoLSDB, an integrated platform to catalogue disease association studies on mtDNA (http://mitolsdb.igib.res.in). The main goal of MitoLSDB is to provide a central platform for direct submissions of novel variants that can be curated by the Mitochondrial Research Community. MitoLSDB provides access to standardized and annotated data from literature and databases encompassing information from 5231 individuals, 675 populations and 27 phenotypes. This platform is developed using the Leiden Open (source) Variation Database (LOVD) software. MitoLSDB houses information on all 37 genes in each population amounting to 132397 variants, 5147 unique variants. For each variant its genomic location as per the Revised Cambridge Reference Sequence, codon and amino acid change for variations in protein-coding regions, frequency, disease/phenotype, population, reference and remarks are also listed. MitoLSDB curators have also reported errors documented in literature which includes 94 phantom mutations, 10 NUMTs, six documentation errors and one artefactual recombination. MitoLSDB is the largest repository of mtDNA variants systematically standardized and presented using the LOVD platform. We believe that this is a good starting resource to curate mtDNA variants and will facilitate direct submissions enhancing data coverage, annotation in context of pathogenesis and quality control by ensuring non-redundancy in reporting novel disease associated variants.	[Shamnamole, K.] Univ Madras, Stella Maris Coll, Dept Bioinformat, Madras, Tamil Nadu, India; [Jalali, Saakshi; Scaria, Vinod] CSIR Inst Genom & Integrat Biol, Delhi, India; [Bhardwaj, Anshu] Council Sci & Ind Res CSIR, Open Source Drug Discovery Unit, Delhi, India	University of Madras; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery	Bhardwaj, A (corresponding author), Council Sci & Ind Res CSIR, Open Source Drug Discovery Unit, Delhi, India.	anshu@csir.res.in	Scaria, Vinod/AAS-3151-2021; Scaria, Vinod/B-2819-2008	Scaria, Vinod/0000-0001-7644-7181; bhardwaj, anshu/0000-0001-5830-2616	European Community [200754]	European Community(European Commission)	The research leading to results of MitoLSDB has received funding from the European Community's Seventh Framework Programme under grant agreement 200754 (the GEN2PHEN project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bhardwaj A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S7; Brandstatter A, 2005, ELECTROPHORESIS, V26, P3414, DOI 10.1002/elps.200500307; Celli J, 2011, HUM MUTAT; CHANDRASEKARAN K, 1994, MOL BRAIN RES, V24, P336, DOI 10.1016/0169-328X(94)90147-3; Cho YM, 2007, DIABETES RES CLIN PR, V77, pS172, DOI 10.1016/j.diabres.2007.01.052; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Goios A, 2008, INT J LEGAL MED, V122, P341, DOI 10.1007/s00414-007-0191-5; Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456; Hanagasi HA, 2005, INT J NEUROSCI, V115, P479, DOI 10.1080/00207450590523017; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kierdaszuk B, 2009, NEUROL NEUROCHIR POL, V43, P216; Knight RD, 2001, J MOL EVOL, V53, P299, DOI 10.1007/s002390010220; Kong QP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003016; Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663; Lee YS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S12; McKusick-Nathans Institute of Genetic Medicine JHUB MD) and National Center for Biotechnology Information National Library of Medicine (Bethesda MD), 2009, ONLINE MENDELIAN INH; MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; van Eijsden RGE, 2006, GENET MED, V8, P620, DOI 10.1097/01.gim.0000237782.94878.05; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025; Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P693, DOI 10.1016/j.bbrc.2009.06.102; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023; Zeviani M, 1996, J INHERIT METAB DIS, V19, P504, DOI 10.1007/BF01799111	43	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60066	10.1371/journal.pone.0060066	http://dx.doi.org/10.1371/journal.pone.0060066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585830	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600012
J	Yahaya, B; McLachlan, G; McCorquodale, C; Collie, D				Yahaya, Badrul; McLachlan, Gerry; McCorquodale, Caroline; Collie, David			Gene Expression Changes Associated with the Airway Wall Response to Injury	PLOS ONE			English	Article							ACUTE LUNG INJURY; EPITHELIAL-CELLS; MATRIX METALLOPROTEINASES; PULMONARY-FIBROSIS; TISSUE INHIBITOR; IN-VIVO; METALLOTHIONEIN; MICE; TRANSCRIPTOME; PATHOGENESIS	Background: Understanding the way in which the airway heals in response to injury is fundamental to dissecting the mechanisms underlying airway disease pathology. As only limited data is available in relation to the in vivo characterisation of the molecular features of repair in the airway we sought to characterise the dynamic changes in gene expression that are associated with the early response to physical injury in the airway wall. Methodology/Principal Findings: We profiled gene expression changes in the airway wall using a large animal model of physical injury comprising bronchial brush biopsy in anaesthetised sheep. The experimental design featured sequential studies in the same animals over the course of a week and yielded data relating to the response at 6 hours, and 1, 3 and 7 days after injury. Notable features of the transcriptional response included the early and sustained preponderance of down-regulated genes associated with angiogenesis and immune cell activation, selection and differentiation. Later features of the response included the up-regulation of cell cycle genes at d1 and d3, and the latter pronounced upregulation of extracellular matrix-related genes at d3 and d7. Conclusions/Significance: It is possible to follow the airway wall response to physical injury in the same animal over the course of time. Transcriptional changes featured coordinate expression of functionally related genes in a reproducible manner both within and between animals. This characterisation will provide a foundation against which to assess the perturbations that accompany airway disease pathologies of comparative relevance.	[Yahaya, Badrul] Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Penang, Malaysia; [McLachlan, Gerry; McCorquodale, Caroline; Collie, David] Univ Edinburgh, Easter Bush Vet Ctr, Roslin Inst, Edinburgh, Midlothian, Scotland; [McLachlan, Gerry; McCorquodale, Caroline; Collie, David] Univ Edinburgh, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	Universiti Sains Malaysia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Yahaya, B (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Penang, Malaysia.	badrul@amdi.usm.edu.my	Yahaya, Badrul/AAG-6801-2021; Yahaya, Badrul/I-2983-2012	Yahaya, Badrul/0000-0002-3295-9676; Collie, David/0000-0001-9313-8137; McLachlan, Gerry/0000-0001-5362-9804	Malaysian Government; Universiti Sains Malaysia (USM); Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish; BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [MR/K001744/1] Funding Source: UKRI	Malaysian Government; Universiti Sains Malaysia (USM)(Universiti Sains Malaysia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant in the form of a fellowship for Dr. Yahaya from the Malaysian Government and Universiti Sains Malaysia (USM) under the Academic Staff Training Fellowship Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buisson AC, 1996, LAB INVEST, V74, P658; Carey WA, 2010, AM J PHYSIOL-LUNG C, V299, pL785, DOI 10.1152/ajplung.00385.2009; Coraux C, 2005, J PATHOL, V206, P160, DOI 10.1002/path.1757; Coulombe PA, 2003, J INVEST DERMATOL, V121, P219, DOI 10.1046/j.1523-1747.2003.12387.x; Daniels JT, 2003, EXP EYE RES, V77, P653, DOI 10.1016/j.exer.2003.08.010; Dolhnikoff M, 1998, AM J RESP CELL MOL, V19, P582, DOI 10.1165/ajrcmb.19.4.2979; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Dvorak A, 2011, AM J RESP CELL MOL, V44, P465, DOI 10.1165/rcmb.2009-0453OC; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Fukuda Y, 1998, LAB INVEST, V78, P687; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gong R, 2003, J AM SOC NEPHROL, V14, P3047, DOI 10.1097/01.ASN.0000098686.72971.DB; Inoue K, 2008, FREE RADICAL BIO MED, V45, P1714, DOI 10.1016/j.freeradbiomed.2008.09.008; Kim KH, 2005, AM J RESP CELL MOL, V33, P271, DOI 10.1165/rcmb.2005-0111OC; Lee EJ, 2009, CHEST, V135, P344, DOI 10.1378/chest.08-1583; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; LUNDGREN R, 1983, EUR J RESPIR DIS, V64, P9; Mulholland B, 2005, EYE, V19, P584, DOI 10.1038/sj.eye.6701557; Nourani MR, 2011, INT J GEN MED, V4, P413, DOI 10.2147/IJGM.S17916; Poschmann G, 2009, MOL CELL PROTEOMICS, V8, P1105, DOI 10.1074/mcp.M800422-MCP200; REEVE DRE, 1975, J ANAT, V119, P333; Roy S, 2008, PHYSIOL GENOMICS, V34, P162, DOI 10.1152/physiolgenomics.00045.2008; SANDVIG KU, 1994, CHRONOBIOL INT, V11, P173, DOI 10.3109/07420529409057237; Sarafian T, 2005, TOXICOL LETT, V158, P95, DOI 10.1016/j.toxlet.2005.03.008; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Suga M, 2000, AM J RESP CRIT CARE, V162, P1949, DOI 10.1164/ajrccm.162.5.9906096; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takano H, 2004, THORAX, V59, P1057, DOI 10.1136/thx.2004.024232; Wesselkamper SC, 2006, AM J RESP CELL MOL, V34, P73, DOI 10.1165/rcmb.2005-0248OC; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zhou Y, 2012, J BIOL CHEM, V287, P41991, DOI 10.1074/jbc.M112.356824; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e58930	10.1371/journal.pone.0058930	http://dx.doi.org/10.1371/journal.pone.0058930			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593124	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600004
J	Ataie-Kachoie, P; Morris, DL; Pourgholami, MH				Ataie-Kachoie, Parvin; Morris, David L.; Pourgholami, Mohammad H.			Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies	PLOS ONE			English	Article							GENE-EXPRESSION; STAT3; THERAPY; GROWTH; PROLIFERATION; DOXYCYCLINE; ACTIVATION; TARGET; IL-6; NEUROINFLAMMATION	Interleukin (IL)-6 has been shown to be a major contributing factor in growth and progression of ovarian cancer. The cytokine exerts pro-tumorigenic activity through activation of several signaling pathways in particular signal transducer and activator of transcription (STAT3) and extracellular signal-regulated kinase (ERK)1/2. Hence, targeting IL-6 is becoming increasingly attractive as a treatment option in ovarian cancer. Here, we investigated the effects of minocycline on IL-6 and its signaling pathways in ovarian cancer. In vitro, minocycline was found to significantly suppress both constitutive and IL-1 beta or 4-hydroxyestradiol (4-OH-E2)-stimulated IL-6 expression in human ovarian cancer cells; OVCAR-3, SKOV-3 and CAOV-3. Moreover, minocycline down-regulated two major components of IL-6 receptor system (IL-6R alpha and gp130) and blocked the activation of STAT3 and ERK1/2 pathways leading to suppression of the downstream product MCL-1. In female nude mice bearing intraperitoneal OVCAR-3 tumors, acute administration (4 and 24 h) of minocycline (30 mg/kg) led to suppression of IL-6. Even single dose of minocycline was effective at significantly lowering plasma and tumor IL-6 levels. In line with this, tumoral expression of p-STAT3, p-ERK1/2 and MCL-1 were decreased in minocycline-treated mice. Evaluation of the functional implication of minocycline on metastatic activity revealed the capacity of minocycline to inhibit cellular migration, invasion and adhesion associated with down-regulation of matrix metalloproteinases (MMP)-2 and 9. Thus, the data suggest a potential role for minocycline in suppressing IL-6 expression and activity. These effects may prove to be an important attribute to the upcoming clinical trials of minocycline in ovarian cancer.	[Ataie-Kachoie, Parvin; Morris, David L.; Pourgholami, Mohammad H.] Univ New S Wales, St George Hosp, Dept Surg, Sydney, NSW, Australia	St George Hospital; University of New South Wales Sydney	Morris, DL (corresponding author), Univ New S Wales, St George Hosp, Dept Surg, Sydney, NSW, Australia.	david.morris@unsw.edu.au	Mekkawy, Ahmed/AAX-5666-2021; Pourgholami, Mohammad Hossein/AAA-3474-2020	Mekkawy, Ahmed/0000-0001-7162-8936; Pourgholami, Mohammad Hossein/0000-0002-1158-801X				Ataie-Kachoie P, 2012, CYTOKINE GROWTH FACT; Bar JK, 2004, GYNECOL ONCOL, V95, P23, DOI 10.1016/j.ygyno.2004.06.046; Bhatt LK, 2010, AM J TRANSL RES, V2, P181; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Cai ZY, 2010, NEUROSCI BULL, V26, P28, DOI 10.1007/s12264-010-0818-2; Campbell JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018688; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Couto JP, 2012, P NATL ACAD SCI USA, V109, pE2361, DOI 10.1073/pnas.1201232109; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; de la Iglesia N, 2009, CURR MOL MED, V9, P580; Dijkgraaf EM, 2012, CURR PHARM DESIGN, V18, P3816; Dorff TB, 2010, CLIN CANCER RES, V16, P3028, DOI 10.1158/1078-0432.CCR-09-3122; Duan ZF, 2009, CANCER CHEMOTH PHARM, V63, P681, DOI 10.1007/s00280-008-0785-8; Gao N, 2004, TOXICOL APPL PHARM, V196, P124, DOI 10.1016/j.taap.2003.12.002; Gao S Paul, 2006, Sci STKE, V2006, ppe30, DOI 10.1126/stke.3432006pe30; Gastl G, 2000, METH MOLEC MED, V39, P121; Gordon PH, 2004, NEUROLOGY, V62, P1845, DOI 10.1212/01.WNL.0000125321.92112.7E; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027097; Guo Y, 2012, CANC TREAT REV; Guo Yu-qi, 2010, Zhonghua Fu Chan Ke Za Zhi, V45, P854; Guo YQ, 2010, CLIN CANCER RES, V16, P5759, DOI 10.1158/1078-0432.CCR-10-1095; Hsu CP, 2011, EUR J CLIN INVEST, V41, P277, DOI 10.1111/j.1365-2362.2010.02405.x; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kleiman LB, 2011, MOL CELL, V43, P723, DOI 10.1016/j.molcel.2011.07.014; Leite Liz M., 2011, Inflammopharmacology, V19, P99, DOI 10.1007/s10787-011-0077-5; Libbey JE, 2011, J VIROL; Lo CW, 2011, CANCER RES, V71, P424, DOI 10.1158/0008-5472.CAN-10-1496; Loo WJ, 2001, CLIN EXP DERMATOL, V26, P376, DOI 10.1046/j.1365-2230.2001.00838.x; Maccio A, 2008, J CELL MOL MED; Maccio A, 2012, CYTOKINE, V58, P133, DOI 10.1016/j.cyto.2012.01.015; MACDONALD H, 1973, CLIN PHARMACOL THER, V14, P852; Maffeis L, 2010, GIORN ITAL DERMAT V, V145, P425; Mano Y, 2009, GYNECOL OBSTET INVES, V68, P145, DOI 10.1159/000229021; Meng QH, 2000, CLIN EXP METASTAS, V18, P139, DOI 10.1023/A:1006732424102; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Park CH, 2011, KOREAN J PHYSIOL PHA, V15, P115, DOI 10.4196/kjpp.2011.15.2.115; Pourgholami MH, 2012, GYNECOL ONCOL; Pourgholami MH, 2012, GYNECOL ONCOL, V125, P433, DOI 10.1016/j.ygyno.2012.01.006; Rosen DG, 2006, CANCER-AM CANCER SOC, V107, P2730, DOI 10.1002/cncr.22293; Ruh MF, 1998, J STEROID BIOCHEM, V66, P203, DOI 10.1016/S0960-0760(98)00042-9; Sapadin AN, 2002, ARCH DERMATOL, V138, P99, DOI 10.1001/archderm.138.1.99; Seeger H, 2005, EUR J GYNAECOL ONCOL, V26, P383; Shieh JM, 2010, BRIT J PHARMACOL, V160, P1171, DOI 10.1111/j.1476-5381.2010.00746.x; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; SMITH C, 1984, J ANTIMICROB CHEMOTH, V13, P93, DOI 10.1093/jac/13.1.93; Smith CJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3491; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Torres-Roca JF, 2007, UROLOGY, V69, P505, DOI 10.1016/j.urology.2006.11.006; VANDENBOGERT C, 1985, LEUKEMIA RES, V9, P617, DOI 10.1016/0145-2126(85)90142-0; VANDENBOGERT C, 1986, CANCER RES, V46, P3283; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang Y, 2012, CYTOKINE, V59, P228, DOI 10.1016/j.cyto.2012.04.020; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Wang Yue, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P21; Woolery KT, 2011, OBSTET GYNECOL INT, V2011, DOI 10.1155/2011/358493; Xiao O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041858; Xing DY, 2005, CELL CYCLE, V4, P1004, DOI 10.4161/cc.4.8.1869; Yanaihara N, 2012, INT J ONCOL, V41, P1094, DOI 10.3892/ijo.2012.1533; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025; Zanjani TM, 2006, EUR J PHARMACOL, V538, P66, DOI 10.1016/j.ejphar.2006.03.063; Zhang XL, 2007, ONCOL REP, V17, P1377	63	35	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60817	10.1371/journal.pone.0060817	http://dx.doi.org/10.1371/journal.pone.0060817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593315	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000073
J	Verhaal, J; Luksch, H				Verhaal, Josine; Luksch, Harald			Mapping of the Receptive Fields in the Optic Tectum of Chicken (Gallus gallus) Using Sparse Noise	PLOS ONE			English	Article							PIGEON COLUMBA-LIVIA; GUTTATA-CASTANOTIS GOULD; CATS STRIATE CORTEX; SINGLE CELLS; SPATIOTEMPORAL ORGANIZATION; SPATIAL-ORGANIZATION; TECTOFUGAL PATHWAY; VISUAL PATHWAYS; NEURONS; MOTION	The optic tectum plays a key role in visual processing in birds. While the input from the retina is topographic in the superficial layers, the deep layers project to the thalamic nucleus rotundus in a functional topographical manner. Although the receptive fields of tectal neurons in birds have been mapped before, a high resolution description of the white and black subfields of the receptive fields of tectal neurons is not available. We measured the receptive fields of neurons in the different layers of the tectum of anesthetized chickens with black and white stimuli that were flashed on a grey background in fast progression. Our results show that neurons in the deep layers of the optic tectum tend to respond stronger to black stimuli compared to white stimuli. In addition, the receptive field sizes are larger when measured using black stimuli than with white stimuli. While the black subfield was significantly larger than the white subfield for the intermediate and deep layers, no significant effects were found for the superficial layers. Finally, we investigated the optimal stimulus size in a subset of the neurons and found that these cells respond best to small white stimuli and to large black stimuli. In the majority of the cases the response was stronger to a large black bar than to a small white bar. We propose that such a stronger response to black stimuli might be advantageous for the detection of darker objects against the brighter sky.	[Verhaal, Josine; Luksch, Harald] Tech Univ Munich, Lehrstuhl Zool, Freising Weihenstephan, Germany	Technical University of Munich	Verhaal, J (corresponding author), Tech Univ Munich, Lehrstuhl Zool, Freising Weihenstephan, Germany.	josine.verhaal@wzw.tum.de		Luksch, Harald/0000-0002-9835-7715; Verhaal, Josine/0000-0002-2505-9768	Bernstein Center of Computational Neuroscience	Bernstein Center of Computational Neuroscience	The study was partly funded by the Bernstein Center of Computational Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Cajal RYS, 1911, LOBE OPTIQUE VERTEBR, P196; Chen YX, 1999, BRAIN BEHAV EVOLUT, V53, P75, DOI 10.1159/000006584; CLARKE PGH, 1976, Q J EXP PHYSIOL CMS, V61, P351, DOI 10.1113/expphysiol.1976.sp002366; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; Frost B.J., 1993, Reviews of Oculomotor Research, V5, P159; FROST BJ, 1976, VISION RES, V16, P1229, DOI 10.1016/0042-6989(76)90046-8; FROST BJ, 1988, J COMP PHYSIOL A, V162, P639, DOI 10.1007/BF01342639; FROST BJ, 1981, EXP BRAIN RES, V43, P173; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; Garcia Samuel, 2009, Front Neuroinform, V3, P14, DOI 10.3389/neuro.11.014.2009; GOODALE MA, 1983, BRAIN BEHAV EVOLUT, V22, P22, DOI 10.1159/000121504; Gu Y, 2000, BRAIN BEHAV EVOLUT, V55, P221, DOI 10.1159/000006654; HARDY O, 1982, EXP BRAIN RES, V46, P59; HARDY O, 1984, BRAIN RES, V311, P65, DOI 10.1016/0006-8993(84)91399-4; Hellmann B, 2004, J COMP NEUROL, V472, P395, DOI 10.1002/cne.20056; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUGHES CP, 1974, BRAIN RES, V80, P365, DOI 10.1016/0006-8993(74)91023-3; JASSIK-GERSCHENFELD D, 1970, Brain Research, V24, P407, DOI 10.1016/0006-8993(70)90182-4; JASSIKGE.D, 1972, BRAIN RES, V40, P303, DOI 10.1016/0006-8993(72)90136-9; JASSIKGERSCHENFELD D, 1979, VISION RES, V19, P993, DOI 10.1016/0042-6989(79)90224-4; JASSIKGERSCHENFELD D, 1975, VISION RES, V15, P1037, DOI 10.1016/0042-6989(75)90250-3; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LERESCHE N, 1984, EXP BRAIN RES, V53, P327; LERESCHE N, 1983, BRAIN RES, V267, P225, DOI 10.1016/0006-8993(83)90874-0; Letelier JC, 2004, J NEUROSCI METH, V132, P161, DOI 10.1016/j.jneumeth.2003.09.007; Letelier JC, 2002, NEUR M PLANN ORL; Li DP, 2007, CEREB CORTEX, V17, P885, DOI 10.1093/cercor/bhk043; Lisney TJ, 2011, VISION RES, V51, P1324, DOI 10.1016/j.visres.2011.04.009; Luksch H, 2003, REV NEUROSCIENCE, V14, P85; Luksch H, 1998, J COMP NEUROL, V396, P399; Luksch H, 2001, J NEUROSCI, V21, P6440, DOI 10.1523/JNEUROSCI.21-16-06440.2001; Mahani AS, 2006, BIOL CYBERN, V94, P276, DOI 10.1007/s00422-005-0046-4; Manns M, 2007, NEUROSCIENCE, V144, P645, DOI 10.1016/j.neuroscience.2006.09.043; Marin G, 2005, J NEUROSCI, V25, P7081, DOI 10.1523/JNEUROSCI.1379-05.2005; Marin G, 2003, J COMP NEUROL, V458, P361, DOI 10.1002/cne.10591; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; MICELI D, 1983, BRAIN RES, V276, P147, DOI 10.1016/0006-8993(83)90556-5; PETTIGREW JD, 1979, PROC R SOC SER B-BIO, V204, P435, DOI 10.1098/rspb.1979.0038; REINER A, 1983, BRAIN RES, V275, P349, DOI 10.1016/0006-8993(83)90996-4; Schmidt A, 1999, J COMP PHYSIOL A, V185, P69, DOI 10.1007/s003590050367; Schmidt A, 2001, J COMP PHYSIOL A, V187, P913, DOI 10.1007/s00359-001-0264-8; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; Wylie DRW, 2009, CAN J EXP PSYCHOL, V63, P328, DOI 10.1037/a0016826; Xing DJ, 2010, J NEUROSCI, V30, P13504, DOI 10.1523/JNEUROSCI.2473-10.2010; Yeh CI, 2009, J NEUROSCI, V29, P11753, DOI 10.1523/JNEUROSCI.1991-09.2009	50	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60782	10.1371/journal.pone.0060782	http://dx.doi.org/10.1371/journal.pone.0060782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593310	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000067
J	Jakab, A; Emri, M; Spisak, T; Szeman-Nagy, A; Beres, M; Kis, SA; Molnar, P; Berenyi, E				Jakab, Andras; Emri, Miklos; Spisak, Tamas; Szeman-Nagy, Anita; Beres, Monika; Kis, Sandor Attila; Molnar, Peter; Berenyi, Ervin			Autistic Traits in Neurotypical Adults: Correlates of Graph Theoretical Functional Network Topology and White Matter Anisotropy Patterns	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ASPERGER-SYNDROME; FUSIFORM GYRUS; CONNECTIVITY PATTERNS; SPECTRUM DISORDERS; CEREBRAL-CORTEX; FRONTAL-CORTEX; BASAL GANGLIA; BRAIN; CHILDREN	Attempts to explicate the neural abnormalities behind autism spectrum disorders frequently revealed impaired brain connectivity, yet our knowledge is limited about the alterations linked with autistic traits in the non-clinical population. In our study, we aimed at exploring the neural correlates of dimensional autistic traits using a dual approach of diffusion tensor imaging (DTI) and graph theoretical analysis of resting state functional MRI data. Subjects were sampled from a public neuroimaging dataset of healthy volunteers. Inclusion criteria were adult age (age: 18-65), availability of DTI and resting state functional acquisitions and psychological evaluation including the Social Responsiveness Scale (SRS) and Autistic Spectrum Screening Questionnaire (ASSQ). The final subject cohort consisted of 127 neurotypicals. Global brain network structure was described by graph theoretical parameters: global and average local efficiency. Regional topology was characterized by degree and efficiency. We provided measurements for diffusion anisotropy. The association between autistic traits and the neuroimaging findings was studied using a general linear model analysis, controlling for the effects of age, gender and IQ profile. Significant negative correlation was found between the degree and efficiency of the right posterior cingulate cortex and autistic traits, measured by the combination of ASSQ and SRS scores. Autistic phenotype was associated with the decrease of whole-brain local efficiency. Reduction of diffusion anisotropy was found bilaterally in the temporal fusiform and parahippocampal gyri. Numerous models describe the autistic brain connectome to be dominated by reduced long-range connections and excessive short-range fibers. Our finding of decreased efficiency supports this hypothesis although the only prominent effect was seen in the posterior limbic lobe, which is known to act as a connector hub. The neural correlates of the autistic trait in neurotypicals showed only limited similarities to the reported findings in clinical populations with low functioning autism.	[Jakab, Andras; Beres, Monika; Berenyi, Ervin] Univ Debrecen Med & Hlth Sci Ctr, Dept Biomed Lab & Imaging Sci, Debrecen, Hungary; [Emri, Miklos; Spisak, Tamas; Kis, Sandor Attila] Univ Debrecen Med & Hlth Sci Ctr, Inst Nucl Med, Debrecen, Hungary; [Szeman-Nagy, Anita] Univ Debrecen, Dept Personal & Clin Psychol, Inst Psychol, H-4012 Debrecen, Hungary; [Molnar, Peter] Univ Debrecen Med & Hlth Sci Ctr, Dept Behav Sci, Debrecen, Hungary	University of Debrecen; University of Debrecen; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Debrecen; University of Debrecen	Jakab, A (corresponding author), Univ Debrecen Med & Hlth Sci Ctr, Dept Biomed Lab & Imaging Sci, Debrecen, Hungary.	jakaba@med.unideb.hu	Jakab, András/U-9436-2019; Emri, Miklós/AAK-3515-2020	Jakab, András/0000-0001-6291-9889; Emri, Miklós/0000-0001-9884-9202; Beresova, Monika/0000-0001-8610-3788	ENIAC CSI project [120209]; New York State Office of Mental Health; Research Foundation for Mental Hygiene; NKI Center for Advanced Brain Imaging (CABI); Brain Research Foundation (Chicago, IL); Stavros Niarchos Foundation; NIH [P50 MH086385-S1]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086385] Funding Source: NIH RePORTER	ENIAC CSI project; New York State Office of Mental Health; Research Foundation for Mental Hygiene; NKI Center for Advanced Brain Imaging (CABI); Brain Research Foundation (Chicago, IL); Stavros Niarchos Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partly supported by the ENIAC CSI project (No. 120209). The authors would like to thank the efforts of F. Xavier Castellanos, Bennett Leventhal, Michael Milham who played a fundamental role in creating the Nathan Kline Institute Rockland Sample. Funding for the above mentioned key personnel was provided in part by the New York State Office of Mental Health and Research Foundation for Mental Hygiene. Additional project support was provided by the NKI Center for Advanced Brain Imaging (CABI), the Brain Research Foundation (Chicago, IL), the Stavros Niarchos Foundation, and NIH grant P50 MH086385-S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; APA, 2007, DIAGN STAT MAN MENT; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Belmonte MK, 2003, COGNITIVE BRAIN RES, V17, P651, DOI 10.1016/S0926-6410(03)00189-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloemen OJN, 2010, AUTISM RES, V3, P203, DOI 10.1002/aur.146; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabral J, 2012, PHARMACOPSYCHIATRY, V45, pS57, DOI 10.1055/s-0032-1309001; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Cheng YW, 2010, NEUROIMAGE, V50, P873, DOI 10.1016/j.neuroimage.2010.01.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dennis EL, 2011, BRAIN CONNECT, V1, P245, DOI [10.1089/brain.2011.0064, 10.1089/brain.2011.0030]; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Ecker C, 2012, ARCH GEN PSYCHIAT, V69, P195, DOI 10.1001/archgenpsychiatry.2011.1251; Ehlers S, 1999, J AUTISM DEV DISORD, V29, P129, DOI 10.1023/A:1023040610384; Estes A, 2011, AUTISM RES, V4, P212, DOI 10.1002/aur.193; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greimel E, 2013, BRAIN STRUCT FUNCT, V218, P929, DOI 10.1007/s00429-012-0439-9; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Hardan AY, 2008, PSYCHIAT RES-NEUROIM, V163, P97, DOI 10.1016/j.pscychresns.2007.12.002; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Jakab A, 2012, BRAIN IMAGING BEHAV, V6, P472, DOI 10.1007/s11682-012-9172-5; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiao Y, 2010, NEUROIMAGE, V50, P589, DOI 10.1016/j.neuroimage.2009.12.047; Jones TB, 2010, NEUROIMAGE, V49, P401, DOI 10.1016/j.neuroimage.2009.07.051; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Ke XY, 2008, NEUROREPORT, V19, P921, DOI 10.1097/WNR.0b013e328300edf3; Ke XY, 2009, BRAIN RES, V1265, P171, DOI 10.1016/j.brainres.2009.02.013; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Korkmaz B, 2006, J CHILD NEUROL, V21, P600, DOI 10.1177/08830738060210070601; Kubicki M, 2002, HARVARD REV PSYCHIAT, V10, P324, DOI 10.1093/hrp/10.6.324; Kwon H, 2004, DEV MED CHILD NEUROL, V46, P760, DOI 10.1017/S0012162204001306; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Moseley M, 2002, BRAIN COGNITION, V50, P396, DOI 10.1016/S0278-2626(02)00524-9; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Nooner KB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00152; Oblak AL, 2011, AUTISM RES, V4, P200, DOI 10.1002/aur.188; Oblak AL, 2011, BRAIN RES, V1380, P218, DOI 10.1016/j.brainres.2010.09.021; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Riva D, 2011, AM J NEURORADIOL, V32, P1430, DOI 10.3174/ajnr.A2527; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sahyoun CP, 2010, BRAIN COGNITION, V73, P180, DOI 10.1016/j.bandc.2010.05.002; Scheel C, 2011, NEUROIMAGE, V58, P391, DOI 10.1016/j.neuroimage.2011.06.040; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Schneider K, 2013, SOC COGN AFFECT NEUR, V8, P702, DOI 10.1093/scan/nss051; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Siegel DJ, 1996, J AUTISM DEV DISORD, V26, P389, DOI 10.1007/BF02172825; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sokolowski K, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00055; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Tsatsanis KD, 2003, BIOL PSYCHIAT, V53, P121, DOI 10.1016/S0006-3223(02)01530-5; Uddin LQ, 2011, BIOL PSYCHIAT, V70, P833, DOI 10.1016/j.biopsych.2011.07.014; van Kooten IAJ, 2008, BRAIN, V131, P987, DOI 10.1093/brain/awn033; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Williams DL, 2008, RES AUTISM SPECT DIS, V2, P353, DOI 10.1016/j.rasd.2007.08.005; Wing L., 1988, DIAGNOSIS ASSESSMENT, P91, DOI 10.1007/978-1-4899-0792-9_7; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yu KK, 2011, J PSYCHIATR NEUROSCI, V36, P412, DOI 10.1503/jpn.100138; Zhang H, 2011, NEUROIMAGE, V56, P1301, DOI 10.1016/j.neuroimage.2011.01.084	113	29	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60982	10.1371/journal.pone.0060982	http://dx.doi.org/10.1371/journal.pone.0060982			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23593367	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800115
J	Bringmann, LF; Vissers, N; Wichers, M; Geschwind, N; Kuppens, P; Peeters, F; Borsboom, D; Tuerlinckx, F				Bringmann, Laura F.; Vissers, Nathalie; Wichers, Marieke; Geschwind, Nicole; Kuppens, Peter; Peeters, Frenk; Borsboom, Denny; Tuerlinckx, Francis			A Network Approach to Psychopathology: New Insights into Clinical Longitudinal Data	PLOS ONE			English	Article							LINEAR MIXED MODELS; TIME-SERIES; POSITIVE EMOTIONS; NEGATIVE AFFECT; WORRY; EXPERIENCE; RUMINATION; LIFE; ACTIVATION; DYNAMICS	In the network approach to psychopathology, disorders are conceptualized as networks of mutually interacting symptoms (e.g., depressed mood) and transdiagnostic factors (e.g., rumination). This suggests that it is necessary to study how symptoms dynamically interact over time in a network architecture. In the present paper, we show how such an architecture can be constructed on the basis of time-series data obtained through Experience Sampling Methodology (ESM). The proposed methodology determines the parameters for the interaction between nodes in the network by estimating a multilevel vector autoregression (VAR) model on the data. The methodology allows combining between-subject and within-subject information in a multilevel framework. The resulting network architecture can subsequently be analyzed through network analysis techniques. In the present study, we apply the method to a set of items that assess mood-related factors. We show that the analysis generates a plausible and replicable network architecture, the structure of which is related to variables such as neuroticism; that is, for subjects who score high on neuroticism, worrying plays a more central role in the network. Implications and extensions of the methodology are discussed.	[Bringmann, Laura F.; Vissers, Nathalie; Kuppens, Peter; Tuerlinckx, Francis] Univ Louvain, Dept Psychol, Louvain, Belgium; [Wichers, Marieke; Peeters, Frenk] Maastricht Univ, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Geschwind, Nicole] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [Borsboom, Denny] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	Maastricht University; Maastricht University; University of Amsterdam	Bringmann, LF (corresponding author), Univ Louvain, Dept Psychol, Louvain, Belgium.	laura.bringmann@ppw.kuleuven.be	kuppens, peter/DHG-5268-2022; Wichers, Marieke/N-6667-2014; Geschwind, Nicole/J-4617-2019	Wichers, Marieke/0000-0001-5024-9064; Geschwind, Nicole/0000-0001-7171-6426; Borsboom, Denny/0000-0001-9720-4162; tuerlinckx, francis/0000-0002-1775-7654; Peeters, F/0000-0002-6167-8582; Vissers, Nathalie/0000-0001-6202-6079; kuppens, peter/0000-0002-2363-2356				[Anonymous], R PROJECT STAT COMPU; ARNOLD BC, 1991, SANKHYA SER B, V53, P233; Baas M, 2008, PSYCHOL BULL, V134, P779, DOI 10.1037/a0012815; Baltagi BH, 2005, ECONOMOTRIC ANAL PAN; Barrett LF, 1998, COGNITION EMOTION, V12, P579, DOI 10.1080/026999398379574; Bates D. M., 2011, IME4 LINEAR MIXED EF; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Borkovec TD, 1998, COGNITIVE THER RES, V22, P561, DOI 10.1023/A:1018790003416; Borsboom D, 2008, J CLIN PSYCHOL, V64, P1089, DOI 10.1002/jclp.20503; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Box J, 1994, TIME SERIES ANAL FOR; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Cramer AOJ, 2012, PSYCHOL MED, V42, P957, DOI 10.1017/S003329171100211X; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Ebner-Priemer UW, 2009, J ABNORM PSYCHOL, V118, P195, DOI 10.1037/a0014868; Efron B., 1994, INTRO BOOTSTRAP; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fieuws S, 2006, BIOMETRICS, V62, P424, DOI 10.1111/j.1541-0420.2006.00507.x; Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431; Funatogawa I, 2007, STAT MED, V26, P2113, DOI 10.1002/sim.2670; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Gather U, 2002, STAT MED, V21, P2685, DOI 10.1002/sim.1209; Gelman A., 2007, DATA ANAL USING REGR; Geschwind N, 2011, J CONSULT CLIN PSYCH, V79, P618, DOI 10.1037/a0024595; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Gruber J, 2008, BEHAV RES THER, V46, P1096, DOI 10.1016/j.brat.2008.05.004; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Hendrickx DM, 2011, MOL BIOSYST, V7, P511, DOI 10.1039/c0mb00083c; Hoekstra HA., 1996, NEO PI R NEO FFI BIG; Hofmans J, 2008, PERS INDIV DIFFER, V45, P750, DOI 10.1016/j.paid.2008.08.004; Horvath C, 2008, STAT NEERL, V62, P208, DOI 10.1111/j.1467-9574.2007.00382.x; Kendler KS, 2012, MOL PSYCHIATR, V17, P11, DOI 10.1038/mp.2011.70; Kendler KS, 2011, PSYCHOL MED, V41, P1143, DOI 10.1017/S0033291710001844; Koval P, 2012, COGNITION EMOTION, V26, P1412, DOI 10.1080/02699931.2012.667392; Kuppens P, 2010, J PERS SOC PSYCHOL, V99, P1042, DOI 10.1037/a0020962; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Larsen JT, 2001, J PERS SOC PSYCHOL, V81, P684, DOI 10.1037//0022-3514.81.4.684; Larsen R.J., 1992, EMOTION, P25; Lavie P, 2001, ANNU REV PSYCHOL, V52, P277, DOI 10.1146/annurev.psych.52.1.277; Lodewyckx T, 2011, J MATH PSYCHOL, V55, P68, DOI 10.1016/j.jmp.2010.08.004; Luatkepohl H., 1993, INTRO MULTIPLE TIME, DOI 10.1007/978-3-642-61695-2; McLaughlin KA, 2007, BEHAV THER, V38, P23, DOI 10.1016/j.beth.2006.03.003; MENEY I, 1998, CHRONOBIOL INT, V14, P125; Moberly NJ, 2008, J ABNORM PSYCHOL, V117, P314, DOI 10.1037/0021-843X.117.2.314; Muris P, 2004, COGNITIVE THER RES, V28, P539, DOI 10.1023/B:COTR.0000045563.66060.3e; Neyman J, 1948, ECONOMETRICA, V16, P1, DOI 10.2307/1914288; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Oravecz Z, 2011, PSYCHOL METHODS, V16, P468, DOI 10.1037/a0024375; Pe ML, 2013, COGNITION EMOTION, V27, P492, DOI 10.1080/02699931.2012.719489; Pe ML, 2012, EMOTION, V12, P1320, DOI 10.1037/a0028262; Pe ML, 2012, COGNITION IN PRESS, DOI [10.1016/j. cognition.2012.10.002, DOI 10.1016/J.C0GNITI0N.2012.10.002]; Pfaff B, 2008, USE R, P3; REISENZEIN R, 1994, J PERS SOC PSYCHOL, V67, P525, DOI 10.1037/0022-3514.67.3.525; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 1999, PSYCHOL BULL, V125, P3, DOI 10.1037/0033-2909.125.1.3; Schmid CH, 2001, STAT MED, V20, P3295, DOI 10.1002/sim.950.abs; Schmittmann VD, 2013, NEW IDEAS PSYCHOL, V31, P43, DOI 10.1016/j.newideapsych.2011.02.007; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Schwartz JE, 1998, HEALTH PSYCHOL, V17, P6, DOI 10.1037/0278-6133.17.1.6; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segerstrom SC, 2000, COGNITIVE THER RES, V24, P671, DOI 10.1023/A:1005587311498; Shumway R.H., 2006, TIME SERIES ANAL ITS; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Sporns O., 2011, NETWORKS BRAIN; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Tschacher W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039687; Tschacher W, 2009, PSYCHOTHER RES, V19, P469, DOI 10.1080/10503300802654496; Tuerlinckx F, 2006, BRIT J MATH STAT PSY, V59, P225, DOI 10.1348/000711005x79857; Verbeke G, 2001, AM STAT, V55, P25, DOI 10.1198/000313001300339905; Verbeke G, 2000, LINEAR MIXED MODELS; Walls T. A., 2006, MODELS INTENSIVE LON; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Wild B, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-28; Zelenski JM, 2000, J RES PERS, V34, P178, DOI 10.1006/jrpe.1999.2275	79	317	321	8	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60188	10.1371/journal.pone.0060188	http://dx.doi.org/10.1371/journal.pone.0060188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RK	23593171	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100020
J	Luz, PR; Boldt, ABW; Grisbach, C; Kun, JFJ; Velavan, TP; Messias-Reason, IJT				Luz, Paola R.; Boldt, Angelica B. W.; Grisbach, Caroline; Kun, Juergen F. J.; Velavan, Thirumalaisamy P.; Messias-Reason, Iara J. T.			Association of L-Ficolin Levels and FCN2 Genotypes with Chronic Chagas Disease	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; SINGLE NUCLEOTIDE POLYMORPHISMS; FUNCTIONAL POLYMORPHISMS; GENE; COMPLEMENT; PATHWAY; RISK; RECOGNITION; INFECTIONS; HAPLOTYPES	Background: L-ficolin (encoded by FCN2) binds to acetylated sugar moieties of many pathogens, including Trypanosoma cruzi, promoting their phagocytosis and lysis by the complement system. Methods: We investigated L-ficolin levels in 160 T. cruzi infected patients with chronic Chagas disease and 71 healthy individuals, and FCN2 polymorphisms (-986 G>A, 2602 G>A, and 24 A>G in the promoter and A258S in exon 8) in 243 patients, being 88 indeterminate (asymptomatic), 96 with cardiac, 23 with digestive and 33 with cardiodigestive manifestations (two were unspecified) and 305 controls (135 for A258S). Results: Patients presented lower L-ficolin plasma levels than controls (p<0.0001). Among the different groups of cardiac commitment, individuals with moderate forms had higher L-ficolin levels than the severe forms (P = 0.039). Lower L-ficolin levels were found associated with the 258S variant in the patients (P = 0.034). We found less -4A/G heterozygotes in the cardiac patients, than in the controls (OR = 0.56 [95% CI = 0.33-0.94], P = 0.034). Heterozygote -4A/G genotypes with the 258S variant and 258SS homozygotes were nevertheless more frequent among cardiodigestive patients than in controls (OR = 14.1 [95% CI = 3.5-56.8], P = 0.0001) and in indeterminate patients (OR = 3.2 [95% CI = 1.1-9.4], P = 0.037). We also found an association of the allelic frequency of the 258S variant with cardiodigestive Chagas disease compared to controls (OR = 2.24 [95% CI = 1.1-4.5], P = 0.037). Thus, decreased patient levels of L-ficolin reflect not only protein consumption due to the disease process, but also the higher frequency of the 258S variant in patients with cardiodigestive symptoms. Conclusion: The very first study on Brazilian cohort associates both L-ficolin plasma levels and FCN2 variants to Chagas disease and subsequent disease progression. The prognostic value of L-ficolin levels and the FCN2*A258S polymorphism should be further evaluated in other settings.	[Luz, Paola R.; Boldt, Angelica B. W.; Grisbach, Caroline; Messias-Reason, Iara J. T.] Univ Fed Parana, Hosp Clin, Dept Patol Med, Lab Imunopatol Mol, BR-80060000 Curitiba, Parana, Brazil; [Kun, Juergen F. J.; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany	Universidade Federal do Parana; Eberhard Karls University of Tubingen	Velavan, TP (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	velavan@medizin.uni-tuebingen.de; iarareason@hc.ufpr.br	Boldt, Angelica/G-3630-2012; Velavan, Thirumalaisamy P/C-1223-2010	Velavan, Thirumalaisamy P/0000-0002-9809-9883; Boldt, Angelica/0000-0002-0902-9622; Jose de Messias Reason, Iara/0000-0002-5573-260X	CNPq; CAPES; DAAD (Deutscher Akademischer Austausch Dienst); Bundesministeriums fur Bildung und Forschung (BMBF) [01DN11001-BRA11/A33]; Deutsche Forschungsgemeinschaft (DFG); Tuebingen University	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); DAAD (Deutscher Akademischer Austausch Dienst)(Deutscher Akademischer Austausch Dienst (DAAD)); Bundesministeriums fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tuebingen University	This study was supported by CNPq, CAPES and DAAD (Deutscher Akademischer Austausch Dienst), who provided a scholarship for PRL. This study was also supported by grant from Bundesministeriums fur Bildung und Forschung (BMBF 01DN11001-BRA11/A33) to TP Velavan. The authors acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ouf E, 2012, J INFECT DIS, V206, P562, DOI 10.1093/infdis/jis396; Acosta DM, 2011, PARASITE IMMUNOL, V33, P363, DOI 10.1111/j.1365-3024.2011.01291.x; Aiello VD, 2002, J PATHOL, V197, P224, DOI 10.1002/path.1095; Assaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034113; Boldt ABW, 2006, HUM IMMUNOL, V67, P722, DOI 10.1016/j.humimm.2006.05.009; Boldt ABW, 2002, HUM MUTAT, V19, P296, DOI 10.1002/humu.10051; Boldt ABW, 2011, CLIN IMMUNOL, V140, P63, DOI 10.1016/j.clim.2011.03.008; Cedzynski M, 2007, CLIN EXP IMMUNOL, V150, P99, DOI 10.1111/j.1365-2249.2007.03471.x; Cedzynski M, 2009, MOL IMMUNOL, V47, P415, DOI 10.1016/j.molimm.2009.08.028; Cestari ID, 2009, MOL IMMUNOL, V47, P426, DOI 10.1016/j.molimm.2009.08.030; Chapman SJ, 2007, MOL IMMUNOL, V44, P3267, DOI 10.1016/j.molimm.2006.04.013; Chen X, 2006, J DERMATOL SCI, V43, P201, DOI 10.1016/j.jdermsci.2006.05.010; Cruyssen BV, 2007, RHEUMATOLOGY, V46, P1792, DOI 10.1093/rheumatology/kem266; de Messias-Reason I, 2009, J INFECT DIS, V199, P801, DOI 10.1086/597070; de Rooij BJF, 2011, J HEPATOL, V55, P800, DOI 10.1016/j.jhep.2011.01.039; de Rooij BJF, 2010, HEPATOLOGY, V52, P1100, DOI 10.1002/hep.23782; Dias JCP, 2008, SCI M RIO DE JAN BRA; Dutra WO, 2008, CURR OPIN INFECT DIS, V21, P287, DOI 10.1097/QCO.0b013e3282f88b80; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faik I, 2011, HUM IMMUNOL, V72, P74, DOI 10.1016/j.humimm.2010.10.003; Haerynck F, 2012, HUM IMMUNOL, V73, P1175, DOI 10.1016/j.humimm.2012.08.010; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Jensen ML, 2007, MOL IMMUNOL, V44, P856, DOI 10.1016/j.molimm.2006.04.002; Kilpatrick DC, 1999, IMMUNOL LETT, V67, P109, DOI 10.1016/S0165-2478(98)00147-3; Kipnis T L, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P571, DOI 10.1590/S0074-02761988000500069; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Krarup A, 2008, IMMUNOL LETT, V118, P152, DOI 10.1016/j.imlet.2008.03.014; Luz PR, 2010, INT J CARDIOL, V143, P448, DOI 10.1016/j.ijcard.2009.09.467; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x; Messias-Reason IJ, 2003, TISSUE ANTIGENS, V62, P308, DOI 10.1034/j.1399-0039.2003.00101.x; Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, Rev Soc Bras Med Trop, V38 Suppl 3, P7; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Ojurongbe O, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-37; Ribeiro A L, 1998, Rev Soc Bras Med Trop, V31, P301, DOI 10.1590/S0037-86821998000300008; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Ruskamp JM, 2009, CLIN EXP IMMUNOL, V155, P433, DOI 10.1111/j.1365-2249.2008.03844.x; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Swierzko AS, 2009, MOL IMMUNOL, V46, P551, DOI 10.1016/j.molimm.2008.07.025; Tong HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028113	42	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60237	10.1371/journal.pone.0060237	http://dx.doi.org/10.1371/journal.pone.0060237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593180	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100025
J	Hariganeya, N; Tanimoto, Y; Yamaguchi, H; Nishimura, T; Tawong, W; Sakanari, H; Yoshimatsu, T; Sato, S; Preston, CM; Adachi, M				Hariganeya, Naohito; Tanimoto, Yuko; Yamaguchi, Haruo; Nishimura, Tomohiro; Tawong, Wittaya; Sakanari, Hiroshi; Yoshimatsu, Takamichi; Sato, Shinya; Preston, Christina M.; Adachi, Masao			Quantitative PCR Method for Enumeration of Cells of Cryptic Species of the Toxic Marine Dinoflagellate Ostreopsis spp. in Coastal Waters of Japan	PLOS ONE			English	Article							REAL-TIME PCR; HARMFUL ALGAL BLOOMS; PFIESTERIA-PISCICIDA; ALEXANDRIUM-FUNDYENSE; PALYTOXIN ANALOGS; RAPID DETECTION; UNITED-STATES; IN-FIELD; QUANTIFICATION; DINOPHYCEAE	Monitoring of harmful algal bloom (HAB) species in coastal waters is important for assessment of environmental impacts associated with HABs. Co-occurrence of multiple cryptic species such as toxic dinoflagellate Ostreopsis species make reliable microscopic identification difficult, so the employment of molecular tools is often necessary. Here we developed new qPCR method by which cells of cryptic species can be enumerated based on actual gene number of target species. The qPCR assay targets the LSU rDNA of Ostreopsis spp. from Japan. First, we constructed standard curves with a linearized plasmid containing the target rDNA. We then determined the number of rDNA copies per cell of target species from a single cell isolated from environmental samples using the qPCR assay. Differences in the DNA recovery efficiency was calculated by adding exogenous plasmid to a portion of the sample lysate before and after DNA extraction followed by qPCR. Then, the number of cells of each species was calculated by division of the total number of rDNA copies of each species in the samples by the number of rDNA copies per cell. To test our procedure, we determined the total number of rDNA copies using environmental samples containing no target cells but spiked with cultured cells of several species of Ostreopsis. The numbers estimated by the qPCR method closely approximated total numbers of cells added. Finally, the numbers of cells of target species in environmental samples containing cryptic species were enumerated by the qPCR method and the total numbers also closely approximated the microscopy cell counts. We developed a qPCR method that provides accurate enumeration of each cryptic species in environments. This method is expected to be a powerful tool for monitoring the various HAB species that occur as cryptic species in coastal waters.	[Hariganeya, Naohito; Yamaguchi, Haruo; Sakanari, Hiroshi; Yoshimatsu, Takamichi; Adachi, Masao] Kochi Univ, Nankoku, Kochi, Japan; [Tanimoto, Yuko; Nishimura, Tomohiro; Tawong, Wittaya] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime, Japan; [Sato, Shinya] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Preston, Christina M.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA	Kochi University; Ehime University; Monterey Bay Aquarium Research Institute	Adachi, M (corresponding author), Kochi Univ, Nankoku, Kochi, Japan.	madachi@kochi-u.ac.jp	Nishimura, Tomohiro/G-6073-2019	Nishimura, Tomohiro/0000-0001-7040-7576	Food Safety Commission, Japan [0904]; Grants-in-Aid for Scientific Research [24580268] Funding Source: KAKEN	Food Safety Commission, Japan(Food Safety Commission of Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in Aid from Food Safety Commission, Japan (no. 0904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2006, APPL ENVIRON MICROB, V72, P5742, DOI 10.1128/AEM.00332-06; Aligizaki K, 2011, TOXICON, V57, P390, DOI 10.1016/j.toxicon.2010.11.014; Bowers HA, 2000, APPL ENVIRON MICROB, V66, P4641, DOI 10.1128/AEM.66.11.4641-4648.2000; Bowers HA, 2006, J PHYCOL, V42, P1333, DOI 10.1111/j.1529-8817.2006.00285.x; Bowers HA, 2006, HARMFUL ALGAE, V5, P342, DOI 10.1016/j.hal.2005.09.005; Chinain M, 1999, J PHYCOL, V35, P1282, DOI 10.1046/j.1529-8817.1999.3561282.x; Coyne KJ, 2005, LIMNOL OCEANOGR-METH, V3, P381, DOI 10.4319/lom.2005.3.381; Cullen DW, 2002, PLANT PATHOL, V51, P281, DOI 10.1046/j.1365-3059.2002.00690.x; Dyhrman ST, 2006, HARMFUL ALGAE, V5, P242, DOI 10.1016/j.hal.2005.07.005; FUKUYO Y, 1981, B JPN SOC SCI FISH, V47, P967; Galluzzi L, 2004, APPL ENVIRON MICROB, V70, P1199, DOI 10.1128/AEM.70.2.1199-1206.2004; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Godhe A, 2007, HARMFUL ALGAE, V6, P56, DOI 10.1016/j.hal.2006.06.002; Gray M, 2003, APPL ENVIRON MICROB, V69, P5726, DOI 10.1128/AEM.69.9.5726-5730.2003; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Handy SM, 2008, HARMFUL ALGAE, V7, P599, DOI 10.1016/j.hal.2007.12.018; Handy SM, 2006, LIMNOL OCEANOGR-METH, V4, P193, DOI 10.4319/lom.2006.4.193; Handy SM, 2005, AQUAT MICROB ECOL, V40, P121, DOI 10.3354/ame040121; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hoagland P, 2002, ESTUARIES, V25, P819, DOI 10.1007/BF02804908; Hosoi-Tanabe S, 2005, MAR BIOTECHNOL, V7, P506, DOI 10.1007/s10126-004-4128-4; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Kamikawa R, 2007, HARMFUL ALGAE, V6, P413, DOI 10.1016/j.hal.2006.12.004; Kolb S, 2003, APPL ENVIRON MICROB, V69, P2423, DOI 10.1128/AEM.69.5.2423-2429.2003; Lenoir S, 2004, J PHYCOL, V40, P1042, DOI 10.1111/j.1529-8817.2004.04016.x; Lin SJ, 2006, J PLANKTON RES, V28, P667, DOI 10.1093/plankt/fbi150; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangialajo L, 2011, TOXICON, V57, P408, DOI 10.1016/j.toxicon.2010.11.019; Moorthi SD, 2006, MICROB ECOL, V52, P136, DOI 10.1007/s00248-006-9030-3; NAKAJIMA I, 1981, B JPN SOC SCI FISH, V47, P1029; Park TG, 2007, POLAR BIOL, V30, P843, DOI 10.1007/s00300-006-0244-0; Perini F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017699; Popels LC, 2003, LIMNOL OCEANOGR-METH, V1, P92, DOI 10.4319/lom.2003.1.92; Rhodes L, 2011, TOXICON, V57, P400, DOI 10.1016/j.toxicon.2010.05.010; Saito K, 2002, APPL ENVIRON MICROB, V68, P5394, DOI 10.1128/AEM.68.11.5394-5407.2002; Sato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027983; Suzuki T, 2012, HARMFUL ALGAE, V20, P81, DOI 10.1016/j.hal.2012.08.002; Taniyama S, 2003, TOXICON, V42, P29, DOI 10.1016/S0041-0101(03)00097-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; USAMI M, 1995, J AM CHEM SOC, V117, P5389, DOI 10.1021/ja00124a034; Vaitomaa J, 2003, APPL ENVIRON MICROB, V69, P7289, DOI 10.1128/AEM.69.12.7289-7297.2003; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vandersea MW, 2012, J PHYCOL, V48, P902, DOI 10.1111/j.1529-8817.2012.01146.x; Vila M, 2001, AQUAT MICROB ECOL, V26, P51, DOI 10.3354/ame026051; YASUMOTO T, 1987, BIOL BULL, V172, P128, DOI 10.2307/1541612; Zhang H, 2005, APPL ENVIRON MICROB, V71, P7053, DOI 10.1128/AEM.71.11.7053-7063.2005	47	23	23	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57627	10.1371/journal.pone.0057627	http://dx.doi.org/10.1371/journal.pone.0057627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23593102	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849200016
J	Dolinsek, T; Markelc, B; Sersa, G; Coer, A; Stimac, M; Lavrencak, J; Brozic, A; Kranjc, S; Cemazar, M				Dolinsek, Tanja; Markelc, Bostjan; Sersa, Gregor; Coer, Andrej; Stimac, Monika; Lavrencak, Jaka; Brozic, Andreja; Kranjc, Simona; Cemazar, Maja			Multiple Delivery of siRNA against Endoglin into Murine Mammary Adenocarcinoma Prevents Angiogenesis and Delays Tumor Growth	PLOS ONE			English	Article							HUMAN SOLID TUMORS; CD105 MONOCLONAL-ANTIBODIES; VASCULAR ENDOTHELIAL-CELLS; SHORT INTERFERING RNA; TGF-BETA; IN-VIVO; ESTABLISHED TUMORS; SIGNALING PATHWAYS; SCID MICE; THERAPY	Endoglin is a transforming growth factor-beta (TGF-beta)co-receptor that participates in the activation of a signaling pathwaythat mediates endothelial cell proliferation and migration in angiogenic tumorvasculature. Therefore, silencing of endoglin expression is an attractiveapproach for antiangiogenic therapy of tumors. The aim of our study was toevaluate the therapeutic potential of small interfering RNA (siRNA) molecules against endoglin in vitro and invivo. Therapeutic potential in vitro wasassessed in human and murine endothelial cells (HMEC-1, 2H11)by determining endoglin expression level, cell proliferation and tube formation. In vivo, the therapeutic potential of siRNA moleculeswas evaluated in TS/A mammary adenocarcinoma growing in BALB/c mice. Results of our study showed that siRNA molecules against endoglin have a goodantiangiogenic therapeutic potential in vitro, as expression of endoglin mRNA and protein levels in mouse and human microvascularendothelial cells after lipofection were efficiently reduced, which resultedin the inhibition of endothelial cell proliferation and tube formation. In vivo, silencing of endoglin with triple electrotransferof siRNA molecules into TS/A mammary adenocarcinoma also significantlyreduced the mRNA levels, number of tumor blood vessels and the growth of tumors. The obtained results demonstrate that silencing of endoglin is a promisingantiangiogenic therapy of tumors that could not be used as single treatment, but as an adjunct to the established cytotoxic treatment approaches.	[Dolinsek, Tanja; Markelc, Bostjan; Sersa, Gregor; Stimac, Monika; Kranjc, Simona; Cemazar, Maja] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Coer, Andrej; Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Dept Nat & Med Subjects, Izola, Slovenia; [Lavrencak, Jaka; Brozic, Andreja] Inst Oncol Ljubljana, Dept Cytopathol, Ljubljana, Slovenia	Institute of Oncology - Slovenia; University of Primorska; Institute of Oncology - Slovenia	Cemazar, M (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.	mcemazar@onko-i.si	Markelc, Bostjan/AAC-2968-2022; Cemazar, Maja/K-6182-2013; Lavrencak, Jaka/K-8259-2017; Savarin, Monika/V-5451-2017	Markelc, Bostjan/0000-0002-8674-702X; Cemazar, Maja/0000-0002-1418-1928; Lavrencak, Jaka/0000-0002-8210-5046; Savarin, Monika/0000-0002-8316-8110; Kranjc, Simona/0000-0003-0538-7841	Slovenian Research Agency [P3-0003, J3-4211]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (program no. P3-0003, project no. J3-4211). Research was conducted in the scope of EBAMEuropean Associated Laboratory (LEA). This manuscript is a result of the networking efforts of the COST Action TD1104. The funders had no role in study design, data collection and analysis, decision to publish, or preparationof the manuscript.	Ahmadvand D, 2009, MOL IMMUNOL, V46, P1814, DOI 10.1016/j.molimm.2009.01.021; Alt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029948; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Bredow S, 2000, EUR J CANCER, V36, P675, DOI 10.1016/S0959-8049(99)00335-4; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Cemazar M, 2006, CURR PHARM DESIGN, V12, P3817, DOI 10.2174/138161206778559740; Cemazar M, 2002, CANCER GENE THER, V9, P399, DOI 10.1038/sj.cgt.7700454; Costello B, 2004, INT J CANCER, V109, P436, DOI 10.1002/ijc.11699; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Edhemovic I, 2011, TECHNOL CANCER RES T, V10, P475, DOI 10.7785/tcrt.2012.500224; Fonsatti E, 2000, CLIN CANCER RES, V6, P2037; Golzio M, 2007, GENE THER, V14, P752, DOI 10.1038/sj.gt.3302920; Golzio M, 2009, METHODS MOL BIOL, V555, P15, DOI 10.1007/978-1-60327-295-7_2; Kimelman-Bleich N, 2011, MOL THER, V19, P53, DOI 10.1038/mt.2010.190; Kumar S, 1999, CANCER RES, V59, P856; Kyzas PA, 2006, VIRCHOWS ARCH, V448, P768, DOI 10.1007/s00428-006-0195-4; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Maier JAM, 1997, ANTI-CANCER DRUG, V8, P238, DOI 10.1097/00001813-199703000-00004; Maitland ML, 2010, PHARMACOGENET GENOM, V20, P346, DOI 10.1097/FPC.0b013e3283364ed7; Matsuno F, 1999, CLIN CANCER RES, V5, P371; Miller DW, 1999, INT J CANCER, V81, P568, DOI 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.3.CO;2-O; NANNI P, 1983, CLIN EXP METASTAS, V1, P373, DOI 10.1007/BF00121199; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Nishimura T, 2011, WORLD J GASTROENTERO, V17, P4440, DOI 10.3748/wjg.v17.i39.4440; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; Pardali E, 2012, INT J BIOL SCI, V8, P195, DOI [10.7150/ijbs.8.195, 10.7150/ijbs.3805]; Pavlin D, 2011, RADIOL ONCOL, V45, P31, DOI 10.2478/v10019-010-0041-9; Seon BK, 1997, CLIN CANCER RES, V3, P1031; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; She XW, 2004, INT J CANCER, V108, P251, DOI 10.1002/ijc.11551; Tabata M, 1999, INT J CANCER, V82, P737, DOI 10.1002/(SICI)1097-0215(19990827)82:5<737::AID-IJC18>3.3.CO;2-#; Takahashi D, 2012, CLIN EXP NEPHROL, V16, P310, DOI 10.1007/s10157-011-0543-9; Takahashi N, 2001, CANCER RES, V61, P7846; Takei Y, 2008, MOL CANCER THER, V7, P211, DOI 10.1158/1535-7163.MCT-07-0319; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Tsujie M, 2006, INT J ONCOL, V29, P1087; Uneda S, 2009, INT J CANCER, V125, P1446, DOI 10.1002/ijc.24482; Vader P, 2011, ANGIOGENESIS, V14, P457, DOI 10.1007/s10456-011-9229-x; Vo E, 2010, STEM CELL REV REP, V6, P237, DOI 10.1007/s12015-010-9144-3; White PJ, 2008, CLIN EXP PHARMACOL P, V35, P1371, DOI 10.1111/j.1440-1681.2008.04992.x; Yamamoto T, 2001, J CELL BIOCHEM, V82, P591, DOI 10.1002/jcb.1179; Zhang Y, 2011, INT J CLIN EXP MED, V4, P32	49	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58723	10.1371/journal.pone.0058723	http://dx.doi.org/10.1371/journal.pone.0058723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23593103	gold, Green Submitted, Green Published			2022-12-27	WOS:000315637900164
J	Ahn, JE; Zhou, X; Dowd, SE; Chapkin, RS; Zhu-Salzman, K				Ahn, Ji-Eun; Zhou, Xin; Dowd, Scot E.; Chapkin, Robert S.; Zhu-Salzman, Keyan			Insight into Hypoxia Tolerance in Cowpea Bruchid: Metabolic Repression and Heat Shock Protein Regulation via Hypoxia-Inducible Factor 1	PLOS ONE			English	Article							GENE-EXPRESSION; UP-REGULATION; OXYGEN; HIF-1; MECHANISMS; RESISTANCE; DEFENSE; BEETLE	Oxygen is of fundamental importance for most living organisms including insects. Hermetic storage uses airtight containment facilities to withhold oxygen required for development, thus preventing damage by insect pests in stored grain. Cowpea bruchid (Callosobruchus maculatus) ceases feeding and growth when exposed to 2% oxygen. However, although population expansion is temporarily arrested, the bruchids (especially late stage larvae) can survive extended periods of hypoxia and recover development if normoxic conditions resume, an ability rarely found in mammals. To begin to understand fundamental mechanisms that enable insects to cope with oxygen deprivation, we constructed a 3'-anchored cDNA library from 4th instar larvae subjected to normoxic and hypoxic treatments (respectively), and performed 454-pyrosequencing. Quality filtering and contig assembly resulted in 20,846 unique sequences. Of these, 5,335 sequences had hits in BLAST searches (E = 10(-6)), constituting a 2,979 unigene set. Further analysis based on gene ontology terms indicated that 1,036 genes were involved in a diverse range of cellular functions. Genes encoding putative glycolytic and TCA cycle enzymes as well as components of respiratory chain complexes were selected and assessed for transcript responses to low oxygen. The majority of these genes were down-regulated, suggesting that hypoxia repressed metabolic activity. However, a group of genes encoding heat shock proteins (HSPs) was induced. Promoter analyses of representative HSP genes suggested the involvement of hypoxia-inducible transcription factor 1 (HIF1) in regulating these hypoxia-induced genes. Its activator function has been confirmed by transient co-transfection into S2 cells of constructs of HIF1 subunits and the HSP promoter-driven reporter.	[Zhu-Salzman, Keyan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Ahn, Ji-Eun; Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Ahn, Ji-Eun; Zhou, Xin; Zhu-Salzman, Keyan] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Dowd, Scot E.] MR DNA Mol Res, Shallowater, TX USA; [Chapkin, Robert S.] Texas A&M Univ, Program Integrat Nutr & Complex Dis, College Stn, TX USA	Shanghai Jiao Tong University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Zhu-Salzman, K (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	ksalzman@tamu.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Chapkin, Robert/0000-0002-6515-3898	SJTU 985-III disciplines platform and talents fund; United States Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) [2007-35607-17887]; USDA Cooperative State Research, Education and Extension Service [2010-34402-20875]	SJTU 985-III disciplines platform and talents fund; United States Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI); USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This research was partially supported by SJTU 985-III disciplines platform and talents fund, the United States Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) 2007-35607-17887, and USDA Cooperative State Research, Education and Extension Service 2010-34402-20875. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JE, 2007, FEBS J, V274, P2800, DOI 10.1111/j.1472-4658.2007.05816.x; Azad P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005371; Baird NA, 2006, J BIOL CHEM, V281, P38675, DOI 10.1074/jbc.M608013200; Banks H.J., 1990, FOOD PRESERVATION MO, P93; Boutilier RG, 2000, COMP BIOCHEM PHYS A, V126, P481, DOI 10.1016/S1095-6433(00)00234-8; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cheng WN, 2012, J INSECT PHYSIOL, V58, P792, DOI 10.1016/j.jinsphys.2012.02.005; CHERBAS L, 1993, INSECT BIOCHEM MOLEC, V23, P81, DOI 10.1016/0965-1748(93)90085-7; Chi YH, 2011, J INSECT PHYSIOL, V57, P220, DOI 10.1016/j.jinsphys.2010.11.011; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; David JC, 2006, J NEUROCHEM, V99, P570, DOI 10.1111/j.1471-4159.2006.04071.x; DONAHAYE E, 1993, PHYSIOL ENTOMOL, V18, P247, DOI 10.1111/j.1365-3032.1993.tb00595.x; DONAHAYE E, 1990, PHYTOPARASITICA, V18, P189, DOI 10.1007/BF02980989; Duran J, 2008, BIOCHEM BIOPH RES CO, V365, P291, DOI 10.1016/j.bbrc.2007.10.181; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; Gleadle JM, 1998, MOL MED TODAY, V4, P122, DOI 10.1016/S1357-4310(97)01198-2; Gorr TA, 2006, J INSECT PHYSIOL, V52, P349, DOI 10.1016/j.jinsphys.2006.01.002; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Greenberg S, 1996, J INSECT PHYSIOL, V42, P991, DOI 10.1016/S0022-1910(96)00071-6; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Lessard F.F., 1990, FOOD PRESERVATION MO, P21; LOUDON C, 1988, J INSECT PHYSIOL, V34, P97, DOI 10.1016/0022-1910(88)90160-6; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mbata GN, 2005, J ECON ENTOMOL, V98, P1070, DOI 10.1603/0022-0493-98.3.1070; Minchenko O, 2003, FEBS LETT, V554, P264, DOI 10.1016/S0014-5793(03)01179-7; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Weaver D, 2005, PEST MANAGEMENT GRAI; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1092, DOI 10.1167/iovs.04-0043; XIONG B, 1995, P NATL ACAD SCI USA, V92, P9313, DOI 10.1073/pnas.92.20.9313; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221; Zhu-Salzman K., 2006, ENCY PEST MANAGEMENT, P1	41	24	26	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e57267	10.1371/journal.pone.0057267	http://dx.doi.org/10.1371/journal.pone.0057267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593115	Green Submitted, Green Published, gold			2022-12-27	WOS:000317385300002
J	Kinoshita, H; Hirata, Y; Nakagawa, H; Sakamoto, K; Hayakawa, Y; Takahashi, R; Nakata, W; Sakitani, K; Serizawa, T; Hikiba, Y; Akanuma, M; Shibata, W; Maeda, S; Koike, K				Kinoshita, Hiroto; Hirata, Yoshihiro; Nakagawa, Hayato; Sakamoto, Kei; Hayakawa, Yoku; Takahashi, Ryota; Nakata, Wachiko; Sakitani, Kosuke; Serizawa, Takako; Hikiba, Yohko; Akanuma, Masao; Shibata, Wataru; Maeda, Shin; Koike, Kazuhiko			Interleukin-6 Mediates Epithelial-Stromal Interactions and Promotes Gastric Tumorigenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER STEM-CELLS; TUMOR-GROWTH; SIGNALING PATHWAY; STAT3 ACTIVATION; EXPRESSION; FIBROBLASTS; SURVIVAL; ANGIOGENESIS; CARCINOMA	Interleukin-6 (IL-6) is a pleiotropic cytokine that affects various functions, including tumor development. Although the importance of IL-6 in gastric cancer has been documented in experimental and clinical studies, the mechanism by which IL-6 promotes gastric cancer remains unclear. In this study, we investigated the role of IL-6 in the epithelial-stromal interaction in gastric tumorigenesis. Immunohistochemical analysis of human gastritis, gastric adenoma, and gastric cancer tissues revealed that IL-6 was frequently detected in the stroma. IL-6-positive cells in the stroma showed positive staining for the fibroblast marker alpha-smooth muscle actin, suggesting that stromal fibroblasts produce IL-6. We compared IL-6 knockout (IL-6(-/-)) mice with wild-type (WT) mice in a model of gastric tumorigenesis induced by the chemical carcinogen N-methyl-N-nitrosourea. The stromal fibroblasts expressed IL-6 in tumors from WT mice. Gastric tumorigenesis was attenuated in IL-6(-/-) mice, compared with WT mice. Impaired tumor development in IL-6(-/-) mice was correlated with the decreased activation of STAT3, a factor associated with gastric cancer cell proliferation. In vitro, when gastric cancer cell line was co-cultured with primary human gastric fibroblast, STAT3-related genes including COX-2 and iNOS were induced in gastric cancer cells and this response was attenuated with neutralizing anti-IL-6 receptor antibody. IL-6 production from fibroblasts was increased when fibroblasts were cultured in the presence of gastric cancer cell-conditioned media. IL-6 production from fibroblasts was suppressed by an interleukin-1 (IL-1) receptor antagonist and siRNA inhibition of IL-1 alpha in the fibroblasts. IL-1 alpha mRNA and protein were increased in fibroblast lysate, suggesting that cell-associated IL-1 alpha in fibroblasts may be involved. Our results suggest the importance of IL-6 mediated stromal-epithelial cell interaction in gastric tumorigenesis.	[Kinoshita, Hiroto; Hirata, Yoshihiro; Nakagawa, Hayato; Hayakawa, Yoku; Takahashi, Ryota; Nakata, Wachiko; Sakitani, Kosuke; Serizawa, Takako; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan; [Sakamoto, Kei; Hikiba, Yohko; Akanuma, Masao] Asahi Life Fdn, Inst Adult Dis, Div Gastroenterol, Tokyo, Japan; [Shibata, Wataru; Maeda, Shin] Yokohama City Univ, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan	University of Tokyo; Asahi Life Foundation; Yokohama City University	Maeda, S (corresponding author), Yokohama City Univ, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan.	smaeda@med.yokohama-cu.ac.jp	Nakagawa, Hayato/I-2837-2012; Hayakawa, Yoku/AAI-8581-2020	Nakagawa, Hayato/0000-0002-6973-5094; Hayakawa, Yoku/0000-0002-3988-2499; Sakitani, Kosuke/0000-0002-4537-6023	 [22300317];  [23114508];  [22590679]; Grants-in-Aid for Scientific Research [22590679, 22300317] Funding Source: KAKEN	; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	SM was supported by a Grant-in-Aid for Scientific Research (#22300317 and #23114508). YH was supported by a Grant-in-Aid for Scientific Research (#22590679). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Ashizawa Tatsuto, 2005, Gastric Cancer, V8, P124, DOI 10.1007/s10120-005-0315-x; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Chen CN, 2006, J SURG ONCOL, V94, P226, DOI 10.1002/jso.20372; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Fleischmann RM, 2006, ANN RHEUM DIS, V65, P1006, DOI 10.1136/ard.2005.048371; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Howlett M, 2005, GASTROENTEROLOGY, V129, P1005, DOI 10.1053/j.gastro.2005.06.068; Howlett M, 2009, GASTROENTEROLOGY, V136, P967, DOI 10.1053/j.gastro.2008.12.003; Huang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Inoue M, 2005, POSTGRAD MED J, V81, P419, DOI 10.1136/pgmj.2004.029330; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Lee SA, 2010, DIGEST DIS SCI, V55, P1955, DOI 10.1007/s10620-009-0967-1; Liao WC, 2008, CLIN CANCER RES, V14, P428, DOI 10.1158/1078-0432.CCR-07-1032; Lin MT, 2007, INT J CANCER, V120, P2600, DOI 10.1002/ijc.22599; Lin WC, 2000, ONCOGENE, V19, P5680, DOI 10.1038/sj.onc.1203924; Maeda S, 2009, HEPATOLOGY, V50, P1851, DOI 10.1002/hep.23199; MAHARA K, 1994, BRIT J CANCER, V69, P777, DOI 10.1038/bjc.1994.147; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; NISHIYAMA M, 1993, INT J CANCER, V53, P1013; OCHIAI A, 1985, JPN J CANCER RES, V76, P1064; Okamoto W, 2011, BRIT J CANCER, V105, P407, DOI 10.1038/bjc.2011.246; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Paland N, 2009, MOL CANCER RES, V7, P1212, DOI 10.1158/1541-7786.MCR-09-0073; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Sakamoto K, 2010, GASTROENTEROLOGY, V139, P226, DOI 10.1053/j.gastro.2010.03.047; Sebba A, 2008, AM J HEALTH-SYST PH, V65, P1413, DOI 10.2146/ajhp070449; Shibata W, 2008, CANCER RES, V68, P5031, DOI 10.1158/0008-5472.CAN-07-6332; Takahashi M, 1997, BIOCHEM BIOPH RES CO, V234, P493, DOI 10.1006/bbrc.1997.5974; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tang CH, 2011, J BIOL CHEM, V286, P11056, DOI 10.1074/jbc.M110.204081; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271	47	62	65	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60914	10.1371/journal.pone.0060914	http://dx.doi.org/10.1371/journal.pone.0060914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593346	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300034
J	Yang, B; Cao, L; Liu, B; McCaig, CD; Pu, J				Yang, Bo; Cao, Lin; Liu, Bin; McCaig, Colin D.; Pu, Jin			The Transition from Proliferation to Differentiation in Colorectal Cancer Is Regulated by the Calcium Activated Chloride Channel A1	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INTESTINAL EPITHELIAL-CELLS; GENE-EXPRESSION; UP-REGULATION; SODIUM-BUTYRATE; BETA-CATENIN; ADENOCARCINOMA CELLS; CORNEAL EPITHELIUM; TUMOR PROGRESSION; PROSTATE-CANCER	Breaking the balance between proliferation and differentiation in animal cells can lead to cancer, but the mechanisms maintaining this balance remain largely undefined. The calcium activated chloride channel A1 (CLCA1) is a member of the calcium sensitive chloride conductance family of proteins and is expressed mainly in the colon, small intestine and appendix. We show that CLCA1 plays a functional role in differentiation and proliferation of Caco-2 cells and of intestinal tissue. Caco-2 cells spontaneously differentiate either in confluent culture or when treated with butyrate, a molecule present naturally in the diet. Here, we compared CLCA1 expressional levels between patients with and without colorectal cancer (CRC) and determined the functional role of CLCA1 in differentiation and proliferation of Caco-2 cells. We showed that: 1) CLCA1 and CLCA4 expression were down-regulated significantly in CRC patients; 2) CLCA1 expression was up-regulated in Caco-2 cells induced to differentiate by confluent culture or by treatment with sodium butyrate (NaBT); 3) Knockdown of CLCA1 with siRNA significantly inhibited cell differentiation and promoted cell proliferation in Caco-2 confluent cultures, and 4) In Caco-2 3D culture, suppression of CLCA1 significantly increased cell proliferation and compromised NaBT-induced inhibition of proliferation. In conclusion, CLCA1 may contribute to promoting spontaneous differentiation and reducing proliferation of Caco-2 cells and may be a target of NaBT-induced inhibition of proliferation and therefore a potential diagnostic marker for CRC prognosis.	[Yang, Bo; Liu, Bin] 309th Hosp PLA, Dept Gen Surg, Beijing, Peoples R China; [Cao, Lin; McCaig, Colin D.; Pu, Jin] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen, Scotland	University of Aberdeen	Yang, B (corresponding author), 309th Hosp PLA, Dept Gen Surg, Beijing, Peoples R China.	y7115@sina.com; jin.pu@abdn.ac.uk			NHS Endowment Fund [12/50]; Friends of Anchor	NHS Endowment Fund; Friends of Anchor	This work was funded by NHS Endowment Fund (12/50) to LC, JP and CDM, and Friends of Anchor to JP and CDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; ARDAWI MSM, 1985, BIOCHEM J, V231, P713, DOI 10.1042/bj2310713; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Bajka BH, 2008, CARCINOGENESIS, V29, P2169, DOI 10.1093/carcin/bgn173; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Blouin JM, 2011, INT J CANCER, V128, P2591, DOI 10.1002/ijc.25599; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; Buhrke T, 2011, DEV GROWTH DIFFER, V53, P411, DOI 10.1111/j.1440-169X.2011.01258.x; Bustin SA, 2001, DNA CELL BIOL, V20, P331, DOI 10.1089/10445490152122442; BYRD JC, 1987, DEV BRAIN RES, V31, P151, DOI 10.1016/0165-3806(87)90096-4; Cao L, 2010, EXP EYE RES, V90, P771, DOI 10.1016/j.exer.2010.03.013; Chen Ying-xuan, 2004, Zhonghua Yi Xue Za Zhi, V84, P312; Chirakkal H, 2006, ONCOGENE, V25, P7192, DOI 10.1038/sj.onc.1209702; CHUNG YS, 1985, CANCER RES, V45, P2976; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Comalada M, 2006, J CANCER RES CLIN, V132, P487, DOI 10.1007/s00432-006-0092-x; Connon CJ, 2006, CELL TISSUE RES, V323, P177, DOI 10.1007/s00441-005-0059-2; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Doyon G, 2009, J BIOL CHEM, V284, P25220, DOI 10.1074/jbc.M109.022632; Dupasquier S, 2009, J CELL SCI, V122, P2191, DOI 10.1242/jcs.036483; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; Gandhi R, 1998, J BIOL CHEM, V273, P32096, DOI 10.1074/jbc.273.48.32096; Gray LS, 2004, CELL CALCIUM, V36, P489, DOI 10.1016/j.ceca.2004.05.001; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Gruber AD, 1999, CANCER RES, V59, P5488; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Hara T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.40; Heo JI, 2010, ANIM CELLS SYST, V14, P261, DOI 10.1080/19768354.2010.528204; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Hodin RA, 1996, CELL GROWTH DIFFER, V7, P647; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kobayashi H, 2004, INT J CANCER, V109, P207, DOI 10.1002/ijc.11697; Kobayashi H, 2003, NUTR CANCER, V46, P202, DOI 10.1207/S15327914NC4602_14; Kouraklis G, 2006, ONCOL REP, V15, P489; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee JY, 2012, MOL CELL BIOCHEM, V365, P251, DOI 10.1007/s11010-012-1266-2; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Lemonnier L, 2004, CANCER RES, V64, P4841, DOI 10.1158/0008-5472.CAN-03-3223; Leschelle X, 2000, EUR J BIOCHEM, V267, P6435, DOI 10.1046/j.1432-1327.2000.01731.x; Mariadason JM, 2001, CANCER RES, V61, P3465; McCaig CD, 2009, J CELL SCI, V122, P4267, DOI 10.1242/jcs.023564; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Ribiczey P, 2007, CELL CALCIUM, V42, P590, DOI 10.1016/j.ceca.2007.02.003; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Ruemmele FM, 1999, CELL DEATH DIFFER, V6, P729, DOI 10.1038/sj.cdd.4400545; Ruemmele FM, 2003, GUT, V52, P94, DOI 10.1136/gut.52.1.94; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Scheppach W, 2004, CURR OPIN CLIN NUTR, V7, P563, DOI 10.1097/00075197-200409000-00009; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; Shen MR, 2002, J BIOL CHEM, V277, P15592, DOI 10.1074/jbc.M111043200; Siavoshian S, 2000, GUT, V46, P507, DOI 10.1136/gut.46.4.507; Takanami I, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-79; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; Tsavaler L, 2001, CANCER RES, V61, P3760; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; WHITEHEAD RH, 1986, GUT, V27, P1457, DOI 10.1136/gut.27.12.1457; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yu DCW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-276	72	54	54	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60861	10.1371/journal.pone.0060861	http://dx.doi.org/10.1371/journal.pone.0060861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593331	gold, Green Submitted, Green Published			2022-12-27	WOS:000317385300030
J	Bai, YH; Liu, RP; Liang, JS; Qu, JH				Bai, Yaohui; Liu, Ruiping; Liang, Jinsong; Qu, Jiuhui			Integrated Metagenomic and Physiochemical Analyses to Evaluate the Potential Role of Microbes in the Sand Filter of a Drinking Water Treatment System	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; DIVERSITY; COMMUNITY; OXIDATION; SCALE; DEGRADATION; NAPHTHALENE; EXPRESSION; BACTERIA; REMOVAL	While sand filters are widely used to treat drinking water, the role of sand filter associated microorganisms in water purification has not been extensively studied. In the current investigation, we integrated molecular (based on metagenomic) and physicochemical analyses to elucidate microbial community composition and function in a common sand filter used to treat groundwater for potable consumption. The results revealed that the biofilm developed rapidly within 2 days (reaching similar to 10(11) prokaryotes per gram) in the sand filter along with abiotic and biotic particulates accumulated in the interstitial spaces. Bacteria (up to 90%) dominated the biofilm microbial community, with Alphaproteobacteria being the most common class. Thaumarchaeota was the sole phylum of Archaea, which might be involved in ammonia oxidation. Function annotation of metagenomic datasets revealed a number of aromatic degradation pathway genes, such as aromatic oxygenase and dehydrogenase genes, in the biofilm, suggesting a significant role for microbes in the breakdown of aromatic compounds in groundwater. Simultaneous nitrification and denitrification pathways were confirmed as the primary routes of nitrogen removal. Dissolved heavy metals in groundwater, e.g. Mn2+ and As3+, might be biologically oxidized to insoluble or easily adsorbed compounds and deposited in the sand filter. Our study demonstrated that the role of the microbial community in the sand filter treatment system are critical to effective water purification in drinking water.	[Bai, Yaohui; Liu, Ruiping; Liang, Jinsong; Qu, Jiuhui] Chinese Acad Sci, State Key Lab Environm Aquat Chem, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Qu, JH (corresponding author), Chinese Acad Sci, State Key Lab Environm Aquat Chem, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	jhqu@rcees.ac.cn	liang, jinsong/AAP-5012-2021		National Natural Science Foundation of China [51290282]; State Key Joint Laboratory of Environment Simulation and Pollution Control [12L03ESPC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Joint Laboratory of Environment Simulation and Pollution Control	This study was supported by a Major Program (51290282) granted by the National Natural Science Foundation of China and a special fund (12L03ESPC) granted by the State Key Joint Laboratory of Environment Simulation and Pollution Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037796; Bai YH, 2012, FEMS MICROBIOL ECOL, V80, P323, DOI 10.1111/j.1574-6941.2012.01296.x; Campos LC, 2002, WATER RES, V36, P4543, DOI 10.1016/S0043-1354(02)00167-7; Chuang YH, 2011, CHEMOSPHERE, V85, P1146, DOI 10.1016/j.chemosphere.2011.08.037; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; El Gheriany IA, 2011, ARCH MICROBIOL, V193, P89, DOI 10.1007/s00203-010-0645-x; Feng S, 2012, INT BIODETER BIODEGR, V70, P148, DOI 10.1016/j.ibiod.2012.03.003; Fernandez N, 2008, MICROB ECOL, V56, P121, DOI 10.1007/s00248-007-9330-2; FLEMING JT, 1993, ENVIRON SCI TECHNOL, V27, P1068, DOI 10.1021/es00043a005; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Geszvain K, 2010, APPL ENVIRON MICROB, V76, P1224, DOI 10.1128/AEM.02473-09; Gregoracci GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031408; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Kasuga I, 2010, WATER RES, V44, P5039, DOI 10.1016/j.watres.2010.07.015; Kim BK, 2011, J BACTERIOL, V193, P5539, DOI 10.1128/JB.05717-11; Kwon S, 2011, MICROBES ENVIRON, V26, P149, DOI 10.1264/jsme2.ME10205; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nakhla G, 2003, J HAZARD MATER, V96, P291, DOI 10.1016/S0304-3894(02)00219-4; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Pang CM, 2006, APPL ENVIRON MICROB, V72, P5702, DOI 10.1128/AEM.02982-05; Park JW, 2006, APPL MICROBIOL BIOT, V72, P1322, DOI 10.1007/s00253-006-0423-5; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; PEITCHEV T, 1988, WATER SCI TECHNOL, V20, P173; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; PR China EPA, 2006, GB57492006 PR CHIN E; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Queinnec I, 2006, BIOTECHNOL BIOENG, V94, P209, DOI 10.1002/bit.20794; Rhodes ME, 2010, ENVIRON MICROBIOL, V12, P2613, DOI 10.1111/j.1462-2920.2010.02232.x; Rooklidge SJ, 2005, WATER RES, V39, P331, DOI 10.1016/j.watres.2004.09.024; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silva CC, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-18; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; State Environmental Protection Administration of China, 1989, MON AN METH WAT WAST; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Thomas V, 2008, ENVIRON MICROBIOL, V10, P2728, DOI 10.1111/j.1462-2920.2008.01693.x; VANDENABEELE J, 1992, MICROBIAL ECOL, V24, P91, DOI 10.1007/BF00171973; Weber M, 2011, ISME J, V5, P918, DOI 10.1038/ismej.2010.180; Yergeau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030058; You J, 2009, WATER RES, V43, P1801, DOI 10.1016/j.watres.2009.01.016; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang LM, 2010, P NATL ACAD SCI USA, V107, P17240, DOI 10.1073/pnas.1004947107	43	49	54	3	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61011	10.1371/journal.pone.0061011	http://dx.doi.org/10.1371/journal.pone.0061011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593378	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200035
J	Dang, YW; Luo, DZ; Rong, MH; Chen, G				Dang, Yiwu; Luo, Dianzhong; Rong, Minhua; Chen, Gang			Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; DECOY RECEPTOR-3; DOWN-REGULATION; CANCER CELLS; EXPRESSION; HEPATOCARCINOGENESIS; LIVER; INTERFERENCE; COMBINATION; MICRORNAS	Aberrant expression of microRNA-34a (miR-34a) has been reported to be involved in the tumorigenesis and progression of various classes of malignancies. However, its role in hepatocellular carcinoma (HCC) has not been completely clarified. In the current study, we have investigated the clinical significance and the in vitro contribution of miR-34a on biological functions of human HCCs. miR-34a expression in eighty-three cases of HCC formalin-fixed paraffin-embedded (FFPE) tissues decreased significantly compared to that in the adjacent liver tissues (P<0.01), as detected by real-time quantitative RT-PCR (RT-qPCR). miR-34a expression in the groups of TNM stage I and II, without metastasis and without portal vein tumor embolus, was significantly higher than that of their corresponding groups (P<0.05). In functional experiments, miR-34a mimic suppressed cell growth, migration and invasion, meanwhile it increased cellular apoptosis and caspase activity in HCC cells. miR-34a mimic also reduced phospho-ERK1/2 and phospho-stat5 signaling. In addition, miR-34a mimic enhanced the effect of cell proliferation inhibition and caspase activity induction of agents targeting c-MET (siRNAs and small molecular inhibitor su11274). In conclusion, miR-34a may act as a tumor suppressor miRNA of HCC. The strategies to increase miR-34a level might be a critical targeted therapy for HCC in future.	[Dang, Yiwu; Luo, Dianzhong; Chen, Gang] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi Zhuang, Peoples R China; [Rong, Minhua] Guangxi Med Univ, Affiliated Hosp 1, Res Dept, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University	Chen, G (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi Zhuang, Peoples R China.	chen_gang_triones@163.com			Fund of Guangxi Natural Scientific Research [2010GXNSFB013059]	Fund of Guangxi Natural Scientific Research	The study was supported by the Fund of Guangxi Natural Scientific Research (No. 2010GXNSFB013059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello C, 2012, LIVER INT, V32, P772, DOI 10.1111/j.1478-3231.2012.02795.x; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen G, 2006, W INDIAN MED J, V55, P403; Chen G, 2008, ONCOL RES, V17, P183, DOI 10.3727/096504008785114138; Chen G, 2013, BIOCHEM BIOPH RES CO, V431, P623, DOI 10.1016/j.bbrc.2012.12.070; Chen G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-28; Chen G, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-1; Chen G, 2010, PATHOL RES PRACT, V206, P631, DOI 10.1016/j.prp.2010.05.011; Chen G, 2010, ANAL BIOCHEM, V398, P266, DOI 10.1016/j.ab.2009.11.034; Chen G, 2008, NATL MED J INDIA, V21, P275; Cheng J, 2010, PROTEOMICS, V10, P1557, DOI 10.1002/pmic.200900646; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Dai Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-198; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu L, 2010, HEPATOL INT, V4, P423, DOI 10.1007/s12072-010-9164-8; Hu ZQ, 2012, CELL MOL IMMUNOL, V9, P7, DOI 10.1038/cmi.2011.30; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Inagaki Y, 2011, BIOSCI TRENDS, V5, P52, DOI 10.5582/bst.2011.v5.2.52; Karabork A, 2010, PATHOL RES PRACT, V206, P572, DOI 10.1016/j.prp.2010.03.004; Koivusalo R, 2005, MOL PHARMACOL, V68, P372, DOI 10.1124/mol.105.011189; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Lin YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050924; Meguro M, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/818672; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Santoro A, 2013, BRIT J CANCER, V108, P21, DOI 10.1038/bjc.2012.556; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Sukata T, 2011, TOXICOL LETT, V200, P46, DOI 10.1016/j.toxlet.2010.10.013; Syed ZA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-180; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Tsou HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053974; Yang MSZ, 2010, UPSALA J MED SCI, V115, P232, DOI 10.3109/03009734.2010.516410	31	107	112	125	289	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61054	10.1371/journal.pone.0061054	http://dx.doi.org/10.1371/journal.pone.0061054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593387	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000041
J	Lettat, A; Benchaar, C				Lettat, Abderzak; Benchaar, Chaouki			Diet-Induced Alterations in Total and Metabolically Active Microbes within the Rumen of Dairy Cows	PLOS ONE			English	Article							REAL-TIME PCR; BACTERIAL COMMUNITIES; CLONE LIBRARIES; SWINE MANURE; GROWTH-RATE; RNA-CONTENT; DIVERSITY; MICROORGANISMS; METHANOGENS; PREVOTELLA	DNA-based techniques are widely used to study microbial populations; however, this approach is not specific to active microbes, because DNA may originate from inactive and/or dead cells. Using cDNA and DNA, respectively, we aimed to discriminate the active microbes from the total microbial community within the rumen of dairy cows fed diets with increasing proportions of corn silage (CS). Nine multiparous lactating Holstein cows fitted with ruminal cannulas were used in a replicated 3 x 3 Latin square (32-d period; 21-d adaptation) design to investigate diet-induced shifts in microbial populations by targeting the rDNA gene. Cows were fed a total mixed ration with the forage portion being either barley silage (0% CS), a 50: 50 mixture of barley silage and corn silage (50% CS), or corn silage (100% CS). No differences were found for total microbes analyzed by quantitative PCR, but changes were observed within the active ones. Feeding more CS to dairy cows was accompanied by an increase in Prevotella rRNA transcripts (P = 0.10) and a decrease in the protozoal rRNA transcripts (P < 0.05). Although they were distributed differently among diets, 78% of the amplicons detected in DNA- and cDNA-based fingerprints were common to total and active bacterial communities. These may represent a bacterial core of abundant and active cells that drive the fermentation processes. In contrast, 10% of amplicons were specific to total bacteria and may represent inactive or dead cells, whereas 12% were only found within the active bacterial community and may constitute slow-growing bacteria with high metabolic activity. It appears that cDNA-based analysis is more discriminative to identify diet-induced shifts within the microbial community. This approach allows the detection of diet-induced changes in the microbial populations as well as particular bacterial amplicons that remained undetected using DNA-based methods.	[Lettat, Abderzak; Benchaar, Chaouki] Agr & Agri Food Canada, Dairy & Swine Res & Dev Ctr, Sherbrooke, PQ, Canada	Agriculture & Agri Food Canada	Benchaar, C (corresponding author), Agr & Agri Food Canada, Dairy & Swine Res & Dev Ctr, Sherbrooke, PQ, Canada.	Chaouki.Benchaar@agr.gc.ca			grant (Dairy Research Cluster) from Agriculture and Agri-Food Canada (Ottawa, ON); Dairy Farmers of Canada (Ottawa, ON); Canadian Dairy Commission (Ottawa, ON); National Science and Engineering Research Council of Canada (Ottawa, ON)	grant (Dairy Research Cluster) from Agriculture and Agri-Food Canada (Ottawa, ON); Dairy Farmers of Canada (Ottawa, ON); Canadian Dairy Commission (Ottawa, ON); National Science and Engineering Research Council of Canada (Ottawa, ON)	This study was funded by a grant (Dairy Research Cluster) from Agriculture and Agri-Food Canada (Ottawa, ON), Dairy Farmers of Canada (Ottawa, ON) and Canadian Dairy Commission (Ottawa, ON). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Dairy and Swine Research and Development Centre (Agriculture and Agri-Food Canada, Sherbrooke, QC) staff including, L. Croteau (technical support), S. Methot (statistical analyses) and the barn crew (care of the cows). AL was a recipient of a postdoctoral fellowship from the National Science and Engineering Research Council of Canada (Ottawa, ON).	Akob DM, 2007, FEMS MICROBIOL ECOL, V59, P95, DOI 10.1111/j.1574-6941.2006.00203.x; Barret M, 2012, FEMS MICROBIOL ECOL, V80, P427, DOI 10.1111/j.1574-6941.2012.01308.x; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Chaucheyras-Durand F, 2010, APPL ENVIRON MICROB, V76, P7931, DOI 10.1128/AEM.01784-10; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Duffield T. F., 1999, P AM ASS BOVINE PRAC, V32, P179; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Edwards JE, 2008, ANIMAL, V2, P653, DOI 10.1017/S1751731108002164; Edwards JE, 2008, FEMS MICROBIOL ECOL, V63, P141, DOI 10.1111/j.1574-6941.2008.00563.x; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Flint HJ, 2004, ADV APPL MICROBIOL, V56, P89, DOI 10.1016/S0065-2164(04)56003-3; Fonty G., 1995, P299; Gagnon N, 2011, FEMS MICROBIOL LETT, V325, P115, DOI 10.1111/j.1574-6968.2011.02418.x; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; KERKHOF L, 1993, APPL ENVIRON MICROB, V59, P1303, DOI 10.1128/AEM.59.5.1303-1309.1993; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Lassey KR, 2008, AUST J EXP AGR, V48, P114, DOI 10.1071/EA07220; LEE SH, 1994, LIMNOL OCEANOGR, V39, P869, DOI 10.4319/lo.1994.39.4.0869; Lettat A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-142; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Martin C, 2010, ANIMAL, V4, P351, DOI 10.1017/S1751731109990620; McCune B., 1999, PC ORD WINDOWS MULTI; Mills HJ, 2005, APPL ENVIRON MICROB, V71, P3235, DOI 10.1128/AEM.71.6.3235-3247.2005; Moeseneder MM, 2005, FEMS MICROBIOL ECOL, V51, P341, DOI 10.1016/j.femsec.2004.09.012; Morgavi DP, 2012, BRIT J NUTR, V107, P388, DOI 10.1017/S0007114511002935; Morgavi DP, 2012, ANIMAL; Mosoni P, 2011, J ANIM SCI, V89, P783, DOI 10.2527/jas.2010-2947; Ohene-Adjei S, 2008, MICROB ECOL, V56, P234, DOI 10.1007/s00248-007-9340-0; Portillo MC, 2008, J APPL MICROBIOL, V104, P681, DOI 10.1111/j.1365-2672.2007.03594.x; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Reid NM, 2011, APPL ENVIRON MICROB, V77, P7000, DOI 10.1128/AEM.05609-11; Roy CS, 2009, WATER RES, V43, P21, DOI 10.1016/j.watres.2008.09.034; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Talbot G, 2008, WATER RES, V42, P513, DOI 10.1016/j.watres.2007.08.003; Talbot G, 2009, FEMS MICROBIOL ECOL, V70, P540, DOI 10.1111/j.1574-6941.2009.00749.x; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	42	24	24	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60978	10.1371/journal.pone.0060978	http://dx.doi.org/10.1371/journal.pone.0060978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593365	gold, Green Published, Green Submitted			2022-12-27	WOS:000317382000034
J	Yan, MX; Li, H; Zhu, MX; Zhao, FY; Zhang, LX; Chen, TY; Jiang, GP; Xie, HY; Cui, Y; Yao, M; Li, JJ				Yan, Mingxia; Li, Hong; Zhu, Miaoxin; Zhao, Fangyu; Zhang, Lixing; Chen, Taoyang; Jiang, Guoping; Xie, Haiyang; Cui, Ying; Yao, Ming; Li, Jinjun			G Protein-Coupled Receptor 87 (GPR87) Promotes the Growth and Metastasis of CD133(+) Cancer Stem-Like Cells in Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; SELF-RENEWAL; COLON-CANCER; DIFFERENTIATION; TUMORIGENICITY; POPULATION; ACTIVATION; EXPRESSION; SURVIVAL; AKT	Hepatocellular carcinoma (HCC) is a prevalent disease worldwide, and the majority of HCC-related deaths occur due to local invasion and distant metastasis. Cancer stem cells (CSCs) are a small subpopulation of cancer cells that have been hypothesized to be responsible for metastatic disease. Recently, we and others have identified a CSC population from human HCC cell lines and xenograft tumors characterized by their expression of CD133. However, the precise molecular mechanisms by which CD133(+) cancer stem-like cells mediate HCC metastasis have not been sufficiently analyzed. Here, we have sorted HCC cells using CD133 as a cancer stem cell (CSC) marker by magnetic-activated cell sorting (MACS) and demonstrated that the CD133(+) HCC cells not only possess greater migratory and invasive capacity in vitro but are also endowed with enhanced metastatic capacity in vivo and in human HCC specimens when compared to CD133 2 HCC cells. Gene expression analysis of the CD133(+) and CD133(-) cells of the HCC line SMMC-7721 revealed that G protein-coupled receptor 87 (GPR87) is highly expressed in CD133(+) HCC cells. In this study, we explored the role of GPR87 in the regulation of CD133 expression. We demonstrated that the overexpression of GPR87 up-regulated CD133 expression, promoted CSC-associated migratory and invasive properties in vitro, and increased tumor initiation in vivo. Conversely, silencing of GPR87 expression reduced the levels of CD133 expression. Conclusion: GPR87 promotes the growth and metastasis of CD133(+) cancer stem-like cells, and our findings may reveal new targets for HCC prevention or therapy.	[Yan, Mingxia; Li, Hong; Zhu, Miaoxin; Zhao, Fangyu; Zhang, Lixing; Yao, Ming; Li, Jinjun] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong, Jiangsu, Peoples R China; [Jiang, Guoping; Xie, Haiyang] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Cui, Ying] Canc Inst Guangxi, Nanning, Peoples R China	Shanghai Jiao Tong University; Zhejiang University	Li, JJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China.	jjli@shsci.org			National Key Program for Basic Research of China (973) [2009CB521803]; National Natural Science Foundation of China [81272438]; National Key Sci-Tech Special Project of China [2013ZX10002-11]; Program of Shanghai Subject Chief Science [09XD1403600]; Leading Academic Discipline Project of Shanghai Municipal Education Committee [J50208]	National Key Program for Basic Research of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Program of Shanghai Subject Chief Science; Leading Academic Discipline Project of Shanghai Municipal Education Committee	This work was supported in part by grants from the National Key Program for Basic Research of China (973) (2009CB521803), the National Natural Science Foundation of China (81272438), the National Key Sci-Tech Special Project of China (2013ZX10002-11), the Program of Shanghai Subject Chief Science (A) (09XD1403600) and Leading Academic Discipline Project of Shanghai Municipal Education Committee (J50208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodzin AS, 2012, J CELL PHYSIOL, V227, P2947, DOI 10.1002/jcp.23041; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033544; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Glatt S, 2008, INT J CANCER, V122, P2008, DOI 10.1002/ijc.23349; Hayashi T, 2012, CANCER SCI, V103, P889, DOI 10.1111/j.1349-7006.2012.02235.x; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P2970, DOI 10.1002/cncr.25869; Hu C, 2008, CARCINOGENESIS, V29, P2289, DOI 10.1093/carcin/bgn223; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044805; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; Nakashima O, 2001, J Hepatobiliary Pancreat Surg, V8, P404, DOI 10.1007/s005340100001; Paku S, 2004, HEPATOLOGY, V39, P1353, DOI 10.1002/hep.20178; Petersen BE, 1998, HEPATOLOGY, V27, P1030, DOI 10.1002/hep.510270419; Puglisi MA, 2009, EUR REV MED PHARMACO, V13, P55; Shi L, 2012, NEUROMOL MED, V14, P303, DOI 10.1007/s12017-012-8188-8; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wu Chun-ping, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P752; Yang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028405; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhang LX, 2012, CANCER RES, V72, P4276, DOI 10.1158/0008-5472.CAN-12-1013; Zhang Yanhong, 2010, Mol Cell Pharmacol, V2, P111; Zhang YH, 2009, CANCER RES, V69, P6049, DOI 10.1158/0008-5472.CAN-09-0621; Zhu LF, 2012, LAB INVEST, V92, P744, DOI 10.1038/labinvest.2012.8	33	79	86	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61056	10.1371/journal.pone.0061056	http://dx.doi.org/10.1371/journal.pone.0061056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593389	Green Submitted, gold, Green Published			2022-12-27	WOS:000317382000042
J	Bao, YP; Qiu, Y; Yan, SY; Jia, ZJ; Li, SX; Lian, Z; Mu, Y; Liu, ZM				Bao, Yan-ping; Qiu, Yi; Yan, Shi-yan; Jia, Zhen-jun; Li, Su-xia; Lian, Zhi; Mu, Yue; Liu, Zhi-min			Pattern of Drug Use and Depressive Symptoms among Amphetamine Type Stimulants Users in Beijing and Guangdong Province, China	PLOS ONE			English	Article							METHAMPHETAMINE USE; YOUNG-ADULTS; ASSOCIATIONS; SMOKING; DISORDERS; MORBIDITY; ALCOHOL; ONSET; MOOD	Background: In recent years, amphetamine-type stimulants (ATS) have increased dramatically in East-south Asia, especially in China. Most ATS users suffered from psychosis comorbidity, and depression is the main syndrome in ATS users. Methodology: A cross-sectional study of depressive symptoms and associated factors among ATS users was conducted in compulsory and voluntary drug detoxification and rehabilitation centers of Beijing and Guangdong Province from March, 2010 to August, 2010. Total 402 eligible participants were recruited and investigated by trained interviewers using a structured questionnaire, the depression was measured by the short 13-item Beck Depression Inventory (BDI-13). Multiple logistic regression was used to determine the impact of associated risk factors of depressive symptoms (%>= 8). Principle Finding: The mean score of BDI-13 is 8.11, and 169 participants (42.04%) have depressive symptoms, including 106 (26.37%) with moderate and 63 (15.67%) with severe depressive symptoms. Higher dose of ATS use, history of ATS relapse were associated with moderate and severe depressive symptoms, the adjusted odds ratios (OR) was 2.62, (95% CI: 1.45-4.74) and 2.01 (95% CI: 1.18-3.42) respectively. The cessation of 12 months or more had less risk of depressive symptoms than the current users, the OR was 0.46 (95% CI: 0.24-0.91), and the ATS users reporting nicotine dependence and alcohol drinking had significantly more risk of depressive symptoms for 3.11 (1.83-5.28) and 2.22 (1.35-3.65) times than those without these behaviors. Conclusions: Depressive symptoms co-occurred frequently among ATS users in China. The efforts that facilitate drug users' attempts to stop using ATS use and relapse, quit cigarette smoking and stop alcohol drinking during the ATS treatment and management process should be supported as they may contribute to improving the mental health among this population.	[Bao, Yan-ping; Qiu, Yi; Yan, Shi-yan; Jia, Zhen-jun; Li, Su-xia; Lian, Zhi; Mu, Yue; Liu, Zhi-min] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Yan, Shi-yan] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China	Peking University; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS	Bao, YP (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	baoypstat@163.com; zhiminliu@bjmu.edu.cn	Li, Su-Xia/AAR-6218-2021	Bao, Yanping/0000-0002-1881-0939	National Basic Research Program of China [2009CB522007]; Twelfth Five-Year Program of the Chinese Ministry of Science and Technology [2012BAI01B07, 2012ZX10001001]; National Natural Science Foundation of China [81001265]	National Basic Research Program of China(National Basic Research Program of China); Twelfth Five-Year Program of the Chinese Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2009CB522007), the Twelfth Five-Year Program of the Chinese Ministry of Science and Technology (2012BAI01B07 and 2012ZX10001001), and the National Natural Science Foundation of China (81001265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdacic-Gross V, 2009, ADDICTION, V104, P1411, DOI 10.1111/j.1360-0443.2009.02640.x; ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; BECK AT, 1974, PSYCHOL REP, V34, P1184; Celentano DD, 2008, J ADDICT MED, V2, P66, DOI 10.1097/ADM.0b013e31816c60c1; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Degenhardt L, 2007, ADDICTION, V102, P1076, DOI 10.1111/j.1360-0443.2007.01839.x; Hall W, 1996, ADDICTION, V91, P81, DOI 10.1046/j.1360-0443.1996.9118110.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; [刘志民 Liu Zhimin], 2002, [中国药物依赖性杂志, Chinese Journal of Drug Dependence], V11, P286; Marshall BDL, 2010, ADDICTION, V105, P991, DOI 10.1111/j.1360-0443.2010.02932.x; McCarty CA, 2012, J STUD ALCOHOL DRUGS, V73, P444, DOI 10.15288/jsad.2012.73.444; McGregor C, 2005, ADDICTION, V100, P1320, DOI 10.1111/j.1360-0443.2005.01160.x; McKetin R, 2011, MED J AUSTRALIA, V195, pS51; *NAT NARC CONTR CO, 2006, ANN REP DRUG CONTR C; National Narcotics Control Commission, 2012, ANN REP DRUG CONTR C; Subramaniam G, 2009, J SUBST ABUSE TREAT, V37, P25, DOI 10.1016/j.jsat.2008.09.008; Sutcliffe CG, 2009, DRUG ALCOHOL DEPEN, V101, P146, DOI 10.1016/j.drugalcdep.2008.11.014; Tsuang MT, 2012, HUM GENET, V131, P905, DOI 10.1007/s00439-012-1170-6; *UN OFF DRUGS CRIM, 2008, AMPH ECST 2008 GLOB; United Nations Office on Drugs and Crime, 2012, WORLD DRUG REP 2012; Yen CF, 2006, SUBST USE MISUSE, V41, P35, DOI 10.1080/10826080500318616; Zhang YY, 2013, ADDICT BEHAV, V38, P1424, DOI 10.1016/j.addbeh.2012.06.024; Zweben JE, 2004, AM J ADDICTION, V13, P181, DOI 10.1080/10550490490436055	24	19	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60544	10.1371/journal.pone.0060544	http://dx.doi.org/10.1371/journal.pone.0060544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JB	23585838	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600026
J	Huang, Y; Xie, C; Ye, AY; Li, CY; Gao, G; Wei, LP				Huang, Yue; Xie, Chen; Ye, Adam Y.; Li, Chuan-Yun; Gao, Ge; Wei, Liping			Recent Adaptive Events in Human Brain Revealed by Meta-Analysis of Positively Selected Genes	PLOS ONE			English	Article							NATURAL-SELECTION; EVOLUTION; SIGNATURES; GENETICS; FOXP2; MOUSE; SCANS; GO	Background and Objectives: Analysis of positively-selected genes can help us understand how human evolved, especially the evolution of highly developed cognitive functions. However, previous works have reached conflicting conclusions regarding whether human neuronal genes are over-represented among genes under positive selection. Methods and Results: We divided positively-selected genes into four groups according to the identification approaches, compiling a comprehensive list from 27 previous studies. We showed that genes that are highly expressed in the central nervous system are enriched in recent positive selection events in human history identified by intra-species genomic scan, especially in brain regions related to cognitive functions. This pattern holds when different datasets, parameters and analysis pipelines were used. Functional category enrichment analysis supported these findings, showing that synapse-related functions are enriched in genes under recent positive selection. In contrast, immune-related functions, for instance, are enriched in genes under ancient positive selection revealed by inter-species coding region comparison. We further demonstrated that most of these patterns still hold even after controlling for genomic characteristics that might bias genome-wide identification of positively-selected genes including gene length, gene density, GC composition, and intensity of negative selection. Conclusion: Our rigorous analysis resolved previous conflicting conclusions and revealed recent adaptation of human brain functions.	[Huang, Yue; Xie, Chen; Ye, Adam Y.; Li, Chuan-Yun; Gao, Ge; Wei, Liping] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Ctr Bioinformat, Beijing 100871, Peoples R China; [Li, Chuan-Yun] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Peking University; Peking University	Wei, LP (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Ctr Bioinformat, Beijing 100871, Peoples R China.	weilp@mail.cbi.pku.edu.cn	Huang, August Yue/E-9983-2016; Ye, Yongxin/AAR-4486-2020	Huang, August Yue/0000-0002-0416-2854; Ye, Yongxin/0000-0002-1542-0740; Li, Chuan-Yun/0000-0002-8008-8430	Natural Science Foundation of China [31025014]; Johnson and Johnson	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA)	Funding was provided by the "National Outstanding Young Investigator" award from the Natural Science Foundation of China (31025014) and Johnson and Johnson (scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Arbiza L, 2006, PLOS COMPUT BIOL, V2, P288, DOI 10.1371/journal.pcbi.0020038; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Daszykowski M, 2007, CHEMOMETR INTELL LAB, V85, P203, DOI 10.1016/j.chemolab.2006.06.016; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Enard D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000840; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fletcher W, 2010, MOL BIOL EVOL, V27, P2257, DOI 10.1093/molbev/msq115; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hurst LD, 2009, NAT REV GENET, V10, P83, DOI 10.1038/nrg2506; Jensen JD, 2007, TRENDS GENET, V23, P568, DOI 10.1016/j.tig.2007.08.009; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lin K-T, 2007, GENE NAME SERVICE NO, P185; Mallick S, 2009, GENOME RES, V19, P922, DOI 10.1101/gr.086512.108; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moreno-Estrada A, 2009, MOL BIOL EVOL, V26, P2285, DOI 10.1093/molbev/msp134; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Pertea M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-206; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231; Zhang JZ, 2002, GENETICS, V162, P1825	48	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61280	10.1371/journal.pone.0061280	http://dx.doi.org/10.1371/journal.pone.0061280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593450	gold, Green Submitted, Green Published			2022-12-27	WOS:000317909600098
J	Xia, S; Liu, JM				Xia, Shang; Liu, Jiming			A Computational Approach to Characterizing the Impact of Social Influence on Individuals' Vaccination Decision Making	PLOS ONE			English	Article							IMITATION DYNAMICS; A/H1N1 VACCINATION; PUBLIC-OPINION; PANDEMIC PHASE; HERD-IMMUNITY; SELF-INTEREST; BEHAVIOR; ACCEPTABILITY; PERSPECTIVES; IMMUNIZATION	In modeling individuals vaccination decision making, existing studies have typically used the payoff-based (e. g., game-theoretical) approaches that evaluate the risks and benefits of vaccination. In reality, whether an individual takes vaccine or not is also influenced by the decisions of others, i.e., due to the impact of social influence. In this regard, we present a dual-perspective view on individuals decision making that incorporates both the cost analysis of vaccination and the impact of social influence. In doing so, we consider a group of individuals making their vaccination decisions by both minimizing the associated costs and evaluating the decisions of others. We apply social impact theory (SIT) to characterize the impact of social influence with respect to individuals interaction relationships. By doing so, we propose a novel modeling framework that integrates an extended SIT-based characterization of social influence with a game-theoretical analysis of cost minimization. We consider the scenario of voluntary vaccination against an influenza-like disease through a series of simulations. We investigate the steady state of individuals' decision making, and thus, assess the impact of social influence by evaluating the coverage of vaccination for infectious diseases control. Our simulation results suggest that individuals high conformity to social influence will increase the vaccination coverage if the cost of vaccination is low, and conversely, will decrease it if the cost is high. Interestingly, if individuals are social followers, the resulting vaccination coverage would converge to a certain level, depending on individuals' initial level of vaccination willingness rather than the associated costs. We conclude that social influence will have an impact on the control of an infectious disease as they can affect the vaccination coverage. In this respect, our work can provide a means for modeling the impact of social influence as well as for estimating the effectiveness of a voluntary vaccination program.	[Xia, Shang; Liu, Jiming] Hong Kong Baptist Univ, Dept Comp Sci, Kowloon Tong, Hong Kong, Peoples R China	Hong Kong Baptist University	Liu, JM (corresponding author), Hong Kong Baptist Univ, Dept Comp Sci, Kowloon Tong, Hong Kong, Peoples R China.	jiming@Comp.HKBU.Edu.HK		Liu, Jiming/0000-0002-8669-9064	HIT Strategic Development Fund at HKBU	HIT Strategic Development Fund at HKBU	The research work reported in this article has been supported in part by the HIT Strategic Development Fund at HKBU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barriere J, 2010, VACCINE, V28, P7030, DOI 10.1016/j.vaccine.2010.08.021; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Breban R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028300; Breban R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031127; BURNKRANT RE, 1975, J CONSUM RES, V2, P206, DOI 10.1086/208633; Chen FH, 2006, J MATH BIOL, V53, P253, DOI 10.1007/s00285-006-0006-1; Codeco CT, 2007, J R SOC INTERFACE, V4, P1119, DOI 10.1098/rsif.2007.0234; Coelho FC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000425; Cojocaru MG, 2008, J GLOBAL OPTIM, V40, P51, DOI 10.1007/s10898-007-9204-7; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; d'Onofrio A, 2007, THEOR POPUL BIOL, V71, P301, DOI 10.1016/j.tpb.2007.01.001; d'Onofrio A, 2011, J THEOR BIOL, V273, P63, DOI 10.1016/j.jtbi.2010.12.029; d'Onofrio A, 2010, J THEOR BIOL, V264, P237, DOI 10.1016/j.jtbi.2010.02.007; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Eames KTD, 2009, J R SOC INTERFACE, V6, P811, DOI 10.1098/rsif.2009.0085; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Francois G, 2005, PEDIATR INFECT DIS J, V24, P953, DOI 10.1097/01.inf.0000183853.16113.a6; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Grinblatt M, 2008, REV ECON STAT, V90, P735, DOI 10.1162/rest.90.4.735; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Henrich N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018479; Holyst JA, 2001, ANN REV COMP PHYS, V9, P253; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; Keelan J, 2007, JAMA-J AM MED ASSOC, V298, P2482, DOI 10.1001/jama.298.21.2482; Keelan J, 2010, VACCINE, V28, P1535, DOI 10.1016/j.vaccine.2009.11.060; Keeling MJ, 2000, J THEOR BIOL, V203, P51, DOI 10.1006/jtbi.1999.1064; Kottonau J, 2004, JASSS-J ARTIF SOC S, V7, P107; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; Lau JTF, 2010, VACCINE, V28, P4632, DOI 10.1016/j.vaccine.2010.04.076; Liao QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017713; Mbah MLN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002469; Myers LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-15; NOWAK A, 1990, PSYCHOL REV, V97, P362, DOI 10.1037/0033-295X.97.3.362; Pandey Ambarish, 2010, Am J Prev Med, V38, pe1, DOI 10.1016/j.amepre.2009.11.007; Perisic A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-77; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Reluga TC, 2006, MATH BIOSCI, V204, P185, DOI 10.1016/j.mbs.2006.08.015; Reluga TC, 2011, MATH BIOSCI, V230, P67, DOI 10.1016/j.mbs.2011.01.003; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Singh VK, 2011, COMM COM INF SC, V204, P542; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; Tai ZX, 2007, NEW MEDIA SOC, V9, P987, DOI 10.1177/1461444807082691; Vance K, 2009, DERMATOL CLIN, V27, P133, DOI 10.1016/j.det.2008.11.010; Vardavas R, 2007, PLOS COMPUT BIOL, V3, P796, DOI 10.1371/journal.pcbi.0030085; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Witteman HO, 2012, VACCINE, V30, P3734, DOI 10.1016/j.vaccine.2011.12.039; Wu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020577; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang HF, 2011, PHYSICA D, V240, P943, DOI 10.1016/j.physd.2011.02.001; Zijtregtop EAM, 2009, VACCINE, V28, P207, DOI 10.1016/j.vaccine.2009.09.099	63	47	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60373	10.1371/journal.pone.0060373	http://dx.doi.org/10.1371/journal.pone.0060373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JB	23585835	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600022
J	Xiao, H; Shen, HY; Liu, W; Xiong, RP; Li, P; Meng, G; Yang, N; Chen, X; Si, LY; Zhou, YG				Xiao, Hang; Shen, Hai-Ying; Liu, Wei; Xiong, Ren-ping; Li, Ping; Meng, Gang; Yang, Nan; Chen, Xing; Si, Liang-Yi; Zhou, Yuan-Guo			Adenosine A(2A) Receptor: A Target for Regulating Renal Interstitial Fibrosis in Obstructive Nephropathy	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; UNILATERAL URETERAL OBSTRUCTION; T-CELLS; TUBULOINTERSTITIAL FIBROSIS; PROGRESSIVE FIBROSIS; A2A RECEPTOR; RHO-KINASE; CGS 21680; INFLAMMATION; INJURY	Renal interstitial fibrosis (RIF) is the common pathological process of chronic kidney diseases leading inevitably to renal function deterioration. RIF and its preceding epithelial-mesenchymal transition (EMT) are commonly triggered by an early occurring renal inflammation. However, an effective approach to prevent EMT and RIF is still lacking and of urgent need. Recently, the adenosine A(2A) receptor (A(2A)R) emerges as a novel inflammation regulator, therefore manipulation of A(2A)R may suppress the EMT process and as such protect against RIF. To test this hypothesis we applied a unilateral ureteral obstruction (UUO) model of RIF on A(2A)R knockout mice and their wild-type littermates, combined with the intervention of a selective A(2A)R agonist, CGS 21680. On days 3, 7 and 14 post-UUO we evaluated the effects of A(2A)R manipulation on the molecular pathological progresses of RIF, including the cellular component of interstitial infiltration, expression of profibrotic factors, cellular biomarkers of EMT, and collagen deposition of extracellular matrix. Our data demonstrated that activation of A(2A)R significantly suppressed the deposition of collagen types I and III, reduced the infiltration of CD4+ T lymphocytes, and attenuated the expression of TGF-beta 1 and ROCK1, which in turn inhibited and postponed the EMT progress. Conversely, genetic inactivation of A(2A)R exacerbated the aforementioned pathological processes of UUO-induced RIF. Together, activation of A(2A)R effectively alleviated EMT and RIF in mice, suggesting A(2A)R as a potential therapeutic target for the treatment of RIF.	[Xiao, Hang; Si, Liang-Yi] Third Mil Med Univ, Southwest Hosp, Dept Geriatr, Chongqing, Peoples R China; [Xiao, Hang; Shen, Hai-Ying; Xiong, Ren-ping; Li, Ping; Yang, Nan; Chen, Xing; Zhou, Yuan-Guo] Third Mil Med Univ, Ctr Mol Biol, State Key Lab Trauma Burn & Combined Injury, Inst Surg Res, Chongqing, Peoples R China; [Xiao, Hang; Shen, Hai-Ying; Liu, Wei; Xiong, Ren-ping; Li, Ping; Yang, Nan; Chen, Xing; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Liu, Wei] Third Mil Med Univ, Dept Ophthalmol, Inst Surg Res, Chongqing, Peoples R China; [Meng, Gang] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University	Si, LY (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Geriatr, Chongqing, Peoples R China.	siliangyi@163.com; ygzhou@tmmu.edu.cn	Li, ping/J-6507-2019	Li, Ping/0000-0002-4926-3835; Shen, Hai-Ying/0000-0001-8430-2978	National Natural Science Foundation of China [30871170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (No. 30871170) to HYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2002, J CLIN INVEST, V109, P251, DOI 10.1172/JCI14040; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; Eis V, 2004, J AM SOC NEPHROL, V15, P337, DOI 10.1097/01.ASN.0000111246.87175.32; Ferenbach DA, 2011, KIDNEY INT, V80, P329, DOI 10.1038/ki.2011.167; Fu P, 2006, J AM SOC NEPHROL, V17, P3105, DOI 10.1681/ASN.2005121366; Garcia GE, 2011, KIDNEY INT, V80, P378, DOI 10.1038/ki.2011.101; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Impellizzeri D, 2011, EUR J PHARMACOL, V668, P305, DOI 10.1016/j.ejphar.2011.06.049; Isaka Y, 2008, CONTRIB NEPHROL, V159, P109, DOI 10.1159/000125668; Iwano Masayuki, 2010, Front Biosci (Schol Ed), V2, P229; Kalaji R, 2012, BIOL CELL; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Lee J, 2012, TRANSPL P, V44, P1166, DOI 10.1016/j.transproceed.2012.01.079; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lukashev D, 2004, J IMMUNOL, V173, P21, DOI 10.4049/jimmunol.173.1.21; Mao HP, 2008, AM J PHYSIOL-RENAL, V295, pF202, DOI 10.1152/ajprenal.00468.2007; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Mazzon E, 2011, J RHEUMATOL, V38, P2119, DOI 10.3899/jrheum.110111; Moriyama T, 1998, KIDNEY INT, V54, P110, DOI 10.1046/j.1523-1755.1998.00964.x; Mucsi I, 2007, ACTA PHYSIOL HUNG, V94, P117, DOI 10.1556/APhysiol.94.2007.1-2.11; Ohta A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00190; Otsu K, 2011, J CELL PHYSIOL, V226, P2527, DOI 10.1002/jcp.22597; Pannarale Giovanni, 2010, J Nephrol, V23 Suppl 15, pS37; Pozdzik AA, 2008, NEPHROL DIAL TRANSPL, V23, P2480, DOI 10.1093/ndt/gfn140; Prakash J, 2008, J AM SOC NEPHROL, V19, P2086, DOI 10.1681/ASN.2007070794; Robertson H, 2004, J AM SOC NEPHROL, V15, P390, DOI 10.1097/01.ASN.0000108521.39082.E1; Sitkovsky M, 2008, BRIT J PHARMACOL, V153, pS457, DOI 10.1038/bjp.2008.23; Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589; STRUTZ F, 1994, KIDNEY INT, V45, pS106; Strutz F, 2001, EXPERT OPIN INV DRUG, V10, P1989, DOI 10.1517/13543784.10.11.1989; Tan XY, 2007, J STEROID BIOCHEM, V103, P491, DOI 10.1016/j.jsbmb.2006.11.011; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Tian YC, 2003, AM J PHYSIOL-RENAL, V285, pF130, DOI 10.1152/ajprenal.00408.2002; Tipping PG, 2006, J AM SOC NEPHROL, V17, P1253, DOI 10.1681/ASN.2005091013; Vaughan E Darracott Jr, 2004, J Urol, V172, P2563, DOI 10.1097/01.ju.0000144286.53562.95; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; Wu GL, 2010, BIOMED PHARMACOTHER, V64, P124, DOI 10.1016/j.biopha.2009.06.001; Yang NS, 1998, KIDNEY INT, V54, P143, DOI 10.1046/j.1523-1755.1998.00978.x; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang L, 2011, LUPUS, V20, P667, DOI 10.1177/0961203310393262; Zheng GP, 2005, KIDNEY INT, V67, pS96, DOI 10.1111/j.1523-1755.2005.09423.x; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]	48	28	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60173	10.1371/journal.pone.0060173	http://dx.doi.org/10.1371/journal.pone.0060173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585831	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600014
J	Bebbere, D; Bauersachs, S; Furst, RW; Reichenbach, HD; Reichenbach, M; Medugorac, I; Ulbrich, SE; Wolf, E; Ledda, S; Hiendleder, S				Bebbere, Daniela; Bauersachs, Stefan; Fuerst, Rainer W.; Reichenbach, Horst-Dieter; Reichenbach, Myriam; Medugorac, Ivica; Ulbrich, Susanne E.; Wolf, Eckhard; Ledda, Sergio; Hiendleder, Stefan			Tissue-Specific and Minor Inter-Individual Variation in Imprinting of IGF2R Is a Common Feature of Bos taurus Concepti and Not Correlated with Fetal Weight	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; FACTOR TYPE-2 RECEPTOR; II RECEPTORS; GROWTH; MOUSE; GENE; METHYLATION; OVERGROWTH; RELAXATION; REPRESSION	The insulin-like growth factor 2 receptor (IGF2R) is essential for prenatal growth regulation and shows gene dosage effects on fetal weight that can be affected by in-vitro embryo culture. Imprinted maternal expression of murine Igf2r is well documented for all fetal tissues excluding brain, but polymorphic imprinting and biallelic expression were reported for IGF2R in human. These differences have been attributed to evolutionary changes correlated with specific reproductive strategies. However, data from species suitable for testing this hypothesis are lacking. The domestic cow (Bos taurus) carries a single conceptus with a similar gestation length as human. We identified 12 heterozygous concepti informative for imprinting studies among 68 Bos taurus fetuses at Day 80 of gestation (28% term) and found predominantly maternal IGF2R expression in all fetal tissues but brain, which escapes imprinting. Inter-individual variation in allelic expression bias, i.e. expression of the repressed paternal allele relative to the maternal allele, ranged from 4.6-8.9% in heart, 4.3-10.2% in kidney, 6.1-11.2% in liver, 4.6-15.8% in lung and 3.2-12.2% in skeletal muscle. Allelic bias for mesodermal tissues (heart, skeletal muscle) differed significantly (P < 0.05) from endodermal tissues (liver, lung). The placenta showed partial imprinting with allelic bias of 22.9-34.7% and differed significantly (P < 0.001) from all other tissues. Four informative fetuses were generated by in-vitro fertilization (IVF) with embryo culture and two individuals displayed fetal overgrowth. However, there was no evidence for changes in imprinting or DNA methylation after IVF, or correlations between allelic bias and fetal weight. In conclusion, imprinting of Bos taurus IGF2R is similar to mouse except in placenta, which could indicate an effect of reproductive strategy. Common minor inter-individual variation in allelic bias and absence of imprinting abnormalities in IVF fetuses suggest changes in IGF2R expression in overgrown fetuses could be modulated through other mechanisms than changes in imprinting.	[Bebbere, Daniela; Bauersachs, Stefan; Reichenbach, Myriam; Wolf, Eckhard; Hiendleder, Stefan] Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Bebbere, Daniela; Ledda, Sergio] Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy; [Bauersachs, Stefan; Wolf, Eckhard] Univ Munich, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Fuerst, Rainer W.; Ulbrich, Susanne E.] Tech Univ Munich, Freising Weihenstephan, Germany; [Reichenbach, Horst-Dieter] Bavarian State Res Ctr Agr, Inst Anim Breeding, Grub, Germany; [Medugorac, Ivica] Univ Munich, Fac Vet Med, Chair Anim Genet & Husb, Munich, Germany; [Hiendleder, Stefan] Univ Adelaide, Sch Anim & Vet Sci, JS Davies Nonmendelian Genet Grp, Roseworthy, Australia; [Hiendleder, Stefan] Univ Adelaide, Robinson Inst, Res Ctr Reprod Hlth, Roseworthy, Australia	University of Munich; University of Sassari; University of Munich; Technical University of Munich; University of Munich; University of Adelaide; Robinson Research Institute; University of Adelaide	Hiendleder, S (corresponding author), Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany.	Stefan.Hiendleder@adelaide.edu.au	Ulbrich, Susanne E/D-1815-2014; Bebbere, Daniela/N-6290-2017	Ulbrich, Susanne E/0000-0003-0355-3869; Bebbere, Daniela/0000-0002-5277-5698; Medugorac, Ivica/0000-0002-6891-3039; LEDDA, Sergio/0000-0002-9779-5684; Bauersachs, Stefan/0000-0003-2450-1216; Wolf, Eckhard/0000-0002-0430-9510	JS Davies Bequest	JS Davies Bequest	This work was supported by the JS Davies Bequest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Buckberry S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051210; Daelemans C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-25; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Furst RW, 2012, J STEROID BIOCHEM, V130, P96, DOI 10.1016/j.jsbmb.2012.01.009; Furst RW, 2012, MOL CELL ENDOCRINOL, V348, P67, DOI 10.1016/j.mce.2011.07.032; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Hiendleder S, 2004, CLONING STEM CELLS, V6, P150, DOI 10.1089/1536230041372391; Hiendleder S, 2006, BIOL REPROD, V75, P17, DOI 10.1095/biolreprod.105.043919; Hudson QJ, 2011, DEV BIOL, V353, P420, DOI 10.1016/j.ydbio.2011.02.017; Jiang S, 1998, GENOMICS, V53, P395, DOI 10.1006/geno.1998.5511; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; Kiess W, 1999, CONT ENDOCRINOL, V17, P89; Killian JK, 2001, HUM MUTAT, V18, P25, DOI 10.1002/humu.1146; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Leiser R, 1997, MICROSC RES TECHNIQ, V38, P76; Lerchner W, 1997, MECH DEVELOP, V61, P141, DOI 10.1016/S0925-4773(96)00630-2; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; O'Doherty AM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094946; OGAWA O, 1993, HUM MOL GENET, V2, P2163, DOI 10.1093/hmg/2.12.2163; Oudejans CBM, 2001, GENOMICS, V73, P331, DOI 10.1006/geno.2001.6522; Powell K, 2006, THERIOGENOLOGY, V66, P1901, DOI 10.1016/j.theriogenology.2006.05.008; Proudhon C, 2010, BRIEF FUNCT GENOMICS, V9, P374, DOI 10.1093/bfgp/elq020; Radford EJ, 2011, FEBS LETT, V585, P2059, DOI 10.1016/j.febslet.2011.05.063; Schauser KH, 1998, BIOL REPROD, V59, P684, DOI 10.1095/biolreprod59.3.684; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097; Thurston A, 2008, REPRODUCTION, V135, P29, DOI 10.1530/REP-07-0211; VILLAR AJ, 1994, NAT GENET, V8, P373, DOI 10.1038/ng1294-373; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Wutz A, 2001, DEVELOPMENT, V128, P1881; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	39	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59564	10.1371/journal.pone.0059564	http://dx.doi.org/10.1371/journal.pone.0059564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593146	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000013
J	Gao, XY; An, HZ; Zhong, WQ				Gao, Xiangyun; An, Haizhong; Zhong, Weiqiong			Features of the Correlation Structure of Price Indices	PLOS ONE			English	Article							INFLATION; WHOLESALE; NETWORKS; PPI	What are the features of the correlation structure of price indices? To answer this question, 5 types of price indices, including 195 specific price indices from 2003 to 2011, were selected as sample data. To build a weighted network of price indices each price index is represented by a vertex, and a positive correlation between two price indices is represented by an edge. We studied the features of the weighted network structure by applying economic theory to the analysis of complex network parameters. We found that the frequency of the price indices follows a normal distribution by counting the weighted degrees of the nodes, and we identified the price indices which have an important impact on the network's structure. We found out small groups in the weighted network by the methods of k-core and k-plex. We discovered structure holes in the network by calculating the hierarchy of the nodes. Finally, we found that the price indices weighted network has a small-world effect by calculating the shortest path. These results provide a scientific basis for macroeconomic control policies.	[Gao, Xiangyun; An, Haizhong; Zhong, Weiqiong] China Univ Geosci, Sch Humanities & Econ Management, Beijing, Peoples R China; [Gao, Xiangyun; An, Haizhong; Zhong, Weiqiong] Minist Land & Resource, Key Lab Carrying Capac Assessment Resource & Envi, Beijing, Peoples R China; [Gao, Xiangyun; An, Haizhong] China Univ Geosci, Lab Resources & Environm Management, Beijing, Peoples R China	China University of Geosciences; China University of Geosciences	An, HZ (corresponding author), China Univ Geosci, Sch Humanities & Econ Management, Beijing, Peoples R China.	ahz369@163.com	Gao, Xiangyun/R-6133-2016	Gao, Xiangyun/0000-0003-2101-1609	Natural Science Foundation of China [71173199]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The paper is supported by the Natural Science Foundation of China (Grant No. 71173199). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchian A.A., 1973, J MONEY CREDIT BANK, V5, P173, DOI DOI 10.2307/1991070; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Blomberg S.B., 1995, EC POLICY REV, P21; Clark, 1995, EC REV FEDERAL RESER, V80, P25; CUSHING MJ, 1990, SOUTHERN ECON J, V56, P1059, DOI 10.2307/1059891; Doroodian K, 2003, ENERG POLICY, V31, P989, DOI 10.1016/S0301-4215(02)00141-6; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Elgazzar AS, 2003, PHYSICA A, V324, P402, DOI 10.1016/S0378-4371(02)01956-8; Gujarati D.N., 2010, ECONOMETRIA; He LP, 2011, CHINA WORLD ECON, V19, P18, DOI 10.1111/j.1749-124X.2011.01240.x; Johnson GD, 1998, WORKING PAPER; Kaderabek P, 2007, POLIT EKON, V55, P226, DOI 10.18267/j.polek.598; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kyrtsou C, 2006, J MACROECON, V28, P256, DOI 10.1016/j.jmacro.2005.10.019; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lebow DE, 2006, FINANCE EC DISCUSSIO, P1; Liu XF, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501428; Mahdavi S., 1997, J ECON BUS, V49, P475, DOI [10.1016/s0148-6195(97)00034-9, DOI 10.1016/S0148-6195(97)00034-9]; Mankiw NG, 2003, J EUR ECON ASSOC, V1, P1058, DOI 10.1162/154247603770383398; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; PERAZZO RPJ, 1995, CHAOS SOLITON FRACT, V6, P455, DOI 10.1016/0960-0779(95)80053-J; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; SILVER JL, 1980, J ECONOMETRICS, V12, P375; Tse CK, 2010, J EMPIR FINANC, V17, P659, DOI 10.1016/j.jempfin.2010.04.008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weinhagen J, 2005, MON LABOR REV, V128, P41	26	17	20	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61091	10.1371/journal.pone.0061091	http://dx.doi.org/10.1371/journal.pone.0061091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130FG	23593399	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000100
J	Luersen, K; Stegehake, D; Daniel, J; Drescher, M; Ajonina, I; Ajonina, C; Hertel, P; Woltersdorf, C; Liebau, E				Lueersen, Kai; Stegehake, Dirk; Daniel, Jens; Drescher, Mike; Ajonina, Irene; Ajonina, Caroline; Hertel, Patrick; Woltersdorf, Christian; Liebau, Eva			The Glutathione Reductase GSR-1 Determines Stress Tolerance and Longevity in Caenorhabditis elegans	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SKN-1; INDUCED OXIDATIVE STRESS; HUMAN-DISEASE; C. ELEGANS; ANTIOXIDANT DEFENSE; LIFE-SPAN; EXPRESSION; TOXICITY; STRATEGIES; SEQUENCES	Glutathione (GSH) and GSH-dependent enzymes play a key role in cellular detoxification processes that enable organism to cope with various internal and environmental stressors. However, it is often not clear, which components of the complex GSH-metabolism are required for tolerance towards a certain stressor. To address this question, a small scale RNAi-screen was carried out in Caenorhabditis elegans where GSH-related genes were systematically knocked down and worms were subsequently analysed for their survival rate under sub-lethal concentrations of arsenite and the redox cycler juglone. While the knockdown of gamma-glutamylcysteine synthetase led to a diminished survival rate under arsenite stress conditions, GSR-1 (glutathione reductase) was shown to be essential for survival under juglone stress conditions. gsr-1 is the sole GSR encoding gene found in C. elegans. Knockdown of GSR-1 hardly affected total glutathione levels nor reduced glutathione/glutathione disulphide (GSH/GSSG) ratio under normal laboratory conditions. Nevertheless, when GSSG recycling was impaired by gsr-1(RNAi), GSH synthesis was induced, but not vice versa. Moreover, the impact of GSSG recycling was potentiated under oxidative stress conditions, explaining the enormous effect gsr-1(RNAi) knockdown had on juglone tolerance. Accordingly, overexpression of GSR-1 was capable of increasing stress tolerance. Furthermore, expression levels of SKN-1-regulated GSR-1 also affected life span of C. elegans, emphasising the crucial role the GSH redox state plays in both processes.	[Lueersen, Kai; Stegehake, Dirk; Daniel, Jens; Drescher, Mike; Ajonina, Irene; Ajonina, Caroline; Hertel, Patrick; Woltersdorf, Christian; Liebau, Eva] Univ Munster, Dept Mol Physiol, Inst Anim Physiol, D-48149 Munster, Germany	University of Munster	Liebau, E (corresponding author), Univ Munster, Dept Mol Physiol, Inst Anim Physiol, D-48149 Munster, Germany.	liebaue@uni-muenster.de			Deutsche Forschungsgemeinschaft DFG [LI 793/5-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft DFG, grant LI 793/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahinger J, 2006, REVERSE GENETICS WOR, DOI [10.1895/wormbook.1.47.1, DOI 10.1895/WORMBOOK.1.47.1]; Ahringer J, 1996, GENE DEV, V10, P1120, DOI 10.1101/gad.10.9.1120; Ahsan N, 2008, PROTEOMICS, V8, P3561, DOI 10.1002/pmic.200701189; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braeckman BP, 2007, EXP GERONTOL, V42, P90, DOI 10.1016/j.exger.2006.04.010; BRENNER S, 1974, GENETICS, V77, P71; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CLOS J, 1994, PROTEIN EXPRES PURIF, V5, P133, DOI 10.1006/prep.1994.1020; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hartwig K, 2009, GENES NUTR, V4, P59, DOI 10.1007/s12263-009-0113-x; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ishii N, 2005, BRIT J DERMATOL, V153, P1, DOI 10.1111/j.1365-2133.2005.06963.x; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kertulis-Tartar GM, 2009, PLANT PHYSIOL BIOCH, V47, P960, DOI 10.1016/j.plaphy.2009.05.009; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Lant B, 2010, INT J BIOL SCI, V6, P9; LEE TC, 1989, IN VITRO CELL DEV B, V25, P442; LEWIS JA, 1987, MOL PHARMACOL, V31, P185; Liao VHC, 2005, BIOMETALS, V18, P519, DOI 10.1007/s10534-005-2996-3; Limon-Pacheco J, 2009, MUTAT RES-GEN TOX EN, V674, P137, DOI 10.1016/j.mrgentox.2008.09.015; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Muller S, 1997, BIOCHEM J, V325, P645; NEUSCHWANDERTETRI BA, 1989, ANAL BIOCHEM, V179, P236, DOI 10.1016/0003-2697(89)90121-8; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Park HA, 2009, CELL DEATH DIFFER, V16, P1167, DOI 10.1038/cdd.2009.37; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Rebrin I, 2008, ADV DRUG DELIVER REV, V60, P1545, DOI 10.1016/j.addr.2008.06.001; Rizki M, 2006, ENVIRON MOL MUTAGEN, V47, P162, DOI 10.1002/em.20178; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Spanier B, 2010, AGING CELL, V9, P636, DOI 10.1111/j.1474-9726.2010.00591.x; Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Strayer A, 2003, FASEB J, V17, P2305, DOI 10.1096/fj.03-0376fje; Thomas DJ, 2009, TOXICOL SCI, V107, P309, DOI 10.1093/toxsci/kfn257; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Yeh JY, 2002, CELL MOL LIFE SCI, V59, P1972, DOI 10.1007/PL00012519; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1	61	32	39	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60731	10.1371/journal.pone.0060731	http://dx.doi.org/10.1371/journal.pone.0060731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593298	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000056
J	Rogovskyy, AS; Bankhead, T				Rogovskyy, Artem S.; Bankhead, Troy			Variable VlsE Is Critical for Host Reinfection by the Lyme Disease Spirochete	PLOS ONE			English	Article							OUTER-SURFACE PROTEIN; BORRELIA-BURGDORFERI-VLSE; ANTIGENIC VARIATION; GENETIC-VARIATION; LINEAR PLASMID-25; IMMUNE EVASION; INFECTION; EXPRESSION; OSPC; TICKS	Many pathogens make use of antigenic variation as a way to evade the host immune response. A key mechanism for immune evasion and persistent infection by the Lyme disease spirochete, Borrelia burgdorferi, is antigenic variation of the VlsE surface protein. Recombination results in changes in the VlsE surface protein that prevent recognition by VlsE-specific antibodies in the infected host. Despite the presence of a substantial number of additional proteins residing on the bacterial surface, VlsE is the only known antigen that exhibits ongoing variation of its surface epitopes. This suggests that B. burgdorferi may utilize a VlsE-mediated system for immune avoidance of its surface antigens. To address this, the requirement of VlsE for host reinfection by the Lyme disease pathogen was investigated. Host-adapted wild type and VlsE mutant spirochetes were used to reinfect immunocompetent mice that had naturally cleared an infection with a VlsE-deficient clone. Our results demonstrate that variable VlsE is necessary for reinfection by B. burgdorferi, and this ability is directly related to evasion of the host antibody response. Moreover, the data presented here raise the possibility that VlsE prevents recognition of B. burgdorferi surface antigens from host antibodies. Overall, our findings represent a significant advance in our knowledge of immune evasion by B. burgdorferi, and provide insight to the possible mechanisms involved in VlsE-mediated immune avoidance.	[Rogovskyy, Artem S.; Bankhead, Troy] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Bankhead, Troy] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; Washington State University	Bankhead, T (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	tbankhead@vetmed.wsu.edu	Bankhead, Troy/V-9033-2019	Bankhead, Troy/0000-0002-4336-0298	College of Veterinary Medicine, Washington State University	College of Veterinary Medicine, Washington State University	This work was supported by an intramural grant from the College of Veterinary Medicine, Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankhead T, 2007, MOL MICROBIOL, V65, P1547, DOI 10.1111/j.1365-2958.2007.05895.x; Barbour AG, 2001, EMERGING INFECTIONS 5, P153; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; BARTHOLD SW, 1993, INFECT IMMUN, V61, P4955, DOI 10.1128/IAI.61.12.4955-4961.1993; Barthold SW, 1999, INFECT IMMUN, V67, P36, DOI 10.1128/IAI.67.1.36-42.1999; BARTHOLD SW, 1995, INFECT IMMUN, V63, P2255, DOI 10.1128/IAI.63.6.2255-2261.1995; Battisti JM, 2008, INFECT IMMUN, V76, P5228, DOI 10.1128/IAI.00410-08; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; Bunikis J, 1999, INFECT IMMUN, V67, P2874, DOI 10.1128/IAI.67.6.2874-2883.1999; Bykowski T, 2006, J BACTERIOL, V188, P4879, DOI 10.1128/JB.00229-06; Chaconas G, 2001, EMBO J, V20, P3229, DOI 10.1093/emboj/20.12.3229; Coutte L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000293; Crother TR, 2003, INFECT IMMUN, V71, P3419, DOI 10.1128/IAI.71.6.3419-3428.2003; de Silva AM, 1998, J INFECT DIS, V177, P395, DOI 10.1086/514200; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Embers ME, 2007, FEMS IMMUNOL MED MIC, V50, P421, DOI 10.1111/j.1574-695X.2007.00276.x; Golde WT, 1998, J CLIN MICROBIOL, V36, P1015, DOI 10.1128/JCM.36.4.1015-1019.1998; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hovius KE, 1999, VET QUART, V21, P16, DOI 10.1080/01652176.1999.9694985; Hudson CR, 2001, MOL MICROBIOL, V41, P229, DOI 10.1046/j.1365-2958.2001.02511.x; Indest KJ, 2001, INFECT IMMUN, V69, P7083, DOI 10.1128/IAI.69.11.7083-7090.2001; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; KENEDY MR, 2012, FEMS IMMUNOL MED MIC; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Lawrenz MB, 2004, INFECT IMMUN, V72, P6577, DOI 10.1128/IAI.72.11.6577-6585.2004; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2002, J EXP MED, V195, P415, DOI 10.1084/jem.20011870; MACDONALD HR, 1981, J IMMUNOL, V126, P865; McDowell JV, 2002, INFECT IMMUN, V70, P4196, DOI 10.1128/IAI.70.8.4196-4203.2002; McKisic MD, 2000, INFECT IMMUN, V68, P5190, DOI 10.1128/IAI.68.9.5190-5197.2000; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Norris SJ, 2006, MOL MICROBIOL, V60, P1319, DOI 10.1111/j.1365-2958.2006.05204.x; NORRIS SJ, 1992, INFECT IMMUN, V60, P4662, DOI 10.1128/IAI.60.11.4662-4672.1992; Nowakowski J, 1997, ANN INTERN MED, V127, P130, DOI 10.7326/0003-4819-127-2-199707150-00006; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Ohnishi J, 2003, J BACTERIOL, V185, P4432, DOI 10.1128/JB.185.15.4432-4441.2003; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Palmer GH, 2009, CELL MICROBIOL, V11, P1697, DOI 10.1111/j.1462-5822.2009.01366.x; Philipp MT, 2001, J INFECT DIS, V184, P870, DOI 10.1086/323392; Piesman J, 1997, INFECT IMMUN, V65, P4043, DOI 10.1128/IAI.65.10.4043-4047.1997; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; SALAZAR JC, 1993, J PEDIATR-US, V122, P591, DOI 10.1016/S0022-3476(05)83541-3; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tilly K, 2009, INFECT IMMUN, V77, P2672, DOI 10.1128/IAI.01193-08; WEBER K, 1986, INFECTION, V14, P32, DOI 10.1007/BF01644807; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhang JR, 1998, INFECT IMMUN, V66, P3689, DOI 10.1128/IAI.66.8.3689-3697.1998; Zhang JR, 1998, INFECT IMMUN, V66, P3698, DOI 10.1128/IAI.66.8.3698-3704.1998	60	46	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61226	10.1371/journal.pone.0061226	http://dx.doi.org/10.1371/journal.pone.0061226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593438	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000115
J	Harris, MR; Lee, D; Farmer, S; Lowndes, NF; de Bruin, RAM				Harris, Michael R.; Lee, Dave; Farmer, Sarah; Lowndes, Noel F.; de Bruin, Robertus A. M.			Binding Specificity of the G1/S Transcriptional Regulators in Budding Yeast	PLOS ONE			English	Article							G1-SPECIFIC TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; POSITIVE FEEDBACK; CYCLE; CLN3; SBF; PROTEIN; SWI4; IMMUNOPRECIPITATION; TRANSITION	Background: G1/S transcriptional regulation in the budding yeast Saccharomyces cerevisiae depends on three main transcriptional components, Swi4, Swi6 and Mbp1. These proteins constitute two transcription factor complexes that regulate over 300 G1/S transcripts, namely SBF (Swi4-Swi6) and MBF (Mbp1-Swi6). SBF and MBF are involved in regulating largely non-overlapping sets of G1/S genes via clearly distinct mechanisms. Methodology/Principal Findings: Here we establish and confirm protein-protein and protein-DNA interactions using specific polyclonal antisera to whole Swi6 and to the C-terminal domains of related proteins Swi4 and Mbp1. Our data confirm the protein-protein binding specificity of Swi4 and Mbp1 to Swi6 but not to each other, and support the binding specificity of the transcriptional inhibitor Whi5 to SBF and of the corepressor Nrm1 to MBF. We also show the DNA binding preference of Swi4 to the CLN2 promoter and Mbp1 to the RNR1 promoter, while Swi6 binds both promoters. Finally, we establish the binding dynamics of Swi4 and Whi5 to the CLN2 promoter during the cell cycle. Conclusions/Significance: These data confirm the binding specificity of the G1/S transcriptional regulators. Whereas previous observations were made using tagged Swi4, Swi6 and Mbp1, here we use specific polyclonal antisera to reestablish the protein-protein and protein-DNA interactions of these G1/S transcriptional components. Our data also reveal the dynamic changes in promoter binding of Swi4 during the cell cycle, which suggests a possible positive feedback loop involving Swi4.	[Harris, Michael R.; Farmer, Sarah; de Bruin, Robertus A. M.] UCL, MRC, Mol Cell Biol Lab, London, England; [de Bruin, Robertus A. M.] UCL, UCL Canc Inst, London, England; [Lee, Dave; Lowndes, Noel F.] Natl Univ Ireland Galway, Sch Nat Sci, Genome Stabil Lab, Ctr Chromosome Biol, Galway, Ireland	University of London; University College London; University of London; University College London; Ollscoil na Gaillimhe-University of Galway	Lowndes, NF (corresponding author), Natl Univ Ireland Galway, Sch Nat Sci, Genome Stabil Lab, Ctr Chromosome Biol, Galway, Ireland.	noel.lowndes@nuigalway.ie; r.debruin@ucl.ac.uk	Lowndes, Noel F/B-9084-2008	Lowndes, Noel F/0000-0002-3216-4427	Medical Research Council [G0800297]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council, grant number G0800297, http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Ashe M, 2008, J BIOL CHEM, V283, P6040, DOI 10.1074/jbc.M708248200; Bean JM, 2005, GENETICS, V171, P49, DOI 10.1534/genetics.105.044560; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Caetano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017211; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Costanzo M, 2003, MOL CELL BIOL, V23, P5064, DOI 10.1128/MCB.23.14.5064-5077.2003; CROSS FR, 1994, MOL CELL BIOL, V14, P4779, DOI 10.1128/MCB.14.7.4779; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2008, MOL CELL BIOL, V28, P6919, DOI 10.1128/MCB.00211-08; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; de Oliveira FMB, 2012, EMBO J, V31, P1798, DOI 10.1038/emboj.2012.27; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Li JM, 2008, CELL CYCLE, V7, P3388, DOI 10.4161/cc.7.21.6932; MacKay VL, 2001, MOL CELL BIOL, V21, P4140, DOI 10.1128/MCB.21.13.4140-4148.2001; McInerny CJ, 1995, NUCLEIC ACIDS RES, V23, P4761; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Siegmund RF, 1996, MOL CELL BIOL, V16, P2647; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Smolka MB, 2012, CELL CYCLE, V11, P3166, DOI 10.4161/cc.21197; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; TRAVESA A, 2013, MOL CELLULAR BIOL; Wijnen H, 2002, MOL CELL BIOL, V22, P4402, DOI 10.1128/MCB.22.12.4402-4418.2002	27	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61059	10.1371/journal.pone.0061059	http://dx.doi.org/10.1371/journal.pone.0061059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593391	gold, Green Submitted, Green Published			2022-12-27	WOS:000319108100072
J	Jager, G; Nilsson, K; Bjork, GR				Jager, Gunilla; Nilsson, Kristina; Bjork, Glenn R.			The Phenotype of Many Independently Isolated+1 Frameshift Suppressor Mutants Supports a Pivotal Role of the P-Site in Reading Frame Maintenance	PLOS ONE			English	Article							TRANSFER-RNA ABUNDANCE; RIBOSOMAL-PROTEIN L9; COLI DNA-POLYMERASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; TRANSLATIONAL ACCURACY; MESSENGER-RNA; IN-VIVO; STRUCTURAL ALTERATIONS; NUCLEOSIDES PRESENT	The main features of translation are similar in all organisms on this planet and one important feature of it is the way the ribosome maintain the reading frame. We have earlier characterized several bacterial mutants defective in tRNA maturation and found that some of them correct a +1 frameshift mutation; i.e. such mutants possess an error in reading frame maintenance. Based on the analysis of the frameshifting phenotype of such mutants we proposed a pivotal role of the ribosomal grip of the peptidyl-tRNA to maintain the correct reading frame. To test the model in an unbiased way we first isolated many (467) independent mutants able to correct a +1 frameshift mutation and thereafter tested whether or not their frameshifting phenotypes were consistent with the model. These 467+1 frameshift suppressor mutants had alterations in 16 different loci of which 15 induced a defective tRNA by hypo- or hypermodifications or altering its primary sequence. All these alterations of tRNAs induce a frameshift error in the P-site to correct a +1 frameshift mutation consistent with the proposed model. Modifications next to and 39 of the anticodon (position 37), like 1-methylguanosine, are important for proper reading frame maintenance due to their interactions with components of the ribosomal P-site. Interestingly, two mutants had a defect in a locus (rpsI), which encodes ribosomal protein S9. The C-terminal of this protein contacts position 32-34 of the peptidyl-tRNA and is thus part of the P-site environment. The two rpsI mutants had a C-terminal truncated ribosomal protein S9 that destroys its interaction with the peptidyl-tRNA resulting in +1 shift in the reading frame. The isolation and characterization of the S9 mutants gave strong support of our model that the ribosomal grip of the peptidylt-RNA is pivotal for the reading frame maintenance.	[Jager, Gunilla; Nilsson, Kristina; Bjork, Glenn R.] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University	Bjork, GR (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	glenn.bjork@molbiol.umu.se	Björk, Glenn/AAE-8219-2022		Swedish Science Research Council [BU-2930]; Carl Trygger Foundation	Swedish Science Research Council; Carl Trygger Foundation	This work was supported by the Swedish Science Research Council (BU-2930), The Carl Trygger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RP, 1976, J MOL BIOL, V105, P201, DOI 10.1016/0022-2836(76)90107-8; ATKINS JF, 1979, CELL, V18, P1119, DOI 10.1016/0092-8674(79)90225-3; Atkins JF, 2001, COLD SPRING HARB SYM, V66, P217, DOI 10.1101/sqb.2001.66.217; ATKINS JF, 1991, ANNU REV GENET, V25, P201; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; BJORK GR, 2005, CELLULAR MOL BIOL; Carlson BA, 2001, VIROLOGY, V279, P130, DOI 10.1006/viro.2000.0692; Carlson BA, 1999, VIROLOGY, V255, P2, DOI 10.1006/viro.1998.9569; Chen P, 2005, EMBO J, V24, P1842, DOI 10.1038/sj.emboj.7600666; Chen P, 2002, J MOL BIOL, V317, P481, DOI 10.1006/jmbi.2002.5435; Dale T, 2005, TRENDS BIOCHEM SCI, V30, P659, DOI 10.1016/j.tibs.2005.10.006; DAVIS W, 1980, MANUAL GENETIC ENG A; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dumelin CE, 2012, NAT CHEM BIOL, V8, P913, DOI [10.1038/nchembio.1070, 10.1038/NCHEMBIO.1070]; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; EMILSSON V, 1990, EMBO J, V9, P4359, DOI 10.1002/j.1460-2075.1990.tb07885.x; Esberg B, 1999, J BACTERIOL, V181, P7256, DOI 10.1128/JB.181.23.7256-7265.1999; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; Farabaugh P. J., 1997, PROGRAMMED ALTERNATI; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Farabaugh PJ, 1999, EMBO J, V18, P1427, DOI 10.1093/emboj/18.6.1427; Gallant J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P385; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Gehrke CW, 1990, J CHROMATOGRAPHY LIB, pA3; Gurvich OL, 2005, J BACTERIOL, V187, P4023, DOI 10.1128/JB.187.12.4023-4032.2005; HAGERVALL TG, 1993, J MOL BIOL, V232, P756, DOI 10.1006/jmbi.1993.1429; HAGERVALL TG, 1987, J BIOL CHEM, V262, P8488; Hansen TM, 2003, EMBO REP, V4, P499, DOI 10.1038/sj.embor.embor825; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Herr AJ, 2001, J MOL BIOL, V309, P1029, DOI 10.1006/jmbi.2001.4717; HONG JS, 1971, P NATL ACAD SCI USA, V68, P3158, DOI 10.1073/pnas.68.12.3158; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; JAGER G, 2010, 23 TRNA WORKSH OR LI, P153; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kramer EB, 2010, RNA, V16, P1797, DOI 10.1261/rna.2201210; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Lauhon CT, 2002, J BACTERIOL, V184, P6820, DOI 10.1128/JB.184.24.6820-6829.2002; Lecointe F, 2002, J BIOL CHEM, V277, P30445, DOI 10.1074/jbc.M203456200; Leipuviene R, 2007, J BACTERIOL, V189, P7024, DOI 10.1128/JB.00710-07; Li JN, 1999, RNA, V5, P395, DOI 10.1017/S1355838299980834; Li JN, 1997, J MOL BIOL, V271, P209, DOI 10.1006/jmbi.1997.1176; LIAO PY, 2008, NUCL ACIDS IN PRESS; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Nasvall SJ, 2009, J MOL BIOL, V385, P350, DOI 10.1016/j.jmb.2008.10.069; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; Nilsson K, 2002, J BACTERIOL, V184, P6830, DOI 10.1128/JB.184.24.6830-6835.2002; O'Connor M, 1998, J MOL BIOL, V279, P727, DOI 10.1006/jmbi.1998.1832; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Qian Q, 1997, J MOL BIOL, V273, P978, DOI 10.1006/jmbi.1997.1363; Qian Q, 1998, MOL CELL, V1, P471, DOI 10.1016/S1097-2765(00)80048-9; Rappleye CA, 1997, J BACTERIOL, V179, P5827, DOI 10.1128/jb.179.18.5827-5834.1997; RIDDLE DL, 1972, J MOL BIOL, V66, P483, DOI 10.1016/0022-2836(72)90428-7; RIDDLE DL, 1970, J MOL BIOL, V54, P131, DOI 10.1016/0022-2836(70)90451-1; ROTH JR, 1981, CELL, V24, P601, DOI 10.1016/0092-8674(81)90086-6; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SPANJAARD RA, 1988, P NATL ACAD SCI USA, V85, P7967, DOI 10.1073/pnas.85.21.7967; Spirin A, 1986, RIBOSOME STRUCTURE P; SROGA GE, 1992, NUCLEIC ACIDS RES, V20, P3463, DOI 10.1093/nar/20.13.3463; Stahl G, 2004, EUKARYOT CELL, V3, P331, DOI 10.1128/EC.3.2.331-338.2004; Stahl G, 2002, TRENDS BIOCHEM SCI, V27, P178, DOI 10.1016/S0968-0004(02)02064-9; Sundararajan A, 1999, MOL CELL, V4, P1005, DOI 10.1016/S1097-2765(00)80229-4; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Waas WF, 2007, J BIOL CHEM, V282, P26026, DOI 10.1074/jbc.M703391200; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Weiss R B, 1990, Prog Nucleic Acid Res Mol Biol, V39, P159, DOI 10.1016/S0079-6603(08)60626-1; WEISS RB, 1987, COLD SPRING HARB SYM, V52, P687, DOI 10.1101/SQB.1987.052.01.078; Wenthzel AMK, 1998, FEBS LETT, V421, P237, DOI 10.1016/S0014-5793(97)01570-6; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; YOURNO J, 1970, NATURE, V225, P422, DOI 10.1038/225422a0; Zahn K, 1996, J BACTERIOL, V178, P2926, DOI 10.1128/jb.178.10.2926-2933.1996	89	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60246	10.1371/journal.pone.0060246	http://dx.doi.org/10.1371/journal.pone.0060246			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593181	Green Submitted, Green Published, gold			2022-12-27	WOS:000319108100026
J	Gosavi, S				Gosavi, Shachi			Understanding the Folding-Function Tradeoff in Proteins	PLOS ONE			English	Article							BETA-TREFOIL PROTEIN; ENERGY LANDSCAPE; IL-1 RECEPTOR; CRYSTAL-STRUCTURE; BINDING; KINETICS; GROWTH; HISACTOPHILIN; FRUSTRATION; SEQUENCE	When an amino-acid sequence cannot be optimized for both folding and function, folding can get compromised in favor of function. To understand this tradeoff better, we devise a novel method for extracting the "function-less" folding-motif of a protein fold from a set of structurally similar but functionally diverse proteins. We then obtain the beta-trefoil folding-motif, and study its folding using structure-based models and molecular dynamics simulations. Comparison with the folding of wild-type beta-trefoil proteins shows that function affects folding in two ways: In the slower folding interleukin-1 beta, binding sites make the fold more complex, increase contact order and slow folding. In the faster folding hisactophilin, residues which could have been part of the folding-motif are used for function. This reduces the density of native contacts in functional regions and increases folding rate. The folding-motif helps identify subtle structural deviations which perturb folding. These may then be used for functional annotation. Further, the folding-motif could potentially be used as a first step in the sequence design of function-less scaffold proteins. Desired function can then be engineered into these scaffolds.	Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Gosavi, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	shachi@ncbs.res.in			Government of India-DAE; Govt of India-DST-Ramanujan Fellowship [SR/S2/RJN-63/2009]	Government of India-DAE; Govt of India-DST-Ramanujan Fellowship	SG was supported by core funding from the Government of India-DAE and the Govt of India-DST-Ramanujan Fellowship (SR/S2/RJN-63/2009, 5 years, wef 29/06/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Banks DD, 2011, J MOL BIOL, V412, P536, DOI 10.1016/j.jmb.2011.07.061; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Capraro DT, 2012, P NATL ACAD SCI USA, V109, P1490, DOI 10.1073/pnas.1114430109; Capraro DT, 2008, P NATL ACAD SCI USA, V105, P14844, DOI 10.1073/pnas.0807812105; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; Chavez LL, 2004, J AM CHEM SOC, V126, P8426, DOI 10.1021/ja049510+; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P2315, DOI 10.1021/bi00223a005; Danielsson J, 2011, J BIOL CHEM, V286, P33070, DOI 10.1074/jbc.M111.251223; Dill KA, 1999, PROTEIN SCI, V8, P1166, DOI 10.1110/ps.8.6.1166; Estape D, 1999, J BIOL CHEM, V274, P34083, DOI 10.1074/jbc.274.48.34083; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Ferreiro DU, 2011, P NATL ACAD SCI USA, V108, P3499, DOI 10.1073/pnas.1018980108; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gosavi S, 2006, J MOL BIOL, V357, P986, DOI 10.1016/j.jmb.2005.11.074; Gosavi S, 2008, P NATL ACAD SCI USA, V105, P10384, DOI 10.1073/pnas.0801343105; Gruebele M, 2005, CR BIOL, V328, P701, DOI 10.1016/j.crvi.2005.02.007; Gruebele M, 2002, CURR OPIN STRUC BIOL, V12, P161, DOI 10.1016/S0959-440X(02)00304-4; HABAZETTL J, 1992, NATURE, V359, P855, DOI 10.1038/359855a0; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HANAKAM F, 1995, J BIOL CHEM, V270, P596, DOI 10.1074/jbc.270.2.596; Heidary DK, 1997, NAT STRUCT BIOL, V4, P725, DOI 10.1038/nsb0997-725; Hills RD, 2010, J MOL BIOL, V398, P332, DOI 10.1016/j.jmb.2010.03.001; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyeon C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1481; Itoh K, 2004, CHEM PHYS, V307, P121, DOI 10.1016/j.chemphys.2004.05.024; Jager M, 2006, P NATL ACAD SCI USA, V103, P10648, DOI 10.1073/pnas.0600511103; Karanicolas J, 2004, P NATL ACAD SCI USA, V101, P3432, DOI 10.1073/pnas.0304825101; Kloczkowski A., 2005, J BIOMOL STRUCT DYN, V22, P621; Koussounadis AI, 2004, CURR PHARM DESIGN, V10, P3857, DOI 10.2174/1381612043382585; Krishna MMG, 2003, J MOL BIOL, V331, P29, DOI 10.1016/S0022-2836(03)00697-1; Liu CS, 2002, PROTEIN SCI, V11, P669, DOI 10.1110/ps.31702; MAKHATADZE GI, 1994, BIOCHEMISTRY-US, V33, P9327, DOI 10.1021/bi00197a037; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Onuchic JN, 2000, ADV PROTEIN CHEM, V53, P87; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Samuel D, 2001, J BIOL CHEM, V276, P4134, DOI 10.1074/jbc.M005921200; SCHREIBER C, 1994, STRUCTURE, V2, P945, DOI 10.1016/S0969-2126(94)00096-4; Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0; Schug A, 2007, P NATL ACAD SCI USA, V104, P17674, DOI 10.1073/pnas.0706077104; Shental-Bechor D, 2012, P NATL ACAD SCI US; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Smith MTJ, 2010, P NATL ACAD SCI USA, V107, P20952, DOI 10.1073/pnas.1008026107; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Tang J, 2009, J MOL BIOL, V389, P90, DOI 10.1016/j.jmb.2009.03.074; Thomas C, 2012, NAT STRUCT MOL BIOL, V19, P455, DOI 10.1038/nsmb.2260; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; VARLEY P, 1993, SCIENCE, V260, P1110, DOI 10.1126/science.8493553; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Wang J, 2006, PLOS COMPUT BIOL, V2, P842, DOI 10.1371/journal.pcbi.0020078; Whitford PC, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/076601	59	21	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61222	10.1371/journal.pone.0061222	http://dx.doi.org/10.1371/journal.pone.0061222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593437	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300063
J	Shin, W; Lee, J; Son, SY; Ahn, K; Kim, HS; Han, K				Shin, Wonseok; Lee, Jungnam; Son, Seung-Yeol; Ahn, Kung; Kim, Heui-Soo; Han, Kyudong			Human-Specific HERV-K Insertion Causes Genomic Variations in the Human Genome	PLOS ONE			English	Article							HUMAN ENDOGENOUS RETROVIRUS; LONG TERMINAL REPEATS; EXPRESSION; IDENTIFICATION; SEQUENCES; TRANSCRIPTS; PARTICLES; ELEMENTS; GENES	Human endogenous retroviruses (HERV) sequences account for about 8% of the human genome. Through comparative genomics and literature mining, we identified a total of 29 human-specific HERV-K insertions. We characterized them focusing on their structure and flanking sequence. The results showed that four of the human-specific HERV-K insertions deleted human genomic sequences via non-classical insertion mechanisms. Interestingly, two of the human-specific HERV-K insertion loci contained two HERV-K internals and three LTR elements, a pattern which could be explained by LTR-LTR ectopic recombination or template switching. In addition, we conducted a polymorphic test and observed that twelve out of the 29 elements are polymorphic in the human population. In conclusion, human-specific HERV-K elements have inserted into human genome since the divergence of human and chimpanzee, causing human genomic changes. Thus, we believe that human-specific HERV-K activity has contributed to the genomic divergence between humans and chimpanzees, as well as within the human population.	[Shin, Wonseok; Lee, Jungnam; Han, Kyudong] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Shin, Wonseok; Lee, Jungnam; Han, Kyudong] Dankook Univ, WCU Res Ctr, Cheonan, South Korea; [Son, Seung-Yeol] Dankook Univ, Coll Adv Sci, Dept Microbiol, Cheonan, South Korea; [Ahn, Kung; Kim, Heui-Soo] Pusan Natl Univ, Coll Nat Sci, Dept Biol Sci, Pusan, South Korea	Dankook University; Dankook University; Dankook University; Pusan National University	Han, K (corresponding author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.	jim97@dankook.ac.kr	Han, Kyudong/AAF-1788-2019; Kim, Heui-Soo/ABF-3773-2021	Han, Kyudong/0000-0001-6791-2408; Kim, Heui-Soo/0000-0002-5226-6594; Shin, Wonseok/0000-0001-5964-1425	World Class University through the National Research Foundation of Korea (NRF) [R31-10069]; Basic Science Research program, through the National Research Foundation of Korea (NRF) [2011-0009080]; Ministry of Education, Science, and Technology	World Class University through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Basic Science Research program, through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the World Class University (R31-10069) and by the Basic Science Research (2011-0009080) program, through the National Research Foundation of Korea (NRF, http://www.nrf.re.kr/nrf_eng_cms/), funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Balada E, 2009, REV MED VIROL, V19, P273, DOI 10.1002/rmv.622; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Boller K, 2008, J GEN VIROL, V89, P567, DOI 10.1099/vir.0.83534-0; Brady T, 2009, GENE DEV, V23, P633, DOI 10.1101/gad.1762309; Buzdin A, 2003, GENOMICS, V81, P149, DOI 10.1016/S0888-7543(02)00027-7; Carter Anthony B., 2004, Human Genomics, V1, P167; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Clerici M, 1999, J NEUROIMMUNOL, V99, P173, DOI 10.1016/S0165-5728(99)00123-X; Costas J, 2001, J MOL EVOL, V53, P237, DOI 10.1007/s002390010213; Depil S, 2002, LEUKEMIA, V16, P254, DOI 10.1038/sj.leu.2402355; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Dunn CA, 2005, GENE, V364, P2, DOI 10.1016/j.gene.2005.05.045; Griffiths DJ, 2001, GENOME BIOL, V2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hishikawa T, 1997, VIRAL IMMUNOL, V10, P137, DOI 10.1089/vim.1997.10.137; Hughes JF, 2002, GENOMICS, V80, P453, DOI 10.1006/geno.2002.6856; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Hughes JR, 2005, GENETICS, V171, P1183, DOI 10.1534/genetics.105.043976; Jha AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020234; Khodosevich K, 2002, COMP FUNCT GENOM, V3, P494, DOI 10.1002/cfg.216; Kim TH, 2004, MOL CELLS, V18, P87; Kurdyukov SG, 2001, GENE, V273, P51, DOI 10.1016/S0378-1119(01)00570-4; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2007, GENE, V390, P18, DOI 10.1016/j.gene.2006.08.029; Macfarlane C, 2004, J MOL EVOL, V59, P642, DOI 10.1007/s00239-004-2656-1; Mayer J, 2005, J MOL EVOL, V61, P706, DOI 10.1007/s00239-005-0066-7; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; ONO M, 1987, J VIROL, V61, P2059, DOI 10.1128/JVI.61.6.2059-2062.1987; Otieno AC, 2004, J MOL BIOL, V342, P109, DOI 10.1016/j.jmb.2004.07.016; Ruprecht K, 2008, J VIROL, V82, P10008, DOI 10.1128/JVI.01016-08; Seifarth W, 1998, J VIROL, V72, P8384, DOI 10.1128/JVI.72.10.8384-8391.1998; Simpson GR, 1996, VIROLOGY, V222, P451, DOI 10.1006/viro.1996.0443; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; Srikanta D, 2009, GENOMICS, V93, P205, DOI 10.1016/j.ygeno.2008.09.016; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Sugimoto J, 2001, GENOMICS, V72, P137, DOI 10.1006/geno.2001.6473; Sverdlov ED, 2000, BIOESSAYS, V22, P161, DOI 10.1002/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tonjes RR, 1999, J VIROL, V73, P9187; Towler EM, 1998, BIOCHEMISTRY-US, V37, P17137, DOI 10.1021/bi9818927; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Wang-Johanning F, 2001, CLIN CANCER RES, V7, P1553	45	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60605	10.1371/journal.pone.0060605	http://dx.doi.org/10.1371/journal.pone.0060605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593260	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300023
J	Stuelten, CH; Cervoni-Curet, FN; Busch, JI; Sutton, E; Webster, JD; Kavalukas, SL; Wakefield, LM; Barbul, A; Niederhuber, JE				Stuelten, Christina H.; Cervoni-Curet, Frances N.; Busch, Johanna I.; Sutton, Emily; Webster, Joshua D.; Kavalukas, Sandra L.; Wakefield, Lalage M.; Barbul, Adrian; Niederhuber, John E.			SDF-1 alpha Mediates Wound-Promoted Tumor Growth in a Syngeneic Orthotopic Mouse Model of Breast Cancer	PLOS ONE			English	Article							RECEPTOR CXCR4; ANTAGONIST; MICROENVIRONMENT; MOBILIZATION; AMD3100; REPAIR; CELLS	Increased growth of residual tumors in the proximity of acute surgical wounds has been reported; however, the mechanisms of wound-promoted tumor growth remain unknown. Here, we used a syngeneic, orthotopic mouse model of breast cancer to study mechanisms of wound-promoted tumor growth. Our results demonstrate that exposure of metastatic mouse breast cancer cells (4T1) to SDF-1 alpha, which is increased in wound fluid, results in increased tumor growth. Both, wounding and exposure of 4T1 cells to SDF-1 alpha not only increased tumor growth, but also tumor cell proliferation rate and stromal collagen deposition. Conversely, systemic inhibition of SDF-1 alpha signaling with the small molecule AMD 3100 abolished the effect of wounding, and decreased cell proliferation, collagen deposition, and neoangiogenesis to the levels observed in control animals. Furthermore, using different mouse strains we could demonstrate that the effect of wounding on tumor growth and SDF-1 alpha levels is host dependent and varies between mouse strains. Our results show that wound-promoted tumor growth is mediated by elevated SDF-1 alpha levels and indicate that the effect of acute wounds on tumor growth depends on the predetermined wound response of the host background and its predetermined wound response.	[Stuelten, Christina H.; Cervoni-Curet, Frances N.; Busch, Johanna I.; Sutton, Emily; Niederhuber, John E.] NCI, Cell & Canc Biol Branch, Bethesda, MD 20892 USA; [Stuelten, Christina H.] NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA; [Webster, Joshua D.; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Kavalukas, Sandra L.; Barbul, Adrian] Sinai Hosp, Dept Surg, Baltimore, MD 21215 USA; [Barbul, Adrian] Johns Hopkins Med Sch, Dept Surg, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sinai Hospital of Baltimore; Johns Hopkins University; Johns Hopkins Medicine	Stuelten, CH (corresponding author), NCI, Cell & Canc Biol Branch, Bethesda, MD 20892 USA.	chrisstu@mail.nih.gov	Kavalukas, Sandra/AAN-9117-2020; Wakefield, Lalage M/M-1963-2017	Kavalukas, Sandra/0000-0001-6642-7267; Wakefield, Lalage M/0000-0003-4124-5250; Stuelten, Christina/0000-0002-2850-5399	Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC010953] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (http://www.cancer.gov/researchandfunding/intramural). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; BAKER DG, 1989, SURGERY, V106, P525; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; DOLBERG DS, 1985, SCIENCE, V230, P676, DOI 10.1126/science.2996144; Hofer SOP, 1999, EUR J SURG ONCOL, V25, P231, DOI 10.1053/ejso.1998.0634; Juarez J, 2004, HISTOL HISTOPATHOL, V19, P299, DOI 10.14670/HH-19.299; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Kucia M, 2004, J MOL HISTOL, V35, P233; Kurian AW, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2780; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 2001, ANN NY ACAD SCI, V947, P112; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pazdur R, 2010, FDA APPROVAL PLERIXA; Proia DA, 2005, CELL CYCLE, V4, P1022, DOI 10.4161/cc.4.8.1903; Stuelten CH, 2008, CANCER RES, V68, P7278, DOI 10.1158/0008-5472.CAN-08-1842; Takemoto Y, 2011, SURGERY, V149, P792, DOI 10.1016/j.surg.2011.02.005; Tepper OM, 2010, DIABETES, V59, P1974, DOI 10.2337/db09-0185; Toupadakis CA, 2012, J ORTHOP RES, V30, P1853, DOI 10.1002/jor.22145; Yates CC, 2011, CELL MOL LIFE SCI, V68, P1871, DOI 10.1007/s00018-011-0663-0	22	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60919	10.1371/journal.pone.0060919	http://dx.doi.org/10.1371/journal.pone.0060919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593347	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200028
J	Hall, L; Strandberg, T; Parnamets, P; Lind, A; Tarning, B; Johansson, P				Hall, Lars; Strandberg, Thomas; Parnamets, Philip; Lind, Andreas; Tarning, Betty; Johansson, Petter			How the Polls Can Be Both Spot On and Dead Wrong: Using Choice Blindness to Shift Political Attitudes and Voter Intentions	PLOS ONE			English	Article							POLARIZATION; COMPETITION; BEHAVIOR	Political candidates often believe they must focus their campaign efforts on a small number of swing voters open for ideological change. Based on the wisdom of opinion polls, this might seem like a good idea. But do most voters really hold their political attitudes so firmly that they are unreceptive to persuasion? We tested this premise during the most recent general election in Sweden, in which a left- and a right-wing coalition were locked in a close race. We asked our participants to state their voter intention, and presented them with a political survey of wedge issues between the two coalitions. Using a sleight-of-hand we then altered their replies to place them in the opposite political camp, and invited them to reason about their attitudes on the manipulated issues. Finally, we summarized their survey score, and asked for their voter intention again. The results showed that no more than 22% of the manipulated replies were detected, and that a full 92% of the participants accepted and endorsed our altered political survey score. Furthermore, the final voter intention question indicated that as many as 48% (+/- 9.2%) were willing to consider a left-right coalition shift. This can be contrasted with the established polls tracking the Swedish election, which registered maximally 10% voters open for a swing. Our results indicate that political attitudes and partisan divisions can be far more flexible than what is assumed by the polls, and that people can reason about the factual issues of the campaign with considerable openness to change.	[Hall, Lars; Strandberg, Thomas; Parnamets, Philip; Lind, Andreas; Tarning, Betty; Johansson, Petter] Lund Univ, Lund Univ Cognit Sci, Lund, Sweden; [Johansson, Petter] Uppsala Univ, Swedish Coll Adv Study, Uppsala, Sweden	Lund University; Swedish Collegium for Advanced Study (SCAS); Uppsala University	Johansson, P (corresponding author), Lund Univ, Lund Univ Cognit Sci, Lund, Sweden.	petter.johansson@lucs.lu.se	Lind, Andreas/HDN-3220-2022; Pärnamets, Philip/AAM-7681-2020	Pärnamets, Philip/0000-0001-8360-9097; Lind, Andreas/0000-0001-9568-2865	Swedish Research Council; Crafoord Foundation; Bank of Sweden Tercentenary Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Bank of Sweden Tercentenary Foundation	The Swedish Research Council, The Crafoord Foundation, and The Bank of Sweden Tercentenary Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz AI, 2008, J POLIT, V70, P542, DOI 10.1017/S0022381608080493; Ariely D, 2008, TRENDS COGN SCI, V12, P13, DOI 10.1016/j.tics.2007.10.008; Ashkenas J., 2012, NY TIMES; Bafumi J, 2009, J POLIT, V71, P1, DOI 10.1017/S0022381608090014; Carpini MXD., 1997, WHAT AM KNOW POLITIC; Carter TJ, 2011, PSYCHOL SCI, P23; Clarke HD, 2009, ELECT STUD, V28, P632, DOI 10.1016/j.electstud.2009.05.019; Cwalina W, 2010, EUR J MARKETING, V44, P351, DOI 10.1108/03090561011020462; Dalton RJ, 2009, PERSPECT POLIT, V7, P628, DOI 10.1017/S1537592709990600; Dodson K, 2010, SOCIOL PERSPECT, V53, P443, DOI 10.1525/sop.2010.53.3.443; Druckman JN, 2004, AM POLIT SCI REV, V98, P671, DOI 10.1017/S0003055404041413; Easley J, 2012, HILL; Elinder M, 2009, WORKING PAPER SERIES, P12; Enyedi Z, 2010, WEST EUR POLIT, V33, P415, DOI 10.1080/01402381003654254; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hall L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045457; Holmberg S, 2004, VALJARE SVENSKT VALJ; HoltzBacha C, 2012, OPINION POLLS AND THE MEDIA: REFLECTING AND SHAPING PUBLIC OPINION, P1, DOI 10.1057/9780230374959; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; Jordan J, 2012, NATL REV ONLINE; Kitschelt H, 2010, WEST EUR POLIT, V33, P659, DOI 10.1080/01402381003654692; Krosnick JA, 1992, QUESTIONS QUESTIONS; Kuklinski J. H., 2000, ELEMENTS REASON UNDE; Lee L, 2009, J CONSUM RES, V36, P173, DOI 10.1086/597160; Lewis-Beck MicahelS., 2008, AM VOTER REVISITED; Mayer WG, 2012, FORUM-J APPL RES CON, V10, DOI 10.1515/1540-8884.1520; McLaughlin D, 2012, RED STATE; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; Oscarsson H, 2007, SCAND POLIT STUD, V30, P301, DOI 10.1111/j.1467-9477.2007.00182.x; Petrocik JR, 2009, ELECT STUD, V28, P562, DOI 10.1016/j.electstud.2009.05.022; Sulkin T, 2008, J POLIT, V70, P232, DOI 10.1017/S0022381607080164; Sulkin T, 2009, J POLIT, V71, P1093, DOI 10.1017/S0022381609090902; Wilson T, 1989, ADV EXPT SOCIAL PSYC, V19, P123	34	62	62	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60554	10.1371/journal.pone.0060554	http://dx.doi.org/10.1371/journal.pone.0060554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123IQ	23593244	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000020
J	Schuch, R; Pelzek, AJ; Raz, A; Euler, CW; Ryan, PA; Winer, BY; Farnsworth, A; Bhaskaran, SS; Stebbins, CE; Xu, Y; Clifford, A; Bearss, DJ; Vankayalapati, H; Goldberg, AR; Fischetti, VA				Schuch, Raymond; Pelzek, Adam J.; Raz, Assaf; Euler, Chad W.; Ryan, Patricia A.; Winer, Benjamin Y.; Farnsworth, Andrew; Bhaskaran, Shyam S.; Stebbins, C. Erec; Xu, Yong; Clifford, Adrienne; Bearss, David J.; Vankayalapati, Hariprasad; Goldberg, Allan R.; Fischetti, Vincent A.			Use of a Bacteriophage Lysin to Identify a Novel Target for Antimicrobial Development	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; TEICHOIC-ACIDS; ANTIBIOTIC-RESISTANCE; STRUCTURAL BASIS; WALL; IDENTIFICATION; PHAGE; CARBOHYDRATE; MUTATIONS; SEQUENCE	We identified an essential cell wall biosynthetic enzyme in Bacillus anthracis and an inhibitor thereof to which the organism did not spontaneously evolve measurable resistance. This work is based on the exquisite binding specificity of bacteriophage-encoded cell wall-hydrolytic lysins, which have evolved to recognize critical receptors within the bacterial cell wall. Focusing on the B. anthracis-specific PlyG lysin, we first identified its unique cell wall receptor and cognate biosynthetic pathway. Within this pathway, one biosynthetic enzyme, 2-epimerase, was required for both PlyG receptor expression and bacterial growth. The 2-epimerase was used to design a small-molecule inhibitor, epimerox. Epimerox prevented growth of several Gram-positive pathogens and rescued mice challenged with lethal doses of B. anthracis. Importantly, resistance to epimerox was not detected (<10(-11) frequency) in B. anthracis and S. aureus. These results describe the use of phage lysins to identify promising lead molecules with reduced resistance potential for antimicrobial development.	[Schuch, Raymond; Pelzek, Adam J.; Raz, Assaf; Euler, Chad W.; Ryan, Patricia A.; Winer, Benjamin Y.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Ryan, Patricia A.] CUNY Hunter Coll, Sch Hlth Sci, New York, NY 10021 USA; [Farnsworth, Andrew] Cornell Lab Ornithol, Informat Sci Program, Ithaca, NY USA; [Bhaskaran, Shyam S.; Stebbins, C. Erec] Rockefeller Univ, Lab Struct Microbiol, New York, NY 10021 USA; [Xu, Yong; Clifford, Adrienne; Bearss, David J.; Vankayalapati, Hariprasad; Goldberg, Allan R.] Astex Pharmaceut Inc, Dublin, CA USA	Rockefeller University; City University of New York (CUNY) System; Hunter College (CUNY); Cornell University; Rockefeller University	Schuch, R (corresponding author), ContraFect Corp, Yonkers, NY USA.	rschuch@contrafect.com	Vankayalapati, Hariprasad/ABB-5375-2020; Stebbins, Erec/N-2565-2018; Bearss, David/Q-9141-2019	Vankayalapati, Hariprasad/0000-0002-5477-2124; Stebbins, Erec/0000-0001-6229-5308; Winer, Benjamin/0000-0001-7895-2544; Farnsworth, Andrew/0000-0002-9854-4449; Bearss, David/0000-0002-4280-5670; Bearss, David/0000-0002-4458-826X	National Institute of Allergy and Infectious Disease [1U19AI056510, 2U54AI057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057472, U19AI056510, U54AI057153] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants 1U19AI056510 and 2U54AI057153 to Dr. Vincent A. Fischetti from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KBR, 2011, EXP HEMATOL, V39, P14, DOI 10.1016/j.exphem.2010.09.013; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bearss DJ, 2008, United States Patent, Patent No. 7750007; BELLAND RJ, 1994, MOL MICROBIOL, V14, P371, DOI 10.1111/j.1365-2958.1994.tb01297.x; Bode E, 2004, J CLIN MICROBIOL, V42, P5825, DOI 10.1128/JCM.42.12.5825-5831.2004; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Brotz-Oesterhelt H, 2010, FUTURE MICROBIOL, V5, P1553, DOI 10.2217/FMB.10.119; Cheng Q, 2005, ANTIMICROB AGENTS CH, V49, P111, DOI 10.1128/AAC.49.1.111-117.2005; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; Day WA, 2007, J BACTERIOL, V189, P3296, DOI 10.1128/JB.01860-06; Dubail I, 2006, J BACTERIOL, V188, P6580, DOI 10.1128/JB.00771-06; EKWUNIFE FS, 1991, FEMS MICROBIOL LETT, V82, P257; Fenton Mark, 2010, Bioeng Bugs, V1, P9, DOI 10.4161/bbug.1.1.9818; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fischetti VA, 2006, NAT BIOTECHNOL, V24, P1508, DOI 10.1038/nbt1206-1508; Fisher N, 2005, J BACTERIOL, V187, P8055, DOI 10.1128/JB.187.23.8055-8062.2005; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Jorgensen WL, 2009, ACCOUNTS CHEM RES, V42, P724, DOI 10.1021/ar800236t; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Leoff C, 2008, J BACTERIOL, V190, P112, DOI 10.1128/JB.01292-07; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; Ryan PA, 2007, PLOS COMPUT BIOL, V3, P1177, DOI 10.1371/journal.pcbi.0030132; Sabharwal H, 2006, J INFECT DIS, V193, P129, DOI 10.1086/498618; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Schuch R, 2006, J BACTERIOL, V188, P3037, DOI 10.1128/JB.188.8.3037-3051.2006; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Soldo B, 2002, J BACTERIOL, V184, P4316, DOI 10.1128/JB.184.15.4316-4320.2002; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Velloso LM, 2008, EMBO REP, V9, P199, DOI 10.1038/sj.embor.7401154; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Woodford N, 2007, CLIN MICROBIOL INFEC, V13, P5, DOI 10.1111/j.1469-0691.2006.01492.x; Yoong P, 2004, J BACTERIOL, V186, P4808, DOI 10.1128/JB.186.14.4808-4812.2004	39	42	47	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60754	10.1371/journal.pone.0060754	http://dx.doi.org/10.1371/journal.pone.0060754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593301	Green Published, gold, Green Submitted			2022-12-27	WOS:000317382000023
J	Gupta, SK; Mi, DM; Dube, MP; Saha, CK; Johnson, RM; Stein, JH; Clauss, MA; Mather, KJ; Desta, Z; Liu, ZY				Gupta, Samir K.; Mi, Deming; Dube, Michael P.; Saha, Chandan K.; Johnson, Raymond M.; Stein, James H.; Clauss, Matthias A.; Mather, Kieren J.; Desta, Zeruesenay; Liu, Ziyue			Pentoxifylline, Inflammation, and Endothelial Function in HIV-Infected Persons: A Randomized, Placebo-Controlled Trial	PLOS ONE			English	Article							FLOW-MEDIATED VASODILATION; BRACHIAL-ARTERY; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; DISEASE; DYSFUNCTION; RISK; INTERRUPTION; ASSOCIATION	Background: Untreated HIV may increase the risk of cardiovascular events. Our preliminary in vitro and in vivo research suggests that pentoxifylline (PTX) reduces vascular inflammation and improves endothelial function in HIV-infected persons not requiring antiretroviral therapy. Methods: We performed a randomized, placebo-controlled trial of PTX 400 mg orally thrice daily for 8 weeks in 26 participants. The primary endpoint was change in flow-mediated dilation (FMD) of the brachial artery after 8 weeks. Nitroglycerin-mediated dilation (NTGMD) and circulating markers of inflammation, cellular immune activation, coagulation, and metabolism were also assessed. Results: The difference in mean absolute change (SD) in FMD after 8 weeks between the placebo [21.06 (1.45)%] and PTX [21.93 (3.03)%] groups was not significant (P = 0.44). No differences in NTGMD were observed. The only significant between-group difference in the changes in biomarkers from baseline to week 8 was in soluble tumor necrosis factor receptor-1 (sTNFRI) [283.2 pg/mL in the placebo group vs. +65.9 pg/mL in the PTX group; P = 0.03]. PTX was generally well-tolerated. Conclusions: PTX did not improve endothelial function and unexpectedly increased the inflammatory biomarker sTNFRI in HIV-infected participants not requiring antiretroviral therapy. Additional interventional research is needed to reduce inflammation and cardiovascular risk in this population.	[Gupta, Samir K.; Johnson, Raymond M.] Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN USA; [Mi, Deming; Saha, Chandan K.; Liu, Ziyue] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN USA; [Dube, Michael P.] Univ So Calif, Keck Sch Med, Div Infect Dis, Dept Med, Los Angeles, CA 90033 USA; [Stein, James H.] Univ Wisconsin, Sch Med & Publ Hlth, Div Cardiovasc Med, Madison, WI USA; [Clauss, Matthias A.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Ctr Vasc Biol, Indianapolis, IN USA; [Mather, Kieren J.] Indiana Univ Sch Med, Div Endocrinol & Metab, Dept Med, Indianapolis, IN USA; [Desta, Zeruesenay] Indiana Univ Sch Med, Div Clin Pharmacol, Dept Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Southern California; University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Gupta, SK (corresponding author), Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN USA.	sgupta1@iupui.edu	Dubé, Marie-Pierre/B-9364-2008; Mather, Kieren/ABE-4117-2020	Dubé, Marie-Pierre/0000-0001-8442-4393; Clauss, Matthias/0000-0001-5180-3899; Stein, James/0000-0002-2770-8223	National Heart, Lung & Blood Institute at the National Institutes of Health [R01HL095149, R01HL09526]; Indiana Clinical and Translational Sciences Institute; National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TR000006]; National Center for Research Resources at the National Institutes of Health [RR020128]; Gilead Sciences, Inc.; Merck Co.; Janssen (Tibotec) Therapeutics; Bristol-Myers Squibb; ViiV Healthcare/GlaxoSmithKline; Serono; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060455] Funding Source: NIH RePORTER	National Heart, Lung & Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Indiana Clinical and Translational Sciences Institute; National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Gilead Sciences, Inc.(Gilead Sciences); Merck Co.(Merck & Company); Janssen (Tibotec) Therapeutics(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb); ViiV Healthcare/GlaxoSmithKline; Serono; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung & Blood Institute at the National Institutes of Health [R01HL095149, R01HL09526]. Additional support was provided by the Indiana Clinical and Translational Sciences Institute funded in part from the National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [Grant Number TR000006] and from the National Center for Research Resources [RR020128] at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SKG reports having received unrestricted research grant support from Gilead Sciences, Inc., Merck & Co., and Janssen (Tibotec) Therapeutics and receives consultant fees from Bristol-Myers Squibb. MPD reports having received research grant support from ViiV Healthcare/GlaxoSmithKline and grant support from Serono. CKS reports having received statistical consulting fees from Merck & Co. and serves on a Data and Safety Monitoring Committee for Merck & Co. JHS serves on the Data and Safety Monitoring Committees for Abbott, Lilly, and Takeda. KJM reports having received research support for unrelated projects from Merck & Co. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Berger VW, 1999, CONTROL CLIN TRIALS, V20, P319, DOI 10.1016/S0197-2456(99)00014-8; Bilsborough W, 2002, CLIN SCI, V103, P163; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Clerici M, 1997, J INFECT DIS, V175, P1210, DOI 10.1086/593570; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; DEZUBE BJ, 1995, J INFECT DIS, V171, P1628, DOI 10.1093/infdis/171.6.1628; DEZUBE BJ, 1993, J ACQ IMMUN DEF SYND, V6, P787; Dezube BJ, 1995, J CARDIOVASC PHARM, V25, pS139, DOI 10.1097/00005344-199500252-00029; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; FAZELY F, 1991, BLOOD, V77, P1653; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Green LA, 2012, AIDS RES HU IN PRESS; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Gupta SK, 2010, AIDS, V24, P1377, DOI 10.1097/QAD.0b013e3283396024; Gupta SK, 2012, PLOS ONE IN PRESS; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Kang SM, 2002, ECHOCARDIOGR-J CARD, V19, P661, DOI 10.1046/j.1540-8175.2002.00661.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lachin JM, 1999, CONTROL CLIN TRIALS, V20, P408, DOI 10.1016/S0197-2456(99)00022-7; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Suessenbacher A, 2006, VASC MED, V11, P239, DOI 10.1177/1358863x06075006; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190	26	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60852	10.1371/journal.pone.0060852	http://dx.doi.org/10.1371/journal.pone.0060852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593327	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600060
J	Ouldzeidoune, N; Keating, J; Bertrand, J; Rice, J				Ouldzeidoune, Nacerdine; Keating, Joseph; Bertrand, Jane; Rice, Janet			A Description of Female Genital Mutilation and Force-Feeding Practices in Mauritania: Implications for the Protection of Child Rights and Health	PLOS ONE			English	Article							CIRCUMCISION; CONSEQUENCES; SUDAN	Objectives: To establish the prevalence of female genital mutilation (FGM) and force feeding (gavage) practices among children in Mauritania; to investigate factors related to FGM and gavage practices and attitude in Mauritania; and to explore implications related to the protection of children's rights and welfare. Methods: Data from the Mauritania 2000-2001 DHS were used in this analysis. Data were collected from men and women about their attitude toward the continuation of FGM and gavage; women only were asked if they ever experienced one of these practices. Chi-square statistics were used to investigate differences in attitude and practice of FGM and gavage by demographic characteristics. Binary logistic regression was used to identify socio-demographic factors related to FGM and gavage outcomes. Findings: The overall prevalence of FGM was 77% but varied depending on ethnicity. The majority of both female and male respondents favored the continuation of the practice (64% and 70%, respectively). Almost a quarter (23%) of women reported being force fed as a child and 32% of women and 29% of men approved the continuation of the practice. Gavage is almost exclusively practiced among Arabs. Conclusion: The practice of both FGM and gavage is ongoing, although the prevalence and attitude towards both appears to vary as a function of ethnicity, wealth, education, marital status, and age. Contextually relevant intervention and enforcement strategies are needed to challenge these cultural norms and protect the rights and welfare of children in Mauritania.	[Ouldzeidoune, Nacerdine] Tulane Univ, Payson Ctr Int Dev, New Orleans, LA 70118 USA; [Keating, Joseph; Bertrand, Jane] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA; [Rice, Janet] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinfomat, New Orleans, LA USA	Tulane University; Tulane University; Tulane University	Keating, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA.	jkeating@tulane.edu						Abeille B, 1979, STUDY FEMALE LIFE MA; Adam T, 2010, B WORLD HEALTH ORGAN, V88, P281, DOI 10.2471/BLT.09.064808; Allam MF, 2001, PUBLIC HEALTH, V115, P350, DOI 10.1016/S0033-3506(01)00474-7; Almroth L, 2005, LANCET, V366, P385, DOI 10.1016/S0140-6736(05)67023-7; [Anonymous], ENQ DEM SANT MAUR 20; [Anonymous], 2011, COUNTR REP HUM RIGHT; [Anonymous], 2007, MUT GEN FEM MAUR; Centre WM, 2012, FEM GEN MUT FACT SHE; Dalal Koustuv, 2010, J Inj Violence Res, V2, P41, DOI 10.5249/jivr.v2i1.33; Duval SA, 2009, GUARDIAN; Duvall S, 2012, TOP 10 COUNTRIES CEL; Freymeyer RH, 2007, POPUL RES POLICY REV, V26, P69, DOI 10.1007/s11113-006-9016-3; Hausmann R, 2011, GLOBAL GENDER GAP IN; Herieka E, 2003, SEX TRANSM INFECT, V79, P220, DOI 10.1136/sti.79.3.220; Kaplan A, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-26; Karmaker B, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-20; Klugman J., 2011, HUMAN DEV REPORT 201; Lafraniere Sharon, 2007, NY TIMES; Leonard L, 1996, SOC SCI MED, V43, P255, DOI 10.1016/0277-9536(95)00376-2; Muennig P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-128; Netherlands Institute of Human Rights: Utrecht School of Law, 2009, 2 PER REP MAUR; Obermeyer CM, 2005, CULT HEALTH SEX, V7, P443, DOI 10.1080/14789940500181495; Rutstein S. O., 2004, DHS WEALTH INDEX; Shaaban LM, 2005, LANCET, V366, P347, DOI 10.1016/S0140-6736(05)67003-1; Shell-Duncan B, 2011, SOC SCI MED, V73, P1275, DOI 10.1016/j.socscimed.2011.07.022; Sipsma HL, 2012, B WORLD HEALTH ORGAN, V90, P120, DOI 10.2471/BLT.11.090886; Tag-Eldin MA, 2008, B WORLD HEALTH ORGAN, V86, P269, DOI 10.2471/BLT.07.042093; Terry LL, 2010, FOOD FEEDING FEMALE; UNICEF, 2010, DYN SOC CHANG AB FEM; United Nations, 1948, UN DECL HUM RIGHTS; United Nations Children Fund (UNICEF), 2007, MAUR MULT IND CLUST; United Nations Children's Fund (UNICEF), 2005, FEM GEN MUT CUTT STA; United Nations: Human Rights Council, 2011, REP WORK GROUP UN PE; United Nations Statistics Division, 2010, UNDATA MAUR; Walentowitz S, 2011, FATNESS MATERNAL BOD; World Health Organization, 2014, 311 WHO; Yahya AWM, 2010, CNN; Yirga WS, 2012, INT J WOMENS HEALTH, V4, P45, DOI 10.2147/IJWH.S28805; Yoder P, 2004, FEMALE GENITAL CUTTI; Zara Spencer, 2002, MURDOCH U ELECT J LA	40	15	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60594	10.1371/journal.pone.0060594	http://dx.doi.org/10.1371/journal.pone.0060594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JB	23593257	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600029
J	Roselli, S; Nadalig, T; Vuilleumier, S; Bringel, F				Roselli, Sandro; Nadalig, Thierry; Vuilleumier, Stephane; Bringel, Francoise			The 380 kb pCMU01 Plasmid Encodes Chloromethane Utilization Genes and Redundant Genes for Vitamin B-12- and Tetrahydrofolate-Dependent Chloromethane Metabolism in Methylobacterium extorquens CM4: A Proteomic and Bioinformatics Study	PLOS ONE			English	Article							SERINE CYCLE GENES; ESCHERICHIA-COLI; LOWER LIGAND; METHIONINE SYNTHASE; CRYSTAL-STRUCTURE; GENOME SEQUENCES; C1 COMPOUNDS; STRAIN; IDENTIFICATION; PATHWAY	Chloromethane (CH3Cl) is the most abundant volatile halocarbon in the atmosphere and contributes to the destruction of stratospheric ozone. The only known pathway for bacterial chloromethane utilization (cmu) was characterized in Methylobacterium extorquens CM4, a methylotrophic bacterium able to utilize compounds without carbon-carbon bonds such as methanol and chloromethane as the sole carbon source for growth. Previous work demonstrated that tetrahydrofolate and vitamin B-12 are essential cofactors of cmuA- and cmuB-encoded methyltransferases of chloromethane dehalogenase, and that the pathway for chloromethane utilization is distinct from that for methanol. This work reports genomic and proteomic data demonstrating that cognate cmu genes are located on the 380 kb pCMU01 plasmid, which drives the previously defined pathway for tetrahydrofolate-mediated chloromethane dehalogenation. Comparison of complete genome sequences of strain CM4 and that of four other M. extorquens strains unable to grow with chloromethane showed that plasmid pCMU01 harbors unique genes without homologs in the compared genomes (bluB2, btuB, cobA, cbiD), as well as 13 duplicated genes with homologs of chromosome-borne genes involved in vitamin B-12-associated biosynthesis and transport, or in tetrahydrofolate-dependent metabolism (folC2). In addition, the presence of both chromosomal and plasmid-borne genes for corrinoid salvaging pathways may ensure corrinoid coenzyme supply in challenging environments. Proteomes of M. extorquens CM4 grown with one-carbon substrates chloromethane and methanol were compared. Of the 49 proteins with differential abundance identified, only five (CmuA, CmuB, PurU, CobH2 and a PaaE-like uncharacterized putative oxidoreductase) are encoded by the pCMU01 plasmid. The mainly chromosome-encoded response to chloromethane involves gene clusters associated with oxidative stress, production of reducing equivalents (PntAA, Nuo complex), conversion of tetrahydrofolate-bound one-carbon units, and central metabolism. The mosaic organization of plasmid pCMU01 and the clustering of genes coding for dehalogenase enzymes and for biosynthesis of associated cofactors suggests a history of gene acquisition related to chloromethane utilization.	[Roselli, Sandro; Nadalig, Thierry; Vuilleumier, Stephane; Bringel, Francoise] Univ Strasbourg, CNRS, Dept Mol Genet, UMR7156, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bringel, F (corresponding author), Univ Strasbourg, CNRS, Dept Mol Genet, UMR7156, Strasbourg, France.	francoise.bringel@unistra.fr	Bringel, Francoise/AAQ-6484-2021; Vuilleumier, Stéphane/D-2647-2012	Bringel, Francoise/0000-0002-4529-5143; Vuilleumier, Stéphane/0000-0003-2232-7023	French ministry of research and higher education; REALISE, the Alsace Network for Engineering and Environmental Sciences; EC2CO program of Institut National des Sciences de l'Univers, Centre national de la recherche scientifique	French ministry of research and higher education; REALISE, the Alsace Network for Engineering and Environmental Sciences; EC2CO program of Institut National des Sciences de l'Univers, Centre national de la recherche scientifique	S. Roselli was supported by a PhD grant from the French ministry of research and higher education. Support of this work is by REALISE, the Alsace Network for Engineering and Environmental Sciences (http://realise.u-strasbg.fr), and by the EC2CO program of Institut National des Sciences de l'Univers, Centre national de la recherche scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber BE, 2011, APPL MICROBIOL BIOT, V89, P17, DOI 10.1007/s00253-010-2873-z; Barynin VV, 2001, STRUCTURE, V9, P725, DOI 10.1016/S0969-2126(01)00628-1; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Borodina E, 2004, APPL ENVIRON MICROB, V70, P4177, DOI 10.1128/AEM.70.7.4177-4186.2004; Bosi E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-403; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588; Cadieux N, 2002, J BACTERIOL, V184, P706, DOI 10.1128/JB.184.3.706-717.2002; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Cevallos MA, 2002, PLASMID, V48, P104, DOI 10.1016/S0147-619X(02)00119-1; Chistoserdova L, 2011, ENVIRON MICROBIOL, V13, P2603, DOI 10.1111/j.1462-2920.2011.02464.x; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Clerbaux C., 2007, 50 WORLD MET ORG; Cotton NPJ, 2001, STRUCTURE, V9, P165, DOI 10.1016/S0969-2126(01)00571-8; Daniel R, 1998, FEMS MICROBIOL REV, V22, P553, DOI 10.1111/j.1574-6976.1998.tb00387.x; Doronina NV, 1996, FEMS MICROBIOL LETT, V142, P179; Ferguson T, 2009, J BIOL CHEM, V284, P2285, DOI 10.1074/jbc.M807392200; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; GOSSETT JM, 1987, ENVIRON SCI TECHNOL, V21, P202, DOI 10.1021/es00156a012; Gray MJ, 2007, P NATL ACAD SCI USA, V104, P2921, DOI 10.1073/pnas.0609270104; Halsey KH, 2012, ENVIRON MICROBIOL, V14, P630, DOI 10.1111/j.1462-2920.2011.02605.x; Haydock SF, 2004, J BIOTECHNOL, V113, P55, DOI 10.1016/j.jbiotec.2004.03.022; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Jarrett JT, 1998, BIOCHEMISTRY-US, V37, P12649, DOI 10.1021/bi9808565; Kalyuzhnaya MG, 2005, J BACTERIOL, V187, P7511, DOI 10.1128/JB.187.21.7511-7517.2005; Kalyuzhnaya MG, 2003, J BACTERIOL, V185, P1229, DOI 10.1128/JB.185.4.1229-1235.2003; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; Lee HY, 2001, J BIOCHEM-TOKYO, V130, P807, DOI 10.1093/oxfordjournals.jbchem.a003052; Lequette Y, 2004, J BACTERIOL, V186, P3695, DOI 10.1128/JB.186.12.3695-3702.2004; LI C, 1994, J BACTERIOL, V176, P6015, DOI 10.1128/jb.176.19.6015-6022.1994; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; Marx CJ, 2012, J BACTERIOL, V194, P4746, DOI 10.1128/JB.01009-12; Matthews RG, 1998, EUR J PEDIATR, V157, pS54, DOI 10.1007/PL00014305; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Morgan RD, 2008, NUCLEIC ACIDS RES, V36, P6558, DOI 10.1093/nar/gkn711; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Muller EEL, 2011, ENVIRON MICROBIOL, V13, P2518, DOI 10.1111/j.1462-2920.2011.02524.x; Muller EEL, 2011, RES MICROBIOL, V162, P869, DOI 10.1016/j.resmic.2011.01.008; Nadalig T, 2011, FEMS MICROBIOL ECOL, V77, P438, DOI 10.1111/j.1574-6941.2011.01125.x; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Petersen J, 2009, ENVIRON MICROBIOL, V11, P2627, DOI 10.1111/j.1462-2920.2009.01987.x; Peyraud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048271; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Pinto UM, 2012, NAT REV MICROBIOL, V10, P755, DOI 10.1038/nrmicro2882; POLLICH M, 1995, J BACTERIOL, V177, P4481, DOI 10.1128/jb.177.15.4481-4487.1995; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roessner CA, 2005, J BIOL CHEM, V280, P16748, DOI 10.1074/jbc.M501805200; Schafer H, 2007, ADV APPL MICROBIOL, V61, P307, DOI 10.1016/S0065-2164(06)61009-5; Scott AI, 2002, BIOCHEM SOC T, V30, P613, DOI 10.1042/bst0300613; Sluis MK, 2002, J BACTERIOL, V184, P2969, DOI 10.1128/JB.184.11.2969-2977.2002; Smejkalova H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013001; Streit WR, 1997, MOL PLANT MICROBE IN, V10, P933, DOI 10.1094/MPMI.1997.10.7.933; Studer A, 1999, EUR J BIOCHEM, V264, P242, DOI 10.1046/j.1432-1327.1999.00629.x; Studer A, 2002, J BACTERIOL, V184, P3476, DOI 10.1128/JB.184.13.3476-3484.2002; Studer A, 2001, EUR J BIOCHEM, V268, P2931, DOI 10.1046/j.1432-1327.2001.02182.x; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Touze T, 2004, J BACTERIOL, V186, P5547, DOI 10.1128/JB.186.16.5547-5550.2004; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Vannelli T, 1998, APPL ENVIRON MICROB, V64, P1933; Vannelli T, 1999, P NATL ACAD SCI USA, V96, P4615, DOI 10.1073/pnas.96.8.4615; Vevodova J, 2004, J MOL BIOL, V344, P419, DOI 10.1016/j.jmb.2004.09.020; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Vuilleumier S, 2011, J BACTERIOL, V193, P5035, DOI 10.1128/JB.05627-11; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Warner KL, 2005, FEMS MICROBIOL LETT, V251, P45, DOI 10.1016/j.femsle.2005.07.021; WARREN MJ, 1990, BIOCHEM J, V265, P725, DOI 10.1042/bj2650725; Yi S, 2012, APPL ENVIRON MICROB, V78, P7745, DOI 10.1128/AEM.02150-12; Zhang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-78	73	24	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e56598	10.1371/journal.pone.0056598	http://dx.doi.org/10.1371/journal.pone.0056598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593113	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600003
J	Ukhanov, K; Corey, EA; Ache, BW				Ukhanov, Kirill; Corey, Elizabeth A.; Ache, Barry W.			Phosphoinositide 3-Kinase Dependent Inhibition as a Broad Basis for Opponent Coding in Mammalian Olfactory Receptor Neurons	PLOS ONE			English	Article							SENSORY NEURONS; ACTIVATION; IDENTIFICATION; ANTAGONISM; MECHANISM; SURVIVAL; BINDING	Phosphoinositide 3-kinase (PI3K) signaling has been implicated in mediating inhibitory odorant input to mammalian olfactory receptor neurons (ORNs). To better understand the breadth of such inhibition in odor coding, we screened a panel of odorants representing different chemical classes, as well as odorants known to occur in a natural odor object (tomato), for their ability to rapidly activate PI3K-dependent inhibitory signaling. Odorants were screened on dissociated native rat ORNs before and after pre-incubation with the PI3K-isoform specific blockers AS252424 and TGX221. Many different odorants increased their excitatory strength for particular ORNs following PI3K blockade in a manner consistent with activating PI3K-dependent inhibitory signaling in those cells. The PI3K-dependent inhibitory odorants overlapped with conventional excitatory odorants, but did not share the same bias, indicating partial partitioning of the odor space. Finding that PI3K-dependent inhibition can be activated by a wide range of otherwise conventional excitatory odorants strongly implies PI3K-dependent inhibition provides a broad basis for opponent coding in mammalian ORNs.	[Ukhanov, Kirill; Corey, Elizabeth A.; Ache, Barry W.] McKnight Brain Inst, Ctr Smell & Taste, Whitney Lab, Gainesville, FL USA; [Ukhanov, Kirill; Corey, Elizabeth A.; Ache, Barry W.] Univ Florida, Gainesville, FL USA; [Ache, Barry W.] Univ Florida, Dept Biol, Gainesville, FL USA; [Ache, Barry W.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ukhanov, K (corresponding author), McKnight Brain Inst, Ctr Smell & Taste, Whitney Lab, Gainesville, FL USA.	ukhanov@mbi.ufl.edu			National Institute on Deafness and Other Communication Disorders [DC001655, DC005995]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005995, R01DC001655] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders through awards DC001655 and DC005995 to BWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2010, CHEM SENSES, V35, P533, DOI 10.1093/chemse/bjq045; Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Bachtiar LR, 2011, IEEE ENG MED BIO, P2752, DOI 10.1109/IEMBS.2011.6090754; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; BELL GA, 1987, BRAIN RES, V426, P8, DOI 10.1016/0006-8993(87)90419-7; Brady JD, 2006, P NATL ACAD SCI USA, V103, P15635, DOI 10.1073/pnas.0603344103; Caceres NC, 2003, REV BRAS ZOOL, V20, P4; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Duchamp-Viret P, 2003, EUR J NEUROSCI, V18, P2690, DOI 10.1111/j.1460-9568.2003.03001.x; Firestein Stuart, 2004, Sci STKE, V2004, ppe15; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Grossman KJ, 2008, EUR J NEUROSCI, V27, P2676, DOI 10.1111/j.1460-9568.2008.06213.x; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HERRERA CM, 1985, OIKOS, V44, P132, DOI 10.2307/3544054; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Kaluza JF, 2000, J EXP BIOL, V203, P927; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mathieu S, 2009, J EXP BOT, V60, P325, DOI 10.1093/jxb/ern294; Moon C, 2009, J NEUROSCI RES, V87, P1098, DOI 10.1002/jnr.21919; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Peterlin Z, 2008, CHEM BIOL, V15, P1317, DOI 10.1016/j.chembiol.2008.10.014; Quignon P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r83; Rospars JP, 2008, J NEUROSCI, V28, P2659, DOI 10.1523/JNEUROSCI.4670-07.2008; SATO T, 1994, J NEUROPHYSIOL, V72, P2980, DOI 10.1152/jn.1994.72.6.2980; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Takeuchi H, 2009, J GEN PHYSIOL, V133, P583, DOI 10.1085/jgp.200810085; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; Ukhanov K, 2010, J NEUROPHYSIOL, V103, P1114, DOI 10.1152/jn.00980.2009; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang CL, 2001, PHYTOCHEMISTRY, V58, P227, DOI 10.1016/S0031-9422(01)00233-3; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; Zhainazarov AB, 2004, J MEMBRANE BIOL, V201, P51, DOI 10.1007/s00232-004-0707-4; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	43	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61553	10.1371/journal.pone.0061553	http://dx.doi.org/10.1371/journal.pone.0061553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585911	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600126
J	Wang, Q; Zhao, ZB; Wang, G; Hui, Z; Wang, MH; Pan, JF; Zheng, H				Wang, Qun; Zhao, Zong-Bin; Wang, Geng; Hui, Zhen; Wang, Ming-Hua; Pan, Jun-Feng; Zheng, Hong			High Expression of KIF26B in Breast Cancer Associates with Poor Prognosis	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; KINESIN SUPERFAMILY; MOTOR PROTEINS; LUNG-CANCER; KIF14; SALL1; MOUSE; MICROTUBULES; PREDICTOR; HOMOLOG	To date, a great number of studies have demonstrated that altered expression of kinesins is associated with development and progression of various human cancers. Kinesin family member 26B (KIF26B), a member of the kinesin superfamily proteins (KIFs), is essential for kidney development. However, the role of KIF26B during tumorigenesis and progression is limited. Here, we demonstrate that both KIF26B mRNA and protein are overexpression in breast cancer tissues by RT-qPCR and western blot. Immunohistochemistry revealed that KIF26B expression significantly correlated with clinicopathological factors, including tumor size (P = 0.011), grade (P = 0.017), lymph node status (P = 0.009) and ER status (P = 0.012). Moreover, the Kaplan-Meier analysis indicated that breast cancer patients with high KIF26B expression had a shorter survival than those with low KIF26B expression. In addition, multivariate analysis indicated that KIF26B is an independent prognostic for outcome in breast cancer (HR, 2.356; 95% CI, 1.268-4.378; P = 0.007). Collectively, our study demonstrated that KIF26B was overexpression in breast cancer and could be served as a potential prognostic marker.	[Wang, Qun; Zhao, Zong-Bin; Wang, Geng; Hui, Zhen; Wang, Ming-Hua; Pan, Jun-Feng] Taihe Hosp, Dept Gen Surg, Hubei, Shiyan, Peoples R China; [Zheng, Hong] Taihe Hosp, Dept Prevent Med, Hubei, Peoples R China		Zheng, H (corresponding author), Taihe Hosp, Dept Prevent Med, Hubei, Peoples R China.	kathy0701@yeah.net						Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Huszar D, 2009, CANCER METAST REV, V28, P197, DOI 10.1007/s10555-009-9185-8; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lillie SH, 1998, J CELL BIOL, V140, P873, DOI 10.1083/jcb.140.4.873; Liu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041293; Ma Y, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730437; Madhavan J, 2007, INVEST OPHTH VIS SCI, V48, P4901, DOI 10.1167/iovs.07-0063; Marikawa Y, 2004, DEV GENES EVOL, V214, P64, DOI 10.1007/s00427-003-0377-x; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Phelps MA, 2003, DRUG DISCOV TODAY, V8, P494, DOI 10.1016/S1359-6446(03)02707-7; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Sablin EP, 2000, CURR OPIN CELL BIOL, V12, P35, DOI 10.1016/S0955-0674(99)00054-X; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Taniwaki M, 2007, CLIN CANCER RES, V13, P6624, DOI 10.1158/1078-0432.CCR-07-1328; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Yamashita K, 2007, GENES CELLS, V12, P171, DOI 10.1111/j.1365-2443.2007.01042.x; Yu Y, 2010, CANCER-AM CANCER SOC, V116, P5150, DOI 10.1002/cncr.25461; Zhang CP, 2010, CARCINOGENESIS, V31, P1676, DOI 10.1093/carcin/bgq134; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	29	36	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61640	10.1371/journal.pone.0061640	http://dx.doi.org/10.1371/journal.pone.0061640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585914	Green Submitted, gold, Green Published			2022-12-27	WOS:000317909600129
J	Tai, KK; Truong, DD				Tai, Kwok Keung; Truong, Daniel D.			Amiloride but Not Memantine Reduces Neurodegeneration, Seizures and Myoclonic Jerks in Rats with Cardiac Arrest-Induced Global Cerebral Hypoxia and Reperfusion	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; POSTHYPOXIC MYOCLONUS; GLUTAMATE NEUROTOXICITY; NEURONAL INJURY; STROKE PATIENTS; KETOGENIC DIET; BRAIN-LESIONS; DRUGS WORK; CALCIUM; MODELS	It has been reported that both activation of N-methyl-D-aspartate receptors and acid-sensing ion channels during cerebral ischemic insult contributed to brain injury. But which of these two molecular targets plays a more pivotal role in hypoxia-induced brain injury during ischemia is not known. In this study, the neuroprotective effects of an acid-sensing cation channel blocker and an N-methyl-D-aspartate receptor blocker were evaluated in a rat model of cardiac arrest-induced cerebral hypoxia. We found that intracisternal injection of amiloride, an acid-sensing ion channel blocker, dose-dependently reduced cerebral hypoxia-induced neurodegeneration, seizures, and audiogenic myoclonic jerks. In contrast, intracisternal injection of memantine, a selective uncompetitive N-methyl-D-aspartate receptor blocker, had no significant effect on cerebral hypoxia-induced neurodegeneration, seizure and audiogenic myoclonic jerks. Intracisternal injection of zoniporide, a specific sodium-hydrogen exchanger inhibitor, before cardiac arrest-induced cerebral hypoxia, also did not reduce cerebral hypoxia-induced neurodegeneration, seizures and myoclonic jerks. These results suggest that acid-sensing ion channels play a more pivotal role than N-methyl-D-aspartate receptors in mediating cerebral hypoxia-induced brain injury during ischemic insult.	[Tai, Kwok Keung; Truong, Daniel D.] Long Beach Mem Med Ctr, Parkinsons & Movement Disorder Res Lab, Long Beach, CA 90806 USA; [Tai, Kwok Keung; Truong, Daniel D.] Parkinsons & Movement Disorder Inst, Fountain Valley, CA USA		Tai, KK (corresponding author), Long Beach Mem Med Ctr, Parkinsons & Movement Disorder Res Lab, Long Beach, CA 90806 USA.	kktai@uci.edu	Truong, Daniel/A-1185-2010		Long Beach Memorial Medical Center Foundation; Parkinson's and Movement Disorder Foundation	Long Beach Memorial Medical Center Foundation; Parkinson's and Movement Disorder Foundation	The study was supported by funding from the Long Beach Memorial Medical Center Foundation, and the Parkinson's and Movement Disorder Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2005, BRIT J PHARMACOL, V145, P880, DOI 10.1038/sj.bjp.0706291; Ali A, 2004, EPILEPSY BEHAV, V5, P322, DOI 10.1016/j.yebeh.2004.01.005; Allen BS, 2003, J THORAC CARDIOV SUR, V125, P625, DOI 10.1067/mtc.2003.96; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Castella M, 2005, ANN THORAC SURG, V79, P646, DOI 10.1016/j.athoracsur.2004.07.007; CHOI DW, 1990, STROKE, V21, P20; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; DELZOPPO GJ, 1995, J INTERN MED, V237, P79; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; GOLDBERG MP, 1987, J PHARMACOL EXP THER, V243, P784; Gomez-Villafuertes R, 2007, MOL NEUROBIOL, V35, P195, DOI 10.1007/s12035-007-0007-0; GROTTA J, 1995, J INTERN MED, V237, P89, DOI 10.1111/j.1365-2796.1995.tb01145.x; Helfaer MA, 1998, STROKE, V29, P824, DOI 10.1161/01.STR.29.4.824; Hossmann KA, 1998, CARDIOVASC RES, V39, P106, DOI 10.1016/S0008-6363(98)00075-3; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; LEAHY JC, 1994, NEUROSCIENCE, V63, P457, DOI 10.1016/0306-4522(94)90543-6; Li MH, 2010, J CEREBR BLOOD F MET, V30, P1247, DOI 10.1038/jcbfm.2010.30; Lin Y.P., 2010, PLOS ONE, V5; Luszczki J, 2009, J NEURAL TRANSM, V116, P57, DOI 10.1007/s00702-008-0152-2; Marala RB, 2002, EUR J PHARMACOL, V451, P37, DOI 10.1016/S0014-2999(02)02193-3; MELDRUM B, 1985, BRIT J ANAESTH, V57, P44, DOI 10.1093/bja/57.1.44; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SIESJO BK, 1995, ANN THORAC SURG, V59, P1316, DOI 10.1016/0003-4975(95)00077-X; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; TACHE Y, 1980, P NATL ACAD SCI-BIOL, V77, P5515, DOI 10.1073/pnas.77.9.5515; Tai KK, 2008, J NEURAL TRANSM, V115, P1011, DOI 10.1007/s00702-008-0050-7; Tai KK, 2009, BRAIN INJURY, V23, P1081, DOI 10.3109/02699050903421123; Tai KK, 2005, BRAIN RES, V1059, P122, DOI 10.1016/j.brainres.2005.08.027; Tai KK, 2007, BRAIN RES, V1133, P209, DOI 10.1016/j.brainres.2006.11.076; Tai KK, 2010, BRAIN RES, V1343, P194, DOI 10.1016/j.brainres.2010.04.058; Truong DD, 2002, ADV NEUROL, V89, P295; Truong DD, 2000, MOVEMENT DISORD, V15, P26, DOI 10.1002/mds.870150706; TRUONG DD, 1994, MOVEMENT DISORD, V9, P201, DOI 10.1002/mds.870090214; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	40	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60309	10.1371/journal.pone.0060309	http://dx.doi.org/10.1371/journal.pone.0060309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593189	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000025
J	Xie, L; Yang, ZZ; Li, GQ; Shen, LD; Xiang, XD; Liu, XF; Xu, D; Xu, L; Chen, YJ; Tian, Z; Chen, X				Xie, Lin; Yang, Zuozhang; Li, Guoqi; Shen, Lida; Xiang, Xudong; Liu, Xuefeng; Xu, Da; Xu, Lei; Chen, Yanjin; Tian, Zhao; Chen, Xin			Genome-Wide Identification of Bone Metastasis-Related MicroRNAs in Lung Adenocarcinoma by High-Throughput Sequencing	PLOS ONE			English	Article							SKELETAL METASTASES; CANCER; EXPRESSION; SURVIVAL; MIRNAS; TARGET	Background: MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression at the post-transcriptional level. They participate in a wide variety of biological processes, including apoptosis, proliferation and metastasis. The aberrant expression of miRNAs has been found to play an important role in many cancers. Results: To understand the roles of miRNAs in the bone metastasis of lung adenocarcinoma, we constructed two small RNA libraries from blood of lung adenocarcinoma patients with and without bone metastasis. High-throughput sequencing combined with differential expression analysis identified that 7 microRNAs were down-regulated and 21 microRNAs were up-regulated in lung adenocarcinoma with bone metastasis. A total of 797 target genes of the differentially expressed microRNAs were identified using a bioinformatics approach. Functional annotation analysis indicated that a number of pathways might be involved in bone metastasis, survival of the primary origin and metastatic angiogenesis of lung adenocarcinoma. These include the MAPK, Wnt, and NF-kappaB signaling pathways, as well as pathways involving the matrix metalloproteinase, cytoskeletal protein and angiogenesis factors. Conclusions: This study provides some insights into the molecular mechanisms that underlie lung adenocarcinoma development, thereby aiding the diagnosis and treatment of the disease.	[Xie, Lin; Yang, Zuozhang; Shen, Lida] Kunming Med Univ, Tumor Hosp Yunnan Prov, Affiliated Hosp 3, Dept Med Oncol, Kunming, Peoples R China; [Yang, Zuozhang; Li, Guoqi; Liu, Xuefeng; Xu, Da; Xu, Lei; Chen, Yanjin; Tian, Zhao; Chen, Xin] Kunming Med Univ, Tumor Hosp Yunnan Prov, Affiliated Hosp 3, Dept Orthoped, Kunming, Peoples R China; [Xiang, Xudong] Kunming Med Univ, Tumor Hosp Yunnan Prov, Affiliated Hosp 3, Dept Thorac Surg, Kunming, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University	Yang, ZZ (corresponding author), Kunming Med Univ, Tumor Hosp Yunnan Prov, Affiliated Hosp 3, Dept Med Oncol, Kunming, Peoples R China.	yangzuozhangsci@163.com			National Natural Science Foundation of China [81260322/H1606]; Natural Science Foundation of Yunnan Province [2012FB163]; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University [2011FB201]; Kunming Major Program of Science and Technology Development [11S030003]; scientific research fund from department of Education of Yunnan Province [2011Y192]; specialty fund of high-level talents medical personnel training of Yunnan province [D-201242]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University; Kunming Major Program of Science and Technology Development; scientific research fund from department of Education of Yunnan Province; specialty fund of high-level talents medical personnel training of Yunnan province	This work was supported in part by grants (no. 81260322/H1606) from the National Natural Science Foundation of China, grants (no. 2012FB163) from the Natural Science Foundation of Yunnan Province, grants (no. 2011FB201) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University, grants (no. 11S030003) from Kunming Major Program of Science and Technology Development, grants (no. 2011Y192) from the scientific research fund from department of Education of Yunnan Province, and grants (no. D-201242) from the specialty fund of high-level talents medical personnel training of Yunnan province. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; [Anonymous], 2012, NUCL ACIDS RES; Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Cho William C. S., 2011, Frontiers in Genetics, V2, P7, DOI 10.3389/fgene.2011.00007; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hsieh IS, 2012, CARCINOGENESIS; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Ji S, 2012, GUT; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Ma LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026502; Malleter M, 2012, GENE, V506, P355, DOI 10.1016/j.gene.2012.06.008; Scagliotti GV, 2012, J THORAC ONCOL, V7, P1823, DOI 10.1097/JTO.0b013e31826aec2b; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Theriault RL, 2012, CANCER CONTROL, V19, P92, DOI 10.1177/107327481201900203; TOFE AJ, 1975, J NUCL MED, V16, P986; Vashisht S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049401; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; WILSON MA, 1981, J NUCL MED, V22, P594; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	35	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61212	10.1371/journal.pone.0061212	http://dx.doi.org/10.1371/journal.pone.0061212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593434	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000112
J	Gleichgerrcht, E; Young, L				Gleichgerrcht, Ezequiel; Young, Liane			Low Levels of Empathic Concern Predict Utilitarian Moral Judgment	PLOS ONE			English	Article							PERSPECTIVE-TAKING; FRONTOTEMPORAL DEMENTIA; INDIVIDUAL-DIFFERENCES; GENDER-DIFFERENCES; PREFRONTAL CORTEX; DECISION-MAKING; DISGUST; SENSITIVITY; DAMAGE; HARM	Is it permissible to harm one to save many? Classic moral dilemmas are often defined by the conflict between a putatively rational response to maximize aggregate welfare (i.e., the utilitarian judgment) and an emotional aversion to harm (i.e., the non-utilitarian judgment). Here, we address two questions. First, what specific aspect of emotional responding is relevant for these judgments? Second, is this aspect of emotional responding selectively reduced in utilitarians or enhanced in non-utilitarians? The results reveal a key relationship between moral judgment and empathic concern in particular (i.e., feelings of warmth and compassion in response to someone in distress). Utilitarian participants showed significantly reduced empathic concern on an independent empathy measure. These findings therefore reveal diminished empathic concern in utilitarian moral judges.	[Gleichgerrcht, Ezequiel] Inst Cognit Neurol INECO, Buenos Aires, DF, Argentina; [Young, Liane] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA; [Gleichgerrcht, Ezequiel] Favaloro Univ, Inst Neurosci, Buenos Aires, DF, Argentina; [Gleichgerrcht, Ezequiel] Diego Portales Univ, Lab Neurosci, Santiago, Chile	Boston College	Gleichgerrcht, E (corresponding author), Inst Cognit Neurol INECO, Buenos Aires, DF, Argentina.	egleich@ineco.org.ar		Gleichgerrcht, Ezequiel/0000-0002-4212-4146	Institute of Cognitive Neurology (INECO) Foundation; Sloan Foundation	Institute of Cognitive Neurology (INECO) Foundation; Sloan Foundation(Alfred P. Sloan Foundation)	EG received a grant from the Institute of Cognitive Neurology (INECO) Foundation. LY received a grant from The Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bartels DM, 2011, COGNITION, V121, P154, DOI 10.1016/j.cognition.2011.05.010; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Conway P, 2013, J PERS SOC PSYCHOL, V104, P216, DOI 10.1037/a0031021; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Cushman F, 2012, EMOTION, V12, P2, DOI 10.1037/a0025071; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2013, CHILD DEV PERSPECT, V7, P49, DOI 10.1111/cdep.12020; Decety J, 2012, J NEUROPHYSIOL, V108, P3068, DOI 10.1152/jn.00473.2012; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; Fumagalli M, 2010, COGN PROCESS, V11, P219, DOI 10.1007/s10339-009-0335-2; Fumagalli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008865; Galinsky AD, 2008, PSYCHOL SCI, V19, P378, DOI 10.1111/j.1467-9280.2008.02096.x; Gilin D, 2013, PERS SOC PSYCHOL B, V39, P3, DOI 10.1177/0146167212465320; Gleichgerrcht E, 2011, SOC NEUROSCI-UK, V6, P113, DOI 10.1080/17470919.2010.506751; Greene J, 2003, NAT REV NEUROSCI, V4, P846, DOI 10.1038/nrn1224; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hall OF, 2012, SOC COGN AFFECT NEUR, V7, P743, DOI 10.1093/scan/nss069; Hare R. D., 1993, CONSCIENCE; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Hodges SD, 2007, EMPATHY IN MENTAL ILLNESS, P389, DOI 10.1017/CBO9780511543753.022; Huebner B, 2011, MIND LANG, V26, P210, DOI 10.1111/j.1468-0017.2011.01416.x; Inbar Y, 2012, SOC PSYCHOL PERS SCI, V3, P537, DOI 10.1177/1948550611429024; Inbar Y, 2012, EMOTION, V12, P23, DOI 10.1037/a0023984; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Inbar Y, 2009, EMOTION, V9, P435, DOI 10.1037/a0015960; Iyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042366; Jaffee S, 2000, PSYCHOL BULL, V126, P703, DOI 10.1037//0033-2909.126.5.703; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koven NS, 2011, EMOTION, V11, P1255, DOI 10.1037/a0025616; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Montoya ER, 2013, PSYCHONEUROENDOCRINO, DOI [10.1016/j.psyneuen.2012.12.001, DOI 10.1016/J.PSY-NEUEN.2012.12.001]; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; Moretto G, 2010, J COGNITIVE NEUROSCI, V22, P1888, DOI 10.1162/jocn.2009.21367; Navarrete CD, 2012, EMOTION, V12, P364, DOI 10.1037/a0025561; Nichols S, 2002, COGNITION, V84, P221, DOI 10.1016/S0010-0277(02)00048-3; Nichols S, 2006, COGNITION, V100, P530, DOI 10.1016/j.cognition.2005.07.005; PETRINOVICH L, 1995, HUMAN EVOLUTION REPR; Prinz, 2006, PHILOS EXPLOR, V9, P29, DOI [10.1080/13869790500492466, DOI 10.1080/13869790500492466, 10.1080/]; Prinz J., 2008, EMOTIONAL CONSTRUCTI; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Strohminger N, 2011, COGNITION, V119, P295, DOI 10.1016/j.cognition.2010.12.012; Suter RS, 2011, COGNITION, V119, P454, DOI 10.1016/j.cognition.2011.01.018; Underwood LG, 2002, ANN BEHAV MED, V24, P22, DOI 10.1207/S15324796ABM2401_04; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Van Lange PAM, 2008, EMOTION, V8, P766, DOI 10.1037/a0013967; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x	62	140	145	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60418	10.1371/journal.pone.0060418	http://dx.doi.org/10.1371/journal.pone.0060418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RK	23593213	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100040
J	Vernone, A; Berchialla, P; Pescarmona, G				Vernone, Annamaria; Berchialla, Paola; Pescarmona, Gianpiero			Human Protein Cluster Analysis Using Amino Acid Frequencies	PLOS ONE			English	Article								The paper focuses on the development of a software tool for protein clustering according to their amino acid content. All known human proteins were clustered according to the relative frequencies of their amino acids starting from the UniProtKB/Swiss-Prot reference database and making use of hierarchical cluster analysis. Results were compared to those based on sequence similarities. Results: Proteins display different clustering patterns according to type. Many extracellular proteins with highly specific and repetitive sequences (keratins, collagens etc.) cluster clearly confirming the accuracy of the clustering method. In our case clustering by sequence and amino acid content overlaps. Proteins with a more complex structure with multiple domains (catalytic, extracellular, transmembrane etc.), even if classified very similar according to sequence similarity and function (aquaporins, cadherins, steroid 5-alpha reductase etc.) showed different clustering according to amino acid content. Availability of essential amino acids according to local conditions (starvation, low or high oxygen, cell cycle phase etc.) may be a limiting factor in protein synthesis, whatever the mRNA level. This type of protein clustering may therefore prove a valuable tool in identifying so far unknown metabolic connections and constraints.	[Vernone, Annamaria; Pescarmona, Gianpiero] Univ Turin, Dept Oncol, Turin, Italy; [Berchialla, Paola] Univ Turin, Dept Clin & Biol Sci, Turin, Italy	University of Turin; University of Turin	Vernone, A (corresponding author), Univ Turin, Dept Oncol, Turin, Italy.	annamaria.vernone@unito.it	Berchialla, Paola/A-3208-2009	Berchialla, Paola/0000-0001-5835-5638; PESCARMONA, GIAN PIERO/0000-0003-2143-8901; Vernone, Annamaria/0000-0002-9748-2178				Ackermann MR, 2011, LEIBNIZ INT PR INFOR, V9, P308, DOI 10.4230/LIPIcs.STACS.2011.308; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Chen CY, 2004, BIOINFORMATICS, V20, P2586, DOI 10.1093/bioinformatics/bth290; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; *JCBN, 1985, J BIOL CHEM, V260, P14; Kimball Scot R, 2004, Nutr Metab (Lond), V1, P3, DOI 10.1186/1743-7075-1-3; Kriventseva EV, 2001, CURR OPIN STRUC BIOL, V11, P334, DOI 10.1016/S0959-440X(00)00211-6; Lesk A. M., 2002, INTRO BIOINFORMATICS; Lucas A, 2005, CTC CLUSTER TREE CON; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mishra P, 2011, BIOINFORMATION, V6, P372, DOI 10.6026/97320630006372; MULLNER D, 2012, FASTCLUSTER FAST HIE; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Walter B, 2008, RT08: IEEE/EG SYMPOSIUM ON INTERACTIVE RAY TRACING 2008, PROCEEDINGS, P81, DOI 10.1109/RT.2008.4634626; Wernerman J, 2008, J NUTR, V138, p2040S, DOI 10.1093/jn/138.10.2040S; Yang F, 2009, EVOL BIOINFORM, V5, P137	18	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60220	10.1371/journal.pone.0060220	http://dx.doi.org/10.1371/journal.pone.0060220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593177	Green Submitted, Green Published, gold			2022-12-27	WOS:000319108100023
J	Feng, JY; Zhang, J; Zhang, WJ; Wang, SB; Han, SF; Zhang, YM				Feng, Jian-Ying; Zhang, Jin; Zhang, Wen-Jie; Wang, Shi-Bo; Han, Shi-Feng; Zhang, Yuan-Ming			An Efficient Hierarchical Generalized Linear Mixed Model for Mapping QTL of Ordinal Traits in Crop Cultivars	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CATEGORICAL TRAITS; EM ALGORITHM; LOCI; CROSSES; VARIANCE; MAIZE	Many important phenotypic traits in plants are ordinal. However, relatively little is known about the methodologies for ordinal trait association studies. In this study, we proposed a hierarchical generalized linear mixed model for mapping quantitative trait locus (QTL) of ordinal traits in crop cultivars. In this model, all the main-effect QTL and QTL-by-environment interaction were treated as random, while population mean, environmental effect and population structure were fixed. In the estimation of parameters, the pseudo data normal approximation of likelihood function and empirical Bayes approach were adopted. A series of Monte Carlo simulation experiments were performed to confirm the reliability of new method. The result showed that new method works well with satisfactory statistical power and precision. The new method was also adopted to dissect the genetic basis of soybean alkaline-salt tolerance in 257 soybean cultivars obtained, by stratified random sampling, from 6 geographic ecotypes in China. As a result, 6 main-effect QTL and 3 QTL-by-environment interactions were identified.	[Feng, Jian-Ying; Zhang, Jin; Zhang, Wen-Jie; Wang, Shi-Bo; Han, Shi-Feng; Zhang, Yuan-Ming] Nanjing Agr Univ, Dept Crop Genet & Breeding, State Key Lab Crop Genet & Germplasm Enhancement, Sect Stat Genom, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, YM (corresponding author), Nanjing Agr Univ, Dept Crop Genet & Breeding, State Key Lab Crop Genet & Germplasm Enhancement, Sect Stat Genom, Nanjing, Jiangsu, Peoples R China.	soyzhang@njau.edu.cn		Zhang, Yuan-Ming/0000-0003-2317-2190	National Basic Research Program of China [2011CB109306]; National Natural Science Foundation of China [30971848]; Fundamental Research Funds for the Central Universities [KYT201002, KJ2011003]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Specialized Research Fund for the Doctoral Program of Higher Education [20100097110035, 20120097110023]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Basic Research Program of China grant 2011CB109306; the National Natural Science Foundation of China grant 30971848; the Fundamental Research Funds for the Central Universities grants KYT201002 and KJ2011003; a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Specialized Research Fund for the Doctoral Program of Higher Education grants 20100097110035 and 20120097110023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brisbin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012307; Che X, 2012, HEREDITY, V109, P41, DOI 10.1038/hdy.2012.10; Coffman CJ, 2005, GENETICS, V170, P1281, DOI 10.1534/genetics.104.033910; Diao G, 2010, GENET EPIDEMIOL, V34, P232, DOI 10.1002/gepi.20453; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gelman A., 2004, BAYESIAN DATA ANAL; Gonzalez-Recio O, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-7; Hackett CA, 1995, BIOMETRICS, V51, P1252, DOI 10.2307/2533257; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Iwata H, 2009, THEOR APPL GENET, V118, P865, DOI 10.1007/s00122-008-0945-6; Li J, 2006, GENETICS, V173, P1649, DOI 10.1534/genetics.105.054619; Li M, 2011, THESIS NANJING AGR U; Lipp M, 1999, J AOAC INT, V82, P923; Lu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017773; MCGILCHRIST CA, 1994, J ROY STAT SOC B MET, V56, P61; Pritchard JK, 2000, GENETICS, V155, P945; Ramalingam J, 2010, MOLECULAR PLANT BREEDING: PRINCIPLE, METHOD AND APPLICATION, P135; Rao SQ, 1998, HEREDITY, V81, P214, DOI 10.1038/sj.hdy.6883780; Rao SQ, 2000, GENETICA, V109, P183, DOI 10.1023/A:1017507624695; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; [魏世平 Wei Shiping], 2011, [南京农业大学学报, Journal of Nanjing Agricultural University], V34, P13; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; Wu XL, 2009, GENETICA, V135, P367, DOI 10.1007/s10709-008-9283-5; Xu C, 2005, HEREDITY, V94, P119, DOI 10.1038/sj.hdy.6800583; Xu S, 2010, HEREDITY, V105, P483, DOI 10.1038/hdy.2009.180; Xu SZ, 2003, GENET RES, V82, P127, DOI 10.1017/S0016672303006414; Xu SZ, 1996, GENETICS, V143, P1417; Xu Y, 2011, THEOR APPL GENET, V122, P581, DOI 10.1007/s00122-010-1471-x; Yi NJ, 2007, GENETICS, V176, P1855, DOI 10.1534/genetics.107.071142; Yi NJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002382; Yi NJ, 2000, GENETICS, V155, P1391; Yi NJ, 2004, BEHAV GENET, V34, P3, DOI 10.1023/B:BEGE.0000009473.43185.43; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang WJ, 2012, THESIS NANJING AGR U; Zhang YM, 2005, HEREDITY, V95, P96, DOI 10.1038/sj.hdy.6800702; Zhang YM, 2005, GENETICS, V169, P2267, DOI 10.1534/genetics.104.033217; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	38	7	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59541	10.1371/journal.pone.0059541	http://dx.doi.org/10.1371/journal.pone.0059541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23593144	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300024
J	Gullingsrud, J; Saveria, T; Amos, E; Duffy, PE; Oleinikov, AV				Gullingsrud, Justin; Saveria, Tracy; Amos, Emily; Duffy, Patrick E.; Oleinikov, Andrew V.			Structure-Function-Immunogenicity Studies of PfEMP1 Domain DBL2 beta(PF11_0521), a Malaria Parasite Ligand for ICAM-1	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; PLASMODIUM-FALCIPARUM; CRYSTAL-STRUCTURE; BINDING DOMAIN; IMMUNE EVASION; CYTOADHERENCE; RECEPTOR; PROTEIN; SEQUESTRATION; ERYTHROCYTES	Plasmodium falciparum virulence has been ascribed to its ability to sequester in deep vascular beds, mediated by the variant surface antigen family PfEMP1 binding endothelial receptors like ICAM-1. We previously observed that naturally-acquired antibodies that block a PfEMP1 domain, DBL2 beta of PF11_0521 allele, from binding to the human ICAM1 receptor, reduce the risk of malaria hospitalization in children. Here, we find that DBL2 beta(PF11_0521) binds ICAM-1 in the low nM range and relate the structure of this domain with its function and immunogenicity. We demonstrate that the interaction with ICAM-1 is not impaired by point mutations in the N-terminal subdomain or in the flexible Loop 4 of DBL2 beta(PF11_0521), although both substructures were previously implicated in binding ICAM-1. These data will help to refine the existing model of DBL beta::ICAM-1 interactions. Antibodies raised against full-length DBL2 beta(PF11_0521), but not truncated forms lacking the N terminal fragment, block its interaction with ICAM-1. Our data suggest that full length domain is optimal for displaying functional epitopes and has a broad surface of interaction with ICAM-1 that is not disrupted by individual amino acid substitutions at putative key residues. This information might be important for the future design of anti-malarial vaccines based on PfEMP1 antigens.	[Gullingsrud, Justin; Saveria, Tracy; Amos, Emily; Duffy, Patrick E.; Oleinikov, Andrew V.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Duffy, Patrick E.] Univ Washington, Program Pathobiol, Dept Global Hlth, Seattle, WA 98195 USA; [Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Oleinikov, AV (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	andrew.oleinikov@sbri.org			National Institutes of Health [1R21AI064503, 1R56AI083668, 1R01AI092120]; Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative [29202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092120, R56AI083668, R21AI064503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health (http://www.nih.gov) [grants 1R21AI064503, 1R56AI083668, and 1R01AI092120 to AVO], and funded in part by the Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative (http://www.grandchallenges.org/Pages/default.aspx) [Grant No. 29202 to PED]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson A, 2013, J IMMUNOL, V190, P240, DOI 10.4049/jimmunol.1202578; Bertonati C, 2007, PROTEINS, V69, P215, DOI 10.1002/prot.21691; BIGGS BA, 1990, J EXP MED, V171, P1883, DOI 10.1084/jem.171.6.1883; Chakravorty SJ, 2008, BIOCHEM SOC T, V36, P221, DOI 10.1042/BST0360221; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Dondorp AM, 2008, TRANSFUS CLIN BIOL, V15, P56, DOI 10.1016/j.tracli.2008.04.013; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Howell DPG, 2006, MOL BIOCHEM PARASIT, V148, P1, DOI 10.1016/j.molbiopara.2006.03.004; Hughes KR, 2010, MOL BIOCHEM PARASIT, V169, P71, DOI 10.1016/j.molbiopara.2009.09.007; Klein MM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000147; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; McHenry AM, 2006, TRENDS BIOCHEM SCI, V31, P487, DOI 10.1016/j.tibs.2006.07.003; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Oleinikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031011; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Singh K, 2008, NAT STRUCT MOL BIOL, V24, P24; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Springer AL, 2004, MOL BIOCHEM PARASIT, V137, P55, DOI 10.1016/j.molbiopara.2004.03.019; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Wang W, 1999, BIOTECHNIQUES	35	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61323	10.1371/journal.pone.0061323	http://dx.doi.org/10.1371/journal.pone.0061323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593462	gold, Green Submitted, Green Published			2022-12-27	WOS:000317385300071
J	Marelja, Z; Chowdhury, MM; Dosche, C; Hille, C; Baumann, O; Lohmannsroben, HG; Leimkuhler, S				Marelja, Zvonimir; Chowdhury, Mita Mullick; Dosche, Carsten; Hille, Carsten; Baumann, Otto; Loehmannsroeben, Hans-Gerd; Leimkuehler, Silke			The L-Cysteine Desulfurase NFS1 Is Localized in the Cytosol where it Provides the Sulfur for Molybdenum Cofactor Biosynthesis in Humans	PLOS ONE			English	Article							FE-S CLUSTER; ASSIMILATORY NITRATE REDUCTASE; NIFS-LIKE PROTEIN; TRANSFER-RNA; NEUROSPORA MUTANT; THIO-MODIFICATION; ESCHERICHIA-COLI; MITOCHONDRIAL LOCALIZATION; MOLYBDOPTERIN BIOSYNTHESIS; IRON HOMEOSTASIS	In humans, the L-cysteine desulfurase NFS1 plays a crucial role in the mitochondrial iron-sulfur cluster biosynthesis and in the thiomodification of mitochondrial and cytosolic tRNAs. We have previously demonstrated that purified NFS1 is able to transfer sulfur to the C-terminal domain of MOCS3, a cytosolic protein involved in molybdenum cofactor biosynthesis and tRNA thiolation. However, no direct evidence existed so far for the interaction of NFS1 and MOCS3 in the cytosol of human cells. Here, we present direct data to show the interaction of NFS1 and MOCS3 in the cytosol of human cells using Forster resonance energy transfer and a split-EGFP system. The colocalization of NFS1 and MOCS3 in the cytosol was confirmed by immunodetection of fractionated cells and localization studies using confocal fluorescence microscopy. Purified NFS1 was used to reconstitute the lacking molybdoenzyme activity of the Neurospora crassa nit-1 mutant, giving additional evidence that NFS1 is the sulfur donor for Moco biosynthesis in eukaryotes in general.	[Marelja, Zvonimir; Chowdhury, Mita Mullick; Leimkuehler, Silke] Univ Potsdam, Inst Biochem, Dept Mol Enzymol, Potsdam, Germany; [Dosche, Carsten; Hille, Carsten; Loehmannsroeben, Hans-Gerd] Univ Potsdam, Dept Phys Chem, Inst Chem, Potsdam, Germany; [Baumann, Otto] Univ Potsdam, Dept Anim Physiol, Inst Biochem, Potsdam, Germany	University of Potsdam; University of Potsdam; University of Potsdam	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem, Dept Mol Enzymol, Potsdam, Germany.	sleim@uni-potsdam.de	Marelja, Zvonimir/AAL-3557-2020; Löhmannsröben, Hans-Gerd/U-5884-2019	Leimkuhler, Silke/0000-0003-3238-2122; Marelja, Zvonimir/0000-0002-3702-7528; Hille, Carsten/0000-0003-3454-8077	Studienstiftung des deutschen Volkes; DFG [LE1171/5-3]	Studienstiftung des deutschen Volkes; DFG(German Research Foundation (DFG))	This work was supported by the Studienstiftung des deutschen Volkes and the DFG grant LE1171/5-3 (to S.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chowdhury MM, 2012, J BIOL CHEM, V287, P17297, DOI 10.1074/jbc.M112.351429; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Flint DH, 1996, J BIOL CHEM, V271, P16068; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Hinz J, 2012, J BIOL CHEM, V287, P2068, DOI 10.1074/jbc.M111.318915; JOHNSON ME, 1987, J BACTERIOL, V169, P117, DOI 10.1128/jb.169.1.117-125.1987; JOHNSON ME, 1987, J BACTERIOL, V169, P110, DOI 10.1128/jb.169.1.110-116.1987; KETCHUM PA, 1970, P NATL ACAD SCI USA, V66, P1016, DOI 10.1073/pnas.66.3.1016; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lajoie P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015245; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; MENDEL RR, 1981, MOL GEN GENET, V181, P395, DOI 10.1007/BF00425618; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 1998, FEBS LETT, V433, P143, DOI 10.1016/S0014-5793(98)00897-7; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; NASON A, 1970, P NATL ACAD SCI USA, V65, P137, DOI 10.1073/pnas.65.1.137; NASON A, 1974, J LESS-COMMON MET, V36, P449, DOI 10.1016/0022-5088(74)90129-5; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Reiss J, 2011, HUM MUTAT, V32, P10, DOI 10.1002/humu.21390; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Xia HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047847; Yogev O, 2011, FEBS J, V278, P4230, DOI 10.1111/j.1742-4658.2011.08359.x; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	67	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60869	10.1371/journal.pone.0060869	http://dx.doi.org/10.1371/journal.pone.0060869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593335	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300032
J	Teillet, A; Dybal, K; Kerry, BR; Miller, AJ; Curtis, RHC; Hedden, P				Teillet, Alice; Dybal, Katarzyna; Kerry, Brian R.; Miller, Anthony J.; Curtis, Rosane H. C.; Hedden, Peter			Transcriptional Changes of the Root-Knot Nematode Meloidogyne incognita in Response to Arabidopsis thaliana Root Signals	PLOS ONE			English	Article							POTATO CYST-NEMATODE; DIFFERENTIAL GENE-EXPRESSION; PLANT-PARASITIC NEMATODES; CELLULOSE-BINDING PROTEIN; 2ND-STAGE JUVENILES; EFFECTOR PROTEIN; IN-VITRO; HOST; IDENTIFICATION; SECRETION	Root-knot nematodes are obligate parasites that invade roots and induce the formation of specialized feeding structures. Although physiological and molecular changes inside the root leading to feeding site formation have been studied, very little is known about the molecular events preceding root penetration by nematodes. In order to investigate the influence of root exudates on nematode gene expression before plant invasion and to identify new genes potentially involved in parasitism, sterile root exudates from the model plant Arabidopsis thaliana were produced and used to treat Meloidogyne incognita pre-parasitic second-stage juveniles. After confirming the activity of A. thaliana root exudates (ARE) on M. incognita stylet thrusting, six new candidate genes identified by cDNA-AFLP were confirmed by qRT-PCR as being differentially expressed after incubation for one hour with ARE. Using an in vitro inoculation method that focuses on the events preceding the root penetration, we show that five of these genes are differentially expressed within hours of nematode exposure to A. thaliana roots. We also show that these genes are up-regulated post nematode penetration during migration and feeding site initiation. This study demonstrates that preceding root invasion plant-parasitic nematodes are able to perceive root signals and to respond by changing their behaviour and gene expression.	[Teillet, Alice; Dybal, Katarzyna; Kerry, Brian R.; Curtis, Rosane H. C.; Hedden, Peter] Rothamsted Res, Harpenden, Herts, England; [Teillet, Alice] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Miller, Anthony J.] John Innes Ctr, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Wisconsin System; University of Wisconsin Madison; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Teillet, A (corresponding author), Rothamsted Res, Harpenden, Herts, England.	teillet@wisc.edu	Miller, Anthony John/B-5139-2008	Miller, Anthony John/0000-0003-0572-7607	Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/F021577/1]; BBSRC [BBS/E/C/00005202, BB/F021577/1, BBS/E/C/00004967] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005202, BB/F021577/1, BBS/E/C/00004967] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grant BB/F021577/1 from the Biotechnology and Biological Sciences Research Council of the United Kingdom, which also provides strategic support to Rothamsted Research and to the John Innes Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abad P, 2010, ADV BOT RES, V53, P147, DOI 10.1016/S0065-2296(10)53005-2; ATKINSON HJ, 1987, ANN APPL BIOL, V110, P105, DOI 10.1111/j.1744-7348.1987.tb03237.x; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bellafiore S, 2010, CURR OPIN PLANT BIOL, V13, P442, DOI 10.1016/j.pbi.2010.05.006; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blair L, 1999, NEMATOLOGY, V1, P103, DOI 10.1163/156854199507910; BYBD DW, 1983, J NEMATOL, V15, P142; Caillaud MC, 2008, J PLANT PHYSIOL, V165, P104, DOI 10.1016/j.jplph.2007.05.007; Curtis RHC, 1996, PARASITOLOGY, V113, P589, DOI 10.1017/S0031182000067640; Dalzell JJ, 2011, NEMATOLOGY, V13, P211, DOI 10.1163/138855410X516760; De Mendoza MEL, 2000, PARASITOLOGY, V120, P203, DOI 10.1017/S0031182099005326; Devine KJ, 1996, ANN APPL BIOL, V129, P323, DOI 10.1111/j.1744-7348.1996.tb05755.x; DIEZ JA, 1989, J CHEM ECOL, V15, P2445, DOI 10.1007/BF01020375; Ding X, 1998, MOL PLANT MICROBE IN, V11, P952, DOI 10.1094/MPMI.1998.11.10.952; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Dubreuil G, 2011, INT J PARASITOL, V41, P385, DOI 10.1016/j.ijpara.2010.10.008; Ehwaeti ME, 1999, NEMATOLOGY, V1, P421, DOI 10.1163/156854199508315; Fuller VL, 2007, MOL PLANT PATHOL, V8, P595, DOI 10.1111/J.1364-3703.2007.00416.X; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Goverse A, 1999, MOL PLANT MICROBE IN, V12, P872, DOI 10.1094/MPMI.1999.12.10.872; GRUNDLER F, 1991, PARASITOLOGY, V103, P149, DOI 10.1017/S0031182000059394; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Hamamouch N, 2011, MOL PLANT PATHOL, V12, P355, DOI 10.1111/j.1364-3703.2010.00675.x; Hammes UZ, 2005, MOL PLANT MICROBE IN, V18, P1247, DOI 10.1094/MPMI-18-1247; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Hewezi T, 2008, PLANT CELL, V20, P3080, DOI 10.1105/tpc.108.063065; HO JY, 1992, PLANT J, V2, P971; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang GZ, 2005, INT J PARASITOL, V35, P685, DOI 10.1016/j.ijpara.2005.01.006; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; Jaouannet M, 2012, NEW PHYTOL, V194, P924, DOI 10.1111/j.1469-8137.2012.04164.x; Jaubert S, 2005, MOL PLANT MICROBE IN, V18, P1277, DOI 10.1094/MPMI-18-1277; Jaubert S, 2004, INT J PARASITOL, V34, P873, DOI 10.1016/j.ijpara.2004.02.008; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Jones J, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P1, DOI 10.1007/978-94-007-0434-3; Jones JT, 1997, PARASITOLOGY, V114, P309, DOI 10.1017/S0031182096008451; Koenning SR, 1999, J NEMATOL, V31, P587; Lee C, 2011, PLANT PHYSIOL, V155, P866, DOI 10.1104/pp.110.167197; Lopez de Mendoza M.E., 2002, International Journal of Nematology, V12, P149; Masler EP, 2007, J HELMINTHOL, V81, P421, DOI 10.1017/S0022149X07850243; MCCLURE MA, 1987, PHYTOPATHOLOGY, V77, P1463, DOI 10.1094/Phyto-77-1463; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neveu C, 2003, MOL PLANT MICROBE IN, V16, P1077, DOI 10.1094/MPMI.2003.16.12.1077; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Qin L, 2000, MOL PLANT MICROBE IN, V13, P830, DOI 10.1094/MPMI.2000.13.8.830; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rosso M. N., 2009, Annual Review of Phytopathology, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Roze E, 2008, MOL PLANT PATHOL, V9, P1, DOI [10.1111/j.1364-3703.2007.00435.x, 10.1111/J.1364-3703.2007.00435.X]; Semblat JP, 2001, MOL PLANT MICROBE IN, V14, P72, DOI 10.1094/MPMI.2001.14.1.72; Shanmugam V, 2010, CELL MICROBIOL, V12, P1421, DOI 10.1111/j.1462-5822.2010.01479.x; Sheridan JP, 2004, J EXP BOT, V55, P751, DOI 10.1093/jxb/erh063; SIJMONS PC, 1991, PLANT J, V1, P245, DOI 10.1111/j.1365-313X.1991.00245.x; Smant G, 1997, PHYTOPATHOLOGY, V87, P839, DOI 10.1094/PHYTO.1997.87.8.839; Spiegel Y, 2003, PHYTOPATHOLOGY, V93, P127, DOI 10.1094/PHYTO.2003.93.1.127; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Vanholme B, 2004, GENE, V332, P13, DOI [10.1016/j.gene.2004.02.024, 10.1016/j.gnee.2004.02.024]; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; Wang CL, 2009, NEMATOLOGY, V11, P453, DOI 10.1163/156854109X447024; Weerasinghe RR, 2005, P NATL ACAD SCI USA, V102, P3147, DOI 10.1073/pnas.0407926102; WYSS U, 1992, NEMATOLOGICA, V38, P98, DOI 10.1163/187529292X00081; Yang SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002973; Zhao XW, 2000, PHYTOPATHOLOGY, V90, P1239, DOI 10.1094/PHYTO.2000.90.11.1239	73	30	32	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61259	10.1371/journal.pone.0061259	http://dx.doi.org/10.1371/journal.pone.0061259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593446	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300068
J	Nishimura, T; Sato, S; Tawong, W; Sakanari, H; Uehara, K; Shah, MMR; Suda, S; Yasumoto, T; Taira, Y; Yamaguchi, H; Adachi, M				Nishimura, Tomohiro; Sato, Shinya; Tawong, Wittaya; Sakanari, Hiroshi; Uehara, Keita; Shah, Md Mahfuzur Rahman; Suda, Shoichiro; Yasumoto, Takeshi; Taira, Yohsuke; Yamaguchi, Haruo; Adachi, Masao			Genetic Diversity and Distribution of the Ciguatera-Causing Dinoflagellate Gambierdiscus spp. (Dinophyceae) in Coastal Areas of Japan	PLOS ONE			English	Article							TOXIC BENTHIC DINOFLAGELLATE; 1ST REPORT; JEJU ISLAND; TAXONOMY; GONYAULACALES; IDENTIFICATION; MORPHOLOGY; INFERENCE; CARIBAEUS; MRBAYES	Background: The marine epiphytic dinoflagellate genus Gambierdiscus produce toxins that cause ciguatera fish poisoning (CFP): one of the most significant seafood-borne illnesses associated with fish consumption worldwide. So far, occurrences of CFP incidents in Japan have been mainly reported in subtropical areas. A previous phylogeographic study of Japanese Gambierdiscus revealed the existence of two distinct phylotypes: Gambierdiscus sp. type 1 from subtropical and Gambierdiscus sp. type 2 from temperate areas. However, details of the genetic diversity and distribution for Japanese Gambierdiscus are still unclear, because a comprehensive investigation has not been conducted yet. Methods/Principal Finding: A total of 248 strains were examined from samples mainly collected from western and southern coastal areas of Japan during 2006-2011. The SSU rDNA, the LSU rDNA D8-D10 and the ITS region were selected as genetic markers and phylogenetic analyses were conducted. The genetic diversity of Japanese Gambierdiscus was high since five species/phylotypes were detected: including two reported phylotypes (Gambierdiscus sp. type 1 and Gambierdiscus sp. type 2), two species of Gambierdiscus (G. australes and G. cf. yasumotoi) and a hitherto unreported phylotype Gambierdiscus sp. type 3. The distributions of type 3 and G. cf. yasumotoi were restricted to the temperate and the subtropical area, respectively. On the other hand, type 1, type 2 and G. australes occurred from the subtropical to the temperate area, with a tendency that type 1 and G. australes were dominant in the subtropical area, whereas type 2 was dominant in the temperate area. By using mouse bioassay, type 1, type 3 and G. australes exhibited mouse toxicities. Conclusions/Significance: This study revealed a surprising diversity of Japanese Gambierdiscus and the distribution of five species/phylotypes displayed clear geographical patterns in Japanese coastal areas. The SSU rDNA and the LSU rDNA D8-D10 as genetic markers are recommended for further use.	[Nishimura, Tomohiro; Tawong, Wittaya; Sakanari, Hiroshi; Uehara, Keita; Yamaguchi, Haruo; Adachi, Masao] Kochi Univ, Fac Agr, Nankoku, Kochi 783, Japan; [Nishimura, Tomohiro; Tawong, Wittaya] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime, Japan; [Sato, Shinya] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Sato, Shinya] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Shah, Md Mahfuzur Rahman; Suda, Shoichiro] Univ Ryukyus, Fac Sci, Okinawa, Japan; [Shah, Md Mahfuzur Rahman] Jeju Natl Univ, Coll Ocean Sci, Cheju, South Korea; [Yasumoto, Takeshi] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Taira, Yohsuke] Okinawa Inst Sci & Technol, Evolutionary Syst Biol Unit, Okinawa, Japan	Kochi University; Ehime University; Cardiff University; University of the Ryukyus; Jeju National University; Japan Fisheries Research & Education Agency (FRA); Okinawa Institute of Science & Technology Graduate University	Adachi, M (corresponding author), Kochi Univ, Fac Agr, Nankoku, Kochi 783, Japan.	madachi@kochi-u.ac.jp	Suda, Shoichiro/ABA-9738-2020; Nishimura, Tomohiro/G-6073-2019	Nishimura, Tomohiro/0000-0001-7040-7576	Food Safety Commission, Japan [0904]; Grants-in-Aid for Scientific Research [24580268] Funding Source: KAKEN	Food Safety Commission, Japan(Food Safety Commission of Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid from Food Safety Commission, Japan (NO. 0904). The URL is http://www.fsc.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI R, 1979, B JPN SOC SCI FISH, V45, P67; [Anonymous], 2002, 23 PICES; Bagnis Raymond, 1993, P105; Caillaud A, 2010, TOXICON, V56, P36, DOI 10.1016/j.toxicon.2010.03.012; Chinain M, 1999, J PHYCOL, V35, P1282, DOI 10.1046/j.1529-8817.1999.3561282.x; Chinain M, 2010, TOXICON, V56, P674, DOI 10.1016/j.toxicon.2009.05.032; Chinain M, 2010, TOXICON, V56, P739, DOI 10.1016/j.toxicon.2009.06.013; Chou HN, 2001, P JOINT TAIW AUSTR A, V4, P277; Faust MA, 1995, J PHYCOL, V31, P996, DOI 10.1111/j.0022-3646.1995.00996.x; Fleming L. E., 1998, HARMFUL ALGAE, P245; Fraga S, 2011, HARMFUL ALGAE, V11, P10, DOI 10.1016/j.hal.2011.06.013; Hara Y., 1982, MEM NATL SCI MUS, V15, P99; Hatayama Y, 2011, NIPPON SUISAN GAKK, V77, P685, DOI 10.2331/suisan.77.685; Holmes MJ, 1998, J PHYCOL, V34, P661, DOI 10.1046/j.1529-8817.1998.340661.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishikawa Akira, 2010, Bulletin of the Japanese Society of Fisheries Oceanography, V74, P13; Jeong HJ, 2012, J EUKARYOT MICROBIOL, V59, P637, DOI 10.1111/j.1550-7408.2012.00645.x; Jung SW, 2010, J APPL PHYCOL, V22, P319, DOI 10.1007/s10811-009-9462-5; Ki JS, 2011, J PHYCOL, V47, P426, DOI 10.1111/j.1529-8817.2010.00950.x; Kim Hyung Seop, 2011, Ocean Science Journal, V46, P205, DOI 10.1007/s12601-011-0016-9; KOIKE K, 1991, NIPPON SUISAN GAKK, V57, P2261; Kuno S, 2010, PHYCOL RES, V58, P44, DOI 10.1111/j.1440-1835.2009.00557.x; Leaw CP, 2011, PHYCOL RES, V59, P143, DOI 10.1111/j.1440-1835.2011.00612.x; Lehane L, 2000, INT J FOOD MICROBIOL, V61, P91, DOI 10.1016/S0168-1605(00)00382-2; LENAERS G, 1989, J MOL EVOL, V29, P40, DOI 10.1007/BF02106180; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Litaker RW, 2010, TOXICON, V56, P711, DOI 10.1016/j.toxicon.2010.05.017; Litaker RW, 2009, PHYCOLOGIA, V48, P344, DOI 10.2216/07-15.1; Litaker RW, 2005, J PHYCOL, V41, P643, DOI 10.1111/j.1529-8817.2005.00075.x; Litaker RW, 2003, J PHYCOL, V39, P754, DOI 10.1046/j.1529-8817.2003.02112.x; Mohammad-Noor N, 2004, NORD J BOT, V24, P629, DOI 10.1111/j.1756-1051.2004.tb01938.x; Moniz MBJ, 2009, MOL ECOL RESOUR, V9, P65, DOI 10.1111/j.1755-0998.2009.02633.x; Naik RK, 2011, ENVIRON MONIT ASSESS, V182, P15, DOI 10.1007/s10661-010-1855-z; Nylander JAA., 2004, BIOINFORMATICS; Omura T, 2010, GEOHAB M HON HAW US; Oshiro N., 2011, Tropical Medicine and Health, V39, P53, DOI 10.2149/tmh.2011-03; Oshiro N, 2010, TOXICON, V56, P656, DOI 10.1016/j.toxicon.2009.05.036; Parsons ML, 2012, HARMFUL ALGAE, V14, P107, DOI 10.1016/j.hal.2011.10.017; Pocsidio GN, 2004, PHILIPP AGRIC SCI, V87, P148; Ragelis E.P., 1984, SEAFOOD TOXINS, P22; Richlen ML, 2008, HARMFUL ALGAE, V7, P614, DOI 10.1016/j.hal.2007.12.020; Roeder K, 2010, TOXICON, V56, P731, DOI 10.1016/j.toxicon.2009.07.039; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027983; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takano Y, 2006, J PHYCOL, V42, P251, DOI 10.1111/j.1529-8817.2006.00177.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taniyama S, 2008, NIPPON SUISAN GAKK, V74, P917, DOI 10.2331/suisan.74.917; Tester PA, 2010, TOXICON, V56, P698, DOI 10.1016/j.toxicon.2010.02.026; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Usup G, 2002, P REG S ENV NAT RES, V1, P144; Yasumoto T, 1996, J TOXICOL-TOXIN REV, V15, P91, DOI 10.3109/15569549609064079; YASUMOTO T, 1977, B JPN SOC SCI FISH, V43, P1021, DOI 10.2331/suisan.43.1021; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x	56	86	89	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60882	10.1371/journal.pone.0060882	http://dx.doi.org/10.1371/journal.pone.0060882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593339	gold, Green Published, Green Submitted			2022-12-27	WOS:000317383200024
J	Roca-Rivada, A; Castelao, C; Senin, LL; Landrove, MO; Baltar, J; Crujeiras, AB; Seoane, LM; Casanueva, FF; Pardo, M				Roca-Rivada, Arturo; Castelao, Cecilia; Senin, Lucia L.; Landrove, Maria O.; Baltar, Javier; Belen Crujeiras, Ana; Maria Seoane, Luisa; Casanueva, Felipe F.; Pardo, Maria			FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; GENE-EXPRESSION; ENDOCRINE ORGAN; IRISIN; MUSCLE; IDENTIFICATION; EXERCISE; FAT; THERMOGENESIS; PGC-1-ALPHA	Exercise provides clear beneficial effects for the prevention of numerous diseases. However, many of the molecular events responsible for the curative and protective role of exercise remain elusive. The recent discovery of FNDC5/irisin protein that is liberated by muscle tissue in response to exercise might be an important finding with regard to this unsolved mechanism. The most striking aspect of this myokine is its alleged capacity to drive brown-fat development of white fat and thermogenesis. However, the nature and secretion form of this new protein is controversial. The present study reveals that rat skeletal muscle secretes a 25 kDa form of FNDC5, while the 12 kDa/irisin theoretical peptide was not detected. More importantly, this study is the first to reveal that white adipose tissue (WAT) also secretes FNDC5; hence, it may also behave as an adipokine. Our data using rat adipose tissue explants secretomes proves that visceral adipose tissue (VAT), and especially subcutaneous adipose tissue (SAT), express and secrete FNDC5. We also show that short-term periods of endurance exercise training induced FNDC5 secretion by SAT and VAT. Moreover, we observed that WAT significantly reduced FNDC5 secretion in fasting animals. Interestingly, WAT of obese animals over-secreted this hormone, which might suggest a type of resistance. Because 72% of circulating FNDC5/irisin was previously attributed to muscle secretion, our findings suggest a muscle-adipose tissue crosstalk through a regulatory feedback mechanism.	[Roca-Rivada, Arturo; Castelao, Cecilia; Landrove, Maria O.; Pardo, Maria] Complexo Hosp Univ Santiago CHUS SERGAS, Lab Endocrinol Mol & Celular, Inst Invest Sanitaria Santiago de Compostela IDIS, Grp Obesidom, Santiago De Compostela, Spain; [Castelao, Cecilia; Senin, Lucia L.; Maria Seoane, Luisa] Complexo Hosp Univ Santiago CHUS SERGAS, Lab Endocrinol Mol & Celular, Inst Invest Sanitaria Santiago de Compostela, Grp Fisiopatol Endocrina, Santiago De Compostela, Spain; [Roca-Rivada, Arturo; Castelao, Cecilia; Belen Crujeiras, Ana; Maria Seoane, Luisa; Casanueva, Felipe F.; Pardo, Maria] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain; [Baltar, Javier] Complexo Hosp Univ Santiago CHUS SERGAS, Serv Cirugia Gen, Santiago De Compostela, Spain; [Belen Crujeiras, Ana; Casanueva, Felipe F.] Complejo Hosp Santiago CHUS SERGAS, Lab Endocrinol Mol & Celular, Inst Invest Sanitaria Santiago IDIS, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Pardo, M (corresponding author), Complexo Hosp Univ Santiago CHUS SERGAS, Lab Endocrinol Mol & Celular, Inst Invest Sanitaria Santiago de Compostela IDIS, Grp Obesidom, Santiago De Compostela, Spain.	maruxapardo@hotmail.com	Pardo, María/C-5124-2012; Crujeiras, Ana/ABA-8866-2021	Pardo, María/0000-0002-9967-1650; Crujeiras, Ana/0000-0003-4392-0301; Roca-Rivada, Arturo/0000-0002-0048-3589	Instituto de Salud Carlos III (Ministerio de Economia y Competitividad de Espana) [FISP10/00537]; CIBER Fisiopatologia Obesidad y Nutricion (CB06/03), Instituto de Salud Carlos III	Instituto de Salud Carlos III (Ministerio de Economia y Competitividad de Espana); CIBER Fisiopatologia Obesidad y Nutricion (CB06/03), Instituto de Salud Carlos III	This work has been funded by Instituto de Salud Carlos III (Ministerio de Economia y Competitividad de Espana): FISP10/00537. AR-R and CC are funded by CIBER Fisiopatologia Obesidad y Nutricion (CB06/03), Instituto de Salud Carlos III. MP is a Miguel Servet Fellow (Instituto de Salud Carlos III/SERGAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Massadi O, 2010, AM J PHYSIOL-ENDOC M, V299, pE341, DOI 10.1152/ajpendo.00057.2010; Alvarez-Llamas G, 2007, MOL CELL PROTEOMICS, V6, P589, DOI 10.1074/mcp.M600265-MCP200; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bouassida A, 2010, BRIT J SPORT MED, V44, P620, DOI 10.1136/bjsm.2008.046151; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Castillo-Quan JI, 2012, DIS MODEL MECH, V5, P293, DOI 10.1242/dmm.009894; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Cunha Andreia, 2012, Nat Rev Endocrinol, V8, P195, DOI 10.1038/nrendo.2012.11; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hathout Y, 2007, EXPERT REV PROTEOMIC, V4, P239, DOI 10.1586/14789450.4.2.239; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kelly DP, 2012, SCIENCE, V336, P42, DOI 10.1126/science.1221688; Kozak LP, 2010, INT J OBESITY, V34, pS23, DOI 10.1038/ijo.2010.179; Matsuzawa Y, 2008, INT J OBESITY, V32, pS83, DOI 10.1038/ijo.2008.243; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Pardo M, 2007, J PROTEOME RES, V6, P2802, DOI 10.1021/pr070021t; Pardo M, 2010, PEPTIDES, V31, P1912, DOI 10.1016/j.peptides.2010.06.022; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Roca-Rivada A, 2012, J PROTEOMICS, V75, P5414, DOI 10.1016/j.jprot.2012.06.037; Roca-Rivada A, 2011, J PROTEOMICS, V74, P1068, DOI 10.1016/j.jprot.2011.03.010; ROUTTENBERG A, 1967, J COMP PHYSIOL PSYCH, V64, P414, DOI 10.1037/h0025205; Ruschke K, 2010, EUR J ENDOCRINOL, V162, P515, DOI 10.1530/EJE-09-0767; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sanchis-Gomar F, 2012, J DIABETES, V4, P196, DOI 10.1111/j.1753-0407.2012.00194.x; Santosa S, 2008, AM J PHYSIOL-ENDOC M, V295, pE531, DOI 10.1152/ajpendo.90357.2008; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Timmons JA, 2005, FASEB J, V19, P750, DOI 10.1096/fj.04-1980com; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Villarroya F, 2012, CELL METAB, V15, P277, DOI 10.1016/j.cmet.2012.02.010; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105	41	425	446	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60563	10.1371/journal.pone.0060563	http://dx.doi.org/10.1371/journal.pone.0060563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593248	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200013
J	Yoo, HS; Seo, JH; Yoo, JY				Yoo, Hyun-Seok; Seo, Jung-Hwa; Yoo, Joo-Yeon			CTR9, a Component of PAF Complex, Controls Elongation Block at the c-Fos Locus via Signal-Dependent Regulation of Chromatin-Bound NELF Dissociation	PLOS ONE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; GENE-EXPRESSION; TERMINAL DOMAIN; KINASE-I; POL-II; INITIATION; IDENTIFICATION; PROMOTER	PAF complex (PAFc) is an RNA polymerase II associated factor that controls diverse steps of transcription. Although it is generally associated with actively transcribed genes, a repressive PAFc has also been suggested. Here, we report that PAFc regulates the transition from transcription initiation to transcription elongation. PAFc repressed IL-6-induced, but not TNF-alpha-induced, immediate early gene expression. PAFc constitutively associated with the 5'-coding region of the c-Fos locus, then transiently dissociated upon IL-6 stimulation. When CTR9, a component of PAFc, was depleted, higher levels of serine 5-phosphorylated or serine 2-phosphorylated forms of RNA Polymerase II were associated with the unstimulated c-Fos locus. We also observed an increased association of CDK9, a kinase component of the pTEF-b elongation factor, with the c-Fos locus in the CTR9-depleted condition. Furthermore, association of negative elongation factor, NELF, which is required to proceed to the elongation phase, was significantly reduced by CTR9 depletion, whereas elongation factor SPT5 recruitment was enhanced by CTR9 depletion. Finally, the chromatin association of CTR9 was specifically controlled by IL-6-induced kinase activity, because a JAK2 kinase inhibitor, AG-490, blocked its association. In conclusion, our data suggest that PAFc controls the recruitment of NELF and SPT5 to target loci in a signal- and locus-specific manner.	[Yoo, Hyun-Seok; Seo, Jung-Hwa; Yoo, Joo-Yeon] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea	Pohang University of Science & Technology (POSTECH)	Yoo, JY (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea.	jyoo@postech.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A2A2A01007525, KRF-2008-313-C00604]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NO. 2012R1A2A2A01007525 and KRF-2008-313-C00604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; BLANCHARD JM, 1988, BIOCHIMIE, V70, P877, DOI 10.1016/0300-9084(88)90228-3; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Cochran B H, 1993, NIDA Res Monogr, V125, P3; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crisucci EM, 2011, EUKARYOT CELL, V10, P712, DOI 10.1128/EC.05013-11; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; Fujita T, 2009, EXP CELL RES, V315, P274, DOI 10.1016/j.yexcr.2008.10.032; Gess B, 1997, PFLUG ARCH EUR J PHY, V433, P827, DOI 10.1007/s004240050351; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Koch C, 1999, NUCLEIC ACIDS RES, V27, P2126, DOI 10.1093/nar/27.10.2126; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Malek SN, 1996, J BIOL CHEM, V271, P6952, DOI 10.1074/jbc.271.12.6952; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; NAKAJIMA K, 1993, MOL CELL BIOL, V13, P3027, DOI 10.1128/MCB.13.5.3027; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Pruneski JA, 2011, EUKARYOT CELL, V10, P1283, DOI 10.1128/EC.05141-11; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Takahashi A, 2011, MOL CELL, V43, P45, DOI 10.1016/j.molcel.2011.05.014; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; Youn MY, 2007, J BIOL CHEM, V282, P34727, DOI 10.1074/jbc.M705411200; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	47	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61055	10.1371/journal.pone.0061055	http://dx.doi.org/10.1371/journal.pone.0061055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593388	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200037
J	Amendah, DD; Mukamah, G; Komba, A; Ndila, C; Williams, TN				Amendah, Djesika D.; Mukamah, George; Komba, Albert; Ndila, Carolyne; Williams, Thomas N.			Routine Paediatric Sickle Cell Disease (SCD) Outpatient Care in a Rural Kenyan Hospital: Utilization and Costs	PLOS ONE			English	Article							HEALTH-CARE; CHILDREN; EXPENDITURES; PROGRAM; COHORT; ADULTS	Background: More than 70% of children with sickle cell disease (SCD) are born in sub-Saharan Africa where the prevalence at birth of this disease reaches 2% or higher in some selected areas. There is a dearth of knowledge on comprehensive care received by children with SCD in sub-Saharan Africa and its associated cost. Such knowledge is important for setting prevention and treatment priorities at national and international levels. This study focuses on routine care for children with SCD in an outpatient clinic of the Kilifi District Hospital, located in a rural area on the coast of Kenya. Objective: To estimate the per-patient costs for routine SCD outpatient care at a rural Kenyan hospital. Methods: We collected routine administrative and primary cost data from the SCD outpatient clinic and supporting departments at Kilifi District Hospital, Kenya. Costs were estimated by evaluating inputs - equipment, medication, supplies, building use, utility, and personnel - to reflect the cost of offering this service within an existing healthcare facility. Annual economic costs were similarly calculated based on input costs, prorated lifetime of equipment and appropriate discount rate. Sensitivity analyses evaluated these costs under different pay scales and different discount rate. Results: We estimated that the annual economic cost per patient attending the SCD clinic was USD 138 in 2010 with a range of USD 94 to USD 229. Conclusion: This study supplies the first published estimate of the cost of routine outpatient care for children born with SCD in sub-Saharan Africa. Our study provides policy makers with an indication of the potential future costs of maintaining specialist outpatient clinics for children living with SCD in similar contexts.	[Amendah, Djesika D.] African Populat Hlth Res Ctr, Nairobi, Kenya; [Mukamah, George; Komba, Albert; Ndila, Carolyne; Williams, Thomas N.] Ctr Geog Med Res Coast, Kenya Med Res Inst KEMRI, Kilifi, Kenya; [Williams, Thomas N.] INDEPTH Network Demog Surveillance Sites, Accra, Ghana; [Williams, Thomas N.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Williams, Thomas N.] Global Network Sickle Cell Dis, Toronto, ON, Canada	African Population & Health Research Centre; Kenya Medical Research Institute; INDEPTH Network; University of Oxford	Amendah, DD (corresponding author), African Populat Hlth Res Ctr, Nairobi, Kenya.	damendah@aphrc.org			Wellcome Trust [076934]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust through a fellowship awarded to TNW (grant 076934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa Public Health Information Service, 2010, AFRICA HEALTH FINANC; Amendah DD, 2010, AM J PREV MED, V38, pS550, DOI 10.1016/j.amepre.2010.01.004; Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Berruti AA, 2011, THE COST OF COMPREHE; Central Bank of Kenya, 2010, INDICATIVE EXCHANGE; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Gold MR, 1996, COST EFFECTIVENESS I; Kauf TL, 2009, AM J HEMATOL, V84, P323, DOI 10.1002/ajh.21408; Komba AN, 2009, CLIN INFECT DIS, V49, P216, DOI 10.1086/599834; Lanzkron S, 2008, ANN INTERN MED, V148, P939, DOI 10.7326/0003-4819-148-12-200806170-00221; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; Marsh VM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-13; Marti-Carvajal AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004344.pub3; Mosf, 2009, PLANNING MOSF; Mvundura M, 2009, PEDIATR BLOOD CANCER, V53, P642, DOI 10.1002/pbc.22069; Obiero W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053380; Odunvbun ME, 2008, PUBLIC HEALTH, V122, P1111, DOI 10.1016/j.puhe.2008.01.008; Ohene-Frempong K, 2010, BURDEN OF SICKLE CEL; Olnes M, 2009, AM J HEMATOL, V84, P530, DOI 10.1002/ajh.21446; Rahimy MC, 1999, AM J HEMATOL, V62, P1; RAHIMY MC, 2003, BLOOD, V102, P834, DOI DOI 10.1182/blood-2002-05-1453; Raphael JL, 2008, PEDIATR BLOOD CANCER, V51, P82, DOI 10.1002/pbc.21483; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sadarangani M, 2009, BRIT J HAEMATOL, V146, P675, DOI 10.1111/j.1365-2141.2009.07771.x; Scott JAG, LANCET IN PRESS; Segbena AY, 1998, AM J HEMATOL, V59, P208, DOI 10.1002/(SICI)1096-8652(199811)59:3<208::AID-AJH5>3.0.CO;2-R; Streetly A, 2010, J CLIN PATHOL, V63, P626, DOI 10.1136/jcp.2010.077560; Weatherall DJ, 2011, BR J HAEMATOL; Williams RM, 2007, J NATL MED ASSOC, V99, P276; World Health Organization, 2006, EXECUTIVE BOARD RESO	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61130	10.1371/journal.pone.0061130	http://dx.doi.org/10.1371/journal.pone.0061130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593408	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600084
J	Huang, G; Wen, QJ; Zhao, YL; Gao, QG; Bai, Y				Huang, Gang; Wen, Qianjun; Zhao, Yongliang; Gao, Qiangguo; Bai, Yun			NF-kappa B Plays a Key Role in Inducing CD274 Expression in Human Monocytes after Lipopolysaccharide Treatment	PLOS ONE			English	Article							AUTOIMMUNE-DISEASE; T-CELLS; PD-1; ACTIVATION; RECEPTOR; LIGANDS; B7-H1; TRANSCRIPTION; PATHWAYS; SEPSIS	CD274, one of two co-stimulatory ligands for programmed death 1 and widely expressed in the mononuclear phagocyte system (MPS), may co-stimulate T cells and regulates inflammatory responses. However, changes in CD274 gene expression and the underlying molecular mechanism are poorly understood during inflammatory responses. Therefore, delineation of the complex mechanisms regulating CD274 expression is critical to understand this immunoregulatory system during inflammatory responses. The purpose of this study was to assess the molecular mechanisms regulating CD274 expression in an in vitro monocyte model of inflammatory response. Firstly, CD274 expression levels in human primary monocytes after lipopolysaccharide (LPS) treatment were observed and correlated with NF-kappa B activation. Secondly, based on the distribution of putative NF-kappa B binding sites, 59 truncated human CD274 promoter reporters were constructed, transfected into U937 cells and critical promoter regions for basal (nt -570 to +94) and LPS-induced (nt -1735 to -570) transcription were identified by dual luciferase assays. Finally, a key NF-kappa B binding site (nt -610 to -601) for LPS-inducible CD274 transcriptional activity was characterized by point mutation analysis and chromatin immunoprecipitation analysis assays (ChIP). Thus, the present study establishes a molecular basis to understand the mechanisms governing CD274 expression in certain infections and inflammatory disorders.	[Huang, Gang; Bai, Yun] Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China; [Wen, Qianjun] Guiyang Med Coll, Affiliated Hosp, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Zhao, Yongliang] Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Gao, Qiangguo] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China	Army Medical University; Guizhou Medical University; Army Medical University; Army Medical University	Bai, Y (corresponding author), Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China.	baiyungene@gmail.com			National Natural Science Foundation of China [81000834]; China Postdoctoral Science Foundation [20070420769]; Natural Science Foundation of Chongqing [CSTC2007BB5077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This work was supported by the National Natural Science Foundation of China (No. 81000834), the China Postdoctoral Science Foundation funded project (20070420769), the Natural Science Foundation of Chongqing (CSTC2007BB5077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Chang ZL, 2009, BIOL CELL, V101, P709, DOI 10.1042/BC20080227; Dong HD, 2006, CELL MOL IMMUNOL, V3, P179; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kumar V, 2009, INT IMMUNOPHARMACOL; Lee SK, 2005, J DERMATOL SCI, V40, P95, DOI 10.1016/j.jdermsci.2005.06.008; LegrandPoels S, 1997, BIOCHEM PHARMACOL, V53, P339; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Maier LM, 2009, IMMUNOL REV, V229, P322, DOI 10.1111/j.1600-065X.2009.00777.x; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Paukov V S, 2005, Arkh Patol, V67, P3; Pentcheva-Hoang T, 2009, IMMUNOL REV, V229, P67, DOI 10.1111/j.1600-065X.2009.00763.x; Podojil JR, 2009, IMMUNOL REV, V229, P337, DOI 10.1111/j.1600-065X.2009.00773.x; Qian YG, 2008, CANCER INVEST, V26, P816, DOI 10.1080/07357900801941852; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; Seo SK, 2008, IMMUNOLOGY, V123, P90, DOI 10.1111/j.1365-2567.2007.02708.x; Wang TS, 2008, J MOL MED, V86, P495, DOI 10.1007/s00109-007-0300-4; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538	29	63	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61602	10.1371/journal.pone.0061602	http://dx.doi.org/10.1371/journal.pone.0061602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585913	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600128
J	Soriano-Tarraga, C; Jimenez-Conde, J; Giralt-Steinhauer, E; Ois, A; Rodriguez-Campello, A; Cuadrado-Godia, E; Fernandez-Cadenas, I; Montaner, J; Lucas, G; Elosua, R; Roquer, J				Soriano-Tarraga, Carolina; Jimenez-Conde, Jordi; Giralt-Steinhauer, Eva; Ois, Angel; Rodriguez-Campello, Ana; Cuadrado-Godia, Elisa; Fernandez-Cadenas, Israel; Montaner, Joan; Lucas, Gavin; Elosua, Roberto; Roquer, Jaume		GeneStroke Spanish Stroke Genetics	DNA Isolation Method Is a Source of Global DNA Methylation Variability Measured with LUMA. Experimental Analysis and a Systematic Review	PLOS ONE			English	Article							CANCER; IMPACT; DAMAGE; CELLS; EPIGENOMICS; EPIGENETICS; ASSAY	In DNA methylation, methyl groups are covalently bound to CpG dinucleotides. However, the assumption that methyl groups are not lost during routine DNA extraction has not been empirically tested. To avoid nonbiological associations in DNA methylation studies, it is essential to account for potential batch effect bias in the assessment of this epigenetic mechanism. Our purpose was to determine if the DNA isolation method is an independent source of variability in methylation status. We quantified Global DNA Methylation (GDM) by luminometric methylation assay (LUMA), comparing the results from 3 different DNA isolation methods. In the controlled analysis (n = 9), GDM differed slightly for the same individual depending on extraction method. In the population analysis (n = 580) there were significant differences in GDM between the 3 DNA isolation methods (medians, 78.1%, 76.5% and 75.1%; p<0.001). A systematic review of published data from LUMA GDM studies that specify DNA extraction methods is concordant with our findings. DNA isolation method is a source of GDM variability measured with LUMA. To avoid possible bias, the method used should be reported and taken into account in future DNA methylation studies.	[Soriano-Tarraga, Carolina; Jimenez-Conde, Jordi; Giralt-Steinhauer, Eva; Ois, Angel; Rodriguez-Campello, Ana; Cuadrado-Godia, Elisa; Roquer, Jaume] Inst Hosp Mar Invest Med IMIM, Dept Neurol, Neurovasc Res Grp, Barcelona, Spain; [Fernandez-Cadenas, Israel; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall dHebron, Neurovasc Res Lab, Inst Recerca, E-08193 Barcelona, Spain; [Fernandez-Cadenas, Israel] Fundacio Docencia & Recerca Mutua Terrassa, Lab Neurovasc Pharmacogen & Genet, Terrassa, Barcelona, Spain; [Lucas, Gavin; Elosua, Roberto] Inst Hosp Mar Invest Med IMIM, Cardiovasc Epidemiol & Genet Group, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut Hospital del Mar d'Investigacions Mediques (IMIM)	Soriano-Tarraga, C (corresponding author), Inst Hosp Mar Invest Med IMIM, Dept Neurol, Neurovasc Res Grp, Barcelona, Spain.	csoriano@imim.es	TARRAGA, CAROLINA SORIANO/AAG-8777-2019; Campello, Ana Rodriguez/AAP-7757-2021; JIMENEZ-CONDE, JORDI/C-1941-2012; Montaner, Joan/D-3063-2015; Ois, A/X-2922-2019; Roquer, Jaume/G-8919-2017; Ois, A/AAE-7583-2022	Campello, Ana Rodriguez/0000-0001-8621-1420; Montaner, Joan/0000-0003-4845-2279; Ois, A/0000-0002-1375-5950; Roquer, Jaume/0000-0001-5992-2606; Ois, A/0000-0002-1375-5950; ELOSUA, ROBERTO/0000-0001-8235-0095; Giralt Steinhauer, Eva/0000-0002-7463-0983; Fernandez-Cadenas, Israel/0000-0003-4821-2363; Lucas, Gavin/0000-0003-4166-9416; Soriano Tarraga, Carolina/0000-0002-5635-273X; Cuadrado-Godia, Elisa/0000-0002-9147-875X	Spain's Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III "Registro BASICMAR'' [PI051737]; GWALA [PI10/02064]; Spanish Research Networks: "Red HERACLES'' [RD06/0009]; FEDER	Spain's Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III "Registro BASICMAR''; GWALA; Spanish Research Networks: "Red HERACLES''; FEDER(European Commission)	Grants were awarded by Spain's Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III "Registro BASICMAR'' Funding for Research in Health (PI051737) and "GWALA project (PI10/02064)'', and by Spanish Research Networks: "Red HERACLES'' (RD06/0009). FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Butcher LM, 2008, J GENET GENOMICS, V35, P391, DOI 10.1016/S1673-8527(08)60057-0; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Guetens G, 2002, CRIT REV CL LAB SCI, V39, P331, DOI 10.1080/10408360290795547; HARRIS G, 1994, CARCINOGENESIS, V15, P411, DOI 10.1093/carcin/15.2.411; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Karimi M, 2006, EPIGENETICS-US, V1, P45; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kvam E, 1997, CARCINOGENESIS, V18, P2281, DOI 10.1093/carcin/18.11.2281; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lumey LH, 2012, INT J EPIDEMIOL, V41, P116, DOI 10.1093/ije/dyr137; Nakajima M, 1996, CARCINOGENESIS, V17, P787, DOI 10.1093/carcin/17.4.787; Ois A, 2007, STROKE, V38, P2085, DOI 10.1161/STROKEAHA.107.482950; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pilsner JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037147; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Sugawara H, 2011, EPIGENETICS-US, V6, P509, DOI 10.4161/epi.6.4.14876; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Virani S, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-8; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wu HC, 2012, CANC EPIDEMIOL BIOMA; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; Xu XR, 2012, FASEB J, V26, P2657, DOI 10.1096/fj.11-197251; Zawia NH, 2009, FREE RADICAL BIO MED, V46, P1241, DOI 10.1016/j.freeradbiomed.2009.02.006; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	35	18	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60750	10.1371/journal.pone.0060750	http://dx.doi.org/10.1371/journal.pone.0060750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585847	gold, Green Published			2022-12-27	WOS:000317909600044
J	Chang, CY; Choi, DK; Lee, DK; Hong, YJ; Park, EJ				Chang, Chi Young; Choi, Dong-Kug; Lee, Dae Kee; Hong, Young Jun; Park, Eun Jung			Resveratrol Confers Protection against Rotenone-Induced Neurotoxicity by Modulating Myeloperoxidase Levels in Glial Cells	PLOS ONE			English	Article							MESENCEPHALIC DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; INFLAMMATORY RESPONSES; ACTIVATED MICROGLIA; MECHANISMS; MICE; EXPRESSION; DEATH; LIPOPOLYSACCHARIDE; ATHEROSCLEROSIS	Myeloperoxidase (MPO) functions as a key molecular component of the host defense system against diverse pathogens. We have previously reported that increased MPO levels and activity is a distinguishing feature of rotenone-exposed glial cells, and that either overactivation or deficiency of MPO leads to pathological conditions in the brain. Here, we provide that modulation of MPO levels in glia by resveratrol confers protective effects on rotenone-induced neurotoxicity. We show that resveratrol significantly reduced MPO levels but did not trigger abnormal nitric oxide (NO) production in microglia and astrocytes. Resveratrol-induced down-regulation of MPO, in the absence of an associated overproduction of NO, markedly attenuated rotenone-triggered inflammatory responses including phagocytic activity and reactive oxygen species production in primary microglia and astrocytes. In addition, impaired responses of primary mixed glia from Mpo(-/-) mice to rotenone were relieved by treatment with resveratrol. We further show that rotenone-induced neuronal injury, particularly dopaminergic cell death, was attenuated by resveratrol in neuron-glia co-cultures, but not in neurons cultured alone. Similar regulatory effects of resveratrol on MPO levels were observed in microglia treated with MPP+, another Parkinson's disease-linked neurotoxin, supporting the beneficial effects of resveratrol on the brain. Collectively, our findings provide that resveratrol influences glial responses to rotenone by regulating both MPO and NO, and thus protects against rotenone-induced neuronal injury.	[Chang, Chi Young; Park, Eun Jung] Natl Canc Ctr, Canc Immunol Branch, Goyang, South Korea; [Chang, Chi Young; Lee, Dae Kee] Ewha Womans Univ, Grad Sch, Div Life & Pharmaceut Sci, Seoul, South Korea; [Choi, Dong-Kug] Konkuk Univ, Dept Biotechnol, Coll Biomed & Hlth Sci, Chungju, South Korea; [Hong, Young Jun] Korea Canc Ctr Hosp, Dept Lab Med, Seoul, South Korea	National Cancer Center - Korea (NCC); Ewha Womans University; Konkuk University; National Cancer Center - Korea (NCC)	Park, EJ (corresponding author), Natl Canc Ctr, Canc Immunol Branch, Goyang, South Korea.	ejpark@ncc.re.kr		Lee, Daekee/0000-0001-8130-2059; Choi, Dong-Kug/0000-0001-7041-1524	National Cancer Center [1210380-1]; Korea Health Industry Development Institute [A090570-1002-0000100]	National Cancer Center; Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This work was supported by the National Cancer Center (1210380-1 to E.J.P.) and by a grant of the Korea Health Industry Development Institute (A090570-1002-0000100 to EJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2002, BEHAV BRAIN RES, V136, P317, DOI 10.1016/S0166-4328(02)00180-8; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bianchini F, 2003, EUR J CANCER PREV, V12, P417, DOI 10.1097/00008469-200310000-00011; Bournival J, 2009, CELL MOL NEUROBIOL, V29, P1169, DOI 10.1007/s10571-009-9411-5; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Candelario-Jalil E., 2007, J NEUROINFLAMM, V10, P4; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chang CY, 2011, AM J PATHOL, V179, P964, DOI 10.1016/j.ajpath.2011.04.033; Choi DK, 2005, J NEUROSCI, V25, P6594, DOI 10.1523/JNEUROSCI.0970-05.2005; Collo G, 2008, EUR J NEUROSCI, V28, P1231, DOI 10.1111/j.1460-9568.2008.06423.x; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Gao HM, 2003, J NEUROSCI, V23, P6181; Gao HM, 2003, J NEUROSCI, V23, P1228, DOI 10.1523/JNEUROSCI.23-04-01228.2003; Han BS, 2003, J NEUROSCI, V23, P5069; Jou I, 2006, AM J PATHOL, V168, P1619, DOI 10.2353/ajpath.2006.050924; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kumar AP, 2005, NITRIC OXIDE-BIOL CH, V13, P42, DOI 10.1016/j.niox.2005.04.002; Kutter D, 2000, ACTA HAEMATOL-BASEL, V104, P10, DOI 10.1159/000041062; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Matthijsen RA, 2007, AM J PATHOL, V171, P1743, DOI 10.2353/ajpath.2007.070184; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Milla C, 2004, AM J PHYSIOL-LUNG C, V287, pL706, DOI 10.1152/ajplung.00015.2004; Miller RL, 2009, NEUROCHEM RES, V34, P55, DOI 10.1007/s11064-008-9656-2; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Pasinetti GM, 2011, EXP NEUROL, V232, P1, DOI 10.1016/j.expneurol.2011.08.014; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Radad K, 2006, NEUROCHEM INT, V49, P379, DOI 10.1016/j.neuint.2006.02.003; Robb EL, 2008, BIOCHEM BIOPH RES CO, V367, P406, DOI 10.1016/j.bbrc.2007.12.138; Sawayama Y, 2008, LEUKEMIA, V22, P956, DOI 10.1038/leu.2008.8; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Sherer TB, 2003, NEUROSCI LETT, V341, P87, DOI 10.1016/S0304-3940(03)00172-1; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Yang MS, 2002, GLIA, V38, P273, DOI 10.1002/glia.10057; Zhang F, 2010, MOL PHARMACOL, V78, P466, DOI 10.1124/mol.110.064535; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	50	34	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60654	10.1371/journal.pone.0060654	http://dx.doi.org/10.1371/journal.pone.0060654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593274	Green Submitted, gold, Green Published			2022-12-27	WOS:000317898000046
J	Sun, H; Zhou, C; Huang, XQ; Lin, KQ; Shi, L; Yu, L; Liu, SY; Chu, JY; Yang, ZQ				Sun, Hao; Zhou, Chi; Huang, Xiaoqin; Lin, Keqin; Shi, Lei; Yu, Liang; Liu, Shuyuan; Chu, Jiayou; Yang, Zhaoqing			Autosomal STRs Provide Genetic Evidence for the Hypothesis That Tai People Originate from Southern China	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; MICROSATELLITE LOCI; MOLECULAR-DATA; INFERENCE; SOFTWARE; HISTORY; GENOME; MODEL; SEQUENCE	Tai people are widely distributed in Thailand, Laos and southwestern China and are a large population of Southeast Asia. Although most anthropologists and historians agree that modern Tai people are from southwestern China and northern Thailand, the place from which they historically migrated remains controversial. Three popular hypotheses have been proposed: northern origin hypothesis, southern origin hypothesis or an indigenous origin. We compared the genetic relationships between the Tai in China and their "siblings'' to test different hypotheses by analyzing 10 autosomal microsatellites. The genetic data of 916 samples from 19 populations were analyzed in this survey. The autosomal STR data from 15 of the 19 populations came from our previous study (Lin et al., 2010). 194 samples from four additional populations were genotyped in this study: Han (Yunnan), Dai (Dehong), Dai (Yuxi) and Mongolian. The results of genetic distance comparisons, genetic structure analyses and admixture analyses all indicate that populations from northern origin hypothesis have large genetic distances and are clearly differentiated from the Tai. The simulation-based ABC analysis also indicates this. The posterior probability of the northern origin hypothesis is just 0.04 [95%CI: (0.01-0.06)]. Conversely, genetic relationships were very close between the Tai and populations from southern origin or an indigenous origin hypothesis. Simulation-based ABC analyses were also used to distinguish the southern origin hypothesis from the indigenous origin hypothesis. The results indicate that the posterior probability of the southern origin hypothesis [0.640, 95%CI: (0.524-0.757)] is greater than that of the indigenous origin hypothesis [0.324, 95%CI: (0.211-0.438)]. Therefore, we propose that the genetic evidence does not support the hypothesis of northern origin. Our genetic data indicate that the southern origin hypothesis has higher probability than the other two hypotheses statistically, suggesting that the Tai people most likely originated from southern China.	[Chu, Jiayou] Peking Union Med Coll, Beijing, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College		chujy@imbcams.com.cn; zyang@imbcams.com.cn			Chinese National Natural Science Foundation [30971578]; Yunnan Science and Technology Program [2008ZC068M]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Yunnan Science and Technology Program	This work was supported by the Chinese National Natural Science Foundation (NO. 30971578 http://www.nsfc.gov.cn) and the Yunnan Science and Technology Program (NO. 2008ZC068M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no any individuals employed or contracted by the funders played a role in this study.	Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Cavalli-Sforza LL, 1998, P NATL ACAD SCI USA, V95, P11501, DOI 10.1073/pnas.95.20.11501; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chen L, 2005, ORIGIN THAI PEOPLE N; Chen X, 1962, 1 DRAFT SHAN DAI ANC; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Cochrane WW, 1915, SHANS; Colquhoun AR, 1885, AMONGST SHANS; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Davies HR, 1909, YUNNAN LIFE INDIA YA; de Laciyoerie T, 1887, LANGUAGES CHINA CHIN; Dodd WC, 1996, TAI RACE ELDER BROTH; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Excoffier L, 1998, AM J HUM GENET, V62, P171, DOI 10.1086/301674; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fan H, 2000, NATION SAME ROOT CUL; Fan HG, 2002, J GUANGXI U NATL, V24, P53; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; He P, 2001, YUNNAN ASSAM REEXAMI; Huang QY, 2002, AM J HUM GENET, V70, P625, DOI 10.1086/338997; Huang X, 2008, INVESTIGATION DIFFER; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jiang Y, 1983, HIST DAI; Jin HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004210; Lacouperie T, 1885, CRADLE SHAN RACE; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; LATTER BDH, 1972, GENETICS, V70, P475; Lin HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009895; Nakbunlung S, 1994, ORIGINS BIOL AFFINIT; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M, 1996, MOL BIOL EVOL, V13, P170, DOI 10.1093/oxfordjournals.molbev.a025553; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Scott JG, 1983, GAZETTEER UPPER BURM; SEAC, 2009, BRIEF HIST DAI; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Wright S, 1984, EVOLUTION GENETICS P, V4; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	51	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60822	10.1371/journal.pone.0060822	http://dx.doi.org/10.1371/journal.pone.0060822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593317	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000074
J	Zhu, NQ; Xia, HH; Wang, ZW; Zhao, XM; Chen, T				Zhu, Nianqing; Xia, Huihua; Wang, Zhiwen; Zhao, Xueming; Chen, Tao			Engineering of Acetate Recycling and Citrate Synthase to Improve Aerobic Succinate Production in Corynebacterium glutamicum	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACETYL-COENZYME; ACID; METABOLISM; FLUX; GROWTH	Corynebacterium glutamicum lacking the succinate dehydrogenase complex can produce succinate aerobically with acetate representing the major byproduct. Efforts to increase succinate production involved deletion of acetate formation pathways and overexpression of anaplerotic pathways, but acetate formation could not be completely eliminated. To address this issue, we constructed a pathway for recycling wasted carbon in succinate-producing C. glutamicum. The acetyl-CoA synthetase from Bacillus subtilis was heterologously introduced into C. glutamicum for the first time. The engineered strain ZX1 (pEacsA) did not secrete acetate and produced succinate with a yield of 0.50 mol (mol glucose)(-1). Moreover, in order to drive more carbon towards succinate biosynthesis, the native citrate synthase encoded by gltA was overexpressed, leading to strain ZX1 (pEacsAgltA), which showed a 22% increase in succinate yield and a 62% decrease in pyruvate yield compared to strain ZX1 (pEacsA). In fed-batch cultivations, strain ZX1 (pEacsAgltA) produced 241 mM succinate with an average volumetric productivity of 3.55 mM h-(1) and an average yield of 0.63 mol (mol glucose)(-1), making it a promising platform for the aerobic production of succinate at large scale.	[Zhu, Nianqing; Xia, Huihua; Wang, Zhiwen; Zhao, Xueming; Chen, Tao] Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; [Zhu, Nianqing; Xia, Huihua; Wang, Zhiwen; Zhao, Xueming; Chen, Tao] Tianjin Univ, Dept Biochem Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Chen, T (corresponding author), Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	chentao@tju.edu.cn	CHEN, Tao/N-1817-2015; Zhao, Xueming/W-4891-2019	CHEN, Tao/0000-0001-9588-1821; 	National Program on Key Basic Research Project [2011CBA00804, 2012CB725203]; National Natural Science Foundation of China [NSFC-21176182, NSFC-21206112]; National High-tech R&D Program of China [2012AA02A702, 2012AA022103]	National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China)	This work was supported by National Program on Key Basic Research Project (2011CBA00804, 2012CB725203), National Natural Science Foundation of China (NSFC-21176182, NSFC-21206112) and National High-tech R&D Program of China (2012AA02A702, 2012AA022103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauprez JJ, 2010, PROCESS BIOCHEM, V45, P1103, DOI 10.1016/j.procbio.2010.03.035; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Chang DE, 1999, J BACTERIOL, V181, P6656, DOI 10.1128/JB.181.21.6656-6663.1999; EIKMANNS BJ, 1994, MICROBIOL-SGM, V140, P1817, DOI 10.1099/13500872-140-8-1817; Huhn S, 2011, APPL MICROBIOL BIOT, V89, P327, DOI 10.1007/s00253-010-2855-1; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Kirchner O, 2003, J BIOTECHNOL, V104, P287, DOI 10.1016/S0168-1656(03)00148-2; Lee PC, 2003, BIOTECHNOL LETT, V25, P111, DOI 10.1023/A:1021907116361; Lee SJ, 2006, APPL ENVIRON MICROB, V72, P1939, DOI 10.1128/AEM.72.3.1939-1948.2006; Lee SY, 2004, MACROMOL BIOSCI, V4, P157, DOI 10.1002/mabi.200300096; Lin H, 2005, METAB ENG, V7, P337, DOI 10.1016/j.ymben.2005.06.002; Lin H, 2005, METAB ENG, V7, P116, DOI 10.1016/j.ymben.2004.10.003; Lin H, 2005, BIOTECHNOL BIOENG, V89, P148, DOI 10.1002/bit.20298; Litsanov B, 2012, APPL ENVIRON MICROB, V78, P3325, DOI 10.1128/AEM.07790-11; Litsanov B, 2012, MICROB BIOTECHNOL, V5, P116, DOI [10.1111/j.1751-7915.2011.00310.x, 10.1111/j.1751-7915.2012.00347.x]; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Petersen S, 2000, J BIOL CHEM, V275, P35932, DOI 10.1074/jbc.M908728199; Raab AM, 2010, METAB ENG, V12, P518, DOI 10.1016/j.ymben.2010.08.005; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Thakker C, 2013, BIORESOURCE TECHNOL, V130, P398, DOI 10.1016/j.biortech.2012.10.154; Underwood SA, 2002, APPL ENVIRON MICROB, V68, P1071, DOI 10.1128/AEM.68.3.1071-1081.2002; van Ooyen J, 2012, BIOTECHNOL BIOENG, V109, P2070, DOI 10.1002/bit.24486; Veit A, 2009, J BIOTECHNOL, V140, P75, DOI 10.1016/j.jbiotec.2008.12.014; Wendisch VF, 1997, ARCH MICROBIOL, V168, P262, DOI 10.1007/s002030050497; Werpy T, 2004, TOP VALUE ADDED CHEM, P31; Wieschalka S, 2012, APPL MICROBIOL BIOT, V94, P449, DOI 10.1007/s00253-011-3843-9; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yasuda K, 2007, APPL MICROBIOL BIOT, V77, P853, DOI 10.1007/s00253-007-1199-y; Youn JW, 2008, J BACTERIOL, V190, P6458, DOI 10.1128/JB.00780-08; Youn JW, 2009, J BACTERIOL, V191, P5480, DOI 10.1128/JB.00640-09; Yuzbashev TV, 2010, BIOTECHNOL BIOENG, V107, P673, DOI 10.1002/bit.22859; Zheng P, 2009, BIORESOURCE TECHNOL, V100, P2425, DOI 10.1016/j.biortech.2008.11.043; Zheng ZB, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-37; Zimmermann HF, 2006, APPL MICROBIOL BIOT, V72, P1157, DOI 10.1007/s00253-006-0414-6	34	40	48	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60659	10.1371/journal.pone.0060659	http://dx.doi.org/10.1371/journal.pone.0060659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593275	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000047
J	Athens, AA; Makris, EA; Hu, JC				Athens, Aristos A.; Makris, Eleftherios A.; Hu, Jerry C.			Induced Collagen Cross-Links Enhance Cartilage Integration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; CHONDROITINASE-ABC; REPAIR; TISSUE; BOVINE; MATURATION; STRENGTH; FAILURE; VITRO	Articular cartilage does not integrate due primarily to a scarcity of cross-links and viable cells at the interface. The objective of this study was to test the hypothesis that lysyl-oxidase, a metalloenzyme that forms collagen cross-links, would be effective in improving integration between native-to-native, as well as tissue engineered-to-native cartilage surfaces. To examine these hypotheses, engineered cartilage constructs, synthesized via the self-assembling process, as well as native cartilage, were implanted into native cartilage rings and treated with lysyl-oxidase for varying amounts of time. For both groups, lysyl-oxidase application resulted in greater apparent stiffness across the cartilage interface 2-2.2 times greater than control. The construct-to-native lysyl-oxidase group also exhibited a statistically significant increase in the apparent strength, here defined as the highest observed peak stress during tensile testing. Histology indicated a narrowing gap at the cartilage interface in lysyl-oxidase treated groups, though this alone is not sufficient to indicate annealing. However, when the morphological and mechanical data are taken together, the longer the duration of lysyl-oxidase treatment, the more integrated the interface appeared. Though further data are needed to confirm the mechanism of action, the enhancement of integration may be due to lysyl-oxidase-induced pyridinoline cross-links. This study demonstrates that lysyl-oxidase is a potent agent for enhancing integration between both native-to-native and native-to-engineered cartilages. The fact that interfacial strength increased manifold suggests that cross-linking agents should play a significant role in solving the difficult problem of cartilage integration. Future studies must examine dose, dosing regimen, and cellular responses to lysyl-oxidase to optimize its application.	[Athens, Aristos A.; Makris, Eleftherios A.; Hu, Jerry C.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Athens, Aristos A.] Davis Senior High Sch, Davis, CA USA; [Makris, Eleftherios A.] Univ Thessaly BIOMED, Dept Orthoped Surg & Musculoskeletal Trauma, Larisa, Greece	University of California System; University of California Davis	Hu, JC (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	jcyhu@ucdavis.edu	Hu, Jerry/E-7385-2013	Hu, Jerry/0000-0003-0651-1461	DHS Blue and White Foundation	DHS Blue and White Foundation	This work was supported by the DHS Blue and White Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan T, 2005, OSTEOARTHR CARTILAGE, V13, P709, DOI 10.1016/j.joca.2005.03.005; Ahsan T, 1999, J ORTHOPAED RES, V17, P850, DOI 10.1002/jor.1100170610; Archer CW, 2006, J ANAT, V209, P481, DOI 10.1111/j.1469-7580.2006.00624.x; Athanasiou K.A., 2009, ARTICULAR CARTILAGE; Augst A, 2008, J R SOC INTERFACE, V5, P929, DOI 10.1098/rsif.2007.1302; Bos PK, 2002, ARTHRITIS RHEUM-US, V46, P976, DOI 10.1002/art.10208; Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216; Elder BD, 2011, J MECH MED BIOL, V11, P433, DOI 10.1142/S0219519410003769; Eleswarapu SV, 2011, BIOCHEM BIOPH RES CO, V414, P431, DOI 10.1016/j.bbrc.2011.09.107; Englert C, 2006, ARTHRITIS RHEUM-US, V54, P3890, DOI 10.1002/art.22250; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Gratz KR, 2006, J BIOMECH, V39, P138, DOI 10.1016/j.jbiomech.2004.10.016; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS182; Hunziker EB, 1999, CLIN ORTHOP RELAT R, pS135; Hunziker EB, 2003, J BONE JOINT SURG AM, V85A, P85, DOI 10.2106/00004623-200300002-00011; Ionescu LC, 2011, TISSUE ENG PT A, V17, P193, DOI [10.1089/ten.tea.2010.0272, 10.1089/ten.TEA.2010.0272]; Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04; Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958; Leddy HA, 2003, ANN BIOMED ENG, V31, P753, DOI 10.1114/1.1581879; Maher SA, 2010, J TISSUE ENG REGEN M, V4, P25, DOI 10.1002/term.205; MAKRIS EA, 2013, FASEB IN PRESS; MAKRIS EA, 2013, OSTEOARTHRITIS CARTI; McGowan KB, 2005, J ORTHOP RES, V23, P594, DOI 10.1016/j.orthres.2004.02.015; MINNS RJ, 1977, J ANAT, V123, P437; Natoli RM, 2009, J ORTHOP RES, V27, P949, DOI 10.1002/jor.20821; Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4; Peretti GM, 2003, J BIOMED MATER RES A, V64A, P517, DOI 10.1002/jbm.a.10367; REINDEL ES, 1995, J ORTHOP RES, V13, P751, DOI 10.1002/jor.1100130515; Responte DJ, 2012, BIOMATERIALS, V33, P3187, DOI 10.1016/j.biomaterials.2012.01.028; Sierra DH, 2002, J BIOMED MATER RES, V59, P1; Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4; SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607; St-Pierre JP, 2012, ACTA BIOMATER, V8, P1603, DOI 10.1016/j.actbio.2011.12.022; Sun Y, 2012, TISSUE ENG PART C-ME, V18, P215, DOI [10.1089/ten.tec.2011.0343, 10.1089/ten.TEC.2011.0343]; Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X; Theodoropoulos JS, 2011, CLIN ORTHOP RELAT R, V469, P2785, DOI 10.1007/s11999-011-1856-4; Wang W, 2010, BIOMATERIALS, V31, P5953, DOI 10.1016/j.biomaterials.2010.04.029	38	30	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60719	10.1371/journal.pone.0060719	http://dx.doi.org/10.1371/journal.pone.0060719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593295	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100063
J	Park, J; Noh, K; Lee, HW; Lim, MS; Seong, SJ; Seo, JJ; Kim, EJ; Kang, W; Yoon, YR				Park, Jeonghyeon; Noh, Keumhan; Lee, Hae Won; Lim, Mi-Sun; Seong, Sook Jin; Seo, Jeong Ju; Kim, Eun-Jung; Kang, Wonku; Yoon, Young-Ran			Pharmacometabolomic Approach to Predict QT Prolongation in Guinea Pigs	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SUDDEN CARDIAC DEATH; FLUOROQUINOLONE ANTIBACTERIAL AGENTS; CORONARY-HEART-DISEASE; TORSADES-DE-POINTES; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; METABOLIC SYNDROME; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE	Drug-induced torsades de pointes (TdP), a life-threatening arrhythmia associated with prolongation of the QT interval, has been a significant reason for withdrawal of several medicines from the market. Prolongation of the QT interval is considered as the best biomarker for predicting the torsadogenic risk of a new chemical entity. Because of the difficulty assessing the risk for TdP during drug development, we evaluated the metabolic phenotype for predicting QT prolongation induced by sparfloxacin, and elucidated the metabolic pathway related to the QT prolongation. We performed electrocardiography analysis and liquid chromatography-mass spectroscopy-based metabolic profiling of plasma samples obtained from 15 guinea pigs after administration of sparfloxacin at doses of 33.3, 100, and 300 mg/kg. Principal component analysis and partial least squares modelling were conducted to select the metabolites that substantially contributed to the prediction of QT prolongation. QTc increased significantly with increasing dose (r = 0.93). From the PLS analysis, the key metabolites that showed the highest variable importance in the projection values (>1.5) were selected, identified, and used to determine the metabolic network. In particular, cytidine-5'-diphosphate (CDP), deoxycorticosterone, L-aspartic acid and stearic acid were found to be final metabolomic phenotypes for the prediction of QT prolongation. Metabolomic phenotypes for predicting drug-induced QT prolongation of sparfloxacin were developed and can be applied to cardiac toxicity screening of other drugs. In addition, this integrative pharmacometabolomic approach would serve as a good tool for predicting pharmacodynamic or toxicological effects caused by changes in dose.	[Park, Jeonghyeon; Seong, Sook Jin; Seo, Jeong Ju; Yoon, Young-Ran] Kyungpook Natl Univ, Sch Med, Dept Mol Med, Taegu, South Korea; [Park, Jeonghyeon; Seong, Sook Jin; Seo, Jeong Ju; Yoon, Young-Ran] Kyungpook Natl Univ, Sch Med, Program BK21, Taegu, South Korea; [Park, Jeonghyeon; Lee, Hae Won; Lim, Mi-Sun; Seong, Sook Jin; Seo, Jeong Ju; Yoon, Young-Ran] Kyungpook Natl Univ Hosp, Clin Trial Ctr, Taegu, South Korea; [Noh, Keumhan; Kang, Wonku] Yeungnam Univ, Coll Pharm, Kyungbuk, South Korea; [Kim, Eun-Jung] Korea Food & Drug Adm, Natl Inst Food & Drug Safety Evaluat, Chungbuk, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital; Yeungnam University; Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation	Kang, W (corresponding author), Yeungnam Univ, Coll Pharm, Kyungbuk, South Korea.	wonkuk@yu.ac.kr; yry@knu.ac.kr	Noh, Keumhan/AAM-8482-2021; Yoon, Young-Ran/GLT-0172-2022	Yoon, Young-Ran/0000-0003-2166-7579	Korea Food & Drug Administration [09172KFDA662]; National Project for Personalized Genomic Medicine [A111218-PG02]; Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology, Republic of Korea [2010-0022996]	Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Project for Personalized Genomic Medicine; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a grant (09172KFDA662) from the Korea Food & Drug Administration & the National Project for Personalized Genomic Medicine (A111218-PG02), Ministry of Health & Welfare, Republic of Korea, and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0022996), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests	Adamantidis MM, 1998, FUNDAM CLIN PHARM, V12, P70, DOI 10.1111/j.1472-8206.1998.tb00926.x; AHNVE S, 1982, CIRCULATION, V65, P435, DOI 10.1161/01.CIR.65.3.435; Akita Megumi, 2004, J Toxicol Sci, V29, P63, DOI 10.2131/jts.29.63; Anderson ME, 2001, J PHARMACOL EXP THER, V296, P806; Ball P, 1999, DRUG SAFETY, V21, P407, DOI 10.2165/00002018-199921050-00005; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Beckwith-Hall BM, 1998, CHEM RES TOXICOL, V11, P260, DOI 10.1021/tx9700679; Belardinelli L, 2003, TRENDS PHARMACOL SCI, V24, P619, DOI 10.1016/j.tips.2003.10.002; BELLAVERE F, 1988, BRIT HEART J, V59, P379; Beringer PM, 1998, PHARMACOECONOMICS, V13, P35, DOI 10.2165/00019053-199813010-00004; Bischoff U, 2000, EUR J PHARMACOL, V406, P341, DOI 10.1016/S0014-2999(00)00693-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burnham AJ, 1999, CHEMOMETR INTELL LAB, V48, P167, DOI 10.1016/S0169-7439(99)00018-0; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chan C, 2003, BIOTECHNOL PROGR, V19, P580, DOI 10.1021/bp025660h; Chen HJ, 2006, STROKE, V37, P1060, DOI 10.1161/01.STR.0000206458.58142.f3; Chen MJ, 2008, CHEM RES TOXICOL, V21, P288, DOI 10.1021/tx7002905; Cheng Hsien C., 2006, Journal of Pharmacological and Toxicological Methods, V54, P278, DOI 10.1016/j.vascn.2006.01.002; Chiba K, 2000, TOXICOL APPL PHARM, V169, P8, DOI 10.1006/taap.2000.9041; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Cox DA, 1997, J PHARMACOL EXP THER, V283, P305; Cubbon S, 2010, MASS SPECTROM REV, V29, P671, DOI 10.1002/mas.20252; De Sarro A, 2001, CURR MED CHEM, V8, P371; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Dufort I, 2001, J STEROID BIOCHEM, V77, P223, DOI 10.1016/S0960-0760(01)00057-7; ELGAMAL A, 1995, AM J CARDIOL, V75, P956, DOI 10.1016/S0002-9149(99)80700-0; EWING DJ, 1991, DIABETOLOGIA, V34, P182, DOI 10.1007/BF00418273; Festa A, 2000, AM J CARDIOL, V86, P1117, DOI 10.1016/S0002-9149(00)01170-X; FRANK S, 1986, J AM COLL CARDIOL, V7, P295, DOI 10.1016/S0735-1097(86)80494-6; Gastaldelli A, 2000, AM J PHYSIOL-REG I, V279, pR2022, DOI 10.1152/ajpregu.2000.279.6.R2022; Gavaghan CL, 2001, ANAL BIOCHEM, V291, P245, DOI 10.1006/abio.2000.5034; GHAURI FYK, 1993, NMR BIOMED, V6, P163, DOI 10.1002/nbm.1940060210; Hagiwara T, 2001, JPN J PHARMACOL, V87, P231, DOI 10.1254/jjp.87.231; Hamlin R. L., 2007, Journal of Pharmacological and Toxicological Methods, V55, P1, DOI 10.1016/j.vascn.2006.05.003; Hauser Daniela S., 2005, Journal of Pharmacological and Toxicological Methods, V52, P106, DOI 10.1016/j.vascn.2005.03.003; Haverkamp W, 2000, CARDIOVASC RES, V47, P219, DOI 10.1016/S0008-6363(00)00119-X; HAYES E, 1994, J PHARMACOL TOXICOL, V32, P201, DOI 10.1016/1056-8719(94)90088-4; Hwang DH, 2004, BIOINFORMATICS, V20, P487, DOI 10.1093/bioinformatics/btg433; Idborg H, 2005, J CHROMATOGR B, V828, P9, DOI 10.1016/j.jchromb.2005.07.031; Irish Medicines Board, 2002, DRUG SAFETY NEWSLETT; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang JS, 2001, MOL PHARMACOL, V59, P122, DOI 10.1124/mol.59.1.122; KAUL U, 1985, CARDIOLOGY, V72, P140, DOI 10.1159/000173854; KEHOE RF, 1990, AM J CARDIOL, V65, pA58; Kwon HN, 2011, KIDNEY INT, V79, P529, DOI 10.1038/ki.2010.440; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee J, 2012, ANAL SCI, V28, P801, DOI 10.2116/analsci.28.801; Li HK, 2007, J PROTEOME RES, V6, P1364, DOI 10.1021/pr060513q; Lindgren F, 1996, J CHEMOMETR, V10, P521; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; MERTENS B, 1995, STAT COMPUT, V5, P227, DOI 10.1007/BF00142664; Moco S, 2007, TRAC-TREND ANAL CHEM, V26, P855, DOI 10.1016/j.trac.2007.08.003; Mortishire-Smith RJ, 2004, CHEM RES TOXICOL, V17, P165, DOI 10.1021/tx034123j; Murphy RC, 2011, MASS SPECTROM REV, V30, P579, DOI 10.1002/mas.20284; Nicholls AW, 2001, CHEM RES TOXICOL, V14, P975, DOI 10.1021/tx000231j; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; NICHOLSON JK, 1984, BIOCHEM J, V217, P365, DOI 10.1042/bj2170365; Nordstrom A, 2006, ANAL CHEM, V78, P3289, DOI 10.1021/ac060245f; Ohtani H, 1997, J PHARM PHARMACOL, V49, P458, DOI 10.1111/j.2042-7158.1997.tb06824.x; Owens RC, 2005, CLIN INFECT DIS, V41, pS144, DOI 10.1086/428055; Phapale PB, 2010, CLIN PHARMACOL THER, V87, P426, DOI 10.1038/clpt.2009.296; Roden DM, 2008, BRIT J PHARMACOL, V154, P1502, DOI 10.1038/bjp.2008.238; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; ROSSI M, 1989, CLIN SCI, V76, P567, DOI 10.1042/cs0760567; Rubinstein E, 2001, CHEMOTHERAPY S3, V47, P44, DOI DOI 10.1159/000057838; Savci V, 2003, EUR J PHARMACOL, V468, P129, DOI 10.1016/S0014-2999(03)01602-9; Schnackenberg LK, 2007, EXPERT REV MOL DIAGN, V7, P247, DOI 10.1586/14737159.7.3.247; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Shantsila E, 2007, EUROPACE, V9, P37, DOI 10.1093/europace/eum169; Shin HS, 2005, CIRC J, V69, P409, DOI 10.1253/circj.69.409; Shockcor JP, 1996, ANAL CHEM, V68, P4431, DOI 10.1021/ac9606463; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; STANTON MS, 1989, J AM COLL CARDIOL, V14, P209, DOI 10.1016/0735-1097(89)90074-0; STRATMANN HG, 1987, AM HEART J, V113, P1470, DOI 10.1016/0002-8703(87)90664-8; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; TAN HL, 1995, ANN INTERN MED, V122, P701, DOI 10.7326/0003-4819-122-9-199505010-00009; Theodoridis G, 2008, TRAC-TREND ANAL CHEM, V27, P251, DOI 10.1016/j.trac.2008.01.008; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; VESELL ES, 1991, MUTAT RES, V247, P241, DOI 10.1016/0027-5107(91)90020-O; VLAY SC, 1984, ARCH INTERN MED, V144, P833, DOI 10.1001/archinte.144.4.833; Wang L, 2003, AM J CLIN NUTR, V78, P91; Wang Q, 2005, HYPERTENSION, V46, P547, DOI 10.1161/01.HYP.0000178572.63064.73; Want EJ, 2007, J PROTEOME RES, V6, P459, DOI 10.1021/pr060505+; Waters NJ, 2001, CHEM RES TOXICOL, V14, P1401, DOI 10.1021/tx010067f; Winnike JH, 2010, CLIN PHARMACOL THER, V88, P45, DOI 10.1038/clpt.2009.240; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P131, DOI 10.1016/S0169-7439(01)00156-3; WOOSLEY RL, 1993, JAMA-J AM MED ASSOC, V269, P1532, DOI 10.1001/jama.269.12.1532; Yap YG, 2000, BRIT MED J, V320, P1158, DOI 10.1136/bmj.320.7243.1158; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363; Yoo YH, 2002, J KOREAN ACAD FAM ME, V23, P593	95	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60556	10.1371/journal.pone.0060556	http://dx.doi.org/10.1371/journal.pone.0060556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593245	gold, Green Submitted, Green Published			2022-12-27	WOS:000319108100053
J	Arruda, LF; Arruda, SF; Campos, NA; de Valencia, FF; Siqueira, EMD				Arruda, Lorena Fernandes; Arruda, Sandra Fernandes; Campos, Natalia Aboudib; de Valencia, Fernando Fortes; de Almeida Siqueira, Egle Machado			Dietary Iron Concentration May Influence Aging Process by Altering Oxidative Stress in Tissues of Adult Rats	PLOS ONE			English	Article							REGULATORY HORMONE HEPCIDIN; ANTIOXIDANT ENZYMES; DOWN-REGULATION; UP-REGULATION; CREB-H; EXPRESSION; METABOLISM; SENESCENCE; DAMAGE; LIVER	Iron is an essential element. However, in its free form, iron participates in redox-reactions, leading to the production of free radicals that increase oxidative stress and the risk of damaging processes. Living organisms have an efficient mechanism that regulates iron absorption according to their iron content to protect against oxidative damage. The effects of restricted and enriched-iron diets on oxidative stress and aging biomarkers were investigated. Adult Wistar rats were fed diets containing 10, 35 or 350 mg/kg iron (adult restricted-iron, adult control-iron and adult enriched-iron groups, respectively) for 78 days. Rats aged two months were included as a young control group. Young control group showed higher hemoglobin and hematocrit values, lower levels of iron and lower levels of MDA or carbonyl in the major studied tissues than the adult control group. Restricted-iron diet reduced iron concentrations in skeletal muscle and oxidative damage in the majority of tissues and also increased weight loss. Enriched-iron diet increased hematocrit values, serum iron, gamma-glutamyl transferase, iron concentrations and oxidative stress in the majority of tissues. As expected, young rats showed higher mRNA levels of heart and hepatic L-Ferritin (Ftl) and kidneys SMP30 as well as lower mRNA levels of hepatic Hamp and interleukin-1 beta (Il1b) and also lower levels of liver protein ferritin. Restricted-iron adult rats showed an increase in heart Ftl mRNA and the enriched-iron adult rats showed an increase in liver nuclear factor erythroid derived 2 like 2 (Nfe2l2) and Il1b mRNAs and in gut divalent metal transporter-1 mRNA (Slc11a2) relative to the control adult group. These results suggest that iron supplementation in adult rats may accelerate aging process by increasing oxidative stress while iron restriction may retards it. However, iron restriction may also impair other physiological processes that are not associated with aging.	[Arruda, Lorena Fernandes] Univ Brasilia, Fac Hlth Sci, Brasilia, DF, Brazil; [Arruda, Sandra Fernandes; Campos, Natalia Aboudib] Univ Brasilia, Dept Nutr, Fac Hlth Sci, Brasilia, DF, Brazil; [de Valencia, Fernando Fortes; de Almeida Siqueira, Egle Machado] Univ Brasilia, Inst Biol Sci, Dept Cell Biol, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	Arruda, LF (corresponding author), Univ Brasilia, Fac Hlth Sci, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil.	fernandeslfarruda@gmail.com	Arruda, Sandra/A-9528-2014; Arruda, Sandra Fernandes/AAC-6778-2019	Fernandes Arruda, Sandra/0000-0003-0774-8276	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Decanato de Pesquisa e Pos-Graduacao (DPP), University of Brasilia, Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Decanato de Pesquisa e Pos-Graduacao (DPP), University of Brasilia, Brazil	This study was financially supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Decanato de Pesquisa e Pos-Graduacao (DPP), University of Brasilia, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Ago T, 2010, AGING-US, V2, P1012, DOI 10.18632/aging.100261; Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Arvapalli RK, 2010, CARDIOVASC TOXICOL, V10, P108, DOI 10.1007/s12012-010-9068-9; BARANOWSKA I, 1995, SCI TOTAL ENVIRON, V159, P155, DOI 10.1016/0048-9697(95)04218-P; Beard JL, 1996, NUTR REV, V54, P295, DOI 10.1111/j.1753-4887.1996.tb03794.x; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021; Bulvik B, 2009, MECH AGEING DEV, V130, P139, DOI 10.1016/j.mad.2008.10.002; Bulvik BE, 2012, AGE, V34, P693, DOI 10.1007/s11357-011-9268-7; Candan N, 2008, NEUROTOXICOLOGY, V29, P708, DOI 10.1016/j.neuro.2008.04.012; CHAM BE, 1985, ANAL BIOCHEM, V151, P561, DOI 10.1016/0003-2697(85)90220-9; Chen HJ, 2009, BIOMETALS, V22, P827, DOI 10.1007/s10534-009-9229-0; Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332; Christiansen H, 2007, RADIOLOGY, V242, P189, DOI 10.1148/radiol.2421060083; Collins JE, 2008, J NUTR, V138, P2284, DOI 10.3945/jn.108.096347; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; De Domenico I, 2009, CELL METAB, V10, P245, DOI 10.1016/j.cmet.2009.09.005; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; Du F, 2012, J NUTR BIOCHEM, V23, P1694, DOI 10.1016/j.jnutbio.2011.12.002; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771; Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312; Fan Y, 2009, TOXICOL PATHOL, V37, P209, DOI 10.1177/0192623308328544; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5; Galaris D, 2008, HORM-INT J ENDOCRINO, V7, P114, DOI 10.1007/BF03401502; Garrick MD, 2012, BIOMETALS, V25, P787, DOI 10.1007/s10534-012-9522-1; Gentile CL, 2010, MOL CELL BIOCHEM, V344, P99, DOI 10.1007/s11010-010-0533-3; Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697; Habig W H, 1981, Methods Enzymol, V77, P218; Hahn P, 2009, EXP GERONTOL, V44, P594, DOI 10.1016/j.exger.2009.06.006; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163; HermesLima M, 1996, AM J PHYSIOL-REG I, V271, pR918, DOI 10.1152/ajpregu.1996.271.4.R918; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Huang Q, 2001, TOXICOL SCI, V63, P196, DOI 10.1093/toxsci/63.2.196; Inamura J, 2005, HEPATOL RES, V33, P198, DOI 10.1016/j.hepres.2005.08.005; Joanisse DR, 1996, AM J PHYSIOL-REG I, V271, pR545, DOI 10.1152/ajpregu.1996.271.3.R545; Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005; Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158; Kurz T, 2011, INT J BIOCHEM CELL B, V43, P1686, DOI 10.1016/j.biocel.2011.08.016; Levenson CW, 2004, AGEING RES REV, V3, P251, DOI 10.1016/j.arr.2004.03.001; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Maranhao AQ, 2003, TECNICAS BASICAS BIO; Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; Moon MS, 2012, TOXICOL SCI, V129, P74, DOI 10.1093/toxsci/kfs193; Munoz M, 2011, J CLIN PATHOL, V64, P281, DOI 10.1136/jcp.2010.079046; Oliveira BF, 2010, THESCIENTIFICWORLDJO, V10, P1121, DOI 10.1100/tsw.2010.94; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Palsamy P, 2011, BBA-MOL BASIS DIS, V1812, P719, DOI 10.1016/j.bbadis.2011.03.008; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Pietrangelo A, 2011, J HEPATOL, V54, P173, DOI 10.1016/j.jhep.2010.08.004; Polla AS, 2003, AGEING RES REV, V2, P25, DOI 10.1016/S1568-1637(02)00048-X; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Richert S, 2002, ARCH BIOCHEM BIOPHYS, V397, P430, DOI 10.1006/abbi.2001.2683; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Siqueira EMAASG, 2006, COMUN CIENC SAUDE, V17, P229; Sobocanec S, 2008, BIOGERONTOLOGY, V9, P335, DOI 10.1007/s10522-008-9145-7; Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005; Souza HP, 2002, AM J PHYSIOL-HEART C, V282, pH466, DOI 10.1152/ajpheart.00482.2001; Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2; Umur EE, 2011, GERIATR GERONTOL INT, V11, P504, DOI 10.1111/j.1447-0594.2011.00694.x; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Villar-Cheda B, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.006; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wang Q, 2008, ENDOCRINOLOGY, V149, P3920, DOI 10.1210/en.2007-1626; Watt RK, 2011, BIOMETALS, V24, P489, DOI 10.1007/s10534-011-9415-8; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Xu JZ, 2012, EXP GERONTOL, V47, P100, DOI 10.1016/j.exger.2011.10.011; Xu JZ, 2010, MECH AGEING DEV, V131, P487, DOI 10.1016/j.mad.2010.04.007; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	76	32	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61058	10.1371/journal.pone.0061058	http://dx.doi.org/10.1371/journal.pone.0061058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593390	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300046
J	Iwata, M; Ochi, H; Hara, Y; Tagawa, M; Koga, D; Okawa, A; Asou, Y				Iwata, Munetaka; Ochi, Hiroki; Hara, Yasushi; Tagawa, Masahiro; Koga, Daisuke; Okawa, Atsushi; Asou, Yoshinori			Initial Responses of Articular Tissues in a Murine High-Fat Diet-Induced Osteoarthritis Model: Pivotal Role of the IPFP as a Cytokine Fountain	PLOS ONE			English	Article							SYNOVIAL-FLUID; CARTILAGE DEGRADATION; KNEE OSTEOARTHRITIS; INSULIN-RESISTANCE; INDUCED OBESITY; ADIPOSE-TISSUE; IN-VITRO; MICE; CHONDROCYTES; INFLAMMATION	Obesity and high body mass index are associated with a higher incidence of osteoarthritis (OA). The aim of this study is to investigate the involvement of the infrapatellar fat pad (IPFP) in the sub-acute effect of a high fat diet (HFD) on the development of knee-OA. C57BL/6J male mice were fed either a HFD or a normal diet beginning at seven weeks of age. Tissue sections were evaluated with immunohistological analysis. The IPFP was excised, and mRNA expression profiles were compared using real-time RT-PCR analysis. Osteoarthritic changes were initiated in the HFD group after eight weeks of the HFD. Increased synovial cell number and angiogenesis at the anterior edge of the tibial plateau were exhibited prior to osteophyte formation. Quantitative histological analysis indicated that osteophyte volume was significantly increased in the HFD group after eight weeks, along with an increase in the IPFP volume, the size of individual adipocytes and the number of vessels in the IPFP. Histomorphometrical analysis revealed osteophyte area was significantly associated with IPFP area, individual adipocyte area and vascular area. Real-time RT-PCR analysis demonstrated elevated mRNA expression of inflammatory cytokines, growth factor, and adipokines in the IPFP after eight weeks of the HFD. These findings are in parallel with increased expression of the CD68 macrophage marker after eight weeks of the HFD. Expression levels of the adipokines were significantly correlated with expression of TNF-alpha, VEGF and TGF-beta. Immunohistological analysis revealed that the Nampt protein was highly expressed in the IPFP especially around the site of osteophyte formation. Apoptosis and proliferation of chondrocytes were both enhanced at the site of osteophyte formation, indicating higher cell turnover at this region. These observations suggest the IPFP plays a pivotal role in the formation of osteophytes and functions as a secretory organ in response to a HFD.	[Iwata, Munetaka; Hara, Yasushi; Tagawa, Masahiro] Nippon Vet & Life Sci Univ, Sch Vet Med, Div Vet Surg, Musashino, Tokyo, Japan; [Ochi, Hiroki] Nippon Vet & Life Sci Univ, Lab Vet Microbiol, Musashino, Tokyo, Japan; [Koga, Daisuke; Okawa, Atsushi; Asou, Yoshinori] Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, Tokyo, Japan	Nippon Veterinary & Life Science University; Nippon Veterinary & Life Science University; Tokyo Medical & Dental University (TMDU)	Asou, Y (corresponding author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, Tokyo, Japan.	aso.orth@tmd.ac.jp		Iwata, Munetaka/0000-0002-5561-4996	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The supporter had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; CARMAN WJ, 1994, AM J EPIDEMIOL, V139, P119, DOI 10.1093/oxfordjournals.aje.a116974; Chang YC, 2010, METABOLISM, V59, P93, DOI 10.1016/j.metabol.2009.07.011; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Davidson ENB, 2007, ARTHRITIS RHEUM, V56, P4065, DOI 10.1002/art.23034; Distel E, 2009, ARTHRITIS RHEUM-US, V60, P3374, DOI 10.1002/art.24881; Doi T, 2002, OSTEOARTHR CARTILAGE, V10, P270, DOI 10.1053/joca.2001.0503; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Francin PJ, 2011, J CELL PHYSIOL, V226, P2790, DOI 10.1002/jcp.22627; Gabay O, 2008, JOINT BONE SPINE, V75, P675, DOI 10.1016/j.jbspin.2008.07.011; Gomez R, 2011, NAT REV RHEUMATOL, V7, P528, DOI 10.1038/nrrheum.2011.107; Gosset M, 2008, ARTHRITIS RHEUM-US, V58, P1399, DOI 10.1002/art.23431; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Honsawek S, 2010, ARCH MED RES, V41, P593, DOI 10.1016/j.arcmed.2010.11.007; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hui W, 2011, ANN RHEUM DIS; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Laurberg TB, 2009, J RHEUMATOL, V36, P1885, DOI 10.3899/jrheum.080907; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Magliano Malgorzata, 2008, Menopause Int, V14, P149, DOI 10.1258/mi.2008.008018; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Owen HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE1023, DOI 10.1152/ajpendo.00586.2007; Presle N, 2006, OSTEOARTHR CARTILAGE, V14, P690, DOI 10.1016/j.joca.2006.01.009; Saamanen AMK, 2000, OSTEOARTHR CARTILAGE, V8, P248, DOI 10.1053/joca.2000.0298; Schaffler A, 2003, JAMA-J AM MED ASSOC, V290, P1709, DOI 10.1001/jama.290.13.1709-c; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; SILBERBERG M, 1952, Exp Med Surg, V10, P76; SILBERBERG M, 1951, Bull Hosp Joint Dis, V12, P256; SOKOLOFF L, 1960, AM J PHYSIOL, V198, P765, DOI 10.1152/ajplegacy.1960.198.4.765; Sommer G, 2009, J CELL BIOCHEM, V106, P103, DOI 10.1002/jcb.21980; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Ushiyama T, 2003, ANN RHEUM DIS, V62, P108, DOI 10.1136/ard.62.2.108; van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006; van Dielen FMH, 2001, INT J OBESITY, V25, P1759, DOI 10.1038/sj.ijo.0801825; WALTON M, 1979, J PATHOL, V127, P165, DOI 10.1002/path.1711270402; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WILHELMI G, 1976, PHARMACOLOGY, V14, P289, DOI 10.1159/000136607; Wilson R, 2008, ARTHRITIS RHEUM, V58, P3120, DOI 10.1002/art.23789; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382	48	47	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60706	10.1371/journal.pone.0060706	http://dx.doi.org/10.1371/journal.pone.0060706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593289	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300027
J	Jabbar, TK; Calvo-Pinilla, E; Mateos, F; Gubbins, S; Bin-Tarif, A; Bachanek-Bankowska, K; Alpar, O; Ortego, J; Takamatsu, HH; Mertens, PPC; Castillo-Olivares, J				Jabbar, Tamara Kusay; Calvo-Pinilla, Eva; Mateos, Francisco; Gubbins, Simon; Bin-Tarif, Abdelghani; Bachanek-Bankowska, Katarzyna; Alpar, Oya; Ortego, Javier; Takamatsu, Haru-Hisa; Mertens, Peter Paul Clement; Castillo-Olivares, Javier			Protection of IFNAR (-/-) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2	PLOS ONE			English	Article							RT-PCR ASSAY; IMMUNE-RESPONSES; ANKARA; GENES; VACCINES; DISEASE; MVA; DNA; ALPHA/BETA; INFECTION	The protective efficacy of recombinant vaccines expressing serotype 8 bluetongue virus (BTV-8) capsid proteins was tested in a mouse model. The recombinant vaccines comprised plasmid DNA or Modified Vaccinia Ankara viruses encoding BTV VP2, VP5 or VP7 proteins. These constructs were administered alone or in combination using either a homologous prime boost vaccination regime (rMVA/rMVA) or a heterologous vaccination regime (DNA/rMVA). The DNA/rMVA or rMVA/rMVA prime-boost were administered at a three week interval and all of the animals that received VP2 generated neutralising antibodies. The vaccinated and non-vaccinated-control mice were subsequently challenged with a lethal dose of BTV-8. Mice vaccinated with VP7 alone were not protected. However, mice vaccinated with DNA/rMVA or rMVA/rMVA expressing VP2, VP5 and VP7 or VP2 alone were all protected.	[Jabbar, Tamara Kusay; Calvo-Pinilla, Eva; Gubbins, Simon; Bin-Tarif, Abdelghani; Bachanek-Bankowska, Katarzyna; Takamatsu, Haru-Hisa; Mertens, Peter Paul Clement; Castillo-Olivares, Javier] Pirbright Inst, Woking, Surrey, England; [Mateos, Francisco; Ortego, Javier] Ctr Invest & Sanidad Anim, Madrid, Spain; [Alpar, Oya] London Sch Pharm, Ctr Drug Delivery Res, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of London; University College London; University of London School of Pharmacy	Calvo-Pinilla, E (corresponding author), Pirbright Inst, Woking, Surrey, England.	eva.calvo-pinilla@pirbright.ac.uk	ortego, javier/K-6020-2014; CALVO-PINILLA, EVA/L-5348-2014; Castillo-Olivares, Javier/L-5337-2014; Castillo-Olivares, Javier/AAA-7603-2019; Ortego, Javier/M-6810-2019; Castillo-Olivares, Javier/AAA-8837-2019	ortego, javier/0000-0002-4275-7277; CALVO-PINILLA, EVA/0000-0002-4667-4081; Castillo-Olivares, Javier/0000-0003-3453-8557; Ortego, Javier/0000-0002-4275-7277; Castillo-Olivares, Javier/0000-0003-3453-8557; Mertens, Peter/0000-0002-3438-3738; Gubbins, Simon/0000-0003-0538-4173	Defra; BBSRC; Wellcome Trust; European Commission; Comision Interministerial de Ciencia y Tecnologia (CICYT) [245266, 222633-2, K1303206, AGL2011-23506/GAN]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001717] Funding Source: researchfish; BBSRC [BBS/E/I/00001717, BB/D014204/1, BBS/E/I/00001455, BBS/E/I/00001446] Funding Source: UKRI	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Defra, BBSRC, Wellcome Trust, the European Commission and the Comision Interministerial de Ciencia y Tecnologia (CICYT) (OrbiVac - Grant no.: 245266; WildTech - Grant no.: 222633-2; EMIDA grant OrbiNet - K1303206; and grant AGL2011-23506/GAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Anderson RJ, 2007, VACCINE, V25, pB24, DOI 10.1016/j.vaccine.2007.05.030; Anthony S, 2007, J VIROL METHODS, V141, P188, DOI 10.1016/j.jviromet.2006.12.013; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Bonneau KR, 2001, J VIROL, V75, P8298, DOI 10.1128/JVI.75.17.8298-8305.2001; Boone JD, 2007, VACCINE, V25, P672, DOI 10.1016/j.vaccine.2006.08.025; Calvo-Pinilla E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034735; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Calvo-Pinilla E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005171; Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503; Chiam R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005997; COWLEY JA, 1987, J VIROL, V61, P2304, DOI 10.1128/JVI.61.7.2304-2306.1987; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; DeMaula CD, 2000, VIRUS RES, V67, P59, DOI 10.1016/S0168-1702(00)00130-1; Dunham SP, 2002, RES VET SCI, V73, P9, DOI 10.1016/S0034-5288(02)00032-2; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Elia G, 2008, MOL CELL PROBE, V22, P38, DOI 10.1016/j.mcp.2007.06.005; ERASMUS BJ, 1975, AUST VET J, V51, P165, DOI 10.1111/j.1751-0813.1975.tb00048.x; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; FIETTE L, 1995, J EXP MED, V181, P2069, DOI 10.1084/jem.181.6.2069; Fournillier A, 2007, VACCINE, V25, P7339, DOI 10.1016/j.vaccine.2007.08.020; Franceschi V, 2011, VACCINE, V29, P3074, DOI 10.1016/j.vaccine.2011.01.075; Gethmann J, 2009, VACCINE, V27, P4118, DOI 10.1016/j.vaccine.2009.04.072; Gloster J, 2008, VET REC, V162, P298, DOI 10.1136/vr.162.10.298; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Harrop R, 2006, CLIN CANCER RES, V12, P3416, DOI 10.1158/1078-0432.CCR-05-2732; Hofmann M, 2008, SCHWEIZ ARCH TIERH, V150, P49, DOI 10.1024/0036-7281.150.2.49; HUISMANS H, 1985, ONDERSTEPOORT J VET, V52, P149; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; Hutchinson I, 1999, ROLE VP7 INITIATION; Kennedy JS, 2009, EXPERT REV VACCINES, V8, P13, DOI 10.1586/14760584.8.1.13; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Ma GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034425; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; MacLachlan NJ, 2007, VACCINE, V25, P5577, DOI 10.1016/j.vaccine.2006.12.058; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1989, VIROLOGY, V170, P561, DOI 10.1016/0042-6822(89)90447-9; Moore AC, 2004, IMMUNOL REV, V199, P126, DOI 10.1111/j.0105-2896.2004.00138.x; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; Paradell H, 2008, EFFICACY ZULVAC INAC; Ramirez JC, 2000, J VIROL, V74, P7651, DOI 10.1128/JVI.74.16.7651-7655.2000; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Romito M, 1999, ONDERSTEPOORT J VET, V66, P139; ROY P, 1990, J VIROL, V64, P1998, DOI 10.1128/JVI.64.5.1998-2003.1990; Roy P, 1990, FEMS Microbiol Immunol, V2, P223; ROY P, 1992, J GEN VIROL, V73, P3051, DOI 10.1099/0022-1317-73-12-3051; ROY P, 1992, VET MICROBIOL, V33, P155, DOI 10.1016/0378-1135(92)90043-S; Saegerman C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009405; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; Scanlen M, 2002, VACCINE, V20, P1079, DOI 10.1016/S0264-410X(01)00445-5; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; StoneMarschat MA, 1996, VIROLOGY, V220, P219, DOI 10.1006/viro.1996.0304; Veronesi E, 2010, VACCINE, V28, P1397, DOI 10.1016/j.vaccine.2009.10.107; WADEEVANS AM, 1993, J VIROL METHODS, V45, P179, DOI 10.1016/0166-0934(93)90102-W; Waibler Z, 2007, J VIROL, V81, P12102, DOI 10.1128/JVI.01190-07; Wang ZD, 2010, VACCINE, V28, P1547, DOI 10.1016/j.vaccine.2009.11.056	63	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60574	10.1371/journal.pone.0060574	http://dx.doi.org/10.1371/journal.pone.0060574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593251	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300021
J	Stone, R; Takimoto, T				Stone, Raychel; Takimoto, Toru			Critical Role of the Fusion Protein Cytoplasmic Tail Sequence in Parainfluenza Virus Assembly	PLOS ONE			English	Article							HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN; TEMPERATURE-SENSITIVE MUTANT; SENDAI-VIRUS; HN-GLYCOPROTEIN; TYPE-1; MATRIX; DOMAIN; GENE; RECOMBINANT; EXPRESSION	Interactions between viral glycoproteins, matrix protein and nucleocapsid sustain assembly of parainfluenza viruses at the plasma membrane. Although the protein interactions required for virion formation are considered to be highly specific, virions lacking envelope glycoprotein(s) can be produced, thus the molecular interactions driving viral assembly and production are still unclear. Sendai virus (SeV) and human parainfluenza virus type 1 (hPIV1) are highly similar in structure, however, the cytoplasmic tail sequences of the envelope glycoproteins (HN and F) are relatively less conserved. To unveil the specific role of the envelope glycoproteins in viral assembly, we created chimeric SeVs whose HN (rSeVhHN) or HN and F (rSeVh(HN+F)) were replaced with those of hPIV1. rSeVhHN grew as efficiently as wt SeV or hPIV1, suggesting that the sequence difference in HN does not have a significant impact on SeV replication and virion production. In sharp contrast, the growth of rSeVh(HN+F) was significantly impaired compared to rSeVhHN. rSeVh(HN+Fstail) which expresses a chimeric hPIV1 F with the SeV cytoplasmic tail sequence grew similar to wt SeV or rSeVhHN. Further analysis indicated that the F cytoplasmic tail plays a critical role in cell surface expression/accumulation of HN and F, as well as NP and M association at the plasma membrane. Trafficking of nucelocapsids in infected cells was not significantly affected by the origin of F, suggesting that F cytoplasmic tail is not involved in intracellular movement. These results demonstrate the role of the F cytoplasmic tail in accumulation of structural components at the plasma membrane assembly sites.	[Stone, Raychel; Takimoto, Toru] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Takimoto, T (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	toru_takimoto@urmc.rochester.edu			National Institutes of Health [R01AI081779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01AI081779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2000, VIROLOGY, V276, P289, DOI 10.1006/viro.2000.0556; Battisti AJ, 2012, P NATL ACAD SCI USA, V109, P13996, DOI 10.1073/pnas.1210275109; BOUSSE T, 1994, VIROLOGY, V204, P506, DOI 10.1006/viro.1994.1564; Bousse T, 2002, J VIROL, V76, P8244, DOI 10.1128/JVI.76.16.8244-8251.2002; Bruce EA, 2012, BIOCHEM SOC T, V40, P1409, DOI 10.1042/BST20120166; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; Coronel EC, 1999, J VIROL, V73, P7035, DOI 10.1128/JVI.73.8.7035-7038.1999; Coronel EC, 2001, J VIROL, V75, P1117, DOI 10.1128/JVI.75.3.1117-1123.2001; Fouillot-Coriou N, 2000, VIROLOGY, V270, P464, DOI 10.1006/viro.2000.0291; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GORMAN WL, 1990, VIROLOGY, V175, P211, DOI 10.1016/0042-6822(90)90201-2; GORMAN WL, 1991, VIROLOGY, V183, P83, DOI 10.1016/0042-6822(91)90120-Z; Gosselin-Grenet AS, 2010, VIROLOGY, V405, P439, DOI 10.1016/j.virol.2010.06.030; HEGGENESS MH, 1982, P NATL ACAD SCI-BIOL, V79, P6232, DOI 10.1073/pnas.79.20.6232; HEWITT JA, 1977, J GEN VIROL, V34, P127, DOI 10.1099/0022-1317-34-1-127; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; KONDO T, 1993, J BIOL CHEM, V268, P21924; Li M, 2009, J VIROL, V83, P7261, DOI 10.1128/JVI.00421-09; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MERSON JR, 1988, VIROLOGY, V167, P97, DOI 10.1016/0042-6822(88)90058-X; Oomens AGP, 2006, J VIROL, V80, P10465, DOI 10.1128/JVI.01439-06; Popa A, 2011, BIOCHEMISTRY-US, V50, P945, DOI 10.1021/bi101597k; PORTNER A, 1975, VIROLOGY, V67, P179, DOI 10.1016/0042-6822(75)90415-8; PORTNER A, 1981, VIROLOGY, V115, P375, DOI 10.1016/0042-6822(81)90118-5; PORTNER A, 1987, VIROLOGY, V158, P61, DOI 10.1016/0042-6822(87)90238-8; PORTNER A, 1974, J VIROL, V13, P298, DOI 10.1128/JVI.13.2.298-304.1974; ROUX L, 1982, CELL, V28, P293, DOI 10.1016/0092-8674(82)90347-6; SANDERSON CM, 1993, J VIROL, V67, P651, DOI 10.1128/JVI.67.2.651-663.1993; SANDERSON CM, 1994, J VIROL, V68, P69, DOI 10.1128/JVI.68.1.69-76.1994; Schmitt AP, 2005, J VIROL, V79, P2988, DOI 10.1128/JVI.79.5.2988-2997.2005; Schmitt AP, 1999, J VIROL, V73, P8703, DOI 10.1128/JVI.73.10.8703-8712.1999; Shaikh FY, 2012, MBIO, V3, DOI 10.1128/mBio.00270-11; STRICKER R, 1991, J GEN VIROL, V72, P1703, DOI 10.1099/0022-1317-72-7-1703; Takimoto T, 1998, J VIROL, V72, P9747, DOI 10.1128/JVI.72.12.9747-9754.1998; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Takimoto T, 2001, J VIROL, V75, P11384, DOI 10.1128/JVI.75.23.11384-11391.2001; TAKIMOTO T, 1994, VIRUS RES, V32, P85, DOI 10.1016/0168-1702(94)90063-9; TUFFEREAU C, 1985, J GEN VIROL, V66, P2313, DOI 10.1099/0022-1317-66-11-2313; Waning DL, 2002, J VIROL, V76, P9284, DOI 10.1128/JVI.76.18.9284-9297.2002; YOSHIDA T, 1979, VIROLOGY, V92, P139, DOI 10.1016/0042-6822(79)90220-4; YOSHIDA T, 1982, VIROLOGY, V120, P329, DOI 10.1016/0042-6822(82)90034-4; Zhan X, 2008, VACCINE, V26, P3480, DOI 10.1016/j.vaccine.2008.04.022	43	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61281	10.1371/journal.pone.0061281	http://dx.doi.org/10.1371/journal.pone.0061281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593451	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300069
J	Wang, Y; Liu, BY; Yu, JN; Wu, JN; Wang, J; Liu, ZS				Wang, Yang; Liu, Baoyan; Yu, Jinna; Wu, Jiani; Wang, Jing; Liu, Zhishun			Electroacupuncture for Moderate and Severe Benign Prostatic Hyperplasia: A Randomized Controlled Trial	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; ACUPUNCTURE; MANAGEMENT	Purpose: To evaluate the effects of electroacupuncture (EA) on the International Prostate Symptom Score (IPSS), postvoid residual urine (PVR), and maximum urinary flow rate (Qmax), and explore the difference between EA at acupoints and non-acupoints in patients with moderate to severe benign prostate hyperplasia (BPH). Subjects and Methods: Men with BPH and IPSS >= 8 were enrolled. Participants were randomly allocated to receive EA at acupoint (treatment group, n = 50) and EA at non-acupoint (control group, n = 50). The primary outcome measure includes the change of IPSS at the 6th week and the secondary outcome measures include changes of PVR and Qmax at the 6th week and change of IPSS at the 18th week. Results: 100/192 patients were included. At the 6th week, treatment group patients had a 4.51 (p<0.001) and 4.12 (p<0.001) points greater decline in IPSS than the control group in the intention to treat (ITT) and per-protocol (PP) populations. At the 18th week, a 3.2 points (p = 0.001) greater decline was found in IPSS for the treatment. No significant differences were found between the two groups in Qmax at the 6th week (p = 0.819). No significant difference was observed in PVR (P = 0.35). Conclusion: Acupoint EA at BL 33 had better effects on IPSS, but no difference on PVR and Qmax as compared with non-acupoint EA. The results indicate that EA is effective in improving patient's quality of life and acupoint may have better therapeutic effects than non-acupoints in acupuncture treatments of BPH.	[Wang, Yang; Yu, Jinna; Wu, Jiani; Wang, Jing; Liu, Zhishun] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Liu, Baoyan] China Acad Chinese Med Sci, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; China Academy of Chinese Medical Sciences	Liu, ZS (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China.	liuzhishun@yahoo.com.cn			"Twelfth Five-Year Plan" of National Science and Technology Support Program [2012BAI24B01]; Guang'anmen Hospital [2009S208]	"Twelfth Five-Year Plan" of National Science and Technology Support Program; Guang'anmen Hospital	This study is supported by a grant from the "Twelfth Five-Year Plan" of National Science and Technology Support Program (Project Number: 2012BAI24B01) and Guang'anmen Hospital (2009S208). No other potential conflict of interest related to this trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz W.L., 2011, J CLIN ACUPUNCTURE M, V27, P1; Alraek T, 2002, AM J PUBLIC HEALTH, V92, P1609, DOI 10.2105/AJPH.92.10.1609; American Urology Association, 2012, GUID MAN BEN PROST H; Aune A, 1998, SCAND J PRIM HEALTH, V16, P37; Bruskewitz Reginald C, 2003, Rev Urol, V5, P72; Capodice Jillian L, 2007, Chin Med, V2, P1, DOI 10.1186/1749-8546-2-1; Chapple CR, 2011, EUR UROL, V59, P342, DOI 10.1016/j.eururo.2010.10.046; [程凯 Cheng Kai], 2004, [针刺研究, Acupuncture Research], V29, P204; Chung IM, 2008, NEUROSCI LETT, V439, P18, DOI 10.1016/j.neulet.2008.04.100; Diracoglu D, 2012, J BACK MUSCULOSKELET, V25, P285, DOI 10.3233/BMR-2012-0338; Fang JL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/515893; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Hino K, 2010, UROLOGY, V75, P730, DOI 10.1016/j.urology.2009.04.025; Hong SK, 2010, BJU INT, V105, P1424, DOI 10.1111/j.1464-410X.2009.08975.x; Johnstone PAS, 2003, J UROLOGY, V169, P1037, DOI 10.1097/01.ju.0000044925.03113.ab; Kalichman L, 2010, J AM BOARD FAM MED, V23, P640, DOI 10.3122/jabfm.2010.05.090296; Karaman MI, 2011, J UROLOGY, V185, P1852, DOI 10.1016/j.juro.2010.12.071; KUBISTA E, 1976, American Journal of Chinese Medicine, V4, P177, DOI 10.1142/S0192415X76000226; Liu ZS, 2011, ACUPUNCT MED, V29, P188, DOI 10.1136/aim.2010.003913; Napadow V, 2012, HUM BRAIN MAPP, DOI 10.1002/hbm.22091; Nickel JC, 2006, CURR OPIN UROL, V16, P5, DOI 10.1097/01.mou.0000193365.46081.cd; PHILP T, 1988, BRIT J UROL, V61, P490, DOI 10.1111/j.1464-410X.1988.tb05086.x; Ricci L, 2004, NEUROUROL URODYNAM, V23, P58, DOI 10.1002/nau.10105; Shuran J, 1987, ACUPUNCTURE REAEARCH, V1, P73; Tanguay S, 2009, CUAJ-CAN UROL ASSOC, V3, pS92; Vignes Jr, 2005, ADV TECH STAND NEUR, V30, P177, DOI 10.1007/3-211-27208-9_5; Wang J, 2001, CLIN EPIDEMIOLOGY DE, P41; Wang QC, 2003, ACUPUNCTURE THERAPEU; Wang Y, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-211; Wendy WL, 2005, UROLCLIN N AM, V32, P11; Xu Bin, 2010, Zhen Ci Yan Jiu, V35, P422; [杨涛 YANG Tao], 2008, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V23, P1028; Yang Tao, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P998; Yu HJ, 2011, BJU INT, V108, P1843, DOI 10.1111/j.1464-410X.2011.10233.x; Yu JS, 2011, EVID-BASED COMPL ALT, V20	35	98	103	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e59449	10.1371/journal.pone.0059449	http://dx.doi.org/10.1371/journal.pone.0059449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593139	Green Submitted, Green Published, gold			2022-12-27	WOS:000317385300007
J	Fera, F; Passamonti, L; Cerasa, A; Gioia, MC; Liguori, M; Manna, I; Valentino, P; Quattrone, A				Fera, Francesco; Passamonti, Luca; Cerasa, Antonio; Gioia, Maria Cecilia; Liguori, Maria; Manna, Ida; Valentino, Paola; Quattrone, Aldo			The BDNF Val(66)Met Polymorphism Has Opposite Effects on Memory Circuits of Multiple Sclerosis Patients and Controls	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; COGNITIVE DYSFUNCTION; HIPPOCAMPAL VOLUME; ANTERIOR HIPPOCAMPUS; IMAGING GENETICS; FUNCTIONAL MRI; MET ALLELE; BRAIN; RISK	Episodic memory deficits are frequent symptoms in Multiple Sclerosis and have been associated with dysfunctions of the hippocampus, a key region for learning. However, it is unclear whether genetic factors that influence neural plasticity modulate episodic memory in MS. We thus studied how the Brain Derived Neurotrophic Factor Val(66)Met genotype, a common polymorphism influencing the hippocampal function in healthy controls, impacted on brain networks underlying episodic memory in patients with Multiple Sclerosis. Functional magnetic resonance imaging was used to assess how the Brain Derived Neurotrophic Factor Val(66)Met polymorphism modulated brain regional activity and functional connectivity in 26 cognitively unimpaired Multiple Sclerosis patients and 25 age- and education-matched healthy controls while performing an episodic memory task that included encoding and retrieving visual scenes. We found a highly significant group by genotype interaction in the left posterior hippocampus, bilateral parahippocampus, and left posterior cingulate cortex. In particular, Multiple Sclerosis patients homozygous for the Val(66) allele, relative to Met(66) carriers, showed greater brain responses during both encoding and retrieval while the opposite was true for healthy controls. Furthermore, a robust group by genotype by task interaction was detected for the functional connectivity between the left posterior hippocampus and the ipsilateral posterior cingulate cortex. Here, greater hippocampus-posterior cingulate cortex connectivity was observed in Multiple Sclerosis Met(66) carriers relative to Val(66) homozygous during retrieval (but not encoding) while, again, the reverse was true for healthy controls. The Val(66)Met polymorphism has opposite effects on hippocampal circuitry underlying episodic memory in Multiple Sclerosis patients and healthy controls. Enhancing the knowledge of how genetic factors influence cognitive functions may improve the clinical management of memory deficits in patients with Multiple Sclerosis.	[Fera, Francesco; Passamonti, Luca; Valentino, Paola; Quattrone, Aldo] Magna Graecia Univ Catanzaro, Dipartimento Sci Med & Chirurg, Catanzaro, Italy; [Passamonti, Luca; Cerasa, Antonio; Gioia, Maria Cecilia] CNR, Unita Ric Neuroimmagini, Catanzaro, Italy; [Liguori, Maria; Manna, Ida] CNR, Ist Sci Neurol, Mangone, CS, Italy	Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR)	Fera, F (corresponding author), Magna Graecia Univ Catanzaro, Dipartimento Sci Med & Chirurg, Catanzaro, Italy.	fera@unicz.it; luca.passamonti@cnr.it	cerasa, antonio/E-8614-2011; QUATTRONE, Aldo/A-6734-2016; VALENTINO, Paola/AAA-4243-2019; Passamonti, Luca/I-7057-2019; Liguori, Maria/D-4390-2016	cerasa, antonio/0000-0002-8022-4770; QUATTRONE, Aldo/0000-0003-2001-957X; VALENTINO, Paola/0000-0001-7863-9195; Passamonti, Luca/0000-0002-7937-0615; MANNA, IDA/0000-0002-4777-7138; Liguori, Maria/0000-0003-4338-0392	Fondazione Italiana Sclerosi Multipla (FISM) [2003/R/24]	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM))	This research was founded by the Fondazione Italiana Sclerosi Multipla (FISM) (grant number #2003/R/24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Benedict RHB, 2011, NAT REV NEUROL, V7, P332, DOI 10.1038/nrneurol.2011.61; BENTON A L, 1978, Archives of Neurology, V35, P364; Benton AL, 1994, MULTILINGUAL APHASIA; Bigos KL, 2007, NEUROIMAG CLIN N AM, V17, P459, DOI 10.1016/j.nic.2007.09.005; Brown SM, 2006, COGN AFFECT BEHAV NE, V6, P44, DOI 10.3758/CABN.6.1.44; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Cerasa A, 2012, J NEUROL; Cerasa A, 2006, BRAIN RES BULL, V69, P597, DOI 10.1016/j.brainresbull.2005.11.006; Cerasa A, 2010, BEHAV BRAIN RES, V207, P377, DOI 10.1016/j.bbr.2009.10.022; Charil A, 2003, NEUROIMAGE, V19, P532, DOI 10.1016/S1053-8119(03)00117-4; Dawant BM, 1999, IEEE T MED IMAGING, V18, P909, DOI 10.1109/42.811271; De Stefano N, 2004, ARCH NEUROL-CHICAGO, V61, P536, DOI 10.1001/archneur.61.4.536; Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809; Dinacci D, 2011, NEUROL SCI, V32, P117, DOI 10.1007/s10072-010-0433-z; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fisher PM, 2008, AM J MED GENET C, V148C, P147, DOI 10.1002/ajmg.c.30173; Friston K. J., 1994, Human Brain Mapping, V2, P189, DOI 10.1002/hbm.460020402; Friston KJ, 1997, HUM BRAIN MAPP, V5, P133, DOI 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4; Gerritsen L, 2012, MOL PSYCHIATR, V17, P597, DOI 10.1038/mp.2011.51; Gioia MC, 2009, BRAIN COGNITION, V71, P320, DOI 10.1016/j.bandc.2009.07.009; Gioia MC, 2007, BRAIN RES, V1167, P71, DOI 10.1016/j.brainres.2007.06.023; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hulst HE, 2011, HUM BRAIN MAPP; Javeri S, 2010, CLIN IMMUNOL, V137, P181, DOI 10.1016/j.clim.2010.08.001; Joffe RT, 2009, HUM BRAIN MAPP, V30, P1246, DOI 10.1002/hbm.20592; Kern KC, 2012, NEUROIMAGE, V59, P2932, DOI 10.1016/j.neuroimage.2011.09.071; Kohler S, 2002, HIPPOCAMPUS, V12, P718, DOI 10.1002/hipo.10077; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lau JYF, 2010, NEUROIMAGE, V53, P952, DOI 10.1016/j.neuroimage.2009.11.026; Lee DH, 2012, ACTA NEUROPATHOL, V123, P247, DOI 10.1007/s00401-011-0890-3; Liguori M, 2007, GENES BRAIN BEHAV, V6, P177, DOI 10.1111/j.1601-183X.2006.00245.x; Liguori M, 2009, BRAIN RES, V1256, P123, DOI 10.1016/j.brainres.2008.11.047; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Mancini L, 2009, NEUROIMAGE, V45, P500, DOI 10.1016/j.neuroimage.2008.12.006; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oroszi G, 2006, ANN RHEUM DIS, V65, P1330, DOI 10.1136/ard.2006.051623; Passamonti L, 2009, BRAIN, V132, P3380, DOI 10.1093/brain/awp095; Patanella AK, 2010, J NEUROSCI RES, V88, P1106, DOI 10.1002/jnr.22276; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Piras MR, 2003, J NEUROL NEUROSUR PS, V74, P878, DOI 10.1136/jnnp.74.7.878; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Prince SE, 2009, NEUROPSYCHOLOGIA, V47, P2282, DOI 10.1016/j.neuropsychologia.2009.01.021; Prokopenko I, 2003, NEUROEPIDEMIOLOGY, V22, P290, DOI 10.1159/000071192; Ramasamy Deepa P, 2011, Pathophysiology, V18, P53, DOI 10.1016/j.pathophys.2010.04.006; Rey A., 1958, MEMORISATION SERIE 1; Rey A., 1968, REATTIVO FIGURA COMP; Rocca MA, 2010, NEUROLOGY, V74, P142, DOI 10.1212/WNL.0b013e3181c91a00; Rocca MA, 2005, LANCET NEUROL, V4, P618, DOI 10.1016/S1474-4422(05)70171-X; Rocca MA, 2002, ANN NEUROL, V51, P330, DOI 10.1002/ana.10120; Rocca MA, 2009, HUM BRAIN MAPP, V30, P2844, DOI 10.1002/hbm.20712; Rocca MA, 2009, HUM BRAIN MAPP, V30, P276, DOI 10.1002/hbm.20504; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Smith GN, 2012, SCHIZOPHR RES, V134, P253, DOI 10.1016/j.schres.2011.11.022; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Solari A, 2004, NEUROL SCI, V24, P375, DOI 10.1007/s10072-003-0192-1; Staffen W, 2002, BRAIN, V125, P1275, DOI 10.1093/brain/awf125; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Thornton AE, 2002, J INT NEUROPSYCH SOC, V8, P395, DOI 10.1017/S1355617702813200; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Viding E, 2006, DEV PSYCHOPATHOL, V18, P877, DOI 10.1017/S0954579406060433; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zivadinov R, 2007, HUM MOL GENET, V16, P2659, DOI 10.1093/hmg/ddm189	75	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61063	10.1371/journal.pone.0061063	http://dx.doi.org/10.1371/journal.pone.0061063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593393	Green Submitted, Green Published, gold			2022-12-27	WOS:000317383200039
J	Flegr, J; Preiss, M; Klose, J				Flegr, Jaroslav; Preiss, Marek; Klose, Jiri			Toxoplasmosis-Associated Difference in Intelligence and Personality in Men Depends on Their Rhesus Blood Group but Not ABO Blood Group	PLOS ONE			English	Article							LATENT TOXOPLASMOSIS; BEHAVIORAL-CHANGES; MOTOR-PERFORMANCE; FATAL ATTRACTION; RHD MOLECULE; GONDII; INFECTION; CAT; PHENOTYPE; PARASITE	Background: The parasite Toxoplasma gondii influences the behaviour of infected animals and probably also personality of infected humans. Subjects with a Rhesus-positive blood group are protected against certain behavioural effects associated with Toxoplasma infection, including the deterioration of reaction times and personality factor shift. Methodology/Principal Findings: Here, we searched for differences in the toxoplasmosis-associated effects between RhD-positive and RhD-negative subjects by testing 502 soldiers with two personality tests and two intelligence tests. The infected subjects expressed lower levels of all potentially pathognomic factors measured with the N-70 questionnaire and in neurasthenia measured with NEO-PI-R. The RhD-positive, Toxoplasma-infected subjects expressed lower while RhD-negative, Toxoplasma-infected subjects expressed higher intelligence than their Toxoplasma-free peers. The observed Toxoplasma-associated differences were always larger in RhD-negative than in RhD-positive subjects. Conclusions: RhD phenotype plays an important role in the strength and direction of association between latent toxoplasmosis and not only psychomotor performance, but also personality and intelligence.	[Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic; [Preiss, Marek] Prague Psychiat Ctr, Dept Biochem & Brain Pathophysiol, Prague, Czech Republic; [Klose, Jiri] Mil Univ Hosp Prague, Cent Med Psychol Dept, Prague, Czech Republic	Charles University Prague; Military University Hospital Prague	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic.	flegr@cesnet.cz	Preiss, Marek/AAG-9405-2020; Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Preiss, Marek/0000-0002-4463-6313	Grand Agency of the Czech Republic [P303/11/1398]; Charles University of Prague [GAUK 18810, UNCE 204004]	Grand Agency of the Czech Republic; Charles University of Prague	The authors' work was supported by the Grand Agency of the Czech Republic (Grant No. P303/11/1398) and Charles University of Prague (GAUK 18810, grant UNCE 204004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1958, STANDARD PROGR MATRI; Barnard C.J., 1990, PARASITISM HOST BEHA; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Biver S, 2006, TRANSFUS CLIN BIOL, V13, P167, DOI 10.1016/j.tracli.2006.03.003; Carritt B, 1997, HUM MOL GENET, V6, P843, DOI 10.1093/hmg/6.6.843; CATTELL RB, 1972, AM J HUM GENET, V24, P485; Cernochova D, 2002, VIENNA MATRIX TEST; Flegel WA, 2006, TRANSFUS CLIN BIOL, V13, P4, DOI 10.1016/j.tracli.2006.02.011; Flegr J, 1996, PARASITOLOGY, V113, P49, DOI 10.1017/S0031182000066269; Flegr J, 1999, FOLIA PARASIT, V46, P22; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2007, SCHIZOPHRENIA BULL, V33, P757, DOI 10.1093/schbul/sbl074; Flegr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049478; Flegr J, 2012, NEUROENDOCRINOL LETT, V33, P224; Flegr J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001389; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2010, FOLIA PARASIT, V57, P81, DOI 10.14411/fp.2010.010; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Formann AK., 1979, WIENER MATRIZEN TEST; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; HAY J, 1983, ANN TROP MED PARASIT, V77, P261, DOI 10.1080/00034983.1983.11811707; HAY J, 1984, Z PARASITENKD, V70, P575, DOI 10.1007/BF00926588; HAY J, 1985, Z PARASITENKD, V71, P459, DOI 10.1007/BF00928348; Hodkova H, 2007, PARASITOLOGY, V134, P1329, DOI 10.1017/S0031182007002673; House PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023277; Hrda S, 2000, J PARASITOL, V86, P657, DOI 10.1645/0022-3395(2000)086[0657:TNOTGI]2.0.CO;2; Hrebickova M, 2002, CESK PSYCHOL, V46, P521; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P507, DOI 10.1080/00034983.1980.11687376; Kankova S, 2010, PARASITOLOGY, V137, P1773, DOI 10.1017/S0031182010000661; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; Kustu S, 2006, TRANSFUS CLIN BIOL, V13, P103, DOI 10.1016/j.tracli.2006.03.001; Lafferty KD, 2006, P ROY SOC B-BIOL SCI, V273, P2749, DOI 10.1098/rspb.2006.3641; Lindova J, 2012, EUR J PERSONALITY, V26, P285, DOI 10.1002/per.838; Lindova J, 2010, FOLIA PARASIT, V57, P136, DOI 10.14411/fp.2010.017; Ling VJ, 2011, J NERV MENT DIS, V199, P440, DOI 10.1097/NMD.0b013e318221416e; Moore J, 2005, BEHAV PROCESS, V68, P283, DOI 10.1016/j.beproc.2004.10.005; Novotna M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-54; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Otis A. S., 1954, OTIS QUICK SCORING M; Prandota J, 2012, NEUROINFLAMMATION PA; Prandota Joseph, 2004, Am J Ther, V11, P517, DOI 10.1097/01.mjt.0000140648.30948.bd; Prandota J, 2010, INT J NEUROSCI, V120, P81, DOI 10.3109/00207450903458647; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Rasch G., 1960, PROBABILISTIC MODELS; Raven J. C., 1947, ADV PROGR MATRICES; Raven J.C., 1958, ADV PROGR MATRICES, V2nd ed.; Rogers M, 2003, PERS INDIV DIFFER, V34, P1099, DOI 10.1016/S0191-8869(02)00101-0; Siegel S., 1988, NONPARAMETRIC STAT B, pXXIII; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Thomas F, 2012, BIOL LETTERS, V8, P101, DOI 10.1098/rsbl.2011.0588; Vacir K, 1973, THESIS FACULTY PHILO; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Wagner FF, 2000, BLOOD, V95, P3662; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; WIENER AS, 1965, AM J HUM GENET, V17, P369; Wu KH, 2005, PERS INDIV DIFFER, V38, P797, DOI 10.1016/j.paid.2004.06.004; Xiao J, 2012, NEUROSCIENCE, V206, P39, DOI 10.1016/j.neuroscience.2011.12.051; Yazar S, 2006, J MED MICROBIOL, V55, P89, DOI 10.1099/jmm.0.46255-0; Yolken RH, 2009, PARASITE IMMUNOL, V31, P706, DOI 10.1111/j.1365-3024.2009.01131.x	64	21	21	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61272	10.1371/journal.pone.0061272	http://dx.doi.org/10.1371/journal.pone.0061272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593448	Green Published, gold			2022-12-27	WOS:000317382000046
J	Mathieu, S; Chan, AW; Ravaud, P				Mathieu, Sylvain; Chan, An-Wen; Ravaud, Philippe			Use of Trial Register Information during the Peer Review Process	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; OUTCOME-REPORTING BIAS; EMPIRICAL-EVIDENCE; REGISTRATION; INTERNET; CLINICALTRIALS.GOV; PROTOCOLS; QUALITY; CONSORT	Introduction: Evidence in the medical literature suggests that trial registration may not be preventing selective reporting of results. We wondered about the place of such information in the peer-review process. Method: We asked 1,503 corresponding authors of clinical trials and 1,733 reviewers to complete an online survey soliciting their views on the use of trial registry information during the peer-review process. Results: 1,136 authors (n = 713) and reviewers (n = 423) responded (37.5%); 676 (59.5%) had reviewed an article reporting a clinical trial in the past 2 years. Among these, 232 (34.3%) examined information registered on a trial registry. If one or more items (primary outcome, eligibility criteria, etc.) differed between the registry record and the manuscript, 206 (88.8%) mentioned the discrepancy in their review comments, 46 (19.8%) advised editors not to accept the manuscript, and 8 did nothing. The reviewers' reasons for not using the trial registry information included a lack of registration number in the manuscript (n = 132; 34.2%), lack of time (n = 128; 33.2%), lack of usefulness of registered information for peer review (n = 100; 25.9%), lack of awareness about registries (n = 54; 14%), and excessive complexity of the process (n = 39; 10.1%). Conclusion: This survey revealed that only one-third of the peer reviewers surveyed examined registered trial information and reported any discrepancies to journal editors.	[Mathieu, Sylvain; Ravaud, Philippe] Univ Paris 05, INSERM U738, Ctr Epidemiol Clin, French Cochrane Ctr, Paris, France; [Mathieu, Sylvain; Ravaud, Philippe] Hop Hotel Dieu, Paris, France; [Mathieu, Sylvain] Univ Clermont 1, Dept Rheumatol, Clermont Ferrand, France; [Chan, An-Wen] Univ Toronto, Womens Coll, Res Inst, Toronto, ON, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Clermont Auvergne (UCA); University of Toronto; Women's College Research Institute	Ravaud, P (corresponding author), Univ Paris 05, INSERM U738, Ctr Epidemiol Clin, French Cochrane Ctr, Paris, France.	philippe.ravaud@htd.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206				Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Berg JO, 2007, JAMA-J AM MED ASSOC, V298, P1514, DOI 10.1001/jama.298.13.1514-b; Braithwaite D, 2003, FAM PRACT, V20, P545, DOI 10.1093/fampra/cmg509; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Ewart R, 2009, ANN FAM MED, V7, P542, DOI 10.1370/afm.1017; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Leece P, 2004, J MED INTERNET RES, V6, P26, DOI 10.2196/jmir.6.3.e30; Mathieu S, 2012, JOINT BONE SPINE, V79, P262, DOI 10.1016/j.jbspin.2011.05.008; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moja Lorenzo P, 2009, Trials, V10, P56, DOI 10.1186/1745-6215-10-56; NANKERVIS H, 2012, J INVEST DERMATOL, V132, P2727, DOI DOI 10.1038/jid.2012.231; Reveiz L, 2010, J CLIN EPIDEMIOL, V63, P1216, DOI 10.1016/j.jclinepi.2010.01.013; Reviz L, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-30; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Sekeres M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001610; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	26	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e59910	10.1371/journal.pone.0059910	http://dx.doi.org/10.1371/journal.pone.0059910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593154	Green Published, gold, Green Submitted			2022-12-27	WOS:000317382000006
J	Ling, C; Hamada, T; Bai, JN; Li, XB; Chesters, D; Zheng, WM; Shi, WF				Ling, Cheng; Hamada, Tsuyoshi; Bai, Jianing; Li, Xianbin; Chesters, Douglas; Zheng, Weimin; Shi, Weifeng			MrBayes tgMC(3) : A Tight GPU Implementation of MrBayes	PLOS ONE			English	Article							MONTE-CARLO; EVOLUTION; SEQUENCES; INSECTA; MODEL	MrBayes is model-based phylogenetic inference tool using Bayesian statistics. However, model-based assessment of phylogenetic trees adds to the computational burden of tree-searching, and so poses significant computational challenges. Graphics Processing Units (GPUs) have been proposed as high performance, low cost acceleration platforms and several parallelized versions of the Metropolis Coupled Markov Chain Mote Carlo (MC3) algorithm in MrBayes have been presented that can run on GPUs. However, some bottlenecks decrease the efficiency of these implementations. To address these bottlenecks, we propose a tight GPU MC3 (tgMC(3)) algorithm. tgMC(3) implements a different architecture from the one-to-one acceleration architecture employed in previously proposed methods. It merges multiply discrete GPU kernels according to the data dependency and hence decreases the number of kernels launched and the complexity of data transfer. We implemented tgMC(3) and made performance comparisons with an earlier proposed algorithm, nMC(3), and also with MrBayes MC3 under serial and multiply concurrent CPU processes. All of the methods were benchmarked on the same computing node from DEGIMA. Experiments indicate that the tgMC(3) method outstrips nMC(3) (v1.0) with speedup factors from 2.1 to 2.7x. In addition, tgMC(3) outperforms the serial MrBayes MC3 by a factor of 6 to 30x when using a single GTX480 card, whereas a speedup factor of around 51x can be achieved by using two GTX 480 cards on relatively long sequences. Moreover, tgMC(3) was compared with MrBayes accelerated by BEAGLE, and achieved speedup factors from 3.7 to 5.7x. The reported performance improvement of tgMC(3) is significant and appears to scale well with increasing dataset sizes. In addition, the strategy proposed in tgMC(3) could benefit the acceleration of other Bayesian-based phylogenetic analysis methods using GPUs.	[Ling, Cheng; Bai, Jianing; Li, Xianbin; Chesters, Douglas; Zheng, Weimin] Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China; [Hamada, Tsuyoshi] Nagasaki Univ, Dept Comp & Informat Sci, Nagasaki 852, Japan; [Li, Xianbin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chesters, Douglas] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Shi, Weifeng] Taishan Med Coll, Sch Basic Med Sci, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Nagasaki University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Shandong First Medical University & Shandong Academy of Medical Sciences	Ling, C (corresponding author), Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China.	c.ling@giat.ac.cn; wfshi.tsmc@gmail.com	Chesters, Douglas/AAF-7926-2019					Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; NVIDIA Corporation, 2009, NVIDIA CUDA PROGR GU; Pratas Frederico, 2009, Proceedings of the 2009 International Conference on Parallel Processing (ICPP 2009), P9, DOI 10.1109/ICPP.2009.30; Pratas F, 2009, LECT NOTES COMPUT SC, V5657, P237, DOI 10.1007/978-3-642-03138-0_26; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; The Green500 List, 2011, ENV RESP SUP; Xie Q, 2005, MOL PHYLOGENET EVOL, V34, P448, DOI 10.1016/j.ympev.2004.10.015; Xie Q, 2008, MOL PHYLOGENET EVOL, V47, P463, DOI 10.1016/j.ympev.2008.01.024; Xie Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029468; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Zhou JF, 2011, BIOINFORMATICS, V27, P1255, DOI 10.1093/bioinformatics/btr140	19	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60667	10.1371/journal.pone.0060667	http://dx.doi.org/10.1371/journal.pone.0060667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593277	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600033
J	Okonkwo, OW; Batwara, R; Granja, I; Asplin, JR; Goldfarb, DS				Okonkwo, Onyeka W.; Batwara, Ruchika; Granja, Ignacio; Asplin, John R.; Goldfarb, David S.			A Pilot Study of the Effect of Sodium Thiosulfate on Urinary Lithogenicity and Associated Metabolic Acid Load in Non-Stone Formers and Stone Formers with Hypercalciuria	PLOS ONE			English	Article							CALCIUM; CALCIPHYLAXIS; PATIENT; RATS; SUPERSATURATION; NEPHROLITHIASIS; PREVENTION; THERAPY; KIDNEY	Background and Objectives: Sodium thiosulfate (STS) reduced calcium stone formation in both humans and genetic hypercalciuric stone forming (GHS) rats. We sought to measure urine chemistry changes resulting from STS administration in people. Design, Setting, Participants & Measurements: STS was given to healthy and hypercalciuric stone forming adults. Five normal non-stone forming adults (mean age 33 years), and 5 people with idiopathic hypercalciuria and calcium kidney stones (mean age 66 years) participated. Two baseline 24-hour urine collections were performed on days 2 and 3 of 3 days of self-selected diets. Subjects then drank STS 10 mmol twice a day for 7 days and did urine collections while repeating the self-selected diet. Results were compared by non-parametric Wilcoxon signed rank test. The primary outcome was the resulting change in urine chemistry. Results: STS administration did not cause a significant change in urinary calcium excretion in either group. In both groups, 24 hour urinary ammonium (P = 0.005) and sulfate excretion (P = 0.007) increased, and urinary pH fell (P = 0.005); citrate excretion fell (P < 0.05) in hypercalciuric participants but not in non-stone formers. Among stone formers with hypercalciuria, 3 of 5 patients had measurement of serum HCO3 concentration after the STS period: it did not change. The net effect was an increase in supersaturation of uric acid, and no change in supersaturation of calcium oxalate or calcium phosphate. Conclusions: The basis for studies demonstrating that STS prevented stones in rats and people was not reflected by the changes in urine chemistry reported here. Although serum HCO3 did not change, urine tests suggested an acid load in both non-stone forming and hypercalciuric stone-forming participants. The long term safety of STS needs to be determined before the drug can be tested in humans for long-term prevention of stone recurrence.	[Okonkwo, Onyeka W.; Goldfarb, David S.] New York Harbor VA Healthcare Syst, Dept Med, New York, NY USA; [Okonkwo, Onyeka W.; Goldfarb, David S.] NYU, Sch Med, New York, NY USA; [Batwara, Ruchika] Newark Beth Israel Med Ctr, Dept Surg, Newark, NJ 07112 USA; [Granja, Ignacio; Asplin, John R.] Litholink Corp, Chicago, IL USA; [Goldfarb, David S.] New York Harbor VA Healthcare Syst, Nephrol Sect, New York, NY USA; [Goldfarb, David S.] NYU, Langone Med Ctr, New York, NY USA	New York University; Newark Beth Israel Medical Center; New York University; NYU Langone Medical Center	Goldfarb, DS (corresponding author), New York Harbor VA Healthcare Syst, Dept Med, New York, NY USA.	david.goldfarb@va.gov		Goldfarb, David/0000-0002-9215-1273				Adirekkiat S, 2010, NEPHROL DIAL TRANSPL, V25, P1923, DOI 10.1093/ndt/gfp755; Asplin JR, 2009, J AM SOC NEPHROL, V20, P1246, DOI 10.1681/ASN.2008070754; Asplin JR, 2003, KIDNEY INT, V63, P662, DOI 10.1046/j.1523-1755.2003.00763.x; BARTHOLOMEW TC, 1980, BIOCHEM PHARMACOL, V29, P2431, DOI 10.1016/0006-2952(80)90346-9; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; Brucculeri M, 2005, SEMIN DIALYSIS, V18, P431, DOI 10.1111/j.1525-139X.2005.00082.x; Bushinsky DA, 1999, KIDNEY INT, V55, P234, DOI 10.1046/j.1523-1755.1999.00247.x; Bushinsky DA, 2001, KIDNEY INT, V59, P1415, DOI 10.1046/j.1523-1755.2001.0590041415.x; Cicone JS, 2004, AM J KIDNEY DIS, V43, P1104, DOI 10.1053/j.ajkd.2004.03.018; Finlayson B., 1977, CALCIUM METABOLISM R, P337; GILMAN A, 1946, AM J PHYSIOL, V146, P348, DOI 10.1152/ajplegacy.1946.146.3.348; Goldfarb DS, 2012, CLIN J AM SOC NEPHRO, V7, P1172, DOI 10.2215/CJN.00560112; Hackett BC, 2009, CLIN EXP DERMATOL, V34, P39, DOI 10.1111/j.1365-2230.2008.02877.x; Hall AH, 2007, ANN EMERG MED, V49, P806, DOI 10.1016/j.annemergmed.2006.09.021; HOWELL SB, 1982, ANN INTERN MED, V97, P845, DOI 10.7326/0003-4819-97-6-845; LaGrange CA, 2009, J ENDOUROL, V23, P529, DOI 10.1089/end.2008.0204; Lingeman J, 1998, J UROLOGY, V160, P1629, DOI 10.1016/S0022-5347(01)62365-6; Pasch A, 2008, KIDNEY INT, V74, P1444, DOI 10.1038/ki.2008.455; PREMINGER GM, 1985, J UROLOGY, V134, P20, DOI 10.1016/S0022-5347(17)46963-1; Sauve V, 2009, J BIOL CHEM, V284, P21707, DOI 10.1074/jbc.M109.002709; Selk N, 2011, SEMIN DIALYSIS, V24, P85, DOI 10.1111/j.1525-139X.2011.00848.x; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Thorpe MP, 2011, NUTR REV, V69, P215, DOI 10.1111/j.1753-4887.2011.00379.x; YATZIDIS H, 1985, CLIN NEPHROL, V23, P63	24	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60380	10.1371/journal.pone.0060380	http://dx.doi.org/10.1371/journal.pone.0060380			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593205	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000029
J	Long, WC; Swiney, KM; Harris, C; Page, HN; Foy, RJ				Long, William Christopher; Swiney, Katherine M.; Harris, Caitlin; Page, Heather N.; Foy, Robert J.			Effects of Ocean Acidification on Juvenile Red King Crab (Paralithodes camtschaticus) and Tanner Crab (Chionoecetes bairdi) Growth, Condition, Calcification, and Survival	PLOS ONE			English	Article							OYSTER SACCOSTREA-GLOMERATA; LARVAL DEVELOPMENT; SEAWATER ACIDIFICATION; EMBRYONIC-DEVELOPMENT; COMMUNITY STRUCTURE; INCUBATION PERIOD; ELEVATED PCO(2); LIFE-HISTORY; HIGH CO2; IMPACT	Ocean acidification, a decrease in the pH in marine waters associated with rising atmospheric CO2 levels, is a serious threat to marine ecosystems. In this paper, we determine the effects of long-term exposure to near-future levels of ocean acidification on the growth, condition, calcification, and survival of juvenile red king crabs, Paralithodes camtschaticus, and Tanner crabs, Chionoecetes bairdi. Juveniles were reared in individual containers for nearly 200 days in flowing control (pH 8.0), pH 7.8, and pH 7.5 seawater at ambient temperatures (range 4.4-11.9 degrees C). In both species, survival decreased with pH, with 100% mortality of red king crabs occurring after 95 days in pH 7.5 water. Though the morphology of neither species was affected by acidification, both species grew slower in acidified water. At the end of the experiment, calcium concentration was measured in each crab and the dry mass and condition index of each crab were determined. Ocean acidification did not affect the calcium content of red king crab but did decrease the condition index, while it had the opposite effect on Tanner crabs, decreasing calcium content but leaving the condition index unchanged. This suggests that red king crab may be able to maintain calcification rates, but at a high energetic cost. The decrease in survival and growth of each species is likely to have a serious negative effect on their populations in the absence of evolutionary adaptation or acclimatization over the coming decades.	[Long, William Christopher; Swiney, Katherine M.; Harris, Caitlin; Page, Heather N.; Foy, Robert J.] Natl Marine Fisheries Serv, NOAA, Alaska Fisheries Sci Ctr,Kodiak Lab, Resource Assessment & Conservat Engn Div, Kodiak, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA	Long, WC (corresponding author), Natl Marine Fisheries Serv, NOAA, Alaska Fisheries Sci Ctr,Kodiak Lab, Resource Assessment & Conservat Engn Div, Kodiak, AK USA.	chris.long@noaa.gov	Page, Heather/AAP-4668-2021; Long, William C/C-7074-2009	Long, William C/0000-0002-7095-1245; Swiney, Katherine/0000-0001-5482-2710; Page, Heather/0000-0001-9997-0004	NOAA Ocean Acidification Program; NOAA Hollings Fellowship; Pollock Conservation Cooperative Fund Award from Alaska Pacific University	NOAA Ocean Acidification Program; NOAA Hollings Fellowship; Pollock Conservation Cooperative Fund Award from Alaska Pacific University	Funding was supplied through the NOAA Ocean Acidification Program (http://www.oar.noaa.gov/oceans/ocean-acidification/index.html). HP was supported by a NOAA Hollings Fellowship (http://www.oesd.noaa.gov/scholarships/hollings.html), and CH by was supported by a Pollock Conservation Cooperative Fund Award from Alaska Pacific University (http://marine.alaskapacific.edu/marine/announcement.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri AH, 2008, ECOLOGY, V89, P2808, DOI 10.1890/07-0994.1; Amaral V, 2012, MAR ECOL PROG SER, V445, P117, DOI 10.3354/meps09487; Amaral V, 2011, ESTUAR COAST SHELF S, V93, P460, DOI 10.1016/j.ecss.2011.05.024; Appelhans YS, 2012, MAR ECOL PROG SER, V459, P85, DOI 10.3354/meps09697; Arnold KE, 2009, BIOGEOSCIENCES, V6, P1747, DOI 10.5194/bg-6-1747-2009; Beesley A, 2008, CLIM RES, V37, P215, DOI 10.3354/cr00765; Bell GW, 2005, MAR BIOL, V146, P761, DOI 10.1007/s00227-004-1483-7; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Byrne M, 2010, MAR ENVIRON RES, V69, P234, DOI 10.1016/j.marenvres.2009.10.014; Byrne RH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL040999; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DONALDSON W E, 1992, Journal of Shellfish Research, V11, P85; Donaldson W. E., 2005, BIOL FIELD TECHNIQUE; DONALDSON WE, 1981, CRUSTACEANA, V40, P286, DOI 10.1163/156854081X00750; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donohue PJC, 2012, AQUAT BIOL, V15, P73, DOI 10.3354/ab00408; Dupont S, 2012, MAR BIOL, DOI [10.1007/s00227-012-1921-x: 1-9, DOI 10.1007/S00227-012-1921-X:1-9]; Dupont S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029568; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Findlay HS, 2010, MAR BIOL, V157, P725, DOI 10.1007/s00227-009-1356-1; Findlay HS, 2009, MAR ECOL PROG SER, V389, P193, DOI 10.3354/meps08141; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Hale R, 2011, OIKOS, V120, P661, DOI 10.1111/j.1600-0706.2010.19469.x; Hauton C, 2009, BIOGEOSCIENCES, V6, P1479, DOI 10.5194/bg-6-1479-2009; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; HOOPES DT, 1972, FISH BULL NATL OC AT, V70, P225; Jadamec L.S., 1999, BIOL FIELD TECHNIQUE; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Kurihara H, 2008, J EXP MAR BIOL ECOL, V367, P41, DOI 10.1016/j.jembe.2008.08.016; Lavigne H, 2012, seacarb: Seawater carbonate chemistry with R; Lenihan HS, 2001, ECOL APPL, V11, P764, DOI 10.1890/1051-0761(2001)011[0764:COHDOR]2.0.CO;2; Long WC, 2008, J EXP MAR BIOL ECOL, V359, P34, DOI 10.1016/j.jembe.2008.02.013; Long WC, 2013, MAR POLLUT BULL, V69, P38, DOI 10.1016/j.marpolbul.2013.01.011; Long WC, 2012, J EXP MAR BIOL ECOL, V422, P101, DOI 10.1016/j.jembe.2012.04.019; Long WC, 2008, AQUAT BIOL, V3, P187, DOI 10.3354/ab00075; Long WC, 2008, MAR ECOL PROG SER, V362, P59, DOI 10.3354/meps07395; Long WC, 2009, ESTUAR COAST, V32, P287, DOI 10.1007/s12237-009-9132-5; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Mathis JT, J GEOPHYS RES OCEANS, V116, P24; McDonald MR, 2009, MAR ECOL PROG SER, V385, P179, DOI 10.3354/meps08099; McGraw CM, 2010, LIMNOL OCEANOGR-METH, V8, P686, DOI 10.4319/lom.2010.8.686; MILLERO FJ, 1986, LIMNOL OCEANOGR, V31, P839, DOI 10.4319/lo.1986.31.4.0839; Modig H, 1998, J EXP MAR BIOL ECOL, V229, P133, DOI 10.1016/S0022-0981(98)00043-4; NPFMC (North Pacific Fishery Management Council), 2011, STOCK ASS FISH EV RE; Pane EF, 2007, MAR ECOL PROG SER, V334, P1, DOI 10.3354/meps334001; Pansch C, 2012, J EXP MAR BIOL ECOL, V420, P48, DOI 10.1016/j.jembe.2012.03.023; Parker LM, 2011, MAR BIOL, V158, P689, DOI 10.1007/s00227-010-1592-4; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pirtle JL, 2012, MAR ECOL PROG SER, V465, P169, DOI 10.3354/meps09883; Raven J, 2006, 125 ROYAL SOC, V12, P5; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Seitz RD, 2009, J EXP MAR BIOL ECOL, V381, pS4, DOI 10.1016/j.jembe.2009.07.004; SHIRLEY SM, 1989, MAR ECOL PROG SER, V54, P51, DOI 10.3354/meps054051; SKINNER DM, 1985, BIOL CRUSTACEA, V9, P44; Small D, 2010, AQUAT BIOL, V10, P11, DOI 10.3354/ab00266; SOMERTON DA, 1983, J CRUSTACEAN BIOL, V3, P183, DOI 10.2307/1548254; SOMERTON DA, 1981, FISH B-NOAA, V79, P259; STEVENS BG, 1990, CAN J FISH AQUAT SCI, V47, P1307, DOI 10.1139/f90-150; Stevens BG, 2007, J CRUSTACEAN BIOL, V27, P37, DOI 10.1651/S-2663.1; Stevens BG, 2009, J CRUSTACEAN BIOL, V29, P157, DOI 10.1651/08-3039R.1; Stevens Bradley G., 2007, ALASKA FISHERY RESEARCH BULLETIN, V12, P270; Stoner AW, 2009, J EXP MAR BIOL ECOL, V382, P54, DOI 10.1016/j.jembe.2009.10.003; Swiney KM, 2008, J CRUSTACEAN BIOL, V28, P334, DOI 10.1651/0278-0372(2008)028[0334:EEEDTA]2.0.CO;2; Swiney KM, 2013, AQUAC RES, V44, P1007, DOI 10.1111/j.1365-2109.2012.03105.x; Swiney KM, 2012, J SHELLFISH RES, V31, P925, DOI 10.2983/035.031.0403; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tamone SL, 2007, J CRUSTACEAN BIOL, V27, P635, DOI 10.1651/S-2802.1; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Walther K, 2010, MAR ECOL PROG SER, V417, P159, DOI 10.3354/meps08807; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	84	104	110	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60959	10.1371/journal.pone.0060959	http://dx.doi.org/10.1371/journal.pone.0060959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593357	Green Published, gold			2022-12-27	WOS:000319108100070
J	Jain, S; Kapetanaki, MG; Raghavachari, N; Woodhouse, K; Yu, GY; Barge, S; Coronnello, C; Benos, PV; Kato, GJ; Kaminski, N; Gladwin, MT				Jain, Shilpa; Kapetanaki, Maria G.; Raghavachari, Nalini; Woodhouse, Kimberly; Yu, Guoying; Barge, Suchitra; Coronnello, Claudia; Benos, Panayiotis V.; Kato, Gregory J.; Kaminski, Naftali; Gladwin, Mark T.			Expression of Regulatory Platelet MicroRNAs in Patients with Sickle Cell Disease	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; RETICULATED PLATELETS; ERYTHROCYTE ADHERENCE; POTENTIAL ROLE; ACTIVATION; PROFILES; MICROPARTICLES; MECHANISMS; TARGETS; ANEMIA	Background: Increased platelet activation in sickle cell disease (SCD) contributes to a state of hypercoagulability and confers a risk of thromboembolic complications. The role for post-transcriptional regulation of the platelet transcriptome by microRNAs (miRNAs) in SCD has not been previously explored. This is the first study to determine whether platelets from SCD exhibit an altered miRNA expression profile. Methods and Findings: We analyzed the expression of miRNAs isolated from platelets from a primary cohort (SCD = 19, controls = 10) and a validation cohort (SCD = 7, controls = 7) by hybridizing to the Agilent miRNA microarrays. A dramatic difference in miRNA expression profiles between patients and controls was noted in both cohorts separately. A total of 40 differentially expressed platelet miRNAs were identified as common in both cohorts (p-value 0.05, fold change>2) with 24 miRNAs downregulated. Interestingly, 14 of the 24 downregulated miRNAs were members of three families - miR-329, miR-376 and miR-154 - which localized to the epigenetically regulated, maternally imprinted chromosome 14q32 region. We validated the downregulated miRNAs, miR-376a and miR-409-3p, and an upregulated miR-1225-3p using qRT-PCR. Overexpression of the miR-1225-3p in the Meg01 cells was followed by mRNA expression profiling to identify mRNA targets. This resulted in significant transcriptional repression of 1605 transcripts. A combinatorial approach using Meg01 mRNA expression profiles following miR-1225-3p overexpression, a computational prediction analysis of miRNA target sequences and a previously published set of differentially expressed platelet transcripts from SCD patients, identified three novel platelet mRNA targets: PBXIP1, PLAGL2 and PHF20L1. Conclusions: We have identified significant differences in functionally active platelet miRNAs in patients with SCD as compared to controls. These data provide an important inventory of differentially expressed miRNAs in SCD patients and an experimental framework for future studies of miRNAs as regulators of biological pathways in platelets.	[Jain, Shilpa] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Hematol Oncol, Pittsburgh, PA 15213 USA; [Jain, Shilpa; Barge, Suchitra; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA; [Kapetanaki, Maria G.; Yu, Guoying; Kaminski, Naftali] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA; [Raghavachari, Nalini; Woodhouse, Kimberly] NHLBI, Genom Core Facil, NIH, Bethesda, MD 20892 USA; [Coronnello, Claudia; Benos, Panayiotis V.] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Coronnello, Claudia] Fdn Ri Med, Palermo, Italy; [Kato, Gregory J.] NHLBI, Sickle Cell Vasc Dis Sect, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Gladwin, Mark T.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaminski, N (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA.	kaminskin@upmc.edu; gladwinmt@upmc.edu	Kato, Gregory J/I-7615-2014; coronnello, claudia/AAP-2478-2021	Kato, Gregory J/0000-0003-4465-3217; Kaminski, Naftali/0000-0001-5917-4601; CORONNELLO, Claudia/0000-0001-5962-8642; Benos, Panayiotis/0000-0003-3172-3132	National Institutes of Health (NIH) [R01HL098032, RO1HL096973, PO1HL103455]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NIH [R01LM009657, R01LM007994]; Fondazione RiMED Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103455, ZIAHL006012, ZICHL006058, R01HL096973, U01HL108642, R01HL098032] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009657, R01LM007994] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione RiMED Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr. Mark Gladwin receives research support from National Institutes of Health (NIH) grants R01HL098032, RO1HL096973, and PO1HL103455, the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania. Panayiotis V. Benos was supported by NIH grants R01LM009657 and R01LM007994. Claudia Coronnello was supported by a Fondazione RiMED Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Amisten S, 2012, METHODS MOL BIOL, V788, P155, DOI 10.1007/978-1-61779-307-3_12; Ammons MCB, 2007, J BIOL CHEM, V282, P17941, DOI 10.1074/jbc.M610618200; ANTONUCCI R, 1990, AM J HEMATOL, V34, P44, DOI 10.1002/ajh.2830340110; Badeaux AI, 2012, J BIOL CHEM, V287, P429, DOI 10.1074/jbc.M111.271163; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzoni G, 2011, ANTIOXID REDOX SIGN, V15, P1221, DOI 10.1089/ars.2010.3867; Benetatos L, 2012, CELL MOL LIFE SCI; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Blann AD, 2003, BLOOD COAGUL FIBRIN, V14, P255, DOI 10.1097/01.mbc.0000061293.28953.8c; BRITTAIN HA, 1993, BLOOD, V81, P2137; Browne PV, 1996, AM J HEMATOL, V51, P296, DOI 10.1002/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Chavda N, 1996, PLATELETS, V7, P189, DOI 10.3109/09537109609023578; Coronnello C HR, 2012, PLOS COMPUT IN PRESS; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; FREEDMAN ML, 1975, BLOOD, V46, P579; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gnatenko DV, 2005, THROMB HAEMOSTASIS, V94, P412, DOI 10.1160/TH05-01-0037; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Kannan M, 2009, TRANSFUSION, V49, P1443, DOI 10.1111/j.1537-2995.2009.02140.x; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim S, 2007, BLOOD, V110, P4206, DOI 10.1182/blood-2007-03-080804; Kondkar AA, 2010, J THROMB HAEMOST, V8, P369, DOI 10.1111/j.1538-7836.2009.03700.x; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2; Lood C, BLOOD, V116, P1951; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Milosevic J, 2012, AM J RESP CELL MOL B; Mohan JS, 2006, THROMB RES, V117, P623, DOI 10.1016/j.thromres.2005.05.010; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Noronha JFA, 2007, THROMB RES, V121, P259, DOI 10.1016/j.thromres.2007.04.002; Novelli EM, 2012, AM J HEMATOL, V87, P326, DOI 10.1002/ajh.22274; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; POPESCU ER, 1977, BLOOD, V49, P490; Queen LR, 2006, CELL MOL LIFE SCI, V63, P1070, DOI 10.1007/s00018-005-5451-2; Raghavachari N, 2007, CIRCULATION, V115, P1551, DOI 10.1161/CIRCULATIONAHA.106.658641; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; Rossi S, BLOOD, V116, P945; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schedel Angelika, 2009, V496, P273, DOI 10.1007/978-1-59745-553-4_17; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Steele BM, 2009, P NATL ACAD SCI USA, V106, P19836, DOI 10.1073/pnas.0906268106; Toma I, 2012, CELL TISSUE RES, V347, P155, DOI 10.1007/s00441-011-1189-3; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Wun T, 1998, BRIT J HAEMATOL, V100, P741, DOI 10.1046/j.1365-2141.1998.00627.x	65	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60932	10.1371/journal.pone.0060932	http://dx.doi.org/10.1371/journal.pone.0060932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593351	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000317385300035
J	Mohamed, AA; Ali, SI; El-Baz, FK				Mohamed, Amal A.; Ali, Sami I.; El-Baz, Farouk K.			Antioxidant and Antibacterial Activities of Crude Extracts and Essential Oils of Syzygium cumini Leaves	PLOS ONE			English	Article							TOTAL PHENOLIC CONTENTS; EUGENIA-JAMBOLANA; IN-VITRO; CHEMICAL-COMPOSITION; FOOD; CONSTITUENTS; AUTOXIDATION; FLAVONOIDS; RADICALS; FRUIT	This research highlights the chemical composition, antioxidant and antibacterial activities of essential oils and various crude extracts (using methanol and methylene chloride) from Syzygium cumini leaves. Essential oils were analyzed by gas chromatography-mass spectrometry (GC-MS). The abundant constituents of the oils were: alpha-pinene (32.32%), beta-pinene (12.44%), trans-caryophyllene (11.19%), 1, 3, 6-octatriene (8.41%), delta-3-carene (5.55%), alpha-caryophyllene (4.36%), and alpha-limonene (3.42%). The antioxidant activities of all extracts were examined using two complementary methods, namely diphenylpicrylhydrazyl (DPPH) and ferric reducing power (FRAP). In both methods, the methanol extract exhibited a higher activity than methylene chloride and essential oil extracts. A higher content of both total phenolics and flavonoids were found in the methanolic extract compared with other extracts. Furthermore, the methanol extract had higher antibacterial activity compared to methylene chloride and the essential oil extracts. Due to their antioxidant and antibacterial properties, the leaf extracts from S. cumini may be used as natural preservative ingredients in food and/or pharmaceutical industries.	[Mohamed, Amal A.; Ali, Sami I.; El-Baz, Farouk K.] Natl Res Ctr, Dept Plant Biochem, Cairo, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Mohamed, AA (corresponding author), Natl Res Ctr, Dept Plant Biochem, Cairo, Egypt.	amin_amal@yahoo.com	Mohamed, Amal A/Q-8854-2016; Ali, Sami I./Q-2780-2015	Mohamed, Amal A/0000-0002-4903-547X; Ali, Sami I./0000-0002-7403-4372; El-Baz, Farouk K./0000-0002-4750-3559				Adams R.P., 1995, IDENTIFICATION ESSEN; Al-Reza SM, 2009, INT J FOOD SCI TECH, V44, P1176, DOI 10.1111/j.1365-2621.2009.01939.x; Ayyanar Muniappan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P240, DOI 10.1016/S2221-1691(12)60050-1; Bajpai M, 2005, INT J FOOD SCI NUTR, V56, P287, DOI 10.1080/09637480500146606; Banerjee A, 2005, FOOD CHEM, V90, P727, DOI 10.1016/j.foodchem.2004.04.033; Benherlal PS, 2007, J SCI FOOD AGR, V87, P2560, DOI 10.1002/jsfa.2957; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Chandhuri AKN, 1990, PHYTOTHERAPY RES, V4, P5; Chandrasekaran M, 2004, J ETHNOPHARMACOL, V91, P105, DOI 10.1016/j.jep.2003.12.012; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Chattopadhyay D, 1998, FITOTERAPIA, V69, P365; Choi Y, 2007, FOOD CHEM, V103, P130, DOI 10.1016/j.foodchem.2006.08.004; Cui K, 2004, PROG NEURO-PSYCHOPH, V28, P771, DOI 10.1016/j.pnpbp.2004.05.023; DAS NP, 1990, J AM OIL CHEM SOC, V67, P255, DOI 10.1007/BF02540652; Decker EA, 1997, NUTR REV, V55, P396, DOI 10.1111/j.1753-4887.1997.tb01580.x; Duh PD, 1998, J AM OIL CHEM SOC, V75, P455, DOI 10.1007/s11746-998-0248-8; Gowri S S, 2010, INT J PHARMTECH RES, V2, P1569; Guenther G., 1961, ESSENTIAL OILS, VIII; Hajji F., 1993, Fitoterapia, V64, P71; Halliwell B, 1997, NUTR REV, V55, pS44, DOI 10.1111/j.1753-4887.1997.tb06100.x; Indira G, 1992, JAMUN FRUITS, P34; Kamatou GPP, 2010, J AM OIL CHEM SOC, V87, P1, DOI 10.1007/s11746-009-1483-3; Kaur C, 2002, INT J FOOD SCI TECH, V37, P153, DOI 10.1046/j.1365-2621.2002.00552.x; Kessler M, 2003, J PHARM PHARMACOL, V55, P131, DOI 10.1211/002235702559; Li HB, 2008, LWT-FOOD SCI TECHNOL, V41, P385, DOI 10.1016/j.lwt.2007.03.011; Maestri D. M., 2006, Phytochemistry: advances in research, P105; Mahmoud II, 2001, PHYTOCHEMISTRY, V58, P1239, DOI 10.1016/S0031-9422(01)00365-X; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Mohamed AA, 2010, GRASAS ACEITES, V61, P67, DOI 10.3989/gya.064509; Murray P.R., 1995, MANUAL CLIN MICROBIO; Naik GH, 2003, PHYTOCHEMISTRY, V63, P97, DOI 10.1016/S0031-9422(02)00754-9; Oomah BD, 2005, J SCI FOOD AGR, V85, P935, DOI 10.1002/jsfa.2019; Paganga G, 1999, FREE RADICAL RES, V30, P153, DOI 10.1080/10715769900300161; Pandey A., 2011, J PLANT SCI RES, V1, P69; Rastogi RM, 1990, COMPENDIUM INDIAN ME, P388; Rastogi RP, 1995, COMPENDIUM INDIAN ME, V4, P1985; Ravi K, 2004, BIOL PHARM BULL, V27, P1212, DOI 10.1248/bpb.27.1212; Reynertson KA, 2008, FOOD CHEM, V109, P883, DOI 10.1016/j.foodchem.2008.01.021; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Sah A. K., 2011, Journal of Chemical and Pharmaceutical Research, V3, P108; SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473; Shafi PM, 2002, FITOTERAPIA, V73, P414, DOI 10.1016/S0367-326X(02)00131-4; Sharma SB, 2003, J ETHNOPHARMACOL, V85, P201, DOI 10.1016/S0378-8741(02)00366-5; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Sultana B, 2007, FOOD CHEM, V104, P1106, DOI 10.1016/j.foodchem.2007.01.019; Sultana B, 2009, MOLECULES, V14, P2167, DOI 10.3390/molecules14062167; Tantaoui-Elaraki A, 1993, J ESSENT OIL RES, V5, P45; Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002; Warrier P., 1996, INDIAN MED PLANTS, V5, P225; Zhao HF, 2008, FOOD CHEM, V107, P296, DOI 10.1016/j.foodchem.2007.08.018; Zheng N, 2011, AFR J PHARM PHARMACO, V5, P2411, DOI 10.5897/AJPP11.691	52	72	74	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60269	10.1371/journal.pone.0060269	http://dx.doi.org/10.1371/journal.pone.0060269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593183	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300012
J	Raval, AP; Borges-Garcia, R; Moreno, WJ; Perez-Pinzon, MA; Bramlett, H				Raval, Ami P.; Borges-Garcia, Raquel; Moreno, William Javier; Perez-Pinzon, Miguel A.; Bramlett, Helen			Periodic 17 beta-Estradiol Pretreatment Protects Rat Brain from Cerebral Ischemic Damage via Estrogen Receptor-beta	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; MITOCHONDRIAL GENE-EXPRESSION; CYTOCHROME-C; ER-ALPHA; GLOBAL-ISCHEMIA; NEURONAL DEATH; CA1 NEURONS; ESTRADIOL; MECHANISMS; PROLIFERATION	Although chronic 17 beta-estradiol (E-2) has been shown to be a cognition-preserving and neuroprotective agent in animal brain injury models, concern regarding its safety was raised by the failed translation of this phenomenon to the clinic. Previously, we demonstrated that a single bolus of E-2 48 hr prior to ischemia protected the hippocampus from damage in ovariectomized rats via phosphorylation of cyclic-AMP response element binding protein, which requires activation of estrogen receptor subtype beta (ER-beta). The current study tests the hypothesis that long-term periodic E-2-treatment improves cognition and reduces post-ischemic hippocampal injury by means of ER-beta activation. Ovariectomized rats were given ten injections of E-2 at 48 hr intervals for 21 days. Hippocampal-dependent learning, memory and ischemic neuronal loss were monitored. Results demonstrated that periodic E-2 treatments improved spatial learning, memory and ischemic neuronal survival in ovariectomized rats. Additionally, periodic ER-beta agonist treatments every 48 hr improved post-ischemic cognition. Silencing of hippocampal ER-beta attenuated E-2-mediated ischemic protection suggesting that ER-beta plays a key role in mediating the beneficial effects of periodic E-2 treatments. This study emphasizes the need to investigate a periodic estrogen replacement regimen to reduce cognitive decline and cerebral ischemia incidents/impact in post-menopausal women.	[Raval, Ami P.; Borges-Garcia, Raquel; Perez-Pinzon, Miguel A.] Univ Miami, Cerebral Vasc Dis Res Labs, Dept Neurol, Miami, FL USA; [Moreno, William Javier; Bramlett, Helen] Univ Miami, Dept Neurol Surg, Miami, FL USA; [Perez-Pinzon, Miguel A.; Bramlett, Helen] Univ Miami, Leonard M Miller Sch Med, Neurosci Program, Miami, FL USA; [Bramlett, Helen] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL USA	University of Miami; University of Miami; University of Miami	Raval, AP (corresponding author), Univ Miami, Cerebral Vasc Dis Res Labs, Dept Neurol, Miami, FL USA.	ARaval@med.miami.edu			American Heart Association [11GRNT7370069]; National Institutes of Health [NS45676, NS34773, 5 P50 DA024584-05]; Stanley J. Glaser Foundation Research Grant; Drs. Chantal and Peritz Scheinberg Research Fund; Veterans Affairs Grant [BX000521]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS034773, R01NS045676, R29NS034773, R01NS034773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA024584] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley J. Glaser Foundation Research Grant; Drs. Chantal and Peritz Scheinberg Research Fund; Veterans Affairs Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by American Heart Association grant 11GRNT7370069 (APR), National Institutes of Health grants NS45676 (MAPP), NS34773 (MAPP), 5 P50 DA024584-05 (APR), Stanley J. Glaser Foundation Research Grant (APR), Drs. Chantal and Peritz Scheinberg Research Fund (APR), and Veterans Affairs Grant BX000521 (HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Bagetta G, 2004, NEUROSCI LETT, V368, P87, DOI 10.1016/j.neulet.2004.06.062; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BETTINI E, 1992, J NEUROCHEM, V58, P1923, DOI 10.1111/j.1471-4159.1992.tb10070.x; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chen JQ, 2004, ANN NY ACAD SCI, V1028, P258, DOI 10.1196/annals.1322.030; Dave KR, 2004, BRAIN RES, V1024, P89, DOI 10.1016/j.brainres.2004.07.050; De Rasmo D, 2010, IUBMB LIFE, V62, P447, DOI 10.1002/iub.342; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Edinger KL, 2007, NEUROBIOL LEARN MEM, V87, P78, DOI 10.1016/j.nlm.2006.07.001; Farr TD, 2007, BRAIN RES, V1185, P275, DOI 10.1016/j.brainres.2007.09.009; Frasor J, 2003, ENDOCRINOLOGY, V144, P3159, DOI 10.1210/en.2002-0143; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Jayachandran M, 2009, AGE DORDR; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Kristian T, 2004, CELL CALCIUM, V36, P221, DOI 10.1016/j.ceca.2004.02.016; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Luoma JI, 2008, MOL CELL ENDOCRINOL, V290, P8, DOI 10.1016/j.mce.2008.04.005; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Mirebeau-Prunier D, 2010, FEBS J; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Noppens RR, 2009, J CEREBR BLOOD F MET, V29, P277, DOI 10.1038/jcbfm.2008.116; ORDY JM, 1993, EXP NEUROL, V119, P128, DOI 10.1006/exnr.1993.1014; Ramara A, 2007, BRAIN RES, V1176, P71, DOI 10.1016/j.brainres.2007.08.036; Raval AP, 2006, NEUROSCIENCE, V141, P1721, DOI 10.1016/j.neuroscience.2006.05.016; Raval AP, 2011, NEUROSCIENCE, V181, P216, DOI 10.1016/j.neuroscience.2011.02.036; Raval AP, 2009, NEUROSCIENCE, V160, P307, DOI 10.1016/j.neuroscience.2009.02.065; Raval AP, 2012, J NEUROCHEM, V121, P157, DOI 10.1111/j.1471-4159.2012.07661.x; Raval AP, 2003, J NEUROSCI, V23, P384, DOI 10.1523/JNEUROSCI.23-02-00384.2003; Rissman EF, 2002, P NATL ACAD SCI USA, V99, P3996, DOI 10.1073/pnas.012032699; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; SCHMIDTKASTNER R, 1990, ACTA NEUROPATHOL, V79, P444, DOI 10.1007/BF00308722; Simpkins J. W., 2009, BIOCH BIOPHYS ACTA; Simpkins JW, 2012, NEUROENDOCRINOLOGY; Utian WFH, 2007, MENOPAUSE, V14, P1056, DOI 10.1097/gme.0b013e3181589bfe; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Waters EM, 2011, BRAIN RES, V1379, P86, DOI 10.1016/j.brainres.2010.09.069; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhao LQ, 2011, MENOPAUSE, V18, P1131, DOI 10.1097/gme.0b013e3182175b66	52	26	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60716	10.1371/journal.pone.0060716	http://dx.doi.org/10.1371/journal.pone.0060716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593292	Green Submitted, gold, Green Published			2022-12-27	WOS:000317385300028
J	Fang, L; Zhou, Y; Cao, HD; Wen, P; Jiang, L; He, WC; Dai, CS; Yang, JW				Fang, Li; Zhou, Yang; Cao, Hongdi; Wen, Ping; Jiang, Lei; He, Weichun; Dai, Chunsun; Yang, Junwei			Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte Injury	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; QUALITY-CONTROL; ER STRESS; RENAL PATHOPHYSIOLOGY; CELL BIOLOGY; DISEASE; DIFFERENTIATION; NEPHROPATHY; DEGRADATION	Despite the recent attention focused on the important role of autophagy in maintaining podocyte homeostasis, little is known about the changes and mechanisms of autophagy in podocyte dysfunction under diabetic condition. In this study, we investigated the role of autophagy in podocyte biology and its involvement in the pathogenesis of diabetic nephropathy. Podocytes had a high basal level of autophagy. And basal autophagy inhibition either by 3-methyladenenine (3-MA) or by Beclin-1 siRNA was detrimental to its architectural structure. However, under diabetic condition in vivo and under high glucose conditions in vitro, high basal level of autophagy in podocytes became defective and defective autophagy facilitated the podocyte injury. Since the dynamics of endoplasmic reticulum(ER) seemed to play a vital role in regulating the autophagic flux, the results that Salubrinal/Tauroursodeoxycholic acid (TUDCA) could restore defective autophagy further indicated that the evolution of autophagy may be mediated by the changes of cytoprotective output in the ER stress. Finally, we demonstrated in vivo that the autophagy of podocyte was inhibited under diabetic status and TUDCA could improve defective autophagy. Taken together, these data suggested that autophagy might be interrupted due to the failure of ER cytoprotective capacity upon high glucose induced unmitigated stress, and the defective autophagy might accelerate the irreparable progression of diabetic nephropathy.	[Fang, Li; Zhou, Yang; Cao, Hongdi; Wen, Ping; Jiang, Lei; He, Weichun; Dai, Chunsun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn		Liu, Zhi-Hong/0000-0001-6093-0726	"973" Science Program of the Ministry of Science and Technology, China [2011CB504000]; National Science Foundation of China [30270616, 30771010]	"973" Science Program of the Ministry of Science and Technology, China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by "973" Science Program of the Ministry of Science and Technology, China (2011CB504000), and National Science Foundation of China grants 30270616, 30771010 to Junwei Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Cina DP, 2012, J AM SOC NEPHROL, V23, P412, DOI 10.1681/ASN.2011070690; Cybulsky AV, 2012, KIDNEY INT; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kobayashi N, 2002, MICROSC RES TECHNIQ, V57, P217, DOI 10.1002/jemt.10077; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; MISRA RP, 1972, AM J CLIN PATHOL, V58, P135; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Quaggin SE, 2002, MICROSC RES TECHNIQ, V57, P208, DOI 10.1002/jemt.10076; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Stitt-Cavanagh E, 2009, THESCIENTIFICWORLDJO, V9, P1127, DOI 10.1100/tsw.2009.133; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wolf G, 2007, NEPHRON PHYSIOL, V106, P26, DOI 10.1159/000101797; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yang LY, 2013, AM J MED SCI, V345, P1, DOI 10.1097/MAJ.0b013e318249d387; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005	40	158	182	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60546	10.1371/journal.pone.0060546	http://dx.doi.org/10.1371/journal.pone.0060546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593240	Green Submitted, Green Published, gold			2022-12-27	WOS:000317383200009
J	Miller, JL; Murray, S; Vaughan, AM; Harupa, A; Sack, B; Baldwin, M; Crispe, IN; Kappe, SHI				Miller, Jessica L.; Murray, Sara; Vaughan, Ashley M.; Harupa, Anke; Sack, Brandon; Baldwin, Michael; Crispe, Ian N.; Kappe, Stefan H. I.			Quantitative Bioluminescent Imaging of Pre-Erythrocytic Malaria Parasite Infection Using Luciferase-Expressing Plasmodium yoelii	PLOS ONE			English	Article							LIVER-STAGE; BERGHEI PARASITES; DIFFERENT STRAINS; MICE; SUSCEPTIBILITY; SPOROZOITES; PROTECTION; IMMUNITY	The liver stages of Plasmodium parasites are important targets for the development of anti-malarial vaccine candidates and chemoprophylaxis approaches that aim to prevent clinical infection. Analyzing the impact of interventions on liver stages in the murine malaria model system Plasmodium yoelii has been cumbersome and requires terminal procedures. In vivo imaging of bioluminescent parasites has previously been shown to be an effective and non-invasive alternative to monitoring liver stage burden in the Plasmodium berghei model. Here we report the generation and characterization of a transgenic P. yoelii parasite expressing the reporter protein luciferase throughout the parasite life cycle. In vivo bioluminescent imaging of these parasites allows for quantitative analysis of P. yoelii liver stage burden and parasite development, which is comparable to quantitative RT-PCR analysis of liver infection. Using this system, we show that both BALB/cJ and C57BL/6 mice show comparable susceptibility to P. yoelii infection with sporozoites and that bioluminescent imaging can be used to monitor protective efficacy of attenuated parasite immunizations. Thus, this rapid, simple and noninvasive method for monitoring P. yoelii infection in the liver provides an efficient system to screen and evaluate the effects of anti-malarial interventions in vivo and in real-time.	[Miller, Jessica L.; Murray, Sara; Vaughan, Ashley M.; Harupa, Anke; Sack, Brandon; Baldwin, Michael; Crispe, Ian N.; Kappe, Stefan H. I.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Murray, Sara; Kappe, Stefan H. I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Harupa, Anke] Free Univ Berlin, Inst Biol, Berlin, Germany; [Crispe, Ian N.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; Free University of Berlin; University of Washington; University of Washington Seattle	Kappe, SHI (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	stefan.kappe@seattlebiomed.org			National Institutes of Health [1R01AI095178]; Bill and Melinda Gates Foundation [OPP1016829]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant number 1R01AI095178 from the National Institutes of Health (www.nih.gov) and grant number OPP1016829 from the Bill and Melinda Gates Foundation (www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Belmonte M, 2003, J PARASITOL, V89, P602, DOI 10.1645/0022-3395(2003)089[0602:TIOPYI]2.0.CO;2; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2006, NAT PROTOC, V1, P476, DOI 10.1038/nprot.2006.69; Jacobs-Lorena VY, 2010, MOL BIOCHEM PARASIT, V171, P40, DOI 10.1016/j.molbiopara.2009.12.009; JAFFE RI, 1990, AM J TROP MED HYG, V42, P309, DOI 10.4269/ajtmh.1990.42.309; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; KHAN ZM, 1991, INFECT IMMUN, V59, P2529, DOI 10.1128/IAI.59.8.2529-2534.1991; Lin JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029289; Lindner SE, 2012, CELL MICROBIOL, V14, P316, DOI 10.1111/j.1462-5822.2011.01734.x; Mikolajczak SA, 2008, MOL BIOCHEM PARASIT, V158, P213, DOI 10.1016/j.molbiopara.2007.12.006; Mwakingwe A, 2009, DEV EFFICIENT TOOLS; Mwakingwe A, 2009, J INFECT DIS, V200, P1470, DOI 10.1086/606115; Ploemen I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-350; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; Vaughan AM, 2012, CURR OPIN IMMUNOL, V24, P324, DOI 10.1016/j.coi.2012.03.009; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; WHO, 2010, WORLD MALARIA REPORT 2010, P1	22	44	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60820	10.1371/journal.pone.0060820	http://dx.doi.org/10.1371/journal.pone.0060820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593316	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200019
J	Xu, MP; Qi, HZ; Ma, L; Sun, CC; Zhang, LX; Wan, BK; Yin, T; Ming, D				Xu, Minpeng; Qi, Hongzhi; Ma, Lan; Sun, Changcheng; Zhang, Lixin; Wan, Baikun; Yin, Tao; Ming, Dong			Channel Selection Based on Phase Measurement in P300-Based Brain-Computer Interface	PLOS ONE			English	Article							BCI COMPETITION 2003; P300 SPELLER; LARGE-SCALE; RESPONSES; ELECTROPHYSIOLOGY; SYNCHRONIZATION; CONTRIBUTES; POTENTIALS; GENERATION; ATTENTION	Most EEG-based brain-computer interface (BCI) paradigms include specific electrode positions. As the structures and activities of the brain vary with each individual, contributing channels should be chosen based on original records of BCIs. Phase measurement is an important approach in EEG analyses, but seldom used for channel selections. In this paper, the phase locking and concentrating value-based recursive feature elimination approach (PLCV-RFE) is proposed to produce robust-EEG channel selections in a P300 speller. The PLCV-RFE, deriving from the phase resetting mechanism, measures the phase relation between EEGs and ranks channels by the recursive strategy. Data recorded from 32 electrodes on 9 subjects are used to evaluate the proposed method. The results show that the PLCV-RFE substantially reduces channel sets and improves recognition accuracies significantly. Moreover, compared with other state-of-the-art feature selection methods (SSNRSF and SVM-RFE), the PLCV-RFE achieves better performance. Thus the phase measurement is available in the channel selection of BCI and it may be an evidence to indirectly support that phase resetting is at least one reason for ERP generations.	[Xu, Minpeng; Qi, Hongzhi; Ma, Lan; Sun, Changcheng; Zhang, Lixin; Wan, Baikun; Yin, Tao; Ming, Dong] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Qi, Hongzhi; Yin, Tao] Chinese Acad Med Sci, Inst Biomed Engn, Beijing 100730, Peoples R China; [Qi, Hongzhi; Yin, Tao] Peking Union Med Coll, Beijing 100021, Peoples R China	Tianjin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of BioMedical Engineering - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qi, HZ (corresponding author), Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China.	qhz@tju.edu.cn; richardming@tju.edu.cn	Qi, Hongzhi/AAY-4423-2020; Zhang, Li/GWM-7501-2022; Ming, Dong/G-8786-2011		National Natural Science Foundation of China [81222021, 61172008, 81171423, 81127003]; National Key Technology R&D Program of the Ministry of Science and Technology of China [2012BAI34B02]; Program for New Century Excellent Talents in University of the Ministry of Education of China [NCET-10-0618]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Program for New Century Excellent Talents in University of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This paper was supported by National Natural Science Foundation of China (81222021, 61172008, 81171423, 81127003,), National Key Technology R&D Program of the Ministry of Science and Technology of China (2012BAI34B02) and Program for New Century Excellent Talents in University of the Ministry of Education of China (NCET-10-0618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; Basar E., 1980, EEG BRAIN DYNAMICS R; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; BRANDT ME, 1991, ELECTROEN CLIN NEURO, V80, P16, DOI 10.1016/0168-5597(91)90037-X; Brunner C, 2006, IEEE T BIO-MED ENG, V53, P2501, DOI 10.1109/TBME.2006.881775; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cecotti H, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/016001; Donchin E., 1986, PSYCHOPHYSIOLOGY SYS, P244; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Frenzel S, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036021; Fuentemilla LI, 2006, NEUROIMAGE, V30, P909, DOI 10.1016/j.neuroimage.2005.10.036; Geng T, 2008, COMPUT INTEL NEUROSC; Hanslmayr S, 2007, CEREB CORTEX, V17, P1, DOI 10.1093/cercor/bhj129; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; HILLYARD SA, 1985, TRENDS NEUROSCI, V8, P400, DOI 10.1016/0166-2236(85)90142-0; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Kruglikov SY, 2003, J NEUROSCI, V23, P10122; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lal TN, 2004, IEEE T BIO-MED ENG, V51, P1003, DOI 10.1109/TBME.2004.827827; Le Van Quyen M, 2003, BIOL RES, V36, P67, DOI 10.4067/S0716-97602003000100006; Liu Y, 2011, CLIN NEUROPHYSIOL, V122, P1127, DOI 10.1016/j.clinph.2010.10.049; Mak JN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025003; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makinen V, 2004, NEUROIMAGE, V21, P701, DOI 10.1016/j.neuroimage.2003.10.009; McFarland DJ, 2011, COMMUN ACM, V54, P60, DOI 10.1145/1941487.1941506; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Rakotomarnonjy A, 2008, IEEE T BIO-MED ENG, V55, P1147, DOI 10.1109/TBME.2008.915728; Rivet B., 2008, P EUR SIGN PROC C EU; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; Schroder M, 2003, I IEEE EMBS C NEUR E, P626, DOI 10.1109/CNE.2003.1196906; Schroeder CE, 1995, EEG CL N SU, P55; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Shih EI, 2009, MOBISYS'09: PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON MOBILE SYSTEMS, APPLICATIONS, AND SERVICES, P347; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vaughan Jr HG, 1988, HUMAN EVENT RELATED, V3, P45; Vaughan TM, 2006, IEEE T NEUR SYS REH, V14, P229, DOI 10.1109/TNSRE.2006.875577; Vaughan TM, 2003, IEEE T NEUR SYS REH, V11, P94, DOI 10.1109/TNSRE.2003.814799; Vaughan TM, 2003, SOC NEUR ABS	48	23	24	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60608	10.1371/journal.pone.0060608	http://dx.doi.org/10.1371/journal.pone.0060608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593261	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200015
J	Stanistreet, JE; Risch, D; Van Parijs, SM				Stanistreet, Joy E.; Risch, Denise; Van Parijs, Sofie M.			Passive Acoustic Tracking of Singing Humpback Whales (Megaptera novaeangliae) on a Northwest Atlantic Feeding Ground	PLOS ONE			English	Article							BALAENOPTERA-PHYSALUS; MORAY FIRTH; SONGS; MOVEMENTS; PACIFIC; SPACE; RADIO; SOUND; LOCALIZATION; WHISTLES	Passive acoustic tracking provides an unobtrusive method of studying the movement of sound-producing animals in the marine environment where traditional tracking methods may be costly or infeasible. We used passive acoustic tracking to characterize the fine-scale movements of singing humpback whales (Megaptera novaeangliae) on a northwest Atlantic feeding ground. Male humpback whales produce complex songs, a phenomenon that is well documented in tropical regions during the winter breeding season, but also occurs at higher latitudes during other times of year. Acoustic recordings were made throughout 2009 using an array of autonomous recording units deployed in the Stellwagen Bank National Marine Sanctuary. Song was recorded during spring and fall, and individual singing whales were localized and tracked throughout the array using a correlation sum estimation method on the time-synchronized recordings. Tracks were constructed for forty-three song sessions, revealing a high level of variation in movement patterns in both the spring and fall seasons, ranging from slow meandering to faster directional movement. Tracks were 30 min to 8 h in duration, and singers traveled distances ranging from 0.9 to 20.1 km. Mean swimming speed was 2.06 km/h (SD 0.95). Patterns and rates of movement indicated that most singers were actively swimming. In one case, two singers were tracked simultaneously, revealing a potential acoustic interaction. Our results provide a first description of the movements of singers on a northwest Atlantic feeding ground, and demonstrate the utility of passive acoustic tracking for studying the fine-scale movements of cetaceans within the behavioral context of their calls. These methods have further applications for conservation and management purposes, particularly by enhancing our ability to estimate cetacean densities using passive acoustic monitoring.	[Stanistreet, Joy E.; Van Parijs, Sofie M.] Northeast Fisheries Sci Ctr, Woods Hole, MA USA; [Stanistreet, Joy E.] Duke Univ, Marine Lab, Beaufort, NC 28516 USA; [Risch, Denise] Integrated Stat Inc, Woods Hole, MA USA	Duke University	Stanistreet, JE (corresponding author), Northeast Fisheries Sci Ctr, Woods Hole, MA USA.	joy.stanistreet@duke.edu	Risch, Denise/W-1070-2019	Risch, Denise/0000-0002-3719-7420; Stanistreet, Joy/0000-0002-1090-2169	National Oceanographic Partnership Program [N00014-07-1-1029]	National Oceanographic Partnership Program	This work was supported by grant number N00014-07-1-1029 from the National Oceanographic Partnership Program (http://www.nopp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Baumgartner MF, 2008, J ACOUST SOC AM, V124, P1339, DOI 10.1121/1.2945155; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; CATT DC, 1987, J ZOOL, V211, P681, DOI 10.1111/j.1469-7998.1987.tb04479.x; Charif RA, 2001, MAR MAMMAL SCI, V17, P751, DOI 10.1111/j.1748-7692.2001.tb01297.x; Cholewiak DM, 2008, THESIS CORNELL U; Clark Christopher W., 1996, Report of the International Whaling Commission, V46, P541; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Cortopassi KA, 2005, 2 INT WORKSH DET LOC; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Darling JD, 2006, BEHAVIOUR, V143, P1051, DOI 10.1163/156853906778607381; Darling JD, 2001, MAR MAMMAL SCI, V17, P570, DOI 10.1111/j.1748-7692.2001.tb01005.x; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; Dunn RA, 2009, J ACOUST SOC AM, V126, P1084, DOI 10.1121/1.3158929; Figueroa H, 2012, XBAT EXTENSIBLE BIOA; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE79, DOI 10.1111/j.1748-7692.2010.00438.x; Hansen BB, 2009, OIKOS, V118, P859, DOI 10.1111/j.1600-0706.2009.17098.x; Hastie GD, 2006, MAR BIOL, V148, P1181, DOI 10.1007/s00227-005-0143-x; Hatch LT, 2012, CONSERV BIOL, V26, P983, DOI 10.1111/j.1523-1739.2012.01908.x; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; HELWEG DA, 1992, MARINE MAMMAL SENSORY SYSTEMS, P459; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Janik VM, 2000, J COMP PHYSIOL A, V186, P673, DOI 10.1007/s003590000120; Kelly BP, 2010, POLAR BIOL, V33, P1095, DOI 10.1007/s00300-010-0796-x; Kusel ET, 2011, J ACOUST SOC AM, V129, P3610, DOI 10.1121/1.3583504; Li SH, 2009, J ACOUST SOC AM, V126, P468, DOI 10.1121/1.3147507; Marques Tiago A., 2011, Endangered Species Research, V13, P163, DOI 10.3354/esr00325; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; Marshell A, 2011, CORAL REEFS, V30, P631, DOI 10.1007/s00338-011-0770-2; Matthews CJD, 2011, POLAR BIOL, V34, P1091, DOI 10.1007/s00300-010-0958-x; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; McCarthy TM, 2005, BIOL CONSERV, V124, P527, DOI 10.1016/j.biocon.2005.03.003; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Muanke PB, 2007, J ACOUST SOC AM, V121, P2049, DOI 10.1121/1.2532210; Noad MJ, 2007, MAR MAMMAL SCI, V23, P481, DOI 10.1111/j.1748-7692.2007.02414.x; OVERHOLTZ WJ, 1979, FISH B-NOAA, V77, P285; Parks SE, 2012, J ACOUST SOC AM, V131, P3173, DOI 10.1121/1.3688507; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Quick NJ, 2012, P ROY SOC B-BIOL SCI, V279, P2539, DOI 10.1098/rspb.2011.2537; R Development Core Team, 2012, R LANG ENV STAT COMP; Rankin S, 2005, J ACOUST SOC AM, V118, P3346, DOI 10.1121/1.2046747; Robbins J., 2007, THESIS U ST ANDREWS; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Simard Y, 2008, J ACOUST SOC AM, V123, P4109, DOI 10.1121/1.2912453; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; Sousa-Lima RS, 2009, PARK SCI, V26; Stimpert AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051214; Tchamba MN, 1995, AFR J ECOL, V33, P335, DOI 10.1111/j.1365-2028.1995.tb01043.x; Thompson PM, 1996, J APPL ECOL, V33, P1572, DOI 10.2307/2404795; Turchin Peter, 1998; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; TYACK P, 1983, BEHAVIOUR, V83, P132, DOI 10.1163/156853982X00067; Van Parijs SM, 2004, ANIM BEHAV, V68, P89, DOI 10.1016/j.anbehav.2003.09.013; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; Van Parijs SM, 2006, ANIM BEHAV, V72, P1269, DOI 10.1016/j.anbehav.2006.03.026; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; WATKINS WA, 1981, DEEP-SEA RES, V28, P577, DOI 10.1016/0198-0149(81)90118-7; WHITEHEAD H, 1982, CAN J ZOOL, V60, P2203, DOI 10.1139/z82-282; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631; Wright AJ, 2010, J MAR BIOL ASSOC UK, V90, P1489, DOI 10.1017/S0025315410000913	69	27	28	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61263	10.1371/journal.pone.0061263	http://dx.doi.org/10.1371/journal.pone.0061263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593447	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000045
J	Yan, BW; Gregory, S				Yan, Bowen; Gregory, Steve			Identifying Communities and Key Vertices by Reconstructing Networks from Samples	PLOS ONE			English	Article							COMPLEX NETWORKS; POPULATIONS; DISEASE	Sampling techniques such as Respondent-Driven Sampling (RDS) are widely used in epidemiology to sample "hidden'' populations, such that properties of the network can be deduced from the sample. We consider how similar techniques can be designed that allow the discovery of the structure, especially the community structure, of networks. Our method involves collecting samples of a network by random walks and reconstructing the network by probabilistically coalescing vertices, using vertex attributes to determine the probabilities. Even though our method can only approximately reconstruct a part of the original network, it can recover its community structure relatively well. Moreover, it can find the key vertices which, when immunized, can effectively reduce the spread of an infection through the original network.	[Yan, Bowen; Gregory, Steve] Univ Bristol, Dept Comp Sci, Bristol, Avon, England	University of Bristol	Yan, BW (corresponding author), Univ Bristol, Dept Comp Sci, Bristol, Avon, England.	yan@cs.bris.ac.uk			University of Bristol Research Strategy Fund	University of Bristol Research Strategy Fund	This research was partly funded by the University of Bristol Research Strategy Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batagelj V, 2000, SOC NETWORKS, V22, P173, DOI 10.1016/S0378-8733(00)00023-X; Borgatti S. P., 2006, Computational & Mathematical Organization Theory, V12, P21, DOI 10.1007/s10588-006-7084-x; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Goel S, 2009, STAT MED, V28, P2202, DOI 10.1002/sim.3613; Gregory S, 2007, LECT NOTES ARTIF INT, V4702, P91; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Guo F, 2012, ARXIV12062199; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Leskovec J., 2010, P INT C WORLD WID WE, P641, DOI DOI 10.1109/ICDE.2018.00077; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Mendenhall W., 2002, MATH STAT APPL; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736	19	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61006	10.1371/journal.pone.0061006	http://dx.doi.org/10.1371/journal.pone.0061006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593375	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000038
J	Almohmeed, YH; Avenell, A; Aucott, L; Vickers, MA				Almohmeed, Yahya H.; Avenell, Alison; Aucott, Lorna; Vickers, Mark A.			Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis	PLOS ONE			English	Article							IMMUNE-RESPONSE; ANTIBODY-TITERS; DISEASE-ACTIVITY; COMMON VIRUSES; RISK-FACTORS; INFECTION; EBV; HERPESVIRUS; PREVALENCE; CHILDREN	Background: A role for Epstein Barr virus (EBV) in multiple sclerosis (MS) has been postulated. Previous systematic reviews found higher prevalences of anti-EBV antibodies in MS patients compared to controls, but many studies have since been published, and there is a need to apply more rigorous systematic review methods. Methodology/Principal Findings: We examined the link between EBV and MS by conducting a systematic review and meta-analysis of case-control and cohort studies that examined the prevalence of anti-EBV antibodies in the serum of cases and controls. We searched Medline and Embase databases from 1960 to 2012, with no language restriction. The Mantel-Haenszel odds ratios (OR) for anti-EBV antibodies sero-positivity were calculated, and meta-analysis conducted. Quality assessment was performed using a modified version of the Newcastle Ottawa scale. Thirty-nine studies were included. Quality assessment found most studies reported acceptable selection and comparability of cases and controls. However the majority had poor reporting of ascertainment of exposure. Most studies found a higher sero-prevalence of anti-EBNA IgG and anti-VCA IgG in cases compared to controls. The results for anti-EA IgG were mixed with only half the studies finding a higher sero-prevalence in cases. The meta-analysis showed a significant OR for sero-positivity to anti-EBNA IgG and anti-VCA IgG in MS cases (4.5 [95% confidence interval (CI) 3.3 to 6.6, p<0.00001] and 4.5 [ 95% CI 2.8 to 7.2, p<0.00001] respectively). However, funnel plot examination suggested publication bias for the reporting of the anti-EBNA IgG. No significant difference in the OR for sero-positivity to anti-EA IgG was found (1.4 [ 95% CI 0.9 to 2.1, p = 0.09]). Conclusion/Significance: These findings support previous systematic reviews, however publication bias cannot be excluded. The methodological conduct of studies could be improved, particularly with regard to reporting and conduct of laboratory analyses.	[Almohmeed, Yahya H.; Avenell, Alison] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Aucott, Lorna] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Vickers, Mark A.] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Vickers, MA (corresponding author), Univ Aberdeen, Div Appl Med, Aberdeen, Scotland.	m.a.vickers@abdn.ac.uk		Aucott, Lorna/0000-0001-6277-7972; Vickers, Mark/0000-0002-3154-1040	government of Kuwait; Chief Scientist Office [HSRU1] Funding Source: researchfish	government of Kuwait; Chief Scientist Office	Yahya Almohmeed received funding from the government of Kuwait to complete an MSc project in health services research. The systematic review was part of this MSc programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alotaibi S, 2004, JAMA-J AM MED ASSOC, V291, P1875, DOI 10.1001/jama.291.15.1875; [Anonymous], 2011, REV MAN REVMAN COMP; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; BRAY PF, 1983, ARCH NEUROL-CHICAGO, V40, P406, DOI 10.1001/archneur.1983.04050070036006; Buljevac D, 2005, J NEUROL NEUROSUR PS, V76, P1377, DOI 10.1136/jnnp.2004.048504; Comabella M, 2010, MULT SCLER, V16, P355, DOI 10.1177/1352458509357066; DeLorenze GN, 2006, ARCH NEUROL-CHICAGO, V63, P839, DOI 10.1001/archneur.63.6.noc50328; Disanto G, 2012, MULT SCLER, P1; FERRANTE P, 1987, ITAL J NEUROL SCI, P45; Gutierrez J, 2002, INFECTION, V30, P145, DOI 10.1007/s15010-002-2056-7; Haahr S, 2004, ACTA NEUROL SCAND, V109, P270, DOI 10.1046/j.1600-0404.2003.00221.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Ingram G, 2010, EUR J NEUROL, V17, P1386, DOI 10.1111/j.1468-1331.2010.03083.x; Jafari N, 2010, J CLIN VIROL, V49, P26, DOI 10.1016/j.jcv.2010.06.007; Jaquiery E, 2010, EUR J IMMUNOL, V40, P878, DOI 10.1002/eji.200939761; Jilek S, 2008, BRAIN, V131, P1712, DOI 10.1093/brain/awn108; Kakalacheva K, 2011, BBA-MOL BASIS DIS, V1812, P132, DOI 10.1016/j.bbadis.2010.06.012; Khaki M, 2011, NEUROSCIENCES, V16, P224; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS96; Lalive PH, 2011, MULT SCLER J, V17, P297, DOI 10.1177/1352458510389220; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Lindsey JW, 2010, EUR J NEUROL, V17, P1263, DOI 10.1111/j.1468-1331.2010.03005.x; Lucas RM, 2011, NEUROLOGY, V77, P371, DOI 10.1212/WNL.0b013e318227062a; MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mowry EM, 2011, MULT SCLER J, V17, P666, DOI 10.1177/1352458510394398; Munch M, 1998, ACTA NEUROL SCAND, V97, P171; Myhr KM, 1998, J NEUROL NEUROSUR PS, V64, P539, DOI 10.1136/jnnp.64.4.539; Nociti V, 2010, J NEUROIMMUNOL, V225, P149, DOI 10.1016/j.jneuroim.2010.04.007; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pakpoor J, 2012, MULT SCLER, P1; Pohl D, 2006, NEUROLOGY, V67, P2063, DOI 10.1212/01.wnl.0000247665.94088.8d; Pohl D, 2009, J NEUROL SCI, V286, P62, DOI 10.1016/j.jns.2009.03.028; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Riverol M, 2007, J NEUROIMMUNOL, V192, P184, DOI 10.1016/j.jneuroim.2007.08.010; Santiago O, 2010, EUR J CLIN MICROBIOL, V29, P857, DOI 10.1007/s10096-010-0940-0; Sellner J, 2010, NEUROCHEM INT, V57, P662, DOI 10.1016/j.neuint.2010.08.003; Selter RC, 2010, NEUROLOGY, V74, P1711, DOI 10.1212/WNL.0b013e3181e04096; SHIRODARIA PV, 1987, ARCH NEUROL-CHICAGO, V44, P1237, DOI 10.1001/archneur.1987.00520240019006; SUMAYA CV, 1980, ARCH NEUROL-CHICAGO, V37, P94, DOI 10.1001/archneur.1980.00500510052009; SUMAYA CV, 1985, ANN NEUROL, V17, P371, DOI 10.1002/ana.410170412; Sundqvist E, 2012, GENES IMMUN, V13, P14, DOI 10.1038/gene.2011.42; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; Villegas E, 2011, DIAGN MICR INFEC DIS, V70, P85, DOI 10.1016/j.diagmicrobio.2010.11.013; Villoslada P, 2003, NEUROLOGY, V60, P1944, DOI 10.1212/01.WNL.0000069461.53733.F7; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Wagner HJ, 2000, VIRAL IMMUNOL, V13, P497, DOI 10.1089/vim.2000.13.497; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Waubant E, 2011, NEUROLOGY, V76, P1989, DOI 10.1212/WNL.0b013e31821e552a; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Woodward M., 2014, EPIDEMIOLOGY STUDY D; Zivadinov R, 2006, NEUROL RES, V28, P262, DOI 10.1179/016164106X98134	61	72	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61110	10.1371/journal.pone.0061110	http://dx.doi.org/10.1371/journal.pone.0061110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585874	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600083
J	Koski, A; Karli, E; Kipar, A; Escutenaire, S; Kanerva, A; Hemminki, A				Koski, Anniina; Karli, Eerika; Kipar, Anja; Escutenaire, Sophie; Kanerva, Anna; Hemminki, Akseli			Mutation of the Fiber Shaft Heparan Sulphate Binding Site of a 5/3 Chimeric Adenovirus Reduces Liver Tropism	PLOS ONE			English	Article							MEDIATED GENE DELIVERY; PHASE-I TRIAL; OVARIAN-CANCER; COAGULATION-FACTORS; ONCOLYTIC ADENOVIRUS; NONHUMAN-PRIMATES; ORTHOTOPIC MODELS; SEROTYPE-5 FIBER; RECEPTOR; VECTORS	Natural tropism to the liver is a major obstacle in systemic delivery of adenoviruses in cancer gene therapy. Adenovirus binding to soluble coagulation factors and to cellular heparan sulphate proteoglycans via the fiber shaft KKTK domain are suggested to cause liver tropism. Serotype 5 adenovirus constructs with mutated KKTK regions exhibit liver detargeting, but they also transduce tumors less efficiently, possibly due to altered fiber conformation. We constructed Ad5/3lucS*, a 5/3 chimeric adenovirus with a mutated KKTK region. The fiber knob swap was hypothesized to facilitate tumor transduction. This construct was studied with or without additional coagulation factor ablation. Ad5/3lucS* exhibited significantly reduced transduction of human hepatic cells in vitro and mouse livers in vivo. Combination of coagulation factor ablation by warfarinization to Ad5/3lucS* seemed to further enhance liver detargeting. Cancer cell transduction by Ad5/3lucS* was retained in vitro. In vivo, viral particle accumulation in M4A4-LM3 xenograft tumors was comparable to controls, but Ad5/3lucS* transgene expression was nearly abolished. Coagulation factor ablation did not affect tumor transduction. These studies set the stage for further investigations into the effects of the KKTK mutation and coagulation factor ablation in the context of 5/3 serotype chimerism. Of note, the putative disconnect between tumor transduction and transgene expression could prove useful in further understanding of adenovirus biology.	[Koski, Anniina; Karli, Eerika; Escutenaire, Sophie; Kanerva, Anna; Hemminki, Akseli] Univ Helsinki, Mol Canc Biol Program, Canc Gene Therapy Grp, Helsinki, Finland; [Koski, Anniina; Karli, Eerika; Escutenaire, Sophie; Kanerva, Anna; Hemminki, Akseli] Univ Helsinki, Transplantat Lab, Helsinki, Finland; [Koski, Anniina; Karli, Eerika; Escutenaire, Sophie; Kanerva, Anna; Hemminki, Akseli] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Kipar, Anja] Univ Helsinki, Fac Vet Med, Finnish Ctr Lab Anim Pathol, Helsinki, Finland; [Kipar, Anja] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja] Univ Liverpool, Dept Infect Biol, Inst Global Hlth, Liverpool L69 3BX, Merseyside, England; [Kanerva, Anna] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Liverpool; University of Liverpool; University of Helsinki; Helsinki University Central Hospital	Kanerva, A (corresponding author), Univ Helsinki, Mol Canc Biol Program, Canc Gene Therapy Grp, Helsinki, Finland.	anna.kanerva@helsinki.fi; akseli.hemminki@helsinki.fi	Kipar, Anja/L-7214-2014	Kipar, Anja/0000-0001-7289-3459; Koski-Palken, Anniina/0000-0003-3601-2786	Helsinki Biomedical Graduate School; HUCH Research Funds (EVO); Finnish Foundation for Research on Viral Diseases; Finnish-Norwegian Medical Foundation; Alfred Kordelin Foundation; K. Albin Johansson Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; European Research Council; ASCO Foundation; Finnish Cancer Foundation; Sigrid Juselius Foundation; Academy of Finland; Biocentrum Helsinki; Biocenter Finland; University of Helsinki	Helsinki Biomedical Graduate School; HUCH Research Funds (EVO); Finnish Foundation for Research on Viral Diseases(Finnish IT center for science); Finnish-Norwegian Medical Foundation; Alfred Kordelin Foundation; K. Albin Johansson Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; European Research Council(European Research Council (ERC)European Commission); ASCO Foundation; Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Biocentrum Helsinki; Biocenter Finland; University of Helsinki	This work was supported by: Helsinki Biomedical Graduate School, HUCH Research Funds (EVO), Finnish Foundation for Research on Viral Diseases, Finnish-Norwegian Medical Foundation, Alfred Kordelin Foundation, K. Albin Johansson Foundation, Emil Aaltonen Foundation, Finnish Medical Foundation, the European Research Council, ASCO Foundation, Finnish Cancer Foundation, Sigrid Juselius Foundation, Academy of Finland, Biocentrum Helsinki, Biocenter Finland and the University of Helsinki. A. H. is K. Albin Johansson Research Professor of the Finnish Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2012, GENE THER, V19, P109, DOI 10.1038/gt.2011.87; Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Alvarez-Lafuente R, 2007, EUR J NEUROL, V14, P233, DOI 10.1111/j.1468-1331.2006.01638.x; Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bayo-Puxan N, 2009, HUM GENE THER, V20, P1214, DOI 10.1089/hum.2009.038; Corjon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018205; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; Di Paolo NC, 2007, J VIROL, V81, P12249, DOI 10.1128/JVI.01584-07; Diaconu I, 2012, CANCER RES, V72, P2327, DOI 10.1158/0008-5472.CAN-11-2975; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; Fukuhara H, 2010, INT J UROL, V17, P20, DOI 10.1111/j.1442-2042.2009.02383.x; Gimenez-Alejandre M, 2008, HUM GENE THER, V19, P1415, DOI [10.1089/hum.2008.053, 10.1089/hgt.2008.053]; Goodison S, 2005, CANCER GENET CYTOGEN, V156, P37, DOI 10.1016/j.cancergencyto.2004.04.005; Guse K, 2007, MOL CANCER THER, V6, P2728, DOI 10.1158/1535-7163.MCT-07-0176; Hemminki A, 2001, CANCER RES, V61, P6377; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2003, MOL THER, V8, P449, DOI 10.1016/S1525-0016(03)00200-4; Kanerva A, 2002, MOL THER, V5, P695, DOI 10.1006/mthe.2002.0599; Kangasniemi L, 2006, CLIN CANCER RES, V12, P3137, DOI 10.1158/1078-0432.CCR-05-2576; Khare R, 2011, CURR GENE THER, V11, P241, DOI 10.2174/156652311796150363; Koizumi N, 2006, HUM GENE THER, V17, P264, DOI 10.1089/hum.2006.17.264; Koski A, 2009, J GENE MED, V11, P966, DOI 10.1002/jgm.1373; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/sj.mt.6300094; Law LK, 2005, MOL THER, V12, P599, DOI 10.1016/j.ymthe.2005.05.017; Liang M, 2011, CURR PHARM BIOTECHNO; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Nemunaitis J, 2007, CANCER GENE THER, V14, P885, DOI 10.1038/sj.cgt.7701080; Nicol CG, 2004, MOL THER, V10, P344, DOI 10.1016/j.ymthe.2004.05.020; Nunes FA, 1999, HUM GENE THER, V10, P2515, DOI 10.1089/10430349950016852; Parker AL, 2007, J VIROL, V81, P3627, DOI 10.1128/JVI.02786-06; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Peeters MJTFDV, 1996, BIOTECHNIQUES, V20, P278; Rajecki M, 2007, MOL CANCER THER, V6, P742, DOI 10.1158/1535-7163.MCT-06-0403; Ranki T, 2007, INT J CANCER, V121, P165, DOI 10.1002/ijc.22627; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Reid T, 2002, CANCER GENE THER, V9, P979, DOI 10.1038/sj.cgt.7700539; Schnell MA, 2001, MOL THER, V3, P708, DOI 10.1006/mthe.2001.0330; Shashkova EV, 2008, CANCER RES, V68, P5896, DOI 10.1158/0008-5472.CAN-08-0488; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Small EJ, 2006, MOL THER, V14, P107, DOI 10.1016/j.ymthe.2006.02.011; Smith TAG, 2003, HUM GENE THER, V14, P1595, DOI 10.1089/104303403322542248; Smith TAG, 2003, HUM GENE THER, V14, P777, DOI 10.1089/104303403765255165; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Toth K, 2010, VIRUSES-BASEL, V2, P1844, DOI 10.3390/v2091844; Trinh HV, 2012, J VIROL, V86, P1623, DOI 10.1128/JVI.06181-11; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; Tuve S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000189; Uil TG, 2003, CANCER GENE THER, V10, P121, DOI 10.1038/sj.cgt.7700543; Volk AL, 2003, CANCER BIOL THER, V2, P511, DOI 10.4161/cbt.2.5.440; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; Wang HJ, 2012, J VIROL, V86, P6286, DOI 10.1128/JVI.00205-12; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wu E, 2003, J VIROL, V77, P7225, DOI 10.1128/JVI.77.13.7225-7235.2003; YU DH, 1993, CANCER RES, V53, P891; Zheng S, 2007, J GENE MED, V9, P151, DOI 10.1002/jgm.1008	64	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60032	10.1371/journal.pone.0060032	http://dx.doi.org/10.1371/journal.pone.0060032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585829	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000317909600011
J	Paulis, LE; Klein, AM; Ghanem, A; Geelen, T; Coolen, BF; Breitbach, M; Zimmermann, K; Nicolay, K; Fleischmann, BK; Roell, W; Strijkers, GJ				Paulis, Leonie E.; Klein, Alexandra M.; Ghanem, Alexander; Geelen, Tessa; Coolen, Bram F.; Breitbach, Martin; Zimmermann, Katrin; Nicolay, Klaas; Fleischmann, Bernd K.; Roell, Wilhelm; Strijkers, Gustav J.			Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC-FUNCTION; MOUSE HEART; ENDOTHELIAL-CELLS; REPORTER GENE; DIFFERENTIATION; CARDIOMYOPLASTY; SEGMENTATION; DYSFUNCTION; ENGRAFTMENT	Aims: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic progenitor cells upon myocardial injury. We have therefore investigated the functional short- and long-term consequences after intramyocardial transplantation of these cell types in a murine lesion model. Methods and Results: Myocardial infarction (MI) was induced in mice (n = 75), followed by the intramyocardial injection of 1-2 x 10(5) luciferase- and GFP-expressing embryonic cardiomyocytes (eCMs), skeletal myoblasts (SMs), mesenchymal stem cells (MSCs) or medium into the infarct. Non-treated healthy mice (n = 6) served as controls. Bioluminescence and fluorescence imaging confirmed the engraftment and survival of the cells up to seven weeks postoperatively. After two weeks MRI was performed, which showed that infarct volume was significantly decreased by eCMs only (14.8 +/- 2.2% MI+eCM vs. 26.7 +/- 1.6% MI). Left ventricular dilation was significantly decreased by transplantation of any cell type, but most efficiently by eCMs. Moreover, eCM treatment increased the ejection fraction and cardiac output significantly to 33.4 +/- 2.2% and 22.3 +/- 1.2 ml/min. In addition, this cell type exclusively and significantly increased the end-systolic wall thickness in the infarct center and borders and raised the wall thickening in the infarct borders. Repetitive echocardiography examinations at later time points confirmed that these beneficial effects were accompanied by better survival rates. Conclusion: Cellular cardiomyoplasty employing contractile and electrically coupling embryonic cardiomyocytes (eCMs) into ischemic myocardium provoked significantly smaller infarcts with less adverse remodeling and improved cardiac function and long-term survival compared to transplantation of somatic cells (SMs and MSCs), thereby proving that a cardiomyocyte phenotype is important to restore myocardial function.	[Paulis, Leonie E.; Geelen, Tessa; Coolen, Bram F.; Nicolay, Klaas; Strijkers, Gustav J.] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Klein, Alexandra M.; Breitbach, Martin; Fleischmann, Bernd K.; Roell, Wilhelm] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, D-53115 Bonn, Germany; [Ghanem, Alexander] Univ Bonn, Dept Med Cardiol, D-53115 Bonn, Germany; [Zimmermann, Katrin] Univ Bonn, Dept Pharmacol & Toxicol, Biomed Ctr, D-53115 Bonn, Germany; [Roell, Wilhelm] Univ Bonn, Dept Cardiac Surg, D-53115 Bonn, Germany	Eindhoven University of Technology; University of Bonn; University of Bonn; University of Bonn; University of Bonn	Roell, W (corresponding author), Univ Bonn, Inst Physiol 1, Life & Brain Ctr, Nussallee 11, D-53115 Bonn, Germany.	wroell@uni-bonn.de; g.j.strijkers@tue.nl		Nicolay, Klaas/0000-0002-4179-616X; Coolen, Bram/0000-0003-3946-653X; Strijkers, Gustav/0000-0001-6700-5058	Dutch Technology Foundation STW; applied science division of NWO; Technology Program of the Ministry of Economic Affairs [07952]; EU FP7 consortium grant CardioCell [223372]; EC-FP6-project DiMI [LSHB-CT-2005-512146]	Dutch Technology Foundation STW(Technologiestichting STW); applied science division of NWO(Netherlands Organization for Scientific Research (NWO)); Technology Program of the Ministry of Economic Affairs; EU FP7 consortium grant CardioCell; EC-FP6-project DiMI(European Commission)	This work was supported by the Dutch Technology Foundation STW, applied science division of NWO and the Technology Program of the Ministry of Economic Affairs (grant number 07952) (Dr. Gustav J. Strijkers), EU FP7 consortium grant CardioCell (grant No223372) (Dr. Bernd K. Fleischmann), and EC-FP6-project DiMI (grant number LSHB-CT-2005-512146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Arai T, 2006, MAGN RESON MED, V55, P203, DOI 10.1002/mrm.20702; Blankesteijn WM, 2001, ACTA PHYSIOL SCAND, V173, P75, DOI 10.1046/j.1365-201X.2001.00887.x; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Buller VGM, 1997, INVEST RADIOL, V32, P529, DOI 10.1097/00004424-199709000-00005; Cerqueira MD, 2002, J NUCL CARDIOL, V9, P240, DOI 10.1067/mnc.2002.123122; Dowell JD, 2003, CARDIOVASC RES, V58, P336, DOI 10.1016/S0008-6363(03)00254-2; Fleischmann M, 1998, FEBS LETT, V440, P370, DOI 10.1016/S0014-5793(98)01476-8; Gaudette GR, 2006, CIRCULATION, V114, P2575, DOI 10.1161/CIRCULATIONAHA.106.668707; Ghanem A, 2008, ULTRASOUND MED BIOL, V34, P559, DOI 10.1016/j.ultrasmedbio.2007.09.013; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Heijman E, 2008, J MAGN RESON IMAGING, V27, P86, DOI 10.1002/jmri.21236; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; Hill JM, 2003, CIRCULATION, V108, P1009, DOI 10.1161/01.CIR.0000084537.66419.7A; Jackson BM, 2002, J AM COLL CARDIOL, V40, P1160, DOI 10.1016/S0735-1097(02)02121-6; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Liu JW, 2012, CIRC-CARDIOVASC IMAG, V5, P481, DOI 10.1161/CIRCIMAGING.111.969329; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Qiao H, 2011, CIRC-CARDIOVASC IMAG, V4, P33, DOI 10.1161/CIRCIMAGING.110.957431; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Roell W, 2002, TRANSPLANTATION, V73, P462, DOI 10.1097/00007890-200202150-00022; Roell W, 2002, CIRCULATION, V105, P2435, DOI 10.1161/01.CIR.0000016063.66513.BB; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Ross AJ, 2002, MAGN RESON MED, V47, P1158, DOI 10.1002/mrm.10166; Sakai T, 1999, J THORAC CARDIOV SUR, V118, P715, DOI 10.1016/S0022-5223(99)70018-8; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Stegger L, 2009, J NUCL MED, V50, P132, DOI 10.2967/jnumed.108.056051; Strijkers GJ, 2009, NMR BIOMED, V22, P182, DOI 10.1002/nbm.1299; Tang GHL, 2003, EUR J CARDIO-THORAC, V23, P907, DOI 10.1016/S1010-7940(03)00140-4; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; van der Bogt KEA, 2009, TRANSPLANTATION, V87, P642, DOI 10.1097/TP.0b013e31819609d9; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270; WEISMAN HF, 1988, CIRCULATION, V78, P186, DOI 10.1161/01.CIR.78.1.186; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Winter EM, 2008, ACTA PHYSIOL, V194, P111, DOI 10.1111/j.1748-1716.2008.01863.x; Xiong Q, 2013, CIRCULATION; Yang ZQ, 2004, CIRCULATION, V109, P1161, DOI 10.1161/01.CIR.0000118495.88442.32	45	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61510	10.1371/journal.pone.0061510	http://dx.doi.org/10.1371/journal.pone.0061510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585908	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600123
J	Horiuchi, Y; Ishikawa, M; Kaito, N; Iijima, Y; Tanabe, Y; Ishiguro, H; Arinami, T				Horiuchi, Yasue; Ishikawa, Maya; Kaito, Nobuko; Iijima, Yoshimi; Tanabe, Yoshiko; Ishiguro, Hiroki; Arinami, Tadao			Experimental Evidence for the Involvement of PDLIM5 in Mood Disorders in Hetero Knockout Mice	PLOS ONE			English	Article							PROTEIN-KINASE-C; BIPOLAR AFFECTIVE-DISORDER; GENE-EXPRESSION; PKC-EPSILON; ASSOCIATION ANALYSIS; PREFRONTAL CORTEX; POSTMORTEM BRAINS; MAJOR DEPRESSION; LIM DOMAINS; LITHIUM	Background: Reports indicate that PDLIM5 is involved in mood disorders. The PDLIM5 (PDZ and LIM domain 5) gene has been genetically associated with mood disorders; it's expression is upregulated in the postmortem brains of patients with bipolar disorder and downregulated in the peripheral lymphocytes of patients with major depression. Acute and chronic methamphetamine (METH) administration may model mania and the evolution of mania into psychotic mania or schizophrenia-like behavioral changes, respectively. Methods: To address whether the downregulation of PDLIM5 protects against manic symptoms and cause susceptibility to depressive symptoms, we evaluated the effects of reduced Pdlim5 levels on acute and chronic METH-induced locomotor hyperactivity, prepulse inhibition, and forced swimming by using Pdlim5 hetero knockout (KO) mice. Results: The homozygous KO of Pdlim5 is embryonic lethal. The effects of METH administration on locomotor hyperactivity and the impairment of prepulse inhibition were lower in Pdlim5 hetero KO mice than in wild-type mice. The transient inhibition of PDLIM5 (achieved by blocking the translocation of protein kinase C epsilon before the METH challenge) had a similar effect on behavior. Pdlim5 hetero KO mice showed increased immobility time in the forced swimming test, which was diminished after the chronic administration of imipramine. Chronic METH treatment increased, whereas chronic haloperidol treatment decreased, Pdlim5 mRNA levels in the prefrontal cortex. Imipramine increased Pdlim5 mRNA levels in the hippocampus. Conclusion: These findings are partially compatible with reported observations in humans, indicating that PDLIM5 is involved in psychiatric disorders, including mood disorders.	[Horiuchi, Yasue; Ishikawa, Maya; Kaito, Nobuko; Iijima, Yoshimi; Tanabe, Yoshiko; Ishiguro, Hiroki; Arinami, Tadao] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Med Genet, Tsukuba, Ibaraki, Japan	University of Tsukuba	Arinami, T (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Med Genet, Tsukuba, Ibaraki, Japan.	tarinami@md.tsukuba.ac.jp	Ishiguro, Hiroki/Q-7532-2019; Horiuchi, Yasue/ABC-6248-2021	Horiuchi, Yasue/0000-0003-0597-2514	JSPS KAKENHI [23390285, 10212648]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23129501]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JSPS KAKENHI (Grant Nos. 23390285 and 10212648) and Grant-in-Aid for Scientific Research on Innovative Areas (23129501) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHEN G, 1994, J NEUROCHEM, V63, P2361; Chen Y, 2006, CELL SIGNAL, V18, P215, DOI 10.1016/j.cellsig.2005.04.007; Coccurello R, 2007, ANN NY ACAD SCI, V1122, P260, DOI 10.1196/annals.1403.019; da-Rosa DD, 2012, PSYCHIAT RES, V198, P521, DOI 10.1016/j.psychres.2012.01.019; Dawirs RR, 1998, J NEURAL TRANSM, V105, P317, DOI 10.1007/s007020050061; Feier G, 2012, PHARM BIOCH BEHAV, V103, P589; Friedman E, 1996, J NEUROCHEM, V67, P1145; FRIEDMAN E, 1993, BIOL PSYCHIAT, V33, P520, DOI 10.1016/0006-3223(93)90006-Y; Gardezi SR, 2009, NAT NEUROSCI, V12, P957, DOI 10.1038/nn0809-957a; GEYER MA, 2003, CURRENT PROTOCOLS NE; Hahn C G, 1999, Bipolar Disord, V1, P81, DOI 10.1034/j.1399-5618.1999.010204.x; Hahn CG, 2005, J PSYCHIATR RES, V39, P355, DOI 10.1016/j.jpsychires.2004.10.007; Herrick S, 2010, MOL CELL NEUROSCI, V43, P188, DOI 10.1016/j.mcn.2009.10.009; Horiuchi Y, 2006, BIOL PSYCHIAT, V59, P434, DOI 10.1016/j.biopsych.2005.07.041; Iga J, 2006, NEUROSCI LETT, V400, P203, DOI 10.1016/j.neulet.2006.02.044; Iwamoto K, 2004, J HUM GENET, V49, P227, DOI 10.1007/s10038-004-0136-5; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kato T, 2005, MOL PSYCHIATR, V10, P1045, DOI 10.1038/sj.mp.4001719; Keilhoff G, 2010, EUR ARCH PSY CLIN N, V260, P151, DOI 10.1007/s00406-009-0033-1; Koga M, 2009, HUM MOL GENET, V18, P2483, DOI 10.1093/hmg/ddp166; Kohl S, 2012, J PSYCHIAT RES; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Lasorella A, 2006, P NATL ACAD SCI USA, V103, P4976, DOI 10.1073/pnas.0600168103; Li C, 2008, INT J NEUROPSYCHOPH, V11, P27, DOI 10.1017/S1461145707007687; Liu ZC, 2008, J PSYCHIATR NEUROSCI, V33, P43; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Manji HK, 1999, BIOL PSYCHIAT, V46, P1328, DOI 10.1016/S0006-3223(99)00235-8; MANJI HK, 1993, J NEUROCHEM, V61, P2303, DOI 10.1111/j.1471-4159.1993.tb07474.x; Maturana AD, 2008, CARDIOVASC RES, V78, P458, DOI 10.1093/cvr/cvn052; Maturana AD, 2011, CELL SIGNAL, V23, P928, DOI 10.1016/j.cellsig.2011.01.021; Nakagawa N, 2000, BIOCHEM BIOPH RES CO, V272, P505, DOI 10.1006/bbrc.2000.2787; Niederlander N, 2004, BIOCHEM BIOPH RES CO, V325, P1304, DOI 10.1016/j.bbrc.2004.10.178; Numata S, 2007, NEUROSCI LETT, V415, P28, DOI 10.1016/j.neulet.2007.01.018; Ott EB, 2007, DEV DYNAM, V236, P3144, DOI 10.1002/dvdy.21346; Pandey GN, 2008, J PSYCHIATR RES, V42, P106, DOI 10.1016/j.jpsychires.2006.11.004; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Przyklenk K, 2003, J APPL PHYSIOL, V95, P2563, DOI 10.1152/japplphysiol.00404.2003; Shelton RC, 2009, INT J NEUROPSYCHOPH, V12, P1223, DOI 10.1017/S1461145709000285; Shi JJ, 2008, PSYCHIAT GENET, V18, P116, DOI 10.1097/YPG.0b013e3282fa184b; Shilling PD, 2006, NEUROPSYCHOPHARMACOL, V31, P2359, DOI 10.1038/sj.npp.1301162; Squassina A, 2008, PSYCHIAT GENET, V18, P128, DOI 10.1097/YPG.0b013e3282fb003d; Syu A, 2010, NEUROPSYCHOPHARMACOL, V35, P1155, DOI 10.1038/npp.2009.220; Ueki N, 1999, J HUM GENET, V44, P256, DOI 10.1007/s100380050155; Wang HY, 1996, BIOL PSYCHIAT, V40, P568, DOI 10.1016/0006-3223(95)00611-7; Wang HY, 1999, J PSYCHIATR RES, V33, P171, DOI 10.1016/S0022-3956(98)90057-7; Wong ML, 2012, MOL PSYCHIATR, V17, P624, DOI 10.1038/mp.2012.13; Young LT, 1999, NEUROPSYCHOBIOLOGY, V40, P63, DOI 10.1159/000026598; Zain MA, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-91	51	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59320	10.1371/journal.pone.0059320	http://dx.doi.org/10.1371/journal.pone.0059320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593136	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000010
J	Lin, Y; Li, MM; Song, HL; Xu, LL; Meng, Q; Liu, XQ				Lin, Ying; Li, Mengmeng; Song, Huiling; Xu, Lingling; Meng, Qing; Liu, Xiang-Qin			Protein Trans-Splicing of Multiple Atypical Split Inteins Engineered from Natural Inteins	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SYNTHETIC PEPTIDE; MINI-INTEIN; IN-VITRO; SENSITIVITY; EVOLUTION; TERMINUS; CLEAVAGE; HEDGEHOG; PCC6803	Protein trans-splicing by split inteins has many uses in protein production and research. Splicing proteins with synthetic peptides, which employs atypical split inteins, is particularly useful for site-specific protein modifications and labeling, because the synthetic peptide can be made to contain a variety of unnatural amino acids and chemical modifications. For this purpose, atypical split inteins need to be engineered to have a small N-intein or C-intein fragment that can be more easily included in a synthetic peptide that also contains a small extein to be trans-spliced onto target proteins. Here we have successfully engineered multiple atypical split inteins capable of protein trans-splicing, by modifying and testing more than a dozen natural inteins. These included both S1 split inteins having a very small (11-12 aa) N-intein fragment and S11 split inteins having a very small (6 aa) C-intein fragment. Four of the new S1 and S11 split inteins showed high efficiencies (85-100%) of protein trans-splicing both in E. coli cells and in vitro. Under in vitro conditions, they exhibited reaction rate constants ranging from similar to 1.7x10(-4) s(-1) to similar to 3.8x10(-4) s(-1), which are comparable to or higher than those of previously reported atypical split inteins. These findings should facilitate a more general use of trans-splicing between proteins and synthetic peptides, by expanding the availability of different atypical split inteins. They also have implications on understanding the structure-function relationship of atypical split inteins, particularly in terms of intein fragment complementation.	[Lin, Ying; Li, Mengmeng; Song, Huiling; Xu, Lingling; Meng, Qing] Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China; [Song, Huiling; Xu, Lingling; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Donghua University; Dalhousie University	Meng, Q (corresponding author), Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China.	mengqing@dhu.edu.cn; Paul.Liu@Dal.Ca			National High Technology Research and Development Program 863 [2006AA03Z451]; National Natural Science Foundation of China [31070698, 30800186]; Shanghai key projects of basic research [10JC1400300]; Ph.D. Programs Foundation of Ministry of Education of China [200802551026]; Natural Science and Engineering Research Council of Canada	National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai key projects of basic research; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants to Q. M. from the National High Technology Research and Development Program 863 (NO 2006AA03Z451), the National Natural Science Foundation of China (NO 31070698) and the Shanghai key projects of basic research (NO 10JC1400300); by grants to Y. L. from the National Natural Science Foundation of China (NO 30800186) and the Ph.D. Programs Foundation of Ministry of Education of China (NO 200802551026); and by a grant to X.-Q. L. from the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders' websites include: http://www.nsfc.gov.cn/Portal0/default152.htm http://www.863.gov.cn/http://www.stcsm.gov.cn/structure/index.htm http://www.cutech.edu.cn/cn/index.htm http://www.nserc-crsng.gc.ca/.	Appleby JH, 2009, J BIOL CHEM, V284, P6194, DOI 10.1074/jbc.M805474200; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Dalgaard JZ, 1997, J COMPUT BIOL, V4, P193, DOI 10.1089/cmb.1997.4.193; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Li J, 2008, HUM GENE THER, V19, P958, DOI 10.1089/hum.2008.009; Liu XQ, 2004, FEBS LETT, V572, P46, DOI 10.1016/j.febslet.2004.07.016; Liu XQ, 2000, ANNU REV GENET, V34, P61, DOI 10.1146/annurev.genet.34.1.61; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Ozawa T, 2001, ANAL CHEM, V73, P5866, DOI 10.1021/ac010717k; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; Qi XM, 2011, PROTEIN PEPTIDE LETT, V18, P1226, DOI 10.2174/092986611797642760; Qi XM, 2011, FEBS LETT, V585, P2513, DOI 10.1016/j.febslet.2011.06.035; Song H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045355; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun L, 2001, APPL ENVIRON MICROB, V67, P1025, DOI 10.1128/AEM.67.3.1025-1029.2001; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Tan LP, 2005, PROTEIN PEPTIDE LETT, V12, P769, DOI 10.2174/0929866054864193; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volkmann G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008381; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Wu W, 2002, NUCLEIC ACIDS RES, V30, P4864, DOI 10.1093/nar/gkf621; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o; Yang JJ, 2003, P NATL ACAD SCI USA, V100, P3513, DOI 10.1073/pnas.0635899100; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003	34	13	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59516	10.1371/journal.pone.0059516	http://dx.doi.org/10.1371/journal.pone.0059516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593141	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000012
J	Shafique, M; Meijerhof, T; Wilschut, J; de Haan, A				Shafique, Muhammad; Meijerhof, Tjarko; Wilschut, Jan; de Haan, Aalzen			Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses	PLOS ONE			English	Article							INFLUENZA SUBUNIT VACCINE; RECEPTOR AGONISTS; RSV INFECTION; CHOLERA-TOXIN; B-LYMPHOCYTES; BALB/C MICE; ADJUVANT; IGA; IMMUNOADJUVANT; PROTECTION	Introduction: RSV infection remains a serious threat to newborns and the elderly. Currently, there is no vaccine available to prevent RSV infection. A mucosal RSV vaccine would be attractive as it could induce mucosal as well as systemic antibodies, capable of protecting both the upper and lower respiratory tract. Previously, we reported on a virosomal RSV vaccine for intramuscular injection with intrinsic adjuvant properties mediated by an incorporated lipophilic Toll-like receptor 2 (TLR2) ligand. However, it has not been investigated whether this virosomal RSV vaccine candidate would be suitable for use in mucosal immunization strategies and if additional incorporation of other innate receptor ligands, like NOD2-ligand, could further enhance the immunogenicity and protective efficacy of the vaccine. Objective: To explore if intranasal (IN) immunization with a virosomal RSV vaccine, supplemented with TLR2 and/or NOD2-ligands, is an effective strategy to induce RSV-specific immunity. Methods: We produced RSV-virosomes carrying TLR2 (Pam(3)CSK(4)) and/or NOD2 (L18-MDP) ligands. We tested the immunopotentiating properties of these virosomes in vitro, using TLR2- and/or NOD2-ligand-responsive murine and human cell lines, and in vivo by assessing induction of protective antibody and cellular responses upon IN immunization of BALB/c mice. Results: Incorporation of Pam(3)CSK(4) and/or L18-MDP potentiates the capacity of virosomes to activate (antigen-presenting) cells in vitro, as demonstrated by NF-kappa B induction. In vivo, incorporation of Pam(3)CSK(4) in virosomes boosted serum IgG antibody responses and mucosal antibody responses after IN immunization. While L18-MDP alone was ineffective, incorporation of L18-MDP in Pam(3)CSK(4)-carrying virosomes further boosted mucosal antibody responses. Finally, IN immunization with adjuvanted virosomes, particularly Pam(3)CSK(4)/L18-MDP-adjuvanted-virosomes, protected mice against infection with RSV, without priming for enhanced disease. Conclusion: Mucosal immunization with RSV-virosomes, supplemented with incorporated TLR2- and/or NOD2-ligands, represents a promising approach to induce effective and safe RSV-specific immunity.	[de Haan, Aalzen] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands; Univ Groningen, Groningen, Netherlands	University of Groningen; University of Groningen	de Haan, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands.	aalzen.de.haan@umcg.nl		Shafique, Muhammad/0000-0003-0554-7622	Higher Education Commission (HEC), Government of Pakistan, under the HEC-NUFFIC overseas scholarship programme; Jan Kornelis de Cock stichting	Higher Education Commission (HEC), Government of Pakistan, under the HEC-NUFFIC overseas scholarship programme; Jan Kornelis de Cock stichting	This work was financially supported by the Higher Education Commission (HEC), Government of Pakistan, under the HEC-NUFFIC overseas scholarship programme, and by a grant from the "Jan Kornelis de Cock stichting." The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Ainai A, 2010, J MED VIROL, V82, P476, DOI 10.1002/jmv.21694; Auci DL, 1998, IMMUNOL INVEST, V27, P105, DOI 10.3109/08820139809070894; Baca-Estrada ME, 2000, J BIOTECHNOL, V83, P91, DOI 10.1016/S0168-1656(00)00313-8; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Cashman SB, 2009, MOL IMMUNOL, V47, P365, DOI 10.1016/j.molimm.2009.09.007; Chabot SM, 2007, VACCINE, V25, P5348, DOI 10.1016/j.vaccine.2007.05.029; de Jonge J, 2007, BIOCHEM J, V405, P41, DOI 10.1042/BJ20061756; DEHAAN A, 1995, VACCINE, V13, P155, DOI 10.1016/0264-410X(95)93129-W; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Fukushima A, 1996, VACCINE, V14, P485, DOI 10.1016/0264-410X(95)00236-T; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; HOLMGREN J, 1993, VACCINE, V11, P1179, DOI 10.1016/0264-410X(93)90039-Z; Huckriede A, 2005, VACCINE, V23, pS26, DOI 10.1016/j.vaccine.2005.04.026; Hussell T, 2002, CLIN EXP IMMUNOL, V130, P359, DOI 10.1046/j.1365-2249.2002.02038.x; Johnson TR, 2009, VACCINE, V27, P3045, DOI 10.1016/j.vaccine.2009.03.026; Kamphuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036812; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lawson LB, 2011, CURR OPIN IMMUNOL, V23, P414, DOI 10.1016/j.coi.2011.03.009; Liang YM, 2011, CLIN IMMUNOL, V138, P33, DOI 10.1016/j.clim.2010.09.003; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Nguyen DT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001049; OGAWA T, 1989, INFECT IMMUN, V57, P3466, DOI 10.1128/IAI.57.11.3466-3471.1989; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Prince GA, 2001, VACCINE, V19, P2048, DOI 10.1016/S0264-410X(00)00417-5; ROBERTS M, 1995, INFECT IMMUN, V63, P2100, DOI 10.1128/IAI.63.6.2100-2108.1995; Shafique M, 2012, VACCINE, V30, P597, DOI 10.1016/j.vaccine.2011.11.054; Stegmann T, 2010, VACCINE, V28, P5543, DOI 10.1016/j.vaccine.2010.06.041; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Walsh EE, 2004, J INFECT DIS, V190, P373, DOI 10.1086/421524; Walsh EE, 2004, J INFECT DIS, V189, P233, DOI 10.1086/380907; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Yamamoto S, 1997, J EXP MED, V185, P1203, DOI 10.1084/jem.185.7.1203	42	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61287	10.1371/journal.pone.0061287	http://dx.doi.org/10.1371/journal.pone.0061287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593453	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000120
J	Lortet, S; Lacombe, E; Boulanger, N; Rihet, P; Nguyen, C; Goff, LKL; Salin, P				Lortet, Sylviane y; Lacombe, Emilie; Boulanger, Nicolas; Rihet, Pascal; Nguyen, Catherine; Goff, Lydia Kerkerian-Le; Salin, Pascal			Striatal Molecular Signature of Subchronic Subthalamic Nucleus High Frequency Stimulation in Parkinsonian Rat	PLOS ONE			English	Article							DOPA-INDUCED DYSKINESIA; DEEP BRAIN-STIMULATION; LEVODOPA-INDUCED DYSKINESIA; MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; BASAL GANGLIA; SUBVENTRICULAR ZONE; RETINOIC ACID; MODEL; TRANSTHYRETIN	This study addresses the molecular mechanisms underlying the action of subthalamic nucleus high frequency stimulation (STN-HFS) in the treatment of Parkinson's disease and its interaction with levodopa (L-DOPA), focusing on the striatum. Striatal gene expression profile was assessed in rats with nigral dopamine neuron lesion, either treated or not, using agilent microarrays and qPCR verification. The treatments consisted in anti-akinetic STN-HFS (5 days), chronic L-DOPA treatment inducing dyskinesia (LIDs) or the combination of the two treatments that exacerbated LIDs. STN-HFS modulated 71 striatal genes. The main biological processes associated with the differentially expressed gene products include regulation of growth, of apoptosis and of synaptic transmission, and extracellular region is a major cellular component implicated. In particular, several of these genes have been shown to support survival or differentiation of striatal or of dopaminergic neurons. These results indicate that STN HFS may induce widespread anatomo-functional rearrangements in the striatum and create a molecular environment favorable for neuroprotection and neuroplasticity. STN-HFS and L-DOPA treatment share very few common gene regulation features indicating that the molecular substrates underlying their striatal action are mostly different; among the common effects is the down-regulation of Adrb1, which encodes the adrenergic beta-1-receptor, supporting a major role of this receptor in Parkinson's disease. In addition to genes already reported to be associated with LIDs (preprodynorphin, thyrotropin-releasing hormone, metabotropic glutamate receptor 4, cannabinoid receptor 1), the comparison between DOPA and DOPA/HFS identifies immunity-related genes as potential players in L-DOPA side effects.	[Lortet, Sylviane y; Lacombe, Emilie; Goff, Lydia Kerkerian-Le; Salin, Pascal] Aix Marseille Univ, CNRS, IBDM UMR 7288, Marseille, France; [Boulanger, Nicolas; Rihet, Pascal; Nguyen, Catherine] Aix Marseille Univ, INSERM, TAGC U1090, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lortet, S (corresponding author), Aix Marseille Univ, CNRS, IBDM UMR 7288, Marseille, France.	sylviane.lortet@univ-amu.fr	Nguyen, Catherine/M-4119-2016; Rihet, Pascal/L-2173-2016; Rihet, Pascal/GQP-1381-2022; Rihet, Pascal/AAD-2018-2022	Nguyen, Catherine/0000-0001-9376-6360; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Lortet, Sylviane/0000-0002-7169-4375; Kerkerian-Le Goff, Lydia/0000-0002-7951-3479	Centre National de la Recherche Scientifique (CNRS); Aix-Marseille University; Federation pour la Recherche sur le Cerveau (FRC)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Federation pour la Recherche sur le Cerveau (FRC)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), Aix-Marseille University, and Federation pour la Recherche sur le Cerveau (FRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert I, 2007, BIOL PSYCHIAT, V61, P836, DOI 10.1016/j.biopsych.2006.06.038; Aviles-Olmos I, 2013, BRAIN, V136, P374, DOI 10.1093/brain/aws009; Azam L, 2003, NEUROSCIENCE, V119, P965, DOI 10.1016/S0306-4522(03)00220-3; Bassilana F, 2005, NEUROBIOL DIS, V20, P93, DOI 10.1016/j.nbd.2005.02.005; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bezard E, 2001, NAT REV NEUROSCI, V2, P577, DOI 10.1038/35086062; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Brouillette J, 2008, NEUROBIOL AGING, V29, P1721, DOI 10.1016/j.neurobiolaging.2007.04.007; Bruet N, 2001, J NEUROPATH EXP NEUR, V60, P15, DOI 10.1093/jnen/60.1.15; Cabeza-Arvelaiz Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-83; Calabresi P, 2000, ANN NEUROL, V47, pS60; Cannizzaro C, 2003, MOL BRAIN RES, V110, P169, DOI 10.1016/S0169-328X(02)00555-7; Cantuti-Castelvetri I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013861; Cenci MA, 2007, PARKINSONISM RELAT D, V13, pS263, DOI 10.1016/S1353-8020(08)70014-2; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Groot J, 1959, RAT FOREBRAIN STEREO; DeLong M, 2009, PARKINSONISM RELAT D, V15, pS237, DOI 10.1016/S1353-8020(09)70822-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding YM, 2011, P NATL ACAD SCI USA, V108, P840, DOI 10.1073/pnas.1006511108; Eells JB, 2012, J MOL NEUROSCI, V46, P545, DOI 10.1007/s12031-011-9642-z; El Atifi-Borel M, 2009, NEUROBIOL DIS, V34, P340, DOI 10.1016/j.nbd.2009.02.002; Fabbrini G, 2007, MOVEMENT DISORD, V22, P1379, DOI 10.1002/mds.21475; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Ferrario JE, 2004, J NEUROCHEM, V90, P1348, DOI 10.1111/j.1471-4159.2004.02595.x; Garcia-Dominguez M, 2003, DEVELOPMENT, V130, P6013, DOI 10.1242/dev.00840; Gertz M, 2010, BBA-PROTEINS PROTEOM, V1804, P1658, DOI 10.1016/j.bbapap.2009.09.011; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Gottwald MD, 2011, ANN NEUROL, V69, P919, DOI 10.1002/ana.22423; Grunblatt E, 2011, J NEURAL TRANSM, V118, P1717, DOI 10.1007/s00702-010-0552-y; Gubellini P, 2006, EUR J NEUROSCI, V24, P1802, DOI 10.1111/j.1460-9568.2006.05047.x; Gubellini P, 2009, PROG NEUROBIOL, V89, P79, DOI 10.1016/j.pneurobio.2009.06.003; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hara M, 2010, J NEUROCHEM, V113, P1046, DOI 10.1111/j.1471-4159.2010.06668.x; Henry B, 2003, EXP NEUROL, V183, P458, DOI 10.1016/S0014-4886(03)00064-5; Huang Y, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00033; Iravani MM, 2011, J NEURAL TRANSM, V118, P1661, DOI 10.1007/s00702-011-0698-2; Jin HJ, 2011, J BIOL CHEM, V286, P19840, DOI 10.1074/jbc.M110.203687; Katayama Y, 2006, STEREOT FUNCT NEUROS, V84, P176, DOI 10.1159/000094957; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KERKERIAN L, 1986, NEUROSCI LETT, V66, P106, DOI 10.1016/0304-3940(86)90174-6; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Khaindrava V, 2011, NEUROBIOL DIS, V42, P284, DOI 10.1016/j.nbd.2011.01.018; Kita Y, 2012, PSYCHOPHARMACOLOGY; Konradi C, 2004, NEUROBIOL DIS, V17, P219, DOI 10.1016/j.nbd.2004.07.005; Lacombe E, 2007, EUR J NEUROSCI, V26, P1670, DOI 10.1111/j.1460-9568.2007.05747.x; Lacombe E, 2009, NEUROBIOL DIS, V36, P116, DOI 10.1016/j.nbd.2009.07.002; Li MD, 2000, J NEUROSCI, V20, P1318; Li XY, 2011, J NEUROSCI, V31, P12483, DOI 10.1523/JNEUROSCI.2417-11.2011; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; LINDEFORS N, 1990, EXP BRAIN RES, V80, P489; Lindgren HS, 2009, NEUROPSYCHOPHARMACOL, V34, P2477, DOI 10.1038/npp.2009.74; Liz MA, 2012, BIOCHEM J, V443, P769, DOI 10.1042/BJ20111690; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lundblad M, 2004, NEUROBIOL DIS, V16, P110, DOI 10.1016/j.nbd.2004.01.007; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Meissner W, 2003, J NEUROCHEM, V85, P601, DOI 10.1046/j.1471-4159.2003.01665.x; Naydenov AV, 2010, ACTA NEUROPATHOL, V120, P623, DOI 10.1007/s00401-010-0740-8; Nicholson SL, 2002, EUR J NEUROL, V9, P1, DOI 10.1046/j.1468-1331.9.s3.1.x; Oueslati A, 2007, J NEUROSCI, V27, P2377, DOI 10.1523/JNEUROSCI.2949-06.2007; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pisani A, 2003, J NEUROSCI, V23, P5272; Plane JM, 2008, EXP NEUROL, V214, P125, DOI 10.1016/j.expneurol.2008.08.006; Quik M, 2009, BIOCHEM PHARMACOL, V78, P677, DOI 10.1016/j.bcp.2009.05.003; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robelet S, 2004, EUR J NEUROSCI, V20, P1255, DOI 10.1111/j.1460-9568.2004.03591.x; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Salin P, 2002, J NEUROSCI, V22, P5137, DOI 10.1523/JNEUROSCI.22-12-05137.2002; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Schmeisser MJ, 2012, J NEUROSCI, V32, P5688, DOI 10.1523/JNEUROSCI.0111-12.2012; Sgambato-Faure V, 2012, PROG NEUROBIOL, V96, P69, DOI 10.1016/j.pneurobio.2011.10.005; Smith Y, 2009, PARKINSONISM RELAT D, V15, pS156, DOI 10.1016/S1353-8020(09)70805-3; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Toresson H, 1999, DEVELOPMENT, V126, P1317; Toulorge D, 2011, FASEB J, V25, P2563, DOI 10.1096/fj.11-182824; Vazin T., 2009, PLOS ONE, V4; Wang TW, 2005, DEVELOPMENT, V132, P2721, DOI 10.1242/dev.01867; Werme M, 2000, BRAIN RES, V863, P112, DOI 10.1016/S0006-8993(00)02109-0; Zeng BY, 1999, NEUROSCI LETT, V276, P71, DOI 10.1016/S0304-3940(99)00762-4; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhao XD, 2009, BRAIN RES, V1286, P230, DOI 10.1016/j.brainres.2009.06.069	85	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60447	10.1371/journal.pone.0060447	http://dx.doi.org/10.1371/journal.pone.0060447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593219	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100045
J	Zhang, T; Lou, J; Zhong, R; Wu, J; Zou, L; Sun, Y; Lu, XZ; Liu, L; Miao, XP; Xiong, GL				Zhang, Ti; Lou, Jiao; Zhong, Rong; Wu, Jing; Zou, Li; Sun, Yu; Lu, Xuzai; Liu, Li; Miao, Xiaoping; Xiong, Guanglian			Genetic Variants in the Folate Pathway and the Risk of Neural Tube Defects: A Meta-Analysis of the Published Literature	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; ONE-CARBON METABOLISM; SPINA-BIFIDA; FOLIC-ACID; VASCULAR-DISEASE; COMMON MUTATION; C677T MUTATION; POLYMORPHISMS; ASSOCIATION; MTHFR	Background: Neural Tube Defects (NTDs) are among the most prevalent and most severe congenital malformationsworldwide. Polymorphisms in key genes involving the folate pathway have been reported to be associated with the risk of NTDs. However, the results from these published studies are conflicting. We surveyed the literature (1996-2011) and performed a comprehensive meta-analysis to provide empirical evidence on the association. Methods and Findings: We investigated the effects of 5 genetic variants from 47 study populations, for a total of 85 casecontrol comparisons MTHFR C677T (42 studies; 4374 cases, 7232 controls), MTHFR A1298C (22 studies; 2602 cases, 4070 controls), MTR A2756G (9 studies; 843 cases, 1006 controls), MTRR A66G (8 studies; 703 cases, 1572 controls), and RFC-1 A80G (4 studies; 1107 cases, 1585 controls). We found a convincing evidence of dominant effects of MTHFR C677T (OR 1.23; 95% CI 1.07-1.42) and suggestive evidence of RFC-1 A80G (OR 1.55; 95% CI 1.24-1.92). However, we found no significant effects of MTHFR A1298C, MTR A2756G, MTRR A66G in risk of NTDs in dominant, recessive or in allelic models. Conclusions: Our meta-analysis strongly suggested a significant association of the variant MTHFR C677T and a suggestive association of RFC-1 A80G with increased risk of NTDs. However, other variants involved in folate pathway do not demonstrate any evidence for a significant marginal association on susceptibility to NTDs.	[Zhang, Ti; Lou, Jiao; Zhong, Rong; Wu, Jing; Zou, Li; Sun, Yu; Lu, Xuzai; Miao, Xiaoping; Xiong, Guanglian] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Zhang, Ti; Lou, Jiao; Zhong, Rong; Wu, Jing; Zou, Li; Sun, Yu; Lu, Xuzai; Miao, Xiaoping; Xiong, Guanglian] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangdong Pharmaceutical University	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	miaoxp@gmail.com; weixiong@mails.tjmu.edu.cn	miao, xiaoping/C-4336-2011; Zhong, Rong/Q-1813-2019	miao, xiaoping/0000-0002-6818-9722; 				Amorim MR, 2007, AM J MED GENET A, V143A, P1726, DOI 10.1002/ajmg.a.31812; Bassuk AG, 2009, SEMIN PEDIATR NEUROL, V16, P101, DOI 10.1016/j.spen.2009.06.001; Beaudin Anna E., 2007, Birth Defects Research, V81, P183, DOI 10.1002/bdrc.20100; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; BjorkeMonsen AL, 1997, QJM-INT J MED, V90, P593, DOI 10.1093/qjmed/90.9.593; Boduroglu K, 2005, TURKISH J PEDIATR, V47, P327; Christiansen Marianne, 2005, Ugeskr Laeger, V167, P2875; Christianson A, 2006, GLOBAL REPORT BIRTH; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; de Franchis R, 1998, J MED GENET, V35, P1009, DOI 10.1136/jmg.35.12.1009; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Detrait ER, 2005, NEUROTOXICOL TERATOL, V27, P515, DOI 10.1016/j.ntt.2004.12.007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Godbole K, 2011, BIRTH DEFECTS RES A, V91, P848, DOI 10.1002/bdra.20841; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; Kirke PN, 2004, BRIT MED J, V328, P1535, DOI 10.1136/bmj.38036.646030.EE; Kondo A, 2009, INT J UROL, V16, P49, DOI 10.1111/j.1442-2042.2008.02163.x; Laurence K M, 1985, Prog Clin Biol Res, V163B, P383; Li YN, 1996, HUM MOL GENET, V5, P1851, DOI 10.1093/hmg/5.12.1851; MARCO PD, 2002, J HUM GENET, V47, P319; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Molloy AM, 2009, BIRTH DEFECTS RES A, V85, P285, DOI 10.1002/bdra.20566; Mornet E, 1997, HUM GENET, V100, P512, DOI 10.1007/s004390050544; Motulsky AG, 1996, AM J HUM GENET, V58, P17; Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.0.CO;2-L; Parle-McDermott A, 2003, J HUM GENET, V48, P190, DOI 10.1007/s10038-003-0008-4; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Relton CL, 2004, J MED GENET, V41, P256, DOI 10.1136/jmg.2003.010694; Richter B, 2001, J HUM GENET, V46, P105, DOI 10.1007/s100380170096; Rothenberg SP, 2004, NEW ENGL J MED, V350, P134, DOI 10.1056/NEJMoa031145; Selzer RR, 2003, NEW ENGL J MED, V349, P45, DOI 10.1056/NEJMoa021867; Shaw GM, 1998, AM J EPIDEMIOL, V148, P30, DOI 10.1093/oxfordjournals.aje.a009555; SMITHELLS RW, 1976, ARCH DIS CHILD, V51, P944, DOI 10.1136/adc.51.12.944; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Ulrich CM, 2003, NAT REV CANCER, V3, P912, DOI 10.1038/nrc1233; van der Linden IJM, 2006, P NUTR SOC, V65, P204, DOI 10.1079/PNS2006495; vanderPut NMJ, 1997, QJM-INT J MED, V90, P505, DOI 10.1093/qjmed/90.8.505; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wolff T, 2009, ANN INTERN MED, V150, P632, DOI 10.7326/0003-4819-150-9-200905050-00010; YATES JRW, 1987, CLIN GENET, V31, P279; Zintzaras E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-9	48	78	83	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e59570	10.1371/journal.pone.0059570	http://dx.doi.org/10.1371/journal.pone.0059570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593147	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100009
J	Steinmann, C; Fedorov, DG; Jensen, JH				Steinmann, Casper; Fedorov, Dmitri G.; Jensen, Jan H.			Mapping Enzymatic Catalysis Using the Effective Fragment Molecular Orbital Method: Towards all ab initio Biochemistry	PLOS ONE			English	Article							QUANTUM-MECHANICAL CALCULATIONS; TRANSITION-STATE STABILIZATION; ENERGY DECOMPOSITION ANALYSIS; CHORISMATE MUTASE REACTION; LARGE SYSTEMS; GEOMETRY OPTIMIZATION; POTENTIAL METHOD; METHOD FMO; QM/MM; SIMULATION	We extend the Effective Fragment Molecular Orbital (EFMO) method to the frozen domain approach where only the geometry of an active part is optimized, while the many-body polarization effects are considered for the whole system. The new approach efficiently mapped out the entire reaction path of chorismate mutase in less than four days using 80 cores on 20 nodes, where the whole system containing 2398 atoms is treated in the ab initio fashion without using any force fields. The reaction path is constructed automatically with the only assumption of defining the reaction coordinate a priori. We determine the reaction barrier of chorismate mutase to be 18.3 +/- 3.5 kcal mol(-1) for MP2/cc-pVDZ and 19.3 +/- 3.6 for MP2/cc-pVTZ in an ONIOM approach using EFMO-RHF/6-31G(d) for the high and low layers, respectively.	[Steinmann, Casper; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Fedorov, Dmitri G.] Natl Inst Adv Ind Sci & Technol, NRI, Tsukuba, Ibaraki, Japan	University of Copenhagen; National Institute of Advanced Industrial Science & Technology (AIST)	Jensen, JH (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	jhjensen@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; Svendsen, Casper/T-6775-2018	Jensen, Jan Halborg/0000-0002-1465-1010; Svendsen, Casper/0000-0002-5638-1346	IRENE; Next Generation Super Computing Project, Nanoscience Program (MEXT, Japan); Strategic Programs for Innovative Research (SPIRE, Japan)	IRENE; Next Generation Super Computing Project, Nanoscience Program (MEXT, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Programs for Innovative Research (SPIRE, Japan)	CS was funded by IRENE: http://www.irene-fp7.eu/. DF thanks the Next Generation Super Computing Project, Nanoscience Program (MEXT, Japan) and Strategic Programs for Innovative Research (SPIRE, Japan) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev Y, 2012, CURR TOP ME IN PRESS; Antony J, 2012, J COMPUT CHEM, V33, P1730, DOI 10.1002/jcc.23004; Asada N, 2012, J PHYS CHEM LETT, V3, P2604, DOI 10.1021/jz3010688; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CHOOK YM, 1993, P NATL ACAD SCI USA, V90, P8600, DOI 10.1073/pnas.90.18.8600; Claeyssens F, 2006, ANGEW CHEM, V118, P7010, DOI [10.1002/ange.200602711, DOI 10.1002/ANGE.200602711]; Claeyssens F, 2011, ORG BIOMOL CHEM, V9, P1578, DOI 10.1039/c0ob00691b; Crespo A, 2005, J AM CHEM SOC, V127, P6940, DOI 10.1021/ja0452830; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; Davidson MM, 1996, J CHEM SOC PERK T 2, P525, DOI 10.1039/p29960000525; Day PN, 1996, J CHEM PHYS, V105, P1968, DOI 10.1063/1.472045; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Fedorov DG, 2009, FRAGMENT MOLECULAR ORBITAL METHOD: PRACTICAL APPLICATIONS TO LARGE MOLECULAR SYSTEMS, P1, DOI 10.1201/9781420078497; Fedorov DG, 2004, J CHEM PHYS, V120, P6832, DOI 10.1063/1.1687334; Fedorov DG, 2004, J COMPUT CHEM, V25, P872, DOI 10.1002/jcc.20018; Fedorov DG, 2005, J PHYS CHEM A, V109, P2638, DOI 10.1021/jp047186z; Fedorov DG, 2008, J PHYS CHEM A, V112, P11808, DOI 10.1021/jp805435n; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Fedorov DG, 2007, J PHYS CHEM A, V111, P2722, DOI 10.1021/jp0671042; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Fedorov DG, 2012, J PHYS CHEM A, V116, P704, DOI 10.1021/jp209579w; Fedorov DG, 2009, CHEM PHYS LETT, V477, P169, DOI 10.1016/j.cplett.2009.06.072; Fedorov DG, 2007, J COMPUT CHEM, V28, P222, DOI 10.1002/jcc.20496; Frankcombe TJ, 2012, J PHYS CHEM C, V116, P7793, DOI 10.1021/jp212409e; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Furtado JP, 2012, J PHYS CHEM LETT, V3, P2253, DOI 10.1021/jz300663u; Gao JL, 2002, ANNU REV PHYS CHEM, V53, P467, DOI 10.1146/annurev.physchem.53.091301.150114; Gao JL, 1997, J PHYS CHEM B, V101, P657, DOI 10.1021/jp962833a; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; Gordon MS, 2001, J PHYS CHEM A, V105, P293, DOI 10.1021/jp002747h; Guo WP, 2012, J COMPUT CHEM, V33, P2142, DOI 10.1002/jcc.23051; Hall RJ, 2000, J COMPUT CHEM, V21, P1433, DOI 10.1002/1096-987X(200012)21:16<1433::AID-JCC2>3.0.CO;2-P; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hertwig RH, 1997, CHEM PHYS LETT, V268, P345, DOI 10.1016/S0009-2614(97)00207-8; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hu LH, 2009, J PHYS CHEM A, V113, P11793, DOI 10.1021/jp9029024; Hua SG, 2011, J PHYS CHEM B, V115, P11462, DOI 10.1021/jp203423w; Huang LL, 2012, FUTURE MED CHEM, V4, P1479, DOI [10.4155/fmc.12.92, 10.4155/FMC.12.92]; Ishida T, 2006, J PHYS CHEM B, V110, P1457, DOI 10.1021/jp0557159; Ishikawa T, 2010, CHEM PHYS LETT, V500, P149, DOI 10.1016/j.cplett.2010.09.071; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Komeiji Y, 2003, CHEM PHYS LETT, V372, P342, DOI 10.1016/S0009-2614(03)00430-5; Komeiji Y, 2012, MOLECULAR DYNAMICS - THEORETICAL DEVELOPMENTS AND APPLICATIONS IN NANOTECHNOLOGY AND ENERGY, P3; Lee WH, 2003, THEOR CHEM ACC, V109, P140; Lee YS, 2002, J PHYS CHEM B, V106, P12059, DOI 10.1021/jp0268718; Leverentz HR, 2012, PHYS CHEM CHEM PHYS, V14, P7669, DOI 10.1039/c2cp24113g; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu K, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1277-9; LYNE PD, 1995, J AM CHEM SOC, V117, P11345, DOI 10.1021/ja00150a037; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Marti S, 2001, THEOR CHEM ACC, V105, P207, DOI 10.1007/s002140000203; Minikis RM, 2001, J PHYS CHEM A, V105, P3829, DOI 10.1021/jp0032659; Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003; Nagata T, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4714601; OTTO P, 1975, CHEM PHYS, V8, P192, DOI 10.1016/0301-0104(75)80107-8; Polyakov IV, 2012, CHEM PHYS L IN PRESS; Ranaghan KE, 2004, ORG BIOMOL CHEM, V2, P968, DOI 10.1039/b313759g; Ranaghan KE, 2003, MOL PHYS, V101, P2695, DOI 10.1080/00268970310001593286; Saparpakorn P, 2013, INT J QUANT IN PRESS; Sato M, 2008, J AM CHEM SOC, V130, P2396, DOI 10.1021/ja710038c; Sawada T, 2010, J AM CHEM SOC, V132, P16862, DOI 10.1021/ja105051e; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrodinger L., 2020, PYMOL; Soderhjelm P, 2010, J CHEM THEORY COMPUT, V6, P1726, DOI 10.1021/ct9006986; Steinmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044480; Steinmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041117; Steinmann C, 2010, J PHYS CHEM A, V114, P8705, DOI 10.1021/jp101498m; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; STONE AJ, 1981, CHEM PHYS LETT, V83, P233, DOI 10.1016/0009-2614(81)85452-8; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Worthington SE, 2001, J PHYS CHEM B, V105, P7087, DOI 10.1021/jp010227w; Zoete V, 2011, J COMPUT CHEM	77	23	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60602	10.1371/journal.pone.0060602	http://dx.doi.org/10.1371/journal.pone.0060602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593259	Green Submitted, gold, Green Published			2022-12-27	WOS:000317385300022
J	Tao, T; Shi, H; Huang, DL; Peng, JR				Tao, Ting; Shi, Hui; Huang, Delai; Peng, Jinrong			Def Functions as a Cell Autonomous Factor in Organogenesis of Digestive Organs in Zebrafish	PLOS ONE			English	Article							ENRICHED TRANSCRIPTION FACTORS; ACID-BINDING PROTEIN; TRANSGENIC ZEBRAFISH; GENE-EXPRESSION; RIBOSOMAL-RNA; PANCREAS DEVELOPMENT; LIVER MORPHOGENESIS; DANIO-RERIO; ENDODERM; SYSTEM	Digestive organs originate from the endoderm. Morphogenesis of the digestive system is precisely controlled by multiple factors that dictate the cell fate and behavior so that the specific digestive organs are timely formed in the right place and develop into right size and structure. We showed previously that digestive organ expansion factor (def) is a gene whose expression is enriched in the liver, pancreas and intestine. Loss-of-function of def in the def(hi429) mutant confers hypoplastic digestive organs partly due to alteration of expression of genes related to the p53 pathway. However, the molecular mechanism for the involvement of Def in the organogenesis of digestive organs is still largely unknown. For example, it is not known whether Def regulates specific pathways in a specific organ. To address this question, we generated four independent Tg(fabp10a:def) transgenic fish lines which over-expressed Def specifically in the liver. We characterized Tg-I, one of the transgenic lines, in detail with genetic, molecular and histological approaches. We found that Tg-I restored the liver but not exocrine pancreas and intestine development in the def(hi429) mutant. However, Tg-I adult fish in the wild type (WT) background exhibits reduced liver-to-body ratio and all four transgenic lines conferred abnormal intrahepatic structure. Microarray data analysis showed that certain specific functional pathways were affected in the liver of Tg-I. These results demonstrate that Def functions in a cell autonomous manner during early liver development and aberrant Def protein expression might lead to disruption of the structural integrity of a normal adult liver.	[Tao, Ting; Shi, Hui; Huang, Delai; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Peng, JR (corresponding author), Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	pengjr@zju.edu.cn	Huang, Dylan/HAX-3386-2022	Huang, Dylan/0000-0002-3966-6462; Peng, Jinrong/0000-0002-0793-4848; Tao, Ting/0000-0003-1260-2351	National Natural Science Foundation of China [30825025]; "973 Program" [2012CB944500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973 Program"(National Basic Research Program of China)	This work is financially supported by the National Natural Science Foundation of China (30825025) and "973 Program" (2012CB944500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Charette JM, 2010, RNA, V16, P2156, DOI 10.1261/rna.2359810; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Denovan-Wright EM, 2000, BBA-GENE STRUCT EXPR, V1492, P227, DOI 10.1016/S0167-4781(00)00102-0; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Goldfeder MB, 2010, FEBS J, V277, P2838, DOI 10.1111/j.1742-4658.2010.07701.x; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Harscoet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012829; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Kan NG, 2009, FASEB J, V23, P3516, DOI 10.1096/fj.09-131730; Kawamoto S, 1996, GENE, V174, P151, DOI 10.1016/0378-1119(96)00512-4; Niu XB, 2012, DEV BIOL, V367, P197, DOI 10.1016/j.ydbio.2012.05.004; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Skarie JM, 2008, HUM MOL GENET, V17, P2474, DOI 10.1093/hmg/ddn147; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Warga RM, 1999, DEVELOPMENT, V126, P827; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	32	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e58858	10.1371/journal.pone.0058858	http://dx.doi.org/10.1371/journal.pone.0058858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593122	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300004
J	Stock, WD; Finn, H; Parker, J; Dods, K				Stock, William D.; Finn, Hugh; Parker, Jackson; Dods, Ken			Pine as Fast Food: Foraging Ecology of an Endangered Cockatoo in a Forestry Landscape	PLOS ONE			English	Article							SHORT-BILLED FORM; CARNABYS COCKATOO; BLACK COCKATOO; GROWTH; BIRDS; NUTRITION; MOVEMENTS; PROTEINS; BEHAVIOR; ARGININE	Pine plantations near Perth, Western Australia have provided an important food source for endangered Carnaby's Cockatoos (Calyptorhynchus latirostris) since the 1940s. Plans to harvest these plantations without re-planting will remove this food source by 2031 or earlier. To assess the impact of pine removal, we studied the ecological association between Carnaby's Cockatoos and pine using behavioural, nutritional, and phenological data. Pine plantations provided high densities of seed (158 025 seeds ha(-1)) over a large area (c. 15 000 ha). Carnaby's Cockatoos fed throughout these plantations and removed almost the entire annual crop of pine cones. Peak cockatoo abundance coincided with pine seed maturation. Pine seed had energy and protein contents equivalent to native food sources and, critically, is available in summer when breeding pairs have young offspring to feed. This strong and enduring ecological association clearly suggests that removing pine will have a significant impact on this endangered species unless restoration strategies, to establish alternative food sources, are implemented.	[Stock, William D.] Edith Cowan Univ, Ctr Ecosyst Management, Joondalup, WA, Australia; [Finn, Hugh] Murdoch Univ, Sch Biol Sci & Biotechnol, Perth, WA, Australia; [Parker, Jackson] Dept Agr & Food, S Perth, WA, Australia; [Dods, Ken] ChemCtr, Bentley, WA, Australia	Edith Cowan University; Murdoch University; Government of Western Australia; Department of Agriculture & Food - Western Australia	Stock, WD (corresponding author), Edith Cowan Univ, Ctr Ecosyst Management, Joondalup, WA, Australia.	w.stock@ecu.edu.au	Stock, William/B-8858-2008	Stock, William/0000-0003-2475-2963; Finn, Hugh/0000-0002-2363-9558	Forest Products Commission of WA as part of the Gnangara Sustainability Study	Forest Products Commission of WA as part of the Gnangara Sustainability Study	The study was funded by the Forest Products Commission of WA as part of the Gnangara Sustainability Study. The FPC also provided access to plantation records. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLONA I, 1994, TREE PHYSIOL, V14, P211, DOI 10.1093/treephys/14.2.211; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AOAC International, 1995, OFFICIAL METHODS ANA, V1; Archibald Robert D., 2010, Ecological Management & Restoration, V11, P108, DOI 10.1111/j.1442-8903.2010.00527.x; AUSTIC RE, 1976, FED PROC, V35, P1914; Beeton RJS, 2006, AUSTR STATE ENV 2006; Berry PF, 2010, W AUSTR NATURALIST, V27, P27; BirdLife International, 2012, IUCN 2012 IUCN RED L; Blakemore P, 2010, W AUSTR SOFTWOOD RES; Cameron M, 2007, AUSTRAL NAT HIST SER, P1; Cooper CE, 2002, AUST J ZOOL, V50, P67, DOI 10.1071/ZO00067; Crowley GM, 2001, AUSTRAL ECOL, V26, P116, DOI 10.1046/j.1442-9993.2001.01093.x; Department of Environment and Conservation, 2012, CARN COCK CAL LAT RE; Diaz M, 1996, COMP BIOCHEM PHYS A, V113, P239, DOI 10.1016/0300-9629(95)02093-4; Environmental Protection Agency, 2007, STAT ENV REP W AUSTR; Finn H, 2009, ECOLOGY CARNABYS BLA; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Gnangara Coordinating Committee, 2009, GNANG SUST STRAT DRA; Gonzalez-Ochoa AI, 2004, FOREST ECOL MANAG, V188, P235, DOI 10.1016/j.foreco.2003.07.015; Greenfield H, 2003, FOOD COMPOSITION DAT; Hepworth G, 2001, BEHAVIOUR, V138, P1391, DOI 10.1163/156853901317367654; HOBBS RJ, 1993, BIOL CONSERV, V64, P231, DOI 10.1016/0006-3207(93)90324-T; Johnstone R.E., 1998, HDB W AUSTR BIRDS, V1; Koutsos EA, 2001, J AVIAN MED SURG, V15, P257, DOI 10.1647/1082-6742(2001)015[0257:NOBITO]2.0.CO;2; Laidlaw WS, 2006, WILDLIFE RES, V33, P639, DOI 10.1071/WR05080; Lopez-Mata L, 2001, INTERCIENCIA, V26, P606; MACMILLEN RE, 1993, FUNCT ECOL, V7, P704, DOI 10.2307/2390192; Matuzak GD, 2007, J FIELD ORNITHOL, V78, P159, DOI 10.1111/j.1557-9263.2007.00099.x; Perry D. H., 1948, West Australian Naturalist, V1, P133; Public Health England, 2021, MCCANCE WIDDOWSONS C; ROBINSON ANGUS, 1965, WESTERN AUSTRALIAN NATUR, V9, P169; ROUDYBUSH TE, 1986, J NUTR, V116, P552, DOI 10.1093/jn/116.4.552; Saunders D.A., 1987, P249; SAUNDERS D A, 1974, Australian Wildlife Research, V1, P45; Saunders D.A., 1985, P309; Saunders D.A., 1995, BIRDS SW AUSTR ATLAS; SAUNDERS DA, 1990, BIOL CONSERV, V54, P277, DOI 10.1016/0006-3207(90)90057-V; SAUNDERS DA, 1980, AUST WILDLIFE RES, V7, P257; SAUNDERS DA, 1977, EMU, V77, P180, DOI 10.1071/MU9770180; SAUNDERS DA, 1982, IBIS, V124, P422, DOI 10.1111/j.1474-919X.1982.tb03790.x; SAUNDERS DA, 1986, AUST WILDLIFE RES, V13, P261; Saunders Denis A., 2011, Pacific Conservation Biology, V17, P141; Saunders Denis A., 2009, Pacific Conservation Biology, V15, P72; Shah B., 2006, CONSERVATION CARNABY; Stahl S, 1998, SEMIN AVIAN EXOT PET, V7, P128, DOI 10.1016/S1055-937X(98)80003-0; STOCK WD, 1991, NEW PHYTOL, V117, P109, DOI 10.1111/j.1469-8137.1991.tb00950.x; Tapias R, 2001, J ECOL, V89, P629, DOI 10.1046/j.1365-2745.2001.00575.x; Valentine Leonie, 2008, FOOD RESOURCES CARNA; VANSOEST PJ, 1963, J ASSOC OFF AGR CHEM, V46, P829; Vesk PA, 2008, BIOL CONSERV, V141, P174, DOI 10.1016/j.biocon.2007.09.010; WILLIAMS JB, 1991, AUST J ZOOL, V39, P131, DOI 10.1071/ZO9910131	51	26	26	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61145	10.1371/journal.pone.0061145	http://dx.doi.org/10.1371/journal.pone.0061145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593413	gold, Green Published			2022-12-27	WOS:000317383200043
J	Ascher, JM; Geneva, AJ; Ng, J; Wyatt, JD; Glor, RE				Ascher, Jill M.; Geneva, Anthony J.; Ng, Julienne; Wyatt, Jeffrey D.; Glor, Richard E.			Phylogenetic Analyses of Novel Squamate Adenovirus Sequences in Wild-Caught Anolis Lizards	PLOS ONE			English	Article							DRAGONS POGONA-VITTICEPS; BEARDED DRAGON; INFECTION; VIRUSES; GENUS; DEPENDOVIRUS; HEPATITIS; REPTILES; ORIGIN; GENOME	Adenovirus infection has emerged as a serious threat to the health of captive snakes and lizards (i.e., squamates), but we know relatively little about this virus' range of possible hosts, pathogenicity, modes of transmission, and sources from nature. We report the first case of adenovirus infection in the Iguanidae, a diverse family of lizards that is widely-studied and popular in captivity. We report adenovirus infections from two closely-related species of Anolis lizards (anoles) that were recently imported from wild populations in the Dominican Republic to a laboratory colony in the United States. We investigate the evolution of adenoviruses in anoles and other squamates using phylogenetic analyses of adenovirus polymerase gene sequences sampled from Anolis and a range of other vertebrate taxa. These phylogenetic analyses reveal that (1) the sequences detected from each species of Anolis are novel, and (2) adenoviruses are not necessarily host-specific and do not always follow a co-speciation model under which host and virus phylogenies are perfectly concordant. Together with the fact that the Anolis adenovirus sequences reported in our study were detected in animals that became ill and subsequently died shortly after importation while exhibiting clinical signs consistent with acute adenovirus infection, our discoveries suggest the need for renewed attention to biosecurity measures intended to prevent the spread of adenovirus both within and among species of snakes and lizards housed in captivity.	[Ascher, Jill M.; Wyatt, Jeffrey D.] Univ Rochester, Med Ctr, Dept Lab Anim Med, Rochester, NY 14642 USA; [Geneva, Anthony J.; Ng, Julienne; Glor, Richard E.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Ascher, JM (corresponding author), Univ Rochester, Med Ctr, Dept Lab Anim Med, Rochester, NY 14642 USA.	jill.ascher@fda.hhs.gov	Glor, Richard/N-4656-2013; Geneva, Anthony J/H-2471-2011	Glor, Richard/0000-0002-3359-1631; Geneva, Anthony J/0000-0001-8253-6527; NG, JULIENNE/0000-0002-2994-6233	National Science Foundation [DEB-090892]; Direct For Biological Sciences [0920892] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The current work was funded in part by grant DEB-090892 (to REG) from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; [Anonymous], 2010, R LANG ENV STAT COMP; Ariel E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-100; Ascher JM, 2012, J AM ASSOC LAB ANIM, V51, P83; Benko M, 1998, ARCH VIROL, V143, P829, DOI 10.1007/s007050050335; Drummond A., 2011, GENEIOUS V5 5; Farkas SL, 2002, J GEN VIROL, V83, P2403, DOI 10.1099/0022-1317-83-10-2403; Farkas SL, 2008, VIRUS RES, V132, P132, DOI 10.1016/j.virusres.2007.11.009; FRYE FL, 1994, J ZOO WILDLIFE MED, V25, P167; Garner Michael M., 2008, Journal of Herpetological Medicine and Surgery, V18, P86; Glor RE, 2004, P ROY SOC B-BIOL SCI, V271, P2257, DOI 10.1098/rspb.2004.2819; Glor RE, 2012, MOL PHYLOGENET EVOL, V64, P255, DOI 10.1016/j.ympev.2010.11.004; Harrach Balazs, 2007, Methods Mol Med, V131, P299; HELDSTAB A, 1984, J ZOO ANIM MED, V15, P118, DOI 10.2307/20094703; Hyndman T, 2011, AUST VET J, V89, P232, DOI 10.1111/j.1751-0813.2011.00712.x; Jacobson E, 2008, REPTILE ADENOVIRUS P; JACOBSON ER, 1986, J ZOO WILDLIFE MED, V17, P149, DOI 10.2307/20094810; JACOBSON ER, 1990, VET PATHOL, V27, P210, DOI 10.1177/030098589002700313; Jacobson ER, 1996, VET PATHOL, V33, P343, DOI 10.1177/030098589603300313; JACOBSON ER, 1984, J AM VET MED ASSOC, V185, P1421; JUHASZ A, 1993, ARCH VIROL, V130, P429, DOI 10.1007/BF01309671; JULIAN AF, 1982, NEW ZEAL VET J, V30, P59, DOI 10.1080/00480169.1982.34880; Kim DY, 2002, J VET DIAGN INVEST, V14, P332, DOI 10.1177/104063870201400411; Kinsel MJ, 1997, J ZOO WILDLIFE MED, V28, P498; Macey JR, 1997, J MOL EVOL, V44, P660, DOI 10.1007/PL00006190; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Marschang RE, 2003, P 6 INT C VET VIR VI, P152; Moormann S, 2009, J COMP PATHOL, V141, P78, DOI 10.1016/j.jcpa.2009.03.002; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; OGAWA M, 1992, J VET MED B, V39, P732, DOI 10.1111/j.1439-0450.1992.tb01228.x; Papp T, 2009, VET MICROBIOL, V134, P233, DOI 10.1016/j.vetmic.2008.08.003; Parkin DB, 2009, INFECT GENET EVOL, V9, P501, DOI 10.1016/j.meegid.2009.01.010; Pasmans F, 2008, VET J, V175, P53, DOI 10.1016/j.tvjl.2006.12.009; Perkins LEL, 2001, J VET DIAGN INVEST, V13, P365, DOI 10.1177/104063870101300418; Rambaut A, 2009, TRACER V1 5; Raymond JT, 2003, J WILDLIFE DIS, V39, P431, DOI 10.7589/0090-3558-39.2.431; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schulte JA, 2003, HERPETOLOGICA, V59, P399, DOI 10.1655/02-48; SCHUMACHER J, 1994, J ZOO WILDLIFE MED, V25, P461; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Wellehan JFX, 2004, J VIROL, V78, P13366, DOI 10.1128/JVI.78.23.13366-13369.2004; Wozniak E. J., 2000, Journal of Herpetological Medicine and Surgery, V10, P4	44	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60977	10.1371/journal.pone.0060977	http://dx.doi.org/10.1371/journal.pone.0060977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593364	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000033
J	Cao, XL; Lu, YG; Di, DP; Zhang, ZY; Liu, H; Tian, LZ; Zhang, AH; Zhang, YJ; Shi, LD; Guo, BH; Xu, J; Duan, XF; Wang, XB; Han, CG; Miao, HQ; Yu, JL; Li, DW				Cao, Xiuling; Lu, Yingui; Di, Dianping; Zhang, Zhiyan; Liu, He; Tian, Lanzhi; Zhang, Aihong; Zhang, Yanjing; Shi, Lindan; Guo, Bihong; Xu, Jin; Duan, Xifei; Wang, Xianbing; Han, Chenggui; Miao, Hongqin; Yu, Jialin; Li, Dawei			Enhanced Virus Resistance in Transgenic Maize Expressing a dsRNA-Specific Endoribonuclease Gene from E. coli	PLOS ONE			English	Article							STREAKED-DWARF-VIRUS; DIFFERENT CEREAL CROPS; ROUGH-DWARF; SEQUENCE-ANALYSIS; RIBONUCLEASE-III; COMPLETE GENOME; MOSAIC-VIRUS; RICE; PLANTS; DISEASE	Maize rough dwarf disease (MRDD), caused by several Fijiviruses in the family Reoviridae, is a global disease that is responsible for substantial yield losses in maize. Although some maize germplasm have low levels of polygenic resistance to MRDD, highly resistant cultivated varieties are not available for agronomic field production in China. In this work, we have generated transgenic maize lines that constitutively express rnc70, a mutant E. coli dsRNA-specific endoribonuclease gene. Transgenic lines were propagated and screened under field conditions for 12 generations. During three years of evaluations, two transgenic lines and their progeny were challenged with Rice black-streaked dwarf virus (RBSDV), the causal agent of MRDD in China, and these plants exhibited reduced levels of disease severity. In two normal years of MRDD abundance, both lines were more resistant than non-transgenic plants. Even in the most serious MRDD year, six out of seven progeny from one line were resistant, whereas non-transgenic plants were highly susceptible. Molecular approaches in the T12 generation revealed that the rnc70 transgene was integrated and expressed stably in transgenic lines. Under artificial conditions permitting heavy virus inoculation, the T12 progeny of two highly resistant lines had a reduced incidence of MRDD and accumulation of RBSDV in infected plants. In addition, we confirmed that the RNC70 protein could bind directly to RBSDV dsRNA in vitro. Overall, our data show that RNC70-mediated resistance in transgenic maize can provide efficient protection against dsRNA virus infection.	[Cao, Xiuling; Zhang, Zhiyan; Liu, He; Zhang, Yanjing; Shi, Lindan; Guo, Bihong; Xu, Jin; Wang, Xianbing; Han, Chenggui; Yu, Jialin; Li, Dawei] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Cao, Xiuling; Zhang, Zhiyan; Liu, He; Zhang, Yanjing; Shi, Lindan; Guo, Bihong; Xu, Jin; Wang, Xianbing; Han, Chenggui; Yu, Jialin; Li, Dawei] China Agr Univ, MOA Key Lab Soil Microbiol, Coll Biol Sci, Beijing 100094, Peoples R China; [Lu, Yingui; Di, Dianping; Tian, Lanzhi; Zhang, Aihong; Duan, Xifei; Miao, Hongqin] Hebei Acad Agr & Forestry Sci, Inst Plant Protect, Baoding, Peoples R China	China Agricultural University; China Agricultural University; Hebei Academy of Agricultural & Forestry Sciences	Miao, HQ (corresponding author), Hebei Acad Agr & Forestry Sci, Inst Plant Protect, Baoding, Peoples R China.	miao5058345@163.com; yjl@cau.edu.cn; Dawei.Li@cau.edu.cn	Li, Dawei/I-8751-2016; Wang, Xianbing/E-4831-2013	Li, Dawei/0000-0003-4133-1263; 	National Science & Technology Specific Projects of China [2011ZX08003-001, 2009ZX08003-010B]	National Science & Technology Specific Projects of China	This work was supported by the National Science & Technology Specific Projects of China (2011ZX08003-001 and 2009ZX08003-010B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2012, J INTEGR PLANT BIOL, V54, P134, DOI 10.1111/j.1744-7909.2012.01105.x; Hoang AT, 2011, PLANT DIS, V95, P1063, DOI 10.1094/PDIS-07-10-0535; Bai FW, 2001, ACTA VIROL, V45, P335; Bai FW, 2002, VIRUS GENES, V25, P201, DOI 10.1023/A:1020170020581; [包云轩 BAO YunXuan], 2007, [生态学报, Acta Ecologica Sinica], V27, P4527; Brunner S, 2012, PLANT BIOTECHNOL J, V10, P398, DOI 10.1111/j.1467-7652.2011.00670.x; Cheng M, 2004, IN VITRO CELL DEV-PL, V40, P31, DOI 10.1079/IVP2003501; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; Court D. L., 1993, CONTROL MESSENGER RN, P71; DEGREEF W, 1989, BIO-TECHNOL, V7, P61, DOI 10.1038/nbt0189-61; [邸垫平 Di Dianping], 2005, [河北农业大学学报, Journal of Agricultural University of Hebei], V28, P76; Di DP, 2005, JOURNAL OF HEBEI AGR, V28, P103; Distefano AJ, 2002, ARCH VIROL, V147, P1699, DOI 10.1007/s00705-002-0840-4; Dovas CI, 2004, PLANT PATHOL, V53, P238, DOI 10.1111/j.0032-0862.2004.00973.x; Fang S, 2001, ARCH VIROL, V146, P167, DOI 10.1007/s007050170200; Fang S, 2000, J AGR BIOTECHNOLOGY, V8, P12; FINNEGAN J, 1994, BIO-TECHNOL, V12, P883, DOI 10.1038/nbt0994-883; Fuchs M., 2008, ENCY VIROLOGY, P156; Harpaz I, 1972, MAIZE ROUGH DWARF A; Herrero S, 2000, PHYTOPATHOLOGY, V90, P139, DOI 10.1094/PHYTO.2000.90.2.139; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Huang Qiang, 2011, Journal of Maize Sciences, V19, P140; Ishida I, 2002, PEST MANAG SCI, V58, P1132, DOI 10.1002/ps.536; Isogai M., 2001, Plant Pathology Journal, V17, P164; [贾志森 JIA Zhisen], 2008, [山西农业科学, Journal of Shanxi Agricultural Sciences], V36, P76; King A. M. Q., 2011, VIRUS TAXONOMY NINTH; Kohm B., 1995, Phytopathology, V85, P1142; Lamontagne B, 2001, YEAST, V45, P154; Langenberg WG, 1997, MOL BREEDING, V3, P391, DOI 10.1023/A:1009697507261; Li HL, 1996, EMBO J, V15, P1421, DOI 10.1002/j.1460-2075.1996.tb00484.x; Lin SS, 2007, PLANT BIOTECHNOL REP, V1, P125, DOI 10.1007/s11816-007-0021-8; [路银贵 Lu Yingui], 2010, [河北农业大学学报, Journal of Agricultural University of Hebei], V33, P5; Nicholson Allen W., 2003, P149; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1016/S0168-6445(99)00013-3; Ogawa T, 1996, NAT BIOTECHNOL, V14, P1566, DOI 10.1038/nbt1196-1566; POWELL NT, 1971, PHYTOPATHOLOGY, V61, P1332, DOI 10.1094/Phyto-61-1332; Prins M, 2008, MOL PLANT PATHOL, V9, P73, DOI [10.1111/J.1364-3703.2007.00447.X, 10.1111/j.1364-3703.2007.00447.x]; Redinbaugh Margaret G., 2009, P251, DOI 10.1007/978-0-387-79418-1_13; SANDERS PR, 1992, PHYTOPATHOLOGY, V82, P683, DOI 10.1094/Phyto-82-683; SANFORD JC, 1985, J THEOR BIOL, V113, P395, DOI 10.1016/S0022-5193(85)80234-4; Sano T, 1997, NAT BIOTECHNOL, V15, P1290, DOI 10.1038/nbt1197-1290; SCHLAPPI M, 1992, PLANT CELL, V4, P7, DOI 10.1105/tpc.4.1.7; SHIKATA E, 1977, VIROLOGY, V77, P826, DOI 10.1016/0042-6822(77)90502-5; SHIKATA E, 1974, CMI AAB DESCRIPTION, V135; Shinkai A., 1952, ANN PHYTOPATHOL SOC, V16, P41; Simon-Mateo C, 2011, BBA-GENE REGUL MECH, V1809, P722, DOI 10.1016/j.bbagrm.2011.05.011; SLYKHUIS JT, 1976, ANNU REV PHYTOPATHOL, V14, P189, DOI 10.1146/annurev.py.14.090176.001201; Stam M, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; Sun WM, 2004, BIOCHEMISTRY-US, V43, P13054, DOI 10.1021/bi049258i; Sun WM, 2001, BIOCHEMISTRY-US, V40, P5102, DOI 10.1021/bi010022d; UYEDA I, 1995, ADV VIRUS RES, V45, P249, DOI 10.1016/S0065-3527(08)60063-9; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Wang F, 2006, EUR J PLANT PATHOL, V116, P289, DOI 10.1007/s10658-006-9060-1; Wang QA, 2010, J PHYTOPATHOL, V158, P733, DOI 10.1111/j.1439-0434.2010.01679.x; Wang ZH, 2003, VIRUS GENES, V27, P163, DOI 10.1023/A:1025776527286; Wang ZH, 2006, J VIROL METHODS, V134, P61, DOI 10.1016/j.jviromet.2005.11.019; WATANABE Y, 1995, FEBS LETT, V372, P165, DOI 10.1016/0014-5793(95)00901-K; Wu M, 1998, J CHINA AGR U, V5, P97; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Xiao JP, 2009, RNA, V15, P984, DOI 10.1261/rna.1196509; Yang H, 2001, J AGR BIOTECHNOLOGY, V4, P334; Ye GY, 2003, CROP PROT, V22, P171, DOI 10.1016/S0261-2194(02)00142-4; Zhang HM, 2008, ARCH VIROL, V153, P1893, DOI 10.1007/s00705-008-0209-4; Zhang LY, 2001, TRANSGENIC RES, V10, P13, DOI 10.1023/A:1008931706679; Zhao ZY, 2002, MOL BREEDING, V8, P323, DOI 10.1023/A:1015243600325; Zhou GH, 2008, CHINESE SCI BULL, V53, P3677, DOI 10.1007/s11434-008-0467-2	75	15	19	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60829	10.1371/journal.pone.0060829	http://dx.doi.org/10.1371/journal.pone.0060829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593318	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600053
J	Fallows, C; Gallagher, AJ; Hammerschlag, N				Fallows, Chris; Gallagher, Austin J.; Hammerschlag, Neil			White Sharks (Carcharodon carcharias) Scavenging on Whales and Its Potential Role in Further Shaping the Ecology of an Apex Predator	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; AFRICAN WILD DOGS; DEEP-SEA; SOUTH-AFRICA; ISLAND; PREY; PATTERNS; BEHAVIOR; CARCASS; QUALITY	Scavenging, a result of a temporary pulse of resources, occurs in virtually all ecosystems containing carnivores, and is an important energy transfer pathway that can impact ecosystem structure and function, and this ecological significance has largely been considered from a terrestrial standpoint; however, little is known about the role of scavenging in shaping the behavioral ecology of marine species, specifically apex predators. Here we present findings from multiple opportunistic observations of white sharks scavenging on whale carcasses in False Bay, South Africa. Observations of white sharks scavenging over successive days provided evidence of strategic and selective scavenging by this species. Moreover, extended daily observations permitted recordings of unique social, aggregative, and feeding behaviors. We further compare these data against observations of natural predation by sharks on seals in the study area. We discuss these data in relation to environmental conditions, shark social interactions, migration patterns, whale biology, and behaviorally-mediated trophic cascades. While the appearance of a whale carcass is largely a stochastic event, we propose that white shark scavenging on whales may represent an underestimated, yet significant component to the overall foraging ecology of this species, especially as individuals attain sexual maturity.	[Fallows, Chris] Apex Expedit, Cape Town, South Africa; [Gallagher, Austin J.; Hammerschlag, Neil] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA; [Gallagher, Austin J.; Hammerschlag, Neil] Univ Miami, RJ Dunlap Marine Conservat Program, Miami, FL USA; [Hammerschlag, Neil] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	University of Miami; University of Miami; University of Miami	Hammerschlag, N (corresponding author), Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA.	nhammerschlag@rsmas.miami.edu			RJ Dunlap Marine Conservation Program; Apex Expeditions	RJ Dunlap Marine Conservation Program; Apex Expeditions	Funding was provided by the RJ Dunlap Marine Conservation Program and Apex Expeditions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SD, 2011, MAR BIOL, V158, P1233, DOI 10.1007/s00227-011-1643-5; Atema J., 1988, P29; ATEMA J, 1995, P NATL ACAD SCI USA, V92, P62, DOI 10.1073/pnas.92.1.62; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Best PB, 2001, MAR ECOL PROG SER, V220, P277, DOI 10.3354/meps220277; Best Peter B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P161; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; CAREY FG, 1982, COPEIA, P254; Casey J.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P2; Castro J. I, 2011, SHARKS N AM; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Clua Eric, 2012, P343; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Cortes-Avizanda A, 2009, BASIC APPL ECOL, V10, P265, DOI 10.1016/j.baae.2008.03.009; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Curtis TH, 2006, CALIF FISH GAME, V92, P113; DAY JH, 1970, T ROY SOC S AFR, V39, P211, DOI 10.1080/00359197009519114; DAY JH, 1970, T ROY SOC S AFR, V39, P1; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dicken ML, 2008, MAR FRESHWATER RES, V59, P596, DOI 10.1071/MF07223; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Dudley SFJ, 2000, FISH B-NOAA, V98, P646; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Fallows Chris, 2012, P105; Foltan P, 2005, MOL ECOL, V14, P4147, DOI 10.1111/j.1365-294X.2005.02732.x; Guttridge TL, 2009, ANIM BEHAV, V78, P543, DOI 10.1016/j.anbehav.2009.06.009; Hammerschlag N, 2006, ENVIRON BIOL FISH, V76, P341, DOI 10.1007/s10641-006-9038-z; Hammerschlag Neil, 2012, P91; Hussey NE, GLOBAL PERSPECTIVES, P27; Jacoby DMP, 2012, FISH FISH, V13, P399, DOI 10.1111/j.1467-2979.2011.00436.x; Johnson R, 2009, ENVIRON BIOL FISH, V85, P189, DOI 10.1007/s10641-009-9477-4; KLIMLEY AP, 1981, FISH B-NOAA, V79, P356; KLIMLEY AP, 1994, AM SCI, V82, P122; Klimley AP, 1996, GREAT WHITE SHARKS, P175, DOI 10.1016/B978-012415031-7/50017-3; Knowlton Amy R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P193; Long DJ, 1996, GREAT WHITE SHARKS, P293, DOI 10.1016/B978-012415031-7/50028-8; Martin RA, 2009, J ZOOL, V279, P111, DOI 10.1111/j.1469-7998.2009.00586.x; Martin RA, 2012, MAR BIOL RES, V8, P90, DOI 10.1080/17451000.2011.614255; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; Moore Michael J., 2004, Journal of Cetacean Research and Management, V6, P199; Nowlin WH, 2008, ECOLOGY, V89, P647, DOI 10.1890/07-0303.1; ODUM EP, 1984, AM NAT, V124, P360, DOI 10.1086/284279; Penry GS, 2011, AFR J MAR SCI, V33, P403, DOI 10.2989/1814232X.2011.637617; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Pratt HL, 1996, GREAT WHITE SHARKS, P131, DOI 10.1016/B978-012415031-7/50014-8; PRATT HL, 1982, FISH B-NOAA, V80, P153; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Sims DW, 2012, J ANIM ECOL, V81, P432, DOI 10.1111/j.1365-2656.2011.01914.x; Skomal Gregory B., 2012, P405; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Sperone E, 2010, MAR BIOL RES, V6, P408, DOI 10.1080/17451000903078648; STOCKTON WL, 1982, DEEP-SEA RES, V29, P157, DOI 10.1016/0198-0149(82)90106-6; Taylor JKD, 2013, MAR MAMMAL SCI, V29, P204, DOI 10.1111/j.1748-7692.2011.00542.x; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	61	58	62	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60797	10.1371/journal.pone.0060797	http://dx.doi.org/10.1371/journal.pone.0060797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585850	Green Published, gold			2022-12-27	WOS:000317909600048
J	Rodrigues, VRM; Mondal, A; Dharmadhikari, JA; Panigrahi, S; Mathur, D; Dharmadhikari, AK				Rodrigues, Vanessa R. M.; Mondal, Argha; Dharmadhikari, Jayashree A.; Panigrahi, Swapnesh; Mathur, Deepak; Dharmadhikari, Aditya K.			Enhancing the Strength of an Optical Trap by Truncation	PLOS ONE			English	Article							RED-BLOOD-CELLS; TWEEZERS; SINGLE; STRESS; POWER	Optical traps (tweezers) are beginning to be used with increasing efficacy in diverse studies in the biological and biomedical sciences. We report here results of a systematic study aimed at enhancing the efficiency with which dielectric (transparent) materials can be optically trapped. Specifically, we investigate how truncation of the incident laser beam affects the strength of an optical trap in the presence of a circular aperture. Apertures of various sizes have been used by us to alter the beam radius, thereby changing the effective numerical aperture and intensity profile. We observe significant enhancement of the radial and axial trap stiffness when an aperture is used to truncate the beam compared to when no aperture was used, keeping incident laser power constant. Enhancement in trap stiffness persists even when the beam intensity profile is modulated. The possibility of applying truncation to multiple traps is explored; to this end a wire mesh is utilized to produce multiple trapping that also alters the effective numerical aperture. The use of a mesh leads to reduction in trap stiffness compared to the case when no wire mesh is used. Our findings lead to a simple-to-implement and inexpensive method of significantly enhancing optical trapping efficiency under a wide range of circumstances.	[Rodrigues, Vanessa R. M.; Mondal, Argha; Panigrahi, Swapnesh; Mathur, Deepak; Dharmadhikari, Aditya K.] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; [Dharmadhikari, Jayashree A.; Mathur, Deepak] Manipal Univ, Ctr Atom & Mol Phys, Manipal, Karnataka, India	Tata Institute of Fundamental Research (TIFR); Manipal Academy of Higher Education (MAHE)	Dharmadhikari, AK (corresponding author), Tata Inst Fundamental Res, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	aditya@tifr.res.in	Mondal, Argha/GRO-4485-2022; Mathur, Deepak/K-5000-2019	Mondal, Argha/0000-0003-3464-0615; Mathur, Deepak/0000-0002-2322-6331; Dague, Etienne/0000-0003-3290-9166	Department of Science and Technology	Department of Science and Technology(Department of Science & Technology (India))	Financial support from the Department of Science and Technology is acknowledged by JAD (Disha Women Scientists Scheme) and by DM (J C Bose National Fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; Bambardekar K, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3430732; Bambardekar K, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3037342; Bankapur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035075; Bankapur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010427; Barjas-Castro ML, 2002, TRANSFUSION, V42, P1196, DOI 10.1046/j.1537-2995.2002.00201.x; Basu H, 2011, BIOPHYS J, V101, P1604, DOI 10.1016/j.bpj.2011.08.043; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Bowman R, 2010, OPT EXPRESS, V18, P11785, DOI 10.1364/OE.18.011785; Brandao MM, 2009, CLIN HEMORHEOL MICRO, V43, P217, DOI 10.3233/CH-2009-1211; Brandao MM, 2003, EUR J HAEMATOL, V70, P207, DOI 10.1034/j.1600-0609.2003.00027.x; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; D'Souza JS, 2009, BIOCHEM BIOPH RES CO, V380, P266, DOI 10.1016/j.bbrc.2009.01.049; Dharmadhikari JA, 2007, CURR SCI INDIA, V93, P1265; Dharmadhikari JA, 2006, SENSOR ACTUAT B-CHEM, V115, P439, DOI 10.1016/j.snb.2005.10.006; Dharmadhikari JA, 2004, OPT EXPRESS, V12, P1179, DOI 10.1364/OPEX.12.001179; Dinu CZ, 2009, SOFT MATTER, V5, P3818, DOI 10.1039/b904639a; Fontes A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2870108; Ghosh A, 2006, PHYS BIOL, V3, P67, DOI 10.1088/1478-3975/3/1/007; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Henon S, 1999, BIOPHYS J, V76, P1145, DOI 10.1016/S0006-3495(99)77279-6; KIANG YC, 1983, APPL OPTICS, V22, P1296, DOI 10.1364/AO.22.001296; Kim HI, 2003, J KOREAN PHYS SOC, V43, P348; Kumari P, 2012, OPT EXPRESS, V20, P4645, DOI 10.1364/OE.20.004645; Ladiwala U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038613; Laliberte M, 2009, P SOC PHOTO-OPT INS, V7386; MAHAJAN VN, 1986, J OPT SOC AM A, V3, P470, DOI 10.1364/JOSAA.3.000470; Mahamdeh M, 2011, OPT EXPRESS, V19, P11759, DOI 10.1364/OE.19.011759; Mauritz JMA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3458919; Meng BH, 2008, CHINESE PHYS LETT, V25, P2300, DOI 10.1088/0256-307X/25/6/103; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Nascimento JM, 2008, J R SOC INTERFACE, V5, P297, DOI 10.1098/rsif.2007.1118; Nieminen TA, 2003, J QUANT SPECTROSC RA, V79, P1005, DOI 10.1016/S0022-4073(02)00335-7; Nieminen TA, 2007, J OPT A-PURE APPL OP, V9, pS196, DOI 10.1088/1464-4258/9/8/S12; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Pozzo LY, 2009, MICRON, V40, P617, DOI 10.1016/j.micron.2009.02.008; Roy S, 2005, CURR SCI INDIA, V89, P1563; Samadi A, 2010, OPT LETT, V35, P1494, DOI 10.1364/OL.35.001494; Sheetz M. P., 1998, METHODS CELL BIOL, V55; Wang Shi-Kang, 2006, Cardiovasc Eng, V6, P111, DOI 10.1007/s10558-006-9012-6; YURA HT, 1995, APPL OPTICS, V34, P6826, DOI 10.1364/AO.34.006826; Zachariah E, 2010, J PHOTOCH PHOTOBIO B, V100, P113, DOI 10.1016/j.jphotobiol.2010.05.009	42	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61310	10.1371/journal.pone.0061310	http://dx.doi.org/10.1371/journal.pone.0061310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593458	Green Submitted, gold, Green Published			2022-12-27	WOS:000317898000123
J	Ding, JL; Ponce-Coria, J; Delpire, E				Ding, Jinlong; Ponce-Coria, Jose; Delpire, Eric			A Trafficking-Deficient Mutant of KCC3 Reveals Dominant-Negative Effects on K-Cl Cotransport Function	PLOS ONE			English	Article							CATION-CHLORIDE COTRANSPORTERS; MOLECULAR PHYSIOLOGY; SENSORY NEUROPATHY; HEREDITARY MOTOR; CYSTIC-FIBROSIS; AGENESIS; EXPRESSION; TRANSPORT; HYPERTENSION; ACTIVATION	The K-Cl cotransporter (KCC) functions in maintaining chloride and volume homeostasis in a variety of cells. In the process of cloning the mouse KCC3 cDNA, we came across a cloning mutation (E289G) that rendered the cotransporter inactive in functional assays in Xenopus laevis oocytes. Through biochemical studies, we demonstrate that the mutant E289G cotransporter is glycosylation-deficient, does not move beyond the endoplasmic reticulum or the early Golgi, and thus fails to reach the plasma membrane. We establish through co-immunoprecipitation experiments that both wild-type and mutant KCC3 with KCC2 results in the formation of hetero-dimers. We further demonstrate that formation of these hetero-dimers prevents the proper trafficking of the cotransporter to the plasma membrane, resulting in a significant decrease in cotransporter function. This effect is due to interaction between the K-Cl cotransporter isoforms, as this was not observed when KCC3-E289G was co-expressed with NKCC1. Our studies also reveal that the glutamic acid residue is essential to K-Cl cotransporter function, as the corresponding mutation in KCC2 also leads to an absence of function. Interestingly, mutation of this conserved glutamic acid residue in the Na+-dependent cation-chloride cotransporters had no effect on NKCC1 function in isosmotic conditions, but diminished cotransporter activity under hypertonicity. Together, our data show that the glutamic acid residue (E289) is essential for proper trafficking and function of KCCs and that expression of a nonfunctional but full-length K-Cl cotransporter might results in dominant-negative effects on other K-Cl cotransporters.	[Ding, Jinlong; Ponce-Coria, Jose; Delpire, Eric] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Ding, Jinlong] Vanderbilt Univ, Sch Med, Mol Physiol & Biophys Grad Program, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Delpire, E (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA.	eric.delpire@vanderbilt.edu	Ponce-Coria, Jose/D-4866-2016	Ponce-Coria, Jose/0000-0002-3345-0206	National Institutes of Health [GM074771]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by National Institutes of Health, grant GM074771, to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adragna NC, 2004, ADV EXP MED BIOL, V559, P379; Belenky MA, 2010, NEUROSCIENCE, V165, P1519, DOI 10.1016/j.neuroscience.2009.11.040; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; Byun N, 2007, NEUROBIOL DIS, V28, P39, DOI 10.1016/j.nbd.2007.06.014; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Chen YF, 2010, AM J TRANSL RES, V2, P345; Crable SC, 2005, EXP HEMATOL, V33, P624, DOI 10.1016/j.exphem.2005.02.006; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 2011, J AM ASSOC LAB ANIM, V50, P46; Di Fulvio M, 2001, J BIOL CHEM, V276, P21046, DOI 10.1074/jbc.M100901200; FILTEAU MJ, 1991, ARCH NEUROL-CHICAGO, V48, P1275, DOI 10.1001/archneur.1991.00530240079027; Gagnon KB, 2013, AM J PHYSL IN PRESS; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; Gagnon KB, 2011, CELL PHYSIOL BIOCHEM, V28, P1219, DOI 10.1159/000335854; Gagnon KB, 2010, J PHYSIOL-LONDON, V588, P3385, DOI 10.1113/jphysiol.2010.191932; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P121, DOI 10.1159/000104160; Garzon-Muvdi T, 2007, AM J PHYSIOL-RENAL, V292, pF1197, DOI 10.1152/ajprenal.00335.2006; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; JENNINGS ML, 1991, J GEN PHYSIOL, V97, P799, DOI 10.1085/jgp.97.4.799; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Labrisseau A, 1984, CAN J NEUROL SCI, V11, P257; Lauf PK, 2006, EXP EYE RES, V82, P55, DOI 10.1016/j.exer.2005.05.002; LAUF PK, 1992, AM J PHYSIOL, V263, pC917, DOI 10.1152/ajpcell.1992.263.5.C917; Le Rouzic P, 2006, BRAIN RES, V1110, P39, DOI 10.1016/j.brainres.2006.06.055; Leduc-Nadeau A, 2007, AM J PHYSIOL-CELL PH, V292, pC1132, DOI 10.1152/ajpcell.00136.2006; Mercier-Zuber A, 2011, CURR OPIN NEPHROL HY, V20, P534, DOI 10.1097/MNH.0b013e3283484b06; Pacheco-Alvarez D, 2012, CELL PHYSIOL BIOCHEM, V29, P291, DOI 10.1159/000337610; Pacheco-Alvarez D, 2011, CELL PHYSIOL BIOCHEM, V28, P1123, DOI 10.1159/000335848; Payne JA, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P333; Pearson MM, 2001, NEUROSCIENCE, V103, P481, DOI 10.1016/S0306-4522(00)00567-4; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Rust MB, 2006, CIRC RES, V98, P549, DOI 10.1161/01.RES.0000204449.83861.22; Salin-Cantegrel A, 2011, J BIOL CHEM, V286, P28456, DOI 10.1074/jbc.M111.226894; Shekarabi M, 2012, J NEUROSCI, V32, P3865, DOI 10.1523/JNEUROSCI.3679-11.2012; Shekarabi M, 2011, BRAIN RES, V1374, P15, DOI 10.1016/j.brainres.2010.12.010; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61112	10.1371/journal.pone.0061112	http://dx.doi.org/10.1371/journal.pone.0061112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593405	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100076
J	Fairley, CK; Vodstrcil, LA; Huffam, S; Cummings, R; Chen, MY; Sze, JK; Fehler, G; Bradshaw, CS; Schmidt, T; Berzins, K; Hocking, JS				Fairley, Christopher K.; Vodstrcil, Lenka A.; Huffam, Sarah; Cummings, Rosey; Chen, Marcus Y.; Sze, Jun K.; Fehler, Glenda; Bradshaw, Catriona S.; Schmidt, Tina; Berzins, Karen; Hocking, Jane S.			Evaluation of Electronic Medical Record (EMR) at Large Urban Primary Care Sexual Health Centre	PLOS ONE			English	Article							PRODUCTIVITY; EFFICIENCY; PHYSICIANS; QUALITY; LESSONS; IMPACT	Objective: Despite substantial investment in Electronic Medical Record (EMR) systems there has been little research to evaluate them. Our aim was to evaluate changes in efficiency and quality of services after the introduction of a purpose built EMR system, and to assess its acceptability by the doctors, nurses and patients using it. Methods: We compared a nine month period before and after the introduction of an EMR system in a large sexual health service, audited a sample of records in both periods and undertook anonymous surveys of both staff and patients. Results: There were 9,752 doctor consultations (in 5,512 consulting hours) in the Paper Medical Record (PMR) period and 9,145 doctor consultations (in 5,176 consulting hours in the EMR period eligible for inclusion in the analysis. There were 5% more consultations per hour seen by doctors in the EMR period compared to the PMR period (rate ratio = 1.05; 95% confidence interval, 1.02, 1.08) after adjusting for type of consultation. The qualitative evaluation of 300 records for each period showed no difference in quality (P>0.17). A survey of clinicians demonstrated that doctors and nurses preferred the EMR system (P<0.01) and a patient survey in each period showed no difference in satisfaction of their care (97% for PMR, 95% for EMR, P = 0.61). Conclusion: The introduction of an integrated EMR improved efficiency while maintaining the quality of the patient record. The EMR was popular with staff and was not associated with a decline in patient satisfaction in the clinical care provided.	[Fairley, Christopher K.; Huffam, Sarah; Cummings, Rosey; Chen, Marcus Y.; Sze, Jun K.; Fehler, Glenda; Bradshaw, Catriona S.; Schmidt, Tina; Berzins, Karen] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Fairley, Christopher K.; Vodstrcil, Lenka A.; Chen, Marcus Y.; Bradshaw, Catriona S.] Univ Melbourne, Sch Populat Hlth, Sexual Hlth Unit, Melbourne, Vic, Australia; [Hocking, Jane S.] Univ Melbourne, Ctr Womens Hlth, Melbourne Sch Populat Hlth, Gender & Soc, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Fairley, CK (corresponding author), Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.	cfairley@unimelb.edu.au	Vodstrcil, Lenka/AAF-8722-2020; Hocking, Jane/AAD-5203-2021; Vodstrcil, Lenka/AAC-1896-2019	Vodstrcil, Lenka/0000-0003-3679-9195; Hocking, Jane/0000-0001-9329-8501; Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678				Bomba D., 2004, International Journal of Healthcare Technology and Management, V6, P83, DOI 10.1504/IJHTM.2004.004827; Callen Joanne L, 2005, Health Inf Manag, V34, P8, DOI 10.1177/183335830503400104; Cheriff AD, 2010, INT J MED INFORM, V79, P492, DOI 10.1016/j.ijmedinf.2010.04.006; Christensen T, 2009, INT J MED INFORM, V78, P808, DOI 10.1016/j.ijmedinf.2009.08.004; Fairley CK, 1997, JAMA-J AM MED ASSOC, V278, P117, DOI 10.1001/jama.278.2.117; Furukawa MF, 2011, AM J MANAG CARE, V17, P296; Gamm LD, 1998, J HEALTHC MANAG, V43, P51, DOI 10.1097/00115514-199801000-00009; Garrison GM, 2002, FAM MED, V34, P362; Gonzalez CM, 2008, UROLOGY, V71, P173, DOI 10.1016/j.urology.2007.09.024; Hamilton WT, 2003, BRIT J GEN PRACT, V53, P929; Hippisley-Cox J, 2003, BRIT MED J, V326, P1439, DOI 10.1136/bmj.326.7404.1439; Holroyd-Leduc JM, 2011, J AM MED INFORM ASSN, V18, P732, DOI 10.1136/amiajnl-2010-000019; Jones SS, 2012, NEW ENGL J MED, V366, P2243, DOI 10.1056/NEJMp1204980; Pearce C, 2009, AUST FAM PHYSICIAN, V38, P537; Poissant L, 2005, J AM MED INFORM ASSN, V12, P505, DOI 10.1197/jamia.M1700; Protti D, 2010, COMMONWEALTH FUND, V96, P1; Rouf E, 2007, J GEN INTERN MED, V22, P43, DOI 10.1007/s11606-007-0112-9; Schade CP, 2006, J AM MED INFORM ASSN, V13, P470, DOI 10.1197/jamia.M2041; Vodstrcil LA, 2011, PLOS MED, P6; White PJ, 2005, J INFECT DIS, V192, P824, DOI 10.1086/432004	20	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60636	10.1371/journal.pone.0060636	http://dx.doi.org/10.1371/journal.pone.0060636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RK	23593268	gold, Green Published			2022-12-27	WOS:000319108100060
J	Lin, HY; Amankwah, EK; Tseng, TS; Qu, XT; Chen, DT; Park, JY				Lin, Hui-Yi; Amankwah, Ernest K.; Tseng, Tung-Sung; Qu, Xiaotao; Chen, Dung-Tsa; Park, Jong Y.			SNP-SNP Interaction Network in Angiogenesis Genes Associated with Prostate Cancer Aggressiveness	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-FACTOR RECEPTOR; TUMOR ANGIOGENESIS; LOGISTIC-REGRESSION; PANCREATIC-CANCER; BREAST-CANCER; MATRIX METALLOPROTEINASES; ANDROGEN RECEPTOR; METABOLISM GENES; DOWN-REGULATION	Angiogenesis has been shown to be associated with prostate cancer development. The majority of prostate cancer studies focused on individual single nucleotide polymorphisms (SNPs) while SNP-SNP interactions are suggested having a great impact on unveiling the underlying mechanism of complex disease. Using 1,151 prostate cancer patients in the Cancer Genetic Markers of Susceptibility (CGEMS) dataset, 2,651 SNPs in the angiogenesis genes associated with prostate cancer aggressiveness were evaluated. SNP-SNP interactions were primarily assessed using the two-stage Random Forests plus Multivariate Adaptive Regression Splines (TRM) approach in the CGEMS group, and were then re-evaluated in the Moffitt group with 1,040 patients. For the identified gene pairs, cross-evaluation was applied to evaluate SNP interactions in both study groups. Five SNP-SNP interactions in three gene pairs (MMP16+ ROBO1, MMP16+ CSF1, and MMP16+ EGFR) were identified to be associated with aggressive prostate cancer in both groups. Three pairs of SNPs (rs1477908+ rs1387665, rs1467251+ rs7625555, and rs1824717+ rs7625555) were in MMP16 and ROBO1, one pair (rs2176771+ rs333970) in MMP16 and CSF1, and one pair (rs1401862+ rs6964705) in MMP16 and EGFR. The results suggest that MMP16 may play an important role in prostate cancer aggressiveness. By integrating our novel findings and available biomedical literature, a hypothetical gene interaction network was proposed. This network demonstrates that our identified SNP-SNP interactions are biologically relevant and shows that EGFR may be the hub for the interactions. The findings provide valuable information to identify genotype combinations at risk of developing aggressive prostate cancer and improve understanding on the genetic etiology of angiogenesis associated with prostate cancer aggressiveness.	[Lin, Hui-Yi; Chen, Dung-Tsa] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33612 USA; [Amankwah, Ernest K.; Park, Jong Y.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Tseng, Tung-Sung] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Qu, Xiaotao] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Lin, HY (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33612 USA.	Hui-Yi.Lin@moffitt.org; Jong.Park@moffitt.org	Tseng, Tung-Sung/AFL-4208-2022	Lin, Hui-Yi/0000-0002-3307-5549; Tseng, Tung-Sung/0000-0001-6266-9891	American Cancer Society [IRG-93-092-14]; National Cancer Institute [R01CA128813]; cancer prevention fellowship from the National Cancer Institute [R25T CA147832]; NATIONAL CANCER INSTITUTE [R01CA128813, R25CA147832, P30CA076292] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); cancer prevention fellowship from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the American Cancer Society (IRG-93-092-14, PI: WJP/HYL); and the National Cancer Institute (R01CA128813, PI: JYP). EKA is supported by a cancer prevention fellowship from the National Cancer Institute (R25T CA147832). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen Peter C, 2006, Arch Ital Urol Androl, V78, P152; Albig Allan R, 2005, Future Oncol, V1, P23, DOI 10.1517/14796694.1.1.23; Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254; Bedard PL, 2007, J CLIN ONCOL, V25, P3482, DOI 10.1200/JCO.2007.11.3670; Bonaccorsi L, 2007, J MOL ENDOCRINOL, V38, P51, DOI 10.1677/jme.1.02155; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Datta MW, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-9; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; Enjuanes A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019736; Espinosa I, 2011, AM J PATHOL, V179, P2100, DOI 10.1016/j.ajpath.2011.06.021; Faupel-Badger JM, 2008, CANCER CAUSE CONTROL, V19, P119, DOI 10.1007/s10552-007-9077-6; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Garcia-Magarinos M, 2009, ANN HUM GENET, V73, P360, DOI 10.1111/j.1469-1809.2009.00511.x; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hadchouel A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003188; Hanahan D, 1996, EUR J CANCER, V32A, P2386, DOI 10.1016/S0959-8049(96)00401-7; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hrouda D, 2003, UROL RES, V30, P347, DOI 10.1007/s00240-002-0287-9; Hua Lin, 2012, Genomics Proteomics & Bioinformatics, V10, P23, DOI 10.1016/S1672-0229(11)60030-2; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; Ioannidis JPA, 2010, JNCI-J NATL CANCER I, V102, P846, DOI 10.1093/jnci/djq173; Ito H, 2006, CLIN CANCER RES, V12, P3257, DOI 10.1158/1078-0432.CCR-05-2787; Jacobs EJ, 2008, CANCER EPIDEM BIOMAR, V17, P972, DOI 10.1158/1055-9965.EPI-07-2787; Jain L, 2009, MOL CANCER THER, V8, P2496, DOI 10.1158/1535-7163.MCT-09-0302; Jung M, 2003, PROSTATE, V55, P89, DOI 10.1002/pros.10194; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Leotoing L, 2007, J MOL ENDOCRINOL, V39, P151, DOI 10.1677/JME-07-0021; Li HQ, 2012, J AM MED INFORM ASSN, V19, P295, DOI 10.1136/amiajnl-2011-000482; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin F, 2011, J HUAZHONG U SCI-MED, V31, P509, DOI 10.1007/s11596-011-0481-5; Lin HY, 2008, J HUM GENET, V53, P802, DOI 10.1007/s10038-008-0313-z; Lin HY, 2008, EUR J HUM GENET, V16, P735, DOI 10.1038/sj.ejhg.5202010; Lin HY, 2012, ANN HUM GENET, V76, P53, DOI 10.1111/j.1469-1809.2011.00692.x; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Nam RK, 2011, CANCER BIOL THER, V12, P997, DOI 10.4161/cbt.12.11.18366; Nicholson B, 2004, J CELL BIOCHEM, V91, P125, DOI 10.1002/jcb.10772; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Penney KL, 2010, CANCER EPIDEM BIOMAR, V19, P2869, DOI 10.1158/1055-9965.EPI-10-0601; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Pyonteck SM, 2012, ONCOGENE, V31, P1459, DOI 10.1038/onc.2011.337; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Seki M, 2010, FEBS LETT, V584, P2909, DOI 10.1016/j.febslet.2010.05.009; Sfar S, 2006, CYTOKINE, V35, P21, DOI 10.1016/j.cyto.2006.07.003; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Van Emburgh BO, 2008, MOL CARCINOGEN, V47, P88, DOI 10.1002/mc.20365; Wang Y, 2011, COMPUT BIOL CHEM, V35, P151, DOI 10.1016/j.compbiolchem.2011.04.003; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wlazlinski A, 2007, PROSTATE, V67, P1770, DOI 10.1002/pros.20667; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	69	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59688	10.1371/journal.pone.0059688	http://dx.doi.org/10.1371/journal.pone.0059688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23593148	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100026
J	Desai, A; Marwah, VS; Yadav, A; Jha, V; Dhaygude, K; Bangar, U; Kulkarni, V; Jere, A				Desai, Aarti; Marwah, Veer Singh; Yadav, Akshay; Jha, Vineet; Dhaygude, Kishor; Bangar, Ujwala; Kulkarni, Vivek; Jere, Abhay			Identification of Optimum Sequencing Depth Especially for De Novo Genome Assembly of Small Genomes Using Next Generation Sequencing Data	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; ALGORITHMS; DISCOVERY; GENETICS	Next Generation Sequencing (NGS) is a disruptive technology that has found widespread acceptance in the life sciences research community. The high throughput and low cost of sequencing has encouraged researchers to undertake ambitious genomic projects, especially in de novo genome sequencing. Currently, NGS systems generate sequence data as short reads and de novo genome assembly using these short reads is computationally very intensive. Due to lower cost of sequencing and higher throughput, NGS systems now provide the ability to sequence genomes at high depth. However, currently no report is available highlighting the impact of high sequence depth on genome assembly using real data sets and multiple assembly algorithms. Recently, some studies have evaluated the impact of sequence coverage, error rate and average read length on genome assembly using multiple assembly algorithms, however, these evaluations were performed using simulated datasets. One limitation of using simulated datasets is that variables such as error rates, read length and coverage which are known to impact genome assembly are carefully controlled. Hence, this study was undertaken to identify the minimum depth of sequencing required for de novo assembly for different sized genomes using graph based assembly algorithms and real datasets. Illumina reads for E. coli (4.6 MB) S. kudriavzevii (11.18 MB) and C. elegans (100 MB) were assembled using SOAPdenovo, Velvet, ABySS, Meraculous and IDBA-UD. Our analysis shows that 50X is the optimum read depth for assembling these genomes using all assemblers except Meraculous which requires 100X read depth. Moreover, our analysis shows that de novo assembly from 50X read data requires only 6-40 GB RAM depending on the genome size and assembly algorithm used. We believe that this information can be extremely valuable for researchers in designing experiments and multiplexing which will enable optimum utilization of sequencing as well as analysis resources.	[Desai, Aarti; Marwah, Veer Singh; Yadav, Akshay; Jha, Vineet; Dhaygude, Kishor; Bangar, Ujwala; Kulkarni, Vivek; Jere, Abhay] Persistent Syst Ltd, Persistent LABS, Pune, Maharashtra, India		Jere, A (corresponding author), Persistent Syst Ltd, Persistent LABS, Pune, Maharashtra, India.	Abhay_jere@persistent.co.in		Dhaygude, Kishor/0000-0003-4499-6180; Marwah, Veer Singh/0000-0002-8272-0655				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chapman JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023501; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Dinh HQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041528; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Haiminen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024182; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Roedelsperger C, 2011, BIOINFORMATICS, V27, P829, DOI 10.1093/bioinformatics/btr022; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tantia MS, 2011, INDIAN J ANIM SCI, V81, P465; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang JK, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-144; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Yu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029450; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	43	53	54	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60204	10.1371/journal.pone.0060204	http://dx.doi.org/10.1371/journal.pone.0060204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593174	Green Submitted, Green Published, gold			2022-12-27	WOS:000317385300011
J	Hocking, KM; Baudenbacher, FJ; Putumbaka, G; Venkatraman, S; Cheung-Flynn, J; Brophy, CM; Komalavilas, P				Hocking, Kyle M.; Baudenbacher, Franz J.; Putumbaka, Gowthami; Venkatraman, Sneha; Cheung-Flynn, Joyce; Brophy, Colleen M.; Komalavilas, Padmini			Role of Cyclic Nucleotide-Dependent Actin Cytoskeletal Dynamics: [Ca2+](i) and Force Suppression in Forskolin-Pretreated Porcine Coronary Arteries	PLOS ONE			English	Article							SMOOTH-MUSCLE CONTRACTION; VASODILATOR-STIMULATED PHOSPHOPROTEIN; SHOCK-RELATED PROTEIN; SWINE CAROTID-ARTERY; CROSS-BRIDGE CYCLE; MYOSIN PHOSPHORYLATION; FOCAL ADHESION; TYROSINE PHOSPHORYLATION; KINASE PHOSPHORYLATION; INTRACELLULAR CALCIUM	Initiation of force generation during vascular smooth muscle contraction involves a rise in intracellular calcium ([Ca2+](i)) and phosphorylation of myosin light chains (MLC). However, reversal of these two processes alone does not account for the force inhibition that occurs during relaxation or inhibition of contraction, implicating that other mechanisms, such as actin cytoskeletal rearrangement, play a role in the suppression of force. In this study, we hypothesize that forskolin-induced force suppression is dependent upon changes in actin cytoskeletal dynamics. To focus on the actin cytoskeletal changes, a physiological model was developed in which forskolin treatment of intact porcine coronary arteries (PCA) prior to treatment with a contractile agonist resulted in complete suppression of force. Pretreatment of PCA with forskolin suppressed histamine-induced force generation but did not abolish [Ca2+](i) rise or MLC phosphorylation. Additionally, forskolin pretreatment reduced filamentous actin in histamine-treated tissues, and prevented histamine-induced changes in the phosphorylation of the actin-regulatory proteins HSP20, VASP, cofilin, and paxillin. Taken together, these results suggest that forskolin-induced complete force suppression is dependent upon the actin cytoskeletal regulation initiated by the phosphorylation changes of the actin regulatory proteins and not on the MLC dephosphorylation. This model of complete force suppression can be employed to further elucidate the mechanisms responsible for smooth muscle tone, and may offer cues to pathological situations, such as hypertension and vasospasm.	[Hocking, Kyle M.; Putumbaka, Gowthami; Venkatraman, Sneha; Cheung-Flynn, Joyce; Brophy, Colleen M.; Komalavilas, Padmini] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [Hocking, Kyle M.; Baudenbacher, Franz J.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Brophy, Colleen M.; Komalavilas, Padmini] VA Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Komalavilas, P (corresponding author), VA Tennessee Valley Healthcare Syst, Nashville, TN USA.	padmini.komalavilas@vanderbilt.edu	Venkatraman, Subramanian/A-2228-2011	Venkatraman, Subramanian/0000-0002-8693-1070; Hocking, Kyle/0000-0002-3603-7185	Department of Veterans Affairs; Veterans Health Administration; Biomedical Laboratory Research and Development Grant; United States National Institutes of Health grant [RO1HL70715]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070715] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Biomedical Laboratory Research and Development Grant; United States National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported, in part, by the Department of Veterans Affairs, Veterans Health Administration, Biomedical Laboratory Research and Development Grant and a United States National Institutes of Health grant RO1HL70715 to CM Brophy. This material is the result of work supported, in part, with resources and the use of facilities at the VA Tennessee Valley Healthcare System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER KB, 1983, CELL MOTIL CYTOSKEL, V3, P545, DOI 10.1002/cm.970030521; Ba M, 2009, CELL HEALTH CYTOSKEL, V1, P27; Barman SA, 2003, AM J PHYSIOL-LUNG C, V284, pL1004, DOI 10.1152/ajplung.00295.2002; Beall A, 1999, J BIOL CHEM, V274, P11344, DOI 10.1074/jbc.274.16.11344; Beall AC, 1997, J BIOL CHEM, V272, P11283; Birkenfeld J, 2003, BIOCHEM J, V369, P45, DOI 10.1042/BJ20021152; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chernik IS, 2007, MOL CELL BIOCHEM, V295, P9, DOI 10.1007/s11010-006-9266-8; Chitaley K, 2004, FEBS LETT, V556, P211, DOI 10.1016/S0014-5793(03)01435-2; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; Dreiza CM, 2004, FASEB J, V18, P261, DOI 10.1096/fj.04-2911fje; DRISKA SP, 1981, AM J PHYSIOL, V240, pC222, DOI 10.1152/ajpcell.1981.240.5.C222; FRANCIS SH, 1988, MOL PHARMACOL, V34, P506; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; GERTHOFFER WT, 1983, AM J PHYSIOL, V244, pC182, DOI 10.1152/ajpcell.1983.244.3.C182; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Komalavilas P, 1996, J BIOL CHEM, V271, P21933, DOI 10.1074/jbc.271.36.21933; Komalavilas P, 2001, J APPL PHYSIOL, V91, P1819, DOI 10.1152/jappl.2001.91.4.1819; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Lu Z, 2001, BIOPHYS J, V81, P334, DOI 10.1016/S0006-3495(01)75703-7; MCDANIEL NL, 1992, AM J PHYSIOL, V263, pC461, DOI 10.1152/ajpcell.1992.263.2.C461; Meeks MK, 2005, AM J PHYSIOL-CELL PH, V288, pC633, DOI 10.1152/ajpcell.00269.2004; Mehta D, 2000, AM J PHYSIOL-CELL PH, V279, pC308, DOI 10.1152/ajpcell.2000.279.2.C308; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Morgado M, 2012, CELL MOL LIFE SCI, V69, P247, DOI 10.1007/s00018-011-0815-2; MORGAN JP, 1982, PFLUG ARCH EUR J PHY, V395, P75, DOI 10.1007/BF00584972; Murphy RA, 2005, CAN J PHYSIOL PHARM, V83, P857, DOI 10.1139/Y05-090; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; PAVALKO FM, 1995, AM J PHYSIOL-CELL PH, V268, pC563, DOI 10.1152/ajpcell.1995.268.3.C563; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; RATZ PH, 1987, CIRC RES, V60, P410, DOI 10.1161/01.RES.60.3.410; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; REMBOLD CM, 1989, AM J PHYSIOL, V257, pC122, DOI 10.1152/ajpcell.1989.257.1.C122; REMBOLD CM, 1990, CIRC RES, V66, P1354, DOI 10.1161/01.RES.66.5.1354; Rembold CM, 2000, J PHYSIOL-LONDON, V524, P865, DOI 10.1111/j.1469-7793.2000.00865.x; Saito Shin-Ya, 1996, Journal of Smooth Muscle Research, V32, P51; Salinthone S, 2008, PHARMACOL THERAPEUT, V119, P44, DOI 10.1016/j.pharmthera.2008.04.005; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Shaw L, 2003, J VASC RES, V40, P1, DOI 10.1159/000068940; SINGER HA, 1986, AM J PHYSIOL, V251, pC465, DOI 10.1152/ajpcell.1986.251.3.C465; Somara S, 2010, AM J PHYSIOL-GASTR L, V299, pG1164, DOI 10.1152/ajpgi.00479.2009; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Woodrum DA, 1999, AM J PHYSIOL-HEART C, V277, pH931, DOI 10.1152/ajpheart.1999.277.3.H931	59	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60986	10.1371/journal.pone.0060986	http://dx.doi.org/10.1371/journal.pone.0060986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593369	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300040
J	Sexton, K; Tichauer, K; Samkoe, KS; Gunn, J; Hoopes, PJ; Pogue, BW				Sexton, Kristian; Tichauer, Kenneth; Samkoe, Kimberley S.; Gunn, Jason; Hoopes, P. Jack; Pogue, Brian W.			Fluorescent Affibody Peptide Penetration in Glioma Margin Is Superior to Full Antibody	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; BLOOD-BRAIN-BARRIER; INDUCED PROTOPORPHYRIN IX; 5-AMINOLEVULINIC ACID; FACTOR RECEPTOR; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMAS; IN-VIVO; GUIDED RESECTION; MODEL	Object: Fluorescence imaging has the potential to significantly improve neurosurgical resection of oncologic lesions through improved differentiation between normal and cancerous tissue at the tumor margins. In order to successfully mark glioma tissue a fluorescent tracer must have the ability to penetrate through the blood brain barrier (BBB) and provide delineation in the tumor periphery where heterogeneously intact BBB may exist. In this study it was hypothesized that, due to its smaller size, fluorescently labeled anti-EGFR Affibody protein (similar to 7 kDa) would provide a more clear delineation of the tumor margin than would fluorescently labeled cetuximab, a full antibody (similar to 150 kDa) to the epidermal growth factor receptor (EGFR). Methods: Cetuximab and anti-EGFR targeted Affibody were conjugated to two different fluorescent dyes (both emitting in the near-infrared) and injected intravenously into 6 athymic mice which were inoculated orthotopically with green fluorescent protein (GFP) expressing human U251 glioma cells. Each mouse was sacrificed at 1-h post injection, at which time brains were removed, snap frozen, sectioned and quantitatively analyzed for fluorescence distribution. Results: Ex vivo analysis showed on average, nearly equal concentrations of cetuximab and Affibody within the tumor (on average Affibody made up 49+/-6% of injected protein), however, the cetuximab was more confined to the center of the tumor with Affibody showing significantly higher concentrations at the tumor periphery (on average Affibody made up 72+/-15% of injected protein in the outer 50 um of the tumor). Further ex vivo analysis of detection studies showed that the Affibody provided superior discrimination for differentiation of tumor from surrounding normal brain. Conclusions: The present study indicates that fluorescently labeled anti-EGFR Affibody can provide significantly better delineation of tumor margins than a fluorescently labeled anti-EGFR antibody and shows considerable potential for guiding margin detection during neurosurgery.	[Sexton, Kristian; Tichauer, Kenneth; Gunn, Jason; Hoopes, P. Jack; Pogue, Brian W.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Samkoe, Kimberley S.; Hoopes, P. Jack; Pogue, Brian W.] Dartmouth Coll, Geisel Sch Med, Dept Surg, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Sexton, K (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	kristian.j.sexton.th@dartmouth.edu	Pogue, Brian/AAD-8114-2020	Pogue, Brian/0000-0002-9887-670X	National Institutes of Health [U54 CA151662, R01CA109558, RO1CA156177]; NATIONAL CANCER INSTITUTE [R01CA156177, U54CA151662, R01CA109558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by National Institutes of Health grants U54 CA151662, R01CA109558 and RO1CA156177 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; BOTTOMLEY SS, 1988, SEMIN HEMATOL, V25, P282; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; ELSHARABASY MMH, 1992, BRIT J CANCER, V65, P409, DOI 10.1038/bjc.1992.83; ENNIS BW, 1991, CANCER INVEST, V9, P553, DOI 10.3109/07357909109018953; Friedman M, 2008, J MOL BIOL, V376, P1388, DOI 10.1016/j.jmb.2007.12.060; Gerstner ER, 2007, J CLIN ONCOL, V25, P2306, DOI 10.1200/JCO.2006.10.0677; Gibbs-Strauss S, 2008, THESIS DARTMOUT COLL; Gibbs-Strauss SL, 2010, ACAD RADIOL, V17, P7, DOI 10.1016/j.acra.2009.07.027; Gibbs-Strauss SL, 2009, MED PHYS, V36, P974, DOI 10.1118/1.3075770; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; HANSEN DA, 1993, SURG NEUROL, V40, P451, DOI 10.1016/0090-3019(93)90046-4; Hefti M, 2010, CURR MED IMAGING, V6, P254, DOI 10.2174/157340510793205503; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Kim ES, 2001, CURR OPIN ONCOL, V13, P506, DOI 10.1097/00001622-200111000-00014; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Lammertsma AA, 1996, J CEREBR BLOOD F MET, V16, P42, DOI 10.1097/00004647-199601000-00005; Lampson LA, 2011, MABS-AUSTIN, V3, P153, DOI 10.4161/mabs.3.2.14239; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; McCabe KE, 2010, CANCER BIOTHER RADIO, V25, P253, DOI 10.1089/cbr.2010.0776; MOORE GE, 1948, J NEUROSURG, V5, P392, DOI 10.3171/jns.1948.5.4.0392; NARAMURA M, 1993, CANCER IMMUNOL IMMUN, V37, P343, DOI 10.1007/BF01518458; Nicholson C, 2001, REP PROG PHYS, V64, P815, DOI 10.1088/0034-4885/64/7/202; NIGROVIC V, 1993, BRIT J ANAESTH, V71, P908, DOI 10.1093/bja/71.6.908; NITTA T, 1995, CANCER-AM CANCER SOC, V75, P2727, DOI 10.1002/1097-0142(19950601)75:11<2727::AID-CNCR2820751115>3.0.CO;2-H; Nordberg E, 2007, NUCL MED BIOL, V34, P609, DOI 10.1016/j.nucmedbio.2007.05.010; Roberts DW, 2011, J NEUROSURG, V114, P595, DOI 10.3171/2010.2.JNS091322; ROSEN GD, 2000, INT MOUS GEN C; Samkoe KS, 2011, MOL IMAGING BIOL; Samkoe KS, 2011, DETERMINATION BLOOD; Samkoe KS, 2011, IMAGE CONTRAST FLUOR; Sanai N, 2011, J NEUROSURG, V115, P740, DOI 10.3171/2011.6.JNS11252; Schnell O, 2008, BRAIN PATHOL, V18, P378, DOI 10.1111/j.1750-3639.2008.00137.x; Shinoda J, 2003, J NEUROSURG, V99, P597, DOI 10.3171/jns.2003.99.3.0597; STEWART PA, 1987, J NEUROSURG, V67, P697, DOI 10.3171/jns.1987.67.5.0697; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 1998, J PHOTOCH PHOTOBIO B, V45, P160, DOI 10.1016/S1011-1344(98)00176-6; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; Stummer W, 2003, ACT NEUR S, V88, P9; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; Toda Masahiro, 2008, Keio Journal of Medicine, V57, P155; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tolmachev V, 2009, J NUCL MED, V50, P274, DOI 10.2967/jnumed.108.055525; Utsuki S, 2007, NEUROL MED-CHIR, V47, P210, DOI 10.2176/nmc.47.210; Valdes PA, 2011, J NEUROSURG, V115, P11, DOI 10.3171/2011.2.JNS101451; Valdes PA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00798; Valdes PA, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646916; Valdes PA, 2010, PHOTOCHEM PHOTOBIOL, V86, P471, DOI 10.1111/j.1751-1097.2009.00664.x; Vincenzi B, 2008, CRIT REV ONCOL HEMAT, V68, P93, DOI 10.1016/j.critrevonc.2008.07.006; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899	52	45	46	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60390	10.1371/journal.pone.0060390	http://dx.doi.org/10.1371/journal.pone.0060390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593208	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300016
J	Sueoka, E; Sueoka-Aragane, N; Sato, A; Ide, M; Nakamura, H; Sotomaru, Y; Taya, C; Yonekawa, H; Kitagawa, T; Kubota, Y; Kimura, S; Nakachi, K; Tanimoto, K				Sueoka, Eisaburo; Sueoka-Aragane, Naoko; Sato, Akemi; Ide, Masaru; Nakamura, Hideaki; Sotomaru, Yusuke; Taya, Choji; Yonekawa, Hiromichi; Kitagawa, Tomoyuki; Kubota, Yasushi; Kimura, Shinya; Nakachi, Kei; Tanimoto, Keiji			Development of Lymphoproliferative Diseases by Hypoxia Inducible Factor-1alpha Is Associated with Prolonged Lymphocyte Survival	PLOS ONE			English	Article							FACTOR 1-ALPHA; CELL CARCINOMA; STEM-CELLS; CANCER; OVEREXPRESSION; FACTOR-1-ALPHA; HIF-1-ALPHA; EXPRESSION; ALPHA; HIF-1	Hypoxia-inducible factor-1alpha (HIF-1 alpha) plays an essential role in the regulation of various genes associated with low oxygen consumption. Elevated expression of HIF-1alpha has been reported to be associated with tumor progression, invasion and metastasis in many cancers. To investigate the role of HIF-1alpha in tumor development and metastasis, we established transgenic mice constitutively expressing HIF1A gene under regulation of the cytomegalovirus gene promoter. Although HIF-1alpha protein levels varied among organs, expression of HIF1A mRNA in most organs gradually increased in an age-dependent manner. The transgenic mice showed no gross morphological abnormality up to 8 weeks after birth, although they subsequently developed tumors in the lymphoid, lung, and breast; the most prominent tumor was lymphoma appearing in the intestinal mucosa and intra-mesenchymal tissues. The prevalence of tumors reached 80% in 13 months after birth. The constitution of lymphocyte populations in the transgenic mice did not differ from that in wildtype mice. However, lymphocytes of the transgenic mice revealed prolonged survival under long-term culture conditions and revealed increased resistance to cytotoxic etoposide. These results suggest that HIF-1alpha itself is not oncogenic but it may play an important role in lymphomagenesis mediated through the prolonged survival of lymphocytes in this transgenic mouse model.	[Sueoka, Eisaburo; Sueoka-Aragane, Naoko; Sato, Akemi; Ide, Masaru; Kubota, Yasushi; Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Saga 840, Japan; [Nakamura, Hideaki; Tanimoto, Keiji] Hiroshima Univ, Dept Radiat Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Taya, Choji; Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Kitagawa, Tomoyuki] Canc Inst Hosp, Tokyo, Japan; [Nakachi, Kei] Radiat Effects Res Fdn, Hiroshima, Japan	Saga University; Hiroshima University; Hiroshima University; Tokyo Metropolitan Institute of Medical Science; Japanese Foundation for Cancer Research; Radiation Effects Research Foundation - Japan	Sueoka, E (corresponding author), Saga Univ, Fac Med, Dept Internal Med, Saga 840, Japan.	sueokae@cc.saga-u.ac.jp; ktanimo@hiroshima-u.ac.jp	Sotomaru, Yusuke/G-5508-2019; Keiji, Tanimoto/U-1839-2019	Keiji, Tanimoto/0000-0003-4912-4197	Ministry of Education, Science, Sports and Culture, Japan [23591393]; Grants-in-Aid for Scientific Research [25461425] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the following Grants-in Aid for Cancer Research: Special Cancer Research, from the Ministry of Education, Science, Sports and Culture, Japan (Grant No. 23591393). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold DM, 2001, CANCER RES, V61, P2911; Beasley NJP, 2002, CANCER RES, V62, P2493; Bertout JA, 2009, CANCER RES, V69, P3213, DOI 10.1158/0008-5472.CAN-08-4223; Birner P, 2000, CANCER RES, V60, P4693; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Bos R, 2003, ONCOGENE, V22, P8948, DOI 10.1038/sj.onc.1206995; Chen L, 2007, J BIOL CHEM, V282, P12707, DOI 10.1074/jbc.M700423200; Clifford SC, 2001, ADV CANCER RES, V82, P85, DOI 10.1016/S0065-230X(01)82003-0; Elson DA, 2000, CANCER RES, V60, P6189; Hisatomi T, 2011, BLOOD, V117, P3575, DOI 10.1182/blood-2010-02-270439; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Koukourakis MI, 2001, CANCER RES, V61, P1830; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Marzec M, 2011, ONCOGENE, V30, P1372, DOI 10.1038/onc.2010.505; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ravi R, 2000, GENE DEV, V14, P34; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Wiesener MS, 2001, CANCER RES, V61, P5215; Zhong H, 1999, CANCER RES, V59, P5830	31	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e57833	10.1371/journal.pone.0057833	http://dx.doi.org/10.1371/journal.pone.0057833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593116	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300003
J	Zhou, XJ; Cheng, FJ; Qi, YY; Zhao, YF; Hou, P; Zhu, L; Lv, JC; Zhang, H				Zhou, Xu-jie; Cheng, Fa-juan; Qi, Yuan-yuan; Zhao, Yan-feng; Hou, Ping; Zhu, Li; Lv, Ji-cheng; Zhang, Hong			FCGR2B and FCRLB Gene Polymorphisms Associated with IgA Nephropathy	PLOS ONE			English	Article							COPY NUMBER VARIATION; FC-GAMMA-RIIB; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; RECEPTOR-LIKE MOLECULES; HUMAN MESANGIAL CELLS; IMMUNE-COMPLEXES; RHEUMATOID-ARTHRITIS; GLYCOSYLATED IGA1; TISSUE-INJURY	Background: IgA nephropathy (IgAN) is a complex syndrome characterized by deposition of IgA and IgA containing immune complexes (ICs) composed of IgG and complement C3 proteins in the mesangial area of glomeruli. The low-affinity receptors for the Fc region of IgG (Fc gamma Rs) are involved in autoantibody/immune complex-induced organ injury as well as ICs clearance. The aim of the study was to associate multiple polymorphisms within FCGR gene locus with IgAN in a large Chinese cohort. Patients and Methods: 60 single nucleotide polymorphisms (SNPs) spanning a 400 kb range within FCGR gene locus were analyzed in 2100 DNA samples from patients with biopsy proven IgAN and healthy age- and sex-matched controls from the same population in Chinese. Results: Among the 60 SNPs investigated, 15 gene polymorphisms within FCGR gene locus (25%) were associated with susceptibility to IgAN. The most significantly associated SNPs within individual genes were FCGR2B rs12118043 (p = 8.74*10(-3), OR 0.76, 95% CI 0.62-0.93), and FCRLB rs4657093 (p = 2.28*10(-3), OR 0.77, 95% CI 0.65-0.91). Both conditional analysis and linkage disequilibrium analysis suggested they were independent signals associated with IgAN. Associations between FCGR2B rs12118043 and proteinuria (p = 3.65 x 10(-2)) as well as gross hematuria (p = 4.53 x 10(-2)), between FCRLB rs4657093 and levels of serum creatinine (p = 2.67 x 10(-2)) as well as eGFR (p = 5.41*10(-3)) were also observed. Electronic cis-expression quantative trait loci analysis supported their possible functional significance, with protective genotypes correlating lower gene expressions. Conclusion: Our data from genetic associations and expression associations revealed potentially pathogenic roles of Fc receptor gene polymorphisms in IgAN.	[Zhou, Xu-jie; Cheng, Fa-juan; Qi, Yuan-yuan; Zhao, Yan-feng; Hou, Ping; Zhu, Li; Lv, Ji-cheng; Zhang, Hong] Peking Univ, Minist Educ,Hosp 1,Renal Div, Key Lab Chron Kidney Dis Prevent & Treatment, Inst Nephrol,Key Lab Renal Dis,Minist Hlth China, Beijing 100871, Peoples R China	Peking University	Zhang, H (corresponding author), Peking Univ, Minist Educ,Hosp 1,Renal Div, Key Lab Chron Kidney Dis Prevent & Treatment, Inst Nephrol,Key Lab Renal Dis,Minist Hlth China, Beijing 100871, Peoples R China.	hongzh@bjmu.edu.cn	Zhou, Xu-jie/A-3740-2012	Zhou, Xu-jie/0000-0002-7215-707X	Major State Basic Research Development Program of China (973 program) [2012CB517700]; National Natural Science Foundation of China [81200524]; Research Fund of Beijing Municipal Science and Technology for the Outstanding PhD Program [20121000110]; Foundation of Ministry of Education of China [20120001120008]; Natural Science Fund of China to the Innovation Research Group [81021004]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of Beijing Municipal Science and Technology for the Outstanding PhD Program; Foundation of Ministry of Education of China(Ministry of Education, China); Natural Science Fund of China to the Innovation Research Group	This work was supported by grants from the Major State Basic Research Development Program of China (973 program, No. 2012CB517700), National Natural Science Foundation of China (No. 81200524), Research Fund of Beijing Municipal Science and Technology for the Outstanding PhD Program (20121000110), The Foundation of Ministry of Education of China (20120001120008), and Natural Science Fund of China to the Innovation Research Group (81021004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai UD, 2012, ARTHRITIS RHEUM-US, V64, P2451, DOI 10.1002/art.34457; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; Ehrhardt GRA, 2011, CURR TOP MICROBIOL, V350, P89, DOI 10.1007/82_2010_88; Espeli M, 2012, J EXP MED, V209, P2307, DOI 10.1084/jem.20121752; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Hashimoto A, 2012, AM J PATHOL, V181, P1338, DOI 10.1016/j.ajpath.2012.06.038; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; Hu XP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042439; Jancar S, 2005, TRENDS IMMUNOL, V26, P48, DOI 10.1016/j.it.2004.11.007; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040495; Kiryluk K, 2012, ANN REV MED; Lv JC, 2008, NEPHROLOGY, V13, P242, DOI 10.1111/j.1440-1797.2007.00898.x; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Masuda K, 2010, CELL IMMUNOL, V266, P24, DOI 10.1016/j.cellimm.2010.08.007; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; McKinney C, 2012, HUM MOL GENET, V21, P2370, DOI 10.1093/hmg/dds039; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Novak J, 2002, KIDNEY INT, V62, P465, DOI 10.1046/j.1523-1755.2002.00477.x; Novak J, 2011, NEPHROL DIAL TRANSPL, V26, P3451, DOI 10.1093/ndt/gfr448; Oortwijn BD, 2008, SEMIN NEPHROL, V28, P58, DOI 10.1016/j.semnephrol.2007.10.007; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Santiago T, 2011, INT IMMUNOL, V23, P43, DOI 10.1093/intimm/dxq456; Smith KGC, 2010, NAT REV IMMUNOL, V10, P674, DOI 10.1038/nri2762; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Tanaka Y, 2005, NEPHROL DIAL TRANSPL, V20, P2439, DOI 10.1093/ndt/gfi043; Thabet MM, 2007, ANN RHEUM DIS, V66, P803, DOI 10.1136/ard.2006.064949; Tissandie E, 2011, KIDNEY INT, V80, P1352, DOI 10.1038/ki.2011.276; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Xu G, 2007, J CLIN LAB ANAL, V21, P298, DOI 10.1002/jcla.20189; Zeng Z, 2012, CLIN RHEUMATOL, V31, P1449, DOI 10.1007/s10067-012-2028-y; Zhou XJ, 2011, LUPUS, V20, P1198, DOI 10.1177/0961203311409269; Zhou XJ, 2010, INT IMMUNOL, V22, P45, DOI 10.1093/intimm/dxp113	42	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61208	10.1371/journal.pone.0061208	http://dx.doi.org/10.1371/journal.pone.0061208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593433	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300061
J	Chen, H; Bukach, CM; Wong, ACN				Chen, Hui; Bukach, Cindy M.; Wong, Alan C-N			Early Electrophysiological Basis of Experience-Associated Holistic Processing of Chinese Characters	PLOS ONE			English	Article							HUMAN BRAIN; OBJECT; EXPERTISE; RECOGNITION; FACES; FMRI; ERP; SELECTIVITY; ADAPTATION; ACCOUNT	Recent studies have found holistic processing to be a marker of expertise for perception of words in alphabetic (e.g., English) and non-alphabetic (e.g., Chinese) writing systems, consistent with what has been found for faces and other objects of face-like expertise. It is unknown, however, whether holistic processing of words occurs in an early, perceptual stage as it does for faces. We examined how early holistic processing of Chinese characters emerges by recording the event-related potentials (ERPs) in an adaptation paradigm. Participants judged if the top parts of two sequentially presented characters were the same or different while ignoring the bottom part. An early potential (P1) at the posterior channels was smaller when the attended top parts were the same compared with when they are different, indicating an adaptation effect. Critically, for trials with identical top parts, P1 was larger when the irrelevant bottom parts were different, indicating a release of adaptation. This effect was present only when the two character parts were aligned but not misaligned, and only for characters but not for pseudocharacters. The finding of early sensitivity to all parts of a Chinese character suggests that Chinese characters are represented holistically at a perceptual level.	[Chen, Hui; Wong, Alan C-N] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Bukach, Cindy M.] Univ Richmond, Dept Psychol, Richmond, VA 23173 USA	Chinese University of Hong Kong; University of Richmond	Wong, ACN (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	alanwong@psy.cuhk.edu.hk	Wong, Alan C.-N./H-3414-2019	Wong, Alan C.-N./0000-0002-2129-3485	Department of Psychology at the Chinese University of Hong Kong	Department of Psychology at the Chinese University of Hong Kong	This work was supported by internal research funding from the Department of Psychology at the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Bilalic M, 2011, J NEUROSCI, V31, P10206, DOI 10.1523/JNEUROSCI.5727-10.2011; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Curran T, 2002, COGN AFFECT BEHAV NE, V2, P1, DOI 10.3758/CABN.2.1.1; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Fahle M, 2004, J VISION, V4, P879, DOI 10.1167/4.10.4; Farah M., 2004, VISUAL AGNOSIA, V2nd; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FARAH MJ, 1991, COGNITIVE NEUROPSYCH, V8, P1, DOI 10.1080/02643299108253364; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; Gore JC, 2006, MAGN RESON IMAGING, V24, P507, DOI 10.1016/j.mri.2005.12.039; Horovitz SG, 2004, NEUROIMAGE, V22, P1587, DOI 10.1016/j.neuroimage.2004.04.018; Iidaka T, 2006, BRAIN COGNITION, V60, P176, DOI 10.1016/j.bandc.2005.11.004; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jacques C, 2009, J VISION, V9, DOI 10.1167/9.6.8; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Kuefner D, 2010, BRAIN COGNITION, V74, P225, DOI 10.1016/j.bandc.2010.08.001; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Letourneau SM, 2008, BRAIN COGNITION, V67, P234, DOI 10.1016/j.bandc.2008.01.007; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Maurer U, 2008, J COGNITIVE NEUROSCI, V20, P1878, DOI 10.1162/jocn.2008.20125; Nazir TA, 2004, BRAIN LANG, V88, P294, DOI 10.1016/S0093-934X(03)00168-8; Rabovsky M, 2012, J COGNITIVE NEUROSCI, V24, P990, DOI 10.1162/jocn_a_00117; Rentzeperis I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00089; Richler JJ, 2008, J EXP PSYCHOL LEARN, V34, P1356, DOI 10.1037/a0013080; Richler JJ, 2011, PSYCHOL SCI, V22, P464, DOI 10.1177/0956797611401753; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Sawamura H, 2006, NEURON, V49, P307, DOI 10.1016/j.neuron.2005.11.028; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Schiltz C, 2010, J VISION, V10, DOI 10.1167/10.2.25; Scott LS, 2006, J COGNITIVE NEUROSCI, V18, P1453, DOI 10.1162/jocn.2006.18.9.1453; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Szwed M, 2011, NEUROIMAGE, V56, P330, DOI 10.1016/j.neuroimage.2011.01.073; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Wong ACN, 2005, COGN AFFECT BEHAV NE, V5, P306, DOI 10.3758/CABN.5.3.306; Wong ACN, 2012, J VISION, V12, DOI 10.1167/12.13.7; Wong ACN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020753; Wong ACN, 2009, PSYCHOL SCI, V20, P1108, DOI 10.1111/j.1467-9280.2009.02430.x; Wong ACN, 2009, COGN NEUROPSYCHOL, V26, P111, DOI 10.1080/02643290802340972; Wong YK, 2013, ROLE EARLY VISUAL CO	47	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61221	10.1371/journal.pone.0061221	http://dx.doi.org/10.1371/journal.pone.0061221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593436	gold, Green Published, Green Submitted			2022-12-27	WOS:000317383200046
J	Sansoni, V; Forcella, M; Mozzi, A; Fusi, P; Ambrosini, R; Ferini-Strambi, L; Combi, R				Sansoni, Veronica; Forcella, Matilde; Mozzi, Alessandra; Fusi, Paola; Ambrosini, Roberto; Ferini-Strambi, Luigi; Combi, Romina			Functional Characterization of a CRH Missense Mutation Identified in an ADNFLE Family	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; FRONTAL-LOBE EPILEPSY; SLEEP; RAT	Nocturnal frontal lobe epilepsy has been historically considered a channelopathy caused by mutations in subunits of the neuronal nicotinic acetylcholine receptor or in a recently reported potassium channel. However, these mutations account for only a minority of patients, and the existence of at least a new locus for the disease has been demonstrated. In 2005, we detected two nucleotide variations in the promoter of the CRH gene coding for the corticotropin releasing hormone in 7 patients. These variations cosegregated with the disease and were demonstrated to alter the cellular levels of this hormone. Here, we report the identification in an Italian affected family of a novel missense mutation (hpreproCRH p.Pro30Arg) located in the region of the CRH coding for the protein pro-sequence. The mutation was detected in heterozygosity in the two affected individuals. In vitro assays demonstrated that this mutation results in reduced levels of protein secretion in the short time thus suggesting that mutated people could present an altered capability to respond immediately to stress agents.	[Sansoni, Veronica; Combi, Romina] Univ Milano Bicocca, Dept Surg & Interdisciplinary Med, Monza, Italy; [Forcella, Matilde; Mozzi, Alessandra; Fusi, Paola; Ambrosini, Roberto] Univ Milano Bicocca, Dept Biotechnol & Biosci, Monza, Italy; [Ferini-Strambi, Luigi] Univ Vita & Salute San Raffaele, Sleep Disorders Ctr, Milan, Italy	University of Milano-Bicocca; University of Milano-Bicocca; Vita-Salute San Raffaele University	Combi, R (corresponding author), Univ Milano Bicocca, Dept Surg & Interdisciplinary Med, Monza, Italy.	romina.combi@unimib.it	Sansoni, Veronica/B-1375-2017; STRAMBI, Luigi FERINI/K-3620-2018; Mozzi, Alessandra/K-5645-2016; Ambrosini, Roberto/F-3188-2012; Mozzi, Alessandra/AAB-8608-2019; Combi, Romina/AAC-2944-2020	Sansoni, Veronica/0000-0003-0337-975X; STRAMBI, Luigi FERINI/0000-0003-2867-5424; Mozzi, Alessandra/0000-0003-3911-1042; Ambrosini, Roberto/0000-0002-7148-1468; Mozzi, Alessandra/0000-0003-3911-1042; Combi, Romina/0000-0003-1742-6078; FORCELLA, Matilde/0000-0002-9706-4654; Fusi, Paola/0000-0002-2746-1742	University of Milano-Bicocca, FA Grant Combi Romina [12-1-101]	University of Milano-Bicocca, FA Grant Combi Romina	This work was supported by the University of Milano-Bicocca (http://www.unimib.it/), FA Grant 2011 Combi Romina, grant number 12-1-101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Antonijevic IA, 1999, NEUROENDOCRINOLOGY, V69, P88, DOI 10.1159/000054406; Baram TZ, 1998, TRENDS NEUROSCI, V21, P471, DOI 10.1016/S0166-2236(98)01275-2; Brar B, 1997, J ENDOCRINOL, V154, P431, DOI 10.1677/joe.0.1540431; Buwalda B, 1997, PSYCHONEUROENDOCRINO, V22, P297, DOI 10.1016/S0306-4530(97)00032-2; Combi R, 2005, ANN NEUROL, V58, P899, DOI 10.1002/ana.20660; Combi R, 2004, J NEUROL, V251, P923, DOI 10.1007/s00415-004-0541-x; Combi R, 2008, J SLEEP RES, V17, P361, DOI 10.1111/j.1365-2869.2008.00674.x; CUMMINGS S, 1983, J NEUROSCI, V3, P1355; Ferini-Strambi L, 2012, NEUROLOGIST, V18, P343, DOI 10.1097/NRL.0b013e31826a99b8; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; KELLOGG J, 1989, CYTOGENET CELL GENET, V51, P1022; Manly BFJ, 1997, RANDOMIZATION BOOTST; R Core Team, 2012, R LANG ENV STAT COMP; Radulovic J, 1999, J NEUROSCI, V19, P5016; SCHEFFER IE, 1994, LANCET, V343, P515, DOI 10.1016/S0140-6736(94)91463-X; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; TERZANO MG, 1992, SLEEP, V15, P64	19	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61306	10.1371/journal.pone.0061306	http://dx.doi.org/10.1371/journal.pone.0061306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593457	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200050
J	Ocampo, CB; Caicedo, PA; Jaramillo, G; Bedoya, RU; Baron, O; Serrato, IM; Cooper, DM; Lowenberger, C				Ocampo, Clara B.; Caicedo, Paola A.; Jaramillo, Gloria; Bedoya, Raul Ursic; Baron, Olga; Serrato, Idalba M.; Cooper, Dawn M.; Lowenberger, Carl			Differential Expression of Apoptosis Related Genes in Selected Strains of Aedes aegypti with Different Susceptibilities to Dengue Virus	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; EQUINE ENCEPHALOMYELITIS VIRUS; QUANTITATIVE TRAIT LOCI; VECTOR COMPETENCE; RNA INTERFERENCE; INNATE IMMUNITY; DROSOPHILA-MELANOGASTER; ORAL INFECTION; CULICIDAE; DIPTERA	Aedes aegypti is the principal vector of Dengue viruses worldwide. We identified field collected insects with differential susceptibility to Dengue-2 virus (DENv-2) and used isofemale selection to establish susceptible and refractory strains based on midgut infection barriers. Previous experiments had identified higher expression of apoptosis-related genes in the refractory strain. To identify potential molecular mechanisms associated with DENv susceptibility, we evaluated the differential expression of Caspase-16, Aedronc, Aedredd, Inhibitor of apoptosis (AeIAP1) and one member of the RNAi pathway, Argonaute-2 in the midguts and fat body tissues of the selected strains at specific times post blood feeding or infection with DENv-2. In the refractory strain there was significantly increased expression of caspases in midgut and fatbody tissues in the presence of DENv-2, compared to exposure to blood alone, and significantly higher caspase expression in the refractory strain compared with the susceptible strain at timepoints when DENv was establishing in these tissues. We used RNAi to knockdown gene expression; knockdown of AeIAP1 was lethal to the insects. In the refractory strain, knockdown of the pro-apoptotic gene Aedronc increased the susceptibility of refractory insects to DENv-2 from 53% to 78% suggesting a contributing role of this gene in the innate immune response of the refractory strain.	[Ocampo, Clara B.; Caicedo, Paola A.; Jaramillo, Gloria; Baron, Olga; Serrato, Idalba M.] Ctr Int Entrenamiento & Invest Med CIDEIM, Cali, Colombia; [Bedoya, Raul Ursic; Cooper, Dawn M.; Lowenberger, Carl] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Bedoya, Raul Ursic] Tekmira Pharmaceut Corp, Burnaby, BC, Canada; [Baron, Olga] Univ Nice Sophia Antipolis, Nice, France; [Cooper, Dawn M.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; UDICE-French Research Universities; Universite Cote d'Azur; University of British Columbia	Lowenberger, C (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	clowenbe@sfu.ca	; Jaramillo, Gloria Isabel/HCH-3263-2022	Baron, Olga Lucia/0000-0003-0576-7211; CAICEDO, PAOLA A/0000-0002-4517-427X; Jaramillo, Gloria Isabel/0000-0002-7597-3873	COLCIENCIAS [2229_ 408-20409, 159-2008]; Royal Society of Tropical Medicine and Hygiene Centenary Scholarship [797-2009]; National Science and Engineering Council of Canada (NSERC) [261940]; Canadian Institutes of Health Research (CIHR) [69558]; Canada Research Chair Program; Michael Smith Foundation for Health Research Scholar Award; FOGARTY INTERNATIONAL CENTER [D43TW006589] Funding Source: NIH RePORTER	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Royal Society of Tropical Medicine and Hygiene Centenary Scholarship; National Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs); Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was funded in part by COLCIENCIAS contract 2229_ 408-20409 to CBO, the young investigators awards by COLCIENCIAS to Paola A. Caicedo (159-2008) and Idalba M. Serrato (797-2009), a Royal Society of Tropical Medicine and Hygiene Centenary Scholarship to Raul Ursic, and by grants to CL by National Science and Engineering Council of Canada (NSERC) (261940), the Canadian Institutes of Health Research (CIHR) (69558), and the Canada Research Chair Program and a Michael Smith Foundation for Health Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron OL, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.4101; Behura SK, 2012, INFECT GENET EVOL, V12, P1413, DOI 10.1016/j.meegid.2012.04.027; Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Bennett KE, 2005, GENETICS, V170, P185, DOI 10.1534/genetics.104.035634; Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; BERRY WJ, 1987, J MED ENTOMOL, V24, P286, DOI 10.1093/jmedent/24.3.286; Bosio CF, 2000, GENETICS, V156, P687; Bowers DF, 2003, J MED ENTOMOL, V40, P698, DOI 10.1603/0022-2585-40.5.698; Bryant B, 2008, INSECT BIOCHEM MOLEC, V38, P331, DOI 10.1016/j.ibmb.2007.11.012; Caicedo PA, 2012, CANADIAN EN IN PRESS; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Chauhan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047350; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49; Clarke TE, 2003, INT REV IMMUNOL, V22, P401, DOI 10.1080/08830180305215; Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189; Cooper DM, 2007, INSECT MOL BIOL, V16, P563, DOI 10.1111/j.1365-2583.2007.00758.x; Cooper DM, 2007, INSECT BIOCHEM MOLEC, V37, P559, DOI 10.1016/j.ibmb.2007.03.005; Cooper DM, 2009, INSECT BIOCHEM MOLEC, V39, P47, DOI 10.1016/j.ibmb.2008.09.011; Cooper DM, 2008, APOPTOSIS IMMUNITY C; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Girard YA, 2005, J MED ENTOMOL, V42, P429, DOI 10.1603/0022-2585(2005)042[0429:USOWNV]2.0.CO;2; Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45; Higgs S, 1996, BIOTECHNIQUES, V21, P660; Higgs S, 1997, MOL BIOL INSECT DIS; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Igaki T, 2002, J BIOL CHEM, V277, P23103, DOI 10.1074/jbc.C200222200; Impoinvil DE, 2007, HEALTH POLICY, V83, P196, DOI 10.1016/j.healthpol.2007.01.009; JAMES AA, 2007, J VIS EXP, V231; Lambrechts L, 2011, TRENDS PARASITOL; Lambrechts L, 2010, PLOS PATHOG, V6; Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li Q, 2007, INSECT MOL BIOL, V16, P93, DOI 10.1111/j.1365-2583.2007.00705.x; Liu B, 2011, CELL DEATH DIFFER, V18, P1337, DOI 10.1038/cdd.2011.8; Liu QZ, 2011, APOPTOSIS, V16, P105, DOI 10.1007/s10495-010-0558-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Lowenberger CA, 2001, ADV EXP MED BIOL, V484, P113; Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252; Mahmood F, 2004, J MED ENTOMOL, V41, P982, DOI 10.1603/0022-2585-41.5.982; Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Moncayo AC, 2004, EMERG INFECT DIS, V10, P1790, DOI 10.3201/eid1010.030846; Moncayo AC, 2000, J MED ENTOMOL, V37, P701, DOI 10.1603/0022-2585-37.5.701; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Ocampo Clara B., 2004, American Journal of Tropical Medicine and Hygiene, V71, P506; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Reiter P, 2010, EUROSURVEILLANCE, V15, P11; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider JR, 2011, INFECT GENET EVOL, V11, P11, DOI 10.1016/j.meegid.2010.10.019; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; TARDIEUX I, 1990, AM J TROP MED HYG, V43, P308, DOI 10.4269/ajtmh.1990.43.308; TARDIEUX I, 1991, J MED ENTOMOL, V28, P518, DOI 10.1093/jmedent/28.4.518; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; WALLIS GP, 1985, AM J TROP MED HYG, V34, P1225, DOI 10.4269/ajtmh.1985.34.1225; Wang H, 2008, J GEN VIROL, V89, P2651, DOI 10.1099/vir.0.2008/005314-0; Wang H, 2011, APOPTOSIS, V16, P235, DOI 10.1007/s10495-011-0575-3; Zhou L, 2005, EMBO REP, V6, P769, DOI 10.1038/sj.embor.7400473	87	49	50	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61187	10.1371/journal.pone.0061187	http://dx.doi.org/10.1371/journal.pone.0061187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593426	gold, Green Published, Green Submitted			2022-12-27	WOS:000317382000044
J	Warman, L; Bradford, MG; Moles, AT				Warman, Laura; Bradford, Matt G.; Moles, Angela T.			A Broad Approach to Abrupt Boundaries: Looking Beyond the Boundary at Soil Attributes within and Across Tropical Vegetation Types	PLOS ONE			English	Article							CENTRAL BRAZILIAN SAVANNAS; RAIN-FOREST BOUNDARY; NORTH QUEENSLAND; NORTHEASTERN QUEENSLAND; EUCALYPTUS SAVANNA; EASTERN AUSTRALIA; WET TROPICS; FIRE; DYNAMICS; NITROGEN	Most research on boundaries between vegetation types emphasizes the contrasts and similarities between conditions on either side of a boundary, but does not compare boundary to non-boundary vegetation. That is, most previous studies lack suitable controls, and may therefore overlook underlying aspects of landscape variability at a regional scale and underestimate the effects that the vegetation itself has on the soil. We compared 25 soil chemistry variables in rainforest, sclerophyll vegetation and across rainforest-sclerophyll boundaries in north-eastern Queensland, Australia. Like previous studies, we did find some contrasts in soil chemistry across vegetation boundaries. However we did not find greater variation in chemical parameters across boundary transects than in transects set in either rainforest or woodland. We also found that soil on both sides of the boundary is more similar to "rainforest soil'' than to "woodland soil''. Transects in wet sclerophyll forests with increasing degrees of rainforest invasion showed that as rainforest invades wet sclerophyll forest, the soil beneath wet sclerophyll forest becomes increasingly similar to rainforest soil. Our results have implications for understanding regional vegetation dynamics. Considering soil-vegetation feedbacks and the differences between soil at boundaries and in non-boundary sites may hold clues to some of the processes that occur across and between vegetation types in a wide range of ecosystems. Finally, we suggest that including appropriate controls should become standard practice for studies of vegetation boundaries and edge effects worldwide.	[Warman, Laura; Moles, Angela T.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Warman, Laura] US Forest Serv, Inst Pacific Isl Forestry, USDA, Hilo, HI USA; [Bradford, Matt G.] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Atherton, Qld, Australia	University of New South Wales Sydney; United States Department of Agriculture (USDA); United States Forest Service; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Warman, L (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	lwarman@fs.fed.us	Bradford, Matt G/D-3389-2011; Moles, Angela T/C-3083-2008; Warman, Laura/C-6651-2011	Moles, Angela T/0000-0003-2041-7762; Warman, Laura/0000-0001-7339-749X	UNSW Science Faculty grant; UIPA scholarship	UNSW Science Faculty grant; UIPA scholarship	This study was funded by a UNSW Science Faculty grant awarded to A. Moles and L. Warman and by a UIPA scholarship awarded to L. Warman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1992, AUSTR RAINFORESTS; Amorim PK, 2007, ACTA OECOL, V32, P319, DOI 10.1016/j.actao.2007.06.003; ASH J, 1988, J BIOGEOGR, V15, P619, DOI 10.2307/2845440; Baldock JA, 1999, SOIL ANAL INTERPRETA; Baltar F, 2010, ISME J, V4, P975, DOI 10.1038/ismej.2010.33; Blamey FPC, 1999, PLANTS ACTION ADAPTA, P537; Bond WJ, 2010, PLANT SOIL, V334, P47, DOI 10.1007/s11104-010-0440-0; Bowman D.M., 2000, AUSTR RAINFORESTS IS; BOWMAN DMJS, 1993, J ECOL, V81, P297, DOI 10.2307/2261499; Bowman DMJS, 2002, AUSTRAL ECOL, V27, P94, DOI 10.1046/j.1442-9993.2002.01158.x; BOWMAN DMJS, 1992, AUST J BOT, V40, P89, DOI 10.1071/BT9920089; Dick DA, 2007, WETLANDS, V27, P951, DOI 10.1672/0277-5212(2007)27[951:SHADOS]2.0.CO;2; Duff GA, 1987, THESIS J COOK U N QU; Fernando DR, 2009, ANN BOT-LONDON, V103, P931, DOI 10.1093/aob/mcp013; Furley P. A., 1992, NATURE DYNAMICS FORE; Furley P, 2010, PROG PHYS GEOG, V34, P563, DOI 10.1177/0309133310364934; Groves R.H., 1994, AUSTR VEGETATION; Harrington G. N., 1994, Pacific Conservation Biology, V1, P319; HARRINGTON GN, 2005, WET SCLEROPHYLL ADJA; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Herbohn JL, 1998, J TROP ECOL, V14, P217, DOI 10.1017/S0266467498000170; Hilbert DW, 2007, PALAEOGEOGR PALAEOCL, V251, P104, DOI 10.1016/j.palaeo.2007.02.020; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hoffmann WA, 2003, FUNCT ECOL, V17, P720, DOI 10.1111/j.1365-2435.2003.00796.x; Hoffmann WA, 2009, ECOLOGY, V90, P1326, DOI 10.1890/08-0741.1; Hofgaard A, 2013, J BIOGEOGRA IN PRESS; HOLT JA, 1986, J APPL ECOL, V23, P227, DOI 10.2307/2403093; Hopkins MS, 1996, J BIOGEOGR, V23, P737, DOI 10.1111/j.1365-2699.1996.tb00035.x; Ibanez T, 2013, AUSTR ECOLO IN PRESS; Kamprath EJ, 1972, SOIL ACIDITY LIMING; Kirchhof G, 2008, SOIL USE MANAGE, V24, P331, DOI 10.1111/j.1475-2743.2008.00160.x; Little D, 2003, ADV REGOLITH, P275; Little JK, 2012, AUSTRAL ECOL, V37, P915, DOI 10.1111/j.1442-9993.2011.02350.x; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Menaut J.-C., 1993, V13, P215; Moody PW, 2007, AUST J SOIL RES, V45, P55, DOI 10.1071/SR06056; Murphy BP, 2012, ECOL LETT, V15, P748, DOI 10.1111/j.1461-0248.2012.01771.x; Paul M, 2010, FOREST ECOL MANAG, V259, P2083, DOI 10.1016/j.foreco.2010.02.019; PLOWMAN KP, 1979, AUST J ECOL, V4, P87, DOI 10.1111/j.1442-9993.1979.tb01200.x; PUYRAVAUD JP, 1994, J BIOGEOGR, V21, P581, DOI 10.2307/2846033; R Core Team, 2020, R LANG ENV STAT COMP; Read J, 2006, J BIOGEOGR, V33, P1055, DOI 10.1111/j.1365-2699.2006.01470.x; Ruggiero PGC, 2002, PLANT ECOL, V160, P1, DOI 10.1023/A:1015819219386; Schwartz D, 1996, OECOLOGIA, V106, P516, DOI 10.1007/BF00329710; Silva LCR, 2008, GLOBAL CHANGE BIOL, V14, P2108, DOI 10.1111/j.1365-2486.2008.01637.x; Silva LCR, 2010, PLANT SOIL, V333, P431, DOI 10.1007/s11104-010-0358-6; SWAINE MD, 1992, J VEG SCI, V3, P365, DOI 10.2307/3235762; Tng DYP, 2012, ECOL EVOL, V2, P34, DOI 10.1002/ece3.70; Turnbull MH, 1999, PLANTS ACTION ADAPTA, P529; Turner J, 2008, FOREST ECOL MANAG, V256, P1133, DOI 10.1016/j.foreco.2008.06.021; TURTON SM, 1992, AUST J ECOL, V17, P415, DOI 10.1111/j.1442-9993.1992.tb00824.x; Turton SM, 1996, AUST J ECOL, V21, P245, DOI 10.1111/j.1442-9993.1996.tb00606.x; UNWIN GL, 1989, AUST J BOT, V37, P413, DOI 10.1071/BT9890413; Unwin GL, 1983, THESIS J COOK U TOWN; Warman L, 2009, LANDSCAPE ECOL, V24, P1, DOI 10.1007/s10980-008-9285-9; WEBB L. J., 1954, AUSTRALIAN JOUR BOT, V2, P176, DOI 10.1071/BT9540176; WEBB LJ, 1969, J ECOL, V57, P817, DOI 10.2307/2258502	57	22	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60789	10.1371/journal.pone.0060789	http://dx.doi.org/10.1371/journal.pone.0060789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593312	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000026
J	Mourtada, R; Fonseca, SB; Wisnovsky, SP; Pereira, MP; Wang, XM; Hurren, R; Parfitt, J; Larsen, L; Smith, RAJ; Murphy, MP; Schimmer, AD; Kelley, SO				Mourtada, Rida; Fonseca, Sonali B.; Wisnovsky, Simon P.; Pereira, Mark P.; Wang, Xiaoming; Hurren, Rose; Parfitt, Jeremy; Larsen, Lesley; Smith, Robin A. J.; Murphy, Michael P.; Schimmer, Aaron D.; Kelley, Shana O.			Re-Directing an Alkylating Agent to Mitochondria Alters Drug Target and Cell Death Mechanism	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NITROGEN-MUSTARD; IN-VIVO; PENETRATING PEPTIDES; CHLORAMBUCIL; RESISTANCE; METABOLISM; APOPTOSIS; PHARMACOKINETICS; INDUCTION	We have successfully delivered a reactive alkylating agent, chlorambucil (Cbl), to the mitochondria of mammalian cells. Here, we characterize the mechanism of cell death for mitochondria-targeted chlorambucil (mt-Cbl) in vitro and assess its efficacy in a xenograft mouse model of leukemia. Using a rho degrees cell model, we show that mt-Cbl toxicity is not dependent on mitochondrial DNA damage. We also illustrate that re-targeting Cbl to mitochondria results in a shift in the cell death mechanism from apoptosis to necrosis, and that this behavior is a general feature of mitochondria-targeted Cbl. Despite the change in cell death mechanisms, we show that mt-Cbl is still effective in vivo and has an improved pharmacokinetic profile compared to the parent drug. These findings illustrate that mitochondrial rerouting changes the site of action of Cbl and also alters the cell death mechanism drastically without compromising in vivo efficacy. Thus, mitochondrial delivery allows the exploitation of Cbl as a promiscuous mitochondrial protein inhibitor with promising therapeutic potential.	[Mourtada, Rida; Fonseca, Sonali B.; Kelley, Shana O.] Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada; [Wisnovsky, Simon P.; Pereira, Mark P.; Kelley, Shana O.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON, Canada; [Wang, Xiaoming; Hurren, Rose; Schimmer, Aaron D.] Princess Margaret Hosp, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M4X 1K9, Canada; [Parfitt, Jeremy] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Larsen, Lesley; Smith, Robin A. J.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge, England	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Western University (University of Western Ontario); University of Otago	Kelley, SO (corresponding author), Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada.	shana.kelley@utoronto.ca	Kelley, Shana/ABA-7403-2021; Kelley, Shana/H-5856-2015; Murphy, Michael P/C-2120-2009	Kelley, Shana/0000-0003-3360-5359; Murphy, Michael P/0000-0003-1115-9618; Schimmer, Aaron/0000-0003-4023-3899	Canadian Institute of Health; Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21) at CIHR; NATIONAL CANCER INSTITUTE [R01CA157456] Funding Source: NIH RePORTER; Medical Research Council [MC_U105663142] Funding Source: researchfish; MRC [MC_U105663142] Funding Source: UKRI	Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21) at CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to acknowledge the Canadian Institute of Health for the support of this work with an Operating Grant and a Proof of Principle I grant, and also acknowledge The Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21) at CIHR for their fellowship support of Rida Mourtada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS DS, 1979, CANCER TREAT REV, V6, P9, DOI 10.1016/S0305-7372(79)80005-5; Amantana A, 2007, BIOCONJUGATE CHEM, V18, P1325, DOI 10.1021/bc070060v; ANSLOW WP, 1948, J PHARMACOL EXP THER, V93, P1; Begleiter A, 1996, LEUKEMIA LYMPHOMA, V23, P187, DOI 10.3109/10428199609054821; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; BROOKES P, 1961, BIOCHEM J, V80, P496, DOI 10.1042/bj0800496; Carreon JR, 2007, BIOORG MED CHEM LETT, V17, P5182, DOI 10.1016/j.bmcl.2007.06.097; CHEN W, 1989, LEUKEMIA, V3, P264; Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002; Fonseca SB, 2011, CHEM BIOL, V18, P445, DOI 10.1016/j.chembiol.2011.02.010; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Ganguly S, 2008, OLIGONUCLEOTIDES, V18, P277, DOI 10.1089/oli.2008.0140; GILMAN A, 1963, AM J SURG, V105, P574, DOI 10.1016/0002-9610(63)90232-0; Guidicelli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005493; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Hu X, 2008, CANCER LETT, V259, P127, DOI 10.1016/j.canlet.2007.11.007; King D, 1998, LEUKEMIA, V12, P1553, DOI 10.1038/sj.leu.2401153; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kiziltepe T, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.10; Krumbhaar EB, 1919, J MED RES, V40, P497; MASTA A, 1995, NUCLEIC ACIDS RES, V23, P3508, DOI 10.1093/nar/23.17.3508; MONTSERRAT E, 1993, BLOOD REV, V7, P164, DOI 10.1016/0268-960X(93)90003-M; Naito M, 2004, CANCER SCI, V95, P361, DOI 10.1111/j.1349-7006.2004.tb03216.x; Neidle S, 2005, NAT REV CANCER, V5, P285, DOI 10.1038/nrc1587; OCONNOR PM, 1993, J BIOL CHEM, V268, P8298; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; Ross WCJ., 1962, BIOL ALKYLATING AGEN; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Smith RA, 2011, ANTIOXID REDOX SIGNA; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; Veerman G, 1996, CANCER CHEMOTH PHARM, V38, P335, DOI 10.1007/s002800050492; Yousif LF, 2009, CHEMBIOCHEM, V10, P2081, DOI 10.1002/cbic.200900017	34	31	32	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60253	10.1371/journal.pone.0060253	http://dx.doi.org/10.1371/journal.pone.0060253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585833	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600016
J	Bennett, MR; Farnell, L; Gibson, WG				Bennett, Max R.; Farnell, Les; Gibson, William G.			Fiber Pathway Pathology, Synapse Loss and Decline of Cortical Function in Schizophrenia	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; MAGNETIC-RESONANCE-SPECTROSCOPY; POSITRON-EMISSION-TOMOGRAPHY; ABNORMAL GLUCOSE-METABOLISM; WHITE-MATTER ABNORMALITIES; M2 MUSCARINIC RECEPTOR; BASAL FOREBRAIN; PREFRONTAL CORTEX; NUCLEUS BASALIS; WORKING-MEMORY	A quantitative cortical model is developed, based on both computational and simulation approaches, which relates measured changes in cortical activity of gray matter with changes in the integrity of longitudinal fiber pathways. The model consists of modules of up to 5,000 neurons each, 80% excitatory and 20% inhibitory, with these having different degrees of synaptic connectiveness both within a module as well as between modules. It is shown that if the inter-modular synaptic connections are reduced to zero while maintaining the intra-modular synaptic connections constant, then activity in the modules is reduced by about 50%. This agrees with experimental observations in which cortical electrical activity in a region of interest, measured using the rate of oxidative glucose metabolism (CMRglc(ox)), is reduced by about 50% when the cortical region is isolated, either by surgical means or by transient cold block. There is also a 50% decrease in measured cortical activity following inactivation of the nucleus of Meynert and the intra-laminar nuclei of the thalamus, which arise either following appropriate lesions or in sleep. This occurs in the model if the inter-modular synaptic connections require input from these nuclei in order to function. In schizophrenia there is a 24% decrease in functional anisotropy of longitudinal fasciculi accompanied by a 7% decrease in cortical activity (CMRglc(ox)). The cortical model predicts this, namely for a 24% decrease in the functioning of the inter-modular connections, either through the complete loss of 24% of axons subserving the connections or due to such a decrease in the efficacy of all the inter-modular connections, there will be about a 7% decrease in the activity of the modules. This work suggests that deterioration of longitudinal fasciculi in schizophrenia explains the loss of activity in the gray matter.	[Bennett, Max R.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Bennett, Max R.; Farnell, Les; Gibson, William G.] Univ Sydney, Ctr Math Biol, Sydney, NSW 2006, Australia; [Farnell, Les; Gibson, William G.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Bennett, MR (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	max.bennett@sydney.edu.au			Australian Research Council; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funders: Australian Research Council; National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LC, 2011, DYNAMIC BRAIN; Abbott LF, 2011, DYNAMIC BRAIN EXPLOR, P65; AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Alkire MT, 1999, ANESTHESIOLOGY, V90, P701, DOI 10.1097/00000542-199903000-00011; AlMousawi AH, 1996, BRIT J PSYCHIAT, V169, P509, DOI 10.1192/bjp.169.4.509; Amit DJ, 1997, NETWORK-COMP NEURAL, V8, P373, DOI 10.1088/0954-898X/8/4/003; BARONE FC, 1981, BRAIN RES BULL, V7, P75, DOI 10.1016/0361-9230(81)90101-5; BATINI C, 1958, SCIENCE, V128, P30, DOI 10.1126/science.128.3314.30-a; Bennett M R, 1972, Monogr Physiol Soc, P1; Bennett MR, 2011, PROG NEUROBIOL, V95, P275, DOI 10.1016/j.pneurobio.2011.08.003; BIVER F, 1995, PSYCHIAT RES-NEUROIM, V61, P161, DOI 10.1016/0925-4927(95)02672-K; Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197; Bozoki AC, 2012, HUM BRAIN MAPP, V33, P1792, DOI 10.1002/hbm.21320; Buchsbaum MS, 1998, NEUROREPORT, V9, P425, DOI 10.1097/00001756-199802160-00013; BUCHSBAUM MS, 1982, ARCH GEN PSYCHIAT, V39, P251; Buchsbaum MS, 1996, AM J PSYCHIAT, V153, P191; BUCHSBAUM MS, 1989, LIFE SCI, V45, P1349, DOI 10.1016/0024-3205(89)90021-0; BUCZEK M, 1991, J CEREBR BLOOD F MET, V11, P845, DOI 10.1038/jcbfm.1991.144; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Cai D, 2005, P NATL ACAD SCI USA, V102, P5868, DOI 10.1073/pnas.0501913102; Cape EG, 2000, EUR J NEUROSCI, V12, P2166, DOI 10.1046/j.1460-9568.2000.00099.x; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; CAVAZZUTI M, 1987, J CEREBR BLOOD F MET, V7, P806, DOI 10.1038/jcbfm.1987.138; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Chen W, 2001, MAGN RESON MED, V45, P349, DOI 10.1002/1522-2594(200103)45:3<349::AID-MRM1045>3.0.CO;2-8; Chhina N, 2001, J NEUROSCI RES, V66, P737, DOI 10.1002/jnr.10053; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; COLLE LM, 1986, BRAIN RES, V397, P27, DOI 10.1016/0006-8993(86)91366-1; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; CROSBY G, 1984, ANESTHESIOLOGY, V61, P434, DOI 10.1097/00000542-198410000-00012; CROSBY G, 1982, ANESTHESIOLOGY, V56, P437, DOI 10.1097/00000542-198206000-00005; da Silva CG, 2002, BBA-MOL BASIS DIS, V1586, P81, DOI 10.1016/S0925-4439(01)00088-6; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; DELISI LE, 1985, J CEREBR BLOOD F MET, V5, P201, DOI 10.1038/jcbfm.1985.26; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Dringenberg HC, 2003, NEUROSCIENCE, V119, P839, DOI 10.1016/S0306-4522(03)00197-0; Eintrei C, 1999, BRIT J ANAESTH, V82, P596, DOI 10.1093/bja/82.4.596; FARKAS T, 1984, ARCH GEN PSYCHIAT, V41, P293; Federspiel A, 2006, NEUROBIOL DIS, V22, P702, DOI 10.1016/j.nbd.2006.01.015; Fisher E, 2007, ANN NEUROL, V62, P219, DOI 10.1002/ana.21113; Ford JM, 2001, AM J PSYCHIAT, V158, P2069, DOI 10.1176/appi.ajp.158.12.2069; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Fujimoto T, 2007, PSYCHIAT RES-NEUROIM, V154, P49, DOI 10.1016/j.pscychresns.2006.04.002; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; GAYKEMA RPA, 1990, J COMP NEUROL, V293, P103, DOI 10.1002/cne.902930109; Gerstner W, 2002, SPIKING NEURON MODEL; Giuditta M, 2003, BLOOD PRESSURE, V12, P175, DOI 10.1080/08037050310010912; GJEDDE A, 1980, J NEUROCHEM, V35, P1382, DOI 10.1111/j.1471-4159.1980.tb09013.x; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Gruetter R, 2002, NEUROCHEM INT, V41, P143, DOI 10.1016/S0197-0186(02)00034-7; Gruetter R, 2001, AM J PHYSIOL-ENDOC M, V281, pE100, DOI 10.1152/ajpendo.2001.281.1.E100; GUR RE, 1987, ARCH GEN PSYCHIAT, V44, P126; Hamano K, 1996, DEV BRAIN RES, V93, P18, DOI 10.1016/0165-3806(96)00025-9; Hao YH, 2006, NEUROREPORT, V17, P23, DOI 10.1097/01.wnr.0000195664.15090.46; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hayashi T, 1999, NEUROREPORT, V10, P2113, DOI 10.1097/00001756-199907130-00022; Hazlett EA, 2004, AM J PSYCHIAT, V161, P305, DOI 10.1176/appi.ajp.161.2.305; HEISS WD, 1985, BRAIN RES, V327, P362, DOI 10.1016/0006-8993(85)91537-9; Hobson JA, 2000, BEHAV BRAIN SCI, V23, P793, DOI 10.1017/S0140525X00003976; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Hyder F, 2013, P NATL ACAD SCI USA, V110, P3549, DOI 10.1073/pnas.1214912110; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017; Kaur S, 2008, J NEUROSCI, V28, P491, DOI 10.1523/JNEUROSCI.1585-07.2008; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kircher TTJ, 2001, ARCH GEN PSYCHIAT, V58, P769, DOI 10.1001/archpsyc.58.8.769; Kitamura H, 2005, EUR ARCH PSY CLIN N, V255, P313, DOI 10.1007/s00406-005-0564-z; KIYOSAWA M, 1989, BRAIN, V112, P435, DOI 10.1093/brain/112.2.435; KLING AS, 1986, AM J PSYCHIAT, V143, P175; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; Koch G, 2008, BIOL PSYCHIAT, V64, P815, DOI 10.1016/j.biopsych.2008.05.026; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; Kumra S, 2004, BIOL PSYCHIAT, V55, P1138, DOI 10.1016/j.biopsych.2004.02.025; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Lee MG, 2004, J NEUROPHYSIOL, V92, P1182, DOI 10.1152/jn.01003.2003; Lim KO, 1999, ARCH GEN PSYCHIAT, V56, P367, DOI 10.1001/archpsyc.56.4.367; Livingston MG, 1998, ACTA PSYCHIAT SCAND, V97, P440, DOI 10.1111/j.1600-0447.1998.tb10029.x; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; LONDON ED, 1984, J CEREBR BLOOD F MET, V4, P381, DOI 10.1038/jcbfm.1984.56; Mason GF, 2007, J NEUROCHEM, V100, P73, DOI 10.1111/j.1471-4159.2006.04200.x; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2010, COGN NEUROSCI-UK, V1, P176, DOI 10.1080/17588921003731578; Mesulam M-M, 1995, PSYCHOPHARMACOLOGY 4; METHERATE R, 1987, NEUROSCIENCE, V22, P75, DOI 10.1016/0306-4522(87)90198-9; Minami T, 2003, NEUROPSYCHOBIOLOGY, V47, P141, DOI 10.1159/000070583; MRZLJAK L, 1995, J COMP NEUROL, V357, P603; MRZLJAK L, 1993, P NATL ACAD SCI USA, V90, P5194, DOI 10.1073/pnas.90.11.5194; Mrzljak L, 1998, J COMP NEUROL, V390, P112; Mrzljak L, 1996, P NATL ACAD SCI USA, V93, P7337, DOI 10.1073/pnas.93.14.7337; Nakao Y, 2001, P NATL ACAD SCI USA, V98, P7593, DOI 10.1073/pnas.121179898; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; NEWMAN GC, 1989, J NEUROSCI METH, V28, P23, DOI 10.1016/0165-0270(89)90006-X; NEWMAN GC, 1992, J NEUROSCI, V12, P2015; NEWMAN GC, 1991, J CEREBR BLOOD F MET, V11, P398, DOI 10.1038/jcbfm.1991.80; Newman GC, 1996, J CEREBR BLOOD F MET, V16, P864, DOI 10.1097/00004647-199609000-00011; NEWMAN GC, 1988, J CEREBR BLOOD F MET, V8, P586, DOI 10.1038/jcbfm.1988.100; OTSUKA T, 1991, AM J PHYSIOL, V261, pH110, DOI 10.1152/ajpheart.1991.261.1.H110; Pan JW, 2000, J CEREBR BLOOD F MET, V20, P1502, DOI 10.1097/00004647-200010000-00012; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; PARELLADA E, 1994, PSYCHIAT RES-NEUROIM, V55, P131, DOI 10.1016/0925-4927(94)90021-3; Parellada E, 1998, BIOL PSYCHIAT, V44, P787, DOI 10.1016/S0006-3223(98)00057-2; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Pellicer F, 1999, EUR J PAIN, V3, P287, DOI 10.1016/S1090-3801(99)90056-3; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Rajji TK, 2012, SCHIZOPHR RES, V139, P46, DOI 10.1016/j.schres.2012.06.006; RAOS VC, 1995, NEUROSCIENCE, V68, P299, DOI 10.1016/0306-4522(95)00114-X; REDIES C, 1987, NEUROSCIENCE, V22, P601, DOI 10.1016/0306-4522(87)90357-5; RESNICK SM, 1988, PSYCHIAT RES, V24, P1, DOI 10.1016/0165-1781(88)90134-5; ROLLESTON FS, 1967, BIOCHEM J, V104, P519, DOI 10.1042/bj1040519; Rowland LM, 2009, NEUROPSYCHOPHARMACOL, V34, P1514, DOI 10.1038/npp.2008.207; RUBIN P, 1994, PSYCHIAT RES, V53, P57, DOI 10.1016/0165-1781(94)90095-7; Sachdev P, 1997, SCHIZOPHR RES, V27, P105, DOI 10.1016/S0920-9964(97)00088-1; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Schlunzen L, 2010, ACTA ANAESTH SCAND, V54, P610, DOI 10.1111/j.1399-6576.2009.02181.x; Schmahmann JD, 2007, J HIST NEUROSCI, V16, P362, DOI 10.1080/09647040600620468; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; SCHWARTZ ML, 1984, J COMP NEUROL, V226, P403, DOI 10.1002/cne.902260309; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Seok JH, 2007, PSYCHIAT RES-NEUROIM, V156, P93, DOI 10.1016/j.pscychresns.2007.02.002; Shelley MJ, 2001, J COMPUT NEUROSCI, V11, P111, DOI 10.1023/A:1012885314187; Shen J, 1999, P NATL ACAD SCI USA, V96, P8235, DOI 10.1073/pnas.96.14.8235; Shergill SS, 2000, AM J PSYCHIAT, V157, P1691, DOI 10.1176/appi.ajp.157.10.1691; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; Shergill SS, 2007, AM J PSYCHIAT, V164, P467, DOI 10.1176/appi.ajp.164.3.467; SHIBATA S, 1987, BRAIN RES, V426, P332, DOI 10.1016/0006-8993(87)90886-9; SHIBATA S, 1988, BRAIN RES, V438, P374, DOI 10.1016/0006-8993(88)91367-4; SIEGEL BV, 1993, AM J PSYCHIAT, V150, P1325; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Silver H, 2003, AM J PSYCHIAT, V160, P1809, DOI 10.1176/appi.ajp.160.10.1809; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Soma S, 2012, J NEUROPHYSIOL, V107, P283, DOI 10.1152/jn.00330.2011; SONCRANT TT, 1986, BRAIN RES, V369, P1, DOI 10.1016/0006-8993(86)90507-X; Soyka M, 2005, EUR ARCH PSY CLIN N, V255, P308, DOI 10.1007/s00406-005-0563-0; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; STARZL TE, 1951, J NEUROPHYSIOL, V14, P133, DOI 10.1152/jn.1951.14.2.133; STEINBERG JL, 1995, PSYCHIAT RES-NEUROIM, V61, P15, DOI 10.1016/0925-4927(95)02574-H; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; SUAREZ RK, 1989, AM J PHYSIOL, V257, pR1083, DOI 10.1152/ajpregu.1989.257.5.R1083; Sukhotinsky I, 2007, EUR J NEUROSCI, V25, P1417, DOI 10.1111/j.1460-9568.2007.05399.x; Swenson RS, 2006, REV CLIN FUNCTIONAL; SZELIES B, 1991, ARCH NEUROL-CHICAGO, V48, P178, DOI 10.1001/archneur.1991.00530140072019; Szeszko PR, 2005, AM J PSYCHIAT, V162, P602, DOI 10.1176/appi.ajp.162.3.602; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Toyama H, 2004, J NUCL MED, V45, P1398; TREMBLAY N, 1990, J NEUROPHYSIOL, V64, P1212, DOI 10.1152/jn.1990.64.4.1212; VANDERWOLF CH, 1988, BRAIN RES BULL, V20, P529, DOI 10.1016/0361-9230(88)90143-8; Veraart J, 2011, NEUROIMAGE, V58, P975, DOI 10.1016/j.neuroimage.2011.06.063; VILLABLANCA J, 1972, ARCH ITAL BIOL, V110, P383; VITA A, 1994, PSYCHIAT RES, V53, P41, DOI 10.1016/0165-1781(94)90094-9; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Whitford TJ, 2006, NEUROIMAGE, V32, P511, DOI 10.1016/j.neuroimage.2006.03.041; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; WOLKIN A, 1994, BIOL PSYCHIAT, V36, P317, DOI 10.1016/0006-3223(94)90629-7; YAMAGUCHI T, 1990, J CEREBR BLOOD F MET, V10, P618, DOI 10.1038/jcbfm.1990.113; Yildiz A, 2000, NUCL MED COMMUN, V21, P1113, DOI 10.1097/00006231-200012000-00004	163	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60518	10.1371/journal.pone.0060518	http://dx.doi.org/10.1371/journal.pone.0060518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593232	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000035
J	Xu, JN; Hillyer, JF; Coulibaly, B; Sacko, M; Dao, A; Niare, O; Riehle, MM; Traore, SF; Vernick, KD				Xu, Jiannong; Hillyer, Julian F.; Coulibaly, Boubacar; Sacko, Madjou; Dao, Adama; Niare, Oumou; Riehle, Michelle M.; Traore, Sekou F.; Vernick, Kenneth D.			Wild Anopheles funestus Mosquito Genotypes Are Permissive for Infection with the Rodent Malaria Parasite, Plasmodium berghei	PLOS ONE			English	Article							TRANSMISSION; INTENSITY; DYNAMICS	Background: Malaria parasites undergo complex developmental transitions within the mosquito vector. A commonly used laboratory model for studies of mosquito-malaria interaction is the rodent parasite, P. berghei. Anopheles funestus is a major malaria vector in sub-Saharan Africa but has received less attention than the sympatric species, Anopheles gambiae. The imminent completion of the A. funestus genome sequence will provide currently lacking molecular tools to describe malaria parasite interactions in this mosquito, but previous reports suggested that A. funestus is not permissive for P. berghei development. Methods: An A. funestus population was generated in the laboratory by capturing female wild mosquitoes in Mali, allowing them to oviposit, and rearing the eggs to adults. These F1 progeny of wild mosquitoes were allowed to feed on mice infected with a fluorescent P. berghei strain. Fluorescence microscopy was used to track parasite development inside the mosquito, salivary gland sporozoites were tested for infectivity to mice, and parasite development in A. funestus was compared to A. gambiae. Results: P. berghei oocysts were detectable on A. funestus midguts by 7 days post-infection. By 18-20 days post-infection, sporozoites had invaded the median and distal lateral lobes of the salivary glands, and hemocoel sporozoites were observed in the hemolymph. Mosquitoes were capable of infecting mice via bite, demonstrating that A. funestus supports the complete life cycle of P. berghei. In a random sample of wild mosquito genotypes, A. funestus prevalence of infection and the characteristics of parasite development were similar to that observed in A. gambiae-P. berghei infections. Conclusions: The data presented in this study establish an experimental laboratory model for Plasmodium infection of A. funestus, an important vector of human malaria. Studying A. funestus-Plasmodium interactions is now feasible in a laboratory setting. This information lays the groundwork for exploitation of the awaited genome sequence of A. funestus.	[Xu, Jiannong; Vernick, Kenneth D.] Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol, Paris, France; [Xu, Jiannong; Hillyer, Julian F.; Riehle, Michelle M.; Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, Microbial & Plant Genom Inst, St Paul, MN USA; [Xu, Jiannong] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Hillyer, Julian F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Hillyer, Julian F.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN USA; [Coulibaly, Boubacar; Sacko, Madjou; Dao, Adama; Niare, Oumou; Traore, Sekou F.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Minnesota System; University of Minnesota Twin Cities; New Mexico State University; Vanderbilt University; Vanderbilt University; University of Bamako	Vernick, KD (corresponding author), Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol, Paris, France.	jxu@nmsu.edu	Xu, Jiannong/N-1583-2019	Xu, Jiannong/0000-0001-7332-4370; Hillyer, Julian/0000-0002-3178-0201	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [R01AI042361, AI073685]; NIH/NIAID [F32AI065075]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI065075, R01AI042361, R01AI073685] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) R01AI042361 and AI073685 to KDV and NIH/NIAID F32AI065075 to JFH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; Bigoga JD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-5; BILLINGSLEY PF, 1994, AM J TROP MED HYG, V51, P260, DOI 10.4269/ajtmh.1994.51.260; Bray R. S., 1954, Indian Journal of Malariology, V8, P263; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frischknecht F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-23; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; KALUCY EC, 1970, NATURE, V225, P97, DOI 10.1038/225097a0; King JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003058; MARGOLIS L, 1982, J PARASITOL, V68, P131, DOI 10.2307/3281335; MEDLEY GF, 1993, PARASITOLOGY, V106, P441, DOI 10.1017/S0031182000076721; Nkuo-Akenji Theresa, 2006, Afr J Health Sci, V13, P40; PIMENTA PF, 1994, J EUKARYOT MICROBIOL, V41, P608, DOI 10.1111/j.1550-7408.1994.tb01523.x; Sinden R. E., 1997, The molecular biology of insect disease vectors: a methods manual., P67; Sinden Robert E, 2002, Methods Mol Med, V72, P25, DOI 10.1385/1-59259-271-6:25; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; STERLING CR, 1973, J PARASITOL, V59, P593, DOI 10.2307/3278847; VAUGHAN JA, 1991, J PARASITOL, V77, P758, DOI 10.2307/3282712; Vincke I. H., 1954, Indian Journal of Malariology, V8, P245; Vincke I. H., 1948, Annales de la Societe Belge de Medecine Tropicale, V28, P97; Vincke I. H., 1954, Indian Journal of Malariology, V8, P257; YOELI M, 1964, SCIENCE, V144, P1580, DOI 10.1126/science.144.3626.1580	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61181	10.1371/journal.pone.0061181	http://dx.doi.org/10.1371/journal.pone.0061181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593423	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000110
J	Zhou, X; Gu, Y; Wang, DN; Ni, S; Yan, J				Zhou, Xin; Gu, Yang; Wang, Ding-ning; Ni, Sha; Yan, Jun			Eight Functional Polymorphisms in the Estrogen Receptor 1 Gene and Endometrial Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							ALPHA GENE; ER-ALPHA; ASSOCIATION; BETA; HETEROGENEITY	Background and Objective: Emerging evidence indicates that common functional polymorphisms in the estrogen receptor 1 (ESR1) gene may have an impact on an individual's susceptibility to endometrial cancer, but individually published results are inconclusive. The aim of this meta-analysis is to derive a more precise estimation of the associations between eight polymorphisms in the ESR1 gene and endometrial cancer risk. Methods: A literature search of PubMed, Embase, Web of Science and China Biology Medicine (CBM) databases was conducted on publications published before November 1st, 2012. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Statistical analyses were performed using the STATA 12.0 software. Results: Thirteen case-control studies were included with a total of 7,649 endometrial cancer cases and 16,855 healthy controls. When all the eligible studies were pooled into the meta-analysis, the results indicated that PvuII (C>T) polymorphism was associated with an increased risk of endometrial cancer, especially among Caucasian populations. There were also significant associations between rs3020314 (C>T) polymorphism and an increased risk of endometrial cancer. Furthermore, rs2234670 (S/L) polymorphism may decrease the risk of endometrial cancer. However, no statistically significant associations were found in XbaI (A>G), Codon 325 (C>G), Codon 243 (C>T), VNTR (S/L) and rs2046210 (G>A) polymorphisms. Conclusion: The current meta-analysis suggests that PvuII (C>T) and rs3020314 (C>T) polymorphisms may be risk factors for endometrial cancer, especially among Caucasian populations.	[Zhou, Xin; Gu, Yang; Wang, Ding-ning; Ni, Sha; Yan, Jun] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Liaoning, Peoples R China	China Medical University	Zhou, X (corresponding author), China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Liaoning, Peoples R China.	cmu_zx@126.com			National Science Foundation of China [81101990]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This was funded by the National Science Foundation of China (No. 81101990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Ashton KA, 2010, CANCER EPIDEMIOL, V34, P328, DOI 10.1016/j.canep.2010.03.005; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; Healey CS, 2011, CARCINOGENESIS, V32, P1862, DOI 10.1093/carcin/bgr214; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Iwamoto I, 2003, OBSTET GYNECOL, V102, P506, DOI 10.1016/S0029-7844(03)00578-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jongen V, 2009, GYNECOL ONCOL, V112, P537, DOI 10.1016/j.ygyno.2008.10.032; Kataoka N, 2007, CANCER, V109, P1296, DOI 10.1002/cncr.22531; Koukouras D, 2012, GYNECOL ENDOCRINOL, V28, P859, DOI 10.3109/09513590.2012.671393; Li Guoliang, 2011, Chin J Cancer, V30, P138; Li N, 2010, BREAST CANCER RES TR, V121, P177, DOI 10.1007/s10549-009-0532-9; Lluis-Ganella C, 2009, ATHEROSCLEROSIS, V207, P480, DOI 10.1016/j.atherosclerosis.2009.05.038; Long JR, 2012, CANCER EPIDEM BIOMAR, V21, P980, DOI 10.1158/1055-9965.EPI-11-1160; Lundin E, 2012, CANCER EPIDEMIOL, V36, P445, DOI 10.1016/j.canep.2012.04.006; McKean-Cowdin R, 2001, CANCER RES, V61, P848; Olson SH, 2007, AM J EPIDEMIOL, V165, P235, DOI 10.1093/aje/kwk015; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Safarinejad MR, 2012, MOL CARCINOGEN, V51, pE104, DOI 10.1002/mc.21870; Sasaki M, 2002, BIOCHEM BIOPH RES CO, V297, P558, DOI 10.1016/S0006-291X(02)02248-9; Shan D, 2003, CHIN J CLIN OBSTET G, V4, P201; Sliwinski T, 2010, J OBSTET GYNAECOL RE, V36, P311, DOI 10.1111/j.1447-0756.2009.01143.x; Sobczuk A, 2009, EUR J GYNAECOL ONCOL, V30, P431; Tsezou A, 2008, BREAST, V17, P159, DOI 10.1016/j.breast.2007.08.007; Wang YM, 2012, ACTA OBSTET GYN SCAN, V91, P911, DOI 10.1111/j.1600-0412.2012.01393.x; Wedren S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-322; Weiderpass E, 2000, CARCINOGENESIS, V21, P623, DOI 10.1093/carcin/21.4.623; Yang HP, 2010, CARCINOGENESIS, V31, P827, DOI 10.1093/carcin/bgp328; Yang XS, 2007, PROG OBSTET GYNECOL, V16, P76; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	30	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60851	10.1371/journal.pone.0060851	http://dx.doi.org/10.1371/journal.pone.0060851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593326	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000077
J	Gao, M; Ding, DX; Huang, JH; Qu, YL; Wang, Y; Huang, QY				Gao, Meng; Ding, Daxia; Huang, Jinghua; Qu, Yali; Wang, Yu; Huang, Qingyang			Association of Genetic Variants in the Adiponectin Gene with Metabolic Syndrome: A Case-Control Study and a Systematic Meta-Analysis in the Chinese Population	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; WIDE LINKAGE SCAN; QUANTITATIVE TRAIT LOCI; INCREASES PLASMA-LEVELS; INSULIN-RESISTANCE; SERUM ADIPONECTIN; RISK; OBESITY; COMPONENTS; ADIPOSE	Background: The prevalence of metabolic syndrome has been rising worldwide, including in China, but knowledge on specific genetic determinants of metabolic syndrome is very limited. A number of studies have reported that polymorphisms in the ADIPOQ gene are associated with metabolic syndrome in Chinese Han populations. However, data is still conflicting. The objective of this study was to examine the associations of the adiponectin genetic variants with metabolic syndrome by a case-control study and meta-analyses in Chinese. Methods: We first investigated the association of ADIPOQ rs2241766 (+45T>G in exon 2), rs266729 (211377C>G in promoter) and rs1501299 (+276G>T in intron 2) polymorphisms with metabolic syndrome in a Hubei Han Chinese population with 322 metabolic syndrome patients and 161 normal controls recruited from the Yichang, Hubei. Then we comprehensively reviewed the association between ADIPOQ rs2241766/rs266729/rs1501299 and metabolic syndrome in the Chinese populations via a meta-analysis. The strength of association was assessed by odds ratios (ORs) with 95% confidence intervals (CI). Results: The G allele frequency of rs2241766 in metabolic syndrome patients was significantly higher than those of controls group (29.8% vs 23.3%, OR = 1.40, P = 0.033). The logistic regression analysis adjusted by gender and age showed a nominally significant association for rs2241766 GG+GT genotype (P = 0.065, OR = 1.55) and rs1501299 GG genotype in recessive model (OR = 1.54, P = 0.066). However, no association was observed for rs266729 in our sample. We identified thirteen studies for rs2241766 (2,684 metabolic syndrome patients and 2,864 controls), three studies for rs266729, and eleven studies for rs1501299 (2,889 metabolic syndrome patients and 3,304 controls) in Chinese. Meta-analysis indicated significant associations for the rs2241766 G allele (OR = 1.14, 95% CI = 1.05-1.24, P = 0.003), rs266729 GG+GT genotypes (OR = 0.80, 95% CI = 0.68-0.92, P = 0.003) and rs1501299 GG+TG genotypes (OR = 1.42, 95% CI 1.16-1.75, P = 0.001). Conclusions: Our results demonstrated ADIPOQ as a pleiotropic locus for metabolic syndrome and its components in the Han Chinese population.	[Gao, Meng; Ding, Daxia; Huang, Jinghua; Huang, Qingyang] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Qu, Yali] Wuhan Ctr Med Therapeut, Wuhan, Peoples R China; [Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China	Central China Normal University; University of Hong Kong	Huang, QY (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	huangqy@mail.ccnu.edu.cn		wang, yu/0000-0001-8697-2940	National Basic Research Program of China (973 Program) [2011CB504004]; CCNU from the colleges' basic research and operation of MOE	National Basic Research Program of China (973 Program)(National Basic Research Program of China); CCNU from the colleges' basic research and operation of MOE	This work was supported by National Basic Research Program of China (973 Program, No. 2011CB504004) and self-determined research funds of CCNU from the colleges' basic research and operation of MOE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2003, AM J HYPERTENS, V16, P72, DOI 10.1016/S0895-7061(02)03197-7; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2004, CHIN J DIABETES, V12, P156; Arya R, 2002, NAT GENET, V30, P102, DOI 10.1038/ng810; Bellia A, 2009, NUTR METAB CARDIOVAS, V19, P455, DOI 10.1016/j.numecd.2008.11.002; Bosse Y, 2007, OBESITY, V15, P544, DOI 10.1038/oby.2007.577; Bosy-Westphal A, 2007, INT J OBESITY, V31, P784, DOI 10.1038/sj.ijo.0803481; Cai Q., 2010, CLIN J MED OFFICERS, V38, P813; [陈芳 Chen Fang], 2012, [中国急救医学, Chinese Journal of Critical Care Medicine], V32, P24; Chen J, 2012, ENDOCRINE, V42, P307, DOI 10.1007/s12020-012-9643-x; Cheng CY, 2010, OBESITY, V18, P146, DOI 10.1038/oby.2009.142; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Du J, 2012, ANN HUM GENET, V76, P101, DOI 10.1111/j.1469-1809.2012.00699.x; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Edwards KL, 2008, OBESITY, V16, P1596, DOI 10.1038/oby.2008.236; Edwards KL, 2011, OBESITY, V19, P1235, DOI 10.1038/oby.2010.299; Farook VS, 2012, OBESITY, V20, P2083, DOI 10.1038/oby.2012.74; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E; Gong M, 2010, MOL CELL ENDOCRINOL, V325, P78, DOI 10.1016/j.mce.2010.05.007; Gonzalez-Sanchez JL, 2005, OBES RES, V13, P807, DOI 10.1038/oby.2005.91; Haluzik M, 2004, PHYSIOL RES, V53, P123; Han LY, 2011, DIABETOLOGIA, V54, P2303, DOI 10.1007/s00125-011-2202-9; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Hirose H, 2010, J ATHEROSCLER THROMB, V17, P1201, DOI 10.5551/jat.6106; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huang F., 2008, THESIS; Huang KC, 2003, J CLIN ENDOCR METAB, V88, P4130, DOI 10.1210/jc.2003-030158; Hung J, 2008, INT J OBESITY, V32, P772, DOI 10.1038/sj.ijo.0803793; Kazumi T, 2002, DIABETES CARE, V25, P971, DOI 10.2337/diacare.25.6.971; King GA, 2012, ACTA DIABETOL, V49, pS41, DOI 10.1007/s00592-010-0192-6; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Koh KK, 2004, CIRCULATION, V110, P3687, DOI 10.1161/01.CIR.0000143085.86697.13; Koh SB, 2011, YONSEI MED J, V52, P234, DOI 10.3349/ymj.2011.52.2.234; Kovac IP, 2007, DIABETES, V56, P537, DOI 10.2337/db06-0443; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kraja AT, 2005, OBES RES, V13, P1885, DOI 10.1038/oby.2005.231; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Langefeld CD, 2004, DIABETES, V53, P1170, DOI 10.2337/diabetes.53.4.1170; Lee CY, 2009, KAOHSIUNG J MED SCI, V25, P116, DOI 10.1016/S1607-551X(09)70050-6; Leu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019999; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Li SB, 2008, CLIN ENDOCRINOL, V68, P885, DOI 10.1111/j.1365-2265.2007.03114.x; Li XT, 2012, ASIA PAC J CLIN NUTR, V21, P296; Li YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019686; [李奕平 Li Yiping], 2010, [基础医学与临床, Basic & Clinical Medicine], V30, P1288; Li YP, 2009, CLIN FOCUS, V24, P786; Li YY, 2012, DIABETES-METAB RES, V28, P349, DOI 10.1002/dmrr.2277; Lin HF, 2005, DIABETOLOGIA, V48, P2006, DOI 10.1007/s00125-005-1892-2; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Ling H, 2008, OBESITY SILVER SPRIN, V17, P737; Liu D. X., 2006, CHIN J CLIN REHABILI, V10, P4; Liu F, 2011, MOL BIOL REP, V38, P1983, DOI 10.1007/s11033-010-0320-y; Loos RJF, 2003, J CLIN ENDOCR METAB, V88, P5935, DOI 10.1210/jc.2003-030553; Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; Menzaghi C, 2007, DIABETES, V56, P1198, DOI 10.2337/db06-0506; Ng MCY, 2004, DIABETES, V53, P2676, DOI 10.2337/diabetes.53.10.2676; Ryu HK, 2010, J AM COLL NUTR, V29, P171, DOI 10.1080/07315724.2010.10719831; Shankar A, 2008, ACTA CARDIOL, V63, P160, DOI 10.2143/AC.63.2.2029522; Stein CM, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S99; Tam CHT, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-14; Tang WH, 2003, DIABETES, V52, P2840, DOI 10.2337/diabetes.52.11.2840; Thomas GN, 2007, CLIN ENDOCRINOL, V66, P666, DOI 10.1111/j.1365-2265.2007.02798.x; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Wang J, 2008, OBESITY, V16, P172, DOI 10.1038/oby.2007.42; Wang S. J., 2012, J CHINESE PRACTICAL, V26, P659; Xi B, 2012, MOL BIOL REP, V39, P8771, DOI 10.1007/s11033-012-1739-0; Xu WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-246; Yang WS, 2007, AM J CLIN NUTR, V86, P509, DOI 10.1093/ajcn/86.2.509; Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Yang WS, 2002, DIABETES CARE, V25, P376, DOI 10.2337/diacare.25.2.376; Yao M., 2004, THESIS; Yu ZB, 2012, OBESITY, V20, P396, DOI 10.1038/oby.2011.148; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961; Zhang SC, 2009, OBESITY, V17, P1581, DOI 10.1038/oby.2009.125; Zhao TF, 2011, CLIN ENDOCRINOL, V74, P214, DOI 10.1111/j.1365-2265.2010.03902.x; Zhu X. W., 2010, SHANDONG MED J, V50, P10; Zhuo Q, 2010, BIOMED ENVIRON SCI, V23, P53, DOI 10.1016/S0895-3988(10)60032-3; 卜瑞芳, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P4112; 刘德敏, 2004, [中华糖尿病杂志, Chinese Journal of Diabetes], V12, P397	89	20	23	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e58412	10.1371/journal.pone.0058412	http://dx.doi.org/10.1371/journal.pone.0058412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593121	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100004
J	Mead, D; Drinkwater, C; Brumm, PJ				Mead, David; Drinkwater, Colleen; Brumm, Phillip J.			Genomic and Enzymatic Results Show Bacillus cellulosilyticus Uses a Novel Set of LPXTA Carbohydrases to Hydrolyze Polysaccharides	PLOS ONE			English	Article							SP STRAIN N-4; CELLULASE GENES; HALODURANS; ALKALINE; PH; PROTEIN; PURIFICATION; ANNOTATION; EXPRESSION; PROPOSAL	Background: Alkaliphilic Bacillus species are intrinsically interesting due to the bioenergetic problems posed by growth at high pH and high salt. Three alkaline cellulases have been cloned, sequenced and expressed from Bacillus cellulosilyticus N-4 (Bcell) making it an excellent target for genomic sequencing and mining of biomass-degrading enzymes. Methodology/Principal Findings: The genome of Bcell is a single chromosome of 4.7 Mb with no plasmids present and three large phage insertions. The most unusual feature of the genome is the presence of 23 LPXTA membrane anchor proteins; 17 of these are annotated as involved in polysaccharide degradation. These two values are significantly higher than seen in any other Bacillus species. This high number of membrane anchor proteins is seen only in pathogenic Gram-positive organisms such as Listeria monocytogenes or Staphylococcus aureus. Bcell also possesses four sortase D subfamily 4 enzymes that incorporate LPXTA-bearing proteins into the cell wall; three of these are closely related to each other and unique to Bcell. Cell fractionation and enzymatic assay of Bcell cultures show that the majority of polysaccharide degradation is associated with the cell wall LPXTA-enzymes, an unusual feature in Gram-positive aerobes. Genomic analysis and growth studies both strongly argue against Bcell being a truly cellulolytic organism, in spite of its name. Preliminary results suggest that fungal mycelia may be the natural substrate for this organism. Conclusions/Significance: Bacillus cellulosilyticus N-4, in spite of its name, does not possess any of the genes necessary for crystalline cellulose degradation, demonstrating the risk of classifying microorganisms without the benefit of genomic analysis. Bcell is the first Gram-positive aerobic organism shown to use predominantly cell-bound, non-cellulosomal enzymes for polysaccharide degradation. The LPXTA-sortase system utilized by Bcell may have applications both in anchoring cellulases and other biomass-degrading enzymes to Bcell itself and in anchoring proteins other Gram-positive organisms.	[Mead, David; Drinkwater, Colleen] Lucigen Corp, Middleton, WI USA; [Mead, David; Brumm, Phillip J.] C5 6 Technol, Middleton, WI USA; [Mead, David; Drinkwater, Colleen; Brumm, Phillip J.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Brumm, PJ (corresponding author), C5 6 Technol, Middleton, WI USA.	pbrumm@c56technologies.com		MEAD, David/0000-0003-1982-9356	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); Office of Science of the US Department of Energy(United States Department of Energy (DOE))	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494) supporting CD, DM, and PJB. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. All work performed by employees of Lucigen or C5-6 Technologies was performed under and supported by subcontract to the GLBRC. Neither corporation was a funder of the work; no funds of either corporation was used for this research or to support the researchers during performance of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW MD, 1995, SYST APPL MICROBIOL, V18, P221, DOI 10.1016/S0723-2020(11)80392-9; Aino K, 2008, INT J SYST EVOL MICR, V58, P120, DOI 10.1099/ijs.0.65193-0; Akita M, 2005, FEMS MICROBIOL LETT, V248, P9, DOI 10.1016/j.femsle.2005.05.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Budzik JM, 2009, J BIOL CHEM, V284, P12989, DOI 10.1074/jbc.M900927200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang PC, 2004, BIOCHEM BIOPH RES CO, V319, P1017, DOI 10.1016/j.bbrc.2004.05.078; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Echigo Akinobu, 2005, Saline Syst, V1, P8, DOI 10.1186/1746-1448-1-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fujisawa M, 2010, J BIOL CHEM, V285, P32105, DOI 10.1074/jbc.M110.165084; FUKUMORI F, 1989, GENE, V76, P289, DOI 10.1016/0378-1119(89)90169-8; FUKUMORI F, 1986, J BACTERIOL, V168, P479, DOI 10.1128/jb.168.2.479-485.1986; Gilmour R, 2000, J BACTERIOL, V182, P5969, DOI 10.1128/JB.182.21.5969-5981.2000; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Han C., 2006, P 2006 INT C BIOINF, P141; Hashim SO, 2004, BIOTECHNOL LETT, V26, P823, DOI 10.1023/B:BILE.0000025885.19910.d7; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hirasawa K, 2006, ANTON LEEUW INT J G, V89, P211, DOI 10.1007/s10482-005-9023-0; HITOMI J, 1994, J BIOCHEM-TOKYO, V116, P554, DOI 10.1093/oxfordjournals.jbchem.a124561; HORIKOSHI K, 1984, CAN J MICROBIOL, V30, P774, DOI 10.1139/m84-118; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krulwich TA, 1996, BBA-BIOENERGETICS, V1275, P21, DOI 10.1016/0005-2728(96)00044-8; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kumar V, 2011, BIOTECHNOL LETT, V33, P2279, DOI 10.1007/s10529-011-0698-1; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lawton EM, 2007, FEMS MICROBIOL LETT, V267, P64, DOI 10.1111/j.1574-6968.2006.00539.x; Lee WH, 2004, BIOINFORMATICS, V20, P2863, DOI 10.1093/bioinformatics/bth301; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Machado Moara, 2011, Investig Genet, V2, P3, DOI 10.1186/2041-2223-2-3; Mamo G, 2006, ENZYME MICROB TECH, V39, P1492, DOI 10.1016/j.enzmictec.2006.03.040; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Martins RF, 2003, BIOTECHNOL LETT, V25, P1555, DOI 10.1023/A:1025430532333; McMillan DGG, 2007, J BIOL CHEM, V282, P17395, DOI 10.1074/jbc.M611709200; Mongkolthanaruk W, 2012, J MICROBIOL BIOTECHN, V22, P1597, DOI 10.4014/jmb.1204.04013; Murakami S, 2007, BIOSCI BIOTECH BIOCH, V71, P2393, DOI 10.1271/bbb.60666; Nakagawa Y, 2008, BBA-PROTEINS PROTEOM, V1784, P2004, DOI 10.1016/j.bbapap.2008.08.022; NAKAMURA S, 1993, APPL ENVIRON MICROB, V59, P2311, DOI 10.1128/AEM.59.7.2311-2316.1993; NIELSEN P, 1995, MICROBIOL-UK, V141, P1745, DOI 10.1099/13500872-141-7-1745; Nogi Y, 2005, INT J SYST EVOL MICR, V55, P2309, DOI 10.1099/ijs.0.63649-0; Olsson K, 2003, J BACTERIOL, V185, P461, DOI 10.1128/JB.185.2.461-465.2003; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SASHIHARA N, 1984, J BACTERIOL, V158, P503, DOI 10.1128/JB.158.2.503-506.1984; Sayer DC, 2004, TISSUE ANTIGENS, V64, P556, DOI 10.1111/j.1399-0039.2004.00283.x; Shrinivas D, 2012, J IND MICROBIOL BIOT, V39, P93, DOI 10.1007/s10295-011-1003-y; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; TAKII Y, 1990, APPL MICROBIOL BIOT, V34, P57; Yamamoto M, 1998, FEBS LETT, V433, P41, DOI 10.1016/S0014-5793(98)00881-3	59	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61131	10.1371/journal.pone.0061131	http://dx.doi.org/10.1371/journal.pone.0061131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593409	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100078
J	Ye, J; Wu, XG; Wu, D; Wu, P; Ni, C; Zhang, ZG; Chen, ZG; Qiu, FM; Xu, JH; Huang, J				Ye, Jun; Wu, Xianguo; Wu, Dang; Wu, Pin; Ni, Chao; Zhang, Zhigang; Chen, Zhigang; Qiu, Fuming; Xu, Jinghong; Huang, Jian			miRNA-27b Targets Vascular Endothelial Growth Factor C to Inhibit Tumor Progression and Angiogenesis in Colorectal Cancer	PLOS ONE			English	Article							STEM-CELLS; MICRORNA EXPRESSION; COLON; METASTASIS; LIVER; PROGNOSIS; SURVIVAL	Colorectal cancer (CRC) is one of the most prevalent cancers globally and is one of the leading causes of cancer-related deaths due to therapy resistance and metastasis. Understanding the mechanism underlying colorectal carcinogenesis is essential for the diagnosis and treatment of CRC. microRNAs (miRNAs) can act as either oncogenes or tumor suppressors in many cancers. A tumor suppressor role for miR-27b has recently been reported in neuroblastoma, while no information about miR-27b in CRC is available. In this study, we demonstrated that miR-27b expression is decreased in most CRC tissues and determined that overexpression of miR-27b represses CRC cell proliferation, colony formation and tumor growth in vitro and in vivo. We identified vascular endothelial growth factor C (VEGFC) as a novel target gene of miR-27b and determined that miR-27b functioned as an inhibitor of tumor progression and angiogenesis through targeting VEGFC in CRC. We further determined that DNA hypermethylation of miR-27b CpG islands decreases miR-27b expression. In summary, an anti-tumor role for miR-27b and its novel target VEGFC in vivo could lead to tumor necrosis and provide a rationale for developing miR-27b as a therapeutic agent.	[Ye, Jun; Wu, Xianguo; Wu, Dang; Wu, Pin; Ni, Chao; Zhang, Zhigang; Chen, Zhigang; Qiu, Fuming; Xu, Jinghong; Huang, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2,Key Lab Mol Biol Med Sci, Canc Inst,Key Lab Canc Prevent & Intervent,China, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Huang, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2,Key Lab Mol Biol Med Sci, Canc Inst,Key Lab Canc Prevent & Intervent,China, Hangzhou 310003, Zhejiang, Peoples R China.	Drhuangjian@zju.edu.cn	xu, jing/GRR-8698-2022	Huang, Jian/0000-0003-3340-5007	National Natural Science Foundation of China [91019005]; Zhejiang Provincial Natural Science Foundation of China [Y2110034]; 151 Talent Project of Zhejiang Province; Science and Technology Bureau of Zhejiang Province [2011C37004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); 151 Talent Project of Zhejiang Province; Science and Technology Bureau of Zhejiang Province	This work was supported by grants from the National Natural Science Foundation of China (No. 91019005), Zhejiang Provincial Natural Science Foundation of China (No. Y2110034), the 151 Talent Project of Zhejiang Province (HJ) and the Science and Technology Bureau of Zhejiang Province (No. 2011C37004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biyashev D, 2011, BLOOD; Bjerkvig R, 2009, SEMIN CANCER BIOL, V19, P279, DOI 10.1016/j.semcancer.2009.09.001; Borel F, 2012, J HEPATOL; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cambien B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028842; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fang YX, 2012, HEPATOLOGY; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Francipane MG, 2008, CANCER RES, V68, P4022, DOI 10.1158/0008-5472.CAN-07-6874; Gore AV, 2011, DEVELOPMENT, V138, P4875, DOI 10.1242/dev.068460; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kawamoto H, 2010, CELL TRANSPLANT, V19, P857, DOI 10.3727/096368910X508988; Khromova N, 2012, ONCOGENE, V31, P1389, DOI 10.1038/onc.2011.330; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kumar B, 2011, ANGIOGENESIS, V14, P371, DOI 10.1007/s10456-011-9221-5; Lee JJ, 2011, ONCOGENE; Liston A, 2010, J CLIN IMMUNOL, V30, P339, DOI 10.1007/s10875-010-9378-5; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2007, CELL CYCLE, V6, P1455; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Urbich C, 2011, BLOOD; Van Trappen Philippe O., 2005, Angiogenesis, V8, P137; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vo DM, 2010, MINERVA CHIR, V65, P677; Wee EJ, 2012, ONCOGENE; Wissmann C, 2006, CLIN CANCER RES, V12, P6865, DOI 10.1158/1078-0432.CCR-06-1800; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Zhao Y, 2011, INT J DEV BIOL, V55, P477, DOI 10.1387/ijdb.103225yz	42	136	144	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60687	10.1371/journal.pone.0060687	http://dx.doi.org/10.1371/journal.pone.0060687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593282	Green Submitted, Green Published, gold			2022-12-27	WOS:000317385300026
J	Zhang, YY; Post, WS; Cheng, A; Blasco-Colmenares, E; Tomaselli, GF; Guallar, E				Zhang, Yiyi; Post, Wendy S.; Cheng, Alan; Blasco-Colmenares, Elena; Tomaselli, Gordon F.; Guallar, Eliseo			Thyroid Hormones and Electrocardiographic Parameters: Findings from the Third National Health and Nutrition Examination Survey	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; VENTRICULAR REPOLARIZATION; SUBCLINICAL HYPERTHYROIDISM; SPECTRAL-ANALYSIS; QT DISPERSION; HYPOTHYROIDISM; DISEASE; INTERVAL; MORTALITY; RISK	Introduction: Altered thyroid status exerts a major effect on the heart. Individuals with hypo- or hyperthyroidism showed various changes in electrocardiograms. However, little is known about how variations in thyroid hormone levels within the normal range affect electrical activities of the heart in the general population. Methods and Results: We conducted a cross-sectional analysis of 5,990 men and women from the Third National Health and Nutrition Examination Survey. Serum total T4 was measured by immunoassay and TSH was measured by chemiluminescent assay. We categorized T4 and TSH into 7 groups with cut-offs at the 5th, 20th, 40th, 60th, 80th, and 95th percentiles of the weighted population distribution. Electrocardiographic parameters were measured from the standard 12-lead electrocardiogram. We found a positive linear association between serum total T4 level and heart rate in men, and a U-shape association between T4 and PR interval in men and women. TSH level was positively associated with QRS interval in men, while a U-shape association between TSH and QRS was observed in women. No clear graded association between thyroid hormones and corrected QT or JT was found, except that men in the highest category of T4 levels appeared to have longer corrected QT and JT, and men in the lowest category of T4 appeared to have shorter corrected QT and JT. Conclusions: Variation in thyroid hormone levels in the general population, even within the normal range, was associated with various ECG changes.	[Zhang, Yiyi; Post, Wendy S.; Blasco-Colmenares, Elena; Guallar, Eliseo] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Zhang, Yiyi; Post, Wendy S.; Blasco-Colmenares, Elena; Guallar, Eliseo] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Post, Wendy S.; Cheng, Alan; Tomaselli, Gordon F.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Guallar, Eliseo] Natl Ctr Cardiovasc Res CNIC, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Guallar, E (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	eguallar@jhsph.edu	Guallar, Eliseo/D-3807-2014; zhang, yiyi/J-2592-2012	Guallar, Eliseo/0000-0002-4471-9565; 	National Center for Cardiovascular Research (CNIC Translational Cardiology grant) [2008-03]; National Institutes of Health [ES015597, HL091062]; Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015597] Funding Source: NIH RePORTER	National Center for Cardiovascular Research (CNIC Translational Cardiology grant); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University(Johns Hopkins University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The present study was funded in part by grants from the National Center for Cardiovascular Research (CNIC Translational Cardiology grant 2008-03), the National Institutes of Health (grants ES015597 and HL091062), and the Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, VITAL HLTH STAT, P1; BINAH O, 1987, AM J PHYSIOL, V252, pH1265, DOI 10.1152/ajpheart.1987.252.6.H1265; Bosch RF, 1999, AM J PHYSIOL-HEART C, V277, pH211, DOI 10.1152/ajpheart.1999.277.1.H211; Cacciatori V, 2000, EUR J ENDOCRINOL, V143, P327, DOI 10.1530/eje.0.1430327; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Chen JL, 2006, CLIN ENDOCRINOL, V64, P611, DOI 10.1111/j.1365-2265.2006.02514.x; Colzani RM, 2001, CLIN ENDOCRINOL, V55, P27, DOI 10.1046/j.1365-2265.2001.01295.x; Danzi S, 2002, THYROID, V12, P467, DOI 10.1089/105072502760143836; Dazai Y, 1999, ANGIOLOGY, V50, P591, DOI 10.1177/000331979905000709; Dorr M, 2006, J CLIN ENDOCR METAB, V91, P4938, DOI 10.1210/jc.2006-1017; Fadel BM, 2000, CLIN CARDIOL, V23, P402, DOI 10.1002/clc.4960230605; FAZIO S, 1992, ANGIOLOGY, V43, P287, DOI 10.1177/000331979204300402; Galetta F, 2006, BIOMED PHARMACOTHER, V60, P425, DOI 10.1016/j.biopha.2006.07.009; GALLOE AM, 1993, DAN MED BULL, V40, P492; Guntekin U, 2009, PACE, V32, P494, DOI 10.1111/j.1540-8159.2009.02310.x; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Kohno I, 1998, CHRONOBIOL INT, V15, P337, DOI 10.3109/07420529808998694; Kweon KH, 2007, J KOREAN MED SCI, V22, P114, DOI 10.3346/jkms.2007.22.1.114; MCDEVITT DG, 1968, LANCET, V1, P998; Osborn L A, 1999, Heart Dis, V1, P8; Osman F, 2004, AM J CARDIOL, V94, P465, DOI 10.1016/j.amjcard.2004.04.061; Owecki M, 2006, HORM METAB RES, V38, P44, DOI 10.1055/s-2006-924977; Paslawska U, 2006, POL J VET SCI, V9, P253; RAUTAHARJU PM, 1990, METHOD INFORM MED, V29, P362; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; SARMA JSM, 1990, AM J CARDIOL, V66, P959, DOI 10.1016/0002-9149(90)90933-R; Sawin CT, 2002, THYROID, V12, P501, DOI 10.1089/105072502760143881; SHARP NA, 1985, J MOL CELL CARDIOL, V17, P119, DOI 10.1016/S0022-2828(85)80015-8; Toft AD, 2000, HEART, V84, P455, DOI 10.1136/heart.84.4.455; Tribulova N, 2010, VASC PHARMACOL, V52, P102, DOI 10.1016/j.vph.2009.10.001; van Noord C, 2008, J ENDOCRINOL, V198, P253, DOI 10.1677/JOE-08-0140; VENKATESH N, 1991, J CARDIOVASC PHARM, V18, P703, DOI 10.1097/00005344-199111000-00008	33	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e59489	10.1371/journal.pone.0059489	http://dx.doi.org/10.1371/journal.pone.0059489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593140	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300008
J	Avraham-Chakim, L; Elad, D; Zaretsky, U; Kloog, Y; Jaffa, A; Grisaru, D				Avraham-Chakim, Liron; Elad, David; Zaretsky, Uri; Kloog, Yoel; Jaffa, Ariel; Grisaru, Dan			Fluid-Flow Induced Wall Shear Stress and Epithelial Ovarian Cancer Peritoneal Spreading	PLOS ONE			English	Article							TUMOR-CELL ADHESION; CULTURED ENDOTHELIAL-CELLS; METASTATIC ESOPHAGEAL CANCER; IN-VITRO; EXTRACELLULAR-MATRIX; MOTILITY; REORGANIZATION; INVASIVENESS; CYTOSKELETON; ORIENTATION	Epithelial ovarian cancer (EOC) is usually discovered after extensive metastasis have developed in the peritoneal cavity. The ovarian surface is exposed to peritoneal fluid pressures and shear forces due to the continuous peristaltic motions of the gastro-intestinal system, creating a mechanical micro-environment for the cells. An in vitro experimental model was developed to expose EOC cells to steady fluid flow induced wall shear stresses (WSS). The EOC cells were cultured from OVCAR-3 cell line on denuded amniotic membranes in special wells. Wall shear stresses of 0.5, 1.0 and 1.5 dyne/cm(2) were applied on the surface of the cells under conditions that mimic the physiological environment, followed by fluorescent stains of actin and beta-tubulin fibers. The cytoskeleton response to WSS included cell elongation, stress fibers formation and generation of microtubules. More cytoskeletal components were produced by the cells and arranged in a denser and more organized structure within the cytoplasm. This suggests that WSS may have a significant role in the mechanical regulation of EOC peritoneal spreading.	[Avraham-Chakim, Liron; Elad, David; Zaretsky, Uri] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel; [Kloog, Yoel] Tel Aviv Univ, Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel; [Jaffa, Ariel] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Ultrasound Unit Obstet & Gynecol, IL-69978 Tel Aviv, Israel; [Grisaru, Dan] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Oncogynecol Unit,Lis Matern Hosp, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Grisaru, D (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Oncogynecol Unit,Lis Matern Hosp, IL-69978 Tel Aviv, Israel.	grisaro@post.tau.ac.il			Israel Cancer Association	Israel Cancer Association	This work was partially funded by a grant from the Israel Cancer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Bijman MNA, 2008, BIOCHEM PHARMACOL, V76, P707, DOI 10.1016/j.bcp.2008.06.014; Carmignani C. Pablo, 2003, Cancer and Metastasis Reviews, V22, P465, DOI 10.1023/A:1023791229361; Chobanian N, 2008, SURG CLIN N AM, V88, P285, DOI 10.1016/j.suc.2007.12.002; Chotard-Ghodsnia R, 2007, J BIOMECH, V40, P335, DOI 10.1016/j.jbiomech.2006.01.001; Davidovich NET, 2011, BIOPHYS J, V100, P2855, DOI 10.1016/j.bpj.2011.04.040; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dong C, 2005, FRONT BIOSCI-LANDMRK, V10, P379, DOI 10.2741/1535; ESKIN SG, 1988, SEMIN THROMB HEMOST, V14, P170, DOI 10.1055/s-2007-1002771; ESKIN SG, 1984, MICROVASC RES, V28, P87, DOI 10.1016/0026-2862(84)90031-1; Even-Tzur N, 2008, BIOPHYS J, V95, P2998, DOI 10.1529/biophysj.107.127142; Even-Tzur N, 2010, CELL MOL BIOENG, V3, P307, DOI 10.1007/s12195-010-0118-y; FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Haier J, 1999, CLIN EXP METASTAS, V17, P377, DOI 10.1023/A:1006658414040; Haier J, 2001, APMIS, V109, P241, DOI 10.1034/j.1600-0463.2001.d01-118.x; HAMILTON TC, 1983, CANCER RES, V43, P5379; IVES CL, 1986, IN VITRO CELL DEV B, V22, P500; Jeffrey B, 2003, AM J PHYSIOL-GASTR L, V285, pG907, DOI 10.1152/ajpgi.00062.2003; Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226; Korb T, 2004, EXP CELL RES, V299, P236, DOI 10.1016/j.yexcr.2004.06.001; Lawler K, 2004, AM J PHYSIOL-CELL PH, V287, pC1320, DOI 10.1152/ajpcell.00159.2004; Lawler K, 2006, AM J PHYSIOL-CELL PH, V291, pC668, DOI 10.1152/ajpcell.00626.2005; Lawler K, 2009, CANCER SCI, V100, P1082, DOI 10.1111/j.1349-7006.2009.01160.x; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; MALEK AM, 1994, CIRC RES, V74, P852, DOI 10.1161/01.RES.74.5.852; Malek AM, 1996, J CELL SCI, V109, P713; McCue S, 2006, CIRC RES, V98, P939, DOI 10.1161/01.RES.0000216595.15868.55; NIEDBALA MJ, 1985, EXP CELL RES, V160, P499, DOI 10.1016/0014-4827(85)90197-1; Pannu HK, 2004, RADIOGRAPHICS, V24, P209, DOI 10.1148/rg.241035078; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; SATO M, 1987, ARTERIOSCLEROSIS, V7, P276, DOI 10.1161/01.ATV.7.3.276; Slattery MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC831, DOI 10.1152/ajpcell.00439.2004; STRACKE ML, 1993, KIDNEY INT, V43, P151, DOI 10.1038/ki.1993.25; Thamilselvan V, 2004, GASTROENTEROLOGY, V126, P8, DOI 10.1053/j.gastro.2003.10.078; Thamilselvan V, 2004, J CELL BIOCHEM, V92, P361, DOI 10.1002/jcb.20072; THOUMINE O, 1995, EXP CELL RES, V219, P427, DOI 10.1006/excr.1995.1249; van Zyp JV, 2006, CANCER BIOL THER, V5, P1169; WECHEZAK AR, 1985, LAB INVEST, V53, P639; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	42	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60965	10.1371/journal.pone.0060965	http://dx.doi.org/10.1371/journal.pone.0060965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593358	Green Submitted, Green Published, gold			2022-12-27	WOS:000317382000030
J	Van Hemelrijck, M; Michaelsson, K; Linseisen, J; Rohrmann, S				Van Hemelrijck, Mieke; Michaelsson, Karl; Linseisen, Jakob; Rohrmann, Sabine			Calcium Intake and Serum Concentration in Relation to Risk of Cardiovascular Death in NHANES III	PLOS ONE			English	Article							VITAMIN-D; DIETARY CALCIUM; MORTALITY; HEALTH; SUPPLEMENTATION; ASSOCIATION; NUTRITION; DISEASE; EVENTS; CONSUMPTION	Background: Evidence for an association between calcium intake and risk of cardiovascular death remains controversial. By assessing dietary intake, use of supplements, and serum levels of calcium, we aimed to disentangle this link in the third National Health and Nutrition Examination Survey (NHANES III). Methods: Mortality linkage of NHANES III to death certificate data for those aged 17 years or older (n = 20,024) was used to estimate risk of overall cardiovascular death as well as death from ischemic heart disease (IHD), acute myocardial infarction (AMI), heart failure (HF), and cerebrovascular disease (CD) with multivariate Cox proportional hazards regression analysis. Results: About 10.0% of the population died of cardiovascular disease and the majority (5.4%) died of IHD. There was increased risk of overall CVD death for those in the bottom 5% of serum calcium compared to those in the mid 90% (HR: 1.51 (95% CI: 1.03-2.22)). For women there was a statistically significant increased risk of IHD death for those with serum calcium levels in the top 5% compared to those in the mid 90% (HR: 1.72 (95% CI: 1.13-2.61)), whereas in men, low serum calcium was related to increased IHD mortality (HR: 2.32 (95% CI 1.14-3.01), P-interaction: 0.306). No clear association with CVD death was observed for dietary or supplemental calcium intake. Conclusions: Calcium as assessed by serum concentrations is involved in cardiovascular health, though differential effects by sex may exist. No clear evidence was found for an association between dietary or supplementary intake of calcium and cardiovascular death.	[Van Hemelrijck, Mieke] Kings Coll London, Canc Epidemiol Grp, Div Canc Studies, Sch Med, London WC2R 2LS, England; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Linseisen, Jakob] Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Rohrmann, Sabine] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland	University of London; King's College London; Uppsala University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Zurich	Rohrmann, S (corresponding author), Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland.	sabine.rohrmann@ifspm.uzh.ch	Michaelsson, Karl/AAM-9094-2021; Linseisen, Jakob/B-5353-2014; Rohrmann, Sabine/D-2113-2012	Linseisen, Jakob/0000-0002-9386-382X; Rohrmann, Sabine/0000-0002-2215-1200; Van Hemelrijck, Mieke/0000-0002-7317-0858; Michaelsson, Karl/0000-0003-2815-1217				[Anonymous], 1994, Vital Health Stat 1, P1; Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Bolland MJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2040; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bonthuis M, 2010, EUR J CLIN NUTR, V64, P569, DOI 10.1038/ejcn.2010.45; Cartwright EJ, 2011, SCI CHINA LIFE SCI, V54, P691, DOI 10.1007/s11427-011-4199-1; Cashman KD, 2011, BRIT J NUTR, V106, P1617, DOI 10.1017/S0007114511004995; Centers for Disease Control and Prevention, 2009, NHANES 3 LINKED MORT; Centers for Disease Control and Prevention, 2012, NAT HLTH NUTR EX SUR; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Goldfarb-Rumyantzev AS, 2010, NEPHROL DIAL TRANSPL, V25, P3672, DOI 10.1093/ndt/gfq177; Grandi NC, 2012, HEART, V98, P926, DOI 10.1136/heartjnl-2011-300806; Harrell FE, 2001, REGRESSION MODELING; Kaluza J, 2010, AM J EPIDEMIOL, V171, P801, DOI 10.1093/aje/kwp467; Leifsson BG, 1996, J CLIN ENDOCR METAB, V81, P2149, DOI 10.1210/jc.81.6.2149; Lewis JR, 2011, J BONE MINER RES, V26, P35, DOI 10.1002/jbmr.176; Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345; Lundgren E, 2001, SURGERY, V130, P978, DOI 10.1067/msy.2001.118377; Marco MP, 2003, KIDNEY INT, V63, pS111, DOI 10.1046/j.1523-1755.63.s85.26.x; Miller PD, 2011, ENDOCR PRACT, V17, P798, DOI 10.4158/EP11203.RA; NIH Office of Dietary Supplements, 2012, DIET SUPPL FACT SHEE; Ogard CG, 2006, EUR J EPIDEMIOL, V21, P123, DOI 10.1007/s10654-005-5438-1; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Reid IR, 2012, HEART, V98, P895, DOI 10.1136/heartjnl-2012-301904; Reunanen A, 1996, EUR J CLIN NUTR, V50, P431; Sabanayagam C, 2011, J CLIN HYPERTENS, V13, P716, DOI 10.1111/j.1751-7176.2011.00503.x; Shab-Bidar S, 2012, DIABETES-METAB RES, V28, P424, DOI 10.1002/dmrr.2290; Shah SM, 2010, PHARMACOEPIDEM DR S, V19, P59, DOI 10.1002/pds.1859; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Targher G, 2012, SEMIN THROMB HEMOST, V38, P114, DOI 10.1055/s-0031-1300957; Tietz N, CLIN GUIDE LAB TESTS; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Willett C, 1998, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Xiao Q, 2013, AMA INTERN MED; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	37	45	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61037	10.1371/journal.pone.0061037	http://dx.doi.org/10.1371/journal.pone.0061037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593383	Green Published, gold			2022-12-27	WOS:000317382000040
J	Stemmer, N; Strekalova, E; Djogo, N; Ploger, F; Loers, G; Lutz, D; Buck, F; Michalak, M; Schachner, M; Kleene, R				Stemmer, Nina; Strekalova, Elena; Djogo, Nevena; Ploeger, Frank; Loers, Gabriele; Lutz, David; Buck, Friedrich; Michalak, Marek; Schachner, Melitta; Kleene, Ralf			Generation of Amyloid-beta Is Reduced by the Interaction of Calreticulin with Amyloid Precursor Protein, Presenilin and Nicastrin	PLOS ONE			English	Article							GAMMA-SECRETASE; CATALYTIC PORE; ENDOPLASMIC-RETICULUM; MUTATIONAL ANALYSIS; NEURITE OUTGROWTH; APP FAMILY; A-BETA; BINDING; CHAPERONE; PEPTIDE	Dysregulation of the proteolytic processing of amyloid precursor protein by gamma-secretase and the ensuing generation of amyloid-beta is associated with the pathogenesis of Alzheimer's disease. Thus, the identification of amyloid precursor protein binding proteins involved in regulating processing of amyloid precursor protein by the gamma-secretase complex is essential for understanding the mechanisms underlying the molecular pathology of the disease. We identified calreticulin as novel amyloid precursor protein interaction partner that binds to the gamma-secretase cleavage site within amyloid precursor protein and showed that this Ca2+ - and N-glycan-independent interaction is mediated by amino acids 330-344 in the C-terminal C-domain of calreticulin. Co-immunoprecipitation confirmed that calreticulin is not only associated with amyloid precursor protein but also with the gamma-secretase complex members presenilin and nicastrin. Calreticulin was detected at the cell surface by surface biotinylation of cells overexpressing amyloid precursor protein and was co-localized by immunostaining with amyloid precursor protein and presenilin at the cell surface of hippocampal neurons. The P-domain of calreticulin located between the N-terminal N-domain and the C-domain interacts with presenilin, the catalytic subunit of the gamma-secretase complex. The P- and C-domains also interact with nicastrin, another functionally important subunit of this complex. Transfection of amyloid precursor protein overexpressing cells with full-length calreticulin leads to a decrease in amyloid-beta(42) levels in culture supernatants, while transfection with the P-domain increases amyloid-beta(40) levels. Similarly, application of the recombinant P-or C-domains and of a synthetic calreticulin peptide comprising amino acid 330-344 to amyloid precursor protein overexpressing cells result in elevated amyloid-beta(40) and amyloid-beta(42) levels, respectively. These findings indicate that the interaction of calreticulin with amyloid precursor protein and the gamma-secretase complex regulates the proteolytic processing of amyloid precursor protein by the gamma-secretase complex, pointing to calreticulin as a potential target for therapy in Alzheimer's disease.	[Stemmer, Nina; Strekalova, Elena; Djogo, Nevena; Ploeger, Frank; Loers, Gabriele; Lutz, David; Schachner, Melitta; Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Buck, Friedrich] Univ Klinikum Hamburg Eppendorf, Inst Klin Chem, Hamburg, Germany; [Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Alberta; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Shantou University	Schachner, M (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany.	schachner@stu.edu.cn	Lutz, David/AAX-1607-2021	Lutz, David/0000-0001-9171-4081	Canadian Institutes of Health Research [MOP-15291]; New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	The work was supported by the Canadian Institutes of Health Research (grant MOP-15291 to MM). MS is supported by the New Jersey Commission for Spinal Cord Research and the Li Ka-Shing Foundation at Shantou University Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrin C, 1998, BIOCHEMISTRY-US, V37, P10386, DOI 10.1021/bi980595z; Baksh S, 1991, J BIOL CHEM, V266, P21548; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; BLALOCK JE, 1984, BIOCHEM BIOPH RES CO, V121, P203, DOI 10.1016/0006-291X(84)90707-1; BRENTANI RR, 1988, J THEOR BIOL, V135, P495, DOI 10.1016/S0022-5193(88)80272-8; BRENTANI RR, 1988, P NATL ACAD SCI USA, V85, P364, DOI 10.1073/pnas.85.2.364; DESOUZA SJ, 1992, J BIOL CHEM, V267, P13763; Duus K, 2008, PROTEIN PEPTIDE LETT, V15, P103; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heal JR, 2002, CHEMBIOCHEM, V3, P137, DOI 10.1002/1439-7633(20020301)3:2/3<136::AID-CBIC136>3.0.CO;2-7; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Johnson RJ, 2001, NEUROBIOL AGING, V22, P387, DOI 10.1016/S0197-4580(00)00247-5; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kaether C, 2006, NEURODEGENER DIS, V3, P275, DOI 10.1159/000095267; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kapoor M, 2004, BIOCHEMISTRY-US, V43, P97, DOI 10.1021/bi0355286; Kijimoto-Ochiai S, 2000, BIOCHEM BIOPH RES CO, V267, P686, DOI 10.1006/bbrc.1999.2021; Kimberly WT, 2002, J BIOL CHEM, V277, P35113, DOI 10.1074/jbc.M204446200; Kleene R, 2010, J NEUROSCI, V30, P10784, DOI 10.1523/JNEUROSCI.0297-10.2010; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Li ITS, 2007, BIOCHEM BIOPH RES CO, V352, P932, DOI 10.1016/j.bbrc.2006.11.123; LOCHTER A, 1991, J CELL BIOL, V113, P1159, DOI 10.1083/jcb.113.5.1159; Loers G, 2012, J NEUROSCI, V32, P3917, DOI 10.1523/JNEUROSCI.6165-11.2012; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Martins VR, 1997, NAT MED, V3, P1376, DOI 10.1038/nm1297-1376; Michaki V, 2012, J BIOL CHEM, V287, P1100, DOI 10.1074/jbc.M111.288258; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; NASH PD, 1994, MOL CELL BIOCHEM, V135, P71, DOI 10.1007/BF00925962; Nelson O, 2011, J BIOL CHEM, V286, P22339, DOI 10.1074/jbc.M111.243063; PAHLSSON P, 1992, BIOCHEM BIOPH RES CO, V189, P1667, DOI 10.1016/0006-291X(92)90269-Q; Preissner R, 1997, FEBS LETT, V414, P425, DOI 10.1016/S0014-5793(97)00907-1; PRESTA M, 1991, J CELL PHYSIOL, V149, P512, DOI 10.1002/jcp.1041490322; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SISODIA SS, 1995, FASEB J, V9, P366, DOI 10.1096/fasebj.9.5.7896005; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Stambuk N, 2005, THEOR BIOSCI, V123, P265, DOI 10.1016/j.thbio.2005.02.001; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Taguchi J, 2000, ACTA NEUROPATHOL, V100, P153, DOI 10.1007/s004019900165; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takeo K, 2012, J BIOL CHEM, V287, P25834, DOI 10.1074/jbc.M111.336347; Toft KN, 2008, BBA-PROTEINS PROTEOM, V1784, P1265, DOI 10.1016/j.bbapap.2008.05.005; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200	61	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61299	10.1371/journal.pone.0061299	http://dx.doi.org/10.1371/journal.pone.0061299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585889	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600103
J	Yang, X; Guo, AK				Yang, Xing; Guo, Aike			Distinct Acute Zones for Visual Stimuli in Different Visual Tasks in Drosophila	PLOS ONE			English	Article							FLIGHT ORIENTATION; MOTION DETECTION; FRUIT-FLY; MELANOGASTER; PERIPHERY; ATTENTION; BEHAVIOR; VISION; EYES; SENSITIVITY	The fruit fly Drosophila melanogaster has a sophisticated visual system and exhibits complex visual behaviors. Visual responses, vision processing and higher cognitive processes in Drosophila have been studied extensively. However, little is known about whether the retinal location of visual stimuli can affect fruit fly performance in various visual tasks. We tested the response of wild-type Berlin flies to visual stimuli at several vertical locations. Three paradigms were used in our study: visual operant conditioning, visual object fixation and optomotor response. We observed an acute zone for visual feature memorization in the upper visual field when visual patterns were presented with a black background. However, when a white background was used, the acute zone was in the lower visual field. Similar to visual feature memorization, the best locations for visual object fixation and optomotor response to a single moving stripe were in the lower visual field with a white background and the upper visual field with a black background. The preferred location for the optomotor response to moving gratings was around the equator of the visual field. Our results suggest that different visual processing pathways are involved in different visual tasks and that there is a certain degree of overlap between the pathways for visual feature memorization, visual object fixation and optomotor response.	[Yang, Xing; Guo, Aike] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Yang, Xing; Guo, Aike] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [Yang, Xing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Guo, Aike] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Guo, AK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.	akguo@ion.ac.cn		Yang, Xing/0000-0001-6710-0012	973 Program [2011CBA00400]; National Science Foundation of China [30921064, 90820008, 31130027]; Chinese Academy of Sciences [XDB02040100]	973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by a 973 Program (Grant 2011CBA00400 to A. G.), the National Science Foundation of China (Grants 30921064, 90820008, and 31130027 to A. G.), and the "Strategic Priority Research Program" of the Chinese Academy of Sciences, grant No. XDB02040100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender JA, 2006, J EXP BIOL, V209, P3170, DOI 10.1242/jeb.02369; BUCHNER E, 1978, BIOL CYBERN, V31, P235, DOI 10.1007/BF00337095; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Guo FZ, 2005, SCIENCE, V309, P307, DOI 10.1126/science.1111280; Heisenberg M., 1984, Vision in Drosophila.Genetics of microbehaviour.; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; LAND MF, 1985, J COMP PHYSIOL A, V156, P525, DOI 10.1007/BF00613976; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Newton JR, 2003, VISUAL NEUROSCI, V20, P511, DOI 10.1017/S0952523803205058; Peng YQ, 2007, J NEUROSCI, V27, P5139, DOI 10.1523/JNEUROSCI.0472-07.2007; Poeck B, 2008, DEV NEUROBIOL, V68, P1046, DOI 10.1002/dneu.20643; POGGIO T, 1976, Quarterly Reviews of Biophysics, V9, P377; POGGIO T, 1973, KYBERNETIK, V12, P185, DOI 10.1007/BF00270572; Ren QZ, 2012, J NEUROSCI, V32, P11524, DOI 10.1523/JNEUROSCI.0827-12.2012; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Sareen P, 2011, P NATL ACAD SCI USA, V108, P7230, DOI 10.1073/pnas.1102522108; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; SHERK TE, 1978, J EXP ZOOL, V203, P61, DOI 10.1002/jez.1402030107; Straw AD, 2006, J EXP BIOL, V209, P4339, DOI 10.1242/jeb.02517; Tammero LF, 2002, J EXP BIOL, V205, P2785; Tammero LF, 2002, J EXP BIOL, V205, P327; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; Theobald JC, 2008, CURR BIOL, V18, pR464, DOI 10.1016/j.cub.2008.03.050; van Breugel F, 2012, J EXP BIOL, V215, P1783, DOI 10.1242/jeb.066498; VANNORREN D, 1975, EXP BRAIN RES, V23, P150; Wang SP, 2003, BEHAV PROCESS, V64, P57, DOI 10.1016/S0376-6357(03)00105-0; Wernet MF, 2012, CURR BIOL, V22, P12, DOI 10.1016/j.cub.2011.11.028; Wernet MF, 2004, TRENDS CELL BIOL, V14, P576, DOI 10.1016/j.tcb.2004.09.007; WOLF R, 1990, J COMP PHYSIOL A, V167, P269, DOI 10.1007/BF00188119; WRIGHT MJ, 1987, J OPT SOC AM A, V4, P1627, DOI 10.1364/JOSAA.4.001627; Wu ZH, 2000, BIOL CYBERN, V82, P61, DOI 10.1007/s004220050006; Xi W, 2008, EUR J NEUROSCI, V27, P1441, DOI 10.1111/j.1460-9568.2008.06114.x; Ye YZ, 2004, EUR J NEUROSCI, V20, P1001, DOI 10.1111/j.1460-9568.2004.03575.x; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357; Zhang XN, 2013, J EXP BIOL, V216, P524, DOI 10.1242/jeb.079095	38	2	2	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61313	10.1371/journal.pone.0061313	http://dx.doi.org/10.1371/journal.pone.0061313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585891	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600105
J	Durieux, D; Fassotte, B; Vanderplanck, M; Deneubourg, JL; Fischer, C; Lognay, G; Haubruge, E; Verheggen, FJ				Durieux, Delphine; Fassotte, Berenice; Vanderplanck, Maryse; Deneubourg, Jean-Louis; Fischer, Christophe; Lognay, Georges; Haubruge, Eric; Verheggen, Francois J.			Substrate Marking by an Invasive Ladybeetle: Seasonal Changes in Hydrocarbon Composition and Behavioral Responses	PLOS ONE			English	Article							HARMONIA-AXYRIDIS COLEOPTERA; PALLAS COLEOPTERA; COCCINELLIDAE; RECOGNITION; CUES; DISCRIMINATION; REPRODUCTION; PHOTOPERIOD; NESTMATE; BEETLE	The multicolored Asian ladybeetle, Harmonia axyridis (Pallas), aggregates inside dwellings during the winter to survive the cold. Recent published reports have highlighted that overwintering individuals use hydrocarbon markings deposited on surfaces by conspecifics to orient toward aggregation sites. In the current study, monthly GC-MS analyses revealed seasonal modifications in the chemical profile of substrate markings deposited by moving individuals. The markings of overwintering ladybeetles contained larger proportions of heptacosadiene, nonacosadiene, hentriacontadienes, and methyl-nonacosanes, along with a lower proportion of heptacosene and nonacosene. This finding suggests the importance of the unsaturated and/or branched hydrocarbons in the H. axyridis aggregation process. Subsequently, we conducted behavioral assays to test whether (1) there is seasonal variation in the behavioral response of H. axyridis individuals toward substrate markings deposited by conspecifics in the same physiological state and (2) the observed behavioral modification is due to a change in ladybeetle sensitivity and/or a change in the chemical composition of the substrate marking. The results indicate that overwintering individuals exhibit a stronger "following" response toward conspecific substrate markings. This behavior is linked to both the physiological state of ladybeetles and the specific chemical profile of the marking biomolecules deposited under overwintering conditions.	[Durieux, Delphine; Fassotte, Berenice; Haubruge, Eric; Verheggen, Francois J.] Univ Liege, Gembloux Agrobio Tech, Unit Funct & Evolutionary Entomol, Gembloux, Belgium; [Vanderplanck, Maryse] Univ Mons, Zool Lab, B-7000 Mons, Belgium; [Deneubourg, Jean-Louis] Univ Libre Brussels, Unit Social Ecol, Brussels, Belgium; [Fischer, Christophe; Lognay, Georges] Univ Liege, Gembloux Agrobio Tech, Analyt Chem Lab, Unit Anal Qual & Risk, Gembloux, Belgium	University of Liege; University of Mons; Universite Libre de Bruxelles; University of Liege	Durieux, D (corresponding author), Univ Liege, Gembloux Agrobio Tech, Unit Funct & Evolutionary Entomol, Gembloux, Belgium.	entomologie.gembloux@ulg.ac.be	Vanderplanck, Maryse/K-1072-2019	Vanderplanck, Maryse/0000-0002-0110-8019; Haubruge, Eric/0000-0002-8138-0476; Verheggen, Francois/0000-0002-5849-1661	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA), Belgium; Centre universitaire de recherche en agronomie et ingenierie biologique de Gembloux (CURAGx); University of Liege; Belgian Fund for Scientific Research (FNRS)	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA), Belgium(Fonds de la Recherche Scientifique - FNRS); Centre universitaire de recherche en agronomie et ingenierie biologique de Gembloux (CURAGx); University of Liege(University of Liege); Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	Delphine Durieux and Christophe Fischer are financially supported by a PhD grant from the Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA), Belgium. Berenice Fassotte was financially supported by a PhD grant from the Centre universitaire de recherche en agronomie et ingenierie biologique de Gembloux (CURAGx), University of Liege. Maryse Vanderplanck is a PhD student funded by the Belgian Fund for Scientific Research (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Berkvens N, 2008, BIOCONTROL, V53, P211, DOI 10.1007/s10526-007-9130-0; Berkvens N, 2010, J INSECT PHYSIOL, V56, P438, DOI 10.1016/j.jinsphys.2009.11.019; Chaline N, 2005, CHEM SENSES, V30, P327, DOI 10.1093/chemse/bji027; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; Dani FR, 2001, ANIM BEHAV, V62, P165, DOI 10.1006/anbe.2001.1714; Durieux D, 2012, J INSECT PHYSIOL, V58, P801, DOI 10.1016/j.jinsphys.2012.03.006; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Hemptinne JL, 1998, J INSECT PHYSIOL, V44, P1163, DOI 10.1016/S0022-1910(98)00081-X; Iperti Gabriel, 2001, Acta Societatis Zoologicae Bohemicae, V65, P207; Jamart B, 2009, CHIMIE ORGANIQUE COU; Kosaki A, 1996, JPN J APPL ENTOMOL Z, V40, P47, DOI 10.1303/jjaez.40.47; Lognay G, 1987, REV FR CORPS GRAS, V9, P407; Mallet G, 1985, REV FR CORPS GRAS, V11-12, P439; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Martin SJ, 2009, J CHEM ECOL, V35, P368, DOI 10.1007/s10886-009-9612-x; MCCARTHY ED, 1968, ANAL CHEM, V40, P1475, DOI 10.1021/ac60266a021; ONGAGNA P, 1994, J APPL ENTOMOL, V117, P314, DOI 10.1111/j.1439-0418.1994.tb00740.x; Raak-van den Berg CL, 2012, BIOCONTROL, V57, P71, DOI 10.1007/s10526-011-9394-2; Reznik SY, 2011, EUR J ENTOMOL, V108, P385, DOI 10.14411/eje.2011.048; SAKURAI H, 1992, APPL ENTOMOL ZOOL, V27, P479, DOI 10.1303/aez.27.479; Sloggett JJ, 2011, BIOCONTROL, V56, P643, DOI 10.1007/s10526-011-9376-4; Steiger S, 2011, BIOL LETTERS, V7, P822, DOI 10.1098/rsbl.2011.0457; Wagner D, 2001, J CHEM ECOL, V27, P1805, DOI 10.1023/A:1010408725464	24	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61124	10.1371/journal.pone.0061124	http://dx.doi.org/10.1371/journal.pone.0061124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593406	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100077
J	Kushner, LE; Wendelboe, AM; Lazzeroni, LC; Chary, A; Winters, MA; Osinusi, A; Kottilil, S; Polis, MA; Holodniy, M				Kushner, Lauren E.; Wendelboe, Aaron M.; Lazzeroni, Laura C.; Chary, Aarthi; Winters, Mark A.; Osinusi, Anu; Kottilil, Shyam; Polis, Michael A.; Holodniy, Mark			Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C; CARDIOVASCULAR-DISEASE; MULTIPLE COMPARISONS; LIVER-DAMAGE; HIV; PATHOGENESIS; CHEMOKINES; EXPRESSION; CYTOKINES	Background: Immune biomarkers are implicated in HCV treatment response, fibrosis, and accelerated pathogenesis of comorbidities, though only D-dimer and C-reactive protein have been consistently studied. Few studies have evaluated HIV/HCV co-infection, and little longitudinal data exists describing a broader antiviral cytokine response Methods: Fifty immune biomarkers were analyzed at baseline(BL) and HCV end of treatment follow-up(FU) time point using the Luminex 50-plex assay in plasma samples from 15 HCV-cleared, 24 HCV mono- and 49 HIV/HCV co-infected patients receiving antiretroviral treatment, who either did or did not receive pegylated-interferon/ribavirin HCV treatment. Biomarker levels were compared among spontaneous clearance patients, mono- and co-infected, untreated and HCV-treated, and sustained virologic responders (SVR) and non-responders (NR) at BL and FU using nonparametric analyses. A Bonferroni correction, adjusting for tests of 50 biomarkers, was used to reduce Type I error Results: Compared to HCV patients at BL, HIV/HCV patients had 22 significantly higher and 4 significantly lower biomarker levels, following correction for multiple testing. There were no significantly different BL levels when comparing SVR and NR in mono- or co-infected patients; however, FU levels changed considerably in co-infected patients, with seven becoming significantly higher and eight becoming significantly lower in SVR patients. Longitudinally between BL and FU, 13 markers significantly changed in co-infected SVR patients, while none significantly changed in co-infected NR patients. There were also no significant changes in longitudinal analyses of mono-infected patients achieving SVR or mono-infected and co-infected groups deferring treatment Conclusions: Clear differences exist in pattern and quantity of plasma immune biomarkers among HCV mono-infected, HIV/HCV co-infected, and HCV-cleared patients; and with SVR in co-infected patients treated for HCV. Though >90% of patients were male and co-infected had a larger percentage of African American patients, our findings may have implications for better understanding HCV pathogenesis, treatment outcomes, and future therapeutic targets	[Kushner, Lauren E.; Chary, Aarthi; Winters, Mark A.; Holodniy, Mark] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Wendelboe, Aaron M.] Univ Oklahoma, Oklahoma City, OK USA; [Lazzeroni, Laura C.; Chary, Aarthi; Winters, Mark A.; Holodniy, Mark] Stanford Univ, Stanford, CA 94305 USA; [Osinusi, Anu; Kottilil, Shyam; Polis, Michael A.] NIAID, Immunoregulat Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Oklahoma System; University of Oklahoma Health Sciences Center; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Holodniy, M (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	mark.holodniy@va.gov	Kottilil, Shyam/ABF-7605-2021; Lazzeroni, Laura/F-2903-2010	Lazzeroni, Laura/0000-0002-1846-6920; Kushner, Lauren/0000-0003-2626-316X; Holodniy, Mark/0000-0002-6655-7982; Polis, Michael/0000-0002-9151-2268	Department of Veterans Affairs [HOM0057]; National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E]; Intramural Research Program of the NIH (National Institute of Allergy and Infectious Diseases); Clinical Science Research & Development Service of the Department of Veterans Affairs (A Cooperative Studies Program-Wide DNA Bank, CSP) [478]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000390] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Clinical Science Research & Development Service of the Department of Veterans Affairs (A Cooperative Studies Program-Wide DNA Bank, CSP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a grant to MH from the Department of Veterans Affairs(Grant HOM0057 for "Evaluation of Viral and Immune Responses to Treatment in People with HIV or HCV Infections''). This project was also funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under Contract No. HHSN261200800001E. This research was supported in whole or in part by the Intramural Research Program of the NIH (National Institute of Allergy and Infectious Diseases) and by the Clinical Science Research & Development Service of the Department of Veterans Affairs (A Cooperative Studies Program-Wide DNA Bank, CSP#478). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ES, 2011, EUR J CLIN MICROBIOL, V30, P761, DOI 10.1007/s10096-010-1149-y; Bortolami M, 2008, J VIRAL HEPATITIS, V15, P515, DOI 10.1111/j.1365-2893.2008.00974.x; Bruno R, 2008, AIDS REV, V10, P15; Cacciarelli TV, 1996, HEPATOLOGY, V24, P6, DOI 10.1053/jhep.1996.v24.pm0008707283; Calabrese F, 2000, HEPATOLOGY, V31, P1153, DOI 10.1053/he.2000.7123; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Carr A, 2008, CURR OPIN HIV AIDS, V3, P234, DOI 10.1097/COH.0b013e3282fb7be0; Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; De Lorenzo F, 2008, CURR MED CHEM, V15, P2991, DOI 10.2174/092986708786848668; Fan XG, 1998, MEDIAT INFLAMM, V7, P295, DOI 10.1080/09629359890992; Farci P, 2012, P NATL ACAD SCI USA, V109, P14562, DOI 10.1073/pnas.1210592109; Farrugia PM, 2009, CARDIOL REV, V17, P211, DOI 10.1097/CRD.0b013e3181b151a3; Florholmen J, 2011, CLIN MICROBIOL INFEC, V17, P204, DOI 10.1111/j.1469-0691.2010.03206.x; Fukuda R, 1996, LIVER, V16, P390; Graham CS, 2005, AIDS, V19, P767, DOI 10.1097/01.aids.0000168970.80551.3d; Guzman-Fulgencio M, 2011, EUR J CLIN MICROBIOL, V30, P1213, DOI 10.1007/s10096-011-1215-0; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Heydtmann M, 2009, HEPATOLOGY, V49, P676, DOI 10.1002/hep.22763; Iannello A, 2009, AIDS REV, V11, P115; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kuntzen T, 2008, AIDS, V22, P203, DOI 10.1097/QAD.0b013e3282f3553b; Larrubia JR, 2008, WORLD J GASTROENTERO, V14, P7149, DOI 10.3748/wjg.14.7149; Loskutoff DJ, 2000, J CLIN INVEST, V106, P1441, DOI 10.1172/JCI11765; Masia M, 2011, J ANTIMICROB CHEMOTH, V66, P1861, DOI 10.1093/jac/dkr202; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Page EE, 2011, CURR OPIN HIV AIDS, V6, P472, DOI 10.1097/COH.0b013e32834bbc71; Panasiuk A, 2004, WORLD J GASTROENTERO, V10, P3639, DOI 10.3748/wjg.v10.i24.3639; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Spengler U, 2007, CLIN SCI, V112, P141, DOI 10.1042/CS20060171; Sudano I, 2006, AM HEART J, V151, P1147, DOI 10.1016/j.ahj.2005.07.030; Thompson JR, 1998, AM J EPIDEMIOL, V147, P801, DOI 10.1093/oxfordjournals.aje.a009530; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wald O, 2007, CYTOKINE, V39, P50, DOI 10.1016/j.cyto.2007.05.013; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Woitas RP, 1999, AIDS, V13, P1313, DOI 10.1097/00002030-199907300-00007; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; WYNN TA, 1995, NATURE, V376, P594, DOI 10.1038/376594a0; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60387	10.1371/journal.pone.0060387	http://dx.doi.org/10.1371/journal.pone.0060387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593207	Green Submitted, Green Published, gold			2022-12-27	WOS:000319108100036
J	Lulli, V; Romania, P; Morsilli, O; Cianciulli, P; Gabbianelli, M; Testa, U; Giuliani, A; Marziali, G				Lulli, Valentina; Romania, Paolo; Morsilli, Ornella; Cianciulli, Paolo; Gabbianelli, Marco; Testa, Ugo; Giuliani, Alessandro; Marziali, Giovanna			MicroRNA-486-3p Regulates gamma-Globin Expression in Human Erythroid Cells by Directly Modulating BCL11A	PLOS ONE			English	Article							FETAL-HEMOGLOBIN EXPRESSION; KIT-LIGAND; GENE; ERYTHROPOIESIS; REACTIVATION; ADULT; HEMATOPOIESIS; PROGRESSION; PROFILES; CANCER	MicroRNAs (miRNAs) play key roles in modulating a variety of cellular processes through repression of mRNAs target. The functional relevance of microRNAs has been proven in normal and malignant hematopoiesis. While analyzing miRNAs expression profile in unilineage serum-free liquid suspension unilineage cultures of peripheral blood CD34(+) hematopoietic progenitor cells (HPCs) through the erythroid, megakaryocytic, granulocytic and monocytic pathways, we identified miR-486-3p as mainly expressed within the erythroid lineage. We showed that miR-486-3p regulates BCL11A expression by binding to the extra-long isoform of BCL11A 3'UTR. Overexpression of miR-486-3p in erythroid cells resulted in reduced BCL11A protein levels, associated to increased expression of gamma-globin gene, whereas inhibition of physiological miR-486-3p levels increased BCL11A and, consequently, reduced gamma-globin expression. Thus, miR-486-3p regulating BCL11A expression might contributes to fetal hemoglobin (HbF) modulation and arise the question as to what extent this miRNA might contribute to different HbF levels observed among beta-thalassemia patients. Erythroid cells, differentiated from PB CD34(+) cells of a small cohort of patients affected by major or intermedia beta-thalassemia, showed miR-486-3p levels significantly higher than those observed in normal counterpart. Importantly, in these patients, miR-486-3p expression correlates with increased HbF synthesis. Thus, our data indicate that miR-486-3p might contribute to different HbF levels observed among thalassemic patients and, possibly, to the clinical severity of the disease.	[Lulli, Valentina; Romania, Paolo; Morsilli, Ornella; Gabbianelli, Marco; Testa, Ugo; Marziali, Giovanna] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Romania, Paolo] Bambino Gesu Childrens Hosp IRCCS, Paediat Haematol Oncol Dept, Rome, Italy; [Cianciulli, Paolo] St Eugenio Hosp, Thalassemia Unit, Rome, Italy; [Giuliani, Alessandro] Ist Super Sanita, Dept Environm Hlth, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; Sant'Eugenio Hospital; Istituto Superiore di Sanita (ISS)	Marziali, G (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanna.marziali@iss.it	Giuliani, Alessandro/AAF-1740-2020; Gabbianelli, Marco/O-1210-2017; Romania, Paolo/K-3839-2018; Giuliani, Alessandro/K-7589-2016; Lulli, Valentina/J-9189-2016; Marziali, Giovanna/J-9808-2016; Testa, Ugo/J-6472-2016	Giuliani, Alessandro/0000-0002-4640-804X; Gabbianelli, Marco/0000-0002-7824-780X; Romania, Paolo/0000-0001-6855-1464; Giuliani, Alessandro/0000-0002-4640-804X; Lulli, Valentina/0000-0002-2143-4436; Marziali, Giovanna/0000-0001-7450-1017; Testa, Ugo/0000-0001-7900-8942	Italy-USA Oncology program, Istituto Superiore di Sanita, Rome, Italy [Fasc.527M-cap527]	Italy-USA Oncology program, Istituto Superiore di Sanita, Rome, Italy	This work was supported by the Italy-USA Oncology program, Istituto Superiore di Sanita, Rome, Italy, to Giovanna Marziali (Fasc.527M-cap527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Azzouzi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022838; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer DE, 2012, BLOOD, V120, P2945, DOI 10.1182/blood-2012-06-292078; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Byon JCH, 2012, J CELL PHYSIOL, V227, P7, DOI 10.1002/jcp.22729; Chan E, 2011, CELL CYCLE, V10, P1845, DOI 10.4161/cc.10.11.15777; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Felli N, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-85; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Gabbianelli M, 2000, BLOOD, V95, P3555, DOI 10.1182/blood.V95.11.3555.011k16_3555_3561; Gabbianelli M, 2008, BLOOD, V111, P421, DOI 10.1182/blood-2007-06-097550; Gabbianelli M, 2010, HAEMATOL-HEMATOL J, V95, P1253, DOI 10.3324/haematol.2009.018259; Gallagher PG, 2000, BLOOD, V96, P1136, DOI 10.1182/blood.V96.3.1136.015k48_1136_1143; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Hummel R, 2011, ONCOL REP, V26, P1011, DOI 10.3892/or.2011.1381; Jiang J, 2006, BLOOD, V108, P1077, DOI 10.1182/blood-2006-01-008912; Kiefer CM, 2011, BLOOD, V118, P6200, DOI 10.1182/blood-2011-06-363101; Konishi H, 2011, BRIT J CANCER, V106, P740; Lawrie CH, 2010, BRIT J HAEMATOL, V150, P144, DOI 10.1111/j.1365-2141.2009.07978.x; LEONE L, 1985, J CHROMATOGR, V321, P407, DOI 10.1016/S0021-9673(01)90459-5; Liu H, 2006, MOL CANCER, V16, P5; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Noh SJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-98; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Rasmussen KD, 2011, BLOOD, V118, P2988, DOI 10.1182/blood-2011-04-350728; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Sankaran VG, 2011, HEMATOL-AM SOC HEMAT, P459, DOI 10.1182/asheducation-2011.1.459; Sankaran VG, 2011, P NATL ACAD SCI USA, V108, P1519, DOI 10.1073/pnas.1018384108; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621	56	84	93	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60436	10.1371/journal.pone.0060436	http://dx.doi.org/10.1371/journal.pone.0060436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593217	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100043
J	Feng, XM; Shikama, Y; Shichishima, T; Noji, H; Ikeda, K; Ogawa, K; Kimura, H; Takeishi, Y; Kimura, J				Feng, Xiaomin; Shikama, Yayoi; Shichishima, Tsutomu; Noji, Hideyoshi; Ikeda, Kazuhiko; Ogawa, Kazuei; Kimura, Hideo; Takeishi, Yasuchika; Kimura, Junko			Impairment of FOS mRNA Stabilization Following Translation Arrest in Granulocytes from Myelodysplastic Syndrome Patients	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; AU-RICH ELEMENTS; C-FOS; BINDING PROTEINS; STRESS GRANULES; GENE-EXPRESSION; NEUTROPHILS; HUR; CELLS	Although quantitative and qualitative granulocyte defects have been described in myelodysplastic syndromes (MDS), the underlying molecular basis of granulocyte dysfunction in MDS is largely unknown. We recently found that FOS mRNA elevation under translation-inhibiting stimuli was significantly smaller in granulocytes from MDS patients than in healthy individuals. The aim of this study is to clarify the cause of the impaired FOS induction in MDS. We first examined the mechanisms of FOS mRNA elevation using granulocytes from healthy donors cultured with the translation inhibitor emetine. Emetine increased both transcription and mRNA stability of FOS. p38 MAPK inhibition abolished the emetine-induced increase of FOS transcription but did not affect FOS mRNA stabilization. The binding of an AU-rich element (ARE)binding protein HuR to FOS mRNA containing an ARE in 3'UTR was increased by emetine, and the knockdown of HuR reduced the FOS mRNA stabilizing effect of emetine. We next compared the emetine-induced transcription and mRNA stabilization of FOS between MDS patients and healthy controls. Increased rates of FOS transcription by emetine were similar in MDS and controls. In the absence of emetine, FOS mRNA decayed to nearly 17% of initial levels in 45 min in both groups. In the presence of emetine, however, 76.7 +/- 19.8% of FOS mRNA remained after 45 min in healthy controls, versus 37.9 +/- 25.5% in MDS (P<0.01). To our knowledge, this is the first report demonstrating attenuation of stress-induced FOS mRNA stabilization in MDS granulocytes.	[Feng, Xiaomin; Shikama, Yayoi; Kimura, Junko] Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Japan; [Shichishima, Tsutomu; Noji, Hideyoshi; Ikeda, Kazuhiko; Ogawa, Kazuei; Takeishi, Yasuchika] Fukushima Med Univ, Sch Med, Dept Cardiol & Hematol, Fukushima, Japan; [Shichishima, Tsutomu] Fukushima Res Inst Environm & Med, Futaba, Japan; [Kimura, Hideo] Kita Fukushima Med Ctr, Dept Hematol, Date, Japan	Fukushima Medical University; Fukushima Medical University	Shikama, Y (corresponding author), Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Japan.	yayois@fmu.ac.jp			Japan Society for the Promotion of Science [MO23591400]; Smoking Research Foundation [KI18003];  [KPJ20005]; Grants-in-Aid for Scientific Research [23591400] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (C) [MO23591400] to YS from Japan Society for the Promotion of Science, Grants-in-Aid for Fukushima Medical University Research Project [KPJ20005] to YS, and Smoking Research Foundation [Grant KI18003] to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Badran A, 2004, BIOCHEM BIOPH RES CO, V314, P902, DOI 10.1016/j.bbrc.2003.12.178; Barker A, 2012, J BIOCHEM, V151, P423, DOI 10.1093/jb/mvs010; Bebien M, 2003, ONCOGENE, V22, P1836, DOI 10.1038/sj.onc.1206334; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Briata P, 2003, MOL CELL, V12, P1201, DOI 10.1016/S1097-2765(03)00407-6; Carulli G, 1997, LEUKEMIA RES, V21, P513, DOI 10.1016/S0145-2126(97)00009-X; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dunand-Sauthier I, 2011, BLOOD, V117, P4490, DOI 10.1182/blood-2010-09-308064; Fianchi L, 2012, LEUKEMIA RES, V36, P331, DOI 10.1016/j.leukres.2011.11.012; Fuhler GM, 2005, J LEUKOCYTE BIOL, V77, P257, DOI 10.1189/jlb.0504306; Fuhler GM, 2003, BLOOD, V101, P1172, DOI 10.1182/blood.V101.3.1172; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hu HY, 2008, J LEUKOCYTE BIOL, V83, P393, DOI 10.1189/jlb.0507282; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim HH, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/981487; Kouides PA, 1996, SEMIN HEMATOL, V33, P95; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Laroia G, 2002, NUCLEIC ACIDS RES, V30, P3052, DOI 10.1093/nar/gkf444; Li SL, 2001, J BIOL CHEM, V276, P39368, DOI 10.1074/jbc.M106111200; Liebermann DA, 1998, INT J ONCOL, V12, P685; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; MAQUAT LE, 1995, RNA, V1, P453; MARTIN S, 1983, J CLIN PATHOL, V36, P1120, DOI 10.1136/jcp.36.10.1120; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Pellagatti A, 2004, BRIT J HAEMATOL, V125, P576, DOI 10.1111/j.1365-2141.2004.04958.x; RAHMSDORF HJ, 1987, NUCLEIC ACIDS RES, V15, P1643, DOI 10.1093/nar/15.4.1643; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Sarkar S, 2008, J INTERF CYTOK RES, V28, P679, DOI 10.1089/jir.2008.0028; Scott BL, 2010, ANNU REV MED, V61, P345, DOI 10.1146/annurev.med.051308.132852; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shetty V, 2000, BLOOD, V96, P1388, DOI 10.1182/blood.V96.4.1388.h8001388_1388_1392; Shetty VT, 2001, BLOOD, V98, P1273, DOI 10.1182/blood.V98.4.1273; Shikama Y, 2005, J LEUKOCYTE BIOL, V77, P811, DOI 10.1189/jlb.0904488; Shikama Y, 2011, BRIT J HAEMATOL, V154, P525, DOI 10.1111/j.1365-2141.2010.08504.x; Shikama Y, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-42; Shimizu R, 1999, EXP HEMATOL, V27, P229, DOI 10.1016/S0301-472X(98)00048-4; Simi A, 2005, J NEUROCHEM, V92, P915, DOI 10.1111/j.1471-4159.2004.02938.x; van der Giessen K, 2007, MOL BIOL CELL, V18, P2619, DOI 10.1091/mbc.E07-02-0167; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Zouki C, 2001, J LEUKOCYTE BIOL, V69, P815	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61107	10.1371/journal.pone.0061107	http://dx.doi.org/10.1371/journal.pone.0061107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593403	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300050
J	Guillemot, V; Bender, A; Boulesteix, AL				Guillemot, Vincent; Bender, Andreas; Boulesteix, Anne-Laure			Iterative Reconstruction of High-Dimensional Gaussian Graphical Models Based on a New Method to Estimate Partial Correlations under Constraints	PLOS ONE			English	Article							COVARIANCE ESTIMATION; RIDGE REGRESSION; SHRINKAGE	In the context of Gaussian Graphical Models (GGMs) with high-dimensional small sample data, we present a simple procedure, called PACOSE - standing for PArtial COrrelation SElection - to estimate partial correlations under the constraint that some of them are strictly zero. This method can also be extended to covariance selection. If the goal is to estimate a GGM, our new procedure can be applied to re-estimate the partial correlations after a first graph has been estimated in the hope to improve the estimation of non-zero coefficients. This iterated version of PACOSE is called iPACOSE. In a simulation study, we compare PACOSE to existing methods and show that the re-estimated partial correlation coefficients may be closer to the real values in important cases. Plus, we show on simulated and real data that iPACOSE shows very interesting properties with regards to sensitivity, positive predictive value and stability.	[Guillemot, Vincent; Bender, Andreas; Boulesteix, Anne-Laure] Univ Munich, Dept Med Informat Biometry & Epidemiol, Fac Med, Munich, Germany	University of Munich	Boulesteix, AL (corresponding author), Univ Munich, Dept Med Informat Biometry & Epidemiol, Fac Med, Munich, Germany.	boulesteix@ibe.med.uni-muenchen.de	Guillemot, Vincent/E-1598-2011; Boulesteix, Anne-Laure/A-3948-2010; Bender, Andreas/ABB-9021-2020; Guillemot, Vincent/AAV-6018-2021	Guillemot, Vincent/0000-0002-7421-0655; Boulesteix, Anne-Laure/0000-0002-2729-0947; Bender, Andreas/0000-0001-5628-8611; 	German Science Foundation (DFG) [BO3139/2-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	VG was supported by grant BO3139/2-1 from the German Science Foundation (DFG: http://www.dfg.de/en) to ALB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianca C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S21; D'Aspremont A, 2008, SIAM J MATRIX ANAL A, V30, P56, DOI 10.1137/060670985; DEMPSTER AP, 1972, BIOMETRICS, V28, P157, DOI 10.2307/2528966; Fisher L, 1993, BIOSTATISTICS METHOD; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; GRONE R, 1984, LINEAR ALGEBRA APPL, V58, P109, DOI 10.1016/0024-3795(84)90207-6; HOERL AE, 1975, COMMUN STAT, V4, P105, DOI 10.1080/03610927508827232; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Kramer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-384; Krishnamurthy V, 2009, OPT 2009 2 NIPS WORK; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Segal MR, 2001, BIOMETRICS, V57, P632, DOI 10.1111/j.0006-341X.2001.00632.x; SPEED TP, 1986, ANN STAT, V14, P138, DOI 10.1214/aos/1176349846; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tenenhaus A, 2010, IEEE ACM T COMPUT BI, V7, P251, DOI 10.1109/TCBB.2008.87; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Varoquaux G, 2010, NEUROIMAGE, V51, P288, DOI 10.1016/j.neuroimage.2010.02.010; Vert JP, 2008, TECHNICAL REPORT; Verzelen N, 2009, COMPUT STAT DATA AN, V53, P1894, DOI 10.1016/j.csda.2008.09.022; Wermuth N, 1977, APPL STAT, V26, P88; Whittaker J., 1990, GRAPHICAL MODELS APP; Wiesel A, 2010, IEEE T SIGNAL PROCES, V58, P1482, DOI 10.1109/TSP.2009.2037350; Witten DM, 2009, J R STAT SOC B, V71, P615, DOI 10.1111/j.1467-9868.2009.00699.x; Wold H., 1975, QUANTITATIVE SOCIOLO; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	30	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60536	10.1371/journal.pone.0060536	http://dx.doi.org/10.1371/journal.pone.0060536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593235	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200008
J	Zhang, XY; Lu, LJ; Song, Q; Yang, QQ; Li, DP; Sun, JM; Li, TH; Cong, PS				Zhang, Xiao-yan; Lu, Long-jian; Song, Qi; Yang, Qian-qian; Li, Da-peng; Sun, Jiang-ming; Li, Tong-hua; Cong, Pei-sheng			DomHR: Accurately Identifying Domain Boundaries in Proteins Using a Hinge Region Strategy	PLOS ONE			English	Article							SECONDARY STRUCTURE; NEURAL-NETWORK; PREDICTION; DATABASE; CLASSIFICATION; PERFORMANCE; ASSIGNMENT; ALIGNMENT; SPINE; CATH	Motivation: The precise prediction of protein domains, which are the structural, functional and evolutionary units of proteins, has been a research focus in recent years. Although many methods have been presented for predicting protein domains and boundaries, the accuracy of predictions could be improved. Results: In this study we present a novel approach, DomHR, which is an accurate predictor of protein domain boundaries based on a creative hinge region strategy. A hinge region was defined as a segment of amino acids that covers part of a domain region and a boundary region. We developed a strategy to construct profiles of domain-hinge-boundary (DHB) features generated by sequence-domain/hinge/boundary alignment against a database of known domain structures. The DHB features had three elements: normalized domain, hinge, and boundary probabilities. The DHB features were used as input to identify domain boundaries in a sequence. DomHR used a nonredundant dataset as the training set, the DHB and predicted shape string as features, and a conditional random field as the classification algorithm. In predicted hinge regions, a residue was determined to be a domain or a boundary according to a decision threshold. After decision thresholds were optimized, DomHR was evaluated by cross-validation, large-scale prediction, independent test and CASP (Critical Assessment of Techniques for Protein Structure Prediction) tests. All results confirmed that DomHR outperformed other well-established, publicly available domain boundary predictors for prediction accuracy. Availability: The DomHR is available at http://cal.tongji.edu.cn/domain/.	[Zhang, Xiao-yan; Lu, Long-jian; Song, Qi; Yang, Qian-qian; Li, Da-peng; Sun, Jiang-ming; Li, Tong-hua; Cong, Pei-sheng] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China	Tongji University	Li, TH (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	lith@tongji.edu.cn; pshcong@tongji.edu.cn	Sun, Jiangming/AFT-1203-2022	Sun, Jiangming/0000-0001-6814-1297	National Natural Science Foundation of China [21275108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (21275108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2004, BIOINFORMATICS SEQUE; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chen P, 2010, AMINO ACIDS, V39, P713, DOI 10.1007/s00726-010-0506-6; Cheng J, 2007, NUCLEIC ACIDS RES, V35, pW354, DOI 10.1093/nar/gkm390; Cheng JL, 2006, DATA MIN KNOWL DISC, V13, P1, DOI 10.1007/s10618-005-0023-5; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Csaba G, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-23; David S, 2009, PROTEIN DOMAIN BOUND, P209; Dor O, 2007, PROTEINS, V68, P76, DOI 10.1002/prot.21408; Dumontier M, 2005, J MOL BIOL, V350, P1061, DOI 10.1016/j.jmb.2005.05.037; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Eickholt J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-43; Galzitskaya OV, 2003, PROTEIN SCI, V12, P696, DOI 10.1110/ps.0233103; George RA, 2002, J MOL BIOL, V316, P839, DOI 10.1006/jmbi.2001.5387; Gewehr JE, 2006, BIOINFORMATICS, V22, P181, DOI 10.1093/bioinformatics/bti751; Gunn S. R., 1998, ISIS TECH REP, V14, P5; Heger A, 2003, J MOL BIOL, V328, P749, DOI 10.1016/S0022-2836(03)00269-9; Ison RE, 2005, IEEE ENG MED BIOL, V24, P41, DOI 10.1109/MEMB.2005.1436459; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li DP, 2012, BIOINFORMATICS, V28, P32, DOI 10.1093/bioinformatics/btr611; Liu JF, 2004, NUCLEIC ACIDS RES, V32, P3522, DOI 10.1093/nar/gkh684; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Nagarajan N, 2004, BIOINFORMATICS, V20, P1335, DOI 10.1093/bioinformatics/bth086; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Sikder AR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S6; Sim J, 2005, PROTEINS, V59, P627, DOI 10.1002/prot.20442; Sun JM, 2012, NUCLEIC ACIDS RES, V40, pW298, DOI 10.1093/nar/gks361; Suyama M, 2003, BIOINFORMATICS, V19, P673, DOI 10.1093/bioinformatics/btg031; Tai CH, 2011, PROTEINS, V79, P853, DOI 10.1002/prot.22923; Tang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-283; Tress M, 2005, PROTEINS, V61, P8, DOI 10.1002/prot.20717; von Ohsen N, 2004, BIOINFORMATICS, V20, P2228, DOI 10.1093/bioinformatics/bth232; Walsh I, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-195; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Wheelan SJ, 2000, BIOINFORMATICS, V16, P613, DOI 10.1093/bioinformatics/16.7.613; Yao X, 1999, P IEEE, V87, P1423, DOI 10.1109/5.784219; Ye L, 2008, PROTEINS, V71, P300, DOI 10.1002/prot.21745; Yoo P, 2008, BMC BIOINFORMATICS, V9, P1; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhu YJ, 2012, AMINO ACIDS, V42, P1749, DOI 10.1007/s00726-011-0889-z; Zou SX, 2008, J BIONIC ENG, V5, P215, DOI 10.1016/S1672-6529(08)60027-X	49	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60559	10.1371/journal.pone.0060559	http://dx.doi.org/10.1371/journal.pone.0060559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593247	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200012
J	Horn, CC; Kimball, BA; Wang, H; Kaus, J; Dienel, S; Nagy, A; Gathright, GR; Yates, BJ; Andrews, PLR				Horn, Charles C.; Kimball, Bruce A.; Wang, Hong; Kaus, James; Dienel, Samuel; Nagy, Allysa; Gathright, Gordon R.; Yates, Bill J.; Andrews, Paul L. R.			Why Can't Rodents Vomit? A Comparative Behavioral, Anatomical, and Physiological Study	PLOS ONE			English	Article							CISPLATIN-INDUCED EMESIS; HOUSE MUSK SHREW; BRAIN-STEM PREPARATION; TACHYKININ NK1 RECEPTOR; DRUG-INDUCED EMESIS; SUNCUS-MURINUS; ANTIEMETIC ACTIVITY; EXPERIMENTAL-MODEL; PHRENIC MOTONEURONS; LITHIUM-CHLORIDE	The vomiting (emetic) reflex is documented in numerous mammalian species, including primates and carnivores, yet laboratory rats and mice appear to lack this response. It is unclear whether these rodents do not vomit because of anatomical constraints (e.g., a relatively long abdominal esophagus) or lack of key neural circuits. Moreover, it is unknown whether laboratory rodents are representative of Rodentia with regards to this reflex. Here we conducted behavioral testing of members of all three major groups of Rodentia; mouse-related (rat, mouse, vole, beaver), Ctenohystrica (guinea pig, nutria), and squirrel-related (mountain beaver) species. Prototypical emetic agents, apomorphine (sc), veratrine (sc), and copper sulfate (ig), failed to produce either retching or vomiting in these species (although other behavioral effects, e.g., locomotion, were noted). These rodents also had anatomical constraints, which could limit the efficiency of vomiting should it be attempted, including reduced muscularity of the diaphragm and stomach geometry that is not well structured for moving contents towards the esophagus compared to species that can vomit (cat, ferret, and musk shrew). Lastly, an in situ brainstem preparation was used to make sensitive measures of mouth, esophagus, and shoulder muscular movements, and phrenic nerve activity-key features of emetic episodes. Laboratory mice and rats failed to display any of the common coordinated actions of these indices after typical emetic stimulation (resiniferatoxin and vagal afferent stimulation) compared to musk shrews. Overall the results suggest that the inability to vomit is a general property of Rodentia and that an absent brainstem neurological component is the most likely cause. The implications of these findings for the utility of rodents as models in the area of emesis research are discussed.	[Horn, Charles C.] Univ Pittsburgh, Biobehav Med Oncol Program, Inst Canc, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Horn, Charles C.; Yates, Bill J.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kimball, Bruce A.] Wildlife Serv, USDA, Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr,Monell Chem Senses Ctr, Philadelphia, PA USA; [Wang, Hong] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Kaus, James; Dienel, Samuel; Nagy, Allysa; Yates, Bill J.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Gathright, Gordon R.] Wildlife Serv, USDA, Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Yates, Bill J.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Andrews, Paul L. R.] St Georges Univ London, Div Biomed Sci, London, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Monell Chemical Senses Center; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Georges University London	Horn, CC (corresponding author), Univ Pittsburgh, Biobehav Med Oncol Program, Inst Canc, Pittsburgh, PA 15260 USA.	chorn@pitt.edu	Yates, Bill/D-5602-2009; Horn, Charles C./AAH-3927-2020; Dienel, Samuel/AAJ-2639-2020	Yates, Bill/0000-0001-6819-097X; Horn, Charles C./0000-0002-5587-3912; Dienel, Samuel/0000-0002-1751-5460; Wang, Hong/0000-0003-0477-2908	National Institutes of Health [DK-065971, DC-003732, CA-047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants DK-065971, DC-003732, and CA-047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 1996, EUR J PHARMACOL, V307, P305, DOI 10.1016/0014-2999(96)00275-0; Andrews PLR, 2006, AUTON NEUROSCI-BASIC, V125, P100, DOI 10.1016/j.autneu.2006.01.008; Andrews PLR, 2004, HANDB EXP PHARM, V164, P359; ANDREWS PLR, 1990, CAN J PHYSIOL PHARM, V68, P325, DOI 10.1139/y90-047; Andrews PLR, 2000, BRIT J PHARMACOL, V130, P1247, DOI 10.1038/sj.bjp.0703428; ANDREWS PLR, 1990, PHARMACODYN THER LIF, V9, P135; ANDREWS PLR, 2003, NEUROGASTROENTERO MO, V15, P28; ANDREWS PLR, 1995, PHYSIOL ZOOL, V68, P61; Billig I, 2001, AM J PHYSIOL-REG I, V281, pR1243, DOI 10.1152/ajpregu.2001.281.4.R1243; Billig I, 2000, J NEUROSCI, V20, P7446; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; BOBKOV YG, 1965, FED PROC, V24, pT325; BORISON HL, 1949, J NEUROPHYSIOL, V12, P305, DOI 10.1152/jn.1949.12.5.305; Churakov G, 2010, MOL BIOL EVOL, V27, P1315, DOI 10.1093/molbev/msq019; COSTALL B, 1990, NEUROPHARMACOLOGY, V29, P453, DOI 10.1016/0028-3908(90)90167-P; COSTELLO DJ, 1977, J PHARMACOL EXP THER, V203, P222; Darmani NA, 2005, PHARMACOL BIOCHEM BE, V80, P35, DOI 10.1016/j.pbb.2004.10.019; Darmani NA, 1998, J NEURAL TRANSM, V105, P1143, DOI 10.1007/s007020050118; DeStefino VJ, 2011, J APPL PHYSIOL, V110, P1699, DOI 10.1152/japplphysiol.00180.2011; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; FLORCZYK AP, 1982, CANCER TREAT REP, V66, P187; FLYNN FW, 1991, BEHAV NEUROSCI, V105, P933, DOI 10.1037/0735-7044.105.6.933; FOSS JF, 1993, J CLIN PHARMACOL, V33, P747, DOI 10.1002/j.1552-4604.1993.tb05618.x; FUKUI H, 1993, EUR J PHARMACOL, V249, P13; Furukawa N, 1998, AM J PHYSIOL-GASTR L, V275, pG1193, DOI 10.1152/ajpgi.1998.275.5.G1193; Gerstner GE, 1998, PHYSIOL BEHAV, V65, P569, DOI 10.1016/S0031-9384(98)00200-5; GRABOWSK.M, 1974, PHARMACOL BIOCHEM BE, V2, P263, DOI 10.1016/0091-3057(74)90063-X; GRELOT L, 1992, J NEUROPHYSIOL, V68, P2110, DOI 10.1152/jn.1992.68.6.2110; GRELOT L, 1994, NEWS PHYSIOL SCI, V9, P142; GYLYS JA, 1979, RES COMMUN CHEM PATH, V23, P61; HARDING RK, 1987, EUR J PHARMACOL, V144, P61, DOI 10.1016/0014-2999(87)90009-4; HARPER AA, 1959, J PHYSIOL-LONDON, V148, P417, DOI 10.1113/jphysiol.1959.sp006297; HAWTHORN J, 1988, BRAIN RES, V438, P193, DOI 10.1016/0006-8993(88)91338-8; Horn CC, 2008, APPETITE, V50, P430, DOI 10.1016/j.appet.2007.09.015; Horn CC, 2012, PHYSIOL BEHAV, V106, P562, DOI 10.1016/j.physbeh.2012.03.031; Huang D, 2011, J NEUROSCI METH, V197, P249, DOI 10.1016/j.jneumeth.2011.02.032; INGRAM DK, 1982, J GEN PSYCHOL, V106, P233; Kayashima N, 1975, Nihon Yakurigaku Zasshi, V71, P169; KAYASHIMA N, 1978, JPN J PHARMACOL, V28, P797, DOI 10.1254/jjp.28.797; KNOX AP, 1993, BRAIN RES BULL, V31, P477, DOI 10.1016/0361-9230(93)90112-O; KOCH KL, 1990, J CLIN ENDOCR METAB, V71, P1269, DOI 10.1210/jcem-71-5-1269; KRIS MG, 1985, J CLIN ONCOL, V3, P1379, DOI 10.1200/JCO.1985.3.10.1379; Lang IM, 1999, AM J PHYSIOL-GASTR L, V277, pG642, DOI 10.1152/ajpgi.1999.277.3.G642; LAWES INC, 1990, CAN J PHYSIOL PHARM, V68, P254; LEFEBVRE RA, 1981, EUR J PHARMACOL, V69, P139, DOI 10.1016/0014-2999(81)90408-8; Lois JH, 2009, J APPL PHYSIOL, V106, P138, DOI 10.1152/japplphysiol.91125.2008; MATSUKI N, 1993, EXP ANIM TOKYO, V42, P225, DOI 10.1538/expanim1978.42.2_225; MATSUKI N, 1988, JPN J PHARMACOL, V48, P303, DOI 10.1254/jjp.48.303; Matsuki N, 1997, PHARMACOL BIOCHEM BE, V57, P721, DOI 10.1016/S0091-3057(96)00389-9; MCCARTHY LE, 1981, J CLIN PHARMACOL, V21, pS30, DOI 10.1002/j.1552-4604.1981.tb02570.x; MIASKIEWICZ SL, 1989, J CLIN ENDOCR METAB, V68, P837, DOI 10.1210/jcem-68-4-837; MILLER AD, 1993, BRAIN RES, V606, P143, DOI 10.1016/0006-8993(93)91582-D; Nakayama H, 2005, J PHARMACOL SCI, V98, P396, DOI 10.1254/jphs.FPJ05001X; Onishi T, 2007, AUTON NEUROSCI-BASIC, V136, P20, DOI 10.1016/j.autneu.2007.03.002; PAPP RH, 1966, J PHARMACOL EXP THER, V154, P333; Parker LA, 2008, CAN J EXP PSYCHOL, V62, P198, DOI 10.1037/a0012531; Paton JFR, 1996, J PHYSIOL-LONDON, V493, P819, DOI 10.1113/jphysiol.1996.sp021425; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; Pickering AE, 2006, J NEUROSCI METH, V155, P260, DOI 10.1016/j.jneumeth.2006.01.011; Pickering M, 2002, J ANAT, V201, P305, DOI 10.1046/j.1469-7580.2002.00095.x; RABIN BM, 1992, BEHAV NEURAL BIOL, V58, P83, DOI 10.1016/0163-1047(92)90291-B; Rudd JA, 1999, EUR J PHARMACOL, V366, P243, DOI 10.1016/S0014-2999(98)00920-0; Sanger GJ, 2011, TRENDS PHARMACOL SCI, V32, P402, DOI 10.1016/j.tips.2011.03.009; SCHURIG JE, 1982, CANCER TREAT REP, V66, P1831; Schwartzberg Lee, 2006, J Support Oncol, V4, P3; Smith JE, 2002, EXP PHYSIOL, V87, P563, DOI 10.1113/eph8702424; Smith JE, 2001, AUTON NEUROSCI-BASIC, V89, P54, DOI 10.1016/S1566-0702(01)00251-X; Smith JE, 2001, PHYSIOL BEHAV, V73, P593, DOI 10.1016/S0031-9384(01)00538-8; SMITH WL, 1989, J PHARM PHARMACOL, V41, P101, DOI 10.1111/j.2042-7158.1989.tb06402.x; STARR BS, 1986, NEUROPHARMACOLOGY, V25, P455, DOI 10.1016/0028-3908(86)90168-1; Stegmann M, 2002, INFORM MATH MODELLIN; Stern R. M., 2011, NAUSEA MECH MANAGEME; UENO S, 1987, LIFE SCI, V41, P513, DOI 10.1016/0024-3205(87)90229-3; VERBALIS JG, 1986, BEHAV NEUROSCI, V100, P466, DOI 10.1037/0735-7044.100.4.466; VERBALIS JG, 1987, AM J PHYSIOL, V252, pR749, DOI 10.1152/ajpregu.1987.252.4.R749; VERBALIS JG, 1986, SCIENCE, V232, P1417, DOI 10.1126/science.3715453; Yates BJ, 1999, NEUROSCIENCE, V90, P1501, DOI 10.1016/S0306-4522(98)00554-5; Zhang F, 2006, WORLD J GASTROENTERO, V12, P1300, DOI 10.3748/wjg.v12.i8.1300	80	127	132	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60537	10.1371/journal.pone.0060537	http://dx.doi.org/10.1371/journal.pone.0060537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593236	Green Accepted, Green Published, gold			2022-12-27	WOS:000317382000018
J	Matthews, GV; Ali, RJ; Avihingsanon, A; Amin, J; Hammond, R; Bowden, S; Lewin, SR; Sasadeusz, J; Littlejohn, M; Locarnini, SL; Ruxrungtham, K; Dore, GJ				Matthews, Gail V.; Ali, Rachel J.; Avihingsanon, Anchalee; Amin, Janaki; Hammond, Rachel; Bowden, Scott; Lewin, Sharon R.; Sasadeusz, Joe; Littlejohn, Margaret; Locarnini, Stephen L.; Ruxrungtham, Kiat; Dore, Gregory J.			Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; E-ANTIGEN SEROCONVERSION; SURFACE-ANTIGEN; PEGINTERFERON ALPHA-2A; VIROLOGICAL RESPONSE; ADEFOVIR DIPIVOXIL; NATURAL-HISTORY; THERAPY; LAMIVUDINE; COMBINATION	Objective: Anti-HBe seroconversion and HBsAg loss are important therapeutic endpoints in patients with hepatitis B virus (HBV) infection. Quantitative measures of hepatitis B surface antigen (qHBsAg) and e antigen (qHBeAg) have been identified as potentially useful indicators of therapeutic response in HBV monoinfection. The aim of this study was to examine serological change including quantitative biomarkers in HIV-HBV coinfected patients initiating HBV active antiretroviral therapy (ART). Methods: HIV-HBV coinfected individuals from Thailand were followed for up to 168 weeks post ART. Rates and associations of qualitative serological change were determined. Longitudinal changes in qHBsAg and qHBeAg were measured and their utility as predictors of response examined. Results: Forty seven patients were included of whom 27 (57%) were HBeAg positive at baseline. Median CD4 count was 48 cells/mm(3). Over a median follow-up of 108 weeks 48% (13/27) lost HBeAg, 12/27 (44%) achieved anti-HBe seroconversion and 13% (6/47) HBsAg loss. Anti-HBe seroconversion was associated with higher baseline ALT (p = 0.034), lower qHBsAg (p = 0.015), lower qHBeAg (p = 0.031) and greater HBV DNA decline to week 24 (p = 0.045). Sensitivity and specificity for qHBsAg and qHBeAg decline of >0.5 log at week 12 and >1.0 log at week 24 were high for both anti-HBe seroconversion and HBsAg loss. Conclusions: Rates of serological change in these HIV-HBV coinfected individuals with advanced immunodeficiency initiating HBV-active ART were high. Baseline and on treatment factors were identified that were associated with a greater likelihood of subsequent anti-HBe seroconversion, including both quantitative HBsAg and HBeAg, suggesting these biomarkers may have utility in this clinical setting.	[Matthews, Gail V.; Ali, Rachel J.; Amin, Janaki; Dore, Gregory J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Avihingsanon, Anchalee; Ruxrungtham, Kiat] Chulongkorn Univ, Dept Med, Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand; [Hammond, Rachel; Bowden, Scott; Littlejohn, Margaret; Locarnini, Stephen L.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Lewin, Sharon R.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Sasadeusz, Joe] Royal Melbourne Hosp, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Chulalongkorn University; Thai Red Cross Society; Victorian Infectious Diseases Reference Laboratory; Monash University; Florey Institute of Neuroscience & Mental Health; Burnet Institute; Royal Melbourne Hospital	Matthews, GV (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	gmatthews@kirby.unsw.edu.au	Lewin, Sharon/Z-3297-2019; matthews, gail/AFL-8501-2022; matthews, gail/AAG-8626-2022; Dore, Gregory John/ABD-5665-2021	Dore, Gregory John/0000-0002-4741-2622; Littlejohn, Margaret/0000-0002-8206-2664; Matthews, Gail/0000-0002-1048-6396; Amin, Janaki/0000-0003-2161-9366; Ruxrungtham, Kiat/0000-0001-7348-2352; Lewin, Sharon Ruth/0000-0002-0330-8241	Gilead sciences; Gilead; MSD; Merck; BMS; Roche; Melbourne Health; Receipt of Intellectual Property Rights/Patent Holder; National Research University Project of CHE [HR1161A]; Ministry of Education; GlaxoSmithKline; Janssen	Gilead sciences(Gilead Sciences); Gilead(Gilead Sciences); MSD; Merck(Merck & Company); BMS(Bristol-Myers Squibb); Roche(Roche Holding); Melbourne Health; Receipt of Intellectual Property Rights/Patent Holder; National Research University Project of CHE; Ministry of Education; GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Gilead sciences provided unrestricted grant support to complete quantitative testing for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journals policy and declare the following conflicts. Matthews GV: Grant funding: Gilead, MSD, Speakers bureau: Gilead, Roche, MSD, BMS, Janssen, Travel support: Janssen, MSD. Ali RJ: None. Avihingsanon A: None. Lewin SR: Grant funding: Gilead and Merck; Paid consultant and speaker: Gilead, Viiv Healthcare; Advisory Board: Gilead and Merck. Sasadeusz J: Gilead: research funding, meeting sponsorship, Merck: research funding, meeting sponsorship, BMS: research funding, Roche: research funding, paid speaker, advisory board. Hammond R: None. Bowden S: Speaker with honorarium for Gilead, Bristol-Myers Squibb, Roche and Merck. Littlejohn M: None. Locarnini S: Royalties - "Melbourne Health; Receipt of Intellectual Property Rights/Patent Holder -" Melbourne Health; Consulting Fees (eg. Advisory Boards) - Evivar Pty Ltd, Gilead, Bristol-Myers Squibb; Fees for Non-CME Services Received Directly from a Commercial Interest or their Agent -Bristol-Myers Squibb, Merck Sharpe and Dohme Pty Ltd. Ruxrungtham K has been awarded Senior Researcher Scholar, Thai Research Fund; The National Research University Project of CHE (HR1161A), Ministry of Education; and the Professional Research Team Strengthening Fund, from the National Science and Technology Development Agency (NSTDA), BIOTEC, Ministry of Science and Technology; Thailand. He has also served as a consultant for Merck, and Tibotec. He has been a speaker with honorarium for Bristol-Myers Squibb, Merck, Roche, Jensen-Cilag, GlaxoSmithKline, and GPO. Dore GJ: Board membership: Roche, Merck, Janssen, Gilead, BMS; Honoraria: Roche, Merck, Janssen, Gilead, BMS; Research grants: Roche, Merck, Janssen, Gilead, BMS; Scholarship: Roche, Merck, Janssen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ayihingsanon A, 2010, ANTIVIR THER, V15, P917, DOI 10.3851/IMP1645; BODSWORTH NJ, 1991, J INFECT DIS, V163, P1138, DOI 10.1093/infdis/163.5.1138; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Cai W, 2010, J CLIN VIROL, V48, P22, DOI 10.1016/j.jcv.2010.02.014; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CH, 2004, EUR J GASTROEN HEPAT, V16, P1213, DOI 10.1097/00042737-200411000-00021; de Vries-Sluijs TEMS, 2010, GASTROENTEROLOGY, V139, P1934, DOI 10.1053/j.gastro.2010.08.045; Gane E, 2010, 61 ANN M AM ASS STUD; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; JANSSEN HLA, 1994, ANTIVIR RES, V23, P251, DOI 10.1016/0166-3542(94)90022-1; Jung YK, 2010, J CLIN GASTROENTEROL, V44, P653, DOI 10.1097/MCG.0b013e3181d52946; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee JM, 2011, HEPATOLOGY, V53, P1486, DOI 10.1002/hep.24221; Leung NWY, 2001, HEPATOLOGY, V33, P1527, DOI 10.1053/jhep.2001.25084; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P246, DOI 10.1046/j.1440-1746.2003.02976.x; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Matthews GV, 2008, HEPATOLOGY, V48, P1062, DOI 10.1002/hep.22462; Maylin S, 2012, AIDS, V26, P939, DOI 10.1097/QAD.0b013e328352224d; Miailhes P, 2007, CLIN INFECT DIS, V45, P624, DOI 10.1086/520752; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Piratvisuth T, 2011, HEPATOL INT; Reijnders JGP, 2011, J HEPATOL, V54, P449, DOI 10.1016/j.jhep.2010.07.046; Thibault V, 2011, ANTIVIR THER, V16, P199, DOI 10.3851/IMP1723; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Yuen MF, 2003, GUT, V52, P416, DOI 10.1136/gut.52.3.416	28	37	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61297	10.1371/journal.pone.0061297	http://dx.doi.org/10.1371/journal.pone.0061297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593455	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600102
J	Paschon, V; Higa, GSV; Walter, LT; de Sousa, E; Zuzarte, FCC; Weber, VRS; Resende, RR; Kihara, AH				Paschon, Vera; Vilar Higa, Guilherme Shigueto; Walter, Lais Takata; de Sousa, Erica; Cortesao Zuzarte, Fausto Colla; Schwendler Weber, Vivian Roca; Resende, Rodrigo Ribeiro; Kihara, Alexandre Hiroaki			A New and Reliable Guide for Studies of Neuronal Loss Based on Focal Lesions and Combinations of In Vivo and In Vitro Approaches	PLOS ONE			English	Article							CELL-PROLIFERATION; CARBON NANOTUBES; FIXED TISSUE; RETINA; EXPRESSION; PROTEINS; VULNERABILITY; MECHANISMS; INCREASES; PATTERNS	In this study, we describe a simple and reliable method to study neuroprotective effects in living and organized neural tissue. This method, which was based on retinal explants for in vivo focal lesions, was conceived as a collection of modular procedures, which can be customized for particular demands. With this model, it is possible to combine immunohistochemistry with image data analysis to track the two-or three-dimensional redistribution of proteins as a time/space function of primary cell loss. At the same time, it is possible to finely control the exposure of the tissue to specific drugs and molecules. In order to illustrate the use of the proposed method, we tested the effects of two different nanotube compounds on retinal explant viability. Transcriptome analyses can be separately performed in the lesion focus and penumbra with laser capture microdissection followed by polymerase chain reaction analyses. In addition, other common experimental drawbacks, such as high individual variance, are eliminated. With intraocular injections, treatments can be verified in vivo, with one eye serving as the experimental tissue and the other serving as the control tissue. In summary, we describe a flexible and easy method, which can be useful in combination with a broad variety of recently developed neuroprotective strategies, to study neurodegeneration.	[Paschon, Vera; Vilar Higa, Guilherme Shigueto; Walter, Lais Takata; de Sousa, Erica; Cortesao Zuzarte, Fausto Colla; Schwendler Weber, Vivian Roca; Kihara, Alexandre Hiroaki] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Nucleo Cognicao & Sistemas Complexos, Sao Paulo, Brazil; [Paschon, Vera; Vilar Higa, Guilherme Shigueto; Kihara, Alexandre Hiroaki] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, BR-05508 Sao Paulo, Brazil; [Resende, Rodrigo Ribeiro] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Kihara, AH (corresponding author), Univ Fed ABC, Ctr Matemat Comp & Cognicao, Nucleo Cognicao & Sistemas Complexos, Sao Paulo, Brazil.	alexandrekihara@gmail.com	KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Higa, Guilherme S. V./G-4282-2016; Kihara, Alexandre H/C-2458-2012; de Sousa, Erica/HGD-9751-2022; Paschon, Vera/F-7363-2013	KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; Higa, Guilherme S. V./0000-0001-7006-9263; Kihara, Alexandre H/0000-0002-4027-7261; Resende, Rodrigo/0000-0002-2003-0739	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Universidade Federal do ABC (UFABC)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do ABC (UFABC)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Universidade Federal do ABC (UFABC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahori Y, 1997, NEUROREPORT, V8, P2265, DOI 10.1097/00001756-199707070-00034; Becker D, 1998, CELL BIOL INT, V22, P781, DOI 10.1006/cbir.1998.0390; Belmonte MA, 2006, INVEST OPHTH VIS SCI, V47, P1193, DOI 10.1167/iovs.05-0446; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Bittencourt J., 2007, METODOS NEUROCIENCIA; Bull ND, 2011, INVEST OPHTH VIS SCI, V52, P3309, DOI 10.1167/iovs.10-6873; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; da Silva EE, 2009, NANO RES, V2, P462, DOI 10.1007/s12274-009-9042-7; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Eckstein F, 2007, EXPERT OPIN BIOL TH, V7, P1021, DOI 10.1517/14712598.7.7.1021; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; FOSS RD, 1994, DIAGN MOL PATHOL, V3, P148, DOI 10.1097/00019606-199409000-00003; Friedrich S, 2012, J NEUROSCI METH, V205, P1, DOI 10.1016/j.jneumeth.2011.12.009; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; KEILHOFF G, 1993, NEUROREPORT, V5, P129, DOI 10.1097/00001756-199311180-00008; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Khabashesku VN, 2002, ACCOUNTS CHEM RES, V35, P1087, DOI 10.1021/ar020146y; Kihara AH, 2008, NEUROSCIENCE, V151, P995, DOI 10.1016/j.neuroscience.2007.09.088; Kihara AH, 2005, J NEUROSCI METH, V148, P103, DOI 10.1016/j.jneumeth.2005.04.019; Kihara AH, 2010, INT J DEV NEUROSCI, V28, P39, DOI 10.1016/j.ijdevneu.2009.09.006; Ladeira MS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385101; Lee HJ, 2011, NAT NANOTECHNOL, V6, P120, DOI 10.1038/nnano.2010.281; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Magharious MM, 2011, J VIS EXP; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Nastasijevic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039595; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Paschon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045449; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Qin Y, 2003, J NEUROSCI METH, V131, P205, DOI 10.1016/j.jneumeth.2003.08.010; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Rawanduzy A, 1997, Neurosurg Focus, V2, pE1; ROMANO C, 1995, J NEUROCHEM, V65, P59; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Seigel G, 1999, MOL VIS, V5; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Silva GA, 2006, NAT REV NEUROSCI, V7, P65, DOI 10.1038/nrn1827; Striedinger K, 2005, EUR J NEUROSCI, V22, P605, DOI 10.1111/j.1460-9568.2005.04228.x; Sureda FX, 2011, CURR PHARM DESIGN, V17, P230; TORELLI S, 1989, EXP BIOL, V48, P187; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wines-Samuelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010195; Zhang SSM, 2002, METHODS, V28, P439, DOI 10.1016/S1046-2023(02)00263-3	44	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60486	10.1371/journal.pone.0060486	http://dx.doi.org/10.1371/journal.pone.0060486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585836	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600024
J	Schaffner, F; Yokota, N; Carneiro-Lobo, T; Kitano, M; Schaffer, M; Anderson, GM; Mueller, BM; Esmon, CT; Ruf, W				Schaffner, Florence; Yokota, Naho; Carneiro-Lobo, Tatiana; Kitano, Maki; Schaffer, Michael; Anderson, G. Mark; Mueller, Barbara M.; Esmon, Charles T.; Ruf, Wolfram			Endothelial Protein C Receptor Function in Murine and Human Breast Cancer Development	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; FACTOR CYTOPLASMIC DOMAIN; TISSUE FACTOR; STEM-CELLS; IN-VIVO; MESENCHYMAL TRANSITION; TUMOR-GROWTH; ACTIVATED RECEPTOR-1; HEMATOPOIETIC STEM; BONE-MARROW	Several markers identify cancer stem cell-like populations, but little is known about the functional roles of stem cell surface receptors in tumor progression. Here, we show that the endothelial protein C receptor (EPCR), a stem cell marker in hematopoietic, neuronal and epithelial cells, is crucial for breast cancer growth in the orthotopic microenvironment of the mammary gland. Mice with a hypomorphic allele of EPCR show reduced tumor growth in the PyMT-model of spontaneous breast cancer development and deletion of EPCR in established PyMT tumor cells significantly attenuates transplanted tumor take and growth. We find expansion of EPCR+ cancer stem cell-like populations in aggressive, mammary fat pad-enhanced human triple negative breast cancer cells. In this model, EPCR-expressing cells have markedly increased mammosphere- and tumor-cell initiating activity compared to another stable progenitor-like subpopulation present at comparable frequency. We show that receptor blocking antibodies to EPCR specifically attenuate in vivo tumor growth initiated by either EPCR+ cells or the heterogenous mixture of EPCR+ and EPCR- cells. Furthermore, we have identified tumor associated macrophages as a major source for recognized ligands of EPCR, suggesting a novel mechanism by which cancer stem cell-like populations are regulated by innate immune cells in the tumor microenvironment.	[Schaffner, Florence; Yokota, Naho; Carneiro-Lobo, Tatiana; Kitano, Maki; Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Schaffer, Michael; Anderson, G. Mark] Janssen Res & Dev, Biol Res, Radnor, PA USA; [Mueller, Barbara M.] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Coagulat Biol Lab, Oklahoma City, OK 73104 USA; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma City, OK USA	Scripps Research Institute; Torrey Pines Institute for Molecular Studies, California; Oklahoma Medical Research Foundation; Howard Hughes Medical Institute	Ruf, W (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	ruf@scripps.edu			NIH [HL-60742]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060742] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grant HL-60742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Albrektsen T, 2007, J THROMB HAEMOST, V5, P1588, DOI 10.1111/j.1538-7836.2007.02603.x; Anastassiou D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-529; Anton I, 2012, AM J RESP CRIT CARE, V186, P96, DOI 10.1164/rccm.201110-1826OC; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Beaulieu LM, 2007, EXP CELL RES, V313, P677, DOI 10.1016/j.yexcr.2006.11.019; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bezuhly M, 2009, BLOOD, V113, P3371, DOI 10.1182/blood-2008-05-159434; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Castellino FJ, 2002, THROMB HAEMOSTASIS, V88, P462; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; CHAPMAN HA, 1985, J CLIN INVEST, V75, P2030, DOI 10.1172/JCI111922; Disse J, 2011, J THROMB HAEMOST, V9, P2516, DOI 10.1111/j.1538-7836.2011.04521.x; Disse J, 2011, J BIOL CHEM, V286, P5756, DOI 10.1074/jbc.M110.201228; Dorfleutner A, 2004, MOL BIOL CELL, V15, P4416, DOI 10.1091/mbc.E03-09-0640; Esmon CT, 2006, CURR OPIN HEMATOL, V13, P382, DOI 10.1097/01.moh.0000239712.93662.35; Gessler F, 2010, NEUROSCIENCE, V165, P1312, DOI 10.1016/j.neuroscience.2009.11.049; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kerschen E, 2010, J CLIN INVEST, V120, P3167, DOI 10.1172/JCI42629; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Koizume S, 2006, CANCER RES, V66, P9453, DOI 10.1158/0008-5472.CAN-06-1803; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Li WH, 2005, BLOOD, V106, P2716, DOI 10.1182/blood-2005-01-0406; Liaw PCY, 2001, J BIOL CHEM, V276, P8364, DOI 10.1074/jbc.M010572200; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian H, 2006, BLOOD, V107, P3503, DOI 10.1182/blood-2005-10-3932; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Ruf W, 2011, J THROMB HAEMOST, V9, P306, DOI 10.1111/j.1538-7836.2011.04318.x; RUF W, 1994, FASEB J, V8, P385, DOI 10.1096/fasebj.8.6.8168689; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Ryden L, 2010, INT J CANCER, V126, P2330, DOI 10.1002/ijc.24921; Schaffner F, 2010, BLOOD, V116, P6106, DOI 10.1182/blood-2010-06-289314; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048	61	53	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61071	10.1371/journal.pone.0061071	http://dx.doi.org/10.1371/journal.pone.0061071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593394	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600081
J	Tiwary, P; Kumar, D; Mishra, M; Singh, RP; Rai, M; Sundar, S				Tiwary, Puja; Kumar, Dinesh; Mishra, Mukesh; Singh, Rudra Pratap; Rai, Madhukar; Sundar, Shyam			Seasonal Variation in the Prevalence of Sand Flies Infected with Leishmania donovani	PLOS ONE			English	Article							PHLEBOTOMUS-ARGENTIPES; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; PSYCHODIDAE; DIPTERA; DNA; IDENTIFICATION; PCR; INDIA; STATE	Background: Visceral Leishmaniasis (VL) is a life threatening neglected infectious disease in the Indian subcontinent, transmitted by the bite of female sand flies. Estimation of the infectivity in the vector population, collected in different seasons, may be useful to better understanding the transmission dynamics of VL as well as to plan vector control measures. Methodology: We collected sand flies from highly endemic regions of Bihar state, India for one year over three seasons. The species of the sand flies were confirmed by species-specific PCR-RFLP. Leishmania donovani infection was investigated in 1397 female Phlebotomus argentipes using PCR, targeting the Leishmania specific minicircle of the kDNA region. Further, the parasitic load in the infected sand flies was measured using quantitative PCR. Conclusion: Though sand flies were most abundant in the rainy season, the highest rate of infection was detected in the winter season with 2.84% sand flies infected followed by the summer and rainy seasons respectively. This study can help in vector elimination programmes and to reduce disease transmission.	[Tiwary, Puja; Kumar, Dinesh; Mishra, Mukesh; Singh, Rudra Pratap; Rai, Madhukar; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Infect Dis Res Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Sundar, S (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Med, Infect Dis Res Lab, Varanasi 221005, Uttar Pradesh, India.	doctorshyamsundar@gmail.com		TIWARY, PUJA/0000-0002-8180-2739	National Institute of Allergy and Infectious Disease (NIAID); Tropical Medicine Research Center [P50AI074321]; CSIR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074321] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Tropical Medicine Research Center; CSIR(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by National Institute of Allergy and Infectious Disease (NIAID), DMID funding mechanism: Tropical Medicine Research Center Grant number: P50AI074321. Puja Tiwary and Dinesh Kumar thank CSIR for providing fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, PLOS NEGL TROP DIS, V5, pe1139; Aransay AM, 2000, APPL ENVIRON MICROB, V66, P1933, DOI 10.1128/AEM.66.5.1933-1938.2000; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; BARKER DC, 1986, PARASITOLOGY, V92, pS139, DOI 10.1017/S0031182000085747; Bhattarai NR, 2009, T ROY SOC TROP MED H, V103, P1087, DOI 10.1016/j.trstmh.2009.03.008; Boussaa S, 2005, ACTA TROP, V95, P86, DOI 10.1016/j.actatropica.2005.05.002; Brewster S, 1998, PARASITOL TODAY, V14, P437, DOI 10.1016/S0169-4758(98)01330-1; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Dinesh DS, 2000, ANN TROP MED PARASIT, V94, P447, DOI 10.1080/00034983.2000.11813563; Dinesh DS, 2001, ANN TROP MED PARASIT, V95, P197, DOI 10.1080/00034980120041071; Galvez R, 2010, ACTA TROP, V115, P95, DOI 10.1016/j.actatropica.2010.02.009; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Kato H, 2005, AM J TROP MED HYG, V72, P87, DOI 10.4269/ajtmh.2005.72.87; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lewis D.J., 1982, Bulletin of the British Museum (Natural History) Entomology, V45, P121; Malaviya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014751; MORRISON AC, 1995, J MED ENTOMOL, V32, P605, DOI 10.1093/jmedent/32.5.605; Mukhopadhyay AK, 1990, EFFECTS FLOOD CONTRO, P986; Nicolas L, 2002, J CLIN MICROBIOL, V40, P1666, DOI 10.1128/JCM.40.5.1666-1669.2002; Paiva BR, 2010, ACTA TROP, V115, P126, DOI 10.1016/j.actatropica.2010.02.013; Rocha LS, 2010, T ROY SOC TROP MED H, V104, P461, DOI 10.1016/j.trstmh.2010.02.005; Sanchez-Garcia L, 2010, T ROY SOC TROP MED H, V104, P406, DOI 10.1016/j.trstmh.2010.01.010; Souza NA, 2002, MEM I OSWALDO CRUZ, V97, P759, DOI 10.1590/S0074-02762002000600001; Svobodova M, 2009, INT J PARASITOL, V39, P251, DOI 10.1016/j.ijpara.2008.06.016; Swaminath CS, 2006, INDIAN J MED RES, V123, pA473; Tiwary P, 2012, J MED ENTOMOL, V49, P1515, DOI 10.1603/ME12033; Tiwary P, 2012, VECTOR-BORNE ZOONOT, V12, P467, DOI 10.1089/vbz.2011.0808; WHO, 2010, WHO TECH REP SER, V949, P1	28	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61370	10.1371/journal.pone.0061370	http://dx.doi.org/10.1371/journal.pone.0061370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585896	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600110
J	Yan, JC; Su, HL; Xu, LJ; Wang, CP				Yan, Jinchuan; Su, Hongling; Xu, Liangjie; Wang, Cuiping			OX40-OX40L Interaction Promotes Proliferation and Activation of Lymphocytes via NFATc1 in ApoE-Deficient Mice	PLOS ONE			English	Article							OX40 LIGAND; TH2 RESPONSES; CALCINEURIN; CELLS; ATHEROSCLEROSIS; DIFFERENTIATION; ATHEROGENESIS; PATHOGENESIS; ARTHRITIS; SELECTION	Background: Our previous studies have shown that OX40-OX40L interaction regulates the expression of nuclear factor of activated T cells c1(NFATc1) in ApoE(-/-) mice during atherogenesis. The aim of this study was to investigate whether OX40-OX40L interaction promotes Th cell activation via NFATc1 in ApoE(-/-) mice. Methods and Results: The lymphocytes isolated from spleen of ApoE(-/-) mice were cultured with anti-CD3 mAb in the presence or absence of anti-OX40 or anti-OX40L antibodies. The expression of NFATc1 mRNA and protein in isolated lymphocytes were measured by real time PCR (RT-PCR) and flow cytometry (FCM), respectively. The proliferation of lymphocytes was analyzed by MTT method, and the expression of IL-2, IL-4 and IFN-gamma in the cultured cells and supernatant were measured by RT-PCR and enzyme-linked immunosorbent assary (ELISA), respectively. After stimulating OX40-OX40L signal pathway, the expression of NFATc1 and the proliferation of leukocytes were significantly increased. Anti-OX40L suppressed the expression of NFATc1 in lymphocytes of ApoE(-/-) mice. Anti-OX40L or the NFATc1 inhibitor (CsA) markedly suppressed the cell proliferation induced by anti-OX40. Moreover, the expression of IL-2 and IFN-gamma was increased in lymphocytes induced by OX40-OX40L interaction. Blocking OX40-OX40L interaction or NFATc1 down-regulated the expression of IL-2 and IFN-gamma, but didn't alter the expression of IL-4 in supernatants. Conclusion: These results suggest that OX40-OX40L interaction promotes the proliferation and activation of lymphocytes through NFATc1.	[Yan, Jinchuan; Su, Hongling; Xu, Liangjie; Wang, Cuiping] Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Yan, JC (corresponding author), Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China.	yanjinchuan@hotmail.com			Natural Science Foundation; development health engineering of Jiangsu Province [BK2011486, LJ201116]; National Natural Science Foundation of China [81170279]; Key Laboratory of Cardiovascular Disease of Zhenjiang [SS2012002]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); development health engineering of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Cardiovascular Disease of Zhenjiang	This project was supported by the Natural Science Foundation and the development health engineering of Jiangsu Province (BK2011486, LJ201116) and National Natural Science Foundation of China (81170279) and Key Laboratory of Cardiovascular Disease of Zhenjiang (SS2012002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2000, J EXP MED, V191, P375, DOI 10.1084/jem.191.2.375; AlShamkhani A, 1996, EUR J IMMUNOL, V26, P1695, DOI 10.1002/eji.1830260805; Arestides RSS, 2002, EUR J IMMUNOL, V32, P2874, DOI 10.1002/1521-4141(2002010)32:10<2874::AID-IMMU2874>3.0.CO;2-4; Carboni S, 2003, J NEUROIMMUNOL, V145, P1, DOI 10.1016/j.jneuroim.2003.07.001; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Gotsman I, 2008, CIRC RES, V103, P1220, DOI 10.1161/CIRCRESAHA.108.182428; Healy AM, 2006, J IMMUNOL, V177, P1886, DOI 10.4049/jimmunol.177.3.1886; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Huber SA, 2001, CIRCULATION, V103, P2610; Ishii N, 2003, EUR J IMMUNOL, V33, P2372, DOI 10.1002/eji.200324031; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Lane P, 2000, J EXP MED, V191, P201, DOI 10.1084/jem.191.2.201; Laurat E, 2001, CIRCULATION, V104, P197, DOI 10.1161/01.CIR.104.2.197; Liu DM, 2008, CLIN CHIM ACTA, V397, P22, DOI 10.1016/j.cca.2008.07.003; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; van Wanrooij EJA, 2007, ARTERIOSCL THROM VAS, V27, P204, DOI 10.1161/01.ATV.0000251007.07648.81; Walker LSK, 2000, IMMUNOL TODAY, V21, P333, DOI 10.1016/S0167-5699(00)01636-4; Xu Liang-Jie, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P526; Yan JC, 2009, CHEM-BIOL INTERACT, V180, P460, DOI 10.1016/j.cbi.2009.04.009; Yoshioka T, 2000, EUR J IMMUNOL, V30, P2815, DOI 10.1002/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-#	24	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60854	10.1371/journal.pone.0060854	http://dx.doi.org/10.1371/journal.pone.0060854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593329	Green Submitted, gold, Green Published			2022-12-27	WOS:000317909600061
J	Biesbroek, JM; Kuijf, HJ; van der Graaf, Y; Vincken, KL; Postma, A; Mali, WPTM; Biessels, GJ; Geerlings, MI				Biesbroek, J. Matthijs; Kuijf, Hugo J.; van der Graaf, Yolanda; Vincken, Koen L.; Postma, Albert; Mali, Willem P. T. M.; Biessels, Geert J.; Geerlings, Mirjam I.		SMART Study Grp	Association between Subcortical Vascular Lesion Location and Cognition: A Voxel-Based and Tract-Based Lesion-Symptom Mapping Study. The SMART-MR Study	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; EXECUTIVE FUNCTION; PROBABILISTIC SEGMENTATION; CLINICAL DETERMINANTS; DEMENTIA; CADASIL; INTELLIGENCE; IMPAIRMENT; DECLINE; STROKE	Introduction: Lacunar lesions (LLs) and white matter lesions (WMLs) affect cognition. We assessed whether lesions located in specific white matter tracts were associated with cognitive performance taking into account total lesion burden. Methods: Within the Second Manifestations of ARTerial disease Magnetic Resonance (SMART-MR) study, cross-sectional analyses were performed on 516 patients with manifest arterial disease. We applied an assumption-free voxel-based lesion-symptom mapping approach to investigate the relation between LL and WML locations on 1.5 Tesla brain MRI and compound scores of executive functioning, memory and processing speed. Secondly, a multivariable linear regression model was used to relate the regional volume of LLs and WMLs within specific white matter tracts to cognitive functioning. Results: Voxel-based lesion-symptom mapping identified several clusters of voxels with a significant correlation between WMLs and executive functioning, mostly located within the superior longitudinal fasciculus and anterior thalamic radiation. In the multivariable linear regression model, a statistically significant association was found between regional LL volume within the superior longitudinal fasciculus and anterior thalamic radiation and executive functioning after adjustment for total LL and WML burden. Conclusion: These findings identify the superior longitudinal fasciculus and anterior thalamic radiation as key anatomical structures in executive functioning and emphasize the role of strategically located vascular lesions in vascular cognitive impairment.	[Biesbroek, J. Matthijs; Postma, Albert; Biessels, Geert J.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Kuijf, Hugo J.; Vincken, Koen L.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [van der Graaf, Yolanda; Geerlings, Mirjam I.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Postma, Albert] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Mali, Willem P. T. M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center	Geerlings, MI (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	M.Geerlings@umcutrecht.nl	Mali, Willem PThM/I-1123-2014; Geerlings, Mirjam I/F-4087-2015; Vincken, Koen/AAP-3558-2021; Kuijf, Hugo J/G-2711-2013	Mali, Willem PThM/0000-0003-4391-0904; Geerlings, Mirjam I/0000-0002-4037-036X; Kuijf, Hugo J/0000-0001-6997-9059; Biesbroek, Matthijs/0000-0001-7017-2148	Netherlands Heart Foundation (NHF) [2007B027]; Utrecht University; ZonMw, The Netherlands Organisation for Health Research and Development [91711384]; Netherlands Heart Foundation [2010T073]	Netherlands Heart Foundation (NHF)(Netherlands Heart Foundation); Utrecht University; ZonMw, The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported by a programme grant from The Netherlands Heart Foundation (NHF: project no 2007B027). The work of JM Biesbroek was supported by a Neuroscience & Cognition grant from Utrecht University. The work of GJ Biessels was supported by VIDI grant 91711384 from ZonMw, The Netherlands Organisation for Health Research and Development, and by grant 2010T073 from the Netherlands Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbeek P, 2005, NEUROIMAGE, V27, P795, DOI 10.1016/j.neuroimage.2005.05.046; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bolandzadeh N, 2012, BMC NEUROL IN PRESS, P12; BRAND N, 1985, J GEN PSYCHOL, V112, P201, DOI 10.1080/00221309.1985.9711004; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Charlton RA, 2006, NEUROLOGY, V66, P1523, DOI 10.1212/01.wnl.0000216270.02610.7e; Duering M, 2011, BRAIN, V134, P2366, DOI 10.1093/brain/awr169; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Geerlings MI, 2010, ATHEROSCLEROSIS, V210, P130, DOI 10.1016/j.atherosclerosis.2009.10.039; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Grool AM, 2011, J NEUROL NEUROSUR PS, V82, P1093, DOI 10.1136/jnnp.2010.232413; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Kahle W, 2003, COLOR ATLAS TXB HUMA, V3, P178; Kimberg DY, 2007, J COGNITIVE NEUROSCI, V19, P1067, DOI 10.1162/jocn.2007.19.7.1067; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Liem MK, 2007, STROKE, V38, P923, DOI 10.1161/01.STR.0000257968.24015.bf; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Muller M, 2011, ANN NEUROL, V70, P237, DOI 10.1002/ana.22392; Muller M, 2011, NEUROBIOL AGING, V32, P885, DOI 10.1016/j.neurobiolaging.2009.05.005; Mungas D, 2005, NEUROLOGY, V65, P565, DOI 10.1212/01.wnl.0000172913.88973.0d; O'Brien JT, 2002, ANN NY ACAD SCI, V977, P436, DOI 10.1111/j.1749-6632.2002.tb04849.x; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Pohjasvaara T, 1998, STROKE, V29, P75, DOI 10.1161/01.STR.29.1.75; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rorden C, 2007, NEUROIMAGE, V35, P1531, DOI 10.1016/j.neuroimage.2006.12.043; Schmand B, 1998, J CLIN EXP NEUROPSYC, V20, P42, DOI 10.1076/jcen.20.1.42.1485; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; TATEMICHI TK, 1993, ANN NEUROL, V33, P568, DOI 10.1002/ana.410330603; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; van der Flier WM, 2005, STROKE, V36, P2116, DOI 10.1161/01.STR.0000179092.59909.42; van der Lijn F, 2009, I S BIOMED IMAGING, P221, DOI 10.1109/ISBI.2009.5193023	39	70	71	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60541	10.1371/journal.pone.0060541	http://dx.doi.org/10.1371/journal.pone.0060541			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593238	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000037
J	Sun, G; Qian, SW; Jiang, QJ; Liu, K; Li, B; Li, M; Zhao, L; Zhou, ZY; von Deneen, KM; Liu, YJ				Sun, Gang; Qian, Shaowen; Jiang, Qingjun; Liu, Kai; Li, Bo; Li, Min; Zhao, Lun; Zhou, Zhenyu; von Deneen, Karen M.; Liu, Yijun			Hyperthermia-Induced Disruption of Functional Connectivity in the Human Brain Network	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; COGNITIVE PERFORMANCE; DEFAULT-MODE; HEAT-STRESS; PROLONGED EXERCISE; PASSIVE HYPERTHERMIA; INDUCED DEHYDRATION; WORKING-MEMORY; RESTING BRAIN; SMALL-WORLD	Background: Passive hyperthermia is a potential risk factor to human cognitive performance and work behavior in many extreme work environments. Previous studies have demonstrated significant effects of passive hyperthermia on human cognitive performance and work behavior. However, there is a lack of a clear understanding of the exact affected brain regions and inter-regional connectivities. Methodology and Principal Findings: We simulated 1 hour environmental heat exposure to thirty-six participants under two environmental temperature conditions (25 degrees C and 50 degrees C), and collected resting-state functional brain activity. The functional connectivities with a preselected region of interest (ROI) in the posterior cingulate cortex and precuneus (PCC/PCu), furthermore, inter-regional connectivities throughout the entire brain using a prior Anatomical Automatic Labeling (AAL) atlas were calculated. We identified decreased correlations of a set of regions with the PCC/PCu, including the medial orbitofrontal cortex (mOFC) and bilateral medial temporal cortex, as well as increased correlations with the partial orbitofrontal cortex particularly in the bilateral orbital superior frontal gyrus. Compared with the normal control (NC) group, the hyperthermia (HT) group showed 65 disturbed functional connectivities with 50 of them being decreased and 15 of them being increased. While the decreased correlations mainly involved with the mOFC, temporal lobe and occipital lobe, increased correlations were mainly located within the limbic system. In consideration of physiological system changes, we explored the correlations of the number of significantly altered inter-regional connectivities with differential rectal temperatures and weight loss, but failed to obtain significant correlations. More importantly, during the attention network test (ANT) we found that the number of significantly altered functional connectivities was positively correlated with an increase in executive control reaction time. Conclusions/Significance: We first identified the hyperthermia-induced altered functional connectivity patterns. The changes in the functional connectivity network might be a possible explanation for the cognitive performance and work behavior alteration.	[Sun, Gang; Qian, Shaowen; Jiang, Qingjun; Liu, Kai; Li, Bo; Li, Min; Zhao, Lun] Jinan Mil Gen Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China; [Zhou, Zhenyu; von Deneen, Karen M.; Liu, Yijun] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	State University System of Florida; University of Florida	Sun, G (corresponding author), Jinan Mil Gen Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China.	cjr.sungang@vip.163.com; zhaolunlun@yahoo.com.cn			Jinan Military General Hospital [2011Z02]	Jinan Military General Hospital	This work was supported by grants from President Funding of Jinan Military General Hospital (Grant No 2011Z02). The funding could be accessed through the website: http://www.jnjqzyy.cn/htm/YXYXK/Index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bridge MW, 2003, EUR J APPL PHYSIOL, V89, P451, DOI 10.1007/s00421-003-0800-z; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabeza R, 2002, NEUROIMAGE, V16, P317, DOI 10.1006/nimg.2002.1063; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Cheung SS, 2007, APPL PHYSIOL NUTR ME, V32, P808, DOI 10.1139/H07-043; Cheung SS, 2010, SCAND J MED SCI SPOR, V20, P53, DOI 10.1111/j.1600-0838.2010.01209.x; Cian C, 2001, INT J PSYCHOPHYSIOL, V42, P243, DOI 10.1016/S0167-8760(01)00142-8; CRAIG AD, 1994, NATURE, V372, P770, DOI 10.1038/372770a0; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; DUBOIS M, 1980, ELECTROEN CLIN NEURO, V50, P486, DOI 10.1016/0013-4694(80)90015-2; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Flouris AD, 2011, EUR J APPL PHYSIOL, V111, P1, DOI 10.1007/s00421-010-1602-8; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gaoua N, 2012, J ENVIRON PSYCHOL, V32, P158, DOI 10.1016/j.jenvp.2012.01.002; Gaoua N, 2011, INT J HYPERTHER, V27, P1, DOI 10.3109/02656736.2010.519371; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; GOPINATHAN PM, 1988, ARCH ENVIRON HEALTH, V43, P15, DOI 10.1080/00039896.1988.9934367; Grandjean AC, 2007, J AM COLL NUTR, V26, p549S, DOI 10.1080/07315724.2007.10719657; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hancock PA, 2003, INT J HYPERTHER, V19, P355, DOI 10.1080/0265673021000054630; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Hocking C, 2001, COMP BIOCHEM PHYS A, V128, P719, DOI 10.1016/S1095-6433(01)00278-1; Kanosue K, 2002, NEUROSCI LETT, V329, P157, DOI 10.1016/S0304-3940(02)00621-3; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Lieberman HR, 2007, J AM COLL NUTR, V26, p555S, DOI 10.1080/07315724.2007.10719658; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; MADSEN PL, 1993, J APPL PHYSIOL, V74, P245, DOI 10.1152/jappl.1993.74.1.245; McMorris T, 2006, INT J PSYCHOPHYSIOL, V61, P204, DOI 10.1016/j.ijpsycho.2005.10.002; Moran DS, 2002, SPORTS MED, V32, P879, DOI 10.2165/00007256-200232140-00001; Morley J, 2012, EUR J APPL PHYSIOL, V112, P1733, DOI 10.1007/s00421-011-2144-4; Morris R, 1999, EUR J NEUROSCI, V11, P2506, DOI 10.1046/j.1460-9568.1999.00672.x; Nielsen B, 2001, PFLUG ARCH EUR J PHY, V442, P41, DOI 10.1007/s004240100515; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; Nybo L, 2008, J APPL PHYSIOL, V104, P871, DOI 10.1152/japplphysiol.00910.2007; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Racinais S, 2008, J PHYSIOL-LONDON, V586, P4751, DOI 10.1113/jphysiol.2008.157420; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramsey J., 1983, J SAFETY RES, V14, P105, DOI DOI 10.1016/0022-4375(83)90021-X; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Ross EZ, 2012, J APPL PHYSIOL, V112, P748, DOI 10.1152/japplphysiol.00988.2011; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; SHARMA VM, 1986, ERGONOMICS, V29, P791, DOI 10.1080/00140138608968315; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Simmons SE, 2008, EUR J APPL PHYSIOL, V104, P281, DOI 10.1007/s00421-007-0652-z; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Smith DL, 1997, ERGONOMICS, V40, P500, DOI 10.1080/001401397188125; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sun G.C., 2012, INT J HYPERTHER, P1; Sun G, 2011, NEUROSCI LETT, V502, P94, DOI 10.1016/j.neulet.2011.07.029; Szinnai G, 2005, AM J PHYSIOL-REG I, V289, pR275, DOI 10.1152/ajpregu.00501.2004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang LH, 2006, BIOL PSYCHIAT, V60, P1139, DOI 10.1016/j.biopsych.2006.01.021; Wetsel WC, 2011, INT J HYPERTHER, V27, P353, DOI 10.3109/02656736.2010.550905; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; ZOBL EG, 1965, J APPL PHYSIOL, V20, P1289, DOI 10.1152/jappl.1965.20.6.1289	70	69	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61157	10.1371/journal.pone.0061157	http://dx.doi.org/10.1371/journal.pone.0061157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593416	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000106
J	Schuster, TM; Setaro, SD; Kron, KA				Schuster, Tanja M.; Setaro, Sabrina D.; Kron, Kathleen A.			Age Estimates for the Buckwheat Family Polygonaceae Based on Sequence Data Calibrated by Fossils and with a Focus on the Amphi-Pacific Muehlenbeckia	PLOS ONE			English	Article							DIVERGENCE TIMES; MOLECULAR PHYLOGENY; PLANT DIVERSITY; ANDEAN UPLIFT; NEW-ZEALAND; EVOLUTION; RADIATION; DIVERSIFICATION; POLLEN; FLORA	The buckwheat family Polygonaceae is a diverse group of plants and is a good model for investigating biogeography, breeding systems, coevolution with symbionts such as ants and fungi, functional trait evolution, hybridization, invasiveness, morphological plasticity, pollen morphology and wood anatomy. The main goal of this study was to obtain age estimates for Polygonaceae by calibrating a Bayesian phylogenetic analysis, using a relaxed molecular clock with fossil data. Based on the age estimates, we also develop hypotheses about the historical biogeography of the Southern Hemisphere group Muehlenbeckia. We are interested in addressing whether vicariance or dispersal could account for the diversification of Muehlenbeckia, which has a "Gondwanan" distribution. Eighty-one species of Polygonaceae were analysed with MRBAYES to infer species relationships. One nuclear (nrITS) and three chloroplast markers (the trnL-trnF spacer region, matK and ndhF genes) were used. The molecular data were also analysed with BEAST to estimate divergence times. Seven calibration points including fossil pollen and a leaf fossil of Muehlenbeckia were used to infer node ages. Results of the BEAST analyses indicate an age of 110.9 (exponential/lognormal priors)/118.7 (uniform priors) million years (Myr) with an uncertainty interval of (90.7-125.0) Myr for the stem age of Polygonaceae. This age is older than previously thought (Maastrichtian, approximately 65.5-70.6 Myr). The estimated divergence time for Muehlenbeckia is 41.0/41.6 (39.6-47.8) Myr and its crown clade is 20.5/22.3 (14.2-33.5) Myr old. Because the breakup of Gondwana occurred from 95-30 Myr ago, diversification of Muehlenbeckia is best explained by oceanic long-distance and maybe stepping-stone dispersal rather than vicariance. This study is the first to give age estimates for clades of Polygonaceae and functions as a jumping-off point for future studies on the historical biogeography of the family.	[Schuster, Tanja M.; Setaro, Sabrina D.; Kron, Kathleen A.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University	Schuster, TM (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	tschuste@umd.edu.com		Schuster, Tanja M./0000-0003-0851-3372	Richter Scholarship Program, Wake Forest University; Vecellio Graduate Student Fund, Wake Forest University; Graduate School, Wake Forest University	Richter Scholarship Program, Wake Forest University; Vecellio Graduate Student Fund, Wake Forest University; Graduate School, Wake Forest University	This work was supported by the Richter Scholarship Program, Wake Forest University; the Vecellio Graduate Student Fund, Wake Forest University; and the Graduate School, Wake Forest University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alsos IG, SANDBAKK BE FLORA SV; Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; [Anonymous], 1991, POLLEN SPORES PATTER; Antonelli A, 2011, SYST BIOL, V60, P596, DOI 10.1093/sysbio/syr062; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Ayodele AE, 2006, S AFR J BOT, V72, P442, DOI 10.1016/j.sajb.2005.12.009; BAILEY JP, 1992, PLANT SYST EVOL, V180, P29, DOI 10.1007/BF00940396; Barker NP, 2007, J BIOGEOGR, V34, P2012, DOI 10.1111/j.1365-2699.2007.01749.x; Barlow B. A., 1988, Proceedings of the Ecological Society of Australia, V15, P1; Beucher F, 1975, CTR RECHERCHES ZON G, V20; Blackmore S, 2007, PLANT SYST EVOL, V263, P3, DOI 10.1007/s00606-006-0464-3; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; Brandbyge John, 1992, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V114, P349; Burke JM, 2011, BRITTONIA, V63, P510, DOI 10.1007/s12228-011-9197-x; Bytebier B, 2011, P ROY SOC B-BIOL SCI, V278, P188, DOI 10.1098/rspb.2010.1035; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cook LG, 2005, J BIOGEOGR, V32, P741, DOI 10.1111/j.1365-2699.2005.01261.x; Cooper R. A., 2004, NZ GEOLOGICAL TIMESC; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Crayn DM, 2006, AM J BOT, V93, P1328, DOI 10.3732/ajb.93.9.1328; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 1995, SYST BIOL, V44, P457, DOI 10.2307/2413654; De Craene LPR, 2004, ANN MO BOT GARD, V91, P320; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Demarcq G., 1976, Notes Serv Geol Tunis, VNo. 42, P97; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Elias M, 2009, MOL ECOL, V18, P1716, DOI 10.1111/j.1365-294X.2009.04149.x; Exon NF, 2006, AUST J EARTH SCI, V53, P541, DOI 10.1080/08120090600632300; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Frakes LA, 1999, FLORA AUSTR INTRO, V1, P163; Freeman CC, 2005, FLORA N AM, V5, P216; Gandolfo MA, 2008, ANN MO BOT GARD, V95, P34, DOI 10.3417/2007064; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; Givnish TJ, 2004, INT J PLANT SCI, V165, pS1, DOI 10.1086/424022; GRAHAM A, 1976, ANN MO BOT GARD, V63, P787, DOI 10.2307/2395250; Graham R. A., 1957, KEW B, V12, P145, DOI [10.2307/4109117, DOI 10.2307/4109117]; Graham R. A., 1958, FLORA TROPICAL E AFR, P1; Gray J., 1964, ANCIENT PACIFIC FLOR, P21; Greene PS, 1994, POLYGONACEAE FLORA A; Gruas-Cavagnetto C, 1978, MEM SOC GEOL FRANCE, V56, P1; Hedberg O., 1946, SVENSK BOT TIDSKR, V40, P370; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Hong SP, 2005, PLANT SYST EVOL, V254, P13, DOI 10.1007/s00606-005-0334-4; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; HUGHES NF, 1990, REV PALAEOBOT PALYNO, V65, P145, DOI 10.1016/0034-6667(90)90065-Q; HUTCHINSON J, 1927, FLORA W TROPICAL AFR, V1, P116; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KEMP EM, 1978, PALAEOGEOGR PALAEOCL, V24, P169, DOI 10.1016/0031-0182(78)90042-1; Kempton EA, 2012, SYST BOT, V37, P723, DOI 10.1600/036364412X648698; Kim ST, 2008, AM J BOT, V95, P1122, DOI 10.3732/ajb.0700008; Kim ST, 2008, P NATL ACAD SCI USA, V105, P12370, DOI 10.1073/pnas.0805141105; Kim ST, 2008, SYST BOT, V33, P77, DOI 10.1600/036364408783887302; KRUTZSCH W., 1962, GEOLOGIE, V11, P265; Krutzsch W, 1970, JB GEOL, V3, P103; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; Leigh JW, 2011, GENOME BIOL EVOL, V3, P571, DOI 10.1093/gbe/evr050; Luteyn JL, 2002, BOT REV, V68, P55, DOI 10.1663/0006-8101(2002)068[0055:DAAEIN]2.0.CO;2; MacPhail M. K., 1999, Palynology, V23, P197; Magallon SA, 2004, INT J PLANT SCI, V165, pS7, DOI 10.1086/383336; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; McGlone MS, 2005, J BIOGEOGR, V32, P739, DOI 10.1111/j.1365-2699.2005.01278.x; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Nowicke J.W., 1977, SMITHSON CONTRIB BOT, V37, P1; Nylander J. A. A., 2004, MRAIC PROGRAM DISTRI; Ogg G, 2008, INT STRAT CHART; Pennington RT, 2006, NEW PHYTOL, V172, P605, DOI 10.1111/j.1469-8137.2006.01902.x; POLE M, 1993, J ROY SOC NEW ZEAL, V23, P289, DOI 10.1080/03036758.1993.10721227; POLE M, 1994, J BIOGEOGR, V21, P625, DOI 10.2307/2846036; Rambaut A., 2001, TREEEDIT VERSION 1 0; Renner SS, 2000, SYST BIOL, V49, P579, DOI 10.1080/10635159950127402; Sarkinen T, 2012, J BIOGEOGR, V39, P884, DOI 10.1111/j.1365-2699.2011.02644.x; SAH SCD, 1968, PALEOBOTANIST, V16, P177; Sanchez A, 2011, TAXON, V60, P151, DOI 10.1002/tax.601013; Sanchez A, 2009, INT J PLANT SCI, V170, P1044, DOI 10.1086/605121; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sauquet H, 2009, P NATL ACAD SCI USA, V106, P221, DOI 10.1073/pnas.0805607106; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Sauquet H, 2009, MOL PHYLOGENET EVOL, V51, P31, DOI 10.1016/j.ympev.2008.12.013; Schuster TM, 2011, TAXON, V60, P1653, DOI 10.1002/tax.606010; Schuster TM, 2011, INT J PLANT SCI, V172, P1053, DOI 10.1086/661293; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Standley PC, 1939, FLORA PERU, V13, P444; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Thornhill AH, 2012, MOL PHYLOGENET EVOL, V63, P15, DOI 10.1016/j.ympev.2011.12.003; Toon A, 2010, MOL ECOL, V19, P2980, DOI 10.1111/j.1365-294X.2010.04730.x; Truswell E.M., 1982, EVOLUTION FLORA FAUN, P67; Van Campo E., 1976, REV MICROPALEONTOL, V18, P264; von der Brelie G., 1977, GEOL BAVAR, V75, P111; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilson KL, 1990, FLORA NEW S WALES, V1, P278; Winkworth RC, 2002, TRENDS ECOL EVOL, V17, P514, DOI 10.1016/S0169-5347(02)02590-9; Wojciechowski M.F., 2003, HIGHER LEVEL SYSTEMA, P5, DOI DOI 10.1126/SCIADV.AAV8936	106	38	38	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61261	10.1371/journal.pone.0061261	http://dx.doi.org/10.1371/journal.pone.0061261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23585884	gold, Green Published			2022-12-27	WOS:000319109800136
J	Casanovas-Vilar, I; van Dam, J				Casanovas-Vilar, Isaac y; van Dam, Jan			Conservatism and Adaptability during Squirrel Radiation: What Is Mandible Shape Telling Us?	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRICS; MASTICATORY APPARATUS; JAW MUSCLES; PHYLOGENY; RODENTIA; EVOLUTION; ECOLOGY; SKULL; PERCIFORMES; MORPHOLOGY	Both functional adaptation and phylogeny shape the morphology of taxa within clades. Herein we explore these two factors in an integrated way by analyzing shape and size variation in the mandible of extant squirrels using landmark-based geometric morphometrics in combination with a comparative phylogenetic analysis. Dietary specialization and locomotion were found to be reliable predictors of mandible shape, with the prediction by locomotion probably reflecting the underlying diet. In addition a weak but significant allometric effect could be demonstrated. Our results found a strong phylogenetic signal in the family as a whole as well as in the main clades, which is in agreement with the general notion of squirrels being a conservative group. This fact does not preclude functional explanations for mandible shape, but rather indicates that ancient adaptations kept a prominent role, with most genera having diverged little from their ancestral clade morphologies. Nevertheless, certain groups have evolved conspicuous adaptations that allow them to specialize on unique dietary resources. Such adaptations mostly occurred in the Callosciurinae and probably reflect their radiation into the numerous ecological niches of the tropical and subtropical forests of Southeastern Asia. Our dietary reconstruction for the oldest known fossil squirrels (Eocene, 36 million years ago) show a specialization on nuts and seeds, implying that the development from protrogomorphous to sciuromorphous skulls was not necessarily related to a change in diet.	[Casanovas-Vilar, Isaac y; van Dam, Jan] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Cerdanyola Del Valles, Spain; [van Dam, Jan] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Utrecht University	Casanovas-Vilar, I (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Cerdanyola Del Valles, Spain.	isaac.casanovas@icp.cat	Casanovas-Vilar, Isaac/J-2517-2012	Casanovas-Vilar, Isaac/0000-0001-7092-9622; van Dam, Jan/0000-0002-2748-3722	Ministerio de Economia y Competitividad [CGL2010-21672/BTE, CGL2011-27343]; Generalitat de Catalunya, project [2009 SGR 754]; SYNTHESYS Project from the European Community Research Infrastructure [NL-TAF-4084]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya, project(Generalitat de Catalunya); SYNTHESYS Project from the European Community Research Infrastructure	Ministerio de Economia y Competitividad, projects (CGL2010-21672/BTE, CGL2011-27343) and research contract to ICV (JCI2010-08241), as well as Generalitat de Catalunya, project (2009 SGR 754), and the SYNTHESYS Project from the European Community Research Infrastructure (NL-TAF-4084) to ICV supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; BALL SS, 1995, J MORPHOL, V224, P265, DOI 10.1002/jmor.1052240303; BELK M C, 1991, Mammalian Species, P1, DOI 10.2307/3504191; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Cardini A, 2003, SYST BIOL, V52, P186, DOI 10.1080/10635150390192807; Casanovas-Vilar I, 2009, PALEONTOLOGIA EVOLUC, V3, P41; Caumul R, 2005, EVOLUTION, V59, P2460; CIFELLI RL, 1986, J MAMMAL, V67, P274, DOI 10.2307/1380880; Corti M, 1996, NATO ADV SCI INST SE, V284, P303; Cox PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036299; CUENCA G, 1994, GEOBIOS-LYON, V27, P353, DOI 10.1016/S0016-6995(94)80183-5; de Bruijn Hans, 1999, P271; Demeter A, 1996, NATO ADV SCI INST SE, V284, P359; den Tex RJ, 2010, MOL PHYLOGENET EVOL, V55, P711, DOI 10.1016/j.ympev.2009.12.023; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; DRUZINSKY RE, 1995, J MORPHOL, V226, P79, DOI 10.1002/jmor.1052260106; EMMONS LH, 1980, ECOL MONOGR, V50, P31, DOI 10.2307/2937245; EMMONS LH, 1990, NEOTROPICAL RAINFORE; Emry R.J., 1984, P23; Emry RJ, 1996, J VERTEBR PALEONTOL, V16, P775, DOI 10.1080/02724634.1996.10011366; Emry RJ., 1982, SMITHSONIAN CONTRIBU, V47, P1, DOI [10.5479/si.00810266.47.1, DOI 10.5479/si.00810266.47.1]; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Flynn Lawrence J., 2003, Deinsea (Rotterdam), V10, P183; Freeman PW, 2008, J ZOOL, V275, P418, DOI 10.1111/j.1469-7998.2008.00459.x; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; GOULD SJ, 1975, AM ZOOL, V15, P351; Handley C.O. Jr., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; Hautier L, 2012, J MORPHOL, V273, P1319, DOI 10.1002/jmor.20061; Hautier L, 2009, NATURWISSENSCHAFTEN, V96, P725, DOI 10.1007/s00114-009-0519-8; Helgen KM, 2009, J MAMMAL, V90, P270, DOI 10.1644/07-MAMM-A-309.1; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Klingenberg CP, 2001, GENETICS, V157, P785; KORTH W W, 1992, Annals of Carnegie Museum, V61, P69; Korth W.W., 1994, TERTIARY RECORD RODE; Koyabu DB, 2009, J ZOOL, V279, P372, DOI 10.1111/j.1469-7998.2009.00629.x; Koyabu DB, 2009, J HUM EVOL, V56, P525, DOI 10.1016/j.jhevol.2008.12.009; Loy A, 1998, J MORPHOL, V237, P137, DOI 10.1002/(SICI)1097-4687(199808)237:2<137::AID-JMOR5>3.0.CO;2-Z; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; MacKinnon K.S., 1978, Malayan Nature Journal, V30, P593; MacLeod N., 2002, MORPHOLOGY SHAPE PHY; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Maddison WP, 2007, MESQUITE 2 74 AMODUL; McKenna MC, 1997, CLASSIFICATION MAMMA; Mercer JM, 2003, SCIENCE, V299, P1568, DOI 10.1126/science.1079705; Michaux J, 2007, J ZOOL SYST EVOL RES, V45, P263, DOI 10.1111/j.1439-0469.2006.00390.x; Michaux J, 2008, MAMMALIA, V72, P286, DOI 10.1515/MAMM.2008.049; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; Nicola PA, 2003, BIOL J LINN SOC, V80, P385, DOI 10.1046/j.1095-8312.2003.00245.x; Nogueira MR, 2005, J ZOOL, V266, P355, DOI 10.1017/S0952836905007053; Payne J. B., 1980, MALAYAN FOREST PRIMA, P261; Payne JB, 1979, THESIS U CAMBRIDGE C; PILBEAM D, 1974, SCIENCE, V186, P892, DOI 10.1126/science.186.4167.892; Promel HJ, 2002, STEINER TREE PROBLEM; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; Rohlf F. James, 2002, Systematics Association Special Volume Series, V64, P175; Rohlf FJ, 2006, TPSDIG VER 2 16; Roth VL, 1996, AM ZOOL, V36, P14; Samuels JX, 2009, ZOOL J LINN SOC-LOND, V156, P864, DOI 10.1111/j.1096-3642.2009.00502.x; Singleton M, 2004, J ANTHROPOL SCI, V82, P27; Steppan SJ, 2004, MOL PHYLOGENET EVOL, V30, P703, DOI 10.1016/S1055-7903(03)00204-5; SWEET SS, 1980, AM ZOOL, V20, P643; Swiderski DL, 2010, EVOL BIOL, V37, P1, DOI 10.1007/s11692-010-9081-8; Thorington R.W., 2012, SQUIRRELS WORLD; Thorington RW, 1996, J MORPHOL, V230, P145, DOI 10.1002/(SICI)1097-4687(199611)230:2<145::AID-JMOR3>3.0.CO;2-G; Velhagen WA, 1997, J MORPHOL, V232, P107, DOI 10.1002/(SICI)1097-4687(199705)232:2<107::AID-JMOR1>3.0.CO;2-7; Vinyard CJ, 2003, AM J PHYS ANTHROPOL, V120, P153, DOI 10.1002/ajpa.10129; Walston J, 2008, IUCN RED LIST THREAT; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Zahler P, 2003, J MAMMAL, V84, P480, DOI 10.1644/1545-1542(2003)084<0480:EFDSOP>2.0.CO;2; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	76	40	41	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61298	10.1371/journal.pone.0061298	http://dx.doi.org/10.1371/journal.pone.0061298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593456	gold, Green Published, Green Submitted			2022-12-27	WOS:000319108100082
J	Charlton, RA; Hutchison, A; Davis, KJ; de Vries, CS				Charlton, Rachel A.; Hutchison, Annie; Davis, Kourtney J.; de Vries, Corinne S.			Asthma Management in Pregnancy	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; EMERGENCY-DEPARTMENT; WOMEN; PREVALENCE; SEVERITY	Background: Asthma is common during pregnancy, however research is limited regarding the extent and timing of changes in asthma management associated with pregnancy. Objective: To determine the prevalence of asthma during pregnancy and identify changes in treatment and asthma exacerbation rates associated with pregnancy, while controlling for seasonal influences. Methods: Pregnant women with asthma were identified from the UK General Practice Research Database between 2000 and 2008. For each woman asthma medication prescribed during the study period was identified; for each product combination the British Thoracic Society medication-defined asthma treatment step was identified. Asthma exacerbations were identified during pregnancy and in the corresponding 12 months prior. Analyses of changes in asthma treatment and exacerbation rates during pregnancy relative to the corresponding period 12 months prior, to control for seasonality, were stratified by trimester and asthma treatment intensity level. Results: The prevalence of treated asthma in pregnancies resulting in a delivery was 8.3%. From 14,141 pregnancies, in 12,828 women with asthma, 68.4% received prescriptions for a short-acting beta(2)-agonist and 41.2% for inhaled corticosteroids; 76.5% were managed with asthma treatment Step 1 or 2. Poor persistence to inhaled corticosteroids, defined as a gap of up to 60 days between prescriptions, was common. In 45.0% of pregnancies, an increase in average treatment step was observed whereas in 25.6% the treatment step decreased. Treatment intensity remained the same in 29.5% of pregnancies. Exacerbations occurred in 4.8% of pregnancies compared to 5.9% in the same season the year before (p<0.001). Conclusion: Exacerbation rates during pregnancy were slightly lower than in the year before. However, treatment patterns and exacerbation rates in this study suggest asthma control during pregnancy is variable, and women may require close monitoring especially in those with evidence of poor control before pregnancy.	[Charlton, Rachel A.; Hutchison, Annie; de Vries, Corinne S.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Davis, Kourtney J.] GlaxoSmithKline, Worldwide Epidemiol, Wavre, Belgium	University of Bath; GlaxoSmithKline	Charlton, RA (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	r.a.charlton@bath.ac.uk			GlaxoSmithKline [WEUKBRE5848, EPI40638]	GlaxoSmithKline(GlaxoSmithKline)	This study was funded by GlaxoSmithKline; protocol number WEUKBRE5848. The authors affiliated with GlaxoSmithKline were involved in the study design and preparation of the manuscript but played no role in data collection and analysis. An unequivocal contractual agreement was in place to ensure that the University of Bath had complete freedom to publish.; This study was funded by GlaxoSmithKline; study number EPI40638. The authors affiliated with GlaxoSmithKline were involved in the study design and preparation of the manuscript and this has been acknowledged in the authorship. Dr. Kourtney Davis is a full-time employee of GlaxoSmithKline Research and Development. Dr. Neil Snowise, who was an employee of GlaxoSmithKline during the conduct of the study, helped in determining the clinical likelihood of certain therapy combinations occurring in practice and provided insight into the treatment of asthma in clinical practice. Given this study does not evaluate the safety of asthma medicines but instead provides insight into utilisation patterns of prescription medicines based on retrospective analysis of electronic health records, the authors believe that the integrity of the study is not compromised. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Baibergenova A, 2006, J ASTHMA, V43, P293, DOI 10.1080/02770900600622984; Callaghan ML, 2000, ANN ALLERG ASTHMA IM, V84, P475, DOI 10.1016/S1081-1206(10)62505-7; Charlton RA, 2011, DRUG SAFETY, V34, P157, DOI 10.2165/11584970-000000000-00000; Cleary BJ, 2010, PHARMACOEPIDEM DR S, V19, P408, DOI 10.1002/pds.1906; Cydulka RK, 1999, AM J RESP CRIT CARE, V160, P887, DOI 10.1164/ajrccm.160.3.9812138; Dombrowski MP, 2006, OBSTET GYNECOL, V108, P667, DOI 10.1097/01.AOG.0000235059.84188.9c; Global Initiative for Asthma (GINA), ASTHM MAN GUID 2009; Gluck JC, 2006, IMMUNOL ALLERGY CLIN, V26, P63, DOI 10.1016/j.iac.2005.10.008; Juniper Elizabeth F., 1993, V7, P223; Kurinczuk JJ, 1999, WOMEN HEALTH, V29, P31, DOI 10.1300/J013v29n03_03; Kwon HL, 2004, AM J OBSTET GYNECOL, V190, P1201, DOI 10.1016/j.ajog.2003.09.057; Kwon HL, 2003, ANN EPIDEMIOL, V13, P317, DOI 10.1016/S1047-2797(03)00008-5; Louik C, 2010, ANN ALLERG ASTHMA IM, V105, P110, DOI 10.1016/j.anai.2010.05.016; Murphy VE, 2011, BJOG-INT J OBSTET GY, V118, P1314, DOI 10.1111/j.1471-0528.2011.03055.x; SCHATZ M, 1988, Journal of Allergy and Clinical Immunology, V81, P509, DOI 10.1016/0091-6749(88)90187-X; Schatz M, 2003, J ALLERGY CLIN IMMUN, V112, P283, DOI 10.1067/mai.2003.1516; Schatz M, 1999, LANCET, V353, P1202, DOI 10.1016/S0140-6736(99)00111-7; Snowball JM, 2007, PHARMACOEPIDEM DR S, V16, pS118; Thomas M, 2009, J ALLERGY CLIN IMMUN, V123, P116, DOI 10.1016/j.jaci.2008.09.035; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004	20	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60247	10.1371/journal.pone.0060247	http://dx.doi.org/10.1371/journal.pone.0060247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593182	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100027
J	Gimenez, T; Braga, MM; Raggio, DP; Deery, C; Ricketts, DN; Mendes, FM				Gimenez, Thais; Braga, Mariana Minatel; Raggio, Daniela Procida; Deery, Chris; Ricketts, David N.; Mendes, Fausto Medeiros			Fluorescence-Based Methods for Detecting Caries Lesions: Systematic Review, Meta-Analysis and Sources of Heterogeneity	PLOS ONE			English	Review							APPROXIMAL CARIES; IN-VITRO; DIAGNOSTIC PERFORMANCE; CLINICAL-PERFORMANCE; DIAGNODENT PEN; OCCLUSAL; DEVICE; SEARCH; QUANTIFICATION; STRATEGIES	Background: Fluorescence-based methods have been proposed to aid caries lesion detection. Summarizing and analysing findings of studies about fluorescence-based methods could clarify their real benefits. Objective: We aimed to perform a comprehensive systematic review and meta-analysis to evaluate the accuracy of fluorescence-based methods in detecting caries lesions. Data Source: Two independent reviewers searched PubMed, Embase and Scopus through June 2012 to identify papers/articles published. Other sources were checked to identify non-published literature. Study Eligibility Criteria, Participants and Diagnostic Methods: The eligibility criteria were studies that: (1) have assessed the accuracy of fluorescence-based methods of detecting caries lesions on occlusal, approximal or smooth surfaces, in both primary or permanent human teeth, in the laboratory or clinical setting; (2) have used a reference standard; and (3) have reported sufficient data relating to the sample size and the accuracy of methods. Study Appraisal and Synthesis Methods: A diagnostic 262 table was extracted from included studies to calculate the pooled sensitivity, specificity and overall accuracy parameters (Diagnostic Odds Ratio and Summary Receiver-Operating curve). The analyses were performed separately for each method and different characteristics of the studies. The quality of the studies and heterogeneity were also evaluated. Results: Seventy five studies met the inclusion criteria from the 434 articles initially identified. The search of the grey or non-published literature did not identify any further studies. In general, the analysis demonstrated that the fluorescence-based method tend to have similar accuracy for all types of teeth, dental surfaces or settings. There was a trend of better performance of fluorescence methods in detecting more advanced caries lesions. We also observed moderate to high heterogeneity and evidenced publication bias. Conclusions: Fluorescence-based devices have similar overall performance; however, better accuracy in detecting more advanced caries lesions has been observed.	[Gimenez, Thais; Braga, Mariana Minatel; Raggio, Daniela Procida; Mendes, Fausto Medeiros] Univ Sao Paulo, Sch Dent, Dept Pediat Dent, Sao Paulo, Brazil; [Deery, Chris] Univ Sheffield, Sch Clin Dent, Sheffield, S Yorkshire, England; [Ricketts, David N.] Univ Dundee, Dundee Dent Hosp & Sch, Dundee, Scotland	Universidade de Sao Paulo; University of Sheffield; University of Dundee	Mendes, FM (corresponding author), Univ Sao Paulo, Sch Dent, Dept Pediat Dent, Sao Paulo, Brazil.	fmmendes@usp.br	Gimenez, Thais/D-4895-2013; Braga, Mariana M/E-8536-2012; Raggio, Daniela/B-9411-2012; Mendes, Fausto/E-7067-2010	Gimenez, Thais/0000-0002-1528-0370; Raggio, Daniela/0000-0002-0048-2068; Mendes, Fausto/0000-0003-1711-4103; Minatel Braga, Mariana/0000-0002-4469-6500	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). FMM is recipient of the Research Productivity Scholarship CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilleos EE, 2012, LASERS MED SCI; Angmar-Mansson B, 2001, DENTOMAXILLOFAC RAD, V30, P298, DOI 10.1038/sj.dmfr.4600644; Bader JD, 2004, J AM DENT ASSOC, V135, P1413, DOI 10.14219/jada.archive.2004.0051; Bader JD, 2002, J PUBLIC HEALTH DENT, V62, P201, DOI 10.1111/j.1752-7325.2002.tb03446.x; Baelum V, 2012, COMMUNITY DENT ORAL, V40, P257, DOI 10.1111/j.1600-0528.2011.00655.x; Bonecker M, 2010, INT J PAEDIATR DENT, V20, P125, DOI 10.1111/j.1365-263X.2009.01030.x; Braga Mariana M, 2010, Dent Clin North Am, V54, P479, DOI 10.1016/j.cden.2010.03.006; Braga MM, 2009, ORAL SURG ORAL MED O, V108, pE35, DOI 10.1016/j.tripleo.2009.05.017; Buchalla W, 2005, CARIES RES, V39, P150, DOI 10.1159/000083162; Chen JH, 2012, INT J PAEDIATR DENT, V22, P132, DOI 10.1111/j.1365-263X.2011.01180.x; Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665; De Benedetto MS, 2011, LASER MED SCI, V26, P157, DOI 10.1007/s10103-010-0757-1; de Jong MC, 2012, EUR RADIOL, V22, P1881, DOI 10.1007/s00330-012-2434-1; Deville WLJM, 2000, J CLIN EPIDEMIOL, V53, P65, DOI 10.1016/S0895-4356(99)00144-4; Diniz MB, 2012, J AM DENT ASSOC, V143, P339, DOI 10.14219/jada.archive.2012.0176; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Ekstrand K R, 2004, J Dent Res, V83 Spec No C, pC67; Francescut P, 2006, CARIES RES, V40, P181, DOI 10.1159/000092223; Francescut Paola, 2003, Pediatr Dent, V25, P559; Golder S, 2006, HEALTH INFO LIBR J, V23, P3, DOI 10.1111/j.1471-1842.2006.00634.x; Hibst R., 2001, MED LASER APPL, V16, P205; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Kuhnisch J, 2007, EUR J ORAL SCI, V115, P206, DOI 10.1111/j.1600-0722.2007.00441.x; Kuhnisch J, 2006, EUR J ORAL SCI, V114, P483, DOI 10.1111/j.1600-0722.2006.00404.x; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lussi A, 2006, CARIES RES, V40, P97, DOI 10.1159/000091054; Lussi A, 2001, EUR J ORAL SCI, V109, P14, DOI 10.1034/j.1600-0722.2001.109001014.x; Lussi A, 2006, J DENT, V34, P467, DOI 10.1016/j.jdent.2005.11.002; Macaskill P, 2010, COCHRANE HDB SYSTEMA; Matos R, 2011, CARIES RES, V45, P294, DOI 10.1159/000328673; Mendes FM, 2012, CARIES RES, V46, P536, DOI 10.1159/000341189; Mendes FM, 2005, J DENT, V33, P79, DOI 10.1016/j.jdent.2004.10.010; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MORTIMER K V, 1970, Caries Research, V4, P206; Nelemans PJ, 2000, RADIOLOGY, V217, P105, DOI 10.1148/radiology.217.1.r00oc11105; Novaes TF, 2010, CARIES RES, V44, P465, DOI 10.1159/000320266; Novaes TF, 2009, CARIES RES, V43, P36, DOI 10.1159/000189705; Nyvad B, 2004, CARIES RES, V38, P192, DOI 10.1159/000077754; Pereira AC, 2011, BRAZILIAN J ORAL SCI, V10, P27; Pitts N B, 2003, Community Dent Health, V20, P45; Reitsma JB, 2009, COCHRANE HDB SYSTEMA; Seremidi K, 2012, OPER DENT, V37, P234, DOI 10.2341/10-326-L; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P975, DOI 10.1016/0003-9969(84)90144-4; Shi XQ, 2001, CARIES RES, V35, P21; Staal JB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001824.pub3; Twetman S, 2012, ACTA ODONTOL SCAND; Whiting P, 2008, J CLIN EPIDEMIOL, V61, P357, DOI 10.1016/j.jclinepi.2007.05.013; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	51	66	67	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60421	10.1371/journal.pone.0060421	http://dx.doi.org/10.1371/journal.pone.0060421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593215	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000319108100041
J	Espadinha, D; Faria, NA; Miragaia, M; Lito, LM; Melo-Cristino, J; de Lencastre, H				Espadinha, Diana; Faria, Nuno A.; Miragaia, Maria; Lito, Luis Marques; Melo-Cristino, Jose; de Lencastre, Herminia		Medicos Sentinela Network	Extensive Dissemination of Methicillin-Resistant Staphylococcus aureus (MRSA) between the Hospital and the Community in a Country with a High Prevalence of Nosocomial MRSA	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; MULTIPLEX PCR STRATEGY; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; MEC ELEMENT; CLONES; SEQUENCE; SURVEILLANCE; INFECTIONS; CHROMOSOME	According to the EARS-Net surveillance data, Portugal has the highest prevalence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) in Europe, but the information on MRSA in the community is very scarce and the links between the hospital and community are not known. In this study we aimed to understand the events associated to the recent sharp increase in MRSA frequency in Portugal and to evaluate how this has shaped MRSA epidemiology in the community. With this purpose, 180 nosocomial MRSA isolates recovered from infection in two time periods and 14 MRSA isolates recovered from 89 samples of skin and soft tissue infections (SSTI) were analyzed by pulsed-field gel electrophoresis (PFGE), staphylococcal chromosome cassette mec (SCCmec) typing, spa typing and multilocus sequence typing (MLST). All isolates were also screened for the presence of Panton Valentine leukocidin (PVL) and arginine catabolic mobile element (ACME) by PCR. The results showed that ST22-IVh, accounting for 72% of the nosocomial isolates, was the major clone circulating in the hospital in 2010, having replaced two previous dominant clones in 1993, the Iberian (ST247-I) and Portuguese (ST239-III variant) clones. Moreover in 2010, three clones belonging to CC5 (ST105-II, ST125-IVc and ST5-IVc) accounted for 20% of the isolates and may represent the beginning of new waves of MRSA in this hospital. Interestingly, more than half of the MRSA isolates (8/14) causing SSTI in people attending healthcare centers in Portugal belonged to the most predominant clones found in the hospital, namely ST22-IVh (n = 4), ST5-IVc (n = 2) and ST105-II (n = 1). Other clones found included ST5-V (n = 6) and ST8-VI (n = 1). None of the MRSA isolates carried PVL and only five isolates (ST5-V-t179) carried ACME type II. The emergence and spread of EMRSA-15 may be associated to the observed increase in MRSA frequency in the hospital and the consequent spillover of MRSA into the community.	[Espadinha, Diana; Faria, Nuno A.; Miragaia, Maria; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Lito, Luis Marques; Melo-Cristino, Jose] Ctr Hosp Lisboa Norte, Serv Patol Clin, Lisbon, Portugal; [Melo-Cristino, Jose] Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Rockefeller University	de Lencastre, H (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	lencash@mail.rockfeller.edu	Simoes, Jose Augusto/L-4695-2016; Melo-Cristino, Jose A G/H-3726-2013; Espadinha, Diana/Q-9134-2019; Miragaia, Maria/J-2704-2015; Faria, Nuno A/B-9229-2009	Simoes, Jose Augusto/0000-0003-2264-7086; Melo-Cristino, Jose A G/0000-0001-8643-1722; Espadinha, Diana/0000-0002-5305-6046; Miragaia, Maria/0000-0002-1323-7184; Faria, Nuno A/0000-0003-3762-9809; /0000-0001-6816-8932	TROCAR-FP7-HEALTH-B from the European Commission [223031]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/BIA-EVF/117507/2010]; FCT [SFRH/BPD/66514/2009, Pest-OE/EQB/LAO004/2011]; Fundacao Calouste Gulbenkian [P-99911]; CONCORD-FP7-HEALTH-B from the European Commission [222718]	TROCAR-FP7-HEALTH-B from the European Commission; Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); CONCORD-FP7-HEALTH-B from the European Commission	DE was supported by a fellowship from project TROCAR-FP7-HEALTH-2007-B project no 223031 from the European Commission and project PTDC/BIA-EVF/117507/2010 from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. NAF was supported by a grant SFRH/BPD/66514/2009 from FCT. This work was funded by project Ref. P-99911 from Fundacao Calouste Gulbenkian; CONCORD-FP7-HEALTH-2007-B project no 222718 and TROCAR-FP7-HEALTH-2007-B project no 223031 from the European Commission. The work was supported additionally by FCT through grant #Pest-OE/EQB/LAO004/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Alcoceba E, 2007, CLIN MICROBIOL INFEC, V13, P599, DOI 10.1111/j.1469-0691.2007.01703.x; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Biber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042864; Blanc DS, 2007, J CLIN MICROBIOL, V45, P3729, DOI 10.1128/JCM.00511-07; Campanile F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-22; Carmo MS, 2011, BRAZ J MED BIOL RES, V44, P1013, DOI 10.1590/S0100-879X2011007500114; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chavez TT, 2008, DM-DIS MON, V54, P763, DOI 10.1016/j.disamonth.2008.09.004; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Chung M, 2004, J CLIN MICROBIOL, V42, P542, DOI 10.1128/JCM.42.2.542-547.2004; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; COUTO I, 1995, J CLIN MICROBIOL, V33, P2032, DOI 10.1128/JCM.33.8.2032-2035.1995; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; European Centre for Disease Prevention and Control (ECDC), 2001, EARSS ANN REP 2001; European Centre for Disease Prevention and Control (ECDC), 2010, ANT RES SURV EUR 201; European Surveillance of Antimicrobial Comsumption (ESAC), 2009, ESAC YB 2009; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Fossum AE, 2006, CLIN MICROBIOL INFEC, V12, P627, DOI 10.1111/j.1469-0691.2006.01467.x; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holden MT, 2013, GENOME RES IN PRESS; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Kawaguchiya M, 2011, MICROB DRUG RESIST, V17, P241, DOI 10.1089/mdr.2010.0136; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Linde H, 2005, EUR J CLIN MICROBIOL, V24, P419, DOI 10.1007/s10096-005-1341-7; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Melter O., 2006, EURO SURVEILL, V11; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Mollaghan AM, 2010, EPIDEMIOL INFECT, V138, P673, DOI 10.1017/S0950268810000191; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nazareth R, 2012, REV PORT PNEUMOL, V18, P34, DOI 10.1016/j.rppneu.2011.05.007; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; O'Hara FP, 2012, MICROB DRUG RESIST, V18, P555, DOI 10.1089/mdr.2012.0056; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028; Perez-Roth E, 2004, J CLIN MICROBIOL, V42, P4649, DOI 10.1128/JCM.42.10.4649-4656.2004; Perez-Vazquez M, 2009, J ANTIMICROB CHEMOTH, V63, P21, DOI 10.1093/jac/dkn430; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Sa-Leao R, 2001, MICROB DRUG RESIST, V7, P237, DOI 10.1089/10766290152652783; Salgado CD, 2003, CLIN INFECT DIS, V36, P131, DOI 10.1086/345436; Sharff KA, 2012, J CLIN MICROBIOL, V50, P4151, DOI 10.1128/JCM.01564-12; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P1896, DOI 10.1128/AAC.01756-10; Simoes RR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017630, 10.1371/journal.pone.0029279]; Smith K, 2008, J MED MICROBIOL, V57, P1018, DOI 10.1099/jmm.0.2008/000968-0; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316	59	64	67	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59960	10.1371/journal.pone.0059960	http://dx.doi.org/10.1371/journal.pone.0059960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23593155	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100036
J	Davis, CL; Wahid, R; Toapanta, FR; Simon, JK; Sztein, MB; Levy, D				Davis, Courtney L.; Wahid, Rezwanul; Toapanta, Franklin R.; Simon, Jakub K.; Sztein, Marcelo B.; Levy, Doron			Applying Mathematical Tools to Accelerate Vaccine Development: Modeling Shigella Immune Dynamics	PLOS ONE			English	Article							LYMPH-NODE CELLS; PROTECTIVE IMMUNITY; ANTIBODY-PRODUCTION; HEALTHY-ADULTS; T-CELLS; IN-VIVO; B-CELLS; FLEXNERI; INFECTION; INNATE	We establish a mathematical framework for studying immune interactions with Shigella, a bacteria that kills over one million people worldwide every year. The long-term goal of this novel approach is to inform Shigella vaccine design by elucidating which immune components and bacterial targets are crucial for establishing Shigella immunity. Our delay differential equation model focuses on antibody and B cell responses directed against antigens like lipopolysaccharide in Shigella's outer membrane. We find that antibody-based vaccines targeting only surface antigens cannot elicit sufficient immunity for protection. Additional boosting prior to infection would require a four-orders-of-magnitude increase in antibodies to sufficiently prevent epithelial invasion. However, boosting anti-LPS B memory can confer protection, which suggests these cells may correlate with immunity. We see that IgA antibodies are slightly more effective per molecule than IgG, but more total IgA is required due to spatial functionality. An extension of the model reveals that targeting both LPS and epithelial entry proteins is a promising avenue to advance vaccine development. This paper underscores the importance of multifaceted immune targeting in creating an effective Shigella vaccine. It introduces mathematical models to the Shigella vaccine development effort and lays a foundation for joint theoretical/experimental/clinical approaches to Shigella vaccine design.	[Davis, Courtney L.] Pepperdine Univ, Div Nat Sci, Malibu, CA 90265 USA; [Wahid, Rezwanul; Toapanta, Franklin R.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Simon, Jakub K.] NanoBio Corp, Ann Arbor, MI USA; [Levy, Doron] Univ Maryland, Dept Math, College Pk, MD 20742 USA; [Levy, Doron] Univ Maryland, Ctr Sci Computat & Math Modeling, College Pk, MD 20742 USA	Pepperdine University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Davis, CL (corresponding author), Pepperdine Univ, Div Nat Sci, Malibu, CA 90265 USA.	courtney.davis2@pepperdine.edu	Toapanta, Franklin/Y-1774-2019	Davis, Courtney/0000-0002-3274-5707	University of Maryland, College Park and University of Maryland, Baltimore (UMCP-UMB) Seed Grant; Cooperative Center for Translational Research in Human Immunology and Biodefense; CCHI [U19 AI082655]; NSF/NIGMS program [DMS-0758374];  [R01CA130817];  [K23AI065759]; NATIONAL CANCER INSTITUTE [R01CA130817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082655] Funding Source: NIH RePORTER	University of Maryland, College Park and University of Maryland, Baltimore (UMCP-UMB) Seed Grant; Cooperative Center for Translational Research in Human Immunology and Biodefense; CCHI; NSF/NIGMS program; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a University of Maryland, College Park and University of Maryland, Baltimore (UMCP-UMB) Seed Grant (to DL, JKS, and RW), by Grant Numbers R01CA130817 (to DL), K23AI065759 (to JKS), U19 AI082655 (Cooperative Center for Translational Research in Human Immunology and Biodefense; CCHI, to MBS) and DMS-0758374 (a joint NSF/NIGMS program, to DL). The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Ashida H, 2011, CURR OPIN IMMUNOL, V23, P448, DOI 10.1016/j.coi.2011.06.001; Baker K, 2009, SEMIN IMMUNOPATHOL, V31, P223, DOI 10.1007/s00281-009-0160-9; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Bru A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012985; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; CONRAD RE, 1974, J IMMUNOL, V112, P17; DUPONT HL, 1972, J INFECT DIS, V125, P12, DOI 10.1093/infdis/125.1.12; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; HELMREICH E, 1962, J BIOL CHEM, V237, P1925; HELMREICH E, 1961, J BIOL CHEM, V236, P464; HIBI T, 1986, EUR J IMMUNOL, V16, P139, DOI 10.1002/eji.1830160206; ISLAM D, 1995, INFECT IMMUN, V63, P2941, DOI 10.1128/IAI.63.8.2941-2949.1995; Islam D, 1996, INFECT IMMUN, V64, P1391, DOI 10.1128/IAI.64.4.1391-1399.1996; Janeway CA, 2001, IMMUNOBIOLOGY; Jansen VAA, 2005, J THEOR BIOL, V234, P39, DOI 10.1016/j.jtbi.2004.11.006; Koterski JF, 2005, INFECT IMMUN, V73, P504, DOI 10.1128/IAI.73.1.504-513.2005; Kotloff KL, 2002, INFECT IMMUN, V70, P2016, DOI 10.1128/IAI.70.4.2016-2021.2002; KOTLOFF KL, 1995, VACCINE, V13, P495, DOI 10.1016/0264-410X(94)00011-B; KOTLOFF KL, 1992, INFECT IMMUN, V60, P2218, DOI 10.1128/IAI.60.6.2218-2224.1992; KOTLOFF KL, 1995, VACCINE, V13, P1488, DOI 10.1016/0264-410X(95)00102-7; Kotloff KL, 2000, INFECT IMMUN, V68, P1034, DOI 10.1128/IAI.68.3.1034-1039.2000; Kweon MN, 2008, CURR OPIN INFECT DIS, V21, P313, DOI 10.1097/QCO.0b013e3282f88b92; Le-Barillec K, 2005, J IMMUNOL, V175, P1735, DOI 10.4049/jimmunol.175.3.1735; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; LEVY M, 1987, EUR J IMMUNOL, V17, P849, DOI 10.1002/eji.1830170618; Marino S, 2011, WIRES SYST BIOL MED, V3, P479, DOI 10.1002/wsbm.131; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; NIESEL DW, 1986, INFECT IMMUN, V52, P828, DOI 10.1128/IAI.52.3.828-833.1986; Nowak MA., 2000, VIRUS DYNAMICS MATH; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; PERDOMO JJ, 1994, J CLIN INVEST, V93, P633, DOI 10.1172/JCI117015; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Phalipon A, 2003, CRIT REV IMMUNOL, V23, P371, DOI 10.1615/CritRevImmunol.v23.i56.20; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; RAQIB R, 1995, J INFECT DIS, V171, P376, DOI 10.1093/infdis/171.2.376; Raqib R, 1996, GUT, V38, P328, DOI 10.1136/gut.38.3.328; Riddle MS, 2011, VACCINE, V29, P7009, DOI 10.1016/j.vaccine.2011.07.033; Samandari T, 2000, J IMMUNOL, V164, P2221, DOI 10.4049/jimmunol.164.4.2221; Sansonetti P, 1996, RES IMMUNOL, V147, P595, DOI 10.1016/S0923-2494(97)85227-3; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; Simon JK, 2011, CLIN IMMUNOL, V139, P185, DOI 10.1016/j.clim.2011.02.003; Simon JK, 2009, VACCINE, V27, P565, DOI 10.1016/j.vaccine.2008.10.081; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; STENDAHL O, 1977, IMMUNOLOGY, V32, P11; WHO, 2009, VACC PREV DIS IMM; World Health Organization, 2009, SHIG DIS BURD	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59465	10.1371/journal.pone.0059465	http://dx.doi.org/10.1371/journal.pone.0059465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23589755	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300021
J	Wang, ZH; Wu, L; Cheng, X; Liu, SZ; Li, BS; Li, HJ; Kang, FB; Wang, JP; Xia, H; Ping, CY; Nassal, M; Sun, DX				Wang, Zihua; Wu, Li; Cheng, Xin; Liu, Shizhu; Li, Baosheng; Li, Haijun; Kang, Fubiao; Wang, Junping; Xia, Huan; Ping, Caiyan; Nassal, Michael; Sun, Dianxing			Replication-Competent Infectious Hepatitis B Virus Vectors Carrying Substantially Sized Transgenes by Redesigned Viral Polymerase Translation	PLOS ONE			English	Article							HBV GENOME TRANSDUCTION; RIBOSOME ENTRY SITES; CIS-ACTING SEQUENCES; STRAND DNA-SYNTHESIS; CLOSED CIRCULAR DNA; HEPATOMA-CELL LINES; CORE PROTEIN; MONOCLONAL-ANTIBODIES; NUCLEOTIDE-SEQUENCE; GENE-EXPRESSION	Viral vectors are engineered virus variants able to deliver nonviral genetic information into cells, usually by the same routes as the parental viruses. For several virus families, replication-competent vectors carrying reporter genes have become invaluable tools for easy and quantitative monitoring of replication and infection, and thus also for identifying antivirals and virus susceptible cells. For hepatitis B virus (HBV), a small enveloped DNA virus causing B-type hepatitis, such vectors are not available because insertions into its tiny 3.2 kb genome almost inevitably affect essential replication elements. HBV replicates by reverse transcription of the pregenomic (pg) RNA which is also required as bicistronic mRNA for the capsid (core) protein and the reverse transcriptase (Pol); their open reading frames (ORFs) overlap by some 150 basepairs. Translation of the downstream Pol ORF does not involve a conventional internal ribosome entry site (IRES). We reasoned that duplicating the overlap region and providing artificial IRES control for translation of both Pol and an in-between inserted transgene might yield a functional tricistronic pgRNA, without interfering with envelope protein expression. As IRESs we used a 22 nucleotide element termed Rbm3 IRES to minimize genome size increase. Model plasmids confirmed its activity even in tricistronic arrangements. Analogous plasmids for complete HBV genomes carrying 399 bp and 720 bp transgenes for blasticidin resistance (BsdR) and humanized Renilla green fluorescent protein (hrGFP) produced core and envelope proteins like wild-type HBV; while the hrGFP vector replicated poorly, the BsdR vector generated around 40% as much replicative DNA as wild-type HBV. Both vectors, however, formed enveloped virions which were infectious for HBV-susceptible HepaRG cells. Because numerous reporter and effector genes with sizes of around 500 bp or less are available, the new HBV vectors should become highly useful tools to better understand, and combat, this important pathogen.	[Wang, Zihua; Wu, Li; Cheng, Xin; Liu, Shizhu; Li, Baosheng; Li, Haijun; Kang, Fubiao; Wang, Junping; Xia, Huan; Ping, Caiyan; Sun, Dianxing] Bethune Int Peace Hosp, Liver Dis Diag & Treatment Ctr PLA, Shijiazhuang, Peoples R China; [Wang, Zihua] Third Mil Med Univ, Chongqing, Peoples R China; [Nassal, Michael] Univ Hosp Freiburg, Freiburg, Germany	Army Medical University; University of Freiburg	Nassal, M (corresponding author), Univ Hosp Freiburg, Freiburg, Germany.	nassal2@ukl.uni-freiburg.de; sundianxing@hotmail.com	Nassal, Michael/U-4529-2019; Wang, Zhiquan/HHS-6768-2022; Sharma, Ashwani/AAK-3879-2020	Nassal, Michael/0000-0003-2204-9158; Sharma, Ashwani/0000-0001-9835-1973	National Natural Science Foundation of China [81271843, 81201297]; National Major Science and Technology Special Project for Infectious Diseases of China [2012ZX10004503-012]; Deutsche Forschungsgemeinschaft [DFG Na 154/7-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Science and Technology Special Project for Infectious Diseases of China; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from the National Natural Science Foundation of China (81271843, 81201297) and the National Major Science and Technology Special Project for Infectious Diseases of China (2012ZX10004503-012). Initial experiments were in part supported by the Deutsche Forschungsgemeinschaft (DFG Na 154/7-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Baranick BT, 2008, P NATL ACAD SCI USA, V105, P4733, DOI 10.1073/pnas.0710650105; Bardens A, 2011, CELL MICROBIOL, V13, P602, DOI 10.1111/j.1462-5822.2010.01557.x; BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Berke JM, 2010, J VIROL METHODS, V165, P268, DOI 10.1016/j.jviromet.2010.02.007; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Chaisomchit S, 1997, GENE THER, V4, P1330, DOI 10.1038/sj.gt.3300544; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2003, J BIOL CHEM, V278, P33793, DOI 10.1074/jbc.M303495200; Chen A, 2005, NUCLEIC ACIDS RES, V33, P1169, DOI 10.1093/nar/gki251; Chua PK, 2010, J VIROL, V84, P2340, DOI 10.1128/JVI.01666-09; Dhason MS, 2012, VIROLOGY, V430, P20, DOI 10.1016/j.virol.2012.04.012; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Freed WJ, 2005, EXP NEUROL, V191, pS45, DOI 10.1016/j.expneurol.2004.08.019; GALIBERT F, 1979, NATURE, V281, P646, DOI 10.1038/281646a0; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Haase R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-20; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; HEIJTINK RA, 1995, HEPATOLOGY, V22, P1078, DOI 10.1016/0270-9139(95)90612-6; Hernandez-Alcoceba R, 2011, CLIN TRANSL ONCOL, V13, P229, DOI 10.1007/s12094-011-0647-4; JANG SK, 1990, GENE DEV, V4, P1560, DOI 10.1101/gad.4.9.1560; King RW, 1998, ANTIMICROB AGENTS CH, V42, P3179, DOI 10.1128/AAC.42.12.3179; Kock J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037248; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lentz TB, 2012, NEUROBIOL DIS, V48, P179, DOI 10.1016/j.nbd.2011.09.014; Lewellyn EB, 2007, J VIROL, V81, P6207, DOI 10.1128/JVI.00210-07; Li D, 2011, J BIOCHEM, V150, P371, DOI 10.1093/jb/mvr086; Li F, 2010, J VIROL, V84, P12075, DOI 10.1128/JVI.00046-10; Li SH, 2007, WORLD J GASTROENTERO, V13, P2490, DOI 10.3748/wjg.v13.i17.2490; Licursi M, 2011, GENE THER, V18, P631, DOI 10.1038/gt.2011.11; Liu Jin-Xia, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P316; Liu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053392; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Maguire ML, 2010, J VIROL, V84, P12824, DOI 10.1128/JVI.01487-10; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2009, FUTURE VIROL, V4, P55, DOI 10.2217/17460794.4.1.55; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; OHORI H, 1980, INTERVIROLOGY, V13, P74, DOI 10.1159/000149110; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; OU JH, 1990, J VIROL, V64, P4578, DOI 10.1128/JVI.64.9.4578-4581.1990; PASEK M, 1979, NATURE, V282, P575, DOI 10.1038/282575a0; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Porterfield JZ, 2010, J VIROL, V84, P7174, DOI 10.1128/JVI.00586-10; Protzer U, 1999, P NATL ACAD SCI USA, V96, P10818, DOI 10.1073/pnas.96.19.10818; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; RANEY AK, 1994, J GEN VIROL, V75, P2671, DOI 10.1099/0022-1317-75-10-2671; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Ren ST, 2001, J VIROL, V75, P1104, DOI 10.1128/JVI.75.3.1104-1116.2001; SALLBERG M, 1991, J MED VIROL, V33, P248, DOI 10.1002/jmv.1890330407; Schulze A, 2012, HEPATOLOGY, V55, P373, DOI 10.1002/hep.24707; Sharma P, 2012, NUCLEIC ACIDS RES, V40, P3143, DOI 10.1093/nar/gkr1176; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sun DX, 2006, J HEPATOL, V45, P636, DOI 10.1016/j.jhep.2006.05.019; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Tajiri K, 2010, ANTIVIR RES, V87, P40, DOI 10.1016/j.antiviral.2010.04.006; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Terahara K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00280; Untergasser A, 2004, HUM GENE THER, V15, P203, DOI 10.1089/104303404772680001; von Weizsacker Fritz, 2004, Methods Mol Med, V96, P153; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wang JCY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002919; World Health Organization, 2008, HEP B; Yoo J, 2002, VIRUS GENES, V24, P215, DOI 10.1023/A:1015320314201; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994; Zoulim F, 2012, HEPATOLOGY	76	19	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60306	10.1371/journal.pone.0060306	http://dx.doi.org/10.1371/journal.pone.0060306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23589756	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300091
J	Bax, ML; Buffiere, C; Hafnaoui, N; Gaudichon, C; Savary-Auzeloux, I; Dardevet, D; Sante-Lhoutellier, V; Remond, D				Bax, Marie-Laure; Buffiere, Caroline; Hafnaoui, Noureddine; Gaudichon, Claire; Savary-Auzeloux, Isabelle; Dardevet, Dominique; Sante-Lhoutellier, Veronique; Remond, Didier			Effects of Meat Cooking, and of Ingested Amount, on Protein Digestion Speed and Entry of Residual Proteins into the Colon: A Study in Minipigs	PLOS ONE			English	Article							AMINO-ACIDS; IN-VITRO; METABOLIC UTILIZATION; ILEAL DIGESTIBILITY; NITROGEN-BALANCE; DIETARY PROTEINS; HUMANS; CONSUMPTION; CARNOSINE; QUALITY	The speed of protein digestion impacts on postprandial protein anabolism. After exercise or in the elderly, fast proteins stimulate protein synthesis more efficiently than slow proteins. It has been shown that meat might be a source of fast proteins. However, cooking temperature, acting on the macrostructure and microstructure of the meat could affect both the speed, and efficiency, of protein digestion. This study aims to evaluate, in vivo, the effect of meat cooking on digestion parameters, in the context of a complete meal. Six minipigs fitted with an ileal cannula and an arterial catheter were used. In order to measure the true ileal digestibility, tested meat was obtained from a calf, the muscle proteins of which were intrinsically labelled with N-15-amino acids. Three cooking temperatures (60, 75 and 95 degrees C; core temperature for 30 min), and three levels of intake (1, 1.45, and 1.90 g protein/kg body weight) were tested. Following meat ingestion, ileal digesta and arterial blood were collected over a 9-h period. The speed of digestion, evaluated from the kinetics of amino acid appearance in blood within the first 3 h, was greater for the cooking temperature of 75 degrees C, than for 60 or 95 degrees C. The true ileal digestibility, which averaged 95%, was not affected by cooking temperature or by the level of meat intake. The amino acid composition of the digesta flowing at the ileum was not affected by cooking temperature. These results show that cooking temperature can modulate the speed of meat protein digestion, without affecting the efficiency of the small intestinal digestion, and consequently the entry of meat protein residues into the colon.	[Bax, Marie-Laure; Buffiere, Caroline; Hafnaoui, Noureddine; Savary-Auzeloux, Isabelle; Dardevet, Dominique; Remond, Didier] Univ Auvergne, Clermont Univ, Unite Nutr Humaine, Clermont Ferrand, France; [Bax, Marie-Laure; Buffiere, Caroline; Hafnaoui, Noureddine; Savary-Auzeloux, Isabelle; Dardevet, Dominique; Remond, Didier] CRNH Auvergne, UNH UMR1019, INRA, Clermont Ferrand, France; [Bax, Marie-Laure; Sante-Lhoutellier, Veronique] INRA, Qualite Prod Anim UR370, F-63122 St Genes Champanelle, France; [Gaudichon, Claire] CRNH Ile France, INRA, AgroParisTech, Nutr Physiol & Ingest Behav UMR914, Paris, France	Universite Clermont Auvergne (UCA); INRAE; INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Remond, D (corresponding author), Univ Auvergne, Clermont Univ, Unite Nutr Humaine, Clermont Ferrand, France.	didier.remond@clermont.inra.fr	Sante-Lhoutellier, Veronique/M-8831-2017; Rémond, Didier/G-3550-2013	Sante-Lhoutellier, Veronique/0000-0003-2149-7661; Remond, Didier/0000-0003-4430-0067; GAUDICHON, Claire/0000-0002-0983-4760; Dardevet, Dominique/0000-0001-7320-9970; Savary-Auzeloux, Isabelle/0000-0002-3298-9787	French Research National Agency [ANR-09-ALIA-008-01]; European fund for regional development (FEDER); Auvergne regional council; EU [COST FA 1005]	French Research National Agency(French National Research Agency (ANR)); European fund for regional development (FEDER)(European Commission); Auvergne regional council(Region Auvergne-Rhone-Alpes); EU(European Commission)	The authors are grateful to the French Research National Agency (ANR-09-ALIA-008-01 Program PRONUTRIAL (2010-2013)), the European fund for regional development (FEDER), and the Auvergne regional council for their financial supports. The authors are participants of the EU funded COST action INFOGEST (COST FA 1005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DD, 2011, OBES REV, V12, pe472, DOI 10.1111/j.1467-789X.2010.00785.x; Barbe F, 2013, FOOD CHEM, V136, P1203, DOI 10.1016/j.foodchem.2012.09.022; Bauchart C, 2007, BRIT J NUTR, V98, P1187, DOI 10.1017/S0007114507761810; Bauchart C, 2007, J NUTR, V137, P589, DOI 10.1093/jn/137.3.589; Bax ML, 2012, J AGR FOOD CHEM, V60, P2569, DOI 10.1021/jf205280y; Bingham SA, 2002, J NUTR, V132, p3522S, DOI 10.1093/jn/132.11.3522S; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Bos C, 2005, AM J CLIN NUTR, V81, P87; Bos C, 2007, J NUTR, V137, P594, DOI 10.1093/jn/137.3.594; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Dangin M, 2003, J PHYSIOL-LONDON, V549, P635, DOI 10.1113/jphysiol.2002.036897; de Vrese M, 2000, J NUTR, V130, P2026, DOI 10.1093/jn/130.8.2026; Gaudichon C, 2002, GASTROENTEROLOGY, V123, P50, DOI 10.1053/gast.2002.34233; Gausseres N, 1997, J NUTR, V127, P1160, DOI 10.1093/jn/127.6.1160; Hess V, 2000, BRIT J NUTR, V83, P123, DOI 10.1017/S0007114500000167; Lacroix M, 2006, AM J CLIN NUTR, V84, P1070, DOI 10.1093/ajcn/84.5.1070; Leterme P, 1996, J NUTR, V126, P2188, DOI 10.1093/jn/126.9.2188; Magee EA, 2000, AM J CLIN NUTR, V72, P1488; Mariotti F, 1999, J NUTR, V129, P1992, DOI 10.1093/jn/129.11.1992; Mariotti F, 2001, J NUTR, V131, P1706, DOI 10.1093/jn/131.6.1706; Park YJ, 2005, J AGR FOOD CHEM, V53, P4736, DOI 10.1021/jf047934h; Remond D, 2007, AM J CLIN NUTR, V85, P1286, DOI 10.1093/ajcn/85.5.1286; Remond D, 2009, J NUTR, V139, P720, DOI 10.3945/jn.108.101675; ROWAN AM, 1994, BRIT J NUTR, V71, P29, DOI 10.1079/BJN19940108; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Sante-Lhoijtellier V, 2008, J AGR FOOD CHEM, V56, P1488, DOI 10.1021/jf072999g; SCHMITZ M, 1991, J NUTR, V121, P1575, DOI 10.1093/jn/121.10.1575; SILVESTER KR, 1995, NUTR CANCER, V24, P279, DOI 10.1080/01635589509514417; Symons TB, 2009, J AM DIET ASSOC, V109, P1582, DOI 10.1016/j.jada.2009.06.369; Tabatabaei SM, 2011, EUR J CLIN NUTR, V65, P668, DOI 10.1038/ejcn.2011.17; WAYLER A, 1983, J NUTR, V113, P2485, DOI 10.1093/jn/113.12.2485; West DWD, 2011, AM J CLIN NUTR, V94, P795, DOI 10.3945/ajcn.111.013722; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; YOUNG VR, 1975, J NUTR, V105, P534, DOI 10.1093/jn/105.5.534	34	77	78	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61252	10.1371/journal.pone.0061252	http://dx.doi.org/10.1371/journal.pone.0061252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593443	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300066
J	Cai, Q; Guo, L; Gao, HQ; Li, XA				Cai, Qian; Guo, Ling; Gao, Haiqing; Li, Xiang-An			Caveolar Fatty Acids and Acylation of Caveolin-1	PLOS ONE			English	Article							MEMBRANE; PALMITOYLATION; PROTEIN; MOLECULES; CELLS; MICE; DOMAIN; RAFTS	Purpose: Caveolae are cholesterol and sphingolipids rich subcellular domains on plasma membrane. Caveolae contain a variety of signaling proteins which provide platforms for signaling transduction. In addition to enriched with cholesterol and sphingolipids, caveolae also contain a variety of fatty acids. It has been well-established that acylation of protein plays a pivotal role in subcellular location including targeting to caveolae. However, the fatty acid compositions of caveolae and the type of acylation of caveolar proteins remain largely unknown. In this study, we investigated the fatty acids in caveolae and caveolin-1 bound fatty acids. Methods: Caveolae were isolated from Chinese hamster ovary (CHO) cells. The caveolar fatty acids were extracted with Folch reagent, methyl esterificated with BF3, and analyzed by gas chromatograph-mass spectrometer (GC/MS). The caveolin-1bound fatty acids were immunoprecipitated by anti-caveolin-1 IgG and analyzed with GC/MS. Results: In contrast to the whole CHO cell lysate which contained a variety of fatty acids, caveolae mainly contained three types of fatty acids, 0.48 mu g palmitic acid, 0.61 mu g stearic acid and 0.83 mu g oleic acid/caveolae preparation/5x10(7) cells. Unexpectedly, GC/MS analysis indicated that caveolin-1 was not acylated by myristic acid; instead, it was acylated by palmitic acid and stearic acid. Conclusion: Caveolae contained a special set of fatty acids, highly enriched with saturated fatty acids, and caveolin-1 was acylated by palmitic acid and stearic acid. The unique fatty acid compositions of caveolae and acylation of caveolin-1 may be important for caveolae formation and for maintaining the function of caveolae.	[Cai, Qian; Guo, Ling; Li, Xiang-An] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY USA; [Cai, Qian; Gao, Haiqing] Shandong Univ, Qi Lu Hosp, Dept Geriatr, Jinan 250100, Shandong, Peoples R China	University of Kentucky; Shandong University	Li, XA (corresponding author), Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY USA.	xli2@email.uky.edu			NIGMS/NIH [R01GM085231, R01GM085231-2S1, R01GM085231-5S1]; Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085231] Funding Source: NIH RePORTER	NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by Grant Number R01GM085231, R01GM085231-2S1 and R01GM085231-5S1 from NIGMS/NIH. This work was also supported by a grant from the Children's Miracle Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Bernatchez P, 2011, J CLIN INVEST, V121, P3747, DOI 10.1172/JCI44778; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gafencu A, 1998, CELL TISSUE RES, V293, P101, DOI 10.1007/s004410051102; Galbiati F, 1999, J BIOL CHEM, V274, P5843, DOI 10.1074/jbc.274.9.5843; Huot PSP, 2010, NUTR RES, V30, P179, DOI 10.1016/j.nutres.2010.02.003; Insel PA, 2009, CURR OPIN NEPHROL HY, V18, P50, DOI 10.1097/MNH.0b013e3283186f82; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Lee H, 2001, J BIOL CHEM, V276, P35150, DOI 10.1074/jbc.M104530200; Li XA, 2005, TRENDS CARDIOVAS MED, V15, P92, DOI 10.1016/j.tcm.2005.04.001; Li XA, 2006, CIRC RES, V98, pE60, DOI 10.1161/01.RES.0000219310.00308.10; Liu J, 2010, J LIPID RES, V51, P162, DOI 10.1194/jlr.M900237-JLR200; PALADE GE, 1968, J CELL BIOL, V37, P633, DOI 10.1083/jcb.37.3.633; PALADE GE, 1961, CIRCULATION, V24, P368; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Razani B, 2001, J BIOL CHEM, V276, P38121; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; ROBINSON LJ, 1995, J BIOL CHEM, V270, P995, DOI 10.1074/jbc.270.3.995; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	29	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60884	10.1371/journal.pone.0060884	http://dx.doi.org/10.1371/journal.pone.0060884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593340	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200025
J	Chen, YL; Hong, J; Cui, WY; Zaneveld, J; Wang, W; Gibbs, R; Xiao, YH; Chen, R				Chen, Yaoliang; Hong, Ji; Cui, Wanyun; Zaneveld, Jacques; Wang, Wei; Gibbs, Richard; Xiao, Yanghua; Chen, Rui			CGAP-Align: A High Performance DNA Short Read Alignment Tool	PLOS ONE			English	Article							GENOME; OLIGONUCLEOTIDES; SEQUENCES; ULTRAFAST; PROGRAM	Background: Next generation sequencing platforms have greatly reduced sequencing costs, leading to the production of unprecedented amounts of sequence data. BWA is one of the most popular alignment tools due to its relatively high accuracy. However, mapping reads using BWA is still the most time consuming step in sequence analysis. Increasing mapping efficiency would allow the community to better cope with ever expanding volumes of sequence data. Results: We designed a new program, CGAP-align, that achieves a performance improvement over BWA without sacrificing recall or precision. This is accomplished through the use of Suffix Tarray, a novel data structure combining elements of Suffix Array and Suffix Tree. We also utilize a tighter lower bound estimation for the number of mismatches in a read, allowing for more effective pruning during inexact mapping. Evaluation of both simulated and real data suggests that CGAP-align consistently outperforms the current version of BWA and can achieve over twice its speed under certain conditions, all while obtaining nearly identical results. Conclusion: CGAP-align is a new time efficient read alignment tool that extends and improves BWA. The increase in alignment speed will be of critical assistance to all sequence-based research and medicine. CGAP-align is freely available to the academic community at http://sourceforge.net/p/cgap-align under the GNU General Public License (GPL).	[Chen, Yaoliang; Hong, Ji; Cui, Wanyun; Wang, Wei; Xiao, Yanghua] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Zaneveld, Jacques; Gibbs, Richard; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA	Fudan University; Baylor College of Medicine	Xiao, YH (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China.	shawyh@fudan.edu.cn; ruichen@bcm.edu	XIAO, YANG/GPW-5529-2022		NIH [1S10RR026550]; Microsoft Research Asia [FY10-RES-OPP-010]; National Natural Science Foundation of China [61003001]; Specialized Research Fund for the Doctoral Program of Higher Education [20100071120032]; Key Program of National Natural Science Foundation of China [61033010]; NIH training grant [T32 EY007102]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2010ZX01042-003-004]; Retinal Research Foundation; National Eye Institute [R01EY018571]; National Human Genome Research Institute [U54HG003273]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026550] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007102, R01EY018571] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microsoft Research Asia(Microsoft); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Technology Major Project of the Ministry of Science and Technology of China; Retinal Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Exome and whole genome sequencing was performed at the BCM-FGI core facility supported by NIH shared instrument grant 1S10RR026550 to R.C. This work was largely supported by Microsoft Research Asia with sponsorship number FY10-RES-OPP-010 and partially supported by the National Natural Science Foundation of China under grant No 61003001; Specialized Research Fund for the Doctoral Program of Higher Education No. 20100071120032; Key Program of National Natural Science Foundation of China under grant No. 61033010; NIH training grant T32 EY007102; National Science and Technology Major Project of the Ministry of Science and Technology of China under grant No. 2010ZX01042-003-004. This work is also partially supported by grants from the Retinal Research Foundation and National Eye Institute (R01EY018571) to R.C. and the National Human Genome Research Institute to R.G. (U54HG003273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was largely supported by Microsoft Research Asia with sponsorship number FY10-RES-OPP-010. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; Burrows M, 1994, BLOCK SORTING LOSSLE, V124; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Hon W.-K., 2004, PROC ALENEX ANALC, P31; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Kim YJ, 2009, BIOINFORMATICS, V25, P1424, DOI 10.1093/bioinformatics/btp178; Ko P, 2003, LNCS, V2676, P203; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Manber U, 1990, P 1 ANN ACM SIAM SOD, V90, P327; MCCREIGHT EM, 1976, J ACM, V23, P262, DOI 10.1145/321941.321946; Phoophakdee B, 2007, P 2007 ACM SIGMOD IN, P833, DOI DOI 10.1145/1247480.1247572; Ritz A, 2010, BIOINFORMATICS, V26, P1291, DOI 10.1093/bioinformatics/btq153; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Tata S, 2003, P 30 INT C VLDB, P36	24	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61033	10.1371/journal.pone.0061033	http://dx.doi.org/10.1371/journal.pone.0061033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593381	Green Submitted, Green Published, gold			2022-12-27	WOS:000317383200036
J	Kikuchi, J; Shibayama, N; Yamada, S; Wada, T; Nobuyoshi, M; Izumi, T; Akutsu, M; Kano, Y; Sugiyama, K; Ohki, M; Park, SY; Furukawa, Y				Kikuchi, Jiro; Shibayama, Naoya; Yamada, Satoshi; Wada, Taeko; Nobuyoshi, Masaharu; Izumi, Tohru; Akutsu, Miyuki; Kano, Yasuhiko; Sugiyama, Kanako; Ohki, Mio; Park, Sam-Yong; Furukawa, Yusuke			Homopiperazine Derivatives as a Novel Class of Proteasome Inhibitors with a Unique Mode of Proteasome Binding	PLOS ONE			English	Article							MEDIATED DRUG-RESISTANCE; MULTIPLE-MYELOMA; BORTEZOMIB RESISTANCE; PRECLINICAL MODELS; INITIAL TREATMENT; IN-VITRO; APOPTOSIS; MUTATION; COMPLEX; K-7174	The proteasome is a proteolytic machinery that executes the degradation of polyubiquitinated proteins to maintain cellular homeostasis. Proteasome inhibition is a unique and effective way to kill cancer cells because they are sensitive to proteotoxic stress. Indeed, the proteasome inhibitor bortezomib is now indispensable for the treatment of multiple myeloma and other intractable malignancies, but is associated with patient inconvenience due to intravenous injection and emerging drug resistance. To resolve these problems, we attempted to develop orally bioavailable proteasome inhibitors with distinct mechanisms of action and identified homopiperazine derivatives (HPDs) as promising candidates. Biochemical and crystallographic studies revealed that some HPDs inhibit all three catalytic subunits (beta 1, beta 2 and beta 5) of the proteasome by direct binding, whereas bortezomib and other proteasome inhibitors mainly act on the beta 5 subunit. Proteasome-inhibitory HPDs exhibited cytotoxic effects on cell lines from various hematological malignancies including myeloma. Furthermore, K-7174, one of the HPDs, was able to inhibit the growth of bortezomib-resistant myeloma cells carrying a beta 5-subunit mutation. Finally, K-7174 had additive effects with bortezomib on proteasome inhibition and apoptosis induction in myeloma cells. Taken together, HPDs could be a new class of proteasome inhibitors, which compensate for the weak points of conventional ones and overcome the resistance to bortezomib.	[Kikuchi, Jiro; Yamada, Satoshi; Wada, Taeko; Nobuyoshi, Masaharu; Furukawa, Yusuke] Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi, Japan; [Shibayama, Naoya] Jichi Med Univ, Dept Physiol, Div Biophys, Shimotsuke, Tochigi, Japan; [Izumi, Tohru; Akutsu, Miyuki; Kano, Yasuhiko] Tochigi Canc Ctr, Div Hematol, Utsunomiya, Tochigi, Japan; [Sugiyama, Kanako; Ohki, Mio; Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 232, Japan	Jichi Medical University; Jichi Medical University; Tochigi Prefectural Cancer Center; Yokohama City University	Furukawa, Y (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi, Japan.	furuyu@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418; Shibayama, Naoya/0000-0002-2208-1126	High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT; JSPS; JST; Japan Leukemia Research Fund; Takeda Science Foundation; Kano Foundation; Mitsui Life Social Welfare Foundation	High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kano Foundation; Mitsui Life Social Welfare Foundation	This work was supported in part by the High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT, a Grant-in-Aid for Scientific Research from JSPS (to Y.F. and J.K.), Adaptable and Seamless Technology transfer Program (A-STEP) from JST, Japan Leukemia Research Fund, Takeda Science Foundation, Kano Foundation, and Mitsui Life Social Welfare Foundation (to J.K.). Y.F. is the winner of the Award in Aki's Memory from the International Myeloma Foundation Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Chauhan D, 2010, BLOOD, V116, P4906, DOI 10.1182/blood-2010-04-276626; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; de Bettignies G, 2010, BIOCHIMIE, V92, P1530, DOI 10.1016/j.biochi.2010.06.023; de Leeuw RJ, 2004, HUM MOL GENET, V13, P1827, DOI 10.1093/hmg/ddh195; Drexler Hans G, 2003, Hum Cell, V16, P101, DOI 10.1111/j.1749-0774.2003.tb00140.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke NE, 2012, LEUKEMIA, V26, P757, DOI 10.1038/leu.2011.256; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Furukawa Y, 2007, LEUKEMIA, V21, P1005, DOI 10.1038/sj.leu.2404593; Groll M, 2006, J AM CHEM SOC, V128, P5136, DOI 10.1021/ja058320b; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Harrison SJ, 2011, BLOOD, V118, P6274, DOI 10.1182/blood-2011-03-339879; Imagawa S, 2003, FASEB J, V17, P1742, DOI 10.1096/fj.02-1134fje; Kikuchi J, 2007, STEM CELLS, V25, P2439, DOI 10.1634/stemcells.2007-0207; Kikuchi J, 2010, BLOOD, V116, P406, DOI 10.1182/blood-2009-07-235663; Kitakaze M, 1999, JPN CIRC J, V63, P231, DOI 10.1253/jcj.63.231; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; Lonial S, 2005, BLOOD, V106, P3777, DOI 10.1182/blood-2005-03-1173; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Lu SQ, 2009, EXP HEMATOL, V37, P831, DOI 10.1016/j.exphem.2009.04.001; Mannava S, 2012, BLOOD, V119, P1450, DOI 10.1182/blood-2011-04-346676; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Millward M, 2012, INVEST NEW DRUG, V30, P2303, DOI 10.1007/s10637-011-9766-6; Mitsunaga K, 2012, J CELL PHYSIOL, V227, P1138, DOI 10.1002/jcp.22834; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Mujtaba T, 2011, DISCOV MED, V12, P471; Nakano Y, 2004, BLOOD, V104, P4300, DOI 10.1182/blood-2004-04-1631; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; O'Connor OA, 2009, CLIN CANCER RES, V15, P7085, DOI 10.1158/1078-0432.CCR-09-0822; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Piva R, 2008, BLOOD, V111, P2765, DOI 10.1182/blood-2007-07-100651; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Smith DM, 2002, MOL MED, V8, P382, DOI 10.1007/BF03402019; Suzuki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027996; Takano Y, 2007, BIOCHEM BIOPH RES CO, V360, P470, DOI 10.1016/j.bbrc.2007.06.082; Umetani M, 2000, BIOCHEM BIOPH RES CO, V272, P370, DOI 10.1006/bbrc.2000.2784; Uno K, 2003, BLOOD, V101, P3658, DOI 10.1182/blood-2002-06-1770; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wada T, 2012, EMBO REP, V13, P142, DOI 10.1038/embor.2011.247; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Yanamandra N, 2006, CLIN CANCER RES, V12, P591, DOI 10.1158/1078-0432.CCR-05-1792	52	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60649	10.1371/journal.pone.0060649	http://dx.doi.org/10.1371/journal.pone.0060649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593271	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200016
J	Ardizzi, M; Martini, F; Umilta, MA; Sestito, M; Ravera, R; Gallese, V				Ardizzi, Martina; Martini, Francesca; Umilta, Maria Alessandra; Sestito, Mariateresa; Ravera, Roberto; Gallese, Vittorio			When Early Experiences Build a Wall to Others' Emotions: An Electrophysiological and Autonomic Study	PLOS ONE			English	Article							FACIAL EXPRESSIONS; POLYVAGAL THEORY; RECOGNITION; DISPLAYS; TRAUMA; ATTACHMENT; ATTENTION; RESPONSES; CHILDREN; DEFICITS	Facial expression of emotions is a powerful vehicle for communicating information about others' emotional states and it normally induces facial mimicry in the observers. The aim of this study was to investigate if early aversive experiences could interfere with emotion recognition, facial mimicry, and with the autonomic regulation of social behaviors. We conducted a facial emotion recognition task in a group of "street-boys'' and in an age-matched control group. We recorded facial electromyography (EMG), a marker of facial mimicry, and respiratory sinus arrhythmia (RSA), an index of the recruitment of autonomic system promoting social behaviors and predisposition, in response to the observation of facial expressions of emotions. Results showed an over-attribution of anger, and reduced EMG responses during the observation of both positive and negative expressions only among street-boys. Street-boys also showed lower RSA after observation of facial expressions and ineffective RSA suppression during presentation of non-threatening expressions. Our findings suggest that early aversive experiences alter not only emotion recognition but also facial mimicry of emotions. These deficits affect the autonomic regulation of social behaviors inducing lower social predisposition after the visualization of facial expressions and an ineffective recruitment of defensive behavior in response to non-threatening expressions.	[Ardizzi, Martina; Umilta, Maria Alessandra; Sestito, Mariateresa; Gallese, Vittorio] Univ Parma, Dept Neurosci, Physiol Sect, I-43100 Parma, Italy; [Gallese, Vittorio] IIT, Brain Ctr Social & Motor Cognit, Parma, Italy; [Martini, Francesca; Ravera, Roberto] ASL 1 Azienda Sanitaria Locale Imperiese, Dept Psychol, Imperia, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT	Ardizzi, M (corresponding author), Univ Parma, Dept Neurosci, Physiol Sect, I-43100 Parma, Italy.	martina.ardizzi@nemo.unipr.it	Ghiami, Zeinab/G-5492-2016; Gallese, Vittorio/ABD-5097-2021	Gallese, Vittorio/0000-0003-4815-3607; sestito, mariateresa/0000-0002-7045-6850; Umilta', Maria Alessandra/0000-0003-0180-6818; Ardizzi, Martina/0000-0001-9185-6784	FHM Italia Onlus; EU	FHM Italia Onlus; EU(European Commission)	This study was supported by a fellowship by FHM Italia Onlus to MA and to FM and by the EU Grant TESIS to VG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJB, 2007, BIOL PSYCHOL, V74, P243, DOI 10.1016/j.biopsycho.2006.08.005; [Anonymous], 2012, REPORT NATL HEAD COU; Audet A, 2010, LAW ASSESSING REALIT; Bar KJ, 2010, SCHIZOPHRENIA BULL, V36, P1050, DOI 10.1093/schbul/sbp024; Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3; Baron-Cohen S, 2010, PROG BRAIN RES, V186, P167, DOI 10.1016/B978-0-444-53630-3.00011-7; Beauchaine TP, 2007, BIOL PSYCHOL, V74, P174, DOI 10.1016/j.biopsycho.2005.08.008; Beaupre MG, 2005, J CROSS CULT PSYCHOL, V36, P355, DOI 10.1177/0022022104273656; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; D'Andrea W, 2012, AM J ORTHOPSYCHIAT, V82, P187, DOI 10.1111/j.1939-0025.2012.01154.x; Dale LP, 2009, APPL PSYCHOPHYS BIOF, V34, P299, DOI 10.1007/s10484-009-9111-4; De Wied M, 2009, PSYCHOPHYSIOLOGY, V46, P996, DOI 10.1111/j.1469-8986.2009.00851.x; Decety J, 2003, CONSCIOUS COGN, V12, P577, DOI 10.1016/S1053-8100(03)00076-X; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Dykas MJ, 2011, ADV CHILD DEV BEHAV, V40, P51; Fonagy P, 2007, J CHILD PSYCHOL PSYC, V48, P288, DOI 10.1111/j.1469-7610.2007.01727.x; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese Vittorio, 2007, Novartis Found Symp, V278, P3; Gibb BE, 2009, CHILD MALTREATMENT, V14, P148, DOI 10.1177/1077559508326358; Goodglass H., 1983, BOSTON NAMING TEST; Hagenaars MA, 2012, J EXP PSYCHOL GEN, V141, P98, DOI 10.1037/a0024211; HAYANO J, 1990, AM J CARDIOL, V65, P84, DOI 10.1016/0002-9149(90)90030-5; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Miskovic V, 2009, DEV PSYCHOBIOL, V51, P474, DOI 10.1002/dev.20387; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Patriquin MA, 2011, DEV PSYCHOBIOL; Pollak SD, 2005, CHILD DEV, V76, P968, DOI 10.1111/j.1467-8624.2005.00890.x; Pollak SD, 2003, J ABNORM PSYCHOL, V112, P323, DOI 10.1037/0021-843X.112.3.323; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Pollak SD, 2002, DEV PSYCHOL, V38, P784, DOI 10.1037/0012-1649.38.5.784; Pollak SD, 2001, PSYCHOPHYSIOLOGY, V38, P267, DOI 10.1111/1469-8986.3820267; Pollak SD, 2000, DEV PSYCHOL, V36, P679, DOI 10.1037//0012-1649.36.5.679; Pollak SD, 2008, CURR DIR PSYCHOL SCI, V17, P370, DOI 10.1111/j.1467-8721.2008.00608.x; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; PORGES SW, 1995, PSYCHOPHYSIOLOGY, V32, P301, DOI 10.1111/j.1469-8986.1995.tb01213.x; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Reichmann-Decker A, 2009, J TRAUMA DISSOCIATIO, V10, P276, DOI 10.1080/15299730902956788; Sahar T, 2001, BIOL PSYCHIAT, V49, P637, DOI 10.1016/S0006-3223(00)01045-3; Scrimin S, 2009, DEV PSYCHOL, V45, P1341, DOI 10.1037/a0016689; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Tininenko JR, 2012, BIOL PSYCHOL, V89, P562, DOI 10.1016/j.biopsycho.2011.12.022; Van Boxtel A, 2001, PSYCHOPHYSIOLOGY, V38, P22, DOI 10.1017/S004857720199016X; van der Kolk BA, 2005, PSYCHIAT ANN, V35, P401, DOI 10.3928/00485713-20050501-06; van der Kolk BA, 2007, UNDERSTANDING TRAUMA: INTEGRATING BIOLOGICAL, CLINICAL, AND CULTURAL PERSPECTIVES, P224, DOI 10.1017/CBO9780511500008.016; van der Kolk BA, 2009, PRAX KINDERPSYCHOL K, V58, P572, DOI 10.13109/prkk.2009.58.8.572; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989	57	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61004	10.1371/journal.pone.0061004	http://dx.doi.org/10.1371/journal.pone.0061004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123IQ	23593374	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000037
J	Chen, C; Mei, H; Shi, W; Deng, J; Zhang, B; Guo, T; Wang, HF; Hu, Y				Chen, Chen; Mei, Heng; Shi, Wei; Deng, Jun; Zhang, Bo; Guo, Tao; Wang, Huafang; Hu, Yu			EGFP-EGF1-Conjugated PLGA Nanoparticles for Targeted Delivery of siRNA into Injured Brain Microvascular Endothelial Cells for Efficient RNA Interference	PLOS ONE			English	Article							TISSUE FACTOR; DRUG CARRIER; EXPRESSION	Injured endothelium is an important target for drug and/or gene therapy because brain microvascular endothelial cells (BMECs) play critical roles in various pathophysiological conditions. RNA-mediated gene silencing presents a new therapeutic approach for treating such diseases, but major challenge is to ensure minimal toxicity and target delivery of siRNA to injured BMECs. Injured BMECs overexpress tissue factor (TF), which the fusion protein EGFP-EGF1 could be targeted to. In this study, TNF alpha (TNF-alpha) was chosen as a stimulus for primary BMECs to produce injured endothelium in vitro. The EGFP-EGF1-PLGA nanoparticles (ENPs) with loaded TF-siRNA were used as a new carrier for targeted delivery to the injured BMECs. The nanoparticles then produced intracellular RNA interference against TF. We compared ENP-based transfections with NP-mediated transfections, and our studies show that the ENP-based transfections result in a more efficient downregulation of TF. Our findings also show that the TF siRNA-loaded ENPs had minimal toxicity, with almost 96% of the cells viable 24 h after transfection while Lipofectamine-based transfections resulted in only 75% of the cells. Therefore, ENP-based transfection could be used for efficient siRNA transfection to injured BMECs and for efficient RNA interference (RNAi). This transfection could serve as a potential treatment for diseases, such as stroke, atherosclerosis and cancer.	[Chen, Chen; Mei, Heng; Shi, Wei; Deng, Jun; Zhang, Bo; Guo, Tao; Wang, Huafang; Hu, Yu] Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Chen, Chen; Mei, Heng; Shi, Wei; Deng, Jun; Zhang, Bo; Guo, Tao; Wang, Huafang; Hu, Yu] Minist Educ, Targeted Biotherapy Key Lab, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Hu, Y (corresponding author), Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	dr_huyu@126.com			National Basic Scientific Research Program of China (973 Program) [2007CB935803]; National Nature Science Foundation of China [30825018]; Key Clinical Program of the Ministry of Health of the People's Republic of China [58]; Chinese National Science and Technology Major Project; Mega-Project for New Drugs Development [2011ZX09302-002-01]	National Basic Scientific Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Clinical Program of the Ministry of Health of the People's Republic of China; Chinese National Science and Technology Major Project; Mega-Project for New Drugs Development	This work was supported by the National Basic Scientific Research Program of China (973 Program, No. 2007CB935803), the National Nature Science Foundation of China (No. 30825018), the Key Clinical Program of the Ministry of Health of the People's Republic of China (2010 No. 58), and Chinese National Science and Technology Major Project, Mega-Project for New Drugs Development (No. 2011ZX09302-002-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram JP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000397; BIERHAUS A, 1995, J BIOL CHEM, V270, P26419, DOI 10.1074/jbc.270.44.26419; Bluff JE, 2011, BREAST CANCER RES TR, V128, P691, DOI 10.1007/s10549-010-1149-8; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Calvo P, 2001, PHARMACEUT RES, V18, P1157, DOI 10.1023/A:1010931127745; Camici GG, 2006, CIRCULATION, V114, P1512, DOI 10.1161/CIRCULATIONAHA.106.638460; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Correale J, 2009, NEUROCHEM RES, V34, P2067, DOI 10.1007/s11064-009-0081-y; Cun DM, 2011, EUR J PHARM BIOPHARM, V77, P26, DOI 10.1016/j.ejpb.2010.11.008; Cun DM, 2010, INT J PHARMACEUT, V390, P70, DOI 10.1016/j.ijpharm.2009.10.023; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fahmy TM, 2005, BIOMATERIALS, V26, P5727, DOI 10.1016/j.biomaterials.2005.02.025; Jensen DMK, 2010, J CONTROL RELEASE, V142, P138, DOI 10.1016/j.jconrel.2009.10.010; Jensen DK, 2011, J CONTROL RELEASE; Kim I, 2001, FASEB J, V15, P126, DOI 10.1096/fj.01-0556fje; Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009; Lu W, 2005, J CONTROL RELEASE, V107, P428, DOI 10.1016/j.jconrel.2005.03.027; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Mackman N, 2009, ANESTH ANALG, V108, P1447, DOI 10.1213/ane.0b013e31819bceb1; May Heng, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P181; Mukerjee A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/44/445101; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Patil Y, 2009, INT J PHARMACEUT, V367, P195, DOI 10.1016/j.ijpharm.2008.09.039; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Perrot-Applanat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021589; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rak J, 2009, BEST PRACT RES CL HA, V22, P71, DOI 10.1016/j.beha.2008.12.008; Rao LVM, 2012, THROMB RES, V129, pS13, DOI 10.1016/j.thromres.2012.02.021; Shi W, 2012, BIOMATERIALS, V33, P7643, DOI 10.1016/j.biomaterials.2012.06.094; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Szabo C A, 1997, Neurobiology (Bp), V5, P1; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Zhou J, 2012, BIOMATERIALS, V33, P583, DOI 10.1016/j.biomaterials.2011.09.061	35	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60860	10.1371/journal.pone.0060860	http://dx.doi.org/10.1371/journal.pone.0060860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593330	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000027
J	Echenique, IA; Chan, PA; Chapin, KC; Andrea, SB; Fava, JL; Mermel, LA				Echenique, Ignacio A.; Chan, Philip A.; Chapin, Kimberle C.; Andrea, Sarah B.; Fava, Joseph L.; Mermel, Leonard A.			Clinical Characteristics and Outcomes in Hospitalized Patients with Respiratory Viral Co-Infection during the 2009 H1N1 Influenza Pandemic	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS INFECTIONS; CRITICALLY-ILL PATIENTS; A H1N1; SYNCYTIAL VIRUS; UNITED-STATES; TRACT INFECTIONS; CHILDREN; INFANTS; SEVERITY; PNEUMONIA	Background: The clinical consequences of co-infection with two or more respiratory viruses are poorly understood. We sought to determine if co-infection with pandemic 2009-2010 influenza A H1N1 (pH1N1) and another respiratory virus was associated with worse clinical outcomes. Methods: A retrospective cohort study was performed of all hospitalized patients with a positive respiratory viral panel (RVP) for two or more viruses within 72 hours of admission at our institution from October 2009 to December 2009. We compared patients infected with one respiratory virus to those with respiratory viral co-infection. Results: We identified 617 inpatients with a positive RVP sample with a single virus and 49 inpatients with a positive RVP sample for two viruses (i.e. co-infection). Co-infected patients were significantly younger, more often had fever/chills, tachypnea, and they more often demonstrated interstitial opacities suggestive of viral pneumonia on the presenting chest radiograph (OR 7.5, 95% CI 3.4-16.5). The likelihood of death, length of stay, and requirement for intensive care unit level of care were similar in both groups, but patients with any respiratory virus co-infection were more likely to experience complications, particularly treatment for a secondary bacterial pneumonia (OR 6.8, 95% CI 3.3-14.2). Patients co-infected with pH1N1 and another respiratory virus were more likely to present with chest radiograph changes suggestive of a viral pneumonia, compared to mono-infection with pH1N1 (OR 16.9, 95% CI 4.5-62.7). By logistic regression using mono-infection with non-PH1N1 viruses as the reference group, co-infection with pH1N1 was the strongest independent predictor of treatment for a secondary bacterial pneumonia (OR 17.8, 95% CI 6.7-47.1). Conclusion: Patients with viral co-infection, particularly with pH1N1, were more likely to have chest radiograph features compatible with a viral pneumonia and complications during their hospital course, particularly treatment for secondary bacterial pneumonia. Despite this, co-infection was not associated with ICU admission.	[Echenique, Ignacio A.; Chan, Philip A.; Chapin, Kimberle C.; Mermel, Leonard A.] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA; [Chan, Philip A.; Mermel, Leonard A.] Rhode Isl Hosp, Div Infect Dis, Providence, RI USA; [Chapin, Kimberle C.; Andrea, Sarah B.] Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA; [Fava, Joseph L.] Brown Univ, Ctr Behav & Prevent Med, Alpert Med Sch, Miriam Hosp, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Mermel, LA (corresponding author), Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA.	lmermel@lifespan.org	Mermel, Leonard/Z-1475-2019	Echenique, Ignacio A./0000-0002-6301-0121; Chan, Philip/0000-0003-0964-5895; Fava, Joseph/0000-0001-7129-7903	Rhode Island Hospital Department of Pathology	Rhode Island Hospital Department of Pathology	This study was supported by the Rhode Island Hospital Department of Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; Agarwal PP, 2009, AM J ROENTGENOL, V193, P1488, DOI 10.2214/AJR.09.3599; Altmann M, 2012, EMERG INFECT DIS, V18, P1755, DOI 10.3201/eid1811.120719; Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Blyth CC, 2012, INFLUENZA OTHER RESP; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Camargo C, 2012, BRAZ J INFECT DIS, V16, P180, DOI [10.1016/S1413-8670(12)70302-1, 10.1590/S1413-86702012000200013]; Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Carcione D, 2010, EMERG INFECT DIS, V16, P1388, DOI 10.3201/eid1609.100076; Center for Disease Control and Prevention, 2010, UPD CDC EST 2009 H1N; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chan PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024734; Colamussi ML, 1999, BLOOD, V93, P2395, DOI 10.1182/blood.V93.7.2395.407a22_2395_2403; Cordero E, 2012, CLIN MICROBIOL INFEC, V18, P67, DOI 10.1111/j.1469-0691.2011.03537.x; Cox CM, 2012, J INFECT DIS, V206, P1350, DOI 10.1093/infdis/jis517; Cox CM, 2011, CLIN INFECT DIS, V52, pS69, DOI 10.1093/cid/ciq011; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; Cunha BA, 2011, HEART LUNG, V40, P253, DOI 10.1016/j.hrtlng.2010.07.013; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dhanoa A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-501; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Esper FP, 2011, J INFECTION, V63, P260, DOI 10.1016/j.jinf.2011.04.004; Esposito S, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/j.1750-2659.2012.00340.x; Foulongne V, 2006, PEDIATR INFECT DIS J, V25, P354, DOI 10.1097/01.inf.0000207480.55201.f6; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; Garcia-Garcia ML, 2006, PEDIATR PULM, V41, P863, DOI 10.1002/ppul.20456; Garcia-Garcia ML, 2006, ARCH DIS CHILD, V91, P290, DOI 10.1136/adc.2005.082388; Goka E, 2012, INFLUENZA OTHER RESP; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Guo W, 2012, BR J RADIOL; Hall MW, 2013, CRIT CARE MED, V41, P224, DOI 10.1097/CCM.0b013e318267633c; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Heltzer ML, 2009, J LEUKOCYTE BIOL, V85, P1036, DOI 10.1189/jlb.1108710; Jain S, 2012, CLIN INFECT DIS; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jartti A, 2011, ACTA RADIOL, V52, P297, DOI 10.1258/ar.2010.100379; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Karakitsos P, 2012, CLIN MICROBIOL INFEC; Kaye M, 2006, EPIDEMIOL INFECT, V134, P792, DOI 10.1017/S0950268805005364; Konig B, 2004, J CLIN MICROBIOL, V42, P4632, DOI 10.1128/JCM.42.10.4632-4635.2004; Larrauri Camara Amparo, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 4, P2, DOI 10.1016/S0213-005X(12)70098-8; Lee EY, 2010, RADIOLOGY, V254, P934, DOI 10.1148/radiol.09092083; Lee MH, 2010, J INFECT DIS, V201, P508, DOI 10.1086/650204; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Li GX, 2009, J CLIN VIROL, V46, P275, DOI 10.1016/j.jcv.2009.07.015; Li P, 2011, EUR J RADIOL, V80, pE146, DOI 10.1016/j.ejrad.2010.05.029; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lu PX, 2012, J THORAC DIS, V4, P377, DOI 10.3978/j.issn.2072-1439.2012.08.02; Marchiori E, 2011, AM J ROENTGENOL, V196, pW723, DOI 10.2214/AJR.10.5109; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; Martin ET, 2012, INFLUENZA OTHER RESP, V6, P71, DOI 10.1111/j.1750-2659.2011.00265.x; Mazick A, 2010, EURO SURVEILL, V15; Miron Dan, 2010, Pediatr Infect Dis J, V29, pe7, DOI 10.1097/INF.0b013e3181c2a212; Nascimento MS, 2010, CLINICS, V65, P1133, DOI 10.1590/S1807-59322010001100014; Navarro-Mari Jose Maria, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 4, P25, DOI 10.1016/S0213-005X(12)70101-5; Nisii C, 2010, J CLIN MICROBIOL, V48, P3383, DOI 10.1128/JCM.01179-10; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Peci A, 2012, INFLUENZA OTHER RESP; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Randolph AG, 2011, PEDIATRICS, V128, pE1450, DOI 10.1542/peds.2011-0774; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Rizzi EB, 2010, RADIOL MED, V115, P507, DOI 10.1007/s11547-010-0553-9; Sasaki A, 2005, PEDIATR INFECT DIS J, V24, P905, DOI 10.1097/01.inf.0000180984.61778.1e; Schnepf N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023514; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Stempel HE, 2009, ACTA PAEDIATR, V98, P123, DOI 10.1111/j.1651-2227.2008.01023.x; Tanner HE, 2012, EPIDEMIOL INFECT, V140, P1551, DOI 10.1017/S0950268811002251; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Valente T, 2012, RADIOL MED, V117, P165, DOI 10.1007/s11547-011-0734-1; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wilkesmann A, 2006, EUR J PEDIATR, V165, P467, DOI 10.1007/s00431-006-0105-4; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf; Wright Peter F, 2009, N Engl J Med, V361, pe112, DOI 10.1056/NEJMopv0910749; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028786; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174	91	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60845	10.1371/journal.pone.0060845	http://dx.doi.org/10.1371/journal.pone.0060845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585856	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600058
J	Ip, YK; Soh, MML; Chen, XL; Ong, JLY; Chng, YR; Ching, BY; Wong, WP; Lam, SH; Chew, SF				Ip, Yuen K.; Soh, Melody M. L.; Chen, Xiu L.; Ong, Jasmine L. Y.; Chng, You R.; Ching, Biyun; Wong, Wai P.; Lam, Siew H.; Chew, Shit F.			Molecular Characterization of Branchial aquaporin 1aa and Effects of Seawater Acclimation, Emersion or Ammonia Exposure on Its mRNA Expression in the Gills, Gut, Kidney and Skin of the Freshwater Climbing Perch, Anabas testudineus	PLOS ONE			English	Article							EEL ANGUILLA-ANGUILLA; EUROPEAN EEL; RESPIRATORY ORGANS; ION REGULATION; FISH GILLS; SEA BREAM; CHANNEL; TRANSPORT; EXCRETION; DETERMINANTS	We obtained a full cDNA coding sequence of aquaporin 1aa (aqp1aa) from the gills of the freshwater climbing perch, Anabas testudineus, which had the highest expression in the gills and skin, suggesting an important role of Aqp1aa in these organs. Since seawater acclimation had no significant effects on the branchial and intestinal aqp1aa mRNA expression, and since the mRNA expression of aqp1aa in the gut was extremely low, it can be deduced that Aqp1aa, despite being a water channel, did not play a significant osmoregulatory role in A. testudineus. However, terrestrial exposure led to significant increases in the mRNA expression of aqp1aa in the gills and skin of A. testudineus. Since terrestrial exposure would lead to evaporative water loss, these results further support the proposition that Aqp1aa did not function predominantly for the permeation of water through the gills and skin. Rather, increased aqp1aa mRNA expression might be necessary to facilitate increased ammonia excretion during emersion, because A. testudineus is known to utilize amino acids as energy sources for locomotor activity with increased ammonia production on land. Furthermore, ammonia exposure resulted in significant decreases in mRNA expression of aqp1aa in the gills and skin of A. testudineus, presumably to reduce ammonia influx during ammonia loading. This corroborates previous reports on AQP1 being able to facilitate ammonia permeation. However, a molecular characterization of Aqp1aa from A. testudineus revealed that its intrinsic aquapore might not facilitate NH3 transport. Hence, ammonia probably permeated the central fifth pore of the Aqp1aa tetramer as suggested previously. Taken together, our results indicate that Aqp1aa might have a greater physiological role in ammonia excretion than in osmoregulation in A. testudineus.	[Ip, Yuen K.; Soh, Melody M. L.; Chen, Xiu L.; Ong, Jasmine L. Y.; Chng, You R.; Ching, Biyun; Wong, Wai P.; Lam, Siew H.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore; [Lam, Siew H.] Natl Univ Singapore, NUS Environm Res Inst, Singapore 117548, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; National University of Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsipyk@nus.edu.sg	Chew, Shit Fun/I-2248-2012; Ip, Yuen Kwong/H-8041-2012; Lam, Siew Hong/H-8483-2012	Chew, Shit Fun/0000-0003-4599-5817; Ip, Yuen Kwong/0000-0001-9124-7911; 	Singapore Ministry of Education [R154-000-470-112]; Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme; Environment and Water Industry Programme Office (EWI) of the PUB [2P 10004/82]	Singapore Ministry of Education(Ministry of Education, Singapore); Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme(National Research Foundation, Singapore); Environment and Water Industry Programme Office (EWI) of the PUB	This study was supported in part by the Singapore Ministry of Education through a grant (R154-000-470-112) to YK Ip, and by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment and Water Industry Programme Office (EWI) of the PUB through a grant (2P 10004/82) to SH Lam and YK Ip. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An KW, 2008, FISH PHYSIOL BIOCHEM, V34, P185, DOI 10.1007/s10695-007-9175-0; Aoki M, 2003, J EXP BIOL, V206, P3495, DOI 10.1242/jeb.00579; Beitz E, 2006, BIOL CELL, V98, P101, DOI 10.1042/BC20050025; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Brunelli E, 2010, ACTA HISTOCHEM, V112, P251, DOI 10.1016/j.acthis.2008.11.030; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chang EWY, 2007, J EXP ZOOL PART A, V307A, P708, DOI 10.1002/jez.a.424; Chaube R, 2011, GEN COMP ENDOCR, V170, P162, DOI 10.1016/j.ygcen.2010.10.002; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Chew Shit F., 2006, Fish Physiology, V21, P307; Cutler C.P., 2000, MOL BIOL PHYSL WATER, P433; Cutler CP, 2007, COMP BIOCHEM PHYS A, V148, P82, DOI 10.1016/j.cbpa.2006.09.022; Cutler CP, 2002, J EXP BIOL, V205, P2643; DAVENPORT J, 1990, J FISH BIOL, V37, P175, DOI 10.1111/j.1095-8649.1990.tb05938.x; Deane EE, 2006, MAR BIOTECHNOL, V8, P663, DOI 10.1007/s10126-006-6001-0; Deane EE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00039; Dynowski M, 2008, FEBS LETT, V582, P2458, DOI 10.1016/j.febslet.2008.06.012; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Fabra M, 2005, SCIENCE, V307, P545, DOI 10.1126/science.1106305; Fabra M, 2006, DEV BIOL, V295, P250, DOI 10.1016/j.ydbio.2006.03.034; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RN, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00044; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Giffard-Mena I, 2007, COMP BIOCHEM PHYS A, V148, P430, DOI 10.1016/j.cbpa.2007.06.002; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Herrera M, 2011, PFLUG ARCH EUR J PHY, V462, P623, DOI 10.1007/s00424-011-1002-x; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; HUGHES GM, 1973, J ZOOL, V170, P201; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Ip Y.K., 2001, Fish Physiology, V20, P109; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; Ip YK, 2012, J COMP PHYSIOL B, V182, P793, DOI 10.1007/s00360-012-0664-9; Ip YK, 2012, AM J PHYSIOL-REG I, V303, pR112, DOI 10.1152/ajpregu.00618.2011; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kim YK, 2010, FISHERIES SCI, V76, P695, DOI 10.1007/s12562-010-0259-x; Kim YK, 2008, COMP BIOCHEM PHYS A, V151, P533, DOI 10.1016/j.cbpa.2008.07.016; King SL, 2001, WATER CHANNELS; Laiz-Carrion R, 2005, J EXP ZOOL PART A, V303A, P563, DOI 10.1002/jez.a.183; Loong AM, 2012, J COMP PHYSIOL B, V182, P367, DOI 10.1007/s00360-011-0626-7; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; MAETZ J, 1972, J EXP BIOL, V56, P601; Martinez AS, 2005, ANN NY ACAD SCI, V1040, P395, DOI 10.1196/annals.1327.072; Martinez AS, 2005, BIOL CELL, V97, P615, DOI 10.1042/BC20040111; Martinez AS, 2005, AM J PHYSIOL-REG I, V288, pR1733, DOI 10.1152/ajpregu.00747.2004; McDonald MD, 2006, COMP BIOCHEM PHYS A, V143, P447, DOI 10.1016/j.cbpa.2005.12.029; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Monzani E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006167; MUNSHI JSD, 1986, AM J ANAT, V176, P321, DOI 10.1002/aja.1001760306; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF255, DOI 10.1152/ajprenal.2001.281.2.F255; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Pethiyagoda R, 1991, FRESHWATER FISHES SR, P362; PRESTON GM, 1993, J BIOL CHEM, V268, P17; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Rahman AK., 1989, FRESHWATER FISHES BA; Raldua D, 2008, AM J PHYSIOL-REG I, V294, pR993, DOI 10.1152/ajpregu.00695.2007; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; SHI LB, 1994, J BIOL CHEM, V269, P10417; SOKHENG C, 1999, 299 AMFP; Soria LR, 2010, BIOCHEM BIOPH RES CO, V393, P217, DOI 10.1016/j.bbrc.2010.01.104; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Tay YL, 2006, J EXP BIOL, V209, P4475, DOI 10.1242/jeb.02557; Tingaud-Sequeira A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-259; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; UTIDA S, 1971, GEN COMP ENDOCR, V16, P566, DOI 10.1016/0016-6480(71)90121-3; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Wilkie MP, 2002, J EXP ZOOL, V293, P284, DOI 10.1002/jez.10123; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Yool AJ, 2002, NEWS PHYSIOL SCI, V17, P68, DOI 10.1152/nips.01372.2001; Yu J, 2006, STRUCTURE, V14, P1411, DOI 10.1016/j.str.2006.07.006; ZHANG RB, 1993, BIOCHEMISTRY-US, V32, P2938, DOI 10.1021/bi00063a002	81	14	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61163	10.1371/journal.pone.0061163	http://dx.doi.org/10.1371/journal.pone.0061163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593418	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600089
J	Quintela, T; Goncalves, I; Carreto, LC; Santos, MAS; Marcelino, H; Patriarca, FM; Santos, CRA				Quintela, Telma; Goncalves, Isabel; Carreto, Laura C.; Santos, Manuel A. S.; Marcelino, Helena; Patriarca, Filipa M.; Santos, Cecilia R. A.			Analysis of the Effects of Sex Hormone Background on the Rat Choroid Plexus Transcriptome by cDNA Microarrays	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RETINOIC ACID; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; ANDROGEN RECEPTOR; CIRCADIAN-RHYTHMS; ODOR PERCEPTION; BRAIN; EXPRESSION; ESTROGEN	The choroid plexus (CP) are highly vascularized branched structures that protrude into the ventricles of the brain, and form a unique interface between the blood and the cerebrospinal fluid (CSF), the blood-CSF barrier, that are the main site of production and secretion of CSF. Sex hormones are widely recognized as neuroprotective agents against several neurodegenerative diseases, and the presence of sex hormones cognate receptors suggest that it may be a target for these hormones. In an effort to provide further insight into the neuroprotective mechanisms triggered by sex hormones we analyzed gene expression differences in the CP of female and male rats subjected to gonadectomy, using microarray technology. In gonadectomized female and male animals, 3045 genes were differentially expressed by 1.5-fold change, compared to sham controls. Analysis of the CP transcriptome showed that the top-five pathways significantly regulated by the sex hormone background are olfactory transduction, taste transduction, metabolism, steroid hormone biosynthesis and circadian rhythm pathways. These results represent the first overview of global expression changes in CP of female and male rats induced by gonadectomy and suggest that sex hormones are implicated in pathways with central roles in CP functions and CSF homeostasis.	[Quintela, Telma; Goncalves, Isabel; Santos, Manuel A. S.; Marcelino, Helena; Patriarca, Filipa M.; Santos, Cecilia R. A.] Univ Beira Interior, CICS UBI Hlth Sci Res Ctr, Covilha, Portugal; [Carreto, Laura C.] Univ Aveiro, Dept Biol, RNA Biol Lab, P-3800 Aveiro, Portugal; [Carreto, Laura C.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal	Universidade da Beira Interior; Universidade de Aveiro; Universidade de Aveiro	Santos, CRA (corresponding author), Univ Beira Interior, CICS UBI Hlth Sci Res Ctr, Covilha, Portugal.	csantos@fcsaude.ubi.pt	Santos, Manuel/E-6704-2010; Marcelino, Helena/E-7661-2015; Marcelino, Helena/AAJ-4783-2021; Santos, Cecilia Reis Alves/C-9032-2016	Santos, Manuel/0000-0002-0437-1146; Marcelino, Helena/0000-0002-6218-6192; Marcelino, Helena/0000-0002-6218-6192; Santos, Cecilia Reis Alves/0000-0001-6074-7825; Theriaga Mendes Varanda Goncalves, Isabel Maria/0000-0002-4384-8197; Quintela, Telma/0000-0001-5202-9858	FCT [PTDC/SAU-NEU/114800/2009, PEst-C/SAU/UI0709/2011]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FCT project grants (PTDC/SAU-NEU/114800/2009) and COMPETE (PEst-C/SAU/UI0709/2011)(www.FCT.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CH, 2009, J MOL NEUROSCI, V38, P41, DOI 10.1007/s12031-008-9157-4; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Butler MP, 2012, ENDOCRINOLOGY, V153, P2344, DOI 10.1210/en.2011-1842; Carro E, 2006, NEUROBIOL AGING, V27, P1618, DOI 10.1016/j.neurobiolaging.2005.09.039; Carroll JC, 2012, CURR ALZHEIMER RES, V9, P18; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; Crossgrove JS, 2005, EXP BIOL MED, V230, P771, DOI 10.1177/153537020523001011; Deng L, 2003, J CLIN ENDOCR METAB, V88, P2157, DOI 10.1210/jc.2002-021844; DILORENZO PM, 1990, BRAIN RES BULL, V25, P741, DOI 10.1016/0361-9230(90)90052-2; Do Rego Jean Luc, 2012, Front Endocrinol (Lausanne), V3, P4, DOI 10.3389/fendo.2012.00004; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; Emerich DF, 2005, BIOESSAYS, V27, P262, DOI 10.1002/bies.20193; Emerich DF, 2009, NEUROTOX RES, V15, P205, DOI 10.1007/s12640-009-9021-5; Faas MM, 2010, CHEMOSENS PERCEPT, V3, P51, DOI 10.1007/s12078-009-9061-5; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Ghersi-Egea JF, 2001, MICROSC RES TECHNIQ, V52, P83, DOI 10.1002/1097-0029(20010101)52:1<83::AID-JEMT10>3.0.CO;2-N; Gomez-Sanchez EP, 2010, EXP PHYSIOL, V95, P120, DOI 10.1113/expphysiol.2009.048900; Hong-Goka BC, 2004, NEUROSCI LETT, V360, P113, DOI 10.1016/j.neulet.2004.01.075; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itakura S, 2006, PLACENTA, V27, P103, DOI 10.1016/j.placenta.2004.12.006; Iwahana E, 2008, HORM BEHAV, V53, P422, DOI 10.1016/j.yhbeh.2007.11.014; Johanson C, 2011, TOXICOL PATHOL, V39, P186, DOI 10.1177/0192623310394214; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Krzyzanowska A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00075; Li XH, 2004, ENDOCRINOLOGY, V145, P4756, DOI 10.1210/en.2004-0514; MACDONALD PN, 1990, P NATL ACAD SCI USA, V87, P4265, DOI 10.1073/pnas.87.11.4265; Marques F, 2009, J CEREBR BLOOD F MET, V29, P921, DOI 10.1038/jcbfm.2009.15; Martinez SE, 2001, EUR J BIOCHEM, V268, P5045; Monostory K, 2011, CURR DRUG METAB, V12, P154, DOI 10.2174/138920011795016854; Petito CK, 2005, J NEUROIMMUNOL, V162, P19, DOI 10.1016/j.jneuroim.2004.12.020; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; Quintela T, 2008, BRAIN RES, V1229, P18, DOI 10.1016/j.brainres.2008.06.095; Quintela T, 2009, CELL MOL NEUROBIOL, V29, P475, DOI 10.1007/s10571-008-9339-1; Quintela T, 2009, CELL MOL NEUROBIOL; Quintela T, 2011, J MOL NEUROSCI, V44, P152, DOI 10.1007/s12031-010-9398-x; Redzic ZB, 2004, ADV DRUG DELIVER REV, V56, P1695, DOI 10.1016/j.addr.2004.07.005; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Richardson SJ, 2007, INT REV CYTOL, V258, P137, DOI 10.1016/S0074-7696(07)58003-4; Romand R, 2008, J COMP NEUROL, V508, P879, DOI 10.1002/cne.21707; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sathyanesan M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.64; SCOTT AP, 1992, GEN COMP ENDOCR, V85, P91, DOI 10.1016/0016-6480(92)90176-K; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; Skipor J, 2008, ACTA NEUROBIOL EXP, V68, P414; Sousa JC, 2007, NEUROBIOL AGING, V28, P713, DOI 10.1016/j.neurobiolaging.2006.03.015; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561, DOI 10.1093/jnen/59.7.561; SunayashikiKusuzaki K, 1997, MOL BRAIN RES, V52, P112, DOI 10.1016/S0169-328X(97)00247-7; Vargas T, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/805405; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Yamamoto M, 1998, EUR J BIOCHEM, V257, P344, DOI 10.1046/j.1432-1327.1998.2570344.x; Yucel F, 2002, ANN ANAT, V184, P251, DOI 10.1016/S0940-9602(02)80116-9; Zappaterra MW, 2012, CELL MOL LIFE SCI; ZIMATKIN SM, 1991, J NEUROCHEM, V56, P1, DOI 10.1111/j.1471-4159.1991.tb02555.x	56	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60199	10.1371/journal.pone.0060199	http://dx.doi.org/10.1371/journal.pone.0060199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585832	gold, Green Submitted, Green Published			2022-12-27	WOS:000317909600015
J	Zhu, LX; Barret, EC; Xu, YX; Liu, ZG; Manoharan, A; Chen, Y				Zhu, Lingxiang; Barret, Erika C.; Xu, Yuxue; Liu, Zuguo; Manoharan, Aditya; Chen, Yin			Regulation of Cigarette Smoke (CS)-Induced Autophagy by Nrf2	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; AIRWAY EPITHELIUM; GENE-EXPRESSION; CELL-DEATH; EXACERBATIONS; INDUCTION; DISEASE; SYSTEM; STRESS; DEGRADATION	Cigarette smoke (CS) has been reported to induce autophagy in airway epithelial cells. The subsequent autophagic cell death has been proposed to play an important pathogenic role in chronic obstructive pulmonary disease (COPD); however, the underlying molecular mechanism is not entirely clear. Using CS extract (CSE) as a surrogate for CS, we found that it markedly increased the expressions of both LC3B-I and LC3B-II as well as autophagosomes in airway epithelial cells. This is in contrast to the common autophagy inducer (i.e., starvation) that increases LC3B-II but reduces LC3B-I. Further studies indicate that CSE regulated LC3B at transcriptional and post-translational levels. In addition, CSE, but not starvation, activated Nrf2-mediated adaptive response. Increase of cellular Nrf2 by either Nrf2 overexpression or the knockdown of Keap1 (an Nrf2 inhibitor) significantly repressed CSE-induced LC3B-I and II as well as autophagosomes. Supplement of NAC (a GSH precursor) or GSH recapitulated the effect of Nrf2, suggesting the increase of cellular GSH level is responsible for Nrf2 effect on LC3B and autophagosome. Interestingly, neither Nrf2 activation nor GSH supplement could restore the repressed activities of mTOR or its downstream effctor-S6K. Thus, the Nrf2-dependent autophagy-suppression was not due to the reactivation of mTOR-the master repressor of autophagy. To search for the downstream effector of Nrf2 on LC3B and autophagosome, we tested Nrf2-dependent genes (i.e., NQO1 and P62) that are also increased by CSE treatment. We found that P62, but not NQO1, could mimic the effect of Nrf2 activation by repressing LC3B expression. Thus, Nrf2->P62 appears to play an important role in the regulation of CSE-induced LC3B and autophagosome.	[Zhu, Lingxiang; Barret, Erika C.; Xu, Yuxue; Manoharan, Aditya; Chen, Yin] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Xu, Yuxue; Liu, Zuguo] Xiamen Univ, Sch Med, Xiamen, Peoples R China	University of Arizona; Xiamen University	Chen, Y (corresponding author), Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	ychen@pharmacy.arizona.edu			Arizona Biomedical Research Commission grant; National Institutes of Health grant [RO1AI061695]; Flight Attendant Medical Institute's (FAMRI) Clinical Innovator Award (CIA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	Arizona Biomedical Research Commission grant; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Institute's (FAMRI) Clinical Innovator Award (CIA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by an Arizona Biomedical Research Commission grant, a National Institutes of Health grant RO1AI061695, and a Flight Attendant Medical Institute's (FAMRI) Clinical Innovator Award (CIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard A, 2010, MOL CELL BIOL, V30, P1097, DOI 10.1128/MCB.00868-09; Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Biswal Shyam, 2012, Proc Am Thorac Soc, V9, P47, DOI 10.1513/pats.201201-009MS; Chen Y, 2001, AM J RESP CELL MOL, V25, P542, DOI 10.1165/ajrcmb.25.5.4298; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Csordas A, 2011, CARDIOVASC RES, V92, P141, DOI 10.1093/cvr/cvr165; Deng J, 2000, AM J RESP CELL MOL, V22, P597, DOI 10.1165/ajrcmb.22.5.3520; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Ghosh D, 2005, MOL ENDOCRINOL, V19, P1049, DOI 10.1210/me.2004-0320; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Hwang JW, 2010, ARCH BIOCHEM BIOPHYS, V500, P203, DOI 10.1016/j.abb.2010.05.013; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim HP, 2008, AUTOPHAGY, V4, P887, DOI 10.4161/auto.6767; Klein KA, 2011, J VIROL, V85, P9651, DOI 10.1128/JVI.00316-11; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Mallia P, 2007, CURR PHARM DESIGN, V13, P73, DOI 10.2174/138161207779313777; Mallia P, 2006, CHEST, V130, P1203, DOI 10.1378/chest.130.4.1203; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ratovitski EA, 2011, ARCH BIOCHEM BIOPHYS, V506, P208, DOI 10.1016/j.abb.2010.11.020; Sandford AJ, 2012, PHYSL GENOMICS; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Schneider D, 2010, AM J RESP CRIT CARE, V182, P332, DOI 10.1164/rccm.200911-1673OC; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Tan WC, 2003, AM J MED, V115, P272, DOI 10.1016/S0002-9343(03)00353-X; Tao SS, 2012, AM J RESP CELL MOL, V46, P660, DOI 10.1165/rcmb.2011-0340OC; Verschuere S, 2012, HISTOCHEM CELL BIOL, V137, P293, DOI 10.1007/s00418-011-0902-3; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhu LX, 2008, AM J PHYSIOL-LUNG C, V294, pL469, DOI 10.1152/ajplung.00310.2007	53	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e55695	10.1371/journal.pone.0055695	http://dx.doi.org/10.1371/journal.pone.0055695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585825	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600002
J	Kim, D; Kim, WY; Lee, SY; Lee, SY; Yun, H; Shin, SY; Lee, J; Hong, Y; Won, Y; Kim, SJ; Lee, YS; Ahn, SM				Kim, Deokhoon; Kim, Woo-Yeon; Lee, Sun-Young; Lee, Sung-Yeoun; Yun, Hongseok; Shin, Soo-Yong; Lee, Jungyoun; Hong, Yoojin; Won, Youngmi; Kim, Seong-Jin; Lee, Yong Seok; Ahn, Sung-Min			Revising a Personal Genome by Comparing and Combining Data from Two Different Sequencing Platforms	PLOS ONE			English	Article							SHORT-READ; MUTATIONS; ACCURATE	For the robust practice of genomic medicine, sequencing results must be compatible, regardless of the sequencing technologies and algorithms used. Presently, genome sequencing is still an imprecise science and is complicated by differences in the chemistry, coverage, alignment, and variant-calling algorithms. We identified similar to 3.33 million single nucleotide variants (SNVs) and similar to 3.62 million SNVs in the SJK genome using SOLiD and Illumina data, respectively. Approximately 3 million SNVs were concordant between the two platforms while 68,532 SNVs were discordant; 219,616 SNVs were SOLiD-specific and 516,080 SNVs were Illumina-specific (i.e., platform-specific). Concordant, discordant, and platform-specific SNVs were further analyzed and characterized. Overall, a large portion of heterozygous SNVs that were discordant with genotyping calls of single nucleotide polymorphism chips were highly confident. Approximately 70% of the platform-specific SNVs were located in regions containing repetitive sequences. Such platform-specificity may arise from differences between platforms, with regard to read length (36 bp and 72 bp vs. 50 bp), insert size (similar to 100-300 bp vs. similar to 1-2 kb), sequencing chemistry (sequencing-by-synthesis using single nucleotides vs. ligation-based sequencing using oligomers), and sequencing quality. When data from the two platforms were merged for variant calling, the proportion of callable regions of the reference genome increased to 99.66%, which was 1.43% higher than the average callability of the two platforms, representing similar to 40 million bases. In this study, we compared the differences in sequencing results between two sequencing platforms. Approximately 90% of the SNVs were concordant between the two platforms, yet similar to 10% of the SNVs were either discordant or platform-specific, indicating that each platform had its own strengths and weaknesses. When data from the two platforms were merged, both the overall callability of the reference genome and the overall accuracy of the SNVs improved, demonstrating the likelihood that a re-sequenced genome can be revised using complementary data.	[Kim, Deokhoon; Lee, Sun-Young; Lee, Sung-Yeoun; Kim, Seong-Jin; Ahn, Sung-Min] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Kim, Woo-Yeon; Yun, Hongseok; Shin, Soo-Yong; Lee, Jungyoun; Hong, Yoojin; Won, Youngmi; Lee, Yong Seok] Samsung SDS, Bioinformat Team, Seoul, South Korea; [Ahn, Sung-Min] Gachon Univ Gil Hosp, Dept Translat Med, Inchon, South Korea; [Kim, Seong-Jin] CHA Univ Med & Sci, CHA Canc Inst, Seoul, South Korea	Gachon University; Samsung; Gachon University	Kim, SJ (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea.	kimsj@cha.ac.kr; dolsemtl.lee@samsung.com; smahn@gachon.ac.kr		Ahn, Sung-Min/0000-0002-5031-1929	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0014717]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2011-0014717 to S.M.A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S-M, 2009, GENOME RES; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fuentes Fajardo KV, 2012, HUMAN MUTATION; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; McKernan KJ, 2009, GENOME RES; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Snyder M, 2010, GENE DEV, V24, P423, DOI 10.1101/gad.1864110; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yngvadottir B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-237	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60585	10.1371/journal.pone.0060585	http://dx.doi.org/10.1371/journal.pone.0060585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593254	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000041
J	Salewski, V; Hochachka, WM; Fiedler, W				Salewski, Volker; Hochachka, Wesley M.; Fiedler, Wolfgang			Multiple Weather Factors Affect Apparent Survival of European Passerine Birds	PLOS ONE			English	Article							WARBLERS ACROCEPHALUS-SCHOENOBAENUS; WEST-AFRICAN RAINFALL; CLIMATE-CHANGE; BREEDING DISPERSAL; SAND MARTINS; POPULATION RESILIENCE; WINTER WEATHER; RATES; IMPACT; CONSEQUENCES	Weather affects the demography of animals and thus climate change will cause local changes in demographic rates. In birds numerous studies have correlated demographic factors with weather but few of those examined variation in the impacts of weather in different seasons and, in the case of migrants, in different regions. Using capture-recapture models we correlated weather with apparent survival of seven passerine bird species with different migration strategies to assess the importance of selected facets of weather throughout the year on apparent survival. Contrary to our expectations weather experienced during the breeding season did not affect apparent survival of the target species. However, measures for winter severity were associated with apparent survival of a resident species, two short-distance/partial migrants and a long-distance migrant. Apparent survival of two short distance migrants as well as two long-distance migrants was further correlated with conditions experienced during the non-breeding season in Spain. Conditions in Africa had statistically significant but relatively minor effects on the apparent survival of the two long-distance migrants but also of a presumably short-distance migrant and a short-distance/partial migrant. In general several weather effects independently explained similar amounts of variation in apparent survival for the majority of species and single factors explained only relatively low amounts of temporal variation of apparent survival. Although the directions of the effects on apparent survival mostly met our expectations and there are clear predictions for effects of future climate we caution against simple extrapolations of present conditions to predict future population dynamics. Not only did weather explains limited amounts of variation in apparent survival, but future demographics will likely be affected by changing interspecific interactions, opposing effects of weather in different seasons, and the potential for phenotypic and microevolutionary adaptations.	[Salewski, Volker; Fiedler, Wolfgang] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Hochachka, Wesley M.] Cornell Univ, Ornithol Lab, Ithaca, NY USA	Max Planck Society; Cornell University	Salewski, V (corresponding author), Univ Osnabruck, Dept Behav Biol, Osnabruck, Germany.	volker.salewski@biologie.uni-osnabrueck.de	Hochachka, Wesley M./J-9768-2012; Fiedler, Wolfgang/AAG-4510-2021	Hochachka, Wesley M./0000-0002-0595-7827; Fiedler, Wolfgang/0000-0003-1082-4161	Max-Planck-Institue of Ornithology	Max-Planck-Institue of Ornithology	The study was entirely funded by the Max-Planck-Institue of Ornithology and the submitted manuscript will be a publication of this institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg R, 2006, OECOLOGIA, V149, P44, DOI 10.1007/s00442-006-0430-3; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Bauer H.G., 2005, KOMPENDIUM VOGEL MIT; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Boano Giovanni, 2004, Avocetta, V28, P77; Borrow N., 2001, GUIDE BIRDS W AFRICA; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Bretagnolle Vincent, 2010, P227; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham Kenneth P., 1993, P199; Camberlin P, 2007, REMOTE SENS ENVIRON, V106, P199, DOI 10.1016/j.rse.2006.08.009; CHEKE RA, 1993, ECOL ENTOMOL, V18, P109, DOI 10.1111/j.1365-2311.1993.tb01191.x; Choquet R, 2003, U CARE UTILITIES CAP; Cowley E, 2005, BIRD STUDY, V52, P237, DOI 10.1080/00063650509461397; Dowsett R.J., 1988, Tauraco, V1, P29; Dunn Peter O., 2010, P113; Eraud C, 2009, IBIS, V151, P186, DOI 10.1111/j.1474-919X.2008.00876.x; Fiedler W, 2003, AVIAN MIGRATION, P21; Flade Martin, 2004, Vogelwelt, V125, P177; Foppen R, 1999, ARDEA, V87, P113; Foppen Ruud, 1996, Limosa, V69, P51; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Gruebler M, 2007, THESIS U ZURICH ZURI; Gruebler MU, 2008, ECOLOGY, V89, P2736, DOI 10.1890/07-0786.1; Haas CA, 1998, AUK, V115, P929, DOI 10.2307/4089511; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hurrell JW, 2001, SCIENCE, V291, P603, DOI 10.1126/science.1058761; JANSSON C, 1981, OIKOS, V37, P313, DOI 10.2307/3544122; JARVINEN A, 1987, ANN ZOOL FENN, V24, P275; Jenni L., 1994, BIOL MOULT BIRDS; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Kaiser Andreas, 2004, Studies in Avian Biology, P75; KANYAMIBWA S, 1990, IBIS, V132, P27, DOI 10.1111/j.1474-919X.1990.tb01013.x; Keith S., 1992, BIRDS AFRICA, V4; Kolb H, 1999, VOGEL BODENSEEGEBIET, V14/15, P651; Lahti K, 1998, ECOLOGY, V79, P2904, DOI 10.1890/0012-9658(1998)079[2904:TAFDIW]2.0.CO;2; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moreno J, 2011, CURR ZOOL, V57, P375, DOI 10.1093/czoolo/57.3.375; Mutshinda CM, 2011, J ANIM ECOL, V80, P101, DOI 10.1111/j.1365-2656.2010.01743.x; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Nevoux M, 2008, J ANIM ECOL, V77, P1143, DOI 10.1111/j.1365-2656.2008.01435.x; Norris DR, 2006, BIOL LETTERS, V2, P148, DOI 10.1098/rsbl.2005.0397; NORTH PM, 1979, BIRD STUDY, V26, P23, DOI 10.1080/00063657909476612; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Pasinelli G, 2011, J ANIM ECOL, V80, P225, DOI 10.1111/j.1365-2656.2010.01754.x; Pavel V, 2008, J ORNITHOL, V149, P193, DOI 10.1007/s10336-007-0259-5; PEACH W, 1991, IBIS, V133, P300, DOI 10.1111/j.1474-919X.1991.tb04573.x; Peach WJ, 1995, J APPL STAT, V22, P905, DOI 10.1080/02664769524702; Prochazka P, 2008, J ORNITHOL, V149, P141, DOI 10.1007/s10336-007-0250-1; Rasinen J, 2003, CLIM DYNAM, V22, P13; Robinson RA, 2003, BIRD STUDY, V50, P1; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Robinson Robert A., 2008, Ringing & Migration, V24, P1; Rowell DP, 2005, CLIM DYNAM, V25, P837, DOI 10.1007/s00382-005-0068-6; Saether BE, 2004, ADV ECOL RES, V35, P185, DOI 10.1016/S0065-2504(04)35009-9; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Saether Bernt-Erik, 2010, P191; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Salewski V, 2002, IBIS, V144, P85, DOI 10.1046/j.0019-1019.2001.00007.x; Salewski V, 2010, OECOLOGIA, V162, P247, DOI 10.1007/s00442-009-1446-2; Schaefer T, 2006, J ORNITHOL, V147, P47, DOI 10.1007/s10336-005-0011-y; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; Schaub M, 2011, OECOLOGIA, V167, P445, DOI 10.1007/s00442-011-1999-8; Schlenker R, 1981, POPULATIONEN OKOLOGI, V3, P314; Schwabl H., 1990, P144; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stokke BG, 2005, AUK, V122, P637, DOI 10.1642/0004-8038(2005)122[0637:WITBAA]2.0.CO;2; Svensson L., 1992, IDENTIFICATION GUIDE; SZEP T, 1995, IBIS, V137, P162, DOI 10.1111/j.1474-919X.1995.tb03235.x; Szep T, 1995, J APPL STAT, V22, P891, DOI 10.1080/02664769524694; Thaxter Chris B., 2006, Ringing & Migration, V23, P65; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Todd MC, 2002, J APPL ECOL, V39, P31, DOI 10.1046/j.1365-2664.2002.00691.x; Urban EK, 1997, BIRDS AFRICA, V5; van Vliet J, 2009, BIRD STUDY, V56, P276, DOI 10.1080/00063650902792148; Veistola S, 1997, ORNIS FENNICA, V74, P89; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; WINSTANLEY D, 1974, BIRD STUDY, V21, P1; Zink G., 1973, ZUG EUROPAISCHER SIN	88	34	35	3	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59110	10.1371/journal.pone.0059110	http://dx.doi.org/10.1371/journal.pone.0059110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593131	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000007
J	Lee, JH; Yoon, S; Renshaw, PF; Kim, TS; Jung, JJ; Choi, Y; Kim, BN; Jacobson, AM; Lyoo, IK				Lee, Junghyun H.; Yoon, Sujung; Renshaw, Perry F.; Kim, Tae-Suk; Jung, Jiyoung J.; Choi, Yera; Kim, Binna N.; Jacobson, Alan M.; Lyoo, In Kyoon			Morphometric Changes in Lateral Ventricles of Patients with Recent-Onset Type 2 Diabetes Mellitus	PLOS ONE			English	Article							NEUROANATOMICAL STRUCTURES; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; CEREBRAL ATROPHY; BRAIN STRUCTURE; DEHYDRATION; PROGRESSION; MRI; SCHIZOPHRENIA; ABNORMALITIES	It is becoming increasingly evident that type 2 diabetes mellitus can have effects on global and regional brain morphology. Ventricular enlargement reflecting cerebral atrophy has been reported particularly in elderly type 2 diabetes patients. However, little is known about its timing through the disease course and morphological variability. Using the combined volumetric and advanced three-dimensional morphological approach, we identified differences in size and shape of the lateral ventricles between recent-onset type 2 diabetes patients and healthy individuals. High-resolution T1-weighted images were obtained from 23 type 2 diabetes patients whose illness duration was less than 1 year and 23 carefully matched healthy individuals. By volume measurement, we found enlarged lateral and third ventricles in type 2 diabetes patients, relative to healthy individuals (F-1,F-41 = 7.96, P = 0.007; F-1,F-41 = 11.16, P = 0.002, respectively). Morphological analysis revealed that the expansion of lateral ventricles in the diabetic brain was prominent in the bilateral frontal horns. The current findings suggest that atrophic changes particularly of the anterior frontal lobe can occur as early as the first year after the clinical diagnosis of type 2 diabetes mellitus.	[Lee, Junghyun H.; Lyoo, In Kyoon] Ewha Womans Univ, Dept Pharm, Coll Pharm, Seoul, South Korea; [Yoon, Sujung; Kim, Tae-Suk] Catholic Univ, Dept Psychiat, Korea Sch Med, Seoul, South Korea; [Yoon, Sujung; Renshaw, Perry F.; Kim, Tae-Suk; Lyoo, In Kyoon] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Yoon, Sujung; Renshaw, Perry F.; Kim, Tae-Suk; Lyoo, In Kyoon] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Jung, Jiyoung J.; Choi, Yera; Kim, Binna N.] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul 151742, South Korea; [Jacobson, Alan M.] Winthrop Univ Hosp, Res Inst, Mineola, NY 11501 USA; [Lyoo, In Kyoon] Ewha Womans Univ, Grad Sch, Div Life & Pharmaceut Sci, Seoul, South Korea; [Lyoo, In Kyoon] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea	Ewha Womans University; Catholic University of Korea; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Seoul National University (SNU); Winthrop University Hospital; Ewha Womans University; Ewha Womans University	Lyoo, IK (corresponding author), Ewha Womans Univ, Dept Pharm, Coll Pharm, Seoul, South Korea.	inkylyoo@gmail.com	Renshaw, Perry/O-1384-2018		Korean Health Technology RD Project [A080705]; Ministry of Health and Welfare of Korea; Lundbeck; Eli Lilly; AstraZeneca; GSK; Organon; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031247] Funding Source: NIH RePORTER	Korean Health Technology RD Project; Ministry of Health and Welfare of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Lundbeck(Lundbeck Corporation); Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); GSK(GlaxoSmithKline); Organon; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the grant A080705 from the Korean Health Technology R&D Project, The Ministry of Health and Welfare of Korea. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Lyoo has received research support from Lundbeck, Eli Lilly, AstraZeneca, GSK, and Organon. Other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Apostolova L, 2012, NEUROBIOL AGING, V33, P2113, DOI 10.1016/j.neurobiolaging.2011.06.014; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Biessels GJ, 2006, J NEUROL NEUROSUR PS, V77, P304, DOI 10.1136/jnnp.2005.069583; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOWKER LK, 1992, POSTGRAD MED J, V68, P174, DOI 10.1136/pgmj.68.797.174; BRECHBUHLER C, 1995, PARAMETERIZATION CLO; Bruehl H, 2009, BRAIN RES, V1280, P186, DOI 10.1016/j.brainres.2009.05.032; Brundel M, 2010, J NEUROL SCI, V299, P126, DOI 10.1016/j.jns.2010.08.048; Buckley PF, 1999, BIOL PSYCHIAT, V45, P62, DOI 10.1016/S0006-3223(98)00067-5; Carmichael OT, 2007, NEUROBIOL AGING, V28, P1316, DOI 10.1016/j.neurobiolaging.2006.06.016; Carmichael OT, 2007, ALZ DIS ASSOC DIS, V21, P14, DOI 10.1097/WAD.0b013e318032d2b1; Davis K.M., 1994, PRINCIPLES GERIATRIC, P1182; de Bresser J, 2010, DIABETES CARE, V33, P1309, DOI 10.2337/dc09-1923; den Heijer T, 2003, DIABETOLOGIA, V46, P1604, DOI 10.1007/s00125-003-1235-0; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickson JM, 2005, INT J SPORTS MED, V26, P481, DOI 10.1055/s-2004-821318; Duning T, 2005, NEUROLOGY, V64, P548, DOI 10.1212/01.WNL.0000150542.16969.CC; EATEN D, 1994, BRIT MED J, V308, P1271, DOI 10.1136/bmj.308.6939.1271; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gerig G, 2001, IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, PROCEEDINGS, P171, DOI 10.1109/MMBIA.2001.991731; Glastonbury CM, 2011, RADIOGRAPHICS, V31, P1889, DOI 10.1148/rg.317115083; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hsu JL, 2012, NEUROIMAGE, V59, P1098, DOI 10.1016/j.neuroimage.2011.09.041; Jackson DC, 2011, EPILEPSIA, V52, P2225, DOI 10.1111/j.1528-1167.2011.03323.x; Jongen C, 2007, DIABETOLOGIA, V50, P1509, DOI 10.1007/s00125-007-0688-y; Jongen C, 2008, EUR J PHARMACOL, V585, P208, DOI 10.1016/j.ejphar.2007.11.085; Kaplan RJ, 2000, AM J CLIN NUTR, V72, P825; Kempton MJ, 2011, HUM BRAIN MAPP, V32, P71, DOI 10.1002/hbm.20999; Kempton MJ, 2009, HUM BRAIN MAPP, V30, P291, DOI 10.1002/hbm.20500; Knopman DS, 2005, NEUROLOGY, V65, P876, DOI 10.1212/01.wnl.0000176074.09733.a8; Kumar A, 2008, J MAGN RESON IMAGING, V27, P14, DOI 10.1002/jmri.21224; Manschot SM, 2006, DIABETES, V55, P1106, DOI 10.2337/diabetes.55.04.06.db05-1323; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Meduri M, 2010, PSYCHIAT RES-NEUROIM, V183, P52, DOI 10.1016/j.pscychresns.2010.01.014; Nelson PT, 2009, BBA-MOL BASIS DIS, V1792, P454, DOI 10.1016/j.bbadis.2008.08.005; Pals J K, 1995, J Gerontol Nurs, V21, P13; Reijmer YD, 2011, DIABETES-METAB RES, V27, P195, DOI 10.1002/dmrr.1163; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044195; Styner M, 2005, P NATL ACAD SCI USA, V102, P4872, DOI 10.1073/pnas.0501117102; Styner M, 2003, MED IMAGE ANAL, V7, P207, DOI 10.1016/S1361-8415(02)00110-X; Tan ZS, 2011, DIABETES CARE, V34, P1766, DOI 10.2337/dc11-0308; van Elderen SGC, 2010, NEUROLOGY, V75, P997, DOI 10.1212/WNL.0b013e3181f25f06; van Harten B, 2006, DIABETES CARE, V29, P2539, DOI 10.2337/dc06-1637; Vidal CN, 2008, PSYCHIAT RES-NEUROIM, V163, P106, DOI 10.1016/j.pscychresns.2007.11.002; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; WEINBERG AD, 1994, J AM GERIATR SOC, V42, P1070, DOI 10.1111/j.1532-5415.1994.tb06211.x	52	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60515	10.1371/journal.pone.0060515	http://dx.doi.org/10.1371/journal.pone.0060515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593231	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100050
J	Wang, SL; Yu, ZT; Cao, M; Shen, XX; Li, N; Li, XH; Ma, WJ; Weissgerber, H; Zeller, F; Hsam, S; Yan, YM				Wang, Shunli; Yu, Zitong; Cao, Min; Shen, Xixi; Li, Ning; Li, Xiaohui; Ma, Wujun; Weissgerber, H.; Zeller, Friedrich; Hsam, Sai; Yan, Yueming			Molecular Mechanisms of HMW Glutenin Subunits from 1S(l) Genome of Aegilops longissima Positively Affecting Wheat Breadmaking Quality	PLOS ONE			English	Article							BREAD-MAKING QUALITY; SEED-STORAGE PROTEINS; DOUBLED HAPLOID POPULATION; ISOMERASE FAMILY PROTEINS; TRITICUM-AESTIVUM L.; WEIGHT SUBUNITS; GRAIN DEVELOPMENT; ALLELIC VARIATION; DOUGH PROPERTIES; HEXAPLOID WHEAT	A wheat cultivar "Chinese Spring'' chromosome substitution line CS-1S(l) (1B), in which the 1B chromosome was substituted by 1S(l) from Aegilops longissima, was developed and found to possess superior dough and breadmaking quality. The molecular mechanism of its super quality conformation is studied in the aspects of high molecular glutenin genes, protein accumulation patterns, glutenin polymeric proteins, protein bodies, starch granules, and protein disulfide isomerase (PDI) and PDI-like protein expressions. Results showed that the introduced HMW-GS 1S(l) x 2.3* and 1S(l) y16* in the substitution line possesses long repetitive domain, making both be larger than any known x- and y-type subunits from B genome. The introduced subunit genes were also found to have a higher level of mRNA expressions during grain development, resulting in more HMW-GS accumulation in the mature grains. A higher abundance of PDI and PDI-like proteins was observed which possess a known function of assisting disulfide bond formation. Larger HMW-GS deposited in protein bodies were also found in the substitution line. The CS substitution line is expected to be highly valuable in wheat quality improvement since the novel HMW-GS are located on chromosome 1S(l), making it possible to combine with the known superior Dx5+Dy10 subunits encoded by Glu-D1 for developing high quality bread wheat.	[Wang, Shunli; Yu, Zitong; Cao, Min; Shen, Xixi; Li, Ning; Li, Xiaohui; Yan, Yueming] Capital Normal Univ, Coll Life Sci, Key Lab Genet & Biotechnol, Beijing, Peoples R China; [Wang, Shunli] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Ma, Wujun] Murdoch Univ, State Agr Biotechnol Ctr, Western Australian Dept Agr & Food, Perth, WA, Australia; [Weissgerber, H.; Zeller, Friedrich; Hsam, Sai] Tech Univ Munich, Div Plant Breeding & Appl Genet, Freising Weihenstephan, Germany	Capital Normal University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Murdoch University; Technical University of Munich	Ma, WJ (corresponding author), Murdoch Univ, State Agr Biotechnol Ctr, Western Australian Dept Agr & Food, Perth, WA, Australia.	W.Ma@murdoch.edu.au; yanym@mail.cnu.edu.cn	Ma, Wujun/F-5957-2010	Ma, Wujun/0000-0002-1264-866X; Wang, Shunli/0000-0002-2700-009X	National Natural Science Foundation of China [30830072, 31101145]; Chinese Ministry of Science and Technology [2009CB118303]; Key Project of National Plant Transgenic Genes of China [2011ZX08009-003-004, 2011ZX08002-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Key Project of National Plant Transgenic Genes of China	This research was financially supported by grants from the National Natural Science Foundation of China (30830072, 31101145), the Chinese Ministry of Science and Technology (2009CB118303) and Key Project of National Plant Transgenic Genes of China (2011ZX08009-003-004 and 2011ZX08002-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 1995, APPR METH AM ASS CER; Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Allaby RC, 1999, GENOME, V42, P296, DOI 10.1139/gen-42-2-296; Altenbach SB, 2004, J CEREAL SCI, V40, P115, DOI 10.1016/j.jcs.2004.05.004; Altenbach SB, 2007, J CEREAL SCI, V46, P169, DOI 10.1016/j.jcs.2007.02.001; Anderson OD, 2011, J CEREAL SCI, V54, P288, DOI 10.1016/j.jcs.2011.06.001; Anderson OD, 2011, J CEREAL SCI, V54, P280, DOI 10.1016/j.jcs.2011.04.005; Arbeitsgemeinschaft Getreideforschung, 1994, STAND METH GETR MEHL; Bekes F, 1995, P 45 AUSTR CER CHEM, P92; Belton PS, 1999, J CEREAL SCI, V29, P103, DOI 10.1006/jcrs.1998.0227; BRANLARD G, 1985, J CEREAL SCI, V3, P345, DOI 10.1016/S0733-5210(85)80007-2; Butow BJ, 2003, THEOR APPL GENET, V107, P1524, DOI 10.1007/s00122-003-1396-8; Ciaffi M, 2006, GENE, V366, P209, DOI 10.1016/j.gene.2005.07.032; d'Aloisio E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-101; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; DOVIDIO R, 1994, THEOR APPL GENET, V88, P759, DOI 10.1007/BF01253982; FLAVELL RB, 1989, BIO-TECHNOL, V7, P1281; Gao LY, 2010, J AGR FOOD CHEM, V58, P2777, DOI 10.1021/jf903363z; Gao X, 2012, THEOR APPL GENET, V124, P333, DOI 10.1007/s00122-011-1708-3; Gianibelli MC, 2001, CEREAL CHEM, V78, P635, DOI 10.1094/CCHEM.2001.78.6.635; Gilbert SM, 2000, BBA-PROTEIN STRUCT M, V1479, P135, DOI 10.1016/S0167-4838(00)00059-5; Gobaa S, 2008, J CEREAL SCI, V48, P598, DOI 10.1016/j.jcs.2007.12.006; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Gupta RB, 1996, J EXP BOT, V47, P1377, DOI 10.1093/jxb/47.9.1377; Han FP, 2004, THEOR APPL GENET, V109, P1070, DOI 10.1007/s00122-004-1720-y; Hassani ME, 2005, EUPHYTICA, V141, P191, DOI 10.1007/s10681-005-6982-1; He GY, 1999, MOL BREEDING, V5, P377, DOI 10.1023/A:1009681321708; He ZH, 2005, CEREAL CHEM, V82, P345, DOI 10.1094/CC-82-0345; Iwasaki K, 2009, FEBS J, V276, P4130, DOI 10.1111/j.1742-4658.2009.07123.x; Kamauchi S, 2008, FEBS J, V275, P2644, DOI 10.1111/j.1742-4658.2008.06412.x; Laudencia-Chingcuanco DL, 2007, PLANT MOL BIOL, V63, P651, DOI 10.1007/s11103-006-9114-y; LEVANONY H, 1992, J CELL BIOL, V119, P1117, DOI 10.1083/jcb.119.5.1117; Li XH, 2010, THEOR APPL GENET, V121, P845, DOI 10.1007/s00122-010-1354-1; Li XH, 2008, EUPHYTICA, V159, P181, DOI 10.1007/s10681-007-9471-x; Liu W, 2012, J SCI FOOD AGR, V92, P106, DOI 10.1002/jsfa.4548; Liu Z, 2003, THEOR APPL GENET, V106, P1368, DOI 10.1007/s00122-002-1175-y; Loussert C, 2008, J CEREAL SCI, V47, P445, DOI 10.1016/j.jcs.2007.05.012; Ma W, 2005, THEOR APPL GENET, V111, P410, DOI 10.1007/s00122-005-2001-0; Mackie AM, 1996, J CEREAL SCI, V23, P213, DOI 10.1006/jcrs.1996.0022; Masci S, 1998, PLANT PHYSIOL, V118, P1147, DOI 10.1104/pp.118.4.1147; Masci S, 2000, THEOR APPL GENET, V100, P396, DOI 10.1007/s001220050052; NETZLE S, 1984, PLANT SYST EVOL, V145, P1, DOI 10.1007/BF00984027; NG PKW, 1988, CEREAL CHEM, V65, P408; Pang BS, 2008, J INTEGR PLANT BIOL, V50, P329, DOI 10.1111/j.1744-7909.2007.00573.x; Panozzo JF, 2001, AUST J AGR RES, V52, P485, DOI 10.1071/AR00101; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1988, J CEREAL SCI, V7, P229, DOI [10.1016/S0733-5210(88)80004-3, 10.1006/jcrs.1998.0194]; Pirozi MR, 2008, J CEREAL SCI, V48, P117, DOI 10.1016/j.jcs.2007.08.011; Piston F, 2006, J CEREAL SCI, V43, P120, DOI 10.1016/j.jcs.2005.07.002; Piston F, 2004, THEOR APPL GENET, V108, P1359, DOI 10.1007/s00122-003-1548-x; Rakszegi M, 2008, J CEREAL SCI, V47, P310, DOI 10.1016/j.jcs.2007.04.010; Shewry PR, 2009, J CEREAL SCI, V50, P106, DOI 10.1016/j.jcs.2009.03.009; Shewry PR, 2003, THEOR APPL GENET, V106, P744, DOI 10.1007/s00122-002-1135-6; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; SHEWRY PR, 1992, J CEREAL SCI, V15, P105, DOI 10.1016/S0733-5210(09)80062-3; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Sun X, 2006, THEOR APPL GENET, V113, P631, DOI 10.1007/s00122-006-0327-x; Tamas L, 2002, J CEREAL SCI, V36, P313, DOI 10.1006/jcrs.2001.0457; TATHAM AS, 1985, CEREAL CHEM, V62, P405; Wadahama H, 2008, FEBS J, V275, P399, DOI 10.1111/j.1742-4658.2007.06199.x; Wadahama H, 2007, FEBS J, V274, P687, DOI 10.1111/j.1742-4658.2006.05613.x; Wan Y, 2000, THEOR APPL GENET, V101, P879, DOI 10.1007/s001220051556; Wan Y, 2002, THEOR APPL GENET, V104, P828, DOI 10.1007/s00122-001-0793-0; Wan YF, 2005, THEOR APPL GENET, V111, P1183, DOI 10.1007/s00122-005-0051-y; Wang SL, 2011, GENOME, V54, P273, DOI [10.1139/G10-119, 10.1139/g10-119]; Weegels PL, 1996, J CEREAL SCI, V23, P103, DOI 10.1006/jcrs.1996.0010; Xu Tao, 2006, Agricultural Sciences in China, V5, P725, DOI 10.1016/S1671-2927(06)60117-X; Yan Y, 2004, THEOR APPL GENET, V108, P1349, DOI 10.1007/s00122-003-1547-y; Yan YM, 2009, J CEREAL SCI, V50, P398, DOI 10.1016/j.jcs.2009.08.004; Yan YM, 2003, EUPHYTICA, V130, P377, DOI 10.1023/A:1023062316439; Zhang Y, 2008, GENETICS, V178, P23, DOI 10.1534/genetics.107.077412	72	36	45	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e58947	10.1371/journal.pone.0058947	http://dx.doi.org/10.1371/journal.pone.0058947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593125	Green Published, gold			2022-12-27	WOS:000319108100005
J	Wang, YP; Chen, RH; Cai, JY; Liu, ZG; Zheng, YM; Wang, HT; Li, QB; He, N				Wang, Yuanpeng; Chen, Ronghui; Cai, JiYuan; Liu, Zhenggui; Zheng, Yanmei; Wang, Haitao; Li, Qingbiao; He, Ning			Biosynthesis and Thermal Properties of PHBV Produced from Levulinic Acid by Ralstonia eutropha	PLOS ONE			English	Article							PROTEIN REGULATIONS; POLYHYDROXYALKANOATES; CARBON; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); 3-HYDROXYVALERATE; CULTIVATION; OIL; POLY(3-HYDROXYBUTYRATE-CO-4-HYDROXYBUTYRATE); COPOLYMERS; FRACTION	Levulinic acid (LA) can be cost-effectively produced from a vast array of renewable carbohydrate-containing biomaterials. LA could facilitate the commercialization of the polymer poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) and PHBV-based products as carbon substrates. Therefore, this paper focused on the production of PHBV by Ralstonia eutropha with LA for hydroxyvalerate (HV) production, which plays an important role in enhancing the thermal properties of PHBV. Accordingly, the HV content of PHBV varied from 0-40.9% at different concentrations of LA. Stimulation of cell growth and PHBV accumulation were observed when 2-6 g L-1 LA was supplied to the culture. The optimal nitrogen sources were determined to be 0.5 g L-1 ammonium chloride and 2 g L-1 casein peptone. It was determined that the optimal pH for cell growth and PHBV accumulation was 7.0. When the cultivation was performed in large scale (2 L fermenter) with a low DO concentration of 30% and a pH of 7.0, a high maximum dry cell weight of 15.53 g L-1 with a PHBV concentration of 12.61 g L 21 (53.9% HV), up to 81.2% of the dry cell weight, was obtained. The melting point of PHBV found to be decreased as the fraction of HV present in the polymer increased, which resulted in an improvement in the ductility and flexibility of the polymer. The results of this study will improve the understanding of the PHBV accumulation and production by R. eutropha and will be valuable for the industrial production of biosynthesized polymers.	[He, Ning] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China; Xiamen Univ, Key Lab Synthet Biotechnol Xiamen City, Xiamen, Peoples R China	Xiamen University; Xiamen University	He, N (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China.	hening@xmu.edu.cn	Wang, Yuanpeng/C-4691-2016; Li, QB/G-4616-2010		National Basic Research Program of China [2013CB733505]; National Natural Science Foundation of China [41071302]; Xiamen Science and Technology committee [3502Z20121021, 3502Z20126005]; Fujian Development and Reform Commission [[2011] 1598]; Natural Science Foundation of Fujian Province of China [2010J05121]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xiamen Science and Technology committee; Fujian Development and Reform Commission; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by the National Basic Research Program of China (2013CB733505), National Natural Science Foundation of China (41071302), Xiamen Science and Technology committee (3502Z20121021, 3502Z20126005), Fujian Development and Reform Commission ([2011] 1598) and Natural Science Foundation of Fujian Province of China (2010J05121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Ashby RD, 2012, BIORESOURCE TECHNOL, V118, P272, DOI 10.1016/j.biortech.2012.05.092; Beccari M, 1998, WATER RES, V32, P3403, DOI 10.1016/S0043-1354(98)00100-6; Berezina N, 2012, BIOTECHNOL J, V7, P304, DOI 10.1002/biot.201100191; Bozell JJ, 2000, RESOUR CONSERV RECY, V28, P227, DOI 10.1016/S0921-3449(99)00047-6; Cavalheiro JMBT, 2012, BIORESOURCE TECHNOL, V111, P391, DOI 10.1016/j.biortech.2012.01.176; Cha JY, 2002, IND CROP PROD, V16, P109, DOI 10.1016/S0926-6690(02)00033-X; Chang HF, 2012, BIORESOURCE TECHNOL, V113, P51, DOI 10.1016/j.biortech.2011.12.138; Chen H, 2008, BIORESOURCE TECHNOL, V99, P5538, DOI 10.1016/j.biortech.2007.10.047; Chung SH, 2001, J MICROBIOL, V39, P79; Dionisi D, 2001, IND ENG CHEM RES, V40, P5110, DOI 10.1021/ie001008k; Grothe E, 2000, BIOPROCESS ENG, V22, P441, DOI 10.1007/s004490050757; Gumel AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045214; Guo W, PLOS ONE, V7; Haddouche R, 2011, APPL MICROBIOL BIOT, V91, P1327, DOI 10.1007/s00253-011-3331-2; Jang JH, 1996, BIOTECHNOL LETT, V18, P219, DOI 10.1007/BF00128683; Keenan TM, 2004, BIOTECHNOL PROGR, V20, P1697, DOI 10.1021/bp049873d; Kenny ST, 2012, APPL MICROBIOL BIOT, V95, P623, DOI 10.1007/s00253-012-4058-4; Khanna S, 2006, BIOCHEM ENG J, V27, P197, DOI 10.1016/j.bej.2005.08.006; Kim DY, 2009, J MICROBIOL, V47, P651, DOI 10.1007/s12275-009-0109-7; Kim DY, 2005, J MICROBIOL, V43, P285; Kim JS, 2005, BIOCHEM ENG J, V23, P169, DOI 10.1016/j.bej.2005.01.016; Lee SE, 2009, INT J BIOL SCI, V5, P215; Lee SY, 2000, BIOTECHNOL BIOENG, V68, P466, DOI 10.1002/(SICI)1097-0290(20000520)68:4<466::AID-BIT12>3.0.CO;2-T; Li R, 2007, BIORESOURCE TECHNOL, V98, P2313, DOI 10.1016/j.biortech.2006.09.014; Luengo JM, 2003, CURR OPIN MICROBIOL, V6, P251, DOI 10.1016/S1369-5274(03)00040-7; Morgan-Sagastume F, 2010, WATER RES, V44, P5196, DOI 10.1016/j.watres.2010.06.043; Ng KS, 2011, PROCESS BIOCHEM, V46, P1572, DOI 10.1016/j.procbio.2011.04.012; Park SJ, 2012, APPL MICROBIOL BIOT, V93, P273, DOI 10.1007/s00253-011-3530-x; Riedel SL, 2012, BIOTECHNOL BIOENG, V109, P74, DOI 10.1002/bit.23283; RIIS V, 1988, J CHROMATOGR, V445, P285, DOI 10.1016/S0021-9673(01)84535-0; Shang LG, 2004, BIOTECHNOL PROGR, V20, P140, DOI 10.1021/bp034232o; Sheu DS, 2012, J BACTERIOL, V194, P2620, DOI 10.1128/JB.06543-11; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; Wong YM, 2012, BIORESOURCE TECHNOL, V121, P320, DOI 10.1016/j.biortech.2012.07.015; Yu J, 2009, J BIOBASED MATER BIO, V3, P113, DOI 10.1166/jbmb.2009.1018	36	45	47	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60318	10.1371/journal.pone.0060318	http://dx.doi.org/10.1371/journal.pone.0060318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593190	Green Submitted, Green Published, gold			2022-12-27	WOS:000319108100030
J	Zhang, G; Beati, H; Nilsson, J; Wodarz, A				Zhang, Gang; Beati, Hamze; Nilsson, Jakob; Wodarz, Andreas			The Drosophila Microtubule-Associated Protein Mars Stabilizes Mitotic Spindles by Crosslinking Microtubules through Its N-Terminal Region	PLOS ONE			English	Article							NUMA; REQUIRES; MIDZONE; MITOSIS; CELLS; POLES; PRC1; MAP	Correct segregation of genetic material relies on proper assembly and maintenance of the mitotic spindle. How the highly dynamic microtubules (MTs) are maintained in stable mitotic spindles is a key question to be answered. Motor and non-motor microtubule associated proteins (MAPs) have been reported to stabilize the dynamic spindle through crosslinking adjacent MTs. Mars, a novel MAP, is essential for the early development of Drosophila embryos. Previous studies showed that Mars is required for maintaining an intact mitotic spindle but did not provide a molecular mechanism for this function. Here we show that Mars is able to stabilize the mitotic spindle in vivo. Both in vivo and in vitro data reveal that the N-terminal region of Mars functions in the stabilization of the mitotic spindle by crosslinking adjacent MTs.	[Zhang, Gang; Beati, Hamze; Wodarz, Andreas] Univ Goettingen, Dept Anat & Cell Biol, Gottingen, Germany; [Zhang, Gang; Nilsson, Jakob] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark	University of Gottingen; University of Copenhagen	Nilsson, J (corresponding author), Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark.	jakob.nilsson@cpr.ku.dk; awodarz@gwdg.de	Wodarz, Andreas/D-4642-2013	Wodarz, Andreas/0000-0002-0007-6289; Zhang, Gang/0000-0001-7697-7203; Nilsson, Jakob/0000-0003-4100-1125	Deutsche Forschungsgemeinschaft (Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain) [1756]	Deutsche Forschungsgemeinschaft (Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain)	This work was funded by the Deutsche Forschungsgemeinschaft (Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain; DFG Research Group 1756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Gatlin JC, 2009, CURR BIOL, V19, P287, DOI 10.1016/j.cub.2009.01.055; Harborth J, 1999, EMBO J, V18, P1689, DOI 10.1093/emboj/18.6.1689; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Mao TL, 2005, PLANT PHYSIOL, V138, P654, DOI 10.1104/pp.104.052456; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Mollinari C, 2005, MOL BIOL CELL, V16, P1043, DOI 10.1091/mbc.E04-04-0346; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Mueller H. -Arno J., 2008, V420, P207, DOI 10.1007/978-1-59745-583-1_12; Oladipo A, 2007, MOL BIOL CELL, V18, P3601, DOI 10.1091/mbc.e06-12-1085; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Tan SJ, 2008, J CELL BIOL, V182, P27, DOI 10.1083/jcb.200712080; Thadani R, 2009, CURR BIOL, V19, P1861, DOI 10.1016/j.cub.2009.09.063; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; Walczak CE, 2010, CELL, V142, P364, DOI 10.1016/j.cell.2010.07.023; Wong RW, 2006, P NATL ACAD SCI USA, V103, P19783, DOI 10.1073/pnas.0609582104; Zeng SX, 2010, MOL CELL BIOL, V30, P935, DOI 10.1128/MCB.01379-09; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a; Zhang G, 2009, J CELL SCI, V122, P535, DOI 10.1242/jcs.040352	25	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60596	10.1371/journal.pone.0060596	http://dx.doi.org/10.1371/journal.pone.0060596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593258	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100057
J	Tateishi, R; Shiina, S; Akahane, M; Sato, J; Kondo, Y; Masuzaki, R; Nakagawa, H; Asaoka, Y; Goto, T; Otomo, K; Omata, M; Yoshida, H; Koike, K				Tateishi, Ryosuke; Shiina, Shuichiro; Akahane, Masaaki; Sato, Jiro; Kondo, Yuji; Masuzaki, Ryota; Nakagawa, Hayato; Asaoka, Yoshinari; Goto, Tadashi; Otomo, Kuni; Omata, Masao; Yoshida, Haruhiko; Koike, Kazuhiko			Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma	PLOS ONE			English	Article							PERCUTANEOUS-ETHANOL-INJECTION; INTERSTITIAL THERMAL ABLATION; PROSPECTIVE RANDOMIZED-TRIAL; JAPANESE NATIONWIDE SURVEY; PORTAL VENOUS INVASION; LIVER RESECTION; PROGNOSTIC-FACTORS; INTRAHEPATIC RECURRENCE; PARTIAL-HEPATECTOMY; CURATIVE RESECTION	Background: In the treatment of hepatocellular carcinoma (HCC), hepatic resection has the advantage over radiofrequency ablation (RFA) in terms of systematic removal of a hepatic segment. Methods: We enrolled 303 consecutive patients of a single naive HCC that had been treated by RFA at The University of Tokyo Hospital from 1999 to 2004. Recurrence was categorized as either intra- or extra-subsegmental as according to the Couinaud's segment of the original nodule. To assess the relationship between the subsegments of the original and recurrent nodules, we calculated the kappa coefficient. We assessed the risk factors for intra- and extra-subsegmental recurrence independently using univariate and multivariate Cox proportional hazard regression. We also assessed the impact of the mode of recurrence on the survival outcome. Results: During the follow-up period, 201 patients in our cohort showed tumor recurrence distributed in a total of 340 subsegments. Recurrence was categorized as exclusively intra-subsegmental, exclusively extra-subsegmental, and simultaneously intra- and extra-subsegmental in 40 (20%), 110 (55%), and 51 (25%) patients, respectively. The kappa coefficient was measured at 0.135 (95% CI, 0.079-0.190; P<0.001). Multivariate analysis revealed that of the tumor size, AFP value and platelet count were all risk factors for both intra- and extra-subsegmental recurrence. Of the patients in whom recurrent HCC was found to be exclusively intra-subsegmental, extra-subsegmental, and simultaneously intra- and extra-subsegmental, 37 (92.5%), 99 (90.8%) and 42 (82.3%), respectively, were treated using RFA. The survival outcomes after recurrence were similar between patients with an exclusively intra- or extra-subsegmental recurrence. Conclusions: The effectiveness of systematic subsegmentectomy may be limited in the patients with both HCC and chronic liver disease who frequently undergo multi-focal tumor recurrence.	[Tateishi, Ryosuke; Shiina, Shuichiro; Kondo, Yuji; Masuzaki, Ryota; Nakagawa, Hayato; Asaoka, Yoshinari; Goto, Tadashi; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan; [Akahane, Masaaki; Sato, Jiro; Otomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan; [Omata, Masao] Yamanashi Prefectural Hosp Org, Tokyo, Japan	University of Tokyo; University of Tokyo	Tateishi, R (corresponding author), Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan.	tateishi-tky@umin.ac.jp	Sato, Jiro/AAF-5673-2020; Nakagawa, Hayato/I-2837-2012; Asaoka, Yoshinari/ABC-5412-2021; Tateishi, Ryosuke/G-7758-2014	Nakagawa, Hayato/0000-0002-6973-5094; Asaoka, Yoshinari/0000-0002-2805-8226; Tateishi, Ryosuke/0000-0003-3021-2517; Sato, Jiro/0000-0003-3266-1244	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis); Grants-in-Aid for Scientific Research [23590962] Funding Source: KAKEN	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier HP, 1999, LANCET, V353, P1676, DOI 10.1016/S0140-6736(99)00368-2; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; CASTAING D, 1989, ANN SURG, V210, P20, DOI 10.1097/00000658-198907000-00003; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; COUINAUD C, 1954, PRESSE MED, V62, P709; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; EBARA M, 1990, J GASTROEN HEPATOL, V5, P616, DOI 10.1111/j.1440-1746.1990.tb01115.x; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Fuster J, 1996, ANN SURG, V223, P297, DOI 10.1097/00000658-199603000-00011; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Huang GT, 2005, ANN SURG, V242, P36, DOI 10.1097/01.sla.0000167925.90380.fe; Ikai I, 2004, CANCER-AM CANCER SOC, V101, P796, DOI 10.1002/cncr.20426; IKEDA K, 1993, CANCER, V71, P19, DOI 10.1002/1097-0142(19930101)71:1<19::AID-CNCR2820710105>3.0.CO;2-I; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Imamurai H, 1999, BRIT J SURG, V86, P1032, DOI 10.1046/j.1365-2168.1999.01185.x; Koike Y, 2000, HEPATOLOGY, V32, P1216, DOI 10.1053/jhep.2000.20237; Liang HH, 2008, ANN SURG ONCOL, V15, P3484, DOI 10.1245/s10434-008-0076-y; Liver Cancer Study Group of Japan, 2003, GEN RUL CLIN PATH ST; Livraghi T, 1999, RADIOLOGY, V210, P655, DOI 10.1148/radiology.210.3.r99fe40655; LIVRAGHI T, 1995, RADIOLOGY, V197, P101, DOI 10.1148/radiology.197.1.7568806; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; MULLER HG, 1994, BIOMETRICS, V50, P61, DOI 10.2307/2533197; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Nagasue N, 1996, BRIT J SURG, V83, P127, DOI 10.1002/bjs.1800830142; Nakagawa K, 2005, WORLD J GASTROENTERO, V11, P7237, DOI 10.3748/wjg.v11.i46.7237; Nakajima Y, 2001, J AM COLL SURGEONS, V192, P339, DOI 10.1016/S1072-7515(00)00789-4; Nakashima Y, 2003, HEPATOL RES, V26, P142, DOI 10.1016/S1386-6346(03)00007-X; Obi S, 2006, CANCER-AM CANCER SOC, V106, P1990, DOI 10.1002/cncr.21832; Plessier Aurelie, 2004, Liver Transpl, V10, pS86, DOI 10.1002/lt.20039; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Regimbeau JM, 2002, SURGERY, V131, P311, DOI 10.1067/msy.2002.121892; Rossi S, 1996, AM J ROENTGENOL, V167, P759, DOI 10.2214/ajr.167.3.8751696; Sakon M, 2000, ARCH SURG-CHICAGO, V135, P1456, DOI 10.1001/archsurg.135.12.1456; Seki T, 1999, CANCER, V85, P1694, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1694::AID-CNCR8>3.3.CO;2-V; Shi M, 2007, ANN SURG, V245, P36, DOI 10.1097/01.sla.0000231758.07868.71; SHIINA S, 1993, AM J ROENTGENOL, V160, P1023, DOI 10.2214/ajr.160.5.7682378; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Teratani T, 2006, HEPATOLOGY, V43, P1101, DOI 10.1002/hep.21164; Torzilli G, 1999, HEPATOLOGY, V30, P889, DOI 10.1002/hep.510300411; Yamashiki N, 2005, LIVER TRANSPLANT, V11, P508, DOI 10.1002/lt.20392	45	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e59040	10.1371/journal.pone.0059040	http://dx.doi.org/10.1371/journal.pone.0059040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593129	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300005
J	Damgaard, C; Strandberg, B; Mathiassen, SK; Kudsk, P				Damgaard, Christian; Strandberg, Beate; Mathiassen, Solvejg K.; Kudsk, Per			The Effect of Nitrogen and Glyphosate on Survival and Colonisation of Perennial Grass Species in an Agro-Ecosystem: Does the Relative Importance of Survival Decrease with Competitive Ability?	PLOS ONE			English	Article							AGRICULTURAL INTENSIFICATION; CLIMATE VARIABILITY; BIODIVERSITY; COEXISTENCE; HEDGEROWS; CORRIDORS; GRADIENT; STRESS	The ecological success of a plant species is typically described by the observed change in plant abundance or cover, but in order to more fully understand the fundamental plant ecological processes, it is necessary to inspect the underlying processes of survival and colonization and how they are affected by environmental conditions. A general ecological hypothesis on the effect of environmental gradients on demographic parameters is proposed and tested. The hypothesis is that decreasing fitness or competitive ability along an environmental gradient is associated with an increasing importance of survival for regulating the abundance of the species. The tested hypothesis is related to both the stress gradient hypothesis and whether the importance of competition increases along productivity gradients. The combined effect of nitrogen and glyphosate on the survival and colonization probability of two perennial grass species, Festuca ovina and Agrostis capillaris, which are known to differ in their responses to both glyphosate and nitrogen treatments, is calculated using pin-point cover data in permanent frames. We found that the relative importance of survival increased with the level of glyphosate for the glyphosate sensitive A. capillaris and decreased for the glyphosate tolerant F. ovina. Likewise, increasing levels of nitrogen increased the importance of survival for the relative nitrophobic F. ovina. Consequently, the proposed hypothesis was corroborated in this specific study. The proposed method will enable predictions of the effects of agricultural practices on community dynamics in a relatively simple setup eliminating the need to quantify all the interaction among the species in the plant community. The method will be immediately useful for the regulation of non-cultivated buffer strips between agricultural fields and semi-natural and natural biotopes such as hedgerows and waterways.	[Damgaard, Christian; Strandberg, Beate] Aarhus Univ, Dept Biosci, Silkeborg, Denmark; [Mathiassen, Solvejg K.; Kudsk, Per] Aarhus Univ, Dept Agroecol, Slagelse, Denmark	Aarhus University; Aarhus University	Damgaard, C (corresponding author), Aarhus Univ, Dept Biosci, Vejlsovej 25, Silkeborg, Denmark.	cfd@dmu.dk	Kudsk, Per/AAC-2105-2022; Kudsk, Per/G-1210-2016; Mathiassen, Solvejg K/A-6309-2009; Damgaard, Christian/G-2441-2010	Kudsk, Per/0000-0003-2431-3610; Damgaard, Christian/0000-0003-3932-4312				Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; Adler PB, 2009, ECOLOGY, V90, P3303, DOI 10.1890/08-2241.1; Bruus Pedersen M., 2004, ADSKILLELSE EFFEKTER; Caswell, 2000, MATRIX POPULATION MO; Corbit M, 1999, J ECOL, V87, P220, DOI 10.1046/j.1365-2745.1999.00339.x; Croxton PJ, 2002, AGR ECOSYST ENVIRON, V93, P437, DOI 10.1016/S0167-8809(02)00106-8; Damgaard C, 2003, ECOL MODEL, V170, P45, DOI 10.1016/S0304-3800(03)00299-0; Damgaard C, 2011, AGR ECOSYST ENVIRON, V142, P374, DOI 10.1016/j.agee.2011.06.008; Damgaard C, 2011, METHODS ECOL EVOL, V2, P110, DOI 10.1111/j.2041-210X.2010.00053.x; Damgaard C, 2010, J ECOL, V98, P1, DOI 10.1111/j.1365-2745.2009.01587.x; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1, DOI DOI 10.15468/TPNGMA; Firbank LG, 2008, PHILOS T R SOC B, V363, P777, DOI 10.1098/rstb.2007.2183; Flohre A, 2011, ECOL APPL, V21, P1772, DOI 10.1890/10-0645.1; GRACE JB, 1991, FUNCT ECOL, V5, P583, DOI 10.2307/2389475; Grime P., 2001, PLANT STRATEGIES VEG; Hannon LE, 2009, BIOL CONSERV, V142, P2140, DOI 10.1016/j.biocon.2009.04.014; Harper J. L, 1977, POPULATION BIOL PLAN; Holst N, 2008, EFFECT GLYPHOS UNPUB; Holst N., 2008, SPROJTEPRAKSIS SAEDS; Jensen PK, 2012, VEJLEDNING PLANTEVAE; Kent M., 2012, VEGETATION DESCRIPTI, V2nd ed.; LEVY E. B., 1933, New Zealand Journal of Agriculture, V46, P267; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Rautmann D, 2001, BIOLOGISCHEN BUNDESA; Rees M, 2012, J ECOL, V100, P577, DOI 10.1111/j.1365-2745.2011.01946.x; Roy V, 2008, BIOL CONSERV, V141, P298, DOI 10.1016/j.biocon.2007.10.003; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Storkey J, 2011, P ROYAL SOC B; Strandberg B., 2012, EFFECTS HERBICIDES N	30	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60992	10.1371/journal.pone.0060992	http://dx.doi.org/10.1371/journal.pone.0060992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593371	Green Submitted, Green Published, gold			2022-12-27	WOS:000317383200033
J	Maillot, B; Levy, N; Eiler, S; Crucifix, C; Granger, F; Richert, L; Didier, P; Godet, J; Pradeau-Aubreton, K; Emiliani, S; Nazabal, A; Lesbats, P; Parissi, V; Mely, Y; Moras, D; Schultz, P; Ruff, M				Maillot, Benoit; Levy, Nicolas; Eiler, Sylvia; Crucifix, Corinne; Granger, Florence; Richert, Ludovic; Didier, Pascal; Godet, Julien; Pradeau-Aubreton, Karine; Emiliani, Stephane; Nazabal, Alexis; Lesbats, Paul; Parissi, Vincent; Mely, Yves; Moras, Dino; Schultz, Patrick; Ruff, Marc			Structural and Functional Role of INI1 and LEDGF in the HIV-1 Preintegration Complex	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; VIRUS TYPE-1 INTEGRASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; ACTIVE-SITE; REVERSE TRANSCRIPTION; NUCLEOCAPSID PROTEIN; EARLY STEPS; DNA; MODEL	Integration of the HIV-1 cDNA into the human genome is catalyzed by the viral integrase (IN) protein. Several studies have shown the importance of cellular cofactors that interact with integrase and affect viral integration and infectivity. In this study, we produced a stable complex between HIV-1 integrase, viral U5 DNA, the cellular cofactor LEDGF/p75 and the integrase binding domain of INI1 (INI1-IBD), a subunit of the SWI/SNF chromatin remodeling factor. The stoichiometry of the IN/LEDGF/INI1-IBD/DNA complex components was found to be 4/2/2/2 by mass spectrometry and Fluorescence Correlation Spectroscopy. Functional assays showed that INI1-IBD inhibits the 3' processing reaction but does not interfere with specific viral DNA binding. Integration assays demonstrate that INI1-IBD decreases the amount of integration events but inhibits by-product formation such as donor/donor or linear full site integration molecules. Cryo-electron microscopy locates INI1-IBD within the cellular DNA binding site of the IN/LEDGF complex, constraining the highly flexible integrase in a stable conformation. Taken together, our results suggest that INI1 could stabilize the PIC in the host cell, by maintaining integrase in a stable constrained conformation which prevents non-specific interactions and auto integration on the route to its integration site within nucleosomes, while LEDGF organizes and stabilizes an active integrase tetramer suitable for specific vDNA integration. Moreover, our results provide the basis for a novel type of integrase inhibitor (conformational inhibitor) representing a potential new strategy for use in human therapy.	[Maillot, Benoit; Levy, Nicolas; Eiler, Sylvia; Crucifix, Corinne; Granger, Florence; Pradeau-Aubreton, Karine; Moras, Dino; Schultz, Patrick; Ruff, Marc] Univ Strasbourg, Dept Biol Struct Integrat, Inst Genet & Biol Mol & Cellulaire, CNRS UMR7104,INSERM U596, Illkirch Graffenstaden, France; [Richert, Ludovic; Didier, Pascal; Godet, Julien; Mely, Yves] Fac Pharm, UDS, UMR CNRS 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France; [Emiliani, Stephane] Univ Paris 05, Inst Cochin, CNRS UMR8104, INSERM U567, Paris, France; [Nazabal, Alexis] CovalX AG, Zurich, Switzerland; [Lesbats, Paul; Parissi, Vincent] Univ Bordeaux 2, CNRS UMR5234, Lab Microbiol Fondamentale & Pathogen, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Ruff, M (corresponding author), Univ Strasbourg, Dept Biol Struct Integrat, Inst Genet & Biol Mol & Cellulaire, CNRS UMR7104,INSERM U596, Illkirch Graffenstaden, France.	ruff@igbmc.fr	Richert, Ludovic/B-5006-2008; Julien, Godet/A-7250-2015; ruff, marc/J-3011-2013	Richert, Ludovic/0000-0003-4479-5418; Julien, Godet/0000-0002-8470-0092; ruff, marc/0000-0001-5451-6377; schultz, patrick/0000-0002-7310-6186; Lesbats, Paul/0000-0002-4623-0675	CNRS; INSERM; SIDACTION [AO2011-2013]; French National Agency for Research against AIDS (ANRS); SPINE 2 European Project (FP6) [QLG2-CT-2002-00988, 031220]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; European Strategy Forum on Research Infrastructure (ESFRI); ANRS; ANR [AO2012-2016]; Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale (FRM)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); SIDACTION; French National Agency for Research against AIDS (ANRS)(ANRSFrench National Research Agency (ANR)); SPINE 2 European Project (FP6); French Infrastructure for Integrated Structural Biology (FRISBI); European Strategy Forum on Research Infrastructure (ESFRI); ANRS(ANRSFrench National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by grants from the CNRS, the INSERM, SIDACTION, the French National Agency for Research against AIDS (ANRS), the SPINE 2 European Project (FP6 Contract No QLG2-CT-2002-00988 and 031220), the French Infrastructure for Integrated Structural Biology (FRISBI, ANR-10-INSB-05-01) and Instruct, part of the European Strategy Forum on Research Infrastructure (ESFRI) supported by national members subscription. B. M. was supported by a doctoral fellowship from ANRS. N.L. was supported by a postdoctoral fellowship from ANRS. K. P. A. was supported by a postdoctoral fellowship from SIDACTION. V. P. was supported by ANR "RETROCONTROL" grant AO2012-2016 and SIDACTION AO2011-2013. P. S. acknowledges support from the Association pour la Recherche sur le Cancer (ARC) and the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbottah E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-48; Ao ZJ, 2012, J BIOL CHEM, V287, P10544, DOI 10.1074/jbc.M111.317057; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ariumi Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-47; Azoulay J, 2003, J MOL BIOL, V326, P691, DOI 10.1016/S0022-2836(02)01430-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballandras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023032; Boese A, 2009, J GEN VIROL, V90, P2503, DOI 10.1099/vir.0.013656-0; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briones MS, 2010, J VIROL, V84, P5181, DOI 10.1128/JVI.02382-09; Bukrinsky M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-49; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; Clamme JP, 2003, BIOPHYS J, V84, P1960, DOI 10.1016/S0006-3495(03)75004-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desfarges S, 2009, YEAST, V26, P39, DOI 10.1002/yea.1651; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Egele C, 2007, BIOCHEMISTRY-US, V46, P14650, DOI 10.1021/bi7012239; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes MX, 2002, NUCLEIC ACIDS RES, V30, P1782, DOI 10.1093/nar/30.8.1782; Fitzkee NC, 2010, J BIOL CHEM, V285, P18072, DOI 10.1074/jbc.M110.113407; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jayappa Kallesh Danappa, 2012, Int J Biochem Mol Biol, V3, P70; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kessl JJ, 2011, NUCL ACIDS RES; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Lesbats P, 2008, NUCLEIC ACIDS RES, V36, P7043, DOI 10.1093/nar/gkn796; Lesbats P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001280; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Maroun M, 2006, J BIOL CHEM, V281, P22736, DOI 10.1074/jbc.M604849200; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Mouscadet JF, 2010, DRUG RESIST UPDATE, V13, P139, DOI 10.1016/j.drup.2010.05.001; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Rain JC, 2009, METHODS, V47, P291, DOI 10.1016/j.ymeth.2009.02.002; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sorin M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-56; Sorin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000463; Suhre K, 2006, ACTA CRYSTALLOGR D, V62, P1098, DOI 10.1107/S090744490602244X; Tama F, 2004, J MOL BIOL, V337, P985, DOI 10.1016/j.jmb.2004.01.048; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Yanes O, 2006, J PROTEOME RES, V5, P2711, DOI 10.1021/pr060202f; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yung E, 2004, J VIROL, V78, P2222, DOI 10.1128/JVI.78.5.2222-2231.2004; Yung E, 2001, NAT MED, V7, P920, DOI 10.1038/90959; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	74	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60734	10.1371/journal.pone.0060734	http://dx.doi.org/10.1371/journal.pone.0060734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593299	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200018
J	Mukherjee, M; Sardar, PS; Ghorai, SK; Samanta, SK; Roy, AS; Dasgupta, S; Ghosh, S				Mukherjee, Manini; Sardar, Pinki Saha; Ghorai, Shyamal Kr; Samanta, Swarna Kamal; Roy, Atanu Singha; Dasgupta, Swagata; Ghosh, Sanjib			A Comparative Study of Interaction of Tetracycline with Several Proteins Using Time Resolved Anisotropy, Phosphorescence, Docking and FRET	PLOS ONE			English	Article							DETECTED MAGNETIC-RESONANCE; SINGLE-TRYPTOPHAN MUTANTS; COLI ALKALINE-PHOSPHATASE; PHASE-SENSITIVE DETECTION; PROTON-TRANSFER PROBE; BACTERIOPHAGE-T4 LYSOZYME; ESCHERICHIA-COLI; ENERGY-TRANSFER; SERUM ALBUMINS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE	A comparative study of the interaction of an antibiotic Tetracycline hydrochloride (TC) with two albumins, Human serum albumin (HSA) and Bovine serum albumin (BSA) along with Escherichia Coli Alkaline Phosphatase (AP) has been presented exploiting the enhanced emission and anisotropy of the bound drug. The association constant at 298 K is found to be two orders of magnitude lower in BSA/HSA compared to that in AP with number of binding site being one in each case. Fluorescence resonance energy transfer (FRET) and molecular docking studies have been employed for the systems containing HSA and BSA to find out the particular tryptophan (Trp) residue and the other residues in the proteins involved in the binding process. Rotational correlation time (theta(c)) of the bound TC obtained from time resolved anisotropy of TC in all the protein-TC complexes has been compared to understand the binding mechanism. Low temperature (77 K) phosphorescence (LTP) spectra of Trp residues in the free proteins (HSA/BSA) and in the complexes of HSA/BSA have been used to specify the role of Trp residues in FRET and in the binding process. The results have been compared with those obtained for the complex of AP with TC. The photophysical behaviour (viz., emission maximum, quantum yield, lifetime and theta(c)) of TC in various protic and aprotic polar solvents has been determined to address the nature of the microenvironment of TC in the protein-drug complexes.	[Mukherjee, Manini; Sardar, Pinki Saha; Ghorai, Shyamal Kr; Samanta, Swarna Kamal; Ghosh, Sanjib] Presidency Univ, Dept Chem, Kolkata, India; [Roy, Atanu Singha; Dasgupta, Swagata] Indian Inst Technol, Dept Chem, Kharagpur 721302, W Bengal, India	Presidency University, Kolkata; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Ghosh, S (corresponding author), Presidency Univ, Dept Chem, Kolkata, India.	sanjibg@cal2.vsnl.net.in		Dasgupta, Swagata/0000-0003-2074-1247	DST [SR/S1/PC-57/2008]; CSIR, Government of India [21(0871)/11/EMR-II]; CSIR [08/155(0038)/2009-EMR-I, 08/155(0039)/2009-EMR-I]	DST(Department of Science & Technology (India)); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	S.G. gratefully acknowledges DST (SR/S1/PC-57/2008) and CSIR, Government of India (21(0871)/11/EMR-II) for financially supporting this work. M.M. and P.S.S. thank DST for SRF and RA fellowship respectively (number SR/S1/PC-57/2008). S.K.G. and S.K.S. acknowledge CSIR for SRF fellowship (number 08/155(0038)/2009-EMR-I) and (number 08/155(0039)/2009-EMR-I) respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT A, 1953, NATURE, V172, P201, DOI 10.1038/172201a0; ALBERT A, 1956, NATURE, V177, P433, DOI 10.1038/177433a0; Anand U, 2011, J PHYS CHEM B, V115, P6312, DOI 10.1021/jp2008978; [Anonymous], 2003, FELIX 32 OP MAN VERS; BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bodis E, 2004, BIOPHYS J, V87, P1146, DOI [10.1529/biophysj.104.041855, 10.1592/biophysj.104.041855]; BOSRON WF, 1977, BIOCHEMISTRY-US, V16, P610, DOI 10.1021/bi00623a009; Broos J, 2000, BIOCHEMISTRY-US, V39, P10877, DOI 10.1021/bi000803z; Brown JR, 1977, ALBUMIN STRUCTURE FU, P27; Callis PR, 2004, J PHYS CHEM B, V108, P4248, DOI 10.1021/jp0310551; Callis PR, 2003, CHEM PHYS LETT, V369, P409, DOI 10.1016/S0009-2614(02)02046-8; Chi ZX, 2011, BIOMACROMOLECULES, V12, P203, DOI 10.1021/bm1011568; CIONI P, 1992, EUR J BIOCHEM, V209, P759, DOI 10.1111/j.1432-1033.1992.tb17345.x; CIONI P, 1993, BIOPHYS CHEM, V46, P47, DOI 10.1016/0301-4622(93)87006-I; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; D'Auria S, 2008, J PROTEOME RES, V7, P1151, DOI 10.1021/pr700755z; D'Auria S, 2007, J PROTEOME RES, V6, P1306, DOI 10.1021/pr060650n; D'Auria S, 2009, J PHYS CHEM B, V113, P13171, DOI 10.1021/jp9043286; DAVIS JM, 1984, BIOCHEMISTRY-US, V23, P6249, DOI 10.1021/bi00320a055; DeLano WL, 2004, PYMOL MOL GRAPHICS S; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Eftink M. R., 1992, ADV BIOPHYS CHEM, V2, P81; EFTINK MR, 1993, BIOCHEMISTRY-US, V32, P9189, DOI 10.1021/bi00086a026; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Ghosh R, 2012, J PHYS CHEM B, V116, P12489, DOI 10.1021/jp307526f; GHOSH S, 1988, BIOCHEMISTRY-US, V27, P7816, DOI 10.1021/bi00420a034; Ghosh S, 2003, J PHYS CHEM B, V107, P11520, DOI 10.1021/jp030522b; GHOSH S, 1988, J CHEM PHYS, V88, P2769, DOI 10.1063/1.454008; Ghosh S, 2001, BIOCHEMISTRY-US, V40, P15024, DOI 10.1021/bi011509p; Golub L M, 1992, Curr Opin Dent, V2, P80; Hahn DK, 1997, J PHYS CHEM A, V101, P2686, DOI 10.1021/jp963146m; Han LY, 2006, J CHEM INF MODEL, V46, P445, DOI 10.1021/ci0502146; HARRIS DL, 1990, BIOCHEMISTRY-US, V29, P5276, DOI 10.1021/bi00474a009; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HERSHBERGER MV, 1980, BIOCHEMISTRY-US, V19, P2204, DOI 10.1021/bi00551a032; HOUGH E, 1989, NATURE, V338, P357, DOI 10.1038/338357a0; Hubbard SJ, 1993, NACCESS COMPUTER PRO; KAMLET MJ, 1983, J ORG CHEM, V48, P2877, DOI 10.1021/jo00165a018; Kerwin BA, 2008, PHOTOCHEM PHOTOBIOL, V84, P1172, DOI 10.1111/j.1751-1097.2008.00307.x; Kurz LC, 2005, BIOCHEMISTRY-US, V44, P1394, DOI 10.1021/bi048323l; LAKOWICZ JR, 1982, PHOTOCHEM PHOTOBIOL, V36, P125, DOI 10.1111/j.1751-1097.1982.tb04353.x; LAKOWICZ JR, 1982, BIOPHYS CHEM, V15, P353, DOI 10.1016/0301-4622(82)80018-5; LAKOWICZ JR, 1981, J BIOL CHEM, V256, P6348; Lakowicz JR, 2006, PRINCIPLES FLUORESCE; Liu TQ, 2005, J AM CHEM SOC, V127, P4104, DOI 10.1021/ja043154d; Liu Y, 1998, J DENT RES, V77, P251; LOEWENTHAL R, 1991, BIOCHEMISTRY-US, V30, P6775, DOI 10.1021/bi00241a021; Maity SS, 2008, CHEM PHYS, V354, P162, DOI 10.1016/j.chemphys.2008.10.020; MAO SY, 1987, BIOCHEMISTRY-US, V26, P3576, DOI 10.1021/bi00386a049; MARTIN RB, 1985, MET IONS BIOL SYST, V19, P19; Moriyama Y, 1996, J PROTEIN CHEM, V15, P265, DOI 10.1007/BF01887115; Mukherjee M, 2012, J PHOTOCH PHOTOBIO B, V115, P93, DOI 10.1016/j.jphotobiol.2012.07.002; Ozarowski A, 1999, BIOCHEMISTRY-US, V38, P6715, DOI 10.1021/bi990242f; Purkey ItM, 1970, BIOCHEMISTRY-US, V9, P3569; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Roy A, 2012, BIOCHIMIE IN PRESS; Roy D, 2012, J LUMIN, V132, P1364, DOI 10.1016/j.jlumin.2011.12.063; ROYER CA, 1990, BIOPHYS J, V58, P363, DOI 10.1016/S0006-3495(90)82383-3; Sardar PS, 2008, J PHYS CHEM B, V112, P3451, DOI 10.1021/jp074598+; Sardar PS, 2006, J PHYS CHEM B, V110, P21349, DOI 10.1021/jp064832g; Shapira L, 1996, INFECT IMMUN, V64, P825, DOI 10.1128/IAI.64.3.825-828.1996; STRAMBINI GB, 1989, BIOCHEMISTRY-US, V28, P160, DOI 10.1021/bi00427a023; STRAMBINI GB, 1991, EUR J BIOCHEM, V195, P645, DOI 10.1111/j.1432-1033.1991.tb15749.x; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; VOLBEDA A, 1991, EMBO J, V10, P1607, DOI 10.1002/j.1460-2075.1991.tb07683.x; Willets KA, 2004, J PHYS CHEM B, V108, P10465, DOI 10.1021/jp049684d; ZANG LH, 1989, BIOCHEMISTRY-US, V28, P2245, DOI 10.1021/bi00431a041	70	26	26	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60940	10.1371/journal.pone.0060940	http://dx.doi.org/10.1371/journal.pone.0060940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593355	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200030
J	Occella, C; Bleidl, D; Nozza, P; Mascelli, S; Raso, A; Gimelli, G; Gimelli, S; Tassano, E				Occella, Corrado; Bleidl, Dario; Nozza, Paolo; Mascelli, Samantha; Raso, Alessandro; Gimelli, Giorgio; Gimelli, Stefania; Tassano, Elisa			Identification of an Interstitial 18p11.32-p11.31 Duplication Including the EMILIN2 Gene in a Family with Porokeratosis of Mibelli	PLOS ONE			English	Article							DISSEMINATED SUPERFICIAL POROKERATOSIS; ACTINIC POROKERATOSIS; LOCUS; KERATINOCYTES; APOPTOSIS; PSORIASIS; 18P11.3; PCR	Porokeratosis is a rare disease of epidermal keratinization characterized by the histopathological feature of the cornoid lamella, a column of tightly fitted parakeratocytic cells, whose etiology is still unclear. Porokeratosis of Mibelli is a subtype of porokeratosis presenting a single plaque or a small number of plaques of variable size located unilaterally on limbs. It frequently appears in childhood and occurs with a higher incidence in males. Cytogenetic analyses were performed in all members of the family on lesioned and uninvolved skin. An array-CGH analysis was also performed utilizing the Human Genome CGH Microarray Kit G3 400 with 5.3 KB overall median probe spacing. Gene expression was performed on skin fibroblasts. In this study, we describe a Caucasian healthy 4-year-old child and his father showing features of porokeratosis of Mibelli. Array-CGH analysis revealed an interstitial 429.5 Kb duplication of chromosome 18p11.32-p11.3 containing four genes, namely: SMCHD1, EMILIN2, LPIN2, and MYOM1 both in patient and his father. EMILIN2 resulted overexpressed on skin fibroblasts. Also other members of this family, without evident signs of porokeratosis, carried the same duplication. Among these genes, we focused our attention on elastin microfibril interfacer 2 (EMILIN2) gene. Apoptosis plays a fundamental role in maintaining epidermal homeostasis, balancing keratinocytes proliferation, and forming the stratum corneum. EMILIN2 is known to trigger the apoptosis of different cell lines negatively affecting cell survival. It is expressed in the skin. We could speculate that the duplication and overexpression of EMILIN2 cause an abnormal apoptosis of epidermal keratinocytes and alter the process of keratinization, even if other epigenetic and genetic factors could also be involved. Our results could contribute to a better understanding of the pathogenesis of porokeratosis of Mibelli.	[Occella, Corrado; Bleidl, Dario] Ist Giannina Gaslini, Unita Operat Dermatol, I-16148 Genoa, Italy; [Nozza, Paolo] Ist Giannina Gaslini, Unita Operat Anat Patol, I-16148 Genoa, Italy; [Mascelli, Samantha; Raso, Alessandro] Ist Giannina Gaslini, Unita Operat Neurochirurg, I-16148 Genoa, Italy; [Gimelli, Giorgio; Tassano, Elisa] Ist Giannina Gaslini, Lab Citogenet, Unita Operat Semplice, I-16148 Genoa, Italy; [Gimelli, Stefania] Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Geneva	Tassano, E (corresponding author), Ist Giannina Gaslini, Lab Citogenet, Unita Operat Semplice, I-16148 Genoa, Italy.	eli.tassano@gmail.com	Nozza, Paolo/AAC-5901-2022; Tassano, Elisa/AAB-1108-2020	Tassano, Elisa/0000-0003-2037-0554; Nozza, Paolo/0000-0002-7595-1420				ANDERSON DE, 1969, ARCH DERMATOL, V99, P408, DOI 10.1001/archderm.99.4.408; Andrews GC, 1937, ARCH DERMATOL SYPH, V36, P1111; Arranz-Salas I, 2003, J CUTAN PATHOL, V30, P455, DOI 10.1034/j.1600-0560.2003.00097.x; Asumalahti K, 2003, J INVEST DERMATOL, V121, P735, DOI 10.1046/j.1523-1747.2003.12483.x; Braghetta P, 2004, MATRIX BIOL, V22, P549, DOI 10.1016/j.matbio.2003.10.005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao HM, 2012, CLIN EXP DERMATOL, V37, P672, DOI 10.1111/j.1365-2230.2012.04380.x; CHERNOSKY ME, 1986, ARCH DERMATOL, V122, P869, DOI 10.1001/archderm.122.8.869; GUSS SB, 1971, ARCH DERMATOL, V104, P366, DOI 10.1001/archderm.104.4.366; Hivnor C, 2004, J CUTAN PATHOL, V31, P657, DOI 10.1111/j.0303-6987.2004.00247.x; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; JURECKA W, 1991, J AM ACAD DERMATOL, V24, P96, DOI 10.1016/0190-9622(91)70019-X; Kothny-Wilkes G, 1998, J BIOL CHEM, V273, P29247, DOI 10.1074/jbc.273.44.29247; Milanetto M, 2008, DEV DYNAM, V237, P222, DOI 10.1002/dvdy.21402; Mongiat M, 2007, MOL CELL BIOL, V27, P7176, DOI 10.1128/MCB.00696-07; Palleschi GM, 2008, J CUTAN PATHOL, V35, P253, DOI 10.1111/j.1600-0560.2007.00787.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raso A, 2011, J CLIN LAB ANAL, V25, P389, DOI 10.1002/jcla.20489; SEHGAL VN, 1967, DERMATOLOGICA, V134, P219, DOI 10.1159/000254297; Sertznig P, 2012, J EUR ACAD DERMATOL, V26, P404, DOI 10.1111/j.1468-3083.2011.04275.x; Shen CS, 2002, BRIT J DERMATOL, V147, P498, DOI 10.1046/j.1365-2133.2002.04853.x; Wei S, 2010, CLIN EXP DERMATOL, V35, P664, DOI 10.1111/j.1365-2230.2010.03844.x; Wei SC, 2004, J INVEST DERMATOL, V123, P872, DOI 10.1111/j.0022-202X.2004.23455.x; Zhang SQ, 2012, NAT GENET, V44, P1156, DOI 10.1038/ng.2409; Zhang ZH, 2008, J CUTAN PATHOL, V35, P1058, DOI 10.1111/j.1600-0560.2008.01026.x; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	26	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e61311	10.1371/journal.pone.0061311	http://dx.doi.org/10.1371/journal.pone.0061311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593459	gold, Green Published, Green Submitted			2022-12-27	WOS:000317382000047
J	Davila, ML; Kloss, CC; Gunset, G; Sadelain, M				Davila, Marco L.; Kloss, Christopher C.; Gunset, Gertrude; Sadelain, Michel			CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							CHIMERIC ANTIGEN RECEPTOR; BONE-MARROW; IN-VIVO; ADOPTIVE TRANSFER; EXPRESSION; LYMPHOMA; LINEAGE; CHEMOTHERAPY; LYMPHOCYTES; PERSISTENCE	Although many adults with B cell acute lymphoblastic leukemia (B-ALL) are induced into remission, most will relapse, underscoring the dire need for novel therapies for this disease. We developed murine CD19-specific chimeric antigen receptors (CARs) and an immunocompetent mouse model of B-ALL that recapitulates the disease at genetic, cellular, and pathologic levels. Mouse T cells transduced with an all-murine CD3 zeta/CD28-based CAR that is equivalent to the one being used in our clinical trials, eradicate B-ALL in mice and mediate long-term B cell aplasias. In this model, we find that increasing conditioning chemotherapy increases tumor eradication, B cell aplasia, and CAR-modified T cell persistence. Quantification of recipient B lineage cells allowed us to estimate an in vivo effector to endogenous target ratio for B cell aplasia maintenance. In mice exhibiting a dramatic B cell reduction we identified a small population of progenitor B cells in the bone marrow that may serve as a reservoir for long-term CAR-modified T cell stimulation. Lastly, we determine that infusion of CD8+ CAR-modified T cells alone is sufficient to maintain long-term B cell eradication. The mouse model we report here should prove valuable for investigating CAR-based and other therapies for adult B-ALL.	[Davila, Marco L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; [Davila, Marco L.; Kloss, Christopher C.; Gunset, Gertrude; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA; [Kloss, Christopher C.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Biochem Cell & Mol Biol Program, New York, NY 10021 USA; [Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA.	m-sadelain@ski.mskcc.org	Davila, Marco/P-7912-2014	Davila, Marco/0000-0002-6270-3065	National Institutes of Health [K08 CA148821]; ASH-AMFDP; NATIONAL CANCER INSTITUTE [P30CA076292, K08CA148821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASH-AMFDP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, K08 CA148821 and ASH-AMFDP awards (both to MLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Cheadle EJ, 2009, J IMMUNOTHER; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Corcoran LM, 1999, J IMMUNOL METHODS, V228, P131, DOI 10.1016/S0022-1759(99)00094-0; Davila ML, 2012, ONCOIMMUNOLOGY, V1, P1577, DOI 10.4161/onci.22524; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Gokbuget N, 2012, BLOOD, V120, P2032, DOI 10.1182/blood-2011-12-399287; Gong Michael C., 1999, Neoplasia (New York), V1, P123, DOI 10.1038/sj.neo.7900018; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; James SE, 2009, BLOOD, V114, P5454, DOI 10.1182/blood-2009-08-232967; Jensen MC, 2010, BIOL BLOOD MARROW TR, V16, P1245, DOI 10.1016/j.bbmt.2010.03.014; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kochenderfer JN, 2010, BLOOD, V116, P3875, DOI 10.1182/blood-2010-01-265041; Kochenderfer JN, 2011, BLOOD; Lee James, 2009, V506, P83, DOI 10.1007/978-1-59745-409-4_7; Lee JC, 2011, CANCER RES, V71, P2871, DOI 10.1158/0008-5472.CAN-10-0552; Li N, 2011, BLOOD, V118, P5965, DOI 10.1182/blood-2011-07-367011; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Moeller M, 2005, BLOOD, V106, P2995, DOI 10.1182/blood-2004-12-4906; OPSTELTEN D, 1983, J IMMUNOL, V131, P2635; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Passweg JR, 1998, BONE MARROW TRANSPL, V21, P153, DOI 10.1038/sj.bmt.1701064; Pegram HJ, 2012, BLOOD, V119, P4133, DOI 10.1182/blood-2011-12-400044; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Porter DL, 1999, ANNU REV MED, V50, P369; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Wang YH, 2002, BLOOD, V99, P2459, DOI 10.1182/blood.V99.7.2459; Zheng ZL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-29	39	114	144	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61338	10.1371/journal.pone.0061338	http://dx.doi.org/10.1371/journal.pone.0061338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585892	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600106
J	Giacco, D; Matanov, A; Priebe, S				Giacco, Domenico; Matanov, Aleksandra; Priebe, Stefan			Symptoms and Subjective Quality of Life in Post-Traumatic Stress Disorder: A Longitudinal Study	PLOS ONE			English	Article							MENTAL-DISORDERS; WAR; PTSD; ADOLESCENTS; PREVALENCE; PREDICTORS; STRATEGIES; BEHAVIOR; THERAPY; VICTIMS	Background: Evidence suggests that post-traumatic stress disorder (PTSD) is associated with substantially reduced subjective quality of life (SQOL). This study aimed to explore whether and how changes in the levels of PTSD symptom clusters of intrusion, avoidance and hyperarousal are associated with changes in SQOL. Methods: Two samples with PTSD following the war in former Yugoslavia were studied, i.e. a representative sample of 530 people in five Balkan countries and a non-representative sample of 215 refugees in three Western European countries. They were assessed on average eight years after the war and re-interviewed one year later. PTSD symptoms were assessed on the Impact of Event Scale - Revised and SQOL on the Manchester Short Assessment of Quality of Life. Linear regression and a two-wave cross lagged panel analysis were used to explore the association between PTSD symptom clusters and SQOL. Results: The findings in the two samples were consistent. Symptom reduction over time was associated with improved SQOL. In multivariable analyses adjusted for the influence of all three clusters, gender and time since war exposure, only changes in hyperarousal symptoms were significantly associated with changes in SQOL. The two-wave cross-lagged panel analysis suggested that the link between hyperarousal symptoms and SQOL is bidirectional. Conclusions: Low SQOL of patients with war-related PTSD is particularly associated with hyperarousal symptoms. The findings suggest a bidirectional influence: a reduction in hyperarousal symptoms may result in improved SQOL, and improvements in SQOL may lead to reduced hyperarousal symptoms.	[Giacco, Domenico; Matanov, Aleksandra; Priebe, Stefan] Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England; [Giacco, Domenico] Univ Naples SUN, Dept Psychiat, Naples, Italy	University of London; Queen Mary University London; Universita della Campania Vanvitelli	Giacco, D (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England.	d.giacco@qmul.ac.uk		Priebe, Stefan/0000-0001-9864-3394; Giacco, Domenico/0000-0001-7809-8800	European Commission [INCO-CT-2004-509175]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the grant INCO-CT-2004-509175 from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in the publication are those of the authors and not necessarily those of the European Commission.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews B, 2003, J TRAUMA STRESS, V16, P421, DOI 10.1023/A:1024478305142; [Anonymous], 2011, STAT STAT SOFTW REL; Belleville G, 2009, J NERV MENT DIS, V197, P126, DOI 10.1097/NMD.0b013e3181961d8e; Bogic M, 2012, BRIT J PSYCHIAT, V200, P216, DOI 10.1192/bjp.bp.110.084764; Bouman Yvonne H A, 2008, Crim Behav Ment Health, V18, P279, DOI 10.1002/cbm.703; Calohan J, 2010, J TRAUMA STRESS, V23, P645, DOI 10.1002/jts.20570; d'Ardenne P, 2005, J NERV MENT DIS, V193, P62, DOI 10.1097/01.nmd.0000149221.09294.92; Delsing MJMH, 2005, EUR J PSYCHOL ASSESS, V21, P226, DOI 10.1027/1015-5759.21.4.226; Doctor JN, 2011, PSYCHIAT SERV, V62, P272, DOI 10.1176/ps.62.3.pss6203_0272; Ehlers A, 2010, CLIN PSYCHOL REV, V30, P269, DOI 10.1016/j.cpr.2009.12.001; Ehring T, 2011, PSYCHIAT RES, V185, P161, DOI 10.1016/j.psychres.2009.10.018; Hawkins EJ, 2012, DRUG ALCOHOL DEPEN, V124, P154, DOI 10.1016/j.drugalcdep.2012.01.003; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Johansen VA, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-26; Kyutoku Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031014; Lehman AF, 1996, SOC PSYCH PSYCH EPID, V31, P78, DOI 10.1007/BF00801903; Little R.J.A., 2002, STAT ANAL MISSING DA; Loncar M, 2006, CROAT MED J, V47, P67; McTeague LM, 2012, DEPRESS ANXIETY, V29, P264, DOI 10.1002/da.21891; Meyer EC, 2012, PSYCHOL SERV, V9, P1, DOI 10.1037/a0026414; Morina N, 2008, INT J SOC PSYCHIATR, V54, P425, DOI 10.1177/0020764008090505; Mufti Khalid A, 2007, Int Psychiatry, V4, P7; Norrholm SD, 2010, NEUROPSYCH DIS TREAT, V6, P517, DOI 10.2147/NDT.S10951; Pence BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036304; Perkonigg A, 2005, AM J PSYCHIAT, V162, P1320, DOI 10.1176/appi.ajp.162.7.1320; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Priebe S, PSYCHOL MED IN PRESS; Priebe S, 2004, PSYCHIAT TODAY, V36, P101; Priebe S., 2008, CLIN HDB SCHIZOPHREN, P581; Priebe S, 2011, SCHIZOPHR RES, V133, P17, DOI 10.1016/j.schres.2011.09.021; Priebe S, 2010, PSYCHIAT SERV, V61, P598, DOI 10.1176/ps.2010.61.6.598; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; Robertson M, 2004, INT J GROUP PSYCHOTH, V54, P145, DOI 10.1521/ijgp.54.2.145.40384; Sabes-Figuera R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029603; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Schnurr PP, 2011, PSYCHIAT RES, V185, P161; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith LE, 2008, AM J MENT RETARD, V113, P387, DOI 10.1352/2008.113:387-402; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Taylor S, 2003, J CONSULT CLIN PSYCH, V71, P330, DOI 10.1037/0022-006X.71.2.330; US Food and Drug Administration, 2009, PATIENT REPORTED OUT; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; World Medical Association, 2004, ETH PRINC MED RES IN	45	32	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60991	10.1371/journal.pone.0060991	http://dx.doi.org/10.1371/journal.pone.0060991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JB	23585868	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600075
J	He, F; Ma, J				He, Feng; Ma, Jun			A Spatial Point Pattern Analysis in Drosophila Blastoderm Embryos Evaluating the Potential Inheritance of Transcriptional States	PLOS ONE			English	Article							GENE-EXPRESSION; POSITIONAL INFORMATION; MORPHOGEN GRADIENT; STOCHASTIC PATTERNS; AMACRINE CELLS; NOISE; ACTIVATION; MECHANISMS; PRECISION; MELANOGASTER	The Drosophila blastoderm embryo undergoes rapid cycles of nuclear division. This poses a challenge to genes that need to reliably sense the concentrations of morphogen molecules to form desired expression patterns. Here we investigate whether the transcriptional state of hunchback (hb), a target gene directly activated by the morphogenetic protein Bicoid (Bcd), exhibits properties indicative of inheritance between mitotic cycles. To achieve this, we build a dataset of hb transcriptional states at the resolution of individual nuclei in embryos at early cycle 14. We perform a spatial point pattern (SPP) analysis to evaluate the spatial relationships among the nuclei that have distinct numbers of hb gene copies undergoing active transcription in snapshots of embryos. Our statistical tests and simulation studies reveal properties of dispersed clustering for nuclei with both or neither copies of hb undergoing active transcription. Modeling of nuclear lineages from cycle 11 to cycle 14 suggests that these two types of nuclei can achieve spatial clustering when, and only when, the transcriptional states are allowed to propagate between mitotic cycles. Our results are consistent with the possibility where the positional information encoded by the Bcd morphogen gradient may not need to be decoded de novo at all mitotic cycles in the Drosophila blastoderm embryo.	[He, Feng; Ma, Jun] Cincinnati Childrens Res Fdn, Div Biomed Informat, Cincinnati, OH USA; [Ma, Jun] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Ma, J (corresponding author), Cincinnati Childrens Res Fdn, Div Biomed Informat, Cincinnati, OH USA.	jun.ma@cchmc.org	He, Feng/L-8343-2016; Ma, Jun/GLT-4809-2022	He, Feng/0000-0001-7114-8078; Ma, Jun/0000-0002-1609-3294	American Heart Association [10POST4170015]; National Institutes of Health [1R01GM101373]; National Science Foundation [IOS-0843424]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101373] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a fellowship award from American Heart Association (10POST4170015) to FH and by grants from National Institutes of Health (1R01GM101373) and National Science Foundation (IOS-0843424) to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Bell ML, 2007, J COMP NEUROL, V502, P75, DOI 10.1002/cne.21298; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Blankenship JT, 2001, DEVELOPMENT, V128, P5129; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Bothma JP, 2011, CURR BIOL, V21, P1571, DOI 10.1016/j.cub.2011.08.019; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; Chubb JR, 2010, CURR OPIN GENET DEV, V20, P478, DOI 10.1016/j.gde.2010.06.009; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; de Krom M, 2002, MOL CELL, V9, P1319, DOI 10.1016/S1097-2765(02)00558-0; de Lachapelle AM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.7; DIGGLE PJ, 1986, J NEUROSCI METH, V18, P115, DOI 10.1016/0165-0270(86)90115-9; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Eglen SJ, 2003, J COMP NEUROL, V466, P343, DOI 10.1002/cne.10891; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; He F, 2012, BIOINFORMATICS, V28, P970, DOI 10.1093/bioinformatics/bts068; He F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019122; He F, 2010, BIOPHYS J, V99, P697, DOI 10.1016/j.bpj.2010.04.073; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Le HD, 2004, CHROMOSOMA, V112, P269, DOI 10.1007/s00412-003-0272-2; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Li H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002122; Liu J, 2013, PLOS ONE IN PRESS; Luengo Hendriks CL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r123; Ma J, 2011, PROTEIN CELL, V2, P879, DOI 10.1007/s13238-011-1101-7; Ma XG, 1996, DEVELOPMENT, V122, P1195; McHale P, 2011, DEV BIOL, V360, P230, DOI 10.1016/j.ydbio.2011.08.016; Miles CM, 2011, EVOLUTION, V65, P33, DOI 10.1111/j.1558-5646.2010.01088.x; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; Raven MA, 2005, VISUAL NEUROSCI, V22, P461, DOI 10.1017/S0952523805224070; Razin SV, 2011, NUCLEIC ACIDS RES, V39, P9085, DOI 10.1093/nar/gkr683; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Stavreva DA, 2012, BBA-GENE REGUL MECH, V1819, P657, DOI 10.1016/j.bbagrm.2012.03.004; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Tkacik G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002774; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Tostevin F, 2007, PLOS COMPUT BIOL, V3, P763, DOI 10.1371/journal.pcbi.0030078; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; White MA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.48; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang L, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.45; Zobeck KL, 2010, MOL CELL, V40, P965, DOI 10.1016/j.molcel.2010.11.022	56	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60876	10.1371/journal.pone.0060876	http://dx.doi.org/10.1371/journal.pone.0060876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593336	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600065
J	Li, W; Chen, F; Zhang, F; Ding, WH; Ye, QS; Shi, JJ; Fu, BP				Li, Wen; Chen, Fei; Zhang, Feng; Ding, Wanghui; Ye, Qingsong; Shi, Jiejun; Fu, Baiping			Volumetric Measurement of Root Resorption following Molar Mini-Screw Implant Intrusion Using Cone Beam Computed Tomography	PLOS ONE			English	Article							SKELETAL ANCHORAGE SYSTEM; ORTHODONTIC TREATMENT; APPLIANCE; TEETH	Objective: Molar intrusion by mini-screw implantation can cause different degrees of root resorption. However, most methods (2-D and 3-D) used for evaluating root resorption have focused on the root length without considering 3-D resorption. The purpose of this study was to volumetrically evaluate root resorption using cone beam computed tomography(CBCT) after mini-screw implant intrusion. Materials and Methods: 1. The volumes of 32 teeth were measured using CBCT and laser scanning to verify the accuracy of CBCT. 2. Twelve overerupted molars from adult patients were investigated in this study. After mini-screw implants were inserted into the buccal and palatal alveolar bones, 150 g of force was applied to the mini-screw implants on each side to intrude the molars. CBCT images of all patients were taken immediately prior to intrusion and after intrusion. The volumes of the roots were calculated using the Mimics software program. The differences between the pre-intrusion and post-intrusion root volumes were statistically evaluated with a paired-samples t-test. In addition, the losses of the roots were statistically compared with each other using one-way analysis of variance at the P<0.05 level. Results: No statistically significant volume differences were observed between the physical (laser scanning) and CBCT measurements (P>0.05). The overerupted molars were significantly intruded (P<0.05), and the average intrusion was 3.30+/-1.60 mm. The differences between the pre-intrusion and post-intrusion root volumes were statistically significant for all of the roots investigated (P<0.05). The roots were sorted by volume loss in descending order as follows: mesiobuccal, palatal, and distobuccal. Statistical significance was achieved among the three roots. The average total resorption for each tooth was 58.39+/-1.54 mm(3). Conclusion: Volume measurement using CBCT was able to effectively evaluate root resorption caused by mini-screw intrusion. The highest volume loss was observed in the mesiobuccal root among the three roots of the investigated first molar teeth.	[Li, Wen; Chen, Fei; Zhang, Feng; Ding, Wanghui; Shi, Jiejun; Fu, Baiping] Zhejiang Univ, Sch Stomatol, Dept Orthodont, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ye, Qingsong] James Cook Univ, Sch Med & Dent, Dept Orthodont, Townsville, Qld 4811, Australia	Zhejiang University; James Cook University	Shi, JJ (corresponding author), Zhejiang Univ, Sch Stomatol, Dept Orthodont, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	sjiejun2004@yahoo.com.cn	Ye, Adam/AAR-9145-2020	Ye, Adam/0000-0002-2868-9247				Abuabara A, 2007, MED ORAL PATOL ORAL, V12, P610; ANDREASE.GF, 1970, ANGLE ORTHOD, V40, P151; Artun J, 2005, ANGLE ORTHOD, V75, P919; Baysal A, 2012, ANGLE ORTHOD, V82, P488, DOI 10.2319/060411-367.1; Bernardes RA, 2012, DENT TRAUMATOL, V28, P268, DOI 10.1111/j.1600-9657.2011.01113.x; Carrillo R, 2007, AM J ORTHOD DENTOFAC, V132, P647, DOI 10.1016/j.ajodo.2006.08.017; Cousley RRJ, 2010, J ORTHOD, V37, P202, DOI 10.1179/14653121043101; Daimaruya T, 2001, ANGLE ORTHOD, V71, P60; DELLINGE.EL, 1967, AMER J ORTHODONTICS, V53, P325, DOI 10.1016/0002-9416(67)90100-5; Han GL, 2005, ANGLE ORTHOD, V75, P912; Heravi F, 2011, AM J ORTHOD DENTOFAC, V139, pS170, DOI 10.1016/j.ajodo.2009.06.032; Jiang RP, 2010, EUR J ORTHODONT, V32, P693, DOI 10.1093/ejo/cjp165; Jung MH, 2011, AM J ORTHOD DENTOFAC, V139, pS154, DOI 10.1016/j.ajodo.2009.06.031; KALRA V, 1989, AM J ORTHOD DENTOFAC, V95, P467, DOI 10.1016/0889-5406(89)90410-1; Kato S, 2006, CLIN IMPLANT DENT R, V8, P100, DOI 10.1111/j.1708-8208.2006.00005.x; Kato S, 2010, CLIN IMPLANT DENT R, V12, P48, DOI 10.1111/j.1708-8208.2008.00129.x; Leite V, 2012, ANGLE ORTHOD, V82, P1078, DOI 10.2319/080911-501.1; MELSEN B, 2005, SEMIN ORTHOD, V11, P24; Ng J, 2006, AM J ORTHOD DENTOFAC, V130, P709, DOI 10.1016/j.ajodo.2005.05.049; Ohmae M, 2001, AM J ORTHOD DENTOFAC, V119, P489, DOI 10.1067/mod.2001.114300; Paik Cheol-Ho, 2003, J Clin Orthod, V37, P423; Park YC, 2003, AM J ORTHOD DENTOFAC, V123, P690, DOI 10.1016/S0889-5406(03)00047-7; Sameshima GT, 2001, ANGLE ORTHOD, V71, P185; Sohn DS, 2008, IMPLANT DENT, V17, P32, DOI 10.1097/ID.0b013e318166da1d; Umemori M, 1999, AM J ORTHOD DENTOFAC, V115, P166, DOI 10.1016/S0889-5406(99)70345-8; van Steenbergen E, 2005, ANGLE ORTHOD, V75, P723; Yao CCJ, 2005, ANGLE ORTHOD, V75, P754; Zhen XH, 2012, J KUMMING MED U, V8, P50	28	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60962	10.1371/journal.pone.0060962	http://dx.doi.org/10.1371/journal.pone.0060962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585866	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000317909600073
J	Mendoza-Olazaran, S; Morfin-Otero, R; Rodriguez-Noriega, E; Llaca-Diaz, J; Flores-Trevino, S; Gonzalez-Gonzalez, GM; Villarreal-Trevino, L; Garza-Gonzalez, E				Mendoza-Olazaran, Soraya; Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo; Llaca-Diaz, Jorge; Flores-Trevino, Samantha; Ma Gonzalez-Gonzalez, Gloria; Villarreal-Trevino, Licet; Garza-Gonzalez, Elvira			Microbiological and Molecular Characterization of Staphylococcus hominis Isolates from Blood	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; BIOFILM FORMATION; AUREUS; RESISTANCE; STRAINS; SCCMEC; IDENTIFICATION; HAEMOLYTICUS; BRAZIL	Background: Among Coagulase-Negative Staphylococci (CoNS), Staphylococcus hominis represents the third most common organism recoverable from the blood of immunocompromised patients. The aim of this study was to characterize biofilm formation, antibiotic resistance, define the SCCmec (Staphylococcal Chromosomal Cassette mec) type, and genetic relatedness of clinical S. hominis isolates. Methodology: S. hominis blood isolates (n = 21) were screened for biofilm formation using crystal violet staining. Methicillin resistance was evaluated using the cefoxitin disk test and the mecA gene was detected by PCR. Antibiotic resistance was determined by the broth microdilution method. Genetic relatedness was determined by pulsed-field gel electrophoresis (PFGE) and SCCmec typed by multiplex PCR using two different methodologies described for Staphylococcus aureus. Results: Of the S. hominis isolates screened, 47.6% (10/21) were categorized as strong biofilm producers and 23.8% (5/21) as weak producers. Furthermore, 81% (17/21) of the isolates were methicillin resistant and mecA gene carriers. Resistance to ampicillin, erythromycin, and trimethoprim was observed in >70% of isolates screened. Each isolate showed a different PFGE macrorestriction pattern with similarity ranging between 0-95%. Among mecA-positive isolates, 14 (82%) harbored a non-typeable SCCmec type: eight isolates were not positive for any ccr complex; four contained the mec complex A ccrAB1 and ccrC, one isolate contained mec complex A, ccrAB4 and ccrC, and one isolate contained the mec complex A, ccrAB1, ccrAB4, and ccrC. Two isolates harbored the association: mec complex A and ccrAB1. Only one strain was typeable as SCCmec III. Conclusions: The S. hominis isolates analyzed were variable biofilm producers had a high prevalence of methicillin resistance and resistance to other antibiotics, and high genetic diversity. The results of this study strongly suggested that S. hominis isolates harbor new SCCmec structural elements and might be reservoirs of ccrC1 in addition to ccrAB1 and mec complex A.	[Mendoza-Olazaran, Soraya; Flores-Trevino, Samantha; Ma Gonzalez-Gonzalez, Gloria] Univ Autonoma Nuevo Leon, Fac Med, Dept Microbiol, Monterrey, Nuevo Leon, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo] Univ Guadalajara, Hosp Civil Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo] Univ Guadalajara, Inst Patol Infecciosa & Expt, Ctr Univ Ciencias Salud, Guadalajara 44430, Jalisco, Mexico; [Llaca-Diaz, Jorge; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Dept Patol Clin, Monterrey, Nuevo Leon, Mexico; [Villarreal-Trevino, Licet] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Dept Microbiol & Inmunol, Monterrey, Nuevo Leon, Mexico; [Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; Universidad de Guadalajara; Universidad de Guadalajara; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Dept Patol Clin, Monterrey, Nuevo Leon, Mexico.	elvira_garza_gzz@yahoo.com	Flores-Treviño, Samantha M/E-8601-2019; Morfín-Otero, Rayo/AAR-8027-2021; Flores-Treviño, Samantha/AAB-4537-2020	Flores-Treviño, Samantha M/0000-0003-1259-7425; Morfín-Otero, Rayo/0000-0001-9576-1950; Flores-Treviño, Samantha/0000-0003-1259-7425; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Villarreal, Licet/0000-0002-4721-6162; Mendoza-Olazaran, Soraya/0000-0001-5649-4810; Llaca Diaz, Jorge Martin/0000-0001-6875-2530				Bouchami O, 2011, FOLIA MICROBIOL, V56, P122, DOI 10.1007/s12223-011-0017-1; Bouchami O, 2011, EUR J CLIN MICROBIOL; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Chaves F, 2005, J CLIN MICROBIOL, V43, P4877, DOI 10.1128/JCM.43.9.4877-4879.2005; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; CLSI, 2012, M100S22 CLSI; Cunha BA, 2007, HEART LUNG, V36, P380, DOI 10.1016/j.hrtlng.2006.11.002; d'Azevedo PA, 2008, J MED MICROBIOL, V57, P256, DOI 10.1099/jmm.0.47345-0; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361; Garza-Gonzalez E, 2011, SCAND J INFECT DIS, V43, P930, DOI 10.3109/00365548.2011.598873; Garza-Gonzalez E, 2010, J MED MICROBIOL, V59, P323, DOI 10.1099/jmm.0.015800-0; de Allori MCG, 2006, BIOL PHARM BULL, V29, P1592, DOI 10.1248/bpb.29.1592; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; Hanssen AM, 2004, ANTIMICROB AGENTS CH, V48, P285, DOI 10.1128/AAC.48.1.285-296.2004; Hanssen AM, 2007, ANTIMICROB AGENTS CH, V51, P1671, DOI 10.1128/AAC.00978-06; Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Ibrahem S, 2009, J CLIN MICROBIOL, V47, P32, DOI 10.1128/JCM.01085-08; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Klingenberg C, 2005, PEDIATR INFECT DIS J, V24, P817, DOI 10.1097/01.inf.0000176735.20008.cd; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Machado ABP, 2007, J MED MICROBIOL, V56, P1328, DOI 10.1099/jmm.0.47294-0; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; Soderquist B, 2009, CLIN MICROBIOL INFEC, V15, P1176, DOI 10.1111/j.1469-0691.2009.02771.x; Sunbul M, 2006, PACE, V29, P543, DOI 10.1111/j.1540-8159.2006.00391.x; Urushibara N, 2011, MICROB DRUG RESIST, V17, P291, DOI 10.1089/mdr.2010.0144; Palazzo ICV, 2008, J ANTIMICROB CHEMOTH, V62, P1222, DOI 10.1093/jac/dkn375; Wohoush A, 2011, CLIN MICROBIOL INFEC, V17, P569, DOI 10.1111/j.1469-0691.2010.03372.x; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zong ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020191; Zong ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014016	34	26	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61161	10.1371/journal.pone.0061161	http://dx.doi.org/10.1371/journal.pone.0061161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585877	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000317909600088
J	Mohan, M; Kaushal, D; Aye, PP; Alvarez, X; Veazey, RS; Lackner, AA				Mohan, Mahesh; Kaushal, Deepak; Aye, Pyone P.; Alvarez, Xavier; Veazey, Ronald S.; Lackner, Andrew A.			Focused Examination of the Intestinal Epithelium Reveals Transcriptional Signatures Consistent with Disturbances in Enterocyte Maturation and Differentiation during the Course of SIV Infection	PLOS ONE			English	Article							T-CELL DEPLETION; GENE-EXPRESSION; CROHNS-DISEASE; ENTEROPATHY; PROLIFERATION; LYMPHOCYTES; REPRESSION; PROTEINS; ADHESION; TISSUES	The Gastrointestinal (GI) tract plays a pivotal role in AIDS pathogenesis as it is the primary site for viral transmission, replication and CD4(+) T cell destruction. Accordingly, GI disease (enteropathy) has become a well-known complication and a driver of AIDS progression. To better understand the molecular mechanisms underlying GI disease we analyzed global gene expression profiles sequentially in the intestinal epithelium of the same animals before SIV infection and at 21 and 90 days post infection (DPI). More importantly we obtained sequential excisional intestinal biopsies and examined distinct mucosal components (epithelium. intraepithelial lymphocytes, lamina propria lymphocytes, fibrovascular stroma) separately. Here we report data pertaining to the epithelium. Overall genes associated with epithelial cell renewal/proliferation/differentiation, permeability and adhesion were significantly down regulated (< 1.5-7 fold) at 21 and 90DPI. Genes regulating focal adhesions (n = 6), gap junctions (n = 3), ErbB (n = 3) and Wnt signaling (n = 4) were markedly down at 21DPI and the number of genes in each of these groups that were down regulated doubled between 21 and 90DPI. Notable genes included FAK, ITGA6, PDGF, TGF beta 3, Ezrin, FZD6, WNT10A, and TCF7L2. In addition, at 90DPI genes regulating ECM-receptor interactions (laminins and ITGB1), epithelial cell gene expression (PDX1, KLF6), polarity/tight junction formation (PARD3B&6B) and histone demethylase (JMJD3) were also down regulated. In contrast, expression of NOTCH3, notch target genes (HES4, HES7) and EZH2 (histone methyltransferase) were significantly increased at 90DPI. The altered expression of genes linked to Wnt signaling together with decreased expression of PDX1, PARD3B, PARD6B and SDK1 suggests marked perturbations in intestinal epithelial function and homeostasis leading to breakdown of the mucosal barrier. More importantly, the divergent expression patterns of EZH2 and JMJD3 suggests that an epigenetic mechanism involving histone modifications may contribute to the massive decrease in gene expression at 90DPI leading to defects in enterocyte maturation and differentiation.	[Mohan, Mahesh; Aye, Pyone P.; Alvarez, Xavier; Veazey, Ronald S.; Lackner, Andrew A.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA USA	Tulane University; Tulane University	Lackner, AA (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA.	alackner@tulane.edu			National Institutes of Health [DK083929, DK50550, OD011104, RR00164, RR16930]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR016930, P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083929, R01DK050550] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health grants: DK083929, DK50550, OD011104 (formerly RR00164), and RR16930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Batman PA, 2007, AIDS, V21, P433, DOI 10.1097/QAD.0b013e3280142ee8; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buchert M, 2009, GASTROENTEROLOGY, V137, P156, DOI 10.1053/j.gastro.2009.03.037; Casaletto JB, 2011, P NATL ACAD SCI USA, V108, P11924, DOI 10.1073/pnas.1103418108; Cello JP, 2009, GASTROENTEROLOGY, V136, P1952, DOI 10.1053/j.gastro.2008.12.073; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Chen C, 2009, AM J PHYSIOL-GASTR L, V297, pG1126, DOI 10.1152/ajpgi.90586.2008; Dahan S, 2011, GASTROENTEROLOGY, V140, P550, DOI 10.1053/j.gastro.2010.10.057; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Feasey NA, 2011, ALIMENT PHARM THER, V34, P587, DOI 10.1111/j.1365-2036.2011.04781.x; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gersemann M, 2008, WORLD J GASTROENTERO, V14, P5499, DOI 10.3748/wjg.14.5499; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaufman L, 2010, J BIOL CHEM, V285, P25677, DOI 10.1074/jbc.M110.133959; Kewenig S, 1999, GASTROENTEROLOGY, V116, P1115, DOI 10.1016/S0016-5085(99)70014-4; Ko TC, 2002, WORLD J SURG, V26, P812, DOI 10.1007/s00268-002-4057-1; LACKNER AA, 1994, AM J PATHOL, V145, P428; Lackner AA, 2009, GASTROENTEROLOGY, V136, P1966, DOI 10.1053/j.gastro.2008.12.071; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mohan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034561; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Owen KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023123; Pan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030247; Pedre X, 2011, J NEUROSCI, V31, P3435, DOI 10.1523/JNEUROSCI.4507-10.2011; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Richmond CA, 2010, PROG MOL BIOL TRANSL, V96, P207, DOI 10.1016/S1877-1173(10)96009-2; Schumann M, 2012, GUT, V61, P220, DOI 10.1136/gutjnl-2011-300123; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smit-McBride Z, 1998, J VIROL, V72, P6646, DOI 10.1128/JVI.72.8.6646-6656.1998; Smith GW, 2007, J ANIM SCI, V85, pE20, DOI 10.2527/jas.2006-479; Solanas G, 2011, EXP CELL RES, V317, P2695, DOI 10.1016/j.yexcr.2011.07.019; Spenle C, 2012, PATHOL BIOL, V60, P41, DOI 10.1016/j.patbio.2011.10.005; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Stelzer G, 2008, GENECARDS ONE STOP S; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tsang DPF, 2011, J GASTROEN HEPATOL, V26, P19, DOI 10.1111/j.1440-1746.2010.06447.x; Untergasser G, 2008, INT J CANCER, V122, P1539, DOI 10.1002/ijc.23255; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Ye DZ, 2009, GASTROENTEROLOGY, V137, P2052, DOI 10.1053/j.gastro.2009.08.059	52	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60122	10.1371/journal.pone.0060122	http://dx.doi.org/10.1371/journal.pone.0060122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593167	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600013
J	Nylund, GM; Enge, S; Pavia, H				Nylund, Goran M.; Enge, Swantje; Pavia, Henrik			Costs and Benefits of Chemical Defence in the Red Alga Bonnemaisonia hamifera	PLOS ONE			English	Article							FITNESS COSTS; MARINE ALGA; INDUCED RESPONSES; TRADE-OFFS; RESISTANCE; BACTERIA; COLONIZATION; INHIBITION; COMMUNITY; BROMINE	A number of studies have shown that the production of chemical defences is costly in terrestrial vascular plants. However, these studies do not necessarily reflect the costs of defence production in macroalgae, due to structural and functional differences between vascular plants and macroalgae. Using a specific culturing technique, we experimentally manipulated the defence production in the red alga Bonnemaisonia hamifera to examine if the defence is costly in terms of growth. Furthermore, we tested if the defence provides fitness benefits by reducing harmful bacterial colonisation of the alga. Costly defences should provide benefits to the producer in order to be maintained in natural populations, but such benefits through protection against harmful bacterial colonisation have rarely been documented in macroalgae. We found that algae with experimentally impaired defence production, but with an externally controlled epibacterial load, grew significantly better than algae with normal defence production. We also found that undefended algae exposed to a natural epibacterial load experienced a substantial reduction in growth and a 6-fold increase in cell bleaching, compared to controls. Thus, this study provides experimental evidence that chemical defence production in macroalgae is costly, but that the cost is outweighed by fitness benefits provided through protection against harmful bacterial colonisation.	[Nylund, Goran M.; Enge, Swantje; Pavia, Henrik] Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden	University of Gothenburg	Nylund, GM (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden.	goran.nylund@bioenv.gu.se	Pavia, Henrik/G-2764-2013	Enge, Swantje/0000-0003-4292-0051	Swedish Research Council FORMAS; Swedish Research Council VR; Swedish Research Council [621-2007-5779, 621-2011-5630]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council VR(Swedish Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a Linnaeus-grant from the Swedish Research Councils FORMAS and VR. Support was also provided by the Swedish Research Council through contract nos. 621-2007-5779 and 621-2011-5630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2012, ANAL CHIM ACTA, V737, P37, DOI 10.1016/j.aca.2012.05.047; ANTONOVICS J, 1994, P ROY SOC B-BIOL SCI, V257, P105, DOI 10.1098/rspb.1994.0101; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; BREEMAN AM, 1988, HELGOLANDER MEERESUN, V42, P535, DOI 10.1007/BF02365625; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; BUTLER A, 1993, CHEM REV, V93, P1937, DOI 10.1021/cr00021a014; Campbell AH, 2011, GLOBAL CHANGE BIOL, V17, P2958, DOI 10.1111/j.1365-2486.2011.02456.x; Case RJ, 2011, ENVIRON MICROBIOL, V13, P529, DOI 10.1111/j.1462-2920.2010.02356.x; Cipollini D, 2003, BASIC APPL ECOL, V4, P79, DOI 10.1078/1439-1791-00134; Cole KM., 1990, BIOL RED ALGAE; Dworjanyn SA, 2006, OIKOS, V113, P13; Dworjanyn SA, 1999, MAR BIOL, V133, P727, DOI 10.1007/s002270050514; Enge S, 2012, ECOLOGY, V93, P2736, DOI 10.1890/12-0143.1; FRIES L, 1966, PHYSIOL PLANTARUM, V19, P800, DOI 10.1111/j.1399-3054.1966.tb07066.x; FRIES L, 1963, PHYSIOL PLANTARUM, V16, P695, DOI 10.1111/j.1399-3054.1963.tb08347.x; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Heidel AJ, 2004, GENETICS, V168, P2197, DOI 10.1534/genetics.104.032193; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Johansson G, 1998, HYDROBIOLOGIA, V385, P121, DOI 10.1023/A:1003405826222; Karlsson J, 2007, OVERVAKNING VEGETATI, P28; Kladi Maria, 2004, Phytochemistry Reviews, V3, P337, DOI 10.1007/s11101-004-4155-9; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; Meusnier I, 2001, MOL ECOL, V10, P931, DOI 10.1046/j.1365-294X.2001.01245.x; Muller DG, 2008, CAH BIOL MAR, V49, P59; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Nylund GM, 2005, MAR ECOL PROG SER, V302, P27, DOI 10.3354/meps302027; Nylund GM, 2010, FEMS MICROBIOL ECOL, V71, P84, DOI 10.1111/j.1574-6941.2009.00791.x; Paul NA, 2006, MAR ECOL PROG SER, V306, P87, DOI 10.3354/meps306087; Pavia H, 1999, J ECOL, V87, P761, DOI 10.1046/j.1365-2745.1999.00397.x; Pavia H, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P210; Persson F, 2011, BIOFOULING, V27, P579, DOI 10.1080/08927014.2011.589001; Purrington CB, 2000, CURR OPIN PLANT BIOL, V3, P305, DOI 10.1016/S1369-5266(00)00085-6; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Rao D, 2006, APPL ENVIRON MICROB, V72, P5547, DOI 10.1128/AEM.00449-06; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Simms E. L., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P392; SIMMS EL, 1987, AM NAT, V130, P570, DOI 10.1086/284731; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Svensson JR, 2012, J ECOL IN PRESS; THEILER R, 1978, SCIENCE, V202, P1094, DOI 10.1126/science.202.4372.1094; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Walters D, 2007, PHYSIOL MOL PLANT P, V71, P3, DOI 10.1016/j.pmpp.2007.09.008; Weinberger F, 1997, J APPL PHYCOL, V9, P277, DOI 10.1023/A:1007990712925; WOLK CP, 1968, PLANTA, V78, P371, DOI 10.1007/BF00387095; Wright JT, 2004, ECOLOGY, V85, P2946, DOI 10.1890/03-4041; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101	52	22	22	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61291	10.1371/journal.pone.0061291	http://dx.doi.org/10.1371/journal.pone.0061291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585886	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600099
J	Zheng, DS; Yang, GW; Li, XY; Wang, ZC; Liu, F; He, L				Zheng, Desheng; Yang, Guowu; Li, Xiaoyu; Wang, Zhicai; Liu, Feng; He, Lei			An Efficient Algorithm for Computing Attractors of Synchronous And Asynchronous Boolean Networks	PLOS ONE			English	Article							REGULATORY NETWORKS; SCALAR EQUATIONS; MODEL; TIME	Biological networks, such as genetic regulatory networks, often contain positive and negative feedback loops that settle down to dynamically stable patterns. Identifying these patterns, the so-called attractors, can provide important insights for biologists to understand the molecular mechanisms underlying many coordinated cellular processes such as cellular division, differentiation, and homeostasis. Both synchronous and asynchronous Boolean networks have been used to simulate genetic regulatory networks and identify their attractors. The common methods of computing attractors are that start with a randomly selected initial state and finish with exhaustive search of the state space of a network. However, the time complexity of these methods grows exponentially with respect to the number and length of attractors. Here, we build two algorithms to achieve the computation of attractors in synchronous and asynchronous Boolean networks. For the synchronous scenario, combing with iterative methods and reduced order binary decision diagrams (ROBDD), we propose an improved algorithm to compute attractors. For another algorithm, the attractors of synchronous Boolean networks are utilized in asynchronous Boolean translation functions to derive attractors of asynchronous scenario. The proposed algorithms are implemented in a procedure called geneFAtt. Compared to existing tools such as genYsis, geneFAtt is significantly 3.25-116x faster in computing attractors for empirical experimental systems.	[Zheng, Desheng; Yang, Guowu; Li, Xiaoyu; Wang, Zhicai] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China; [Zheng, Desheng; Li, Xiaoyu; He, Lei] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Liu, Feng] David Geffen Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA	University of Electronic Science & Technology of China; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zheng, DS (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China.	desheng619@gmail.com; guowu@uestc.edu.cn			National Natural Science Foundation of China under Grant [60973016]; 973 Foundation [2010CB328004]	National Natural Science Foundation of China under Grant; 973 Foundation(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China under Grant (No. 60973016) and 973 Foundation (No. 2010CB328004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, HOME UNIVERSE SEARCH; Ay F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007992; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Dubrova E, 2005, IEEE IC CAD, P479, DOI 10.1109/ICCAD.2005.1560115; Farrow C, 2004, IEEE T NEURAL NETWOR, V15, P348, DOI 10.1109/TNN.2004.824262; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Glass L, 1985, BOOLEAN CONTINUOUS M; Harvey I, 1997, FROM ANIM ANIMAT, P67; Heidel J, 2003, INT J BIFURCAT CHAOS, V13, P535, DOI 10.1142/S0218127403006765; Hirose O, 2008, BIOINFORMATICS, V24, P932, DOI 10.1093/bioinformatics/btm639; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lind-Nielsen J, 2000, BDD PACKAGE BUDDY V; Luis M, 2006, THEORETICAL BIOL MED, V3; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Naldi A, 2007, LECT NOTES COMPUT SC, V4695, P233; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Remy E, 2006, LECT NOTES COMPUT SC, V4230, P56; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Vea Devloo, 2003, B MATH BIOL, P1025; Zhao QC, 2005, IEEE T NEURAL NETWOR, V16, P1715, DOI 10.1109/TNN.2005.857944	23	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60593	10.1371/journal.pone.0060593	http://dx.doi.org/10.1371/journal.pone.0060593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585840	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600028
J	Al-Chaqmaqchi, H; Sadeghi, B; Abedi-Valugerdi, M; Al-Hashmi, S; Fares, M; Kuiper, R; Lundahl, J; Hassan, M; Moshfegh, A				Al-Chaqmaqchi, Heevy; Sadeghi, Behnam; Abedi-Valugerdi, Manuchehr; Al-Hashmi, Sulaiman; Fares, Mona; Kuiper, Raoul; Lundahl, Joachim; Hassan, Moustapha; Moshfegh, Ali			The Role of Programmed Cell Death Ligand-1 (PD-L1/CD274) in the Development of Graft versus Host Disease	PLOS ONE			English	Article							HISTOCOMPATIBILITY ANTIGEN BARRIERS; BONE-MARROW-TRANSPLANTATION; PERIPHERAL TOLERANCE; PD-1 PATHWAY; T-CELLS; EXPRESSION; ACTIVATION; MUSCLE; IMMUNOBIOLOGY; AUTOIMMUNITY	Programmed cell death ligand-1 (PD-L1/CD274) is an immunomodulatory molecule involved in cancer and complications of bone marrow transplantation, such as graft rejection and graft-versus-host disease. The present study was designed to assess the dynamic expression of this molecule after hematopoietic stem cell transplantation in relation to acute graft-versus- host disease. Female BALB/c mice were conditioned with busulfan and cyclophosphamide and transplanted with either syngeneic or allogeneic (male C57BL/6 mice) bone marrow and splenic cells. The expression of PD-L1 was evaluated at different time points employing qPCR, western blot and immunohistochemistry. Allogeneic- but not syngeneic-transplanted animals exhibited a marked up-regulation of PD-L1 expression in the muscle and kidney, but not the liver, at days 5 and 7 post transplantation. In mice transplanted with allogeneic bone marrow cells, the enhanced expression of PD-L1 was associated with high serum levels of IFN gamma and TNF alpha at corresponding intervals. Our findings demonstrate that PD-L1 is differently induced and expressed after allogeneic transplantation than it is after syngeneic transplantation, and that it is in favor of target rather than non-target organs at the early stages of acute graft-versus-host disease. This is the first study to correlate the dynamics of PD-L1 at the gene-, protein-and activity levels with the early development of acute graft-versus-host disease. Our results suggest that the higher expression of PD-L1 in the muscle and kidney (non-target tissues) plays a protective role in skeletal muscle during acute graft-versus-host disease.	[Al-Chaqmaqchi, Heevy; Sadeghi, Behnam; Abedi-Valugerdi, Manuchehr; Al-Hashmi, Sulaiman; Fares, Mona; Hassan, Moustapha] Karolinska Inst, Dept Lab Med, Div Clin Res Ctr, Stockholm, Sweden; [Kuiper, Raoul] Karolinska Inst, Dept Lab Med, Unite Morphol Phenotype Anal, Stockholm, Sweden; [Kuiper, Raoul] Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Lundahl, Joachim] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden; [Hassan, Moustapha] Karolinska Univ Hosp Huddinge, Clin Res Ctr, ECM, KFC,Novum, Stockholm, Sweden; [Moshfegh, Ali] Karolinska Univ Hosp, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden; [Moshfegh, Ali] Karolinska Inst, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Hassan, M (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Res Ctr, Stockholm, Sweden.	moustapha.hassan@ki.se	Sadeghi, Behnam/AAH-1221-2019; Hassan, Moustapha/H-9260-2015	Sadeghi, Behnam/0000-0002-8721-0400; Hassan, Moustapha/0000-0003-1927-5859; Kuiper, Raoul/0000-0001-5645-2389; Abedi-Valugerdi, Manuchehr/0000-0002-4122-2879	Swedish Cancer Foundation (CF); Swedish Childhood Cancer Society (BCF)	Swedish Cancer Foundation (CF); Swedish Childhood Cancer Society (BCF)	The authors would like to acknowledge grants obtained from The Swedish Cancer Foundation (CF) and the Swedish Childhood Cancer Society (BCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Asakura S, 2010, J CLIN INVEST, V120, P2370, DOI 10.1172/JCI39165; Bensinger W I, 2001, Rev Clin Exp Hematol, V5, P67, DOI 10.1046/j.1468-0734.2001.00033.x; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Dong HD, 2006, CELL MOL IMMUNOL, V3, P179; Ellison CA, 1998, J IMMUNOL, V161, P631; Eyrich M, 2005, BIOL BLOOD MARROW TR, V11, P371, DOI 10.1016/j.bbmt.2005.02.002; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Ferrara JLM, 1998, TRANSFUS MED REV, V12, P1, DOI 10.1016/S0887-7963(98)80085-0; Fife BT, 2011, ANN NY ACAD SCI, V1217, P45, DOI 10.1111/j.1749-6632.2010.05919.x; Flies DB, 2007, J IMMUNOTHER, V30, P251, DOI 10.1097/CJI.0b013e31802e085a; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Grabie N, 2007, CIRCULATION, V116, P2062, DOI 10.1161/CIRCULATIONAHA.107.709360; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hofmeyer KA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/451694; IMAMURA M, 1994, BONE MARROW TRANSPL, V13, P745; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; KRENGER W, 1995, J IMMUNOL, V155, P585; Lu Y, 2001, BLOOD, V97, P1123, DOI 10.1182/blood.V97.4.1123; Mielcarek M, 2003, BLOOD, V102, P756, DOI 10.1182/blood-2002-08-2628; Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9; Reddy P, 2003, HEMATOL ONCOL, V21, P149, DOI 10.1002/hon.716; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; Sadeghi B, 2008, BONE MARROW TRANSPL, V42, P807, DOI 10.1038/bmt.2008.261; Sadeghi B, 2012, BONE MARROW TRANSPLA; Sadeghi B, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/142943; Schilbach K, 2007, TRANSPLANTATION, V84, P214, DOI 10.1097/01.tp.0000268074.77929.54; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Stevens AM, 2003, RHEUMATOLOGY, V42, P34, DOI 10.1093/rheumatology/keg025; Tanaka K, 2007, J IMMUNOL, V179, P5204, DOI 10.4049/jimmunol.179.8.5204; Vibhakar R, 1997, EXP CELL RES, V232, P25, DOI 10.1006/excr.1997.3493; Wiendl H, 2005, CURR OPIN RHEUMATOL, V17, P714, DOI 10.1097/01.bor.0000184164.69181.ca; Wiendl H, 2005, TRENDS IMMUNOL, V26, P373, DOI 10.1016/j.it.2005.05.003; Wiendl H, 2003, FASEB J, V17, P1892, DOI 10.1096/fj.03-0039fje; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402; Zeiser R, 2004, ANN HEMATOL, V83, P551, DOI 10.1007/s00277-004-0890-7	39	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60367	10.1371/journal.pone.0060367	http://dx.doi.org/10.1371/journal.pone.0060367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593203	Green Submitted, Green Published, gold			2022-12-27	WOS:000319108100034
J	Zhang, SY; Lu, ZM; Luo, XN; Chen, LS; Ge, PJ; Song, XH; Chen, SH; Wu, YL				Zhang, Si-Yi; Lu, Zhong-Ming; Luo, Xiao-Ning; Chen, Liang-Si; Ge, Ping-Jiang; Song, Xin-Han; Chen, Shao-hua; Wu, Yi-Long			Retrospective Analysis of Prognostic Factors in 205 Patients with Laryngeal Squamous Cell Carcinoma Who Underwent Surgical Treatment	PLOS ONE			English	Article							CANCER; SURVIVAL; ALCOHOL; TOBACCO; HYPOPHARYNGEAL; POPULATION; METASTASES; EUROPE; RISK	Objectives: To investigate the most important factors affecting the prognosis of the patients with squamous cell carcinoma (SCC) of the larynx. Methods: Based on the clinical and follow-up data, 205 patients with SCC of the larynx receiving total laryngectomy, partial laryngectomy, or CO2 laser surgery in GuangDong General Hospital were retrospectively analyzed. A survival analysis was performed by the Kaplan-Meier method and a multivariable analysis of prognostic factors was carried out using the Cox proportional hazard model. Results: Subtypes of carcinoma included 69.8% glottic and 30.2% supraglottic. Most patients were in N0 stage (77.6%), and 22.4% patients were in N1 similar to N3 stage. Over half of the patients were in T1 similar to T2 stage (55.1%), 20.0% in T3, and 24.9% in T4. Mean follow-up duration was 49.2 months. The survival rates 1, 2, and 3 years after the surgery were 99.0%, 91.7%, and 81.5%, respectively. The survival rate for those patients with clinical stage IV was significantly lower than for those with clinical stage I and II (p<0.001 and p = 0.013, respectively). The disease-free progression rates 1, 2, and 3 years after the surgery were 83.9%, 74.6%, and 71.2%, respectively. Futhermore, those patients with a Charlson score of 1 to 2 and >= 3 had higher risk of mortality than those with a Charlson score of 0 (hazard ratios of 1.8 and 2.41 p = 0.042 and p = 0.008). Multivariable analysis revealed that clinical stage, surgical margin, and comorbidity were significantly associated with both mortality and disease-free progression. Conclusion: The surgical resection margin, clinical stage, and comorbidity were independent factors affecting the laryngeal cancer prognosis. The survival rates were lower for patients with advanced laryngeal cancer, positive surgical margins, or severe comorbidity, suggesting the importance of early diagnosis, early treatment, negative surgical margins, and conditions of comorbidity.	[Zhang, Si-Yi; Lu, Zhong-Ming; Luo, Xiao-Ning; Chen, Liang-Si; Ge, Ping-Jiang; Song, Xin-Han; Chen, Shao-hua] Guangdong Gen Hosp, Dept Otorhinolaryngol, Guangzhou, Guangdong, Peoples R China; [Zhang, Si-Yi; Lu, Zhong-Ming; Luo, Xiao-Ning; Chen, Liang-Si; Ge, Ping-Jiang; Song, Xin-Han; Chen, Shao-hua; Wu, Yi-Long] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Zhang, Si-Yi; Lu, Zhong-Ming] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Wu, Yi-Long] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Chen, SH (corresponding author), Guangdong Gen Hosp, Dept Otorhinolaryngol, Guangzhou, Guangdong, Peoples R China.	feiyq1122@163.com; syylwu@live.cn	Wu, Yi-Long/AAB-9137-2022; Wu, Yi-Long/AAW-9832-2020; Wu, Yi-Long/C-3396-2008; Wu, Yi-Long/GRJ-9238-2022; Lu, Zhongming/AAJ-1275-2020	Wu, Yi-Long/0000-0002-3611-0258; Wu, Yi-Long/0000-0002-3611-0258; 				Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bianchini C, 2008, EUR ARCH OTO-RHINO-L, V265, P1089, DOI 10.1007/s00405-008-0589-9; Boyle P, 2008, WORLD CANC REPORT 20; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Du Qiang, 2006, Zhonghua Zhongliu Zazhi, V28, P211; Gonzalez-Marquez R, 2012, HEAD NECK-J SCI SPEC, V34, P1023, DOI 10.1002/hed.21866; Gourin CG, 2009, LARYNGOSCOPE, V119, P1312, DOI 10.1002/lary.20477; Hashibe M, 2007, AM J EPIDEMIOL, V165, P814, DOI 10.1093/aje/kwk066; Hoffman HT, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236095.97947.26; Jose J, 2003, HEAD NECK-J SCI SPEC, V25, P451, DOI 10.1002/hed.10214; La Vecchia C, 2008, EUR J CANCER PREV, V17, P116, DOI 10.1097/CEJ.0b013e3282b6fd40; Lin HW, 2008, LARYNGOSCOPE, V118, P1003, DOI 10.1097/MLG.0b013e3181671b3d; Liu Tian-Run, 2009, Ai Zheng, V28, P297; Lohynska R, 2005, NEOPLASMA, V52, P483; LU ST, 2004, J MODERN ONCOLOGY, V12, P158; Lubin JH, 2010, AM J EPIDEMIOL, V171, P1250, DOI 10.1093/aje/kwq088; Markou K, 2011, HIPPOKRATIA, V15, P75; Pantel M, 2012, HNO, V60, P32, DOI 10.1007/s00106-011-2423-8; Papadas TA, 2010, EUR ARCH OTO-RHINO-L, V267, P1095, DOI 10.1007/s00405-009-1156-8; Ramroth H, 2008, EUR ARCH OTO-RHINO-L, V265, P1367, DOI 10.1007/s00405-008-0651-7; Ramroth H, 2011, ORAL ONCOL, V47, P1154, DOI 10.1016/j.oraloncology.2011.08.003; Reid BC, 2002, ORAL ONCOL, V38, P187, DOI 10.1016/S1368-8375(01)00044-6; Sapkota A, 2007, INT J CANCER, V121, P1793, DOI 10.1002/ijc.22832; Shangina O, 2006, AM J EPIDEMIOL, V164, P367, DOI 10.1093/aje/kwj208; Spector JG, 2006, LARYNGOSCOPE, V116, P106, DOI 10.1097/01.mlg.0000184767.62682.3d; WITTEKIND C, 2002, TNM CLASSIFICATION M; Yi Haijin, 2008, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V22, P529; Yilmaz T, 2005, J LARYNGOL OTOL, V119, P784; Zhao HY, 2008, J CANCER RES CLIN, V134, P1051, DOI 10.1007/s00432-008-0391-5	29	45	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60157	10.1371/journal.pone.0060157	http://dx.doi.org/10.1371/journal.pone.0060157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593169	Green Submitted, Green Published, gold			2022-12-27	WOS:000319108100018
J	Zhang, YB; Liu, TK; Jiang, J; Shi, J; Liu, Y; Li, S; Gui, JF				Zhang, Yi-Bing; Liu, Ting-Kai; Jiang, Jun; Shi, Jun; Liu, Ying; Li, Shun; Gui, Jian-Fang			Identification of a Novel Gig2 Gene Family Specific to Non-Amniote Vertebrates	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; GENOME DUPLICATION; ATLANTIC SALMON; CELL-LINE; FISH; EVOLUTION; RESPONSES; POLY(ADP-RIBOSE); DOMAINS; ORIGIN	Gig2 (grass carp reovirus (GCRV)-induced gene 2) is first identified as a novel fish interferon (IFN)-stimulated gene (ISG). Overexpression of a zebrafish Gig2 gene can protect cultured fish cells from virus infection. In the present study, we identify a novel gene family that is comprised of genes homologous to the previously characterized Gig2. EST/GSS search and in silico cloning identify 190 Gig2 homologous genes in 51 vertebrate species ranged from lampreys to amphibians. Further large-scale search of vertebrate and invertebrate genome databases indicate that Gig2 gene family is specific to non-amniotes including lampreys, sharks/rays, ray-finned fishes and amphibians. Phylogenetic analysis and synteny analysis reveal lineage-specific expansion of Gig2 gene family and also provide valuable evidence for the fish-specific genome duplication (FSGD) hypothesis. Although Gig2 family proteins exhibit no significant sequence similarity to any known proteins, a typical Gig2 protein appears to consist of two conserved parts: an N-terminus that bears very low homology to the catalytic domains of poly(ADP-ribose) polymerases (PARPs), and a novel C-terminal domain that is unique to this gene family. Expression profiling of zebrafish Gig2 family genes shows that some duplicate pairs have diverged in function via acquisition of novel spatial and/or temporal expression under stresses. The specificity of this gene family to non-amniotes might contribute to a large extent to distinct physiology in non-amniote vertebrates.	[Zhang, Yi-Bing; Liu, Ting-Kai; Jiang, Jun; Shi, Jun; Liu, Ying; Li, Shun; Gui, Jian-Fang] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhang, YB (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	ybzhang@ihb.ac.cn; jfgui@ihb.ac.cn	Liu, Ting-Kai/B-1880-2013; Liu, Ying/A-7127-2019	Liu, Ting-Kai/0000-0003-2708-0779; Liu, Ying/0000-0002-6419-1980	973 National Basic Research Program of China [2010CB126303]; National Natural Science Foundation of China [31272690, 31172435]	973 National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from 973 National Basic Research Program of China (2010CB126303), and National Natural Science Foundation of China (31272690, 31172435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Baum A, 2010, AMINO ACIDS, V38, P1283, DOI 10.1007/s00726-009-0374-0; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Huang HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009144; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Jensen R.A., 2001, GENOME BIOL, V2, P1002, DOI DOI 10.3201/eid1412.080591; Jiang J, 2009, MOL IMMUNOL, V46, P3131, DOI 10.1016/j.molimm.2009.05.183; Jin DY, 2004, BLOOD, V104, P1733, DOI 10.1182/blood-2004-01-0138; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krasnov A, 2011, MOL IMMUNOL, V49, P163, DOI 10.1016/j.molimm.2011.08.007; Lehmann J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-351; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032427; Liu TK, 2011, J VIROL, V85, P12769, DOI 10.1128/JVI.05849-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; Martin SAM, 2007, PHYSIOL GENOMICS, V32, P33, DOI 10.1152/physiolgenomics.00064.2007; Nacher JC, 2010, BIOSYSTEMS, V101, P127, DOI 10.1016/j.biosystems.2010.05.005; Nehyba J, 2009, MOL BIOL EVOL, V26, P2539, DOI 10.1093/molbev/msp167; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tempera I, 2010, J VIROL, V84, P4988, DOI 10.1128/JVI.02333-09; Timmerhaus G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-459; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Workenhe ST, 2009, MOL IMMUNOL, V46, P2955, DOI 10.1016/j.molimm.2009.06.015; Zhang YB, 2003, CHINESE SCI BULL, V48, P581, DOI 10.1360/03tb9124; Zhang YB, 2007, DEV COMP IMMUNOL, V31, P232, DOI 10.1016/j.dci.2006.05.015; Zhang YB, 2012, DEV COMP IMMUNOL, V38, P193, DOI 10.1016/j.dci.2012.06.003; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	44	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60588	10.1371/journal.pone.0060588	http://dx.doi.org/10.1371/journal.pone.0060588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593256	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100056
J	Zhou, X; Zhang, L; Ji, WJ; Yuan, F; Guo, ZZ; Pang, B; Luo, T; Liu, X; Zhang, WC; Jiang, TM; Zhang, ZL; Li, YM				Zhou, Xin; Zhang, Ling; Ji, Wen-Jie; Yuan, Fei; Guo, Zhao-Zeng; Pang, Bo; Luo, Tao; Liu, Xing; Zhang, Wen-Cheng; Jiang, Tie-Min; Zhang, Zhuoli; Li, Yu-Ming			Variation in Dietary Salt Intake Induces Coordinated Dynamics of Monocyte Subsets and Monocyte-Platelet Aggregates in Humans: Implications in End Organ Inflammation	PLOS ONE			English	Article							PREDICT CARDIOVASCULAR EVENTS; ACUTE MYOCARDIAL-INFARCTION/; CHRONIC KIDNEY-DISEASE; BOLD-MRI; MACROPHAGE INFILTRATION; RENOVASCULAR DISEASE; OXIDATIVE STRESS; BLOOD-PRESSURE; HYPERTENSION; ACTIVATION	Background: Monocyte activation and tissue infiltration are quantitatively associated with high-salt intake induced target organ inflammation. We hypothesized that high-salt challenge would induce the expansion of CD14++CD16+ monocytes, one of the three monocyte subsets with a pro-inflammatory phenotype, that is associated with target organ inflammation in humans. Methodology/Principal Findings: A dietary intervention study was performed in 20 healthy volunteers, starting with a 3-day usual diet and followed with a 7-day high-salt diet (<= 15 g NaCl/day), and a 7-day low-salt diet (<= 5 g NaCl/day). The amounts of three monocyte subsets ("classical'' CD14++CD16-, "intermediate'' CD14++CD16+ and "non-classical'' CD14+CD16++) and their associations with monocyte-platelet aggregates (MPAs) were measured by flow cytometry. Blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI) was used to evaluate renal hypoxia. Switching to a high-salt diet resulted in CD14++ monocyte activation and a rapid expansion of CD14++CD16+ subset and MPAs, with a reciprocal decrease in the percentages of CD14++CD16- and CD14+CD16++ subsets. In vitro study using purified CD14++ monocytes revealed that elevation in extracellular [Na+] could lead to CD14++CD16+ expansion via a ROS dependent manner. In addition, high-salt intake was associated with progressive hypoxia in the renal medulla (increased R2* signal) and enhanced urinary monocyte chemoattractant protein-1 (MCP-1) excretion, indicating a temporal and spatial correlation between CD14++CD16+ subset and renal inflammation. The above changes could be completely reversed by a low-salt diet, whereas blood pressure levels remained unchanged during dietary intervention. Conclusions/Significance: The present work demonstrates that short-term increases in dietary salt intake could induce the expansion of CD14++CD16+ monocytes, as well as an elevation of MPAs, which might be the underlying cellular basis of high-salt induced end organ inflammation and potential thromboembolic risk. In addition, this process seems largely unrelated to changes in blood pressure levels. This finding provides novel links between dietary salt intake, innate immunity and end organ inflammation.	[Zhou, Xin; Zhang, Ling; Guo, Zhao-Zeng; Pang, Bo; Luo, Tao; Liu, Xing; Jiang, Tie-Min; Li, Yu-Ming] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Inst Cardiovasc Dis, Tianjin, Peoples R China; [Zhou, Xin; Zhang, Ling; Guo, Zhao-Zeng; Pang, Bo; Luo, Tao; Liu, Xing; Jiang, Tie-Min; Li, Yu-Ming] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Ctr Heart, Tianjin, Peoples R China; [Ji, Wen-Jie] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Dept Resp, Tianjin, Peoples R China; [Ji, Wen-Jie] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Dept Crit Care Med, Tianjin, Peoples R China; [Yuan, Fei] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, MRI Dept, Tianjin, Peoples R China; [Zhang, Wen-Cheng] Logist Univ Chinese Peoples Armed Police Forces, Dept Physiol & Pathophysiol, Tianjin, Peoples R China; [Zhang, Zhuoli] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA	Northwestern University	Li, YM (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Inst Cardiovasc Dis, Tianjin, Peoples R China.	cardiolab@gmail.com	JI, WENJIE/H-1274-2015; Zhou, Xin/AAH-7351-2019	Zhou, Xin/0000-0003-1395-7103	National Natural Science Foundation of China [81070121, 81170238, 81102088]; Tianjin Municipal Science and Technology Committee [09ZCZDSF04200, 11JCYBJC12000, 12JCYBJC16600]; Tianjin Public Health Bureau [2010KZ122]; Logistics University of Chinese People's Armed Police Forces [WYB201117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Committee; Tianjin Public Health Bureau; Logistics University of Chinese People's Armed Police Forces	National Natural Science Foundation of China (81070121 and 81170238 and 81102088), Tianjin Municipal Science and Technology Committee (09ZCZDSF04200, 11JCYBJC12000 and 12JCYBJC16600), Tianjin Public Health Bureau (2010KZ122) and intramural research program from Logistics University of Chinese People's Armed Police Forces (WYB201117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Blann AD, 2012, THROMB RES, V130, pE103, DOI 10.1016/j.thromres.2012.06.026; Chrysochou C, 2012, NEPHROL DIAL TRANSPL, V27, P1013, DOI 10.1093/ndt/gfr392; Coffman TM, 2011, NAT MED, V17, P1402, DOI 10.1038/nm.2541; Cox N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045674; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; de Wardener HE, 2002, J HUM HYPERTENS, V16, P213, DOI 10.1038/sj.jhh.1001374; Djamali A, 2007, AM J PHYSIOL-RENAL, V292, pF513, DOI 10.1152/ajprenal.00222.2006; Doria AS, 2012, PEDIATR RADIOL, V42, P63, DOI 10.1007/s00247-011-2194-0; Eardley KS, 2008, KIDNEY INT, V74, P495, DOI 10.1038/ki.2008.183; Evans RG, 2008, AM J PHYSIOL-RENAL, V295, pF1259, DOI 10.1152/ajprenal.90230.2008; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; GILL GV, 1985, J ROY SOC MED, V78, P1009, DOI 10.1177/014107688507801206; Gloviczki ML, 2011, HYPERTENSION, V58, P1066, DOI 10.1161/HYPERTENSIONAHA.111.171405; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Heine GH, 2008, KIDNEY INT, V73, P622, DOI 10.1038/sj.ki.5002744; Hilgers KF, 2002, J HYPERTENS, V20, P593, DOI 10.1097/00004872-200204000-00010; Hilgers KF, 2000, KIDNEY INT, V58, P2408, DOI 10.1046/j.1523-1755.2000.00424.x; KIIL F, 1977, KIDNEY INT, V11, P153, DOI 10.1038/ki.1977.23; Kohlhaas M, 2010, CIRCULATION, V121, P1606, DOI 10.1161/CIRCULATIONAHA.109.914911; Krueger LA, 2002, CURR PROTOC CYTOM, V6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukasik M, 2012, THROMB HAEMOSTASIS, V107, P346, DOI 10.1160/TH11-05-0345; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Miravete M, 2012, AM J PHYSIOL-RENAL, V302, pF1409, DOI 10.1152/ajprenal.00409.2011; Miravete M, 2011, BIOCHEM BIOPH RES CO, V407, P813, DOI 10.1016/j.bbrc.2011.03.105; Muller DN, 2011, CURR OPIN NEPHROL HY, V20, P113, DOI 10.1097/MNH.0b013e3283436f88; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Neugarten J, 2012, KIDNEY INT, V81, P613, DOI 10.1038/ki.2011.462; Passacquale G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025595; Prasad PV, 2006, AM J PHYSIOL-RENAL, V290, pF958, DOI 10.1152/ajprenal.00114.2005; Pruijm M, 2010, HYPERTENSION, V55, P1116, DOI 10.1161/HYPERTENSIONAHA.109.149682; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; Rognant N, 2011, NEPHROL DIAL TRANSPL, V26, P1205, DOI 10.1093/ndt/gfq538; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Shantsila E, 2012, EUR J CLIN INVEST, V42, P832, DOI 10.1111/j.1365-2362.2012.02656.x; Shantsila E, 2009, THROMB HAEMOSTASIS, V102, P916, DOI 10.1160/TH09-01-0023; Stogbauer F, 2008, J IMMUNOL METHODS, V337, P78, DOI 10.1016/j.jim.2008.05.008; Suckling RJ, 2012, KIDNEY INT, V81, P407, DOI 10.1038/ki.2011.369; Tapp LD, 2012, J THROMB HAEMOST, V10, P1231, DOI 10.1111/j.1538-7836.2011.04603.x; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhou X, 2009, AM J HYPERTENS, V22, P934, DOI 10.1038/ajh.2009.135; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	51	59	67	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60332	10.1371/journal.pone.0060332	http://dx.doi.org/10.1371/journal.pone.0060332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593194	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100032
J	Askarova, S; Sun, Z; Sun, GY; Meininger, GA; Lee, JCM				Askarova, Sholpan; Sun, Zhe; Sun, Grace Y.; Meininger, Gerald A.; Lee, James C-M			Amyloid-beta Peptide on Sialyl-Lewis(X)-Selectin-Mediated Membrane Tether Mechanics at the Cerebral Endothelial Cell Surface	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; REDUCTASE INHIBITORS; ACTIN POLYMERIZATION; ADHESION; PROTEIN; EXPRESSION; CYTOSKELETON; MIGRATION	Increased deposition of amyloid-beta peptide (A beta) at the cerebral endothelial cell (CEC) surface has been implicated in enhancement of transmigration of monocytes across the brain blood barrier (BBB) in Alzheimer's disease (AD). In this study, quantitative immunofluorescence microscopy (QIM) and atomic force microscopy (AFM) with cantilevers biofunctionalized by sialyl-Lewis(x) (sLe(x)) were employed to investigate A beta-altered mechanics of membrane tethers formed by bonding between sLe(x) and p-selectin at the CEC surface, the initial mechanical step governing the transmigration of monocytes. QIM results indicated the ability for A beta to increase p-selectin expression at the cell surface and promote actin polymerization in both bEND3 cells (immortalized mouse CECs) and human primary CECs. AFM data also showed the ability for A beta to increase cell stiffness and adhesion probability in bEND3 cells. On the contrary, A beta lowered the overall force of membrane tether formation (F-mtf), and produced a bimodal population of F-mtf, suggesting subcellular mechanical alterations in membrane tethering. The lower F-mtf population was similar to the results obtained from cells treated with an F-actin-disrupting drug, latrunculin A. Indeed, AFM results also showed that both A beta and latrunculin A decreased membrane stiffness, suggesting a lower membrane-cytoskeleton adhesion, a factor resulting in lower F-mtf. In addition, these cerebral endothelial alterations induced by A beta were abrogated by lovastatin, consistent with its anti-inflammatory effects. In sum, these results demonstrated the ability for A beta to enhance p-selectin expression at the CEC surface and induce cytoskeleton reorganization, which in turn, resulted in changes in membrane-cytoskeleton adhesion and membrane tethering, mechanical factors important in transmigration of monocytes through the BBB.	[Askarova, Sholpan; Lee, James C-M] Univ Missouri, Dept Biol Engn, Columbia, MO USA; [Sun, Zhe; Meininger, Gerald A.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Sun, Grace Y.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Meininger, Gerald A.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Askarova, Sholpan] Nazarbayev Univ, Ctr Life Sci, Dept Biomed Engn Cell Technol & Transplantat, Astana, Kazakhstan	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Nazarbayev University	Meininger, GA (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	meiningerg@missouri.edu; leejam@missouri.edu	Askarova, Sholpan/P-1091-2017	Askarova, Sholpan/0000-0001-6161-1671	Alzheimer Association Grant [NIRG-06-24448]; NIH Grant [1P01 AG18357, R21NS052385, 5R21AG032579, 1P01HL095486, AHA 0835676N]; "Bolashak" scholarship; Ministry of Education and Science of the Republic of Kazakhstan [1029/GF2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032579, P01AG018357, R01AG044404] Funding Source: NIH RePORTER	Alzheimer Association Grant; NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Bolashak" scholarship; Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Alzheimer Association Grant NIRG-06-24448; NIH Grant 1P01 AG18357, R21NS052385, 5R21AG032579 and in part by 1P01HL095486 and AHA 0835676N; "Bolashak" scholarship and Ministry of Education and Science of the Republic of Kazakhstan 1029/GF2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson O, 2012, J NEUROSCI, V32, P9677, DOI 10.1523/JNEUROSCI.4742-11.2012; Afrin R, 2006, BIOCHEM BIOPH RES CO, V348, P238, DOI 10.1016/j.bbrc.2006.07.050; Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; Atkinson C, 2006, J IMMUNOL, V177, P7266, DOI 10.4049/jimmunol.177.10.7266; Coisne C, 2006, NEUROSCI LETT, V392, P216, DOI 10.1016/j.neulet.2005.09.028; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Eccles KA, 2008, ATHEROSCLEROSIS, V200, P69, DOI 10.1016/j.atherosclerosis.2007.12.018; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Girdhar G, 2007, BIOPHYS J, V92, P1035, DOI 10.1529/biophysj.106.086256; Giri R, 2002, AM J PHYSIOL-CELL PH, V283, pC895, DOI 10.1152/ajpcell.00293.2001; Gonzalez-Velasquez FJ, 2008, J NEUROCHEM, V104, P500, DOI 10.1111/j.1471-4159.2007.04988.x; Gonzalez-Velasquez FJ, 2011, CURR ALZHEIMER RES, V8, P81; Hajjar L, 2002, J GERONTOL A-BIOL, V57, pM414, DOI 10.1093/gerona/57.7.M414; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; JONES DA, 1993, BIOPHYS J, V65, P1560, DOI 10.1016/S0006-3495(93)81195-0; Kato T, 2004, BBA-MOL BASIS DIS, V1689, P267, DOI 10.1016/j.bbadis.2004.04.006; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; KUBES P, 1994, J IMMUNOL, V152, P3570; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; MaatSchieman MLC, 1997, J NEUROPATH EXP NEUR, V56, P273, DOI 10.1097/00005072-199703000-00006; Mendoza-Naranjo A, 2007, J CELL SCI, V120, P279, DOI 10.1242/jcs.03323; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Micic M, 1999, SCANNING, V21, P394, DOI 10.1002/sca.4950210606; Piramowicz MD, 2006, ACTA BIOCHIM POL, V53, P93; Reyes Barcelo Adriana A, 2009, J Biol Eng, V3, P5, DOI 10.1186/1754-1611-3-5; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; SMITH CW, 1993, CAN J PHYSIOL PHARM, V71, P76, DOI 10.1139/y93-012; Song C, 2002, J NEUROCHEM, V83, P828, DOI 10.1046/j.1471-4159.2002.01182.x; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; Sun MZ, 2005, BIOPHYS J, V89, P4320, DOI 10.1529/biophysj.104.058180; Trache A, 2005, BIOPHYS J, V89, P2888, DOI 10.1529/biophysj.104.057026; Trepat X, 2005, J APPL PHYSIOL, V98, P1567, DOI 10.1152/japplphysiol.00925.2004; Uchihara T, 1997, STROKE, V28, P1948, DOI 10.1161/01.STR.28.10.1948; Vega GL, 2003, ARCH NEUROL-CHICAGO, V60, P510, DOI 10.1001/archneur.60.4.510; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wang A, 2011, J NEUROSCI, V31, P4124, DOI 10.1523/JNEUROSCI.5077-10.2011; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Zhang XH, 2004, CHEMPHYSCHEM, V5, P175, DOI 10.1002/cphc.200300813; Zlokovic BV, 2008, NEUROTHERAPEUTICS, V5, P409, DOI 10.1016/j.nurt.2008.05.011	48	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60972	10.1371/journal.pone.0060972	http://dx.doi.org/10.1371/journal.pone.0060972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593361	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300038
J	Park, JH; Park, S; Yang, JS; Kwon, OS; Kim, S; Jang, SK				Park, Ji Hoon; Park, Solip; Yang, Jae-Seong; Kwon, Oh Sung; Kim, Sanguk; Jang, Sung Key			Discovery of Cellular Proteins Required for the Early Steps of HCV Infection Using Integrative Genomics	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ENTRY; NETWORK; CLAUDIN-1; RECEPTOR; BINDING; SCREEN; GENES; CD81	Successful viral infection requires intimate communication between virus and host cell, a process that absolutely requires various host proteins. However, current efforts to discover novel host proteins as therapeutic targets for viral infection are difficult. Here, we developed an integrative-genomics approach to predict human genes involved in the early steps of hepatitis C virus (HCV) infection. By integrating HCV and human protein associations, co-expression data, and tight junction-tetraspanin web specific networks, we identified host proteins required for the early steps in HCV infection. Moreover, we validated the roles of newly identified proteins in HCV infection by knocking down their expression using small interfering RNAs. Specifically, a novel host factor CD63 was shown to directly interact with HCV E2 protein. We further demonstrated that an antibody against CD63 blocked HCV infection, indicating that CD63 may serve as a new therapeutic target for HCV-related diseases. The candidate gene list provides a source for identification of new therapeutic targets.	[Park, Ji Hoon; Yang, Jae-Seong; Kwon, Oh Sung; Kim, Sanguk; Jang, Sung Key] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, South Korea; [Park, Solip; Kim, Sanguk; Jang, Sung Key] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Kim, Sanguk] Pohang Univ Sci & Technol, Div IT Convergence Engn, Pohang, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Biotechnol Res Ctr, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, S (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, South Korea.	sukim@postech.ac.kr; sungkey@postech.ac.kr	Park, Solip/K-7015-2017; Park, Solip/AAA-9326-2020; Jang, Sung K/P-1230-2017; Yang, Jae-Seong/AAH-6965-2019	Park, Solip/0000-0002-5988-5339; Park, Solip/0000-0002-5988-5339; Yang, Jae-Seong/0000-0001-9910-3170; Kim, Sanguk/0000-0002-3449-3814	NRF BRL [2010-0019706]; WCU program through the NRF [R31-2008-10105]; Korea government (MEST)	NRF BRL; WCU program through the NRF; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work is supported by NRF BRL [2010-0019706] and WCU program through the NRF [R31-2008-10105] funded by the Korea government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Aloy P, 2002, TRENDS BIOCHEM SCI, V27, P633, DOI 10.1016/S0968-0004(02)02204-1; Bailer SM, 2009, CURR OPIN MICROBIOL, V12, P453, DOI 10.1016/j.mib.2009.06.004; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Folks LJ, 1984, HDB STAT; Hibbs MA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000322; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Isaacson MK, 2008, CURR TOP MICROBIOL, V325, P85; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Kim CS, 2007, J VIROL, V81, P8814, DOI 10.1128/JVI.02824-06; Kim CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022808; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Paek KY, 2008, J VIROL, V82, P12082, DOI 10.1128/JVI.01405-08; Peng XX, 2009, CURR OPIN MICROBIOL, V12, P432, DOI 10.1016/j.mib.2009.06.003; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Setlur SR, 2007, CANCER RES, V67, P10296, DOI 10.1158/0008-5472.CAN-07-2173; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	46	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60333	10.1371/journal.pone.0060333	http://dx.doi.org/10.1371/journal.pone.0060333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593195	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300014
J	Ishii, A; Li, J; Ogata, S				Ishii, Akio; Li, Ju; Ogata, Shigenobu			"Conjugate Channeling" Effect in Dislocation Core Diffusion: Carbon Transport in Dislocated BCC Iron	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; EDGE DISLOCATION; PIPE DIFFUSION; LIQUIDS	Dislocation pipe diffusion seems to be a well-established phenomenon. Here we demonstrate an unexpected effect, that the migration of interstitials such as carbon in iron may be accelerated not in the dislocation line direction xi, but in a conjugate diffusion direction. This accelerated random walk arises from a simple crystallographic channeling effect. c is a function of the Burgers vector b, but not xi, thus a dislocation loop possesses the same everywhere. Using molecular dynamics and accelerated dynamics simulations, we further show that such dislocation-core-coupled carbon diffusion in iron has temperature-dependent activation enthalpy like a fragile glass. The 71 degrees mixed dislocation is the only case in which we see straightforward pipe diffusion that does not depend on dislocation mobility.	[Ishii, Akio] Osaka Univ, Akio Ishii Dept Mech Sci & Bioengn, Osaka, Japan; [Li, Ju] MIT, Ju Li Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Li, Ju] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Ogata, Shigenobu] Osaka Univ, Shigenobu Ogata Dept Mech Sci & Bioengn, Osaka, Japan	Osaka University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Osaka University	Ishii, A (corresponding author), Osaka Univ, Akio Ishii Dept Mech Sci & Bioengn, Osaka, Japan.	akio.ishii@tsme.me.es.osaka-u.ac.jp; liju@mit.edu; ogata@me.es.osaka-u.ac.jp	Ogata, Shigenobu/G-5497-2011; Li, Ju/A-2993-2008	Ogata, Shigenobu/0000-0002-9072-4496; Li, Ju/0000-0002-7841-8058; Ishii, Akio/0000-0002-9369-6259	Elements Strategy Initiative for Structural Materials; JST; National Science Foundation [CMMI-0728069, DMR-1008104, DMR-1120901];  [23246025];  [22102003];  [22656030]; Grants-in-Aid for Scientific Research [22102003, 25630013] Funding Source: KAKEN	Elements Strategy Initiative for Structural Materials; JST(Japan Science & Technology Agency (JST)); National Science Foundation(National Science Foundation (NSF)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by a Grant-in-Aid for Scientific Research (A), 23246025, Scientific Research on Innovative Area, 22102003, Challenging Exploratory Research, 22656030, the Elements Strategy Initiative for Structural Materials, JST under Collaborative Research Based on Industrial Demand (Heterogeneous Structure Control). JL was supported by the National Science Foundation under Grant No. CMMI-0728069, No. DMR-1008104 and No. DMR-1120901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Balluffi RW, 2005, KINETICS OF MATERIALS, P1; Bitzek E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170201; DASTUR YN, 1981, METALL TRANS A, V12, P749, DOI 10.1007/BF02648339; Eapen J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056712; Feldman L.C., 1982, MAT ANAL ION CHANNEL; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; HUANG J, 1989, PHYS REV LETT, V63, P628, DOI 10.1103/PhysRevLett.63.628; Ishii A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.064303; Ito K, 1999, NATURE, V398, P492, DOI 10.1038/19042; Jiang DE, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.214103; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kushima A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139006; Lau TT, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.215501; Le Claire A. D., 1981, Journal of Physics C (Solid State Physics), V14, P3863, DOI 10.1088/0022-3719/14/27/011; Legros M, 2008, SCIENCE, V319, P1646, DOI 10.1126/science.1151771; Li J, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.104113; LOTHE J, 1960, J APPL PHYS, V31, P1077, DOI 10.1063/1.1735749; LOVE GR, 1964, ACTA METALL MATER, V12, P731, DOI 10.1016/0001-6160(64)90220-2; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI [10.1103/PhysRevB.13.5188, 10.1103/PhysRevB.16.1746]; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Ogata S, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.224102; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Picu RC, 2004, ACTA MATER, V52, P161, DOI 10.1016/j.actamat.2003.09.002; RABIER J, 1989, PHILOS MAG A, V59, P533, DOI 10.1080/01418618908229783; Sarkar S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.014115; Sauvage X, 2007, J MATER SCI, V 42, P1615, DOI 10.1007/s10853-006-0750-z; Shewmon P., 1989, DIFFUSION SOLIDS, P191; Tapasa K, 2007, ACTA MATER, V55, P93, DOI 10.1016/j.actamat.2006.08.015; Voter AF, 1997, PHYS REV LETT, V78, P3908, DOI 10.1103/PhysRevLett.78.3908	31	24	24	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60586	10.1371/journal.pone.0060586	http://dx.doi.org/10.1371/journal.pone.0060586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593255	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200014
J	Laaksonen, K; Helle, L; Parkkonen, L; Kirveskari, E; Makela, JP; Mustanoja, S; Tatlisumak, T; Kaste, M; Forss, N				Laaksonen, Kristina; Helle, Liisa; Parkkonen, Lauri; Kirveskari, Erika; Makela, Jyrki P.; Mustanoja, Satu; Tatlisumak, Turgut; Kaste, Markku; Forss, Nina			Alterations in Spontaneous Brain Oscillations during Stroke Recovery	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; DELTA WAVES; EEG; SIGNAL; PERFORMANCE; MEG; INTERFERENCE; LESIONS; RHYTHM; AREAS	Amplitude or frequency alterations of spontaneous brain oscillations may reveal pathological phenomena in the brain or predict recovery from brain lesions, but the temporal evolution and the functional significance of these changes is not well known. We performed follow-up recordings of spontaneous brain oscillations with whole-head MEG in 16 patients with first-ever stroke in the middle cerebral artery territory, affecting upper limb motor function, 1-7 days (T-0), 1 month (T-1), and 3 months (T-2) after stroke, with concomitant clinical examination. Clinical test results improved significantly from T-0 to T-1 or T-2. During recovery (at T-1 and T-2), the strength of temporo-parietal similar to 10-Hz oscillations in the affected hemisphere (AH) was increased as compared with the unaffected hemisphere. Abnormal low-frequency magnetic activity (ALFMA) at similar to 1 Hz in the AH was detected in the perilesional cortex in seven patients at T-0. In four of these, ALFMA persisted at T-2. In patients with ALFMA, the lesion size was significantly larger than in the rest of the patients, and worse clinical outcome was observed in patients with persisting ALFMA. Our results indicate that temporo-parietal similar to 10-Hz oscillations are enhanced in the AH during recovery from stroke. Moreover, stroke causes ALFMA, which seems to persist in patients with worse clinical outcome.	[Laaksonen, Kristina; Parkkonen, Lauri; Kirveskari, Erika; Forss, Nina] Aalto Univ, Brain Res Unit, OV Lounasmaa Lab, Aalto Neuroimaging, Espoo, Finland; [Laaksonen, Kristina; Parkkonen, Lauri; Kirveskari, Erika; Forss, Nina] Aalto Univ, Aalto Neuroimaging, MEG Core, Espoo, Finland; [Laaksonen, Kristina; Kirveskari, Erika; Mustanoja, Satu; Tatlisumak, Turgut; Kaste, Markku; Forss, Nina] Univ Helsinki, HY, Dept Neurol Sci, Helsinki, Finland; [Laaksonen, Kristina; Mustanoja, Satu; Tatlisumak, Turgut; Kaste, Markku; Forss, Nina] Univ Helsinki, Cent Hosp, Dept Neurol, HUS, Helsinki, Finland; [Helle, Liisa; Parkkonen, Lauri] Elekta Oy, Helsinki, Finland; [Parkkonen, Lauri] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Kirveskari, Erika] Univ Helsinki, Cent Hosp, HUS, Dept Clin Neurophysiol,HUS Med Imaging Ctr, Helsinki, Finland; [Makela, Jyrki P.] Univ Helsinki, Cent Hosp, BioMag Lab, HUS Med Imaging Ctr, Helsinki, Finland	Aalto University; Aalto University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Elekta; Aalto University; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital	Laaksonen, K (corresponding author), Aalto Univ, Brain Res Unit, OV Lounasmaa Lab, Aalto Neuroimaging, Espoo, Finland.	laaks@neuro.hut.fi	Mäkelä, Jyrki/M-1215-2019; Parkkonen, Lauri/G-6755-2012	Parkkonen, Lauri/0000-0002-0130-0801; Forss, Nina/0000-0002-1620-8573; Kaste, Markku/0000-0001-6557-6412; Helle, Liisa/0000-0002-0001-9292; Laaksonen, Kristina/0000-0002-9772-6785; Tatlisumak, Turgut/0000-0002-2430-8988	Academy of Finland (National Centers of Excellence Program); Helsinki University Central Hospital Research Fund; SalWe Research Program for Mind and Body (Tekes-the Finnish Funding Agency for Technology and Innovation) [1104/10]	Academy of Finland (National Centers of Excellence Program); Helsinki University Central Hospital Research Fund; SalWe Research Program for Mind and Body (Tekes-the Finnish Funding Agency for Technology and Innovation)	The study was financially supported by the Academy of Finland (National Centers of Excellence Program 2006-2011), the Helsinki University Central Hospital Research Fund, and the SalWe Research Program for Mind and Body (Tekes-the Finnish Funding Agency for Technology and Innovation grant 1104/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli M, 2009, ANN NEUROL, V66, P298, DOI 10.1002/ana.21725; [Anonymous], 1974, Electroencephalogr Clin Neurophysiol, V37, P538; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Butz M, 2004, NEUROSCI LETT, V355, P93, DOI 10.1016/j.neulet.2003.10.065; Carmichael ST, 2002, J NEUROSCI, V22, P6062; DASILVA FHL, 1977, NEUROSCI LETT, V6, P237, DOI 10.1016/0304-3940(77)90024-6; Fernandez-Bouzas A, 2000, CLIN ELECTROENCEPHAL, V31, P165, DOI 10.1177/155005940003100403; Forss N, HUM BRAIN MAPP; GASSER T, 1985, ELECTROEN CLIN NEURO, V60, P312, DOI 10.1016/0013-4694(85)90005-7; GIAQUINTO S, 1994, STROKE, V25, P2204, DOI 10.1161/01.STR.25.11.2204; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Haegens S, 2011, J NEUROSCI, V31, P5197, DOI 10.1523/JNEUROSCI.5199-10.2011; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Jensen O, 2002, NEUROIMAGE, V15, P568, DOI 10.1006/nimg.2001.1020; Kamada K, 1997, ANN NEUROL, V42, P554, DOI 10.1002/ana.410420405; Laaksonen K, 2012, CLIN NEUROPHYSIOL; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Liepert J, 2005, STROKE, V36, P2648, DOI 10.1161/01.STR.0000189629.10603.02; Makela JP, 1998, ELECTROEN CLIN NEURO, V106, P433, DOI 10.1016/S0013-4694(98)00005-4; Narici L, 2001, NEUROIMAGE, V13, P662, DOI 10.1006/nimg.2000.0725; PFURTSCHELLER G, 1981, ELECTROEN CLIN NEURO, V52, P473, DOI 10.1016/0013-4694(81)90032-8; Roiha K, 2011, CLIN NEUROPHYSIOL, V122, P339, DOI 10.1016/j.clinph.2010.06.032; SAINIO K, 1983, ELECTROEN CLIN NEURO, V56, P117, DOI 10.1016/0013-4694(83)90066-4; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Tecchio F, 2006, J NEUROSCI RES, V83, P1077, DOI 10.1002/jnr.20796; Tecchio F, 2005, NEUROIMAGE, V28, P72, DOI 10.1016/j.neuroimage.2005.05.051; Tecchio F, 2007, J NEUROL, V254, P296, DOI 10.1007/s00415-006-0355-0; TIIHONEN J, 1991, NEUROSCI LETT, V129, P303, DOI 10.1016/0304-3940(91)90486-D; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Van Albada Sacha J., 2007, Journal of Integrative Neuroscience, V6, P279, DOI 10.1142/S0219635207001520; VANHUFFELEN AC, 1984, PROG BRAIN RES, V62, P3; Vieth J B, 1990, Adv Neurol, V54, P261	38	29	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61146	10.1371/journal.pone.0061146	http://dx.doi.org/10.1371/journal.pone.0061146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593414	gold, Green Published, Green Submitted			2022-12-27	WOS:000317383200044
J	Lo, PHY; Urabe, Y; Kumar, V; Tanikawa, C; Koike, K; Kato, N; Miki, D; Chayama, K; Kubo, M; Nakamura, Y; Matsuda, K				Lo, Paulisally Hau Yi; Urabe, Yuji; Kumar, Vinod; Tanikawa, Chizu; Koike, Kazuhiko; Kato, Naoya; Miki, Daiki; Chayama, Kazuaki; Kubo, Michiaki; Nakamura, Yusuke; Matsuda, Koichi			Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHRONIC HEPATITIS-B; TRANSCRIPTIONAL REGULATION; SUSCEPTIBILITY LOCUS; CHAIN-A; EPIDEMIOLOGY; JAPANESE; GENE; POLYMORPHISM	Hepatitis C virus (HCV) infection is the major cause of hepatocellular carcinoma (HCC) in Japan. We previously identified the association of SNP rs2596542 in the 5' flanking region of the MHC class I polypeptide-related sequence A (MICA) gene with the risk of HCV-induced HCC. In the current study, we performed detailed functional analysis of 12 candidate SNPs in the promoter region and found that a SNP rs2596538 located at 2.8 kb upstream of the MICA gene affected the binding of a nuclear protein(s) to the genomic segment including this SNP. By electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assay, we identified that transcription factor Specificity Protein 1 (SP1) can bind to the protective G allele, but not to the risk A allele. In addition, reporter construct containing the G allele was found to exhibit higher transcriptional activity than that containing the A allele. Moreover, SNP rs2596538 showed stronger association with HCV-induced HCC (P = 1.82 x 10(-5) and OR = 1.34) than the previously identified SNP rs2596542. We also found significantly higher serum level of soluble MICA (sMICA) in HCV-induced HCC patients carrying the G allele than those carrying the A allele (P = 0.00616). In summary, we have identified a functional SNP that is associated with the expression of MICA and the risk for HCV-induced HCC.	[Lo, Paulisally Hau Yi; Urabe, Yuji; Kumar, Vinod; Tanikawa, Chizu; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Urabe, Yuji; Miki, Daiki; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med, Div Frontier Med Sci,Programs Biomed Res, Hiroshima, Japan; [Urabe, Yuji; Miki, Daiki; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Sci, Div Frontier Med Sci,Programs Biomed Res, Hiroshima, Japan; [Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan; [Kato, Naoya] Univ Tokyo, Inst Med Sci, Unit Dis Control Genome Med, Tokyo, Japan; [Miki, Daiki; Chayama, Kazuaki; Kubo, Michiaki] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA	University of Tokyo; Hiroshima University; Hiroshima University; University of Tokyo; University of Tokyo; RIKEN; University of Chicago; University of Chicago; University of Chicago	Matsuda, K (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Miki, Daiki/L-5069-2018; Kubo, Michiaki/N-7947-2015; Kumar, Vinod/ABC-4866-2020; Matsuda, Koichi/D-4597-2011	Miki, Daiki/0000-0002-6505-9826; Kumar, Vinod/0000-0002-2775-6049; Chayama, Kazuaki/0000-0002-5530-5341; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Ministry of Health, Labour, and Welfare of the Japanese government; Grants-in-Aid for Scientific Research [25670369] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of the Japanese government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government, the Ministry of Health, Labour, and Welfare of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cabibbo G, 2010, EUR REV MED PHARMACO, V14, P352; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Fassio E, 2010, ANN HEPATOL, V9, pS119, DOI 10.1016/S1665-2681(19)31736-3; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kim JR, 2004, INT J BIOCHEM CELL B, V36, P2293, DOI 10.1016/j.biocel.2004.04.022; Kohga K, 2008, CANCER SCI, V99, P1643, DOI 10.1111/j.1349-7006.2008.00859.x; Komatsu-Wakui M, 2001, TISSUE ANTIGENS, V57, P1, DOI 10.1034/j.1399-0039.2001.057001001.x; Kumar V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044743; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lee S, 2001, VIROLOGY, V283, P167, DOI 10.1006/viro.2001.0892; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Miki D, 2011, NAT GENET, V43, P797, DOI 10.1038/ng.876; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Negro F, 2011, LIVER INT, V31, P1, DOI 10.1111/j.1478-3231.2011.02537.x; Ota M, 1997, TISSUE ANTIGENS, V49, P448, DOI 10.1111/j.1399-0039.1997.tb02778.x; Ou DP, 2007, INT J CANCER, V120, P1208, DOI 10.1002/ijc.22452; Rodriguez-Rodero S, 2007, EUR J IMMUNOL, V37, P1938, DOI 10.1002/eji.200737031; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sun DH, 2011, CELL BIOL INT, V35, P569, DOI 10.1042/CBI20100431; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Tse KP, 2011, HUM MOL GENET, V20, P2889, DOI 10.1093/hmg/ddr191; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Urabe Y, 2013, J HEPATOL; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Yu FL, 2005, J HEPATOL, V42, P520, DOI 10.1016/j.jhep.2004.11.031; Zhang C, 2009, CANCER IMMUNOL IMMUN, V58, P1275, DOI 10.1007/s00262-008-0645-8; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	38	48	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61279	10.1371/journal.pone.0061279	http://dx.doi.org/10.1371/journal.pone.0061279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593449	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200048
J	Komiyama, Y; Ohba, S; Shimohata, N; Nakajima, K; Hojo, H; Yano, F; Takato, T; Docheva, D; Shukunami, C; Hiraki, Y; Chung, UI				Komiyama, Yuske; Ohba, Shinsuke; Shimohata, Nobuyuki; Nakajima, Keiji; Hojo, Hironori; Yano, Fumiko; Takato, Tsuyoshi; Docheva, Denitsa; Shukunami, Chisa; Hiraki, Yuji; Chung, Ung-il			Tenomodulin Expression in the Periodontal Ligament Enhances Cellular Adhesion	PLOS ONE			English	Article							CHONDROMODULIN-I; MOLECULAR-CLONING; ANGIOGENESIS; DOMAIN; LOCALIZATION; PROTEINS; HOMOLOGY; BRICHOS; MOUSE	Tenomodulin (Tnmd) is a type II transmembrane protein characteristically expressed in dense connective tissues such as tendons and ligaments. Its expression in the periodontal ligament (PDL) has also been demonstrated, though the timing and function remain unclear. We investigated the expression of Tnmd during murine tooth eruption and explored its biological functions in vitro. Tnmd expression was related to the time of eruption when occlusal force was transferred to the teeth and surrounding tissues. Tnmd overexpression enhanced cell adhesion in NIH3T3 and human PDL cells. In addition, Tnmd-knockout fibroblasts showed decreased cell adhesion. In the extracellular portions of Tnmd, the BRICHOS domain or CS region was found to be responsible for Tnmd-mediated enhancement of cell adhesion. These results suggest that Tnmd acts on the maturation or maintenance of the PDL by positively regulating cell adhesion via its BRICHOS domain.	[Komiyama, Yuske; Nakajima, Keiji; Takato, Tsuyoshi] Univ Tokyo, Dept Sensory & Motor Syst Med, Bunkyo Ku, Tokyo, Japan; [Komiyama, Yuske; Nakajima, Keiji; Hojo, Hironori; Takato, Tsuyoshi] Univ Tokyo, Dept Oral & Maxilofacial Surg, Bunkyo Ku, Tokyo, Japan; [Ohba, Shinsuke; Shimohata, Nobuyuki; Hojo, Hironori; Yano, Fumiko; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo, Japan; [Docheva, Denitsa] Univ Munich, Lab Expt Surg & Regenerat Med, Dept Surg, Munich, Germany; [Shukunami, Chisa; Hiraki, Yuji] Kyoto Univ, Dept Cellular Differentiat, Inst Frontier Med Sci, Kyoto, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Munich; Kyoto University	Komiyama, Y (corresponding author), Univ Tokyo, Dept Sensory & Motor Syst Med, Bunkyo Ku, Tokyo, Japan.	y-komi@umin.ac.jp; soba@bmw.t.u-tokyo.ac.jp	Shukunami, Chisa/G-2887-2019; Docheva, Denitsa/R-1259-2018	Shukunami, Chisa/0000-0001-5616-6761; Docheva, Denitsa/0000-0002-7588-1290; Ohba, Shinsuke/0000-0002-6874-8539; Hojo, Hironori/0000-0003-2245-6853	Japan Society for the Promotion of Science (JSPS) [22890047]; Center for NanoBio Integration (CNBI); Center for Medical System Innovation (CMSI); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program); Grants-in-Aid for Scientific Research [25670851] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration (CNBI); Center for Medical System Innovation (CMSI); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (22890047), as well as by the Center for NanoBio Integration (CNBI), the Center for Medical System Innovation (CMSI), and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program). This work was performed in part under the Cooperative Research Program of Institute for Frontier Medical Sciences, Kyoto University, Japan.	Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; Belini L, 2012, J PERIODONTAL RES, P28; Brandau O, 2001, DEV DYNAM, V221, P72, DOI 10.1002/dvdy.1126; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Docheva D, 2010, EUR CELLS MATER, V19, P228, DOI 10.22203/eCM.v019a22; Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI [10.1902/jop.2009.097001, 10.1016/j.amjcard.2009.05.002]; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Itaya T, 2009, J PERIODONTAL RES, V44, P425, DOI 10.1111/j.1600-0765.2008.01137.x; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Kimura N, 2008, CIRCULATION, V118, P1737, DOI 10.1161/CIRCULATIONAHA.108.780031; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Miyaki K, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-131; Nanci A, 2009, TEN CAATES ORAL HIST, P268; Nareyeck G, 2004, EUR J BIOCHEM, V271, P3389, DOI 10.1111/j.1432-1033.2004.04273.x; Oshima Y, 2004, J CELL SCI, V117, P2731, DOI 10.1242/jcs.01112; Oshima Y, 2003, INVEST OPHTH VIS SCI, V44, P1814, DOI 10.1167/iovs.02-0664; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Qi J, 2012, J APPL PHYSIOL, V113, P861, DOI 10.1152/japplphysiol.00198.2012; Ritty TM, 2002, ANAT RECORD, V268, P430, DOI 10.1002/ar.10175; Rivas-Tumanyan S, 2012, J PERIODONTOL; Rutger Persson G, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.11829; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Sandberg GE, 2000, DIABETES RES CLIN PR, V50, P27, DOI 10.1016/S0168-8227(00)00159-5; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Shukunami C, 2001, BIOCHEM BIOPH RES CO, V280, P1323, DOI 10.1006/bbrc.2001.4271; Shukunami C, 2008, CELL TISSUE RES, V332, P111, DOI 10.1007/s00441-007-0570-8; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Shukunami Chisa, 2002, Clin Calcium, V12, P356; TENCATE AR, 1972, ARCH ORAL BIOL, V17, P1781, DOI 10.1016/0003-9969(72)90242-7; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Willander H, 2012, P NATL ACAD SCI USA, V109, P2325, DOI 10.1073/pnas.1114740109; Yamana K, 2001, BIOCHEM BIOPH RES CO, V280, P1101, DOI 10.1006/bbrc.2000.4245	34	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60203	10.1371/journal.pone.0060203	http://dx.doi.org/10.1371/journal.pone.0060203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593173	Green Published, Green Submitted, gold			2022-12-27	WOS:000317382000008
J	Benegiamo, G; Mazzoccoli, G; Cappello, F; Rappa, F; Scibetta, N; Oben, J; Greco, A; Williams, R; Andriulli, A; Vinciguerra, M; Pazienza, V				Benegiamo, Giorgia; Mazzoccoli, Gianluigi; Cappello, Francesco; Rappa, Francesca; Scibetta, Nunzia; Oben, Jude; Greco, Azzura; Williams, Roger; Andriulli, Angelo; Vinciguerra, Manlio; Pazienza, Valerio			Mutual Antagonism between Circadian Protein Period 2 and Hepatitis C Virus Replication in Hepatocytes	PLOS ONE			English	Article							CORE PROTEIN; GENE-EXPRESSION; CLOCK PROTEIN; RHYTHMS; MPER2; MODEL; 3A	Background: Hepatitis C virus (HCV) infects approximately 3% of the world population and is the leading cause of liver disease, impacting hepatocyte metabolism, depending on virus genotype. Hepatic metabolic functions show rhythmic fluctuations with 24-h periodicity (circadian), driven by molecular clockworks ticking through translational-transcriptional feedback loops, operated by a set of genes, called clock genes, encoding circadian proteins. Disruption of biologic clocks is implicated in a variety of disorders including fatty liver disease, obesity and diabetes. The relation between HCV replication and the circadian clock is unknown. Methods: We investigated the relationship between HCV core infection and viral replication and the expression of clock genes (Rev-Erb alpha, Ror alpha, ARNTL, ARNTL2, CLOCK, PER1, PER2, PER3, CRY1 and CRY2) in two cellular models, the Huh-7 cells transiently expressing the HCV core protein genotypes 1b or 3a, and the OR6 cells stably harboring the full-length hepatitis C genotype 1b replicon, and in human liver biopsies, using qRT-PCR, immunoblotting, luciferase assays and immunohistochemistry. Results: In Huh-7 cells expressing the HCV core protein genotype 1b, but not 3a, and in OR6 cells, transcript and protein levels of PER2 and CRY2 were downregulated. Overexpression of PER2 led to a consistent decrease in HCV RNA replicating levels and restoration of altered expression pattern of a subset of interferon stimulated genes (ISGs) in OR6 cells. Furthermore, in liver biopsies from HCV genotype 1b infected patients, PER2 was markedly localized to the nucleus, consistent with an auto-inhibitory transcriptional feedback loop. Conclusions: HCV can modulate hepatic clock gene machinery, and the circadian protein PER2 counteracts viral replication. Further understanding of circadian regulation of HCV replication and rhythmic patterns of host-hosted relationship may improve the effectiveness of HCV antiviral therapy. This would extend to hepatic viral infections the current spectrum of chronotherapies, implemented to treat metabolic, immune related and neoplastic disease.	[Benegiamo, Giorgia; Andriulli, Angelo; Pazienza, Valerio] Hosp San Giovanni Rotondo FG, IRCCS Casa Sollievo Sofferenza, Gastroenterol Unit, San Giovanni, Italy; [Mazzoccoli, Gianluigi] IRCCS Sci Inst, Div Internal Med, Dept Med Sci, San Giovanni Rotondo, FG, Italy; [Mazzoccoli, Gianluigi] Reg Gen Hosp Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy; [Cappello, Francesco; Vinciguerra, Manlio] Euro Mediterranean Inst Sci & Technol IEMEST, Palermo, Italy; [Cappello, Francesco; Rappa, Francesca] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Sect Human Anat, Palermo, Italy; [Scibetta, Nunzia] Civ Hosp, Unit Pathol, Palermo, Italy; [Oben, Jude; Vinciguerra, Manlio] UCL, Inst Liver & Digest Hlth, Div Med, London, England; [Greco, Azzura; Williams, Roger] Fdn Liver Res, Inst Hepatol, London, England	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; University of Palermo; University of London; University College London; University of London; University College London	Vinciguerra, M (corresponding author), Euro Mediterranean Inst Sci & Technol IEMEST, Palermo, Italy.	m.vinciguerra@ucl.ac.uk; pazienza_valerio@yahoo.it	Vinciguerra, Manlio/N-1309-2015; Andriulli, Angelo/B-5027-2017; Francesca, Rappa/ADW-8431-2022; Mazzoccoli, Gianluigi/H-2447-2016; Pazienza, Valerio/K-5073-2012; OBEN, JUDE A/K-4331-2013; Cappello, Francesco/F-9153-2012	Vinciguerra, Manlio/0000-0002-1768-3894; Andriulli, Angelo/0000-0001-8862-7083; Mazzoccoli, Gianluigi/0000-0003-3535-7635; Pazienza, Valerio/0000-0002-3492-1153; Oben, Jude/0000-0003-3350-8356; Cappello, Francesco/0000-0001-9288-1148; rappa, francesca/0000-0001-6610-5268; Benegiamo, Giorgia/0000-0001-7164-6771	Italian Ministry of Health through the Division of Gastroenterology and Research Laboratory [RC1103GA48, RC1201ME04]; Department of Medical Sciences, Division of Internal Medicine IRCCS "Casa Sollievo della Sofferenza" Hospital; Italian Ministry of Health, Bando [GR-2010-2311017]; Foundation for Liver Research, London, UK; My First AIRC Grant (MFAG) of the Italian Association for Cancer Research	Italian Ministry of Health through the Division of Gastroenterology and Research Laboratory; Department of Medical Sciences, Division of Internal Medicine IRCCS "Casa Sollievo della Sofferenza" Hospital; Italian Ministry of Health, Bando; Foundation for Liver Research, London, UK; My First AIRC Grant (MFAG) of the Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by "Italian Ministry of Health" grant RC1103GA48 and RC1201ME04 through the Division of Gastroenterology and Research Laboratory, and Department of Medical Sciences, Division of Internal Medicine IRCCS "Casa Sollievo della Sofferenza" Hospital and by the "5 x 1000" voluntary contributions. PV and MV are supported by Italian Ministry of Health, Bando GR-2010-2311017. MV acknowledges funding by the Foundation for Liver Research, London, UK, and by a My First AIRC Grant (MFAG) of the Italian Association for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Canaple L, 2003, CANCER RES, V63, P7545; Chen P, 2010, FEBS LETT, V584, P1597, DOI 10.1016/j.febslet.2010.03.019; Chen P, 2009, AM J PATHOL, V174, P63, DOI 10.2353/ajpath.2009.080430; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Chu LW, 2008, PROSTATE CANCER P D, V11, P342, DOI 10.1038/sj.pcan.4501024; Collaco AM, 2005, MOL IMAGING BIOL, V7, P342, DOI 10.1007/s11307-005-0019-y; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Jonas MM, 1996, J PEDIATR GASTR NUTR, V23, P93, DOI 10.1097/00005176-199608000-00001; Kalamvoki M, 2010, P NATL ACAD SCI USA, V107, P17721, DOI 10.1073/pnas.1012991107; Kang TH, 2009, CELL CYCLE, V8, P1665, DOI 10.4161/cc.8.11.8707; Keum SJ, 2012, VIROLOGY, V433, P462, DOI 10.1016/j.virol.2012.08.046; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Kwon YC, 2013, FEBS LETT, V587, P156, DOI 10.1016/j.febslet.2012.11.010; Lange CM, 2013, J HEPATOL, V58, P583, DOI 10.1016/j.jhep.2012.10.019; Lin YM, 2008, MOL CARCINOGEN, V47, P925, DOI 10.1002/mc.20446; Miyazaki K, 2007, GENES CELLS, V12, P1225, DOI 10.1111/j.1365-2443.2007.01129.x; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Ohdo S, 2010, ADV DRUG DELIVER REV, V62, P857, DOI 10.1016/j.addr.2010.05.007; Oshima T, 2011, ONCOL REP, V25, P1439, DOI 10.3892/or.2011.1207; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Pazienza V, 2010, J GEN VIROL, V91, P1678, DOI 10.1099/vir.0.020644-0; Rappa F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054458; Ripoli M, 2011, EXPERT REV ANTI-INFE, V9, P747, DOI [10.1586/ERI.11.94, 10.1586/eri.11.94]; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Salva MAQ, 2011, CURR PHARM DESIGN, V17, P1459; Schibler Ueli, 2007, Dialogues Clin Neurosci, V9, P257; Shadan FF, 2007, MED HYPOTHESES, V68, P546, DOI 10.1016/j.mehy.2006.08.018; Tevy MF, 2013, TRENDS ENDOCRINOL ME; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Zhu Y, 2008, BREAST CANCER RES TR, V107, P421, DOI 10.1007/s10549-007-9565-0	38	34	34	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60527	10.1371/journal.pone.0060527	http://dx.doi.org/10.1371/journal.pone.0060527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593233	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000036
J	Hodgson, MC; VanOstran, G; Alghamdi, S; Poppiti, RJ; Agoulnik, AI; Agoulnik, IU				Hodgson, Myles C.; VanOstran, Garrett; Alghamdi, Sarah; Poppiti, Robert J.; Agoulnik, Alexander I.; Agoulnik, Irina U.			Reduced Androgen Receptor Expression Accelerates the Onset of ERBB2 Induced Breast Tumors in Female Mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; TRANSGENIC MICE; MAMMARY-TUMORS; POSTMENOPAUSAL WOMEN; 1ST-LINE THERAPY; PROTO-ONCOGENE; MESSENGER-RNA; PHASE-III; CANCER; FOXA1	Androgen receptor (AR) is commonly expressed in both the epithelium of normal mammary glands and in breast cancers. AR expression in breast cancers is independent of estrogen receptor alpha (ER alpha) status and is frequently associated with overexpression of the ERBB2 oncogene. AR signaling effects on breast cancer progression may depend on ER alpha and ERBB2 status. Up to 30% of human breast cancers are driven by overactive ERBB2 signaling and it is not clear whether AR expression affects any steps of tumor progression in this cohort of patients. To test this, we generated mammary specific Ar depleted mice (MARKO) by combining the floxed allele of Ar with the MMTV-cre transgene on an MMTV-NeuNT background and compared them to littermate MMTV-NeuNT, Ar-fl/+ control females. Heterozygous MARKO females displayed reduced levels of AR in mammary glands with mosaic AR expression in ductal epithelium. The loss of AR dramatically accelerated the onset of MMTV-NeuNT tumors in female MARKO mice. In this report we show that accelerated MMTV-NeuNT-dependent tumorigenesis is due specifically to the loss of AR, as hormonal levels, estrogen and progesterone receptors expression, and MMTV-NeuNT expression were similar between MARKO and control groups. MMTV-NeuNT induced tumors in both cohorts displayed distinct loss of AR in addition to ER alpha, PR, and the pioneer factor FOXA1. Erbb3 mRNA levels were significantly elevated in tumors in comparison to normal mammary glands. Thus the loss of AR in mouse mammary epithelium accelerates malignant transformation rather than the rate of tumorigenesis.	[Hodgson, Myles C.; VanOstran, Garrett; Agoulnik, Irina U.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA; [Alghamdi, Sarah; Poppiti, Robert J.] Mt Sinai Med Ctr, Dept Pathol, Miami Beach, FL 33140 USA; [Agoulnik, Alexander I.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Mol & Human Genet, Miami, FL 33199 USA; [Agoulnik, Alexander I.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Agoulnik, Irina U.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	State University System of Florida; Florida International University; Mount Sinai Medical Center; State University System of Florida; Florida International University; Baylor College of Medicine; Baylor College of Medicine	Agoulnik, IU (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA.	Irina.Agoulnik@fiu.edu	Agoulnik, Irina/AAD-4687-2020; Agoulnik, Alexander/AAK-3213-2020	Agoulnik, Irina/0000-0003-4889-0324; Agoulnik, Alexander/0000-0001-6587-6845; Hodgson, Myles/0000-0002-0194-1254	Department of Defense BCRP [BC097064]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health (SCCPIR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER	Department of Defense BCRP(United States Department of Defense); Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health (SCCPIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research has been supported by the Department of Defense BCRP grant BC097064. It did not affect the research conclusions in any way. Steroid analysis of the mouse sera was supported in part by Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health (SCCPIR) grant U54-HD28934. It did not affect the results of blood hormone measurements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; Day JK, 2001, NUTR CANCER, V39, P226, DOI 10.1207/S15327914nc392_11; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DRINKWATER NR, 1986, CARCINOGENESIS, V7, P1701, DOI 10.1093/carcin/7.10.1701; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Festing MFW, 1998, GENOMICS, V53, P129, DOI 10.1006/geno.1998.5450; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Geschickter CF, 1939, SCIENCE, V89, P35, DOI 10.1126/science.89.2298.35-a; Gonzalez LO, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-149; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hewitt SC, 2002, CANCER RES, V62, P2798; Hickey TE, 2012, MOL ENDOCRINOL; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Jackson-Fisher AJ, 2006, ONCOGENE, V25, P5664, DOI 10.1038/sj.onc.1209574; Jozwik KM, 2012, NAT REV CANC; Korach KS, 1996, RECENT PROG HORM RES, V51, P159; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lydon JP, 1999, CANCER RES, V59, P4276; Lydon JP, 1996, J STEROID BIOCHEM, V56, P67, DOI 10.1016/0960-0760(95)00254-5; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Naderi A, 2008, NEOPLASIA, V10, P542, DOI 10.1593/neo.08274; Naderi A, 2012, NEOPLASIA, V14, P283, DOI 10.1593/neo.12294; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Notini AJ, 2005, J MOL ENDOCRINOL, V35, P547, DOI 10.1677/jme.1.01884; Paridaens RJ, 2008, J CLIN ONCOL, V26, P4883, DOI 10.1200/JCO.2007.14.4659; Peters AA, 2011, ENDOCRINOLOGY, V152, P3728, DOI 10.1210/en.2011-1133; Peters AA, 2009, CANCER RES, V69, P6131, DOI 10.1158/0008-5472.CAN-09-0452; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; ROSE DP, 1988, ANTICANCER RES, V8, P845; Rowse GJ, 1998, CANCER RES, V58, P2675; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Simanainen U, 2012, HORM CANCER-US, V3, P113, DOI 10.1007/s12672-012-0107-9; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Srinivasan R, 1998, J PATHOL, V185, P236, DOI 10.1002/(SICI)1096-9896(199807)185:3<236::AID-PATH118>3.0.CO;2-7; Taneja P, 2009, EXPERT REV MOL DIAGN, V9, P423, DOI 10.1586/ERM.09.31; Teschendorff AE, 2006, BIOINFORMATICS, V22, P2269, DOI 10.1093/bioinformatics/btl174; Toneff MJ, 2010, NEOPLASIA, V12, P718, DOI 10.1593/neo.10516; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vaught DB, 2012, CANCER RES, V72, P2672, DOI 10.1158/0008-5472.CAN-11-3594; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399	50	11	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60455	10.1371/journal.pone.0060455	http://dx.doi.org/10.1371/journal.pone.0060455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593223	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000033
J	Lehner, A; Magdolen, V; Schuster, T; Kotzsch, M; Kiechle, M; Meindl, A; Sweep, FCGJ; Span, PN; Gross, E				Lehner, Anna; Magdolen, Viktor; Schuster, Tibor; Kotzsch, Matthias; Kiechle, Marion; Meindl, Alfons; Sweep, Fred C. G. J.; Span, Paul N.; Gross, Eva			Downregulation of Serine Protease HTRA1 Is Associated with Poor Survival in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SMALL-VESSEL DISEASE; OVARIAN-CANCER; ENDOMETRIAL CANCER; GENE-EXPRESSION; CELLS; PROGRESSION; CHEMOTHERAPY; TGF-BETA-1; PREDICTOR	HTRA1 is a highly conserved serine protease which has been implicated in suppression of epithelial-to-mesenchymal-transition (EMT) and cell motility in breast cancer. Its prognostic relevance for breast cancer is unclear so far. Therefore, we evaluated the impact of HTRA1 mRNA expression on patient outcome using a cohort of 131 breast cancer patients as well as a validation cohort including 2809 publically available data sets. Additionally, we aimed at investigating for the presence of promoter hypermethylation as a mechanism for silencing the HTRA1 gene in breast tumors. HTRA1 downregulation was detected in more than 50% of the breast cancer specimens and was associated with higher tumor stage (p = 0.025). By applying Cox proportional hazard models, we observed favorable overall (OS) and disease-free survival (DFS) related to high HTRA1 expression (HR = 0.45 [CI 0.23-0.90], p = 0.023; HR = 0.55 [CI 0.32-0.94], p = 0.028, respectively), with even more pronounced impact in node-positive patients (HR = 0.21 [CI 0.07-0.63], p = 0.006; HR = 0.29 [CI 0.13-0.65], p = 0.002, respectively). Moreover, HTRA1 remained a statistically significant factor predicting DFS among established clinical parameters in the multivariable analysis. Its impact on patient outcome was independently confirmed in the validation set (for relapse-free survival (n = 2809): HR = 0.79 [CI 0.7-0.9], log-rank p = 0.0003; for OS (n = 971): HR = 0.63 [CI 0.48-0.83], log-rank p = 0.0009). In promoter analyses, we in fact detected methylation of HTRA1 in a small subset of breast cancer specimens (two out of a series of 12), and in MCF-7 breast cancer cells which exhibited 22-fold lower HTRA1 mRNA expression levels compared to unmethylated MDA-MB-231 cells. In conclusion, we show that downregulation of HTRA1 is associated with shorter patient survival, particularly in node-positive breast cancer. Since HTRA1 loss was demonstrated to induce EMT and cancer cell invasion, these patients might benefit from demethylating agents or histone deacetylase inhibitors previously reported to lead to HTRA1 upregulation, or from novel small-molecule inhibitors targeting EMT-related processes.	[Lehner, Anna; Magdolen, Viktor; Kiechle, Marion; Meindl, Alfons; Gross, Eva] Tech Univ Munich, Dept Gynecol & Obstet, D-80290 Munich, Germany; [Schuster, Tibor] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Kotzsch, Matthias] Tech Univ Dresden, Inst Pathol, Dresden, Germany; [Sweep, Fred C. G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands	Technical University of Munich; Technical University of Munich; Technische Universitat Dresden; Radboud University Nijmegen; Radboud University Nijmegen	Gross, E (corresponding author), Tech Univ Munich, Dept Gynecol & Obstet, D-80290 Munich, Germany.	eva.gross@lrz.tum.de	Span, Paul/G-4710-2012; Sweep, C.G.J./H-8096-2014	Span, Paul/0000-0002-1930-6638; Sweep, C.G.J./0000-0003-1103-3070	Dept. of Gynecology, Technische Universitat Munchen, Germany	Dept. of Gynecology, Technische Universitat Munchen, Germany	Funding source was internal funding by the Dept. of Gynecology, Technische Universitat Munchen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Ajayi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.046; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Baldi A, 2008, PHARMACOGENOMICS, V9, P1069, DOI 10.2217/14622416.9.8.1069; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; Campioni Mara, 2011, Front Biosci (Elite Ed), V3, P1493; Catalano V, 2011, HISTOPATHOLOGY, V58, P669, DOI 10.1111/j.1365-2559.2011.03818.x; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Esposito V, 2006, ANTICANCER RES, V26, P3455; Fang YZ, 2013, JNCI-J NATL CANCER I, V105, P47, DOI 10.1093/jnci/djs485; FARTHMANN J, 2004, RADIOL ONCOL, V38, P111; Folgueira MAAK, 2005, CLIN CANCER RES, V11, P7434; Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; He XP, 2012, INT J CANCER, V130, P1029, DOI 10.1002/ijc.26044; He XP, 2010, CANCER RES, V70, P3109, DOI 10.1158/0008-5472.CAN-09-3557; Holzscheiter L, 2006, CLIN CHEM, V52, P1070, DOI 10.1373/clinchem.2005.065599; Hothorn T, 2002, R NEWS, V2, P3; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Lv ZD, 2013, ONCOL REP, V29, P219, DOI 10.3892/or.2012.2111; Malet H, 2012, NAT STRUCT MOL BIOL, V19, P152, DOI 10.1038/nsmb.2210; Mauney J, 2010, MATRIX BIOL, V29, P657, DOI 10.1016/j.matbio.2010.08.008; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mullany SA, 2011, CLIN CANCER RES, V17, P427, DOI 10.1158/1078-0432.CCR-09-3069; Narkiewicz J, 2009, ONCOL REP, V21, P1529, DOI 10.3892/or_00000385; Polur I, 2010, HISTOL HISTOPATHOL, V25, P599, DOI 10.14670/HH-25.599; Sato S, 2011, BREAST CANCER RES TR, V127, P649, DOI 10.1007/s10549-010-1042-5; Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Span PN, 2003, ONCOGENE, V22, P4898, DOI 10.1038/sj.onc.1206818; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039446; Zhu F, 2010, HEPATOB PANCREAT DIS, V9, P508; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06; Zurawa-Janicka D, 2008, ACTA BIOCHIM POL, V55, P9, DOI 10.18388/abp.2008_3123	40	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60359	10.1371/journal.pone.0060359	http://dx.doi.org/10.1371/journal.pone.0060359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580433	Green Published, gold			2022-12-27	WOS:000317898000028
J	Moleirinho, S; Patrick, C; Tilston-Lunel, AM; Higginson, JR; Angus, L; Antkowiak, M; Barnett, SC; Prystowsky, MB; Reynolds, PA; Gunn-Moore, FJ				Moleirinho, Susana; Patrick, Calum; Tilston-Luenel, Andrew M.; Higginson, Jennifer R.; Angus, Liselotte; Antkowiak, Maciej; Barnett, Susan C.; Prystowsky, Michael B.; Reynolds, Paul A.; Gunn-Moore, Frank J.			Willin, an Upstream Component of the Hippo Signaling Pathway, Orchestrates Mammalian Peripheral Nerve Fibroblasts	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL SELF-RENEWAL; YAP ONCOPROTEIN; SCHWANN-CELLS; SIZE-CONTROL; ORGAN SIZE; CCN FAMILY; REGENERATION; TISSUE; PROTEIN	Willin/FRMD6 was first identified in the rat sciatic nerve, which is composed of neurons, Schwann cells, and fibroblasts. Willin is an upstream component of the Hippo signaling pathway, which results in the inactivation of the transcriptional co-activator YAP through Ser127 phosphorylation. This in turn suppresses the expression of genes involved in cell growth, proliferation and cancer development ensuring the control of organ size, cell contact inhibition and apoptosis. Here we show that in the mammalian sciatic nerve, Willin is predominantly expressed in fibroblasts and that Willin expression activates the Hippo signaling cascade and induces YAP translocation from the nucleus to the cytoplasm. In addition within these cells, although it inhibits cellular proliferation, Willin expression induces a quicker directional migration towards scratch closure and an increased expression of factors linked to nerve regeneration. These results show that Willin modulates sciatic nerve fibroblast activity indicating that Willin may have a potential role in the regeneration of the peripheral nervous system.	[Moleirinho, Susana; Patrick, Calum; Reynolds, Paul A.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Moleirinho, Susana; Tilston-Luenel, Andrew M.; Angus, Liselotte; Antkowiak, Maciej; Gunn-Moore, Frank J.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Prystowsky, Michael B.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Higginson, Jennifer R.; Barnett, Susan C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of St Andrews; University of St Andrews; Yeshiva University; Albert Einstein College of Medicine; University of Glasgow	Reynolds, PA (corresponding author), Univ St Andrews, Sch Med, Med & Biol Sci Bldg, St Andrews, Fife, Scotland.	par10@st-andrews.ac.uk; fjg1@st-andrews.ac.uk		Antkowiak, Maciej/0000-0002-2390-1966; Tilston-Lunel, Andrew/0000-0002-5582-6884; Gunn-Moore, Francis James/0000-0003-3422-3387; Reynolds, Paul/0000-0001-8738-1245; Moleirinho, Susana/0000-0002-0593-7172	Scottish University Life Science Alliance; School of Biology, University of St Andrews; BBSRC	Scottish University Life Science Alliance; School of Biology, University of St Andrews; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Scottish University Life Science Alliance for funding for SM; School of Biology, University of St Andrews for funding for ATL; and the BBSRC for funding for LA. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus L, 2012, ONCOGENE, V31, P238, DOI 10.1038/onc.2011.224; Block ER, 2008, MOL BIOL CELL, V19, P4909, DOI 10.1091/mbc.E08-01-0097; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao C, 2006, BIOCHEM J, V400, P225, DOI 10.1042/BJ20060816; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; FUJII K, 1995, EXP CELL RES, V216, P261, DOI 10.1006/excr.1995.1032; GABBIANI G, 1972, J EXP MED, V135, P719, DOI 10.1084/jem.135.4.719; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Gunn-Moore FJ, 2005, FEBS LETT, V579, P5089, DOI 10.1016/j.febslet.2005.07.097; Gunn-Moore FJ, 2006, MOL CELL NEUROSCI, V33, P441, DOI 10.1016/j.mcn.2006.09.003; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Judson RN, 2012, J CELL SCI; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; MATTHAY MA, 1993, J CELL SCI, V106, P869; Moleirinho S, 2012, ONCOGENE; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Oumi N, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/476820; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; SCARAVILLI F, 1984, J ANAT, V139, P411; SCHRODER JM, 1993, CLIN NEUROL NEUROSUR, V95, pS78; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Tsujii M, 2009, CLIN ORTHOP RELAT R, V467, P3183, DOI 10.1007/s11999-009-1009-1; Umeda N, 2004, AM J OPHTHALMOL, V138, P270, DOI 10.1016/j.ajo.2004.04.006; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Xie Z, 2012, ONCOGENE, V31, P5090, DOI 10.1038/onc.2012.10; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	60	21	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60028	10.1371/journal.pone.0060028	http://dx.doi.org/10.1371/journal.pone.0060028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593160	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000317898000018
J	Postol, E; Alencar, R; Higa, FT; de Barros, SF; Demarchi, LMF; Kalil, J; Guilherme, L				Postol, Edilberto; Alencar, Raquel; Higa, Fabio T.; de Barros, Samar Freschi; Demarchi, Lea M. F.; Kalil, Jorge; Guilherme, Luiza			StreptInCor: A Candidate Vaccine Epitope against S. pyogenes Infections Induces Protection in Outbred Mice	PLOS ONE			English	Article							A STREPTOCOCCAL INFECTION; M-PROTEIN; RHEUMATIC-FEVER; CARDIAC MYOSIN; PATHOGENESIS; INTRANASAL; BURDEN; IMMUNOGENICITY; EPIDEMIOLOGY; PHARYNGITIS	Infection with Streptococcus pyogenes (S. pyogenes) can result in several diseases, particularly in children. S. pyogenes M protein is the major virulence factor, and certain regions of its N-terminus can trigger autoimmune sequelae such as rheumatic fever in susceptible individuals with untreated group A streptococcal pharyngitis. In a previous study, we utilized a large panel of human peripheral blood cells to define the C-terminal protective epitope StreptInCor (medical identity), which does not induce autoimmune reactions. We recently confirmed the results in HLA-transgenic mice. In the present study, we extended the experimental assays to outbred animals (Swiss mice). Herein, we demonstrate high titers of StreptInCor-specific antibodies, as well as appropriate T-cell immune responses. No cross-reaction to cardiac myosin was detected. Additionally, immunized Swiss mice exhibited 87% survival one month after challenge with S. pyogenes. In conclusion, the data presented herein reinforce previous results in humans and animals and further emphasize that StreptInCor could be an effective and safe vaccine for the prevention of S. pyogenes infections.	[Postol, Edilberto; Alencar, Raquel; Higa, Fabio T.; de Barros, Samar Freschi; Demarchi, Lea M. F.; Kalil, Jorge; Guilherme, Luiza] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil; [Postol, Edilberto; Alencar, Raquel; Higa, Fabio T.; de Barros, Samar Freschi; Kalil, Jorge; Guilherme, Luiza] Univ Sao Paulo, Natl Inst Sci & Technol, Inst Immunol Invest, Sao Paulo, Brazil; [Kalil, Jorge] Univ Sao Paulo, Sch Med, Clin Immunol & Allergy Div, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Guilherme, L (corresponding author), Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil.	luizagui@usp.br	KALIL, JORGE/C-8029-2012; de Barros, Samar Freschi/Q-4970-2018	KALIL, JORGE/0000-0001-8415-4274; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP), Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP), Brazil(Financiadora de Inovacao e Pesquisa (Finep))	This study was supported by grants from the "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)", "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)" and "Financiadora de Estudos e Projetos (FINEP)", Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzloff MR, 2005, J INFECT DIS, V192, P1450, DOI 10.1086/466528; BESSEN D, 1988, J EXP MED, V167, P1945, DOI 10.1084/jem.167.6.1945; Bisno AL, 2005, CLIN INFECT DIS, V41, P1150, DOI 10.1086/444505; Bronze MS, 2010, AM J MED SCI, V340, P218, DOI 10.1097/MAJ.0b013e3181e939ab; Brook I, 2007, INT J PEDIATR OTORHI, V71, P1501, DOI 10.1016/j.ijporl.2007.06.006; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cunningham MW, 2004, MOL IMMUNOL, V40, P1121, DOI 10.1016/j.molimm.2003.11.023; Cunningham MW, 2001, AM J PATHOL, V159, P5, DOI 10.1016/S0002-9440(10)61665-3; DAJANI A, 1995, PEDIATRICS, V96, P758; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; Danchin MH, 2007, PEDIATRICS, V120, P950, DOI 10.1542/peds.2006-3368; Fae KC, 2006, J IMMUNOL, V176, P5662, DOI 10.4049/jimmunol.176.9.5662; FISCHETTI VA, 1991, SCI AM, V264, P58, DOI 10.1038/scientificamerican0691-58; Guerino MT, 2011, VACCINE, V29, P8250, DOI 10.1016/j.vaccine.2011.08.113; Guilherme L, 2006, CLIN DEV IMMUNOL, V13, P125, DOI 10.1080/17402520600877026; Guilherme L, 2011, ANN PEDIAT CARDIOL, V4, P13, DOI 10.4103/0974-2069.79617; Guilherme L, 2011, ADV CLIN CHEM, V53, P31, DOI 10.1016/S0065-2423(11)53002-1; Guilherme L, 2009, METHODS, V49, P316, DOI 10.1016/j.ymeth.2009.03.024; Guilherme L, 2011, J BIOL CHEM, V286, P6989, DOI 10.1074/jbc.M110.132118; Guilherme L, 2010, J CLIN IMMUNOL, V30, P17, DOI 10.1007/s10875-009-9332-6; Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Kotloff KL, 2005, INFECT IMMUN, V73, P2360, DOI 10.1128/IAI.73.4.2360-2366.2005; Kotloff KL, 2004, JAMA-J AM MED ASSOC, V292, P709, DOI 10.1001/jama.292.6.709; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Olive C, 2007, VACCINE, V25, P1789, DOI 10.1016/j.vaccine.2006.11.031; Olive C, 2005, VACCINE, V23, P2298, DOI 10.1016/j.vaccine.2005.01.041; Pfoh E, 2008, PEDIATRICS, V121, P229, DOI 10.1542/peds.2007-0484; Quinn A, 1998, INFECT IMMUN, V66, P4418; Smeesters PR, 2008, VACCINE, V26, P5835, DOI 10.1016/j.vaccine.2008.08.037; Smeesters PR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000010; Sociedade Brasileira de Cardiologia, 2009, Arq Bras Cardiol, V93, P3; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Vohra H, 2005, RES MICROBIOL, V156, P575, DOI 10.1016/j.resmic.2004.12.009	38	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60969	10.1371/journal.pone.0060969	http://dx.doi.org/10.1371/journal.pone.0060969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593359	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000087
J	Stalter, D; Magdeburg, A; Quednow, K; Botzat, A; Oehlmann, J				Stalter, Daniel; Magdeburg, Axel; Quednow, Kristin; Botzat, Alexandra; Oehlmann, Joerg			Do Contaminants Originating from State-of-the-Art Treated Wastewater Impact the Ecological Quality of Surface Waters?	PLOS ONE			English	Article							AQUATIC INVERTEBRATES; OXYGEN DEFICIENCY; POLYCYCLIC MUSKS; STREAMS; PHARMACEUTICALS; EFFLUENT; RIVERS; MACROINVERTEBRATES; SENSITIVITY; GERMANY	Since the 1980s, advances in wastewater treatment technology have led to considerably improved surface water quality in the urban areas of many high income countries. However, trace concentrations of organic wastewater-associated contaminants may still pose a key environmental hazard impairing the ecological quality of surface waters. To identify key impact factors, we analyzed the effects of a wide range of anthropogenic and environmental variables on the aquatic macroinvertebrate community. We assessed ecological water quality at 26 sampling sites in four urban German lowland river systems with a 0-100% load of state-of-the-art biological activated sludge treated wastewater. The chemical analysis suite comprised 12 organic contaminants (five phosphor organic flame retardants, two musk fragrances, bisphenol A, nonylphenol, octylphenol, diethyltoluamide, terbutryn), 16 polycyclic aromatic hydrocarbons, and 12 heavy metals. Non-metric multidimensional scaling identified organic contaminants that are mainly wastewater-associated (i.e., phosphor organic flame retardants, musk fragrances, and diethyltoluamide) as a major impact variable on macroinvertebrate species composition. The structural degradation of streams was also identified as a significant factor. Multiple linear regression models revealed a significant impact of organic contaminants on invertebrate populations, in particular on Ephemeroptera, Plecoptera, and Trichoptera species. Spearman rank correlation analyses confirmed wastewater-associated organic contaminants as the most significant variable negatively impacting the biodiversity of sensitive macroinvertebrate species. In addition to increased aquatic pollution with organic contaminants, a greater wastewater fraction was accompanied by a slight decrease in oxygen concentration and an increase in salinity. This study highlights the importance of reducing the wastewater-associated impact on surface waters. For aquatic ecosystems in urban areas this would lead to: (i) improvement of the ecological integrity, (ii) reduction of biodiversity loss, and (iii) faster achievement of objectives of legislative requirements, e.g., the European Water Framework Directive.	[Stalter, Daniel; Magdeburg, Axel; Oehlmann, Joerg] Goethe Univ Frankfurt, Div Biol Sci, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany; [Quednow, Kristin] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60054 Frankfurt, Germany; [Botzat, Alexandra] Univ Marburg, Fac Biol, Dept Ecol Conservat Ecol, Marburg, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Philipps University Marburg	Stalter, D (corresponding author), Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld, Australia.	d.stalter@uq.edu.au	Oehlmann, Jörg/B-4565-2010; Magdeburg, Axel/G-5609-2011	Oehlmann, Jörg/0000-0002-6075-2701; 	Hessian Ministry for Science and the Arts (Germany)	Hessian Ministry for Science and the Arts (Germany)	This work was supported by grants of the Hessian Ministry for Science and the Arts (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQEM, 2006, ASTERICS SOFTW MAN V; Artola-Garicano E, 2003, ENVIRON TOXICOL CHEM, V22, P1086, DOI [10.1897/1551-5028(2003)022&lt;1086:BAATOP&gt;2.0.CO;2, 10.1002/etc.5620220516]; Backhaus K., 2006, MULTIVARIATE ANAL ME; Beasley G, 2002, PROG PHYS GEOG, V26, P236, DOI 10.1191/0309133302pp334ra; Beketov MA, 2004, RUSS J ECOL+, V35, P200, DOI 10.1023/B:RUSE.0000025972.29638.46; [BMU Bundesministerium fuer Umwelt Naturschutz und Reaktorsicherheit [German Federal Ministry for the Environment Nature Conservation and Nuclear Safety]], 2007, WAST FLOW PROC GERM; Borja A, 2008, ECOL INDIC, V8, P331, DOI 10.1016/j.ecolind.2007.05.004; Brack Werner, 2009, Integrated Environmental Assessment and Management, V5, P5, DOI 10.1897/IEAM_2008-024.1; Buerge IJ, 2003, ENVIRON SCI TECHNOL, V37, P5636, DOI 10.1021/es0300721; Bundschuh M, 2011, ENVIRON POLLUT, V159, P244, DOI 10.1016/j.envpol.2010.08.030; Clements WH, 2000, ECOL APPL, V10, P626, DOI 10.1890/1051-0761(2000)010[0626:HMSBCI]2.0.CO;2; Coimbra CN, 1996, ENVIRON POLLUT, V94, P301, DOI 10.1016/S0269-7491(96)00091-7; Crawley M.J., 2007, R BOOK; Daughton CG, 2003, ENVIRON HEALTH PERSP, V111, P757, DOI 10.1289/ehp.5947; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; [DIN Fachgruppe Wasserchemie der GDCh und Normenausschuss Wasserwesen (NAW) DIN Deutsches Institut fur Normung e.V.], 1996, DTSCH VERF WASS ABW, V1; [DIN Fachgruppe Wasserchemie der GDCh und Normenausschuss Wasserwesen (NAW) DIN Deutsches Institut fur Normung e.V.], 1987, DTSCH VERF WASS ABW, V1; EC, 2003, 37 EC EUR UN EUR CHE; EC, 2000, EUR COMM IUCLID DAT; EC, 2002, 10 EC EUR UN EUR CHE; Ehlert T, 2002, INT REV HYDROBIOL, V87, P151, DOI 10.1002/1522-2632(200205)87:2/3<151::AID-IROH151>3.0.CO;2-A; Fahrenberger G, 1986, HESSISCHES RIED BERG; Ginebreda A, 2010, ENVIRON INT, V36, P153, DOI 10.1016/j.envint.2009.10.003; Haase P, 2006, INFORMATIONSTEXT OPE; Haase P., 2004, STANDARDISIERUNG ERF; Hakanson L., 1983, PRINCIPLES LAKE SEDI; Hering D, 2004, HYDROBIOLOGIA, V516, P1, DOI 10.1023/B:HYDR.0000025255.70009.a5; Hollender J, 2009, ENVIRON SCI TECHNOL, V43, P7862, DOI 10.1021/es9014629; Jacobsen D, 2003, FRESHWATER BIOL, V48, P2025, DOI 10.1046/j.1365-2427.2003.01140.x; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Jobling S, 2003, AQUAT TOXICOL, V65, P205, DOI 10.1016/S0166-445X(03)00134-6; Karlson K, 2002, OCEANOGR MAR BIOL, V40, P427; Kefford BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035224; Kefford BJ, 2011, ENVIRON POLLUT, V159, P302, DOI 10.1016/j.envpol.2010.08.025; Koh YKK, 2009, ENVIRON SCI TECHNOL, V43, P6646, DOI 10.1021/es901612v; Laursen AE, 2004, FRESHWATER BIOL, V49, P1448, DOI 10.1111/j.1365-2427.2004.01280.x; Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1; Linke S, 1999, FRESHWATER BIOL, V42, P575, DOI 10.1046/j.1365-2427.1999.00492.x; Liu ZH, 2009, SCI TOTAL ENVIRON, V407, P731, DOI 10.1016/j.scitotenv.2008.08.039; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; Magdeburg A, 2012, CHEMOSPHERE, V88, P1008, DOI 10.1016/j.chemosphere.2012.04.017; Nentwig G, 2007, ARCH ENVIRON CON TOX, V52, P163, DOI 10.1007/s00244-005-7190-7; Oehlmann J, 2006, ENVIRON HEALTH PERSP, V114, P127, DOI 10.1289/ehp.8065; Oetken M, 2005, ARCH ENVIRON CON TOX, V49, P353, DOI 10.1007/s00244-004-0211-0; Oksanen J., 2016, R PACKAG; Parrott JL, 2005, ENVIRON TOXICOL, V20, P131, DOI 10.1002/tox.20087; Pond GJ, 2010, HYDROBIOLOGIA, V641, P185, DOI 10.1007/s10750-009-0081-6; Pottgiesser T, 2003, MAP GERMAN STREAM TY; Quednow K, 2008, ENVIRON POLLUT, V152, P476, DOI 10.1016/j.envpol.2007.05.032; Quednow K, 2008, CLEAN-SOIL AIR WATER, V36, P70, DOI 10.1002/clen.200700023; Quednow K, 2007, J ENVIRON MONITOR, V9, P1337, DOI 10.1039/b711854f; Quednow K, 2009, ENVIRON SCI POLLUT R, V16, P630, DOI 10.1007/s11356-009-0169-6; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Spanhoff B, 2007, RESTOR ECOL, V15, P317, DOI 10.1111/j.1526-100X.2007.00216.x; Stalter D, 2011, WATER RES, V45, P1015, DOI 10.1016/j.watres.2010.10.008; Stalter D, 2010, WATER RES, V44, P2610, DOI 10.1016/j.watres.2010.01.023; Stalter D, 2010, WATER RES, V44, P439, DOI 10.1016/j.watres.2009.07.025; Triebskorn R, 2007, ANAL BIOANAL CHEM, V387, P1405, DOI 10.1007/s00216-006-1033-x; UNSD, 2010, ENV IND INL WAT RES; Usepa, 1982, FED REGISTER, V47, P52309; Vaughan IP, 2012, GLOBAL CHANGE BIOL, V18, P2184, DOI 10.1111/j.1365-2486.2012.02662.x; Von Der Ohe PC, 2004, ENVIRON TOXICOL CHEM, V23, P150, DOI 10.1897/02-577; Weemaes M, 2011, WATER SCI TECHNOL, V63, P72, DOI 10.2166/wst.2011.011; WHO, 2000, ENV HLTH CRIT, V218; World Health Organization, 1998, ENV HLTH CRIT, V209; Zumbroich T, 1999, STRUKTURGUETE FLIESS	68	42	43	2	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60616	10.1371/journal.pone.0060616	http://dx.doi.org/10.1371/journal.pone.0060616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593263	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000043
J	Wang, W; Gu, F; Wei, C; Tang, YG; Zheng, X; Ren, MQ; Qin, YD				Wang, Wei; Gu, Fang; Wei, Cai; Tang, Yigui; Zheng, Xin; Ren, Mingqiang; Qin, Yide			PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer Growth by Targeting BCL2	PLOS ONE			English	Article							MILK PROTEIN; BETA-CASEIN; BINDING-SITES; PEPTIDES; APOPTOSIS; CELLS; LACTOFERRIN; INHIBITION	Bioactive peptides, either derived from nature resources or synthesized by rational design, have been demonstrated potential for therapeutic agents against numerous human diseases, including cancer. However, the mechanism of therapeutic peptides against cancer has not been well elucidated. Here we show that PGPIPN, a hexapeptide derived from bovine beta-casein, inhibited the proliferation of human ovarian cancer cells line SKOV3 as well as the primary ovarian cancer cells in vitro. Consistently, PGPIPIN also decreased tumor growth rate in xenograft ovarian cancer model mice in a dose-dependent manner. Further study demonstrated that the anti-tumor effect of PGPIPN is partially through promoting cell apoptosis by inhibiting BCL2 pathway. Thus, our study suggests that PGPIPN is a potential therapeutic agent for the treatment of ovarian cancer or other types of cancer.	[Wang, Wei; Gu, Fang; Wei, Cai; Tang, Yigui; Zheng, Xin; Ren, Mingqiang; Qin, Yide] Anhui Med Univ, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China; [Ren, Mingqiang] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA	Anhui Medical University; University System of Georgia; Augusta University	Qin, YD (corresponding author), Anhui Med Univ, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China.	yideqin@hotmail.com			National Natural Science Foundation of China [30872992]; Province Natural Science Foundation of Anhui [03043802]; National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Province Natural Science Foundation of Anhui; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30872992) and the Province Natural Science Foundation of Anhui (03043802). The 300000 RMB was granted for this research by the National Natural Science Foundation of China, the URL of which is http://www.nsfc.gov.cn. The Province Natural Science Foundation of Anhui funded 100000 RMB for the study. The funders had role in study design, experiments, data collection and analysis, preparation of the manuscript.	Almansour NM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-65; Bishop EF, 2007, MODERN PATHOL, V20, P1036, DOI 10.1038/modpathol.3800933; Brix S, 2005, J DAIRY RES, V72, P217, DOI 10.1017/S0022029905000877; Cheok CF, 2012, DISCOV MED, V14, P263; Chronopoulou R, 2006, BRIT J NUTR, V96, P553, DOI 10.1079/BJN20061834; Dong Hua-sheng, 2007, Chinese Pharmacological Bulletin, V23, P73; Fiedorowicz E, 2011, PEPTIDES, V32, P707, DOI 10.1016/j.peptides.2010.12.003; Gill HS, 2000, BRIT J NUTR, V84, pS111; Gu Fang, 2006, Acta Nutrimenta Sinica, V28, P326; Istivan TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024809; JAZIRI M, 1992, BIOCHIM BIOPHYS ACTA, V1160, P251, DOI 10.1016/0167-4838(92)90085-R; Jiang B, 1999, BASIS CLIN CELL APOP; Kannan A, 2011, J SCI FOOD AGR, V91, P1920, DOI 10.1002/jsfa.4464; Kanwar JR, 2009, CURR PROTEIN PEPT SC, V10, P308, DOI 10.2174/138920309788922234; Kitazawa H, 2007, INT IMMUNOPHARMACOL, V7, P1150, DOI 10.1016/j.intimp.2007.04.008; Kreider RB, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-99; Li DP, 2011, ANTICANCER RES, V31, P529; Li JT, 2013, FOOD CHEM TOXICOL, V51, P297, DOI 10.1016/j.fct.2012.09.038; Li SP, 2005, ACTA U MED ANHUI, V40, P499; Mader JS, 2006, AM J PATHOL, V169, P1753, DOI 10.2353/ajpath.2006.051229; Martinez-Maqueda D, 2012, J AGR FOOD CHEM, V60, P8600, DOI 10.1021/jf301279k; Meisel H, 2003, CURR PHARM DESIGN, V9, P1289, DOI 10.2174/1381612033454847; MIGLIORESAMOUR D, 1989, J DAIRY RES, V56, P357, DOI 10.1017/S0022029900028806; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Urista CM, 2011, FOOD SCI TECHNOL INT, V17, P293, DOI 10.1177/1082013211398801; Nagpal R, 2011, FOOD FUNCT, V2, P18, DOI 10.1039/c0fo00016g; Raucher D, 2009, EXPERT OPIN DRUG DEL, V6, P1049, DOI 10.1517/17425240903158909; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Saito T, 2008, ADV EXP MED BIOL, V606, P295, DOI 10.1007/978-0-387-74087-4_12; Sambrook J, 2001, MOL CLONING LAB MANU, p[387, 611]; Spadaro M, 2008, FASEB J, V22, P2747, DOI 10.1096/fj.07-098038; Spadaro M, 2007, CANCER RES, V67, P6425, DOI 10.1158/0008-5472.CAN-06-4080; Su LY, 2010, ONCOL REP, V23, P3, DOI 10.3892/or_00000599; Takada K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003808; Xiao CW, 2001, J SCI FOOD AGR, V81, P300, DOI 10.1002/1097-0010(200102)81:3&lt;300::AID-JSFA807&gt;3.0.CO;2-D; Xiao Yan, 2007, Ai Zheng, V26, P386; Xue QS, 2003, PRINCIPLE TECHNOLOGY, P343; Yan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024705; Zheng DH, 2012, TRENDS MOL MED, V18, P304, DOI 10.1016/j.molmed.2012.03.006	39	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60701	10.1371/journal.pone.0060701	http://dx.doi.org/10.1371/journal.pone.0060701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593287	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000053
J	Ollinger, J; Bailey, MA; Moraski, GC; Casey, A; Florio, S; Alling, T; Miller, MJ; Parish, T				Ollinger, Juliane; Bailey, Mai Ann; Moraski, Garrett C.; Casey, Allen; Florio, Stephanie; Alling, Torey; Miller, Marvin J.; Parish, Tanya			A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis	PLOS ONE			English	Article							EARLY BACTERICIDAL ACTIVITY; CELL-WALL SYNTHESIS; PLATE-BASED SCREEN; INHIBITOR; AGENTS	Tuberculosis is a serious global health problem caused by the bacterium Mycobacterium tuberculosis. There is an urgent need for discovery and development of new treatments, but this can only be accomplished through rapid and reproducible M. tuberculosis assays designed to identify potent inhibitors. We developed an automated 96-well assay utilizing a recombinant strain of M. tuberculosis expressing a far-red fluorescent reporter to determine the activity of novel compounds; this allowed us to measure growth by monitoring both optical density and fluorescence. We determined that optical density and fluorescence were correlated with cell number during logarithmic phase growth. Fluorescence was stably maintained without antibiotic selection over 5 days, during which time cells remained actively growing. We optimized parameters for the assay, with the final format being 5 days' growth in 96-well plates in the presence of 2% w/v DMSO. We confirmed reproducibility using rifampicin and other antibiotics. The dual detection method allows for a reproducible calculation of the minimum inhibitory concentration (MIC), at the same time detecting artefacts such as fluorescence quenching or compound precipitation. We used our assay to confirm anti-tubercular activity and establish the structure activity relationship (SAR) around the imidazo[1,2-a]pyridine-3-carboxamides, a promising series of M. tuberculosis inhibitors.	[Ollinger, Juliane; Bailey, Mai Ann; Casey, Allen; Florio, Stephanie; Alling, Torey; Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA; [Moraski, Garrett C.; Miller, Marvin J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Parish, T (corresponding author), Infect Dis Res Inst, Seattle, WA USA.	tanya.parish@idri.org	Moraski, Garrett/AAH-3616-2021	Moraski, Garrett/0000-0002-6992-5584	Eli Lilly; NIH [R01 AI054193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054193] Funding Source: NIH RePORTER	Eli Lilly(Eli Lilly); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work at IDRI was funded in part by Eli Lilly and Company in support of the mission of the Lilly TB Drug Discovery Initiative. Syntheses and characterization of the imidazopyridines was supported by NIH grant R01 AI054193 to the Notre Dame group. The funders had no role in assay design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andreu N, 2012, J ANTIMICROB CHEMOTH, V67, P404, DOI 10.1093/jac/dkr472; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Changsen C, 2003, ANTIMICROB AGENTS CH, V47, P3682, DOI 10.1128/AAC.47.12.3682-3687.2003; Collins LA, 1998, ANTIMICROB AGENTS CH, V42, P344; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; COOKSEY RC, 1993, ANTIMICROB AGENTS CH, V37, P1348, DOI 10.1128/AAC.37.6.1348; Diacon AH, 2011, INT J TUBERC LUNG D, V15, P949, DOI 10.5588/ijtld.10.0616; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3027, DOI 10.1128/AAC.06125-11; Foongladda S, 2002, INT J TUBERC LUNG D, V6, P1118; Franzblau SG, 2012, TUBERCULOSIS, V92, P453, DOI 10.1016/j.tube.2012.07.003; Ginsburg AS, 2003, CLIN INFECT DIS, V37, P1448, DOI 10.1086/379328; Gruppo V, 2006, ANTIMICROB AGENTS CH, V50, P1245, DOI 10.1128/AAC.50.4.1245-1250.2006; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Lambert RJW, 2000, J APPL MICROBIOL, V88, P784, DOI 10.1046/j.1365-2672.2000.01017.x; Lilly NaE, 2004, ASSAY GUIDANCE MANUA; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; Moghazeh SL, 1996, ANTIMICROB AGENTS CH, V40, P2655, DOI 10.1128/AAC.40.11.2655; Moraski GC, 2012, BIOORGAN MED CHEM, V20, P2214, DOI 10.1016/j.bmc.2012.02.025; Moraski GC, 2011, ACS MED CHEM LETT, V2, P466, DOI 10.1021/ml200036r; NILSSON LE, 1988, ANTIMICROB AGENTS CH, V32, P1208, DOI 10.1128/AAC.32.8.1208; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; Scherman MS, 2003, ANTIMICROB AGENTS CH, V47, P378, DOI 10.1128/AAC.47.1.378-382.2003; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Sirgel Frederick A., 2008, V465, P173, DOI 10.1007/978-1-59745-207-6_11; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; WHO Global Tuberculosis Control Report, 2010, CENT EUR J PUBL HEAL, V18, P237	34	128	130	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60531	10.1371/journal.pone.0060531	http://dx.doi.org/10.1371/journal.pone.0060531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593234	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100051
J	Riganti, C; Castella, B; Kopecka, J; Campia, I; Coscia, M; Pescarmona, G; Bosia, A; Ghigo, D; Massaia, M				Riganti, Chiara; Castella, Barbara; Kopecka, Joanna; Campia, Ivana; Coscia, Marta; Pescarmona, Gianpiero; Bosia, Amalia; Ghigo, Dario; Massaia, Massimo			Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells	PLOS ONE			English	Article							MEDIATED DRUG-RESISTANCE; P-GLYCOPROTEIN; NITRIC-OXIDE; ANTITUMOR-ACTIVITY; ADAPTIVE IMMUNITY; BISPHOSPHONATES; CHEMOTHERAPY; MODULATION; ACTIVATION; EXPRESSION	Durable tumor cell eradication by chemotherapy is challenged by the development of multidrug-resistance (MDR) and the failure to induce immunogenic cell death. The aim of this work was to investigate whether MDR and immunogenic cell death share a common biochemical pathway eventually amenable to therapeutic intervention. We found that mevalonate pathway activity, Ras and RhoA protein isoprenylation, Ras- and RhoA-downstream signalling pathway activities, Hypoxia Inducible Factor-1alpha activation were significantly higher in MDR+ compared with MDR- human cancer cells, leading to increased P-glycoprotein expression, and protection from doxorubicin-induced cytotoxicity and immunogenic cell death. Zoledronic acid, a potent aminobisphosphonate targeting the mevalonate pathway, interrupted Ras- and RhoA-dependent downstream signalling pathways, abrogated the Hypoxia Inducible Factor-1alpha-driven P-glycoprotein expression, and restored doxorubicin-induced cytotoxicity and immunogenic cell death in MDR+ cells. Immunogenic cell death recovery was documented by the ability of dendritic cells to phagocytise MDR+ cells treated with zoledronic acid plus doxorubicin, and to recruit anti-tumor cytotoxic CD8+ T lymphocytes. These data indicate that MDR+ cells have an hyper-active mevalonate pathway which is targetable with zoledronic acid to antagonize their ability to withstand chemotherapy-induced cytotoxicity and escape immunogenic cell death.	[Riganti, Chiara; Kopecka, Joanna; Campia, Ivana; Pescarmona, Gianpiero; Bosia, Amalia; Ghigo, Dario] Univ Turin, Dept Oncol, Turin, Italy; [Riganti, Chiara; Castella, Barbara; Coscia, Marta; Pescarmona, Gianpiero; Bosia, Amalia; Ghigo, Dario; Massaia, Massimo] Univ Turin, Ctr Expt Res & Med Studies CeRMS, Turin, Italy; [Coscia, Marta; Massaia, Massimo] Univ Turin, Div Hematol, Turin, Italy	University of Turin; University of Turin; University of Turin	Riganti, C (corresponding author), Univ Turin, Dept Oncol, Turin, Italy.	chiara.riganti@unito.it	coscia, marta/K-4832-2016	coscia, marta/0000-0003-2123-7675; MASSAIA, Massimo/0000-0002-0021-1428; Ghigo, Dario/0000-0001-6050-1577; Riganti, Chiara/0000-0001-9787-4836; CASTELLA, Barbara/0000-0002-5880-2263; PESCARMONA, GIAN PIERO/0000-0003-2143-8901; KOPECKA, JOANNA/0000-0003-3612-3953	Italian Association for Cancer Research (AIRC) [MFAG 11475, IG 13119]; Italian Ministry of University and Research; Fondazione Internazionale Ricerche Medicina Sperimentale; Regione Piemonte; "Mario and Valeria Rindi" fellowship from Italian Foundation for Cancer Research (FIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Internazionale Ricerche Medicina Sperimentale; Regione Piemonte(Regione Piemonte); "Mario and Valeria Rindi" fellowship from Italian Foundation for Cancer Research (FIRC)(Fondazione AIRC per la ricerca sul cancro)	Italian Association for Cancer Research (AIRC, www.airc.it; MFAG 11475 to Chiara Riganti, IG 13119 to Massimo Massaia); Italian Ministry of University and Research (www.miur.it; PRIN 2010-2011 to Massimo Massaia, FIRB 2012 to Chiara Riganti); Fondazione Internazionale Ricerche Medicina Sperimentale (www.cerms.it, to Amalia Bosia, Massimo Massaia); Regione Piemonte (Ricerca Sanitaria Finalizzata 2009 to Chiara Riganti, Amalia Bosia; Progetto Immonc to Massimo Massaia). Joanna Kopecka is the recipient of a "Mario and Valeria Rindi" fellowship from Italian Foundation for Cancer Research (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2008, TRENDS MOL MED, V14, P141, DOI 10.1016/j.molmed.2008.02.002; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Castella B, 2011, J IMMUNOL, V187, P1578, DOI 10.4049/jimmunol.1002514; Castella B, 2011, CELL MOL LIFE SCI, V68, P2419, DOI 10.1007/s00018-011-0704-8; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Clezardin P, 2010, CURR PHARM DESIGN, V16, P3007, DOI 10.2174/138161210793563545; Coleman RE, 2010, BRIT J CANCER, V102, P1099, DOI 10.1038/sj.bjc.6605604; Connelly-Smith L, 2007, EXP HEMATOL, V35, P1793, DOI 10.1016/j.exphem.2007.07.017; Coscia M, 2010, J CELL MOL MED, V14, P2803, DOI 10.1111/j.1582-4934.2009.00926.x; Daubine F, 2007, J NATL CANCER I, V99, P322, DOI 10.1093/jnci/djk054; De Boo S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-108; Doublier S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-4; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; Fiore F, 2007, BLOOD, V110, P921, DOI 10.1182/blood-2006-09-044321; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Kooij G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008212; Kopecka J, 2011, J CELL MOL MED, V15, P1492, DOI 10.1111/j.1582-4934.2010.01137.x; Kopecka J, 2011, J CONTROL RELEASE, V149, P196, DOI 10.1016/j.jconrel.2010.10.003; Laufs U, 2000, CIRC RES, V87, P526, DOI 10.1161/01.RES.87.7.526; Matsumoto S, 2005, LUNG CANCER, V47, P31, DOI 10.1016/j.lungcan.2004.06.003; Mattarollo SR, 2011, CANCER RES, V71, P4809, DOI 10.1158/0008-5472.CAN-11-0753; Morgan C, 2007, ACTA ONCOL, V46, P669, DOI 10.1080/02841860600996447; O'Donnell JL, 2006, CANCER TREAT REV, V32, P407, DOI 10.1016/j.ctrv.2006.05.003; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Ottewell PD, 2010, INT J CANCER, V126, P522, DOI 10.1002/ijc.24756; Pallottini V, 2008, J CELL BIOCHEM, V104, P701, DOI 10.1002/jcb.21757; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Riganti C, 2005, CANCER RES, V65, P516; Riganti C, 2006, INT J CANCER, V119, P17, DOI 10.1002/ijc.21832; Riganti C, 2011, BIOCHEM PHARMACOL, V82, P1079, DOI 10.1016/j.bcp.2011.07.079; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Schmidmaier R, 2004, BLOOD, V104, P1825, DOI 10.1182/blood-2003-12-4218; Sharma V, 2011, J MOL MED, V89, P123, DOI 10.1007/s00109-010-0683-5; Shukla A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-314; Sieczkowski E, 2010, INT J CANCER, V126, P2025, DOI 10.1002/ijc.24885; Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007; Swanson KM, 2006, CURR CANCER DRUG TAR, V6, P15, DOI 10.2174/156800906775471743; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Takata K, 2008, MOL CANCER THER, V7, P1551, DOI 10.1158/1535-7163.MCT-07-0428; Troost J, 2004, MOL PHARMACOL, V66, P1332, DOI 10.1124/mol.104.002329; Turk D, 2009, CANCER RES, V69, P8293, DOI 10.1158/0008-5472.CAN-09-2422; Zappasodi R, 2010, CANCER RES, V70, P9062, DOI 10.1158/0008-5472.CAN-10-1825; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	45	45	46	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60975	10.1371/journal.pone.0060975	http://dx.doi.org/10.1371/journal.pone.0060975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593363	gold, Green Published, Green Submitted			2022-12-27	WOS:000317385300039
J	Wang, YB; Hu, Y; Li, Z; Wang, P; Xue, YX; Yao, YL; Yu, B; Liu, YH				Wang, Ying-Bin; Hu, Yi; Li, Zhen; Wang, Ping; Xue, Yi-Xue; Yao, Yi-Long; Yu, Bo; Liu, Yun-Hui			Artemether Combined with shRNA Interference of Vascular Cell Adhesion Molecule-1 Significantly Inhibited the Malignant Biological Behavior of Human Glioma Cells	PLOS ONE			English	Article							GROWTH IN-VITRO; MATRIX METALLOPROTEINASE-2; ARTEMISININ DERIVATIVES; EXTRACELLULAR-MATRIX; EXPRESSION; VIVO; ANGIOGENESIS; VCAM-1; CARCINOMA; INVASION	Artemether is the derivative extracted from Chinese traditional herb and originally used for malaria. Artemether also has potential therapeutic effects against tumors. Vascular cell adhesion molecule-1 (VCAM-1) is an important cell surface adhesion molecule associated with malignancy of gliomas. In this work, we investigated the role and mechanism of artemether combined with shRNA interference of VCAM-1 (shRNA-VCAM-1) on the migration, invasion and apoptosis of glioma cells. U87 human glioma cells were treated with artemether at various concentrations and shRNA interfering technology was employed to silence the expression of VCAM-1. Cell viability, migration, invasiveness and apoptosis were assessed with MTT, wound healing, Transwell and Annexin V-FITC/PI staining. The expression of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and phosphorylated Akt (p-Akt) was checked by Western blot assay. Results showed that artemether and shRNA-VCAM-1 not only significantly inhibited the migration, invasiveness and expression of MMP-2/9 and p-Akt, but also promoted the apoptosis of U87 cells. Combined treatment of both displayed the maximum inhibitory effects on the malignant biological behavior of glioma cells. Our work revealed the potential therapeutic effects of artemether and antiVCAM-1 in the treatments of gliomas.	[Wang, Ying-Bin; Hu, Yi; Li, Zhen; Yao, Yi-Long; Yu, Bo; Liu, Yun-Hui] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Liaoning Provin, Peoples R China; [Wang, Ping; Xue, Yi-Xue] China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Liaoning Provin, Peoples R China; [Wang, Ping; Xue, Yi-Xue] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University	Liu, YH (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Liaoning Provin, Peoples R China.	liuyunhuicmu@yahoo.com.cn			Natural Science Foundation of China [81171131, 81172197, 81272564, 30973079, 81072056]; special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities [20092104110015, 20102104110009]; Natural Science Foundation of Liaoning Province in China [201102300]; Liaoning Science and Technology Plan Projects [2011225020]; College Science and Technology Research Project of Education Department in Liaoning Province [L2010585]; Shenyang Science and Technology Plan Projects [F11-264-1-15, F12-277-1-05]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities; Natural Science Foundation of Liaoning Province in China(Natural Science Foundation of Liaoning Province); Liaoning Science and Technology Plan Projects; College Science and Technology Research Project of Education Department in Liaoning Province; Shenyang Science and Technology Plan Projects	This work was supported by grants from the Natural Science Foundation of China (no. 81171131, no. 81172197, no. 81272564, no. 30973079 and no. 81072056) (www.nsfc.gov.cn), the special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities, (no. 20092104110015, 20102104110009) (www.cutech.edu.cn), the Natural Science Foundation of Liaoning Province in China (no. 201102300) (www.lninfo.gov.cn), Liaoning Science and Technology Plan Projects (no. 2011225020) (www.lninfo.gov.cn), College Science and Technology Research Project of Education Department in Liaoning Province (no. L2010585) (www.lnein.gov.cn), and Shenyang Science and Technology Plan Projects (no. F11-264-1-15 and F12-277-1-05) (http: //www.systplan.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara DDA, 2013, J APPL TOXICOL, V33, P151, DOI 10.1002/jat.1734; Bai J, 2012, J CANCER RES CLIN, V138, P991, DOI 10.1007/s00432-012-1172-8; Chen HH, 2003, PHARMACOL RES, V48, P231, DOI 10.1016/S1043-6618(03)00107-5; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Ding YB, 2003, WORLD J GASTROENTERO, V9, P1409, DOI 10.3748/wjg.v9.i7.1409; Efferth T, 2002, BIOCHEM PHARMACOL, V64, P617, DOI 10.1016/S0006-2952(02)01221-2; Farsam V, 2011, INT IMMUNOPHARMACOL, V11, P1802, DOI 10.1016/j.intimp.2011.07.008; FISHWICK J, 1995, CHEM-BIOL INTERACT, V96, P263, DOI 10.1016/0009-2797(94)03597-2; Florio T, 2012, DRUG DISCOV TODAY, V17, P1103, DOI 10.1016/j.drudis.2012.06.001; Forsyth PA, 1999, BRIT J CANCER, V79, P1828, DOI 10.1038/sj.bjc.6690291; Gautam A, 2009, CURR DRUG METAB, V10, P289, DOI 10.2174/138920009787846323; Geisberger G, 2013, CARBOHYD POLYM, V91, P58, DOI 10.1016/j.carbpol.2012.08.009; Hai J, 2008, NEUROL RES, V30, P99, DOI 10.1179/016164107X228697; Hartmann W, 2006, CLIN CANCER RES, V12, P3019, DOI 10.1158/1078-0432.CCR-05-2187; Horn L, 2009, J CLIN ONCOL, V27, P6006, DOI 10.1200/JCO.2009.23.7545; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Hu Y, 2012, J MOL NEUROSCI, V48, P127, DOI 10.1007/s12031-012-9784-7; Kamugisha E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-58; Klemke M, 2007, J CELL PHYSIOL, V212, P368, DOI 10.1002/jcp.21029; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; Kokwaro G O, 1998, Afr J Health Sci, V5, P8; Kubiatowski T, 2001, J NEUROSURG, V95, P480, DOI 10.3171/jns.2001.95.3.0480; Lai SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038103; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Li Y, 1998, Med Trop (Mars), V58, P9; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Lodge NJ, 2013, NEUROPHARMACOLOGY, V67, P284, DOI 10.1016/j.neuropharm.2012.10.025; Maenpaa A, 1997, ACTA NEUROPATHOL, V94, P216, DOI 10.1007/s004010050696; Manning L, 2011, ANTIMICROB AGENTS CH, V55, P5027, DOI 10.1128/AAC.00375-11; Maurer CA, 1998, INT J CANCER, V79, P76, DOI 10.1002/(SICI)1097-0215(19980220)79:1<76::AID-IJC15>3.0.CO;2-F; Nakase I, 2008, INT J PHARM, V354, P28, DOI 10.1016/j.ijpharm.2007.09.003; Nyakern M, 2006, LEUKEMIA, V20, P230, DOI 10.1038/sj.leu.2404057; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Pu PY, 2006, TECHNOL CANCER RES T, V5, P271, DOI 10.1177/153303460600500308; Pu PY, 2006, J NEURO-ONCOL, V76, P1, DOI 10.1007/s11060-005-3029-3; Pu PY, 2004, TUMOR BIOL, V25, P172, DOI 10.1159/000081099; Qi ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038842; Roos N, 2007, J PHARMACOL EXP THER, V321, P583, DOI 10.1124/jpet.106.117051; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Shabaik YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054346; Shao JF, 2011, ACTA BIOCH BIOPH SIN, V43, P267, DOI 10.1093/abbs/gmr011; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Siebzehnrubl FA, 2011, GLIA, V59, P1135, DOI 10.1002/glia.21143; Singh NP, 2006, INTEGR CANCER THER, V5, P391, DOI 10.1177/1534735406295311; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Uegaki K, 2005, ONCOL REP, V14, P389; Wang DY, 2005, BRAIN PATHOL, V15, P318; Wang MD, 2005, J NEURO-ONCOL, V72, P1, DOI 10.1007/s11060-004-1392-0; Wu ZP, 2009, INTEGR CANCER THER, V8, P88, DOI 10.1177/1534735408330714; Xie LH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-112; Zhan Q, 2011, BRAZ J MED BIOL RES, V44, P489, DOI 10.1590/S0100-879X2011007500052; Zhang CZ, 2012, BIOCHEM PHARMACOL, V83, P1278, DOI 10.1016/j.bcp.2012.02.002; Zhao JX, 2007, EUR J NEUROL, V14, P510, DOI 10.1111/j.1468-1331.2006.01705.x	55	21	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60834	10.1371/journal.pone.0060834	http://dx.doi.org/10.1371/journal.pone.0060834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593320	Green Published, Green Submitted, gold			2022-12-27	WOS:000317383200020
J	Yang, LX; Li, J; Spaniol, J; Hasher, L; Wilkinson, AJ; Yu, J; Niu, YN				Yang, Lixia; Li, Juan; Spaniol, Julia; Hasher, Lynn; Wilkinson, Andrea J.; Yu, Jing; Niu, Yanan			Aging, Culture, and Memory for Socially Meaningful Item-Context Associations: An East-West Cross-Cultural Comparison Study	PLOS ONE			English	Article							COGNITIVE NEUROSCIENCE; STANDARDIZED SET; NAME AGREEMENT; SELF; AGE; OBJECT; NORMS; PERSPECTIVE; FAMILIARITY; AMERICAN	Research suggests that people in Eastern interdependent cultures process information more holistically and attend more to contextual information than do people in Western independent cultures. The current study examined the effects of culture and age on memory for socially meaningful item-context associations in 71 Canadians of Western European descent (35 young and 36 older) and 72 native Chinese citizens (36 young and 36 older). All participants completed two blocks of context memory tasks. During encoding, participants rated pictures of familiar objects. In one block, objects were rated either for their meaningfulness in the independent living context or their typicality in daily life. In the other block, objects were rated for their meaningfulness in the context of fostering relationships with others or for their typicality in daily life. The encoding in each block was followed by a recognition test in which participants identified pictures and their associated contexts. The results showed that Chinese outperformed Canadians in context memory, though both culture groups showed similar age-related deficits in item and context memory. The results suggest that Chinese are at an advantage in memory for socially meaningful item-context associations, an advantage that continues from young adulthood into old age.	[Yang, Lixia; Spaniol, Julia; Wilkinson, Andrea J.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Li, Juan; Yu, Jing; Niu, Yanan] Chinese Acad Sci, Inst Psychol, Ctr Aging Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Hasher, Lynn] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Hasher, Lynn] Rotman Res Inst, Toronto, ON, Canada	Toronto Metropolitan University; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Yang, LX (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	lixiay@psych.ryerson.ca; lijuan@psych.ac.cn	Hasher, Lynn/O-7423-2019; Yu, Jing/AAN-1565-2020		China-Canada Joint Health Research Initiative; Canadian Institutes of Health Research (CIHR) [CCI-102930]; National Natural Science Foundation of China (NSFC) [30911120494]	China-Canada Joint Health Research Initiative; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the China-Canada Joint Health Research Initiative, jointly funded by the Canadian Institutes of Health Research (CIHR, CCI-102930) (http://www.cihr-irsc.gc.ca/) and the National Natural Science Foundation of China (NSFC, 30911120494) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, AM CHINESE PASSAGE D; [Anonymous], 1983, ACTA PSYCHOL SIN; BALTES PB, 1993, GERONTOLOGIST, V33, P580, DOI 10.1093/geront/33.5.580; Chua HF, 2006, GERONTOLOGY, V52, P306, DOI 10.1159/000094612; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Craik FIM, 2010, PSYCHOL AGING, V25, P968, DOI 10.1037/a0020276; FERNALD A, 1993, CHILD DEV, V64, P637; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fung Y, 1983, HIST CHINESE PHILOS; Gallo DA, 2007, PSYCHOL AGING, V22, P209, DOI 10.1037/0882-7974.22.1.209; Goh JO, 2007, COGN AFFECT BEHAV NE, V7, P44, DOI 10.3758/CABN.7.1.44; Gutchess AH, 2006, GERONTOLOGY, V52, P314, DOI 10.1159/000094613; Gutchess AH, 2006, COGN AFFECT BEHAV NE, V6, P102, DOI 10.3758/CABN.6.2.102; Gutchess AH, 2011, LECT NOTES ARTIF INT, V6780, P67; Gutchess AH, 2010, SOC COGN AFFECT NEUR, V5, P254, DOI 10.1093/scan/nsp059; Gutchess AH, 2009, PROG BRAIN RES, V178, P137, DOI 10.1016/S0079-6123(09)17809-3; Jenkins LJ, 2010, SOC COGN AFFECT NEUR, V5, P236, DOI 10.1093/scan/nsp056; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Kitayama S, 2011, ANNU REV PSYCHOL, V62, P419, DOI 10.1146/annurev-psych-120709-145357; Liang B, 2010, J INT CONSUM MARK, V22, P187, DOI 10.1080/08961530903476253; Light L.L., 2000, PSYCHOL AGING REVOLU, DOI [https://doi.org/10.1037/10363-005, DOI 10.1037/10363-005]; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Nisbett R.E, 2003, GEOGRAPHY THOUGHT AS; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Park DC, 2002, NEUROSCI BIOBEHAV R, V26, P859, DOI 10.1016/S0149-7634(02)00072-6; Park DC, 1999, J GERONTOL B-PSYCHOL, V54, pP75, DOI 10.1093/geronb/54B.2.P75; Park D, 2006, CURR DIR PSYCHOL SCI, V15, P105, DOI 10.1111/j.0963-7214.2006.00416.x; Park DC, 2010, PERSPECT PSYCHOL SCI, V5, P391, DOI 10.1177/1745691610374591; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rowe G, 2009, Q J EXP PSYCHOL, V62, P1873, DOI 10.1080/17470210902834852; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; SINGELIS TM, 1995, HUM COMMUN RES, V21, P354, DOI 10.1111/j.1468-2958.1995.tb00351.x; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Yoon C, 2004, BEHAV RES METH INS C, V36, P639, DOI 10.3758/BF03206545; Yoon C, 2006, GERONTOLOGY, V52, P295, DOI 10.1159/000094611; Zacks R. T., 2000, HDB AGING COGNITION, V2nd, P293, DOI DOI 10.3758/S13423-011-0086-9	39	16	16	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60703	10.1371/journal.pone.0060703	http://dx.doi.org/10.1371/journal.pone.0060703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123JA	23593288	Green Submitted, Green Published, gold			2022-12-27	WOS:000317383200017
J	Vinas, JL; Ventayol, M; Brune, B; Jung, M; Sola, A; Pi, F; Mastora, C; Hotter, G				Luis Vinas, Jose; Ventayol, Marina; Bruene, Bernhard; Jung, Michaela; Sola, Anna; Pi, Felip; Mastora, Chrysoula; Hotter, Georgina			miRNA let-7e Modulates the Wnt Pathway and Early Nephrogenic Markers in Mouse Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							ACTIVATION; BETA; PLURIPOTENCY; INDUCTION	This study indicates that embryonic stem cells [ESCs] cultured with retinoic acid and activin A significantly upregulate the miRNA let-7e. This specific miRNA modulates the Wnt pathway and the expression of early nephrogenic markers under these differentiation conditions. The differentiation markers WT1, Pax2 and Wnt4 were downregulated when miRNA let-7e was silenced, thus indicating the role of miRNA let-7e in the differentiation process. PKC beta, GSK3 beta phosphorylation (GSK3 beta(P)) and beta-catenin expression was reduced in differentiated cells and reversed by miRNA let-7e silencing. Addition of a PKC beta inhibitor to the miRNA let-7e silenced cells abolished let-7e-derived effects in differentiation markers, and reversed the increase in GSK3 beta(P) and beta-catenin, thus indicating that miRNA let-7e is involved in differentiation via the modulation of GSK3 beta phosphorylation and beta-catenin production.	[Luis Vinas, Jose; Ventayol, Marina; Sola, Anna; Pi, Felip; Mastora, Chrysoula; Hotter, Georgina] CSIC, IIBB, IDIBAPS, Dept Expt Pathol, Barcelona, Spain; [Luis Vinas, Jose; Sola, Anna; Hotter, Georgina] Networking Ctr Bioengn Biomat & Nanomed, CIBER BBN, Zaragoza, Spain; [Mastora, Chrysoula] Univ Barcelona, Dept Fisiol, Barcelona, Spain; [Bruene, Bernhard; Jung, Michaela] Goethe Univ Frankfurt, Inst Biochem I ZAFES, D-60054 Frankfurt, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Goethe University Frankfurt	Vinas, JL (corresponding author), CSIC, IIBB, IDIBAPS, Dept Expt Pathol, Barcelona, Spain.	vinasmjose@gmail.com	Vinas, Jose/AAD-5795-2020; Hotter, Georgina/R-1156-2018	Vinas, Jose/0000-0001-7770-7133; SOLA, ANNA/0000-0003-2379-9313; Hotter, Georgina/0000-0001-7324-1305	EU [LSHBT-CT-2006-036813]; Miguel Servet contracting system [CP08/00138];  [SAF 2012-39947-CO2-01];  [FIS PS09/01288];  [PI 12/00720]	EU(European Commission); Miguel Servet contracting system; ; ; 	This study has been supported by EU project PROLIGEN (Hypoxic renal Proliferation, LSHBT-CT-2006-036813), awarded to Georgina Hotter and by grants from Plan Nacional project referenced: SAF 2012-39947-CO2-01 awarded to Georgina Hotter and Fondo de Investigacion Sanitaria projects referenced :FIS PS09/01288 and PI 12/00720 awarded to Anna Sola. Anna Sola is supported by Miguel Servet contracting system (CP08/00138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle SC, 2011, DEVELOPMENT, V138, P4245, DOI 10.1242/dev.070433; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Daley GQ, 2003, ANN NY ACAD SCI, V996, P122, DOI 10.1111/j.1749-6632.2003.tb03240.x; Dastjerdi FV, 2012, CELL BIOL INT, V36, P967, DOI 10.1042/CBI20110541; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farias GG, 2004, NEUROBIOL DIS, V17, P337, DOI 10.1016/j.nbd.2004.07.016; Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Jeong HM, 2012, BBA-MOL CELL RES, V1823, P1225, DOI 10.1016/j.bbamcr.2012.05.018; Kania G, 2003, METHOD ENZYMOL, V365, P287; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V336, P585, DOI 10.1016/j.bbrc.2005.08.136; Lin YF, 2011, J CELL PHYSIOL, V226, P122, DOI 10.1002/jcp.22312; Liu YG, 2011, BIOCHEM BIOPH RES CO, V408, P259, DOI 10.1016/j.bbrc.2011.04.009; Ma J, 2012, J IMMUNOL, V188, P5337, DOI 10.4049/jimmunol.1102979; McNally AK, 2008, EXP MOL PATHOL, V84, P37, DOI 10.1016/j.yexmp.2007.10.005; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Mobley S, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/701212; Osafune K, 2002, DEV GROWTH DIFFER, V44, P161; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Ren XH, 2010, ACTA BIOCH BIOPH SIN, V42, P464, DOI 10.1093/abbs/gmq046; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Steenhard BM, 2005, J AM SOC NEPHROL, V16, P1623, DOI 10.1681/ASN.2004070584; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107	32	19	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60937	10.1371/journal.pone.0060937	http://dx.doi.org/10.1371/journal.pone.0060937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593353	gold, Green Published, Green Submitted			2022-12-27	WOS:000317382000029
J	Han, PF; Jin, FL; Dong, XL; Fan, JQ; Qiu, BL; Ren, SX				Han, Pengfei; Jin, Fengliang; Dong, Xiaolin; Fan, Jiqiao; Qiu, Baoli; Ren, Shunxiang			Transcript and Protein Profiling Analysis of the Destruxin A-Induced Response in Larvae of Plutella xylostella	PLOS ONE			English	Article							SPODOPTERA-LITURA LEPIDOPTERA; INNATE IMMUNE-RESPONSES; METARHIZIUM-ANISOPLIAE; INSECTICIDAL ACTIVITY; DIAMONDBACK MOTH; ACTIVATION; EXPRESSION; STRAINS; METAMORPHOSIS; PATHOGENICITY	Background: Destruxins (dtxs) are the mycotoxin produced by certain entomopathogenic fungi, such as Metarhizium anisopliae, Aschersonia sp, Alternaria brassicae and Ophiosphaerella herpotrichae. It can affect a wide variety of biological processes in insects, including innate immune, Ca2+ channel in cells, and apoptosis in a dose-dependent manner. Dtxs have been used as biological control agent for a long time, however, their molecular mechanism of action is still unknown. Principal Findings: In this study, both digital gene expression (DGE) and two-dimensional electrophoresis (2-DE) approaches were adopted to examine the effects of dtx A on Plutella xyllostella (L.) larvae. By using DGE and 2-DE analyses, 1584 genes and 42 protein points were identified as being up-or down regulated at least 2-fold in response to dtx A. Firstly, injection of dtx A to larvae accelerated the increase of peptidoglycan recognition protein (PGRP), which could activate the Toll signal pathway inducing production of antibacterial substances such as cecropin and gloverin. Dtx A also stimulated prophenoloxidase (proPO) system which plays an important role in innate immunity and leads to melanization of external organisms. Secondly, dtx A suppressed the expression of genes related to the Toll pathway, and induced expression of serine proteinase inhibitors (serpins), especially the serpin 2 that blocked process of the proPO system. Finally, other physiological process like xenobiotics detoxification, apoptosis, calcium signaling pathway and insect hormone biosynthesis, were also mediated in response to dtx A toxicity. Conclusions: Transcript and protein profiling analyses will provide an insight into the potential molecular mechanism of action in P. xylostella larvae in response to dtx A.	[Han, Pengfei; Jin, Fengliang; Dong, Xiaolin; Fan, Jiqiao; Qiu, Baoli; Ren, Shunxiang] South China Agr Univ SCAU, Engn Res Ctr Biol Control, Minist Educ, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Ren, SX (corresponding author), South China Agr Univ SCAU, Engn Res Ctr Biol Control, Minist Educ, Guangzhou, Guangdong, Peoples R China.	rensxcn@yahoo.com.cn			National Basic Research Program of China [2013CB127604]; Guangdong Province Natural Science Foundation in Key Projects [S2012020010951]	National Basic Research Program of China(National Basic Research Program of China); Guangdong Province Natural Science Foundation in Key Projects	This work was supported by National Basic Research Program of China (2013CB127604) and Guangdong Province Natural Science Foundation in Key Projects (S2012020010951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, CROP PROT, V38, P7, DOI 10.1016/j.cropro.2012.03.006; Altincicek B, 2007, INFECT IMMUN, V75, P175, DOI 10.1128/IAI.01385-06; Amiri B, 1999, BIOCONTROL SCI TECHN, V9, P487, DOI 10.1080/09583159929451; Amiri-Besheli B, 2000, MYCOL RES, V104, P447, DOI 10.1017/S095375629900146X; An CJ, 2010, INSECT BIOCHEM MOLEC, V40, P683, DOI 10.1016/j.ibmb.2010.07.001; Asgari S, 2003, INSECT BIOCHEM MOLEC, V33, P1017, DOI 10.1016/S0965-1748(03)00116-4; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bandani AR, 2001, BBA-BIOMEMBRANES, V1510, P367, DOI 10.1016/S0005-2736(00)00370-9; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Bock KW, 2003, BIOCHEM PHARMACOL, V66, P691, DOI 10.1016/S0006-2952(03)00296-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castelo Branco M., 1997, Anais da Sociedade Entomologica do Brasil, V26, P75, DOI 10.1590/S0301-80591997000100010; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; CLARK AG, 1982, PESTIC BIOCHEM PHYS, V17, P307, DOI 10.1016/0048-3575(82)90142-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Hahn DA, 2003, J INSECT PHYSIOL, V49, P1189, DOI 10.1016/j.jinsphys.2003.09.002; Hirata K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018354; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hu QB, 2007, J APPL ENTOMOL, V131, P262, DOI 10.1111/j.1439-0418.2007.01159.x; Hu QB, 2006, TOXICON, V48, P491, DOI 10.1016/j.toxicon.2006.06.018; Hu QB, 2009, TOXICON, V53, P115, DOI 10.1016/j.toxicon.2008.10.019; [胡琼波 HU QiongBo], 2007, [昆虫学报, Acta Entomologica Sinica], V50, P461; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Karlhofer J, 2012, J INVERTEBR PATHOL, V110, P126, DOI 10.1016/j.jip.2012.02.001; Kurata S, 2006, IMMUNOBIOLOGY, V211, P237, DOI 10.1016/j.imbio.2005.10.016; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Meng X, 2011, TOXICON, V58, P327, DOI 10.1016/j.toxicon.2011.06.002; Mitsumasu K, 2008, ZOOL SCI, V25, P693, DOI 10.2108/zsj.25.693; Osta MA, 2004, J EXP BIOL, V207, P2551, DOI 10.1242/jeb.01066; PAIS M, 1981, PHYTOCHEMISTRY, V20, P715, DOI 10.1016/0031-9422(81)85160-6; Pal S, 2007, J BIOL CHEM, V282, P8969, DOI 10.1074/jbc.M605927200; Pan M. L., 2001, Journal of Insect Science (Tucson), V1, P1; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P579, DOI 10.1016/S0031-9422(02)00016-X; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Pyati PS, 2009, INSECT BIOCHEM MOLEC, V39, P535, DOI 10.1016/j.ibmb.2009.05.003; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Ruiz-Sanchez E, 2010, TOXICON, V56, P1043, DOI 10.1016/j.toxicon.2010.07.012; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SAMUELS RI, 1988, COMP BIOCHEM PHYS C, V90, P403, DOI 10.1016/0742-8413(88)90018-7; SAMUELS RI, 1988, MYCOPATHOLOGIA, V104, P51, DOI 10.1007/BF00437924; Santos VC, 2011, NEOTROP ENTOMOL, V40, P264, DOI 10.1590/S1519-566X2011000200017; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sree KS, 2008, PEST MANAG SCI, V64, P119, DOI 10.1002/ps.1480; Strasser H, 2000, BIOCONTROL SCI TECHN, V10, P717, DOI 10.1080/09583150020011690; Sumathipala N, 2010, INSECT BIOCHEM MOLEC, V40, P487, DOI 10.1016/j.ibmb.2010.04.008; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Thomsen L, 2000, ENVIRON ENTOMOL, V29, P1041, DOI 10.1603/0046-225X-29.5.1041; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yin Fei, 2010, Acta Entomologica Sinica, V53, P61; Zhang YH, 2012, GENOMICS, V100, P35, DOI 10.1016/j.ygeno.2012.05.002; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103	56	24	26	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60771	10.1371/journal.pone.0060771	http://dx.doi.org/10.1371/journal.pone.0060771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585848	gold, Green Submitted, Green Published			2022-12-27	WOS:000317909600045
J	Li, YY; Yang, ZJ; Zhou, CW; Wang, XM; Qian, Y; Xu, J; Wang, B; Wu, J				Li, Yan-yan; Yang, Zhi-jian; Zhou, Chuan-wei; Wang, Xiang-ming; Qian, Yun; Xu, Jian; Wang, Bei; Wu, Jun			Adiponectin-11377CG Gene Polymorphism and Type 2 Diabetes Mellitus in the Chinese Population: A Meta-Analysis of 6425 Subjects	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PROMOTER REGION; APM1 GENE; ASSOCIATION; OBESITY; BIAS	Background: Although adiponectin -11377CG gene polymorphism is implied to be associated with increased type 2 diabetes mellitus (T2DM) risk, results of individual studies are inconsistent. Objective and Methods: A meta-analysis consisting of 12 individual studies, including a total of 6425 participants, was carried out in order to investigate the association of adiponectin -11377CG gene polymorphism with T2DM. The pooled odds ratio (OR) and its corresponding confidence interval (CI) at 95% were assessed through the random-or fixed-effect model. Results: A significant relationship was observed between adiponectin -11377CG gene polymorphism and T2DM under allelic (OR: 1.150, 95% CI: 1.060 to 1.250, P = 0.001), recessive (OR: 1.450, 95% CI: 1.180-1.770, P = 0.0004), dominant (OR: 1.071, 95% CI: 1.013-1.131, P = 0.015), additive (OR: 1.280, 95% CI: 1.090-1.510, P = 0.002), and homozygous genetic models (OR: 1.620, 95% CI: 1.310-1.990, P<0.00001). No significant association was found between them under the heterozygous genetic model (OR: 1.640, 95% CI: 0.850-3.170, P = 0.140). Conclusions: Adiponectin -11377CG gene polymorphism was significantly associated with T2DM risk susceptibility. G allele carriers are predisposed to T2DM risk.	[Li, Yan-yan; Yang, Zhi-jian; Zhou, Chuan-wei; Wang, Xiang-ming; Qian, Yun; Xu, Jian; Wang, Bei; Wu, Jun] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Li, YY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China.	lyynjmu123@126.com		Wu, Jun/0000-0003-4605-1148	National Natural Science Foundation of China [NSFC 81100073]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by the National Natural Science Foundation of China (NSFC 81100073 to Dr Yan-yan Li) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Cai QY, 2008, ASS GENE POLYMORPHIS; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052354; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gao SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044544; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; Han LY, 2011, DIABETOLOGIA, V54, P2303, DOI 10.1007/s00125-011-2202-9; Holst D, 2002, CURR OPIN LIPIDOL, V13, P241, DOI 10.1097/00041433-200206000-00002; [贾玫 JIA Mei], 2008, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V31, P163; [李奕平 Li Yiping], 2011, [中国糖尿病杂志, Chinese Journal of Diabetes], V19, P101; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Min Y., 2011, SHANDONG MED J, V51, P65; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; [史晓红 Shi XH], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P6815; [孙红 SUN Hong], 2010, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V15, P82; Tian J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025338; Vasseur F, 2005, DIABETOLOGIA, V48, P892, DOI 10.1007/s00125-005-1729-z; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wang Y, 2008, STUDY ADIPONECTIN 11; Wang YB, 2009, J GENET GENOMICS, V36, P417, DOI 10.1016/S1673-8527(08)60131-9; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yang M, 2008, BIOMED ENVIRON SCI, V21, P454, DOI 10.1016/S0895-3988(09)60002-7; [叶枫 Ye Feng], 2008, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V29, P74; Zhang DY, 2009, J DIABETES COMPLICAT, V23, P265, DOI 10.1016/j.jdiacomp.2008.05.004; Zhao HaiYan, 2009, Journal of Shandong University (Health Sciences), V47, P62	31	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61153	10.1371/journal.pone.0061153	http://dx.doi.org/10.1371/journal.pone.0061153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585875	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600086
J	Daniel-Carlier, N; Harscoet, E; Thepot, D; Auguste, A; Pailhoux, E; Jolivet, G				Daniel-Carlier, Nathalie; Harscoet, Erwana; Thepot, Dominique; Auguste, Aurelie; Pailhoux, Eric; Jolivet, Genevieve			Gonad Differentiation in the Rabbit: Evidence of Species-Specific Features	PLOS ONE			English	Article							SEX DETERMINATION; FOLLICULAR DEVELOPMENT; EXPRESSION PROFILES; GENE-TRANSCRIPTION; ESTROGEN FORMATION; AROMATASE-ACTIVITY; RETINOIC ACID; FETAL; TESTIS; SRY	The rabbit is an attractive species for the study of gonad differentiation because of its 31-day long gestation, the timing of female meiosis around birth and the 15-day delay between gonadal switch and the onset of meiosis in the female. The expression of a series of genes was thus determined by qPCR during foetal life until adulthood, completed by a histological analysis and whenever possible by an immunohistological one. Interesting gene expression profiles were recorded. Firstly, the peak of SRY gene expression that is observed in early differentiated XY gonads in numerous mammals was also seen in the rabbit, but this expression was maintained at a high level until the end of puberty. Secondly, a peak of aromatase gene expression was observed at two-thirds of the gestation in XX gonads as in many other species except in the mouse. Thirdly, the expression of STRA8 and DMC1 genes (which are known to be specifically expressed in germ cells during meiosis) was enhanced in XX gonads around birth but also slightly and significantly in XY gonads at the same time, even though no meiosis occurs in XY gonad at this stage. This was probably a consequence of the synchronous strong NANOS2 gene expression in XY gonad. In conclusion, our data highlighted some rabbit-specific findings with respect to the gonad differentiation process.	[Daniel-Carlier, Nathalie; Harscoet, Erwana; Thepot, Dominique; Auguste, Aurelie; Pailhoux, Eric; Jolivet, Genevieve] INRA, UMR 1198, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Jolivet, G (corresponding author), INRA, UMR 1198, Jouy En Josas, France.	genevieve.jolivet@jouy.inra.fr		Auguste, Aurelie/0000-0001-5115-0218	Agence Nationale de la Recherche (ANR-GenAnimal GENIDOV)	Agence Nationale de la Recherche (ANR-GenAnimal GENIDOV)(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (ANR-GenAnimal GENIDOV 2010/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; BERNIER N, 1964, CR SOC BIOL, V158, P2227; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Carreau Serge, 2003, Reprod Biol Endocrinol, V1, P35, DOI 10.1186/1477-7827-1-35; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; CHRETIEN FC, 1966, J EMBRYOL EXP MORPH, V16, P591; Diaz-Hernandez V, 2008, SEX DEV, V2, P152, DOI 10.1159/000143433; DICKMANN Z, 1975, P NATL ACAD SCI USA, V72, P298, DOI 10.1073/pnas.72.1.298; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; GEORGE FW, 1978, SCIENCE, V199, P200, DOI 10.1126/science.579477; GEORGE FW, 1978, J CLIN ENDOCR METAB, V47, P550, DOI 10.1210/jcem-47-3-550; GONDOS B, 1983, BIOL REPROD, V29, P791, DOI 10.1095/biolreprod29.3.791; GONDOS B, 1981, CELL TISSUE RES, V215, P143, DOI 10.1007/BF00236255; HACKER A, 1995, DEVELOPMENT, V121, P1603; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hayashi T, 2000, BIOL REPROD, V62, P1722, DOI 10.1095/biolreprod62.6.1722; HOVERSLAND RC, 1982, J REPROD FERTIL, V66, P259, DOI 10.1530/jrf.0.0660259; Hutt KJ, 2006, CELL TISSUE RES, V326, P809, DOI 10.1007/s00441-006-0223-3; ICZKOWSKI KA, 1991, AM J ANAT, V190, P266, DOI 10.1002/aja.1001900306; Jameson SA, 2012, DEV BIOL, V370, P24, DOI 10.1016/j.ydbio.2012.06.009; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Maatouk DM, 2008, CURR TOP DEV BIOL, V83, P151, DOI 10.1016/S0070-2153(08)00405-5; Mandon-Pepin B, 2003, BIOL REPROD, V68, P985, DOI 10.1095/biolreprod.102.008557; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; MAULEON P, 1977, ANN BIOL ANIM BIOCH, V17, P399, DOI 10.1051/rnd:19770315; MILEWICH L, 1977, ENDOCRINOLOGY, V100, P187, DOI 10.1210/endo-100-1-187; Montazer-Torbati F, 2010, DEV DYNAM, V239, P3324, DOI 10.1002/dvdy.22452; NIELSEN HC, 1983, LAB ANIM, V17, P148, DOI 10.1258/002367783780959411; Onohara Y, 2010, HISTOCHEM CELL BIOL, V133, P627, DOI 10.1007/s00418-010-0699-5; Otsuka F, 2011, MOL REPROD DEV, V78, P9, DOI 10.1002/mrd.21265; Pailhoux E, 2001, DEV DYNAM, V222, P328, DOI 10.1002/dvdy.1194; Pannetier M, 2012, SEX DEV, V6, P33, DOI 10.1159/000334056; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Paulini F, 2011, REPROD DOMEST ANIM, V46, P354, DOI 10.1111/j.1439-0531.2010.01739.x; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Ross DGF, 2009, SEX DEV, V3, P273, DOI 10.1159/000252791; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SUN EL, 1986, CELL TISSUE RES, V243, P575; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; WENIGER JP, 1990, J DEV PHYSIOL, V14, P303; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006	54	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60451	10.1371/journal.pone.0060451	http://dx.doi.org/10.1371/journal.pone.0060451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593221	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000032
J	Lewis, CAB; Manning, J; Barr, C; Peake, K; Humphries, RK; Rossi, F; Krieger, C				Lewis, Coral-Ann B.; Manning, John; Barr, Christine; Peake, Kyle; Humphries, R. Keith; Rossi, Fabio; Krieger, Charles			Myelosuppressive Conditioning Using Busulfan Enables Bone Marrow Cell Accumulation in the Spinal Cord of a Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HEMATOPOIETIC-CELLS; T-LYMPHOCYTES; MICROGLIA; BRAIN; CNS; EXPRESS; ORIGIN; MICE	Myeloablative preconditioning using irradiation is the most commonly used technique to generate rodents having chimeric bone marrow, employed for the study of bone marrow-derived cell accumulation in the healthy and diseased central nervous system. However, irradiation has been shown to alter the blood-brain barrier, potentially creating confounding artefacts. To better study the potential of bone marrow-derived cells to function as treatment vehicles for neurodegenerative diseases alternative preconditioning regimens must be developed. We treated transgenic mice that over-express human mutant superoxide dismutase 1, a model of amyotrophic lateral sclerosis, with busulfan to determine whether this commonly used chemotherapeutic leads to stable chimerism and promotes the entry of bone marrow-derived cells into spinal cord. Intraperitoneal treatment with busulfan at 60 mg/kg or 80 mg/kg followed by intravenous injection of green fluorescent protein-expressing bone marrow resulted in sustained levels of chimerism (similar to 80%). Bone marrow-derived cells accumulated in the lumbar spinal cord of diseased mice at advanced stages of pathology at both doses, with limited numbers of bone marrow derived cells observed in the spinal cords of similarly treated, age-matched controls; the majority of bone marrow-derived cells in spinal cord immunolabelled for macrophage antigens. Comparatively, significantly greater numbers of bone marrow-derived cells were observed in lumbar spinal cord following irradiative myeloablation. These results demonstrate bone marrow-derived cell accumulation in diseased spinal cord is possible without irradiative preconditioning.	[Lewis, Coral-Ann B.; Manning, John; Barr, Christine; Peake, Kyle; Krieger, Charles] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Lewis, Coral-Ann B.; Rossi, Fabio] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Humphries, R. Keith] BC Canc Agcy, Dept Pathol, Terry Fox Lab, Vancouver, BC, Canada; [Krieger, Charles] VHHSC, Dept Med, Div Neurol, Neuromuscular Dis Unit, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia; British Columbia Cancer Agency	Krieger, C (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada.	ckrieger@sfu.ca	Rossi, Fabio MV/B-5587-2013	Rossi, Fabio MV/0000-0002-0368-2620; Humphries, Richard/0000-0003-0540-7005	CIHR; Muscular Dystrophy Canada [JNM-69682]; ALS Society of America [57969]; ALS Society of Canada	CIHR(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Canada(Muscular Dystrophy Association); ALS Society of America; ALS Society of Canada	Neuromuscular Research Partnership grant from CIHR, ALS Society of Canada and Muscular Dystrophy Canada (JNM-69682) [www.cihr-irsc.gc.ca/e/193.html, www.als.ca/, muscle.ca], ALS Society of America (57969) [www.alsa.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Andersson G, 2003, BLOOD, V101, P4305, DOI 10.1182/blood-2002-06-1649; Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; BISHOP JB, 1986, MUTAT RES, V168, P15, DOI 10.1016/0165-1110(86)90020-5; Capotondo A, 2012, P NATL ACAD SCI USA, V109, P15018, DOI 10.1073/pnas.1205858109; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; Doeing Diana C, 2003, BMC Clin Pathol, V3, P3; Enquist IB, 2009, STEM CELLS, V27, P744, DOI 10.1634/stemcells.2008-0844; Espejel S, 2009, ANN NEUROL, V66, P100, DOI 10.1002/ana.21670; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hassan M, 1996, LEUKEMIA LYMPHOMA, V22, P395, DOI 10.3109/10428199609054777; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Hsieh MM, 2007, EXP HEMATOL, V35, P1415, DOI 10.1016/j.exphem.2007.05.009; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lampron A, 2012, CELL TRANSPLANT, V21, P1149, DOI 10.3727/096368911X593154; Lewis CAB, 2009, GLIA, V57, P1410, DOI 10.1002/glia.20859; Malm T, 2010, GLIA, V58, P889, DOI 10.1002/glia.20973; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Ramanan S, 2010, PPAR RES, V2010, DOI 10.1155/2010/234975; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Vallieres L, 2003, J NEUROSCI, V23, P5197; YEAGER AM, 1993, TRANSPLANTATION, V56, P185, DOI 10.1097/00007890-199307000-00034	30	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60661	10.1371/journal.pone.0060661	http://dx.doi.org/10.1371/journal.pone.0060661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593276	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000048
J	Schallner, N; Romao, CC; Biermann, J; Lagreze, WA; Otterbein, LE; Buerkle, H; Loop, T; Goebel, U				Schallner, Nils; Romao, Carlos C.; Biermann, Julia; Lagreze, Wolf A.; Otterbein, Leo E.; Buerkle, Hartmut; Loop, Torsten; Goebel, Ulrich			Carbon Monoxide Abrogates Ischemic Insult to Neuronal Cells via the Soluble Guanylate Cyclase-cGMP Pathway	PLOS ONE			English	Article							ROTENONE-INDUCED APOPTOSIS; RETINAL GANGLION-CELLS; NEUROBLASTOMA SH-SY5Y CELLS; PROTEIN-KINASE PATHWAY; INFLAMMATORY RESPONSE; LUNG INJURY; IN-VITRO; OXIDATIVE STRESS; HEME OXYGENASE-1; NITRIC-OXIDE	Purpose: Carbon monoxide (CO) is an accepted cytoprotective molecule. The extent and mechanisms of protection in neuronal systems have not been well studied. We hypothesized that delivery of CO via a novel releasing molecule (CORM) would impart neuroprotection in vivo against ischemia-reperfusion injury (IRI)-induced apoptosis of retinal ganglion cells (RGC) and in vitro of neuronal SH-SY5Y-cells via activation of soluble guanylate-cyclase (sGC). Methods: To mimic ischemic respiratory arrest, SH-SY5Y-cells were incubated with rotenone (100 nmol/L, 4 h) +/- CORM ALF186 (10-100 mu mol/L) or inactivated ALF186 lacking the potential of releasing CO. Apoptosis and reactive oxygen species (ROS) production were analyzed using flow-cytometry (Annexin V, mitochondrial membrane potential, CM-H(2)DCFDA) and Western blot (Caspase-3). The impact of ALF186 +/- respiratory arrest on cell signaling was assessed by measuring expression of nitric oxide synthase (NOS) and soluble guanylate-cyclase (sGC) and by analyzing cellular cGMP levels. The effect of ALF186 (10 mg/kg iv) on retinal IRI in Sprague-Dawley rats was assessed by measuring densities of fluorogold-labeled RGC after IRI and by analysis of apoptosis-related genes in retinal tissue. Results: ALF186 but not inactivated ALF186 inhibited rotenone-induced apoptosis (Annexin V positive cells: 25 +/- 2% rotenone vs. 14 +/- 1% ALF186+rotenone, p<0.001; relative mitochondrial membrane potential: 17 +/- 4% rotenone vs. 55 +/- 3% ALF186+rotenone, p<0.05). ALF186 increased cellular cGMP levels (33 +/- 5 nmol/L vs. 23 +/- 3 nmol/L; p<0.05) and sGC expression. sGC-inhibition attenuated ALF186-mediated protection (relative mitochondrial membrane potential: 55 +/- 3% ALF186+rotenone vs. 20 +/- 1% ODQ+ALF186+rotenone, p<0.05). ALF186 protected RGC in vivo (IRI 1255 +/- 327 RGC/mm(2) vs. ALF186+IRI 2036 +/- 83; p<0.05) while sGC inhibition abolished the protective effects of ALF186 (ALF186+IRI 2036 +/- 83 RGC/mm(2) vs. NS-2028+ALF186+IRI 1263 +/- 170, p<0.05). Conclusions: The CORM ALF186 inhibits IRI-induced neuronal cell death via activation of sGC and may be a useful treatment option for acute ischemic insults to the retina and the brain.	[Schallner, Nils; Buerkle, Hartmut; Loop, Torsten; Goebel, Ulrich] Univ Med Ctr Freiburg, Dept Anesthesiol, Div Expt Anesthesiol, Freiburg, Germany; [Romao, Carlos C.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Biermann, Julia; Lagreze, Wolf A.] Univ Med Ctr Freiburg, Univ Eye Hosp, Freiburg, Germany; [Otterbein, Leo E.] Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Romao, Carlos C.] Alfama Limitida, Inst Biol Expt & Tecnol, Oeiras, Portugal	University of Freiburg; Universidade Nova de Lisboa; University of Freiburg; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Schallner, N (corresponding author), Univ Med Ctr Freiburg, Dept Anesthesiol, Div Expt Anesthesiol, Freiburg, Germany.	nils.schallner@uniklinik-freiburg.de	Goebel, Ulrich M./AGG-1495-2022; Göbel, Ulrich/Q-7613-2016; Romão, Carlos C/D-1162-2010; Buerkle, Hartmut/I-5785-2014	Göbel, Ulrich/0000-0002-9991-3226; Romão, Carlos C/0000-0001-5061-3743; 	Department of Anesthesiology and Critical Care Medicine; University Eye Hospital, University Medical Center Freiburg, Germany	Department of Anesthesiology and Critical Care Medicine; University Eye Hospital, University Medical Center Freiburg, Germany	This work was funded by departmental funding of the Department of Anesthesiology and Critical Care Medicine and the University Eye Hospital, University Medical Center Freiburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2012, J BIOL CHEM, V287, P10761, DOI 10.1074/jbc.M111.306738; ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; Bani-Hani MG, 2006, J PHARMACOL EXP THER, V318, P1315, DOI 10.1124/jpet.106.104729; Basuroy S, 2011, AM J PHYSIOL-CELL PH, V300, pC256, DOI 10.1152/ajpcell.00272.2010; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Bilban M, 2006, IMMUNITY, V24, P601, DOI 10.1016/j.immuni.2006.03.012; BUECHLER WA, 1991, BIOCHEM BIOPH RES CO, V174, P351, DOI 10.1016/0006-291X(91)90527-E; Canas N, 2007, J PHARMACOL EXP THER, V323, P946, DOI 10.1124/jpet.107.123505; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Danias J, 2002, INVEST OPHTH VIS SCI, V43, P587; De Backer O, 2009, GUT, V58, P347, DOI 10.1136/gut.2008.155481; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Foresti R, 2004, BRIT J PHARMACOL, V142, P453, DOI 10.1038/sj.bjp.0705825; Goebel U, 2008, ANESTHESIOLOGY, V108, P1025, DOI 10.1097/ALN.0b013e3181733115; Hoetzel A, 2008, AM J RESP CRIT CARE, V177, P1223, DOI 10.1164/rccm.200708-1265OC; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Jehle T, 2008, INVEST OPHTH VIS SCI, V49, P1056, DOI 10.1167/iovs.07-1050; Kim HJ, 2009, TOXICOLOGY, V262, P171, DOI 10.1016/j.tox.2009.06.004; Kitamura Y, 2002, NEUROSCI LETT, V333, P25, DOI 10.1016/S0304-3940(02)00964-3; LEINDERSZUFALL T, 1995, J NEUROPHYSIOL, V74, P1498, DOI 10.1152/jn.1995.74.4.1498; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Mahan VL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041982; Marazioti A, 2011, ARTERIOSCL THROM VAS, V31, P2570, DOI 10.1161/ATVBAHA.111.229039; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1289, DOI 10.1097/ALN.0b013e318216e7f4; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; Motterlini R, 2004, FASEB J, V18, P284, DOI 10.1096/fj.04-2169fje; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Newhouse K, 2004, TOXICOL SCI, V79, P137, DOI 10.1093/toxsci/kfh089; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Park HJ, 2009, NEUROTOXICOLOGY, V30, P1114, DOI 10.1016/j.neuro.2009.08.005; Resch H, 2005, INVEST OPHTH VIS SCI, V46, P4275, DOI 10.1167/iovs.05-0417; Rodrigues S. S., 2011, U.S. Patent, Patent No. 20110038955; Romao CC, 2012, CHEM SOC REV, V41, P3571, DOI 10.1039/c2cs15317c; Russwurm M, 1998, BIOCHEM J, V335, P125, DOI 10.1042/bj3350125; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Schallner N, 2011, EUR J PHARMACOL, V670, P58, DOI 10.1016/j.ejphar.2011.08.028; Seixas JD, 2013, DALTON T, V42, P5985, DOI 10.1039/c2dt32174b; Sheikh SZ, 2011, J IMMUNOL, V186, P5506, DOI 10.4049/jimmunol.1002433; Song RP, 2003, AM J PATHOL, V163, P231, DOI 10.1016/S0002-9440(10)63646-2; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Tayem Y, 2006, AM J PHYSIOL-RENAL, V290, pF789, DOI 10.1152/ajprenal.00363.2005; Tsoyi K, 2010, SHOCK, V34, P608, DOI 10.1097/SHK.0b013e3181e46f15; Tsoyi K, 2009, MOL PHARMACOL, V76, P173, DOI 10.1124/mol.109.055137; Urquhart P, 2007, J PHARMACOL EXP THER, V321, P656, DOI 10.1124/jpet.106.117218; Vadori M, 2009, XENOTRANSPLANTATION, V16, P99, DOI 10.1111/j.1399-3089.2009.00521.x; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang X, 2007, J BIOL CHEM, V282, P1718, DOI 10.1074/jbc.M607610200; Wang XX, 2002, J NEUROCHEM, V83, P1094, DOI 10.1046/j.1471-4159.2002.01224.x; Wu YC, 2010, NEUROCHEM INT, V57, P198, DOI 10.1016/j.neuint.2010.05.008; Xiong N, 2011, NEUROSCIENCE, V199, P292, DOI 10.1016/j.neuroscience.2011.10.031; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zhang XC, 2003, J BIOL CHEM, V278, P1248, DOI 10.1074/jbc.M208419200; Zhang ZZ, 2012, EXP EYE RES, V94, P98, DOI 10.1016/j.exer.2011.11.013; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	58	40	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60672	10.1371/journal.pone.0060672	http://dx.doi.org/10.1371/journal.pone.0060672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593279	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000050
J	Veland, IR; Montjean, R; Eley, L; Pedersen, LB; Schwab, A; Goodship, J; Kristiansen, K; Pedersen, SF; Saunier, S; Christensen, ST				Veland, Iben R.; Montjean, Rodrick; Eley, Lorraine; Pedersen, Lotte B.; Schwab, Albrecht; Goodship, Judith; Kristiansen, Karsten; Pedersen, Stine F.; Saunier, Sophie; Christensen, Soren T.			Inversin/Nephrocystin-2 Is Required for Fibroblast Polarity and Directional Cell Migration	PLOS ONE			English	Article							WNT SIGNALING PATHWAYS; PRIMARY CILIA; ACTIN REORGANIZATION; EXCHANGER NHE1; ERM PROTEINS; PDGFR-ALPHA; RHO-GTPASES; CYCLIN D1; INVERSIN; GENE	Inversin is a ciliary protein that critically regulates developmental processes and tissue homeostasis in vertebrates, partly through the degradation of Dishevelled (Dvl) proteins to coordinate Wnt signaling in planar cell polarity (PCP). Here, we investigated the role of Inversin in coordinating cell migration, which highly depends on polarity processes at the single-cell level, including the spatial and temporal organization of the cytoskeleton as well as expression and cellular localization of proteins in leading edge formation of migrating cells. Using cultures of mouse embryonic fibroblasts (MEFs) derived from inv(-/-) and inv(+/+) animals, we confirmed that both inv(-/-) and inv(+/+) MEFs form primary cilia, and that Inversin localizes to the primary cilium in inv(+/+) MEFs. In wound healing assays, inv(-/-) MEFs were severely compromised in their migratory ability and exhibited cytoskeletal rearrangements, including distorted lamellipodia formation and cilia orientation. Transcriptome analysis revealed dysregulation of Wnt signaling and of pathways regulating actin organization and focal adhesions in inv(-/-) MEFs as compared to inv(+/+) MEFs. Further, Dvl-1 and Dvl-3 localized to MEF primary cilia, and beta-catenin/Wnt signaling was elevated in inv(-/-) MEFs, which moreover showed reduced ciliary localization of Dvl-3. Finally, inv(-/-) MEFs displayed dramatically altered activity and localization of RhoA, Rac1, and Cdc42 GTPases, and aberrant expression and targeting of the Na+/H+ exchanger NHE1 and ezrin/radixin/moesin (ERM) proteins to the edge of cells facing the wound. Phosphorylation of beta-catenin at the ciliary base and formation of well-defined lamellipodia with localization and activation of ERM to the leading edge of migrating cells were restored in inv(-/-) MEFs expressing Inv-GFP. Collectively, our findings point to the significance of Inversin in controlling cell migration processes, at least in part through transcriptional regulation of genes involved in Wnt signaling and pathways that control cytoskeletal organization and ion transport.	[Veland, Iben R.; Pedersen, Lotte B.; Kristiansen, Karsten; Pedersen, Stine F.; Christensen, Soren T.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Montjean, Rodrick; Saunier, Sophie] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, INSERM, Necker Hosp,U983, Paris, France; [Eley, Lorraine; Goodship, Judith] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Schwab, Albrecht] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany	University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Newcastle University - UK; University of Munster	Christensen, ST (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	stchristensen@bio.ku.dk	Pedersen, Stine Falsig/M-8347-2014; Christensen, Søren Tvorup/ABG-6089-2020; Saunier, Sophie/G-6044-2015; Pedersen, Stine Falsig/O-1133-2019; Pedersen, Lotte Bang/J-6909-2014; Kristiansen, Karsten/J-5148-2014; Christensen, Søren/N-3049-2014	Pedersen, Stine Falsig/0000-0002-3044-7714; Christensen, Søren Tvorup/0000-0001-5004-304X; Saunier, Sophie/0000-0002-1069-0047; Pedersen, Stine Falsig/0000-0002-3044-7714; Pedersen, Lotte Bang/0000-0002-9749-3758; Kristiansen, Karsten/0000-0002-6024-0917; Christensen, Søren/0000-0001-5004-304X	Lundbeck Foundation [32989, 31077]; Novo Nordisk Foundation [34199, 29477]; Danish National Research Foundation [10-085373, 09-070398]; Danish Cancer Society [R2-A273-09-S2]; Nordforsk [30707]; Institut National de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche [R09087KS]; Fondation pour la Recherche Medicale ('Equipe FRM') [DEQ20071210558]; University of Copenhagen; Lundbeck Foundation [R54-2010-5375] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Cancer Society(Danish Cancer Society); Nordforsk; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale ('Equipe FRM')(Fondation pour la Recherche Medicale); University of Copenhagen; Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Lundbeck Foundation (www.lundbeck.dk (STC, LBP) grant numbers 32989, 31077), the Novo Nordisk Foundation (www.novonordiskfonden.dk (STC, SFP) grant numbers 34199 and 29477), Danish National Research Foundation (www.fi.dk (STC, SFP) grant numbers 10-085373 and 09-070398), Danish Cancer Society (www.cancer.dk (SFP) grant number R2-A273-09-S2), Nordforsk (www.nordforsk.org (LBP) grant number 30707), the Institut National de la Sante et de la Recherche Medicale (www.inserm.fr (SS, RM)), the Agence Nationale de la Recherche (www.agence-nationale-recherche.fr (SS) grant number R09087KS), and the Fondation pour la Recherche Medicale ('Equipe FRM' www.frm.org (SS, RM) grant number DEQ20071210558), and the University of Copenhagen for PhD scholarship to IRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTBUEHLER G, 1977, CELL, V12, P333, DOI 10.1016/0092-8674(77)90109-X; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Awan A, 2010, METHODS MOL BIOL, V584, P195, DOI 10.1007/978-1-60761-369-5_11; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baeyens N, 2011, J CELL BIOCHEM, V112, P2574, DOI 10.1002/jcb.23183; Burckle C, 2011, HUM MOL GENET; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Cardone RA, 2005, MOL BIOL CELL, V16, P3117, DOI 10.1091/mbc.e04-10-0945; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Christensen ST, 2001, J BIOL CHEM, V276, P20048, DOI 10.1074/jbc.M008412200; Christensen ST, 2012, METHODS ENZYMOL; Clement CA, 2009, METHOD CELL BIOL, V94, P181, DOI 10.1016/S0091-679X(08)94009-7; Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426; Clement DL, 2012, PDGFRALPHA SIGNALING; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Eley L, 2004, CELL BIOL INT, V28, P119, DOI 10.1016/j.cellbi.2003.11.009; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lienkamp S, 2012, DIFFERENTIATION, V83, pS49, DOI 10.1016/j.diff.2011.11.012; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Lu CJ, 2008, KIDNEY BLOOD PRESS R, V31, P171, DOI 10.1159/000132462; Luyten A, 2010, J AM SOC NEPHROL, V21, P1521, DOI 10.1681/ASN.2010010127; Mahuzier A, 2012, J CELL BIOL, V198, P927, DOI 10.1083/jcb.201111009; Martin C, 2011, AM J PHYSIOL-CELL PH, V300, pC490, DOI 10.1152/ajpcell.00280.2010; May-Simera Helen L, 2012, Cilia, V1, P7, DOI 10.1186/2046-2530-1-7; Mazziotti MV, 1999, HEPATOLOGY, V30, P372, DOI 10.1002/hep.510300223; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; McQuinn TC, 2001, ANAT RECORD, V263, P62, DOI 10.1002/ar.1077; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Morishima M, 1998, TERATOLOGY, V57, P302, DOI 10.1002/(SICI)1096-9926(199806)57:6<302::AID-TERA3>3.0.CO;2-Y; NIEHRS C, 1993, CELL, V72, P491, DOI 10.1016/0092-8674(93)90069-3; Nurnberger J, 2004, J AM SOC NEPHROL, V15, P1700, DOI 10.1097/01.ASN.0000128291.30249.D0; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pedersen SF, 2012, PROTON HOMEOSTASIS T, P13; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Phillips CL, 2004, J AM SOC NEPHROL, V15, P1744, DOI 10.1097/01.ASN.0000131520.07008.B3; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rasmussen M, 2008, AM J PHYSIOL-CELL PH, V294, pC197, DOI 10.1152/ajpcell.00268.2007; Reid CD, 2012, DEV BIOL, V368, P231, DOI 10.1016/j.ydbio.2012.05.018; Rida PCG, 2009, SEMIN CELL DEV BIOL, V20, P978, DOI 10.1016/j.semcdb.2009.02.007; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; Salomon R, 2008, NEPHRONOPHTHISIS PED; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Schneider L, 2009, J CELL BIOL, V185, P163, DOI 10.1083/jcb.200806019; Schroder JM, 2011, J CELL SCI, V124, P2539, DOI 10.1242/jcs.085852; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tory K, 2009, KIDNEY INT, V75, P839, DOI 10.1038/ki.2008.662; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wang L, 2003, J BIOL CHEM, V278, P44617, DOI 10.1074/jbc.M308929200; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Wheeler DS, 2011, ONCOGENE, V30, P32, DOI 10.1038/onc.2010.389; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Wu CS, 2011, J BIOL CHEM, V286, P23511, DOI 10.1074/jbc.M111.245209; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823; Zilber Y, 2013, MOL BIOL CELL, V24, P555, DOI 10.1091/mbc.E12-06-0437	94	39	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60193	10.1371/journal.pone.0060193	http://dx.doi.org/10.1371/journal.pone.0060193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593172	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000024
J	Koutros, S; Berndt, SI; Barry, KH; Andreotti, G; Hoppin, JA; Sandler, DP; Yeager, M; Burdett, LA; Yuenger, J; Alavanja, MCR; Freeman, LEB				Koutros, Stella; Berndt, Sonja I.; Barry, Kathryn Hughes; Andreotti, Gabriella; Hoppin, Jane A.; Sandler, Dale P.; Yeager, Meredith; Burdett, Laurie A.; Yuenger, Jeffrey; Alavanja, Michael C. R.; Freeman, Laura E. Beane			Genetic Susceptibility Loci, Pesticide Exposure and Prostate Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AGRICULTURAL HEALTH; SEQUENCE VARIANTS; CHROMOSOME 8Q24; IDENTIFICATION; APPLICATORS; FARMERS; WORKERS; STATES; SOX9	Uncovering SNP (single nucleotide polymorphisms)-environment interactions can generate new hypotheses about the function of poorly characterized genetic variants and environmental factors, like pesticides. We evaluated SNP-environment interactions between 30 confirmed prostate cancer susceptibility loci and 45 pesticides and prostate cancer risk in 776 cases and 1,444 controls in the Agricultural Health Study. We used unconditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Multiplicative SNP-pesticide interactions were calculated using a likelihood ratio test. After correction for multiple tests using the False Discovery Rate method, two interactions remained noteworthy. Among men carrying two T alleles at rs2710647 in EH domain binding protein 1 (EHBP1) SNP, the risk of prostate cancer in those with high malathion use was 3.43 times those with no use (95% CI: 1.44-8.15) (P-interaction = 0.003). Among men carrying two A alleles at rs7679673 in TET2, the risk of prostate cancer associated with high aldrin use was 3.67 times those with no use (95% CI: 1.43, 9.41) (P-interaction = 0.006). In contrast, associations were null for other genotypes. Although additional studies are needed and the exact mechanisms are unknown, this study suggests known genetic susceptibility loci may modify the risk between pesticide use and prostate cancer.	[Koutros, Stella; Berndt, Sonja I.; Barry, Kathryn Hughes; Andreotti, Gabriella; Alavanja, Michael C. R.; Freeman, Laura E. Beane] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hoppin, Jane A.; Sandler, Dale P.] NIEHS, Epidemiol Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Yeager, Meredith; Burdett, Laurie A.; Yuenger, Jeffrey] NCI, Core Genotyping Facil, Adv Technol Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Koutros, S (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	KoutrosS@mail.nih.gov	Freeman, Laura E. Beane/C-4468-2015; Koutros, Stella/W-5788-2019; Yeager, Meredith/AAA-5322-2020; Berndt, Sonja I/J-8423-2016	Freeman, Laura E. Beane/0000-0003-1294-4124; Koutros, Stella/0000-0001-5294-5485; Hoppin, Jane/0000-0001-8456-0969; Sandler, Dale/0000-0002-6776-0018	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics [Z01CP010119]; National Institute of Environmental Health Sciences [Z01ES049030]; NATIONAL CANCER INSTITUTE [Z01CP010119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049030, Z01ES049030] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (Z01CP010119) and National Institute of Environmental Health Sciences (Z01ES049030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Alavanja MCR, 2003, AM J EPIDEMIOL, V157, P800, DOI 10.1093/aje/kwg040; Alavanja MCR, 2005, SCAND J WORK ENV HEA, V31, P39; Band PR, 2011, PROSTATE, V71, P168, DOI 10.1002/pros.21232; Blair A, 2002, EPIDEMIOLOGY, V13, P94, DOI 10.1097/00001648-200201000-00015; BLAIR A, 1992, SCAND J WORK ENV HEA, V18, P209, DOI 10.5271/sjweh.1578; BLAIR A, 1993, AM J IND MED, V23, P729, DOI 10.1002/ajim.4700230507; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; DOSEMECI M, 1994, JNCI-J NATL CANCER I, V86, P1718, DOI 10.1093/jnci/86.22.1718; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Hoppin JA, 2002, J EXPO ANAL ENV EPID, V12, P313, DOI 10.1038/sj.jea.7500232; Kote-Jarai Z, 2011, HUM GENET, V129, P687, DOI 10.1007/s00439-011-0981-1; Koutros S, 2013, AM J EPIDEMIOL, V177, P59, DOI 10.1093/aje/kws225; Koutros S, 2010, CANCER RES, V70, P9224, DOI 10.1158/0008-5472.CAN-10-1078; Koutros S, 2010, J OCCUP ENVIRON MED, V52, P1098, DOI 10.1097/JOM.0b013e3181f72b7c; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; MacLennan PA, 2002, J OCCUP ENVIRON MED, V44, P1048, DOI 10.1097/00043764-200211000-00011; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Mahajan R, 2006, ENVIRON HEALTH PERSP, V114, P1838, DOI 10.1289/ehp.9301; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Meyer TE, 2007, OCCUP ENVIRON MED, V64, P155, DOI 10.1136/oem.2006.027383; Mills PK, 2003, J OCCUP ENVIRON MED, V45, P249, DOI 10.1097/01.jom.0000058339.05741.0c; Multigner L, 2010, J CLIN ONCOL, V28, P3457, DOI 10.1200/JCO.2009.27.2153; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Parikh H, 2011, HUM GENET, V129, P675, DOI 10.1007/s00439-011-0953-5; Pomerantz MM, 2011, CANCER PREV RES, V4, P719, DOI 10.1158/1940-6207.CAPR-10-0292; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Settimi L, 2003, INT J CANCER, V104, P458, DOI 10.1002/ijc.10955; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thomsen MK, 2008, DIFFERENTIATION, V76, P728, DOI 10.1111/j.1432-0436.2008.00293.x; Thomsen MK, 2010, CANCER RES, V70, P979, DOI 10.1158/0008-5472.CAN-09-2370; Van Maele-Fabry G, 2004, INT ARCH OCC ENV HEA, V77, P559, DOI 10.1007/s00420-004-0548-8; Xu XH, 2010, ENVIRON HEALTH PERSP, V118, P60, DOI 10.1289/ehp.0900919; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444	50	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e58195	10.1371/journal.pone.0058195	http://dx.doi.org/10.1371/journal.pone.0058195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593118	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100003
J	Takahashi, T; Takaguchi, M; Kawakami, T; Suzuki, T				Takahashi, Tadanobu; Takaguchi, Masahiro; Kawakami, Tatsuya; Suzuki, Takashi			Sulfatide Regulates Caspase-3-Independent Apoptosis of Influenza A Virus through Viral PB1-F2 Protein	PLOS ONE			English	Article							CASPASE-INDEPENDENT APOPTOSIS; INDUCED CELL-DEATH; MITOCHONDRIAL PROTEIN; SIALIDASE ACTIVITY; INDUCE APOPTOSIS; EPITHELIAL-CELLS; ACTIVATION; HEMAGGLUTININ; REPLICATION; PROPAGATION	Influenza A virus (IAV) generally causes caspase-dependent apoptosis based on caspase-3 activation, resulting in nuclear export of newly synthesized viral nucleoprotein (NP) and elevated virus replication. Sulfatide, a sulfated galactosyl-sphingolipid, enhances IAV replication through promoting newly synthesized viral NP export induced by association of sulfatide with hemagglutinin delivered to the cell surface. Here, we demonstrated that sulfatide is involved in caspase-3-independent apoptosis initiated by the PB1-F2 protein of IAV by using genetically sulfatide-produced cells and PB1-F2-deficient IAVs. Sulfatide-deficient COS7 cells showed no virus-induced apoptosis, whereas SulCOS1 cells, sulfatide-enriched COS7 cells that genetically expressed the two transferases required for sulfatide synthesis from ceramide, showed an increase in IAV replication and were susceptible to caspase-3-independent apoptosis. Additionally, PB1-F2-deficient IAVs, which were generated by using a plasmid-based reverse genetics system from a genetic background of A/WSN/33 (H1N1), demonstrated that PB1-F2 contributed to caspase-3-independent apoptosis in IAV-infected SulCOS1 cells. Our results show that sulfatide plays a critical role in efficient IAV propagation via caspase-3-independent apoptosis initiated by the PB1-F2 protein.	[Takahashi, Tadanobu; Takaguchi, Masahiro; Kawakami, Tatsuya; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, Shzuoka, Japan	University of Shizuoka	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, Shzuoka, Japan.	Suzukit@u-shizuoka-ken.ac.jp			Global COE Program from the Japan Society for the Promotion of Science [20790357]; MEXT/JSPS KAKENHI [23590549]; Tokyo Biochemical Research Foundation; Hamamatsu Scientific Research Foundation; Takeda Science Foundation; Sasakawa Scientific Research Grant from The Japan Science Society; Research Foundation for Pharmaceutical Sciences; Adaptable and Seamless Technology Transfer Program (A-step) through Target-driven RD, JST; Grants-in-Aid for Scientific Research [23590549] Funding Source: KAKEN	Global COE Program from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo Biochemical Research Foundation; Hamamatsu Scientific Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Sasakawa Scientific Research Grant from The Japan Science Society; Research Foundation for Pharmaceutical Sciences; Adaptable and Seamless Technology Transfer Program (A-step) through Target-driven RD, JST; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global COE Program from the Japan Society for the Promotion of Science and by grant-in-aid for Scientific Research of Young Scientists B (20790357), MEXT/JSPS KAKENHI Grant Number (C, 23590549), Grant-in-Aid from Tokyo Biochemical Research Foundation, Grant-in-Aid from Hamamatsu Scientific Research Foundation, Grant-in-Aid from Takeda Science Foundation, Sasakawa Scientific Research Grant from The Japan Science Society, The Research Foundation for Pharmaceutical Sciences, and Adaptable and Seamless Technology Transfer Program (A-step) through Target-driven R&D, JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Chang LK, 2002, J CELL BIOL, V157, P771, DOI 10.1083/jcb.200112130; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Choi YK, 2006, EXP MOL MED, V38, P11, DOI 10.1038/emm.2006.2; Cummings BS, 2004, J PHARMACOL EXP THER, V310, P126, DOI 10.1124/jpet.104.065862; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Honke K, 1997, J BIOL CHEM, V272, P4864, DOI 10.1074/jbc.272.8.4864; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Morris SJ, 1999, J GEN VIROL, V80, P137, DOI 10.1099/0022-1317-80-1-137; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Sanchez-Alcazar JA, 2003, LUNG CANCER-J IASLC, V40, P33, DOI 10.1016/S0169-5002(02)00530-5; Schultz-Cherry S, 2001, J VIROL, V75, P7875, DOI 10.1128/JVI.75.17.7875-7881.2001; Shih CM, 2003, J CELL BIOCHEM, V89, P335, DOI 10.1002/jcb.10488; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Suzuki T, 1996, BIOCHEM J, V318, P389, DOI 10.1042/bj3180389; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; Takahashi T, 2008, J VIROL, V82, P5940, DOI 10.1128/JVI.02496-07; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Takahashi T, 2010, J BIOCHEM, V147, P459, DOI 10.1093/jb/mvq013; Takizawa T, 1999, MICROBIOL IMMUNOL, V43, P245, DOI 10.1111/j.1348-0421.1999.tb02400.x; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; Yang W, 2009, MOL CELL BIOCHEM, V332, P233, DOI 10.1007/s11010-009-0196-0; Yuan CQ, 2004, BIOCHEM BIOPH RES CO, V317, P1108, DOI 10.1016/j.bbrc.2004.03.169; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2; Zhirnov OP, 2007, APOPTOSIS, V12, P1419, DOI 10.1007/s10495-007-0071-y	31	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61092	10.1371/journal.pone.0061092	http://dx.doi.org/10.1371/journal.pone.0061092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593400	gold, Green Submitted, Green Published			2022-12-27	WOS:000319108100075
J	Corse, E; Rampal, J; Cuoc, C; Pech, N; Perez, Y; Gilles, A				Corse, Emmanuel; Rampal, Jeannine; Cuoc, Corinne; Pech, Nicolas; Perez, Yvan; Gilles, Andre			Phylogenetic Analysis of Thecosomata Blainville, 1824 (Holoplanktonic Opisthobranchia) Using Morphological and Molecular Data	PLOS ONE			English	Article							SYSTEMATIC POSITION; SEQUENCE ALIGNMENTS; OCEAN ACIDIFICATION; MOLLUSCA; GASTROPODA; BIVALVIA; NUCLEAR; EOCENE; TEMPERATURE; PERFORMANCE	Thecosomata is a marine zooplankton group, which played an important role in the carbonate cycle in oceans due to their shell composition. So far, there is important discrepancy between the previous morphological-based taxonomies, and subsequently the evolutionary history of Thecosomata. In this study, the remarkable planktonic sampling of TARA Oceans expedition associated with a set of various other missions allowed us to assess the phylogenetic relationships of Thecosomata using morphological and molecular data (28 S and COI genes). The two gene trees showed incongruities (e.g. Hyalocylis, Cavolinia), and high congruence between morphological and 28S trees (e.g. monophyly of Euthecosomata). The monophyly of straight shell species led us to reviving the Orthoconcha, and the split of Limacinidae led us to the revival of Embolus inflata replacing Limacina inflata. The results also jeopardized the Euthecosomata families that are based on plesiomorphic character state as in the case for Creseidae which was not a monophyletic group. Divergence times were also estimated, and suggested that the evolutionary history of Thecosomata was characterized by four major diversifying events. By bringing the knowledge of palaeontology, we propose a new evolutionary scenario for which macro-evolution implying morphological innovations were rhythmed by climatic changes and associated species turn-over that spread from the Eocene to Miocene, and were shaped principally by predation and shell buoyancy.	[Corse, Emmanuel; Rampal, Jeannine; Cuoc, Corinne; Pech, Nicolas; Perez, Yvan; Gilles, Andre] Aix Marseille Univ, IMBE, CNRS, UMR Evolut Genome Environm 7263,IRD 237, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Corse, E (corresponding author), Aix Marseille Univ, IMBE, CNRS, UMR Evolut Genome Environm 7263,IRD 237, Marseille, France.	Emmanuel.corse@gmail.com		Nicolas, Pech/0000-0002-1822-3558				Abildgaard PC, 1791, NATURHISTORIE SELSKA, V1, P171; Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Bandel K., 1984, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V168, P87; Barber BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037105; Bednarsek N, 2012, EARTH SYST SCI DATA, V5, P317; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Boas JEV, 1886, ZOOL JB, V1, P311; Bonnevie K., 1913, REPORT SCI RESULTS M, V3, P1; Bralower TJ, 2002, PALEOCEANOGRAPHY, V17; Cahuzac B, 1996, CONCEPTS SEDIMENTOLO, V5, P205; Cahuzac B, 1992, CIENCIAS TERRA, V12, P71; Cahuzac B, 1980, THESIS U BORDEAUX 1; Cahuzac Bruno, 2010, Scripta Geologica, V141, P1; Chang Y, 2012, INTEGR COMP BIOL, V52, P597, DOI 10.1093/icb/ics113; Chen J, 2011, ZOOL SCR, V40, P260, DOI 10.1111/j.1463-6409.2011.00471.x; CLARKE A, 1992, PHILOS T ROY SOC B, V338, P299, DOI 10.1098/rstb.1992.0150; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; Curry D., 1965, Proceedings of the Malacological Society of London, V36, P357; Dayrat B, 2001, MOL PHYLOGENET EVOL, V19, P225, DOI 10.1006/mpev.2001.0926; Delanoy G, 2012, C R ACAD SCI 2, V318, P843; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ebbestad JOR, 2009, LETHAIA, V42, P469, DOI 10.1111/j.1502-3931.2009.00167.x; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Fol H., 1875, ARCH ZOOLOGIE EXPT G, V4, P1, DOI [10.5962/bhl.title.10626, DOI 10.5962/BHL.TITLE.10626]; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foucault A, 1995, DICT GEOLOGIE, P324; Fouquet A, 2012, SYST BIOL, V61, P461, DOI 10.1093/sysbio/syr130; Gallager SM, 1998, ANN REPORT WOODS HOL; Gardere P, 2007, CIENCIAS TERRA, V15, P151; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; Gilmer R, 1977, ZOOGEOGRAPHIC TAXONO; GILMER RW, 1991, MAR ECOL PROG SER, V77, P125, DOI 10.3354/meps077125; Giribet G, 2002, INVERTEBR BIOL, V121, P271; GRAY JE, 1840, SYNOPSIS CONTENTS BR, P105; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gurs K, 2004, NETH J GEOSCI, V83, P199; Halfar J, 2005, GEOLOGY, V33, P481, DOI 10.1130/G21462.1; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hodgkinson Kenneth A., 1992, Bulletins of American Paleontology, V103, P5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; JANSSEN A. W., 2004, PALAEONTOS, V5, P103; Janssen AW, 1995, SYSTEMATIC REVISION; Jennings RM, 2010, DEEP-SEA RES PT II, V57, P2199, DOI 10.1016/j.dsr2.2010.09.022; Kappner I, 2006, MOL PHYLOGENET EVOL, V40, P317, DOI 10.1016/j.ympev.2006.02.006; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Keupp H, 2010, NEUES JAHRB GEOL P-A, V255, P301, DOI 10.1127/0077-7749/2009/0026; Klug C, 2004, ACTA PALAEONTOL POL, V49, P235; Klussmann-Kolb A, 2006, J ZOOL SYST EVOL RES, V44, P118, DOI 10.1111/j.1439-0469.2006.00351.x; KORNICKER LOUIS S., 1959, BULL MARINE SCI GULF AND CARIBBEAN, V9, P331; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Kump LR, 2009, OCEANOGRAPHY, V22, P94, DOI 10.5670/oceanog.2009.100; Lef?vre T., 1885, ANN SOC MALACOLOGIQU, V15, P100; Lemoke H., 1948, Kongelige Danske Videnskabernes Selskabs Skrifter, V5, P1; Lischka S, 2010, BIOGEOSCIENCES, V7, P8177, DOI DOI 10.5194/BGD-7-8177-2010; Lozouet P, 1997, THESIS MUSEUM NATL H; Martin DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/j.1755-0998.2011.03026.x; Matthee CA, 2001, SYST BIOL, V50, P367, DOI 10.1080/106351501300317987; McCracken KG, 2005, SYST BIOL, V54, P35, DOI 10.1080/10635150590910249; McGowan JA, 1960, SYSTEMATICS DISTRIBU; Meisenheimer J., 1905, WISS ERGEBN DTSCH TI, VIX, P1; Mikhailova IA, 2009, PALEONTOL J+, V43, P527, DOI 10.1134/S0031030109050086; Mikkelsen PM, 2006, ZOOL J LINN SOC-LOND, V148, P439, DOI 10.1111/j.1096-3642.2006.00262.x; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nei M., 2000, MOL EVOLUTION PHYLOG; NORTON SF, 1988, SCIENCE, V241, P92, DOI 10.1126/science.241.4861.92; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Pelseneer P, 1888, ZOOL, V33, P1; R Development Core Team, 2005, R LANG ENV STAT COMP; Rambaut A., 2003, TRACER MCMC TRACE AN; RAMPAL J, 1973, CR ACAD SCI D NAT, V277, P1345; Rampal J, 1975, THESIS U PROVENCE; Rampal J., 2011, REV I PECHES MARITIM, V37, P369; Rampal Jeannine, 2002, Zoosystema, V24, P209; RICHTER G, 1976, Archiv fuer Molluskenkunde, V107, P137; Roger LM, 2012, ICES J MAR SCI, V69, P465, DOI 10.1093/icesjms/fsr171; Scheibner C., 2008, eEarth, V3, P19; Scheibner C, 2008, EARTH-SCI REV, V90, P71, DOI 10.1016/j.earscirev.2008.07.002; Seibel BA, 2007, INTEGR COMP BIOL, V47, P880, DOI 10.1093/icb/icm089; SLATKIN M, 1991, GENETICS, V129, P555; Sluijs A, 2008, PALEOCEANOGRAPHY, V23; Spinks PQ, 2009, SYST BIOL, V58, P1, DOI 10.1093/sysbio/syp005; Spoel SVD, 1967, EUTHECOSOMATA GROUP; Steiner G, 1996, J MOL EVOL, V43, P58, DOI 10.1007/BF02352300; Steiner G, 2000, GEOL SOC SPEC PUBL, V177, P11, DOI 10.1144/GSL.SP.2000.177.01.02; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tesch JJ, 1946, THECOSOMATOUS PTEROP; Tesch JJ, 1913, TIERREICH ZUSAMMEN S, P1; Ujihara A, 1996, J PALEONTOL, V70, P771, DOI 10.1017/S0022336000023817; Van Simaeys S, 2004, NETH J GEOSCI, V83, P241, DOI 10.1017/S0016774600020308; Vandamme, 2011, PHYLOGENETIC HDB; VAWTER L, 1986, SCIENCE, V234, P194, DOI 10.1126/science.3018931; WALL-PALMER D., 2011, BIOGEOSCIENCES DISCU, V8, P6901; WELLS F E, 1978, Journal of the Malacological Society of Australia, V4, P1; Whidden R, 2010, PALAIOS, V27, P235; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	104	29	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e59439	10.1371/journal.pone.0059439	http://dx.doi.org/10.1371/journal.pone.0059439			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593138	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300006
J	Goncalves, MJF; Ferreira, AA				Ferreira Goncalves, Maria Jacirema; Ferreira, Alaidistania A.			Factors Associated with Length of Hospital Stay among HIV Positive and HIV Negative Patients with Tuberculosis in Brazil	PLOS ONE			English	Article							SOCIAL-FACTORS; SMOKING	Objective: Identify and analyze the factors associated to length of hospital stay among HIV positive and HIV negative patients with tuberculosis in Manaus city, state of Amazonas, Brazil, in 2010. Methods: Epidemiological study with primary data obtained from monitoring of hospitalized patients with tuberculosis in Manaus. Data were collected by interviewing patients and analyzing medical records, according to the following study variables age, sex, co-morbidities, education, race, income, lifestyle, history of previous treatment or hospitalization due to tuberculosis, treatment regimen, adverse reactions, smear test, clinical form, type of discharge, and length of hospital stay. The associated factors were identified through chi-square or t-Student test at a 5% significance level. Results: Income from 1 to 3 minimum wages (P = 0.028), pulmonary tuberculosis form (P = 0.011), negative smear test or no information in this regard (P = 0.014), initial 6-month treatment scheme (P = 0.029), and adverse drug reactions (P = 0.021) were associated to prolonged hospital stay in HIV positive patients. Conclusion: We found out that although there were no significant differences in the length of hospital stay in HIV positive patients, all factors significantly associated to prolonged hospital stay occurred in this group of patients. This finding corroborates other studies indicating the severity of tuberculosis in HIV patients, which may also contribute to lengthen their hospital stay.	[Ferreira Goncalves, Maria Jacirema; Ferreira, Alaidistania A.] Fed Univ Para, Amazonas Fed Univ, Postgrad Program Hlth Soc & Endem Dis Amazon, Leonidas & Maria Deane Inst,Fiocruz Fdn, Manaus, Amazonas, Brazil; [Ferreira Goncalves, Maria Jacirema; Ferreira, Alaidistania A.] Amazonas Fed Univ, Manaus Nursing Sch, Manaus, Amazonas, Brazil; [Ferreira Goncalves, Maria Jacirema] Fiocruz Fdn, Leonidas & Maria Deane Inst, Manaus, Amazonas, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Para; Fundacao Oswaldo Cruz	Goncalves, MJF (corresponding author), Fed Univ Para, Amazonas Fed Univ, Postgrad Program Hlth Soc & Endem Dis Amazon, Leonidas & Maria Deane Inst,Fiocruz Fdn, Manaus, Amazonas, Brazil.	jaciremagoncalves@gmail.com	Goncalves, Maria Jacirema/B-7018-2009; Goncalves, Maria Jacirema/Q-7455-2019	Goncalves, Maria Jacirema/0000-0002-8460-8501; Goncalves, Maria Jacirema/0000-0002-8460-8501; Ferreira, Alaidistania Aparecida Ferreira/0000-0001-8553-7269	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil [014/2008, 481423/2008-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was financed by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil - Universal Announcement 014/2008 - Process no. 481423/2008-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetse K, 2011, Bull Soc Pathol Exot, V104, P352, DOI 10.1007/s13149-011-0139-3; Atun RA, 2005, INT J TUBERC LUNG D, V9, P1140; Brazilian Institute of Geography and Statistics, 2010, DEM CENS; Brazilian Institute of Geography and Statistics, 2008, RAC ETHN FEAT POP ST; Brazilian Institute of Geography and Statistics, 2008, TABL 2 24 PROP PEOPL; Brazilian Ministry of Health, INF SYST NOT DIS SIN; Brazilian Ministry of Health, 2011, MAN REC TUB CONTR BR; Brazilian Ministry of Health, 2008, NAT POL MEN HLTH PRI; Campomizzi JB, 2009, THESIS MINAS GERAIS; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Craig GM, 2007, J ADV NURS, V58, P418, DOI 10.1111/j.1365-2648.2007.04257.x; Cramm JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-72; de Oliveira HMDG, 2009, J BRAS PNEUMOL, V35, P780, DOI 10.1590/S1806-37132009000800010; de Meneses-Gaya IC, 2009, J BRAS PNEUMOL, V35, P73, DOI 10.1590/S1806-37132009000100011; Ewing JA, 1984, CAGE CUT ANNOYED GUI; Fortes Deguenonvo L, 2011, Bull Soc Pathol Exot, V104, P366, DOI 10.1007/s13149-011-0178-9; Kra O, 2012, B SOC PATHOL EXOT, P1; Lins Tatiana Bacelar Acioli, 2012, Infez Med, V20, P108; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Sissolak D, 2010, INT J INFECT DIS, V14, pE423, DOI 10.1016/j.ijid.2009.06.030; Suhadev M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019485; Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292; Wen CP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-156; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	24	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60487	10.1371/journal.pone.0060487	http://dx.doi.org/10.1371/journal.pone.0060487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593227	Green Published, gold, Green Submitted			2022-12-27	WOS:000317385300018
J	Gagnon, K; Rothausler, E; Syrjanen, A; Yli-Renko, M; Jormalainen, V				Gagnon, Karine; Rothausler, Eva; Syrjanen, Anneli; Yli-Renko, Maria; Jormalainen, Veijo			Seabird Guano Fertilizes Baltic Sea Littoral Food Webs	PLOS ONE			English	Article							FUCUS-VESICULOSUS; TEMPORAL-CHANGES; ISOTOPE RATIOS; CORMORANTS; NITROGEN; IMPACT; DIET; DELTA-N-15; CONSUMER; CARBON	Nutrient enrichment in coastal marine systems can have profound impacts on trophic networks. In the Baltic Sea, the population of Great Cormorant (Phalacrocorax carbo sinensis) has increased nearly exponentially since the mid-1990s, and colonies of these seabirds can be important sources of nitrogen enrichment for nearby benthic communities due to guano runoff. In this study we used stable isotope analyses and diet mixing models to determine the extent of nitrogen enrichment from cormorant colonies, as well as to examine any possible changes in herbivore diet preferences due to enrichment. We found significantly higher levels of delta N-15 in samples from colony islands than control islands for producers (the dominant macroalga Fucus vesiculosus, filamentous algae, and periphyton) and herbivores, as well as a positive correlation between enrichment and nest density in colony sites. We also found that enrichment increased over the breeding season of the cormorants, with higher enrichment in late summer than early summer. While the amount of total nitrogen did not differ between colony and control sites, the amount of guano-based nitrogen in algae was >50% in most sites, indicating high nitrogen enrichment from colonies. Herbivores (the isopod Idotea balthica and the gastropod Theodoxus fluviatilis) preferred feeding upon the dominant macroalga Fucus vesiculosus rather than on filamentous algae or periphyton in both control and colony, and there was a significant increase in periphyton consumption near colony sites. Overall, guano from cormorant colonies seems to have effects on both producers and herbivores, as well as the potential to modify algae-herbivore interactions.	[Gagnon, Karine; Rothausler, Eva; Syrjanen, Anneli; Yli-Renko, Maria; Jormalainen, Veijo] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	University of Turku	Gagnon, K (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	karine.gagnon@utu.fi	Gagnon, Karine/O-1514-2013; Jormalainen, Veijo/B-2073-2008	Gagnon, Karine/0000-0002-0971-7740; Jormalainen, Veijo/0000-0001-6346-2585; Rothausler, Eva/0000-0002-3185-4290	Academy of Finland [251102]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (project # 251102). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita MN, 2011, J PLANKTON RES, V33, P1629, DOI 10.1093/plankt/fbr070; [Anonymous], 2006, SAS MIXED MODELS; Axelsson L, 2000, EUR J PHYCOL, V35, P53, DOI 10.1080/09670260010001735621; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Bostrom MK, 2012, ICES J MAR SCI, V69, P175, DOI 10.1093/icesjms/fss002; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Davis AM, 2012, FRESHWATER BIOL, V57, P2156, DOI 10.1111/j.1365-2427.2012.02858.x; Doucette JL, 2011, ECOL APPL, V21, P2987, DOI 10.1890/10-2384.1; Ducrotoy JP, 2008, MAR POLLUT BULL, V57, P8, DOI 10.1016/j.marpolbul.2008.04.030; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Engstrom H, 2001, ECOGRAPHY, V24, P127, DOI 10.1034/j.1600-0587.2001.240203.x; Gillies CL, 2012, ESTUAR COAST SHELF S, V97, P44, DOI 10.1016/j.ecss.2011.11.003; Glahn JF, 1995, COLON WATERBIRD, V18, P168, DOI 10.2307/1521537; GREMILLET D, 1995, MAR ECOL PROG SER, V121, P1, DOI 10.3354/meps121001; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hanson CE, 2010, AQUAT BOT, V93, P114, DOI 10.1016/j.aquabot.2010.04.004; Heck KL, 2007, ESTUAR COAST, V30, P371, DOI 10.1007/BF02819384; Hemmi A, 2005, AQUAT ECOL, V39, P201, DOI 10.1007/s10452-004-3526-z; Hemmi A, 2002, ECOLOGY, V83, P1052, DOI 10.2307/3071913; Honkanen T, 2005, OECOLOGIA, V144, P196, DOI 10.1007/s00442-005-0053-0; Jormalainen V, 2001, MAR ECOL PROG SER, V220, P219, DOI 10.3354/meps220219; Jormalainen V, 2008, OECOLOGIA, V155, P559, DOI 10.1007/s00442-007-0939-0; Kolb GS, 2010, MAR ECOL PROG SER, V417, P287, DOI 10.3354/meps08791; Kolb GS, 2010, ECOSYSTEMS, V13, P353, DOI 10.1007/s10021-010-9323-8; Korpinen S, 2008, ESTUAR COAST SHELF S, V78, P437, DOI 10.1016/j.ecss.2008.01.005; Korpinen S, 2007, J EXP MAR BIOL ECOL, V343, P52, DOI 10.1016/j.jembe.2006.11.012; Lehikoinen A, 2006, ORNIS FENNICA, V83, P34; Lehikoinen A, 2011, BOREAL ENVIRON RES, V16, P61; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Malm T, 1999, MAR ECOL PROG SER, V188, P63, DOI 10.3354/meps188063; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mercado JM, 2009, ESTUAR COAST SHELF S, V85, P449, DOI 10.1016/j.ecss.2009.09.005; Mizota C, 2012, ATMOS ENVIRON, V57, P29, DOI 10.1016/j.atmosenv.2012.02.007; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; OLEARY MH, 1992, PLANT CELL ENVIRON, V15, P1099, DOI 10.1111/j.1365-3040.1992.tb01660.x; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Ridgway MS, 2010, J GREAT LAKES RES, V36, P93, DOI 10.1016/j.jglr.2009.10.002; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Sieben K, 2011, J EXP MAR BIOL ECOL, V397, P79, DOI 10.1016/j.jembe.2010.11.020; SMITH JS, 1995, MAR ECOL PROG SER, V124, P189, DOI 10.3354/meps124189; Suominen T, 2007, EXPOSURE FINNISH COA, V13, P7; Syvaranta J, 2011, AQUAT SCI, V73, P79, DOI 10.1007/s00027-010-0161-8; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; VANEERDEN MR, 1995, ARDEA, V83, P61; Wainright SC, 1998, MAR BIOL, V131, P63, DOI 10.1007/s002270050297; WOOTTON JT, 1991, J EXP MAR BIOL ECOL, V151, P139, DOI 10.1016/0022-0981(91)90121-C; Worm B, 2000, LIMNOL OCEANOGR, V45, P339, DOI 10.4319/lo.2000.45.2.0339; ZELICKMAN EA, 1972, MAR BIOL, V17, P265, DOI 10.1007/BF00366302	54	34	34	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e61284	10.1371/journal.pone.0061284	http://dx.doi.org/10.1371/journal.pone.0061284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593452	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200049
J	Woodcock, P; Edwards, DP; Newton, RJ; Khen, CV; Bottrell, SH; Hamer, KC				Woodcock, Paul; Edwards, David P.; Newton, Rob J.; Khen, Chey Vun; Bottrell, Simon H.; Hamer, Keith C.			Impacts of Intensive Logging on the Trophic Organisation of Ant Communities in a Biodiversity Hotspot	PLOS ONE			English	Article							FOOD-CHAIN LENGTH; STABLE-ISOTOPES; ECOSYSTEM SIZE; EXTINCTION RISK; WEB; CONSERVATION; DISTURBANCE; DYNAMICS; POSITION; ECOLOGY	Trophic organisation defines the flow of energy through ecosystems and is a key component of community structure. Widespread and intensifying anthropogenic disturbance threatens to disrupt trophic organisation by altering species composition and relative abundances and by driving shifts in the trophic ecology of species that persist in disturbed ecosystems. We examined how intensive disturbance caused by selective logging affects trophic organisation in the biodiversity hotspot of Sabah, Borneo. Using stable nitrogen isotopes, we quantified the positions in the food web of 159 leaf-litter ant species in unlogged and logged rainforest and tested four predictions: (i) there is a negative relationship between the trophic position of a species in unlogged forest and its change in abundance following logging, (ii) the trophic positions of species are altered by logging, (iii) disturbance alters the frequency distribution of trophic positions within the ant assemblage, and (iv) disturbance reduces food chain length. We found that ant abundance was 30% lower in logged forest than in unlogged forest but changes in abundance of individual species were not related to trophic position, providing no support for prediction (i). However, trophic positions of individual species were significantly higher in logged forest, supporting prediction (ii). Consequently, the frequency distribution of trophic positions differed significantly between unlogged and logged forest, supporting prediction (iii), and food chains were 0.2 trophic levels longer in logged forest, the opposite of prediction (iv). Our results demonstrate that disturbance can alter trophic organisation even without trophically-biased changes in community composition. Nonetheless, the absence of any reduction in food chain length in logged forest suggests that species-rich arthropod food webs do not experience trophic downgrading or a related collapse in trophic organisation despite the disturbance caused by logging. These food webs appear able to bend without breaking in the face of some forms of anthropogenic disturbance.	[Woodcock, Paul; Edwards, David P.; Hamer, Keith C.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Edwards, David P.] James Cook Univ, Sch Trop & Marine Biol, Cairns, Australia; [Newton, Rob J.; Bottrell, Simon H.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Khen, Chey Vun] Sepilok Forest Res Ctr, Sabah Forestry Dept, Sandakan, Malaysia	University of Leeds; James Cook University; University of Leeds; Pusat Penyelidikan Hutan	Woodcock, P (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	p.woodcock@bangor.ac.uk	Newton, Robert/B-2599-2009; Edwards, David/AAC-5091-2019	Newton, Robert/0000-0003-0144-6867; Edwards, David/0000-0001-8562-3853; Woodcock, Paul/0000-0002-2178-5447	Earth and Biosphere Institute studentship from the University of Leeds; Leverhulme Trust	Earth and Biosphere Institute studentship from the University of Leeds; Leverhulme Trust(Leverhulme Trust)	PW was supported by an Earth and Biosphere Institute studentship from the University of Leeds and the work was additionally supported by a grant from the Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bestelmeyer Brandon T., 2000, P122; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Brashares JS, 2003, CONSERV BIOL, V17, P733, DOI 10.1046/j.1523-1739.2003.01592.x; Brown William L. Jr, 2000, P45; Bruhl CA, 2001, THESIS U WURZBURG WU; CATES RG, 1975, ECOLOGY, V56, P410, DOI 10.2307/1934971; Collen B, 2006, BIODIVERS CONSERV, V15, P1859, DOI 10.1007/s10531-005-4303-6; de Ruiter PC, 2005, SCIENCE, V309, P68, DOI 10.1126/science.1096112; Didham RK, 1998, PHILOS T R SOC B, V353, P437, DOI 10.1098/rstb.1998.0221; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Eklof A, 2012, PHILOS T R SOC B, V367, P2945, DOI 10.1098/rstb.2012.0234; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fayle TM, 2011, KEY ANT GENERA BORNE; Feldhaar H, 2010, MYRMECOL NEWS, V13, P3; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gibb H, 2011, J ANIM ECOL, V80, P119, DOI 10.1111/j.1365-2656.2010.01747.x; Gray MA, 2007, CONSERV BIOL, V21, P133, DOI 10.1111/j.1523-1739.2006.00557.x; Hoeinghaus DJ, 2008, OIKOS, V117, P984, DOI 10.1111/j.0030-1299.2008.16459.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; ITTO, 2008, ANN REV ASS WORLD TI; Koh LP, 2004, CONSERV BIOL, V18, P1571, DOI 10.1111/j.1523-1739.2004.00468.x; Lambert F.R., 2002, Forktail, V18, P127; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; McCann KS, 2009, PHILOS T R SOC B, V364, P1789, DOI 10.1098/rstb.2008.0273; McHugh PA, 2010, ECOL LETT, V13, P881, DOI 10.1111/j.1461-0248.2010.01484.x; Milton Y, 2007, OECOLOGIA, V153, P163, DOI 10.1007/s00442-007-0710-6; MORIN PJ, 1995, ANNU REV ECOL SYST, V26, P505, DOI 10.1146/annurev.es.26.110195.002445; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakagawa M, 2007, CAN J ZOOL, V85, P472, DOI 10.1139/Z07-026; Passos L, 2002, J ECOL, V90, P517, DOI 10.1046/j.1365-2745.2002.00687.x; Peters SL, 2006, CONSERV BIOL, V20, P1410, DOI 10.1111/j.1523-1739.2006.00526.x; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Pinard MA, 1996, BIOTROPICA, V28, P278, DOI 10.2307/2389193; Ponsard S, 2000, ECOLOGY, V81, P852, DOI 10.1890/0012-9658(2000)081[0852:WCSINA]2.0.CO;2; Poorter L, 2004, PLANT BIOLOGY, V6, P746, DOI 10.1055/s-2004-821269; Post DM, 2007, OIKOS, V116, P775, DOI 10.1111/j.2007.0030-1299.15552.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Power ME, 2008, ECOL MONOGR, V78, P263, DOI 10.1890/06-0902.1; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Rooney N, 2008, ECOL LETT, V11, P867, DOI 10.1111/j.1461-0248.2008.01193.x; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Schleuning M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027785; Srinivasan UT, 2007, ECOLOGY, V88, P671, DOI 10.1890/06-0971; Srivastava DS, 2009, ECOL LETT, V12, P1016, DOI 10.1111/j.1461-0248.2009.01357.x; Staniczenko PPA, 2010, ECOL LETT, V13, P891, DOI 10.1111/j.1461-0248.2010.01485.x; Takimoto G, 2013, ECOL RES, V28, P675, DOI 10.1007/s11284-012-0943-7; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Urton EJM, 2005, OECOLOGIA, V145, P317, DOI 10.1007/s00442-005-0124-2; Vasconcelos HL, 2000, J APPL ECOL, V37, P508, DOI 10.1046/j.1365-2664.2000.00512.x; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Walsh RPD, 1999, PHILOS T R SOC B, V354, P1869, DOI 10.1098/rstb.1999.0528; Walters AW, 2008, ECOLOGY, V89, P3261, DOI 10.1890/08-0273.1; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Woodcock P, 2012, NATURWISSENSCHAFTEN, V99, P275, DOI 10.1007/s00114-012-0896-2; Woodcock P, 2011, PHILOS T R SOC B, V366, P3256, DOI 10.1098/rstb.2011.0031	68	37	38	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60756	10.1371/journal.pone.0060756	http://dx.doi.org/10.1371/journal.pone.0060756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593302	Green Accepted, gold, Green Published			2022-12-27	WOS:000317382000024
J	Anson, JR; Dickman, CR; Boonstra, R; Jessop, TS				Anson, Jennifer R.; Dickman, Chris R.; Boonstra, Rudy; Jessop, Tim S.			Stress Triangle: Do Introduced Predators Exert Indirect Costs on Native Predators and Prey?	PLOS ONE			English	Article							POSSUMS PSEUDOCHEIRUS-PEREGRINUS; LARGE CARNIVOROUS LIZARD; COMMON RINGTAIL POSSUMS; FOXES VULPES-VULPES; ANTIPREDATOR BEHAVIOR; MAMMALIAN CARNIVORES; WESTERN-AUSTRALIA; VERTEBRATE FAUNA; GROUND-SQUIRRELS; BUSH RATS	Non-consumptive effects of predators on each other and on prey populations often exceed the effects of direct predation. These effects can arise from fear responses elevating glucocorticoid (GC) hormone levels (predator stress hypothesis) or from increased vigilance that reduces foraging efficiency and body condition (predator sensitive foraging hypothesis); both responses can lead to immunosuppression and increased parasite loads. Non-consumptive effects of invasive predators have been little studied, even though their direct impacts on local species are usually greater than those of their native counterparts. To address this issue, we explored the non-consumptive effects of the invasive red fox Vulpes vulpes on two native species in eastern Australia: a reptilian predator, the lace monitor Varanus varius and a marsupial, the ringtail possum Pseudocheirus peregrinus. In particular, we tested predictions derived from the above two hypotheses by comparing the basal glucocorticoid levels, foraging behaviour, body condition and haemoparasite loads of both native species in areas with and without fox suppression. Lace monitors showed no GC response or differences in haemoparasite loads but were more likely to trade safety for higher food rewards, and had higher body condition, in areas of fox suppression than in areas where foxes remained abundant. In contrast, ringtails showed no physiological or behavioural differences between fox-suppressed and control areas. Predator sensitive foraging is a non-consumptive cost for lace monitors in the presence of the fox and most likely represents a response to competition. The ringtail's lack of response to the fox potentially represents complete naivete or strong and rapid selection to the invasive predator. We suggest evolutionary responses are often overlooked in interactions between native and introduced species, but must be incorporated if we are to understand the suite of forces that shape community assembly and function in the wake of biological invasions.	[Anson, Jennifer R.; Dickman, Chris R.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Boonstra, Rudy] Univ Toronto Scarborough, Ctr Neurobiol Stress, Scarborough, ON, Canada; [Jessop, Tim S.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Sydney; University of Toronto; University Toronto Scarborough; University of Melbourne	Anson, JR (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	jennifer.anson@sydney.edu.au	Dickman, Christopher/Q-4662-2019; Jessop, Tim/Q-2473-2019	Dickman, Christopher/0000-0002-1067-3730; Jessop, Tim S./0000-0002-7712-4373	Zoos Victoria; Norman Wettenhall Foundation	Zoos Victoria; Norman Wettenhall Foundation	Funding support was received from Zoos Victoria (www.zoo.org.au/research) and the Norman Wettenhall Foundation (http://nwf.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; Anson JR, 2012, OECOLOGIA; Augee ML, 1996, WILDLIFE RES, V23, P99, DOI 10.1071/WR9960099; Banks PB, 1998, J MAMMAL, V79, P1260, DOI 10.2307/1383017; Banks PB, 1998, J WILDLIFE MANAGE, V62, P766, DOI 10.2307/3802353; Banks PB, 1999, J APPL ECOL, V36, P1063, DOI 10.1046/j.1365-2664.1999.00463.x; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Berger S, 2007, HORM BEHAV, V52, P653, DOI 10.1016/j.yhbeh.2007.08.004; BOCKING AD, 1986, J DEV PHYSIOL, V8, P237; Boonstra R, 1998, ECOL MONOGR, V68, P371, DOI 10.1890/0012-9615(1998)068[0371:TIOPIS]2.0.CO;2; Boonstra R, 2005, J MAMMAL, V86, P236, DOI 10.1644/BHE-001.1; Buckmaster T, 2011, THESIS U SYDNEY; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Byers JE, 2000, ECOLOGY, V81, P1225, DOI 10.2307/177203; Caro Tim, 2005, pXIII; Christianson D, 2010, ECOLOGY, V91, P1184, DOI 10.1890/09-0221.1; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; Dickman C.R., 2011, ENCY BIOL INVASIONS, P117; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; Diment AN, 2010, THESIS U SYDNEY; Engeman RM, 2005, WILDLIFE RES, V32, P203, DOI 10.1071/WR03120; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Gould J., 1863, MAMMALS AUSTR; Griffin AS, 2001, ANIM BEHAV, V62, P577, DOI 10.1006/anbe.2001.1781; Guarino F, 2002, J ZOOL, V258, P449, DOI 10.1017/S0952836902001607; Guarino F, 2001, WILDLIFE RES, V28, P627, DOI 10.1071/WR01001; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Hawlena D, 2011, FUNCT ECOL, V25, P1223, DOI 10.1111/j.1365-2435.2011.01891.x; HELLGREN EC, 1985, J WILDLIFE DIS, V21, P417, DOI 10.7589/0090-3558-21.4.417; HIK DS, 1995, WILDLIFE RES, V22, P115, DOI 10.1071/WR9950115; Hik DS, 2001, ECOSCIENCE, V8, P275, DOI 10.1080/11956860.2001.11682654; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Jessop Tim, 2010, Biawak, V4, P59; Jessop TS, 2005, AUST J ZOOL, V53, P131, DOI 10.1071/ZO04061; Jones M, 2001, ECOLOGY, V82, P2164, DOI 10.1890/0012-9658(2001)082[2164:COTPSM]2.0.CO;2; Jones ME, 2004, ANIM CONSERV, V7, P155, DOI 10.1017/S136794300400126X; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Koivula K, 1995, ARDEA, V83, P397; Kovacs EM, 2012, OECOLOGIA; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Krebs CJ, 2001, BIOSCIENCE, V51, P25, DOI 10.1641/0006-3568(2001)051[0025:WDTYCO]2.0.CO;2; LEE AK, 1985, OXFORD REV REPROD B, V7, P261; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindenmayer DB, 2008, AUST J ZOOL, V56, P1, DOI 10.1071/ZO08054; Lydekker R, 1896, HDB MARSUPIALIA MONO; Macdonald DW, 2004, J ZOOL, V263, P385, DOI 10.1017/S0952836904005400; Mateo JM, 2007, BEHAV ECOL SOCIOBIOL, V62, P37, DOI 10.1007/s00265-007-0436-9; McClean Ian G., 1995, Biological Conservation, V75, P51; McEvoy J, 2008, AUSTRAL ECOL, V33, P922, DOI 10.1111/j.1442-9993.2008.01863.x; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McKay GM, 2008, MAMMALS AUSTR; Molsher RL, 1999, ECOLOGY FERAL CATS F; Moseby K, 2012, INT J ECOLO IN PRESS; Murray A. J., 2006, PROJECT DELIVERANCE; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Reeder DM, 2004, GEN COMP ENDOCR, V136, P260, DOI 10.1016/j.ygcen.2003.12.020; Rehage JS, 2005, ECOL FRESHW FISH, V14, P352, DOI 10.1111/j.1600-0633.2005.00109.x; Risbey DA, 2000, WILDLIFE RES, V27, P223, DOI 10.1071/WR98092; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, CONDOR, V104, P129, DOI 10.1650/0010-5422(2002)104[0129:CRIWBT]2.0.CO;2; Russell BG, 2007, AUSTRAL ECOL, V32, P277, DOI 10.1111/j.1442-9993.2007.01685.x; Russell BG, 2003, WILDLIFE RES, V30, P389, DOI 10.1071/WR01047; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Schmidt Oswald J., 2005, P256; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Short J, 2002, BIOL CONSERV, V103, P283, DOI 10.1016/S0006-3207(01)00139-2; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Smith B, 2003, P LINN SOC N S W, V124, P183; Strauss Sharon Y, 2006, Ecol Lett, V9, P357, DOI 10.1111/j.1461-0248.2005.00874.x; Sutherland DR, 2011, P ROY SOC B-BIOL SCI, V278, P641, DOI 10.1098/rspb.2010.2103; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Trewby ID, 2008, BIOL LETTERS, V4, P170, DOI 10.1098/rsbl.2007.0516; TRIGGS B, 1984, AUST WILDLIFE RES, V11, P491; Watson M, 2007, J ANIM ECOL, V76, P211, DOI 10.1111/j.1365-2656.2006.01194.x; Watts HE, 2008, J ZOOL, V276, P402, DOI 10.1111/j.1469-7998.2008.00506.x; WEAVERS B W, 1988, Victorian Naturalist (Blackburn), V105, P142; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wilson GJ, 2001, WILDLIFE RES, V28, P151, DOI 10.1071/WR00033; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191	92	33	35	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60916	10.1371/journal.pone.0060916	http://dx.doi.org/10.1371/journal.pone.0060916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585861	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600068
J	Lappe, C; Steinstrater, O; Pantev, C				Lappe, Claudia; Steinstraeter, Olaf; Pantev, Christo			A Beamformer Analysis of MEG Data Reveals Frontal Generators of the Musically Elicited Mismatch Negativity	PLOS ONE			English	Article							AUDITORY CHANGE-DETECTION; CORTEX ACTIVATION; IMAGING REVEALS; NEURAL BASIS; BROCAS AREA; BRAIN; LANGUAGE; RESPONSES; REPRESENTATION; PERCEPTION	To localize the neural generators of the musically elicited mismatch negativity with high temporal resolution we conducted a beamformer analysis (Synthetic Aperture Magnetometry, SAM) on magnetoencephalography (MEG) data from a previous musical mismatch study. The stimuli consisted of a six-tone melodic sequence comprising broken chords in C-and G-major. The musical sequence was presented within an oddball paradigm in which the last tone was lowered occasionally (20%) by a minor third. The beamforming analysis revealed significant right hemispheric neural activation in the superior temporal (STC), inferior frontal (IFC), superior frontal (SFC) and orbitofrontal (OFC) cortices within a time window of 100-200 ms after the occurrence of a deviant tone. IFC and SFC activation was also observed in the left hemisphere. The pronounced early right inferior frontal activation of the auditory mismatch negativity has not been shown in MEG studies so far. The activation in STC and IFC is consistent with earlier electroencephalography (EEG), optical imaging and functional magnetic resonance imaging (fMRI) studies that reveal the auditory and inferior frontal cortices as main generators of the auditory MMN. The observed right hemispheric IFC is also in line with some previous music studies showing similar activation patterns after harmonic syntactic violations. The results demonstrate that a deviant tone within a musical sequence recruits immediately a distributed neural network in frontal and prefrontal areas suggesting that top-down processes are involved when expectation violation occurs within well-known stimuli.	[Lappe, Claudia; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Steinstraeter, Olaf] GSI Helmholzzentrum Schwerionenforsch GmbH, Darmstadt, Germany	University of Munster; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research	Lappe, C (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	clappe@uni-muenster.de						Ardila A, 1999, APHASIOLOGY, V13, P79, DOI 10.1080/026870399402334; Baldeweg T, 2007, J PSYCHOPHYSIOL, V21, P204, DOI 10.1027/0269-8803.21.34.204; Bamiou DE, 2003, BRAIN RES REV, V42, P143, DOI 10.1016/S0165-0173(03)00172-3; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Berti S, 2004, EXP PSYCHOL, V51, P249, DOI 10.1027/1618-3169.51.4.249; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Boh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021458; Brookes MJ, 2007, NEUROIMAGE, V34, P1454, DOI 10.1016/j.neuroimage.2006.11.012; Dalal SS, 2006, IEEE T BIO-MED ENG, V53, P1357, DOI 10.1109/TBME.2006.873752; Deouell LY, 2007, J PSYCHOPHYSIOL, V21, P188, DOI 10.1027/0269-8803.21.34.188; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Fadiga L, 2009, ANN NY ACAD SCI, V1169, P448, DOI 10.1111/j.1749-6632.2009.04582.x; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Herdman AT, 2003, NEUROIMAGE, V20, P995, DOI 10.1016/S1053-8119(03)00403-8; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Jacobsen T, 2005, J COGNITIVE NEUROSCI, V17, P1704, DOI 10.1162/089892905774589262; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Koelsch S, 2010, J COGNITIVE NEUROSCI, V22, P2251, DOI 10.1162/jocn.2009.21338; Krumhansl CL, 2003, ANN NY ACAD SCI, V999, P414, DOI 10.1196/annals.1284.052; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Moiseev A, 2011, NEUROIMAGE, V58, P481, DOI 10.1016/j.neuroimage.2011.05.081; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2003, INT J PSYCHOPHYSIOL, V48, P179, DOI 10.1016/S0167-8760(03)00053-9; Naatanen R, 1995, Int J Neurosci, V80, P317, DOI 10.3109/00207459508986107; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Opitz B, 2005, EUR J NEUROSCI, V21, P531, DOI 10.1111/j.1460-9568.2005.03839.x; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Paavilainen P, 2003, NEUROSCI LETT, V349, P79, DOI 10.1016/S0304-3940(03)00787-0; Pulvermuller F, 2003, NEUROIMAGE, V20, P1020, DOI 10.1016/S1053-8119(03)00356-2; Pulvermuller F, 2003, NEUROIMAGE, V20, P159, DOI 10.1016/S1053-8119(03)00261-1; Restuccia D, 2005, COGNITIVE BRAIN RES, V25, P891, DOI 10.1016/j.cogbrainres.2005.09.023; Rinne T, 2005, NEUROIMAGE, V26, P66, DOI 10.1016/j.neuroimage.2005.01.017; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Robinson SE, 1998, RECENT ADV BIOMAGNIT, V25, P249; SAARINEN J, 1992, NEUROREPORT, V3, P1149, DOI 10.1097/00001756-199212000-00030; Sable JJ, 2007, EUR J NEUROSCI, V25, P298, DOI 10.1111/j.1460-9568.2006.05255.x; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; Schonwiesner M, 2007, J NEUROPHYSIOL, V97, P2075, DOI 10.1152/jn.01083.2006; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Sekihara K, 2002, IEEE T BIO-MED ENG, V49, P1534, DOI 10.1109/TBME.2002.805485; Steinstrater O, 2010, HUM BRAIN MAPP, V31, P1907, DOI 10.1002/hbm.20986; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; Trainor L. J., 2009, OXFORD HDB MUSIC PSY, P171; Trost W, 2012, CEREB CORTEX, V22, P2769, DOI 10.1093/cercor/bhr353; Tse CY, 2008, NEUROIMAGE, V41, P1462, DOI 10.1016/j.neuroimage.2008.03.043; Tse CY, 2007, IEEE ENG MED BIOL, V26, P52, DOI 10.1109/MEMB.2007.384096; Tse CY, 2006, NEUROIMAGE, V29, P314, DOI 10.1016/j.neuroimage.2005.07.013; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Waberski TD, 2001, NEUROSCI LETT, V308, P107, DOI 10.1016/S0304-3940(01)01988-7; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Wong PCM, 2004, J NEUROSCI, V24, P9153, DOI 10.1523/JNEUROSCI.2225-04.2004; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	76	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61296	10.1371/journal.pone.0061296	http://dx.doi.org/10.1371/journal.pone.0061296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585888	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600101
J	Vicente, EF; Basso, LGM; Cespedes, GF; Lorenzon, EN; Castro, MS; Mendes-Giannini, MJS; Costa, AJ; Cilli, EM				Vicente, Eduardo F.; Basso, Luis Guilherme M.; Cespedes, Graziely F.; Lorenzon, Esteban N.; Castro, Mariana S.; Mendes-Giannini, Maria Jose S.; Jose Costa-Filho, Antonio; Cilli, Eduardo M.			Dynamics and Conformational Studies of TOAC Spin Labeled Analogues of Ctx(Ile(21))-Ha Peptide from Hypsiboas albopunctatus	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; ALPHA-AMINO-ACID; ANTIMICROBIAL PEPTIDES; RESIN SOLVATION; BIOLOGICAL-ACTIVITY; CIRCULAR-DICHROISM; CHAIN AGGREGATION; ANGIOTENSIN-II; EPR-SPECTRA; MECHANISM	Antimicrobial peptides (AMPs) isolated from several organisms have been receiving much attention due to some specific features that allow them to interact with, bind to, and disrupt cell membranes. The aim of this paper was to study the interactions between a membrane mimetic and the cationic AMP Ctx(Ile(21))-Ha as well as analogues containing the paramagnetic amino acid 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid (TOAC) incorporated at residue positions n = 0, 2, and 13. Circular dichroism studies showed that the peptides, except for [TOAC(13)] Ctx(Ile(21))-Ha, are unstructured in aqueous solution but acquire different amounts of alpha-helical secondary structure in the presence of trifluorethanol and lysophosphocholine micelles. Fluorescence experiments indicated that all peptides were able to interact with LPC micelles. In addition, Ctx(Ile(21))-Ha and [TOAC(13)] Ctx(Ile(21))-Ha peptides presented similar water accessibility for the Trp residue located near the N-terminal sequence. Electron spin resonance experiments showed two spectral components for [TOAC(0)] Ctx(Ile(21))-Ha, which are most likely due to two membrane-bound peptide conformations. In contrast, TOAC(2) and TOAC(13) derivatives presented a single spectral component corresponding to a strong immobilization of the probe. Thus, our findings allowed the description of the peptide topology in the membrane mimetic, where the N-terminal region is in dynamic equilibrium between an ordered, membrane-bound conformation and a disordered, mobile conformation; position 2 is most likely situated in the lipid polar head group region, and residue 13 is fully inserted into the hydrophobic core of the membrane.	[Vicente, Eduardo F.; Cespedes, Graziely F.; Lorenzon, Esteban N.; Cilli, Eduardo M.] UNESP Univ Estadual Paulista, Inst Quim, Dept Bioquim & Tecnol Quim, Araraquara, SP, Brazil; [Basso, Luis Guilherme M.] Univ Sao Paulo, Grp Biofis Mol Sergio Mascarenhas, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Castro, Mariana S.] Univ Brasilia, Brazilian Ctr Prot Res, Dept Cell Biol, Brasilia, DF, Brazil; [Mendes-Giannini, Maria Jose S.] UNESP Univ Estadual Paulista, Fac Ciencias Farmaceut, Dept Anal Clin, Araraquara, SP, Brazil; [Jose Costa-Filho, Antonio] Univ Sao Paulo, Dept Fis, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Brasilia; Universidade Estadual Paulista; Universidade de Sao Paulo	Cilli, EM (corresponding author), UNESP Univ Estadual Paulista, Inst Quim, Dept Bioquim & Tecnol Quim, Araraquara, SP, Brazil.	cilli@iq.unesp.br	Costa-Filho, Antonio J/D-3153-2012; Basso, Luis GM/N-6692-2013; Basso, Luis GM/AAF-9872-2021; Giannini, Maria José Soares Mendes/C-5387-2012; Vicente, Eduardo Festozo/Y-2439-2019; Costa-Filho, Antonio José/AAZ-1808-2020; Vicente, Eduardo/H-9286-2013; Cilli, Eduardo Maffud/K-1857-2019; Cilli, Eduardo Maffud/B-9130-2012; Lorenzón, Esteban/H-8850-2013	Costa-Filho, Antonio J/0000-0001-6730-8737; Basso, Luis GM/0000-0003-1277-1008; Basso, Luis GM/0000-0003-1277-1008; Giannini, Maria José Soares Mendes/0000-0002-8059-0826; Vicente, Eduardo Festozo/0000-0002-9154-3574; Vicente, Eduardo/0000-0002-9154-3574; Cilli, Eduardo Maffud/0000-0002-4767-0904; Cilli, Eduardo Maffud/0000-0002-4767-0904; S. Castro, Mariana/0000-0001-5143-152X; Lorenzon, Esteban/0000-0002-1645-8564	Brazilian agencies FAPESP [2010/17662-8, 2010/06526-6]; CNPq [305814/2009-5, 302332/2009-0]; CAPES; FAPESP [2009/10997-7]	Brazilian agencies FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors acknowledge the Brazilian agencies FAPESP(Grant 2010/17662-8 and 2010/06526-6), CNPq (Grant 305814/2009-5 and 302332/2009-0), and CAPES for financially supporting this work. LGMB thanks FAPESP for a scholarship (2009/10997-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alston RW, 2008, BIOPHYS J, V94, P2280, DOI 10.1529/biophysj.107.116921; Altenbach C., LABVIEW PROGRAMS ANA; Barbosa SR, 1999, FEBS LETT, V446, P45, DOI 10.1016/S0014-5793(99)00172-6; Bartucci R, 2009, BIOPHYS J, V96, P997, DOI 10.1016/j.bpj.2008.10.024; Bessin Y, 2004, BBA-BIOMEMBRANES, V1667, P148, DOI 10.1016/j.bbamem.2004.09.011; Bordignon E, 2007, BIOL MAGN RESON, V27, P129; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Bui TTT, 2000, J CHEM SOC PERK T 2, V5, P1043; BURGHAUS O, 1992, MEAS SCI TECHNOL, V3, P765, DOI 10.1088/0957-0233/3/8/013; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; Castro MS, 2006, CURR PROTEIN PEPT SC, V7, P473, DOI 10.2174/138920306779025648; Castro MS, 2009, PEPTIDES, V30, P291, DOI 10.1016/j.peptides.2008.11.003; Cespedes GF, 2012, PROTEIN PEPTIDE LETT, V19, P596; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Cilli EM, 2007, TOXICON, V50, P1201, DOI 10.1016/j.toxicon.2007.07.013; Cilli EM, 2007, TETRAHEDRON LETT, V48, P5521, DOI 10.1016/j.tetlet.2007.05.164; Cilli EM, 1999, J ORG CHEM, V64, P9118, DOI 10.1021/jo991035o; Cilli EM, 1997, TETRAHEDRON LETT, V38, P517, DOI 10.1016/S0040-4039(96)02363-5; Conlon JM, 2008, CHEM BIOL DRUG DES, V72, P58, DOI 10.1111/j.1747-0285.2008.00671.x; Crusca E, 2011, BIOPOLYMERS, V96, P41, DOI 10.1002/bip.21454; Fanucci GE, 2006, CURR OPIN STRUC BIOL, V16, P644, DOI 10.1016/j.sbi.2006.08.008; Ghimire H, 2012, J PHYS CHEM B, V116, P3866, DOI 10.1021/jp212272d; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hanson P, 1996, J AM CHEM SOC, V118, P271, DOI 10.1021/ja952423k; HAYASHI H, 1994, CHEM LETT, P2407, DOI 10.1246/cl.1994.2407; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lopes DD, 2008, INT J PEPT RES THER, V14, P121, DOI 10.1007/s10989-007-9120-1; Lopes JLS, 2009, BBA-BIOMEMBRANES, V1788, P2252, DOI 10.1016/j.bbamem.2009.06.026; Lorenzon EN, 2011, BIOPOLYMERS, V96, P469; MARCHETTO R, 1993, J AM CHEM SOC, V115, P11042, DOI 10.1021/ja00076a093; Marsh D, 2002, J MAGN RESON, V157, P114, DOI 10.1006/jmre.2002.2572; Marsh D, 2008, J MAGN RESON, V190, P211, DOI 10.1016/j.jmr.2007.11.005; Marsh D, 2007, BIOPHYS J, V92, P4002, DOI 10.1529/biophysj.107.104026; Marsh D, 2007, BIOPHYS J, V92, P473, DOI 10.1529/biophysj.106.092775; Marsh D, 2006, J MAGN RESON, V180, P305, DOI 10.1016/j.jmr.2006.02.007; Martin L, 2001, J PEPT RES, V58, P424, DOI 10.1034/j.1399-3011.2001.00940.x; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; MEIROVITCH E, 1984, J PHYS CHEM-US, V88, P3454, DOI 10.1021/j150660a018; NAKAIE CR, 1983, BIOCHIM BIOPHYS ACTA, V742, P63, DOI 10.1016/0167-4838(83)90359-X; Nakaie CR, 2001, FEBS LETT, V497, P103, DOI 10.1016/S0014-5793(01)02449-8; Nakaie CR, 2002, PEPTIDES, V23, P65, DOI 10.1016/S0196-9781(01)00580-0; Nesmelov YE, 2007, BIOPHYS J, V93, P2805, DOI 10.1529/biophysj.107.108910; Oliveira E, 2002, EUR J ORG CHEM, V2002, P3686; Orioni B, 2009, BBA-BIOMEMBRANES, V1788, P1523, DOI 10.1016/j.bbamem.2009.04.013; Pispisa B, 2000, BIOPOLYMERS, V53, P169, DOI 10.1002/(SICI)1097-0282(200002)53:2<169::AID-BIP7>3.0.CO;2-F; PRISNER TF, 1995, CHEM PHYS, V194, P361, DOI 10.1016/0301-0104(95)00016-H; Ribeiro SCF, 2001, TETRAHEDRON LETT, V42, P3243, DOI 10.1016/S0040-4039(01)00414-2; Schneider D. J., 1989, BIOL MAGN RESON, V8, P1; Schreier S, 2004, BIOPOLYMERS, V74, P389, DOI 10.1002/bip.20092; Schreier Shirley, 2012, Biophys Rev, V4, P45, DOI 10.1007/s12551-011-0064-5; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Steinhoff HJ, 2000, J MOL LIQ, V84, P17, DOI 10.1016/S0167-7322(99)00107-5; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; Toniolo C, 1998, BIOPOLYMERS, V47, P153, DOI 10.1002/(SICI)1097-0282(1998)47:2<153::AID-BIP4>3.0.CO;2-T; Vieira RFF, 2009, BIOPOLYMERS, V92, P525, DOI 10.1002/bip.21295; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang ZW, 2007, BIOPOLYMERS, V88, P29, DOI 10.1002/bip.20618	64	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60818	10.1371/journal.pone.0060818	http://dx.doi.org/10.1371/journal.pone.0060818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585852	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600050
J	Vignaud, T; Clua, E; Mourier, J; Maynard, J; Planes, S				Vignaud, Thomas; Clua, Eric; Mourier, Johann; Maynard, Jeffrey; Planes, Serge			Microsatellite Analyses of Blacktip Reef Sharks (Carcharhinus melanopterus) in a Fragmented Environment Show Structured Clusters	PLOS ONE			English	Article							GULF-OF-MEXICO; GENETIC-STRUCTURE; WESTERN ATLANTIC; LEMON SHARKS; POPULATION; PHYLOGEOGRAPHY; CONNECTIVITY; CONSERVATION; SOFTWARE; COLLAPSE	The population dynamics of shark species are generally poorly described because highly mobile marine life is challenging to investigate. Here we investigate the genetic population structure of the blacktip reef shark (Carcharhinus melanopterus) in French Polynesia. Five demes were sampled from five islands with different inter-island distances (50-1500 km). Whether dispersal occurs between islands frequently enough to prevent moderate genetic structure is unknown. We used 11 microsatellites loci from 165 individuals and a strong genetic structure was found among demes with both F-statistics and Bayesian approaches. This differentiation is correlated with the geographic distance between islands. It is likely that the genetic structure seen is the result of all or some combination of the following: low gene flow, time since divergence, small effective population sizes, and the standard issues with the extent to which mutation models actually fit reality. We suggest low levels of gene flow as at least a partial explanation of the level of genetic structure seen among the sampled blacktip demes. This explanation is consistent with the ecological traits of blacktip reef sharks, and that the suitable habitat for blacktips in French Polynesia is highly fragmented. Evidence for spatial genetic structure of the blacktip demes we studied highlights that similar species may have populations with as yet undetected or underestimated structure. Shark biology and the market for their fins make them highly vulnerable and many species are in rapid decline. Our results add weight to the case that total bans on shark fishing are a better conservation approach for sharks than marine protected area networks.	[Vignaud, Thomas; Mourier, Johann; Maynard, Jeffrey; Planes, Serge] CRIOBE, Lab Excellence CORAIL USR 3278 CNRS EPHE, Papetoai, Moorea, France; [Clua, Eric] French Minist Agr & Fisheries, Direct Reg Rech & Technol, Paris, France; [Maynard, Jeffrey] UNCW, Ctr Marine Sci, CREST Res Pk, Wilmington, NC USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of North Carolina; University of North Carolina Wilmington	Vignaud, T (corresponding author), CRIOBE, Lab Excellence CORAIL USR 3278 CNRS EPHE, Papetoai, Moorea, France.	contact@thomasvignaud.com; planes@univ-perp.fr	PLANES, Serge/ABF-1360-2021; Johann, Mourier/B-4881-2012; Clua, Eric EG/D-7820-2013	Johann, Mourier/0000-0001-9019-1717; Clua, Eric EG/0000-0001-7629-2685; Maynard, Dr Jeffrey/0000-0002-6444-6373	DIREN Polynesia; Service de la Peche (Polynesia); Ministere de l'Ecologie du Developpement Durable et de l'Energie; FondsPacifique; CRISP; IMODEL	DIREN Polynesia; Service de la Peche (Polynesia); Ministere de l'Ecologie du Developpement Durable et de l'Energie; FondsPacifique; CRISP; IMODEL	The DIREN Polynesia provided funding for the fieldwork in Maria. The Service de la Peche (Polynesia) provided funding for the fieldwork in Fakahina. The Ministere de l'Ecologie du Developpement Durable et de l'Energie, The FondsPacifique, CRISP and IMODEL provided funding or assisted with fieldwork, logistics and analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen H, 2009, MOL ECOL, V18, P4409, DOI 10.1111/j.1365-294X.2009.04377.x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Benavides Martin T., 2011, Endangered Species Research, V14, P13, DOI 10.3354/esr00337; Bonfil R., 1994, 341 FAO; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno L.J.V., 1984, FAO SPECIES CATALOGU, V4; Cornuet JM, 1996, GENETICS, V144, P2001; Corrigan S, 2008, J FISH BIOL, V73, P1662, DOI 10.1111/j.1095-8649.2008.02039.x; Daly-Engel TS, 2012, PLOS ONE, V7, P279, DOI 10.1371/journal.pone.0029986; Feldheim KA, 2001, MOL ECOL, V10, P295, DOI 10.1046/j.1365-294x.2001.01182.x; Feldheim KA, 2002, P ROY SOC B-BIOL SCI, V269, P1655, DOI 10.1098/rspb.2002.2051; Feldheim KA, 2007, MOL ECOL NOTES, V7, P1366, DOI 10.1111/j.1471-8286.2007.01888.x; Gaida IH, 1997, COPEIA, P738; Gibson C., 2009, PEL SHARK RED LIST W; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heist EJ, 1996, FISH B-NOAA, V94, P664; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T., 2011, TUTORIAL DISCRIMINAN; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Keeney DB, 2006, MOL ECOL, V15, P3669, DOI 10.1111/j.1365-294X.2006.03036.x; Keeney DB, 2003, MOL ECOL NOTES, V3, P501, DOI 10.1046/j.1471-8286.2003.00492.x; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Lewallen EA, 2007, MAR BIOL, V152, P599, DOI 10.1007/s00227-007-0714-0; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; Michalakis Y, 1996, GENETICS, V142, P1061; Mossman CA, 1999, MOL ECOL, V8, P1063, DOI 10.1046/j.1365-294x.1999.00652.x; Mourier J, 2013, MOL ECOL, V22, P201, DOI 10.1111/mec.12103; Musick JA, 2004, CRC MAR BIOL SER, P33; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Schultz JK, 2008, MOL ECOL, V17, P5336, DOI 10.1111/j.1365-294X.2008.04000.x; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Sunnucks P, 2011, EMU, V111, P19, DOI 10.1071/MU10008; Van Loon EE, 2007, MOL ECOL NOTES, V7, P579, DOI 10.1111/j.1471-8286.2007.01705.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Watts S, 2005, ROCK BOTTOM DECLININ; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zenger KR, 2006, J HERED, V97, P607, DOI 10.1093/jhered/esl044	57	22	24	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61067	10.1371/journal.pone.0061067	http://dx.doi.org/10.1371/journal.pone.0061067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23585872	Green Submitted, gold, Green Published			2022-12-27	WOS:000317909600080
J	Berhan, A; Berhan, Y				Berhan, Asres; Berhan, Yifru			Virologic Response to Tipranavir-Ritonavir or Darunavir-Ritonavir Based Regimens in Antiretroviral Therapy Experienced HIV-1 Patients: A Meta-Analysis and Meta-Regression of Randomized Controlled Clinical Trials	PLOS ONE			English	Article							ONCE-DAILY DARUNAVIR/RITONAVIR; PROTEASE INHIBITORS; HIV-1-INFECTED PATIENTS; BOOSTED TIPRANAVIR; PHARMACEUTICAL-INDUSTRY; INFECTED PATIENTS; CROSS-RESISTANCE; TREATMENT-NAIVE; VIRAL LOAD; POWER 1	Background: The development of tipranavir and darunavir, second generation non-peptidic HIV protease inhibitors, with marked improved resistance profiles, has opened a new perspective on the treatment of antiretroviral therapy (ART) experienced HIV patients with poor viral load control. The aim of this study was to determine the virologic response in ART experienced patients to tipranavir-ritonavir and darunavir-ritonavir based regimens. Methods and Findings: A computer based literature search was conducted in the databases of HINARI (Health InterNetwork Access to Research Initiative), Medline and Cochrane library. Meta-analysis was performed by including randomized controlled studies that were conducted in ART experienced patients with plasma viral load above 1,000 copies HIV RNA/ml. The odds ratios and 95% confidence intervals (CI) for viral loads of <50 copies and <400 copies HIV RNA/ml at the end of the intervention were determined by the random effects model. Meta-regression, sensitivity analysis and funnel plots were done. The number of HIV-1 patients who were on either a tipranavir-ritonavir or darunavir-ritonavir based regimen and achieved viral load less than 50 copies HIV RNA/ml was significantly higher (overall OR = 3.4; 95% CI, 2.61-4.52) than the number of HIV-1 patients who were on investigator selected boosted comparator HIV-1 protease inhibitors (CPIs-ritonavir). Similarly, the number of patients with viral load less than 400 copies HIV RNA/ml was significantly higher in either the tipranavir-ritonavir or darunavir-ritonavir based regimen treated group (overall OR = 3.0; 95% CI, 2.15 - 4.11). Meta-regression showed that the viral load reduction was independent of baseline viral load, baseline CD4 count and duration of tipranavir-ritonavir or darunavir-ritonavir based regimen. Conclusions: Tipranavir and darunavir based regimens were more effective in patients who were ART experienced and had poor viral load control. Further studies are required to determine their consistent viral load suppression effect as the duration of treatment is more prolonged.	[Berhan, Asres; Berhan, Yifru] Hawassa Univ, Coll Med & Hlth Sci, Hawassa, Ethiopia	Hawassa University	Berhan, Y (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Hawassa, Ethiopia.	yifrub@yahoo.com		Berhan, Asres/0000-0001-7406-0856				Antoniou Tony, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P382, DOI 10.1177/1545109710382041; Arasteh K, 2009, ANTIVIR THER, V14, P859, DOI 10.3851/IMP1301; Cahn P, 2006, CLIN INFECT DIS, V43, P1347, DOI 10.1086/508352; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; De Meyer SMJ, 2008, JAIDS-J ACQ IMM DEF, V49, P179, DOI 10.1097/QAI.0b013e318183a959; Dierynck I, 2007, J VIROL, V81, P13845, DOI 10.1128/JVI.01184-07; Dorrucci M, 2005, AIDS, V19, P331; Elgadi MM, 2011, DRUGS R&D, V11, P295, DOI 10.2165/11596340-000000000-00000; Finucane TE, 2004, AM J MED, V117, P842, DOI 10.1016/j.amjmed.2004.05.029; Gathe J, 2006, CLIN INFECT DIS, V43, P1337, DOI 10.1086/508353; Ghosh A, 2006, CURR OPIN NEUROBIOL, V16, P1, DOI 10.1016/j.conb.2006.01.012; Haubrich R, 2007, AIDS, V21, pF11, DOI 10.1097/QAD.0b013e3280b07b47; Hertogs K, 2000, AIDS, V14, P1203, DOI 10.1097/00002030-200006160-00018; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Hill A, 2007, HIV MED, V8, P259, DOI 10.1111/j.1468-1293.2007.00465.x; Hsieh SM, 2011, INT J STD AIDS, V22, P617, DOI 10.1258/ijsa.2009.009007; Hsieh SM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-154; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; *JOINT UNIT NAT, 2012, TOG WE WILL END AIDS; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; Kempf DJ, 1997, ANTIMICROB AGENTS CH, V41, P654, DOI 10.1128/AAC.41.3.654; Kozal M, 2004, AIDS PATIENT CARE ST, V18, P199, DOI 10.1089/108729104323038874; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Lima VD, 2009, AM J PUBLIC HEALTH, V99, pS193, DOI 10.2105/AJPH.2008.137901; Madruga JV, 2007, LANCET, V370, P49, DOI 10.1016/S0140-6736(07)61049-6; McKinnell JA, 2009, AIDS, V23, P1539, DOI 10.1097/QAD.0b013e32832c7b5c; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Naeger LK, 2007, AIDS, V21, P179, DOI 10.1097/QAD.0b013e3280119213; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Pozniak A, 2008, AIDS RES HUM RETROV, V24, P1275, DOI 10.1089/aid.2007.0275; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Turner SR, 1998, J MED CHEM, V41, P3467, DOI 10.1021/jm9802158; *US ANT THER GUID, 2012, US ANT THER GUID; Willig JH, 2010, AIDS RES HUM RETROV, V26, P1279, DOI 10.1089/aid.2010.0059; Wood E, 2000, AIDS, V14, P1955, DOI 10.1097/00002030-200009080-00011	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60814	10.1371/journal.pone.0060814	http://dx.doi.org/10.1371/journal.pone.0060814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593314	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100066
J	Homburg, K; Drees, C; Gossner, MM; Rakosy, L; Vrezec, A; Assmann, T				Homburg, Katharina; Drees, Claudia; Gossner, Martin M.; Rakosy, Laszlo; Vrezec, Al; Assmann, Thorsten			Multiple Glacial Refugia of the Low-Dispersal Ground Beetle Carabus irregularis: Molecular Data Support Predictions of Species Distribution Models	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION; MITOCHONDRIAL-DNA; MAXIMUM-LIKELIHOOD; GENETIC-STRUCTURE; NORTHERN REFUGIA; MOUNTAIN PLANTS; PHYLOGEOGRAPHY; COLEOPTERA; EUROPE; BIOGEOGRAPHY	Classical glacial refugia such as the southern European peninsulas were important for species survival during glacial periods and acted as sources of post-glacial colonisation processes. Only recently, some studies have provided evidence for glacial refugia north of the southern European peninsulas. In the present study, we combined species distribution models (SDMs) with phylogeographic analyses (using mitochondrial DNA = mtDNA) to investigate if the cold-adapted, stenotopic and flightless ground beetle species, Carabus irregularis, survived the Last Glacial Maximum (LGM) in classical and/or other refugia. SDMs (for both a western European and for a Carpathian subgroup) were calculated with MAXENT on the basis of 645 species records to predict current and past distribution patterns. Two mtDNA loci (CO1 and ND5, concatenated sequence length: 1785 bp) were analyzed from 91 C. irregularis specimens to reconstruct the phylogeography of Central and eastern European populations and to estimate divergence times of the given lineages. Strong intra-specific genetic differentiation (inter-clade Phi(ST) values ranged from 0.92 to 0.99) implied long-term isolation of major clades and subsclades. The high divergence between the nominate subspecies and the Carpathian subspecies C. i. montandoni points to two independent species rather than subspecies (K-2P distance 0.042 +/- 0.004; supposed divergence of the maternal lineages dated back 1.6 to 2.5 million years BP) differing not only morphologically but also genetically and ecologically from each other. The SDMs also inferred classical as well as other refugia for C. irregularis, especially north of the Alps, in southeastern Europe and in the Carpathians. The coincidences between the results of both methods confirm the assumption of multiple glacial refugia for the studied species and the usefulness of combining methodological approaches for the understanding of the history of low-dispersal insect species.	[Homburg, Katharina; Drees, Claudia; Assmann, Thorsten] Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany; [Drees, Claudia] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Drees, Claudia] Univ Hamburg, Zool Museum, Hamburg, Germany; [Gossner, Martin M.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany; [Rakosy, Laszlo] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania; [Vrezec, Al] Natl Inst Biol, Dept Freshwater & Terr Ecosyst Res, Ljubljana, Slovenia	Leuphana University Luneburg; University of Hamburg; University of Hamburg; Technical University of Munich; Babes Bolyai University from Cluj; National Institute of Biology - Slovenia	Homburg, K (corresponding author), Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany.	homburg@uni.leuphana.de	Laszlo, Rakosy/J-3541-2016; Drees, Claudia/D-9353-2017; Rakosy, Laszlo/K-8702-2013; Assmann, Thorsten/Q-9304-2017; Gossner, Martin M./J-2730-2015	Laszlo, Rakosy/0000-0002-1866-3422; Drees, Claudia/0000-0003-2743-395X; Rakosy, Laszlo/0000-0002-7793-6996; Assmann, Thorsten/0000-0002-9203-769X; Gossner, Martin M./0000-0003-1516-6364; Vrezec, Al/0000-0002-4699-6451	German Federal Environmental Foundation (DBU) [AZ 20009/055]	German Federal Environmental Foundation (DBU)	KH is supported by a PhD scholarship from the German Federal Environmental Foundation (DBU, AZ 20009/055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Andujar C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-40; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; ASSMANN T, 2003, INFORMATIONSDIENST N, V23, P70; Babik W, 2005, MOL ECOL, V14, P2475, DOI 10.1111/j.1365-294X.2005.02605.x; Babik W, 2004, MOL ECOL, V13, P1469, DOI 10.1111/j.1365-294X.2004.02157.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; BOUSQUET Y, 2003, CATALOGUE PALAEARCTI, V1, P118; BREUNING S, 1932, MONOGRAPHIE GATTUNG; BREUNING S, 1937, BESTIMMUNGS TABELLEN, P1361; Brouat C, 2006, ENTOMOL EXP APPL, V120, P189, DOI 10.1111/j.1570-7458.2006.00440.x; Caccone A, 2001, EVOLUTION, V55, P122; Casale A., 2003, P73; Casale Achille, 1998, P429; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; DESENDER K, 2008, NIEUWE VERSPREIDINGS; Deuve T, 2012, MOL PHYLOGENET EVOL, V65, P259, DOI 10.1016/j.ympev.2012.06.015; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DRUMMOND A, 2009, GENEIOUS, V47; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; ELIAS SA, 1994, QUATERNARY INSECTS T; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; EXCOFFIER L, 1992, GENETICS, V131, P479; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FLECHTNER G, 2000, NATURWALDRESERVATE H, P1; Franzen Michael, 1995, Fauna und Flora in Rheinland-Pfalz, V8, P5; GEBERT J, ENTOMOLOGISCHE NAC 1, V10, P1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hartmann Matthias, 1998, Thueringer Faunistische Abhandlungen, V5, P147; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; HEJDA R, 2011, MAP DISTRIBUTION CAR, P10; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Knopp T, 2009, HEREDITY, V102, P174, DOI 10.1038/hdy.2008.91; KOHLER F, 2007, NATURWALDRESERVATE 2, P101; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Kropf M, 2012, J BIOGEOGR, V39, P799, DOI 10.1111/j.1365-2699.2011.02668.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LORENZ WMT, 2003, SCHRIFTENREIHE BAYER, V166, P102; Maddison DR, 2012, MOL PHYLOGENET EVOL, V63, P533, DOI 10.1016/j.ympev.2012.01.015; Matern A, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P253, DOI 10.1007/978-3-540-92160-8_14; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mraz P, 2007, J BIOGEOGR, V34, P2100, DOI 10.1111/j.1365-2699.2007.01765.x; Muster C, 2006, MOL ECOL, V15, P2921, DOI 10.1111/j.1365-294X.2006.02989.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Osawa S, 2004, MOL PHYLOGENY EVOLUT; Pauls SU, 2006, MOL ECOL, V15, P2153, DOI 10.1111/j.1365-294X.2006.02916.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rebelo H, 2012, MOL ECOL, V21, P2761, DOI 10.1111/j.1365-294X.2012.05566.x; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodder D, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P373, DOI 10.1007/978-3-540-92160-8_22; Ronikier M, 2008, MOL ECOL, V17, P1763, DOI 10.1111/j.1365-294X.2008.03664.x; Ronikier M, 2011, TAXON, V60, P373, DOI 10.1002/tax.602008; Schmidt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045482; Schmitt T, 2006, J EVOLUTION BIOL, V19, P108, DOI 10.1111/j.1420-9101.2005.00980.x; Schmitt T, 2008, EUR J ENTOMOL, V105, P249, DOI 10.14411/eje.2008.035; Schmitt T, 2008, MOL ECOL, V17, P2194, DOI 10.1111/j.1365-294X.2007.03687.x; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Schoville SD, 2012, BIOL J LINN SOC, V107, P95, DOI 10.1111/j.1095-8312.2012.01911.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SOKOLAR F, 1909, ENTOMOLOGISCHE RUNDS, P87; Sota T, 2001, SYST BIOL, V50, P39, DOI 10.1080/713849547; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Su ZH, 1998, MOL BIOL EVOL, V15, P1026, DOI 10.1093/oxfordjournals.molbev.a026001; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiele H, 1977, CARABID BEETLES THEI; TURIN H, 2003, GENUS CARABUS EUROPE; Valtuena FJ, 2012, MOL ECOL, V21, P1423, DOI 10.1111/j.1365-294X.2012.05473.x; Vega R, 2010, ECOGRAPHY, V33, P260, DOI 10.1111/j.1600-0587.2010.06287.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weber F., 1966, Entomologische Blaetter fuer Biologie und Systematik der Kaefer, V62, P1; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119	92	33	35	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61185	10.1371/journal.pone.0061185	http://dx.doi.org/10.1371/journal.pone.0061185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593425	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100079
J	Jahan, N; Wimmer, E; Mueller, S				Jahan, Nusrat; Wimmer, Eckard; Mueller, Steffen			Polypyrimidine Tract Binding Protein-1 (PTB1) Is a Determinant of the Tissue and Host Tropism of a Human Rhinovirus/Poliovirus Chimera PV1(RIPO)	PLOS ONE			English	Article							INTERNAL RIBOSOMAL ENTRY; TRANSLATION INITIATION-FACTOR; CAP-INDEPENDENT TRANSLATION; 5' NONTRANSLATED REGION; NUCLEAR-PORE COMPLEX; HEPATITIS-C VIRUS; POLIOVIRUS RNA; MESSENGER-RNA; MOLECULAR-CLONING; NONCODING REGION	The internal ribosomal entry site (IRES) of picornavirus genomes serves as the nucleation site of a highly structured ribonucleoprotein complex essential to the binding of the 40S ribosomal subunit and initiation of viral protein translation. The transition from naked RNA to a functional "IRESome" complex are poorly understood, involving the folding of secondary and tertiary RNA structure, facilitated by a tightly concerted binding of various host cell proteins that are commonly referred to as IRES trans-acting factors (ITAFs). Here we have investigated the influence of one ITAF, the polypyrimidine tract-binding protein 1 (PTB1), on the tropism of PV1(RIPO), a chimeric poliovirus in which translation of the poliovirus polyprotein is under the control of a human rhinovirus type 2 (HRV2) IRES element. We show that PV1(RIPO)'s growth defect in restrictive mouse cells is partly due to the inability of its IRES to interact with endogenous murine PTB. Over-expression of human PTB1 stimulated the HRV2 IRES-mediated translation, resulting in increased growth of PV1(RIPO) in murine cells and human neuronal SK-N-MC cells. Mutations within the PV1(RIPO) IRES, selected to grow in restrictive mouse cells, eliminated the human PTB1 supplementation requirement, by restoring the ability of the IRES to interact with endogenous murine PTB. In combination with our previous findings these results give a compelling insight into the thermodynamic behavior of IRES structures. We have uncovered three distinct thermodynamic aspects of IRES formation which may independently contribute to overcome the observed PV1(RIPO) IRES block by lowering the free energy dG of the IRESome formation, and stabilizing the correct and functional structure: 1) lowering the growth temperature, 2) modifying the complement of ITAFs in restricted cells, or 3) selection of adaptive mutations. All three mechanisms can conceivably modulate the thermodynamics of RNA folding, and thus facilitate and stabilize the functional IRES structure.	[Jahan, Nusrat; Wimmer, Eckard; Mueller, Steffen] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mueller, S (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	smueller@ms.cc.sunysb.edu	Mueller, Steffen/HGE-0738-2022	Mueller, Steffen/0000-0003-2660-258X	National Institutes of Health [5R01AI03948508, 5R37AI01512233]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants 5R01AI03948508, 5R37AI01512233 to Eckard Wimmer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER L, 1994, P NATL ACAD SCI USA, V91, P1406, DOI 10.1073/pnas.91.4.1406; Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; Back SH, 2002, J BIOL CHEM, V277, P27200, DOI 10.1074/jbc.M203887200; Belov GA, 2004, J VIROL, V78, P10166, DOI 10.1128/JVI.78.18.10166-10177.2004; Belsham GJ, 1995, CURR TOP MICROBIOL, V203, P85; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Boussadia O, 2003, J VIROL, V77, P3353, DOI 10.1128/JVI.77.6.3353-3359.2003; CALIGUIRI LA, 1968, VIROLOGY, V35, P408, DOI 10.1016/0042-6822(68)90219-5; Campbell SA, 2005, J VIROL, V79, P6281, DOI 10.1128/JVI.79.10.6281-6290.2005; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Cello J, 2008, J MED VIROL, V80, P352, DOI 10.1002/jmv.21063; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Craig AWB, 1997, MOL CELL BIOL, V17, P163, DOI 10.1128/MCB.17.1.163; Dobrikova E, 2003, P NATL ACAD SCI USA, V100, P15125, DOI 10.1073/pnas.2436464100; Dobrikova EY, 2006, J VIROL, V80, P3310, DOI 10.1128/JVI.80.7.3310-3321.2006; EVANS DMA, 1985, NATURE, V314, P548, DOI 10.1038/314548a0; Fernandez-Miragall O, 2009, VIRUS RES, V139, P172, DOI 10.1016/j.virusres.2008.07.009; Florez de Sessions P, 2007, J VIROL, V81, P8396; Florez PM, 2005, J VIROL, V79, P6172, DOI 10.1128/JVI.79.10.6172-6179.2005; Gamarnik AV, 1997, RNA, V3, P882; GIL A, 1991, GENE DEV, V5, P1224, DOI 10.1101/gad.5.7.1224; Gosert R, 2000, MOL CELL BIOL, V20, P1583, DOI 10.1128/MCB.20.5.1583-1595.2000; Gromeier M, 1999, J VIROL, V73, P958, DOI 10.1128/JVI.73.2.958-964.1999; Gromeier M, 1996, P NATL ACAD SCI USA, V93, P2370, DOI 10.1073/pnas.93.6.2370; Grossman JS, 1998, RNA, V4, P613, DOI 10.1017/S1355838298971448; Gustin KE, 2003, VIRUS RES, V95, P35, DOI 10.1016/S0168-1702(03)00165-5; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Haller AA, 1996, J VIROL, V70, P1467, DOI 10.1128/JVI.70.3.1467-1474.1996; HELLEN CUT, 1994, J VIROL, V68, P941, DOI 10.1128/JVI.68.2.941-950.1994; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; Hunt SL, 1999, RNA, V5, P344, DOI 10.1017/S1355838299981414; Hunt SL, 1999, GENE DEV, V13, P437, DOI 10.1101/gad.13.4.437; JACOBSON MF, 1968, J MOL BIOL, V33, P369, DOI 10.1016/0022-2836(68)90195-2; Jahan N, 2011, J VIROL, V85, P7225, DOI 10.1128/JVI.01804-09; JANG SK, 1990, ENZYME, V44, P292, DOI 10.1159/000468766; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; Jang SK, 2006, VIRUS RES, V119, P2, DOI 10.1016/j.virusres.2005.11.003; JOHNSON VH, 1988, VIROLOGY, V162, P47, DOI 10.1016/0042-6822(88)90393-5; Kamath RV, 2001, MOL BIOL CELL, V12, P3808, DOI 10.1091/mbc.12.12.3808; Kikuchi T, 2000, J BIOCHEM, V128, P811, DOI 10.1093/oxfordjournals.jbchem.a022819; Kim YK, 1999, J GEN VIROL, V80, P3159, DOI 10.1099/0022-1317-80-12-3159; LAMONICA N, 1989, J VIROL, V63, P2357, DOI 10.1128/JVI.63.5.2357-2360.1989; Li XY, 2001, J GEN VIROL, V82, P397, DOI 10.1099/0022-1317-82-2-397; Lidsky PV, 2006, J VIROL, V80, P2705, DOI 10.1128/JVI.80.6.2705-2717.2006; Lillevali K, 2001, MECH DEVELOP, V101, P217, DOI 10.1016/S0925-4773(00)00566-9; Lin JC, 2011, J CELL BIOL, V193, P509, DOI 10.1083/jcb.201007131; Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007; Lu HH, 1996, P NATL ACAD SCI USA, V93, P1412, DOI 10.1073/pnas.93.4.1412; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Michael WM, 1995, COLD SPRING HARB SYM, V60, P663, DOI 10.1101/SQB.1995.060.01.071; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Ohno S, 2011, CELL CYCLE, V10, P3706, DOI 10.4161/cc.10.21.17903; Pacheco A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/458927; PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PESTOVA TV, 1991, J VIROL, V65, P6194, DOI 10.1128/JVI.65.11.6194-6204.1991; PILIPENKO EV, 1990, NUCLEIC ACIDS RES, V18, P3371, DOI 10.1093/nar/18.11.3371; PILIPENKO EV, 1989, VIROLOGY, V168, P201, DOI 10.1016/0042-6822(89)90259-6; PILIPENKO EV, 1989, NUCLEIC ACIDS RES, V17, P5701, DOI 10.1093/nar/17.14.5701; Pilipenko EV, 2001, EMBO J, V20, P6899, DOI 10.1093/emboj/20.23.6899; Pilipenko EV, 2000, GENE DEV, V14, P2028; PINCUS SE, 1987, VIROLOGY, V157, P83, DOI 10.1016/0042-6822(87)90316-3; PIPKIN PA, 1993, J VIROL METHODS, V41, P333, DOI 10.1016/0166-0934(93)90022-J; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x; SVITKIN YV, 1988, VIROLOGY, V166, P394, DOI 10.1016/0042-6822(88)90510-7; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; TRONO D, 1988, SCIENCE, V241, P445, DOI 10.1126/science.2839901; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Witherell GW, 1995, VIROLOGY, V214, P660, DOI 10.1006/viro.1995.0081; Yin J, 2003, J VIROL, V77, P5152, DOI 10.1128/JVI.77.9.5152-5166.2003	78	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60791	10.1371/journal.pone.0060791	http://dx.doi.org/10.1371/journal.pone.0060791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593313	Green Published, gold, Green Submitted			2022-12-27	WOS:000319108100065
J	Grisham, RC; Kindt, K; Finger-Baier, K; Schmid, B; Nicolson, T				Grisham, Rachel Clemens; Kindt, Katie; Finger-Baier, Karin; Schmid, Bettina; Nicolson, Teresa			Mutations in ap1b1 Cause Mistargeting of the Na+/K+-ATPase Pump in Sensory Hair Cells	PLOS ONE			English	Article							POLARIZED EPITHELIAL-CELLS; ADAPTER PROTEIN-1; SORTING SIGNALS; INNER-EAR; CAENORHABDITIS-ELEGANS; SYNAPTIC VESICLES; PLASMA-MEMBRANE; ALPHA-SUBUNIT; LATERAL-LINE; IN-VITRO	The hair cells of the inner ear are polarized epithelial cells with a specialized structure at the apical surface, the mechanosensitive hair bundle. Mechanotransduction occurs within the hair bundle, whereas synaptic transmission takes place at the basolateral membrane. The molecular basis of the development and maintenance of the apical and basal compartments in sensory hair cells is poorly understood. Here we describe auditory/vestibular mutants isolated from forward genetic screens in zebrafish with lesions in the adaptor protein 1 beta subunit 1 (ap1b1) gene. Ap1b1 is a subunit of the adaptor complex AP-1, which has been implicated in the targeting of basolateral membrane proteins. In ap1b1 mutants we observed that although the overall development of the inner ear and lateral-line organ appeared normal, the sensory epithelium showed progressive signs of degeneration. Mechanically-evoked calcium transients were reduced in mutant hair cells, indicating that mechanotransduction was also compromised. To gain insight into the cellular and molecular defects in ap1b1 mutants, we examined the localization of basolateral membrane proteins in hair cells. We observed that the Na+/K+-ATPase pump (NKA) was less abundant in the basolateral membrane and was mislocalized to apical bundles in ap1b1 mutant hair cells. Accordingly, intracellular Na+ levels were increased in ap1b1 mutant hair cells. Our results suggest that Ap1b1 is essential for maintaining integrity and ion homeostasis in hair cells.	[Grisham, Rachel Clemens; Kindt, Katie; Nicolson, Teresa] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Grisham, Rachel Clemens; Kindt, Katie; Nicolson, Teresa] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97201 USA; [Finger-Baier, Karin] Max Planck Inst Neurobiol, Dept Genes Circuits Behav, D-82152 Martinsried, Germany; [Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Schmid, Bettina] Univ Munich, Adolf Butenandt Inst, Munich, Germany	Howard Hughes Medical Institute; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Nicolson, T (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	nicolson@ohsu.edu	Kindt, Katie/AAS-3275-2020	Kindt, Katie/0000-0002-1065-8215	National Institutes of Health (NIH) [NIH R01 DC006880]; NIH [T32 HD049309]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD049309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006880] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported in part by National Institutes of Health (NIH) grant NIH R01 DC006880, and RCG was supported in part by NIH T32 HD049309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almomani EY, 2012, AM J PHYSIOL-CELL PH, V303, pC554, DOI 10.1152/ajpcell.00124.2012; Altick AL, 2009, J COMP NEUROL, V514, P641, DOI 10.1002/cne.22047; ANNIKO M, 1986, HEARING RES, V22, P279, DOI 10.1016/0378-5955(86)90104-8; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boyer C, 2001, J NEUROSCI, V21, P2640, DOI 10.1523/JNEUROSCI.21-08-02640.2001; Couloigner V, 2006, PFLUG ARCH EUR J PHY, V453, P11, DOI 10.1007/s00424-006-0103-4; Dambly-Chaudiere C, 2003, BIOL CELL, V95, P579, DOI 10.1016/j.biolcel.2003.10.005; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Dunbar LA, 2001, J BIOL CHEM, V276, P29617, DOI 10.1074/jbc.R100023200; Efendiev R, 2008, J BIOL CHEM, V283, P17561, DOI 10.1074/jbc.M709260200; Einhorn Z, 2012, J NEUROSCI, V32, P11144, DOI 10.1523/JNEUROSCI.1705-12.2012; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2005, TRENDS CELL BIOL, V15, P222, DOI 10.1016/j.tcb.2005.02.006; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Folsch H, 2009, TRAFFIC, V10, P972, DOI 10.1111/j.1600-0854.2009.00927.x; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Granato M, 1996, DEVELOPMENT, V123, P399; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hibino H, 2006, PHYSIOLOGY, V21, P336, DOI 10.1152/physiol.00023.2006; Kim SH, 2011, HEARING RES, V280, P21, DOI 10.1016/j.heares.2011.05.003; Kindt KS, 2012, DEV CELL, V23, P329, DOI 10.1016/j.devcel.2012.05.022; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Meyers JR, 2003, J NEUROSCI, V23, P4054; Mo W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-110; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; MROZ EA, 1993, HEARING RES, V70, P22, DOI 10.1016/0378-5955(93)90049-7; Muth TR, 1998, AM J PHYSIOL-CELL PH, V274, pC688, DOI 10.1152/ajpcell.1998.274.3.C688; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Shafaq-Zadah M, 2012, DEVELOPMENT, V139, P2061, DOI 10.1242/dev.076711; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; Shim J, 2000, MOL BIOL CELL, V11, P2743, DOI 10.1091/mbc.11.8.2743; Shteyn E, 2011, J CELL BIOL, V194, P873, DOI 10.1083/jcb.201106010; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Steyger PS, 2003, JARO-J ASSOC RES OTO, V4, P565, DOI 10.1007/s10162-003-4002-5; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Waguespack JR, 2005, J PHYSIOL-LONDON, V567, P359, DOI 10.1113/jphysiol.2005.094474; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang HJ, 2012, DEVELOPMENT, V139, P2071, DOI 10.1242/dev.077347; Zizioli D, 2010, DEV DYNAM, V239, P2404, DOI 10.1002/dvdy.22372	56	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60866	10.1371/journal.pone.0060866	http://dx.doi.org/10.1371/journal.pone.0060866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593334	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300031
J	Wang, YQ; Inger, M; Jiang, HW; Tenenbaum, H; Glogauer, M				Wang, Yongqiang; Inger, Maayan; Jiang, Hongwei; Tenenbaum, Howard; Glogauer, Michael			CD109 Plays a Role in Osteoclastogenesis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HUMAN KERATINOCYTES; HUMAN PLATELETS; CELL BIOLOGY; BONE LOSS; EXPRESSION; MICROARRAY; RANKL; DIFFERENTIATION; PCR	Osteoclasts are large multinucleated cells that arise from the fusion of cells from the monocyte/macrophage lineage. Osteoclastogenesis is mediated by macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kB ligand (RANKL) and involves a complex multistep process that requires numerous other elements, many of which remain undefined. The primary aim of this project was to identify novel factors which regulate osteoclastogenesis. To carry out this investigation, microarray analysis was performed comparing two pre-osteoclast cell lines generated from RAW264.7 macrophages: one that has the capacity to fuse forming large multinucleated cells and one that does not fuse. It was found that CD109 was up-regulated by>17-fold in the osteoclast forming cell line when compared to the cell line that does not fuse, at day 2 of the differentiation process. Results obtained with microarray were confirmed by RT-qPCR and Western blot analyses in the two cell lines, in the parental RAW264.7 cell line, as well as primary murine monocytes from bone marrow. A significant increase of CD109 mRNA and protein expression during osteoclastogenesis occurred in all tested cell types. In order to characterize the role of CD109 in osteoclastogenesis, CD109 stable knockdown cell lines were established and fusion of osteoclast precursors into osteoclasts was assessed. It was found that CD109 knockdown cell lines were less capable of forming large multinucleated osteoclasts. It has been shown here that CD109 is expressed in monocytes undergoing RANKL-induced osteoclastogenesis. Moreover, when CD109 expression is suppressed in vitro, osteoclast formation decreases. This suggests that CD109 might be an important regulator of osteoclastogenesis. Further research is needed in order to characterize the role played by CD109 in regulation of osteoclast differentiation.	[Wang, Yongqiang; Inger, Maayan; Jiang, Hongwei; Glogauer, Michael] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada; [Tenenbaum, Howard] Univ Toronto, Dept Periodontol, Fac Dent, Toronto, ON, Canada	University of Toronto; University of Toronto	Glogauer, M (corresponding author), Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada.	michael.glogauer@utoronto.ca	Glogauer, Michael/D-2504-2011	Glogauer, Michael/0000-0002-6248-5977	Canadian Institutes of Health Research (CIHR) [MOP-81265]; CIHR [TBO-122068]; China Scholarship Council; Department of Operative Dentistry and Endodontics, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); China Scholarship Council(China Scholarship Council); Department of Operative Dentistry and Endodontics, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China	This work was funded by a Canadian Institutes of Health Research (CIHR) grant MOP-81265 (MG) and a CIHR grant TBO-122068 (MG). HJ was supported by the China Scholarship Council and the Department of Operative Dentistry and Endodontics, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PH, 2008, J BONE MINER RES, V23, P1789, DOI 10.1359/JBMR.080616; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Ballanti P, 1997, OSTEOPOROSIS INT, V7, P39, DOI 10.1007/BF01623458; Bizet AA, BIOCH BIOPHYS ACTA, V1813, P742; Bizet AA, J CELL BIOCH, V113, P238; Chen J, J BIOL CHEM, V285, P36315; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Fox SW, 2005, MOL CELL ENDOCRINOL, V243, P19, DOI 10.1016/j.mce.2005.09.008; Gradin P, CELLS TISSUES ORGANS, V196, P68; Hagikura M, PATHOL INT, V60, P735; Hagiwara S, 2008, CANCER SCI, V99, P1916, DOI 10.1111/j.1349-7006.2008.00949.x; Hasegawa M, 2008, PATHOL INT, V58, P288, DOI 10.1111/j.1440-1827.2008.02225.x; Hasegawa M, 2007, PATHOL INT, V57, P245, DOI 10.1111/j.1440-1827.2007.02097.x; Hashimoto M, 2004, ONCOGENE, V23, P3716, DOI 10.1038/sj.onc.1207418; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jenson SD, 2003, J CLIN PATHOL-MOL PA, V56, P307, DOI 10.1136/mp.56.6.307; Kelton JG, 1998, J LAB CLIN MED, V132, P142, DOI 10.1016/S0022-2143(98)90009-9; Kim MH, AMINO ACIDS, V40, P1447; Koseki T, 2002, CELL SIGNAL, V14, P31, DOI 10.1016/S0898-6568(01)00221-2; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Lee G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004559; Lee SK, 2006, BONE, V38, P678, DOI 10.1016/j.bone.2005.10.011; Leung R, J BONE MINER RES, V25, P1077; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Litvinov IV, EXP DERMATOL, V20, P627; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Man XY, ARTHRITIS RES THER, V14, pR144; MASKOS U, 1992, NUCLEIC ACIDS RES, V20, P1679, DOI 10.1093/nar/20.7.1679; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Murray LJ, 1999, EXP HEMATOL, V27, P1282, DOI 10.1016/S0301-472X(99)00071-5; Nakamura I, 2003, J ELECTRON MICROSC, V52, P527, DOI 10.1093/jmicro/52.6.527; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ohshima Y, J DERMATOL SCI, V57, P140; Porto-Diaz I, NEURAL NETW, V24, P888; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Sato T, 2007, PATHOL INT, V57, P719, DOI 10.1111/j.1440-1827.2007.02168.x; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; SMITH JW, 1995, BLOOD, V86, P2807; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tam BYY, 2003, J BIOL CHEM, V278, P49610, DOI 10.1074/jbc.M308492200; Troen BR, 2003, EXP GERONTOL, V38, P605, DOI 10.1016/S0531-5565(03)00069-X; Vaananen HK, 2000, J CELL SCI, V113, P377; Yan T, 2001, J CELL BIOCHEM, V83, P320, DOI 10.1002/jcb.1200; Yang GZ, 2008, BIOCHEM BIOPH RES CO, V366, P352, DOI 10.1016/j.bbrc.2007.11.106; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Yasuda H, 1998, SEIKAGAKU, V70, P385; Yasui T, J BONE MINER RES, V26, P1447; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204; Yen ML, PLOS ONE, V7; Zhang JM, 2005, PATHOL INT, V55, P165, DOI 10.1111/j.1440-1827.2005.01807.x	55	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61213	10.1371/journal.pone.0061213	http://dx.doi.org/10.1371/journal.pone.0061213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593435	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300062
J	Gao, F; Zhou, YJ; Hu, DY; Zhao, YX; Liu, YY; Wang, ZJ; Yang, SW; Liu, XL				Gao, Fei; Zhou, Yu Jie; Hu, Da Yi; Zhao, Ying Xin; Liu, Yu Yang; Wang, Zhi Jian; Yang, Shi Wei; Liu, Xiao Li			Contemporary Management and Attainment of Cholesterol Targets for Patients with Dyslipidemia in China	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; ACUTE-CORONARY-SYNDROME; LIPID-LOWERING-THERAPY; MYOCARDIAL-INFARCTION; STATIN THERAPY; HYPERCHOLESTEROLEMIA; ATORVASTATIN; DISEASE; INTERVENTION; HYPERTENSION	Aims: It is well-established that lipid disorder is an important cardiovascular risk factor, and failure to reach optimal lipid levels significantly contributes to the residual cardiovascular risks. However, limited information is available on the management and the attainment of recommended cholesterol targets in real-world practice in China. Methods and Results: A nationally representative sample of 12,040 patients with dyslipidemia from 19 provinces and 84 hospitals across China were consecutively enrolled in this survey. Risk stratification and individual cholesterol target was established for all participants. This survey identified a high-risk cohort, with over 50% of patients had hypertension, 37.5% had coronary artery disease, and more than 30% had peripheral artery disease. Thirty-nine percent of all participants received lipid lowering medications. And the majority of them (94.5%) had statins (42.5% with atorvastatin, 29.0% with simvastatin, and 15.2% with rosuvastatin). However, the overall attainment for low-density lipoprotein cholesterol (LDL-C) target is low (25.8%), especially, in female (22.2%), and in patients with increased body mass index (BMI) (38.3% for BMI<18.5, 28.1% for BMI 18.5-24.9, 26.0% for BMI 25.0-29.9, and 17.4% for BMI >= 30, P<0.0001). Subgroup analysis also showed the attainment is significantly lower in patients who were stratified into high (19.9%) and very high (21.1%) risk category. In logistic regression analysis, eight factors (BMI, gender, coronary artery disease, systolic and diastolic blood pressure, hypertension, family history of premature coronary artery disease and current smoking) were identified as independent predictors of LDL-C attainment. Conclusions: Despite the proven benefits of lipid-lowering therapies, current management of dyslipidemia continues to be unsatisfied. A considerable proportion of patients failed to achieve guideline-recommended targets in China, and this apparent treatment gap was more pronounced among patients with increased BMI, higher risk stratification and women.	[Gao, Fei; Zhou, Yu Jie; Zhao, Ying Xin; Liu, Yu Yang; Wang, Zhi Jian; Yang, Shi Wei; Liu, Xiao Li] Capital Med Univ, An Zhen Hosp, Dept Cardiol, Beijing, Peoples R China; [Hu, Da Yi] Peking Univ, Peoples Hosp, Ctr Heart, Beijing 100871, Peoples R China	Capital Medical University; Peking University	Zhou, YJ (corresponding author), Capital Med Univ, An Zhen Hosp, Dept Cardiol, Beijing, Peoples R China.	yjzhou.az@gmail.com	fei, Gao/GQQ-8024-2022; wang, jie/GRS-0942-2022; Zhou, Yu/HHN-3071-2022; Liu, Xiaoli/HGE-7614-2022; WANG, JINGYI/GSJ-1241-2022		Chinese Society of Cardiology; AstraZeneca	Chinese Society of Cardiology; AstraZeneca(AstraZeneca)	This study was supported by the Chinese Society of Cardiology (a federally incorporated none-profit academic research organization) and AstraZeneca. The industry sponsors had no involvement in the study conception or design; collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. The authors had full access to the data and take full responsibility for its integrity. All the authors have read and agreed to the article as written.	ASSMANN G, 1988, AM HEART J, V116, P1713, DOI 10.1016/0002-8703(88)90220-7; Baessler A, 2005, INT J CARDIOL, V101, P293, DOI 10.1016/j.ijcard.2004.03.053; Bhan V, 2010, AM J CARDIOL, V106, P1270, DOI 10.1016/j.amjcard.2010.06.055; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Fodor JG, 2000, CAN MED ASSOC J, V162, P1441; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hu DY, 2006, EUR HEART J, V27, P2573, DOI 10.1093/eurheartj/ehl207; International Diabetes Federation, IDF CONS WORLDW DEF; Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438; Kim HS, 2008, CURR MED RES OPIN, V24, P1951, DOI [10.1185/03007990802138731, 10.1185/03007990802138731 ]; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Murphy SA, 2007, AM J CARDIOL, V100, P1047, DOI 10.1016/j.amjcard.2007.04.053; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Pirro M, 2011, EUR J INTERN MED, V22, P412, DOI 10.1016/j.ejim.2011.04.007; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sarno G, 2011, AM J CARDIOL, V108, P195, DOI 10.1016/j.amjcard.2011.03.023; STAMLER J, 1986, AM J MED, V80, P33, DOI 10.1016/0002-9343(86)90158-0; Wang ZJ, 2009, HEART, V95, P1587, DOI 10.1136/hrt.2009.172395; Wang ZJ, 2012, OBESITY, V20, P141, DOI 10.1038/oby.2011.187; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yan AT, 2006, AM J MED, V119, P676, DOI 10.1016/j.amjmed.2005.11.015	27	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e47681	10.1371/journal.pone.0047681	http://dx.doi.org/10.1371/journal.pone.0047681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593110	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600001
J	Lucas, X; Simon, S; Schubert, R; Gunther, S				Lucas, Xavier; Simon, Silke; Schubert, Rolf; Guenther, Stefan			Discovery of the Inhibitory Effect of a Phosphatidylinositol Derivative on P-Glycoprotein by Virtual Screening Followed by In Vitro Cellular Studies	PLOS ONE			English	Article							DRUG EFFLUX TRANSPORTERS; MULTIDRUG-RESISTANCE; ATPASE ACTIVITY; LINE CACO-2; BINDING; PERMEABILITY; SURFACTANTS; ENVIRONMENT; MECHANISMS; SYSTEM	P-glycoprotein is capable of effluxing a broad range of cytosolic and membrane penetrating xenobiotic substrates, thus leading to multi-drug resistance and posing a threat for the therapeutic treatment of several diseases, including cancer and central nervous disorders. Herein, a virtual screening campaign followed by experimental validation in Caco-2, MDKCII, and MDKCII mdr1 transfected cell lines has been conducted for the identification of novel phospholipids with P-gp transportation inhibitory activity. Phosphatidylinositol-(1,2-dioctanoyl)-sodium salt (8:0 PI) was found to significantly inhibit transmembrane P-gp transportation in vitro in a reproducible-, cell line-, and substrate-independent manner. Further tests are needed to determine whether this and other phosphatidylinositols could be co-administered with oral drugs to successfully increase their bioavailability. Moreover, as phosphatidylinositols and phosphoinositides are present in the human diet and are known to play an important role in signal transduction and cell motility, our finding could be of substantial interest for nutrition science as well.	[Lucas, Xavier; Guenther, Stefan] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany; [Simon, Silke; Schubert, Rolf] Univ Freiburg, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Gunther, S (corresponding author), Univ Freiburg, Inst Pharmaceut Sci, Hugstetter Str 55, D-79106 Freiburg, Germany.	stefan.guenther@pharmazie.uni-freiburg.de	Lucas, Xavier/AAW-7950-2021; Lucas, Xavier/C-6864-2014; Günther, Stefan/AAY-8944-2020	Lucas, Xavier/0000-0003-0887-3976; Lucas, Xavier/0000-0003-0887-3976; 	Excellence Initiative of the German Federal and State Governments through the Junior Research Group Programme [ZUK 43]; Federal State of Baden-Wurttemberg (Ministry of Science, Research, and Arts); Phospholipid e.V. (Heidelberg, Germany); German Research Foundation (DFG); Albert Ludwigs University Freiburg	Excellence Initiative of the German Federal and State Governments through the Junior Research Group Programme; Federal State of Baden-Wurttemberg (Ministry of Science, Research, and Arts); Phospholipid e.V. (Heidelberg, Germany); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work has received funding from the Excellence Initiative of the German Federal and State Governments through the Junior Research Group Programme (ZUK 43), by the Federal State of Baden-Wurttemberg (Ministry of Science, Research, and Arts), and by Phospholipid e.V. (Heidelberg, Germany). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Batrakova EV, 2004, PHARM RES-DORDR, V21, P2226, DOI 10.1007/s11095-004-7675-5; Brill JA, 2011, CURR BIOL, V21, pR930, DOI 10.1016/j.cub.2011.10.001; Burgess JW, 2005, J LIPID RES, V46, P350, DOI 10.1194/jlr.M400438-JLR200; Cevc G., 1993, PHOSPHOLIPID HDB; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Chiu YY, 2003, PHARM RES-DORDR, V20, P749, DOI 10.1023/A:1023481418576; Collnot EM, 2010, MOL PHARMACEUT, V7, P642, DOI 10.1021/mp900191s; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Klepsch F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002036; Larsen UL, 2007, SCAND J CLIN LAB INV, V67, P123, DOI 10.1080/00365510600986084; Lee CA, 2010, EXPERT OPIN DRUG MET, V6, P603, DOI 10.1517/17425251003610640; Lee JY, 2012, ANN NY ACAD SCI, V1271, P68, DOI 10.1111/j.1749-6632.2012.06725.x; Li-Blatter XC, 2012, BIOPHYS J, V102, P1383, DOI 10.1016/j.bpj.2012.02.018; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; Maki N, 2006, J BIOL CHEM, V281, P10769, DOI 10.1074/jbc.M512579200; Matsunaga N, 2008, J PHARMACOL SCI, V106, P128, DOI 10.1254/jphs.FP0071166; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MEUNIER V, 1995, CELL BIOL TOXICOL, V11, P187, DOI 10.1007/BF00756522; Moss SE, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002839; Orlowski S, 1996, BIOCHEM J, V317, P515, DOI 10.1042/bj3170515; Palmeira A, 2012, CURR MED CHEM, V19, P1946, DOI 10.2174/092986712800167392; Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6; Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Shimizu K, 2010, J AGR FOOD CHEM; Simon S, 2012, BBA-MOL CELL BIOL L, V1821, P1211, DOI 10.1016/j.bbalip.2012.06.001; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vogelgesang S, 2011, CURR PHARM DESIGN, V17, P2778, DOI 10.2174/138161211797440168; WALLACE MA, 1994, BBA-MOL BASIS DIS, V1227, P183, DOI 10.1016/0925-4439(94)90093-0; Yuferov V, 2010, ANN NY ACAD SCI, V1187, P184, DOI 10.1111/j.1749-6632.2009.05275.x; Zhang DX, 2010, FUTURE ONCOL, V6, P527, DOI [10.2217/fon.10.21, 10.2217/FON.10.21]; Zhang NY, 2007, LIFE SCI, V80, P1971, DOI 10.1016/j.lfs.2007.02.035	42	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60679	10.1371/journal.pone.0060679	http://dx.doi.org/10.1371/journal.pone.0060679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593281	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600035
J	Qin, XH; Hu, FP; Wu, S; Ye, XY; Zhu, DM; Zhang, Y; Wang, MG				Qin, Xiaohua; Hu, Fupin; Wu, Shi; Ye, Xinyu; Zhu, Demei; Zhang, Ying; Wang, Minggui			Comparison of Adhesin Genes and Antimicrobial Susceptibilities between Uropathogenic and Intestinal Commensal Escherichia coli Strains	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ACUTE CYSTITIS; VIRULENCE; BINDING; WOMEN; HOST; PYELONEPHRITIS; PERSISTENCE; CELLS	The presence of adhesins is arguably an important determinant of pathogenicity for Uropathogenic Escherichia coli (UPEC). Antimicrobial susceptibilities were tested by agar dilution method, fifteen adhesin genes were detected by polymerase chain reaction, and multilocus sequence typing (MLST) was analyzed in 70 UPEC isolates and 41 commensal E. coli strains. Extended-spectrum beta-lactamase (ESBL) was determined with confirmatory test. The prevalence of ESBL-producers in UPEC (53%, 37/70) was higher than the commensal intestinal isolates (7%, 3/41), and 97% (36/37) of the ESBL-producing UPEC harbored bla(CTX-M) genes. afa was present in 36% (10/28) UPEC isolates from recurrent lower urinary tract infection (UTI), and none in the acute pyelonephritis, acute uncomplicated cystitis or commensal strains (P<0.0001). papG was detected in 28% (20/70) of UPEC isolates, while 5% (2/41) of the commensal strains were papG positive (P = 0.0025), and the prevalence of papG was significantly higher in acute pyelonephritis group (71%) than the other two UTI groups (P<0.0001). The prevalence of flu, yqi, yadN and ygiL was significantly higher in UPEC isolates than in the commensal strains. ESBL-producing UPEC showed a lower prevalence of adhesin genes compared with non-ESBL-producing strains. The MLST profiles were different between UPEC and commensal strains, with ST131 (19%, 13/70) and ST10 (20%, 8/41) being the most common MLSTs, respectively. This study demonstrated that several adhesin genes were more prevalent in UPEC isolates than in commensal E. coli, and afa may be associated with recurrent lower UTI whereas papG is more frequently associated with acute pyelonephritis.	[Qin, Xiaohua; Hu, Fupin; Wu, Shi; Ye, Xinyu; Zhu, Demei; Zhang, Ying; Wang, Minggui] Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China; [Qin, Xiaohua; Hu, Fupin; Wu, Shi; Ye, Xinyu; Zhu, Demei; Zhang, Ying; Wang, Minggui] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Qin, Xiaohua; Hu, Fupin; Wu, Shi; Ye, Xinyu; Zhu, Demei; Zhang, Ying; Wang, Minggui] Fudan Univ, Shanghai Med Coll, Minist Hlth, Shanghai 200433, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Fudan University; Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wang, MG (corresponding author), Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China.	mgwang@fudan.edu.cn	Hu, Fupin/AAR-8314-2020; Wang, Minggui/AAR-8281-2020	Wang, Minggui/0000-0001-7682-5859	National Natural Science foundation of China [81102509]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science foundation of China (number 81102509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22; Blanco M, 1997, RES MICROBIOL, V148, P745, DOI 10.1016/S0923-2508(97)82450-3; *CLIN LAB STAND I, 2011, M100S21 CLSI; CLSI, 2018, METHODS DILUTION ANT; Dhakal BK, 2008, EUR J CLIN INVEST, V38, P2, DOI 10.1111/j.1365-2362.2008.01986.x; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Gibreel TM, 2012, J ANTIMICROB CHEMOTH, V67, P346, DOI 10.1093/jac/dkr451; Griebling TL, 2005, J UROLOGY, V173, P1281, DOI 10.1097/01.ju.0000155596.98780.82; Johnson JR, 2005, J CLIN MICROBIOL, V43, P6064, DOI 10.1128/JCM.43.12.6064-6072.2005; Johnson JR, 1998, J INFECT DIS, V177, P97, DOI 10.1086/513824; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson JR, 2000, INFECT IMMUN, V68, P3327, DOI 10.1128/IAI.68.6.3327-3336.2000; Kang YS, 2010, ENVIRON MICROBIOL, V12, P1304, DOI 10.1111/j.1462-2920.2010.02175.x; Korotkova N, 2008, INFECT IMMUN, V76, P3869, DOI 10.1128/IAI.00427-08; Lane MC, 2007, KIDNEY INT, V72, P19, DOI 10.1038/sj.ki.5002230; Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x; Qi C, 2010, DIAGN MICR INFEC DIS, V67, P87, DOI 10.1016/j.diagmicrobio.2009.12.011; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Schlager TA, 2003, J INFECT DIS, V188, P1059, DOI 10.1086/377643; Sokurenko EV, 2004, MOL BIOL EVOL, V21, P1373, DOI 10.1093/molbev/msh136; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; Spurbeck RR, 2011, INFECT IMMUN, V79, P4753, DOI 10.1128/IAI.05621-11; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; Wang MC, 2009, CLIN MICROBIOL INFEC, V15, P372, DOI 10.1111/j.1469-0691.2009.02708.x; Wang P, 2011, J CLIN MICROBIOL, V49, P3127, DOI 10.1128/JCM.00222-11; Zhao LX, 2009, UROLOGY, V74, P702, DOI 10.1016/j.urology.2009.01.042	30	58	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61169	10.1371/journal.pone.0061169	http://dx.doi.org/10.1371/journal.pone.0061169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593422	Green Submitted, Green Published, gold			2022-12-27	WOS:000317909600091
J	Shi, J; Chen, J; Serradji, N; Xu, XM; Zhou, H; Ma, YX; Sun, ZH; Jiang, P; Du, YP; Yang, JB; Dong, CZ; Wang, Q				Shi, Jie; Chen, Jing; Serradji, Nawal; Xu, Ximing; Zhou, Heng; Ma, Yinxing; Sun, Zhihong; Jiang, Peng; Du, Yuping; Yang, Jinbo; Dong, Changzhi; Wang, Qin			PMS1077 Sensitizes TNF-alpha Induced Apoptosis in Human Prostate Cancer Cells by Blocking NF-kappa B Signaling Pathway	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; TUMOR-NECROSIS-FACTOR; BIOLOGICAL EVALUATION; SCORING FUNCTION; IKK-EPSILON; KINASE; TRANSCRIPTION; P65; BETA; PHOSPHORYLATION	Our previous studies have demonstrated that PMS1077, a platelet-activating factor (PAF) antagonist, could induce apoptosis of Raji cells. However, the mechanism of action has not yet been determined. The nuclear transcription factor-kappa B (NF-kappa B) signaling pathway plays a critical role in tumor cell survival, proliferation, invasion, metastasis, and angiogenesis, so we determined the effects of PMS1077 and its structural analogs on tumor necrosis factor-alpha (TNF-alpha) induced activation of NF-kappa B signaling. In this study, we found that PMS1077 inhibited TNF-alpha induced expression of the NF-kappa B regulated reporter gene in a dose dependent manner. Western blot assay indicated that PMS1077 suppressed the TNF-alpha induced inhibitor of kappa B-alpha (I kappa B alpha) phosphorylation, I kappa B-alpha degradation, and p65 phosphorylation. PMS1077 consistently blocked TNF-alpha induced p65 nuclear translocation as demonstrated in the immunofluorescence assay used. Docking studies by molecular modeling predicted that PMS1077 might interact directly with the I kappa B kinase-beta (IKK-beta) subunit. These results suggested that PMS1077 might suppress the activation of NF-kappa B by targeting IKK-beta involved in the NF-kappa B signaling pathway. Finally, we showed that PMS1077 sensitized cells to TNF-alpha induced apoptosis by suppressing the expression of NF-kappa B regulated anti-apoptotic genes. Our results reveal a novel function of PMS1077 on the NF-kappa B signaling pathway and imply that PMS1077 can be considered as an anti-tumor lead compound.	[Shi, Jie; Chen, Jing; Zhou, Heng; Ma, Yinxing; Sun, Zhihong; Du, Yuping; Yang, Jinbo; Wang, Qin] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Serradji, Nawal; Dong, Changzhi] Univ Paris Diderot, ITODYS, CNRS UMR 7086, Paris, France; [Xu, Ximing] Univ Paris Diderot, Unite Biol Fonct & Adaptat, CNRS EAC4413, Paris, France; [Jiang, Peng] Univ Paris Diderot, UMR S 698, Paris, France	Lanzhou University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Dong, CZ (corresponding author), Univ Paris Diderot, ITODYS, CNRS UMR 7086, Paris, France.	dong@univ-paris-diderot.fr; qwang@lzu.edu.cn	Serradji, Nawal/AAJ-9599-2020; Zhou, Heng/ABH-3207-2021	Zhou, Heng/0000-0002-1457-4166; Dong, Changzhi/0000-0001-7927-6306	China Ministry of Education [Z2009-1-62001]; Science and Technology Support Projects of Gansu Province, China [1104FKCA123]	China Ministry of Education(Ministry of Education, China); Science and Technology Support Projects of Gansu Province, China	This work was supported by the Chun Hui Projects (number Z2009-1-62001, http://www.moe.edu.cn) from the China Ministry of Education and in part by the Science and Technology Support Projects of Gansu Province (number 1104FKCA123, http://www.gsstc.gov.cn), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CANC TREAT, V126, P103, DOI 10.1007/0-387-24361-5_5; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Durrant JD, 2011, J CHEM INF MODEL, V51, P2897, DOI 10.1021/ci2003889; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P888, DOI 10.1016/j.jmgm.2011.01.004; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Harikumar KB, 2009, BLOOD, V113, P2003, DOI 10.1182/blood-2008-04-151944; He JX, 2012, J BIOSCIENCES, V37, P243, DOI 10.1007/s12038-012-9202-x; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Jin HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040355; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018915; Lou XW, 2011, J IMMUNOL, V186, P539, DOI 10.4049/jimmunol.1001650; Martin M, 2000, ANTIMICROB AGENTS CH, V44, P3150, DOI 10.1128/AAC.44.11.3150-3154.2000; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Palayoor ST, 1999, ONCOGENE, V18, P7389, DOI 10.1038/sj.onc.1203160; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Serradji N, 2004, J MED CHEM, V47, P6410, DOI 10.1021/jm040860g; Serradji N, 2000, J MED CHEM, V43, P2149, DOI 10.1021/jm9911276; Serradji N, 2006, BIOORGAN MED CHEM, V14, P8109, DOI 10.1016/j.bmc.2006.07.031; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Shi RX, 2004, ONCOGENE, V23, P7712, DOI 10.1038/sj.onc.1208046; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang WD, 2009, ARCH PHARM RES, V32, P1727, DOI 10.1007/s12272-009-2210-1; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Xu ZM, 2008, REV OCCIDENTE, P133; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yang CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039696	37	12	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e61132	10.1371/journal.pone.0061132	http://dx.doi.org/10.1371/journal.pone.0061132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593410	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600085
J	Simoliunas, E; Kaliniene, L; Truncaite, L; Zajanckauskaite, A; Staniulis, J; Kaupinis, A; Ger, M; Valius, M; Meskys, R				Simoliunas, Eugenijus; Kaliniene, Laura; Truncaite, Lidija; Zajanckauskaite, Aurelija; Staniulis, Juozas; Kaupinis, Algirdas; Ger, Marija; Valius, Mindaugas; Meskys, Rolandas			Klebsiella Phage vB_KleM-RaK2-A Giant Singleton of the Family Myoviridae	PLOS ONE			English	Article							BACTERIOPHAGE; GENOME; PNEUMONIAE; PROTEOME; IDENTIFICATION; DIVERSITY; PLASMID	At 346 kbp in size, the genome of a jumbo bacteriophage vB_KleM-RaK2 (RaK2) is the largest Klebsiella infecting myovirus genome sequenced to date. In total, 272 out of 534 RaK2 ORFs lack detectable database homologues. Based on the similarity to biologically defined proteins and/or MS/MS analysis, 117 of RaK2 ORFs were given a functional annotation, including 28 RaK2 ORFs coding for structural proteins that have no reliable homologues to annotated structural proteins in other organisms. The electron micrographs revealed elaborate spike-like structures on the tail fibers of Rak2, suggesting that this phage is an atypical myovirus. While head and tail proteins of RaK2 are mostly myoviridae-related, the bioinformatics analysis indicate that tail fibers/spikes of this phage are formed from podovirus-like peptides predominantly. Overall, these results provide evidence that bacteriophage RaK2 differs profoundly from previously studied viruses of the Myoviridae family.	[Simoliunas, Eugenijus; Kaliniene, Laura; Truncaite, Lidija; Zajanckauskaite, Aurelija; Meskys, Rolandas] Vilnius State Univ, Inst Biochem, Dept Mol Microbiol & Biotechnol, Vilnius, Lithuania; [Staniulis, Juozas] Nat Res Ctr, Lab Plant Viruses, Inst Bot, Vilnius, Lithuania; [Kaupinis, Algirdas; Ger, Marija; Valius, Mindaugas] Vilnius State Univ, Inst Biochem, Prote Ctr, Vilnius, Lithuania	Vilnius University; Nature Research Center - Lithuania; Vilnius University	Kaliniene, L (corresponding author), Vilnius State Univ, Inst Biochem, Dept Mol Microbiol & Biotechnol, Vilnius, Lithuania.	laura.kaliniene@bchi.vu.lt	Kaliniene, Laura/L-2250-2019; Kaupinis, Algirdas/AAE-3889-2019; Truncaitė, Lidija/ADN-3047-2022; Kaliniene, Laura/C-3965-2019; Valius, Mindaugas/N-1220-2019; Valius, Mindaugas/F-2734-2012	Kaliniene, Laura/0000-0002-2989-9537; Kaliniene, Laura/0000-0002-2989-9537; Valius, Mindaugas/0000-0001-8478-8517; Simoliunas, Eugenijus/0000-0001-5712-3587	Lithuanian Science Foundation [SVE-04/2012]	Lithuanian Science Foundation(Research Council of Lithuania (LMTLT))	This work was funded by the Lithuanian Science Foundation (SVE-04/2012). URL:http://www.lmt.lt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman H-W, 2011, BACTERIOPHAGE TAXONO; Adriaenssens EM, 2012, ARCH VIROL, V157, P2035, DOI 10.1007/s00705-012-1360-5; BAGLEY ST, 1978, APPL ENVIRON MICROB, V36, P536, DOI 10.1128/AEM.36.3.536-538.1978; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Born Y, 2011, APPL ENVIRON MICROB, V77, P5945, DOI 10.1128/AEM.03022-10; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Carlson K, 1994, BACTERIOPHAGE T4; Casaite V, 2011, CURR MICROBIOL, V62, P1267, DOI 10.1007/s00284-010-9852-6; Christian NA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-27; Clokie MRJ, 2008, MICROBIOL-SGM, V154, P1775, DOI 10.1099/mic.0.2007/016261-0; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; Drulis-Kawa Z, 2011, APPL MICROBIOL BIOT, V90, P1333, DOI 10.1007/s00253-011-3149-y; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Golec P, 2010, VIRUS GENES, V41, P459, DOI 10.1007/s11262-010-0532-1; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hendrix RW, 2009, CURR TOP MICROBIOL, V328, P229; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Kaliniene L, 2011, ARCH VIROL, V156, P1913, DOI 10.1007/s00705-011-1084-y; Kaliniene L, 2010, ARCH VIROL, V155, P871, DOI 10.1007/s00705-010-0656-6; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Khusainov AA, 1992, BIOCHIM BIOPHYS ACTA, V737, P51; Kiljunen S, 2005, MICROBIOL-SGM, V151, P4093, DOI 10.1099/mic.0.28265-0; Klausa V., 2003, EKOLOGIJA VILNIUS, V1, P47; Kregten E. V., 1984, J CLIN MICROBIOL, V20, P936; Kropinski AM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-102; Kropinski AM, 2011, APPL ENVIRON MICROB, V77, P8265, DOI 10.1128/AEM.05562-11; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Kumari S, 2010, FOLIA MICROBIOL, V55, P221, DOI 10.1007/s12223-010-0032-7; Kumari S, 2010, J MICROBIOL BIOTECHN, V20, P935, DOI 10.4014/jmb.0909.09010; Kumari S, 2009, J MICROBIOL BIOTECHN, V19, P622, DOI 10.4014/jmb.0808.493; Kutter EM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-430; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; LLOYD RS, 1980, NUCLEIC ACIDS RES, V8, P5113, DOI 10.1093/nar/8.21.5113; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Monson R, 2011, MICROBIOL-SGM, V157, P859, DOI 10.1099/mic.0.044701-0; Nolan JM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-30; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Petrov VM, 2006, J MOL BIOL, V361, P46, DOI 10.1016/j.jmb.2006.05.071; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; QUAN S, 1993, PLASMID, V29, P74, DOI 10.1006/plas.1993.1010; Rao VB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-356; Sambrook J., 2001, MOL CLONING LAB MANU; Santos SB, 2011, J VIROL, V85, P11265, DOI 10.1128/JVI.01769-10; Semenaite R, 2000, BIOLOGIJA, V2, P329; Sikarwar Archana Singh, 2011, V9, P130; Simoliunas E, 2012, J VIROL, V86, P5406, DOI 10.1128/JVI.00347-12; Stanislauskiene R, 2012, FEMS MICROBIOL LETT, V327, P78, DOI 10.1111/j.1574-6968.2011.02462.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JA, 2010, MOL CELL PROTEOMICS, V9, P940, DOI 10.1074/mcp.M900488-MCP200; Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Wu LT, 2007, APPL ENVIRON MICROB, V73, P2532, DOI 10.1128/AEM.02113-06; Xu JF, 2010, J GEN APPL MICROBIOL, V56, P241, DOI 10.2323/jgam.56.241; Yamada T, 2010, VIROLOGY, V398, P135, DOI 10.1016/j.virol.2009.11.043	57	42	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60717	10.1371/journal.pone.0060717	http://dx.doi.org/10.1371/journal.pone.0060717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593293	gold, Green Published, Green Submitted			2022-12-27	WOS:000317909600040
J	Wang, R; Xu, S; Jiang, YM; Jiang, JW; Li, XD; Liang, LJ; He, J; Peng, F; Xia, B				Wang, Ren; Xu, Sheng; Jiang, Yumei; Jiang, Jingwei; Li, Xiaodan; Liang, Lijian; He, Jia; Peng, Feng; Xia, Bing			De novo Sequence Assembly and Characterization of Lycoris aurea Transcriptome Using GS FLX Titanium Platform of 454 Pyrosequencing	PLOS ONE			English	Article							MOLECULAR-CLONING; GENE DISCOVERY; PHENOL OXIDATION; JATROPHA-CURCAS; EST RESOURCE; CDNA LIBRARY; CELL-CYCLE; AMARYLLIDACEAE; BIOSYNTHESIS; RADIATA	Background: Lycoris aurea, also called Golden Magic Lily, is an ornamentally and medicinally important species of the Amaryllidaceae family. To date, the sequencing of its whole genome is unavailable as a non-model organism. Transcriptomic information is also scarce for this species. In this study, we performed de novo transcriptome sequencing to produce the first comprehensive expressed sequence tag (EST) dataset for L. aurea using high-throughput sequencing technology. Methodology and Principal Findings: Total RNA was isolated from leaves with sodium nitroprusside (SNP), salicylic acid (SA), or methyl jasmonate (MeJA) treatment, stems, and flowers at the bud, blooming, and wilting stages. Equal quantities of RNA from each tissue and stage were pooled to construct a cDNA library. Using 454 pyrosequencing technology, a total of 937,990 high quality reads (308.63 Mb) with an average read length of 329 bp were generated. Clustering and assembly of these reads produced a non-redundant set of 141,111 unique sequences, comprising 24,604 contigs and 116,507 singletons. All of the unique sequences were involved in the biological process, cellular component and molecular function categories by GO analysis. Potential genes and their functions were predicted by KEGG pathway mapping and COG analysis. Based on our sequence analysis and published literatures, many putative genes involved in Amaryllidaceae alkaloids synthesis, including PAL, TYDC OMT, NMT, P450, and other potentially important candidate genes, were identified for the first time in this Lycoris. Furthermore, 6,386 SSRs and 18,107 high-confidence SNPs were identified in this EST dataset. Conclusions: The transcriptome provides an invaluable new data for a functional genomics resource and future biological research in L. aurea. The molecular markers identified in this study will provide a material basis for future genetic linkage and quantitative trait loci analyses, and will provide useful information for functional genomic research in future.	[Wang, Ren; Xu, Sheng; Jiang, Yumei; Li, Xiaodan; Liang, Lijian; He, Jia; Peng, Feng; Xia, Bing] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing, Jiangsu, Peoples R China; [Jiang, Jingwei] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, R (corresponding author), Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing, Jiangsu, Peoples R China.	jswangren@yahoo.com.cn; xiabingnbg@sina.com			National Natural Science Foundation of China [31270339]; National "863" program [2011AA10A206]; Jiangsu Agricultural Science and Technology Independent Innovation Fund [CX (11)1016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "863" program(National High Technology Research and Development Program of China); Jiangsu Agricultural Science and Technology Independent Innovation Fund	This research was supported by the National Natural Science Foundation of China (Grant No. 31270339), the National "863" program (Grant No. 2011AA10A206), and the Jiangsu Agricultural Science and Technology Independent Innovation Fund (No.CX (11)1016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BARTON DHR, 1962, J CHEM SOC, P806, DOI 10.1039/jr9620000806; BARTON DHR, 1963, J CHEM SOC, P4545, DOI 10.1039/jr9630004545; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Bores GM, 1996, J PHARMACOL EXP THER, V277, P728; BOSE S, 1963, NATURE, V197, P1229, DOI 10.1038/1971229b0; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Chen L, 2005, PLANT SCI, V168, P359, DOI 10.1016/j.plantsci.2004.08.009; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Cheung F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-542; Colque R, 2004, PLANTA MED, V70, P1180, DOI 10.1055/s-2004-835849; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Eichhorn J, 1998, PHYTOCHEMISTRY, V49, P1037, DOI 10.1016/S0031-9422(97)01024-8; Fan CA, 2004, ORG LETT, V6, P4691, DOI 10.1021/ol048105k; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Gonzalez-Ibeas D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-306; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; HARVEY AL, 1995, PHARMACOL THERAPEUT, V68, P113, DOI 10.1016/0163-7258(95)02002-0; HAZAMA N, 1968, J CHEM SOC C, P2947, DOI 10.1039/j39680002947; He QL, 2010, GENOMICS, V96, P119, DOI 10.1016/j.ygeno.2010.04.002; He QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022098; Herbert RB, 2001, NAT PROD REP, V18, P50, DOI 10.1039/a809393h; Hori TA, 2006, GENES GENET SYST, V81, P243, DOI 10.1266/ggs.81.243; Howes MJR, 2003, PHARMACOL BIOCHEM BE, V75, P513, DOI 10.1016/S0091-3057(03)00128-X; Hsu B.S., 1994, SIDA, V16, P301; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Jiang YM, 2011, MOL BIOL REP, V38, P1935, DOI 10.1007/s11033-010-0314-9; Jin Z, 2003, NAT PROD REP, V20, P606, DOI 10.1039/b304144c; Jin Z, 2007, NAT PROD REP, V24, P886, DOI 10.1039/b502163b; Jin Z, 2009, NAT PROD REP, V26, P363, DOI 10.1039/b718044f; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kita Y, 1998, J ORG CHEM, V63, P6625, DOI 10.1021/jo9807868; Kong Q, 2006, MOL ECOL NOTES, V6, P1234, DOI 10.1111/j.1471-8286.2006.01500.x; Kornienko A, 2008, CHEM REV, V108, P1982, DOI 10.1021/cr078198u; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; KURITA S, 1987, CYTOLOGIA, V52, P137, DOI 10.1508/cytologia.52.137; Li SY, 2005, ANTIVIR RES, V67, P18, DOI 10.1016/j.antiviral.2005.02.007; Li XG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-41; Li Y, 2007, ONCOL REP, V17, P377; Liao N, 2012, MOLECULES, V17, P3723, DOI 10.3390/molecules17043723; Liu J, 2004, FEBS LETT, V578, P245, DOI 10.1016/j.febslet.2004.10.095; Liu XS, 2009, CANCER LETT, V274, P16, DOI 10.1016/j.canlet.2008.08.029; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARTIN SF, 1982, J ORG CHEM, V47, P1513, DOI 10.1021/jo00347a029; Meng P, 2008, HORTSCIENCE, V43, P134, DOI 10.21273/HORTSCI.43.1.134; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MISAKA Y, 1968, J CHEM SOC C, P2954, DOI 10.1039/j39680002954; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Mu HM, 2009, Z NATURFORSCH C, V64, P541; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Natarajan P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-606; Nelson D. R., 2008, Tropical Plant Biology, V1, P216, DOI 10.1007/s12042-008-9022-1; Novikova IY., 2002, PHARM CHEM J+, V36, P623, DOI [10.1023/A:1022677601680, DOI 10.1023/A:1022677601680]; Ogawa T, 2005, BREEDING SCI, V55, P265, DOI 10.1270/jsbbs.55.265; Olin J.T., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001747; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; PARKER KA, 1992, J ORG CHEM, V57, P752, DOI 10.1021/jo00028a066; Ptak A, 2010, PLANT CELL TISS ORG, V102, P61, DOI 10.1007/s11240-010-9706-8; Quan MiaoHua, 2012, African Journal of Biotechnology, V11, P3686; Raju NL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-45; SANCHEZ IH, 1984, J ORG CHEM, V49, P157, DOI 10.1021/jo00175a033; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; SCHULTZ AG, 1977, J AM CHEM SOC, V99, P8065, DOI 10.1021/ja00466a057; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi SD, 2006, BIOCHEM GENET, V44, P198, DOI 10.1007/s10528-006-9023-4; Son M, 2010, ONCOL REP, V24, P473, DOI 10.3892/or_00000881; Srivastava A, 2011, DNA RES, V18, P253, DOI 10.1093/dnares/dsr014; Sterky F, 2004, P NATL ACAD SCI USA, V101, P13951, DOI 10.1073/pnas.0401641101; SUHADOLNIK RJ, 1963, BIOCHEM BIOPH RES CO, V11, P208, DOI 10.1016/0006-291X(63)90335-8; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XC, 2012, MOL BIOL REP, V39, P6825, DOI 10.1007/s11033-012-1507-1; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; WIGHTMAN RH, 1972, J CHEM SOC PERK T 1, P2355, DOI 10.1039/p19720002355; Xuan SQ, 2011, GENET MOL RES, V10, P3141, DOI 10.4238/2011.December.19.2; Yamada-Akiyama H, 2009, J PLANT PHYSIOL, V166, P750, DOI 10.1016/j.jplph.2008.10.001; Yang Y, 2005, HELV CHIM ACTA, V88, P2550, DOI 10.1002/hlca.200590193; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhou SB, 2007, ACTA PHYTOTAXON SIN, V45, P513, DOI 10.1360/aps050108	91	38	55	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60449	10.1371/journal.pone.0060449	http://dx.doi.org/10.1371/journal.pone.0060449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593220	Green Published, gold, Green Submitted			2022-12-27	WOS:000317909600023
J	Cheng, BK; Cao, SG; Vasquez, V; Annamalai, T; Tamayo-Castillo, G; Clardy, J; Tse-Dinh, YC				Cheng, Bokun; Cao, Shugeng; Vasquez, Victor; Annamalai, Thirunavukkarasu; Tamayo-Castillo, Giselle; Clardy, Jon; Tse-Dinh, Yuk-Ching			Identification of Anziaic Acid, a Lichen Depside from Hypotrachyna sp., as a New Topoisomerase Poison Inhibitor	PLOS ONE			English	Article							DNA TOPOISOMERASE; ACTIVE-SITE; CLEAVAGE; TARGETS	Topoisomerase inhibitors are effective for antibacterial and anticancer therapy because they can lead to the accumulation of the intermediate DNA cleavage complex formed by the topoisomerase enzymes, which trigger cell death. Here we report the application of a novel enzyme-based high-throughput screening assay to identify natural product extracts that can lead to increased accumulation of the DNA cleavage complex formed by recombinant Yersinia pestis topoisomerase I as part of a larger effort to identify new antibacterial compounds. Further characterization and fractionation of the screening positives from the primary assay led to the discovery of a depside, anziaic acid, from the lichen Hypotrachyna sp. as an inhibitor for both Y. pestis and Escherichia coli topoisomerase I. In in vitro assays, anziaic acid exhibits antibacterial activity against Bacillus subtilis and a membrane permeable strain of E. coli. Anziaic acid was also found to act as an inhibitor of human topoisomerase II but had little effect on human topoisomerase I. This is the first report of a depside with activity as a topoisomerase poison inhibitor and demonstrates the potential of this class of natural products as a source for new antibacterial and anticancer compounds.	[Cheng, Bokun; Annamalai, Thirunavukkarasu; Tse-Dinh, Yuk-Ching] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Cao, Shugeng; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Vasquez, Victor; Tamayo-Castillo, Giselle] Univ Costa Rica, Inst Nacl Biodiversidad INBio, Unidad Estrateg Bioprospecc, San Jose, Costa Rica; [Vasquez, Victor; Tamayo-Castillo, Giselle] Univ Costa Rica, Escuela Quim, San Jose, Costa Rica; [Annamalai, Thirunavukkarasu; Tse-Dinh, Yuk-Ching] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA	New York Medical College; Harvard University; Harvard Medical School; Universidad Costa Rica; Universidad Costa Rica; State University System of Florida; Florida International University	Tse-Dinh, YC (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	ytsedinh@fiu.edu	Tamayo, Giselle/J-3609-2015	Tamayo, Giselle/0000-0002-4912-8895	NIH [R21 NS067592, R01 AI069313, U01 TW007404, AI057159]; FOGARTY INTERNATIONAL CENTER [U01TW007404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069313, U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH grants R21 NS067592 and R01 AI069313 to YT, and U01 TW007404 and AI057159 to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AC, 2012, NAT PROD REP, V29, P1007, DOI 10.1039/c2np20035j; Anderson VE, 2001, CURR PHARM DESIGN, V7, P337, DOI 10.2174/1381612013398013; Annamalai T, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-18; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bansal S, 2012, J ANTIMICROB CHEMOTH, V67, P2882, DOI 10.1093/jac/dks322; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; Bhat AG, 2009, J MOL BIOL, V393, P788, DOI 10.1016/j.jmb.2009.08.064; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Cao SG, 2010, ORG LETT, V12, P4661, DOI 10.1021/ol101972g; Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11; Chatzopoulou A, 2010, J AGR FOOD CHEM, V58, P6064, DOI 10.1021/jf904596m; Cheng B, 2005, J BIOL CHEM, V280, P38489, DOI 10.1074/jbc.M509722200; Cheng B, 2008, NUCLEIC ACIDS RES, V36, P1017, DOI 10.1093/nar/gkm1126; Cheng BK, 2009, J MOL BIOL, V385, P558, DOI 10.1016/j.jmb.2008.10.073; Coan KED, 2009, J MED CHEM, V52, P2067, DOI 10.1021/jm801605r; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; ELIX JA, 1974, AUST J CHEM, V27, P1767, DOI 10.1071/CH9741767; Evering TH, 2007, DRUG TODAY, V43, P865, DOI 10.1358/dot.2007.43.12.1146063; Liu IF, 2009, J BACTERIOL, V191, P5315, DOI 10.1128/JB.00559-09; Narula G, 2011, J BIOL CHEM, V286, P18673, DOI 10.1074/jbc.M111.229450; Podterob P., 2008, PHARM, V42, P582, DOI [DOI 10.1007/S11094-009-0183-5, 10.1007/s11094-009-0183-5]; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; RUNDEL PW, 1978, BIOCHEM SYST ECOL, V6, P157, DOI 10.1016/0305-1978(78)90002-9; SAMPSON BA, 1989, GENETICS, V122, P491; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Sorokin EP, 2008, NUCL ACIDS RES; Tse-Dinh YC, 2009, NUCLEIC ACIDS RES, V37, P731, DOI 10.1093/nar/gkn936; TSEDINH YC, 1986, J BIOL CHEM, V261, P931; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	32	28	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60770	10.1371/journal.pone.0060770	http://dx.doi.org/10.1371/journal.pone.0060770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593306	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000064
J	Cocco, E; Murru, R; Costa, G; Kumar, A; Pieroni, E; Melis, C; Barberini, L; Sardu, C; Lorefice, L; Fenu, G; Frau, J; Coghe, G; Carboni, N; Marrosu, MG				Cocco, Eleonora; Murru, Raffaele; Costa, Gianna; Kumar, Amit; Pieroni, Enrico; Melis, Cristina; Barberini, Luigi; Sardu, Claudia; Lorefice, Lorena; Fenu, Giuseppe; Frau, Jessica; Coghe, Giancarlo; Carboni, Nicola; Marrosu, Maria Giovanna			Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population	PLOS ONE			English	Article							HLA-DR ALLELES; DIAGNOSTIC-CRITERIA; MHC HAPLOTYPES; SUSCEPTIBILITY; ASSOCIATION; DISEASE; RISK; CATEGORIZATION; RESISTANCE; MOLECULE	We performed a case-control study in 2,555 multiple sclerosis (MS) Sardinian patients and 1,365 healthy ethnically matched controls, analyzing the interactions between HLA-DRB1-DQB1 haplotypes and defining a rank of genotypes conferring a variable degree of risk to the disease. Four haplotypes were found to confer susceptibility (*13:03-*03:01 OR = 3.3, Pc 5.1x10(-5), *04:05-*03:01 OR = 2.1, Pc 9.7x10(-8), *15:01-*06:02 OR = 2.0, Pc = 9.1x10(-3), *03:01-*02:01 OR = 1.7 Pc = 7.9x10(-22)) and protection (*11, OR = 0.8, Pc = 2.7x10(-2), *16:01-*05:02 OR = 0.6, Pc = 4.8x10(-16), *14:01-4-*05:031 = OR = 0.5, Pc = 9.8x10(-4) and *15:02-*06:01 OR = 0.4, Pc = 5.1x10(-4)). The relative predispositional effect method confirms all the positively associated haplotypes and showed that also *08 and *04 haplotypes confers susceptibility, while the *11 was excluded as protective haplotype. Genotypic ORs highlighted two typologies of interaction between haplotypes: i) a neutral interaction, in which the global risk is coherent with the sum of the single haplotype risks; ii) a negative interaction, in which the genotypic OR observed is lower than the sum of the OR of the two haplotypes. The phylogenic tree of the MS-associated DRB1 alleles found in Sardinian patients revealed a cluster represented by *14:01, *04:05, *13:03, *08:01 and *03:01 alleles. Sequence alignment analysis showed that amino acids near pocket P4 and pocket P9 differentiated protective from predisposing alleles under investigation. Furthermore, molecular dynamics simulation performed on alleles revealed that position 70 is crucial in binding of MBP 85-99 peptide. All together, these data suggest that propensity to MS observed in Sardinian population carried by the various HLA-DRB1-DQB1 molecules can be due to functional peculiarity in the antigen presentation mechanisms.	[Cocco, Eleonora; Murru, Raffaele; Costa, Gianna; Kumar, Amit; Melis, Cristina; Barberini, Luigi; Sardu, Claudia; Lorefice, Lorena; Fenu, Giuseppe; Frau, Jessica; Coghe, Giancarlo; Carboni, Nicola; Marrosu, Maria Giovanna] Univ Cagliari, Dept Publ Hlth & Clin & Mol Med, Multiple Sclerosis Ctr, Cagliari, Italy; [Kumar, Amit; Pieroni, Enrico] CRS4 Sci & Technol Pk Polaris Piscina Manna, Pula, CA, Italy	University of Cagliari	Marrosu, MG (corresponding author), Univ Cagliari, Dept Publ Hlth & Clin & Mol Med, Multiple Sclerosis Ctr, Cagliari, Italy.	gmarrosu@unica.it	Barberini, Luigi/G-3669-2012; Frau, Jessica/AAC-1622-2019; Kumar, Amit/F-5259-2012; Cocco, Eleonora/G-5064-2012; Barberini, Luigi/Q-5870-2019; Kumar, Amit/F-5259-2012	Barberini, Luigi/0000-0002-3815-0392; Kumar, Amit/0000-0002-2547-0071; Cocco, Eleonora/0000-0002-3878-8820; Barberini, Luigi/0000-0002-3815-0392; Kumar, Amit/0000-0003-1589-6391; Valentini, Maria/0000-0002-4288-8621; pieroni, enrico/0000-0002-4246-6963; Marrosu, Maria Giovanna/0000-0003-2334-2081; Fenu, Giuseppe/0000-0003-0198-0488; MURRU, RAFFAELE/0000-0001-8830-5084; Lorefice, Lorena/0000-0003-2050-2908	Ministero dell'Istruzione, dell'Universita e della Ricerca (call: PRIN)	Ministero dell'Istruzione, dell'Universita e della Ricerca (call: PRIN)	This work was supported by grant project by a grant by "Ministero dell'Istruzione, dell'Universita e della Ricerca" (call: PRIN 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004164; Ballerini C, 2004, J NEUROIMMUNOL, V150, P178, DOI 10.1016/j.jneuroim.2004.01.015; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Brassat D, 2005, NEUROLOGY, V64, P361, DOI 10.1212/01.WNL.0000149765.71212.0A; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Chao MJ, 2007, HUM MOL GENET, V16, P1951, DOI 10.1093/hmg/ddm142; Cocco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033972; Cocco E, 2011, MULT SCLER J, V17, P1282, DOI 10.1177/1352458511408754; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cossu D, 2012, MULT SCLER J, V18, P1181, DOI 10.1177/1352458511433430; Cossu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018482; Dean G, 2008, NEUROLOGY, V70, P101, DOI 10.1212/01.wnl.0000284598.98525.d7; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FU XT, 1995, J EXP MED, V181, P915, DOI 10.1084/jem.181.3.915; Gibert M, 2003, HUM IMMUNOL, V64, P930, DOI 10.1016/S0198-8859(03)00186-1; Greer JM, 2005, J NEUROL NEUROSUR PS, V76, P656, DOI 10.1136/jnnp.2004.042168; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; KW Wuncherpfenning, 1995, CELL, V80, P695; Kwon OJ, 1999, ARCH NEUROL-CHICAGO, V56, P555, DOI 10.1001/archneur.56.5.555; Lampis R, 2000, TISSUE ANTIGENS, V56, P515, DOI 10.1034/j.1399-0039.2000.560605.x; Lampis R, 2000, HUM MOL GENET, V9, P2959, DOI 10.1093/hmg/9.20.2959; Link J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036779; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Ou DW, 1998, HUM IMMUNOL, V59, P665, DOI 10.1016/S0198-8859(98)00067-6; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Zipp F, 2000, HUM IMMUNOL, V61, P1021, DOI 10.1016/S0198-8859(00)00173-7	37	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59790	10.1371/journal.pone.0059790	http://dx.doi.org/10.1371/journal.pone.0059790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593151	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000015
J	Song, JS; Hwang, DH; Kim, SO; Jeon, M; Choi, BJ; Jung, HS; Moon, SJ; Park, W; Choi, HJ				Song, Je Seon; Hwang, Dong Hwan; Kim, Seong-Oh; Jeon, Mijeong; Choi, Byung-Jai; Jung, Han-Sung; Moon, Seok Jun; Park, Wonse; Choi, Hyung-Jun			Comparative Gene Expression Analysis of the Human Periodontal Ligament in Deciduous and Permanent Teeth	PLOS ONE			English	Article							ROOT-RESORPTION; IMMUNOHISTOCHEMICAL LOCALIZATION; MUCOPOLYSACCHARIDASE ACTIVITY; PROINFLAMMATORY CYTOKINE; RECEPTOR ACTIVATOR; DENDRITIC CELLS; TOOTH MOVEMENT; MATRIX PROTEIN; MESSENGER-RNA; SMOOTH-MUSCLE	There are histological and functional differences between human deciduous and permanent periodontal ligament (PDL) tissues. The aim of this study was to determine the differences between these two types of tissue at the molecular level by comparing their gene expression patterns. PDL samples were obtained from permanent premolars (n = 38) and anterior deciduous teeth (n = 31) extracted from 40 healthy persons. Comparative cDNA microarray analysis revealed several differences in gene expression between the deciduous and permanent PDL tissues. These findings were verified by qRT-PCR (quantitative reverse-transcription-polymerase chain reaction) analysis, and the areas where genes are expressed were revealed by immunohistochemical staining. The expressions of 21 genes were up-regulated in deciduous relative to PDL tissues, and those of 30 genes were up-regulated in permanent relative to deciduous PDL tissues. The genes that were up-regulated in deciduous PDL tissues were those involved in the formation of the extracellular matrix (LAMC2, LAMB3, and COMP), tissue development (IGF2BP, MAB21L2, and PAX3), and inflammatory or immune reactions leading to tissue degradation (IL1A, CCL21, and CCL18). The up-regulated genes in permanent PDL tissues were related to tissue degradation (IL6 and ADAMTS18), myocontraction (PDE3B, CASQ2, and MYH10), and neurological responses (FOS, NCAM2, SYT1, SLC22A3, DOCK3, LRRTM1, LRRTM3, PRSS12, and ARPP21). The analysis of differential gene expressions between deciduous and permanent PDL tissues aids our understanding of histological and functional differences between them at the molecular level.	[Song, Je Seon; Hwang, Dong Hwan; Kim, Seong-Oh; Choi, Byung-Jai; Choi, Hyung-Jun] Yonsei Univ, Dept Pediat Dent, Coll Dent, Seoul 120749, South Korea; [Song, Je Seon; Kim, Seong-Oh; Jeon, Mijeong; Choi, Byung-Jai; Choi, Hyung-Jun] Yonsei Univ, Oral Sci Res Ctr, Coll Dent, Seoul 120749, South Korea; [Jung, Han-Sung] Yonsei Univ, Div Anat & Dev Biol, Coll Dent, Dept Oral Biol, Seoul 120749, South Korea; [Moon, Seok Jun] Yonsei Univ, Div Pharmacol, Coll Dent, Dept Oral Biol, Seoul 120749, South Korea; [Park, Wonse] Yonsei Univ, Dept Gen Dent, Coll Dent, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, HJ (corresponding author), Yonsei Univ, Dept Pediat Dent, Coll Dent, Seoul 120749, South Korea.	CHOIHJ88@yuhs.ac	Jung, Han-Sung/I-3848-2012	Kim, Seong Oh/0000-0002-8620-1377; Song, Je Seon/0000-0001-8620-5629; Moon, Seok Jun/0000-0001-7282-2888; Jung, Han-Sung/0000-0003-2795-531X; Park, Wonse/0000-0002-2081-1156; Choi, Hyung-Jun/0000-0002-3315-6912	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0022160, 2012R1A1A2041910]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0022160 and 2012R1A1A2041910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER S A, 1980, Pediatric Dentistry, V2, P287; ALEXANDER SA, 1980, J DENT RES, V59, P766, DOI 10.1177/00220345800590050301; ALEXANDER SA, 1979, ARCH ORAL BIOL, V24, P735, DOI 10.1016/0003-9969(79)90032-3; Alvarez-Perez MA, 2006, BONE, V38, P409, DOI 10.1016/j.bone.2005.09.009; Bosshardt DD, 2005, CELL TISSUE RES, V320, P399, DOI 10.1007/s00441-005-1106-8; Cravens PD, 2007, SCAND J IMMUNOL, V65, P514, DOI 10.1111/j.1365-3083.2007.01933.x; Davies KR, 2001, AM J ORTHOD DENTOFAC, V120, P339, DOI 10.1067/mod.2001.116067; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukushima H, 2003, EUR J ORAL SCI, V111, P346, DOI 10.1034/j.1600-0722.2003.00051.x; Fukushima H, 2005, BONE, V36, P267, DOI 10.1016/j.bone.2004.09.011; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Harokopakis-Hajishengallis Evlambia, 2007, J Oral Sci, V49, P1, DOI 10.2334/josnusd.49.1; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; ITOH K, 1976, ARCH HISTOL JAPON, V39, P379, DOI 10.1679/aohc1950.39.379; JOHNSEN D, 1978, ARCH ORAL BIOL, V23, P825, DOI 10.1016/0003-9969(78)90163-2; JOHNSEN DC, 1985, J DENT RES, V64, P555, DOI 10.1177/002203458506400410; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; Kanzaki H, 2001, J DENT RES, V80, P887, DOI 10.1177/00220345010800030801; KARIMBUX NY, 1995, J DENT RES, V74, P313, DOI 10.1177/00220345950740010501; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Kim KM, 2012, ARCH ORAL BIOL, V57, P1100, DOI 10.1016/j.archoralbio.2012.02.019; Kim SH, 2011, J PERIODONTAL IMPLAN, V41, P192, DOI 10.5051/jpis.2011.41.4.192; Kulahin N, 2010, ADV EXP MED BIOL, V663, P403, DOI 10.1007/978-1-4419-1170-4_25; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Lee A, 2004, AM J ORTHOD DENTOFAC, V126, P173, DOI 10.1016/j.ajodo.2004.02.009; Lee SH, 2002, J BIOCHEM, V131, P161, DOI 10.1093/oxfordjournals.jbchem.a003071; Lee YH, 2007, J PERIODONTOL, V78, P446, DOI 10.1902/jop.2007.060240; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Linsuwanont B, 2002, BONE, V31, P472, DOI 10.1016/S8756-3282(02)00856-6; Lossdorfer S, 2002, CALCIFIED TISSUE INT, V71, P45, DOI 10.1007/s00223-001-2086-7; LUKINMAA PL, 1992, J DENT RES, V71, P391, DOI 10.1177/00220345920710020801; MacNeil RL, 1998, ARCH ORAL BIOL, V43, P779, DOI 10.1016/S0003-9969(98)00054-5; Mariani M, 1999, HUM MOL GENET, V8, P2397, DOI 10.1093/hmg/8.13.2397; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Mimata Y, 2012, INT J RHEUM DIS, V15, P36, DOI 10.1111/j.1756-185X.2011.01656.x; Mitsui S, 2007, BRAIN RES, V1136, P1, DOI 10.1016/j.brainres.2006.11.094; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mooney JJ, 2008, J PSYCHIATR RES, V42, P605, DOI 10.1016/j.jpsychires.2007.07.009; MOTRO B, 1990, P NATL ACAD SCI USA, V87, P3092, DOI 10.1073/pnas.87.8.3092; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857; OUIMET CC, 1989, J NEUROSCI, V9, P865; PARKER KP, 1989, J IMMUNOL, V142, P537; PAULSSON M, 1981, BIOCHEM J, V197, P367, DOI 10.1042/bj1970367; Pertea M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-206; Polson JB, 1996, ANNU REV PHARMACOL, V36, P403, DOI 10.1146/annurev.pa.36.040196.002155; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Ranly DM, 2000, J DENT, V28, P153, DOI 10.1016/S0300-5712(99)00065-2; RAPP R, 1967, ANAT REC, V159, P89, DOI 10.1002/ar.1091590113; ROMERO R, 1989, PROSTAGLANDINS, V37, P13, DOI 10.1016/0090-6980(89)90028-2; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schraufstatter I, 2004, AM J PHYSIOL-LUNG C, V286, pL494, DOI 10.1152/ajplung.00323.2002; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi J, 2004, INFLAMM RES, V53, P377, DOI 10.1007/s00011-004-1271-3; Sone S, 2005, J MOL HISTOL, V36, P281, DOI 10.1007/s10735-005-5534-2; Song JS, 2012, TISSUE ENG PT A, V18, P2040, DOI [10.1089/ten.tea.2011.0318, 10.1089/ten.TEA.2011.0318]; Suda N, 2008, ORTHOD CRANIOFAC RES, V11, P1, DOI 10.1111/j.1601-6343.2008.00397.x; Takahashi I, 2003, J DENT RES, V82, P646, DOI 10.1177/154405910308200815; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3; Tani-Ishii N, 1999, J DENT RES, V78, P1617, DOI 10.1177/00220345990780100601; Terentyev D, 2008, BIOPHYS J, V95, P2037, DOI 10.1529/biophysj.107.128249; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Winther M, 2012, INT J BIOCHEM CELL B, V44, P441, DOI 10.1016/j.biocel.2011.11.020; Wu DY, 1996, J BONE MINER RES, V11, P686; Wu YM, 1999, J DENT RES, V78, P681, DOI 10.1177/00220345990780020801; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; YAMAJI Y, 1995, INFECT IMMUN, V63, P3576, DOI 10.1128/IAI.63.9.3576-3581.1995; Yamamoto T, 2006, ORAL DIS, V12, P171, DOI 10.1111/j.1601-0825.2005.01179.x; Zhang DL, 2003, J PERIODONTAL RES, V38, P324, DOI 10.1034/j.1600-0765.2003.00410.x; Zhang Y, 2011, INT J DEV BIOL, V55, P953, DOI 10.1387/ijdb.113348yz	76	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61231	10.1371/journal.pone.0061231	http://dx.doi.org/10.1371/journal.pone.0061231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593441	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000116
J	Irigoyen, AJ; Galvan, DE; Venerus, LA; Parma, AM				Irigoyen, Alejo J.; Galvan, David E.; Venerus, Leonardo A.; Parma, Ana M.			Variability in Abundance of Temperate Reef Fishes Estimated by Visual Census	PLOS ONE			English	Article							COUNTS; COMMUNITIES; ASSEMBLAGES; POPULATIONS; DENSITY	Identifying sources of sampling variation and quantifying their magnitude is critical to the interpretation of ecological field data. Yet, most monitoring programs of reef fish populations based on underwater visual censuses (UVC) consider only a few of the factors that may influence fish counts, such as the diver or census methodology. Recent studies, however, have drawn attention to a broader range of processes that introduce variability at different temporal scales. This study analyzes the magnitude of different sources of variation in UVCs of temperate reef fishes off Patagonia (Argentina). The variability associated with time-of-day, tidal state, and time elapsed between censuses (minutes, days, weeks and months) was quantified for censuses conducted on the five most conspicuous and common species: Pinguipes brasilianus, Pseudopercis semifasciata, Sebastes oculatus, Acanthistius patachonicus and Nemadactylus bergi. Variance components corresponding to spatial heterogeneity and to the different temporal scales were estimated using nested random models. The levels of variability estimated for the different species were related to their life history attributes and behavior. Neither time-of-day nor tidal state had a significant effect on counts, except for the influence of tide on P. brasilianus. Spatial heterogeneity was the dominant source of variance in all but one species. Among the temporal scales, the intra-annual variation was the highest component for most species due to marked seasonal fluctuations in abundance, followed by the weekly and the instantaneous variation; the daily component was not significant. The variability between censuses conducted at different tidal levels and time-of-day was similar in magnitude to the instantaneous variation, reinforcing the conclusion that stochastic variation at very short time scales is non-negligible and should be taken into account in the design of monitoring programs and experiments. The present study provides baseline information to design and interpret results from visual census programs in temperate reefs.	[Irigoyen, Alejo J.; Galvan, David E.; Venerus, Leonardo A.; Parma, Ana M.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Irigoyen, AJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina.	alejo@cenpat.edu.ar		Galvan, David/0000-0001-8132-6069	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Padifoundation, proyect [98]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Padifoundation, proyect	All authors are supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). Funding for field work: 1) Padifoundation (http://www.padifoundation.org/), year 2007, proyect No 98; 2) Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Bates D, 2012, LME4 LINEAR MIXED EF; Beaudreau AH, 2011, MAR BIOL, V158, P471, DOI 10.1007/s00227-010-1574-6; Beentjes MP, 2005, NEW ZEAL J MAR FRESH, V39, P77, DOI 10.1080/00288330.2005.9517293; Bibby C., 1993, BIRD CENSUS TECHNIQU; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Cappo M., 2007, CUTTINGEDGE TECHNOLO, V1, P101; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; DAVIS GE, 1989, B MAR SCI, V44, P1138; De Girolamo M, 2001, MAR ENVIRON RES, V51, P1, DOI 10.1016/S0141-1136(00)00028-3; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Ebeling A.W., 1991, P509; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Elphick CS, 2008, J APPL ECOL, V45, P1313, DOI 10.1111/j.1365-2664.2008.01545.x; Fletcher DJ, 2002, J EXP MAR BIOL ECOL, V273, P89, DOI 10.1016/S0022-0981(02)00142-9; Galvan David E., 2009, Open Fish Science Journal, V2, P90; Galvan DE, 2008, THESIS U NACL COMAHU; GALZIN R, 1987, MAR ECOL PROG SER, V41, P137, DOI 10.3354/meps041137; Irigoyen AJ, 2006, THESIS U NACL PATAGO; Irigoyen AJ, 2008, ZOOTAXA, P51, DOI 10.11646/zootaxa.1813.1.5; Katsanevakis S, 2012, AQUAT BIOL, V16, P31, DOI 10.3354/ab00426; KIMMEL JJ, 1985, ENVIRON BIOL FISH, V12, P23, DOI 10.1007/BF00007707; Kubecka J, 2012, FISH RES, V123, P1, DOI 10.1016/j.fishres.2011.11.013; Lok A, 2008, TURK J FISH AQUAT SC, V8, P79; MacNeill MA, 2008, MAR ECOL PROG SER, V367, P249, DOI 10.3354/meps07580; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Pinheiro J, NLME LINEAR NONLINEA, V3; Polunin N. V. C., 2009, DEV INDICATORS MPA E; R Development Core Team, 2007, R LANG ENV STAT COMP; ROBINSON DL, 1987, STATISTICIAN, V36, P3, DOI 10.2307/2988267; Santos MN, 2002, J MAR SCI, V59, P32; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Thompson AA, 2002, MAR ECOL PROG SER, V232, P247, DOI 10.3354/meps232247; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Venerus LA, 2008, FISHERIES MANAG ECOL, V15, P217, DOI 10.1111/j.1365-2400.2008.00603.x; Williams ID, 2006, MAR ECOL PROG SER, V310, P185, DOI 10.3354/meps310185; Willis TJ, 2006, J EXP MAR BIOL ECOL, V331, P108, DOI 10.1016/j.jembe.2005.10.003; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721; Zeller DC, 2002, CORAL REEFS, V21, P183, DOI 10.1007/s00338-002-0231-z	42	27	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61072	10.1371/journal.pone.0061072	http://dx.doi.org/10.1371/journal.pone.0061072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593395	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100073
J	Pazdro, R; Harrison, DE				Pazdro, Robert; Harrison, David E.			Murine Adipose Tissue-Derived Stromal Cell Apoptosis and Susceptibility to Oxidative Stress In Vitro Are Regulated by Genetic Background	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DIFFERENTIATION; BRAIN; INJURY; TRANSPLANTATION; CHONDROGENESIS; PROLIFERATION; FIBROBLASTS; GENERATION; CULTURE	Adipose tissue-derived stromal cells (ADSCs) are of interest for regenerative medicine as they are isolated easily and can differentiate into multiple cell lineages. Studies of their in vitro proliferation, survival, and differentiation are common; however, genetic effects on these phenotypes remain unknown. To test if these phenotypes are genetically regulated, ADSCs were isolated from three genetically diverse inbred mouse strains-C57BL/6J (B6), BALB/cByJ (BALB), and DBA/2J (D2)in which genetic regulation of hematopoietic stem function is well known. ADSCs from all three strains differentiated into osteogenic and chondrogenic lineages in vitro. ADSCs from BALB grew least well in vitro, probably due to apoptotic cell death after several days in culture. BALB ADSCs were also the most susceptible to the free radical inducers menadione and H2O2. ADSCs from the three possible F1 hybrids were employed to further define genetic regulation of ADSC phenotypes. D2, but not B6, alleles stimulated ADSC expansion in BALB cells. In contrast, B6, but not D2, alleles rescued BALB H2O2 resistance. We conclude that low oxidative stress resistance does not limit BALB ADSC growth in vitro, as these phenotypes are genetically regulated independently. In addition, ADSCs from these strains are an appropriate model system to investigate genetic regulation of ADSC apoptosis and stress resistance in future studies. Such investigations are essential to optimize cell expansion and differentiation and thus, potential for regenerative medicine.	[Pazdro, Robert; Harrison, David E.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Harrison, DE (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	david.harrison@jax.org			 [AG032333];  [CA034196];  [GM101723];  [DK07449]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM101723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038560, R01AG032333] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the following grants: AG032333, CA034196, DK07449, and GM101723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas A, 2012, METHODS MOL BIOL, V826, P61, DOI 10.1007/978-1-61779-468-1_6; Blasi A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-5; Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chandra V, 2009, STEM CELLS, V27, P1941, DOI 10.1002/stem.117; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; Fang B, 2007, TRANSPL P, V39, P3358, DOI 10.1016/j.transproceed.2007.08.103; George SK, 2011, AGING CELL, V10, P584, DOI 10.1111/j.1474-9726.2011.00686.x; Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Huang SC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-18; Kaewkhaw R, 2011, GLIA, V59, P734, DOI 10.1002/glia.21145; Kang HM, 2009, STEM CELLS, V27, P1999, DOI 10.1002/stem.127; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Leu S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-63; Lin GT, 2009, J SEX MED, V6, P320, DOI 10.1111/j.1743-6109.2008.01190.x; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Merceron C, 2010, AM J PHYSIOL-CELL PH, V298, pC355, DOI 10.1152/ajpcell.00398.2009; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ning HX, 2006, DIFFERENTIATION, V74, P510, DOI 10.1111/j.1432-0436.2006.00081.x; Oh IH, 2012, STEM CELLS, V30, P82, DOI 10.1002/stem.776; Park H, 2011, DIFFERENTIATION, V82, P136, DOI 10.1016/j.diff.2011.06.002; Simons BD, 2011, EXP CELL RES, V317, P2719, DOI 10.1016/j.yexcr.2011.07.010; Song JS, 2011, STEM CELLS DEV, V20, P1530, DOI 10.1089/scd.2010.0364; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Sun CK, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-118; Wei Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027064; Yang L, 2011, J INT MED RES, V39, P1344, DOI 10.1177/147323001103900421; Yao YG, 2007, HUM MOL GENET, V16, P286, DOI 10.1093/hmg/ddl457; Yu B, 2011, BIOCHEM BIOPH RES CO, V414, P412, DOI 10.1016/j.bbrc.2011.09.103; Yuan R, 2005, EXP HEMATOL, V33, P243, DOI 10.1016/j.exphem.2004.10.014; Zhang RP, 2011, J BIOL CHEM, V286, P41083, DOI 10.1074/jbc.M111.258715; Zhang SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029706	42	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61235	10.1371/journal.pone.0061235	http://dx.doi.org/10.1371/journal.pone.0061235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593442	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100081
J	Gerphagnon, M; Latour, D; Colombet, J; Sime-Ngando, T				Gerphagnon, Melanie; Latour, Delphine; Colombet, Jonathan; Sime-Ngando, Telesphore			Fungal Parasitism: Life Cycle, Dynamics and Impact on Cyanobacterial Blooms	PLOS ONE			English	Article							DIATOM ASTERIONELLA; BATRACHOCHYTRIUM-DENDROBATIDIS; ZYGORHIZIDIUM-PLANKTONICUM; TOXIC CYANOBACTERIUM; GENETIC-VARIATION; 2 CHYTRIDS; HOST; GROWTH; PHYTOPLANKTON; COEVOLUTION	Many species of phytoplankton are susceptible to parasitism by fungi from the phylum Chytridiomycota (i.e. chytrids). However, few studies have reported the effects of fungal parasites on filamentous cyanobacterial blooms. To investigate the missing components of bloom ecosystems, we examined an entire field bloom of the cyanobacterium Anabaena macrospora for evidence of chytrid infection in a productive freshwater lake, using a high resolution sampling strategy. A. macrospora was infected by two species of the genus Rhizosiphon which have similar life cycles but differed in their infective regimes depending on the cellular niches offered by their host. R. crassum infected both vegetative cells and akinetes while R. akinetum infected only akinetes. A tentative reconstruction of the developmental stages suggested that the life cycle of R. crassum was completed in about 3 days. The infection affected 6% of total cells (and 4% of akinetes), spread over a maximum of 17% of the filaments of cyanobacteria, in which 60% of the cells could be parasitized. Furthermore, chytrids may reduce the length of filaments of Anabaena macrospora significantly by "mechanistic fragmentation'' following infection. All these results suggest that chytrid parasitism is one of the driving factors involved in the decline of a cyanobacteria blooms, by direct mortality of parasitized cells and indirectly by the mechanistic fragmentation, which could weaken the resistance of A. macrospora to grazing.	[Gerphagnon, Melanie; Latour, Delphine; Colombet, Jonathan; Sime-Ngando, Telesphore] Univ Blaise Pascal, Clermont Univ, UMR CNRS 6023, LMGE, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Latour, D (corresponding author), Univ Blaise Pascal, Clermont Univ, UMR CNRS 6023, LMGE, BP 80026, Aubiere, France.	Delphine.latour@univ-bpclermont.fr	Sime-Ngando, Télesphore/M-4134-2019	Sime-Ngando, Télesphore/0000-0002-7240-5803	French ANR Programme Blanc 'DREP: Diversite et Roles des Eumycetes dans le Pelagos'; French Ministere de la Recherche et de la Technologie	French ANR Programme Blanc 'DREP: Diversite et Roles des Eumycetes dans le Pelagos'(French National Research Agency (ANR)); French Ministere de la Recherche et de la Technologie	This study was supported by a grant from the French ANR Programme Blanc 'DREP: Diversite et Roles des Eumycetes dans le Pelagos'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MG was supported by a PhD Fellowship from the French Ministere de la Recherche et de la Technologie.	Alster A, 2007, HYDROBIOLOGIA, V578, P131, DOI 10.1007/s10750-006-0439-y; Baker AC, 2006, APPL ENVIRON MICROB, V72, P5713, DOI 10.1128/AEM.00270-06; Baker PD, 2000, HYDROBIOLOGIA, V427, P65, DOI 10.1023/A:1003988426561; BEAKES GW, 1988, CAN J BOT, V66, P1054, DOI 10.1139/b88-151; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Bourrelly P, 1966, ALGUES EAU DOUCE; BRUNING K, 1991, J PLANKTON RES, V13, P103, DOI 10.1093/plankt/13.1.103; BRUNING K, 1987, Hydrobiological Bulletin, V21, P49, DOI 10.1007/BF02255454; Burford MA, 2011, CHIN J OCEANOL LIMN, V29, P883, DOI 10.1007/s00343-011-0517-5; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Canter H. M., 1954, T BRIT MYCOLOGICAL S, V37, pIN112; Canter H. M., 1972, TAXONOMY BIOL BLUE G, P145; CANTER HILDA M., 1954, TRANS BRIT MYCOL SOC, V37, P111; CANTER HM, 1951, ANN BOT-LONDON, V15, P129; Canter HM, 1979, NEW PHYTOL, P187; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; De Bruin A, 2008, J EUKARYOT MICROBIOL, V55, P69, DOI 10.1111/j.1550-7408.2008.00306.x; De Nobel WT, 1998, NEW PHYTOL, V138, P579, DOI 10.1046/j.1469-8137.1998.00155.x; DeMott WR, 2001, LIMNOL OCEANOGR, V46, P2054, DOI 10.4319/lo.2001.46.8.2054; Downing JA, 2001, CAN J FISH AQUAT SCI, V58, P1905, DOI 10.1139/cjfas-58-10-1905; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Fuller MS, 1986, CENTURY MYCOLOGY, P161; Geitler L, 1932, CYANOPHYCEAE; Gleason FH, 2009, FUNGAL ECOL, V2, P53, DOI 10.1016/j.funeco.2008.12.002; Gleason Frank H., 2008, Fungal Biology Reviews, V22, P17, DOI 10.1016/j.fbr.2008.02.001; GLIWICZ ZM, 1990, HYDROBIOLOGIA, V200, P83, DOI 10.1007/BF02530331; Grami B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023273; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HENNES KP, 1995, APPL ENVIRON MICROB, V61, P3623, DOI 10.1128/AEM.61.10.3623-3627.1995; HENTER HJ, 1995, EVOLUTION, V49, P427, DOI [10.1111/j.1558-5646.1995.tb02275.x, 10.2307/2410267]; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Holfeld H, 1998, NEW PHYTOL, V138, P507, DOI 10.1046/j.1469-8137.1998.00126.x; Honjo M, 2006, J PLANKTON RES, V28, P407, DOI 10.1093/plankt/fbi128; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Jobard M, 2010, J MICROBIOL METH, V83, P236, DOI 10.1016/j.mimet.2010.09.006; Jobard M, 2010, AQUAT SCI, V72, P255, DOI 10.1007/s00027-010-0133-z; Kagami M, 2002, INT VER THEOR ANGEW, V28, P1001; Kagami M, 2011, MICROB ECOL, P1; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2007, P R SOC B, V274, P1561, DOI 10.1098/rspb.2007.0425; KUDOH S, 1992, ARCH HYDROBIOL, V124, P293; LAMPERT W, 1987, NEW ZEAL J MAR FRESH, V21, P483, DOI 10.1080/00288330.1987.9516244; Lefevre E, 2010, J MICROBIOL METH, V81, P69, DOI 10.1016/j.mimet.2010.02.002; Masclaux H, 2011, LIMNOL OCEANOGR, V56, P939, DOI 10.4319/lo.2011.56.3.0939; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pollard PC, 2010, ACTA OECOL, V36, P114, DOI 10.1016/j.actao.2009.10.007; POWELL MJ, 1994, PROTOPLASMA, V181, P123, DOI 10.1007/BF01666392; Rasconi S, 2012, ENVIRON MICROBIOL, V14, P2151, DOI 10.1111/j.1462-2920.2011.02690.x; Rasconi S, 2009, APPL ENVIRON MICROB, V75, P2545, DOI 10.1128/AEM.02211-08; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Sabart M, 2009, ENV MICROBIOL REP, V1, P263, DOI 10.1111/j.1758-2229.2009.00042.x; SEN B, 1987, Archiv fuer Hydrobiologie Supplement, V76, P101; SEN B, 1988, Archiv fuer Hydrobiologie Supplement, V79, P177; Shin W, 2001, CAN J BOT, V79, P1083, DOI 10.1139/b01-086; Sigee D, 2007, J INFORM, V46; Sigee DC, 1999, HYDROBIOLOGIA, V395, P161, DOI 10.1023/A:1017097502124; Sonstebo JH, 2011, APPL ENVIRON MICROB, V77, P1344, DOI 10.1128/AEM.02153-10; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; SUBERKROPP KF, 1973, ARCH MIKROBIOL, V89, P205, DOI 10.1007/BF00422201; SUTHERLAND JM, 1979, J GEN MICROBIOL, V115, P273, DOI 10.1099/00221287-115-2-273; Takano K, 2008, LIMNOLOGY, V9, P213, DOI 10.1007/s10201-008-0247-3; Tanabe Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017085; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; van Donk E., 1989, P171; VANDONK E, 1983, FRESHWATER BIOL, V13, P241; Vogwill T, 2008, J EVOLUTION BIOL, V21, P1252, DOI 10.1111/j.1420-9101.2008.01574.x; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Whitton B. A., 2002, FRESHWATER ALGAL FLO; Wood SA, 2009, FEMS MICROBIOL ECOL, V67, P252, DOI 10.1111/j.1574-6941.2008.00630.x	71	54	54	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e60894	10.1371/journal.pone.0060894	http://dx.doi.org/10.1371/journal.pone.0060894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593345	Green Submitted, Green Published, gold			2022-12-27	WOS:000317385300033
J	Xiang, H; Mertz, KJ; Arena, VC; Brink, LL; Xu, XH; Bi, YY; Talbott, EO				Xiang, Hao; Mertz, Kristen J.; Arena, Vincent C.; Brink, Luann L.; Xu, Xiaohui; Bi, Yongyi; Talbott, Evelyn O.			Estimation of Short-Term Effects of Air Pollution on Stroke Hospital Admissions in Wuhan, China	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSIS; CARDIOVASCULAR-DISEASES; PARTICULATE MATTER; TIME-SERIES; AMBIENT AIR; CEREBROVASCULAR DISEASES; MEDICARE BENEFICIARIES; MYOCARDIAL-INFARCTION; REFERENT SELECTION; MEASUREMENT-ERROR	Background and Objective: High concentrations of air pollutants have been linked to increased incidence of stroke in North America and Europe but not yet assessed in mainland China. The aim of this study is to evaluate the association between stroke hospitalization and short-term elevation of air pollutants in Wuhan, China. Methods: Daily mean NO2, SO2 and PM10 levels, temperature and humidity were obtained from 2006 through 2008. Data on stroke hospitalizations (ICD 10: I60-I69) at four hospitals in Wuhan were obtained for the same period. A time-stratified case-crossover design was performed by season (April-September and October-March) to assess effects of pollutants on stroke hospital admissions. Results: Pollution levels were higher in October-March with averages of 136.1 mu g/m(3) for PM10, 63.6 mu g/m(3) for NO2 and 71.0 mu g/m(3) for SO2 than in April-September when averages were 102.0 mu g/m(3), 41.7 mu g/m(3) and 41.7 mu g/m(3), respectively (p<.001). During the cold season, every 10 mu g/m(3) increase in NO2 was associated with a 2.9% (95% C.I. 1.2%-4.6%) increase in stroke admissions on the same day. Every 10 mu g/m(3) increase in PM10 daily concentration was significantly associated with an approximate 1% (95% C.I. 0.1%-1.4%) increase in stroke hospitalization. A two-pollutant model indicated that NO2 was associated with stroke admissions when controlling for PM10. During the warm season, no significant associations were noted for any of the pollutants. Conclusions: Exposure to NO2 is significantly associated with stroke hospitalizations during the cold season in Wuhan, China when pollution levels are 50% greater than in the warm season. Larger and multi-center studies in Chinese cities are warranted to validate our findings.	[Xiang, Hao] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430072, Hubei, Peoples R China; [Xiang, Hao; Bi, Yongyi] Wuhan Univ, Wuhan Univ Global Hlth Inst, Wuhan 430072, Hubei, Peoples R China; [Mertz, Kristen J.; Brink, Luann L.; Talbott, Evelyn O.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Arena, Vincent C.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Xu, Xiaohui] Univ Florida, Coll Med, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA; [Bi, Yongyi] Wuhan Univ, Sch Publ Hlth, Dept Labor & Environm Hyg, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; Wuhan University	Talbott, EO (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.	eot1@pitt.edu	Xu, Xiaohui/H-5397-2019	Xu, Xiaohui/0000-0001-7269-4089; Arena, Vincent/0000-0002-1634-7207; Talbott, Evelyn/0000-0002-5198-7939				Abraham JH, 2005, ENVIRON HEALTH PERSP, V113, P1516, DOI 10.1289/ehp.7632; Ali R, 2008, ECOHEALTH, V5, P159, DOI 10.1007/s10393-008-0172-2; Arena VC, 2006, J OCCUP ENVIRON MED, V48, P38, DOI 10.1097/01.jom.0000183096.20678.f1; Ballester F, 2001, J EPIDEMIOL COMMUN H, V55, P57, DOI 10.1136/jech.55.1.57; Burnett RT, 1999, ARCH ENVIRON HEALTH, V54, P130, DOI 10.1080/00039899909602248; Carracedo-Martinez E, 2010, ENVIRON HEALTH PERSP, V118, P1173, DOI 10.1289/ehp.0901485; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; Fang SC, 2010, INT J ENV RES PUB HE, V7, P1773, DOI 10.3390/ijerph7041773; Hong YC, 2002, STROKE, V33, P2165, DOI 10.1161/01.STR.0000026865.52610.5B; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kan HD, 2003, J OCCUP HEALTH, V45, P321, DOI 10.1539/joh.45.321; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; Le Tertre A, 2002, J EPIDEMIOL COMMUN H, V56, P773, DOI 10.1136/jech.56.10.773; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Linn WS, 2000, ENVIRON HEALTH PERSP, V108, P427, DOI 10.2307/3454383; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Moolgavkar SH, 2000, J AIR WASTE MANAGE, V50, P1199, DOI 10.1080/10473289.2000.10464162; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; Peters A, 2001, CIRCULATION, V103, P2810; Poloniecki JD, 1997, OCCUP ENVIRON MED, V54, P535, DOI 10.1136/oem.54.8.535; Ponka A, 1996, AM J PUBLIC HEALTH, V86, P1273, DOI 10.2105/AJPH.86.9.1273; Qian ZM, 2007, ENVIRON RES, V105, P380, DOI 10.1016/j.envres.2007.05.007; Rich DQ, 2005, AM J EPIDEMIOL, V161, P1123, DOI 10.1093/aje/kwi143; Schwartz J, 2001, ENVIRON HEALTH PERSP, V109, P405, DOI 10.2307/3434788; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6; Sunyer J, 2003, EUR HEART J, V24, P752, DOI 10.1016/S0195-668X(02)00808-4; Tong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037500; Tsai SS, 2003, STROKE, V34, P2612, DOI 10.1161/01.STR.0000095564.33543.64; van Eeden SF, 2002, J TOXICOL ENV HEAL A, V65, P1597, DOI 10.1080/00984100290071685; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2005, AM J EPIDEMIOL, V161, P1030, DOI 10.1093/aje/kwi135; Wichmann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022904; Wong TW, 1999, OCCUP ENVIRON MED, V56, P679, DOI 10.1136/oem.56.10.679; Wordley J, 1997, OCCUP ENVIRON MED, V54, P108, DOI 10.1136/oem.54.2.108; Yang CY, 2004, J TOXICOL ENV HEAL A, V67, P483, DOI 10.1080/15287390490276502; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zeka A, 2004, ENVIRON HEALTH PERSP, V112, P1686, DOI 10.1289/ehp.7286	38	50	53	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61168	10.1371/journal.pone.0061168	http://dx.doi.org/10.1371/journal.pone.0061168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23593421	gold, Green Published, Green Accepted			2022-12-27	WOS:000317385300055
J	Yang, XM; Xu, YL; Guo, FH; Ning, YX; Zhi, XL; Yin, LH; Li, XB				Yang, Xiaoming; Xu, Yali; Guo, Fenghua; Ning, Yanxia; Zhi, Xiuling; Yin, Lianhua; Li, Xiaobo			Hydroxysteroid Sulfotransferase SULT2B1b Promotes Hepatocellular Carcinoma Cells Proliferation In Vitro and In Vivo	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SUBCELLULAR-LOCALIZATION; METABOLIZING ENZYMES; LIPID-METABOLISM; HUMAN BREAST; EXPRESSION; OXYSTEROL; GENES; 2B1B; MECHANISMS	Hydroxysteroid sulfotransferase 2B1b (SULT2B1b) is highly selective for the addition of sulfate groups to 3 beta-hydroxysteroids. Although previous reports have suggested that SULT2B1b is correlated with cell proliferation of hepatocytes, the relationship between SULT2B1b and the malignant phenotype of hepatocarcinoma cells was not clear. In the present study, we found that SULT2B1 was comparatively higher in the human hepatocarcinoma tumorous tissues than their adjacent tissues. Besides, SULT2B1b overexpression promoted the growth of the mouse hepatocarcinoma cell line Hepa1-6, while Lentivirus-mediated SULT2B1b interference inhibited growth as assessed by the CCK-8 assay. Likewise, inhibition of SULT2B1b expression induced cell-cycle arrest and apoptosis in Hepa1-6 cells by upregulating the expression of FAS, downregulating the expression of cyclinB1, BCL2 and MYC in vitro and in vivo at both the transcript and protein levels. Knock-down of SULT2B1b expression significantly suppressed tumor growth in nude mouse xenografts. Moreover, proliferation rates and SULT2B1b expression were highly correlated in the human hepatocarcinoma cell lines Huh-7, Hep3B, SMMC-7721 and BEL-7402 cells. Knock-down of SULT2B1b inhibited cell growth and cyclinB1 levels in human hepatocarcinoma cells and suppressed xenograft growth in vivo. In conclusion, SULT2B1b expression promotes proliferation of hepatocellular carcinoma cells in vitro and in vivo, which may contribute to the progression of HCC.	[Yang, Xiaoming; Xu, Yali; Ning, Yanxia; Zhi, Xiuling; Yin, Lianhua; Li, Xiaobo] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China; [Yang, Xiaoming] Ningxia Med Univ, Yinchuan, Ningxia, Peoples R China; [Guo, Fenghua] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University; Ningxia Medical University; Fudan University	Li, XB (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China.	xbli@fudan.edu.cn	Ning, Yanxia/F-3262-2014; Zhi, Xiuling/P-6492-2019	Zhi, Xiuling/0000-0002-8248-4090	National Natural Science Foundation of China [NSFC 81270497, NSFC 81170253, 30830050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (NSFC 81270497 and NSFC 81170253, Key Program: 30830050). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021; Bieche I, 2004, BREAST CANCER RES, V6, pR252, DOI 10.1186/bcr784; Cook IT, 2009, DRUG METAB DISPOS, V37, P2069, DOI 10.1124/dmd.108.025759; Dumas NA, 2008, J STEROID BIOCHEM, V111, P171, DOI 10.1016/j.jsbmb.2008.05.006; Falany CN, 2006, J STEROID BIOCHEM, V102, P214, DOI 10.1016/j.jsbmb.2006.09.011; Fu JQ, 2010, BREAST CANCER RES TR, V120, P35, DOI 10.1007/s10549-009-0363-8; Greenbaum LE, 2004, CANCER BIOL THER, V3, P1200, DOI 10.4161/cbt.3.12.1392; He DN, 2004, BIOCHEM J, V379, P533, DOI 10.1042/BJ20031524; He DN, 2007, PROSTATE, V67, P1318, DOI 10.1002/pros.20615; Hevir N, 2011, MOL CELL ENDOCRINOL, V331, P158, DOI 10.1016/j.mce.2010.09.011; Jusakul A, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-44; Li XB, 2007, J LIPID RES, V48, P2587, DOI 10.1194/jlr.M700301-JLR200; Linseisen J, 2002, CANCER EPIDEM BIOMAR, V11, P1630; Lo Sasso G, 2010, HEPATOLOGY, V51, P1334, DOI 10.1002/hep.23436; Morales A, 2012, ANTI-CANCER AGENT ME, V12, P364, DOI 10.2174/187152012800228689; Ren SL, 2007, BIOCHEM BIOPH RES CO, V360, P802, DOI 10.1016/j.bbrc.2007.06.143; Ren SL, 2004, J LIPID RES, V45, P2123, DOI 10.1194/jlr.M400233-JLR200; Sato K, 2011, CURR MED CHEM, V18, P4375, DOI 10.2174/092986711797200462; Shimizu C, 2003, ENDOCRINOLOGY, V144, P1186, DOI 10.1210/en.2002-221011; Torres CG, 2011, ONCOL REP, V26, P389, DOI 10.3892/or.2011.1284; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wu JM, 2010, HPB, V12, P625, DOI 10.1111/j.1477-2574.2010.00207.x; Xu K, 2011, ANTI-CANCER DRUG, V22, P875, DOI 10.1097/CAD.0b013e328349597d; Yoon JH, 2002, CANCER RES, V62, P6500; Zhang X, 2012, J STEROID BIOCHEM, V132, P262, DOI 10.1016/j.jsbmb.2012.06.001; Zhang X, 2012, AM J PHYSIOL-GASTR L, V303, pG344, DOI 10.1152/ajpgi.00403.2011	28	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60853	10.1371/journal.pone.0060853	http://dx.doi.org/10.1371/journal.pone.0060853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593328	Green Published, gold, Green Submitted			2022-12-27	WOS:000317383200022
J	Le Clec'h, W; Chevalier, FD; Genty, L; Bertaux, J; Bouchon, D; Sicard, M				Le Clec'h, Winka; Chevalier, Frederic D.; Genty, Lise; Bertaux, Joanne; Bouchon, Didier; Sicard, Mathieu			Cannibalism and Predation as Paths for Horizontal Passage of Wolbachia between Terrestrial Isopods	PLOS ONE			English	Article							AEDES-AEGYPTI; CYTOPLASMIC INCOMPATIBILITY; MOLECULAR-IDENTIFICATION; INFECTION; ENDOSYMBIONTS; TRANSMISSION; CRUSTACEANS; BIOLOGY; TRANSINFECTION; MITOCHONDRIAL	The alpha-proteobacteria Wolbachia are the most widespread endosymbionts in arthropods and nematodes. Mainly maternally inherited, these so-called sex parasites have selected several strategies that increase their vertical dispersion in host populations. However, the lack of congruence between the Wolbachia and their host phylogenies suggests frequent horizontal transfers. One way that could be used for horizontal Wolbachia transfers between individuals is predation. The aim of this study was to test whether horizontal passage of Wolbachia is possible when an uninfected terrestrial isopod eats an infected one. After having eaten Armadillidium vulgare harbouring Wolbachia, the predator-recipients (the two woodlice A. vulgare and Porcellio dilatatus dilatatus) that were initially Wolbachia-free were tested positive for the presence of Wolbachia both by quantitative PCR and Fluorescence in situ Hybridization (FISH). Even if the titers were low compared to vertically infected individuals, this constitutes the first demonstration of Wolbachia occurrence in various organs of an initially uninfected host after eating an infected one.	[Le Clec'h, Winka; Chevalier, Frederic D.; Genty, Lise; Bertaux, Joanne; Bouchon, Didier; Sicard, Mathieu] UMR 7267 CNRS, Lab Ecol & Biol Interact, Equipe Ecol, Symbiose, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers	Sicard, M (corresponding author), UMR 7267 CNRS, Lab Ecol & Biol Interact, Equipe Ecol, Symbiose, Batiment B8, Poitiers, France.	mathieu.sicard@univ-poitiers.fr	Le Clec'h, Winka/B-7352-2014; Sicard, Mathieu/C-4984-2009; CHEVALIER, Frédéric D./E-6852-2010; Bouchon, Didier/B-2419-2012	Sicard, Mathieu/0000-0003-3692-0039; CHEVALIER, Frédéric D./0000-0003-2611-8106; Bouchon, Didier/0000-0002-4938-408X; Le Clec'h, Winka/0000-0002-1111-2492	Agence Nationale de la Recherche [ADaWOL ANR-09-JCJC-0109-01]; Region Poitou-charentes	Agence Nationale de la Recherche(French National Research Agency (ANR)); Region Poitou-charentes(Region Nouvelle-Aquitaine)	This work was supported by the Agence Nationale de la Recherche (ADaWOL ANR-09-JCJC-0109-01 coordinated by Dr Mathieu Sicard). Winka Le Clec'h's work was supported by a grant from Region Poitou-charentes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen A, 2004, CRIT REV MICROBIOL, V30, P263, DOI 10.1080/10408410490884757; Apostolaki A, 2011, J APPL ENTOMOL, V135, P546, DOI 10.1111/j.1439-0418.2011.01614.x; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Chevalier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018531; COMBES C., 1995, INTERACTIONS DURABLE; Cordaux R, 2001, J EVOLUTION BIOL, V14, P237, DOI 10.1046/j.1420-9101.2001.00279.x; EDNEY EB, 1974, ECOLOGY, V55, P428, DOI 10.2307/1935231; Enigl M, 2005, EXP APPL ACAROL, V36, P249, DOI 10.1007/s10493-005-6075-9; Farmer EE, 2009, P NATL ACAD SCI USA, V106, P935, DOI 10.1073/pnas.0812182106; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Hurst TP, 2012, J MED ENTOMOL, V49, P624, DOI 10.1603/ME11277; Jaenike J, 2007, TRENDS ECOL EVOL, V22, P167, DOI 10.1016/j.tree.2007.01.008; JUCHAULT P, 1974, Annales d'Embryologie et de Morphogenese, V7, P265; JUCHAULT P, 1988, CR ACAD SCI III-VIE, V306, P321; JUCHAULT P, 1980, INT J INVER REP DEV, V2, P223; Kageyama D, 2008, MICROB ECOL, V56, P733, DOI 10.1007/s00248-008-9392-9; Khan K, 1981, THESIS U PUNJAB PAKI; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kraaijeveld K, 2011, MOL ECOL, V20, P3644, DOI 10.1111/j.1365-294X.2011.05150.x; Le Clec'h W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002844; MARTIN G, 1973, CR ACAD SCI D NAT, V276, P2313; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Plantard O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030692; Pokarzhevskii AD, 2003, PEDOBIOLOGIA, V47, P213, DOI 10.1078/0031-4056-00185; Rasband W., 2006, IMAGEJ; Rasgon JL, 2006, APPL ENVIRON MICROB, V72, P6934, DOI 10.1128/AEM.01673-06; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Riegler M, 2004, APPL ENVIRON MICROB, V70, P273, DOI 10.1128/AEM.70.1.273-279.2004; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; Rigaud T, 2001, J INVERTEBR PATHOL, V77, P251, DOI 10.1006/jipa.2001.5026; Ruang-areerate T, 2006, P NATL ACAD SCI USA, V103, P12534, DOI 10.1073/pnas.0508879103; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stouthamer R, 1997, INFLUENTIAL PASSENGERS, P102; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Warburg M.R., 1984, Symposia of the Zoological Society of London, P339; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9; Yun Y, 2011, NEOTROP ENTOMOL, V40, P164, DOI 10.1590/S1519-566X2011000200002; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zhukova MV, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S15	57	76	77	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60232	10.1371/journal.pone.0060232	http://dx.doi.org/10.1371/journal.pone.0060232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123IQ	23593179	Green Published, gold			2022-12-27	WOS:000317382000009
J	Schiffer, B; Pawliczek, C; Muller, BW; Gizewski, ER; Walter, H				Schiffer, Boris; Pawliczek, Christina; Mueller, Bernhard W.; Gizewski, Elke R.; Walter, Henrik			Why Don't Men Understand Women? Altered Neural Networks for Reading the Language of Male and Female Eyes	PLOS ONE			English	Article							FACIAL-EXPRESSION; EMPATHY; MIND; RESPONSES; EMOTION; BRAIN; NEUROSCIENCE; RECOGNITION; VASOPRESSIN; ACCURACY	Men are traditionally thought to have more problems in understanding women compared to understanding other men, though evidence supporting this assumption remains sparse. Recently, it has been shown, however, that mens problems in recognizing women's emotions could be linked to difficulties in extracting the relevant information from the eye region, which remain one of the richest sources of social information for the attribution of mental states to others. To determine possible differences in the neural correlates underlying emotion recognition from female, as compared to male eyes, a modified version of the Reading the Mind in the Eyes Test in combination with functional magnetic resonance imaging (fMRI) was applied to a sample of 22 participants. We found that men actually had twice as many problems in recognizing emotions from female as compared to male eyes, and that these problems were particularly associated with a lack of activation in limbic regions of the brain (including the hippocampus and the rostral anterior cingulate cortex). Moreover, men revealed heightened activation of the right amygdala to male stimuli regardless of condition (sex vs. emotion recognition). Thus, our findings highlight the function of the amygdala in the affective component of theory of mind (ToM) and in empathy, and provide further evidence that men are substantially less able to infer mental states expressed by women, which may be accompanied by sex-specific differences in amygdala activity.	[Schiffer, Boris] LWL Univ Hosp Bochum, Div Forens Psychiat, Dept Psychiat Psychotherapy & Prevent Med, Bochum, Germany; [Schiffer, Boris; Pawliczek, Christina] Univ Duisburg Essen, Inst Forens Psychiat, Duisburg, Germany; [Mueller, Bernhard W.] Univ Duisburg Essen, Dept Psychiat & Psychotherapy, Duisburg, Germany; [Gizewski, Elke R.] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Pawliczek, Christina] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Gizewski, Elke R.] Univ Innsbruck Hosp, Dept Neuroradiol, Innsbruck, Austria; [Walter, Henrik] Charite, Div Mind & Brain Res, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany	Ruhr University Bochum; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; RWTH Aachen University; RWTH Aachen University Hospital; Medical University of Innsbruck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schiffer, B (corresponding author), LWL Univ Hosp Bochum, Div Forens Psychiat, Dept Psychiat Psychotherapy & Prevent Med, Bochum, Germany.	boris.schiffer@uni-due.de	Müller, Bernhard W./D-9896-2011; Walter, Henrik/O-2612-2013	Müller, Bernhard W./0000-0002-9573-1417; Gizewski, Elke Ruth/0000-0001-6859-8377; Walter, Henrik/0000-0002-9403-6121; Schiffer, Boris/0000-0002-6935-8903	Landschaftsverband Rheinland, Germany	Landschaftsverband Rheinland, Germany	This research was funded by the Landschaftsverband Rheinland, Germany (Dr. Schiffer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; Adams RB, 2012, SOC COGN AFFECT NEUR, V7, P568, DOI 10.1093/scan/nsr038; Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P47, DOI DOI 10.1111/J.1467-7687.2008.00720.X; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Blakemore SJ, 2012, J ROY SOC MED, V105, P111, DOI 10.1258/jrsm.2011.110221; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Demos KE, 2008, CEREB CORTEX, V18, P2729, DOI 10.1093/cercor/bhn034; First M. D., 1996, USERS GUIDE STRUCTUR; Fischer H, 2004, COGN AFFECT BEHAV NE, V4, P326, DOI 10.3758/CABN.4.3.326; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Frick C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041650; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Gizewski ER, 2012, ADDICT BIOL; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; Harkness KL, 2005, COGNITION EMOTION, V19, P999, DOI 10.1080/02699930541000110; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Heatherton TF, 2011, ANNU REV PSYCHOL, V62, P363, DOI 10.1146/annurev.psych.121208.131616; Hoffman KL, 2007, CURR BIOL, V17, P766, DOI 10.1016/j.cub.2007.03.040; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; LeDoux J. E., 1996, EMOTIONAL BRAIN; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; MANDAL MK, 1985, PERCEPT MOTOR SKILL, V60, P96, DOI 10.2466/pms.1985.60.1.96; Mazurski EJ, 1996, PSYCHOPHYSIOLOGY, V33, P416, DOI 10.1111/j.1469-8986.1996.tb01067.x; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; NOWICKI S, 1988, J SOC PSYCHOL, V128, P363, DOI 10.1080/00224545.1988.9713753; Pardini M, 2009, EXP AGING RES, V35, P98, DOI 10.1080/03610730802545259; Perry D, 2011, NEUROIMAGE, V54, P1669, DOI 10.1016/j.neuroimage.2010.08.057; Rahman Q, 2012, EMOTION, V12, P174, DOI 10.1037/a0024416; Scott LN, 2011, PERSONAL DISORD, V2, P98, DOI 10.1037/a0020011; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uzefovsky F, 2012, PSYCHONEUROENDOCRINO, V37, P576, DOI 10.1016/j.psyneuen.2011.07.018; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Williams MA, 2006, CURR BIOL, V16, pR402, DOI 10.1016/j.cub.2006.05.018; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	43	25	25	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2013	8	4							e60278	10.1371/journal.pone.0060278	http://dx.doi.org/10.1371/journal.pone.0060278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123IQ	23593185	gold, Green Published, Green Submitted			2022-12-27	WOS:000317382000010
J	Issa, PC; De Silva, SR; Lipinski, DM; Singh, MS; Mouravlev, A; You, QS; Barnard, AR; Hankins, MW; During, MJ; MacLaren, RE				Issa, Peter Charbel; De Silva, Samantha R.; Lipinski, Daniel M.; Singh, Mandeep S.; Mouravlev, Alexandre; You, Qisheng; Barnard, Alun R.; Hankins, Mark W.; During, Matthew J.; MacLaren, Robert E.			Assessment of Tropism and Effectiveness of New Primate-Derived Hybrid Recombinant AAV Serotypes in the Mouse and Primate Retina	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; HIGH-EFFICIENCY TRANSDUCTION; GENE-THERAPY; ADENOASSOCIATED VIRUS; IMMUNE-RESPONSES; VISUAL FUNCTION; DELIVERY; VECTORS; MICE; BLINDNESS	Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenerations in clinical trials. Thus, improving the efficiency of viral gene delivery has become increasingly important to increase the success of clinical trials. In this study, structural domains of different rAAV serotypes isolated from primate brain were combined to create novel hybrid recombinant AAV serotypes, rAAV2/rec2 and rAAV2/rec3. The efficacy of these novel serotypes were assessed in wild type mice and in two models of retinal degeneration (the Abca4(-/-) mouse which is a model for Stargardt disease and in the Pde6b(rd1/rd1) mouse) in vivo, in primate tissue ex-vivo, and in the human-derived SH-SY5Y cell line, using an identical AAV2 expression cassette. We show that these novel hybrid serotypes can transduce retinal tissue in mice and primates efficiently, although no more than AAV2/2 and rAAV2/5 serotypes. Transduction efficiency appeared lower in the Abca4(-/-) mouse compared to wild type with all vectors tested, suggesting an effect of specific retinal diseases on the efficiency of gene delivery. Shuffling of AAV capsid domains may have clinical applications for patients who develop T-cell immune responses following AAV gene therapy, as specific peptide antigen sequences could be substituted using this technique prior to vector re-treatments.	[Issa, Peter Charbel; De Silva, Samantha R.; Lipinski, Daniel M.; Singh, Mandeep S.; You, Qisheng; Barnard, Alun R.; Hankins, Mark W.; MacLaren, Robert E.] Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford OX2 6AW, England; [Mouravlev, Alexandre; During, Matthew J.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [During, Matthew J.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [MacLaren, Robert E.] Moorfields Eye Hosp Fdn Trust, London, England; [MacLaren, Robert E.] Natl Inst Hlth Res, Biomed Res Ctr, UCL Inst Ophthalmol, London, England; [MacLaren, Robert E.] Oxford Univ Hosp NHS Trust, Oxford Eye Hosp, Oxford, England; [MacLaren, Robert E.] Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England	University of Oxford; University of Auckland; University System of Ohio; Ohio State University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; University of Oxford	MacLaren, RE (corresponding author), Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Walton St, Oxford OX2 6AW, England.	enquiries@eye.ox.ac.uk	Issa, Peter Charbel/E-8935-2018; During, Matthew/AAC-1388-2020; You, Qisheng/AAG-7153-2020; You, Qisheng/A-3619-2014; Issa, Peter Charbel/O-2580-2019; Singh, Mandeep/AAS-8842-2021	Issa, Peter Charbel/0000-0002-0351-6673; You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320; Issa, Peter Charbel/0000-0002-0351-6673; Singh, Mandeep/0000-0003-1749-0088; MacLaren, Robert/0000-0002-3096-4682; Lipinski, Daniel/0000-0001-7828-614X; De Silva, Samantha/0000-0002-4455-2814	Wellcome Trust [086868/Z/08/Z, 094448/Z/10/Z]; Oxford Stem Cell Institute; Health Foundation; Royal College of Surgeons of Edinburgh; NIHR Oxford and Moorfields Biomedical Research Centers; European Commission, FP7, Marie Curie Intra-European Fellowship [237238]; Fight for Sight; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044576] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Stem Cell Institute; Health Foundation; Royal College of Surgeons of Edinburgh; NIHR Oxford and Moorfields Biomedical Research Centers; European Commission, FP7, Marie Curie Intra-European Fellowship; Fight for Sight; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Wellcome Trust Grant 086868/Z/08/Z and 094448/Z/10/Z; Oxford Stem Cell Institute; Health Foundation; Royal College of Surgeons of Edinburgh, NIHR Oxford and Moorfields Biomedical Research Centers, The European Commission, FP7, Marie Curie Intra-European Fellowship 237238; Fight for Sight. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barker SE, 2009, J GENE MED, V11, P486, DOI 10.1002/jgm.1327; Charbel Issa P, 2012, INVESTOPHTHALMOL VIS; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dalkara D, 2009, MOL THER, V17, P2096, DOI 10.1038/mt.2009.181; DiPritmio N, 2008, J VIROL, V82, P5178, DOI 10.1128/JVI.02721-07; Doroudchi MM, 2011, MOL THER, V19, P1220, DOI 10.1038/mt.2011.69; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Hirsch ML, 2010, MOL THER, V18, P6, DOI 10.1038/mt.2009.280; Jacobson SG, 2011, ARCH OPHTHALMOL; Johnson TV, 2008, INVEST OPHTH VIS SCI, V49, P3503, DOI 10.1167/iovs.07-1601; Kells AP, 2009, P NATL ACAD SCI USA, V106, P2407, DOI 10.1073/pnas.0810682106; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Lipinski DM, 2011, INVEST OPHTH VIS SCI, V52, P7340, DOI 10.1167/iovs.11-7996; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Mingozzi F, 2011, CURR GENE THER, V11, P321, DOI 10.2174/156652311796150354; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Vandenberghe LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002103; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yin L, 2011, INVEST OPHTH VIS SCI, V52, P2775, DOI 10.1167/iovs.10-6250; You QS, 2012, EXP EYE RES, V97, P148, DOI 10.1016/j.exer.2011.12.009; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	29	27	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2013	8	4							e60361	10.1371/journal.pone.0060361	http://dx.doi.org/10.1371/journal.pone.0060361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JB	23593201	Green Published, Green Submitted, gold			2022-12-27	WOS:000317909600020
J	Fischer, S; Houston, P; Monk, NAM; Owen, MR				Fischer, Sabine; Houston, Paul; Monk, Nicholas A. M.; Owen, Markus R.			Is a Persistent Global Bias Necessary for the Establishment of Planar Cell Polarity?	PLOS ONE			English	Article							WING EPITHELIUM; DROSOPHILA	Planar cell polarity (PCP)-the coordinated polarisation of a whole field of cells within the plane of a tissue-relies on the interaction of three modules: a global module that couples individual cellular polarity to the tissue axis, a local module that aligns the axis of polarisation of neighbouring cells, and a readout module that directs the correct outgrowth of PCP-regulated structures such as hairs and bristles. While much is known about the molecular components that are required for PCP, the functional details of-and interactions between-the modules remain unclear. In this work, we perform a mathematical and computational analysis of two previously proposed computational models of the local module (Amonlirdviman et al., Science, 307, 2005; Le Garrec et al., Dev. Dyn., 235, 2006). Both models can reproduce wild-type and mutant phenotypes of PCP observed in the Drosophila wing under the assumption that a tissue-wide polarity cue from the global module persists throughout the development of PCP. We demonstrate that both models can also generate tissue-level PCP when provided with only a transient initial polarity cue. However, in these models such transient cues are not sufficient to ensure robustness of the resulting cellular polarisation.	[Fischer, Sabine; Houston, Paul; Monk, Nicholas A. M.; Owen, Markus R.] Univ Nottingham, Sch Math Sci, Ctr Math Med & Biol, Nottingham NG7 2RD, England	University of Nottingham	Fischer, S (corresponding author), Goethe Univ Frankfurt, Inst Biol Sci, Buchmann Inst Mol Life Sci, D-60054 Frankfurt, Germany.	Sabine.Fischer@physikalischebiologie.de	Owen, Markus/F-3082-2011	Owen, Markus/0000-0002-3028-9138; Houston, Paul/0000-0002-3588-2029; Fischer, Sabine C/0000-0001-7237-814X; Monk, Nick/0000-0002-5465-4857	Engineering and Physical Sciences Research Council [EP/C539044/1, EP/C539052/1]; EPSRC [EP/C539052/1, EP/C539044/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grant No. EP/C539044/1 and EP/C539052/1 from the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Le Garrec JF, 2008, DEV GENES EVOL, V218, P413, DOI 10.1007/s00427-008-0235-y; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Raffard RL, 2008, IEEE T AUTOMAT CONTR, V53, P109, DOI 10.1109/TAC.2007.911362; Schamberg S, 2010, B MATH BIOL, V72, P645, DOI 10.1007/s11538-009-9464-0; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Strutt D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000489; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772	16	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60064	10.1371/journal.pone.0060064	http://dx.doi.org/10.1371/journal.pone.0060064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23593163	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000317898000020
J	Muraki, Y; Okuwa, T; Himeda, T; Hongo, S; Ohara, Y				Muraki, Yasushi; Okuwa, Takako; Himeda, Toshiki; Hongo, Seiji; Ohara, Yoshiro			Effect of Cysteine Mutations in the Extracellular Domain of CM2 on the Influenza C Virus Replication	PLOS ONE			English	Article							INTEGRAL MEMBRANE GLYCOPROTEIN; ION-CHANNEL ACTIVITY; RNA SEGMENT 6; EFFICIENT REPLICATION; TRANSMEMBRANE DOMAIN; MATRIX PROTEIN; INFECTED CELLS; M1 PROTEIN; M2 PROTEIN; IDENTIFICATION	CM2 is the second membrane protein of influenza C virus and possesses three conserved cysteines at residue 1, 6 and 20 in its extracellular domain, all of which are involved in the formation of disulfide-linked oligomers of the molecule. In the present study, to examine the effect of CM2 oligomerization on virus replication, we generated a mutant recombinant virus, rC1620A, in which all three cysteines on CM2 were substituted to alanines. The rC1620A virus was more attenuated than the recombinant wild-type (rWT) virus in cultured cells. The CM2 protein synthesized in rC1620A-infected cells could not apparently be detected as a tetramer and was transported to the cell surface less efficiently than was authentic CM2. The amount of CM2 protein incorporated into the rC1620A virions was comparable to that into the rWT virions, although the main CM2 species in the rC1620A virions was in the form of a dimer. Analyses of one-step grown virions and virus-infected cells could not provide evidence for any difference in growth between rC1620A and rWT. On the other hand, the amount of genome present in VLPs possessing the mutant CM2 (C1620A-VLPs) was approximately 31% of that in VLPs possessing wildtype CM2 (WT-VLPs). The incoming genome from VLPs was less efficiently transported to the nucleus in the C1620A-VLP-infected cells than in WT-VLP-infected cells, leading to reduced reporter gene expression in the C1620A-VLP-infected cells. Taken together, these findings demonstrate that CM2 oligomerization affects the packaging and uncoating processes. Thus, we concluded that disulfide-linked CM2 oligomers facilitate virus growth by affecting the replication processes.	[Muraki, Yasushi; Okuwa, Takako; Himeda, Toshiki; Ohara, Yoshiro] Kanazawa Med Univ, Sch Med, Dept Microbiol, Uchinada, Ishikawa 92002, Japan; [Hongo, Seiji] Yamagata Univ, Fac Med, Dept Infect Dis, Iida Nishi, Yamagata, Japan	Kanazawa Medical University; Yamagata University	Muraki, Y (corresponding author), Kanazawa Med Univ, Sch Med, Dept Microbiol, Uchinada, Ishikawa 92002, Japan.	ymuraki@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [21590505, 24590560]; Kanazawa Medical University and Ministry of Education, Culture, Sports, Science and Technology, Japan [H2012-16[S1201022]]; Grant for Assist KAKEN from Kanazawa Medical University [K2012-13]; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanazawa Medical University and Ministry of Education, Culture, Sports, Science and Technology, Japan; Grant for Assist KAKEN from Kanazawa Medical University; Naito Foundation(Naito Memorial Foundation)	This work was supported in part by Grant-in-Aid for Scientific Research (C) (21590505 and 24590560) from Japan Society for the Promotion of Science, Grants of Strategic Research Project (H2012-16[S1201022]) from Kanazawa Medical University and Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant for Assist KAKEN from Kanazawa Medical University (K2012-13), and The Naito Foundation. The funders supported the authors to purchase materials to carry out the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betakova T, 2007, J GEN VIROL, V88, P2291, DOI 10.1099/vir.0.82785-0; Brabec-Zaruba M, 2009, J VIROL, V83, P3770, DOI 10.1128/JVI.00265-08; Castrucci MR, 1997, VIROLOGY, V238, P128, DOI 10.1006/viro.1997.8809; Fischer WB, 2000, BIOPOLYMERS, V53, P529, DOI 10.1002/(SICI)1097-0282(200006)53:7<529::AID-BIP1>3.0.CO;2-6; Furukawa T, 2011, J VIROL, V85, P1322, DOI 10.1128/JVI.01367-10; Hongo S, 1998, J GEN VIROL, V79, P2207, DOI 10.1099/0022-1317-79-9-2207; HONGO S, 1994, J GEN VIROL, V75, P3503, DOI 10.1099/0022-1317-75-12-3503; Hongo S, 1997, J VIROL, V71, P2786, DOI 10.1128/JVI.71.4.2786-2792.1997; Hongo S, 1999, J VIROL, V73, P46, DOI 10.1128/JVI.73.1.46-50.1999; Hongo S, 2004, ARCH VIROL, V149, P35, DOI 10.1007/s00705-003-0209-3; Kimura H, 1997, VIRUS RES, V48, P71, DOI 10.1016/S0168-1702(96)01427-X; Kukol A, 2000, J BIOL CHEM, V275, P4225, DOI 10.1074/jbc.275.6.4225; Li ZN, 2001, J GEN VIROL, V82, P1085, DOI 10.1099/0022-1317-82-5-1085; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matsuzaki Y, 2003, J VIROL, V77, P871, DOI 10.1128/JVI.77.2.871-881.2003; Muraki Y, 2004, J GEN VIROL, V85, P1885, DOI 10.1099/vir.0.79937-0; Muraki Y, 2009, ACTA VIROL, V53, P125, DOI 10.4149/av_2009_02_125; Muraki Y, 2007, J VIROL, V81, P8766, DOI 10.1128/JVI.00075-07; Muraki Y, 2011, VIRUS RES, V157, P99, DOI 10.1016/j.virusres.2011.02.013; Muraki Y, 2010, JPN J INFECT DIS, V63, P157; Muraki Y, 2010, J VIROL, V84, P1957, DOI 10.1128/JVI.01627-09; NISHIMURA H, 1989, J GEN VIROL, V70, P1653, DOI 10.1099/0022-1317-70-7-1653; Okuwa T, 2012, VIROLOGY, V433, P167, DOI 10.1016/j.virol.2012.08.010; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pekosz A, 1998, P NATL ACAD SCI USA, V95, P13233, DOI 10.1073/pnas.95.22.13233; Pekosz A, 1997, VIROLOGY, V237, P439, DOI 10.1006/viro.1997.8788; Sakaguchi T, 1997, P NATL ACAD SCI USA, V94, P5000, DOI 10.1073/pnas.94.10.5000; Stewart SM, 2012, J VIROL, V86, P1277, DOI 10.1128/JVI.05681-11; SUGAWARA K, 1993, J GEN VIROL, V74, P1661, DOI 10.1099/0022-1317-74-8-1661; SUGAWARA K, 1991, J GEN VIROL, V72, P103, DOI 10.1099/0022-1317-72-1-103; Sugawara K, 2006, VIRUS RES, V122, P45, DOI 10.1016/j.virusres.2006.06.009; Tada Y, 1997, VIRUS GENES, V15, P53, DOI 10.1023/A:1007915215958; Tada Y, 1998, VIRUS RES, V58, P65, DOI 10.1016/S0168-1702(98)00103-8; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Torres J, 2001, BIOPHYS J, V81, P2681, DOI 10.1016/S0006-3495(01)75911-5; YAMASHITA M, 1988, J VIROL, V62, P3348, DOI 10.1128/JVI.62.9.3348-3355.1988; YOKOTA M, 1983, VIROLOGY, V130, P105, DOI 10.1016/0042-6822(83)90121-6; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e60510	10.1371/journal.pone.0060510	http://dx.doi.org/10.1371/journal.pone.0060510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593230	Green Published, Green Submitted, gold			2022-12-27	WOS:000319108100049
J	Triantafilou, M; De Glanville, B; Aboklaish, AF; Spiller, OB; Kotecha, S; Triantafilou, K				Triantafilou, Martha; De Glanville, Benjamin; Aboklaish, Ali F.; Spiller, O. Brad; Kotecha, Sailesh; Triantafilou, Kathy			Synergic Activation of Toll-Like Receptor (TLR) 2/6 and 9 in Response to Ureaplasma parvum & urealyticum in Human Amniotic Epithelial Cells	PLOS ONE			English	Article							FETAL INFLAMMATORY RESPONSE; INTRAUTERINE INFECTION; LIPID RAFTS; SURFACE; EXPRESSION; DISEASE	Ureaplasma species are the most frequently isolated microorganisms inside the amniotic cavity and have been associated with spontaneous abortion, chorioamnionitis, premature rupture of the membranes (PROM), preterm labour (PL) pneumonia in neonates and bronchopulmonary dysplasia in neonates. The mechanisms by which Ureaplasmas cause such diseases remain unclear, but it is believed that inappropriate induction of inflammatory responses is involved, triggered by the innate immune system. As part of its mechanism of activation, the innate immune system employs germ-lined encoded receptors, called pattern recognition receptors (PRRs) in order to "sense" pathogens. One such family of PRRs are the Toll like receptor family (TLR). In the current study we aimed to elucidate the role of TLRs in Ureaplasma-induced inflammation in human amniotic epithelial cells. Using silencing, as well as human embryonic kidney (HEK) transfected cell lines, we demonstrate that TLR2, TLR6 and TLR9 are involved in the inflammatory responses against Ureaplasma parvum and urealyticum serovars. Ureaplasma lipoproteins, such as Multiple Banded antigen (MBA), trigger responses via TLR2/TLR6, whereas the whole bacterium is required for TLR9 activation. No major differences were observed between the different serovars. Cell activation by Ureaplasma parvum and urealyticum seem to require lipid raft function and formation of heterotypic receptor complexes comprising of TLR2 and TLR6 on the cell surface and TLR9 intracellularly.	[Triantafilou, Martha; De Glanville, Benjamin; Aboklaish, Ali F.; Spiller, O. Brad; Kotecha, Sailesh; Triantafilou, Kathy] Cardiff Univ, Univ Wales Hosp, Sch Med, Dept Child Hlth, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Triantafilou, K (corresponding author), Cardiff Univ, Univ Wales Hosp, Sch Med, Dept Child Hlth, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.	TriantafilouK@cardiff.ac.uk	Spiller, Owen Brad/AAC-2474-2020	Spiller, Owen Brad/0000-0002-9117-6911; Kotecha, Sailesh/0000-0003-3535-7627	Children & Young People's Research Network (NISCHR, Wales)	Children & Young People's Research Network (NISCHR, Wales)	This work was supported by a grant awarded from the Children & Young People's Research Network (NISCHR, Wales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Beeton ML, 2012, IMMUNOBIOLOGY, V217, P187, DOI 10.1016/j.imbio.2011.07.009; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; Dammann O, 2003, PAEDIATR PERINAT EP, V17, P49, DOI 10.1046/j.1365-3016.2003.00470.x; Daskalakis G, 2009, BJOG-INT J OBSTET GY, V116, P1743, DOI 10.1111/j.1471-0528.2009.02364.x; Fazeli A, 2005, HUM REPROD, V20, P1372, DOI 10.1093/humrep/deh775; Ghidini A, 1996, AM J OBSTET GYNECOL, V174, pS307; Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Knox CL, 2010, BIOL REPROD, V83, P415, DOI 10.1095/biolreprod.109.083121; Nasu K, 2010, MEDIAT INFLAMM, P378; Onderdonk A, 2008, AM J OBSTET GYNECOL, V199, pE14, DOI 10.1016/j.ajog.2008.06.006; Peltier MR, 2007, AM J REPROD IMMUNOL, V57, P186, DOI 10.1111/j.1600-0897.2006.00460.x; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; Shimizu T, 2008, MICROBIOL-SGM, V154, P1318, DOI 10.1099/mic.0.2007/016212-0; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Triantafilou M, 2002, J CELL SCI, V115, P2603; Veleminsky M, 2008, NEUROENDOCRINOL LETT, V29, P205; Viscardi RM, 2010, CLIN PERINATOL, V37, P393, DOI 10.1016/j.clp.2009.12.003; Wang PY, 1996, J INFLAMM, V47, P126; WATSON HL, 1990, INFECT IMMUN, V58, P3679, DOI 10.1128/IAI.58.11.3679-3688.1990; Wenstrom KD, 1996, AM J OBSTET GYNECOL, V175, P830, DOI 10.1016/S0002-9378(96)80007-X; ZHENG XT, 1994, ANN NY ACAD SCI, V730, P299, DOI 10.1111/j.1749-6632.1994.tb44272.x; Zimmerman CUR, 2009, FEMS MICROBIOL LETT, V292, P187, DOI 10.1111/j.1574-6968.2009.01505.x	30	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61199	10.1371/journal.pone.0061199	http://dx.doi.org/10.1371/journal.pone.0061199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	29161737	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000317385300058
J	Hu, GX; Lin, H; Lian, QQ; Zhou, SH; Guo, JJ; Zhou, HY; Chu, YH; Ge, RS				Hu, Guo-Xin; Lin, Han; Lian, Qing-Quan; Zhou, Shu-Hua; Guo, Jingjing; Zhou, Hong-Yu; Chu, Yanhui; Ge, Ren-Shan			Curcumin as a Potent and Selective Inhibitor of 11 beta-Hydroxysteroid Dehydrogenase 1: Improving Lipid Profiles in High-Fat-Diet-Treated Rats	PLOS ONE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; METABOLIC SYNDROME; LEYDIG-CELLS; VISCERAL OBESITY; ADIPOSE-TISSUE; BLOOD-GLUCOSE; TYPE-1; MICE; LIVER; INSULIN	Background: 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) activates glucocorticoid locally in liver and fat tissues to aggravate metabolic syndrome. 11 beta-HSD1 selective inhibitor can be used to treat metabolic syndrome. Curcumin and its derivatives as selective inhibitors of 11 beta-HSD1 have not been reported. Methodology: Curcumin and its 12 derivatives were tested for their potencies of inhibitory effects on human and rat 11 beta-HSD1 with selectivity against 11 beta-HSD2. 200 mg/kg curcumin was gavaged to adult male Sprague-Dawley rats with high-fat-diet-induced metabolic syndrome for 2 months. Results and Conclusions: Curcumin exhibited inhibitory potency against human and rat 11 beta-HSD1 in intact cells with IC50 values of 2.29 and 5.79 mu M, respectively, with selectivity against 11 beta-HSD2 (IC50, 14.56 and 11.92 mu M). Curcumin was a competitive inhibitor of human and rat 11 beta-HSD1. Curcumin reduced serum glucose, cholesterol, triglyceride, low density lipoprotein levels in high-fat-diet-induced obese rats. Four curcumin derivatives had much higher potencies for Inhibition of 11 beta-HSD1. One of them is (1E, 4E)-1,5-bis(thiophen-2-yl) penta-1,4-dien-3-one (compound 6), which had IC50 values of 93 and 184 nM for human and rat 11 beta-HSD1, respectively. Compound 6 did not inhibit human and rat kidney 11 beta-HSD2 at 100 mu M. In conclusion, curcumin is effective for the treatment of metabolic syndrome and four novel curcumin derivatives had high potencies for inhibition of human 11 beta-HSD1 with selectivity against 11 beta-HSD2.	[Hu, Guo-Xin; Zhou, Shu-Hua; Zhou, Hong-Yu] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Lin, Han; Lian, Qing-Quan; Guo, Jingjing; Ge, Ren-Shan] Wenzhou Med Coll, Affiliated Hosp 2, Wenzhou, Peoples R China; [Chu, Yanhui] Mudanjiang Med Univ, Heilongjiang Key Lab Antifibrosis Biotherapy, Mudanjiang, Heilongjiang, Peoples R China; [Ge, Ren-Shan] Populat Council, New York, NY 10021 USA	Wenzhou Medical University; Wenzhou Medical University; Mudanjiang Medical University; Population Council	Ge, RS (corresponding author), Wenzhou Med Coll, Affiliated Hosp 2, Wenzhou, Peoples R China.	r_ge@yahoo.com	; Li, Fu-Li/B-5894-2015	Yuan, Cheng/0000-0001-9517-5206; Li, Fu-Li/0000-0003-0381-2234	Wenzhou Science & Technology Funding [Y20090003, 2008H0121]; Natural Science Foundation of China (NSFC) [81102149]	Wenzhou Science & Technology Funding; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was partially supported by the Wenzhou Science & Technology Funding (Y20090003 to R.S.G. 2008H0121 to HYZ) and Natural Science Foundation of China (NSFC) (81102149 to YHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Babu PS, 1997, MOL CELL BIOCHEM, V166, P169, DOI 10.1023/A:1006819605211; Barf T, 2002, J MED CHEM, V45, P3813, DOI 10.1021/jm025530f; Chen BB, 2009, J STEROID BIOCHEM, V113, P177, DOI 10.1016/j.jsbmb.2008.12.006; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Chiu J, 2009, NUTRITION, V25, P964, DOI 10.1016/j.nut.2008.12.007; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Dominguez JM, METABOLISM, V60, P1775; Gass P, 2001, PHYSIOL BEHAV, V73, P811, DOI 10.1016/S0031-9384(01)00518-2; Ge R., 2009, CURR MED CHEM; Ge RS, 1997, ENDOCRINOLOGY, V138, P2435, DOI 10.1210/en.138.6.2435; Ge RS, 2000, J ANDROL, V21, P303; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Kempaiah RK, 2004, ANN NUTR METAB, V48, P314, DOI 10.1159/000081198; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; LAKSHMI V, 1985, J STEROID BIOCHEM, V22, P331, DOI 10.1016/0022-4731(85)90435-2; LIANG G, 2009, J CELL MOL MED; Liang G, 2008, BIOORG MED CHEM LETT, V18, P1525, DOI 10.1016/j.bmcl.2007.12.068; Livingstone DEW, 2000, J ENDOCRINOL, V167, P533, DOI 10.1677/joe.0.1670533; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MONDER C, 1988, Steroids, V52, P515, DOI 10.1016/0039-128X(88)90118-3; MONDER C, 1994, STEROIDS, V59, P69, DOI 10.1016/0039-128X(94)90078-7; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Munoz R, 2009, OBES SURG, V19, P764, DOI 10.1007/s11695-008-9616-6; Nishiyama T, 2005, J AGR FOOD CHEM, V53, P959, DOI 10.1021/jf0483873; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; PATIL TN, 1971, INDIAN J EXP BIOL, V9, P167; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; RAO DS, 1970, J NUTR, V100, P1307, DOI 10.1093/jn/100.11.1307; Salva A, 2001, J ANDROL, V22, P665; Seo KI, 2008, MOL NUTR FOOD RES, V52, P995, DOI 10.1002/mnfr.200700184; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Stewart PM, 2009, DIABETES, V58, P14, DOI 10.2337/db08-1404; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Wake DJ, 2004, MOL CELL ENDOCRINOL, V215, P45, DOI 10.1016/j.mce.2003.11.015; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; Zhao BH, 2010, CHEM-BIOL INTERACT, V183, P79, DOI 10.1016/j.cbi.2009.09.014	40	51	55	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e49976	10.1371/journal.pone.0049976	http://dx.doi.org/10.1371/journal.pone.0049976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533564	Green Published, gold, Green Submitted			2022-12-27	WOS:000316549400002
J	Richter, L; Neumann, G; Oung, S; Schweikard, A; Trillenberg, P				Richter, Lars; Neumann, Gunnar; Oung, Stephen; Schweikard, Achim; Trillenberg, Peter			Optimal Coil Orientation for Transcranial Magnetic Stimulation	PLOS ONE			English	Article							MOTOR CORTEX; BRAIN-STIMULATION; ACTIVATION; AREA; LOCALIZATION; THRESHOLD; COLUMN; PULSE; TMS	We study the impact of coil orientation on the motor threshold (MT) and present an optimal coil orientation for stimulation of the foot. The result can be compared to results of models that predict this orientation from electrodynamic properties of the media in the skull and from orientations of cells, respectively. We used a robotized TMS system for precise coil placement and recorded motor-evoked potentials with surface electrodes on the abductor hallucis muscle of the right foot in 8 healthy control subjects. First, we performed a hot-spot search in standard (lateral) orientation and then rotated the coil in steps of 10 degrees or 20 degrees. At each step we estimated the MT. For navigated stimulation and for correlation with the underlying anatomy a structural MRI scan was obtained. Optimal coil orientation was 33.1 +/- 18.3 degrees anteriorly in relation to the standard lateral orientation. In this orientation the threshold was 54 +/- 18% in units of maximum stimulator output. There was a significant difference of 8.0 +/- 5.9% between the MTs at optimal and at standard orientation. The optimal coil orientations were significantly correlated with the direction perpendicular to the postcentral gyrus (r=0.78). Robotized TMS facilitates sufficiently precise coil positioning and orientation to study even small variations of the MT with coil orientation. The deviations from standard orientation are more closely matched by models based on field propagation in media than by models based on orientations of pyramidal cells.	[Richter, Lars] Med Univ Lubeck, Inst Robot & Cognit Syst, D-23538 Lubeck, Germany; [Richter, Lars; Oung, Stephen; Schweikard, Achim] Med Univ Lubeck, Grad Sch Comp Med & Life Sci, D-23538 Lubeck, Germany; [Neumann, Gunnar; Trillenberg, Peter] Univ Hosp Schleswig Holstein, Dept Neurol, Lubeck, Germany	University of Lubeck; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital	Richter, L (corresponding author), Med Univ Lubeck, Inst Robot & Cognit Syst, D-23538 Lubeck, Germany.	richter@rob.uni-luebeck.de		Arif, Mohammad/0000-0002-5887-2050; Ochoa-Corona, Francisco/0000-0002-4112-8209	Graduate School for Computing in Medicine and Life Sciences; Germany's Excellence Initiative [DFG GSC 235/1]	Graduate School for Computing in Medicine and Life Sciences; Germany's Excellence Initiative	This work was partially supported by the Graduate School for Computing in Medicine and Life Sciences funded by Germany's Excellence Initiative [DFG GSC 235/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allison T, 1996, EVOKED POTENTIAL, V100, P126, DOI 10.1016/0013-4694(95)00226-X; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Awiszus F, 2011, BRAIN STIMUL, V4, P58, DOI 10.1016/j.brs.2010.09.004; Balslev D, 2007, J NEUROSCI METH, V162, P309, DOI 10.1016/j.jneumeth.2007.01.021; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Brockhardt, 2011, TMS MOTOR THRESHOLD; Cauda F, 2011, HUM BRAIN MAPP, V32, P1566, DOI 10.1002/hbm.21132; Cohen J.E., 1988, STAT POWER ANAL BEHA; DAVEY NJ, 1994, J PHYSIOL-LONDON, V477, P223, DOI 10.1113/jphysiol.1994.sp020186; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Kocak M, 2009, RADIOLOGY, V251, P485, DOI 10.1148/radiol.2512080231; Langguth B, 2010, NEUROPHYSIOL CLIN, V40, P45, DOI 10.1016/j.neucli.2009.03.001; Matthaus L, 2006, STUD HEALTH TECHNOL, V119, P373; Matthaus L, 2008, THESIS U LUBECK; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Niyazov DM, 2005, CLIN NEUROPHYSIOL, V116, P1601, DOI 10.1016/j.clinph.2005.02.028; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; PASCUALLEONE A, 1994, ELECTROEN CLIN NEURO, V93, P42, DOI 10.1016/0168-5597(94)90090-6; Qazi AA, 2009, NEUROIMAGE, V47, pT98, DOI 10.1016/j.neuroimage.2008.06.034; Richter L, 2012, BRAIN STIMUL, P1; Richter L, 2011, INT J MED ROBOT COMP, V7, P414, DOI 10.1002/rcs.411; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Ruohonen J, 1999, EEG CL N SU, P30; Ruohonen J, 1998, THESIS HELSINKI U TE; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; Siebner HR, 2009, BRAIN STIMUL, V2, P58, DOI 10.1016/j.brs.2008.11.002; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; TERAO Y, 1994, ACTA NEUROL SCAND, V89, P378; Terao Y, 1998, EXP BRAIN RES, V121, P145, DOI 10.1007/s002210050446; Terao Y, 2000, BRAIN RES, V859, P137, DOI 10.1016/S0006-8993(00)01975-2; Thielscher A, 2011, NEUROIMAGE, V54, P234, DOI 10.1016/j.neuroimage.2010.07.061; Trillenberg P, 2011, KLIN NEUROPHYSIOL, V42, pP280, DOI [10.1055/s-0031-1272727, DOI 10.1055/S-0031-1272727]; Wagner T, 2012, ANNU REV BIOMED ENG, V9, P527; WERHAHN KJ, 1994, ELECTROEN CLIN NEURO, V93, P138, DOI 10.1016/0168-5597(94)90077-9; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zarkowski P, 2006, CLIN EEG NEUROSCI, V37, P247, DOI 10.1177/155005940603700316	43	59	59	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60358	10.1371/journal.pone.0060358	http://dx.doi.org/10.1371/journal.pone.0060358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593200	Green Submitted, gold, Green Published			2022-12-27	WOS:000317383200006
J	Yuan, ZR; Zeng, X; Yang, D; Wang, WL; Liu, ZH				Yuan, Zhengrong; Zeng, Xu; Yang, Dan; Wang, Weilu; Liu, Zhihua			Effects of Common Polymorphism rs11614913 in Hsa-miR-196a2 on Lung Cancer Risk	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENETIC-VARIANTS; PRE-MICRORNAS; HEPATOCELLULAR-CARCINOMA; FUNCTIONAL POLYMORPHISM; SUSCEPTIBILITY; METAANALYSIS; EXPRESSION; ASSOCIATION; BIOGENESIS	Background: Emerging evidence suggests that single nucleotide polymorphisms (SNPs) in microRNA-coding genes may participate in the pathogenesis of lung cancer by altering the expression of tumor-related microRNAs. Several studies were investigated in recent years to evaluate the association between hsa-miR-196a2 rs11614913 polymorphism and increased/decreased lung cancer risk. In the present study, we performed a meta-analysis to systematically summarize the possible association. Methodology/Principal Findings: We performed a meta-analysis of 4 case-control studies that included 2219 lung-cancer cases and 2232 cancer-free controls. We evaluated the strength of the association using odds ratios (ORs) with 95% confidence intervals (CIs). In the overall analysis, it was found that the rs11614913 polymorphism significantly elevated the risk of lung cancer (CC versus (vs.) TT OR = 1.26, 95% CI 1.07-1.49, P = 0.007; CC/CT vs. TT: OR = 1.13, 95% CI 0.98-1.29, P = 0.007; C vs. T: OR = 1.12, 95% CI 1.03-1.22, P = 0.008). In the subgroup analysis by ethnicity, statistically significantly increased cancer risk was found among Asians (CC vs. TT: OR = 1.30, 95% CI 1.10-1.54, P = 0.003; CT vs. TT: OR = 1.16, 95% CI 1.01-1.34, P = 0.039; CC vs. CT/TT: OR = 1.21, 95% CI 1.04-1.41, P = 0.012; C vs. T: OR = 1.14, 95% CI 1.05-1.25, P = 0.002). For Europeans, a significant association with lung cancer risk was found in recessive model (CC vs. CT/TT: OR = 0.63, 95% CI 0.40-0.98, P = 0.040). No publication bias was found in this study. Conclusions/Significance: Our meta-analysis suggests that the rs11614913 polymorphism is significant associated with the increased risk of lung cancer, especially in Asians. Besides, the C allele of rs11614913 polymorphism may contribute to increased lung cancer risk.	[Yuan, Zhengrong; Zeng, Xu; Yang, Dan; Wang, Weilu; Liu, Zhihua] Chinese Acad Med Sci, Peking Union Med Coll, Dept Computat Biol & Bioinformat, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Liu, Zhihua] Nanjing Forestry Univ, Nanjing, Jiangsu, Peoples R China; [Wang, Weilu] Beijing City Univ, Dept Biotechnol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Nanjing Forestry University	Liu, ZH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Dept Computat Biol & Bioinformat, Inst Med Plant Dev, Beijing 100730, Peoples R China.	zhliu@implad.ac.cn	Ahuja, Anil T/H-4031-2017; Chow, Steven Kwok Keung/GNH-4779-2022; Yuan, Jing/E-4236-2013; King, Ann D/C-9845-2011	Ahuja, Anil T/0000-0002-0726-5402; Yuan, Jing/0000-0001-8112-3608; King, Ann D/0000-0002-5280-8349; Chow, Kwok Keung/0000-0002-7201-4888	National Natural Science Foundation of China [81102746, 81100077, 31201768]; Beijing Natural Science Foundation [5113033]; China Postdoctoral Science Foundation [2012M510011]; Scientific Research Foundation of the State Human Resource Ministry; Education Ministry for Returned Chinese Scholars; New Star Project of Peking Union Medical College; Youth Foundation of Peking Union Medical College; Research Fund for the Doctoral Program of Higher Education [20111106120028]; "Major Drug Discovery" major science and technology research "12nd Five-Year Plan" [2012ZX09301-002-001]; China Medical Board of New York [A2009001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific Research Foundation of the State Human Resource Ministry; Education Ministry for Returned Chinese Scholars; New Star Project of Peking Union Medical College; Youth Foundation of Peking Union Medical College; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); "Major Drug Discovery" major science and technology research "12nd Five-Year Plan"; China Medical Board of New York	This work was supported by National Natural Science Foundation of China (81102746, 81100077, 31201768), Beijing Natural Science Foundation (5113033), China Postdoctoral Science Foundation funded project (2012M510011), Scientific Research Foundation of the State Human Resource Ministry and the Education Ministry for Returned Chinese Scholars, New Star Project of Peking Union Medical College, Youth Foundation of Peking Union Medical College, the Research Fund for the Doctoral Program of Higher Education (20111106120028), "Major Drug Discovery" major science and technology research "12nd Five-Year Plan" (2012ZX09301-002-001), China Medical Board of New York (A2009001) granted to Zhihua Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018108; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Granville CA, 2005, AM J RESP CELL MOL, V32, P169, DOI 10.1165/rcmb.F290; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hamada J, 2001, INT J CANCER, V93, P516, DOI 10.1002/ijc.1357; He BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049032; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hong Young-Seoub, 2011, J Prev Med Public Health, V44, P125, DOI 10.3961/jpmph.2011.44.3.125; Hu RF, 2013, MOL BIOL REP, V40, P1181, DOI 10.1007/s11033-012-2160-4; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Jian Guo, 2012, International Journal of Mechatronics and Automation, V2, P15, DOI 10.1504/IJMA.2012.046583; Kim MJ, 2010, LUNG CANCER, V69, P127, DOI 10.1016/j.lungcan.2010.04.015; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Liu ZH, 2013, MOL BIOL REP, V40, P2491, DOI 10.1007/s11033-012-2330-4; Liu ZH, 2012, CELL PHYSIOL BIOCHEM, V29, P851, DOI 10.1159/000258197; Liu ZH, 2010, BIOCHEM BIOPH RES CO, V400, P34, DOI 10.1016/j.bbrc.2010.07.132; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meyerson M, 2005, J CLIN ONCOL, V23, P3219, DOI 10.1200/JCO.2005.15.511; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Qi P, 2010, HUM IMMUNOL, V71, P621, DOI 10.1016/j.humimm.2010.02.017; Qiu LX, 2011, CYTOKINE, V56, P589, DOI 10.1016/j.cyto.2011.08.019; Ren GM, 2013, BIOINFORMATICS, V29, P279, DOI 10.1093/bioinformatics/bts666; Rong BX, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-170; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Tian T, 2010, INT J MOL EPIDEMIOL, V1, P358; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Vinci S, 2011, CLIN CHEM LAB MED, V49, P2073, DOI 10.1515/CCLM.2011.708; Volpe MV, 2003, BIRTH DEFECTS RES A, V67, P550, DOI 10.1002/bdra.10086; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; Wang JB, 2012, MUTAGENESIS, V27, P779, DOI 10.1093/mutage/ges052; Wang K, 2010, BIOMARKERS, V15, P614, DOI 10.3109/1354750X.2010.505299; Wang PY, 2012, EXP THER MED, V3, P324, DOI 10.3892/etm.2011.399; Wang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040039; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042076; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoon KA, 2012, J THORAC CARDIOV SUR, V144, P794, DOI 10.1016/j.jtcvs.2012.06.030; Yuan ZR, 2012, MOL BIOL REP, V39, P6625, DOI 10.1007/s11033-012-1467-5	73	34	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2013	8	4							e61047	10.1371/journal.pone.0061047	http://dx.doi.org/10.1371/journal.pone.0061047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JP	23527281	Green Published, Green Submitted, gold			2022-12-27	WOS:000317385300044
J	Sugihara, M; Odagiri, F; Suzuki, T; Murayama, T; Nakazato, Y; Unuma, K; Yoshida, K; Daida, H; Sakurai, T; Morimoto, S; Kurebayashi, N				Sugihara, Masami; Odagiri, Fuminori; Suzuki, Takeshi; Murayama, Takashi; Nakazato, Yuji; Unuma, Kana; Yoshida, Ken-ichi; Daida, Hiroyuki; Sakurai, Takashi; Morimoto, Sachio; Kurebayashi, Nagomi			Usefulness of Running Wheel for Detection of Congestive Heart Failure in Dilated Cardiomyopathy Mouse Model	PLOS ONE			English	Article							CHAIN ISOFORM EXPRESSION; KNOCKOUT MICE; TROPONIN MUTATION; NATURAL-HISTORY; EXERCISE; HYPERACTIVITY; DYSFUNCTION; PHENOTYPE	Background: Inherited dilated cardiomyopathy (DCM) is a progressive disease that often results in death from congestive heart failure (CHF) or sudden cardiac death (SCD). Mouse models with human DCM mutation are useful to investigate the developmental mechanisms of CHF and SCD, but knowledge of the severity of CHF in live mice is necessary. We aimed to diagnose CHF in live DCM model mice by measuring voluntary exercise using a running wheel and to determine causes of death in these mice. Methodology/Principal Findings: A knock-in mouse with a mutation in cardiac troponin T (Delta K210) (DCM mouse), which results in frequent death with a t(1/2) of 70 to 90 days, was used as a DCM model. Until 2 months of age, average wheel-running activity was similar between wild-type and DCM mice (approximately 7 km/day). At approximately 3 months, some DCM mice demonstrated low running activity (LO: <1 km/day) while others maintained high running activity (HI: >5 km/day). In the LO group, the lung weight/body weight ratio was much higher than that in the other groups, and the lungs were infiltrated with hemosiderin-loaded alveolar macrophages. Furthermore, echocardiography showed more severe ventricular dilation and a lower ejection fraction, whereas Electrocardiography (ECG) revealed QRS widening. There were two patterns in the time courses of running activity before death in DCM mice: deaths with maintained activity and deaths with decreased activity. Conclusions/Significance: Our results indicate that DCM mice with low running activity developed severe CHF and that running wheels are useful for detection of CHF in mouse models. We found that approximately half of Delta K210 DCM mice die suddenly before onset of CHF, whereas others develop CHF, deteriorate within 10 to 20 days, and die.	[Sugihara, Masami; Odagiri, Fuminori; Suzuki, Takeshi; Murayama, Takashi; Sakurai, Takashi; Kurebayashi, Nagomi] Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Tokyo, Japan; [Sugihara, Masami; Odagiri, Fuminori; Suzuki, Takeshi; Nakazato, Yuji; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Unuma, Kana] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Forens Med, Tokyo, Japan; [Unuma, Kana; Yoshida, Ken-ichi] Univ Tokyo, Dept Forens Med, Grad Sch Med, Tokyo, Japan; [Morimoto, Sachio] Kyushu Univ, Dept Clin Pharmacol, Fac Med Sci, Fukuoka 812, Japan	Juntendo University; Juntendo University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Kyushu University	Kurebayashi, N (corresponding author), Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Tokyo, Japan.	nagomik@juntendo.ac.jp		Morimoto, Sachio/0000-0001-9171-3636	Ministry of Education, Culture, Sports, Science and Technology of Japan [23136514]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences	This work was supported by a Grant-in Aid (# 23136514), a "High Technology Research Center'' Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015. The authors also thank the Vehicle Racing Commemorative Foundation and the Institute of Seizon and Life Sciences for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Goehringer C, 2009, CARDIOVASC RES, V82, P404, DOI 10.1093/cvr/cvp061; Hayek S, 2011, CARDIOVASC THER, V29, P362, DOI 10.1111/j.1755-5922.2010.00152.x; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Jing XF, 1998, ARCH PATHOL LAB MED, V122, P94; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Libby P., 2011, BRAUNWALDS HEART DIS, V8th; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; Luedde M, 2010, CARDIOVASC RES, V86, P452, DOI 10.1093/cvr/cvq009; Lygate CA, 2009, J MOL CELL CARDIOL, V46, P93, DOI 10.1016/j.yjmcc.2008.09.710; Medeiros A, 2008, J APPL PHYSIOL, V104, P103, DOI 10.1152/japplphysiol.00493.2007; Millane T, 2000, BRIT MED J, V320, P559, DOI 10.1136/bmj.320.7234.559; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Ojaimi C, 2005, AM J PHYSIOL-HEART C, V289, pH1399, DOI 10.1152/ajpheart.00170.2005; Okutucu S, 2010, CARDIOL J, V17, P219; Rundell VLM, 2004, AM J PHYSIOL-HEART C, V287, pH408, DOI 10.1152/ajpheart.00049.2004; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035353; Unuma K, 2010, CIRC J, V74, P2693, DOI 10.1253/circj.CJ-10-0529; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; Watanabe T, 2008, J AM COLL CARDIOL, V52, P779, DOI 10.1016/j.jacc.2008.06.003; Watson PA, 2007, AM J PHYSIOL-HEART C, V293, pH246, DOI 10.1152/ajpheart.00734.2006; Zhan DY, 2009, CARDIOVASC RES, V84, P64, DOI 10.1093/cvr/cvp168	32	70	73	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55514	10.1371/journal.pone.0055514	http://dx.doi.org/10.1371/journal.pone.0055514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23585901	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600117
J	Chang, CN; Feng, MJ; Chen, YL; Yuan, RH; Jeng, YM				Chang, Chih-Ning; Feng, Mow-Jung; Chen, Yu-Ling; Yuan, Ray-Hwang; Jeng, Yung-Ming			p15(PAF) Is an Rb/E2F-Regulated S-Phase Protein Essential for DNA Synthesis and Cell Cycle Progression	PLOS ONE			English	Article							PCNA-ASSOCIATED FACTOR; NUCLEAR ANTIGEN; POOR-PROGNOSIS; OVEREXPRESSION; REPLICATION; EXPRESSION; CARCINOMA; PROMOTER; TARGETS; CANCER	The p15(PAF)/KIAA0101 protein is a proliferating cell nuclear antigen (PCNA)-associated protein overexpressed in multiple types of cancer. Attenuation of p15(PAF) expression leads to modifications in the DNA repair process, rendering cells more sensitive to ultraviolet-induced cell death. In this study, we identified that p15(PAF) expression peaks during the S phase of the cell cycle. We observed that p15(PAF) knockdown markedly inhibited cell proliferation, S-phase progression, and DNA synthesis. Depletion of p15(PAF) resulted in p21 upregulation, especially chromatin-bound p21. We further identified that the p15(PAF) promoter contains 3 E2F-binding motifs. Loss of Rb-mediated transcriptional repression resulted in upregulated p15(PAF) expression. Binding of E2F4 and E2F6 to the p15(PAF) promoter caused transcriptional repression. Overall, these results indicate that p15(PAF) is tightly regulated by the Rb/E2F complex. Loss of Rb/E2F-mediated repression during the G1/S transition phase leads to p15(PAF) upregulation, which facilitates DNA synthesis and S-phase progression.	[Chang, Chih-Ning; Feng, Mow-Jung; Chen, Yu-Ling; Jeng, Yung-Ming] Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan; [Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Jeng, YM (corresponding author), Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan.	mrna0912@yahoo.com.tw		Yuan, Ray-Hwang/0000-0002-2767-633X; Chiang, Ming-Hui/0000-0002-2106-7963; JENG, YUNG-MING/0000-0002-3878-4491	National Taiwan University Hospital [NTUH-101-S1788]	National Taiwan University Hospital(National Taiwan University)	The work is supported by a grant (NTUH-101-S1788) from National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkhart DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001003; Cheung KJ, 2001, CANCER RES, V61, P4974; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Egelkrout EM, 2002, PLANT CELL, V14, P3225, DOI 10.1105/tpc.006403; Emanuele MJ, 2011, P NATL ACAD SCI USA, V108, P9845, DOI 10.1073/pnas.1106136108; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hosokawa M, 2007, CANCER RES, V67, P2568, DOI 10.1158/0008-5472.CAN-06-4356; Jain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026866; Kais Z, 2011, MOL CANCER RES, V9, P1091, DOI 10.1158/1541-7786.MCR-10-0503; Kato T, 2012, LUNG CANCER, V75, P110, DOI 10.1016/j.lungcan.2011.05.024; Liao CC, 2010, J BIOL CHEM, V285, P33134, DOI 10.1074/jbc.M110.143461; Mizutani K, 2005, CANCER-AM CANCER SOC, V103, P1785, DOI 10.1002/cncr.20988; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Simpson F, 2006, EXP CELL RES, V312, P73, DOI 10.1016/j.yexcr.2005.09.020; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Turchi L, 2009, CELL DEATH DIFFER, V16, P728, DOI 10.1038/cdd.2009.2; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Yu PW, 2001, ONCOGENE, V20, P484, DOI 10.1038/sj.onc.1204113; Yuan RH, 2007, CLIN CANCER RES, V13, P5368, DOI 10.1158/1078-0432.CCR-07-1113	22	78	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61196	10.1371/journal.pone.0061196	http://dx.doi.org/10.1371/journal.pone.0061196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593430	Green Submitted, gold, Green Published			2022-12-27	WOS:000319108100080
J	Yuan, J; Chow, SKK; Zhang, QW; Yeung, DKW; Ahuja, AT; King, AD				Yuan, Jing; Chow, Steven Kwok Keung; Zhang, Qinwei; Yeung, David Ka Wai; Ahuja, Anil T.; King, Ann D.			The Use of Dynamic Tracer Concentration in Veins for Quantitative DCE-MRI Kinetic Analysis in Head and Neck	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; ARTERIAL INPUT FUNCTION; FAST GRADIENT-ECHO; T-1-WEIGHTED MRI; CLINICAL-TRIALS; PARAMETERS; BLOOD; PREDICTOR; INFLOW; BREAST	Background: Head and neck Magnetic Resonance (MR) Images are vulnerable to the arterial blood in-flow effect. To compensate for this effect and enhance accuracy and reproducibility, dynamic tracer concentration in veins was proposed and investigated for quantitative dynamic contrast-enhanced (DCE) MRI analysis in head and neck. Methodology: 21 patients with head and neck tumors underwent DCE-MRI at 3T. An automated method was developed for blood vessel selection and separation. Dynamic concentration-time-curves (CTCs) in arteries and veins were used for the Tofts model parameter estimations. The estimation differences by using CTCs in arteries and veins were compared. Artery and vein voxels were accurately separated by the automated method. Remarkable inter-slice tracer concentration differences were found in arteries while the inter-slice concentration differences in veins were moderate. Tofts model fitting by using the CTCs in arteries and veins produced significantly different parameter estimations. The individual artery CTCs resulted in large (>50% generally) inter-slice parameter estimation variations. Better inter-slice consistency was achieved by using the vein CTCs. Conclusions: The use of vein CTCs helps to compensate for arterial in-flow effect and reduce kinetic parameter estimation error and inconsistency for head and neck DCE-MRI.	[Yuan, Jing; Chow, Steven Kwok Keung; Zhang, Qinwei; Yeung, David Ka Wai; Ahuja, Anil T.; King, Ann D.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Yuan, Jing] CUHK Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China	Chinese University of Hong Kong	Yuan, J (corresponding author), Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	jyuanbwh@gmail.com	Ahuja, Anil T/H-4031-2017; Chow, Steven Kwok Keung/GNH-4779-2022; Yuan, Jing/E-4236-2013; King, Ann D/C-9845-2011	Ahuja, Anil T/0000-0002-0726-5402; Yuan, Jing/0000-0001-8112-3608; King, Ann D/0000-0002-5280-8349; Chow, Kwok Keung/0000-0002-7201-4888	Hong Kong GRF [CUHK4660088, SEG_CUHK02]	Hong Kong GRF(Hong Kong Research Grants Council)	This work was supported by contract grant sponsor: Hong Kong GRF grant CUHK4660088 and SEG_CUHK02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisdas S, 2010, EUR RADIOL, V20, P2358, DOI 10.1007/s00330-010-1803-x; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; Brookes JA, 1996, BRIT J RADIOL, V69, P206, DOI 10.1259/0007-1285-69-819-206; Buckley DL, 2002, MAGN RESON MED, V47, P601, DOI 10.1002/mrm.10080; Cheng HLM, 2007, J MAGN RESON IMAGING, V25, P1073, DOI 10.1002/jmri.20898; Di Giovanni P, 2010, PHYS MED BIOL, V55, P121, DOI 10.1088/0031-9155/55/1/008; Donaldson SB, 2011, INT J RADIAT ONCOL, V81, P1176, DOI 10.1016/j.ijrobp.2010.09.039; Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9; Foottit C, 2010, MAGN RESON MED, V63, P772, DOI 10.1002/mrm.22253; Hansen AE, 2009, MAGN RESON MED, V62, P1055, DOI 10.1002/mrm.22098; HEYWANGKOBRUNNER SH, 1994, RADIOLOGY, V191, P639, DOI 10.1148/radiology.191.3.8184040; Holdsworth DW, 1999, PHYSIOL MEAS, V20, P219, DOI 10.1088/0967-3334/20/3/301; Hoskin PJ, 1999, BRIT J RADIOL, V72, P1093, DOI 10.1259/bjr.72.863.10700827; Ivancevic MK, 2003, MAGNET RESON MED, V50, P885, DOI 10.1002/mrm.10633; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Lavini C, 2010, MAGN RESON IMAGING, V28, P1420, DOI 10.1016/j.mri.2010.06.017; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Noeske R, 2000, MAGN RESON MED, V44, P978, DOI 10.1002/1522-2594(200012)44:6<978::AID-MRM22>3.0.CO;2-9; Noworolski SM, 2003, J MAGN RESON IMAGING, V17, P455, DOI 10.1002/jmri.10280; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Padhani AR, 2002, J MAGN RESON IMAGING, V16, P407, DOI 10.1002/jmri.10176; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Peeters F, 2004, MAGN RESON MED, V51, P710, DOI 10.1002/mrm.20032; Qin Q, 2011, MAGN RESON MED, V65, P1297, DOI 10.1002/mrm.22723; Rijpkema M, 2001, J MAGN RESON IMAGING, V14, P457, DOI 10.1002/jmri.1207; Roberts C, 2011, MAGN RESON MED, V65, P108, DOI 10.1002/mrm.22593; Schabel MC, 2009, PHYS MED BIOL, V54, pN1, DOI 10.1088/0031-9155/54/1/N01; Shukla-Dave A, 2012, INT J RADIAT ONCOL, V82, P1837, DOI 10.1016/j.ijrobp.2011.03.006; Sumi M, 2011, J MAGN RESON IMAGING, V33, P830, DOI 10.1002/jmri.22454; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Yuan J, 2012, CLIN RADIOL, V67, P216, DOI 10.1016/j.crad.2011.07.052; Yuan J, 2012, QUANT IMAGING MED SU, V2, P21, DOI [10.3978/j.issn.2223-4292.2012.01.06, 10.3978/j.issn.2223-4292.2012.11.04]; Yuan J, 2012, J MAGN RESON IMAGING, V35, P916, DOI 10.1002/jmri.22885; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9	35	34	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59885	10.1371/journal.pone.0059885	http://dx.doi.org/10.1371/journal.pone.0059885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527281	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600102
J	Liu, L; Boffa, MB; Koschinsky, ML				Liu, Lei; Boffa, Michael B.; Koschinsky, Marlys L.			Apolipoprotein(a) Inhibits In Vitro Tube Formation in Endothelial Cells: Identification of Roles for Kringle V and the Plasminogen Activation System	PLOS ONE			English	Article							LYSINE-BINDING SITE; FIBRIN FRAGMENT-E; TUMOR-GROWTH; MATRIX METALLOPROTEINASES; MAMMALIAN-CELLS; NITRIC-OXIDE; RISK-FACTOR; ANGIOGENESIS; LIPOPROTEIN(A); ATHEROSCLEROSIS	Elevated plasma concentrations of lipoprotein(a) are associated with increased risk for atherothrombotic diseases. Apolipoprotein(a), the unique glycoprotein component of lipoprotein(a), is characterized by the presence of multiple kringle domains, and shares a high degree of sequence homology with the serine protease zymogen plasminogen. It has been shown that angiostatin, a proteolytic fragment of plasminogen containing kringles 1-4, can effectively inhibit angiogenesis. Moreover, proteolytic fragments of plasminogen containing kringle 5 are even more potent inhibitors of angiogenesis than angiostatin. Despite its strong similarity with plasminogen, the role of apolipoprotein(a) in angiogenesis remains controversial, with both pro-and anti-angiogenic effects reported. In the current study, we evaluated the ability of apolipoprotein(a) to inhibit VEGF-and angiopoietin-induced tube formation in human umbilical cord endothelial cells. A 17 kringle-containing form of recombinant apo(a) (17K), corresponding to a well-characterized, physiologically-relevant form of the molecule, effectively inhibited tube formation induced by either VEGF or angiopoietin-1. Using additional recombinant apolipoprotein(a) (r-apo(a)) variants, we demonstrated that this effect was dependent on the presence of an intact lysine-binding site in kringle V domain of apo(a), but not on the presence of the functional lysine-binding site in apo(a) kringle IV type 10; sequences within in the amino-terminal half of the molecule were also not required for the inhibitory effects of apo(a). We also showed that the apo(a)-mediated inhibition tube formation could be reversed, in part by the addition of plasmin or urokinase plasminogen activator, or by removal of plasminogen from the system. Further, we demonstrated that apo(a) treated with glycosidases to remove sialic acid was significantly less effective in inhibiting tube formation. This is the first report of a functional role for the glycosylation of apo(a) although the mechanisms underlying this observation remain to be determined in the context of angiogenesis.	[Liu, Lei] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Boffa, Michael B.; Koschinsky, Marlys L.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	Queens University - Canada; University of Windsor	Boffa, MB (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	mboffa@uwindsor.ca	Boffa, Michael/N-6539-2019; Liu, Lei/J-7929-2017; Gundersen, Per/B-2192-2008	Boffa, Michael/0000-0003-1211-3064; Koschinsky, Marlys/0000-0002-2643-2288; Liu, Lei/0000-0002-8063-610X; Gundersen, Per/0000-0002-9199-4033; Qu, Cunmin/0000-0003-2413-2350	Heart and Stroke Foundation of Ontario [T5916]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	Funding: This work was funded by a grant (T5916) from the Heart and Stroke Foundation of Ontario to Dr. Koschinsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Babaei S, 1998, CIRC RES, V82, P1007, DOI 10.1161/01.RES.82.9.1007; Becker L, 2004, BIOCHEMISTRY-US, V43, P9978, DOI 10.1021/bi049536d; Belczewski AR, 2005, BIOCHEMISTRY-US, V44, P555, DOI 10.1021/bi048156p; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; Edelstein C, 2003, J BIOL CHEM, V278, P52841, DOI 10.1074/jbc.M310425200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FLESS GM, 1986, J BIOL CHEM, V261, P8712; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012; Hancock MA, 2003, J BIOL CHEM, V278, P23260, DOI 10.1074/jbc.M302780200; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; Ji WR, 1998, BIOCHEM BIOPH RES CO, V247, P414, DOI 10.1006/bbrc.1998.8825; Kim JS, 2004, BIOCHEM BIOPH RES CO, V313, P534, DOI 10.1016/j.bbrc.2003.11.148; Kim JS, 2003, J BIOL CHEM, V278, P29000, DOI 10.1074/jbc.M301042200; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; KOSCHINSKY ML, 1991, BIOCHEMISTRY-US, V30, P5044, DOI 10.1021/bi00234a029; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; Koschinsky ML, 2009, CLIN LIPIDOLOGY COMP, P130; Kostner KM, 1996, ARTERIOSCL THROM VAS, V16, P905, DOI 10.1161/01.ATV.16.8.905; KRATZIN H, 1987, BIOL CHEM H-S, V368, P1533, DOI 10.1515/bchm3.1987.368.2.1533; Kroon Marielle E., 2002, Angiogenesis, V5, P257, DOI 10.1023/A:1024540701634; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lee K, 2006, HEPATOLOGY, V43, P1063, DOI 10.1002/hep.21149; Lim YM, 2012, DIABETES, V61, P1599, DOI 10.2337/db11-1541; Liu L, 2009, BIOCHEM J, V418, P325, DOI 10.1042/BJ20080744; Lou XJ, 1998, EXP MOL PATHOL, V65, P53, DOI 10.1006/exmp.1998.2230; Marcovina SM, 2003, CURR OPIN LIPIDOL, V14, P361, DOI 10.1097/00041433-200308000-00004; MCCANCE SG, 1994, J BIOL CHEM, V269, P32405; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Morishita R, 2002, CIRCULATION, V105, P1491, DOI 10.1161/01.CIR.0000012146.07240.FD; O'Neil CH, 2004, J BIOL CHEM, V279, P55187, DOI 10.1074/jbc.M409860200; O'Reilly M S, 1997, EXS, V79, P273; Pepper M S, 1996, Vasc Med, V1, P259; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Ribatti D, 1998, EUR J CLIN INVEST, V28, P533; SANGRAR W, 1994, PROTEIN ENG, V7, P723, DOI 10.1093/protein/7.5.723; Sangrar W, 1997, BIOCHEMISTRY-US, V36, P10353, DOI 10.1021/bi962433d; Schulter V, 2001, ARTERIOSCL THROM VAS, V21, P433, DOI 10.1161/01.ATV.21.3.433; Shen L, 2008, BIOL CHEM, V389, P135, DOI 10.1515/BC.2008.016; Stirk CM, 2000, GEN PHARMACOL-VASC S, V35, P261, DOI 10.1016/S0306-3623(01)00114-8; THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V257, P714, DOI 10.1006/bbrc.1999.0519; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; Yang BH, 2004, J CELL PHYSIOL, V200, P360, DOI 10.1002/jcp.20025; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027	57	242	254	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52287	10.1371/journal.pone.0052287	http://dx.doi.org/10.1371/journal.pone.0052287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23593427	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800014
